PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Medrikova, D; Sijmonsma, TP; Sowodniok, K; Richards, DM; Delacher, M; Sticht, C; Gretz, N; Schafmeier, T; Feuerer, M; Herzig, S				Medrikova, Dasa; Sijmonsma, Tjeerd P.; Sowodniok, Katharina; Richards, David M.; Delacher, Michael; Sticht, Carsten; Gretz, Norbert; Schafmeier, Tobias; Feuerer, Markus; Herzig, Stephan			Brown Adipose Tissue Harbors a Distinct Sub-Population of Regulatory T Cells	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPOCYTES; OBESITY; MACROPHAGES; THERMOGENESIS; INFLAMMATION; ACTIVATION; MICE; RECRUITMENT; EXPRESSION	Regulatory T (Treg) cells are critical determinants of both immune responses and metabolic control. Here we show that systemic ablation of Treg cells compromised the adaptation of whole-body energy expenditure to cold exposure, correlating with impairment in thermogenic marker gene expression and massive invasion of pro-inflammatory macrophages in brown adipose tissue (BAT). Indeed, BAT harbored a unique sub-set of Treg cells characterized by a unique gene signature. As these Treg cells respond to BAT activation upon cold exposure, this study defines a BAT-specific Treg sub-set with direct implications for the regulation of energy homeostasis in response to environmental stress.	[Medrikova, Dasa; Sijmonsma, Tjeerd P.; Sowodniok, Katharina; Schafmeier, Tobias; Herzig, Stephan] Heidelberg Univ, Ctr Mol Biol ZMBH, German Canc Res Ctr DKFZ Heidelberg, Joint Res Div Mol Metab Control, D-69120 Heidelberg, Germany; [Medrikova, Dasa; Sijmonsma, Tjeerd P.; Sowodniok, Katharina; Schafmeier, Tobias; Herzig, Stephan] Heidelberg Univ, Univ Hosp, D-69120 Heidelberg, Germany; [Schafmeier, Tobias; Herzig, Stephan] Helmholtz Ctr Munich, Inst Diabet & Canc IDC, D-85764 Neuherberg, Germany; [Schafmeier, Tobias; Herzig, Stephan] Univ Heidelberg Hosp, Joint Heidelberg IDC Translat Diabet Program, D-69120 Heidelberg, Germany; [Richards, David M.; Delacher, Michael; Feuerer, Markus] German Canc Res Ctr DKFZ Heidelberg, Helmholtz Young Investigator Res Grp Immune Toler, D-69120 Heidelberg, Germany; [Sticht, Carsten; Gretz, Norbert] Univ Clin Mannheim, Med Res Ctr, D-68167 Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Herzig, S (corresponding author), Heidelberg Univ, Ctr Mol Biol ZMBH, German Canc Res Ctr DKFZ Heidelberg, Joint Res Div Mol Metab Control, D-69120 Heidelberg, Germany.	s.herzig@dkfz.de	Delacher, Michael/AAM-9710-2021; Delacher, Michael/AAA-5224-2019	Herzig, Stephan/0000-0003-3950-3652	Deutsche Forschungsgemeinschaft [HE-3260/8-1]; EU-FP7 Collaborative Project DIABAT [HEALTH -F2-2011-278373]; Helmholtz Association of German Research Centers [HZ-NG-505]; German-Israeli-Helmholtz Research School in Cancer Biology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU-FP7 Collaborative Project DIABAT; Helmholtz Association of German Research Centers(Helmholtz Association); German-Israeli-Helmholtz Research School in Cancer Biology	This work was funded by a grant of the Deutsche Forschungsgemeinschaft (HE-3260/8-1) and the EU-FP7 Collaborative Project DIABAT (HEALTH -F2-2011-278373) to S. H., Helmholtz Association of German Research Centers (HZ-NG-505 to M. F.), and the German-Israeli-Helmholtz Research School in Cancer Biology (to M. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Diaz MB, 2014, METABOLISM, V63, P1238, DOI 10.1016/j.metabol.2014.07.002; Eheim A, 2014, SEMIN IMMUNOPATHOL, V36, P13, DOI 10.1007/s00281-013-0403-7; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Han JM, 2014, J IMMUNOL, V192, P623, DOI 10.4049/jimmunol.1302181; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Lee YH, 2014, CELL CYCLE, V13, P184, DOI 10.4161/cc.27647; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; MARETTE A, 1991, BIOCHEM J, V277, P119, DOI 10.1042/bj2770119; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rohm M, 2013, CELL METAB, V17, P575, DOI 10.1016/j.cmet.2013.02.010; Sakaguchi S, 2011, DRUG METAB PHARMACOK, V26, P30, DOI 10.2133/dmpk.DMPK-10-RV-087; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SHIMIZU Y, 1991, J BIOCHEM, V110, P688, DOI 10.1093/oxfordjournals.jbchem.a123642; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valladares A, 2001, FEBS LETT, V493, P6, DOI 10.1016/S0014-5793(01)02264-5; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	29	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118534	10.1371/journal.pone.0118534	http://dx.doi.org/10.1371/journal.pone.0118534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714366	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700081
J	Bouet, G; Bouleftour, W; Juignet, L; Linossier, MT; Thomas, M; Vanden-Bossche, A; Aubin, JE; Vico, L; Marchat, D; Malaval, L				Bouet, Guenaelle; Bouleftour, Wafa; Juignet, Laura; Linossier, Marie-Therese; Thomas, Mireille; Vanden-Bossche, Arnaud; Aubin, Jane E.; Vico, Laurence; Marchat, David; Malaval, Luc			The Impairment of Osteogenesis in Bone Sialoprotein (BSP) Knockout Calvaria Cell Cultures Is Cell Density Dependent	PLOS ONE			English	Article							X-LINKED HYPOPHOSPHATEMIA; IN-VITRO; OSTEOBLAST DIFFERENTIATION; ASARM-PEPTIDES; MATRIX MINERALIZATION; OSTEOPROGENITOR CELLS; DEFICIENCY IMPAIRS; PHEX CLEAVAGE; MOUSE BONE; OSTEOPONTIN	Bone sialoprotein (BSP) belongs to the "small integrin-binding ligand N-linked glycoprotein" (SIBLING) family, whose members interact with bone cells and bone mineral. BSP is strongly expressed in bone and we previously showed that BSP knockout (BSP-/-) mice have a higher bone mass than wild type (BSP+/+) littermates, with lower bone remodelling. Because baseline bone formation activity is constitutively lower in BSP-/- mice, we studied the impact of the absence of BSP on in vitro osteogenesis in mouse calvaria cell (MCC) cultures. MCC BSP-/-cultures exhibit fewer fibroblast (CFU-F), preosteoblast (CFU-ALP) and osteoblast colonies (bone nodules) than wild type, indicative of a lower number of osteoprogenitors. No mineralized colonies were observed in BSP-/- cultures, along with little/no expression of either osteogenic markers or SIBLING proteins MEPE or DMP1. Osteopontin (OPN) is the only SIBLING expressed in standard density BSP-/- culture, at higher levels than in wild type in early culture times. At higher plating density, the effects of the absence of BSP were partly rescued, with resumed expression of osteoblast markers and cognate SIBLING proteins, and mineralization of the mutant cultures. OPN expression and amount are further increased in high density BSP-/-cultures, while PHEX and CatB expression are differentiatlly regulated in a manner that may favor mineralization. Altogether, we found that BSP regulates mouse calvaria osteoblast cell clonogenicity, differentiation and activity in vitro in a cell density dependent manner, consistent with the effective skeletogenesis but the low levels of bone formation observed in vivo. The BSP knockout bone microenvironment may alter the proliferation/cell fate of early osteoprogenitors.	[Bouet, Guenaelle; Bouleftour, Wafa; Juignet, Laura; Linossier, Marie-Therese; Thomas, Mireille; Vanden-Bossche, Arnaud; Vico, Laurence; Malaval, Luc] Univ Lyon, SFR IFRESIS, Lab Biol Tissu Osseux, INSERM U1059, St Etienne, France; [Bouet, Guenaelle; Bouleftour, Wafa; Juignet, Laura; Linossier, Marie-Therese; Thomas, Mireille; Vanden-Bossche, Arnaud; Vico, Laurence; Malaval, Luc] Univ St Etienne, St Etienne, France; [Aubin, Jane E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Marchat, David] Ecole Natl Super Mines, Ctr Hlth Engn, SFR IFRESIS, St Etienne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; University of Toronto; IMT - Institut Mines-Telecom; Mines Saint-Etienne	Malaval, L (corresponding author), Univ Lyon, SFR IFRESIS, Lab Biol Tissu Osseux, INSERM U1059, St Etienne, France.	luc.malaval@univ-st-etienne.fr	Malaval, Luc/K-3060-2019; Vico, Laurence/O-1927-2018; Malaval, Luc/D-2206-2011; Vico, Laurence/ABG-7239-2020	Malaval, Luc/0000-0002-8640-2646; Vico, Laurence/0000-0002-2110-287X; Malaval, Luc/0000-0002-8640-2646; Vico, Laurence/0000-0002-2110-287X; BOUET, GUENAELLE/0000-0001-8954-3164; Bouleftour, Wafa/0000-0002-8485-9386; Juignet, Laura/0000-0003-1059-8360; Marchat, David/0000-0002-3052-0029; Aubin, Jane E./0000-0002-7268-5235	French "Institut National de la Sante et de la Recherche Medicale" (INSERM); French Ministry of Research; Rhone-Alpes Region (Cible Program)	French "Institut National de la Sante et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Rhone-Alpes Region (Cible Program)(Region Auvergne-Rhone-Alpes)	This work was funded by the French "Institut National de la Sante et de la Recherche Medicale" (INSERM) and by the French Ministry of Research (PhD fellowship to GB). WB and LJ gratefully acknowledge scholarship funding by the Rhone-Alpes Region (Cible Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Baht GS, 2008, MATRIX BIOL, V27, P600, DOI 10.1016/j.matbio.2008.06.004; Barros NMT, 2013, J BONE MINER RES, V28, P688, DOI 10.1002/jbmr.1766; Bellows CG, 1998, BONE, V23, P119, DOI 10.1016/S8756-3282(98)00084-2; Boskey AL, 2010, CALCIFIED TISSUE INT, V86, P42, DOI 10.1007/s00223-009-9313-z; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Boudiffa M, 2010, J BONE MINER RES, V25, P2393, DOI 10.1002/jbmr.245; Bouleftour W, 2015, J CELL PHYSIOL, V230, P568, DOI 10.1002/jcp.24772; Bouleftour W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095144; CENTRELLA M, 1994, ENDOCRINOLOGY, V135, P1611, DOI 10.1210/en.135.4.1611; Du L, 1996, GENOMICS, V36, P22, DOI 10.1006/geno.1996.0421; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; Guo R, 2002, BIOCHEM BIOPH RES CO, V297, P38, DOI 10.1016/S0006-291X(02)02125-3; Huq NL, 2005, ARCH ORAL BIOL, V50, P599, DOI 10.1016/j.archoralbio.2004.12.009; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Liu SG, 2007, J ENDOCRINOL, V192, P261, DOI 10.1677/joe.1.07059; MacDougall M, 2002, CONNECT TISSUE RES, V43, P320, DOI 10.1080/03008200290000556; Malaval L, 1999, J CELL BIOCHEM, V74, P616; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Malaval L, 2009, BONE, V45, P853, DOI 10.1016/j.bone.2009.06.005; Martin A, 2008, ENDOCRINOLOGY, V149, P1757, DOI 10.1210/en.2007-1205; MCKEE MD, 1995, ANN NY ACAD SCI, V760, P177, DOI 10.1111/j.1749-6632.1995.tb44629.x; Monfoulet L, 2010, BONE, V46, P447, DOI 10.1016/j.bone.2009.09.007; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Narisawa S, 2013, J BONE MINER RES, V28, P1587, DOI 10.1002/jbmr.1901; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Pustylnik S, 2013, J BIOL CHEM, V288, P22096, DOI 10.1074/jbc.M113.481515; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Roche P, 1999, BONE, V24, P329, DOI 10.1016/S8756-3282(98)00194-X; Rowe PSN, 2006, BONE, V39, P773, DOI 10.1016/j.bone.2006.04.012; Rowe PSN, 2005, BONE, V36, P33, DOI 10.1016/j.bone.2004.09.015; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; Ruchon AF, 1998, J HISTOCHEM CYTOCHEM, V46, P459; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; TURKSEN K, 1991, J CELL BIOL, V114, P373, DOI 10.1083/jcb.114.2.373; Wade-Gueye NM, 2012, BONE, V50, P1064, DOI 10.1016/j.bone.2012.02.014; Wade-Gueye NM, 2010, ENDOCRINOLOGY, V151, P5103, DOI 10.1210/en.2010-0091	45	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117402	10.1371/journal.pone.0117402	http://dx.doi.org/10.1371/journal.pone.0117402			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710686	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900032
J	Cheng, Y; Kim, J; Li, XX; Hsueh, AJ				Cheng, Yuan; Kim, Jaehong; Li, Xiao Xiao; Hsueh, Aaron J.			Promotion of Ovarian Follicle Growth following mTOR Activation: Synergistic Effects of AKT Stimulators	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; LIFE-SPAN; DISRUPTION; POOL; PTEN	Mammalian target of rapamycin (mTOR) is a serine/threonine kinase and mTOR signaling is important in regulating cell growth and proliferation. Recent studies using oocyte- and granulosa cell-specific deletion of mTOR inhibitor genes TSC1 or TSC2 demonstrated the important role of mTOR signaling in the promotion of ovarian follicle development. We now report that treatment of ovaries from juvenile mice with an mTOR activator MHY1485 stimulated mTOR, S6K1 and rpS6 phosphorylation. Culturing ovaries for 4 days with MHY1485 increased ovarian explant weights and follicle development. In vivo studies further demonstrated that pre-incubation of these ovaries with MHY1485 for 2 days, followed by allo-grafting into kidney capsules of adult ovariectomized hosts for 5 days, led to marked increases in graft weights and promotion of follicle development. Mature oocytes derived from MHY1485-activated ovarian grafts could be successfully fertilized, leading the delivery of healthy pups. We further treated ovaries with the mTOR activator together with AKT activators (PTEN inhibitor and phosphoinositol-3-kinase stimulator) before grafting and found additive enhancement of follicle growth. Our studies demonstrate the ability of an mTOR activator in promoting follicle growth, leading to a potential strategy to stimulate preantral follicle growth in infertile patients.	[Cheng, Yuan; Kim, Jaehong; Li, Xiao Xiao; Hsueh, Aaron J.] Stanford Univ, Sch Med, Dept Ob Gyn, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA	Stanford University	Hsueh, AJ (corresponding author), Stanford Univ, Sch Med, Dept Ob Gyn, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu			NIH NICHD (Specialized Cooperative Centers Program in Reproduction and Infertility Research) [U54 HD068158]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD068158, P50HD068158] Funding Source: NIH RePORTER	NIH NICHD (Specialized Cooperative Centers Program in Reproduction and Infertility Research); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funds from the NIH NICHD (U54 HD068158 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075072, 10.1371/journal.pone.0053810]; Adhikari D, 2010, CELL CYCLE, V9, P1673, DOI 10.4161/cc.9.9.11626; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Choi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043418; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Huang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054052; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Liu J, 2014, J AGR FOOD CHEM; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Tanaka Y, 2012, ENDOCRINOLOGY, V153, P404, DOI 10.1210/en.2011-1191; Zhang XM, 2013, GENE, V523, P82, DOI 10.1016/j.gene.2013.03.039	20	62	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117769	10.1371/journal.pone.0117769	http://dx.doi.org/10.1371/journal.pone.0117769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710488	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900037
J	Littnerova, S; Parenica, J; Spinar, J; Vitovec, J; Linhart, A; Widimsky, P; Jarkovsky, J; Miklik, R; Spinarova, L; Zeman, K; Belohlavek, J; Malek, F; Felsoci, M; Kettner, J; Ostadal, P; Cihalik, C; Spac, J; Al-Hiti, H; Fedorco, M; Fojt, R; Kruger, A; Malek, J; Mikusova, T; Monhart, Z; Bohacova, S; Pohludkova, L; Rohac, F; Vaclavik, J; Vondrakova, D; Vyskocilova, K; Bambuch, M; Dusek, L				Littnerova, Simona; Parenica, Jiri; Spinar, Jindrich; Vitovec, Jiri; Linhart, Ales; Widimsky, Petr; Jarkovsky, Jiri; Miklik, Roman; Spinarova, Lenka; Zeman, Kamil; Belohlavek, Jan; Malek, Filip; Felsoci, Marian; Kettner, Jiri; Ostadal, Petr; Cihalik, Cestmir; Spac, Jiri; Al-Hiti, Hikmet; Fedorco, Marian; Fojt, Richard; Kruger, Andreas; Malek, Josef; Mikusova, Tereza; Monhart, Zdenek; Bohacova, Stanislava; Pohludkova, Lidka; Rohac, Filip; Vaclavik, Jan; Vondrakova, Dagmar; Vyskocilova, Klaudia; Bambuch, Miroslav; Dusek, Ladislav			Positive Influence of Being Overweight/Obese on Long Term Survival in Patients Hospitalised Due to Acute Heart Failure	PLOS ONE			English	Article							BODY-MASS INDEX; ACUTE CORONARY SYNDROMES; OBESITY PARADOX; RISK-FACTORS; ASSOCIATION; MORTALITY; ADIPOCYTOKINE; GUIDELINES; DATABASE; OUTCOMES	Background Obesity is clearly associated with increased morbidity and mortality rates. However, in patients with acute heart failure (AHF), an increased BMI could represent a protective marker. Studies evaluating the "obesity paradox" on a large cohort with long-term follow-up are lacking. Methods Using the AHEAD database (a Czech multi-centre database of patients hospitalised due to AHF), 5057 patients were evaluated; patients with a BMI <18.5 kg/m(2) were excluded. All cause mortality was compared between groups with a BMI of 18.5-25 kg/m(2) and with BMI >25 kg/m(2). Data were adjusted by a propensity score for 11 parameters. Results In the balanced groups, the difference in 30-day mortality was not significant. The long-term mortality of patients with normal weight was higher than for those who were overweight/obese (HR, 1.36; 95% CI, 1.26-1.48; p<0.001)). In the balanced dataset, the pattern was similar (1.22; 1.09-1.39; p<0.001). A similar result was found in the balanced dataset of a subgroup of patients with de novo AHF (1.30; 1.11-1.52; p = 0.001), but only a trend in a balanced dataset of patients with acute decompensated heart failure. Conclusion These data suggest significantly lower long-term mortality in overweight/obese patients with AHF. The results suggest that at present there is no evidence for weight reduction in overweight/obese patients with heart failure, and emphasize the importance of prevention of cardiac cachexia.	[Littnerova, Simona; Jarkovsky, Jiri; Dusek, Ladislav] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic; [Parenica, Jiri; Spinar, Jindrich; Miklik, Roman; Felsoci, Marian] Univ Hosp Brno, Dept Cardiol, Brno, Czech Republic; [Parenica, Jiri; Spinar, Jindrich; Vitovec, Jiri; Spinarova, Lenka; Spac, Jiri] Masaryk Univ, Fac Med, Brno, Czech Republic; [Parenica, Jiri; Spinar, Jindrich; Miklik, Roman; Felsoci, Marian] Univ Hosp St Annes, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno, Czech Republic; [Vitovec, Jiri; Spinarova, Lenka; Mikusova, Tereza; Vyskocilova, Klaudia] Univ Hosp St Annes, Dept Cardiovasc Internal Med 1, Brno, Czech Republic; [Linhart, Ales; Belohlavek, Jan] Charles Univ Prague, Fac Med 1, Dept Cardiovasc Internal Med 2, Prague, Czech Republic; [Linhart, Ales; Belohlavek, Jan] Gen Teaching Hosp Prague, Prague, Czech Republic; [Widimsky, Petr; Fojt, Richard; Rohac, Filip] Charles Univ Prague, Kralovske Vinohrady Univ Hosp, Prague, Czech Republic; [Widimsky, Petr; Fojt, Richard; Rohac, Filip] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Zeman, Kamil; Pohludkova, Lidka] Hosp Frydek Mistek, Dept Internal Med, Frydek Mystek, Czech Republic; [Malek, Filip; Ostadal, Petr; Kruger, Andreas; Vondrakova, Dagmar] Na Homolce Hosp, Dept Cardiol, Prague, Czech Republic; [Kettner, Jiri; Al-Hiti, Hikmet] Inst Clin & Expt Med, Dept Cardiol, Prague, Czech Republic; [Cihalik, Cestmir; Fedorco, Marian; Vaclavik, Jan] Univ Hosp Olomouc, Dept Internal Med, Olomouc, Czech Republic; [Spac, Jiri] Univ Hosp St Annes, Dept Internal Med 2, Brno, Czech Republic; [Malek, Josef] Hosp Havlickuv Brod, Dept Internal Med, Havlickuv Brod, Czech Republic; [Monhart, Zdenek] Hosp Znojmo, Dept Internal Med, Znojmo, Czech Republic; [Bohacova, Stanislava; Bambuch, Miroslav] T Bata Hosp Zlin, Dept Cardiol, Zlin, Czech Republic	Institute of Biostatistics & Analyses; Masaryk University Brno; University Hospital Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); St Anne's University Hospital Brno (FNUSA-ICRC); Charles University Prague; General University Hospital Prague; Charles University Prague; University Hospital Vinohrady; Charles University Prague; Na Homolce Hospital; Institute for Clinical & Experimental Medicine (IKEM); University Hospital Olomouc; St Anne's University Hospital Brno (FNUSA-ICRC)	Parenica, J (corresponding author), Univ Hosp Brno, Dept Cardiol, Brno, Czech Republic.	jiri.parenica@atlas.cz	Málek, Filip/ABI-1453-2020; Widimsky, Petr/P-8088-2016; Dušek, Ladislav/G-8794-2013; Jarkovsky, Jiri/G-5494-2017; Fojt, Richard/AAD-5928-2019; Linhart, Ales/O-2375-2017	Widimsky, Petr/0000-0001-5686-7752; Linhart, Ales/0000-0002-3372-7850; Vaclavik, Jan/0000-0001-7847-0967; Dusek, Ladislav/0000-0002-8589-4378	European Regional Development Fund (Project of the International Clinical Research Center, Saint Anne's University Hospital Brno, Czech Republic) [CZ.1.05/1.1.00/02.0123]; project of MH CZ - DRO (FNBr) [65269705]; project of Masaryk University [MUNI/A/1012/2013]	European Regional Development Fund (Project of the International Clinical Research Center, Saint Anne's University Hospital Brno, Czech Republic); project of MH CZ - DRO (FNBr); project of Masaryk University	This study was supported by the European Regional Development Fund (Project of the International Clinical Research Center, Saint Anne's University Hospital Brno, Czech Republic; grant number CZ.1.05/1.1.00/02.0123); the project of MH CZ - DRO (FNBr, 65269705); and of Masaryk University [MUNI/A/1012/2013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Angeras O, 2013, EUR HEART J, V34, P345, DOI 10.1093/eurheartj/ehs217; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Biondi-Zoccai G, 2011, CONTEMP CLIN TRIALS, V32, P731, DOI 10.1016/j.cct.2011.05.006; Corkins MR, 2014, JPEN-PARENTER ENTER, V38, P186, DOI 10.1177/0148607113512154; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Diercks DB, 2006, AM HEART J, V152, P140, DOI 10.1016/j.ahj.2005.09.024; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Frankenstein L, 2009, EUR J HEART FAIL, V11, P1189, DOI 10.1093/eurjhf/hfp150; Gao J, 2007, J MOL CELL CARDIOL, V43, P601, DOI 10.1016/j.yjmcc.2007.08.009; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Horwich TB, 2006, J AM COLL CARDIOL, V47, P85, DOI 10.1016/j.jacc.2005.08.050; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lim SY, 2008, J CELL MOL MED, V12, P1395, DOI 10.1111/j.1582-4934.2008.00332.x; Melenovsky V, 2013, J AM COLL CARDIOL, V62, P1660, DOI 10.1016/j.jacc.2013.06.046; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Nieminen MS, 2005, EUR HEART J, V26, P384; Parenica J, 2013, EUR J INTERN MED, V24, P151, DOI 10.1016/j.ejim.2012.11.005; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Shah R, 2014, J AM COLL CARDIOL, V63, P778, DOI 10.1016/j.jacc.2013.09.072; Spinar J, 2011, CRIT CARE, V15, DOI 10.1186/cc10584; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilhelmsen L, 2001, J INTERN MED, V249, P253, DOI 10.1046/j.1365-2796.2001.00801.x; Wu AH, 2010, EUR J HEART FAIL, V12, P566, DOI 10.1093/eurjhf/hfq043; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	29	17	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117142	10.1371/journal.pone.0117142	http://dx.doi.org/10.1371/journal.pone.0117142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710625	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900023
J	Luo, CQ; Wei, C				Luo, Changqing; Wei, Cong			Stridulatory Sound-Production and Its Function in Females of the Cicada Subpsaltria yangi	PLOS ONE			English	Article							ACOUSTIC-SIGNALS; HIGHER CLASSIFICATION; COURTSHIP BEHAVIOR; COMMUNICATION; SONG; HOMOPTERA; HEMIPTERA; MALES; CICADOIDEA; VOCALIZATIONS	Acoustic behavior plays a crucial role in many aspects of cicada biology, such as reproduction and intrasexual competition. Although female sound production has been reported in some cicada species, acoustic behavior of female cicadas has received little attention. In cicada Subpsaltria yangi, the females possess a pair of unusually well-developed stridulatory organs. Here, sound production and its function in females of this remarkable cicada species were investigated. We revealed that the females could produce sounds by stridulatory mechanism during pair formation, and the sounds were able to elicit both acoustic and phonotactic responses from males. In addition, the forewings would strike the body during performing stridulatory sound-producing movements, which generated impact sounds. Acoustic playback experiments indicated that the impact sounds played no role in the behavioral context of pair formation. This study provides the first experimental evidence that females of a cicada species can generate sounds by stridulatory mechanism. We anticipate that our results will promote acoustic studies on females of other cicada species which also possess stridulatory system.	[Luo, Changqing; Wei, Cong] Northwest A&F Univ, Entomol Museum, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Wei, C (corresponding author), Northwest A&F Univ, Entomol Museum, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling 712100, Shaanxi, Peoples R China.	congwei@nwsuaf.edu.cn		Luo, Changqing/0000-0002-6776-7519	National Natural Science Foundation of China [31170360, 31093430, 31493021]; Fundamental Research Funds for the Central Universities of China [QN2011053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This research was partially funded by the National Natural Science Foundation of China (Grant No. 31170360, No. 31093430, No. 31493021) and the Fundamental Research Funds for the Central Universities of China (QN2011053) to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1967, ANNU REV ENTOMOL, V12, P495, DOI 10.1146/annurev.en.12.010167.002431; ALEXANDER RICHARD D., 1957, OHIO JOUR SCI, V57, P101; Bennet-Clark HC, 2002, J EXP BIOL, V205, P613; BENNETCLARK HC, 1992, J EXP BIOL, V173, P123; BOULARD M, 1973, ANN SOC ENTOMOL FR, V9, P841; Boulard M, 2006, CONT T ENT, P331; Bradbury Jack W., 1998, pi; Bush SL, 1996, P ROY SOC B-BIOL SCI, V263, P913, DOI 10.1098/rspb.1996.0135; Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Chen, 1943, JOUR NEW YORK ENT SOC, V51, P19; Chou I., 1997, CICADIDAE CHINA; Claridge MF, 1999, J NAT HIST, V33, P1831, DOI 10.1080/002229399299752; CLARIDGE MF, 1985, ANNU REV ENTOMOL, V30, P297, DOI 10.1146/annurev.en.30.010185.001501; Claridge M, 2006, CONT T ENT, P3; Cooley JR, 2001, BEHAVIOUR, V138, P827, DOI 10.1163/156853901753172674; COONEY R, 1995, ANIM BEHAV, V49, P1635, DOI 10.1016/0003-3472(95)90086-1; Cui JG, 2010, ANIM BEHAV, V80, P181, DOI 10.1016/j.anbehav.2010.05.012; de Silva HG, 2004, WILSON BULL, V116, P186, DOI 10.1676/03-126; DOOLAN JM, 1981, BEHAV ECOL SOCIOBIOL, V9, P269, DOI 10.1007/BF00299882; Drosopoulos S, 2006, INSECT SOUNDS COMMUN; DUFFELS JP, 1993, J NAT HIST, V27, P1223, DOI 10.1080/00222939300770731; Eens M, 1998, TRENDS ECOL EVOL, V13, P322, DOI 10.1016/S0169-5347(98)01410-4; Ekstrom JMM, 2007, IBIS, V149, P313, DOI 10.1111/j.1474-919X.2006.00632.x; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; Ewing AW, 1989, ARTHROPOD BIOACOUSTI; FONSECA P J, 1991, Bioacoustics, V3, P173; Fonseca PJ, 1998, J EXP BIOL, V201, P717; FRINGS H, 1958, ANNU REV ENTOMOL, V3, P87, DOI 10.1146/annurev.en.03.010158.000511; Gagliano M, 2013, BEHAV ECOL, V24, P789, DOI 10.1093/beheco/ars206; Gagliano M, 2012, TRENDS PLANT SCI, V17, P323, DOI 10.1016/j.tplants.2012.03.002; Gerhardt H. Carl, 1992, Seminars in the Neurosciences, V4, P391, DOI 10.1016/1044-5765(92)90047-6; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gilbert WM, 1999, WILSON BULL, V111, P134; GIVEN MF, 1993, ANIM BEHAV, V46, P1139, DOI 10.1006/anbe.1993.1303; Gogala Matija, 2003, Acta Entomologica Slovenica, V11, P5; Goymann W, 2004, ETHOLOGY, V110, P807, DOI 10.1111/j.1439-0310.2004.01015.x; GWYNNE DT, 1987, ANIM BEHAV, V35, P571, DOI 10.1016/S0003-3472(87)80283-X; HARTLEY JC, 1976, PHYSIOL ENTOMOL, V1, P21, DOI 10.1111/j.1365-3032.1976.tb00882.x; HUBER BA, 1995, ACTA ZOOL-STOCKHOLM, V76, P291, DOI 10.1111/j.1463-6395.1995.tb01001.x; Illes AE, 2009, P ROY SOC B-BIOL SCI, V276, P981, DOI 10.1098/rspb.2008.1445; Langmore NE, 1996, P ROY SOC B-BIOL SCI, V263, P141, DOI 10.1098/rspb.1996.0022; Legendre R, 1963, ANN BIOL, V2, P371; Levin RN, 1996, ANIM BEHAV, V52, P1107, DOI 10.1006/anbe.1996.0258; MASTERS WM, 1979, BEHAV ECOL SOCIOBIOL, V5, P187; Montealegre F, 2011, J EXP BIOL, V214, P2105, DOI 10.1242/jeb.056283; Moulds MS, 2005, REC AUST MUS, V57, P375, DOI 10.3853/j.0067-1975.57.2005.1447; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; Peretti A, 2006, ANIM BEHAV, V72, P413, DOI 10.1016/j.anbehav.2006.01.014; Robinson DJ, 2002, ADV INSECT PHYSIOL, V29, P151, DOI 10.1016/S0065-2806(02)29003-7; Sanborn AF, 1999, ANN ENTOMOL SOC AM, V92, P451, DOI 10.1093/aesa/92.3.451; SANDERFORD MV, 1995, J INSECT BEHAV, V8, P19, DOI 10.1007/BF01990967; Shen JX, 2008, NATURE, V453, P914, DOI 10.1038/nature06719; Slater PJB, 2004, J AVIAN BIOL, V35, P289, DOI 10.1111/j.0908-8857.2004.03392.x; SMITH R L, 1978, Southwestern Naturalist, V23, P187, DOI 10.2307/3669767; Dutto MS, 2011, ETHOLOGY, V117, P1040, DOI 10.1111/j.1439-0310.2011.01957.x; Stolting H, 2004, ZOOLOGY, V107, P243, DOI 10.1016/j.zool.2004.07.003; Sueur J, 2004, J ZOOL, V262, P217, DOI 10.1017/S0952836903004680; Sueur J, 2003, J NAT HIST, V37, P2931, DOI 10.1080/0022293021000007534; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Tobias ML, 1998, P NATL ACAD SCI USA, V95, P1870, DOI 10.1073/pnas.95.4.1870; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Uetz G.W., 1982, P123; Uhl Gabriele, 1996, Revue Suisse de Zoologie Volume Hors Serie, V2, P649; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; Wang YS, 2010, J HERPETOL, V44, P475, DOI 10.1670/09-055.1; Whittingham LA, 1997, WILSON BULL, V109, P279; YOUNG D, 1995, J EXP BIOL, V198, P1001	67	10	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118667	10.1371/journal.pone.0118667	http://dx.doi.org/10.1371/journal.pone.0118667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710637	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900063
J	Xie, S; Xu, H; Shan, XF; Liu, BZ; Wang, K; Cai, ZG				Xie, Shang; Xu, Hui; Shan, Xiaofeng; Liu, Baozhong; Wang, Kan; Cai, Zhigang			Clinicopathological and Prognostic Significance of Survivin Expression in Patients with Oral Squamous Cell Carcinoma: Evidence from a Meta-Analysis	PLOS ONE			English	Article							TRIAL SEQUENTIAL-ANALYSIS; MESSENGER-RNA; POOR-PROGNOSIS; APOPTOSIS; CANCER; GENE; PROLIFERATION; STATISTICS; MARKER; P53	Background Survivin has been proposed as a promising prognostic marker in oral squamous cell carcinoma (OSCC), but the published data on survivin expression in patients with this condition are controversial. To address this we performed a meta-analysis systematically to assess the clinicopathological and prognostic significance of survivin expression in OSCC. Methods We searched PubMed, Embase, Web of Science and Ovid databases for papers investigating the clinicopathological and prognostic significance of survivin expression in OSCC. The pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were used to determine the relevance of survivin. Results A total of 15 papers, including 1040 cases in which survivin expression was detected by immunohistochemistry (IHC) or reverse transcription polymerase chain reaction (RT-PCR), were included. A meta-analysis of clinicopathological variables revealed a correlation between survivin expression and lymph node metastasis (OR = 0.62, 95% CI = 0.44-0.88, p < 0.05) and clinical stage (OR = 0.63, 95% CI = 0.41-0.96, p < 0.05). However, no significant associations were found between survivin expression and tumor differentiation grade (OR = 0.72, 95% CI = 0.26-1.11, p > 0.05), depth of invasion (OR = 0.76, 95% CI = 0.50-1.14, p > 0.05), age (OR = 0.78, 95% CI = 0.48-1.29, p > 0.05) or gender (OR = 1.31, 95% CI = 0.86-2.01, p > 0.05). Subgroup analysis using stratified detection methods showed no significant associations between the expression of survivin protein and clinicopathological variables in OSCC. A correlation between survivin expression and poor prognosis of patients with OSCC (HR = 1.62, 95% CI = 1.23-2.01, p < 0.05) was demonstrated. Conclusion Survivin is a potential prognostic marker of OSCC. Future studies with larger sample sizes and well-designed inclusion criteria will be needed to dissect the role of survivin expression in determining the clinicopathological features and/or prognosis of OSCC.	[Xie, Shang; Xu, Hui; Shan, Xiaofeng; Liu, Baozhong; Wang, Kan; Cai, Zhigang] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100081, Peoples R China	Peking University	Cai, ZG (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100081, Peoples R China.	c2013xs@163.com	Xie, Shang/I-2897-2019	Xie, Shang/0000-0003-1461-695X	National Natural Science Foundation of China [NSFC-81371162]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the National Natural Science Foundation of China (NSFC-81371162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177; Barnes L, 2005, PATHOLOGY AND GENETI; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Caldas H, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-11; Chen Gean-Shun, 1996, Kaohsiung Journal of Medical Sciences, V12, P317; Chen P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0775-5; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; De Maria S, 2009, J CANCER RES CLIN, V135, P107, DOI 10.1007/s00432-008-0433-z; Dogan M, 2014, EUR ARCH OTO-RHINO-L, DOI [10.1007/s00405-00014-03009-00403, DOI 10.1007/S00405-00014-03009-00403]; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engels K, 2007, J PATHOL, V211, P532, DOI 10.1002/path.2134; Freier K, 2007, INT J CANCER, V120, P942, DOI 10.1002/ijc.22380; Ikeguchi M, 2002, DIAGN MOL PATHOL, V11, P33, DOI 10.1097/00019606-200203000-00007; Jane C, 2006, J ORAL PATHOL MED, V35, P595, DOI 10.1111/j.1600-0714.2006.00473.x; Jeon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076719; Jha K, 2012, SURG ONCOL, V21, P125, DOI 10.1016/j.suronc.2011.01.001; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; Khan Z, 2009, HEAD NECK-J SCI SPEC, V31, P1039, DOI 10.1002/hed.21071; Kim MJ, 2005, CANCER LETT, V224, P253, DOI 10.1016/j.canlet.2005.01.009; Kim YH, 2010, J ORAL PATHOL MED, V39, P368, DOI 10.1111/j.1600-0714.2009.00844.x; Krieg A, 2013, MOL BIOL REP, V40, P5501, DOI 10.1007/s11033-013-2650-z; Krieg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065338; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li SX, 2012, ASIAN PAC J CANCER P, V13, P5027, DOI 10.7314/APJCP.2012.13.10.5027; Lim YC, 2008, ACTA OTO-LARYNGOL, V128, P1132, DOI 10.1080/00016480801901691; Lin CY, 2005, ORAL ONCOL, V41, P645, DOI 10.1016/j.oraloncology.2005.02.009; Lo Muzio L, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-63; Lo Muzio L, 2003, BRIT J CANCER, V89, P2244, DOI 10.1038/sj.bjc.6601402; Lodi G, 2010, ORAL DIS, V16, P61, DOI 10.1111/j.1601-0825.2009.01614.x; Lu CD, 1998, CANCER RES, V58, P1808; Mahotka C, 2002, CELL DEATH DIFFER, V9, P1334, DOI 10.1038/sj.cdd.4401091; Marioni G, 2005, ACTA OTO-LARYNGOL, V125, P1218, DOI 10.1080/00016480510038194; Mowla Seyed Javad, 2005, Urol J, V2, P141; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pennati M, 2008, EXPERT OPIN THER TAR, V12, P463, DOI 10.1517/14728222.12.4.463 ; Petersen PE, 2009, ORAL ONCOL, V45, P454, DOI 10.1016/j.oraloncology.2008.05.023; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Su LP, 2010, ORAL SURG ORAL MED O, V110, P484, DOI 10.1016/j.tripleo.2010.04.009; Tamm I, 1998, CANCER RES, V58, P5315; Tanaka C, 2003, J DENT RES, V82, P607, DOI 10.1177/154405910308200807; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wells G, 2009, THE NEWCASTLE OTTAWA; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Yang Y, 2011, MED ONCOL, V28, P796, DOI 10.1007/s12032-010-9519-y; Zhang L, 2012, J ENG FIBER FABR, V7, P7; Zhang MB, 2013, ONCOL LETT, V6, P381, DOI 10.3892/ol.2013.1381	53	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116517	10.1371/journal.pone.0116517	http://dx.doi.org/10.1371/journal.pone.0116517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710884	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900009
J	Amorim, CEG; Acuna-Alonzo, V; Salzano, FM; Bortolini, MC; Hunemeier, T				Amorim, Carlos Eduardo G.; Acuna-Alonzo, Victor; Salzano, Francisco M.; Bortolini, Maria Catira; Huenemeier, Tabita			Differing Evolutionary Histories of the ACTN3*R577X Polymorphism among the Major Human Geographic Groups	PLOS ONE			English	Article							POSITIVE SELECTION; POPULATION-GENETICS; GENOME SEQUENCE; ACTN3 GENOTYPE; ALLELE; FREQUENCY; PACKAGE	has been proposed that the functional ACTN3*R577X polymorphism might have evolved due to selection in Eurasian human populations. To test this possibility we surveyed all available population-based data for this polymorphism and performed a comprehensive evolutionary analysis of its genetic diversity, in order to assess the action of adaptive and random mechanisms on its variation across human geographical distribution. The derived 577X allele increases in frequency with distance from Africa, reaching the highest frequencies on the American continent. Positive selection, detected by an extended haplotype homozygosisty test, was consistent only with the Eurasian data, but simulations with neutral models could not fully explain the results found in the American continent. It is possible that particularities of Native American population structure could be responsible for the observed allele frequencies, which would have resulted from a complex interaction between selective and random factors.	[Amorim, Carlos Eduardo G.; Acuna-Alonzo, Victor; Bortolini, Maria Catira; Huenemeier, Tabita] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-91501970 Porto Alegre, RS, Brazil; [Amorim, Carlos Eduardo G.] Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil; [Acuna-Alonzo, Victor] Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unit Mol Biol & Genom Med, Mexico City 14000, DF, Mexico	Universidade Federal do Rio Grande do Sul; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico	Hunemeier, T (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-91501970 Porto Alegre, RS, Brazil.	hunemeier@gmail.com	Salzano, Francisco M/L-7916-2015; Hünemeier, Tábita/F-4181-2011	Hunemeier, Tabita/0000-0002-3156-2079	Programa Nucleos de Excelencia [PRONEX 10.0024-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [142216/2009-7, 473118/2012-2, 471573/2012-4, 405996/2013-6, 480380/2012-0]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS/PqG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BEX 8279-11-0, BEX 9187-138, PNPD 007453/2011-04]	Programa Nucleos de Excelencia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS/PqG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by funding from Programa Nucleos de Excelencia (PRONEX 10.0024-6 to FMS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (142216/2009-7 to CEGA; 473118/2012-2 to FMS; 471573/2012-4; 405996/2013-6 to MCB and 480380/2012-0 to TH), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS/PqG 2011-2013 to MCB), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BEX 8279-11-0 and BEX 9187-138 to CEGA; PNPD 007453/2011-04 to TH).	Alfred T, 2011, HUM MUTAT, V32, P1008, DOI 10.1002/humu.21526; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Augusto DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056755; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fattahi Z, 2012, IRAN RED CRESCENT ME, V14, P617; Friedlander SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052282; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Hancock AM, 2010, PHILOS T R SOC B, V365, P2459, DOI 10.1098/rstb.2010.0032; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hunemeier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038862; Laval G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010284; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Obenchain V, 2014, BIOINFORMATICS, V30, P2076, DOI 10.1093/bioinformatics/btu168; Paixao-Cortes VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015656; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; R Development Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Schroeder KB, 2009, MOL BIOL EVOL, V26, P995, DOI 10.1093/molbev/msp024; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	41	17	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115449	10.1371/journal.pone.0115449	http://dx.doi.org/10.1371/journal.pone.0115449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706920	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100013
J	Borba, GL; Zenki, KC; Kalinine, E; Baggio, S; Pettenuzzo, L; Zimmer, ER; Weis, SN; Calcagnotto, ME; de Souza, DO				Borba Filho, Gilvan Luiz; Zenki, Kamila Cagliari; Kalinine, Eduardo; Baggio, Suelen; Pettenuzzo, Leticia; Zimmer, Eduardo Rigon; Weis, Simone Nardin; Calcagnotto, Maria Elisa; de Souza, Diogo Onofre			A New Device for Step-Down Inhibitory Avoidance Task-Effects of Low and High Frequency in a Novel Device for Passive Inhibitory Avoidance Task That Avoids Bioimpedance Variations	PLOS ONE			English	Article							ADMINISTERED GUANOSINE; MEMORY CONSOLIDATION; BASOLATERAL AMYGDALA; PROTEIN-SYNTHESIS; PARIETAL CORTEX; QUINOLINIC ACID; CA1 REGION; HIPPOCAMPUS; RETRIEVAL; KINASE	Background Step-down inhibitory avoidance task has been widely used to evaluate aversive memory, but crucial parameters inherent to traditional devices that may influence the behavior analysis (as stimulus frequency, animal's bioimpedance) are frequently neglected. New Method We developed a new device for step-down inhibitory avoidance task by modifying the shape and distribution of the stainless steel bars in the box floor where the stimuli are applied. The bars are 2mm wide, with rectangular shape, arranged in pairs at intervals of 1cm from the next pairs. Each pair makes an electrical dipole where the polarity inverts after each pulse. This device also presents a component that acquires and records the exact current received by the animal foot and precisely controls the frequency of stimulus applied during the entire experiment. Result Different from conventional devices, this new apparatus increases the contact surface with bars and animal's paws, allowing the electric current pass through the animal's paws only, drastically reducing the influence of animal's bioimpedance. The analysis of recorded data showed that the current received by the animal was practically the same as applied, independent of the animal's body composition. Importantly, the aversive memory was observed at specific stimuli intensity and frequency (0.35 or 0.5 mA at 62 and 125Hz but not at 0.20 mA or 20 Hz). Moreover, with this device it was possible to observe the well-known step-down inhibitory avoidance task memory impairment induced by guanosine. Conclusion This new device offers a substantial improvement for behavioral analysis in step-down inhibitory avoidance task and allows us to precisely compare data from different animals with distinct body composition.	[Borba Filho, Gilvan Luiz; de Souza, Diogo Onofre] Univ Fed Rio Grande do Sul, ICBS, Programa Posgrad Educ Ciencias, Porto Alegre, RS, Brazil; [Zenki, Kamila Cagliari; Kalinine, Eduardo; Baggio, Suelen; Pettenuzzo, Leticia; Zimmer, Eduardo Rigon; Weis, Simone Nardin; Calcagnotto, Maria Elisa; de Souza, Diogo Onofre] Univ Fed Rio Grande do Sul, ICBS, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil; [Calcagnotto, Maria Elisa; de Souza, Diogo Onofre] Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, Porto Alegre, RS, Brazil; [Kalinine, Eduardo] Univ Fed Sergipe, Programa Posgrad Ciencias Fisiol, Sao Cristovao, Sergipe, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Sergipe	Borba, GL (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Programa Posgrad Educ Ciencias, Porto Alegre, RS, Brazil.	eng.gilvan@gmail.com	Kalinine, Eduardo/G-7366-2017; Nardin Weis, Simone/FNC-4289-2022; Weis, Simone/F-5363-2014; Zimmer, Eduardo R Rigon/I-2932-2015; Pettenuzzo, Leticia F/N-9293-2017; CALCAGNOTTO, MARIA ELISA/AAU-7718-2020; calcagnotto, maria elisa/B-1645-2013; Souza, Diogo/J-8894-2014	Kalinine, Eduardo/0000-0002-2039-038X; Weis, Simone/0000-0002-8705-8613; Zimmer, Eduardo R Rigon/0000-0002-5349-0053; Pettenuzzo, Leticia F/0000-0001-6740-6177; CALCAGNOTTO, MARIA ELISA/0000-0001-8196-0596; calcagnotto, maria elisa/0000-0001-8196-0596; Souza, Diogo/0000-0002-4322-0404	Instituto Nacional de Ciencia e Tecnologia; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul; Concelho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Universidade Federal do Rio Grande do Sul	Instituto Nacional de Ciencia e Tecnologia; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Concelho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade Federal do Rio Grande do Sul	This work was supported by Instituto Nacional de Ciencia e Tecnologia (http://www.inctinofar.ccs.ufrj.br/) (DOS); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (http://www.fapergs.rs.gov.br/) (DOS); Concelho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) (DOS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/) (DOS); and Universidade Federal do Rio Grande do Sul (http://www.ufrgs.br/ufrgs/inicial) (DOS).	Alonso M, 2002, NEUROBIOL LEARN MEM, V77, P119, DOI 10.1006/nlme.2000.4000; Ardenghi P, 1997, BEHAV PHARMACOL, V8, P745, DOI 10.1097/00008877-199712000-00010; Bach SA, 2014, NUTR NEUROSCI, V17, P186, DOI 10.1179/1476830513Y.0000000087; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bevilaqua LRM, 2005, PHARMACOL BIOCHEM BE, V81, P139, DOI 10.1016/j.pbb.2005.03.005; BIANCHIN M, 1993, BEHAV NEURAL BIOL, V59, P83, DOI 10.1016/0163-1047(93)90782-D; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonini JS, 2011, INT J NEUROPSYCHOPH, V14, P1209, DOI 10.1017/S1461145710001501; Botton PH, 2010, BEHAV BRAIN RES, V214, P254, DOI 10.1016/j.bbr.2010.05.034; Brunner D, 2002, DRUG DISCOV TODAY, V7, pS107, DOI 10.1016/S1359-6446(02)02423-6; Cammarota M, 1998, EUR J NEUROSCI, V10, P2669, DOI 10.1046/j.1460-9568.1998.t01-1-00254.x; Cammarota M, 2004, LEARN MEMORY, V11, P572, DOI 10.1101/lm.76804; Cammarota M, 2003, J NEUROSCI, V23, P737; CARRAN AB, 1964, J COMP PHYSIOL PSYCH, V58, P427, DOI 10.1037/h0046774; Cline BH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-110; Detrait ERAY, 2009, BEHAV RES METHODS, V41, P805, DOI 10.3758/BRM.41.3.805; Farmer GE, 2012, HIPPOCAMPUS, V22, P1703, DOI 10.1002/hipo.22005; Furini CRG, 2014, BEHAV BRAIN RES, V271, P212, DOI 10.1016/j.bbr.2014.06.027; Galindo LE, 2008, BEHAV BRAIN RES, V195, P153, DOI 10.1016/j.bbr.2008.01.011; Garin-Aguilar ME, 2014, HIPPOCAMPUS, V24, P102, DOI 10.1002/hipo.22210; GLICK SD, 1973, BEHAV BIOL, V9, P771, DOI 10.1016/S0091-6773(73)80138-5; Hu LF, 2012, J PHARMACOL TOX MET, V65, P75, DOI 10.1016/j.vascn.2012.02.001; HUDSON B B, 1950, Genet Psychol Monogr, V41, P99; Izquierdo I, 1999, BEHAV BRAIN RES, V103, P1, DOI 10.1016/S0166-4328(99)00036-4; Izquierdo I, 1998, NATURE, V393, P635, DOI 10.1038/31371; IZQUIERDO I, 1993, BEHAV NEURAL BIOL, V59, P1, DOI 10.1016/0163-1047(93)91061-Q; Izquierdo I, 1997, EUR J NEUROSCI, V9, P786, DOI 10.1111/j.1460-9568.1997.tb01427.x; Izquierdo LA, 2000, BEHAV BRAIN RES, V111, P93, DOI 10.1016/S0166-4328(00)00137-6; JARVIK ME, 1967, PSYCHOL REP, V21, P221, DOI 10.2466/pr0.1967.21.1.221; JERUSALINSKY D, 1992, BEHAV NEURAL BIOL, V58, P76, DOI 10.1016/0163-1047(92)90982-A; Jiang SC, 2007, PURINERG SIGNAL, V3, P411, DOI 10.1007/s11302-007-9079-6; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lara DR, 2001, BRAIN RES, V912, P176, DOI 10.1016/S0006-8993(01)02734-2; Lloyd T, 1986, Aust J Physiother, V32, P18, DOI 10.1016/S0004-9514(14)60640-1; Matte C, 2009, NEUROSCIENCE, V163, P1039, DOI 10.1016/j.neuroscience.2009.07.023; Saute JAM, 2006, NEUROBIOL LEARN MEM, V85, P206, DOI 10.1016/j.nlm.2005.10.006; Muller AP, 2011, HIPPOCAMPUS, V21, P1082, DOI 10.1002/hipo.20822; Nazari-Serenjeh F, 2013, PROG NEURO-PSYCHOPH, V40, P54, DOI 10.1016/j.pnpbp.2012.10.003; PERRY MLS, 1983, BRAZ J MED BIOL RES, V16, P339; Petronilho F, 2012, BRAIN BEHAV IMMUN, V26, P904, DOI 10.1016/j.bbi.2012.03.007; Quevedo J, 1999, LEARN MEMORY, V6, P600, DOI 10.1101/lm.6.6.600; Roesler R, 2000, NEUROREPORT, V11, P2537, DOI 10.1097/00001756-200008030-00038; Schmidt AP, 2007, PHARMACOL THERAPEUT, V116, P401, DOI 10.1016/j.pharmthera.2007.07.004; Schmidt AP, 2000, BRAIN RES, V864, P40, DOI 10.1016/S0006-8993(00)02106-5; Schmidt AP, 2005, NEUROCHEM RES, V30, P69, DOI 10.1007/s11064-004-9687-2; do Prado-Lima PAS, 2011, J PSYCHIATR NEUROSCI, V36, P250, DOI 10.1503/jpn.100115; Skalicky M, 2001, EXP GERONTOL, V36, P159, DOI 10.1016/S0531-5565(00)00174-1; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; Smith Dl Jr, 2009, Int J Body Compos Res, V7, P21; Tarozzi A, 2010, J BIOL REG HOMEOS AG, V24, P297; THORNDIKE EL, 1898, ANIMAL INTELLIGENCE; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298; Vinade ER, 2005, J NEUROSCI RES, V79, P248, DOI 10.1002/jnr.20327; Vinade ER, 2004, NEUROBIOL LEARN MEM, V81, P137, DOI 10.1016/j.nlm.2003.12.003; WAHLSTEN D, 1972, BEHAV GENET, V2, P211, DOI 10.1007/BF01065691; Walz R, 2000, NEUROBIOL LEARN MEM, V73, P11, DOI 10.1006/nlme.1999.3913; Webster J.G, 2010, MED INSTRUMENTATION	57	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116000	10.1371/journal.pone.0116000	http://dx.doi.org/10.1371/journal.pone.0116000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706879	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100022
J	Bruchmann, J; Sachsenheimer, K; Rapp, BE; Schwartz, T				Bruchmann, Julia; Sachsenheimer, Kai; Rapp, Bastian E.; Schwartz, Thomas			Multi-Channel Microfluidic Biosensor Platform Applied for Online Monitoring and Screening of Biofilm Formation and Activity	PLOS ONE			English	Article							QUARTZ-CRYSTAL MICROBALANCE; PSEUDOMONAS-AERUGINOSA; DRINKING-WATER; BACTERIAL BIOFILMS; REAL-TIME; GROWTH; SENSOR; SURFACES; INVOLVEMENT; MECHANISMS	Bacterial colonization of surfaces and interfaces has a major impact on various areas including biotechnology, medicine, food industries, and water technologies. In most of these areas biofilm development has a strong impact on hygiene situations, product quality, and process efficacies. In consequence, biofilm manipulation and prevention is a fundamental issue to avoid adverse impacts. For such scenario online, non-destructive biofilm monitoring systems become important in many technical and industrial applications. This study reports such a system in form of a microfluidic sensor platform based on the combination of electrical impedance spectroscopy and amperometric current measurement, which allows sensitive online measurement of biofilm formation and activity. A total number of 12 parallel fluidic channels enable real-time online screening of various biofilms formed by different Pseudomonas aeruginosa and Stenotrophomonas maltophilia strains and complex mixed population biofilms. Experiments using disinfectant and antibiofilm reagents demonstrate that the biofilm sensor is able to discriminate between inactivation/killing of bacteria and destabilization of biofilm structures. The impedance and amperometric sensor data demonstrated the high dynamics of biofilms as a consequence of distinct responses to chemical treatment strategies. Gene expression of flagellar and fimbrial genes of biofilms grown inside the microfluidic system supported the detected biofilm growth kinetics. Thus, the presented biosensor platform is a qualified tool for assessing biofilm formation in specific environments and for evaluating the effectiveness of antibiofilm treatment strategies.	[Bruchmann, Julia; Schwartz, Thomas] Karlsruhe Inst Technol KIT, Inst Funct Interfaces IFG, Eggenstein Leopoldshafen, Germany; [Sachsenheimer, Kai; Rapp, Bastian E.] Karlsruhe Inst Technol KIT, Inst Microstruct Technol IMT, Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Bruchmann, J (corresponding author), Karlsruhe Inst Technol KIT, Inst Funct Interfaces IFG, Eggenstein Leopoldshafen, Germany.	julia.bruchmann@kit.edu; thomas.schwartz@kit.edu	Rapp, Bastian E/G-4522-2011; Schwartz, Thomas/H-2920-2013	Rapp, Bastian E/0000-0002-3955-0291; 	German Science Foundation (DFG) [RA 2140/3-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG) under grant number RA 2140/3-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babauta JT, 2013, BIOTECHNOLOGY BIOENG; Bruchmann J, 2013, ENVIRON SCI POLLUT R, V20, P3539, DOI 10.1007/s11356-013-1521-4; Buckingham-Meyer K, 2007, J MICROBIOL METH, V70, P236, DOI 10.1016/j.mimet.2007.04.010; Busscher H J, 1997, Adv Dent Res, V11, P24; Chaw KC, 2005, ANTIMICROB AGENTS CH, V49, P4853, DOI 10.1128/AAC.49.12.4853-4859.2005; Darouiche RO, 2009, J ANTIMICROB CHEMOTH, V64, P88, DOI 10.1093/jac/dkp158; Emtiazi F, 2004, WATER RES, V38, P1197, DOI 10.1016/j.watres.2003.10.056; Fischer M, 2012, BIOSENS BIOELECTRON, V33, P172, DOI 10.1016/j.bios.2011.12.048; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2011, SPRINGER SER BIOFILM, V5, P81, DOI 10.1007/978-3-642-19940-0_5; Gibson H, 1999, J APPL MICROBIOL, V87, P41, DOI 10.1046/j.1365-2672.1999.00790.x; Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0; Jenkins ATA, 2004, BIOTECHNOL PROGR, V20, P1233, DOI 10.1021/bp034367u; Jungfer C, 2013, BIOFOULING, V29, P891, DOI 10.1080/08927014.2013.813936; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Kim YW, 2012, SENSOR ACTUAT B-CHEM, V163, P136, DOI 10.1016/j.snb.2012.01.021; Kirschhofer F, 2013, ANAL CHIM ACTA, V802, P95, DOI 10.1016/j.aca.2013.10.007; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Paredes J, 2012, BIOSENS BIOELECTRON, V38, P226, DOI 10.1016/j.bios.2012.05.027; Paredes J, 2014, J MICROBIOL METH, V100, P77, DOI 10.1016/j.mimet.2014.02.022; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Pires L, 2013, BIOSENS BIOELECTRON, V47, P157, DOI 10.1016/j.bios.2013.03.015; Qian P, 2013, GOOGLE PATENTS; Reipa V, 2006, J MICROBIOL METH, V66, P449, DOI 10.1016/j.mimet.2006.01.016; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Richter L, 2007, LAB CHIP, V7, P1723, DOI 10.1039/b708236c; RUSESKA I, 1982, OIL GAS J, V80, P253; Sanchez CJ, 2014, ANTIMICROBIAL AGENTS; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Strathmann M, 2013, BIOFOULING, V29, P573, DOI 10.1080/08927014.2013.791287; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898	35	26	27	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117300	10.1371/journal.pone.0117300	http://dx.doi.org/10.1371/journal.pone.0117300			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706987	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100074
J	Dai, XF; Zhang, H; He, Y; Qi, Y; Chang, B; Pang, JJ				Dai, Xufeng; Zhang, Hua; He, Ying; Qi, Yan; Chang, Bo; Pang, Ji-jing			The Frequency-Response Electroretinogram Distinguishes Cone and Abnormal Rod Function in rd12 Mice	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; RECESSIVE RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; RPE65 DEFICIENCY; VISUAL CYCLE; MOUSE MODEL; GENE; MUTATIONS; DYSTROPHY; DELIVERY	Early studies on Rpe65 knockout mice reported that remaining visual function was attributable to cone function. However, this finding has been challenged more and more as time has passed. Electroretinograms (ERGs) showed that rd12 mice, a spontaneous animal model of RPE65 Leber's congenital amaurosis, had sizeable photopic responses. Unfortunately, the recorded ERG waveform was difficult to interpret because of a remarkably delayed peak-time, which resembles a rod response more than a cone response. Here, we compare flicker ERGs in animals with normal rod and cone function (C57BL/6J mice), pure rod function (cpfl5 mice), and pure cone function (Rho(-/-) mice) under different adaptation levels and stimulus intensities. These responses were then compared with those obtained from rd12 mice. Our results showed that normal rods respond to low frequency flicker (5 and 15 Hz) and that normal cones respond to both low and high frequency flicker (5-35 Hz). As was seen in cpfl5 mice, rd12 mice had recordable responses to low frequency flicker (5 and 15Hz), but not to high frequency flicker (25 and 35 Hz). We hypothesize that abnormal rods may be the source of residual vision in rd12 mice, which is proved correct here with double mutant rd12mice. In this study, we show, for the first time, that frequency-response ERGs can effectively distinguish cone-and rod-driven responses in the rd12 mouse. It is another simple and valid method for evaluating the respective contributions of retinal rods and cones.	[Dai, Xufeng; Zhang, Hua; He, Ying; Qi, Yan; Pang, Ji-jing] Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Peoples R China; [Dai, Xufeng; Pang, Ji-jing] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Chang, Bo] Jackson Lab, Bar Harbor, ME 04609 USA	Wenzhou Medical University; State University System of Florida; University of Florida; Jackson Laboratory	Dai, XF (corresponding author), Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Peoples R China.	daixufeng2013@gmail.com		Chang, Bo/0000-0001-8259-7290	Zhejiang Provincial Education Department, China [Y201431063]; National Natural Science Foundation of China [81371060]; NATIONAL EYE INSTITUTE [R21EY023543, R01EY019943, R21EY018331] Funding Source: NIH RePORTER	Zhejiang Provincial Education Department, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a scientific research fund from Zhejiang Provincial Education Department, China (Y201431063), the National Natural Science Foundation of China (81371060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Cachafeiro M, 2010, INVEST OPHTH VIS SCI, V51, P6835, DOI 10.1167/iovs.09-3870; Dai XF, 2014, INVEST OPHTH VIS SCI, V55, P1724, DOI 10.1167/iovs.13-13654; Deng WT, 2012, INVEST OPHTH VIS SCI, V53, P1895, DOI 10.1167/iovs.11-8831; Ekesten B, 2001, VISION RES, V41, P2425, DOI 10.1016/S0042-6989(01)00140-7; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Lei B, 2006, INVEST OPHTH VIS SCI, V47, P2732, DOI 10.1167/iovs.05-1461; Li WS, 2009, MOL VIS, V15, P267; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; NOWAK LM, 1983, VISION RES, V23, P845, DOI 10.1016/0042-6989(83)90051-2; Pang J, 2010, GENE THER, V17, P815, DOI 10.1038/gt.2010.29; Pang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035250; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Pang JJ, 2005, MOL VIS, V11, P152; Pardue MT, 2014, DOC OPHTHALMOL, V128, P77, DOI 10.1007/s10633-013-9424-8; Pearson P, 1999, J STUD ALCOHOL, V60, P879, DOI 10.15288/jsa.1999.60.879; Porto FBO, 2002, J GENE MED, V4, P390, DOI 10.1002/jgm.278; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Rubin GR, 2007, DOC OPHTHALMOL, V115, P165, DOI 10.1007/s10633-007-9066-9; Samardzija M, 2009, HUM MOL GENET, V18, P1266, DOI 10.1093/hmg/ddp026; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Testa F, 2013, OPHTHALMOLOGY, V120, P1283, DOI 10.1016/j.ophtha.2012.11.048; Veske A, 1999, GENOMICS, V57, P57, DOI 10.1006/geno.1999.5754	31	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117570	10.1371/journal.pone.0117570	http://dx.doi.org/10.1371/journal.pone.0117570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706871	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100102
J	King, BS; Lu, LZ; Yu, M; Jiang, Y; Standard, J; Su, XY; Zhao, ZH; Wang, WQ				King, Brenee S.; Lu, Lizhi; Yu, Miao; Jiang, Yu; Standard, Joseph; Su, Xiaoyu; Zhao, Zhihui; Wang, Weiqun			Lipidomic Profiling of Di- and Tri-Acylglycerol Species in Weight-Controlled Mice	PLOS ONE			English	Article							PROTEIN-KINASE-C; CALORIE-RESTRICTED MICE; FATTY-ACID-COMPOSITION; CANCER PREVENTION; MASS-SPECTROMETRY; IN-VITRO; DIACYLGLYCEROL; EXERCISE; ACTIVATION; CARCINOGENESIS	Weight control by dietary calorie restriction (DCR) or exercise has been shown to prevent cancer in various models. However, the mechanisms as to how weight control is beneficial are not well understood. While previous reports have investigated the effects of weight control on total lipid levels or lipid composition within cellular membranes, there has been little work surrounding changes to individual lipids following weight control interventions. In this study, using a model of skin carcinogenesis centered on the tumor promotion stage, CD-1 mice were randomly assigned into 4 groups: ad libitum and sedentary (control), ad libitum with exercise (AL+Exe), exercise with pair feeding of a diet isocaloric with control (PF+Exe), and sedentary with 20% DCR compared to control. After ten weeks, body weight and body fat percentages significantly decreased in the PF+Exe and DCR groups but not AL+Exe when compared with sedentary controls. Murine skin and plasma samples were obtained for analysis. Lipidomics using electrospray ionization MS/MS was employed to profile triacylglycerol (TG) and diacylglycerol (DG) species. Both plasma and tissue TG species containing fatty acid chains with length 18: 1 were significantly decreased following DCR when compared to sedentary control animals. In regards to DG, the most significant changes occurred in the plasma. DG species containing fatty acids with lengths 16: 1 or 18: 1 were significantly decreased in PF+Exe and DCR groups when compared to sedentary controls. Due to the significant role of TG in energy storage and DG in cellular signaling, our findings of the effects of weight control on individual TG and DG species in plasma and skin tissue following exposure to a tumor promoter, may provide insight into the mechanism of weight control on cancer prevention.	[King, Brenee S.; Yu, Miao; Jiang, Yu; Standard, Joseph; Su, Xiaoyu; Wang, Weiqun] Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA; [Lu, Lizhi] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet Sci, Hangzhou 310021, Peoples R China; [Zhao, Zhihui] Shanghai Acad Agr Sci, Inst Agri Food Stand & Testing Technol, Shanghai 201403, Peoples R China	Kansas State University; Zhejiang Academy of Agricultural Sciences; Shanghai Academy of Agricultural Sciences	Wang, WQ (corresponding author), Kansas State Univ, Dept Human Nutr, Manhattan, KS 66506 USA.	wwang@ksu.edu			NIH/NCI (National Cancer Institute) [CA167678]; NIH/INBRE (IDeA Networks of Biomedical Research Excellence) [RR16475]; Kansas State University Foundation [J-33950]; NSF/EPS [0236913]; MCB [0920663]; DBI [0521587, 1228622]; NIH/INBRE [P20GM103418]; Kansas State University; NATIONAL CANCER INSTITUTE [R15CA167678] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	NIH/NCI (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/INBRE (IDeA Networks of Biomedical Research Excellence); Kansas State University Foundation; NSF/EPS(National Science Foundation (NSF)); MCB; DBI; NIH/INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH/NCI (National Cancer Institute) CA167678 (WW), NIH/INBRE (IDeA Networks of Biomedical Research Excellence) RR16475 (WW), and Kansas State University Foundation #J-33950 for Nutrition and Cancer (WW). NSF/EPS 0236913 (RW), MCB 0920663 (RW), DBI 0521587 (RW), and DBI1228622, NIH/INBRE P20GM103418 (RW), and Kansas State University (RW).	Anzuini F, 2011, J Prev Med Hyg, V52, P174; Barona T, 2005, J BIOL CHEM, V280, P41171, DOI 10.1074/jbc.M412863200; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BIRT DF, 1995, J NUTR, V125, pS1673; Burton FL, 2008, INT J OBESITY, V32, P481, DOI 10.1038/sj.ijo.0803754; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; CULLINANE E, 1982, METABOLISM, V31, P844, DOI 10.1016/0026-0495(82)90085-3; Faulks SC, 2006, J GERONTOL A-BIOL, V61, P781, DOI 10.1093/gerona/61.8.781; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Haskell W L, 1984, Exerc Sport Sci Rev, V12, P205; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; King B, 2013, EXP BIOL MED, V238, P502, DOI 10.1177/1535370213480695; KRIS ES, 1994, J NUTR, V124, P485, DOI 10.1093/jn/124.4.485; LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee J, 2011, PLANT BIOTECHNOL J, V9, P359, DOI 10.1111/j.1467-7652.2010.00562.x; Marignani PA, 1996, BIOCHEM BIOPH RES CO, V225, P469, DOI 10.1006/bbrc.1996.1196; Mehl KA, 2005, J APPL PHYSIOL, V98, P2219, DOI 10.1152/japplphysiol.00975.2004; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; Michna L, 2006, CARCINOGENESIS, V27, P2108, DOI 10.1093/carcin/bgl057; Murphy RC, 2007, ANAL BIOCHEM, V366, P59, DOI 10.1016/j.ab.2007.03.012; Na HK, 2011, ANN NY ACAD SCI, V1229, P176, DOI 10.1111/j.1749-6632.2011.06105.x; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x; Petitt DS, 2003, METABOLISM, V52, P418, DOI 10.1053/meta.2003.50071; Schachter JB, 1996, BBA-GEN SUBJECTS, V1291, P167, DOI 10.1016/0304-4165(96)00063-3; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Torrecillas A, 2001, BIOCHEMISTRY-US, V40, P15038, DOI 10.1021/bi015599+; Vainio H, 2002, EUR J CANCER PREV, V11, pS94; Wakelam MJO, 1998, BBA-MOL CELL BIOL L, V1436, P117, DOI 10.1016/S0005-2760(98)00123-4; Wang ZH, 2006, J GERONTOL A-BIOL, V61, P323, DOI 10.1093/gerona/61.4.323; Wang ZH, 2007, ENDOCRINOLOGY, V148, P2845, DOI 10.1210/en.2006-1313; Xie LL, 2007, J BIOL CHEM, V282, P28025, DOI 10.1074/jbc.M604857200	38	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116398	10.1371/journal.pone.0116398	http://dx.doi.org/10.1371/journal.pone.0116398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706122	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100036
J	Lopez-de-Andres, A; Jimenez-Trujillo, MI; Hernandez-Barrera, V; de Miguel-Yanes, JM; Mendez-Bailon, M; Perez-Farinos, N; Lunar, CD; Cardenas-Valladolid, J; Salinero-Fort, MA; Jimenez-Garcia, R; Carrasco-Garrido, P				Lopez-de-Andres, Ana; Isabel Jimenez-Trujillo, Ma; Hernandez-Barrera, Valentin; Ma de Miguel-Yanes, Jose; Mendez-Bailon, Manuel; Perez-Farinos, Napoleon; de Burgos Lunar, Carmen; Cardenas-Valladolid, Juan; Angel Salinero-Fort, Miguel; Jimenez-Garcia, Rodrigo; Carrasco-Garrido, Pilar			Trends in the Prevalence of Depression in Hospitalized Patients with Type 2 Diabetes in Spain: Analysis of Hospital Discharge Data from 2001 to 2011	PLOS ONE			English	Article							COMORBID DEPRESSION; CLINICAL DEPRESSION; MORTALITY; SYMPTOMS; DISTRESS; DISORDER; ADULTS; CARE; ASSOCIATION; PEOPLE	Background This study aims to describe trends in the prevalence of depression among hospitalized patients with type 2 diabetes in Spain, 2001-2011. Methods We selected patients with a discharge diagnosis of type 2 diabetes using national hospital discharge data. Discharges were grouped by depression status. Prevalence of depression globally and according to primary diagnoses based on the Charlson comorbidity index (CCI) were analyzed. We calculated length of stay (LOHS) and in-hospital mortality (IHM). Multivariate analysis was adjusted by age, year and comorbidity. Results From 2001 to 2011, 4,723,338 discharges with type 2 diabetes were identified (4.93% with depression). Prevalence of depression in diabetic patients increased from 3.54% in 2001 to 5.80% in 2011 (p<0.05). The prevalence of depression was significantly higher in women than in men in each year studied and increased from 5.22% in 2001 to 9.24% in 2011 (p<0.01). The highest prevalence was observed in the youngest age group (35-59 years). The median LOHS decreased significantly over this period. Men with diabetes and depression had higher IHM than women in all the years studied (p<0.05). Older age and greater comorbidity were significantly associated with a higher risk of dying, among diabetic patients with concomitant depression. Conclusions Prevalence of depression increased significantly among hospitalized diabetic patients from 2001 to 2011 even if the health profile and LOHS have improved over this period. Programs targeted at preventing depression among persons with diabetes should be reinforced in Spain.				ana.lopez@urjc.es	Lopez-de-Andres, Ana/AAD-8703-2019; Jimenez-Trujillo, Isabel/AAP-7746-2021; Pérez-Farinós, Napoleón/I-2023-2017; Jimenez-Garcia, Rodrigo/D-4953-2019; SALINERO-FORT, MIGUEL A./GOP-2536-2022; Lopez-de-Andres, Ana/D-4498-2019	Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Trujillo, Isabel/0000-0002-9394-6799; Pérez-Farinós, Napoleón/0000-0001-7936-1172; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Lopez-de-Andres, Ana/0000-0001-5551-5181; Cardenas Valladolid, Juan/0000-0002-3321-7316; Hernandez-Barrera, Valentin/0000-0001-5790-1959; de Miguel-Yanes, Jose M./0000-0003-2802-033X	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund) [PI13/00118]; FIS (Instituto de Salud Carlos III)	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund)(Instituto de Salud Carlos III); FIS (Instituto de Salud Carlos III)(Instituto de Salud Carlos III)	This study forms part of the research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, grant no. PI13/00118, Instituto de Salud Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Alonso-Moran E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-769; American Diabetes Association, 2009, DIABETES CARE S1, V32, pS26; [Anonymous], 2005, IDF CLIN GUID TASK F; Campayo A, 2010, AM J PSYCHIAT, V167, P580, DOI 10.1176/appi.ajp.2009.09010038; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chien IC, 2012, COMPR PSYCHIAT, V53, P569, DOI 10.1016/j.comppsych.2011.06.004; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024; Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x; Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614; Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175; Frayne SM, 2005, ARCH INTERN MED, V165, P2631, DOI 10.1001/archinte.165.22.2631; Ganasegeran K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004794; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Hofmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079809; Instituto Nacional de Gestion Sanitaria Ministerio de Sanidad y Consumo, CONJ MIN BAS DAT HOS; Jimenez-Garcia R, 2012, PRIM CARE DIABETES, V6, P149, DOI 10.1016/j.pcd.2011.10.002; Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9; Leong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075256; Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998; Lopez-De-Andres A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-3; Lopez-de-Andres A, 2013, DIABETES RES CLIN PR, V99, P300, DOI 10.1016/j.diabres.2012.12.011; Lopez-de-Andres A, 2011, DIABETES CARE, V34, P1570, DOI 10.2337/dc11-0077; Ludman EJ, 2004, GEN HOSP PSYCHIAT, V26, P430, DOI 10.1016/j.genhosppsych.2004.08.010; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Moller-Leimkuhler Anne Maria, 2007, Dialogues Clin Neurosci, V9, P71; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Osborn CY, 2012, GEN HOSP PSYCHIAT, V34, P249, DOI 10.1016/j.genhosppsych.2012.01.015; Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006; Renn BN, 2011, CLIN PSYCHOL REV, V31, P1239, DOI 10.1016/j.cpr.2011.08.001; Ribera A, 2008, REV ESP CARDIOL, V61, P843, DOI 10.1016/S1885-5857(08)60232-7; Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6; Ruiz-Ramos Miguel, 2006, Gac Sanit, V20 Suppl 1, P15, DOI 10.1157/13086022; Schieman S, 2002, J AGING HEALTH, V14, P260, DOI 10.1177/089826430201400205; Schoepf D, 2014, J PSYCHIATR RES, V52, P28, DOI 10.1016/j.jpsychires.2014.01.010; Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x; Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008; Unden AL, 2008, GENDER MED, V5, P162, DOI 10.1016/j.genm.2008.05.003; Valenstein M, 2000, J FAM PRACTICE, V49, P721; Vamos EP, 2009, PSYCHOSOM MED, V71, P501, DOI 10.1097/PSY.0b013e3181a5a7ad; van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058; Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089; Zhao W, 2006, PUBLIC HEALTH, V120, P696, DOI 10.1016/j.puhe.2006.04.012	48	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117346	10.1371/journal.pone.0117346	http://dx.doi.org/10.1371/journal.pone.0117346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706646	gold, Green Published			2022-12-27	WOS:000350662100080
J	Niederdeppe, J; Roh, S; Shapiro, MA				Niederdeppe, Jeff; Roh, Sungjong; Shapiro, Michael A.			Acknowledging Individual Responsibility while Emphasizing Social Determinants in Narratives to Promote Obesity-Reducing Public Policy: A Randomized Experiment	PLOS ONE			English	Article							COMPLEX INTEGRATION; COMMUNICATION; ATTRIBUTIONS; ELABORATION; RESISTANCE; FRAMEWORK	This study tests whether policy narratives designed to increase support for obesity-reducing public policies should explicitly acknowledge individual responsibility while emphasizing social, physical, and economic (social) determinants of obesity. We use a web-based, randomized experiment with a nationally representative sample of American adults (n = 718) to test hypotheses derived from theory and research on narrative persuasion. Respondents exposed to narratives that acknowledged individual responsibility while emphasizing obesity's social determinants were less likely to engage in counterargument and felt more empathy for the story's main character than those exposed to a message that did not acknowledge individual responsibility. Counterarguing and affective empathy fully mediated the relationship between message condition and support for policies to reduce rates of obesity. Failure to acknowledge individual responsibility in narratives emphasizing social determinants of obesity may undermine the persuasiveness of policy narratives. Omitting information about individual responsibility, a strongly-held American value, invites the public to engage in counterargument about the narratives and reduces feelings of empathy for a character that experiences the challenges and benefits of social determinants of obesity.				jdn56@cornell.edu	ROH, Sungjong/H-1126-2015	Shapiro, Michael/0000-0001-9476-4885; Roh, Sungjong/0000-0001-6751-2826	Robert Wood Johnson Foundation; Jeff Niederdeppe's work on the project	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Jeff Niederdeppe's work on the project	This work was supported by the Robert Wood Johnson Foundation via a grant to David Kindig and Pat Remington at the University of Wisconsin Population Health Institute entitled, "Mobilizing Action Toward Community Health (MATCH)". (There is no grant number for this project). The grant supported Jeff Niederdeppe's work on the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brescoll VL, 2008, ANN AM ACAD POLIT SS, V615, P178, DOI 10.1177/0002716207309189; Cacioppo JT, 1997, J CONSULT CLIN PSYCH, V65, P928, DOI 10.1037/0022-006X.65.6.928; Campbell RG, 2004, HEALTH COMMUN, V16, P159, DOI 10.1207/S15327027HC1602_2; FELDMAN S, 1988, AM J POLIT SCI, V32, P416, DOI 10.2307/2111130; Forde I, 2008, LANCET, V372, P1694, DOI 10.1016/S0140-6736(08)61695-5; Gollust SE, 2014, J HEALTH COMMUN, V19, P493, DOI 10.1080/10810730.2013.821561; Green MC, 2000, J PERS SOC PSYCHOL, V79, P701, DOI 10.1037/0022-3514.79.5.701; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; IOM, 2012, ACC PROGR OB PREV SO; Jones MD, 2010, POLICY STUD J, V38, P329, DOI 10.1111/j.1541-0072.2010.00364.x; Lundell H, 2013, J HEALTH COMMUN, V18, P1116, DOI 10.1080/10810730.2013.768724; Niederdeppe J, 2014, HEALTH COMMUN, V29, P431, DOI 10.1080/10410236.2012.761805; Niederdeppe J, 2012, J COMMUN, V62, P758, DOI 10.1111/j.1460-2466.2012.01671.x; Niederdeppe J, 2011, HUM COMMUN RES, V37, DOI 10.1111/j.1468-2958.2011.01409.x; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Raney AA, 2004, COMMUN THEOR, V14, P348, DOI 10.1111/j.1468-2885.2004.tb00319.x; Shanahan EA, 2011, POLITICS POLICY, V39, P373, DOI 10.1111/j.1747-1346.2011.00295.x; Shanahan EA, 2011, POLICY STUD J, V39, P535, DOI 10.1111/j.1541-0072.2011.00420.x; Slater MD, 2002, COMMUN THEOR, V12, P173, DOI 10.1111/j.1468-2885.2002.tb00265.x; Stone Deborah., 2012, POLICY PARADOX; Tompson T., 2012, OBESITY US PUBLIC PE; Wallack L, 1996, HEALTH EDUC QUART, V23, P293, DOI 10.1177/109019819602300303; WEINER B, 1993, AM PSYCHOL, V48, P957, DOI 10.1037/0003-066X.48.9.957; Westen D, 2010, NEW WAY TALK SOCIAL, P21	25	36	36	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117565	10.1371/journal.pone.0117565	http://dx.doi.org/10.1371/journal.pone.0117565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706743	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100101
J	Poller, WC; Dreger, H; Schwerg, M; Melzer, C				Poller, Wolfram C.; Dreger, Henryk; Schwerg, Marius; Melzer, Christoph			Prevalence of E/A Wave Fusion and A Wave Truncation in DDD Pacemaker Patients with Complete AV Block under Nominal AV Intervals	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; OPTIMAL ATRIOVENTRICULAR DELAY; SYSTOLIC FUNCTION; PACED PATIENTS; HEART-FAILURE; OPTIMIZATION; STIMULATION; TRIAL; ASSOCIATION; DOPPLER	Aims Optimization of the AV-interval (AVI) in DDD pacemakers improves cardiac hemodynamics and reduces pacemaker syndromes. Manual optimization is typically not performed in clinical routine. In the present study we analyze the prevalence of E/A wave fusion and A wave truncation under resting conditions in 160 patients with complete AV block (AVB) under the pre-programmed AVI. We manually optimized sub-optimal AVI. Methods We analyzed 160 pacemaker patients with complete AVB, both in sinus rhythm (AV-sense; n = 129) and under atrial pacing (AV-pace; n = 31). Using Doppler analyses of the transmitral inflow we classified the nominal AVI as: a) normal, b) too long (E/A wave fusion) or c) too short (A wave truncation). In patients with a sub-optimal AVI, we performed manual optimization according to the recommendations of the American Society of Echocardiography. Results All AVB patients with atrial pacing exhibited a normal transmitral inflow under the nominal AV-pace intervals (100%). In contrast, 25 AVB patients in sinus rhythm showed E/A wave fusion under the pre-programmed AV-sense intervals (19.4%; 95% confidence interval (CI): 12.6-26.2%). A wave truncations were not observed in any patient. All patients with a complete E/A wave fusion achieved a normal transmitral inflow after AV-sense interval reduction (mean optimized AVI: 79.4 +/- 13.6 ms). Conclusions Given the rate of 19.4% (CI 12.6-26.2%) of patients with a too long nominal AV-sense interval, automatic algorithms may prove useful in improving cardiac hemodynamics, especially in the subgroup of atrially triggered pacemaker patients with AV node diseases.	[Poller, Wolfram C.; Dreger, Henryk; Schwerg, Marius; Melzer, Christoph] Charite, Dept Cardiol & Angiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Poller, WC (corresponding author), Charite, Dept Cardiol & Angiol, D-13353 Berlin, Germany.	wolfram.poller@charite.de	Dreger, Henryk/A-9733-2009	Dreger, Henryk/0000-0003-1909-4329; Poller, Wolfram/0000-0002-4632-5551				Abraham WT, 2012, AM HEART J, V164, P735, DOI 10.1016/j.ahj.2012.07.026; Abraham WT, 2010, AM HEART J, V159, P944, DOI 10.1016/j.ahj.2010.02.034; Auricchio A, 1999, CIRCULATION, V99, P2993, DOI 10.1161/01.CIR.99.23.2993; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Butter C, 2001, CIRCULATION, V104, P3026, DOI 10.1161/hc5001.102229; Connolly SJ, 2000, NEW ENGL J MED, V342, P1385, DOI 10.1056/NEJM200005113421902; Ellenbogen KA, 2010, CIRCULATION, V122, P2660, DOI 10.1161/CIRCULATIONAHA.110.992552; EUGENE M, 1989, EUR HEART J, V10, P250, DOI 10.1093/oxfordjournals.eurheartj.a059473; Kindermann M, 1997, PACE, V20, P2453, DOI 10.1111/j.1540-8159.1997.tb06085.x; LEIER CV, 1979, AM J CARDIOL, V44, P442, DOI 10.1016/0002-9149(79)90394-1; Martin DO, 2012, HEART RHYTHM, V9, P1807, DOI 10.1016/j.hrthm.2012.07.009; MEISNER JS, 1985, AM J PHYSIOL, V249, pH604, DOI 10.1152/ajpheart.1985.249.3.H604; Morales MA, 2006, PACE, V29, P564, DOI 10.1111/j.1540-8159.2006.00402.x; Nielsen JC, 2012, EUROPACE, V14, P682, DOI 10.1093/europace/eur365; Occhetta E, 1993, G Ital Cardiol, V23, P877; Rickards AF, 1996, PACE, V19, P2066, DOI 10.1111/j.1540-8159.1996.tb03280.x; Ritter P, 1999, EUROPACE, V1, P126, DOI 10.1053/eupc.1998.0032; RITTER P, 1994, EUR J CPE, V4, pA163; Ritter P, 2012, EUROPACE, V14, P1324, DOI 10.1093/europace/eus059; Von Knorre GH, 1998, PACE, V21, P264	20	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116075	10.1371/journal.pone.0116075	http://dx.doi.org/10.1371/journal.pone.0116075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25707003	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100024
J	Sharivkin, R; Walker, MD; Soen, Y				Sharivkin, Revital; Walker, Michael D.; Soen, Yoav			Functional Proteomics Screen Enables Enrichment of Distinct Cell Types from Human Pancreatic Islets	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN BETA-CELLS; SURFACE-MARKERS; IN-VIVO; ENDODERM; DIFFERENTIATION; TRANSPLANTATION; IDENTIFICATION; PROGENITORS; EXPRESSION	The current world-wide epidemic of diabetes has prompted attempts to generate new sources of insulin-producing cells for cell replacement therapy. An inherent challenge in many of these strategies is the lack of cell-surface markers permitting isolation and characterization of specific cell types from differentiating stem cell populations. Here we introduce an iterative proteomics procedure allowing tag-free isolation of cell types based on their function. Our method detects and associates specific cell-surface markers with particular cell functionality by coupling cell capture on antibody arrays with immunofluorescent labeling. Using this approach in an iterative manner, we discovered marker combinations capable of enriching for discrete pancreatic cell subtypes from human islets of Langerhans: insulin-producing beta cells (CD9(high)/CD56(+)), glucagon-producing alpha cells (CD9(-)/CD56(+)) and trypsin-producing acinar cells (CD9(-)/CD56(-)). This strategy may assist future beta cell research and the development of diagnostic tools for diabetes. It can also be applied more generally for function-based purification of desired cell types from other limited and heterogeneous biological samples.	[Sharivkin, Revital; Walker, Michael D.; Soen, Yoav] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Walker, MD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	m.walker@weizmann.ac.il; yoavs@weizmann.ac.il	Palmer, Theo/GSI-6635-2022		Juvenile Diabetes Research Foundation (JDRF); Israel Science Foundation (ISF); Leona M. and Harry B. Helmsley Charitable Trust	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Israel Science Foundation (ISF)(Israel Science Foundation); Leona M. and Harry B. Helmsley Charitable Trust	This study was supported by: (1) a grant (to Y.S. and M.W.) from the Juvenile Diabetes Research Foundation (JDRF) and the Israel Science Foundation (ISF), and (2) the Leona M. and Harry B. Helmsley Charitable Trust (to Y.S.). Funder individuals were not involved in the research or in decisions relevant to this study.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Baer PC, 2013, STEM CELLS DEV, V22, P330, DOI 10.1089/scd.2012.0346; Banerjee M, 2009, DIABETOLOGIA, V52, P621, DOI 10.1007/s00125-009-1259-1; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Cleveland MH, 2012, SEMIN CELL DEV BIOL, V23, P711, DOI 10.1016/j.semcdb.2012.06.008; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Drukker M, 2012, NAT BIOTECHNOL, V30, P531, DOI 10.1038/nbt.2239; Fishman B, 2012, STEM CELL REV REP, V8, P792, DOI 10.1007/s12015-012-9363-x; Hald J, 2012, DIABETOLOGIA, V55, P154, DOI 10.1007/s00125-011-2295-1; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Ko IK, 2005, BIOMATERIALS, V26, P4882, DOI 10.1016/j.biomaterials.2004.11.049; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar U, 1999, DIABETES, V48, P77, DOI 10.2337/diabetes.48.1.77; Lindskog C, 2012, J PROTEOMICS, V75, P2611, DOI 10.1016/j.jprot.2012.03.008; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Meivar-Levy I, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/252387; Meyer K, 1998, DIABETES, V47, P1974, DOI 10.2337/diabetes.47.12.1974; Rukstalis JM, 2009, ISLETS, V1, P177, DOI 10.4161/isl.1.3.9877; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Serup P, 2001, BRIT MED J, V322, P29, DOI 10.1136/bmj.322.7277.29; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sharivkin R, 2012, MOL CELL PROTEOMICS, V11, P586, DOI 10.1074/mcp.M111.016840; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Vats D, 2012, DIABETOLOGIA, V55, P2407, DOI 10.1007/s00125-012-2605-2; Wang P, 2011, CELL STEM CELL, V8, P335, DOI 10.1016/j.stem.2011.01.017	25	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115100	10.1371/journal.pone.0115100	http://dx.doi.org/10.1371/journal.pone.0115100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706282	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100007
J	Sharp, AC; Trusler, PW				Sharp, Alana C.; Trusler, Peter W.			Morphology of the Jaw-Closing Musculature in the Common Wombat (Vombatus ursinus) Using Digital Dissection and Magnetic Resonance Imaging	PLOS ONE			English	Article							MASTICATORY MUSCLES; COMPUTED-TOMOGRAPHY; RAT; MARSUPIALIA; ANATOMY; MAMMALS; SKULLS	Wombats are unique among marsupials in having one pair of upper incisors, and hypsodont molars for processing tough, abrasive vegetation. Of the three extant species, the most abundant, the common wombat (Vombatus ursinus), has had the least attention in terms of masticatory muscle morphology, and has never been thoroughly described. Using MRI and digital dissection to compliment traditional gross dissections, the major jaw adductor muscles, the masseter, temporalis and pterygoids, were described. The masseter and medial pterygoid muscles are greatly enlarged compared to other marsupials. This, in combination with the distinctive form and function of the dentition, most likely facilitates processing a tough, abrasive diet. The broad, flat skull and large masticatory muscles are well suited to generate a very high bite force. MRI scans allow more detail of the muscle morphology to be observed and the technique of digital dissections greatly enhances the knowledge obtained from gross dissections.	[Sharp, Alana C.; Trusler, Peter W.] Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic, Australia	Monash University	Sharp, AC (corresponding author), Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic, Australia.	alana.sharp@monash.edu	Sharp, Alana C/H-9740-2019	Sharp, Alana C/0000-0001-5117-5335				Abbie AA, 1939, P ZOOL SOC LOND B-SY, V109, P261; Aplin K, 1987, POSSUMS OPOSSUMS STU, P15; Barnes DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069446; Becht G., 1953, Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen, V56C, P508; Cox PG, 2011, J ANAT, V219, P696, DOI 10.1111/j.1469-7580.2011.01436.x; Cox PG, 2014, PEERJ, V2, DOI 10.7717/peerj.448; Cox PG, 2011, ANAT REC, V294, P915, DOI 10.1002/ar.21381; Crompton AW, 2011, INTEGR COMP BIOL, V51, P271, DOI 10.1093/icb/icr028; Crompton Alfred W., 2008, P83, DOI 10.1007/978-0-387-76585-3_5; CROWCROFT PETER, 1967, REC S AUST MUS ADELAIDE, V15, P383; DAVISON CV, 1990, AUST J ZOOL, V38, P227, DOI 10.1071/ZO9900227; Dawson L, 1983, P LINNEAN SOC NEW S, V107, P99; Green RH, 1988, REC QUEEN VIC MUS, V92, P1; Green RH, 1987, RECORDS QUEEN VICTOR, V91, P1; Holliday CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062806; Hume ID, 1998, WOMBATS, P67; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Johnston P, 2011, COMPUT TOMOGR, P259, DOI [-10.5772/21982, DOI 10.5772/21982]; Lautenschlager S, 2013, PALAEONTOL Z, P1; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; MERRILEES D, 1967, Records of the South Australian Museum (Adelaide), V15, P399; Murray PF, 1998, WOMBATS, P1; Nakajima Koh, 1994, Australian Mammalogy, V17, P65; Price GJ, 2010, ALCHERINGA AUSTRALAS, V35, P21; Quayle MR, 2014, PEERJ, V2, DOI 10.7717/peerj.355; RALLS K, 1976, Q REV BIOL, V51, P245, DOI 10.1086/409310; Sasaki M, 2013, MAMM STUDY, V38, P91; SCOTT GG, 1988, AUST J ZOOL, V36, P599, DOI 10.1071/ZO9880599; Sharp AC, 2014, PEERJ, V2, DOI 10.7717/peerj.514; TATE G. H. H., 1951, AMER MUS NOVITATES, V1525, P1; Tomo S, 2007, ANAT REC, V290, P382, DOI 10.1002/ar.20508; Triggs B., 2009, WOMBATS, V2; Turnbull W. D., 1970, Fieldiana (Geol.), V18, P147; Tyndale-Biscoe H, 2005, WOMBATS VEGETARIANS, P267; Warburton NM, 2009, ANAT REC, V292, P875, DOI 10.1002/ar.20905; Wells R. T, 1989, FAUNA AUSTR	36	21	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117730	10.1371/journal.pone.0117730	http://dx.doi.org/10.1371/journal.pone.0117730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25707001	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100114
J	Wan, F; Cheng, C; Wang, ZW; Xiao, XY; Zeng, HQ; Xing, S; Chen, XP; Wang, J; Li, S; Zhang, YP; Xiang, W; Zhu, ZN; Johnson, C; Zhu, ZH				Wan, Feng; Cheng, Chao; Wang, Zongwei; Xiao, Xingyuan; Zeng, Hanqing; Xing, Shian; Chen, Xuepan; Wang, Jin; Li, Sen; Zhang, Youpeng; Xiang, Wei; Zhu, Zhineng; Johnson, Cameron; Zhu, Zhaohui			SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; E-CADHERIN EXPRESSION; PROGNOSTIC-SIGNIFICANCE; GASTRIC-CANCER; CELL-CARCINOMA; BREAST-CANCER; TUMOR-GROWTH; SNAIL; METASTASIS; CHROMATIN	The global gene regulator Special AT-rich sequence-binding protein-1 (SATB1) has been reported to induce EMT-like changes and be associated with poor clinical outcome in several cancers. This study aims to evaluate whether SATB1 affects the biological behaviors of bladder transitional cell carcinoma (BTCC) and further elucidate if this effect works through an epithelial-mesenchymal transition (EMT) pathway. The expression of SATB1, E-cadherin (epithelial markers), vimentin (mesenchymal markers) in BTCC tissues and adjacent noncancerous tissues, as well as in two cell lines of bladder cancer were investigated. Whether the SATB1 expression is associated with clinicopathological factors or not was statistically analyzed. Cell invasion and migration, cell cycle, cell proliferation and apoptosis were evaluated in SATB1 knockdown and overexpressed cell lines. Our results showed that the expression of SATB1 was remarkably up-regulated both in BTCC tissues and in bladder cancer cell lines with high potential of metastasis. The results were also associated with EMT markers and poor prognosis of BTCC patients. Moreover, SATB1 induced EMT processes through downregulation of E-cadherin, upregulation of E-cadherin repressors (Snail, Slug and vimentin). SATB1 also promoted cell cycle progression, cell proliferation, cell invasion and cell migration, but did not alter cell survival. In conclusion, our results suggest that SATB1 plays a crucial role in the progression of bladder cancer by regulating genes controlling EMT processes. Further, it may be a novel therapeutic target for aggressive bladder cancers.	[Wan, Feng; Xiao, Xingyuan; Zeng, Hanqing; Chen, Xuepan; Wang, Jin; Li, Sen; Zhang, Youpeng; Xiang, Wei; Zhu, Zhaohui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, Wuhan 430022, Hubei, Peoples R China; [Cheng, Chao] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430022, Hubei, Peoples R China; [Wang, Zongwei] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Xing, Shian] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Cent Lab, Wuhan 430022, Hubei, Peoples R China; [Zhu, Zhineng] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan Hosp 1, Dept Urol, Wuhan 430030, Hubei, Peoples R China; [Johnson, Cameron] Connecticut Coll, Dept Chem, New London, CT 06320 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Harvard Medical School; Massachusetts General Hospital; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Connecticut College	Zhu, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, Wuhan 430022, Hubei, Peoples R China.	zhuzhaohui316@sina.com	wang, zongwei/HIA-0279-2022					Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Han B, 2013, TUMOR BIOL, V34, P2943, DOI 10.1007/s13277-013-0857-1; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; Kolev Y, 2007, ANN SURG ONCOL, V14, P2738, DOI 10.1245/s10434-007-9484-7; Kosaka T, 2010, CLIN CANCER RES, V16, P5814, DOI 10.1158/1078-0432.CCR-10-0230; Kouraklis G, 2009, DIGEST DIS SCI, V54, P1015, DOI 10.1007/s10620-008-0464-y; Kwak C, 2006, UROLOGY, V68, P53, DOI 10.1016/j.urology.2006.01.053; Lei Y, 2011, ACTA HISTOCHEM, V113, P514, DOI 10.1016/j.acthis.2010.05.004; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Mhawech-Fauceglia P, 2006, CANCER-AM CANCER SOC, V106, P1205, DOI 10.1002/cncr.21743; Miyamoto H, 2010, PATHOL INT, V60, P1, DOI 10.1111/j.1440-1827.2009.02477.x; Naito S, 2010, CLIN CANCER RES, V16, P5124, DOI 10.1158/1078-0432.CCR-10-0275; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nodin B, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-24; Parker BS, 2003, CANCER BIOL THER, V2, P14; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Potter E, 1999, ENDOCR REV, V20, P207, DOI 10.1210/er.20.2.207; Shan YJ, 2013, J NUTR BIOCHEM, V24, P1062, DOI 10.1016/j.jnutbio.2012.08.004; Shukla S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053527; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; Wu CF, 2010, BRIT J CANCER, V103, P852, DOI 10.1038/sj.bjc.6605835; Yang GL, 2012, J SURG ONCOL, V106, P57, DOI 10.1002/jso.23040; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yu QC, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-119; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777; Zhou Lai-Yong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P534	46	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117518	10.1371/journal.pone.0117518	http://dx.doi.org/10.1371/journal.pone.0117518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706386	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100098
J	Westerman, KA				Westerman, Karen A.			Myospheres Are Composed of Two Cell Types: One That Is Myogenic and a Second That Is Mesenchymal	PLOS ONE			English	Article							MUSCLE STEM-CELLS; SATELLITE CELLS; SKELETAL-MUSCLE; SELF-RENEWAL; PAX7; PROGENITORS; DISTINCT; TRANSPLANTATION; SPECIFICATION; REGENERATION	Previously, in an attempt to isolate stem cells that would be capable of regenerating injured skeletal muscle, we cultured cells derived from muscle, non-adherently, in serum-free media. As a result of the culture conditions used, these cells formed spheres, and thus were referred to as myospheres. It was found that myosphere-derived cells expressed Sca-1, a marker that is not typically associated with myogenic cells, and as a result has generated some questions as to the origin of these cells. The goal of this study was to clearly determine the origin of myosphere-derived cells, and in particular to answer the question of whether myospheres contain myogenic cells. To determine if myospheres were composed of myogenic cells without altering the structure of myospheres or the culture conditions used to maintain myospheres, I isolated these cells from yellow fluorescent protein (YFP)-Myf5, YFP-MyoD, and ZsGreen-Pax7 lineage-tracing mice and monitored their growth over time. I found that myospheres do contain myogenic cells, but that these cells are gradually lost over time (within 2 months). Additionally, the use of the lineage-tracing mice gave an interesting perspective into the composition of myospheres. I found that myospheres were composed of two distinct cell types, one that is myogenic (alpha 7 integrin(+)) and contains cells expressing Myf5, MyoD, and Pax7, and a second that is non-myogenic (alpha 7 integrin(-)) expressing platelet-derived growth factor receptor alpha (PDGFRa) and Sca-1, both of which have been associated with fibro/adipocyte mesenchymal cells.	Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Westerman, KA (corresponding author), Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	kwest@zeus.bwh.harvard.edu			NIH-NIAMS [RO3AR066333]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR066333] Funding Source: NIH RePORTER	NIH-NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Brigham and Women's Hospital Department of Anesthesia, Perioperative and Pain Medicine research fund and by a grant from NIH-NIAMS(RO3AR066333) to KAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BISCHOFF R, 1975, ANAT REC, V182, P215, DOI 10.1002/ar.1091820207; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Boppart MD, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00310; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Ikemoto M, 2007, MOL THER, V15, P2178, DOI 10.1038/sj.mt.6300295; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; KONIGSBERG UR, 1975, DEV BIOL, V45, P260, DOI 10.1016/0012-1606(75)90065-2; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; LIPTON BH, 1979, SCIENCE, V205, P1292, DOI 10.1126/science.472747; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Obokata H, 2011, TISSUE ENG PT A, V17, P607, DOI [10.1089/ten.tea.2010.0385, 10.1089/ten.TEA.2010.0385]; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Penvose A, 2012, BIOL OPEN, V1, P839, DOI 10.1242/bio.20121222; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Roberts EW, 2013, J EXP MED, V210, P1137, DOI 10.1084/jem.20122344; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sarig R, 2006, STEM CELLS, V24, P1769, DOI 10.1634/stemcells.2005-0547; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; SNOW MH, 1978, CELL TISSUE RES, V186, P535; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tateishi K, 2007, J CELL SCI, V120, P1791, DOI 10.1242/jcs.006122; Uezumi A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00068; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Valero MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029760; Wei Y, 2011, EXP CELL RES, V317, P1016, DOI 10.1016/j.yexcr.2011.01.019; Westerman KA, 2010, EXP CELL RES, V316, P1966, DOI 10.1016/j.yexcr.2010.03.022; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116956	10.1371/journal.pone.0116956	http://dx.doi.org/10.1371/journal.pone.0116956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706128	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100056
J	Zhu, JR; Liang, L; Jiao, Y; Liu, LY				Zhu, Jiangrui; Liang, Long; Jiao, Yang; Liu, Liyu		US-China Phys Sci-Oncology Allianc	Enhanced Invasion of Metastatic Cancer Cells via Extracellular Matrix Interface	PLOS ONE			English	Article							CELLULAR-AUTOMATA; TUMOR-GROWTH; MODEL; MIGRATION; EVOLUTION	Cancer cell invasion is a major component of metastasis and is responsible for extensive cell diffusion into and major destruction of tissues. Cells exhibit complex invasion modes, including a variety of collective behaviors. This phenomenon results in the structural heterogeneity of the extracellular matrix (ECM) in tissues. Here, we systematically investigated the environmental heterogeneity facilitating tumor cell invasion via a combination of in vitro cell migration experiments and computer simulations. Specifically, we constructed an ECM microenvironment in a microfabricated biochip and successfully created a three-dimensional (3D) funnel-like matrigel interface inside. Scanning electron microscopy demonstrated that the interface was at the interior defects of the nano-scale molecular anisotropic orientation and the localized structural density variations in the matrigel. Our results, particularly the correlation of the collective migration pattern with the geometric features of the funnel-like interface, indicate that this heterogeneous in vitro ECM structure strongly guides and promotes aggressive cell invasion in the rigid matrigel space. A cellular automaton model was proposed based on our experimental observations, and the associated quantitative analysis indicated that cell invasion was initiated and controlled by several mechanisms, including microenvironment heterogeneity, long-range cell-cell homotype and gradient-driven directional cellular migration. Our work shows the feasibility of constructing a complex and heterogeneous in vitro 3D ECM microenvironment that mimics the in vivo environment. Moreover, our results indicate that ECM heterogeneity is essential in controlling collective cell invasive behaviors and therefore determining metastasis efficiency.	[Zhu, Jiangrui; Liu, Liyu] Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, Beijing 100080, Peoples R China; [Liang, Long; Jiao, Yang] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Jiao, Yang] Arizona State Univ, Mat Sci & Engn, Tempe, AZ USA	Chinese Academy of Sciences; Institute of Physics, CAS; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Liu, LY (corresponding author), Chinese Acad Sci, Inst Phys, Key Lab Soft Matter Phys, POB 603, Beijing 100080, Peoples R China.	liu@iphy.ac.cn			National Key Basic Research Program of China [2013CB837200]; National Science Foundation of China [11474345]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge support from National Key Basic Research Program of China (Grant 2013CB837200) and National Science Foundation of China (Grant 11474345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Bankhead A, 2007, GENET PROGRAM EVOL M, V8, P381, DOI 10.1007/s10710-007-9042-x; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Chen DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109934; Dallon JC, 1999, J THEOR BIOL, V199, P449, DOI 10.1006/jtbi.1999.0971; Deutsch A, 2004, CELLULAR AUTOMATON M; Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]; Edgar LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085178; Evensen NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082811; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gevertz J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051910; Gevertz JL, 2006, J THEOR BIOL, V243, P517, DOI 10.1016/j.jtbi.2006.07.002; Gevertz JL, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036010; Gillette BM, 2011, BIOMATERIALS, V32, P8067, DOI 10.1016/j.biomaterials.2011.05.043; Haessler U, 2009, BIOMED MICRODEVICES, V11, P827, DOI 10.1007/s10544-009-9299-3; Harjanto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024891; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Jiao Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052707; Jiao Y, 2012, AIP ADV, V2, DOI 10.1063/1.3697959; Jiao Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002314; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kabla AJ, 2012, J R SOC INTERFACE, V9, P3268, DOI 10.1098/rsif.2012.0448; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Kansal AR, 2000, J THEOR BIOL, V207, P431, DOI 10.1006/jtbi.2000.2186; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]; Liu LY, 2013, P NATL ACAD SCI USA, V110, P1686, DOI 10.1073/pnas.1221147110; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Menon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017277; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; Neofytou EA, 2011, J BIOMED MATER RES A, V98A, P383, DOI 10.1002/jbm.a.33113; Oshmyansky Alexander R., 2008, Biophysical Reviews and Letters, V3, P103, DOI 10.1142/S1793048008000630; Poincloux R, 2010, PNAS, V108, P1943; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Schmitz JE, 2002, COMPUT MATH METHOD M, V4, P223, DOI [DOI 10.1080/1027366031000086674, 10.1080/1027366031000086674]; Shin Y, 2011, LAB CHIP, V11, P2175, DOI 10.1039/c1lc20039a; Thery M, 2006, PNAS, V103, P19711; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Torquato S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015017; Wlodkowic D, 2010, CURR OPIN CHEM BIOL, V14, P556, DOI 10.1016/j.cbpa.2010.08.016; Yu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030605	50	30	32	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118058	10.1371/journal.pone.0118058	http://dx.doi.org/10.1371/journal.pone.0118058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706718	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100140
J	Wang, HS; Luo, X; You, WW; Dong, YW; Ke, CH				Wang, Haishan; Luo, Xuan; You, Weiwei; Dong, Yunwei; Ke, Caihuan			Cytogenetic Analysis and Chromosomal Characteristics of the Polymorphic 18S rDNA of Haliotis discus hannai from Fujian, China	PLOS ONE			English	Article							PACIFIC ABALONE; RUFESCENS ARCHAEOGASTROPODA; TELOMERIC (TTAGGG)(N); (GATA)(N) REPEATS; ORGANIZER REGION; KARYOTYPE; NUCLEOLUS; PROTEINS; FISH; DNA	We report on novel chromosomal characteristics of Haliotis discus hannai from a breeding population at Fujian, China. The karyotypes of H. discus hannai we obtained from an abalone farm include a common type 2n = 36 = 10M + 8SM (82%) and two rare types 2n = 36 = 11M + 7SM (14%) and 2n = 36 = 10M + 7SM + 1ST (4%). The results of silver staining showed that the NORs of H. discus hannai were usually located terminally on the long arms of chromosome pairs 14 and 17, NORs were also sometimes located terminally on the short arms of other chromosomes, either metacentric or submetacentric pairs. The number of Ag-nucleoli ranged from 2 to 8, and the mean number was 3.61 +/- 0.93. Among the scored interphase cells, 41% had 3 detectable nucleoli and 37% had 4 nucleoli. The 18S rDNA FISH result is the first report of the location of 18S rDNA genes in H. discus hannai. The 18S rDNA locations were highly polymorphic in this species. Copies of the gene were observed in the terminal of long or/and short arms of submetacentric or/and metacentric chromosomes. Using FISH with probe for vertebrate-like telomeric sequences (CCCTAA)(3) displayed positive green FITC signals at telomere regions of all analyzed chromosome types. We found about 7% of chromosomes had breaks in prophase. A special form of nucleolus not previously described from H. discus hannai was observed in some interphase cells. It consists of many small silver-stained nucleoli gathered together to form a larger nucleolus and may correspond to prenucleolar bodies.	[Wang, Haishan; Luo, Xuan; You, Weiwei; Dong, Yunwei; Ke, Caihuan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Wang, Haishan; Luo, Xuan; You, Weiwei; Dong, Yunwei; Ke, Caihuan] Xiamen Univ, Coll Ocean, Xiamen, Peoples R China; [Wang, Haishan; Luo, Xuan; You, Weiwei; Dong, Yunwei; Ke, Caihuan] Xiamen Univ, Coll Earth Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Ke, CH (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	chke@xmu.edu.cn	Dong, Yunwei/C-4617-2011	Dong, Yunwei/0000-0003-4550-2322	Hi-Tech Research and Development (863) Program of China [2012AA10A412]; National Natural Science Foundation of China [U1205121, 41106120, 31101896]; China Postdoctoral Science Foundation [20110490846]; Science & Technology Key Program of Fujian Province [2011N0033]; National Sparking Plan Project [2011GA720001]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]	Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science & Technology Key Program of Fujian Province; National Sparking Plan Project; Earmarked Fund for Modern Agro-industry Technology Research System	The work was supported by Hi-Tech Research and Development (863) Program of China (No. 2012AA10A412), the National Natural Science Foundation of China (U1205121), the National Natural Science Foundation of China (No. 41106120), China Postdoctoral Science Foundation (No. 20110490846), Science & Technology Key Program of Fujian Province (No. 2011N0033), National Sparking Plan Project (No. 2011GA720001) and National Natural Science Foundation of China (No. 31101896), the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar-Basulto G, 2011, AQUAC RES, V42, P1460, DOI 10.1111/j.1365-2109.2010.02738.x; An HS, 2011, INT J MOL SCI, V12, P4836, DOI 10.3390/ijms12084836; Angelier N, 2005, MOL BIOL CELL, V16, P2862, DOI 10.1091/mbc.e05-01-0041; ARAI K, 1986, AQUACULTURE, V58, P305, DOI 10.1016/0044-8486(86)90096-7; Arai K, 1982, B JPN SOC SCI FISHER, V48; BABU KA, 1985, INT REV CYTOL, V94, P151, DOI 10.1016/S0074-7696(08)60396-4; Bell P, 1997, J CELL SCI, V110, P43; Britton-Davidian J, 2012, HEREDITY, V108, P68, DOI 10.1038/hdy.2011.105; Cai MY, 2010, J SHELLFISH RES, V29, P735, DOI 10.2983/035.029.0327; COWELL JK, 1982, ANNU REV GENET, V16, P21, DOI 10.1146/annurev.ge.16.120182.000321; Cross I, 2003, GENETICA, V119, P65, DOI 10.1023/A:1024478407781; Fisheries CBo, 2008, CHIN FISH YB 2007; Gallardo-Escarate C, 2005, J SHELLFISH RES, V24, P1153; Gallardo-Escarate C, 2004, J SHELLFISH RES, V23, P205; Gallardo-Escarate C, 2007, J SHELLFISH RES, V26, P825, DOI 10.2983/0730-8000(2007)26[825:KCITCA]2.0.CO;2; Gallardo-Escarate C, 2005, HEREDITAS, V142, P73, DOI 10.1111/j.1601-5223.2005.01909.x; Guo XM, 1999, J SHELLFISH RES, V18, P19; Hernandez-Ibarra NK, 2007, AQUACULTURE, V272, pS268, DOI 10.1016/j.aquaculture.2007.07.086; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Hernandez-Verdun D, 2002, J CELL SCI, V115, P2265; INSUA A, 1991, AQUACULTURE, V97, P317, DOI 10.1016/0044-8486(91)90324-Z; JORDAN G, 1987, NATURE, V329, P489, DOI 10.1038/329489a0; Kobayashi T, 2010, J SHELLFISH RES, V29, P643, DOI 10.2983/035.029.0313; KOMARU A, 1985, Venus the Japanese Journal of Malacology, V44, P249; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Luo X, 2012, J SHELLFISH RES, V31, P316; Miyaki K, 1999, FISHERIES SCI, V65, P317, DOI 10.2331/fishsci.65.317; Nie HT, 2012, ANIM GENET, V43, P290, DOI 10.1111/j.1365-2052.2011.02254.x; Okumura SI, 1999, J SHELLFISH RES, V18, P605; Sakai M, 2005, J SHELLFISH RES, V24, P1149; Savino TM, 2001, J CELL BIOL, V153, P1097, DOI 10.1083/jcb.153.5.1097; Scheer Ulrich, 1993, Trends in Cell Biology, V3, P236, DOI 10.1016/0962-8924(93)90123-I; Seki Tetsuo, 1997, Bulletin of Tohoku National Fisheries Research Institute, V59, P1; Sekino M, 2007, GENETICS, V175, P945, DOI 10.1534/genetics.106.065839; THIRIOTQUIEVREUX C, 1992, J EXP MAR BIOL ECOL, V157, P33, DOI 10.1016/0022-0981(92)90072-I; VITTURI R, 1992, MAR BIOL, V112, P37, DOI 10.1007/BF00349725	36	23	24	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0113816	10.1371/journal.pone.0113816	http://dx.doi.org/10.1371/journal.pone.0113816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699679	Green Published, gold, Green Submitted			2022-12-27	WOS:000349789800001
J	Husaini, Y; Lockwood, GP; Nguyen, TV; Tsai, VWW; Mohammad, MG; Russell, PJ; Brown, DA; Breit, SN				Husaini, Yasmin; Lockwood, Glen P.; Nguyen, Trung V.; Tsai, Vicky Wang-Wei; Mohammad, Mohammad G.; Russell, Pamela J.; Brown, David A.; Breit, Samuel N.			Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Gene Deletion Promotes Cancer Growth in TRAMP Prostate Cancer Prone Mice	PLOS ONE			English	Article							EXPRESSION; TUMORIGENESIS; CHEMOTHERAPY; GDF-15; IDENTIFICATION; MARKER; MEMBER; CELLS	The divergent TGF-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1/GDF15), is overexpressed by most cancers, including prostate cancer (PCa). Whilst its circulating levels are linked to cancer outcome, the role MIC-1/GDF15 plays in cancer development and progression is incompletely understood. To investigate its effect on PCa development and spread, we have used TRAMP prostate cancer prone mice bearing a germline deletion of MIC-1/GDF15 (TRAMP(MIC-/-)). On average TRAMP(MIC-/-) mice died about 5 weeks earlier and had larger prostatic tumors compared with TRAMP mice that were wild type for MIC-1/GDF15 (TRAMP(MIC+/+)). Additionally, at the time of death or ethical end point, even when adjusted for lifespan, there were no significant differences in the number of mice with metastases between the TRAMP(MIC+/+) and TRAMP(MIC-/-) groups. However, consistent with our previous data, more than twice as many TRAMP mice overexpressing MIC-1/GDF15 (TRAMP(fmsmic-1)) had metastases than TRAMP(MIC+/+) mice (p<0.0001). We conclude that germ line gene deletion of MIC-1/GDF15 leads to increased local tumor growth resulting in decreased survival consistent with an overall protective role for MIC-1/GDF15 in early primary tumor development. However, in advancing disease, as we have previously noted, MIC-1/GDF15 overexpression may promote local invasion and metastatic spread.	[Husaini, Yasmin; Lockwood, Glen P.; Nguyen, Trung V.; Tsai, Vicky Wang-Wei; Mohammad, Mohammad G.; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Husaini, Yasmin; Lockwood, Glen P.; Nguyen, Trung V.; Tsai, Vicky Wang-Wei; Mohammad, Mohammad G.; Brown, David A.; Breit, Samuel N.] Univ New S Wales, Sydney, NSW 2010, Australia; [Russell, Pamela J.] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Inst Hlth & Biomed Innovat, Translat Res Inst, Brisbane, Qld 4102, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; Queensland University of Technology (QUT)	Brown, DA (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	D.Brown@amr.org.au; s.breit@amr.org.au	Russell, Pamela J/G-1685-2010; Russell, Pamela/O-8504-2019	Russell, Pamela J/0000-0002-3995-1239; Nguyen, Trung Viet/0000-0002-1749-8509; Mohammad, Mohammad/0000-0002-6775-1955; Brown, David/0000-0003-1382-9419	Cancer Council New South Wales; National Health and Medical Research Council of Australia (NHMRC)	Cancer Council New South Wales(Cancer Council New South Wales); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from Cancer Council New South Wales (http://www.cancercouncil.com.au/) and The National Health and Medical Research Council of Australia (NHMRC) (https://www.nhmrc.gov.au/). DAB is a National Health and Medical Research Council Biomedical Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertoni M, 2002, ONCOGENE, V21, P4212, DOI 10.1038/sj.onc.1205610; American CS, 2014, CANC FACTS FIG; Baek KE, 2009, CLIN CHIM ACTA, V401, P128, DOI 10.1016/j.cca.2008.12.008; Baek SJ, 2006, GASTROENTEROLOGY, V131, P1553, DOI 10.1053/j.gastro.2006.09.015; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bauskin AR, 2010, J INTERF CYTOK RES, V30, P389, DOI 10.1089/jir.2009.0052; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Boyle GM, 2009, J INVEST DERMATOL, V129, P383, DOI 10.1038/jid.2008.270; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Cekanova M, 2009, CANCER PREV RES, V2, P450, DOI 10.1158/1940-6207.CAPR-09-0057; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; Fluge O, 2006, THYROID, V16, P161; Gingrich JR, 1996, CANCER RES, V56, P4096; Huang CY, 2007, CLIN CANCER RES, V13, P5825, DOI 10.1158/1078-0432.CCR-07-1037; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Joiner MC, 2011, RADIOTHER ONCOL, V101, P233, DOI 10.1016/j.radonc.2011.05.068; Koopmann J, 2006, CLIN CANCER RES, V12, P442, DOI 10.1158/1078-0432.CCR-05-0564; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Mehta RS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju016; Modlich O, 2004, CLIN CANCER RES, V10, P6418, DOI 10.1158/1078-0432.CCR-04-1031; Roth P, 2010, CLIN CANCER RES, V16, P3851, DOI 10.1158/1078-0432.CCR-10-0705; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/1055-9965.EPI-06-0841; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; Staff AC, 2011, CLIN CANCER RES, V17, P4825, DOI 10.1158/1078-0432.CCR-11-0715; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Suesskind D, 2011, GRAEFES ARCH CLIN EX; Tsai VWW, 2012, J CACHEXIA SARCOPENI, V3, P239, DOI 10.1007/s13539-012-0082-6; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; Tsui KH, 2012, J MOL ENDOCRINOL, V49, P153, DOI 10.1530/JME-11-0149; Wallin U, 2011, BRIT J CANCER, V104, P1619, DOI 10.1038/bjc.2011.112; Wang XY, 2012, PROSTATE, V72, P677, DOI 10.1002/pros.21471; Weber F, 2005, J CLIN ENDOCR METAB, V90, P2512, DOI 10.1210/jc.2004-2028; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Zimmers TA, 2008, J CANCER RES CLIN, V134, P753, DOI 10.1007/s00432-007-0336-4; Zimmers TA, 2010, J CANCER RES CLIN, V136, P571, DOI 10.1007/s00432-009-0691-4	44	22	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115189	10.1371/journal.pone.0115189	http://dx.doi.org/10.1371/journal.pone.0115189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695521	Green Submitted, gold, Green Published			2022-12-27	WOS:000350062300004
J	Wang, JH				Wang, Jiun-Hao			Happiness and Social Exclusion of Indigenous Peoples in Taiwan - A Social Sustainability Perspective	PLOS ONE			English	Article								Introduction Happiness and social inclusion are important indicators of social sustainability, as recommended in the Sustainable Development Goals; however, little is known about the social sustainable development of ethnic minorities. To fill this knowledge gap, special attention is paid to understanding the issues of social exclusion and happiness in relation to the indigenous peoples in Taiwan. Methods Data used were drawn from a nationwide representativeness survey of the Taiwanese Indigenous People in 2007; it included 2,200 respondents. This study employed binary logistic regression to examine the effects of different domains of social exclusion on the likelihood of perceiving happiness; other exogenous factors, were controlled. Results The results show that among the respondents, mountain indigenous peoples, females, the elderly and those who are healthier, wealthier, highly educated, possessing western beliefs, and are more likely to be happy, compared to their counterparts. As expected, the results reveal that the likelihood of being happy is higher for those who have received medical benefits, as well as those persons without housing problems or financial difficulties, compared to their excluded counterparts. However, no significant association is found between happiness and some social exclusion domains, such as child and youth benefits, and unemployment benefits. Conclusions The disengagement of the indigenous peoples in mainstream society, with respect to the accessibility of welfare provisions, is a crucial element in regard to social exclusion and happiness. Several policy implications for the social sustainability of indigenous peoples can be inferred from these findings. For example, providing a mobile clinical tour, on-site health counseling, or homecare service can contribute to the removal of institutional and geographic barriers to medical welfare provisions for the mountain indigenes. Moreover, the government may devote more welfare resources to assist indigenous families and tribal communities to develop their own social safety net, instead of the individual-oriented welfare provisions.	Natl Taiwan Univ, Dept Bioind Commun & Dev, Taipei 10764, Taiwan	National Taiwan University	Wang, JH (corresponding author), Natl Taiwan Univ, Dept Bioind Commun & Dev, Taipei 10764, Taiwan.	wangjh@ntu.edu.tw		Wang, Jiun-Hao/0000-0001-7861-0341	Ministry of Science and Technology [NSC 100-2621-M-002-017, NSC 101-2621-M-002-009]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The author declares that this study was supported by a grant from the National Science Counsel of Taiwan (now known as the Ministry of Science and Technology) under Grant No: NSC 100-2621-M-002-017 and NSC 101-2621-M-002-009. However, no additional funding for publication was granted. URL: http://www.most.gov.tw/. The funders had no role in study design, data collection and	ABS (Australian Bureau of Statistics), 2008, NAT AB TORR STRAIT I; Black J.T, 1992, MULTIVARIATE DATA AN; Canada Statistics, 2011, 2011 NAT HOUS SURV; Chang HH, 2015, J HAPPINESS STUD, V16, P295, DOI 10.1007/s10902-014-9510-y; Chang HH, 2010, J HAPPINESS STUD, V11, P261, DOI 10.1007/s10902-009-9139-4; Chang WC, 2009, INT J SOC ECON, V36, P844, DOI 10.1108/03068290910967118; Chang YH, 2010, GOVT POLICY SOCIAL D, P583; CIP (Council of Indigenous Peoples), 2013, HLTH STAT TAIW IND P; CIP (Council of Indigenous Peoples), 2010, EC STAT SURV IND PEO; Colantonio A., 2011, EUROPEAN RES SUSTAIN; DGBAS (Directorate General of Budget Accounting Statistics), 2011, SOC IND; Dockery AM, 2010, SUJECTIVE WELLBEING; Easterlin RA, 2006, J ECON PSYCHOL, V27, P463, DOI 10.1016/j.joep.2006.05.002; Evans M, 1998, IDS BULL-I DEV STUD, V29, P42, DOI 10.1111/j.1759-5436.1998.mp29001005.x; Fetzer Joel S., 2011, TAIWAN J DEMOCRACY, V7.1, P95; Groenfeldt D, 2003, FUTURES, V35, P917, DOI 10.1016/S0016-3287(03)00049-1; Hall GH, 2012, INDIGENOUS PEOPLES, POVERTY, AND DEVELOPMENT, P1, DOI 10.1017/CBO9781139105729; Helliwell J., 2013, WORLD HAPPINESS REPO; Hsu CT, 2012, INT C SOC POL UN WOR; Huang CL, 2014, J SPORT RECRE MANAG, V11, P1; Islam N., 2013, SUSTAINABLE SOCIAL M; Lu L, 1999, J SOC PSYCHOL, V139, P79, DOI 10.1080/00224549909598363; Organisation for Economic Cooperation and Development (OECD), 2011, SOC PROT WELL BEING; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; SAS Institute,, 2009, SAS STATR 9 2 US GUI; SDSN (Sustainable Development Solutions Network), 2014, IND SUST DEV GOALS; Sen A., 2000, SOCIAL DEV PAPERS, V1; Sirkin R. M., 2005, STAT SOCIAL SCI; Stiglitz J., 2009, MEASUREMENT EC PERFO; Veenhoven R, 2007, OECD C MEAS POL REL; Yi C., 2005, J HAPPINESS STUD, V6, P43, DOI DOI 10.1007/S10902-004-1753-6; Ziyauddin KM., 2009, DIMENSIONS SOCIAL EX	32	11	11	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118305	10.1371/journal.pone.0118305	http://dx.doi.org/10.1371/journal.pone.0118305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695773	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300047
J	Yang, M; Zhang, XD; Xu, YG; Mei, XY; Jiang, BB; Liao, JJ; Yin, ZB; Zheng, JF; Zhao, Z; Fan, LM; He, XH; Zhu, YY; Zhu, SS				Yang, Min; Zhang, Xiaodan; Xu, Yanguo; Mei, Xinyue; Jiang, Bingbing; Liao, Jingjing; Yin, Zhaobo; Zheng, Jianfen; Zhao, Zhi; Fan, Liming; He, Xiahong; Zhu, Youyong; Zhu, Shusheng			Autotoxic Ginsenosides in the Rhizosphere Contribute to the Replant Failure of Panax notoginseng	PLOS ONE			English	Article							AMERICAN GINSENG; PHENOLIC-COMPOUNDS; QUINQUEFOLIUM-L; FUSARIUM-WILT; CINNAMIC ACID; GROWTH; ROOTS; L.; IDENTIFICATION; PATHOGENS	Background and Aims Sanqi ginseng (Panax notoginseng) growth is often hampered by replant failure. In this study, we aimed to examine the role of autotoxicity in Sanqi replant failures and assess the role of ginsenosides in autotoxicity. Methods The autotoxicities were measured using seedling emergence bioassays and root cell vigor staining. The ginsenosides in the roots, soils, and root exudates were identified with HPLCMS. Results The seedling emergence and survival rate decreased significantly with the continuous number of planting years from one to three years. The root exudates, root extracts, and extracts from consecutively cultivated soils also showed significant autotoxicity against seedling emergence and growth. Ginsenosides, including R-1, Rg(1), Re, Rb-1, Rb-3, Rg(2), and Rd, were identified in the roots and consecutively cultivated soil. The ginsenosides, Rg(1), Re, Rg(2), and Rd, were identified in the root exudates. Furthermore, the ginsenosides, R-1, Rg(1), Re, Rg(2), and Rd, caused autotoxicity against seedling emergence and growth and root cell vigor at a concentration of 1.0 mu g/mL. Conclusion Our results demonstrated that autotoxicity results in replant failure of Sanqi ginseng. While Sanqi ginseng consecutively cultivated, some ginsenosides can accumulate in rhizosphere soils through root exudates or root decomposition, which impedes seedling emergence and growth.	[Yang, Min; Zhang, Xiaodan; Xu, Yanguo; Mei, Xinyue; Jiang, Bingbing; Liao, Jingjing; Yin, Zhaobo; Zheng, Jianfen; Zhao, Zhi; Fan, Liming; He, Xiahong; Zhu, Youyong; Zhu, Shusheng] Yunnan Agr Univ, Key Lab Agro Biodivers & Pest Management, Educ Minist China, Kunming, Peoples R China	Yunnan Agricultural University	Zhu, SS (corresponding author), Yunnan Agr Univ, Key Lab Agro Biodivers & Pest Management, Educ Minist China, Kunming, Peoples R China.	shushengzhu79@126.com			Yunnan Development and Reform Commission; Natural Science Foundation of China [30800731, 31260447]; Ministry of Science and Technology of China [2011CB100400]	Yunnan Development and Reform Commission; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was partially supported by Yunnan Development and Reform Commission, the Natural Science Foundation of China (30800731 and 31260447) and the "973" program from the Ministry of Science and Technology of China (2011CB100400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaduzzaman M, 2012, SCI HORTIC-AMSTERDAM, V134, P26, DOI 10.1016/j.scienta.2011.11.035; Bi XB, 2010, ALLELOPATHY J, V25, P115; Chen ChangBao, 2006, Journal of Jilin Agricultural University, V28, P534; [陈超 Chen Chao], 2006, [制冷学报, Journal of Refrigeration], V27, P37; Chen ZJ, 2012, J WENSHAN U, V25, P1, DOI [10.1089/scd.2011.0471, DOI 10.1089/SCD.2011.0471, DOI 10.3969/J.ISSN.1674-9200.2012.06.002]; Chou CH, 1976, J CHEM ECOL, V2, P353, DOI 10.1007/BF00988282; Du Jia-fang, 2009, Shengtaixue Zazhi, V28, P445; Fan KW, 2002, MYCOLOGIA, V94, P569, DOI 10.2307/3761708; Fuzzati N, 1999, J CHROMATOGR A, V854, P69, DOI 10.1016/S0021-9673(99)00463-X; Gao Wei-Wei, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1665; He CN, 2009, PLANT SOIL, V318, P63, DOI 10.1007/s11104-008-9817-8; Hoagland DR, 1950, WATER CULTURE METHOD, V347; Jiao XL, 2011, PLANT SOIL, V339, P317, DOI 10.1007/s11104-010-0580-2; Kong CH, 1999, J CHEM ECOL, V25, P2347, DOI 10.1023/A:1020882109682; Leite M, 1999, ANAL CELL PATHOL, V19, P139, DOI 10.1155/1999/176515; Li Y., 2012, OPEN J GENET, V2, P95, DOI [10.4236/ ojgen.2012.22014, DOI 10.4236/OJGEN.2012.22014]; [李勇 LI Yong], 2009, [生态学报, Acta Ecologica Sinica], V29, P161; [李勇 Li Yong], 2008, [生态环境, Ecology and Environment], V17, P1173; Li ZF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028806, 10.1371/journal.pone.0052388]; Luo PX, 1991, SW CHINA J AGR SCI, V4, P77; Luo WF, 1999, J YUNNAN AGR U, V14, P124; Miao ZuoQing, 2006, Scientia Agricultura Sinica, V39, P1371; Ng TB, 2006, J PHARM PHARMACOL, V58, P1007, DOI 10.1211/jpp.58.8.0001; Nicol RW, 2003, PHYTOCHEMISTRY, V64, P257, DOI 10.1016/S0031-9422(03)00271-1; Nicol RW, 2002, CAN J BOT, V80, P557, DOI [10.1139/b02-034, 10.1139/B02-034]; Ogweno JO, 2006, ALLELOPATHY J, V18, P93; Ou Xiaohong, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1905; Rice EL, 1984, ALLELOPATHY; Tan GuoYin, 2012, Journal of Northwest A & F University - Natural Science Edition, V40, P197; WALLER GR, 1993, BOT BULL ACAD SINICA, V34, P1; WILLIAMS RD, 1982, WEED SCI, V30, P206, DOI 10.1017/S0043174500062342; Wu HW, 2007, PLANT SOIL, V296, P85, DOI 10.1007/s11104-007-9292-7; Wu L., 2008, SPECIAL WILD EC ANIM, V2, P68, DOI DOI 10.16720/J.CNKI.TCYJ.2008.02.005; Xiao H, 2010, CHINESE MED J RES PR, V24, P5; Yang JZ, 2010, SPECIAL WILD EC ANIM, V2, P37; [杨敏 Yang Min], 2014, [植物保护, Plant Protection], V40, P76; Ye SF, 2004, PLANT SOIL, V263, P143, DOI 10.1023/B:PLSO.0000047721.78555.dc; Ye SF, 2006, ENVIRON EXP BOT, V56, P255, DOI 10.1016/j.envexpbot.2005.02.010; Yousef LF, 2006, PHYTOCHEMISTRY, V67, P1740, DOI 10.1016/j.phytochem.2005.06.030; YU JQ, 1993, SOIL SCI PLANT NUTR, V39, P13, DOI 10.1080/00380768.1993.10416970; Zhang AH, 2011, J MED PLANTS RES, V5, P3217; Zhang YC, 2012, CHEM RES CHINESE U, V28, P31; Zhao YJ, 2005, ALLELOPATHY J, V15, P67; Zhou JM, 2009, SPECIAL WILD EC ANIM, V3, P37; 周家明, 2007, [中药材, Journal of Chinese Medicinal Materials], V30, P1615	45	85	102	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118555	10.1371/journal.pone.0118555	http://dx.doi.org/10.1371/journal.pone.0118555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695831	gold, Green Published, Green Submitted			2022-12-27	WOS:000350062300056
J	Dufour, CMS; Meynard, C; Watson, J; Rioux, C; Benhamou, S; Perez, J; du Plessis, JJ; Avenant, N; Pillay, N; Ganem, G				Dufour, Claire M. S.; Meynard, Christine; Watson, Johan; Rioux, Camille; Benhamou, Simon; Perez, Julie; du Plessis, Jurie J.; Avenant, Nico; Pillay, Neville; Ganem, Guila			Space Use Variation in Co-Occurring Sister Species: Response to Environmental Variation or Competition?	PLOS ONE			English	Article							HOME-RANGE SIZE; ECOLOGICAL CHARACTER DISPLACEMENT; INTERSPECIFIC COMPETITION; RHABDOMYS-PUMILIO; SPATIAL NICHE; ORGANIZATION; SEPARATION	Coexistence often involves niche differentiation either as the result of environmental divergence, or in response to competition. Disentangling the causes of such divergence requires that environmental variation across space is taken into account, which is rarely done in empirical studies. We address the role of environmental variation versus competition in coexistence between two rodent species: Rhabdomys bechuanae (bechuanae) and Rhabdomys dilectus dilectus (dilectus) comparing their habitat preference and home range (HR) size in areas with similar climates, where their distributions abut (allopatry) or overlap (sympatry). Using Outlying Mean Index analyses, we test whether habitat characteristics of the species deviate significantly from a random sample of available habitats. In allopatry, results suggest habitat selection: dilectus preferring grasslands with little bare soil while bechuanae occurring in open shrublands. In sympatry, shrubland type habitats dominate and differences are less marked, yet dilectus selects habitats with more cover than bechuanae. Interestingly, bechuanae shows larger HRs than dilectus, and both species display larger HRs in sympatry. Further, HR overlaps between species are lower than expected. We discuss our results in light of data on the phylogeography of the genus and propose that evolution in allopatry resulted in adaptation leading to different habitat preferences, even at their distribution margins, a divergence expected to facilitate coexistence. However, since sympatry occurs in sites where environmental characteristics do not allow complete species separation, competition may explain reduced inter-species overlap and character displacement in HR size. This study reveals that both environmental variation and competition may shape species coexistence.	[Dufour, Claire M. S.; Rioux, Camille; Perez, Julie; Ganem, Guila] Univ Montpellier 2, EPHE, IRD, CNRS,UM2,Inst Sci Evolut Montpellier UMR5554, F-34095 Montpellier, France; [Dufour, Claire M. S.; Pillay, Neville; Ganem, Guila] Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2050 Johannesburg, South Africa; [Meynard, Christine] INRA IRD Cirad Montpellier SupAgro, INRA UMR CBGP, F-34988 Montferrier Sur Lez, France; [Watson, Johan] Biodivers Res, Dept Econ Dev Tourism & Environm Affairs, ZA-9300 Bloemfontein, South Africa; [Benhamou, Simon] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, UM2, F-34033 Montpellier, France; [du Plessis, Jurie J.; Avenant, Nico] Univ Orange Free State, Dept Mammal, Natl Museum, Bloemfontein, South Africa; [du Plessis, Jurie J.; Avenant, Nico] Univ Orange Free State, Ctr Environm Management, Bloemfontein, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; University of Witwatersrand; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of the Free State; University of the Free State	Dufour, CMS (corresponding author), Univ Montpellier 2, EPHE, IRD, CNRS,UM2,Inst Sci Evolut Montpellier UMR5554, CC065, F-34095 Montpellier, France.	claire.dufour@univ-montp2.fr; guila.ganem@univ-montp2.fr	Ganem, Guila/AAC-1872-2022; Meynard, Christine N/B-2082-2010	Ganem, Guila/0000-0002-5244-4979; Meynard, Christine N/0000-0002-5983-6289; Avenant, Nico/0000-0002-5390-9010; Pillay, Neville/0000-0002-0778-726X	Free State DTEEA; SIBAGHE; French CNRS/SA NRF [4841, 81859, 191]	Free State DTEEA; SIBAGHE; French CNRS/SA NRF	This work was supported by Free State DTEEA, SIBAGHE, the French CNRS/SA NRF agreements through PICS (no 4841 and no 81859) and GDRI (no 191) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Arakaki S, 2011, J ANIM ECOL, V80, P137, DOI 10.1111/j.1365-2656.2010.01749.x; Benhamou S, 2014, ANIM BEHAV, V90, P171, DOI 10.1016/j.anbehav.2014.01.030; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Doledec S, 2000, ECOLOGY, V81, P2914, DOI 10.1890/0012-9658(2000)081[2914:NSICAA]2.0.CO;2; du Toit N, 2012, MOL PHYLOGENET EVOL, V65, P75, DOI 10.1016/j.ympev.2012.05.036; Ganem G, 2012, ACTA OECOL, V42, P30, DOI 10.1016/j.actao.2012.01.003; Godsall B, 2014, J ANIM ECOL, V83, P126, DOI 10.1111/1365-2656.12116; Goldberg EE, 2006, EVOLUTION, V60, P1344, DOI 10.1111/j.0014-3820.2006.tb01214.x; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; HAWES ML, 1977, J MAMMAL, V58, P354, DOI 10.2307/1379334; HOLMES WG, 1991, ANIM BEHAV, V42, P111, DOI 10.1016/S0003-3472(05)80611-6; Jonsson P, 2002, EVOL ECOL, V16, P455, DOI 10.1023/A:1020854525220; Lira AFA, 2013, ZOOLOGY, V116, P182, DOI 10.1016/j.zool.2013.01.002; Lopez-Darias M, 2012, ECOLOGY, V93, P2512, DOI 10.1890/12-0483.1; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; MACARTHUR R, 1966, AM NAT, V100, P319, DOI 10.1086/282425; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Meynard CN, 2012, ECOL EVOL, V2, P1008, DOI 10.1002/ece3.219; Mikami OK, 2002, ECOGRAPHY, V25, P200, DOI 10.1034/j.1600-0587.2002.250208.x; Mucina L., 2006, VEGETATION S AFRICA; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pfennig DW, 2012, EVOLUTIONS WEDGE COM, DOI [10.1016/S2214-109X(15)70024-0, DOI 10.1016/S2214-109X(15)70024-0]; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; Rambau RV, 2003, MOL PHYLOGENET EVOL, V28, P564, DOI 10.1016/S1055-7903(03)00058-7; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Schradin C, 2006, J ETHOL, V24, P37, DOI 10.1007/s10164-005-0158-2; Schradin C, 2005, J MAMMAL, V86, P99, DOI 10.1644/1545-1542(2005)086<0099:IVITSA>2.0.CO;2; Schradin C, 2004, BEHAV ECOL SOCIOBIOL, V55, P439, DOI 10.1007/s00265-003-0733-x; Schradin C, 2010, ANIM BEHAV, V79, P195, DOI 10.1016/j.anbehav.2009.10.027; Schradin C, 2009, AM NAT, V173, P376, DOI 10.1086/596535; Seidel K., 1992, STAT PROPERTIES APPL; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stapp P, 1997, FUNCT ECOL, V11, P644, DOI 10.1046/j.1365-2435.1997.00133.x; Stradiotto A, 2009, J MAMMAL, V90, P704, DOI 10.1644/08-MAMM-A-120R1.1; Stuart YE, 2013, TRENDS ECOL EVOL, V28, P402, DOI 10.1016/j.tree.2013.02.014; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; TROMBULAK SC, 1985, J MAMMAL, V66, P329, DOI 10.2307/1381245; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zar J.H., 2010, BIOSTAT ANAL	50	28	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117750	10.1371/journal.pone.0117750	http://dx.doi.org/10.1371/journal.pone.0117750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693176	Green Published, gold			2022-12-27	WOS:000350061500072
J	Huettl, RE; Luxenhofer, G; Bianchi, E; Haupt, C; Joshi, R; Prochiantz, A; Huber, AB				Huettl, Rosa-Eva; Luxenhofer, Georg; Bianchi, Elisa; Haupt, Corinna; Joshi, Rajiv; Prochiantz, Alain; Huber, Andrea B.			Engrailed 1 Mediates Correct Formation of Limb Innervation through Two Distinct Mechanisms	PLOS ONE			English	Article							MOTOR AXON GUIDANCE; VERTEBRATE LIMB; MOUSE LIMB; HOMEODOMAIN PROTEIN; VISUAL-CORTEX; RETINAL AXONS; MUTANT MICE; NEURONS; DIFFERENTIATION; EXPRESSION	Engrailed-1 (En1) is expressed in the ventral ectoderm of the developing limb where it plays an instructive role in the dorsal-ventral patterning of the forelimb. Besides its well-described role as a transcription factor in regulating gene expression through its DNA-binding domain, En1 may also be secreted to form an extracellular gradient, and directly impact on the formation of the retinotectal map. We show here that absence of En1 causes mispatterning of the forelimb and thus defects in the dorsal-ventral pathfinding choice of motor axons in vivo. In addition, En1 but not En2 also has a direct and specific repulsive effect on motor axons of the lateral aspect of the lateral motor column (LMC) but not on medial LMC projections. Moreover, an ectopic dorsal source of En1 pushes lateral LMC axons to the ventral limb in vivo. Thus, En1 controls the establishment of limb innervation through two distinct molecular mechanisms.	[Huettl, Rosa-Eva; Luxenhofer, Georg; Bianchi, Elisa; Haupt, Corinna; Huber, Andrea B.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen GmbH, Inst Dev Genet, Munich, Germany; [Haupt, Corinna] Univ Munich, Inst Physiol, D-80539 Munich, Germany; [Joshi, Rajiv; Prochiantz, Alain] Coll France, Ctr Interdisciplinary Res Biol, F-75231 Paris, France	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; UDICE-French Research Universities; PSL Research University Paris; College de France	Huber, AB (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen GmbH, Inst Dev Genet, Munich, Germany.	andrea.huber@helmholtz-muenchen.de		Huettl, Rosa-Eva/0000-0001-8196-9865	German Science Foundation Collaborative Research Centre (CRC) [870]; DAAD-German Academic Exchange Service Scholarship [PKZ: A/07/94958]; Agence Nationale pour la Recherche [ANR-11-BLAN-069467]; Global Research Laboratory Program [2009-00424]; ERC-AdG [339379-Homeosign]	German Science Foundation Collaborative Research Centre (CRC); DAAD-German Academic Exchange Service Scholarship; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Global Research Laboratory Program; ERC-AdG	This work was supported by the German Science Foundation Collaborative Research Centre (CRC) 870, and funded by the DAAD-German Academic Exchange Service Scholarship (PKZ: A/07/94958, EB), the Agence Nationale pour la Recherche (ANR-11-BLAN-069467, AP and RJ), the Global Research Laboratory Program (2009-00424, AP and RJ), and the ERC-2013-AdG (No 339379-Homeosign, AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo M, 1998, DEVELOPMENT, V125, P4195; Beurdeley M, 2012, J NEUROSCI, V32, P9429, DOI 10.1523/JNEUROSCI.0394-12.2012; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chen HX, 1999, CELL TISSUE RES, V296, P67, DOI 10.1007/s004410051267; Chen HX, 2002, INT J DEV BIOL, V46, P937; Cosgaya JM, 1998, J CELL SCI, V111, P2377; Cygan JA, 1997, DEVELOPMENT, V124, P5021; DAVIS CA, 1991, DEVELOPMENT, V111, P287; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Dudanova I, 2012, J NEUROSCI, V32, P5209, DOI 10.1523/JNEUROSCI.5707-11.2012; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Gatto G, 2014, CURR BIOL, V24, P2355, DOI 10.1016/j.cub.2014.08.028; Guimera J, 2006, DEVELOPMENT, V133, P3847, DOI 10.1242/dev.02557; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Huettl RE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001020; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Joliot A, 1998, CURR BIOL, V8, P856, DOI 10.1016/S0960-9822(07)00346-6; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kao TJ, 2012, SEMIN CELL DEV BIOL, V23, P83, DOI 10.1016/j.semcdb.2011.10.016; Krawchuk D, 2008, DEV DYNAM, V237, P1183, DOI 10.1002/dvdy.21514; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Lesaffre B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-2; Logan C, 1996, CURR BIOL, V6, P1006, DOI 10.1016/S0960-9822(02)00645-0; Logan C, 1997, DEVELOPMENT, V124, P2317; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Loomis CA, 1998, DEVELOPMENT, V125, P1137; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Mella S, 2004, GENE EXPR PATTERNS, V4, P537, DOI 10.1016/j.modgep.2004.02.005; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; Nedelec S, 2004, P NATL ACAD SCI US; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Prochiantz A, 2003, NAT REV MOL CELL BIO, V4, P814, DOI 10.1038/nrm1227; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Saueressig H, 1999, DEVELOPMENT, V126, P4201; Stettler O, 2012, DEVELOPMENT, V139, P215, DOI 10.1242/dev.063875; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Swartz ME, 2001, DEVELOPMENT, V128, P4669; Tasssetto M, 2005, EMBO REP, V6, P885, DOI 10.1038/sj.embor.7400487; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018; WURST W, 1994, DEVELOPMENT, V120, P2065; Zarbalis K, 2000, MECH DEVELOP, V93, P165, DOI 10.1016/S0925-4773(00)00252-5; Zhong SC, 2010, CELLS TISSUES ORGANS, V191, P289, DOI 10.1159/000260063	56	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118505	10.1371/journal.pone.0118505	http://dx.doi.org/10.1371/journal.pone.0118505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710467	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900060
J	Boutard, B; Vankerckhove, S; Markine-Goriaynoff, N; Sarlet, M; Desmecht, D; McFadden, G; Vanderplasschen, A; Gillet, L				Boutard, Berengere; Vankerckhove, Sophie; Markine-Goriaynoff, Nicolas; Sarlet, Mickael; Desmecht, Daniel; McFadden, Grant; Vanderplasschen, Alain; Gillet, Laurent			The alpha 2,3-Sialyltransferase Encoded by Myxoma Virus Is a Virulence Factor that Contributes to Immunosuppression	PLOS ONE			English	Article							ALTERNATIVE COMPLEMENT PATHWAY; INTERFERON-GAMMA RECEPTOR; SIALIC-ACID; DENDRITIC CELLS; SINDBIS VIRUS; NEUTROPHILS; HOST; ACTIVATION; HOMOLOG; M-T7	Myxoma virus (MYXV) induces a lethal disease called Myxomatosis in European rabbits. MYXV is one of the rare viruses that encodes an alpha 2,3-sialyltransferase through its M138L gene. In this study, we showed that although the absence of the enzyme was not associated with any in vitro deficit, the M138L deficient strains are highly attenuated in vivo. Indeed, while all rabbits infected with the parental and the revertant strains died within 9 days post-infection from severe myxomatosis, all but one rabbit inoculated with the M138L deficient strains survived the infection. In primary lesions, this resistance to the infection was associated with an increased ability of innate immune cells, mostly neutrophils, to migrate to the site of virus replication at 4 days post-infection. This was followed by the development of a better specific immune response against MYXV. Indeed, at day 9 post-infection, we observed an important proliferation of lymphocytes and an intense congestion of blood vessels in lymph nodes after M138L knockouts infection. Accordingly, in these rabbits, we observed an intense mononuclear cell infiltration throughout the dermis in primary lesions and higher titers of neutralizing antibodies. Finally, this adaptive immune response provided protection to these surviving rabbits against a challenge with the MYXV WT strain. Altogether, these results show that expression of the M138L gene contributes directly or indirectly to immune evasion by MYXV. In the future, these results could help us to better understand the pathogenesis of myxomatosis but also the importance of glycans in regulation of immune responses.	[Boutard, Berengere; Vankerckhove, Sophie; Markine-Goriaynoff, Nicolas; Vanderplasschen, Alain; Gillet, Laurent] Univ Liege, FARAH, Dept Infect & Parasit Dis, Fac Vet Med, Liege, Belgium; [Sarlet, Mickael; Desmecht, Daniel] Univ Liege, FARAH, Fac Vet Med, Dept Morphol & Pathol, Liege, Belgium; [McFadden, Grant] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA	University of Liege; University of Liege; State University System of Florida; University of Florida	Gillet, L (corresponding author), Univ Liege, FARAH, Dept Infect & Parasit Dis, Fac Vet Med, Liege, Belgium.	L.gillet@ulg.ac.be		Gillet, Laurent/0000-0002-1047-2525; Vankerckhove, Sophie/0000-0002-1075-0249; McFadden, Grant/0000-0002-2556-3526	GLYVIR ARC of the University of Liege, Scientific impulse grant [F.4510.10]; FRFC grant of the "Fonds de la Recherche Scientifique - Fonds National Belge de la Recherche Scientifique" (F.R.S. - FNRS) [2.4622.10]; belgian federal BELVIR Interuniversity attraction pole;  [C-11/57]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100987, R01AI080607] Funding Source: NIH RePORTER	GLYVIR ARC of the University of Liege, Scientific impulse grant; FRFC grant of the "Fonds de la Recherche Scientifique - Fonds National Belge de la Recherche Scientifique" (F.R.S. - FNRS)(Fonds de la Recherche Scientifique - FNRS); belgian federal BELVIR Interuniversity attraction pole; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following grants: starting grant (C-11/57) and GLYVIR ARC of the University of Liege (http://www.ulg.ac.be), Scientific impulse grant (no F.4510.10) and FRFC grant (2.4622.10) of the "Fonds de la Recherche Scientifique - Fonds National Belge de la Recherche Scientifique" (F.R.S. - FNRS) (http://www.frs-fnrs.be), and the belgian federal BELVIR Interuniversity attraction pole. B.B. is a Research Fellow of the F.R.S. - FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Best SM, 2000, VIROLOGY, V277, P76, DOI 10.1006/viro.2000.0505; Best SM, 2000, VIROLOGY, V267, P36, DOI 10.1006/viro.1999.0104; Blanie S, 2009, VET RES, V40, DOI 10.1051/vetres:2008049; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Charmoy M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000755; Duffy D, 2012, IMMUNITY, V37, P917, DOI 10.1016/j.immuni.2012.07.015; Eken C, 2008, J IMMUNOL, V180, P817, DOI 10.4049/jimmunol.180.2.817; Favoreel HW, 2003, J GEN VIROL, V84, P1, DOI 10.1099/vir.0.18709-0; FENNER F., 1957, JOUR HYG, V55, P149; Gabriel C, 2013, DNA CELL BIOL, V32, P665, DOI 10.1089/dna.2013.2211; HIRSCH RL, 1983, P NATL ACAD SCI-BIOL, V80, P548, DOI 10.1073/pnas.80.2.548; HIRSCH RL, 1981, J IMMUNOL, V127, P1740; Jackson RJ, 1999, J VIROL, V73, P2376, DOI 10.1128/JVI.73.3.2376-2384.1999; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; Kerr PJ, 2013, J VIROL, V87, P12900, DOI 10.1128/JVI.02060-13; Kerr PJ, 2013, J VIROL, V87, P12080, DOI 10.1128/JVI.01923-13; Kerr PJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002950; Kerr PJ, 2012, ANTIVIR RES, V93, P387, DOI 10.1016/j.antiviral.2012.01.009; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lalani AS, 1999, VIROLOGY, V256, P233, DOI 10.1006/viro.1999.9617; Lalani AS, 1998, VIROLOGY, V250, P173, DOI 10.1006/viro.1998.9340; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Li YH, 2012, APPL MICROBIOL BIOT, V94, P887, DOI 10.1007/s00253-012-4040-1; Liu J, 2009, J VIROL, V83, P5933, DOI 10.1128/JVI.00204-09; Lucas A, 2004, J IMMUNOL, V173, P4765, DOI 10.4049/jimmunol.173.8.4765; MACEN JL, 1993, VIROLOGY, V195, P348, DOI 10.1006/viro.1993.1385; Machiels B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003753; Machiels B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002387; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Markine-Goriaynoff N, 2004, J GEN VIROL, V85, P2741, DOI 10.1099/vir.0.80320-0; MCSHARRY JJ, 1981, VIROLOGY, V114, P507, DOI 10.1016/0042-6822(81)90230-0; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Morel C, 2008, EUR J IMMUNOL, V38, P437, DOI 10.1002/eji.200737905; MOSSMAN K, 1995, J BIOL CHEM, V270, P3031, DOI 10.1074/jbc.270.7.3031; Mossman K, 1996, VIROLOGY, V215, P17, DOI 10.1006/viro.1996.0003; Nakagawa K, 2006, J NEUROCHEM, V96, P924, DOI 10.1111/j.1471-4159.2005.03595.x; Nash P, 2000, BIOCHEM J, V347, P375, DOI 10.1042/0264-6021:3470375; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Rakic B, 2013, GLYCOBIOLOGY, V23, P536, DOI 10.1093/glycob/cwt001; Richards AA, 2010, MOL ENDOCRINOL, V24, P229, DOI 10.1210/me.2009-0133; Soto-Miranda MA, 2013, ANAT REC, V296, P965, DOI 10.1002/ar.22699; Spiesschaert B, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-76; Stacey MA, 2014, CELL HOST MICROBE, V15, P471, DOI 10.1016/j.chom.2014.03.003; Stanford MM, 2007, VET RES, V38, P299, DOI 10.1051/vetres:2006054; Sugiarto G, 2011, GLYCOBIOLOGY, V21, P387, DOI 10.1093/glycob/cwq172; Sujino K, 2000, GLYCOBIOLOGY, V10, P313, DOI 10.1093/glycob/10.3.313; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Zou ZC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024559	56	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118806	10.1371/journal.pone.0118806	http://dx.doi.org/10.1371/journal.pone.0118806			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705900	Green Published, gold			2022-12-27	WOS:000350662100205
J	Cheng, Z; Liu, F; Zhu, S; Tian, HM; Wang, L; Wang, YH				Cheng, Zhe; Liu, Fan; Zhu, Shan; Tian, Huimin; Wang, Liang; Wang, Yanhai			A Rapid and Convenient Method for Fluorescence Analysis of In Vitro Cultivated Metacestode Vesicles from Echinococcus multilocularis	PLOS ONE			English	Article							GROWTH; CELLS	We here describe a convenient method for preparation, fixation and fluorescence analysis of in vitro cultivated metacestode vesicles from E. multilocularis. Parasite materials could be prepared in one hour, did not need to be sectioned, and were subsequently utilized for further whole-mount staining assays directly. Using these preparations, in combination with conventional fluorescence staining techniques, we could detect the expression and subcellular localization of a specific protein and identify in situ proliferative or apoptotic cells in the germinal layer of metacestode vesicles. Based on this approach, future molecular and cellular analysis of Echinococcus metacestode vesicles in the in vitro system will be greatly facilitated.	[Cheng, Zhe; Zhu, Shan; Wang, Liang; Wang, Yanhai] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Liu, Fan; Tian, Huimin] Xiamen Univ, Coll Med, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Wang, YH (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	wangyh@xmu.edu.cn		Wang, Yanhai/0000-0002-0002-2467; Cheng, Zhe/0000-0003-4764-0163	Fundamental Research Funds for the Central Universities of People's Republic of China [2012121044]; National Natural Science Foundation of China [81000740, 81171596, 81201305, 81471970]	Fundamental Research Funds for the Central Universities of People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities of People's Republic of China (No. 2012121044) and the National Natural Science Foundation of China (No. 81000740, 81171596, 81201305, 81471970) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehm K, 2010, PARASITOLOGY, V137, P537, DOI 10.1017/S0031182009991727; Brehm K, 2008, EXP PARASITOL, V119, P506, DOI 10.1016/j.exppara.2008.03.007; Diaz A, 2011, TRENDS PARASITOL, V27, P204, DOI 10.1016/j.pt.2010.12.012; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koziol U, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-10; Koziol U, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-24; Kummer L, 2013, CHEM BIOL, V20, P847, DOI 10.1016/j.chembiol.2013.04.016; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Spiliotis M, 2006, INT J PARASITOL, V36, P1097, DOI 10.1016/j.ijpara.2006.05.008; Spiliotis Markus, 2009, V470, P245, DOI 10.1007/978-1-59745-204-5_17; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4	12	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118215	10.1371/journal.pone.0118215	http://dx.doi.org/10.1371/journal.pone.0118215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705880	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100155
J	Fish, KE; Collins, R; Green, NH; Sharpe, RL; Douterelo, I; Osborn, AM; Boxall, JB				Fish, Katherine E.; Collins, Richard; Green, Nicola H.; Sharpe, Rebecca L.; Douterelo, Isabel; Osborn, A. Mark; Boxall, Joby B.			Characterisation of the Physical Composition and Microbial Community Structure of Biofilms within a Model Full-Scale Drinking Water Distribution System	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; LASER-SCANNING MICROSCOPY; DIVERSITY; BACTERIAL; SOIL; DISCOLORATION; HETEROGENEITY; COAGGREGATION; ARCHAEA; MATRIX	Within drinking water distribution systems (DWDS), microorganisms form multi-species biofilms on internal pipe surfaces. A matrix of extracellular polymeric substances (EPS) is produced by the attached community and provides structure and stability for the biofilm. If the EPS adhesive strength deteriorates or is overcome by external shear forces, biofilm is mobilised into the water potentially leading to degradation of water quality. However, little is known about the EPS within DWDS biofilms or how this is influenced by community composition or environmental parameters, because of the complications in obtaining biofilm samples and the difficulties in analysing EPS. Additionally, although biofilms may contain various microbial groups, research commonly focuses solely upon bacteria. This research applies an EPS analysis method based upon fluorescent confocal laser scanning microscopy (CLSM) in combination with digital image analysis (DIA), to concurrently characterize cells and EPS (carbohydrates and proteins) within drinking water biofilms from a full-scale DWDS experimental pipe loop facility with representative hydraulic conditions. Application of the EPS analysis method, alongside DNA fingerprinting of bacterial, archaeal and fungal communities, was demonstrated for biofilms sampled from different positions around the pipeline, after 28 days growth within the DWDS experimental facility. The volume of EPS was 4.9 times greater than that of the cells within biofilms, with carbohydrates present as the dominant component. Additionally, the greatest proportion of EPS was located above that of the cells. Fungi and archaea were established as important components of the biofilm community, although bacteria were more diverse. Moreover, biofilms from different positions were similar with respect to community structure and the quantity, composition and three-dimensional distribution of cells and EPS, indicating that active colonisation of the pipe wall is an important driver in material accumulation within the DWDS.	[Fish, Katherine E.; Collins, Richard; Douterelo, Isabel; Boxall, Joby B.] Univ Sheffield, Dept Civil & Struct Engn, Pennine Water Grp, Sheffield, S Yorkshire, England; [Fish, Katherine E.] NERC, Biomol Anal Facil, Dept Anim & Plant Sci, Sheffield, S Yorkshire, England; [Green, Nicola H.] Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England; [Sharpe, Rebecca L.] Sheffield Hallam Univ, Dept Nat & Built Environm, Sheffield S1 1WB, S Yorkshire, England; [Osborn, A. Mark] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	University of Sheffield; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Sheffield; Sheffield Hallam University; Royal Melbourne Institute of Technology (RMIT)	Fish, KE (corresponding author), Univ Sheffield, Dept Civil & Struct Engn, Pennine Water Grp, Sheffield, S Yorkshire, England.	k.fish@sheffield.ac.uk	Green, Nicola/K-4674-2019; Osborn, Andrew M/F-5466-2015	Green, Nicola/0000-0001-5413-0642; Osborn, Andrew M/0000-0002-6433-0581; Fish, Katherine/0000-0002-3265-2826; Douterelo Soler, Isabel/0000-0002-3410-8576; Sharpe, Rebecca/0000-0002-2783-9215; Boxall, Joby/0000-0002-4681-6895; Collins, Richard/0000-0001-5449-8535	Natural Environment Research Council (NERC) [NE/H52489X/1]; U.K. Engineering and Physical Sciences Research Council (EPSRC) [EP/G029946/1]; Pennine Water Group EPSRC Platform Grant [EP/1029346/1]; Natural Environment Research Council, UK; University of Sheffield; Engineering and Physical Sciences Research Council [EP/G029946/1, EP/I029346/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010001] Funding Source: researchfish; EPSRC [EP/G029946/1, EP/I029346/1] Funding Source: UKRI; NERC [NBAF010001] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); U.K. Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Pennine Water Group EPSRC Platform Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Sheffield; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KEF was funded by a Natural Environment Research Council (NERC; http://www.nerc.ac.uk/) PhD studentship (NE/H52489X/1). The research was conducted within the Pipe Dreams project, supported by the U.K. Engineering and Physical Sciences Research Council (EPSRC;http://www.epsrc.ac.uk/) (Challenging Engineering: EP/G029946/1) and the Pennine Water Group EPSRC Platform Grant (EP/1029346/1). Microbial community fingerprinting was performed at the NERC Biomolecular Analysis Facility(http://nbaf.nerc.ac.uk/) at Sheffield funded by the Natural Environment Research Council, UK. Article processing charges were funded by The University of Sheffield. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, WATER RES, V46, P1155, DOI 10.1016/j.watres.2011.12.013; Aller JY, 2008, FEMS MICROBIOL ECOL, V65, P74, DOI 10.1111/j.1574-6941.2008.00498.x; Backhus DA, 1997, J CONTAM HYDROL, V28, P337, DOI 10.1016/S0169-7722(97)00018-1; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Boxall J.B., 2001, P COMP CONTR WAT IND; Boxall JB, 2005, J ENVIRON ENG, V131, P716, DOI 10.1061/(ASCE)0733-9372(2005)131:5(716); Buss HL, 2003, GEOMICROBIOL J, V20, P25, DOI 10.1080/01490450303888; Chen MY, 2007, APPL MICROBIOL BIOT, V73, P1463, DOI 10.1007/s00253-006-0617-x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Deines P, 2010, APPL MICROBIOL BIOT, V87, P749, DOI 10.1007/s00253-010-2510-x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Denkhaus E, 2007, MICROCHIM ACTA, V158, P1, DOI 10.1007/s00604-006-0688-5; Douterelo I, 2014, WATER RES, V54, P100, DOI 10.1016/j.watres.2014.01.049; Dror-Ehre A, 2010, WATER RES, V44, P2601, DOI 10.1016/j.watres.2010.01.016; Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3697; Gauthier V, 2001, WATER SCIENCE & TECHNOLOGY: WATER SUPPLY, VOL 1, NO 4, P237, DOI 10.2166/ws.2001.0089; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Gomez-Alvarez V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-122; Hageskal G, 2006, APPL ENVIRON MICROB, V72, P7586, DOI 10.1128/AEM.01628-06; Husband PS, 2008, WATER RES, V42, P4309, DOI 10.1016/j.watres.2008.07.026; Ivleva NP, 2009, ANAL BIOANAL CHEM, V393, P197, DOI 10.1007/s00216-008-2470-5; Jahn A, 1995, WATER SCI TECHNOL, V32, P157, DOI 10.2166/wst.1995.0287; Lawrence JR, 2003, APPL ENVIRON MICROB, V69, P5543, DOI 10.1128/AEM.69.9.5543-5554.2003; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; MANZ W, 1993, APPL ENVIRON MICROB, V59, P2293, DOI 10.1128/AEM.59.7.2293-2298.1993; Martiny AC, 2003, APPL ENVIRON MICROB, V69, P6899, DOI 10.1128/AEM.69.11.6899-6907.2003; McSwain BS, 2005, APPL ENVIRON MICROB, V71, P1051, DOI 10.1128/AEM.71.2.1051-1057.2005; Mohle RB, 2007, BIOTECHNOL BIOENG, V98, P747, DOI 10.1002/bit.21448; Neu TR, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P735; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Privett G, 2007, CREATING ENHANCING D; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramalingam B, 2003, WATER SCI TECHNOL, V13, P1016; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Revetta RP, 2010, WATER RES, V44, P1353, DOI 10.1016/j.watres.2009.11.008; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rickard AH, 2002, APPL ENVIRON MICROB, V68, P3644, DOI 10.1128/AEM.68.7.3644-3650.2002; Schmid M, 2003, WATER RES, V37, P2043, DOI 10.1016/S0043-1354(02)00616-4; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shumi W, 2009, BIOCHIP J, V3, P119; Simoes M, 2005, WATER RES, V39, P5142, DOI 10.1016/j.watres.2005.09.028; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; Staudt C, 2004, BIOTECHNOL BIOENG, V88, P585, DOI 10.1002/bit.20241; STEWART PS, 1995, WATER RES, V29, P2006, DOI 10.1016/0043-1354(94)00339-9; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; van der Wielen PWJJ, 2009, APPL ENVIRON MICROB, V75, P4687, DOI 10.1128/AEM.00387-09; Vreeburg JHG, 2008, WATER RES, V42, P4233, DOI 10.1016/j.watres.2008.05.024; Wagner M, 2009, WATER RES, V43, P63, DOI 10.1016/j.watres.2008.10.034; Wimpenny J, 2000, FEMS MICROBIOL REV, V24, P661, DOI 10.1111/j.1574-6976.2000.tb00565.x; Wu J, 2003, PARTICLES WATER DIST; Yang XM, 2001, WATER RES, V35, P1149, DOI 10.1016/S0043-1354(00)00361-4; Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	56	59	60	5	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115824	10.1371/journal.pone.0115824	http://dx.doi.org/10.1371/journal.pone.0115824			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706303	Green Accepted, Green Published, gold			2022-12-27	WOS:000350662100017
J	Ito, K; Ookawara, S; Ueda, Y; Goto, S; Miyazawa, H; Yamada, H; Kitano, T; Shindo, M; Kaku, Y; Hirai, K; Yoshida, M; Hoshino, T; Nabata, A; Mori, H; Yoshida, I; Kakei, M; Tabei, K				Ito, Kiyonori; Ookawara, Susumu; Ueda, Yuichiro; Goto, Sawako; Miyazawa, Haruhisa; Yamada, Hodaka; Kitano, Taisuke; Shindo, Mitsunobu; Kaku, Yoshio; Hirai, Keiji; Yoshida, Masashi; Hoshino, Taro; Nabata, Aoi; Mori, Honami; Yoshida, Izumi; Kakei, Masafumi; Tabei, Kaoru			Factors Affecting Cerebral Oxygenation in Hemodialysis Patients: Cerebral Oxygenation Associates with pH, Hemodialysis Duration, Serum Albumin Concentration, and Diabetes Mellitus	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; BLOOD-FLOW; RISK; HEMOGLOBIN; HEMATOCRIT; METABOLISM; DEMENTIA; SURGERY	Background Patients undergoing hemodialysis (HD) often develop cerebral disease complications. Furthermore, cerebral regional saturation of oxygen (rSO(2)) was previously reported to be significantly lower in HD patients than in healthy subjects. We aimed to identify the factors affecting the cerebral rSO(2) in HD patients. Methods Fifty-four HD patients (38 men and 16 women; mean age, 67.7 +/- 1.2 years, HD duration, 6.5 +/- 1.9 years) were recruited. Cerebral rSO(2) was monitored at the forehead before HD using an INVOS 5100C (Covidien Japan, Tokyo, Japan). Results The rSO(2) levels were significantly lower in HD patients compared with healthy controls (49.5 +/- 1.7% vs. 68.9 +/- 1.6%, p < 0.001). Multiple regression analysis showed that cerebral rSO(2) independently associated with pH (standardized coefficient: - 0.35), HD duration (standardized coefficient: - 0.33), and serum albumin concentration (standardized coefficient: 0.28). Furthermore, the rSO(2) was significantly lower in HD patients with diabetes mellitus (DM), compared with patients without DM (46.8 +/- 1.7% vs. 52.1 +/- 1.8%, p < 0.05). Conclusions In HD patients, cerebral rSO(2) was affected by multiple factors, including pH, HD duration, and serum albumin concentration. Furthermore, this is the first report describing significantly lower levels of rSO(2) in HD patients with DM than in those without DM.				su-ooka@hb.tp1.jp		Tabei, Seyed MohammadBegher/0000-0001-9923-6969				Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Calderon-Arnulphi M, 2007, J NEUROSURG, V106, P283, DOI 10.3171/jns.2007.106.2.283; Cosentino F, 2009, STROKE, V40, P306, DOI 10.1161/STROKEAHA.108.520627; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; GENNARI FJ, 1984, NEW ENGL J MED, V310, P102, DOI 10.1056/NEJM198401123100207; Hoshino T, 2014, NEPHRON CLIN PRACT, V126, P57, DOI 10.1159/000358432; Jun IG, 2013, TRANSPL P, V45, P245, DOI 10.1016/j.transproceed.2012.10.025; Kanai H, 2001, AM J KIDNEY DIS, V38, pS129, DOI 10.1053/ajkd.2001.27421; Kim YS, 2008, CLIN SCI, V115, P255, DOI 10.1042/CS20070458; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; Lemmers PMA, 2008, PEDIATRICS, V121, P142, DOI 10.1542/peds.2007-0925; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; MACKO RF, 1993, STROKE, V24, P1025, DOI 10.1161/01.STR.24.7.1025; McCusker K, 2006, PERFUSION-UK, V21, P149, DOI 10.1191/0267659106pf863oa; Metry G, 1999, J AM SOC NEPHROL, V10, P854; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Naganuma T, 2005, KIDNEY INT, V67, P2434, DOI 10.1111/j.1523-1755.2005.00351.x; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Nielsen AL, 1999, BLOOD PURIFICAT, V17, P206, DOI 10.1159/000014397; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Ono M, 2013, CRIT CARE MED, V41, P464, DOI 10.1097/CCM.0b013e31826ab3a1; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Parnia S, 2014, CRIT CARE MED, V42, P930, DOI 10.1097/CCM.0000000000000047; Portoles JM, 2008, KIDNEY INT, V74, pS82, DOI 10.1038/ki.2008.524; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Roach RC, 1999, AM J PHYSIOL-HEART C, V276, pH438, DOI 10.1152/ajpheart.1999.276.2.H438; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Stenvinkel P, 2000, NEPHROL DIAL TRANSPL, V15, P953, DOI 10.1093/ndt/15.7.953; Tanaka H, 2007, INT MED J, V14, P35; Tobias JD, 2006, EXPERT REV MED DEVIC, V3, P235, DOI 10.1586/17434440.3.2.235; Ulatowski JA, 1998, AM J PHYSIOL-HEART C, V274, pH1933, DOI 10.1152/ajpheart.1998.274.6.H1933; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443	32	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117474	10.1371/journal.pone.0117474	http://dx.doi.org/10.1371/journal.pone.0117474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706868	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100092
J	Kohler, A; Bocker, U; Shapaval, V; Forsmark, A; Andersson, M; Warringer, J; Martens, H; Omholt, SW; Blomberg, A				Kohler, Achim; Bocker, Ulrike; Shapaval, Volha; Forsmark, Annabelle; Andersson, Mats; Warringer, Jonas; Martens, Harald; Omholt, Stig W.; Blomberg, Anders			High-Throughput Biochemical Fingerprinting of Saccharomyces cerevisiae by Fourier Transform Infrared Spectroscopy	PLOS ONE			English	Article							MULTIPLICATIVE SIGNAL CORRECTION; FT-IR SPECTRA; YEAST	Single-channel optical density measurements of population growth are the dominant large scale phenotyping methodology for bridging the gene-function gap in yeast. However, a substantial amount of the genetic variation induced by single allele, single gene or double gene knock-out technologies fail to manifest in detectable growth phenotypes under conditions readily testable in the laboratory. Thus, new high-throughput phenotyping technologies capable of providing information about molecular level consequences of genetic variation are sorely needed. Here we report a protocol for high-throughput Fourier transform infrared spectroscopy (FTIR) measuring biochemical fingerprints of yeast strains. It includes high-throughput cultivation for FTIR spectroscopy, FTIR measurements and spectral pretreatment to increase measurement accuracy. We demonstrate its capacity to distinguish not only yeast genera, species and populations, but also strains that differ only by a single gene, its excellent signal-to-noise ratio and its relative robustness to measurement bias. Finally, we illustrated its applicability by determining the FTIR signatures of all viable Saccharomyces cerevisiae single gene knock-outs corresponding to lipid biosynthesis genes. Many of the examined knock-out strains showed distinct, highly reproducible FTIR phenotypes despite having no detectable growth phenotype. These phenotypes were confirmed by conventional lipid analysis and could be linked to specific changes in lipid composition. We conclude that the introduced protocol is robust to noise and bias, possible to apply on a very large scale, and capable of generating biologically meaningful biochemical fingerprints that are strain specific, even when strains lack detectable growth phenotypes. Thus, it has a substantial potential for application in the molecular functionalization of the yeast genome.	[Kohler, Achim; Shapaval, Volha; Martens, Harald] Norwegian Univ Life Sci, Dept Math Sci & Technol, CIGENE, As, Norway; [Kohler, Achim; Bocker, Ulrike; Shapaval, Volha; Martens, Harald] Nofima AS, As, Norway; [Forsmark, Annabelle; Warringer, Jonas; Blomberg, Anders] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Forsmark, Annabelle; Warringer, Jonas; Omholt, Stig W.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, CIGENE, As, Norway; [Andersson, Mats] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	Norwegian University of Life Sciences; Nofima; University of Gothenburg; Norwegian University of Life Sciences; University of Gothenburg	Kohler, A (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, CIGENE, As, Norway.	achim.kohler@nmbu.no	Andersson, Mats/E-7958-2010	Andersson, Mats/0000-0003-4279-6572; Blomberg, Anders/0000-0002-1260-3920; Bocker, Ulrike/0000-0001-5443-9340; Kohler, Achim/0000-0001-5759-1989; Shapaval, Volha/0000-0003-2674-1328	Research Council of Norway through its National Programme of Functional Genomics in Norway (FUGE) [183306/S10]; eScience Programme [178901/V30]	Research Council of Norway through its National Programme of Functional Genomics in Norway (FUGE); eScience Programme	The present study was supported by the Research Council of Norway through its National Programme of Functional Genomics in Norway (FUGE) (grant number 183306/S10) and its eScience Programme (grant number 178901/V30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afseth NK, 2010, APPL SPECTROSC, V64, P700, DOI 10.1366/000370210791666200; Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Barwick VJ, 1999, J CHROMATOGR A, V849, P13, DOI 10.1016/S0021-9673(99)00537-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hahn-Hagerdal B, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-31; Helm D., 1991, MICROBIOLOGY, V137, P69; Indahl UG, 2009, J CHEMOMETR, V23, P495, DOI 10.1002/cem.1243; Kohler A, 2008, APPL SPECTROSC, V62, P259, DOI 10.1366/000370208783759669; Kohler A., 2010, Applications of vibrational spectroscopy in food science: Volume II: Analysis of food, drink and related materials, P483; Kohler A, 2005, APPL SPECTROSC, V59, P707, DOI 10.1366/0003702054280649; Kohler A, 2008, BIOMEDICAL VIBRATION, P333; Liti G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-69; Maquelin K, 2002, J MICROBIOL METH, V51, P255, DOI 10.1016/S0167-7012(02)00127-6; Martens H., 2001, MULTIVARIATE ANAL QU; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; Naumann D, 2001, APPL SPECTROSC REV, V36, P239, DOI 10.1081/ASR-100106157; Naumann D., 2008, BIOMEDICAL VIBRATION, P1, DOI DOI 10.1002/9780470283172.CH1; Oust A, 2004, FEMS MICROBIOL LETT, V239, P111, DOI 10.1016/j.femsle.2004.08.024; Oust A, 2006, J MICROBIOL METH, V65, P573, DOI 10.1016/j.mimet.2005.10.009; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Rebuffo C, 2006, APPL ENV MICROBIOLOG; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SOMMARIN M, 1988, BIOCHIM BIOPHYS ACTA, V958, P268, DOI 10.1016/0005-2760(88)90185-3; STEVENS A, 2001, HUMAN HISTOLOGY; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100	29	27	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118052	10.1371/journal.pone.0118052	http://dx.doi.org/10.1371/journal.pone.0118052			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706524	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350662100139
J	Zamudio, C; Krapp, F; Choi, HW; Shah, L; Ciampi, A; Gotuzzo, E; Heymann, J; Seas, C; Brewer, TF				Zamudio, Carlos; Krapp, Fiorella; Choi, Howard W.; Shah, Lena; Ciampi, Antonio; Gotuzzo, Eduardo; Heymann, Jody; Seas, Carlos; Brewer, Timothy F.			Public Transportation and Tuberculosis Transmission in a High Incidence Setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RISK; LIMA	Background Tuberculosis (TB) transmission may occur with exposure to an infectious contact often in the setting of household environments, but extra-domiciliary transmission also may happen. We evaluated if using buses and/or minibuses as public transportation was associated with acquiring TB in a high incidence urban district in Lima, Peru. Methods Newly diagnosed TB cases with no history of previous treatment and community controls were recruited from August to December 2008 for a case-control study. Crude and adjusted odd ratios (OR) and 95% confidence intervals (CI) were calculated using logistic regression to study the association between bus/minibus use and TB risk. Results One hundred forty TB cases and 80 controls were included. The overall use of buses/minibuses was 44.9%; 53.3%(72/135) among cases and 30.4%(24/79) among controls [OR: 3.50, (95% CI: 1.60-7.64)]. In the TB group, 25.7%(36/140) of subjects reported having had a recent household TB contact, and 13%(18/139) reported having had a workplace TB contact; corresponding figures for controls were 3.8% (3/80) and 4.1%(3/73), respectively[OR: 8.88 (95% CI: 2.64-29.92), and OR: 3.89 (95% CI: 1.10-13.70)]. In multivariate analyses, age, household income, household contact and using buses/minibuses to commute to work were independently associated with TB [OR for bus/minibus use: 11.8 (95% CI: 1.45-96.07)]. Conclusions Bus/minibus use to commute to work is associated with TB risk in this high-incidence, urban population in Lima, Peru. Measures should be implemented to prevent TB transmission through this exposure.	[Zamudio, Carlos; Krapp, Fiorella; Gotuzzo, Eduardo; Seas, Carlos] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Choi, Howard W.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Shah, Lena; Ciampi, Antonio; Heymann, Jody] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Gotuzzo, Eduardo; Seas, Carlos] Hosp Nacl Cayetano Heredia, Dept Enfermedades Infecciosas Tropicales & Dermat, Lima, Peru; [Heymann, Jody] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Brewer, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; McGill University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zamudio, C (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.	Carlos.zamudio@upch.pe	Krapp, Fiorella/ABG-7436-2021	Krapp, Fiorella/0000-0002-8404-2827; Heymann, Jody/0000-0003-0008-4198; Seas, Carlos/0000-0001-7067-9141; Zamudio, Carlos/0000-0001-7479-127X	Royal Victoria Hospital Foundation; Fonds de la Recherche en Sante, Quebec; National Institutes of Health, International Clinical, Operational, and Health Services Research and Training Award	Royal Victoria Hospital Foundation; Fonds de la Recherche en Sante, Quebec(Fonds de la Recherche en Sante du Quebec); National Institutes of Health, International Clinical, Operational, and Health Services Research and Training Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the Royal Victoria Hospital Foundation and Fonds de la Recherche en Sante, Quebec. Dr. Fiorella Krapp was supported in part by a National Institutes of Health, International Clinical, Operational, and Health Services Research and Training Award to the Universidad Peruana Cayetano Heredia. The sponsors had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Andrews JR, 2013, AM J EPIDEMIOL, V177, P556, DOI 10.1093/aje/kws331; ARIANO E, 1994, EPIDEMIOL INFECT, V113, P83, DOI 10.1017/S0950268800051499; Bonilla Asalde Cesar, 2008, Acta méd. peruana, V25, P163; Brewer TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025861; Edelson PJ, 2011, TRAVEL MED INFECT DI, V9, P27, DOI 10.1016/j.tmaid.2010.11.001; Feske ML, 2011, TUBERCULOSIS, V91, pS16, DOI 10.1016/j.tube.2011.10.005; Golub JE, 2001, ARCH INTERN MED, V161, P2254, DOI 10.1001/archinte.161.18.2254; Holmes W, 2001, INT J EPIDEMIOL, V30, P1233; Horna-Campos OJ, 2010, INT J TUBERC LUNG D, V14, P714; Horna-Campos OJ, 2007, EMERG INFECT DIS, V13, P1491, DOI 10.3201/eid1310.060793; Instituto Nacional de Estadistica e Informatica, 2007, CENS NAC 2007 11 POB; Horna-Campos OJ, 2011, OCCUP ENVIRON MED, V68, P163, DOI 10.1136/oem.2009.051128; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Ministerio de Salud del Peru, 2006, NORM TECN SAL CONTR; Mohr O, 2012, EURO SURVEILLANCE, V17; Moore M, 1999, CLIN INFECT DIS, V28, P52, DOI 10.1086/515089; Neira-Munoz E, 2008, PEDIATR INFECT DIS J, V27, P836, DOI 10.1097/INF.0b013e31816ff7c5; Quispe Candia L, NUESTRO MENSAJE; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yusuf HR, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.3.e9	21	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115230	10.1371/journal.pone.0115230	http://dx.doi.org/10.1371/journal.pone.0115230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706530	Green Published, gold			2022-12-27	WOS:000350662100009
J	Popa-Lisseanu, AG; Kramer-Schadt, S; Quetglas, J; Delgado-Huertas, A; Kelm, DH; Ibanez, C				Popa-Lisseanu, Ana G.; Kramer-Schadt, Stephanie; Quetglas, Juan; Delgado-Huertas, Antonio; Kelm, Detlev H.; Ibanez, Carlos			Seasonal Variation in Stable Carbon and Nitrogen Isotope Values of Bats Reflect Environmental Baselines	PLOS ONE			English	Article							SEALS CALLORHINUS-URSINUS; ECOSYSTEM RESPIRATION; FEEDING ECOLOGY; GLOBAL PATTERNS; MYOTIS-MYOTIS; DIET QUALITY; AMAZON BASIN; DELTA-N-15; DISCRIMINATION; DELTA-C-13	The stable carbon and nitrogen isotope composition of animal tissues is commonly used to trace wildlife diets and analyze food chains. Changes in an animal's isotopic values over time are generally assumed to indicate diet shifts or, less frequently, physiological changes. Although plant isotopic values are known to correlate with climatic seasonality, only a few studies restricted to aquatic environments have investigated whether temporal isotopic varia-tion in consumers may also reflect environmental baselines through trophic propagation. We modeled the monthly variation in carbon and nitrogen isotope values in whole blood of four insectivorous bat species occupying different foraging niches in southern Spain. We found a common pattern of isotopic variation independent of feeding habits, with an overall change as large as or larger than one trophic step. Physiological changes related to reproduction or to fat deposition prior to hibernation had no effect on isotopic variation, but juvenile bats had higher delta C-13 and delta N-15 values than adults. Aridity was the factor that best explained isotopic variation: bat blood became enriched in both C-13 and N-15 after hotter and/or drier periods. Our study is the first to show that consumers in terrestrial ecosystems reflect seasonal environmental dynamics in their isotope values. We highlight the danger of misinterpreting stable isotope data when not accounting for seasonal isotopic baselines in food web studies. Understanding how environmental seasonality is inte-grated in animals' isotope values will be crucial for developing reliable methods to use stable isotopes as dietary tracers.	[Popa-Lisseanu, Ana G.; Quetglas, Juan; Kelm, Detlev H.; Ibanez, Carlos] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Popa-Lisseanu, Ana G.; Delgado-Huertas, Antonio] CSIC, Estn Expt Zaidin, Granada, Spain; [Kramer-Schadt, Stephanie] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Leibniz Institut fur Zoo und Wildtierforschung	Popa-Lisseanu, AG (corresponding author), Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany.	anapopa@izw-berlin.de	Huertas, Antonio Delgado/F-6866-2011; Ibanez, Carlos/H-7577-2015; Kramer-Schadt, Stephanie/A-8778-2013; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Huertas, Antonio Delgado/0000-0002-7240-1570; Ibanez, Carlos/0000-0003-1181-7641; Kramer-Schadt, Stephanie/0000-0002-9269-4446; Quetglas Santos, Juan/0000-0003-1579-8636	Junta de Andalucia [P06-RNM-02362]; Spanish Ministry of Education and Science [AP-2002-3721]; Alexander von Humboldt Foundation	Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Education and Science(Spanish Government); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This project was funded by the Junta de Andalucia (project P06-RNM-02362). A.G.P.-L. was supported by the Spanish Ministry of Education and Science (pre-doctoral fellowship AP-2002-3721), by the Junta de Andalucia, and during the writing stage, by the Alexander von Humboldt Foundation with a post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1987, NATURE, V325, P201, DOI 10.1038/325201a0; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; [Anonymous], 1985, OECOLOGIA; Anthony E.L.P., 1988, P47; Arlettaz R, 1997, J ANIM ECOL, V66, P897, DOI 10.2307/6005; Bedard-Haughn A, 2003, J HYDROL, V272, P175, DOI 10.1016/S0022-1694(02)00263-9; Blumenthal SA, 2012, P NATL ACAD SCI USA, V109, P21277, DOI 10.1073/pnas.1215782109; Bosch J, 1997, OECOLOGIA, V109, P583, DOI 10.1007/s004420050120; Bowling DR, 2002, OECOLOGIA, V131, P113, DOI 10.1007/s00442-001-0851-y; Cerling TE, 2004, AFR J ECOL, V42, P88, DOI 10.1111/j.1365-2028.2004.00500.x; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Codron J, 2005, J ARCHAEOL SCI, V32, P1757, DOI 10.1016/j.jas.2005.06.006; Consejeria de Agricultura y Pesca, 2004, AN EST AGR PESQ AND; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Della Coletta L, 2009, SCI AGR, V66, P467, DOI 10.1590/S0103-90162009000400006; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Dethier MN, 2013, MAR ECOL PROG SER, V478, P1, DOI 10.3354/meps10310; Dietz C., 2007, HDB FLEDERMAUSE EURO; Ehleringer J.R., 1991, CARBON ISOTOPE TECHN, P187; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gross J., 2012, NORTEST TESTS NORMAL; Gustine DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103471; Habran S, 2010, MAR MAMMAL SCI, V26, P880, DOI 10.1111/j.1748-7692.2010.00372.x; Hache S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094437; Harding AMA, 2008, POLAR BIOL, V31, P725, DOI 10.1007/s00300-008-0413-4; Harding EK, 2001, OECOLOGIA, V129, P436, DOI 10.1007/s004420100729; Hartman G, 2011, FUNCT ECOL, V25, P122, DOI 10.1111/j.1365-2435.2010.01782.x; HERRERA J, 1986, VEGETATIO, V68, P91; Hobson KA, 2000, CAN J ZOOL, V78, P1332, DOI 10.1139/cjz-78-8-1332; Hobson KA, 1997, CAN J ZOOL, V75, P1720, DOI 10.1139/z97-799; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; HoghJensen H, 1997, PLANT PHYSIOL BIOCH, V35, P55; Hopkins JB, 2012, J WILDLIFE MANAGE, V76, P703, DOI 10.1002/jwmg.318; Houlton BZ, 2006, P NATL ACAD SCI USA, V103, P8745, DOI 10.1073/pnas.0510185103; Ibanez C, 2001, P NATL ACAD SCI USA, V98, P9700, DOI 10.1073/pnas.171140598; Ibanez C, 1997, J ZOOL, V243, P836, DOI 10.1111/j.1469-7998.1997.tb01981.x; Ibanez C., 2004, HDB SAUGETIERE EUROP, VII, P695, DOI DOI 10.1080/0964704X.2013.774246; Jardine TD, 2008, FRESHWATER BIOL, V53, P2192, DOI 10.1111/j.1365-2427.2008.02044.x; Jenkins SG, 2001, OECOLOGIA, V129, P336, DOI 10.1007/s004420100755; Kunz T.H., 1988, P277; Kurle CM, 2002, CAN J ZOOL, V80, P902, DOI 10.1139/Z02-069; Kurle CM, 2001, OECOLOGIA, V126, P254, DOI 10.1007/s004420000518; Lee TN, 2012, J EXP BIOL, V215, P3354, DOI 10.1242/jeb.068528; McDowell NG, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002049; Miron MLL, 2006, J EXP BIOL, V209, P541, DOI 10.1242/jeb.02016; Murphy BP, 2006, FUNCT ECOL, V20, P1062, DOI 10.1111/j.1365-2435.2006.01186.x; Nelson DE, 1998, OECOLOGIA, V116, P177, DOI 10.1007/s004420050577; Ometto JPHB, 2006, BIOGEOCHEMISTRY, V79, P251, DOI 10.1007/s10533-006-9008-8; Ometto JPHB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001462; Ostrom PH, 1997, OECOLOGIA, V109, P108, DOI 10.1007/s004420050064; Parker KL, 2005, J MAMMAL, V86, P610, DOI 10.1644/1545-1542(2005)86[610:PCIFCR]2.0.CO;2; Pearson SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062891; Perez-Jorda JL, 1994, THESIS U SEVILLE; Peri PL, 2012, GLOBAL CHANGE BIOL, V18, P311, DOI 10.1111/j.1365-2486.2011.02494.x; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; Popa-Lisseanu AG, 2009, J ZOOL, V278, P126, DOI 10.1111/j.1469-7998.2009.00556.x; Popa-Lisseanu AG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000205; Popa-Lisseanu AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030388; Porte A, 2001, TREE PHYSIOL, V21, P861, DOI 10.1093/treephys/21.12-13.861; Presetnik P, 2013, MAMMALIA, V77, P297, DOI 10.1515/mammalia-2012-0033; Quan C, 2013, PALAEOGEOGR PALAEOCL, V386, P86, DOI 10.1016/j.palaeo.2013.05.008; R Development Core Team, 2014, R LANG ENV STAT COMP; Rascher KG, 2010, TREE PHYSIOL, V30, P1499, DOI 10.1093/treephys/tpq092; Reserva Biologica de Donana, 2014, EQ SEG MED FIS MET P; Rolff C, 2000, MAR ECOL PROG SER, V203, P47, DOI 10.3354/meps203047; Roth JD, 2002, OECOLOGIA, V133, P70, DOI 10.1007/s00442-002-1004-7; Schulze ED, 2006, TREE PHYSIOL, V26, P479, DOI 10.1093/treephys/26.4.479; Sears J, 2009, OECOLOGIA, V159, P41, DOI 10.1007/s00442-008-1199-3; Shim JH, 2009, OECOLOGIA, V160, P321, DOI 10.1007/s00442-009-1302-4; Smirnov DG, 2012, IZVESTIIA AKAD NAUK, V2, P227; Speakman JR, 1999, P NUTR SOC, V58, P123, DOI 10.1079/PNS19990017; Srivastava RK, 2008, J EXP ZOOL PART A, V309A, P94, DOI 10.1002/jez.440; Uhrin Marcel, 2006, Vespertilio, V9-10, P183; Vizzini S, 2003, MAR BIOL, V142, P1009, DOI 10.1007/s00227-003-1027-6; Voigt CC, 2006, J MAMMAL, V87, P1, DOI 10.1644/05-MAMM-F-276R1.1; Voigt CC, 2006, CAN J ZOOL, V84, P397, DOI 10.1139/z06-007; Voigt CC, 2014, BIODIVERS CONSERV, V23, P617, DOI 10.1007/s10531-014-0620-y; Wang L, 2012, BIOGEOSCIENCES, V9, P1583, DOI 10.5194/bg-9-1583-2012; Wang LL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031021; Warren CR, 2001, OECOLOGIA, V127, P476, DOI 10.1007/s004420000609; Werner C, 2006, NEW PHYTOL, V172, P330, DOI 10.1111/j.1469-8137.2006.01836.x; Whitaker JO, 2009, ACTA CHIROPTEROL, V11, P393, DOI 10.3161/150811009X485611; Williams DG, 1996, OECOLOGIA, V106, P455, DOI 10.1007/BF00329701; Wood S, 2014, MGCV MIXED GAM COMPU; Woodland RJ, 2012, OECOLOGIA, V169, P199, DOI 10.1007/s00442-011-2178-7; Woodland RJ, 2012, ECOLOGY, V93, P131, DOI 10.1890/11-0505.1; Zhoufeng Wang, 2011, 2011 International Symposium on Water Resource and Environmental Protection (ISWREP), P2418, DOI 10.1109/ISWREP.2011.5893756	93	9	9	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117052	10.1371/journal.pone.0117052	http://dx.doi.org/10.1371/journal.pone.0117052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700080	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800015
J	Afulani, PA				Afulani, Patience A.			Rural/Urban and Socioeconomic Differentials in Quality of Antenatal Care in Ghana	PLOS ONE			English	Article							MATERNAL MORTALITY; OF-CARE; HEALTH; DELIVERY; SERVICES; STRATEGIES; LEVEL; MODEL; LABOR; TOO	Background Approximately 800 women die of pregnancy-related complications every day. Over half of these deaths occur in sub-Saharan Africa (SSA). Most maternal deaths can be prevented with high quality maternal health services. It is well established that use of maternal health services vary by place of residence and socioeconomic status (SES), but few studies have examined the determinants of quality of maternal health services in SSA. The purpose of this study is to examine the determinants of antenatal care (ANC) quality in Ghana-focusing on the role of place of residence and SES (education and wealth). The analysis also examines the interactions of these variables and the mediating role of ANC timing, frequency, facility type, and provider type. Methods The data are from the Ghana Maternal Health Survey (N = 4,868). Analytic techniques include multilevel linear regression with mediation and moderation analysis. Results Urban residence and higher SES are positively associated with higher ANC quality, but the urban effect is completely explained by sociodemographic factors. Specifically, about half of the urban effect is explained by education and wealth alone, with other variables accounting for the remainder. The effects of education are conditional on wealth and are strongest for poor women. Starting ANC visits early and attending the recommended four visits as well as receiving ANC from a higher level facility and from a skilled provider are associated with higher quality ANC. These factors partially explain the SES differentials.	[Afulani, Patience A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90089 USA; [Afulani, Patience A.] Calif Ctr Populat Res, Los Angeles, CA USA	University of California System; University of California Los Angeles	Afulani, PA (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA 90089 USA.	pafulani@ucla.edu		Afulani, Patience/0000-0002-6739-234X	Bixby Doctoral Fellowship in Population from the UCLA Bixby Center on Population and Reproductive Health; Celia and Joseph Blann Fellowship from the UCLA School of Public Health; UCLA Affiliates Scholarship from the UCLA Graduate Division	Bixby Doctoral Fellowship in Population from the UCLA Bixby Center on Population and Reproductive Health; Celia and Joseph Blann Fellowship from the UCLA School of Public Health; UCLA Affiliates Scholarship from the UCLA Graduate Division	The author received no funding for this work. She was supported by the following fellowships: the Bixby Doctoral Fellowship in Population from the UCLA Bixby Center on Population and Reproductive Health; the Celia and Joseph Blann Fellowship from the UCLA School of Public Health; and the UCLA Affiliates Scholarship from the UCLA Graduate Division. These fellowship funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjiwanou V, 2013, SOC SCI MED, V86, P26, DOI 10.1016/j.socscimed.2013.02.047; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Andersen HM, 2004, SOC SCI MED, V59, P2003, DOI 10.1016/j.socscimed.2004.03.005; Aneshensel CS, 2013, THEOR BAS DAT AN SOC, DOI [10.1016/j.jfo.2013.06.003, DOI 10.1016/J.JFO.2013.06.003]; [Anonymous], 2008, DEMOGRAPHIC HLTH RES; Appiah-Denkyira E, 2013, INTERVENTIONS HUMAN, DOI [10.1016/j.jfo.2013.06.003, DOI 10.1016/J.JFO.2013.06.003]; Atinga RA, 2013, INT J SOC ECON, V40, P852, DOI 10.1108/IJSE-2011-0075; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Bbaale E, 2011, AUSTRALAS MED J, V4, P516, DOI 10.4066/AMJ.2011.849; Boller C, 2003, B WORLD HEALTH ORGAN, V81, P116; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Bullough C, 2005, BJOG-INT J OBSTET GY, V112, P1180, DOI 10.1111/j.1471-0528.2005.00718.x; Cai TJ, 2013, SOCIOL METHODOL, V43, P178, DOI 10.1177/0081175012460221; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carroli G, 2001, PAEDIATR PERINAT EP, V15, P1; Crosby RA., 2006, RES METHODS HLTH PRO; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; Davis J., 1971, ELEMENTARY SURVEY AN; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Duong DV, 2004, SOC SCI MED, V59, P2585, DOI 10.1016/j.socscimed.2004.04.007; Fauveau V, 2006, INT J GYNECOL OBSTET, V94, P179, DOI 10.1016/j.ijgo.2006.05.020; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Ghana Health Service, 2012, GHAN HHLTH SERV 2011; [Ghana Health Service UNICEF UNFPA WHO AMDD Ghana Ministry of Health], 2011, NAT ASS EM OBST NEWB; Ghana Statistical Service, 2012, 2010 CENS REP; Ghana Statistical Service, 2011, MULT IND CLUST SURV; Ghana Statistical Service Ghana Health Service Macro International, 2009, GHAN MAT HLTH SURV 2; Graham WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001368; Graham WJ, 2012, LANCET, V379, pE5, DOI 10.1016/S0140-6736(10)62267-2; GSS, 2008, MEAS DHS MACR INT GH; Hamilton LC, 2012, STAT STATA VERSION 1, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Hox J. J., 2010, MULTILEVEL ANAL; Hulton L, 2000, FRAMEWORK EVALUATION; Hutchinson PL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-203; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Krull JL, 2001, MULTIVAR BEHAV RES, V36, P249, DOI 10.1207/S15327906MBR3602_06; Kyei NNA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046475; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Ministry of Health Ghana Ghana Health service UNDP, 2011, GHAN MDG ACC FRAM CO; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; Moyer CA, 2014, MIDWIFERY, V30, P262, DOI 10.1016/j.midw.2013.05.006; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Nikiema B, 2009, HEALTH POLICY PLANN, V24, P367, DOI 10.1093/heapol/czp017; Rabe-Hesketh S, 2012, MULTILEVEL LONGITUDI, VII, DOI [10.1007/ s12070- 012- 0514- 9, DOI 10.1007/S12070-012-0514-9]; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tran TK, 2012, BMC PLANT BIOL, V12, P0, DOI [10.1186/ 1472- 6963- 12- 40, DOI 10.1186/1471-2229-12-1]; Treiman D., 2009, QUANTITATIVE DATA AN; Tuncalp O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044536; United Nations Secretary General, 2010, GLOB STRAT WOM CHILD; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; van Duong D, 2004, INT J QUAL HEALTH C, V16, P447, DOI 10.1093/intqhc/mzh073; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009; *WHO, 2004, MAK PREG SAF CRIT RO; WHO Department of making pregnancy safer, 2006, STAND MAT NEON CAR M; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Witter S, 2007, REPROD HEALTH MATTER, V15, P61; Witter S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1881; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization U, 2003, ANT CA DEV COUNTR PR; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	65	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117996	10.1371/journal.pone.0117996	http://dx.doi.org/10.1371/journal.pone.0117996			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695737	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300037
J	Serra, AJ; de Carvalho, PDC; Lanza, F; Flandes, CD; Silva, SC; Suzuki, FS; Bocalini, DS; Andrade, E; Casarin, C; Silva, JA				Serra, Andrey Jorge; Camillo de Carvalho, Paulo de Tarso; Lanza, Fernanda; Flandes, Camila de Amorim; Silva, Shirley Cardoso; Suzuki, Frank Shiguemitsu; Bocalini, Danilo Sales; Andrade, Erinaldo; Casarin, Cezar; Silva, Jose Antonio, Jr.			Correlation of Six-Minute Walking Performance with Quality of Life is Domain-and Gender-Specific in Healthy Older Adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; 10 COUNTRIES; SF-36; EXERCISE; WOMEN	We analyzed the relationship between performance on the 6-min walk test (6MWT) and health-related quality of life (HRQoL) in older subjects. Our secondary aim was to determine the distance to be completed on the 6MWT for the subject to achieve a score of 50 on the Short Form (36) Health Survey (SF-36). Associations were tested using linear correlation and multivariate linear regression. Participants were 130 healthy older individuals. The predictive performance of the 6MWT based on an SF-36 score of 50 was assessed using a receiver operating characteristic curve and its area under curve (AUC). Associations were observed between physical functioning, role-emotional, social functioning, vitality, general health score, and 6MWT performance in women, after adjusting for confounding variables (coefficients: 0.57, 0.38, 0.40, and 0.46, respectively; p < 0.05). No association was found for men. The distance for the 6MWT to predict an SF-36 score of 50 was 481 m for men in the physical functioning (AUC: 0.79) and role-physical (AUC: 0.84) domains, and 420 m for women in role-emotional (AUC: 0.75), role-physical (AUC: 0.80), and general health (AUC: 0.80) domains. Our results indicate that superior 6MWT performance may be associated with better HRQoL in several domains in only healthy older women. No association between 6MWT performance and role-emotional, mental health, or vitality domains was found. We suggest that a score of 50 is represented by a 6MWT distance of 481 m for men and 420 m for women, at least in the role-physical domain.	[Serra, Andrey Jorge; Camillo de Carvalho, Paulo de Tarso; Flandes, Camila de Amorim; Silva, Shirley Cardoso; Suzuki, Frank Shiguemitsu; Andrade, Erinaldo; Casarin, Cezar; Silva, Jose Antonio, Jr.] Nove Julho Univ UNINOVE, Sao Paulo, SP, Brazil; [Lanza, Fernanda] Nove Julho Univ UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, SP, Brazil; [Bocalini, Danilo Sales] Univ Sao Judas Tadeu, Sao Paulo, SP, Brazil	Universidade Nove de Julho; Universidade Nove de Julho; Universidade Sao Judas Tadeu	Serra, AJ (corresponding author), Nove Julho Univ UNINOVE, Sao Paulo, SP, Brazil.	andreyserra@gmail.com	Silva, Jose Antonio/AAA-8100-2019; ANDRADE, ERINALDO L/O-8090-2014; Serra, Andrey Jorge/E-7460-2015; de Tarso C de Carvalho, Paulo/G-5333-2011; Bocalini, Danilo/J-1997-2014; Lanza, Fernanda C/N-8414-2013	Silva, Jose Antonio/0000-0001-6904-9185; ANDRADE, ERINALDO L/0000-0002-2598-4558; Serra, Andrey Jorge/0000-0002-5407-8183; de Tarso C de Carvalho, Paulo/0000-0001-9624-4103; Lanza, Fernanda C/0000-0002-4748-6947				Andresen EM, 1999, AGE AGEING, V28, P562, DOI 10.1093/ageing/28.6.562; Brown CD, 2008, COPD, V5, P117, DOI 10.1080/15412550801941265; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Cohen-Mansfield J, 2013, INT J AGING HUM DEV, V77, P37, DOI 10.2190/AG.77.1.c; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Daltroy LH, 1999, SOC SCI MED, V48, P1549, DOI 10.1016/S0277-9536(99)00048-9; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Groepenhoff H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072013; Hsieh CB, 2010, TRANSPL P, V42, P3597, DOI 10.1016/j.transproceed.2010.06.033; KANTZ ME, 1992, MED CARE, V30, pMS240, DOI 10.1097/00005650-199205001-00024; Leinonen R, 2001, SOC SCI MED, V52, P1329, DOI 10.1016/S0277-9536(00)00249-5; Vieira DCL, 2013, CLIN INTERV AGING, V8, P1377, DOI 10.2147/CIA.S50333; Lorraine Phillips J, 2005, Prev Chronic Dis, V2, pA12; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Olivares PR, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-117; Oudegeest-Sander MH, 2014, J AGING PHY IN PRESS; Rejeski WJ, 2001, J GERONTOL A-BIOL, V56, P23, DOI 10.1093/gerona/56.suppl_2.23; Serra AJ, 2009, CONSCIENTIAE SAUDE, V8, P19, DOI [10.1364/OE.22.031568, DOI 10.1364/OE.22.031568]; Smedt DD, 2013, EUR J PREV CARDIOL, V21, P796; Sozeri-Varma G, 2012, AGING DIS, V3, P465; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Wanderley FAC, 2011, QUAL LIFE RES, V20, P1371, DOI 10.1007/s11136-011-9875-x; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Ware JE, 2004, SF 36 HLTH SURV UPDA; Williams JS, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-25; World Health Organization, 2013, AG LIF COURS CAR IND	28	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117359	10.1371/journal.pone.0117359	http://dx.doi.org/10.1371/journal.pone.0117359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695668	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300021
J	Smeeing, DPJ; Houwert, RM; Briet, JP; Kelder, JC; Segers, MJM; Verleisdonk, EJMM; Leenen, LPH; Hietbrink, F				Smeeing, Diederik P. J.; Houwert, Roderick M.; Briet, Jan Paul; Kelder, Johannes C.; Segers, Michiel J. M.; Verleisdonk, Egbert Jan M. M.; Leenen, Luke P. H.; Hietbrink, Falco			Weight-Bearing and Mobilization in the Postoperative Care of Ankle Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Cohort Studies	PLOS ONE			English	Review							INTERNAL-FIXATION; OPERATIVE TREATMENT; OPEN REDUCTION; SURGERY RESEARCH; EARLY MOTION; IMMOBILIZATION; EPIDEMIOLOGY; MANAGEMENT; COST; CAST	Purpose To determine the effectiveness and safety of interventions used for rehabilitation after open reduction and internal fixation of ankle fractures. Methods A systematic review and meta-analysis was performed using both randomized trials and cohort studies. The effect of mobilization, weight-bearing, and unprotected weight-bearing as tolerated on postoperative recovery was compared using the Olerud Molander score, return to work/daily activities, and the rate of complications. Results A total of 25 articles were included. Ankle exercises resulted in earlier return to work and/or daily activities compared to immobilization (mean difference (MD) -20.76 days; 95% confidence interval (CI) -40.02 to -1.50). There was no difference in the rate of complications between exercises and immobilization (risk ratio (RR) 1.22; 95% CI 0.60 to 2.45) or between early and late weight-bearing (RR 1.26; 95% CI 0.56 to 2.85). Interpretation Results of this meta-analysis show that following ankle surgery, 1) active exercises accelerate return to work and daily activities compared to immobilization, 2) early weight-bearing tends to accelerate return to work and daily activities compared to late weight-bearing. Active exercises in combination with immediate weight-bearing may be a safe option.	[Smeeing, Diederik P. J.; Leenen, Luke P. H.; Hietbrink, Falco] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Houwert, Roderick M.] Univ Med Ctr Utrecht, Ctr Trauma, Utrecht, Netherlands; [Briet, Jan Paul; Verleisdonk, Egbert Jan M. M.] Diakonessenhuis Utrecht, Dept Surg, Utrecht, Netherlands; [Kelder, Johannes C.] St Antonius Hosp Nieuwegein, Dept Epidemiol, Nieuwegein, Netherlands; [Segers, Michiel J. M.] St Antonius Hosp Nieuwegein, Dept Surg, Nieuwegein, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Diakonessenhuis; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht	Smeeing, DPJ (corresponding author), Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands.	diederiksmeeing@hotmail.com	Houwert, Roderick/K-7887-2019	Houwert, Roderick/0000-0003-3497-659X				AHL T, 1993, ACTA ORTHOP SCAND, V64, P95, DOI 10.3109/17453679308994541; AHL T, 1988, ACTA ORTHOP SCAND, V59, P302, DOI 10.3109/17453678809149368; AHL T, 1987, ACTA ORTHOP SCAND, V58, P535, DOI 10.3109/17453678709146394; AHL T, 1986, ACTA ORTHOP SCAND, V57, P526, DOI 10.3109/17453678609014785; Antonopoulos CN, 2011, EUR J VASC ENDOVASC, V42, P751, DOI 10.1016/j.ejvs.2011.08.012; Bhandari M, 2004, ACTA ORTHOP SCAND, V75, P100, DOI 10.1080/00016470410001708200; Black J D J, 2013, Foot (Edinb), V23, P78, DOI 10.1016/j.foot.2013.05.002; Christie AD, 1990, PHYSIOTHERAPY, V6, P3; CIMINO W, 1991, CLIN ORTHOP RELAT R, P152; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; DALY PJ, 1987, ACTA ORTHOP SCAND, V58, P539, DOI 10.3109/17453678709146395; Del Buono A, 2013, BRIT MED BULL, V106, P179, DOI 10.1093/bmb/lds039; Distasio Anthony J. Ii, 1994, Contemporary Orthopaedics, V29, P273; Dogra AS, 1999, INJURY, V30, P417, DOI 10.1016/S0020-1383(99)00110-2; Egol KA, 2000, J BONE JOINT SURG BR, V82B, P246, DOI 10.1302/0301-620X.82B2.10039; FINSEN V, 1989, J BONE JOINT SURG AM, V71A, P23, DOI 10.2106/00004623-198971010-00005; GODSIFF SP, 1993, INJURY, V24, P529, DOI 10.1016/0020-1383(93)90029-6; Gul A, 2007, ACTA ORTHOP BELG, V73, P360; Harager K, 2000, J Orthop Sci, V5, P552, DOI 10.1007/s007760070004; HEDSTROM M, 1994, CLIN ORTHOP RELAT R, P193; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Honigmann P, 2007, ARCH ORTHOP TRAUM SU, V127, P195, DOI 10.1007/s00402-006-0255-x; HUGHES JL, 1979, CLIN ORTHOP RELAT R, P111; Jacobs WCH, 2012, SPINE J, V12, P706, DOI 10.1016/j.spinee.2012.08.424; Jacobs WCH, 2012, SPINE J, V12, P339, DOI 10.1016/j.spinee.2012.01.015; Jain N, 2008, ANN ROY COLL SURG, V90, P483, DOI 10.1308/003588408X301145; Jensen SL, 1998, ACTA ORTHOP SCAND, V69, P48, DOI 10.3109/17453679809002356; Kimmel LA, 2012, INJURY, V43, P766, DOI 10.1016/j.injury.2011.08.031; Lauge-Hansen N, 1942, THESIS MUNKSGAARD; Lehtonen H, 2003, J BONE JOINT SURG AM, V85A, P205, DOI 10.2106/00004623-200302000-00004; Lin CWC, 2008, AUST J PHYSIOTHER, V54, P201; Lin CWC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005595.pub3; LUNDKRISTENSEN J, 1981, INJURY, V13, P191, DOI 10.1016/0020-1383(81)90237-0; Murray AM, 2011, INJURY, V42, P1226, DOI 10.1016/j.injury.2010.08.023; Nash CE, 2004, J FAM PRACTICE, V53, P706; Nilsson GM, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-109; OLERUD C, 1984, ARCH ORTHOP TRAUM SU, V103, P190, DOI 10.1007/BF00435553; OLERUD C, 1986, INJURY, V17, P23, DOI 10.1016/0020-1383(86)90008-2; Partenheimer A, 2010, UNFALLCHIRURG, V113, P308, DOI 10.1007/s00113-009-1724-9; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Richter J, 1996, CHIRURG, V67, P1255, DOI 10.1007/s001040050135; Seiger C., 2009, EUR J TRAUMA; Simanski CJP, 2006, J ORTHOP TRAUMA, V20, P108, DOI 10.1097/01.bot.0000197701.96954.8c; Smith TO, 2008, EUR J TRAUMA EMERG S, V34, P69, DOI 10.1007/s00068-007-6111-z; SONDENAA K, 1986, ACTA ORTHOP SCAND, V57, P59, DOI 10.3109/17453678608993217; Starkweather MP, 2012, J FOOT ANKLE SURG, V51, P575, DOI 10.1053/j.jfas.2012.05.022; Thomas G, 2009, FOOT ANKLE INT, V30, P666, DOI 10.3113/FAI.2009.0666; Toivanen JAK, 2003, CURR ORTHOPAED, V17, P167, DOI 10.1016/S0268-0890(03)00047-1; TROPP H, 1995, FOOT ANKLE INT, V16, P79, DOI 10.1177/107110079501600205; vanLaarhoven CJHM, 1996, J BONE JOINT SURG BR, V78B, P395, DOI 10.1302/0301-620X.78B3.0780395; Vioreanu M, 2007, FOOT ANKLE INT, V28, P13, DOI 10.3113/FAI.2007.0003; Wetzler M, 1991, ORTHOP T, V15, P719	52	54	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118320	10.1371/journal.pone.0118320	http://dx.doi.org/10.1371/journal.pone.0118320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695796	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300048
J	Kakumani, PK; Chinnappan, M; Singh, AK; Malhotra, P; Mukherjee, SK; Bhatnagar, RK				Kakumani, Pavan Kumar; Chinnappan, Mahendran; Singh, Ashok K.; Malhotra, Pawan; Mukherjee, Sunil K.; Bhatnagar, Raj K.			Identification and Characteristics of microRNAs from Army Worm, Spodoptera frugiperda Cell Line Sf21	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; TARGET RECOGNITION; RNAS; BIOGENESIS; EVOLUTION; GENES	microRNAs play important regulatory role in all intrinsic cellular functions. Amongst lepidopteran insects, miRNAs from only Bombyx mori have been studied extensively with a little focus on Spodoptera sp. In the present study, we identified a total of 226 miRNAs from Spodoptera frugiperda cell line Sf21. Of the total, 116 miRNAs were well conserved within other insects, like B. mori, Drosophila melanogaster and Tribolium castenum while the remaining 110 miRNAs were identified as novel based on comparative analysis with the insect miRNA data set. Landscape distribution analysis based on Sf21 genome assembly revealed clustering of few novel miRNAs. A total of 5 miRNA clusters were identified and the largest one encodes 5 miRNA genes. In addition, 12 miRNAs were validated using northern blot analysis and putative functional role assignment for 6 Sf miRNAs was investigated by examining their relative abundance at different developmental stages of Spodoptera litura and body parts of 6th instar larvae. Further, we identified a total of 809 potential target genes with GO terms for selected miRNAs, involved in different metabolic and signalling pathways of the insect. The newly identified miRNAs greatly enrich the repertoire of insect miRNAs and analysis of expression profiles reveal their involvement at various steps of biochemical pathways of the army worm.	[Kakumani, Pavan Kumar; Chinnappan, Mahendran; Bhatnagar, Raj K.] Int Ctr Genet Engn & Biotechnol, Insect Resistance Grp, New Delhi 110067, India; [Singh, Ashok K.] Univ Delhi, Dept Zool, New Delhi 110007, India; [Malhotra, Pawan] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi 110067, India; [Mukherjee, Sunil K.] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Malhotra, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	pawanm@icgeb.res.in; sunilm@icgeb.res.in; raj@icgeb.res.in	Chinnappan, Mahendran/AAH-4930-2021; Singh, Ashok/HGF-2506-2022; Kakumani, Pavan Kumar/AFH-9007-2022	Kakumani, Pavan Kumar/0000-0002-8755-860X	Dept. of Biotechnology, Govt. of India [BT/PR10673/AGR/36/579/2008]	Dept. of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported by a financial grant from the Dept. of Biotechnology, Govt. of India, (BT/PR10673/AGR/36/579/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2007, CELL, V131, P11, DOI 10.1016/S0092-8674(04)00045-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Ge X, 2013, INT J BIOL SCI, V9, P1, DOI 10.7150/ijbs.5249; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; He PA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-248; Hussain M, 2010, J VIROL, V84, P612, DOI 10.1128/JVI.01794-09; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Kakumani PK, 2014, GENOMICS, V104, P134, DOI 10.1016/j.ygeno.2014.06.005; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mehrabadi M, 2013, J GEN VIROL, V94, P1385, DOI 10.1099/vir.0.051060-0; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Plasterk R, 2006, FEBS J, V273, P15; Rao ZC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037730; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rubio M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-386; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu XM, 2009, GENOMICS, V94, P438, DOI 10.1016/j.ygeno.2009.08.007; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677	50	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116988	10.1371/journal.pone.0116988	http://dx.doi.org/10.1371/journal.pone.0116988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693181	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500032
J	Alexandre, T; Rayna, B; Munier-Lehmann, H				Alexandre, Thomas; Rayna, Bertrand; Munier-Lehmann, Helene			Two Classes of Bacterial IMPDHs according to Their Quaternary Structures and Catalytic Properties	PLOS ONE			English	Article							INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE; CBS DOMAINS; 5-MONOPHOSPHATE DEHYDROGENASE; MONOPHOSPHATE DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS; SEDIMENTATION-VELOCITY; ALLOSTERIC REGULATION; BORRELIA-BURGDORFERI; ACID DEHYDROGENASE; BACILLUS-SUBTILIS	Inosine-5'-monophosphate dehydrogenase (IMPDH) occupies a key position in purine nucleotide metabolism. In this study, we have performed the biochemical and physico-chemical characterization of eight bacterial IMPDHs, among which six were totally unexplored. This study led to a classification of bacterial IMPDHs according to the regulation of their catalytic properties and their quaternary structures. Class I IMPDHs are cooperative enzymes for IMP, which are activated by MgATP and are octameric in all tested conditions. On the other hand, class II IMPDHs behave as Michaelis-Menten enzymes for both substrates and are tetramers in their apo state or in the presence of IMP, which are shifted to octamers in the presence of NAD or MgATP. Our work provides new insights into the IMPDH functional regulation and a model for the quaternary structure modulation is proposed.	[Alexandre, Thomas; Munier-Lehmann, Helene] Inst Pasteur, Unite Chim & Biocatalyse, Dept Biol Struct & Chim, F-75015 Paris, France; [Alexandre, Thomas; Munier-Lehmann, Helene] Ctr Natl Rech Sci, UMR 3523, F-75015 Paris, France; [Alexandre, Thomas] Univ Paris Diderot, Sorbonne Paris Cite, F-75205 Paris, France; [Rayna, Bertrand] Inst Pasteur, Proteopole, Plateforme Biophys Macromol & Leurs Interact, F-75015 Paris, France; [Rayna, Bertrand] Ctr Natl Rech Sci, UMR 3528, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Munier-Lehmann, H (corresponding author), Inst Pasteur, Unite Chim & Biocatalyse, Dept Biol Struct & Chim, 28 Rue Dr Roux, F-75015 Paris, France.	helene.munier-lehmann@pasteur.fr	Munier-Lehmann, Hélène/Q-1867-2019; Munier-Lehmann, Helene/N-9889-2017	Munier-Lehmann, Hélène/0000-0001-7579-8561; Munier-Lehmann, Helene/0000-0001-7579-8561; raynal, Bertrand/0000-0001-5634-0408	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante Et de la Recherche Medicale (INSERM); Institut Pasteur; Conseil Regional d'Ile-de-France; D.I.M. maladies infectieuses, parasitaires et nosocomiales emergentes	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur(European Commission); Conseil Regional d'Ile-de-France(Region Ile-de-France); D.I.M. maladies infectieuses, parasitaires et nosocomiales emergentes	This work was supported in part by the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante Et de la Recherche Medicale (INSERM), and the Institut Pasteur. Thomas Alexandre was a recipient of a PhD fellowship from the Conseil Regional d'Ile-de-France and the "D.I.M. maladies infectieuses, parasitaires et nosocomiales emergentes" 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, BD TALON MET AFF RES; [Anonymous], 2013, J MOL BIOL, V425, P1391, DOI [10.1016/j.jmb.2013.03.026, DOI 10.1016/J.JMB.2013.03.026]; [Anonymous], 2013, J MOL BIOL, V425, P2227; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Chen LQ, 2007, CURR OPIN DRUG DISC, V10, P403; Chen LQ, 2010, J MED CHEM, V53, P4768, DOI 10.1021/jm100424m; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Evrin C, 2007, J BIOL CHEM, V282, P7242, DOI 10.1074/jbc.M606963200; GILBERT HJ, 1979, BIOCHEM J, V183, P481, DOI 10.1042/bj1830481; Gollapalli DR, 2010, CHEM BIOL, V17, P1084, DOI 10.1016/j.chembiol.2010.07.014; Hedstrom L, 2011, CURR MED CHEM, V18, P1909, DOI 10.2174/092986711795590129; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jaffe EK, 2012, ARCH BIOCHEM BIOPHYS, V519, P144, DOI 10.1016/j.abb.2011.10.010; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; Kerr KM, 1997, BIOCHEMISTRY-US, V36, P13365, DOI 10.1021/bi9714161; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kozhevnikova EN, 2012, MOL CELL, V47, P133, DOI 10.1016/j.molcel.2012.04.030; Labesse G, 2013, STRUCTURE, V21, P975, DOI 10.1016/j.str.2013.03.011; Labesse G, 2011, NUCLEIC ACIDS RES, V39, P3458, DOI 10.1093/nar/gkq1250; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Makowska-Grzyska M, 2012, BIOCHEMISTRY-US, V51, P6148, DOI 10.1021/bi300511w; McMillan FM, 2000, BIOCHEMISTRY-US, V39, P4533, DOI 10.1021/bi992645l; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mortimer SE, 2005, BIOCHEM J, V390, P41, DOI 10.1042/BJ20042051; MUNIER H, 1991, EUR J BIOCHEM, V196, P469, DOI 10.1111/j.1432-1033.1991.tb15838.x; Nair Vasu, 2007, Antiviral Chemistry & Chemotherapy, V18, P245; Pankiewicz K. W., 2003, ACS S SERIES; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; Pimkin M, 2009, J BIOL CHEM, V284, P7960, DOI 10.1074/jbc.M808541200; Ratcliffe AJ, 2006, CURR OPIN DRUG DISC, V9, P595; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; Solovyova A, 2001, BIOPHYS J, V81, P1868, DOI 10.1016/S0006-3495(01)75838-9; Umejiego NN, 2008, CHEM BIOL, V15, P70, DOI 10.1016/j.chembiol.2007.12.010; Usha V, 2011, MICROBIOL-SGM, V157, P290, DOI 10.1099/mic.0.042549-0; WU TW, 1973, CAN J BIOCHEM CELL B, V51, P1380, DOI 10.1139/o73-181; WU TW, 1973, CAN J BIOCHEM CELL B, V51, P1391, DOI 10.1139/o73-182; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang RG, 1999, CURR MED CHEM, V6, P537; Zhou X, 1997, J BIOL CHEM, V272, P21977, DOI 10.1074/jbc.272.35.21977	45	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116578	10.1371/journal.pone.0116578	http://dx.doi.org/10.1371/journal.pone.0116578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706619	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100040
J	Appukuttan, D; Seo, HS; Jeong, S; Im, S; Joe, M; Song, D; Choi, J; Lim, S				Appukuttan, Deepti; Seo, Ho Seong; Jeong, Sunwook; Im, Sunghun; Joe, Minho; Song, Dusup; Choi, Jungjoon; Lim, Sangyong			Expression and Mutational Analysis of DinB-Like Protein DR0053 in Deinococcus radiodurans	PLOS ONE			English	Article							EXTREME RADIORESISTANCE; IONIZING-RADIATION; DNA-REPAIR; TYROSINE-KINASES; DDRB PROTEIN; PPRA; RESISTANCE; GENOME; DAMAGE; RECOMBINATION	In order to understand the mechanism governing radiation resistance in Deinococcus radiodurans, current efforts are aimed at identifying potential candidates from a large repertoire of unique Deinococcal genes and protein families. DR0053 belongs to the DinB/YfiT protein family, which is an over-represented protein family in D. radiodurans. We observed that dr0053 transcript levels were highly induced in response to gamma radiation (gamma-radiation) and mitomycin C (MMC) exposure depending on PprI, RecA and the DrtR/S two-component signal transduction system. Protein profiles demonstrated that DR0053 is a highly induced protein in cultures exposed to 10 kGy gamma-radiation. We were able to determine the transcriptional start site of dr0053, which was induced upon irradiation, and to assign the 133-bp promoter region of dr0053 as essential for radiation responsiveness through primer extension and promoter deletion analyses. A dr0053 mutant strain displayed sensitivity to gamma-radiation and MMC exposure, but not hydrogen peroxide, suggesting that DR0053 helps cells recover from DNA damage. Bioinformatic analyses revealed that DR0053 is similar to the Bacillus subtilis protein YjoA, which is a substrate of bacterial protein-tyrosine kinases. Taken together, the DNA damage-inducible (din) gene dr0053 may be regulated at the transcriptional and post-translational levels.	[Appukuttan, Deepti; Seo, Ho Seong; Jeong, Sunwook; Im, Sunghun; Joe, Minho; Song, Dusup; Lim, Sangyong] Korea Atom Energy Res Inst, Res Div Biotechnol, Jeongeup, South Korea; [Choi, Jungjoon] Seoul Natl Univ, Ctr Agr Biomat, Dept Agr Biotechnol, Seoul, South Korea; [Choi, Jungjoon] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Korea Atomic Energy Research Institute (KAERI); Seoul National University (SNU); Seoul National University (SNU)	Lim, S (corresponding author), Korea Atom Energy Res Inst, Res Div Biotechnol, Jeongeup, South Korea.	saylim@kaeri.re.kr	Seo, Ho Seong/V-1806-2019; Choi, Jeongjoon/AAL-5387-2021	Choi, Jeongjoon/0000-0002-4137-6923; Appukuttan, Deepti/0000-0002-1606-5824; Jeong, Sun-Wook/0000-0003-1763-6489; Seo, Ho Seong/0000-0002-7103-1344	Ministry of Science, ICT, and Future Planning (MSIP), Republic of Korea	Ministry of Science, ICT, and Future Planning (MSIP), Republic of Korea	This research was supported by the Nuclear Research and Development Program of the Ministry of Science, ICT, and Future Planning (MSIP), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Calva E, 2006, MICROB ECOL, V51, P166, DOI 10.1007/s00248-005-0087-1; Confalonieri F, 2011, J PHYS CONF SER, V261, DOI 10.1088/1742-6596/261/1/012005; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; DALY MJ, 1995, J BACTERIOL, V177, P5495, DOI 10.1128/jb.177.19.5495-5505.1995; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; de Groot A, 2014, GENOME BIOL EVOL, V6, P932, DOI 10.1093/gbe/evu069; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; Desai SS, 2011, MICROBIOL-SGM, V157, P2974, DOI 10.1099/mic.0.049361-0; Devigne A, 2013, DNA REPAIR, V12, P265, DOI 10.1016/j.dnarep.2013.01.004; Dorman CJ, 2002, SYMP SOC GEN MICROBI, V61, P41; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; Funayama T, 1999, MUTAT RES-DNA REPAIR, V435, P151, DOI 10.1016/S0921-8777(99)00044-0; Grangeasse C, 2010, BBA-PROTEINS PROTEOM, V1804, P628, DOI 10.1016/j.bbapap.2009.08.018; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Im S, 2013, BIOPROC BIOSYST ENG, V36, P781, DOI 10.1007/s00449-013-0904-8; Jers C, 2010, MOL MICROBIOL, V77, P287, DOI 10.1111/j.1365-2958.2010.07227.x; Joe MH, 2012, BIOPROC BIOSYST ENG, V35, P265, DOI 10.1007/s00449-011-0610-3; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KITAYAMA S, 1982, BIOCHIM BIOPHYS ACTA, V697, P381, DOI 10.1016/0167-4781(82)90103-8; Kota S, 2014, J GENET, V93, P349, DOI 10.1007/s12041-014-0382-z; Kota S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085288; Lenhart JS, 2012, MICROBIOL MOL BIOL R, V76, P530, DOI 10.1128/MMBR.05020-11; LENNON E, 1990, J BACTERIOL, V172, P2955, DOI 10.1128/jb.172.6.2955-2961.1990; Li MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054420; Lim S, 2012, J MICROBIOL BIOTECHN, V22, P1296, DOI 10.4014/jmb.1202.02039; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lu HM, 2012, DNA REPAIR, V11, P139, DOI 10.1016/j.dnarep.2011.10.013; Makarova KS, 2000, GENETICA, V108, P25, DOI 10.1023/A:1004035424657; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Meima R, 2000, APPL ENVIRON MICROB, V66, P3856, DOI 10.1128/AEM.66.9.3856-3867.2000; Meinel T, 2005, NUCLEIC ACIDS RES, V33, pD226; Misra HS, 2013, CURR SCI INDIA, V104, P194; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Norais CA, 2009, J BIOL CHEM, V284, P21402, DOI 10.1074/jbc.M109.010454; Ohba H, 2005, GENE, V363, P133, DOI 10.1016/j.gene.2005.07.035; Ohba H, 2009, EXTREMOPHILES, V13, P471, DOI 10.1007/s00792-009-0232-8; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Rajpurohit YS, 2010, MOL MICROBIOL, V77, P1470, DOI 10.1111/j.1365-2958.2010.07301.x; Satoh K, 2006, MICROBIOL-SGM, V152, P3217, DOI 10.1099/mic.0.29139-0; Sheng DH, 2005, DNA REPAIR, V4, P671, DOI 10.1016/j.dnarep.2005.02.006; Shi L, 2014, GENOME BIOL EVOL, V6, P800, DOI 10.1093/gbe/evu056; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; SOMMER S, 1985, MOL GEN GENET, V198, P456, DOI 10.1007/BF00332939; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; Wang LY, 2012, CHINESE SCI BULL, V57, P98, DOI 10.1007/s11434-011-4790-7; Xu GZ, 2010, DNA REPAIR, V9, P805, DOI 10.1016/j.dnarep.2010.04.006; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875	56	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118275	10.1371/journal.pone.0118275	http://dx.doi.org/10.1371/journal.pone.0118275			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706748	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100161
J	Luo, D; McGettrick, HM; Stone, PC; Rainger, GE; Nash, GB				Luo, Ding; McGettrick, Helen M.; Stone, Phil C.; Rainger, George E.; Nash, Gerard B.			The Roles of Integrins in Function of Human Neutrophils after Their Migration through Endothelium into Interstitial Matrix	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INTERCELLULAR-ADHESION MOLECULE-1; COLONY-STIMULATING FACTOR; IN-VIVO; TRANSENDOTHELIAL MIGRATION; BASEMENT-MEMBRANE; TNF-ALPHA; EXTRAVASCULAR TISSUE; EXTRACELLULAR-MATRIX; FLOWING NEUTROPHILS	We investigated the changes in neutrophil phenotype and function after transendothelial migration, and the roles played by integrin receptors in their behaviour. Neutrophils were tracked microscopically as they migrated through endothelial cells into collagen gels, and were retrieved at desired times. When endothelial cells were treated with increasing doses of tumour necrosis factor-alpha, neutrophils not only migrated in greater number, but also to a greater depth in the gel. Apoptosis was barely detectable in neutrophils retrieved after 24h, and many remained viable and motile at 48h. Neutrophils retrieved after 1h had increased oxidative capacity and at 24h had similar capacity as freshly-isolated neutrophils. However, by then they had impaired ability to phagocytose bacteria. Compared to fresh neutrophils, total mRNA was halved by 24h, but while beta 2-integrin expression decreased, beta 1- and beta 3-integrin increased along with ICAM-1. Studies of integrin blockade indicated that while beta 2-integrins were needed to cross the endothelial barrier, no integrins were required for migration within the gel. beta 2-integrins also contributed to phagocytosis, but their binding was not required for prolonged survival. These results demonstrate a model for integrated analysis of neutrophil migration and function, and describe development of effector functions and the roles of integrins in human neutrophils for the first time.	[Luo, Ding; Stone, Phil C.; Rainger, George E.; Nash, Gerard B.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [McGettrick, Helen M.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Nash, GB (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England.	g.nash@bham.ac.uk	McGettrick, Helen M/H-3442-2011; Nash, Gerard B/E-4182-2010	McGettrick, Helen M/0000-0002-5950-8840; Nash, Gerard B/0000-0002-5935-2831	British Heart Foundation [PG/08/128/26525]	British Heart Foundation(British Heart Foundation)	This work was funded by The British Heart Foundation (grant number PG/08/128/26525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahra P, 1998, CELL ADHES COMMUN, V6, P491, DOI 10.3109/15419069809010797; BOHNSACK JF, 1992, BLOOD, V79, P1545; BRACH MA, 1992, BLOOD, V80, P2920; Buckley CD, 2006, J LEUKOCYTE BIOL, V79, P303, DOI 10.1189/jlb.0905496; Burton VJ, 2011, EXP CELL RES, V317, P276, DOI 10.1016/j.yexcr.2010.10.022; Butler LM, 2008, CELL IMMUNOL, V251, P56, DOI 10.1016/j.cellimm.2008.04.004; BUTTRUM SM, 1993, BLOOD, V82, P1165; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; COOKE BM, 1993, MICROVASC RES, V45, P33, DOI 10.1006/mvre.1993.1004; Coxon A, 1999, J EXP MED, V190, P923, DOI 10.1084/jem.190.7.923; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Dangerfield J, 2002, J EXP MED, V196, P1201, DOI 10.1084/jem.20020324; Dangerfield JP, 2005, J LEUKOCYTE BIOL, V77, P159, DOI 10.1189/jlb.0704421; Decleva E, 2002, J LEUKOCYTE BIOL, V72, P718; Ding ZM, 1999, J IMMUNOL, V163, P5029; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; GINIS I, 1997, AM J PHYSIOL, V272, P295; Gonzalez AL, 2007, J LEUKOCYTE BIOL, V81, P686, DOI 10.1189/jlb.0906553; Kettritz R, 1998, KIDNEY INT, V53, P84, DOI 10.1046/j.1523-1755.1998.00741.x; Khandoga AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004693; Kirton CM, 1999, THESIS U BIRMINGHAM; Klein JB, 2001, CELL SIGNAL, V13, P335, DOI 10.1016/S0898-6568(01)00151-6; Koenderman L, 2010, THROMB HAEMOSTASIS, V104, P599, DOI 10.1160/TH09-10-0740; Kuijper PHM, 1997, BLOOD, V89, P166, DOI 10.1182/blood.V89.1.166.166_166_175; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luu NT, 2003, J VASC RES, V40, P467, DOI 10.1159/000074296; Luu NT, 2000, J IMMUNOL, V164, P5961, DOI 10.4049/jimmunol.164.11.5961; Luu NT, 1999, J VASC RES, V36, P477, DOI 10.1159/000025690; Matsushima H, 2013, BLOOD, V121, P1677, DOI 10.1182/blood-2012-07-445189; McGettrick HM, 2009, EUR J IMMUNOL, V39, P113, DOI 10.1002/eji.200838232; McGettrick HM, 2009, J LEUKOCYTE BIOL, V85, P98, DOI 10.1189/jlb.0508301; McGettrick HM, 2006, J LEUKOCYTE BIOL, V79, P779, DOI 10.1189/jlb.0605350; Mempel TR, 2003, J VASC RES, V40, P435, DOI 10.1159/000073902; PARKHURST MR, 1992, BIOPHYS J, V61, P306, DOI 10.1016/S0006-3495(92)81838-6; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Rainger GE, 1998, BLOOD, V92, P4819, DOI 10.1182/blood.V92.12.4819.424k16_4819_4827; Salamone G, 2001, J IMMUNOL, V166, P3476, DOI 10.4049/jimmunol.166.5.3476; Saltzman WM, 1999, J LEUKOCYTE BIOL, V65, P356, DOI 10.1002/jlb.65.3.356; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scheel-Toellner D, 2002, EUR J IMMUNOL, V32, P486, DOI 10.1002/1521-4141(200202)32:2<486::AID-IMMU486>3.0.CO;2-U; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Wang JH, 1997, SHOCK, V8, P357, DOI 10.1097/00024382-199711000-00007; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Watson RWG, 1997, J IMMUNOL, V158, P945; Werr J, 1998, J EXP MED, V187, P2091, DOI 10.1084/jem.187.12.2091; Werr J, BLOOD, V95, P1804; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	58	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118593	10.1371/journal.pone.0118593	http://dx.doi.org/10.1371/journal.pone.0118593			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706870	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100192
J	Marechal, D; Pereira, PL; Duchon, A; Herault, Y				Marechal, Damien; Pereira, Patricia Lopes; Duchon, Arnaud; Herault, Yann			Dosage of the Abcg1-U2af1 Region Modifies Locomotor and Cognitive Deficits Observed in the Tc1 Mouse Model of Down Syndrome	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; SYNDROME PHENOTYPES; PARTIAL TRISOMY; MICE; DYRK1A; CHROMOSOME-21; IMPAIRMENTS; INHIBITION; SUFFICIENT; MINIBRAIN	Down syndrome (DS) results from one extra copy of human chromosome 21 and leads to several alterations including intellectual disabilities and locomotor defects. The transchromosomic Tc1 mouse model carrying an extra freely-segregating copy of human chromosome 21 was developed to better characterize the relation between genotype and phenotype in DS. The Tc1 mouse exhibits several locomotor and cognitive deficits related to DS. In this report we analyzed the contribution of the genetic dosage of 13 conserved mouse genes located between Abcg1 and U2af1, in the telomeric part of Hsa21. We used the Ms2Yah model carrying a deletion of the corresponding interval in the mouse genome to rescue gene dosage in the Tc1/Ms2Yah compound mice to determine how the different behavioral phenotypes are affected. We detected subtle changes with the Tc1/Ms2Yah mice performing better than the Tc1 individuals in the reversal paradigm of the Morris water maze. We also found that Tc1/Ms2Yah compound mutants performed better in the rotarod than the Tc1 mice. This data support the impact of genes from the Abcg1-U2af1 region as modifiers of Tc1-dependent memory and locomotor phenotypes. Our results emphasize the complex interactions between triplicated genes inducing DS features.	[Marechal, Damien; Duchon, Arnaud; Herault, Yann] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Marechal, Damien; Duchon, Arnaud; Herault, Yann] CNRS, UMR7104, Illkirch Graffenstaden, France; [Marechal, Damien; Duchon, Arnaud; Herault, Yann] INSERM, U964, Illkirch Graffenstaden, France; [Marechal, Damien; Duchon, Arnaud; Herault, Yann] Univ Strasbourg, Illkirch Graffenstaden, France; [Pereira, Patricia Lopes] CNRS, TAAM, UPS44, Transgenese & Archivage Anim Modeles, F-45071 Orleans, France; [Herault, Yann] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Herault, Y (corresponding author), Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	herault@igbmc.fr	Herault, Yann/B-5500-2012; duchon, arnaud/D-2764-2013	Herault, Yann/0000-0001-7049-6900; duchon, arnaud/0000-0003-3043-702X; Marechal, Damien/0000-0001-7948-2679	European commission [LSHG-CT-2006-037627]; Foundation Jerome Lejeune	European commission(European CommissionEuropean Commission Joint Research Centre); Foundation Jerome Lejeune	The National Centre for Scientific Research is a public research agency in France, The European commission funded the AnEUploidy project (LSHG-CT-2006-037627) and the Foundation Jerome Lejeune granted the authors some funding. Nevertheless the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Antonarakis SE, 2006, TRENDS MOL MED, V12, P473, DOI 10.1016/j.molmed.2006.08.005; Belichenko NP, 2009, J NEUROSCI, V29, P5938, DOI 10.1523/JNEUROSCI.1547-09.2009; Bolivar VJ, 2000, BEHAV GENET, V30, P285, DOI 10.1023/A:1026545316455; Campbell C, 2013, AJIDD-AM J INTELLECT, V118, P193, DOI 10.1352/1944-7558-118.3.193; de Lagran MM, 2004, NEUROBIOL DIS, V15, P132, DOI 10.1016/j.nbd.2003.10.002; Dierssen M, 1999, CYTOGENET CELL GENET, V86, P11; Dierssen M, 2009, PHYSIOL REV, V89, P887, DOI 10.1152/physrev.00032.2007; Duchon A, 2011, MAMM GENOME; Duchon A, 2011, BEHAV BRAIN RES, V217, P271, DOI 10.1016/j.bbr.2010.10.023; Dunlevy L, 2010, CARDIOVASC RES, V88, P287, DOI 10.1093/cvr/cvq193; Fotaki V, 2004, BEHAV NEUROSCI, V118, P815, DOI 10.1037/0735-7044.118.4.815; Galante M, 2009, HUM MOL GENET, V18, P1449, DOI 10.1093/hmg/ddp055; GIBSON D, 1988, INT J REHABIL RES, V11, P47, DOI 10.1097/00004356-198803000-00006; Gribble SM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Gubner NR, 2010, ALCOHOL CLIN EXP RES, V34, P1353, DOI 10.1111/j.1530-0277.2010.01219.x; Hannachi H, 2011, CYTOGENET GENOME RES, V135, P102, DOI 10.1159/000330880; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Herault Y, 2012, PROG BRAIN RES, V197, P169, DOI 10.1016/B978-0-444-54299-1.00009-1; Hoelter SM, 2008, FRONT BIOSCI-LANDMRK, V13, P5810; Hutson PH, 2011, NEUROPHARMACOLOGY, V61, P665, DOI 10.1016/j.neuropharm.2011.05.009; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Kroker KS, 2012, NEUROPHARMACOLOGY, V62, P1964, DOI 10.1016/j.neuropharm.2011.12.021; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Melis D, 2011, AM J MED GENET A, V155A, P1697, DOI 10.1002/ajmg.a.33976; Morice E, 2008, LEARN MEMORY, V15, P492, DOI 10.1101/lm.969608; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; Pereira PL, 2009, HUM MOL GENET, V18, P4756, DOI 10.1093/hmg/ddp438; Raveau M, 2012, PLOS GENET, V8, DOI [10.1371/journal.pgen.1003200, DOI 10.1371/JOURNAL.PGEN.1003200]; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Regnier V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051204, DOI 10.1371/JOURNAL.PONE.0051204]; Roberson EDO, 2011, EUR J HUM GENET, V19, P235, DOI 10.1038/ejhg.2010.150; Rustay NR, 2003, BEHAV BRAIN RES, V141, P237, DOI 10.1016/S0166-4328(02)00376-5; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Sahun I, 2014, GENETICS; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Yu T, 2010, BRAIN RES, V1366, P162, DOI 10.1016/j.brainres.2010.09.107; Yu T, 2010, MAMM GENOME, V21, P258, DOI 10.1007/s00335-010-9262-x	46	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115302	10.1371/journal.pone.0115302	http://dx.doi.org/10.1371/journal.pone.0115302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706610	Green Published, gold			2022-12-27	WOS:000350662100010
J	Mejare, IA; Klingberg, G; Mowafi, FK; Stecksen-Blicks, C; Twetman, SHA; Tranaeus, SH				Mejare, Ingegerd A.; Klingberg, Gunilla; Mowafi, Frida K.; Stecksen-Blicks, Christina; Twetman, Svante H. A.; Tranaeus, Sofia H.			A Systematic Map of Systematic Reviews in Pediatric Dentistry-What Do We Really Know?	PLOS ONE			English	Article							PREVENTING DENTAL-CARIES; TOPICAL FLUORIDE TOOTHPASTES; CHLORHEXIDINE VARNISH; MUTANS STREPTOCOCCI; PRESCHOOL-CHILDREN; FISSURE SEALANTS; ANXIOUS CHILDREN; ORAL-HEALTH; ADOLESCENTS; MOUTHRINSES	Objectives To identify, appraise and summarize existing knowledge and knowledge gaps in practice-relevant questions in pediatric dentistry. Methods A systematic mapping of systematic reviews was undertaken for domains considered important in daily clinical practice. The literature search covered questions in the following domains: behavior management problems/dental anxiety; caries risk assessment and caries detection including radiographic technologies; prevention and non-operative treatment of caries in primary and young permanent teeth; operative treatment of caries in primary and young permanent teeth; prevention and treatment of periodontal disease; management of tooth developmental and mineralization disturbances; prevention and treatment of oral conditions in children with chronic diseases/developmental disturbances/obesity; diagnosis, prevention and treatment of dental erosion and tooth wear; treatment of traumatic injuries in primary and young permanent teeth and cost-effectiveness of these interventions. Abstracts and full text reviews were assessed independently by two reviewers and any differences were solved by consensus. AMSTAR was used to assess the risk of bias of each included systematic review. Reviews judged as having a low or moderate risk of bias were used to formulate existing knowledge and knowledge gaps. Results Out of 81 systematic reviews meeting the inclusion criteria, 38 were judged to have a low or moderate risk of bias. Half of them concerned caries prevention. The quality of evidence was high for a caries-preventive effect of daily use of fluoride toothpaste and moderate for fissure sealing with resin-based materials. For the rest the quality of evidence for the effects of interventions was low or very low. Conclusion There is an urgent need for primary clinical research of good quality in most clinically-relevant domains in pediatric dentistry.	[Mejare, Ingegerd A.; Mowafi, Frida K.; Tranaeus, Sofia H.] Swedish Council Hlth Technol Assessment, Stockholm, Sweden; [Klingberg, Gunilla] Malmo Univ, Fac Odontol, Dept Pediat Dent, Malmo, Sweden; [Stecksen-Blicks, Christina] Umea Univ, Fac Med, Dept Odontol, Sect Pediat Dent, Umea, Sweden; [Twetman, Svante H. A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Cariol Endodont Pediat Dent & Clin Genet, Copenhagen, Denmark	Malmo University; Umea University; University of Copenhagen	Mejare, IA (corresponding author), Swedish Council Hlth Technol Assessment, Stockholm, Sweden.	ingegerd.mejare@sbu.se	Klingberg, Gunilla/AAO-7097-2020					Aartman IHA, 1998, J DENT CHILD, V65, P252; Ahangari Z, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008003.pub2; Ahovuo-Saloranta A, 2004, COCHRANE DATABASE SY; Ahovuo-Saloranta A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001830.pub4; Ahovuo-Saloranta A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001830.pub3; Al-Harasi S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007154.pub2; Alavaikko S, 2011, AM J EPIDEMIOL, V174, P631, DOI 10.1093/aje/kwr129; Aleksejuniene J, 2010, J DENT EDUC, V74, P951; Alves P, 2014, REV PANAM SALUD PUBL, V35, P67; Ammari AB, 2003, CARIES RES, V37, P85, DOI 10.1159/000069022; Ammari JB, 2007, MED PRIN PRACT, V16, P437, DOI 10.1159/000107748; Andrade MR, 2013, PEDIAT NEPHROL; Ashley PF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006334.pub3; Ashley PF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008392.pub2; Azarpazhooh A, 2009, BRIT DENT J, V207, DOI [10.1038/sj.bdj.2009.899, 10.1038/sj.bdj.2009.878]; Azarpazhooh A, 2008, J CAN DENT ASSOC, V74, P171; Azarpazhooh Amir, 2009, Hawaii Dent J, V40, P6; Azarpazhooh Amir, 2008, Todays FDA, V20, P21; Bader James D, 2006, J Evid Based Dent Pract, V6, P91; Bader JD, 2004, AM J PREV MED, V26, P315, DOI 10.1016/j.amepre.2003.12.001; Bader JD, 2001, COMMUNITY DENT ORAL, V29, P399, DOI 10.1034/j.1600-0528.2001.290601.x; Beirne P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004346.pub3; Belmonte FM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006203.pub2; Bhaskar V, 2014, CLIN COSMET INVESTIG, V6, P21, DOI 10.2147/CCIDE.S41499; Bloemendal E, 2004, J DENT, V32, P255, DOI 10.1016/j.jdent.2003.12.001; Bonner BC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005101; Brazzelli M, 2006, Health Technol Assess, V10, piii; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009853.pub2; Burt B A, 2001, J Dent Educ, V65, P1024; Cagetti MG, 2013, ACTA ODONTOL SCAND, V71, P381, DOI 10.3109/00016357.2012.690447; Carvalho Denise Martins, 2010, Rev Bras Epidemiol, V13, P139, DOI 10.1590/S1415-790X2010000100013; Chalmers SI, 2011, COCHRANE DB SYST REV, V2010, P12; Chi DL, 2013, INT J PAEDIATR DENT, V23, P376, DOI 10.1111/ipd.12042; Chou R, 2013, PEDIATRICS, V132, P332, DOI 10.1542/peds.2013-1469; Clapton J., 2009, SYSTEMATIC MAPPING G; Cooper AM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009378.pub2; Dashash M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007157.pub2; Davenport CF, 2003, BRIT DENT J, V195, P87, DOI 10.1038/sj.bdj.4810337; Delpier T, 2013, J PEDIATR HEALTH CAR, V27, P470, DOI 10.1016/j.pedhc.2012.07.002; Dos Santos AP, 2012, COMMUNITY DENT ORAL; Espelid I, 2009, EUR ARCH PAEDIATR DE, V10, P149, DOI 10.1007/BF03262676; Ferreira Jainara Maria Soares, 2012, Quintessence Int, V43, pe9; Font-Ribera L, 2014, GAC SANIT; Castilho ARF, 2013, J PEDIAT-BRAZIL, V89, P116, DOI 10.1016/j.jped.2013.03.014; Frencken JE, 2012, CLIN ORAL INVEST, V16, P1337, DOI 10.1007/s00784-012-0783-4; Gawade PL, 2014, PEDIATR BLOOD CANCER, V61, P407, DOI 10.1002/pbc.24842; Gomez J, 2013, COMMUNITY DENT ORAL, V41, P55, DOI 10.1111/cdoe.12021; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harris Rebecca, 2004, Community Dent Health, V21, P71; Hasslof P, 2007, INT J PAEDIATR DENT, V17, P313, DOI 10.1111/j.1365-263X.2007.00847.x; Haugejorden O, 1996, COMMUNITY DENT ORAL, V24, P369, DOI 10.1111/j.1600-0528.1996.tb00881.x; Hayden C, 2013, COMMUNITY DENT ORAL, V41, P289, DOI 10.1111/cdoe.12014; Hiiri A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003067.pub3; Hooley M, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-57; Hujoel PP, 2013, NUTR REV, V71, P88, DOI 10.1111/j.1753-4887.2012.00544.x; Hujoel PP, 2006, J DENT RES, V85, P298, DOI 10.1177/154405910608500404; Ijaz S, 2010, CARIES RES, V44, P579, DOI 10.1159/000322132; Innes NPT, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005512.pub2; Ismail AI, 1999, J PUBLIC HEALTH DENT, V59, P171, DOI 10.1111/j.1752-7325.1999.tb03267.x; Ismail AI, 2008, J AM DENT ASSOC, V139, P1457, DOI 10.14219/jada.archive.2008.0071; James P, 2010, CARIES RES, V44, P333, DOI 10.1159/000315346; Kallestal C, 2003, ACTA ODONTOL SCAND, V61, P341, DOI 10.1080/00016350310007815; Kantovitz Kamila Rosamilia, 2006, Oral Health Prev Dent, V4, P137; Kay E, 1998, Community Dent Health, V15, P132; Khan SQ, 2014, INT DENT J; Koch G., 2009, PEDIAT DENT CLIN APP; Leong PM, 2013, INT J PAEDIATR DENT, V23, P235, DOI 10.1111/j.1365-263X.2012.01260.x; LLODRA JC, 1993, COMMUNITY DENT ORAL, V21, P261, DOI 10.1111/j.1600-0528.1993.tb00771.x; Lourenco-Matharu L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003877.pub4; Marinho V., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002280; Marinho V C, 2003, Cochrane Database Syst Rev, pCD002278, DOI 10.1002/14651858.CD002278; Marinho VCC, 2009, EUR ARCH PAEDIATR DE, V10, P183, DOI 10.1007/BF03262681; Marinho VCC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002279.pub2; MARINHO VC, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002284; MARINHO VC, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002781.PUB2; Marinho VC, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002782; MARINHO VC, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002279; MARINHO VC, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002780.PUB2; Marino RJ, 2013, CARIES RES, V47, P265, DOI 10.1159/000346917; Matharu L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003877.pub3; Matharu LM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14641858.CD003877.pub2; McDonagh MS, 2000, BRIT MED J, V321, P855, DOI 10.1136/bmj.321.7265.855; Mejare I, 2014, ACTA ODONTOL SCAND, V72, P81, DOI 10.3109/00016357.2013.822548; Mejare I, 2003, ACTA ODONTOL SCAND, V61, P321, DOI 10.1080/00016350310007581; Mickenautsch S, 2010, CLIN ORAL INVEST, V14, P233, DOI 10.1007/s00784-009-0335-8; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; Nadin G, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003220; Parisotto TM, 2010, ORAL HLTH PREV DENT, V8, P59; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Petersson LG, 2004, ACTA ODONTOL SCAND, V62, P170, DOI 10.1080/00016350410006392; Alcaraz MGR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005620.pub2; Reisine S T, 2001, J Dent Educ, V65, P1009; Ribeiro Nilza M. E., 2004, J. Pediatr. (Rio J.), V80, ps199, DOI 10.1590/S0021-75572004000700012; Ricketts D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003808.pub3; Riley P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004346.pub4; Riley P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010514.pub2; Rotfyllning SBU, 203 SBU; Salone LR, 2013, J AM DENT ASSOC, V144, P143, DOI 10.14219/jada.archive.2013.0093; Santos APP, 2013, CARIES RES, V47, P382, DOI 10.1159/000348492; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Simancas-Pallares MA, 2010, MED ORAL PATOL ORAL, V15, pE942, DOI 10.4317/medoral.15.e942; Skinner J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1060; Smail-Faugeron V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051908; Steyn NP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-502; Tanzer J M, 2001, J Dent Educ, V65, P1028; Tellez M, 2012, COMMUNITY DENT ORAL; Thenisch NL, 2006, CARIES RES, V40, P366, DOI 10.1159/000094280; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Treasure ET, 2002, BRIT DENT J, V192, P495, DOI 10.1038/sj.bdj.4801410a; Tubert-Jeannin S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007592.pub2; Twetman S, 2004, ACTA ODONTOL SCAND, V62, P223, DOI 10.1080/00016350410001658; Twetman S, 2003, ACTA ODONTOL SCAND, V61, P347, DOI 10.1080/00016350310007590; Twetman S, 2012, Adv Dent Res, V24, P98, DOI 10.1177/0022034512449465; Twetman S, 2013, ACTA ODONTOL SCAND, V71, P388, DOI 10.3109/00016357.2012.690448; Valaitis R, 2000, CAN J PUBLIC HEALTH, V91, P411, DOI 10.1007/BF03404819; Walsh T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007868.pub2; Weyant RJ, 2013, J AM DENT ASSOC, V144, P1279, DOI 10.14219/jada.archive.2013.0057; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; Wong MCM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007693.pub2; Wright JT, 2014, J AM DENT ASSOC, V145, P182, DOI 10.14219/jada.2013.37; Yengopal V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004483.pub2; Yeung CA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003876.pub2; Zhang Q, 2006, EUR J ORAL SCI, V114, P449, DOI 10.1111/j.1600-0722.2006.00392.x; Zhou YF, 2011, PATIENT EDUC COUNS, V85, P4, DOI 10.1016/j.pec.2010.08.002	125	61	62	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117537	10.1371/journal.pone.0117537	http://dx.doi.org/10.1371/journal.pone.0117537			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706629	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100100
J	Pitman, KA; Borgland, SL; MacLeod, B; Puil, E				Pitman, Kimberley A.; Borgland, Stephanie L.; MacLeod, Bernard; Puil, Ernest			Isovaline Does Not Activate GABA(B) Receptor-Coupled Potassium Currents in GABA(B) Expressing AtT-20 Cells and Cultured Rat Hippocampal Neurons	PLOS ONE			English	Article							G-PROTEIN; AMINO-ACID; PHYSIOLOGICAL FUNCTIONS; CHANNELS; SUBUNIT; TRAFFICKING; ASSOCIATION; DESENSITIZATION; DIVERSITY; COMPLEXES	Isovaline is a non-proteinogenic amino acid that has analgesic properties. R-isovaline is a proposed agonist of the.-aminobutyric acid type B (GABA(B)) receptor in the thalamus and peripheral tissue. Interestingly, the responses to R-isovaline differ from those of the canonical GABA(B) receptor agonist R-baclofen, warranting further investigation. Using whole cell recording techniques we explored isovaline actions on GABA(B) receptors coupled to rectifying K+ channels in cells of recombinant and native receptor preparations. In AtT-20 cells transfected with GABA(B) receptor subunits, bath application of the GABA(B) receptor agonists, GABA (1 mu M) and R-baclofen (5 mu M) produced inwardly rectifying currents that reversed approximately at the calculated reversal potential for K+ R-isovaline (50 mu M to 1 mM) and S-isovaline (500 mu M) did not evoke a current. R-isovaline applied either extracellularly (250 mu M) or intracellularly (10 mu M) did not alter responses to GABA at 1 mu M. Co-administration of R-isovaline (250 mu M) with a low concentration (10 nM) of GABA did not result in a response. In cultured rat hippocampal neurons that natively express GABA(B) receptors, R-baclofen (5 mu M) induced GABA(B) receptor-dependent inward currents. Under the same conditions R-isovaline (1 or 50 mu M) did not evoke a current or significantly alter R-baclofen-induced effects. Therefore, R-isovaline does not interact with recombinant or native GABA(B) receptors to open K+ channels in these preparations.	[Pitman, Kimberley A.; MacLeod, Bernard; Puil, Ernest] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Pitman, Kimberley A.; Borgland, Stephanie L.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of British Columbia; University of Calgary	Borgland, SL (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	s.borgland@ucalgary.ca	Borgland, Stephanie/GPC-5260-2022; Pitman, Kimberley/O-4843-2017; Borgland, Stephanie/M-2936-2016	Borgland, Stephanie/0000-0001-7546-5687; Pitman, Kimberley/0000-0003-3198-9336; Borgland, Stephanie/0000-0001-7546-5687	Jean Hugill Anesthesia Research Endowment; Canadian Institutes of Health Research [MOP-104357]	Jean Hugill Anesthesia Research Endowment; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	These studies were supported by the Jean Hugill Anesthesia Research Endowment to B.M and E.P. S.L.B. is supported by a Canadian Institutes of Health Research New Investigator Award (MOP-104357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2007, J BIOL CHEM, V282, P4162, DOI 10.1074/jbc.M607695200; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Cooke JE, 2012, NEUROSCIENCE, V201, P85, DOI 10.1016/j.neuroscience.2011.10.049; Cooke JE, 2009, NEUROSCIENCE, V164, P1235, DOI 10.1016/j.neuroscience.2009.08.045; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; DiversePierluissi M, 1997, P NATL ACAD SCI USA, V94, P5417, DOI 10.1073/pnas.94.10.5417; DOUSMANIS AG, 1992, PFLUG ARCH EUR J PHY, V422, P98, DOI 10.1007/BF00370408; Enna SJ, 2006, ADV PHARMACOL, V54, P1, DOI 10.1016/S1054-3589(06)54001-3; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Franek M, 1999, NEUROPHARMACOLOGY, V38, P1657, DOI 10.1016/S0028-3908(99)00135-5; FURTH J, 1953, P SOC EXP BIOL MED, V84, P253; Galvez T, 2000, J BIOL CHEM, V275, P41166, DOI 10.1074/jbc.M007848200; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Geng Y, 2013, NATURE, V504, P254, DOI 10.1038/nature12725; Hannan S, 2012, P NATL ACAD SCI USA, V109, P12171, DOI 10.1073/pnas.1201660109; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kanaide M, 2007, J CELL PHYSIOL, V210, P237, DOI 10.1002/jcp.20863; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; MacLeod BA, 2010, ANESTH ANALG, V110, P1206, DOI 10.1213/ANE.0b013e3181d27da2; Marti-Solano M, 2013, CURR PHARM DESIGN, V19, P5156, DOI 10.2174/1381612811319280014; Padgett CL, 2010, ADV PHARMACOL, V58, P123, DOI 10.1016/S1054-3589(10)58006-2; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Shin DS, 2011, EPILEPSIA, V52, P2084, DOI 10.1111/j.1528-1167.2011.03260.x; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Thuault SJ, 2004, BIOCHEM PHARMACOL, V68, P1655, DOI 10.1016/j.bcp.2004.07.032; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whitehead RA, 2012, NEUROSCIENCE, V213, P154, DOI 10.1016/j.neuroscience.2012.04.026; Xie CS, 2000, FREE RADICAL BIO MED, V28, P665, DOI 10.1016/S0891-5849(99)00268-3; XU J, 1986, J PHARMACOL EXP THER, V239, P568; Yu W, 2014, EPILEPSY RES, V108, P331, DOI 10.1016/j.eplepsyres.2013.11.020	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118497	10.1371/journal.pone.0118497	http://dx.doi.org/10.1371/journal.pone.0118497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706125	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100186
J	Silva-Sanchez, A; Liu, CR; Vale, AM; Khass, M; Kapoor, P; Elgavish, A; Ivanov, II; Ippolito, GC; Schelonka, RL; Schoeb, TR; Burrows, PD; Schroeder, HW				Silva-Sanchez, Aaron; Liu, Cun Ren; Vale, Andre M.; Khass, Mohamed; Kapoor, Pratibha; Elgavish, Ada; Ivanov, Ivaylo I.; Ippolito, Gregory C.; Schelonka, Robert L.; Schoeb, Trenton R.; Burrows, Peter D.; Schroeder, Harry W., Jr.			Violation of an Evolutionarily Conserved Immunoglobulin Diversity Gene Sequence Preference Promotes Production of dsDNA-Specific IgG Antibodies	PLOS ONE			English	Article							B-CELL DEVELOPMENT; ANTI-DNA ANTIBODIES; CDR-H3 REPERTOIRE; CANONICAL STRUCTURES; MOUSE; SELECTION; EXPRESS; ORIGINS; REGIONS; LENGTH	Variability in the developing antibody repertoire is focused on the third complementarity determining region of the H chain (CDR-H3), which lies at the center of the antigen binding site where it often plays a decisive role in antigen binding. The power of VDJ recombination and N nucleotide addition has led to the common conception that the sequence of CDR-H3 is unrestricted in its variability and random in its composition. Under this view, the immune response is solely controlled by somatic positive and negative clonal selection mechanisms that act on individual B cells to promote production of protective antibodies and prevent the production of self-reactive antibodies. This concept of a repertoire of random antigen binding sites is inconsistent with the observation that diversity (D-H) gene segment sequence content by reading frame (RF) is evolutionarily conserved, creating biases in the prevalence and distribution of individual amino acids in CDR-H3. For example, arginine, which is often found in the CDR-H3 of dsDNA binding autoantibodies, is under-represented in the commonly used D-H RFs rearranged by deletion, but is a frequent component of rarely used inverted RF1 (iRF1), which is rearranged by inversion. To determine the effect of altering this germline bias in D-H gene segment sequence on autoantibody production, we generated mice that by genetic manipulation are forced to utilize an iRF1 sequence encoding two arginines. Over a one year period we collected serial serum samples from these unimmunized, specific pathogen-free mice and found that more than one-fifth of them contained elevated levels of dsDNA-binding IgG, but not IgM; whereas mice with a wild type DH sequence did not. Thus, germline bias against the use of arginine enriched DH sequence helps to reduce the likelihood of producing self-reactive antibodies.	[Silva-Sanchez, Aaron; Liu, Cun Ren; Vale, Andre M.; Khass, Mohamed; Kapoor, Pratibha; Elgavish, Ada; Schroeder, Harry W., Jr.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Vale, Andre M.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Program Immunobiol, Rio De Janeiro, Brazil; [Ivanov, Ivaylo I.; Ippolito, Gregory C.; Burrows, Peter D.; Schroeder, Harry W., Jr.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Schelonka, Robert L.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Schoeb, Trenton R.; Burrows, Peter D.; Schroeder, Harry W., Jr.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Khass, Mohamed] Natl Res Ctr Egypt, Genet Engn Div, Ad Doqi, Egypt	University of Alabama System; University of Alabama Birmingham; Universidade Federal do Rio de Janeiro; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Schroeder, HW (corresponding author), Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA.	hwsj@uab.edu	Silva-Sanchez, Aaron/AAI-8572-2021; Ippolito, Gregory C./AAR-2930-2021	Silva-Sanchez, Aaron/0000-0002-1882-2534; Ippolito, Gregory C./0000-0002-7565-7002; Elgavish, Ada/0000-0002-9446-1777; Schroeder, Harry/0000-0002-3767-6878; Vale, Andre/0000-0001-7501-2370	United States National Institutes of Health (NIH) [AI07051, AI48115, AI100076, AI090742]; NIH [AR48311, AI027767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090742, R56AI048115, T32AI007051, R01AI048115, R03AI100076, P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE022736] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by the United States National Institutes of Health (NIH) (AI07051, AI48115, AI100076 and AI090742). Flow cytometry was supported by NIH AR48311 and AI027767. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; ANDERSSON J, 1977, CELL, V10, P27, DOI 10.1016/0092-8674(77)90136-2; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Burnet F M, 1976, CA Cancer J Clin, V26, P119, DOI 10.3322/canjclin.26.2.119; Capra J.D., 2002, THE ANTIBODIES, P43; Carter LM, 2013, ARTHRITIS RHEUM-US, V65, P2672, DOI 10.1002/art.38074; CHEN C, 1994, J IMMUNOL, V152, P1970; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; Fu SM, 2011, J AUTOIMMUN, V37, P104, DOI 10.1016/j.jaut.2011.05.004; GAUSS GH, 1992, GENE DEV, V6, P1553, DOI 10.1101/gad.6.8.1553; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Ippolito GC, 2003, ANN NY ACAD SCI, V987, P262, DOI 10.1111/j.1749-6632.2003.tb06058.x; Ippolito GC, 2006, J EXP MED, V203, P1567, DOI 10.1084/jem.20052217; ISENBERG DA, 1987, ANN RHEUM DIS, V46, P448, DOI 10.1136/ard.46.6.448; Ivanov II, 2005, J IMMUNOL, V174, P7773, DOI 10.4049/jimmunol.174.12.7773; Kirkham P M, 1994, Semin Immunol, V6, P347, DOI 10.1006/smim.1994.1045; Krishnan MR, 1996, J IMMUNOL, V157, P2430; Langman RE, 2002, CELL IMMUNOL, V216, P15, DOI 10.1016/S0008-8749(02)00503-8; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; Lu AL, 2011, AM J PATHOL, V178, P2573, DOI 10.1016/j.ajpath.2011.02.039; Mahmoud TI, 2011, J IMMUNOL, V187, P879, DOI 10.4049/jimmunol.1100957; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Prak ETL, 2011, ANN NY ACAD SCI, V1217, P96, DOI 10.1111/j.1749-6632.2010.05877.x; Radic MZ, 1995, ANN NY ACAD SCI, V764, P384; RADIC MZ, 1993, J IMMUNOL, V150, P4966; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; ROLINK A, 1991, CELL, V66, P1081, DOI 10.1016/0092-8674(91)90032-T; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Schelonka RL, 2005, J IMMUNOL, V175, P6624, DOI 10.4049/jimmunol.175.10.6624; Schelonka RL, 2007, EUR J IMMUNOL, V37, P1010, DOI 10.1002/eji.200636569; Schelonka RL, 2010, J IMMUNOL, V185, P6075, DOI 10.4049/jimmunol.1001419; Scholz JL, 2013, LUPUS, V22, P350, DOI 10.1177/0961203312469453; Schroeder HW, 2010, CRIT REV IMMUNOL, V30, P327; Schroeder HW, 2006, DEV COMP IMMUNOL, V30, P119, DOI 10.1016/j.dci.2005.06.006; Schroeder HW, 2012, FUNDAMENTAL IMMUNOLO, V1312, P129; Sekiguchi DR, 2006, J IMMUNOL, V176, P6879, DOI 10.4049/jimmunol.176.11.6879; Silverstein AM, 2001, NAT IMMUNOL, V2, P279, DOI 10.1038/86280; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vale AM, 2012, J IMMUNOL METHODS, V376, P143, DOI 10.1016/j.jim.2011.12.005; Vale AM, 2013, JOURNAL OF EXPERIMEN; Vale AM, 2013, J EXP MED, V210, P875, DOI 10.1084/jem.20121861; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Zemlin M, 2005, MOL IMMUNOL, V42, P789, DOI 10.1016/j.molimm.2004.07.049	50	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118171	10.1371/journal.pone.0118171	http://dx.doi.org/10.1371/journal.pone.0118171			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706374	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100148
J	Siraly, E; Szabo, A; Szita, B; Kovacs, V; Fodor, Z; Marosi, C; Salacz, P; Hidasi, Z; Maros, V; Hanak, P; Csibri, E; Csukly, G				Siraly, Eniko; Szabo, Adam; Szita, Bernadett; Kovacs, Vivienne; Fodor, Zsuzsanna; Marosi, Csilla; Salacz, Pal; Hidasi, Zoltan; Maros, Viktor; Hanak, Peter; Csibri, Eva; Csukly, Gabor			Monitoring the Early Signs of Cognitive Decline in Elderly by Computer Games: An MRI Study	PLOS ONE			English	Article							SUBSEQUENT MEMORY DECLINE; SURFACE-BASED ANALYSIS; ALZHEIMERS-DISEASE; OLDER-ADULTS; IMPAIRMENT; DEMENTIA; RISK; SEGMENTATION; INDIVIDUALS; PLASTICITY	Background It is anticipated that current and future preventive therapies will likely be more effective in the early stages of dementia, when everyday functioning is not affected. Accordingly the early identification of people at risk is particularly important. In most cases, when subjects visit an expert and are examined using neuropsychological tests, the disease has already been developed. Contrary to this cognitive games are played by healthy, well functioning elderly people, subjects who should be monitored for early signs. Further advantages of cognitive games are their accessibility and their cost-effectiveness. Purpose The aim of the investigation was to show that computer games can help to identify those who are at risk. In order to validate games analysis was completed which measured the correlations between results of the 'Find the Pairs' memory game and the volumes of the temporal brain regions previously found to be good predictors of later cognitive decline. Participants and Methods 34 healthy elderly subjects were enrolled in the study. The volume of the cerebral structures was measured by MRI. Cortical reconstruction and volumetric segmentation were performed by Freesurfer. Results There was a correlation between the number of attempts and the time required to complete the memory game and the volume of the entorhinal cortex, the temporal pole, and the hippocampus. There was also a correlation between the results of the Paired Associates Learning ( PAL) test and the memory game. Conclusions The results gathered support the initial hypothesis that healthy elderly subjects achieving lower scores in the memory game have increased level of atrophy in the temporal brain structures and showed a decreased performance in the PAL test. Based on these results it can be concluded that memory games may be useful in early screening for cognitive decline.	[Siraly, Eniko; Szita, Bernadett; Kovacs, Vivienne; Fodor, Zsuzsanna; Marosi, Csilla; Salacz, Pal; Hidasi, Zoltan; Csibri, Eva; Csukly, Gabor] Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1085 Budapest, Hungary; [Szabo, Adam] Semmelweis Univ, Magnet Resonance Imaging Res Ctr, H-1085 Budapest, Hungary; [Maros, Viktor; Hanak, Peter] Budapest Univ Technol & Econ, Healthcare Technol Knowledge Ctr, Budapest, Hungary	Semmelweis University; Semmelweis University; Budapest University of Technology & Economics	Csukly, G (corresponding author), Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1085 Budapest, Hungary.	csukly.gabor@med.semmelweis-univ.hu	Szabó, Ádám György/Q-7294-2016; Csukly, Gabor/J-8244-2017; Szita, Bernadett/AAK-8655-2021; Fodor, Zsuzsanna/O-5812-2016	Szabó, Ádám György/0000-0003-4014-3762; Csukly, Gabor/0000-0002-5006-9407; Fodor, Zsuzsanna/0000-0001-9335-4921; Szita, Bernadett/0000-0003-1404-7013	'Ambient Assisted Living Joint Programme (AAL)-Call 2' grant [AAL_08-1-2011-0005 M3W]	'Ambient Assisted Living Joint Programme (AAL)-Call 2' grant	The study was supported by the 'Ambient Assisted Living Joint Programme (AAL)-Call 2' grant (Project Identifier: AAL_08-1-2011-0005 M3W), (http://www.aal-europe.eu). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alexopoulos P, 2010, DEMENT GERIATR COGN, V29, P448, DOI 10.1159/000312685; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; [Anonymous], 2006, COMPENDIUM NEUROPSYC; Ashford JW, 2007, ALZHEIMERS DEMENT, V3, P75, DOI 10.1016/j.jalz.2006.02.005; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Bischkopf J, 2002, ACTA PSYCHIAT SCAND, V106, P403, DOI 10.1034/j.1600-0447.2002.01417.x; Blackwell AD, 2004, DEMENT GERIATR COGN, V17, P42, DOI 10.1159/000074081; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Budd D, 2011, CLINICOECONOMIC OUTC, V3, P189, DOI 10.2147/CEOR.S22265; Chiang GC, 2011, RADIOLOGY, V259, P844, DOI 10.1148/radiol.11101637; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; de Rover M, 2011, NEUROPSYCHOLOGIA, V49, P2060, DOI 10.1016/j.neuropsychologia.2011.03.037; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gates NJ, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-55; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Huckans M, 2013, NEUROPSYCHOL REV, V23, P63, DOI 10.1007/s11065-013-9230-9; JONES E G, 1970, Brain Behavior and Evolution, V93, P793, DOI 10.1093/brain/93.4.793; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Lin JS, 2013, ANN INTERN MED, V159, P601, DOI 10.7326/0003-4819-159-9-201311050-00730; Lonie JA, 2010, BRIT J PSYCHIAT, V197, P135, DOI 10.1192/bjp.bp.110.077958; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Murphy EA, 2010, NEUROIMAGE, V53, P1310, DOI 10.1016/j.neuroimage.2010.07.016; Nettiksimmons J, 2010, NEUROBIOL AGING, V31, P1419, DOI 10.1016/j.neurobiolaging.2010.04.025; Noel-Storr AH, 2014, NEUROLOGY, V83, P364, DOI 10.1212/WNL.0000000000000621; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rey A., 1958, LEXAMEN CLINIQUE PSY; Rosen AC, 2011, J ALZHEIMERS DIS, V26, P349, DOI 10.3233/JAD-2011-0009; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Siraly Eniko, 2013, Neuropsychopharmacol Hung, V15, P139; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Strauss E, 2006, COMPENDIUM NEUROPSYC, P168, DOI [10.1016/j.etap.2006.08.005, DOI 10.1016/J.ETAP.2006.08.005]; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	50	25	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117918	10.1371/journal.pone.0117918	http://dx.doi.org/10.1371/journal.pone.0117918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706380	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100128
J	Ding, Y; Uchida, K; Aizawa, SI; Murphy, K; Berezuk, A; Khursigara, CM; Chong, JPJ; Jarrell, KF				Ding, Yan; Uchida, Kaoru; Aizawa, Shin-Ichi; Murphy, Kathleen; Berezuk, Alison; Khursigara, Cezar M.; Chong, James P. J.; Jarrell, Ken F.			Effects of N-Glycosylation Site Removal in Archaellins on the Assembly and Function of Archaella in Methanococcus maripaludis	PLOS ONE			English	Article							S-LAYER GLYCOPROTEIN; LINKED PROTEIN GLYCOSYLATION; FLAGELLIN GLYCOSYLATION; HELICOBACTER-PYLORI; AMINO-ACIDS; IV PILIN; IDENTIFICATION; GENES; BIOSYNTHESIS; GLYCAN	In Methanococcus maripaludis S2, the swimming organelle, the archaellum, is composed of three archaellins, FlaB1(S2), FlaB2(S2) and FlaB3(S2). All three are modified with an N-linked tetrasaccharide at multiple sites. Disruption of the N-linked glycosylation pathway is known to cause defects in archaella assembly or function. Here, we explored the potential requirement of N-glycosylation of archaellins on archaellation by investigating the effects of eliminating the 4 N-glycosylation sites in the wildtype FlaB2(S2) protein in all possible combinations either by Asn to Glu (N to Q) substitution or Asn to Asp (N to D) substitutions of the N-glycosylation sequon asparagine. The ability of these mutant derivatives to complement a non-archaellated Delta flaB2(S2) strain was examined by electron microscopy (for archaella assembly) and swarm plates (for analysis of swimming). Western blot results showed that all mutated FlaB2(S2) proteins were expressed and of smaller apparent molecular mass compared to wildtype FlaB2(S2), consistent with the loss of glycosylation sites. In the 8 single-site mutant complements, archaella were observed on the surface of Q2, D2 and D4 (numbers after N or Q refer to the 1st to 4th glycosylation site). Of the 6 double-site mutation complementations all were archaellated except D1,3. Of the 4 triple-site mutation complements, only D2,3,4 was archaellated. Elimination of all 4 N-glycosylation sites resulted in non-archaellated cells, indicating some minimum amount of archaellin glycosylation was necessary for their incorporation into stable archaella. All complementations that led to a return of archaella also resulted in motile cells with the exception of the D4 version. In addition, a series of FlaB2(S2) scanning deletions each missing 10 amino acids was also generated and tested for their ability to complement the Delta flaB2(S2) strain. While most variants were expressed, none of them restored archaellation, although FlaB2(S2) harbouring a smaller 3-amino acid deletion was able to partially restore archaellation.	[Ding, Yan; Jarrell, Ken F.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Uchida, Kaoru; Aizawa, Shin-Ichi] Prefectural Univ Hiroshima, Dept Life Sci, Shobara, Hiroshima, Japan; [Murphy, Kathleen; Berezuk, Alison; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Chong, James P. J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Queens University - Canada; University of Guelph; University of York - UK	Jarrell, KF (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	jarrellk@queensu.ca	Chong, James/AAC-4957-2019	Aizawa, Shin-Ichi/0000-0002-9068-0825; Chong, James/0000-0001-9447-7421	Natural Sciences and Engineering Research Council of Canada (NSERC); Biotechnology and Biological Sciences Research Council (BBSRC); China Scholarship Council [20100622028]; Leverhulme Trust; BBSRC [BB/K006630/1, BB/F003099/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003099/1, BB/K006630/1] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); China Scholarship Council(China Scholarship Council); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to K.F.J. and C.M.K. and Biotechnology and Biological Sciences Research Council (BBSRC) to J.P.J.C. K.F.J. was the recipient of a Leverhulme Trust Visiting Professorship. Y.D. thanks the China Scholarship Council (20100622028) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Albers SV, 2003, J BACTERIOL, V185, P3918, DOI 10.1128/JB.185.13.3918-3925.2003; Asakura H, 2010, MOL MICROBIOL, V78, P1130, DOI 10.1111/j.1365-2958.2010.07393.x; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Bardy SL, 2003, MOL MICROBIOL, V50, P1339, DOI 10.1046/j.1365-2958.2003.03758.x; Bardy SL, 2002, FEMS MICROBIOL LETT, V208, P53, DOI 10.1016/S0378-1097(01)00579-1; Beznosov SN, 2013, CENT EUR J BIOL, V8, P828, DOI 10.2478/s11535-013-0202-0; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Chaban B, 2007, MOL MICROBIOL, V66, P596, DOI 10.1111/j.1365-2958.2007.05913.x; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; Cohen-Krausz S, 2002, J MOL BIOL, V321, P383, DOI 10.1016/S0022-2836(02)00616-2; CORDER RE, 1983, ARCH MICROBIOL, V134, P28, DOI 10.1007/BF00429402; Ding Y, 2013, J BACTERIOL, V195, P4094, DOI 10.1128/JB.00668-13; Dubuisson J, 2000, J BIOL CHEM, V275, P30605, DOI 10.1074/jbc.M004326200; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Gardner WL, 1999, GENETICS, V152, P1439; Ghosh A, 2011, BIOCHEM SOC T, V39, P64, DOI 10.1042/BST0390064; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Harvey H, 2011, J BIOL CHEM, V286, P28128, DOI 10.1074/jbc.M111.255794; Jarrell KF, 2014, MICROBIOL MOL BIOL R, V78, P304, DOI 10.1128/MMBR.00052-13; Jarrell Ken F., 2013, Life-Basel, V3, P86, DOI 10.3390/life3010086; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; Jarrell KF, 2009, PILI AND FLAGELLA: CURRENT RESEARCH AND FUTURE TRENDS, P215; Jarrell KF, 2010, ARCHAEA, V2010, DOI 10.1155/2010/612948; Jones GM, 2012, J BACTERIOL, V194, P2693, DOI 10.1128/JB.06686-11; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; KALMOKOFF ML, 1991, J BACTERIOL, V173, P7113, DOI 10.1128/jb.173.22.7113-7125.1991; Kaminski L, 2013, MOL PHYLOGENET EVOL, V68, P327, DOI 10.1016/j.ympev.2013.03.024; Kaminski L, 2013, BIOCHEM SOC T, V41, P432, DOI 10.1042/BST20120142; Kaminski L, 2010, J BACTERIOL, V192, P5572, DOI 10.1128/JB.00705-10; Kelly J, 2009, CARBOHYD RES, V344, P648, DOI 10.1016/j.carres.2009.01.006; Keswani J, 1996, INT J SYST BACTERIOL, V46, P727, DOI 10.1099/00207713-46-3-727; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; KUWAJIMA G, 1988, J BACTERIOL, V170, P3305, DOI 10.1128/jb.170.7.3305-3309.1988; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; Lassak K, 2012, RES MICROBIOL, V163, P630, DOI 10.1016/j.resmic.2012.10.024; Leigh JA, 2011, FEMS MICROBIOL REV, V35, P577, DOI 10.1111/j.1574-6976.2011.00265.x; Nguyen LC, 2012, MOL PLANT PATHOL, V13, P764, DOI 10.1111/j.1364-3703.2012.00789.x; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Merino S, 2014, INT J MOL SCI, V15, P2840, DOI 10.3390/ijms15022840; Meyer BH, 2014, MICROBIOLOGYOPEN, V3, P531, DOI 10.1002/mbo3.185; Meyer BH, 2013, J BACTERIOL, V195, P2177, DOI 10.1128/JB.00035-13; Meyer BH, 2013, BIOCHEM SOC T, V41, P384, DOI 10.1042/BST20120296; Meyer BH, 2011, MOL MICROBIOL, V82, P1150, DOI 10.1111/j.1365-2958.2011.07875.x; Moore BC, 2005, J BACTERIOL, V187, P972, DOI 10.1128/JB.187.3.972-979.2005; Ng SYM, 2011, J BACTERIOL, V193, P804, DOI 10.1128/JB.00822-10; Nothaft H, 2012, MOL CELL PROTEOMICS, V11, P1203, DOI 10.1074/mcp.M112.021519; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Paiment A, 2002, J BACTERIOL, V184, P6437, DOI 10.1128/JB.184.23.6437-6447.2002; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Peyfoon E, 2010, ARCHAEA, V2010, DOI 10.1155/2010/754101; Pohlschroder M, 2011, CURR OPIN MICROBIOL, V14, P357, DOI 10.1016/j.mib.2011.03.002; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Shahapure R, 2014, MOL MICROBIOL, V91, P716, DOI 10.1111/mmi.12486; Smedley JG, 2005, INFECT IMMUN, V73, P7922, DOI 10.1128/IAI.73.12.7922-7931.2005; Stocker B A, 1994, Int Rev Immunol, V11, P167, DOI 10.3109/08830189409061724; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Taguchi F, 2008, J BACTERIOL, V190, P764, DOI 10.1128/JB.01282-07; Thomas NA, 2001, ARCH MICROBIOL, V175, P263, DOI 10.1007/s002030100254; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Trachtenberg S, 2005, J MOL BIOL, V346, P665, DOI 10.1016/j.jmb.2004.12.010; Tripepi M, 2012, J BACTERIOL, V194, P4876, DOI 10.1128/JB.00731-12; Tripepi M, 2010, J BACTERIOL, V192, P3093, DOI 10.1128/JB.00133-10; TUMBULA DL, 1994, FEMS MICROBIOL LETT, V121, P309, DOI 10.1016/0378-1097(94)90309-3; VanDyke DJ, 2009, MOL MICROBIOL, V72, P633, DOI 10.1111/j.1365-2958.2009.06671.x; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; WIELAND F, 1985, J BIOL CHEM, V260, P5180; Wojczyk BS, 2005, GLYCOBIOLOGY, V15, P655, DOI 10.1093/glycob/cwi046; YAMAGUCHI K, 1991, J BIOL CHEM, V266, P20434; Yang Z, 2011, MICROBIOL-SGM, V157, P1920, DOI 10.1099/mic.0.049684-0; Yurist-Doutsch S, 2008, MOL MICROBIOL, V69, P1234, DOI 10.1111/j.1365-2958.2008.06352.x; Yurist-Doutsch S, 2010, MOL MICROBIOL, V75, P1047, DOI 10.1111/j.1365-2958.2009.07045.x	78	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116402	10.1371/journal.pone.0116402	http://dx.doi.org/10.1371/journal.pone.0116402			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700084	gold, Green Published, Green Accepted			2022-12-27	WOS:000349789800009
J	Aggarwal, AN; Gupta, D; Agarwal, R; Sethi, S; Thakur, JS; Anjinappa, SM; Chadha, VK; Kumar, R; Sharma, M; Behera, D; Jindal, SK				Aggarwal, Ashutosh N.; Gupta, Dheeraj; Agarwal, Ritesh; Sethi, Sunil; Thakur, Jarnail S.; Anjinappa, Sharada M.; Chadha, Vineet K.; Kumar, Rajesh; Sharma, Meera; Behera, Digambar; Jindal, Surinder K.			Prevalence of Pulmonary Tuberculosis among Adults in a North Indian District	PLOS ONE			English	Article								Background Recent population prevalence estimates of pulmonary tuberculosis (PTB) are not available for several areas in India. We conducted a field-based population survey at a north Indian district to estimate point prevalence of bacteriologically positive PTB. Methods A stratified cluster sampling design was used to conduct the survey in both urban and rural areas within the district. All adults aged more than 15 years, in 18 rural and 12 urban clusters of 3000 subjects each, were interviewed using a symptom card. Two sputum samples were collected from all persons having symptoms suggestive of PTB, or history of antitubercular treatment, for smear microscopy for acid-fast bacilli and mycobacterial culture. Those having at least one sputum specimen positive on microscopy and/or culture were categorized as having PTB. Prevalence was estimated after adjusting for cluster sampling and incomplete data (through individual level analysis with robust standard error). Results Of 91,030 eligible adult participants (47,714 men and 43,316 women), 85,770 (94.2%) completed the symptom cards. Of them, 2,898 persons were considered eligible for sputum examination and 2,839 (98.0%) provided at least one sample. Overall, 21 persons had bacteriologically positive PTB, and cluster level prevalence was estimated at 24.5 per 100,000 population (95% CI 12.8-36.2). Individual level analysis with robust standard error yielded a prevalence estimate of 24.1 per 100,000 populations (95% CI 12.8-35.4). Conclusion The observed prevalence of bacteriologically positive PTB in this district is lower than empiric national estimates, probably as a result of successful implementation of tuberculosis control measures in the area.	[Aggarwal, Ashutosh N.; Gupta, Dheeraj; Agarwal, Ritesh; Behera, Digambar; Jindal, Surinder K.] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India; [Sethi, Sunil; Sharma, Meera] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India; [Thakur, Jarnail S.; Kumar, Rajesh] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India; [Anjinappa, Sharada M.; Chadha, Vineet K.] Natl TB Inst, Epidemiol & Res Div, Bangalore, Karnataka, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Gupta, D (corresponding author), Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India.	dheeraj1910@gmail.com	Agarwal, Ritesh/A-3063-2009	Agarwal, Ritesh/0000-0003-2547-7668	Central TB Division, Ministry of Health, Government of India	Central TB Division, Ministry of Health, Government of India	The study was funded by the Central TB Division, Ministry of Health, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A N, 2006, Indian J Chest Dis Allied Sci, V48, P13; [Anonymous], 2005, MIN EXP COMM M EST T; [Anonymous], 2013, 2013 WHO; Central TB Division, 2013, REV TUB CONTR PROGR; Chadha VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042625; Gopi PG, 2005, INDIAN J MED RES, V122, P243; Indian Council of Medical Research, 1959, ICMR SPEC REP SER, V34; *INT I POP SCI, 2007, NFHS3 INT I POP SCI, V1; Rao VG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043225; Subramani R, 2008, INT J TUBERC LUNG D, V12, P916; Vestal A, 1975, US PHS7682301 CTR DI, P97	11	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117363	10.1371/journal.pone.0117363	http://dx.doi.org/10.1371/journal.pone.0117363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695761	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300022
J	Palhano-Fontes, F; Andrade, KC; Tofoli, LF; Santos, AC; Crippa, JAS; Hallak, JEC; Ribeiro, S; de Araujo, DB				Palhano-Fontes, Fernanda; Andrade, Katia C.; Tofoli, Luis F.; Santos, Antonio C.; Crippa, Jose Alexandre S.; Hallak, Jaime E. C.; Ribeiro, Sidarta; de Araujo, Draulio B.			The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network	PLOS ONE			English	Article							PROPOFOL-INDUCED LOSS; FUNCTIONAL CONNECTIVITY; SIGMA-1 RECEPTOR; BRAIN NETWORKS; GLOBAL SIGNAL; MEDITATION; SELF; DISEASE; MIND; N,N-DIMETHYLTRYPTAMINE	The experiences induced by psychedelics share a wide variety of subjective features, related to the complex changes in perception and cognition induced by this class of drugs. A remarkable increase in introspection is at the core of these altered states of consciousness. Self-oriented mental activity has been consistently linked to the Default Mode Network (DMN), a set of brain regions more active during rest than during the execution of a goal-directed task. Here we used fMRI technique to inspect the DMN during the psychedelic state induced by Ayahuasca in ten experienced subjects. Ayahuasca is a potion traditionally used by Amazonian Amerindians composed by a mixture of compounds that increase monoaminergic transmission. In particular, we examined whether Ayahuasca changes the activity and connectivity of the DMN and the connection between the DMN and the task-positive network (TPN). Ayahuasca caused a significant decrease in activity through most parts of the DMN, including its most consistent hubs: the Posterior Cingulate Cortex (PCC)/Precuneus and the medial Prefrontal Cortex (mPFC). Functional connectivity within the PCC/Precuneus decreased after Ayahuasca intake. No significant change was observed in the DMN-TPN orthogonality. Altogether, our results support the notion that the altered state of consciousness induced by Ayahuasca, like those induced by psilocybin (another serotonergic psychedelic), meditation and sleep, is linked to the modulation of the activity and the connectivity of the DMN.	[Palhano-Fontes, Fernanda; Andrade, Katia C.; Ribeiro, Sidarta; de Araujo, Draulio B.] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil; [Tofoli, Luis F.] Univ Estadual Campinas, Dept Med Psychol & Psychiat, Campinas, SP, Brazil; [Santos, Antonio C.; Crippa, Jose Alexandre S.; Hallak, Jaime E. C.] Univ Sao Paulo, Dept Neurosci & Behav, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Estadual de Campinas; Universidade de Sao Paulo	de Araujo, DB (corresponding author), Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil.	draulio@neuro.ufrn.br	de Souza Crippa, José Alexandre/A-1215-2008; Araujo, Draulio/I-6038-2012; Tófoli, Luís Fernando/F-9221-2012; Ribeiro, Sidarta/C-5794-2016	Araujo, Draulio/0000-0002-6934-2485; Tófoli, Luís Fernando/0000-0003-2262-8272; Ribeiro, Sidarta/0000-0001-9325-9545	Brazilian Federal Agency CNPq; Brazilian Federal Agency CAPES; FINEP; Sao Paulo State financial agency (FAPESP)	Brazilian Federal Agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); Sao Paulo State financial agency (FAPESP)	Contract grant sponsor: The Brazilian Federal Agencies: CNPq, CAPES; FINEP; The Sao Paulo State financial agency (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossong MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070074; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Callaway JC, 1999, J ETHNOPHARMACOL, V65, P243, DOI 10.1016/S0378-8741(98)00168-8; Carhart-Harris RL, 2013, SCHIZOPHRENIA BULL, V39, P1343, DOI 10.1093/schbul/sbs117; Carhart-Harris RL, 2012, P NATL ACAD SCI USA, V109, P2138, DOI 10.1073/pnas.1119598109; Bouso JC, 2013, PSYCHOPHARMACOLOGY, V230, P415, DOI 10.1007/s00213-013-3167-9; de Araujo DB, 2012, HUMAN BRAIN MAPPING; dos Santos RG, 2012, PSYCHOPHARMACOLOGY, V219, P1039, DOI 10.1007/s00213-011-2434-x; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; GENTILI C, 2009, PSYCHOL HEALTH S1, V24, P181, DOI DOI 10.1016/J.ADDBEH.2015.01.022; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Hasenkamp W, 2012, FRONT HUM NEUROSCI, P6, DOI [10.3389/fnhum.2012.00348, DOI 10.3389/FNHUM.2012.00348]; Hasenkamp W, 2012, NEUROIMAGE, V59, P750, DOI 10.1016/j.neuroimage.2011.07.008; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; James William, 1982, VARIETIES RELIG EXPE; Jang JH, 2011, NEUROSCI LETT, V487, P358, DOI 10.1016/j.neulet.2010.10.056; Josipovic Z, 2012, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00184, DOI 10.3389/FNHUM.2011.00184]; Keller CJ, 2013, J NEUROSCI, V33, P6333, DOI 10.1523/JNEUROSCI.4837-12.2013; Kennedy DP, 2008, SOC COGN AFFECT NEUR, V3, P177, DOI 10.1093/scan/nsn011; Kriegeskorte Nikolaus, 2009, NATURE, V535, P540; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McGeown WJ, 2009, CONSCIOUS COGN, V18, P848, DOI 10.1016/j.concog.2009.09.001; MCKENNA DJ, 1984, J ETHNOPHARMACOL, V10, P195, DOI 10.1016/0378-8741(84)90003-5; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ray TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009019; Riba J, 2006, PSYCHOPHARMACOLOGY, V186, P93, DOI 10.1007/s00213-006-0358-7; Riba J, 2001, PSYCHOPHARMACOLOGY, V154, P85, DOI 10.1007/s002130000606; Riba J, 2003, J PHARMACOL EXP THER, V306, P73, DOI 10.1124/jpet.103.049882; Rinpoche YM, 2007, JOY LIVING, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Samann PG, 2011, CEREB CORTEX, V21, P2082, DOI 10.1093/cercor/bhq295; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Shanon Benny, 2002, ANTIPODES MIND CHART; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sood A, 2013, EXPLORE-NY, V9, P136, DOI 10.1016/j.explore.2013.02.005; Su TP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.261pe12; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; WATTS A, 1968, CALIF LAW REV, V56, P74, DOI 10.2307/3479497; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	54	180	186	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118143	10.1371/journal.pone.0118143	http://dx.doi.org/10.1371/journal.pone.0118143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693169	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500102
J	Yabuki, K; Shiono, O; Komatsu, M; Sano, D; Nishimura, G; Takahashi, M; Taguchi, T; Inoue, T; Oridate, N				Yabuki, Kenichiro; Shiono, Osamu; Komatsu, Masanori; Sano, Daisuke; Nishimura, Goshi; Takahashi, Masahiro; Taguchi, Takahide; Inoue, Tomio; Oridate, Nobuhiko			Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT)/Concurrent Chemoradiotherapy (CCRT)	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HYPOPHARYNX	Purpose To evaluate the predictive and prognostic value of pretreatment metabolic tumor volume (MTV) in patients with treated by radiotherapy (RT) or concurrent chemoradiotherapy (CCRT). Methods We reviewed the records of 118 patients with newly diagnosed laryngeal carcinoma, who had been treated by RT or CCRT. Pretreatment positron emission tomography (PET) was performed, and MTV values were obtained by contouring margins of standardized uptake value. Clinical factors and MTV were analyzed for their association with survival. Results Patients with residual disease showed a significantly higher MTV than those with a complete response (CR) after primary treatment. Univariate analysis showed that the patients with a high MTV had a significantly lower disease-free survival (DFS) (p < 0.001). Subsite (p = 0.010), T-stage (p < 0.001), nodal metastasis (p < 0.001) and clinical stage (p < 0.001) also correlated significantly with DFS. In the multivariate analysis, MTV and clinical stage were both found to be independent prognostic factors for DFS (p = 0.001, p = 0.034, respectively). The 3-year DFS for patients with a high MTV were significantly poorer than those with a low MTV (p < 0.001). Conclusions MTV of the primary tumor is a significant prognostic factor for DFS in patients with laryngeal carcinoma treated by RT or CCRT. The results imply that MTV could be an important factor when planning treatment and follow-up for patients with laryngeal carcinoma.	[Yabuki, Kenichiro; Shiono, Osamu; Komatsu, Masanori; Sano, Daisuke; Nishimura, Goshi; Takahashi, Masahiro; Taguchi, Takahide; Oridate, Nobuhiko] Yokohama City Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yokohama, Kanagawa 232, Japan; [Inoue, Tomio] Yokohama City Univ, Sch Med, Dept Radiol, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University	Yabuki, K (corresponding author), Yokohama City Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yokohama, Kanagawa 232, Japan.	k_yabuki@yokohama-cu.ac.jp	Oridate, Nobuhiko/ABC-4116-2020; Sano, Daisuke/R-6591-2018	Oridate, Nobuhiko/0000-0002-6968-3028; Sano, Daisuke/0000-0002-7686-4724; Yabuki, Kenichiro/0000-0002-5099-1901				Chung MK, 2009, CLIN CANCER RES, V15, P5861, DOI 10.1158/1078-0432.CCR-08-3290; Fletcher JW, 2008, J NUCL MED, V49, P480, DOI 10.2967/jnumed.107.047787; Garsa AA, 2013, J RADIOL ONCOL, V2, P27, DOI 10.1007/s13566-012-0065-4; Kao CH, 2012, EUR J NUCL MED MOL I, V39, P1297, DOI 10.1007/s00259-012-2127-7; Paidpally Vasavi, 2012, Imaging Med, V4, P633; Park GC, 2013, ANN ONCOL, V24, P208, DOI 10.1093/annonc/mds247; Taguchi T, 2014, CANCER CHEMOTH PHARM, V73, P1147, DOI 10.1007/s00280-014-2448-2; Tang C, 2012, INT J RADIAT ONCOL, V83, P1514, DOI 10.1016/j.ijrobp.2011.10.023; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tsukuda M, 2009, CANCER CHEMOTH PHARM, V64, P945, DOI 10.1007/s00280-009-0946-4	10	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117924	10.1371/journal.pone.0117924	http://dx.doi.org/10.1371/journal.pone.0117924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692986	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500080
J	Aleandri, M; Conte, MP; Simonetti, G; Panella, S; Celestino, I; Checconi, P; Marazzato, M; Longhi, C; Goldoni, P; Nicoletti, M; Barnich, N; Palamara, AT; Schippa, S; Nencioni, L				Aleandri, Marta; Conte, Maria Pia; Simonetti, Giovanna; Panella, Simona; Celestino, Ignacio; Checconi, Paola; Marazzato, Massimiliano; Longhi, Catia; Goldoni, Paola; Nicoletti, Mauro; Barnich, Nicolas; Palamara, Anna Teresa; Schippa, Serena; Nencioni, Lucia			Influenza A Virus Infection of Intestinal Epithelial Cells Enhances the Adhesion Ability of Crohn's Disease Associated Escherichia coli Strains	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PEDIATRIC-PATIENTS; ILEAL MUCOSA; GASTROINTESTINAL SYMPTOMS; REPLICATION; CANCER; PATHOGENESIS; MACROPHAGES; EXPRESSION; ADHERENCE	Modifications of intestinal glycoreceptors expression, in particular CEACAM6, typically found in ileal Crohn's disease (CD), favor, among the commensal species of microbiota, the enrichment in Escherichia coli. Removal of protein glycosidic residues by neuraminidase, a sialidase typical of influenza virus, increases adhesion ability of Escherichia coli to Caco-2 intestinal cells. In this study we investigated whether influenza virus infection of human intestinal epithelial cells could influence the adhesiveness of different Escherichia coli strains isolated from CD patients by altering surface glycoreceptors. Influenza virus infection of intestinal cells increased exposure of galactose and mannose residues on the cell surface. In particular, glycoreceptors Thomsen-Friedenreich and CEACAM6 were over-expressed in influenza virus infected cells. In the same experimental conditions, a significant increase in bacterial adhesiveness was observed, independently of their own adhesive ability. The increase was reverted by treatment with anti-TF and anti-CEACAM6 antibodies. Interestingly, influenza virus was able to efficiently replicate in human primary intestinal cells leading to TF exposure. Finally, intestinal infected cells produced high levels of pro-inflammatory cytokines compared to control. Overall these data suggest that influenza virus infection, could constitute an additional risk factor in CD patients.	[Aleandri, Marta; Conte, Maria Pia; Simonetti, Giovanna; Panella, Simona; Celestino, Ignacio; Marazzato, Massimiliano; Longhi, Catia; Goldoni, Paola; Schippa, Serena; Nencioni, Lucia] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Panella, Simona; Palamara, Anna Teresa] Telemat Univ, IRCCS San Raffaele Pisana, Rome, Italy; [Celestino, Ignacio] CEINGE Biotecnol Avanzate, Naples, Italy; [Checconi, Paola; Palamara, Anna Teresa] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Inst Pasteur, Cenci Bolognetti Fdn, I-00185 Rome, Italy; [Nicoletti, Mauro] Univ G DAnnunzio, Dept Expt Sci & Clin, Chieti, Italy; [Barnich, Nicolas] Univ Auvergne, Clermont Univ, INSERM, M2iSH,UMR 1071, Clermont Ferrand, France	Sapienza University Rome; IRCCS San Raffaele Pisana; CEINGE Biotecnologie Avanzate; Fondazione Cenci Bolognetti; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Palamara, AT (corresponding author), Telemat Univ, IRCCS San Raffaele Pisana, Rome, Italy.	annateresa.palamara@uniroma1.it	Checconi, Paola/K-6655-2016; Checconi, Paola/AAH-1985-2019; Nencioni, Lucia/K-5988-2016; simonetti, giovanna/ABD-6675-2020	Checconi, Paola/0000-0001-7518-5730; Checconi, Paola/0000-0001-7518-5730; Nencioni, Lucia/0000-0003-4427-4823; simonetti, giovanna/0000-0003-4321-4626; PALAMARA, ANNA TERESA/0000-0001-8330-4381; GOLDONI, Paola/0000-0002-1071-6999; schippa, serena/0000-0003-1572-2623; Barnich, Nicolas/0000-0001-9465-7844	Italian Ministry of Instruction, University and Research [PON 0101802, FIRB RBIN06E9Z8, PRIN 2010PHT9NF005]; Ateneo grants	Italian Ministry of Instruction, University and Research(Ministry of Education, Universities and Research (MIUR)); Ateneo grants	This work was partially supported by the Italian Ministry of Instruction, University and Research [grant number PON 0101802, FIRB RBIN06E9Z8 and PRIN 2010PHT9NF005] and Ateneo grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-116; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Bodger K, 2006, GUT, V55, P973, DOI 10.1136/gut.2005.086413; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Campbell BJ, 2001, GLYCOCONJUGATE J, V18, P851, DOI 10.1023/A:1022240107040; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chan MCW, 2009, J CLIN VIROL, V45, P208, DOI 10.1016/j.jcv.2009.06.011; Chassaing B, 2011, J CLIN INVEST, V121, P966, DOI 10.1172/JCI44632; Checconi P, 2013, INT J MOL SCI, V14, P4148, DOI 10.3390/ijms14024148; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gaur P, 2012, J BIOL CHEM, V287, P15109, DOI 10.1074/jbc.M111.328070; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Iebba V, 2012, INFECT IMMUN, V80, P1408, DOI 10.1128/IAI.06181-11; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Mahay BW, 1991, VIROLOGY PRACTICAL A; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508fje; Nencioni L, 2009, J BIOL CHEM, V284, P16004, DOI 10.1074/jbc.M900146200; Okayama S, 2011, J MICROBIOL IMMUNOL, V44, P480, DOI 10.1016/j.jmii.2011.04.003; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Pang IK, 2013, P NATL ACAD SCI USA, V110, P13910, DOI 10.1073/pnas.1303275110; Podolsky DK, 1997, ACTA GASTRO-ENT BELG, V60, P163; PRICE DA, 1976, CLIN PEDIATR, V15, P361, DOI 10.1177/000992287601500408; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Rolhion N, 2011, GUT MICROBES, V2, P115, DOI 10.4161/gmic.2.2.15725; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Schippa S, 2012, CAN J MICROBIOL, V58, P426, DOI [10.1139/W2012-007, 10.1139/w2012-007]; Schippa S, 2009, INFLAMM BOWEL DIS, V15, P661, DOI 10.1002/ibd.20818; Sgarbanti R, 2011, ANTIOXID REDOX SIGN, V15, P593, DOI 10.1089/ars.2010.3512; Shu YL, 2010, J INFECT DIS, V201, P1173, DOI 10.1086/651457; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Strober W, 2011, J CLIN INVEST, V121, P841, DOI 10.1172/JCI46333; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Wootton SH, 2006, PEDIATR INFECT DIS J, V25, P1194, DOI 10.1097/01.inf.0000245097.95543.11; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3; Zhirnov O, 2003, VIROLOGY, V313, P198, DOI 10.1016/S0042-6822(03)00264-2	47	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117005	10.1371/journal.pone.0117005	http://dx.doi.org/10.1371/journal.pone.0117005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706391	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100058
J	Bai, JW; Smock, SL; Jackson, GR; MacIsaac, KD; Huang, YS; Mankus, C; Oldach, J; Roberts, B; Ma, YL; Klappenbach, JA; Crackower, MA; Alves, SE; Hayden, PJ				Bai, Jianwu; Smock, Steven L.; Jackson, George R., Jr.; MacIsaac, Kenzie D.; Huang, Yongsheng; Mankus, Courtney; Oldach, Jonathan; Roberts, Brian; Ma, Yu-Lu; Klappenbach, Joel A.; Crackower, Michael A.; Alves, Stephen E.; Hayden, Patrick J.			Phenotypic Responses of Differentiated Asthmatic Human Airway Epithelial Cultures to Rhinovirus	PLOS ONE			English	Article							BRONCHIAL EPITHELIUM; GENE-EXPRESSION; INFECTION; CELLS; SUSCEPTIBILITY; DEFICIENT; INFLAMMATION; REPLICATION; RNA	Objectives Human airway epithelial cells are the principal target of human rhinovirus (HRV), a common cold pathogen that triggers the majority of asthma exacerbations. The objectives of this study were 1) to evaluate an in vitro air liquid interface cultured human airway epithelial cell model for HRV infection, and 2) to identify gene expression patterns associated with asthma intrinsically and/or after HRV infection using this model. Methods Air-liquid interface (ALI) human airway epithelial cell cultures were prepared from 6 asthmatic and 6 non-asthmatic donors. The effects of rhinovirus RV-A16 on ALI cultures were compared. Genome-wide gene expression changes in ALI cultures following HRV infection at 24 hours post exposure were further analyzed using RNA-seq technology. Cellular gene expression and cytokine/chemokine secretion were further evaluated by qPCR and a Luminex-based protein assay, respectively. Main Results ALI cultures were readily infected by HRV. RNA-seq analysis of HRV infected ALI cultures identified sets of genes associated with asthma specific viral responses. These genes are related to inflammatory pathways, epithelial structure and remodeling and cilium assembly and function, including those described previously (e.g. CCL5, CXCL10 and CX3CL1, MUC5AC, CDHR3), and novel ones that were identified for the first time in this study (e.g. CCRL1). Conclusions ALI-cultured human airway epithelial cells challenged with HRV are a useful translational model for the study of HRV-induced responses in airway epithelial cells, given that gene expression profile using this model largely recapitulates some important patterns of gene responses in patients during clinical HRV infection. Furthermore, our data emphasize that both abnormal airway epithelial structure and inflammatory signaling are two important asthma signatures, which can be further exacerbated by HRV infection.	[Bai, Jianwu; Smock, Steven L.; MacIsaac, Kenzie D.; Huang, Yongsheng; Roberts, Brian; Ma, Yu-Lu; Klappenbach, Joel A.; Crackower, Michael A.; Alves, Stephen E.] Merck Res Labs, Boston, MA 02115 USA; [Jackson, George R., Jr.; Mankus, Courtney; Oldach, Jonathan; Hayden, Patrick J.] MatTek Corp, Ashland, MA USA	Merck & Company; MatTek Corporation	Bai, JW (corresponding author), Merck Res Labs, Boston, MA 02115 USA.	jianwu.bai@merck.com; PHayden@mattek.com		Hayden, Patrick/0000-0001-8977-1845	Merck Research Laboratories; MatTek; NHLBI [1R43HL088807-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL088807] Funding Source: NIH RePORTER	Merck Research Laboratories(Merck & Company); MatTek; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Merck Research Laboratories, MatTek and partly by a grant (1R43HL088807-01) to PJH from NHLBI (http://www. nhlbi.nih.gov/). Co-authors Jianwu Bai, Steven L. Smock, Kenzie D. MacIsaac, Yongsheng Huang, Brian Roberts, Yu-Lu Ma, Joel A. Klappenbach, Michael A. Crackower and Stephen E. Alves are employed by Merck Research Laboratories. Coauthors George R. Jackson, Jr, Courtney Mankus, Jonathan Oldach and Patrick J. Hayden are employed by MatTek Corporation. Merck Research Laboratories and MatTek provided support in the form of salaries for authors JB, SLS, KDM, YH, BR, Y-LM, JAK, MAC, SEA, GRJ, CM, JO and PJH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashraf S, 2013, VIROLOGY, V436, P143, DOI 10.1016/j.virol.2012.11.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; Dizier MH, 2000, AM J RESP CRIT CARE, V162, P1812, DOI 10.1164/ajrccm.162.5.2002113; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; Fregonese L, 2005, J ALLERGY CLIN IMMUN, V115, P1148, DOI 10.1016/j.jaci.2005.01.068; Gavala ML, 2011, IMMUNOL REV, V242, P69, DOI 10.1111/j.1600-065X.2011.01031.x; Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hershenson MB, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/405876; Holgate ST, 2013, ALLERGY ASTHMA IMMUN, V5, P343, DOI 10.4168/aair.2013.5.6.343; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Holtzman M, 2011, AM J RESP CELL MOL, V44, P739, DOI 10.1165/rcmb.2011-0120ED; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Jakiela B, 2014, AM J RESP CELL MOL, V51, P229, DOI 10.1165/rcmb.2013-0395OC; Jurgeit A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-264; Kennedy JL, 2014, AM J RESP CRIT CARE, V189, P532, DOI 10.1164/rccm.201310-1767OC; LENNETTE EH, 1972, AM J CLIN PATHOL, V57, P737; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Marsh DG, 1997, NAT GENET, V15, P389; Nakagome K, 2014, J ALLERGY CLIN IMMUN, V134, P332, DOI 10.1016/j.jaci.2014.01.029; Parsons KS, 2014, CLIN EXP ALLERGY, V44, P91, DOI 10.1111/cea.12218; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Pritchard AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106501; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Quint JK, 2010, CHEST, V137, P812, DOI 10.1378/chest.09-1541; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Sanchez-Cuellar S, 2012, CLIN EXP IMMUNOL, V170, P365, DOI 10.1111/j.1365-2249.2012.04665.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sykes A, 2014, THORAX, V69, P240, DOI 10.1136/thoraxjnl-2012-202909; Tapparel C, 2013, VIROLOGY, V446, P1, DOI 10.1016/j.virol.2013.06.031; Thomas B, 2010, J ALLERGY CLIN IMMUN, V126, P722, DOI 10.1016/j.jaci.2010.05.046; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Watson AM, 2010, J INVEST MED, V58, P725, DOI 10.231/JIM.0b013e3181db874e; WHITCUTT MJ, 1988, IN VITRO CELL DEV B, V24, P420; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713	45	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118286	10.1371/journal.pone.0118286	http://dx.doi.org/10.1371/journal.pone.0118286			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706956	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100163
J	Hoek, KL; Samir, P; Howard, LM; Niu, XN; Prasad, N; Galassie, A; Liu, Q; Allos, TM; Floyd, KA; Guo, Y; Shyr, Y; Levy, SE; Joyce, S; Edwards, KM; Link, AJ				Hoek, Kristen L.; Samir, Parimal; Howard, Leigh M.; Niu, Xinnan; Prasad, Nripesh; Galassie, Allison; Liu, Qi; Allos, Tara M.; Floyd, Kyle A.; Guo, Yan; Shyr, Yu; Levy, Shawn E.; Joyce, Sebastian; Edwards, Kathryn M.; Link, Andrew J.			A Cell-Based Systems Biology Assessment of Human Blood to Monitor Immune Responses after Influenza Vaccination	PLOS ONE			English	Article							YELLOW-FEVER VACCINE; RNA-SEQ; SEQUENCES; CORRELATE; PATTERNS; MEMORY	Systems biology is an approach to comprehensively study complex interactions within a biological system. Most published systems vaccinology studies have utilized whole blood or peripheral blood mononuclear cells (PBMC) to monitor the immune response after vaccination. Because human blood is comprised of multiple hematopoietic cell types, the potential for masking responses of under-represented cell populations is increased when analyzing whole blood or PBMC. To investigate the contribution of individual cell types to the immune response after vaccination, we established a rapid and efficient method to purify human T and B cells, natural killer (NK) cells, myeloid dendritic cells (mDC), monocytes, and neutrophils from fresh venous blood. Purified cells were fractionated and processed in a single day. RNA-Seq and quantitative shotgun proteomics were performed to determine expression profiles for each cell type prior to and after inactivated seasonal influenza vaccination. Our results show that transcriptomic and proteomic profiles generated from purified immune cells differ significantly from PBMC. Differential expression analysis for each immune cell type also shows unique transcriptomic and proteomic expression profiles as well as changing biological networks at early time points after vaccination. This cell type-specific information provides a more comprehensive approach to monitor vaccine responses.	[Hoek, Kristen L.; Niu, Xinnan; Allos, Tara M.; Floyd, Kyle A.; Joyce, Sebastian; Link, Andrew J.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Samir, Parimal] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Howard, Leigh M.; Edwards, Kathryn M.] Vanderbilt Univ, Sch Med, Vanderbilt Vaccine Res Program, Div Infect Dis,Dept Pediat, Nashville, TN 37232 USA; [Prasad, Nripesh; Levy, Shawn E.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Galassie, Allison] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Liu, Qi] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA; [Guo, Yan] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Shyr, Yu] Vanderbilt Univ, Sch Med, Dept Canc Biostat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; HudsonAlpha Institute for Biotechnology; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Edwards, KM (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Vaccine Res Program, Div Infect Dis,Dept Pediat, Nashville, TN 37232 USA.	kathryn.edwards@vanderbilt.edu; andrew.link@vanderbilt.edu	Samir, Parimal/N-4144-2014; Floyd, Kyle A./GYD-5355-2022	Samir, Parimal/0000-0001-7655-5713; Floyd, Kyle A./0000-0003-3261-7999; JOYCE, Sebastian/0000-0002-3183-1451; Prasad, Nripesh/0000-0003-4074-2538; Levy, Shawn/0000-0002-1369-5740	Federal funds from the National Institutes of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services [272200800007C]; Vanderbilt Clinical and Translational Science Award [NIH RR024975]; Childhood Infections Research Program [T32-AI095202-01]; Immunobiology of Blood and Vascular Systems training grant [5 T32 HL69765-12]; NIH [GM064779]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765, R01HL121139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064779] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001444] Funding Source: NIH RePORTER	Federal funds from the National Institutes of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services; Vanderbilt Clinical and Translational Science Award; Childhood Infections Research Program; Immunobiology of Blood and Vascular Systems training grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This project was funded in part with Federal funds from the National Institutes of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, under Contract No. 272200800007C, the Vanderbilt Clinical and Translational Science Award grant NIH RR024975, the Childhood Infections Research Program grant T32-AI095202-01, the Immunobiology of Blood and Vascular Systems training grant 5 T32 HL69765-12, and NIH grant GM064779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2007, SCIENCE; [Anonymous], 2014, R LANG ENV STAT COMP; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Brown SM, 2013, NEXT GENERATION DNA, P171; Browne CM, 2013, MOL CELL BIOL, V33, P1041, DOI 10.1128/MCB.00811-12; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Cheung RK, 2011, NAT REV RHEUMATOL, V7, P502, DOI 10.1038/nrrheum.2011.110; Debey-Pascher S, 2011, J MOL DIAGN, V13, P452, DOI 10.1016/j.jmoldx.2011.03.006; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kitano Hiroaki, 2001, P1; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mullard A, 2011, NAT REV DRUG DISCOV, V10, P477, DOI 10.1038/nrd3487; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tan Y, 2014, EUR J IMMUNOL, V44, P285, DOI 10.1002/eji.201343657; Tattermusch S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002480; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trautmann L, 2011, NAT IMMUNOL, V12, P729, DOI 10.1038/ni.2078; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Wang HX, 2005, J PROTEOME RES, V4, P2397, DOI 10.1021/pr050160f	45	54	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118528	10.1371/journal.pone.0118528	http://dx.doi.org/10.1371/journal.pone.0118528			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706537	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100189
J	Lin, IH; Chen, DT; Chang, YF; Lee, YL; Su, CH; Cheng, C; Tsai, YC; Ng, SC; Chen, HT; Lee, MC; Chen, HW; Suen, SH; Chen, YC; Liu, TT; Chang, CH; Hsu, MT				Lin, I-Hsuan; Chen, Dow-Tien; Chang, Yi-Feng; Lee, Yu-Ling; Su, Chia-Hsin; Cheng, Ching; Tsai, Yi-Chien; Ng, Swee-Chuan; Chen, Hsiao-Tan; Lee, Mei-Chen; Chen, Hong-Wei; Suen, Shih-Hui; Chen, Yu-Cheng; Liu, Tze-Tze; Chang, Chuan-Hsiung; Hsu, Ming-Ta			Hierarchical Clustering of Breast Cancer Methylomes Revealed Differentially Methylated and Expressed Breast Cancer Genes	PLOS ONE			English	Article							DNA METHYLATION; DECREASED EXPRESSION; ABERRANT EXPRESSION; RECEPTOR STATUS; X-INACTIVATION; HYPOMETHYLATION; TRANSCRIPTION; PLURIPOTENT; INSIGHTS; EPIGENOMICS	Oncogenic transformation of normal cells often involves epigenetic alterations, including histone modification and DNA methylation. We conducted whole-genome bisulfite sequencing to determine the DNA methylomes of normal breast, fibroadenoma, invasive ductal carcinomas and MCF7. The emergence, disappearance, expansion and contraction of kilobase-sized hypomethylated regions (HMRs) and the hypomethylation of the megabasesized partially methylated domains (PMDs) are the major forms of methylation changes observed in breast tumor samples. Hierarchical clustering of HMR revealed tumor-specific hypermethylated clusters and differential methylated enhancers specific to normal or breast cancer cell lines. Joint analysis of gene expression and DNA methylation data of normal breast and breast cancer cells identified differentially methylated and expressed genes associated with breast and/ or ovarian cancers in cancer-specific HMR clusters. Furthermore, aberrant patterns of X-chromosome inactivation (XCI) was found in breast cancer cell lines as well as breast tumor samples in the TCGA BRCA (breast invasive carcinoma) dataset. They were characterized with differentially hypermethylated XIST promoter, reduced expression of XIST, and over-expression of hypomethylated X-linked genes. High expressions of these genes were significantly associated with lower survival rates in breast cancer patients. Comprehensive analysis of the normal and breast tumor methylomes suggests selective targeting of DNA methylation changes during breast cancer progression. The weak causal relationship between DNA methylation and gene expression observed in this study is evident of more complex role of DNA methylation in the regulation of gene expression in human epigenetics that deserves further investigation.	[Lin, I-Hsuan; Chen, Dow-Tien; Ng, Swee-Chuan; Chen, Hsiao-Tan; Lee, Mei-Chen; Chen, Hong-Wei; Suen, Shih-Hui; Chen, Yu-Cheng; Liu, Tze-Tze; Hsu, Ming-Ta] Natl Yang Ming Univ, VGH YM Genome Ctr, Taipei 112, Taiwan; [Lin, I-Hsuan; Lee, Yu-Ling; Su, Chia-Hsin; Cheng, Ching; Tsai, Yi-Chien; Hsu, Ming-Ta] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chang, Chuan-Hsiung] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Chang, Yi-Feng; Chang, Chuan-Hsiung] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hsu, MT (corresponding author), Natl Yang Ming Univ, VGH YM Genome Ctr, Taipei 112, Taiwan.	mth@ym.edu.tw	Chang, Ian/U-3571-2019; Lin, I-Hsuan/N-6501-2013	Chang, Ian/0000-0001-5840-2051; Lee, Yu-Ling/0000-0003-1897-9918; Lin, I-Hsuan/0000-0002-6207-1299	Ministry of Education, Taiwan; National Core Facility Program for Biotechnology, Taiwan [NSC 102-2319-B-010-001]; National Research Program for Biopharmaceuticals, Taiwan [NSC 102-2325-B-492-001]; National Center for High-performance Computing of National Applied Research Laboratories, Taiwan	Ministry of Education, Taiwan(Ministry of Education, Taiwan); National Core Facility Program for Biotechnology, Taiwan; National Research Program for Biopharmaceuticals, Taiwan; National Center for High-performance Computing of National Applied Research Laboratories, Taiwan	This work was supported by Aim for the Top University Plan from the Ministry of Education, Taiwan. The authors acknowledge the High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan (NSC 102-2319-B-010-001), for their sequencing services. The authors also thank the National Research Program for Biopharmaceuticals, Taiwan (NSC 102-2325-B-492-001) and National Center for High-performance Computing of National Applied Research Laboratories, Taiwan for providing computational and storage resources. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Araujo FD, 1999, J BIOL CHEM, V274, P9335, DOI 10.1074/jbc.274.14.9335; Avraham A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091805; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Chaligne R, 2014, FEBS LETT, V588, P2514, DOI 10.1016/j.febslet.2014.06.023; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Faryna M, 2012, FASEB J, V26, P4937, DOI 10.1096/fj.12-209502; Futscher BW, 2004, NEOPLASIA, V6, P380, DOI 10.1593/neo.04115; Gupta A, 2003, CANCER RES, V63, P664; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Han LL, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-52; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hill VK, 2011, CANCER RES, V71, P2988, DOI 10.1158/0008-5472.CAN-10-4026; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Huang Y, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2925; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kuchiba A, 2014, BRIT J CANCER, V110, P2765, DOI 10.1038/bjc.2014.223; Kundaje A, REPROD MEASURE UNPUB; Kundaje A, ASSESSMENT CHI UNPUB; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li LA, 2010, HUM MOL GENET, V19, P4273, DOI 10.1093/hmg/ddq351; Li Y, 2010, PROCEEDINGS OF 2010 ASIA-PACIFIC YOUTH CONFERENCE ON COMMUNICATION, VOLS 1 AND 2, P10, DOI 10.1371/journal.pbio.1000533; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Locke WJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3237; Lung HL, 2005, ONCOGENE, V24, P6525, DOI 10.1038/sj.onc.1208812; Marzese DM, 2014, HUM MOL GENET, V23, P226, DOI 10.1093/hmg/ddt420; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Park YJ, 2011, PROG DRUG RES, V67, P25, DOI 10.1007/978-3-7643-8989-5_2; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reyngold M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103896; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Schlesinger F, 2013, GENOME RES, V23, P1601, DOI 10.1101/gr.157271.113; Shann YJ, 2008, GENOME RES, V18, P791, DOI 10.1101/gr.070961.107; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Song Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081148; Sproul D, 2013, BRIEF FUNCT GENOMICS, V12, P174, DOI 10.1093/bfgp/els063; Stirzaker C, 2014, TRENDS GENET, V30, P75, DOI 10.1016/j.tig.2013.11.004; Taberlay PC, 2014, GENOME RES, DOI [10.1101/gr.174730.114, DOI 10.1101/GR.174730.114]; Thakur A, 2007, MOL CANCER RES, V5, P171, DOI 10.1158/1541-7786.MCR-06-0071; Tsai Yi-Chien, 2011, Cancers (Basel), V3, P1996, DOI 10.3390/cancers3021996; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wang CY, 2012, BREAST CANCER RES TR, V134, P101, DOI 10.1007/s10549-011-1925-0; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yamashita K, 2013, INT J MOL SCI, V14, P23231, DOI 10.3390/ijms141223231; Yu YP, 2013, AM J PATHOL, V183, P1960, DOI 10.1016/j.ajpath.2013.08.018; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang YC, 2013, MOL BIOL EVOL, V30, P2588, DOI 10.1093/molbev/mst148; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	75	22	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118453	10.1371/journal.pone.0118453	http://dx.doi.org/10.1371/journal.pone.0118453			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706888	gold, Green Submitted, Green Published			2022-12-27	WOS:000350662100182
J	Smith, DK				Smith, David K.			Craniocervical Myology and Functional Morphology of the Small-Headed Therizinosaurian Theropods Falcarius utahensis and Nothronychus mckinleyi	PLOS ONE			English	Article							ANTERIOR PRESACRAL REGION; DINOSAURIA; NECK; BRAINCASE; TYRANNOSAURIDAE; ANATOMY; MUSCLES; MANIRAPTORA; HYPOTHESES; HOMOLOGIES	Therizinosaurs represent a highly unusual clade of herbivorous theropods from the Cretaceous of North America and Asia. Following descriptions of the basicrania of the North American therizinosaurs Falcarius utahenisis and Nothronychus mckinleyi, the craniocervical musculature in both taxa is reconstructed using Tyrannosaurus, Allosaurus, and some extant birds as models. These muscles are subdivided into functional groups as dorsiflexors, lateroflexors, and ventroflexors. Lateroflexors and dorsiflexors in Nothronychus, but not Falcarius, are reduced, from the plesiomorphic theropod condition, but are still well developed. Attachments in both genera are favorable for an increase in ventroflexion in feeding, convergent with Allosaurus fragilis. Falcarius and Nothronychus are both characterized by a flat occipital condyle, followed by centra with shallow articular facets suggesting neck function very similar to that of an ostrich Struthio camelus. Neck movement was a combined result of minimal movement between the individual cervical vertebrae.	Northland Pioneer Coll, Dept Biol, Holbrook, AZ 85901 USA		Smith, DK (corresponding author), Northland Pioneer Coll, Dept Biol, Holbrook, AZ 85901 USA.	dsmith@npc.edu						Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Bakker RT, 2000, GAIA, V15, P145; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Chiasson R, 1984, LAB ANATOMY PIGEON, P1; Clark J. M., 1994, AM MUS NOVIT, V3364, P1; Cobley MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072187; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Dong Zhiming, 1997, P90; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Hutson JD, 2012, J EXP BIOL, V215, P2030, DOI 10.1242/jeb.069567; Kirkland JI, 2005, LIFE O PAST, P87; Lautenschlager S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052289; Lautenschlager S, 2013, J ANAT, V222, P260, DOI 10.1111/joa.12000; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Maryanska T, 1974, Palaeontologia Polonica, VNo. 30, P45; MOLNAR RE, 1973, THESIS U CALIFORNIA; Morhardt A, 2013, J VERTEBR PALEONTO S, p180A; Pu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063423; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; Shufeldt RW, 1890, MYOLOGY RAVEN CORVUS, P1; Smith D., 1992, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V186, P365; Smith DK, 2014, J VERTEBR PALEONTOL, V34, P635, DOI 10.1080/02724634.2013.812097; Smith DK, 2011, J VERTEBR PALEONTOL, V31, P387, DOI 10.1080/02724634.2011.549442; Snively E, 2006, THESIS U CALGARY; Snively E, 2007, PALEOBIOLOGY; Snively E, 2007, ZOOL J LINN SOC-LOND, V151, P759, DOI 10.1111/j.1096-3642.2007.00334.x; Snively E, 2007, ANAT REC, V290, P934, DOI 10.1002/ar.20563; Snively E, 2013, PALAEONTOL ELECTRON, V16; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; SUES H-D, 1987, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V198, P1; TRINKAUS E, 1991, J ANTHROPOL SOC NIP, V99, P257; Tsuihiji T, 2005, J MORPHOL, V263, P151, DOI 10.1002/jmor.10294; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Tsuihiji T, 2010, ANAT REC, V293, P1360, DOI 10.1002/ar.21191; Van der Leeuw AHJ, 2001, NETH J ZOOL, V51, P243, DOI 10.1163/156854201750385172; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu Xing, 2002, Vertebrata Palasiatica, V40, P228; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y; Zanno LE, 2006, J VERTEBR PALEONTOL, V26, P636, DOI 10.1671/0272-4634(2006)26[636:TPGAFO]2.0.CO;2; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zhang Xiao-Hong, 2001, Vertebrata Palasiatica, V39, P282	50	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117281	10.1371/journal.pone.0117281	http://dx.doi.org/10.1371/journal.pone.0117281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706764	Green Published, gold			2022-12-27	WOS:000350662100071
J	Religa, D; Fereshtehnejad, SM; Cermakova, P; Edlund, AK; Garcia-Ptacek, S; Granqvist, N; Hallback, A; Kawe, K; Farahmand, B; Kilander, L; Mattsson, UB; Nagga, K; Nordstrom, P; Wijk, H; Wimo, A; Winblad, B; Eriksdotter, M				Religa, Dorota; Fereshtehnejad, Seyed-Mohammad; Cermakova, Pavla; Edlund, Ann-Katrin; Garcia-Ptacek, Sara; Granqvist, Nicklas; Hallback, Anne; Kawe, Kerstin; Farahmand, Bahman; Kilander, Lena; Mattsson, Ulla-Britt; Nagga, Katarina; Nordstrom, Peter; Wijk, Helle; Wimo, Anders; Winblad, Bengt; Eriksdotter, Maria			SveDem, the Swedish Dementia Registry - A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MORTALITY RISK; OLDER-ADULTS; LEWY BODIES; DRUG-USE; CRITERIA; SWEDEN; MEDICATION; MANAGEMENT; NATIONWIDE	Background The Swedish Dementia Registry (SveDem) was developed with the aim to improve the quality of diagnostic work-up, treatment and care of patients with dementia disorders in Sweden. Methods SveDem is an internet based quality registry where several indicators can be followed over time. It includes information about the diagnostic work-up, medical treatment and community support (www.svedem.se). The patients are diagnosed and followed-up yearly in specialist units, primary care centres or in nursing homes. Results The database was initiated in May 2007 and covers almost all of Sweden. There were 28 722 patients registered with a mean age of 79.3 years during 2007-2012. Each participating unit obtains continuous online statistics from its own registrations and they can be compared with regional and national data. A report from SveDem is published yearly to informmedical and care professionals as well as political and administrative decision-makers about the current quality of diagnostics, treatment and care of patients with dementia disorders in Sweden. Conclusion SveDem provides knowledge about current dementia care in Sweden and serves as a framework for ensuring the quality of diagnostics, treatment and care across the country. It also reflects changes in quality dementia care over time. Data from SveDem can be used to further develop the national guidelines for dementia and to generate new research hypotheses.	[Religa, Dorota; Cermakova, Pavla; Farahmand, Bahman; Wimo, Anders; Winblad, Bengt] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Ctr Alzheimer Res,Div Neurogeriatr, Huddinge, Sweden; [Religa, Dorota; Edlund, Ann-Katrin; Garcia-Ptacek, Sara; Eriksdotter, Maria] Karolinska Univ Hosp, Geriatr Clin, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad; Garcia-Ptacek, Sara; Eriksdotter, Maria] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Ctr Alzheimer Res,Div Clin Geriatr, Huddinge, Sweden; [Granqvist, Nicklas] Tradgardstorgets Primary Care Unit, Linkoping, Sweden; [Hallback, Anne] Municipal Norrtalje, Norrtalje, Sweden; [Kawe, Kerstin] Cent Hosp Karlstad, Karlstad, Sweden; [Kilander, Lena] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden; [Mattsson, Ulla-Britt] Sahlgrens Univ Hosp, Neuropsychiat Clin, Gothenburg, Sweden; [Nagga, Katarina] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden; [Nordstrom, Peter] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Wijk, Helle] Gothenburg Univ, Inst Hlth & Care Sci, Sahlgrenska Acad, Gothenburg, Sweden; [Wimo, Anders] Uppsala Univ, Cty Council Gavleborg, Ctr Res & Dev, Gavle, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Sahlgrenska University Hospital; Lund University; Umea University; University of Gothenburg; Uppsala University	Religa, D (corresponding author), Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Ctr Alzheimer Res,Div Neurogeriatr, Huddinge, Sweden.	Dorota.Religa@ki.se	Eriksdotter, Maria/I-5427-2015; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Wimo, Anders/ABA-2678-2021; Cermakova, Pavla/C-5890-2019; Garcia-Ptacek, Sara/AAD-5631-2019; Ptacek, Sara Garcia/AAS-2618-2021; Wijk, Helle/AAY-9660-2021	Eriksdotter, Maria/0000-0003-2498-4000; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Cermakova, Pavla/0000-0002-9282-9363; Ptacek, Sara Garcia/0000-0002-1537-6129; Wijk, Helle/0000-0003-2396-6505; Religa, Dorota/0000-0003-4583-4570; Nagga, Katarina/0000-0003-0194-8402; Nordstrom, Peter/0000-0003-2924-508X; Wimo, Anders/0000-0003-0963-5750	Swedish Association of Local Authorities and Regions; Swedish Brain Power network; Svenska Lakaresallskapet; Alzheimerfonden; Swedish Research Council [2012-2291]	Swedish Association of Local Authorities and Regions; Swedish Brain Power network; Svenska Lakaresallskapet; Alzheimerfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission)	SveDem register is supported by the Swedish Association of Local Authorities and Regions and the Swedish Brain Power network. Financial support of Svenska Lakaresallskapet, Alzheimerfonden and Swedish Research Council (Drn 2012-2291) for Dorota Religa is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt NJ, 2013, J GERONTOL NURS, V39, P8, DOI 10.3928/00989134-20130315-05; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Cermakova P, 2014, EUR J NEUROL, V21, P34; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Eriksson H, 2014, J ALZHEIMERS DIS, V41, P411, DOI 10.3233/JAD-132273; Falahati F, 2015, DEMENT GERIATR COGN, V39, P81, DOI 10.1159/000366194; Falk H, 2007, INT PSYCHOGERIATR, V19, P1040, DOI 10.1017/S1041610207005777; Faxen-Irving G, 2014, DEMENT GER COGN D EX, V4, P65, DOI 10.1159/000360415; Feldman AL, 2012, NEUROEPIDEMIOLOGY, V38, P186, DOI 10.1159/000336356; Fereshtehnejad SM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0065-2; Fereshtehnejad SM, 2014, DRUG AGING, V31, P215, DOI 10.1007/s40266-014-0154-8; Fereshtehnejad SM, 2013, NEUROPSYCH DIS TREAT, V9, P927, DOI 10.2147/NDT.S45840; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Frisoni GB, 2011, LANCET NEUROL, V10, P598, DOI 10.1016/S1474-4422(11)70126-0; Fritsch T, 2001, Am J Alzheimers Dis Other Demen, V16, P369, DOI 10.1177/153331750101600606; Garcia-Ptacek S, 2014, J ALZHEIMERS DIS, V41, P467, DOI 10.3233/JAD-131856; Garcia-Ptacek S, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2014.03.001; Gustafsson M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-56; Iliffe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-9; Jedenius E, 2011, SCAND J PRIM HEALTH, V29, P181, DOI 10.3109/02813432.2011.585277; Jennings L, 2013, J AM MED DIR ASSOC, V14, P447, DOI 10.1016/j.jamda.2013.03.015; Johannsen P, 2011, AGING MENT HEALTH, V15, P40, DOI 10.1080/13607863.2010.508769; Johnell K, 2013, DEMENT GERIATR COGN, V35, P239, DOI 10.1159/000348408; Johnell K, 2012, DRUG AGING, V29, P751, DOI 10.1007/s40266-012-0002-7; Jonsson L, 2006, ALZ DIS ASSOC DIS, V20, P49; Kling MA, 2013, ALZHEIMERS DEMENT, V9, P76, DOI 10.1016/j.jalz.2012.02.007; Langballe EM, 2014, AM J GERIAT PSYCHIAT, V22, P321, DOI 10.1016/j.jagp.2013.06.007; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; McEvoy Phil, 2008, Br J Community Nurs, V13, P127; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Nordstrom P, 2013, EUR HEART J, V34, P2585, DOI 10.1093/eurheartj/eht182; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Religa D, 2012, DEMENT GERIATR COGN, V33, P90, DOI 10.1159/000337038; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; Rochon PA, 2008, ARCH INTERN MED, V168, P1090, DOI 10.1001/archinte.168.10.1090; Roos LL, 1999, J CLIN EPIDEMIOL, V52, P39, DOI 10.1016/S0895-4356(98)00126-7; Santos M, 2014, QUAL MANAG HEALTH CA, V23, P119, DOI 10.1097/QMH.0000000000000021; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Schulze J, 2013, PHARMACOEPIDEM DR S, V22, P1308, DOI 10.1002/pds.3527; Skillback T, 2014, NEUROLOGY, V83, P1945, DOI 10.1212/WNL.0000000000001015; Skoldunger A, 2012, INT J GERIATR PSYCH, V27, P1112, DOI 10.1002/gps.2828; Socialstyrelsen, 2010, NATL GUID CAR CAS DE; Sorbi S, 2012, EUR J NEUROL, V19, P1159, DOI 10.1111/j.1468-1331.2012.03784.x; Stromberg C N, 1988, J Arthroplasty, V3, P47, DOI 10.1016/S0883-5403(88)80052-4; SveDem, SVEDEM ANN REPORT 20; Tolppanen AM, 2012, J ALZHEIMERS DIS, V32, P531, DOI 10.3233/JAD-2012-120802; van Vollenhoven RF, 2005, CLIN EXP RHEUMATOL, V23, pS195; WHO, 2012, ICD 10 CLASS MENT BE; Wimo A, UNPUB; Wimo A, 2013, INT J GERIATR PSYCH, V28, P1039, DOI 10.1002/gps.3925; Wimo Anders, 2009, Lakartidningen, V106, P1277	54	93	93	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116538	10.1371/journal.pone.0116538	http://dx.doi.org/10.1371/journal.pone.0116538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695768	Green Published, gold			2022-12-27	WOS:000350062300015
J	Platas-Neri, D; Hidalgo-Tobon, S; Alonso, BD; de Leon, FCP; Munoz-Delgado, J; Phillips, KA				Platas-Neri, Diana; Hidalgo-Tobon, Silvia; da Celis Alonso, Benito; Chico-Ponce de Leon, Fernando; Munoz-Delgado, Jairo; Phillips, Kimberley A.			Tractography of the Spider Monkey (Ateles geoffroyi) Corpus Callosum Using Diffusion Tensor Magnetic Resonance Imaging	PLOS ONE			English	Article							ORGANIZATION; SIZE; TOPOGRAPHY; MRI; CONNECTIONS; COMPETITION; EVOLUTION; PRIMATES; CORTEX	The objective of this research was to describe the organization, connectivity and microstructure of the corpus callosum of the spider monkey (Ateles geoffroyi). Non-invasive magnetic resonance imaging and diffusion-tensor imaging were obtained from three subjects using a 3T Philips scanner. We hypothesized that the arrangement of fibers in spider monkeys would be similar to that observed in other non-human primates. A repeated measure (n = 3) of fractional anisotropy values was obtained of each subject and for each callosal subdivision. Measurements of the diffusion properties of corpus callosum fibers exhibited a similar pattern to those reported in the literature for humans and chimpanzees. No statistical difference was reached when comparing this parameter between the different CC regions (p = 0.066). The highest fractional anisotropy values corresponded to regions projecting from the corpus callosum to the posterior cortical association areas, premotor and supplementary motor cortices. The lowest fractional anisotropy corresponded to projections to motor and sensory cortical areas. Analyses indicated that approximately 57% of the fibers projects to the frontal cortex and 43% to the post-central cortex. While this study had a small sample size, the results provided important information concerning the organization of the corpus callosum in spider monkeys.	[Platas-Neri, Diana] Univ Autonoma Estado Morelos, Inst Profes Reg Sur, Jojutla, Morelos, Mexico; [Hidalgo-Tobon, Silvia; Chico-Ponce de Leon, Fernando] Hosp Infantil Mexico Dr Federico Gomez, Dept Neurocirugia, Mexico City, DF, Mexico; [Hidalgo-Tobon, Silvia] Univ Autonoma Metropolitana Iztapalapa, Dept Fis, Mexico City, DF, Mexico; [da Celis Alonso, Benito] Benemerita Univ Puebla, Fac Ciencias Fis & Matemat, Puebla, Puebla, Mexico; [Munoz-Delgado, Jairo] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Direcc Neurociencias, Mexico City, DF, Mexico; [Munoz-Delgado, Jairo] Univ Nacl Autonoma Mexico, Fac Psicol, Mexico City 04510, DF, Mexico; [Phillips, Kimberley A.] Trinity Univ, Dept Psychol, San Antonio, TX 78212 USA	Universidad Autonoma del Estado de Morelos; Hospital Infantil de Mexico Federico Gomez; Universidad Autonoma Metropolitana - Mexico; Benemerita Universidad Autonoma de Puebla; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Universidad Nacional Autonoma de Mexico; Trinity University	Platas-Neri, D (corresponding author), Univ Autonoma Estado Morelos, Inst Profes Reg Sur, Jojutla, Morelos, Mexico.	dplatasn@gmail.com	, de Celis Alonso Benito/AAP-4512-2021; , db/GRS-6835-2022; Phillips, Kimberley/P-1212-2016	, de Celis Alonso Benito/0000-0003-2124-1084; Platas, Diana/0000-0001-6738-0974; Phillips, Kimberley/0000-0002-5517-3596	Council for Science and Technology, Mexico (CONACYT) [109147]; Fulbright-COMEXUS	Council for Science and Technology, Mexico (CONACYT); Fulbright-COMEXUS	This work was supported by the Council for Science and Technology, Mexico (CONACYT) ( project 109147) and Fulbright-COMEXUS (grant to DPN) (www.cies.org;www.comexus.org.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbie AA, 1940, J COMP NEUROL, V72, P9; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Aboitiz F, 1992, Biol Res, V25, P51; Alexander AL, 2000, MAGNET RESON MED, V44, P283, DOI 10.1002/1522-2594(200008)44:2<283::AID-MRM16>3.0.CO;2-V; Allman J, 1991, EVOLVING BRAINS; Aureli F, 2011, PRIMATES PERSPECTIVE, P236; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; CHAPMAN CA, 1989, OIKOS, V54, P315, DOI 10.2307/3565291; CHAPMAN CA, 1990, AM J PRIMATOL, V22, P279, DOI 10.1002/ajp.1350220407; Connolly CJ, 1950, EXTERNAL MORPHOLOGY; Di Fiore A., 2011, PRIMATES PERSPECTIVE, P155; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Duong TQ, 2010, METHODS, V50, P125, DOI 10.1016/j.ymeth.2009.08.001; Fillard P, 2003, LECT NOTES COMPUT SC, V2879, P16; Hartwig W, 2011, ANAT REC, V294, P2207, DOI 10.1002/ar.21515; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Hofer S, 2008, CEREB CORTEX, V18, P1079, DOI 10.1093/cercor/bhm141; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hopkins WD, 2000, BEHAV NEUROSCI, V114, P739, DOI 10.1037//0735-7044.114.4.739; Huxley TH, 1861, ZOOL SOC LONDON SCI, P493; Jancke L, 1997, CEREB CORTEX, V7, P48, DOI 10.1093/cercor/7.1.48; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kaufman JA, 2005, ANAT REC PART A, V287A, P1026, DOI 10.1002/ar.a.20264; Kier E.L., 1987, SURG 3 VENTRICLE PP, P37; Kier EL, 1996, AM J NEURORADIOL, V17, P1631; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Chico-Ponce de León Fernando, 2009, Rev. Cienc. Salud, V7, P10; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Phillips KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031941; Platas D., 2011, THESIS U NACL AUTONO; PUBOLS BH, 1972, BRAIN BEHAV EVOLUT, V5, P342; PUBOLS BH, 1971, J COMP NEUROL, V141, P63, DOI 10.1002/cne.901410106; Ramayya AG, 2010, CEREB CORTEX, V20, P507, DOI 10.1093/cercor/bhp141; Ramos-Fernandez G, 2011, PRIMATES PERSPECTIVE, P220; Rilling JK, 1999, NEUROREPORT, V10, P1453, DOI 10.1097/00001756-199905140-00012; Semendeferi K, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P257; STEPHAN H, 1987, J HIRNFORSCH, V28, P571; SYMINGTON MM, 1990, INT J PRIMATOL, V11, P47, DOI 10.1007/BF02193695; SYMINGTON MM, 1988, BEHAVIOUR, V105, P117; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; Youlatos D, 2011, PRIMATES PERSPECTIVE, P185	50	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117367	10.1371/journal.pone.0117367	http://dx.doi.org/10.1371/journal.pone.0117367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693078	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500051
J	Morgan, DL; Merrick, BA; Gerrish, KE; Stockton, PS; Wang, Y; Foley, JF; Gwinn, WM; Kelly, FL; Palmer, SM; Ton, TVT; Flake, GP				Morgan, Daniel L.; Merrick, B. Alex; Gerrish, Kevin E.; Stockton, Patricia S.; Wang, Yu; Foley, Julie F.; Gwinn, William M.; Kelly, Francine L.; Palmer, Scott M.; Ton, Thai-Vu T.; Flake, Gordon P.			Gene Expression in Obliterative Bronchiolitis-Like Lesions in 2,3-Pentanedione-Exposed Rats	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BRONCHOALVEOLAR LAVAGE FLUID; TGF-BETA; PULMONARY-FIBROSIS; TENASCIN-C; LUNG; PROTEIN; RECEPTOR; THROMBOSPONDIN-2; FIBRONECTIN	Obliterative bronchiolitis (OB) is an irreversible lung disease characterized by progressive fibrosis in the small airways with eventual occlusion of the airway lumens. OB is most commonly associated with lung transplant rejection; however, OB has also been diagnosed in workers exposed to artificial butter flavoring (ABF) vapors. Research has been limited by the lack of an adequate animal model of OB, and as a result the mechanism(s) is unclear and there are no effective treatments for this condition. Exposure of rats to the ABF component, 2,3-pentanedione (PD) results in airway lesions that are histopathologically similar to those in human OB. We used this animal model to evaluate changes in gene expression in the distal bronchi of rats with PD-induced OB. Male Wistar Han rats were exposed to 200 ppm PD or air 6 h/d, 5 d/wk for 2-wks. Bronchial tissues were laser microdissected from serial sections of frozen lung. In exposed lungs, both fibrotic and non-fibrotic airways were collected. Following RNA extraction and microarray analysis, differential gene expression was evaluated. In non-fibrotic bronchi of exposed rats, 4683 genes were significantly altered relative to air-exposed controls with notable down-regulation of many inflammatory cytokines and chemokines. In contrast, in fibrotic bronchi, 3807 genes were significantly altered with a majority of genes being up-regulated in affected pathways. Tgf-beta 2 and downstream genes implicated in fibrosis were significantly up-regulated in fibrotic lesions. Genes for collagens and extracellular matrix proteins were highly up-regulated. In addition, expression of genes for peptidases and peptidase inhibitors were significantly altered, indicative of the tissue remodeling that occurs during airway fibrosis. Our data provide new insights into the molecular mechanisms of OB. This new information is of potential significance with regard to future therapeutic targets for treatment.	[Morgan, Daniel L.; Merrick, B. Alex; Stockton, Patricia S.; Wang, Yu; Foley, Julie F.; Gwinn, William M.; Ton, Thai-Vu T.; Flake, Gordon P.] NIEHS, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA; [Gerrish, Kevin E.] NIEHS, Div Intramural Res, Res Triangle Pk, NC 27709 USA; [Kelly, Francine L.; Palmer, Scott M.] Duke Univ, Med Ctr, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Morgan, DL (corresponding author), NIEHS, Div Natl Toxicol Program, POB 12233, Res Triangle Pk, NC 27709 USA.	morgan3@niehs.nih.gov		Palmer, Scott/0000-0002-1370-3771	National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES103318, ZIAES101865] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH). This article is the work product of a group of employees of the NIEHS; however, the statements, opinions or conclusions contained therein do not necessarily represent the statements, opinions or conclusions of NIEHS, NIH or the United States government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Ask K, 2008, INT J BIOCHEM CELL B, V40, P484, DOI 10.1016/j.biocel.2007.08.016; Askew DJ, 2008, J PERINATOL, V28, pS127, DOI 10.1038/jp.2008.150; Balzar S, 2005, J ALLERGY CLIN IMMUN, V115, P110, DOI 10.1016/j.jaci.2004.09.034; Beeh KM, 2001, J HEART LUNG TRANSPL, V20, P1144, DOI 10.1016/S1053-2498(01)00325-4; Bergmann M, 1998, SCAND CARDIOVASC J, V32, P97; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; BITTERMAN PB, 1983, J CELL BIOL, V97, P1925, DOI 10.1083/jcb.97.6.1925; Bornstein P, 2000, MATRIX BIOL, V19, P557, DOI 10.1016/S0945-053X(00)00104-9; Brunner SM, 2011, TRANSPL INT, V24, P1027, DOI 10.1111/j.1432-2277.2011.01306.x; Carey WA, 2010, AM J PHYSIOL-LUNG C, V299, pL785, DOI 10.1152/ajplung.00385.2009; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chijiwa Tsuyoshi, 2009, Int J Oncol, V34, P5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Gamel A, 1999, J HEART LUNG TRANSPL, V18, P828, DOI 10.1016/S1053-2498(99)00047-9; Elssner A, 2000, TRANSPLANTATION, V70, P362, DOI 10.1097/00007890-200007270-00022; Fernandez FG, 2005, AM J TRANSPLANT, V5, P671, DOI 10.1111/j.1600-6143.2005.00751.x; Fix C, 2011, CYTOKINE, V53, P19, DOI 10.1016/j.cyto.2010.10.002; Gibot S, 2007, CRIT CARE, V11, DOI 10.1186/cc5158; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; HavemosePoulsen A, 1997, CRIT REV ORAL BIOL M, V8, P217, DOI 10.1177/10454411970080020801; Hibino S, 1998, BIOCHEM BIOPH RES CO, V250, P119, DOI 10.1006/bbrc.1998.9258; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Hubner RH, 2005, EUR RESPIR J, V25, P494, DOI 10.1183/09031936.05.00091804; Jeong YH, 2010, BIOCHEM BIOPH RES CO, V392, P495, DOI 10.1016/j.bbrc.2010.01.049; Jiang L, 2009, AM J CLIN PATHOL, V131, P738, DOI 10.1309/AJCP3CX3AUVRBHCF; Jin WT, 2013, RESPIROLOGY, V18, P643, DOI 10.1111/resp.12034; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Kamochi J, 2003, ONCOL REP, V10, P881; Kawayama T, 2012, J INTERF CYTOK RES, V32, P443, DOI 10.1089/jir.2012.0029; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; LIMPER AH, 1992, CHEST, V101, P1663, DOI 10.1378/chest.101.6.1663; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; Lofdahl M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-48; MATSUSHIMA K, 1985, J IMMUNOL, V134, P904; Mehuron T, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-14; Morgan DL, 2012, TOXICOLOGIST, V126, P866; O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8; Ohta H, 2012, AM J PHYSIOL-LUNG C, V302, pL193, DOI 10.1152/ajplung.00349.2010; Oshika Y, 1998, CLIN CANCER RES, V4, P1785; Paivaniemi OE, 2008, J HEART LUNG TRANSPL, V27, P400, DOI 10.1016/j.healun.2008.01.009; Palmer SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017644; POSTLETHWAITE AE, 1984, ARTHRITIS RHEUM, V27, P995, DOI 10.1002/art.1780270905; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; ROBERTS CJ, 1988, J BIOL CHEM, V263, P4586; Ryu JH, 2003, AM J RESP CRIT CARE, V168, P1277, DOI 10.1164/rccm.200301-053SO; Sato M, 2009, AM J TRANSPLANT, V9, P1981, DOI 10.1111/j.1600-6143.2009.02770.x; SCHMIDT JA, 1982, J IMMUNOL, V128, P2177; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Solberg H, 2001, J HISTOCHEM CYTOCHEM, V49, P237, DOI 10.1177/002215540104900211; Streichenberger N, 2001, VIRCHOWS ARCH, V439, P78, DOI 10.1007/s004280100402; Thompson HGR, 2006, AM J PHYSIOL-LUNG C, V291, pL1277, DOI 10.1152/ajplung.00057.2006; Tokunaga T, 1999, BRIT J CANCER, V79, P354, DOI 10.1038/sj.bjc.6690056; Tschumperlin DJ, 2003, AM J RESP CELL MOL, V28, P142, DOI 10.1165/rcmb.2002-0121OC; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Zhao Y, 1998, AM J PHYSIOL-LUNG C, V274, pL1049, DOI 10.1152/ajplung.1998.274.6.L1049; Zheng L, 2004, J HEART LUNG TRANSPL, V23, P446, DOI 10.1016/S1053-2498(03)00199-2; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	64	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118459	10.1371/journal.pone.0118459	http://dx.doi.org/10.1371/journal.pone.0118459			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710175	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900058
J	Okazaki, S; Noisangiam, R; Okubo, T; Kaneko, T; Oshima, K; Hattori, M; Teamtisong, K; Songwattana, P; Tittabutr, P; Boonkerd, N; Saeki, K; Sato, S; Uchiumi, T; Minamisawa, K; Teaumroong, N				Okazaki, Shin; Noisangiam, Rujirek; Okubo, Takashi; Kaneko, Takakazu; Oshima, Kenshiro; Hattori, Masahira; Teamtisong, Kamonluck; Songwattana, Pongpan; Tittabutr, Panlada; Boonkerd, Nantakorn; Saeki, Kazuhiko; Sato, Shusei; Uchiumi, Toshiki; Minamisawa, Kiwamu; Teaumroong, Neung			Genome Analysis of a Novel Bradyrhizobium sp DOA9 Carrying a Symbiotic Plasmid	PLOS ONE			English	Article							BROAD-HOST-RANGE; RHIZOBIUM-LEGUMINOSARUM; GENETIC DIVERSITY; NOD GENES; NODULATION; JAPONICUM; EVOLUTION; SEQUENCE; IDENTIFICATION; EXPRESSION	Bradyrhizobium sp. DOA9 isolated from the legume Aeschynomene americana exhibited a broad host range and divergent nodulation (nod) genes compared with other members of the Bradyrhizobiaceae. Genome analysis of DOA9 revealed that its genome comprised a single chromosome of 7.1 Mbp and a plasmid of 0.7 Mbp. The chromosome showed highest similarity with that of the nod gene-harboring soybean symbiont B. japonicum USDA110, whereas the plasmid showed highest similarity with pBBta01 of the nod gene-lacking photosynthetic strain BTAi1, which nodulates Aeschynomene species. Unlike in other bradyrhizobia, the plasmid of DOA9 encodes genes related to symbiotic functions including nodulation, nitrogen fixation, and type III/IV protein secretion systems. The plasmid has also a lower GC content (60.1%) than the chromosome (64.4%). These features suggest that the plasmid could be the origin of the symbiosis island that is found in the genome of other bradyrhizobia. The nod genes of DOA9 exhibited low similarity with those of other strains. The nif gene cluster of DOA9 showed greatest similarity to those of photosynthetic bradyrhizobia. The type III/IV protein secretion systems of DOA9 are similar to those of nod gene-harboring B. elkanii and photosynthetic BTAi1. The DOA9 genome exhibited intermediate characteristics between nod gene-harboring bradyrhizobia and nod gene-lacking photosynthetic bradyrhizobia, thus providing the evidence for the evolution of the Bradyrhizobiaceae during ecological adaptation. Bradyrhizobium sp. DOA9 isolated from the legume Aeschynomene americana exhibited a broad host range and divergent nodulation (nod) genes compared with other members of the Bradyrhizobiaceae. Genome analysis of DOA9 revealed that its genome comprised a single chromosome of 7.1 Mbp and a plasmid of 0.7 Mbp. The chromosome showed highest similarity with that of the nod gene-harboring soybean symbiont B. japonicum USDA110, whereas the plasmid showed highest similarity with pBBta01 of the nod gene-lacking photosynthetic strain BTAi1, which nodulates Aeschynomene species. Unlike in other bradyrhizobia, the plasmid of DOA9 encodes genes related to symbiotic functions including nodulation, nitrogen fixation, and type III/IV protein secretion systems. The plasmid has also a lower GC content (60.1%) than the chromosome (64.4%). These features suggest that the plasmid could be the origin of the symbiosis island that is found in the genome of other bradyrhizobia. The nod genes of DOA9 exhibited low similarity with those of other strains. The nif gene cluster of DOA9 showed greatest similarity to those of photosynthetic bradyrhizobia. The type III/IV protein secretion systems of DOA9 are similar to those of nod gene-harboring B. elkanii and photosynthetic BTAi1. The DOA9 genome exhibited intermediate characteristics between nod gene-harboring bradyrhizobia and nod gene-lacking photosynthetic bradyrhizobia, thus providing the evidence for the evolution of the Bradyrhizobiaceae during ecological adaptation.	[Okazaki, Shin] Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo, Japan; [Noisangiam, Rujirek; Teamtisong, Kamonluck; Songwattana, Pongpan; Tittabutr, Panlada; Boonkerd, Nantakorn; Teaumroong, Neung] Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Nakhon Ratchasima, Thailand; [Okubo, Takashi; Sato, Shusei; Minamisawa, Kiwamu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Kaneko, Takakazu] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Oshima, Kenshiro; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Ctr Om & Bioinformat, Tokyo, Japan; [Saeki, Kazuhiko] Nara Womens Univ, Kyousei Sci Ctr Life & Nat, Fac Sci, Dept Biol Sci, Nara 6308506, Japan; [Uchiumi, Toshiki] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 890, Japan	Tokyo University of Agriculture & Technology; Suranaree University of Technology; Tohoku University; Kyoto Sangyo University; University of Tokyo; Nara Womens University; Kagoshima University	Okazaki, S (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo, Japan.	sokazaki@cc.tuat.ac.jp; neung@sut.ac.th	Hattori, Masahira/AAD-3785-2019; Minamisawa, Kiwamu/C-1585-2017; Saeki, Kazuhiko/ABC-8447-2020; Hattori, Masahira/C-6958-2016; Saeki, Kazuhiko/F-9904-2013; Sato, Shusei/A-3616-2015; OKAZAKI, Shin/G-1164-2013; OKAZAKI, Shin/AAH-3043-2021	Saeki, Kazuhiko/0000-0002-4198-9754; Hattori, Masahira/0000-0001-9467-0344; Saeki, Kazuhiko/0000-0002-4198-9754; Sato, Shusei/0000-0002-0293-5366; OKAZAKI, Shin/0000-0002-6406-720X; OKAZAKI, Shin/0000-0002-6406-720X; Minamisawa, Kiwamu/0000-0001-7302-4079	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) in the Priority Area "Comprehensive Genomics" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.jsps.go.jp/english/e-grants/). The funding supported data collection and analysis of the present work.	BANFALVI Z, 1988, MOL GEN GENET, V214, P420, DOI 10.1007/BF00330475; Chaintreuil C, 2013, NEW PHYTOL, V200, P1247, DOI 10.1111/nph.12424; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cytryn EJ, 2008, ISME J, V2, P158, DOI 10.1038/ismej.2007.105; Debelle F, 1996, MOL MICROBIOL, V22, P303, DOI 10.1046/j.1365-2958.1996.00069.x; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Fischer H-M, 1994, MICROBIOLOGICAL REV, V58; GEELEN D, 1993, MOL MICROBIOL, V9, P145, DOI 10.1111/j.1365-2958.1993.tb01676.x; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Gonzalez V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r36; GOTTFERT M, 1990, MOL PLANT MICROBE IN, V3, P308, DOI 10.1094/MPMI-3-308; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hubber A, 2004, MOL MICROBIOL, V54, P561, DOI 10.1111/j.1365-2958.2004.04292.x; Hubber AM, 2007, MOL PLANT MICROBE IN, V20, P255, DOI 10.1094/MPMI-20-3-0255; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kaneko T, 2011, GENES-BASEL, V2, P763, DOI 10.3390/genes2040763; Kouchi H, 2010, PLANT CELL PHYSIOL, V51, P1381, DOI 10.1093/pcp/pcq107; Krause A, 2002, MOL PLANT MICROBE IN, V15, P1228, DOI 10.1094/MPMI.2002.15.12.1228; LEWIN A, 1990, MOL PLANT MICROBE IN, V3, P317, DOI 10.1094/MPMI-3-317; Loh J, 2003, APPL ENVIRON MICROB, V69, P10, DOI 10.1128/AEM.69.1.10-17.2003; Noisangiam R, 2012, APPL ENVIRON MICROB, V78, P6236, DOI 10.1128/AEM.00897-12; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Okubo T, 2012, MICROBES ENVIRON, V27, P306, DOI 10.1264/jsme2.ME11321; Ormeno-Orrillo E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-735; Perret X, 1997, J BACTERIOL, V179, P7488, DOI 10.1128/jb.179.23.7488-7496.1997; REGENSBURGER B, 1983, ARCH MICROBIOL, V135, P103, DOI 10.1007/BF00408017; SADOWSKY MJ, 1987, APPL ENVIRON MICROB, V53, P2624, DOI 10.1128/AEM.53.11.2624-2630.1987; SANJUAN J, 1994, MOL PLANT MICROBE IN, V7, P364, DOI 10.1094/MPMI-7-0364; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Sullivan JT, 1998, P NATL ACAD SCI USA, V95, P5145, DOI 10.1073/pnas.95.9.5145; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teamtisong K, 2014, MICROBES ENV; Terpolilli JJ, 2012, ADV MICROB PHYSIOL, V60, P325, DOI 10.1016/B978-0-12-398264-3.00005-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson K., 1987, CURRENT PROTOCOLS MO, V1; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zheng LM, 1997, J BACTERIOL, V179, P5963, DOI 10.1128/jb.179.18.5963-5966.1997	39	27	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117392	10.1371/journal.pone.0117392	http://dx.doi.org/10.1371/journal.pone.0117392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710540	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900031
J	Sukhorukov, AP; Mavrodiev, EV; Struwig, M; Nilova, MV; Dzhalilova, KK; Balandin, SA; Erst, A; Krinitsyna, AA				Sukhorukov, Alexander P.; Mavrodiev, Evgeny V.; Struwig, Madeleen; Nilova, Maya V.; Dzhalilova, Khalima Kh.; Balandin, Sergey A.; Erst, Andrey; Krinitsyna, Anastasiya A.			One-Seeded Fruits in the Core Caryophyllales: Their Origin and Structural Diversity	PLOS ONE			English	Article							SIEVE-ELEMENT PLASTIDS; MOLECULAR PHYLOGENY; TRIBAL CLASSIFICATION; CHARACTER EVOLUTION; POLLEN MORPHOLOGY; SEQUENCE DATA; AMARANTHACEAE; CHENOPODIACEAE; FAMILY; GENUS	The core Caryophyllales consist of approximately 30 families (12 000 species) distributed worldwide. Many members evolved one-seeded or conjoined fruits, but their origin and structural diversity have not been investigated. A comparative anatomical investigation of the one-seeded fruits within the core Caryophyllales was conducted. The origin of the one-seeded fruits and the evolutionary reconstructions of some carpological characters were traced using a tree based on rbcl and matK data in order to understand the ancestral characters and their changes. The one-seeded fruit type is inferred to be an ancestral character state in core Caryophyllales, with a subsequent increase in the seed number seen in all major clades. Most representatives of the 'Earlier Diverging' clade are distinguished in various carpological traits. The organization of the pericarp is diverse in many groups, although fruits with a dry, many-layered pericarp, consisting of sclerenchyma as outer layers and a thin-walled parenchyma below, with seeds occupying a vertical embryo position, are likely ancestral character states in the core Caryophyllales clade. Several carpological peculiarities in fruit and seed structure were discovered in obligate one-seeded Achatocarpaceae, Chenopodiaceae, Nyctaginaceae, Seguieriaceae and Sarcobataceae. The horizontal embryo evolved in only certain groups of Chenopodiaceae. The bar-thickening of endotegmen cells appears to be an additional character typical of core Caryophyllales. The syncarpy-to-lysicarpy paradigm in Caryophyllaceae needs to be reinterpreted.	[Sukhorukov, Alexander P.; Nilova, Maya V.; Dzhalilova, Khalima Kh.; Krinitsyna, Anastasiya A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Higher Plants, Moscow, Russia; [Mavrodiev, Evgeny V.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Struwig, Madeleen] Univ Zululand, Dept Bot, ZA-3880 Kwa Dlangezwa, Kwazulu Natal, South Africa; [Balandin, Sergey A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Geobot, Moscow, Russia; [Erst, Andrey] Russian Acad Sci, Siberian Branch, Cent Siberian Bot Garden, Herbarium, Novosibirsk, Russia	Lomonosov Moscow State University; State University System of Florida; University of Florida; University of Zululand; Lomonosov Moscow State University; Central Siberian Botanical Garden; Russian Academy of Sciences	Sukhorukov, AP (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Higher Plants, Moscow, Russia.	suchor@mail.ru	Nilova, Maya V./T-8332-2017; Erst, Andrey/M-3444-2016; Krinitsina, Anastasiya/H-9801-2017; Sukhorukov, Alexander/D-2084-2013	Krinitsina, Anastasiya/0000-0002-0653-3655; Sukhorukov, Alexander/0000-0003-2220-826X	Russian Fund for Basic Research [14-04-00136-a]; Russian Scientific Foundation [14-50-00029]	Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Scientific Foundation(Russian Science Foundation (RSF))	Grants of the Russian Fund for Basic Research (project 14-04-00136-a: phylogeny of Caryophyllales) and Russian Scientific Foundation (project 14-50-00029: carpological investigations). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhani H, 2007, INT J PLANT SCI, V168, P931, DOI 10.1086/518263; [Anonymous], 2009, MORPHOGENESIS FRUITS; [Anonymous], 1993, FAMILIES GENERA VASC, DOI [10.1007/978-3-662-02899-5_21, DOI 10.1007/978-3-662-02899-5_21]; Applequist Wendy L., 2003, Adansonia (Paris), V25, P13; Applequist WL, 2000, PLANT SYST EVOL, V221, P157, DOI 10.1007/BF01089291; Applequist WL, 2005, TAXON, V54, P681, DOI 10.2307/25065424; Baillon MH, 1887, B MENS SOC LINN LYON, V1, P649; BEHNKE H D, 1971, Taxon, V20, P731, DOI 10.2307/1218598; BEHNKE HD, 1982, PLANT SYST EVOL, V139, P257, DOI 10.1007/BF00989328; BEHNKE HD, 1976, PLANT SYST EVOL, V126, P31, DOI 10.1007/BF00986073; Behnke HD, 1997, TAXON, V46, P495, DOI 10.2307/1224390; BEHNKE HD, 1983, PLANT SYST EVOL, V143, P151, DOI 10.1007/BF00984117; BEHNKE HD, 1993, PLANT SYST EVOL, V186, P231, DOI 10.1007/BF00940800; BEHNKE HD, 1977, PLANT SYST EVOL, V128, P227, DOI 10.1007/BF00984559; Bentham G., 1880, GEN PL, V3; Bittrich V., 1993, FAMILIES GENERA VASC, P473, DOI DOI 10.1007/978-3-662-02899-5_56; BOGLE AL, 1974, J ARNOLD ARBORETUM, V55, P1; Borsch T, 1998, GRANA, V37, P129, DOI 10.1080/00173139809362658; Bortenschlager S, 1972, BER NATURWISS MED VE, V59, P7; Bramwell D, 1976, BOT MACARONESICA, V2, P19; Britton N.L., 1913, ILLUSTRATED FLORA NO, DOI 10.5962/bhl.title.940; Brockington S, 2013, AM J BOT, V100, P1757, DOI 10.3732/ajb.1300083; Brockington SF, 2011, NEW PHYTOL, V190, P854, DOI 10.1111/j.1469-8137.2011.03687.x; Brockington SF, 2009, INT J PLANT SCI, V170, P627, DOI 10.1086/597785; BROWN GK, 1985, SYST BOT, V10, P49, DOI 10.2307/2418434; BUTNIK A A, 1981, Botanicheskii Zhurnal (St. Petersburg), V66, P1433; BUTNIK A. A., 1991, ANATOMIA SEMINUM COM, P77; Butnik AA, 1991, ANATOMIA SEMINUM COM, VIII, P74; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carlquist S, 1999, IAWA J, V20, P149, DOI 10.1163/22941932-90000674; CARLQUIST S., 1995, ALISO, V14, P1, DOI DOI 10.5642/ALIS0.19951401.02; Carlquist S, 2006, BRITTONIA, V58, P301, DOI 10.1663/0007-196X(2006)58[301:AAPCAC]2.0.CO;2; Carlquist Sherwin, 2002, Madrono, V49, P158; Carlquist Sherwin, 2000, SIDA Contributions to Botany, V19, P71; Chen Shih-Huei, 2007, Taiwania, V52, P332; Chew S, 2010, SURG STUDIES UNDERGR, V4, P72; Christenhusz MJM, 2014, PHYTOTAXA, V181, P238, DOI 10.11646/phytotaxa.181.4.4; Christin PA, 2011, EVOLUTION, V65, P643, DOI 10.1111/j.1558-5646.2010.01168.x; CLEMENT JP, 1994, COLL CRIBLES, P247; Corner EJH, 1976, SEED DIOCOTYLEDONS; Costea Mihai, 2001, Aliso, V20, P51; Crowl AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094199; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; da Rosa Sonia M., 2002, Acta Cientifica Venezolana, V53, P245; De Craene LPR, 2013, PLANT SYST EVOL, V299, P1599, DOI 10.1007/s00606-013-0910-y; Devyatov A. G., 2003, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V108, P67; Devyatov AG, 2002, B SOC NAT MOSC B, V107, P69; Douglas N, 2010, TAXON, V59, P905, DOI 10.1002/tax.593018; Douglas NA, 2007, AM J BOT, V94, P856, DOI 10.3732/ajb.94.5.856; DOWNIE SR, 1994, SYST BOT, V19, P236, DOI 10.2307/2419599; Dumortier B.-C., 1829, ANAL FAMILLES PLANTE; ECKARDT T, 1974, PHYTON-ANN REI BOT A, V16, P13; Eckardt T, 1954, BERICHTE DTSCH BOT G, V67, P113; Eckardt T, 1955, BER DEUT BOT GES, V68, P167; Endress M.E., 1993, FAMILIES GENERA VASC, V2, P419, DOI DOI 10.1007/978-3-662-02899-5_49; Falkovitsh MI, 2007, PHASE TRANSITIONS BI, P80; Fay Michael F., 1997, Kew Bulletin, V52, P923, DOI 10.2307/4117819; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; Franchet AR, 1882, FAUNE FLORE PAYS COM; Franz E, 1908, BOT JB SYST S97, V42, P1; FRIEDRICH HANS-CHRISTIAN, 1956, PHYTON ANN REI BOT, V6, P220; Gentry H. S., 1958, Economic Botany, V12, P261, DOI 10.1007/BF02859772; Greenberg AK, 2011, TAXON, V60, P1637, DOI 10.1002/tax.606009; GRUBERT M, 1982, PLANT SYST EVOL, V141, P7, DOI 10.1007/BF01006475; Grubov VI, 1980, PLANT LIFE, V5, P374; Hakki MI, 2013, WILLDENOWIA, V43, P185, DOI 10.3372/wi.43.43120; Harbaugh DT, 2010, INT J PLANT SCI, V171, P185, DOI 10.1086/648993; Hassan NMS, 2005, BOT J LINN SOC, V148, P189, DOI 10.1111/j.1095-8339.2005.00407.x; Heimerl A, 1889, NATURL PFLANZ, V3, P1, DOI [10.1038/ncomms7138, DOI 10.1038/NCOMMS7138]; Heimerl A., 1934, NATURL PFLANZ, V16c, P86, DOI DOI 10.1038/NCOMMS7138; Hill TG, 1912, ANN BOT-LONDON, V26, P175, DOI 10.1093/oxfordjournals.aob.a089384; Hils MH, 2003, FLORA N AM N MEXICO, V4, P387; HOFMANN U, 1973, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V93, P247; HOFMANN U, 1977, BER DEUT BOT GES, V90, P39; Ikonnikov SS, 1995, BOT Z, V80, P113; Iljin MM, 1936, FLORA SSSR, V6, P2; Jansen Steven, 2000, Systematics and Geography of Plants, V70, P171, DOI 10.2307/3668620; JOSHI A. C, 1933, NEW PHYTOLOGIST, V32, P359, DOI 10.1111/j.1469-8137.1933.tb07020.x; Kadereit G, 2003, INT J PLANT SCI, V164, P959, DOI 10.1086/378649; Kadereit G, 2010, AM J BOT, V97, P1664, DOI 10.3732/ajb.1000169; KAJALE L. B., 1938, JOUR INDIAN BOT SOC, V17, P243; Kajale LB, 1954, J INDIAN BOT SOC, V23, P206; Kamelin R. V., 2011, Botanicheskii Zhurnal, V96, P441; KAMELINA O P, 1985, Botanicheskii Zhurnal (St. Petersburg), V70, P721; Kohler E, 2003, FA GE VAS P, V5, P355; Kowal T, 1953, MONOGR BOT, V1, P87; KOWAL TADENSZ, 1954, MONOGR BOT, V2, P162; KOWAL TADEUSZ, 1961, MONOGR BOT, V12, P3; Kull U, 1978, VIERAEA, V8, P187; Kung H.-W., 1978, ACTA PHYTOTAXON SIN, V16, P99; Kunkel G, 1975, CUADERNOS BOT CANARI, V24, P29; Kunth K.S., 1817, NOVA GENERA SPECIES, V2, P130; Lacroix Ch, 1986, THESIS U MCGILL; Le Duc A, 1994, SIDA CONTRIB BOT, V16, P613; Lee J, 2013, GENET MOL RES, V12, P4515, DOI 10.4238/2013.February.28.15; Lepschi B. J., 1996, Nuytsia, V11, P37; Lindley J, 1845, LONDON J BOT, V4, P1; Lopez HA, 2002, PLANT BIOLOGY, V4, P508, DOI 10.1055/s-2002-34134; MABRY TJ, 1977, ANN MO BOT GARD, V64, P210, DOI 10.2307/2395333; Maddison WP, 2009, MESQUITE MODULAR SYS; Maheshwari H, 1975, J INDIAN BOT SOC, V54, P154; Mahrt M, 1994, SIDA CONTRIB BOT, V16, P679; Masson R, 2013, TAXON, V62, P100, DOI 10.1002/tax.621009; MCNEILL J, 1974, Taxon, V23, P725, DOI 10.2307/1218433; MEIKLE R D, 1979, Kew Bulletin, V34, P341, DOI 10.2307/4109994; Meikle R. D., 1985, FLORA CYPRUS; Meimberg H, 2000, PLANT BIOLOGY, V2, P218, DOI 10.1055/s-2000-9460; MELIKYAN A P, 1968, Botanicheskii Zhurnal (St. Petersburg), V53, P1043; Melikyan AP, 1986, SOURCES INFORM PHYLO, P54; Metcalfe C. R., 1950, Anatomy of the Dicotyledons: leaves, stem, and wood, in relation to taxonomy, with notes on economic uses.; Miller AG, 1996, FLORA ARABIAN PENINS, V1, P143; Moquin-Tandon A, 1849, PRODROMUS SYST NAT R, V13, P220; Morton CM, 1997, BOT REV, V63, P231, DOI 10.1007/BF02857950; Muller J, 1869, CANDOLLE PRODROMUS S, V16, P9; Muller K, 2005, ANN MO BOT GARD, V92, P66; Narayana HS, 1963, PHYTOMORPHOLOGY, V13, P54; Nelson A, 1909, NEW MANUAL BOT CENTR; Netolitzky F., 1926, HDB PFLANZENANATOMIE, V10, P1; Nowicke J.W., 1977, SMITHSON CONTRIB BOT, V37, P1; Nowicke JW, 1996, SYST BOT, V21, P187, DOI 10.2307/2419747; NOWICKE JW, 1979, ANN MO BOT GARD, V66, P633, DOI 10.2307/2398914; NYANANYO B L, 1986, Feddes Repertorium, V97, P775; Nyffeler R, 2010, TAXON, V59, P227, DOI 10.1002/tax.591021; Ogundipe OT, 2009, TURK J BOT, V33, P153, DOI 10.3906/bot-0707-15; Oyama SD, 2010, BRAZ ARCH BIOL TECHN, V53, P1425, DOI 10.1590/S1516-89132010000600019; Pal N, 1952, P NAT I SC INDIA, V18, P363; Pax F, 1889, NATURL PFLANZ, V3, P61, DOI [DOI 10.1038/NCOMMS7138, 10.1038/ncomms7138]; Perrier de la Bathie H, 1950, FLORE MADAGASCAR COM, p[72, 1]; Plisko MA, 1996, ANATOMIA SEMINUM DIC, V5, P445; Poddubnaya-Arnoldi V.A., 1976, CYTOEMBRYOLOGY ANGIO; Prance GT, 1968, B JARD BOT NAT BELG, V8, P127, DOI DOI 10.2307/3667547; Prance GT, 1972, FLORA NEOTROPICA MON, V11; PUFF C, 1976, PLANT SYST EVOL, V125, P195, DOI 10.1007/BF00996238; RETTIG JH, 1992, TAXON, V41, P201, DOI 10.2307/1222329; Reveal J.L., 2008, PHYTOLOGIA, V90, P416; Reveal JL, 1992, NOVON, V2, P238; Rocen T, 1927, THESIS UPPSALA; ROHWEDER O, 1970, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V90, P201; ROHWEDER O, 1971, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V90, P447; ROHWEDER O, 1978, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V100, P1; ROHWEDER OTTO, 1965, BOT JAHR BUCHER SYST PFLANZENBESCH PFLANZENGEOGR, V83, P406; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROUSI A, 1988, TAXON, V37, P71, DOI 10.2307/1220935; Sage RF, 2007, AM J BOT, V94, P1992, DOI 10.3732/ajb.94.12.1992; Schaeferhoff Bastian, 2009, Willdenowia, V39, P209, DOI 10.3372/wi.39.39201; SCHIMANCZEIKA H, 1987, PLANT SYST EVOL, V155, P67, DOI 10.1007/BF00936289; Schinz H, 1893, NATURL PFLANZ, V3, P91, DOI [10.1038/ncomms7138, DOI 10.1038/NCOMMS7138]; Schmid R, 1978, 2 C INT JOJOBA APROV, P143; Seubert M, 1844, BOT ZEITUNG BERLIN, V2, P753; Shamrov II, 2012, CARYOPHYLLALES NEW I, P32; Shulz VA, 1989, THE GENUS SAPONARIA; SKVARLA JJ, 1982, TAXON, V31, P244, DOI 10.2307/1219987; Smissen RD, 2002, AM J BOT, V89, P1336, DOI 10.3732/ajb.89.8.1336; SOHMER SH, 1972, BRITTONIA, V24, P283, DOI 10.2307/2805667; SOHMER SH, 1973, PAC SCI, V27, P399; Solereder H, 1899, ANATOMIE DICOTYLEDON; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Standley PC, 1911, CONTRIBUTIONS US NAT, V13, P377; Struwig M, 2011, ACTA BIOL CRACOV BOT, V53, P50, DOI 10.2478/v10182-011-0025-0; Struwig M, 2011, BANGL J PLANT TAXON, V18, P105, DOI 10.3329/bjpt.v18i2.9297; Suchorukow A. P., 2006, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V108, P307; Sukhorukov A. P., 2010, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V115, P39; Sukhorukov A.P., 2005, FEDDES REPER, V116, P168, DOI [10.1002/fedr.200511070, DOI 10.1002/FEDR.200511070]; Sukhorukov AP, 2014, PHYTOTAXA, V172, P81, DOI 10.11646/phytotaxa.172.2.3; Sukhorukov AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061906; Sukhorukov AP, 2012, WILLDENOWIA, V42, P169, DOI 10.3372/wi.42.42202; Sukhorukov AP, 2011, WILLDENOWIA, V41, P75, DOI 10.3372/wi.41.41108; Sukhorukov Alexander P., 2007, Willdenowia, V37, P63, DOI 10.3372/wi.37.37103; Takhtajan A., 2009, FLOWERING PLANTS; Takhtajan AL, 1991, ANATOMIA SEMINUM COM, V3, DOI [10.1111/j.1365-2826.1991.tb00335.x, DOI 10.1111/J.1365-2826.1991.TB00335.X]; Thakur H. A., 2011, Journal of Experimental Sciences, V2, P37; Timonin AK, 2011, ANOMALOUS SECONDARY; Townsend CC, 1993, FAMILIES GENERA VASC, V2, P7; Ulbrich E., 1934, NATURLICHEN PFLANZEN, V16c, P379, DOI DOI 10.1038/NCOMMS7138; Veselova TD, 2009, WULFENIA, V16, P99; Vierhapper F, 1907, OESTERR BOT Z, V57, P41; Vierhapper F, 1907, OESTERR BOT Z, V57, P91; VOLGIN S A, 1980, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V85, P63; Volkens G, 1893, NATURL PFLANZ, V3, p[36, 124], DOI [10.1038/ncomms7138, DOI 10.1038/NCOMMS7138]; Walter H, 1906, BOT JB SYST S85, V37, P1; Walter H., 1909, PFLANZENR, V83, P1; Werker E., 1997, ENCY PLANT ANATOMY 3, V10, P424; Wiger J, 1935, THESIS LUND; WILLSON J, 1977, Madrono, V24, P104; WILSON R C, 1975, Aliso, V8, P289; WOLTERFILHO W, 1989, PHYTOCHEMISTRY, V28, P2355, DOI 10.1016/S0031-9422(00)97983-4; WUNDERLICH R, 1967, PHYTOMORPHOLOGY, V17, P301; Zheng HC, 2010, J SYST EVOL, V48, P318, DOI 10.1111/j.1759-6831.2010.00082.x; Zhu GL, 1988, ACTA PHYTOTAX SINICA, V26, P299; Zhu GL, 1979, FLORA REIPUBLICAE PO, V25, P115	190	30	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117974	10.1371/journal.pone.0117974	http://dx.doi.org/10.1371/journal.pone.0117974			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710481	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900045
J	Cong, WW; Ren, TS; Li, BG				Cong, Weiwei; Ren, Tusheng; Li, Baoguo			Assessing the Impact of Afforestation on Soil Organic C Sequestration by Means of Sequential Density Fractionation	PLOS ONE			English	Article							CARBON STORAGE; AGRICULTURAL SOILS; MATTER; STABILIZATION; GRASSLAND; DYNAMICS; NITROGEN; CHRONOSEQUENCE; ACCUMULATION; ASSOCIATIONS	Afforestation is a prevalent practice carried out for soil recovery and carbon sequestration. Improved understanding of the effects of afforestation on soil organic carbon (SOC) content and dynamics is necessary to identify the particular processes of soil organic matter (SOM) formation and/or decomposition that result from afforestation. To elucidate these mechanisms, we have used a sequential density fractionation technique to identify the transfer mechanisms of forest derived C to soil fractions and investigate the impact of afforestation on SOC sequestration. Surface soil samples from continuous maize crop land (C4) and forest land (C3), which had been established 5, 12 and 25 yr, respectively, on the Northeast China Plain were separated into five density fractions. SOC, nitrogen (N) concentration and delta 13C data from the three forests and adjacent cropland were compared. Afforestation decreased SOC concentration in the < 2.5 g cm-3 fractions from 5 yr forest sites, but increased SOC content in the < 2.0 g cm-3 fractions from 25 yr forest sites. Afforestation did not affect soil mass distribution, SOC and N proportional weight distributions across the density fractions. The < 1.8 g cm-3 fractions from 12 and 25 yr forests showed higher C/N and lower d13C as compared to other fractions. Incorporation of forest litter-derived C occurred from low density (< 1.8 g cm-3) fractions to aggregates of higher density (1.8-2.5 g cm-3) through aggregate recombination and C transport in the pore system of the aggregates. Some forest litter-derived C could transfer from the light fractions or directly diffuse and adsorb onto mineral particles. Results from this study indicate that microaggregate protection and association between organic material and minerals provide major contribution to the SOC sequestration in the afforested soil system.	[Cong, Weiwei; Ren, Tusheng; Li, Baoguo] China Agr Univ, Dept Soil & Water Sci, Beijing 100094, Peoples R China; [Cong, Weiwei] Shenyang Agr Univ, Dept Rural Reg Dev, Shenyang 110161, Liaoning, Peoples R China	China Agricultural University; Shenyang Agricultural University	Li, BG (corresponding author), China Agr Univ, Dept Soil & Water Sci, Beijing 100094, Peoples R China.	libg@cau.edu.cn			National Basic Research Program (973 plan) of China [2015CB150403]	National Basic Research Program (973 plan) of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program (973 plan) of China (2015CB150403), http://www.973.gov.cn/AreaItem.aspx?fid=01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALRIKSSON A, 1995, PLANT SOIL, V168, P103, DOI 10.1007/BF00029319; Balesdent J, 1996, EUR J SOIL SCI, V47, P485, DOI 10.1111/j.1365-2389.1996.tb01848.x; Blakemore LC, 1987, SCIENTIFIC REPORT 80; BOUWMAN AF, 1995, CARBON FORMS AND FUNCTIONS IN FOREST SOILS, P503; Cerli C, 2006, SOIL SCI, V171, P837, DOI 10.1097/01.ss.0000228061.23334.98; Cheng X, 2011, BIOGEOSCIENCES, V8, P1487, DOI 10.5194/bg-8-1487-2011; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; Conant RT, 2002, ENVIRON POLLUT, V116, pS127, DOI 10.1016/S0269-7491(01)00265-2; Davis M, 2007, GLOBAL CHANGE BIOL, V13, P1414, DOI 10.1111/j.1365-2486.2007.01372.x; Del Galdo I, 2003, GLOBAL CHANGE BIOL, V9, P1204, DOI 10.1046/j.1365-2486.2003.00657.x; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; HARRISON KG, 1995, GLOBAL BIOGEOCHEM CY, V9, P449, DOI 10.1029/95GB02380; Hatton PJ, 2012, ORG GEOCHEM, V42, P1489, DOI 10.1016/j.orggeochem.2011.05.002; Higham N.J., 2002, ACCURACY STABILITY N, V80; Huang ZQ, 2011, SOIL BIOL BIOCHEM, V43, P1341, DOI 10.1016/j.soilbio.2011.03.008; Jug A, 1999, FOREST ECOL MANAG, V121, P85, DOI 10.1016/S0378-1127(98)00558-1; Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5; Kogel-Knabner I, 2008, J PLANT NUTR SOIL SC, V171, P61, DOI 10.1002/jpln.200700048; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R., 1999, Progress in Environmental Science, V1, P307; Nave LE, 2013, SOIL SCI SOC AM J, V77, P1035, DOI 10.2136/sssaj2012.0236; OADES JM, 1991, AUST J SOIL RES, V29, P815, DOI 10.1071/SR9910815; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Paustian K, 2000, BIOGEOCHEMISTRY, V48, P147, DOI 10.1023/A:1006271331703; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Prior CA, 2007, RADIOCARBON, V49, P1093, DOI 10.1017/S0033822200042946; RAAD AA, 1978, MANUAL SOIL SAMPLING, P86; Ramnarine R, 2011, CAN J SOIL SCI, V91, P247, DOI [10.4141/CJSS10066, 10.4141/cjss10066]; Rillig MC, 2007, BIOGEOCHEMISTRY, V85, P25, DOI 10.1007/s10533-007-9102-6; Romanya J, 2000, EUR J SOIL SCI, V51, P627, DOI 10.1111/j.1365-2389.2000.00343.x; Roscoe R, 2000, BIOL FERT SOILS, V32, P52, DOI 10.1007/s003740000213; Roscoe R, 2000, EUR J SOIL SCI, V51, P445, DOI 10.1046/j.1365-2389.2000.00321.x; Schwertmann V. U., 1964, Z PFLANZENERNAHRUNG, V105, P194, DOI DOI 10.1107/S0108767309007235; Service. SC, 1984, 1 USDA SERV SC; Six J, 2002, SOIL SCI SOC AM J, V66, P1981, DOI 10.2136/sssaj2002.1981; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Smucker AJM, 2007, VADOSE ZONE J, V6, P282, DOI 10.2136/vzj2007.0031; Sollins P, 2006, SOIL BIOL BIOCHEM, V38, P3313, DOI 10.1016/j.soilbio.2006.04.014; Sollins P, 2009, BIOGEOCHEMISTRY, V96, P209, DOI 10.1007/s10533-009-9359-z; Throop HL, 2013, BIOGEOCHEMISTRY, V112, P409, DOI 10.1007/s10533-012-9735-y; Vesterdal L, 2002, FOREST ECOL MANAG, V169, P137, DOI 10.1016/S0378-1127(02)00304-3; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wang CM, 2006, J INTEGR PLANT BIOL, V48, P503, DOI 10.1111/j.1744-7909.2006.00264.x; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135	48	4	4	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117897	10.1371/journal.pone.0117897	http://dx.doi.org/10.1371/journal.pone.0117897			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705896	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100125
J	Gao, SH; Guan, QN; Chafeeva, I; Brooks, DE; Nguan, CYC; Kizhakkedathu, JN; Du, CG				Gao, Sihai; Guan, Qiunong; Chafeeva, Irina; Brooks, Donald E.; Nguan, Christopher Y. C.; Kizhakkedathu, Jayachandran N.; Du, Caigan			Hyperbranched Polyglycerol as a Colloid in Cold Organ Preservation Solutions	PLOS ONE			English	Article							UNIVERSITY-OF-WISCONSIN; TRYPTOPHAN-KETOGLUTARATE HTK; REDUCED GRAFT-SURVIVAL; HYDROXYETHYL STARCH; RENAL-FUNCTION; UW SOLUTION; CELL; ISCHEMIA; STORAGE; INJURY	Hydroxyethyl starch (HES) is a common colloid in organ preservation solutions, such as in University of Wisconsin (UW) solution, for preventing graft interstitial edema and cell swelling during cold preservation of donor organs. However, HES has undesirable characteristics, such as high viscosity, causing kidney injury and aggregation of erythrocytes. Hyperbranched polyglycerol (HPG) is a branched compact polymer that has low intrinsic viscosity. This study investigated HPG (MW-0.5 to 119 kDa) as a potential alternative to HES for cold organ preservation. HPG was synthesized by ring-opening multibranching polymerization of glycidol. Both rat myocardiocytes and human endothelial cells were used as an in vitro model, and heart transplantation in mice as an in vivo model. Tissue damage or cell death was determined by both biochemical and histological analysis. HPG polymers were more compact with relatively low polydispersity index than HES in UW solution. Cold preservation of mouse hearts ex vivo in HPG solutions reduced organ damage in comparison to those in HES-based UW solution. Both size and concentration of HPGs contributed to the protection of the donor organs; 1 kDa HPG at 3 wt% solution was superior to HES-based UW solution and other HPGs. Heart transplants preserved with HPG solution (1 kDa, 3%) as compared with those with UW solution had a better functional recovery, less tissue injury and neutrophil infiltration in syngeneic recipients, and survived longer in allogeneic recipients. In cultured myocardiocytes or endothelial cells, significantly more cells survived after cold preservation with the HPG solution than those with the UW solution, which was positively correlated with the maintenance of intracellular adenosine triphosphate and cell membrane fluidity. In conclusion, HPG solution significantly enhanced the protection of hearts or cells during cold storage, suggesting that HPG is a promising colloid for the cold storage of donor organs and cells in transplantation.	[Gao, Sihai; Guan, Qiunong; Nguan, Christopher Y. C.; Du, Caigan] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Gao, Sihai] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Thorac & Cardiovasc Surg, Wuhan 430074, Peoples R China; [Chafeeva, Irina; Brooks, Donald E.; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada; [Chafeeva, Irina; Brooks, Donald E.; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Brooks, Donald E.; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Chem, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Huazhong University of Science & Technology; University of British Columbia; University of British Columbia; University of British Columbia	Kizhakkedathu, JN (corresponding author), Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada.	jay@pathology.ubc.ca; caigan@mail.ubc.ca		Brooks, Donald/0000-0002-7946-4320	Kidney Foundation of Canada; Transplant Research Foundation of BC; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation; Tongji Hospital (Wuhan, China); Michael Smith Foundation for Health Research	Kidney Foundation of Canada; Transplant Research Foundation of BC; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Tongji Hospital (Wuhan, China); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This research was supported by the Kidney Foundation of Canada, the Transplant Research Foundation of BC, the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC). The infrastructure facility at the Centre for Blood Research was supported by Canada Foundation for Innovation. SG was supported by the visiting scholar fellowship from Tongji Hospital (Wuhan, China). JNK is a recipient of career investigator scholar award from Michael Smith Foundation for Health Research.	BIGUZAS M, 1990, TRANSPLANTATION, V49, P872, DOI 10.1097/00007890-199005000-00006; Bon D, 2012, NAT REV NEPHROL, V8, P339, DOI 10.1038/nrneph.2012.83; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Calderon M, 2010, ADV MATER, V22, P190, DOI 10.1002/adma.200902144; CARBOGNANI P, 1995, J CARDIOVASC SURG, V36, P93; CARLES J, 1994, LIVER, V14, P50; Chapanian R, 2013, BIOMACROMOLECULES, V14, P2052, DOI 10.1021/bm4003943; Chapanian R, 2012, BIOMATERIALS, V33, P7871, DOI 10.1016/j.biomaterials.2012.07.015; Chen FS, 2004, YONSEI MED J, V45, P1107, DOI 10.3349/ymj.2004.45.6.1107; Cittanova ML, 1996, LANCET, V348, P1620, DOI 10.1016/S0140-6736(96)07588-5; Codas R, 2009, CLIN TRANSPLANT, V23, P337, DOI 10.1111/j.1399-0012.2009.00959.x; CONTRACTOR HH, 1995, CELL TRANSPLANT, V4, P615, DOI 10.1016/0963-6897(95)00039-9; DEMERTZIS S, 1993, ANN THORAC SURG, V55, P1131, DOI 10.1016/0003-4975(93)90019-E; Denlinger DL, 1998, PHYSL COLD SENSITIVI; Dragun D, 2001, KIDNEY INT, V60, P1173, DOI 10.1046/j.1523-1755.2001.0600031173.x; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Du CG, 2014, BIOMATERIALS, V35, P1378, DOI 10.1016/j.biomaterials.2013.10.076; FETTERS LJ, 1993, MACROMOLECULES, V26, P647, DOI 10.1021/ma00056a015; Funakoshi Y, 1997, ARTIF CELL BLOOD SUB, V25, P407, DOI 10.3109/10731199709118930; George TJ, 2012, J HEART LUNG TRANSPL, V31, P410, DOI 10.1016/j.healun.2011.11.023; George TJ, 2011, J HEART LUNG TRANSPL, V30, P1033, DOI 10.1016/j.healun.2011.05.005; Guan QN, 2012, SURGERY, V151, P364, DOI 10.1016/j.surg.2011.09.032; Hadjichristidis N., 2012, POLYM SCI COMPR REF, V6, P29, DOI [10.1016/B978-0-444-53349-4.00161-8, DOI 10.1016/B978-0-444-53349-4.00161-8]; Hartog C, 2009, INTENS CARE MED, V35, P1337, DOI 10.1007/s00134-009-1521-5; Hays LM, 2001, CRYOBIOLOGY, V42, P88, DOI 10.1006/cryo.2001.2307; Henkelman S, 2012, CLIN HEMORHEOL MICRO, V52, P27, DOI 10.3233/CH-2012-1542; Hidalgo MA, 1996, J THORAC CARDIOV SUR, V112, P1027, DOI 10.1016/S0022-5223(96)70104-6; Hoeger S, 2011, J SURG RES, V170, pE149, DOI 10.1016/j.jss.2011.05.020; Jeevanandam V, 1992, J THORAC CARDIOVASC, V103, P198; Jeevanandam V, 1992, J THORAC CARDIOVASC, V103, P194; Kainthan RK, 2008, BIOMATERIALS, V29, P1693, DOI 10.1016/j.biomaterials.2007.11.030; Kainthan RK, 2007, BIOMATERIALS, V28, P4581, DOI 10.1016/j.biomaterials.2007.07.011; Kainthan RK, 2006, BIOMACROMOLECULES, V7, P703, DOI 10.1021/bm0504882; KO W, 1992, CIRCULATION, V86, P326; Kur F, 2009, TRANSPL P, V41, P2247, DOI 10.1016/j.transproceed.2009.06.010; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Lapienis G, 2009, PROG POLYM SCI, V34, P852, DOI 10.1016/j.progpolymsci.2009.04.006; Lee RE, 2006, CRYOBIOLOGY, V52, P459, DOI 10.1016/j.cryobiol.2006.03.003; Li SY, 2011, J HEART LUNG TRANSPL, V30, P819, DOI 10.1016/j.healun.2011.03.007; Liu WL, 2000, AM J PHYSIOL-ENDOC M, V279, pE782, DOI 10.1152/ajpendo.2000.279.4.E782; Liu ZH, 2010, BIOMATERIALS, V31, P3364, DOI 10.1016/j.biomaterials.2010.01.021; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; McCrum NG, 1997, PRINCIPLES OF POLYME; Mendelson AA, 2013, PERITON DIALYSIS INT, V33, P15, DOI 10.3747/pdi.2012.00148; Moers C, 2007, TRANSPL INT, V20, P567, DOI 10.1111/j.1432-2277.2007.00455.x; Morariu AM, 2003, TRANSPLANTATION, V76, P37, DOI 10.1097/01.TP.0000068044.84652.9F; MUELLER AR, 1993, TRANSPLANTATION, V56, P1499, DOI 10.1097/00007890-199312000-00042; Mugabe C, 2011, INT J PHARMACEUT, V404, P238, DOI 10.1016/j.ijpharm.2010.11.010; Muller C, 1999, TRANSPLANTATION, V68, P1139; Neu B, 2001, BIORHEOLOGY, V38, P53; PARKS JE, 1992, THERIOGENOLOGY, V38, P209, DOI 10.1016/0093-691X(92)90231-F; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Perner A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-24; PICKFORD MA, 1992, INT J EXP PATHOL, V73, P685; Pribush A, 2007, EUR BIOPHYS J BIOPHY, V36, P85, DOI 10.1007/s00249-006-0107-1; Rossi NAA, 2010, BIOMATERIALS, V31, P4167, DOI 10.1016/j.biomaterials.2010.01.137; Rossi NAA, 2010, J AM CHEM SOC, V132, P3423, DOI 10.1021/ja909174x; Rubinstein M., 2003, POLYM PHYS; Savier E, 2011, TRANSPL P, V43, P3402, DOI 10.1016/j.transproceed.2011.09.054; Schmitz V, 2006, EUR SURG RES, V38, P388, DOI 10.1159/000094600; SOUTHARD JH, 1995, ANNU REV MED, V46, P235; Stevens RB, 2009, AM J TRANSPLANT, V9, P1055, DOI 10.1111/j.1600-6143.2009.02624.x; Stewart ZA, 2009, AM J TRANSPLANT, V9, P1048, DOI 10.1111/j.1600-6143.2008.02545.x; Stewart ZA, 2009, AM J TRANSPLANT, V9, P286, DOI 10.1111/j.1600-6143.2008.02478.x; Stewart ZA, 2009, AM J TRANSPLANT, V9, P217, DOI 10.1111/j.1600-6143.2008.02449.x; Stringham JC, 1999, J HEART LUNG TRANSPL, V18, P587, DOI 10.1016/S1053-2498(99)00018-2; Sunder A, 1999, MACROMOLECULES, V32, P4240, DOI 10.1021/ma990090w; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; Tojimbara T, 1997, Liver Transpl Surg, V3, P39, DOI 10.1002/lt.500030106; ul-haq MI, 2013, ACS NANO, V7, P10704, DOI 10.1021/nn4035074; ul-Haq MI, 2013, J POLYM SCI POL CHEM, V51, P2614, DOI 10.1002/pola.26649; ul-Haq MI, 2012, BIOMATERIALS, V33, P9135, DOI 10.1016/j.biomaterials.2012.09.007; van der Plaats A, 2004, TRANSPL INT, V17, P227, DOI 10.1007/s00147-004-0705-8; Wilms D, 2010, ACCOUNTS CHEM RES, V43, P129, DOI 10.1021/ar900158p; Winkelmayer WC, 2003, KIDNEY INT, V64, P1046, DOI 10.1046/j.1523-1755.2003.00186.x; Zhao WY, 2011, CLIN HEMORHEOL MICRO, V47, P177, DOI 10.3233/CH-2010-1379	77	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116595	10.1371/journal.pone.0116595	http://dx.doi.org/10.1371/journal.pone.0116595			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706864	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100042
J	In, MH; Posnansky, O; Beall, EB; Lowe, MJ; Speck, O				In, Myung-Ho; Posnansky, Oleg; Beall, Erik B.; Lowe, Mark J.; Speck, Oliver			Distortion Correction in EPI Using an Extended PSF Method with a Reversed Phase Gradient Approach	PLOS ONE			English	Article							POINT-SPREAD FUNCTION; SINGLE-SHOT EPI; DIFFUSION; TRACTOGRAPHY; IMAGES; CORTEX; CONNECTIONS; FMRI	In echo-planar imaging (EPI), such as commonly used for functional MRI (fMRI) and diffusion-tensor imaging (DTI), compressed distortion is a more difficult challenge than local stretching as spatial information can be lost in strongly compressed areas. In addition, the effects are more severe at ultra-high field (UHF) such as 7T due to increased field inhomogeneity. To resolve this problem, two EPIs with opposite phase-encoding (PE) polarity were acquired and combined after distortion correction. For distortion correction, a point spread function (PSF) mapping method was chosen due to its high correction accuracy and extended to perform distortion correction of both EPIs with opposite PE polarity thus reducing the PSF reference scan time. Because the amount of spatial information differs between the opposite PE datasets, the method was further extended to incorporate a weighted combination of the two distortion-corrected images to maximize the spatial information content of a final corrected image. The correction accuracy of the proposed method was evaluated in distortion-corrected data using both forward and reverse phase-encoded PSF reference data and compared with the reversed gradient approaches suggested previously. Further we demonstrate that the extended PSF method with an improved weighted combination can recover local distortions and spatial information loss and be applied successfully not only to spin-echo EPI, but also to gradient-echo EPIs acquired with both PE directions to perform geometrically accurate image reconstruction.	[In, Myung-Ho; Posnansky, Oleg; Speck, Oliver] Otto Von Guericke Univ, Inst Expt Phys, Dept Biomed Magnet Resonance, D-39106 Magdeburg, Germany; [Beall, Erik B.; Lowe, Mark J.] Cleveland Clin, Imaging Inst, Dept Radiol, Cleveland, OH 44106 USA; [Speck, Oliver] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Speck, Oliver] Leibniz Inst Neurobiol, Magdeburg, Germany	Otto von Guericke University; Cleveland Clinic Foundation; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leibniz Institut fur Neurobiologie (LIN)	In, MH (corresponding author), Otto Von Guericke Univ, Inst Expt Phys, Dept Biomed Magnet Resonance, D-39106 Magdeburg, Germany.	myung-ho.in@ovgu.de	Speck, Oliver/F-1406-2013; Posnansky, Oleg/AAF-4497-2019	Speck, Oliver/0000-0002-6019-5597; Beall, Erik/0000-0001-5837-8485	German Research Foundation DFG [SP632-4]	German Research Foundation DFG(German Research Foundation (DFG))	This study was supported by the German Research Foundation DFG (SP632-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Boegle R, 2010, MAGN RESON MATER PHY, V23, P263, DOI 10.1007/s10334-010-0225-8; Chung JY, 2011, MAGN RESON MATER PHY, V24, P179, DOI 10.1007/s10334-011-0251-1; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Embleton KV, 2010, HUM BRAIN MAPP, V31, P1570, DOI 10.1002/hbm.20959; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; In MH, 2012, MAGN RESON MATER PHY, V25, P183, DOI 10.1007/s10334-011-0275-6; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Mansfield P, 1977, J PHYS C SOLID STATE, V10, pL5; Meara SJP, 2008, MAGN RESON IMAGING, V26, P943, DOI 10.1016/j.mri.2008.02.007; Mohammadi S, 2012, MAGN RESON MED, V68, P882, DOI 10.1002/mrm.23308; Morgan PS, 2004, J MAGN RESON IMAGING, V19, P499, DOI 10.1002/jmri.20032; Munger P, 2000, IEEE T MED IMAGING, V19, P681, DOI 10.1109/42.875186; Nunes RG, 2005, J MAGN RESON, V177, P102, DOI 10.1016/j.jmr.2005.07.005; Oh SH, 2012, MAGN RESON MED, V68, P1239, DOI 10.1002/mrm.23317; Ooi MB, 2013, MAGN RESON MED, V69, P803, DOI 10.1002/mrm.24285; Robson MD, 1997, MAGNET RESON MED, V38, P733, DOI 10.1002/mrm.1910380509; Skare S, 2001, MAGN RESON IMAGING, V19, P1125, DOI 10.1016/S0730-725X(01)00415-5; Skare S, 2010, JACOBIAN WEIGHTING D; Speck O, 2008, MAGN RESON MATER PHY, V21, P73, DOI 10.1007/s10334-007-0087-x; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261; Zeng HR, 2002, MAGN RESON MED, V48, P137, DOI 10.1002/mrm.10200	26	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116320	10.1371/journal.pone.0116320	http://dx.doi.org/10.1371/journal.pone.0116320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25707006	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100034
J	Liang, WB; Guo, MH; Fan, EY; Zhang, JJ; Wu, MH; Liu, YC; Cai, L; Li, ZG; Huang, B; Wei, P; Sun, J; Zhu, Y				Liang, Wen-Biao; Guo, Ming-Hua; Fan, En-Yong; Zhang, Jing-Jing; Wu, Min-Hui; Liu, Yan-Chun; Cai, Li; Li, Zheng-Gang; Huang, Bing; Wei, Peng; Sun, Jun; Zhu, Yi			Erythrocyte Concentrates Recovered from Under-Collected Whole Blood: Experimental and Clinical Results	PLOS ONE			English	Article							IN-VITRO CHARACTERISTICS; RED-CELLS; PH; STORAGE; UNITS; ANTICOAGULANT; HEMOGLOBIN; MEMBRANES; SYSTEM; ACID	Background Although periodic blood shortages are widespread in major Chinese cities, approximately 1x10(5) U of whole blood are discarded yearly because of under-collection. To reduce the wastage of acid citrate dextrose solution B (ACD-B) anticoagulated under-collected whole blood (UC-WB), this study was performed to elucidate the effect of extracellular pH and holding time on erythrocyte quality. Mannitol-adenine-phosphate (MAP) erythrocyte concentrates (UC-RBCs) were prepared with UC-WB to assess the safety and efficacy of this component. Methods The effect of the different extracellular pH levels and storage times on erythrocytes was assessed by fluorescent probes, SDS-PAGE electrophoresis, electron microscopy and spectroscopy. In vitro properties of 34 UC-RBCs that were prepared with UC-WB at different times after collection were analyzed and compared to normal RBCs during 35 days of storage. The results of transfusion with UC-RBCs and the incidence of adverse reactions in 49 patients were determined. Results 1) Low extracellular pH levels and long storage time induced increases in RBC fluorescence polarization and mean microviscosity, changes in membrane fluidity, band 1, 2 and 3 protein expression, and erythrocyte morphology. 2) During storage for 35 days, difference in between-subjects effects of K+, hemolysis and supernatant erythrocyte membrane protein (EMP) were statistically significant (P = 0.041, 0.007 and 0.002, respectively), while the differences between these parameters in the 4 h group and comparable controls were less significant. 3) Clinical data from 49 patients confirmed that transfusions with UC-RBCs were satisfactory with no adverse reactions. Conclusion These results suggest that it is feasible to prepare RBCs with ACD-B anticoagulated UC-WB at a minimum of 66% volume of the labeled collection. It was effective and safe to transfuse the UC-RBCs prepared within 4 h after collection and stored within 7 days. The use of UC-WB would be a welcome addition to limited blood resources in China.	[Liang, Wen-Biao; Wu, Min-Hui; Liu, Yan-Chun] Res Dept Jiangsu Prov Blood Ctr, Nanjing, Jiangsu, Peoples R China; [Guo, Ming-Hua; Fan, En-Yong; Li, Zheng-Gang] Yangzhou Red Cross Blood Bank, Qual Management Dept, Yangzhou, Jiangsu, Peoples R China; [Zhang, Jing-Jing; Zhu, Yi] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Cai, Li; Huang, Bing] Jiangsu Prov Blood Ctr, Preparat Div, Nanjing, Jiangsu, Peoples R China; [Wei, Peng; Sun, Jun] Jiangsu Prov Blood Ctr, Dept Management, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Liang, WB (corresponding author), Res Dept Jiangsu Prov Blood Ctr, Nanjing, Jiangsu, Peoples R China.	wenbiaoliang@aliyun.com; zhuyijssry@126.com	Zhu, Yifan/GXH-6179-2022		Scientific researching fund projects of Jiangsu Province Health Department [H201030]; Talents planning of six summit fields of Jiangsu Province [WS-117]	Scientific researching fund projects of Jiangsu Province Health Department; Talents planning of six summit fields of Jiangsu Province	This study was supported by Scientific researching fund projects of Jiangsu Province Health Department (H201030) and Talents planning of six summit fields of Jiangsu Province (WS-117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVINTE T, 1989, BIOCHIM BIOPHYS ACTA, V981, P61, DOI 10.1016/0005-2736(89)90082-5; Burger P, 2012, TRANSFUSION, V52, P1245, DOI 10.1111/j.1537-2995.2011.03472.x; BUTTON LN, 1976, TRANSFUSION, V16, P148, DOI 10.1046/j.1537-2995.1976.16276155109.x; BUTTON LN, 1985, VOX SANG, V48, P122, DOI 10.1111/j.1423-0410.1985.tb00156.x; DAVEY RJ, 1984, TRANSFUSION, V24, P319, DOI 10.1046/j.1537-2995.1984.24484275572.x; de Korte D, 2008, TRANSFUSION, V48, P1081, DOI 10.1111/j.1537-2995.2008.01689.x; GEDDE MM, 1995, BLOOD, V86, P1595, DOI 10.1182/blood.V86.4.1595.bloodjournal8641595; Gedde MM, 1999, BBA-BIOMEMBRANES, V1417, P246, DOI 10.1016/S0005-2736(99)00007-3; Hess JR, 2006, VOX SANG, V91, P13, DOI 10.1111/j.1423-0410.2006.00778.x; Hogman CF, 1998, VOX SANG, V74, P177; Ivanov IT, 1999, BBA-BIOMEMBRANES, V1415, P349, DOI 10.1016/S0005-2736(98)00202-8; JOSEPH J, 1994, VOX SANG, V67, P275, DOI 10.1111/j.1423-0410.1994.tb01251.x; Libera J, 1997, BLOOD, V90, P1684, DOI 10.1182/blood.V90.4.1684.1684_1684_1693; Salhany JM, 1998, BBA-BIOMEMBRANES, V1371, P107, DOI 10.1016/S0005-2736(98)00009-1; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; Snyder EL, 2003, TRANSFUSION, V43, P1695, DOI 10.1111/j.0041-1132.2003.00603.x; Sparrow RL, 2012, BLOOD TRANSFUS-ITALY, V10, pS7, DOI [10.2450/2012.003S, 10.2450/20/2.003S]; Steck T L, 1974, Methods Enzymol, V31, P172; Weisbach V, 2000, TRANSFUSION MED, V10, P23; Wu Y, 2010, BIOPOLYMERS, V93, P348, DOI 10.1002/bip.21348	20	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117928	10.1371/journal.pone.0117928	http://dx.doi.org/10.1371/journal.pone.0117928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706725	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100131
J	Harris, AD; Puts, NAJ; Anderson, BA; Yantis, S; Pekar, JJ; Barker, PB; Edden, RAE				Harris, Ashley D.; Puts, Nicolaas A. J.; Anderson, Brian A.; Yantis, Steven; Pekar, James J.; Barker, Peter B.; Edden, Richard A. E.			Multi-Regional Investigation of the Relationship between Functional MRI Blood Oxygenation Level Dependent (BOLD) Activation and GABA Concentration	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; HUMAN CEREBRAL GABA; IN-VIVO; MENSTRUAL-CYCLE; BRAIN ACTIVITY; INDIVIDUAL VARIABILITY; FMRI; INHIBITION; IMAGES	Several recent studies have reported an inter-individual correlation between regional GABA concentration, as measured by MRS, and the amplitude of the functional blood oxygenation level dependent (BOLD) response in the same region. In this study, we set out to investigate whether this coupling generalizes across cortex. In 18 healthy participants, we performed edited MRS measurements of GABA and BOLD-fMRI experiments using regionally related activation paradigms. Regions and tasks were the: occipital cortex with a visual grating stimulus; auditory cortex with a white noise stimulus; sensorimotor cortex with a finger-tapping task; frontal eye field with a saccade task; and dorsolateral prefrontal cortex with a working memory task. In contrast to the prior literature, no correlation between GABA concentration and BOLD activation was detected in any region. The origin of this discrepancy is not clear. Subtle differences in study design or insufficient power may cause differing results; these and other potential reasons for the discrepant results are discussed. This negative result, although it should be interpreted with caution, has a larger sample size than prior positive results, and suggests that the relationship between GABA and the BOLD response may be more complex than previously thought.	[Harris, Ashley D.; Puts, Nicolaas A. J.; Pekar, James J.; Barker, Peter B.; Edden, Richard A. E.] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Harris, Ashley D.; Puts, Nicolaas A. J.; Pekar, James J.; Barker, Peter B.; Edden, Richard A. E.] FM Kirby Ctr Funct Brain Imaging, Kennedy Krieger Inst, Baltimore, MD USA; [Anderson, Brian A.; Yantis, Steven] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA	Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University	Harris, AD (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	aharr108@jhmi.edu		Pekar, James/0000-0002-9830-0655; Edden, Richard/0000-0002-0671-7374	National Institutes of Health [R21 NS077300, P41 EB015909, R01 EB016089]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015909, R01EB016089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants R21 NS077300 to ADH, SY, JJP, PBB, RAEE, P41 EB015909 to JJP, PPB, RAEE, and R01 EB016089 to ADH, NAJP, PBB, RAEE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2012, NEUROIMAGE, V62, P1279, DOI 10.1016/j.neuroimage.2012.04.039; Bogner W, 2010, EUR J RADIOL, V73, P526, DOI 10.1016/j.ejrad.2009.01.014; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Donahue M.J., 2014, J CEREB BLOOD FLOW M; Donahue MJ, 2010, NEUROIMAGE, V53, P392, DOI 10.1016/j.neuroimage.2010.07.017; Edden RAE, 2014, J MAGN RESO IN PRESS; Edden RAE, 2012, MAGN RESON MED, V68, P657, DOI 10.1002/mrm.24391; Epperson CN, 2005, BIOL PSYCHIAT, V57, P44, DOI 10.1016/j.biopsych.2004.09.021; Epperson CN, 2002, ARCH GEN PSYCHIAT, V59, P851, DOI 10.1001/archpsyc.59.9.851; Evans CJ, 2010, J MAGN RESON IMAGING, V31, P204, DOI 10.1002/jmri.21996; Evans CJ, 2012, J MAGN RESON IMAGING; Field AP, 2010, BRIT J MATH STAT PSY, V63, P665, DOI 10.1348/000711010X502733; Gaxiola-Valdez I, 2012, MAGN RESON IMAGING, V30, P1394, DOI 10.1016/j.mri.2012.05.002; Harada M, 2011, HUM BRAIN MAPP, V32, P828, DOI 10.1002/hbm.21086; Harris AD, 2014, MAGN RESON MED, V72, P941, DOI 10.1002/mrm.25009; Henry PG, 2001, MAGNET RESON MED, V45, P517, DOI 10.1002/1522-2594(200103)45:3<517::AID-MRM1068>3.0.CO;2-6; Hetherington HP, 1998, MAGNET RESON MED, V39, P6, DOI 10.1002/mrm.1910390103; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kleiner M., 2007, WHATS NEW PSYCHTOOLB; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu HZ, 2013, NMR BIOMED, V26, P932, DOI 10.1002/nbm.2905; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Muthukumaraswamy SD, 2012, HUM BRAIN MAPP, V33, P455, DOI 10.1002/hbm.21223; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Near J, 2014, MAGN RESON IN PRESS; Near J, 2011, NMR BIOMED, V24, P1277, DOI 10.1002/nbm.1688; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; O'Gorman RL, 2011, J MAGN RESON IMAGING, V33, P1262, DOI 10.1002/jmri.22520; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Raemaekers M, 2012, NEUROIMAGE, V60, P717, DOI 10.1016/j.neuroimage.2011.11.061; ROTHMAN DL, 1993, P NATL ACAD SCI USA, V90, P5662, DOI 10.1073/pnas.90.12.5662; Sanacora G, 1999, ARCH GEN PSYCHIAT, V56, P1043, DOI 10.1001/archpsyc.56.11.1043; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stagg Charlotte J, 2011, Commun Integr Biol, V4, P573, DOI 10.4161/cib.4.5.16213; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Tagamets MA, 2001, BRAIN RES BULL, V54, P267, DOI 10.1016/S0361-9230(00)00435-4; Terpstra M, 2002, MAGNET RESON MED, V47, P1009, DOI 10.1002/mrm.10146; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; van Gelderen P, 2005, MAGN RESON MED, V54, P569, DOI 10.1002/mrm.20577; Van Horn JD, 2008, BRAIN IMAGING BEHAV, V2, P327, DOI 10.1007/s11682-008-9049-9; Violante IR, 2013, BRAIN, V136, P918, DOI 10.1093/brain/aws368; Wetzels R, 2012, PSYCHON B REV, V19, P1057, DOI 10.3758/s13423-012-0295-x; Wise RG, 2013, NEUROIMAGE, V83, P135, DOI 10.1016/j.neuroimage.2013.06.008; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	51	36	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117531	10.1371/journal.pone.0117531	http://dx.doi.org/10.1371/journal.pone.0117531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699994	Green Published, gold, Green Submitted			2022-12-27	WOS:000349789800026
J	Paiardini, A; Bamert, RS; Kannan-Sivaraman, K; Drinkwater, N; Mistry, SN; Scammells, PJ; McGowan, S				Paiardini, Alessandro; Bamert, Rebecca S.; Kannan-Sivaraman, Komagal; Drinkwater, Nyssa; Mistry, Shailesh N.; Scammells, Peter J.; McGowan, Sheena			Screening the Medicines for Malaria Venture "Malaria Box" against the Plasmodium falciparum Aminopeptidases, M1, M17 and M18	PLOS ONE			English	Article							INHIBITION	Malaria is a parasitic disease that remains a global health burden. The ability of the parasite to rapidly develop resistance to therapeutics drives an urgent need for the delivery of new drugs. The Medicines for Malaria Venture have compounds known for their antimalarial activity, but not necessarily the molecular targets. In this study, we assess the ability of the "MMV 400" compounds to inhibit the activity of three metalloaminopeptidases from Plasmodium falciparum, PfA-M1, PfA-M17 and PfM18 AAP. We have developed a multiplex assay system to allow rapid primary screening of compounds against all three metalloaminopeptidases, followed by detailed analysis of promising compounds. Our results show that there were no PfM18AAP inhibitors, whereas two moderate inhibitors of the neutral aminopeptidases PfA-M1 and PfA-M17 were identified. Further investigation through structure-activity relationship studies and molecular docking suggest that these compounds are competitive inhibitors with novel binding mechanisms, acting through either non-classical zinc coordination or independently of zinc binding altogether. Although it is unlikely that inhibition of PfA-M1 and/or PfA-M17 is the primary mechanism responsible for the antiplasmodial activity reported for these compounds, their detailed characterization, as presented in this work, pave the way for their further optimization as a novel class of dual PfA-M1/PfA-M17 inhibitors utilising non-classical zinc binding groups.	[Paiardini, Alessandro] Univ Roma La Sapienza, Dipartmento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Bamert, Rebecca S.; Kannan-Sivaraman, Komagal; Drinkwater, Nyssa; McGowan, Sheena] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Mistry, Shailesh N.; Scammells, Peter J.] Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic 3004, Australia	Sapienza University Rome; Monash University; Monash University	McGowan, S (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3004, Australia.	Sheena.McGowan@monash.edu	Mistry, Shailesh/O-2697-2014; McGowan, Sheena/C-4797-2014	Mistry, Shailesh/0000-0002-2252-1689; McGowan, Sheena/0000-0001-6863-1106; Drinkwater, Nyssa/0000-0001-9165-7806; Paiardini, Alessandro/0000-0001-9078-7545; Scammells, Peter/0000-0003-2930-895X	Australian National Health and Medical Research Council [1063786]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by an Australian National Health and Medical Research Council Project Grant to SM and PJS (1063786). SM is an Australian Research Council Future Fellow (FT100100690). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, CHEMMEDCHEM, V3, P812, DOI 10.1002/cmdc.200700290; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Deprez-Poulain R, 2012, J MED CHEM, V55, P10909, DOI 10.1021/jm301506h; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; McGowan S, 2013, CURR OPIN STRUC BIOL, V23, P828, DOI 10.1016/j.sbi.2013.07.015; McGowan S, 2010, P NATL ACAD SCI USA, V107, P2449, DOI 10.1073/pnas.0911813107; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mucha A, 2010, BIOCHIMIE, V92, P1509, DOI 10.1016/j.biochi.2010.04.026; Ragheb D, 2011, J BIOL CHEM, V286, P27255, DOI 10.1074/jbc.M111.225318; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sivaraman KK, 2013, J MED CHEM, V56, P5213, DOI 10.1021/jm4005972; Sivaraman KK, 2012, J MOL BIOL, V422, P495, DOI 10.1016/j.jmb.2012.06.006; Skinner-Adams TS, 2012, ANTIMICROB AGENTS CH, V56, P3244, DOI 10.1128/AAC.06245-11; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Teuscher F, 2007, J BIOL CHEM, V282, P30817, DOI 10.1074/jbc.M704938200; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Velmourougane G, 2011, J MED CHEM, V54, P1655, DOI 10.1021/jm101227t; WHO, 2013, WORLD MALARIA REPORT 2013, P1	23	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0115859	10.1371/journal.pone.0115859	http://dx.doi.org/10.1371/journal.pone.0115859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700165	Green Published, gold, Green Submitted			2022-12-27	WOS:000349789800004
J	Tolkien, Z; Stecher, L; Mander, AP; Pereira, DIA; Powell, JJ				Tolkien, Zoe; Stecher, Lynne; Mander, Adrian P.; Pereira, Dora I. A.; Powell, Jonathan J.			Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							INTRAVENOUS IRON SUCROSE; RANDOMIZED CONTROLLED-TRIAL; INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; ORAL IRON; DEFICIENCY ANEMIA; DOUBLE-BLIND; FERRIC CARBOXYMALTOSE; OPEN-LABEL; GUT MICROBIOTA	Background The tolerability of oral iron supplementation for the treatment of iron deficiency anemia is disputed. Objective Our aim was to quantify the odds of GI side-effects in adults related to current gold standard oral iron therapy, namely ferrous sulfate. Methods Systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating GI side-effects that included ferrous sulfate and a comparator that was either placebo or intravenous (IV) iron. Random effects meta-analysis modelling was undertaken and study heterogeneity was summarised using I-2 statistics. Results Forty three trials comprising 6831 adult participants were included. Twenty trials (n = 3168) had a placebo arm and twenty three trials (n = 3663) had an active comparator arm of IV iron. Ferrous sulfate supplementation significantly increased risk of GI side-effects versus placebo with an odds ratio (OR) of 2.32 [95% CI 1.74-3.08, p<0.0001, I-2 = 53.6%] and versus IV iron with an OR of 3.05 [95% CI 2.07-4.48, p<0.0001, I-2 = 41.6%]. Subgroup analysis in IBD patients showed a similar effect versus IV iron (OR = 3.14, 95% CI 1.34-7.36, p = 0.008, I-2 = 0%). Likewise, subgroup analysis of pooled data from 7 RCTs in pregnant women (n = 1028) showed a statistically significant increased risk of GI side-effects for ferrous sulfate although there was marked heterogeneity in the data (OR = 3.33, 95% CI 1.19-9.28, p = 0.02, I-2 = 66.1%). Meta-regression did not provide significant evidence of an association between the study OR and the iron dose. Conclusions Our meta-analysis confirms that ferrous sulfate is associated with a significant increase in gastrointestinal-specific side-effects but does not find a relationship with dose.	[Tolkien, Zoe; Pereira, Dora I. A.; Powell, Jonathan J.] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Stecher, Lynne; Mander, Adrian P.] MRC, Biostat Unit, Inst Publ Hlth, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; MRC Biostatistics Unit; University of Cambridge	Pereira, DIA (corresponding author), MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England.	dora.pereira@mrc-hnr.cam.ac.uk	Pereira, Dora I A/D-4634-2012	Pereira, Dora I A/0000-0001-5688-4448	UK Medical Research Council (MRC) [U105960399, G0800860]; MRC [MC_U105960399, MC_UP_1302/2] Funding Source: UKRI; Medical Research Council [MC_U105960399, MC_UP_1302/2] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (MRC) (U105960399 and G0800860) funded this work but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman KH, 2012, IEEE POW ENER SOC GE; Adamson EA, 2008, ARCH DIS CHILD, V93, P453, DOI 10.1136/adc.2007.116301; Agarwal R, 2006, AM J NEPHROL, V26, P445, DOI 10.1159/000096174; Ahn E, 2006, BMC PREGNANCY AND CH, V6; AlMomen AK, 1996, EUR J OBSTET GYN R B, V69, P121, DOI 10.1016/0301-2115(95)02538-3; Auerbach M, 2004, J CLIN ONCOL, V22, P1301, DOI 10.1200/JCO.2004.08.119; Baykan A, 2006, TURKISH J PEDIATR, V48, P301; Bayoumeu F, 2002, AM J OBSTET GYNECOL, V186, P518, DOI 10.1067/mob.2002.121894; Bencaiova G, 2009, EUR J OBSTET GYN R B, V144, P135, DOI 10.1016/j.ejogrb.2009.03.006; Bhandal N, 2006, BJOG-INT J OBSTET GY, V113, P1248, DOI 10.1111/j.1471-0528.2006.01062.x; Breymann C, 2008, INT J GYNECOL OBSTET, V101, P67, DOI 10.1016/j.ijgo.2007.10.009; Carrier J, 2002, J NUTR, V132, P3146, DOI 10.1093/jn/131.10.3146; Charytan C, 2005, NEPHRON CLIN PRACT, V100, pC55, DOI 10.1159/000085049; COOK JD, 1990, LANCET, V335, P1136, DOI 10.1016/0140-6736(90)91135-W; Cook JD, 2005, BEST PRACT RES CL HA, V18, P319, DOI 10.1016/j.beha.2004.08.022; COPLIN M, 1991, CLIN THER, V13, P606; Davis BJ, 2000, EUR NEUROL, V43, P70, DOI 10.1159/000008138; de Souza AI, 2009, CAD SAUDE PUBLICA, V25, P1225, DOI 10.1590/S0102-311X2009000600005; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dostal A, 2012, J NUTR, V142, P271, DOI 10.3945/jn.111.148643; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Fouad Gameil T., 2013, Journal of Dietary Supplements, V10, P17, DOI 10.3109/19390211.2012.758217; GANZONI AM, 1974, DEUT MED WOCHENSCHR, V99, P1175, DOI 10.1055/s-0028-1107912; Gasche C, 2004, GUT, V53, P1190, DOI 10.1136/gut.2003.035758; Gasche C, 2011, Z Gastroenterol, V49, P627, DOI 10.1055/s-0031-1273324; Gasche C, 2007, INFLAMM BOWEL DIS, V13, P1545, DOI 10.1002/ibd.20285; GORDEUK VR, 1987, TRANSFUSION, V27, P80, DOI 10.1046/j.1537-2995.1987.27187121482.x; Guerra Merino S, 2012, EN EL TRATAMIENTO DE, V39, P190; Habib F, 2009, J OBSTET GYNAECOL, V29, P487, DOI 10.1080/01443610902984961; HALLBERG L, 1966, ACTA MED SCAND, VS, P3; Heading RC, 1999, SCAND J GASTROENTERO, V34, P3, DOI 10.1080/003655299750025200; Henry DH, 2007, ONCOLOGIST, V12, P231, DOI 10.1634/theoncologist.12-2-231; Hercberg S, 2001, Public Health Nutr, V4, P537; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Cancelo-Hidalgo MJ, 2013, CURR MED RES OPIN, V29, P291, DOI 10.1185/03007995.2012.761599; Kochhar PK, 2013, J OBSTET GYNAECOL RE, V39, P504, DOI 10.1111/j.1447-0756.2012.01982.x; Koloski NA, 2003, AM J GASTROENTEROL, V98, P789, DOI 10.1016/S0002-9270(03)00052-2; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; Kulnigg S, 2008, AM J GASTROENTEROL, V103, P1182, DOI 10.1111/j.1572-0241.2007.01744.x; Langstaff RJ, 1993, BRIT J CLIN RES, V4, P191; LEVY F, 1978, ACTA MED SCAND, V204, P303; LIGUORI L, 1993, INT J CLIN PHARM TH, V31, P105; Lindgren S, 2009, SCAND J GASTROENTERO, V44, P838, DOI 10.1080/00365520902839667; Lund EK, 1999, AM J CLIN NUTR, V69, P250; Maghsudlu M, 2008, TRANSFUSION, V48, P1192, DOI 10.1111/j.1537-2995.2007.01671.x; Makrides M, 2003, AM J CLIN NUTR, V78, P145, DOI 10.1093/ajcn/78.1.145; McDiarmid T, 2002, J FAM PRACTICE, V51, P576; Meier Paul R, 2003, Clin Med Res, V1, P29; Mirrezaie SM, 2008, IRAN J MED SCI, V33, P138; Mudge DW, 2012, TRANSPLANTATION, V93, P822, DOI 10.1097/TP.0b013e318248375a; NHS, 2012, GP PRESCRIBING DATA; Ojukwu JU, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub2; Okebe JU, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub3; Orozco MN, 2010, J NUTR, V140, P1105, DOI 10.3945/jn.109.111104; Pasricha SRS, 2012, COCHRANE DATABASE OF, V4; Pavord S, 2012, BRIT J HAEMATOL, V156, P588, DOI 10.1111/j.1365-2141.2011.09012.x; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009997; Pereira DIA, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-103; Pieracci FM, 2009, SURG INFECT, V10, P9, DOI 10.1089/sur.2008.043; Portincasa P, 2009, J GASTROINTEST LIVER, V18, P205; Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003; Reinisch W, 2013, AM J GASTROENTEROL, V108, P1877, DOI 10.1038/ajg.2013.335; Rimon E, 2005, AM J MED, V118, P1142, DOI 10.1016/j.amjmed.2005.01.065; Roth J L, 1998, Pa Nurse, V53, P16; Saha Lekha, 2007, MedGenMed, V9, P1; Santiago Palacios, 2012, ScientificWorldJournal, V2012, P846824, DOI 10.1100/2012/846824; Schroder O, 2005, AM J GASTROENTEROL, V100, P2503, DOI 10.1111/j.1572-0241.2005.00250.x; Seid M, 2008, AMERICAN JOURNAL OF, V199; Sobieraj DM, 2011, AM J MANAG CARE, V17, pE449; Stein J, 2010, NAT REV GASTRO HEPAT, V7, P599, DOI 10.1038/nrgastro.2010.151; STRICKLAND ID, 1977, CLIN NEPHROL, V7, P55; Sutton PM, 2004, J BONE JOINT SURG BR, V86B, P31, DOI 10.1302/0301-620X.86B1.13936; Tokars ML, 2010, COMPARISON OF SAFETY; Tuomainen TP, 1999, NUTR RES, V19, P1121, DOI 10.1016/S0271-5317(99)00073-1; Van Wyck DB, 2007, OBSTET GYNECOL, V110, P267, DOI 10.1097/01.AOG.0000275286.03283.18; Van Wyck DB, 2009, TRANSFUSION, V49, P2719, DOI 10.1111/j.1537-2995.2009.02327.x; Van Wyck DB, 2005, KIDNEY INT, V68, P2846, DOI 10.1111/j.1523-1755.2005.00758.x; Vaucher P, 2012, CAN MED ASSOC J, V184, P1247, DOI 10.1503/cmaj.110950; VAZQUEZPACHECO J, 1980, INVEST MED INT, V7, P129; Waldvogel S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-8; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; WHO, 2008, GLOBAL DATABASE ON A; World Health Organization, 2008, THE GLOBAL BURDEN OF; Yalcin SS, 2009, J PEDIAT HEMATOL ONC, V31, P85, DOI 10.1097/MPH.0b013e31819146c2; Zaim M, 2012, EUR J NUTR, V51, P221, DOI 10.1007/s00394-011-0210-7; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	88	331	342	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117383	10.1371/journal.pone.0117383	http://dx.doi.org/10.1371/journal.pone.0117383			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700159	Green Published, gold, Green Submitted			2022-12-27	WOS:000349789800022
J	Yang, HJ; Wang, M; Wang, L; Cheng, BF; Lin, XY; Feng, ZW				Yang, Hai-Jie; Wang, Mian; Wang, Lei; Cheng, Bin-Feng; Lin, Xiao-Yu; Feng, Zhi-Wei			NF-kappa B Regulates Caspase-4 Expression and Sensitizes Neuroblastoma Cells to Fas-Induced Apoptosis	PLOS ONE			English	Article							MEDIATED APOPTOSIS; DEATH RECEPTOR; T-LYMPHOCYTES; IMMUNE-SYSTEM; STROMAL CELLS; TNF-ALPHA; ACTIVATION; LIGAND; BRAIN; NEUROPROTECTION	Found in neurons and neuroblastoma cells, Fas-induced apoptosis and accompanied activation of NF-kappa B signaling were thought to be associated with neurodegenerative diseases. However, the detailed functions of NF-kappa B activation in Fas killing and the effect of NF-kappa B activation on its downstream events remain unclear. Here, we demonstrated that agonistic Fas antibody induces cell death in a dose-dependent way and NF-kappa B signaling is activated as well, in neuroblastoma cells SH-EP1. Unexpectedly, NF-kappa B activation was shown to be pro-apoptotic, as suggested by the reduction of Fas-induced cell death with either a dominant negative form of I kappa B alpha (DN-I kappa B alpha) or an I kappa B kinase-specific inhibitor. To our interest, when analyzing downstream events of NF-kappa B signaling, we found that DN-I kappa B alpha only suppressed the expression of caspase-4, but not other caspases. Vice versa, enhancement of NF-kappa B activity by p65 (RelA) overexpression increased the expression of caspase-4 at both mRNA and protein levels. More directly, results from dual luciferase reporter assay demonstrated the regulation of caspase-4 promoter activity by NF-kappa B. When caspase-4 activity was blocked by its dominant negative (DN) form, Fas-induced cell death was substantially reduced. Consistently, the cleavage of PARP and caspase-3 induced by Fas was also reduced. In contrast, the cleavage of caspase-8 remained unaffected in caspase-4 DN cells, although caspase-8 inhibitor could rescue Fas-induced cell death. Collectively, these data suggest that caspase-4 activity is required for Fas-induced cell apoptosis and caspase-4 may act upstream of PARP and caspase-3 and downstream of caspase-8. Overall, we demonstrate that NF-kappa B can mediate Fas-induced apoptosis through caspase-4 protease, indicating that caspase-4 is a new mediator of NF-kappa B pro-apoptotic pathway in neuroblastoma cells.	[Yang, Hai-Jie; Wang, Mian; Wang, Lei; Cheng, Bin-Feng; Lin, Xiao-Yu; Feng, Zhi-Wei] Xinxiang Med Univ, Coll Life Sci & Technol, Xinxiang, Peoples R China	Xinxiang Medical University	Feng, ZW (corresponding author), Xinxiang Med Univ, Coll Life Sci & Technol, Xinxiang, Peoples R China.	xxyxy_fzw@163.com			Xinxiang Medical University Scientific Research Foundation [505046, 505047]; Intramural Science Fostering Foundation [2013ZD115]	Xinxiang Medical University Scientific Research Foundation; Intramural Science Fostering Foundation	The authors acknowledge the financial support of Xinxiang Medical University Scientific Research Foundation (contract 505046 and 505047) and the Intramural Science Fostering Foundation (contract 2013ZD115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam M, 2012, CYTOKINE, V57, P269, DOI 10.1016/j.cyto.2011.10.016; Bian X, 2004, J BIOL CHEM, V279, P4663, DOI 10.1074/jbc.M306905200; Brint E, 2013, CELL MOL LIFE SCI, V70, P4085, DOI 10.1007/s00018-013-1327-z; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chinskey ND, 2014, CURR OPIN OPHTHALMOL, V25, P228, DOI 10.1097/ICU.0000000000000043; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Collett GP, 2006, CARCINOGENESIS, V27, P1285, DOI 10.1093/carcin/bgi368; Dietrich PY, 2003, NEUROLOGY, V60, P548, DOI 10.1212/01.WNL.0000042049.74547.7F; Dudley E, 1999, EUR J IMMUNOL, V29, P878, DOI 10.1002/(SICI)1521-4141(199903)29:03<878::AID-IMMU878>3.0.CO;2-9; Eckhardt I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.457; Fluhr H, 2013, REPROD BIOL, V13, P113, DOI 10.1016/j.repbio.2013.03.001; Frank AK, 2011, MOL CELL BIOL, V31, P1201, DOI 10.1128/MCB.01136-10; Gross N, 2001, MED PEDIATR ONCOL, V36, P111, DOI 10.1002/1096-911X(20010101)36:1<111::AID-MPO1026>3.0.CO;2-3; Han W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071656; Huang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071553; Jennewein C, 2012, ONCOGENE, V31, P1468, DOI 10.1038/onc.2011.333; Kamada S, 1997, ONCOGENE, V15, P285, DOI 10.1038/sj.onc.1201192; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuhtrelber WM, 2003, J MOL ENDOCRINOL, V31, P373, DOI 10.1677/jme.0.0310373; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lipton SA, 1997, NAT MED, V3, P20, DOI 10.1038/nm0197-20; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Nickles D, 2012, MOL CELL BIOL, V32, P3372, DOI 10.1128/MCB.06739-11; Packham G, 1997, CELL DEATH DIFFER, V4, P130, DOI 10.1038/sj.cdd.4400217; Ponton A, 1996, J BIOL CHEM, V271, P8991, DOI 10.1074/jbc.271.15.8991; Qin YM, 2002, J IMMUNOL, V169, P3536, DOI 10.4049/jimmunol.169.7.3536; Radhakrishnan SK, 2006, BBA-REV CANCER, V1766, P53, DOI 10.1016/j.bbcan.2006.02.001; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Lopez-Huertas MR, 2013, J BIOL CHEM, V288, P7626, DOI 10.1074/jbc.M112.408294; ROSS RA, 1983, J NATL CANCER I, V71, P741; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Suhara T, 2004, HYPERTENSION, V43, P1208, DOI 10.1161/01.HYP.0000127914.94292.76; Valentin-Acevedo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025467; Villa-Morales M, 2012, EXPERT OPIN THER TAR, V16, P85, DOI 10.1517/14728222.2011.628937; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Yang HJ, 2010, NEUROCHEM INT, V56, P128, DOI 10.1016/j.neuint.2009.09.010; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200	42	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117953	10.1371/journal.pone.0117953	http://dx.doi.org/10.1371/journal.pone.0117953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695505	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300035
J	Bezy, VS; Valverde, RA; Plante, CJ				Bezy, Vanessa S.; Valverde, Roldan A.; Plante, Craig J.			Olive Ridley Sea Turtle Hatching Success as a Function of the Microbial Abundance in Nest Sand at Ostional, Costa Rica	PLOS ONE			English	Article							LEPIDOCHELYS-OLIVACEA; COMMUNITY STRUCTURE; CARETTA-CARETTA; GAS-EXCHANGE; ORGANIC-MATTER; CHELONIA; QUANTIFICATION; GROWTH; FUNGI; BEACH	Several studies have suggested that significant embryo mortality is caused by microbes, while high microbial loads are generated by the decomposition of eggs broken by later nesting turtles. This occurs commonly when nesting density is high, especially during mass nesting events (arribadas). However, no previous research has directly quantified microbial abundance and the associated effects on sea turtle hatching success at a nesting beach. The aim of this study was to test the hypothesis that the microbial abundance in olive ridley sea turtle nest sand affects the hatching success at Ostional, Costa Rica. We applied experimental treatments to alter the microbial abundance within the sand into which nests were relocated. We monitored temperature, oxygen, and organic matter content throughout the incubation period and quantified the microbial abundance within the nest sand using a quantitative polymerase chain reaction (qPCR) molecular analysis. The most successful treatment in increasing hatching success was the removal and replacement of nest sand. We found a negative correlation between hatching success and fungal abundance (fungal 18S rRNA gene copies g(-1) nest sand). Of secondary importance in determining hatching success was the abundance of bacteria (bacterial 16S rRNA gene copies g(-1) g-1 nest sand). Our data are consistent with the hypothesis that high microbial activity is responsible for the lower hatching success observed at Ostional beach. Furthermore, the underlying mechanism appears to be the deprivation of oxygen and exposure to higher temperatures resulting from microbial decomposition in the nest.	[Bezy, Vanessa S.; Plante, Craig J.] Coll Charleston, Dept Biol, Charleston, SC 29401 USA; [Valverde, Roldan A.] SE Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA	College of Charleston; University of Louisiana System; Southeastern Louisiana University	Bezy, VS (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	vanessa.bezy@gmail.com			National Science Foundation Graduate Research Fellowship (VB) [511182]; PADI Foundation (VB) [7813]; National Geographic Young Explorers Grant (VB) [C220-12]; USFWS Marine Turtle Conservation Act (RV) [96200-0-G037]; College of Charleston (VB)	National Science Foundation Graduate Research Fellowship (VB); PADI Foundation (VB); National Geographic Young Explorers Grant (VB)(National Geographic Society); USFWS Marine Turtle Conservation Act (RV); College of Charleston (VB)	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (Grant No. 511182, http://www.nsfgrfp.org, VB). Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Additional funds to support the lab and field research for this study were provided by the PADI Foundation (Application # 7813, http://www.padifoundation.org, VB), National Geographic Young Explorers Grant (C220-12, http://www.nationalgeographic.com/explorers/grants-programs/young-explorers/, VB), USFWS Marine Turtle Conservation Act (96200-0-G037, http://www.fws.gov/international/wildlife-without-borders/marine-turtle-conservation-fund.html, RV), and various internal grants from the College of Charleston (http://www.cofc.edu, VB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN RA, 1980, AM ZOOL, V20, P575; ACKERMAN RA, 1977, RESP PHYSIOL, V31, P19, DOI 10.1016/0034-5687(77)90062-7; ACKERMAN RA, 1981, PHYSIOL ZOOL, V54, P316, DOI 10.1086/physzool.54.3.30159946; ACKERMAN RA, 1981, COPEIA, P757; Ackerman Ralph A., 1997, P83; BARRIENTOS-MUÑOZ KARLA G., 2014, Acta biol.Colomb., V19, P437, DOI 10.15446/abc.v19n3.42457; Bernardo J., 2007, BIOL CONSERVATION RI, P59; Bezy Vanessa S., 2014, Journal of Marine Biology, P351921; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Chen XL, 2013, WATER RES, V47, P1691, DOI 10.1016/j.watres.2012.12.033; Clusella Trullas S, 2007, J ZOOL, V272, P367, DOI 10.1111/j.1469-7998.2006.00277.x; Cornelius S.E., 1991, P111; Cornelius SE, 1986, SEA TURTLES SANTA RO; Cornelius SE., 2007, BIOL CONSERVATION RI, P231; Das M, 2007, APPL ENVIRON MICROB, V73, P756, DOI 10.1128/AEM.01170-06; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; de Solla SR, 2011, SCI TOTAL ENVIRON, V409, P4306, DOI 10.1016/j.scitotenv.2011.06.046; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Figgener C, 2014, P 34 ANN S SEA TURTL, DOI [10.4244/EIJV10I5A93, DOI 10.4244/EIJV10I5A93]; Fonseca L. G., 2011, REPORTE FINAL ANIDAC; Guidot A, 2002, FEMS MICROBIOL ECOL, V42, P477, DOI 10.1111/j.1574-6941.2002.tb01036.x; Honarvar S, 2008, OECOLOGIA, V157, P221, DOI 10.1007/s00442-008-1065-3; Honarvar S, 2011, J EXP MAR BIOL ECOL, V409, P339, DOI 10.1016/j.jembe.2011.09.015; Jackson LE, 2003, GEODERMA, V114, P305, DOI 10.1016/S0016-7061(03)00046-6; KAM YC, 1993, RESP PHYSIOL, V92, P127, DOI 10.1016/0034-5687(93)90033-7; Krumbein W.C., 1938, CENTURY EARTH SCI SE; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lopez-Castro MC, 2004, MAR BIOL, V145, P811, DOI 10.1007/s00227-004-1359-x; Marco A, 2004, B ENVIRON CONTAM TOX, V73, P125, DOI 10.1007/s00128-004-0403-3; Martensson LM, 2012, APPL SOIL ECOL, V62, P8, DOI 10.1016/j.apsoil.2012.07.003; McPherson D, 2008, P 25 ANN S SEA TURTL, DOI [10.1109/TBCAS.2008.2003195, DOI 10.1109/TBCAS.2008.2003195]; Miller Jeffrey D., 1999, P124; Miller NA, 2008, COPEIA, P882, DOI 10.1643/CP-07-256; Mo CL, 1995, P 12 ANN WORKSH SEA, P81; Mo CL, 1990, P 10 ANN WORKSH SEA, P249; MORTIMER JA, 1990, COPEIA, P802, DOI 10.2307/1446446; Ocana M., 2012, Endangered Species Research, V16, P45, DOI 10.3354/esr00388; PAUL EA, 1977, APPL ENVIRON MICROB, V34, P263, DOI 10.1128/AEM.34.3.263-269.1977; Phillott AD, 2001, AUST J ZOOL, V49, P713, DOI 10.1071/ZO00051; Prevost-Boure NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024166; Sarmiento-Ramirez JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085853; Sarmiento-Ramirez JM, 2010, FEMS MICROBIOL LETT, V312, P192, DOI 10.1111/j.1574-6968.2010.02116.x; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Smith CJ, 2006, ENVIRON MICROBIOL, V8, P804, DOI 10.1111/j.1462-2920.2005.00963.x; Stelzer RS, 2003, FRESHWATER BIOL, V48, P1925, DOI 10.1046/j.1365-2427.2003.01141.x; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Uemura N, 2008, J MED MICROBIOL, V57, P50, DOI 10.1099/jmm.0.47216-0; Vainio EJ, 2000, MYCOL RES, V104, P927, DOI 10.1017/S0953756200002471; Valverde RA, 2012, CHELONIAN CONSERV BI, V11, P1; Valverde Roldan A., 2010, Endangered Species Research, V12, P77, DOI 10.3354/esr00296; Valverde Roldan A., 1998, Chelonian Conservation and Biology, V3, P58; VANVEEN JA, 1990, BIOGEOCHEMISTRY, V11, P213, DOI 10.1007/BF00004497; Wallace BP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P423, DOI 10.1086/420951; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WYNEKEN J, 1988, J HERPETOL, V22, P88, DOI 10.2307/1564360	56	26	28	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118579	10.1371/journal.pone.0118579	http://dx.doi.org/10.1371/journal.pone.0118579			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714355	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700089
J	Bishnoi, RJ; Palmer, RF; Royall, DR				Bishnoi, Ram J.; Palmer, Raymond F.; Royall, Donald R.			Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; NF-KAPPA-B; PROINFLAMMATORY CYTOKINES; SYSTEMIC INFLAMMATION; SPINAL-CORD; STEM-CELLS; T-CELLS; IL-15; MICROGLIA; EXPRESSION	Interleukin (IL-15), a pro-inflammatory cytokine has been studied as a possible marker of Alzheimer's disease (AD); however its exact role in neuro-inflammation or the pathogenesis AD is not well understood yet. A Multiple Indicators Multiple Causes (MIMIC) approach was used to examine the relationship between serum IL-15 levels and AD in a well characterized AD cohort, the Texas Alzheimer's Research and Care Consortium (TARCC). Instead of categorical diagnoses, we used two latent construct d (for dementia) and g' (for cognitive impairments not contributing to functional impairments) in our analysis. The results showed that the serum IL-15 level has significant effects on cognition, exclusively mediated by latent construct d and g'. Contrasting directions of association lead us to speculate that IL-15's effects in AD are mediated through functional networks as d scores have been previously found to be specifically related to default mode network (DMN). Our finding warrants the need for further research to determine the changes in structural and functional networks corresponding to serum based biomarkers levels.	[Bishnoi, Ram J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Palmer, Raymond F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA; [Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Syst Audie L Murphy Div, Ctr Geriatr Res Educ & Clin, Dept Psychiat Family & Community Med, San Antonio, TX 78229 USA; [Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Syst Audie L Murphy Div, Ctr Geriatr Res Educ & Clin, Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio	Bishnoi, RJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.	bishnoi@uthscsa.edu	Bishnoi, Ram/P-4019-2014	Bishnoi, Ram/0000-0002-5202-5117; palmer, ray/0000-0001-6621-9038	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders	This study was made possible by the Texas Alzheimer's Research Consortium (TARCC) funded by the state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author(s) however, received no specific funding for this work.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arbuckle JL, 2006, ANAL MOMENT STRUCTUR; Baruch K, 2013, BRAIN BEHAV IMMUN, V34, P11, DOI 10.1016/j.bbi.2013.04.002; Baslund B, 2005, ARTHRITIS RHEUM-US, V52, P2686, DOI 10.1002/art.21249; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Benveniste EN, 2001, NEUROCHEM INT, V39, P381, DOI 10.1016/S0197-0186(01)00045-6; Bishnoi RJ, 2014, J ALZHEIMERS DIS; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bollen K. A., 1993, TESTING STRUCTURAL E; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Carson Verna Benner, 2012, Home Healthc Nurse, V30, P280, DOI 10.1097/NHH.0b013e318252c52b; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Emmerling MR, 2000, BBA-MOL BASIS DIS, V1502, P158, DOI 10.1016/S0925-4439(00)00042-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavett BE, 2014, NEUROPSYCHOLOGY; Gomez-Nicola D, 2008, J NEUROCHEM, V107, P1741, DOI 10.1111/j.1471-4159.2008.05746.x; Gomez-Nicola D, 2008, GLIA, V56, P494, DOI 10.1002/glia.20628; Gomez-Nicola D, 2011, MOL BIOL CELL, V22, P1960, DOI 10.1091/mbc.E11-01-0053; Gomez-Nicola D, 2010, GLIA, V58, P264, DOI 10.1002/glia.20920; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hall JR, 2013, J ALZHEIMERS DIS, V35, P363, DOI 10.3233/JAD-122359; Hall JR, 2012, J ALZHEIMERS DIS, V31, P429, DOI 10.3233/JAD-2012-111481; Hanisch UK, 1997, J BIOL CHEM, V272, P28853, DOI 10.1074/jbc.272.46.28853; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Huang YS, 2009, BRAIN RES, V1304, P38, DOI 10.1016/j.brainres.2009.09.009; Huang Z, 2007, NEUROSCI LETT, V417, P160, DOI 10.1016/j.neulet.2007.01.086; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jonuleit H, 1997, J IMMUNOL, V158, P2610; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; KREINER S, 1989, SOC SCI MED, V29, P253, DOI 10.1016/0277-9536(89)90174-3; Kurowska M, 2002, ANN NY ACAD SCI, V966, P441, DOI 10.1111/j.1749-6632.2002.tb04245.x; Lee YB, 1996, NEUROREPORT, V7, P1062, DOI 10.1097/00001756-199604100-00022; Lewitus GM, 2008, BRAIN BEHAV IMMUN, V22, P1108, DOI 10.1016/j.bbi.2008.05.002; Liang PP, 2012, J ALZHEIMERS DIS, V30, P475, DOI 10.3233/JAD-2012-111721; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MUTHEN B, 1979, J AM STAT ASSOC, V74, P807, DOI 10.2307/2286403; Muthen B, 1993, NEW DIRECTIONS ATTIT, P277; MUTHEN BO, 1989, SOCIOL METHOD RES, V18, P19, DOI 10.1177/0049124189018001002; Palmer RF, 2010, J AM GERIATR SOC, V58, pS343, DOI 10.1111/j.1532-5415.2010.03053.x; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pan WH, 2008, AM J PHYSIOL-CELL PH, V294, pC1436, DOI 10.1152/ajpcell.00489.2007; Pan WH, 2013, NEUROSCI BIOBEHAV R, V37, P184, DOI 10.1016/j.neubiorev.2012.11.009; Pan WH, 2011, CURR PHARM DESIGN, V17, P3729, DOI 10.2174/138161211798220918; Pan WH, 2009, J NEUROCHEM, V111, P819, DOI 10.1111/j.1471-4159.2009.06371.x; Rentzos M, 2006, J GERIATR PSYCH NEUR, V19, P114, DOI 10.1177/0891988706286226; Rentzos M, 2007, J NEUROPSYCH CLIN N, V19, P318, DOI 10.1176/appi.neuropsych.19.3.318; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Royall DR, 2014, NEUROBIOL AGING, V35, P336, DOI 10.1016/j.neurobiolaging.2013.08.006; Royall DR, 2012, J ALZHEIMERS DIS, V32, P467, DOI 10.3233/JAD-2012-120424; Royall DR, 2012, J ALZHEIMERS DIS, V30, P639, DOI 10.3233/JAD-2012-120055; Royall DR, 2012, J NEUROPSYCH CLIN N, V24, P37, DOI 10.1176/appi.neuropsych.11040078; Royall DR, 2002, EXP AGING RES, V28, P143, DOI 10.1080/03610730252800166; Ruchatz H, 1998, J IMMUNOL, V160, P5654; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Stone KP, 2011, CELL PHYSIOL BIOCHEM, V28, P115, DOI 10.1159/000331720; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; Takano M, 1998, INFECT IMMUN, V66, P3270, DOI 10.1128/IAI.66.7.3270-3278.1998; Threlkeld SW, 2010, NEUROIMMUNOMODULAT, V17, P405, DOI 10.1159/000288265; Tomas-Camardiel M, 2004, NEUROBIOL DIS, V16, P190, DOI 10.1016/j.nbd.2004.01.010; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Waldau B, 2008, CELL MOL LIFE SCI, V65, P2372, DOI 10.1007/s00018-008-8053-y; Waring S., 2008, TEX PUBLIC HLTH J, V60, P9; Wheaton B., 1977, SOCIOL METHODOL, V8, P84, DOI [10.2307/270754, DOI 10.2307/270754]	79	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117282	10.1371/journal.pone.0117282	http://dx.doi.org/10.1371/journal.pone.0117282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710473	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900028
J	Chai, JW; Chen, CC; Wu, YY; Chen, HC; Tsai, YH; Chen, HM; Lan, TH; Ouyang, YC; Lee, SK				Chai, Jyh-Wen; Chen, Clayton C.; Wu, Yi-Ying; Chen, Hung-Chieh; Tsai, Yi-Hsin; Chen, Hsian-Min; Lan, Tsuo-Hung; Ouyang, Yen-Chieh; Lee, San-Kan			Robust Volume Assessment of Brain Tissues for 3-Dimensional Fourier Transformation MRI via a Novel Multispectral Technique	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; ATLAS-BASED SEGMENTATION; IMAGES; HEAD; DEMENTIA	A new TRIO algorithm method integrating three different algorithms is proposed to perform brain MRI segmentation in the native coordinate space, with no need of transformation to a standard coordinate space or the probability maps for segmentation. The method is a simple voxel-based algorithm, derived from multispectral remote sensing techniques, and only requires minimal operator input to depict GM, WM, and CSF tissue clusters to complete classification of a 3D high-resolution multislice-multispectral MRI data. Results showed very high accuracy and reproducibility in classification of GM, WM, and CSF in multislice-multispectral synthetic MRI data. The similarity indexes, expressing overlap between classification results and the ground truth, were 0.951, 0.962, and 0.956 for GM, WM, and CSF classifications in the image data with 3% noise level and 0% non-uniformity intensity. The method particularly allows for classification of CSF with 0.994, 0.961 and 0.996 of accuracy, sensitivity and specificity in images data with 3% noise level and 0% non-uniformity intensity, which had seldom performed well in previous studies. As for clinical MRI data, the quantitative data of brain tissue volumes aligned closely with the brain morphometrics in three different study groups of young adults, elderly volunteers, and dementia patients. The results also showed very low rates of the intra-and extra-operator variability in measurements of the absolute volumes and volume fractions of cerebral GM, WM, and CSF in three different study groups. The mean coefficients of variation of GM, WM, and CSF volume measurements were in the range of 0.03% to 0.30% of intra-operator measurements and 0.06% to 0.45% of inter-operator measurements. In conclusion, the TRIO algorithm exhibits a remarkable ability in robust classification of multislice-multispectral brain MR images, which would be potentially applicable for clinical brain volumetric analysis and explicitly promising in cross-sectional and longitudinal studies of different subject groups.	[Chai, Jyh-Wen; Chen, Clayton C.; Wu, Yi-Ying; Chen, Hung-Chieh; Lee, San-Kan] Taichung Vet Gen Hosp, Dept Radiol, Taichung, Taiwan; [Chai, Jyh-Wen; Tsai, Yi-Hsin] China Med Univ, Coll Med, Taichung, Taiwan; [Chen, Clayton C.] Cent Taiwan Univ Sci & Technol, Dept Radiol Technol, Taichung, Taiwan; [Chen, Hsian-Min] Hung Kuang Univ, Dept Biomed Engn, Taichung, Taiwan; [Chen, Hsian-Min] Taichung Vet Gen Hosp, Ctr Quantitat Imaging Med, Dept Med Res, Taichung, Taiwan; [Lan, Tsuo-Hung] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Ouyang, Yen-Chieh] Natl Chung Hsing Univ, Dept Elect Engn, Taichung 40227, Taiwan	Taichung Veterans General Hospital; China Medical University Taiwan; Central Taiwan University Science & Technology; Hungkuang University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Chung Hsing University	Chen, HM (corresponding author), Taichung Vet Gen Hosp, Dept Radiol, Taichung, Taiwan.	hsmin6511@gmail.com	Chen, hung-chieh/AAH-6591-2019	Chen, hung-chieh/0000-0003-3544-5045; Ouyang, Yen-chieh/0000-0002-4221-2787; Lan, Tsuo-Hung/0000-0002-2796-1026	National Science Council in Taiwan [NSC 101-2221-E-241-003]; Taichung Veterans General Hospital; National Chung Hsing University; Hung Kuang University, Taichung, Taiwan [TCVGH-NCHU 1017609, TCVGH-HK 1018003]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital; National Chung Hsing University; Hung Kuang University, Taichung, Taiwan	The study was supported by the National Science Council in Taiwan under NSC 101-2221-E-241-003, and was also supported by the Taichung Veterans General Hospital, National Chung Hsing University and Hung Kuang University, Taichung, Taiwan (TCVGH-NCHU 1017609 and TCVGH-HK 1018003).	Alfano B, 1997, MAGNET RESON MED, V37, P84, DOI 10.1002/mrm.1910370113; Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bishop CM, 2007, PATTERN RECOGN, P186; Cabezas M, 2011, COMPUT METH PROG BIO, V104, pE158, DOI 10.1016/j.cmpb.2011.07.015; Chai JW, 2012, ISMRM 20 ANN M MELB; Chai JW, 2010, J MAGN RESON IMAGING, V32, P24, DOI 10.1002/jmri.22210; Chang C.-I., 2003, HYPERSPECTRAL IMAGIN; Chang C.-I., 2013, HYPERSPECTRAL DATA P, DOI [10.1002/9781118269787, DOI 10.1002/9781118269787]; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CLINE HE, 1990, J COMPUT ASSIST TOMO, V14, P1037, DOI 10.1097/00004728-199011000-00041; Dawant BM, 1999, IEEE T MED IMAGING, V18, P909, DOI 10.1109/42.811271; de Boer R, 2010, NEUROIMAGE, V51, P1047, DOI 10.1016/j.neuroimage.2010.03.012; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DUDA RO, 2001, PATTERN CLASSIFICATI; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Harris G, 1999, J COMPUT ASSIST TOMO, V23, P144, DOI 10.1097/00004728-199901000-00030; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Held K, 1997, IEEE T MED IMAGING, V16, P878, DOI 10.1109/42.650883; Kim S, 2011, J CLIN NEUROSCI, V18, P916, DOI 10.1016/j.jocn.2010.12.019; Lemieux L, 2003, MAGN RESON MED, V49, P872, DOI 10.1002/mrm.10436; Liew AWC, 2006, CURR MED IMAGING, V2, P91, DOI 10.2174/157340506775541604; Lin YC, 2009, THESIS NATL CHUNG HS; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Matsuda H, 2013, AGING DIS, V4, P29; Nakai T, 2004, NEUROIMAGE, V21, P251, DOI 10.1016/j.neuroimage.2003.08.036; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SoltanianZadeh H, 1996, IEEE T MED IMAGING, V15, P749, DOI 10.1109/42.544494; Vaidyanathan M, 1997, MAGN RESON IMAGING, V15, P87, DOI 10.1016/S0730-725X(96)00244-5; VANNIER MW, 1985, RADIOLOGY, V154, P221, DOI 10.1148/radiology.154.1.3964938; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Via E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038299; Wang DM, 1998, J MAGN RESON IMAGING, V8, P480, DOI 10.1002/jmri.1880080232; Yousefi S, 2012, MED IMAGE ANAL, V16, P840, DOI 10.1016/j.media.2012.01.001; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0115527	10.1371/journal.pone.0115527	http://dx.doi.org/10.1371/journal.pone.0115527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710499	gold, Green Submitted, Green Published			2022-12-27	WOS:000350683900005
J	Chakraborty, S; Bartussek, J; Fry, SN; Zapotocky, M				Chakraborty, Soma; Bartussek, Jan; Fry, Steven N.; Zapotocky, Martin			Independently Controlled Wing Stroke Patterns in the Fruit Fly Drosophila melanogaster	PLOS ONE			English	Article							FREE-FLIGHT MANEUVERS; NEUROMUSCULAR CONTROL; YAW TORQUE; AERODYNAMICS; SUPERPOSITION; KINEMATICS; HAWKMOTH; ALTITUDE; FORCES; MODEL	Flies achieve supreme flight maneuverability through a small set of miniscule steering muscles attached to the wing base. The fast flight maneuvers arise from precisely timed activation of the steering muscles and the resulting subtle modulation of the wing stroke. In addition, slower modulation of wing kinematics arises from changes in the activity of indirect flight muscles in the thorax. We investigated if these modulations can be described as a superposition of a limited number of elementary deformations of the wing stroke that are under independent physiological control. Using a high-speed computer vision system, we recorded the wing motion of tethered flying fruit flies for up to 12 000 consecutive wing strokes at a sampling rate of 6250 Hz. We then decomposed the joint motion pattern of both wings into components that had the minimal mutual information (a measure of statistical dependence). In 100 flight segments measured from 10 individual flies, we identified 7 distinct types of frequently occurring least-dependent components, each defining a kinematic pattern (a specific deformation of the wing stroke and the sequence of its activation from cycle to cycle). Two of these stroke deformations can be associated with the control of yaw torque and total flight force, respectively. A third deformation involves a change in the downstroke-to-upstroke duration ratio, which is expected to alter the pitch torque. A fourth kinematic pattern consists in the alteration of stroke amplitude with a period of 2 wingbeat cycles, extending for dozens of cycles. Our analysis indicates that these four elementary kinematic patterns can be activated mutually independently, and occur both in isolation and in linear superposition. The results strengthen the available evidence for independent control of yaw torque, pitch torque, and total flight force. Our computational method facilitates systematic identification of novel patterns in large kinematic datasets.	[Chakraborty, Soma; Bartussek, Jan; Zapotocky, Martin] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague, Czech Republic; [Chakraborty, Soma; Zapotocky, Martin] Charles Univ Prague, Fac Med 1, Inst Biophys & Informat, Prague 12000, Czech Republic; [Fry, Steven N.] SciTrackS Llc, CH-8118 Pfaffhausen, Switzerland	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague	Zapotocky, M (corresponding author), Acad Sci Czech Republ, Inst Physiol, Videnska 1083, CR-14220 Prague, Czech Republic.	zapotocky@biomed.cas.cz	Zapotocky, Martin/B-8225-2008	Zapotocky, Martin/0000-0002-0437-2528	Volkswagen Foundation [I/80 984-986]; Agency of Charles University in Prague [GAUK 676812]; Grant Agency of the Czech Republic [P304-12-G069]; project PRVOUK [P26/LF1/4];  [RVO: 67985823]	Volkswagen Foundation(Volkswagen); Agency of Charles University in Prague; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); project PRVOUK; 	This work was funded by the Volkswagen Foundation (I/80 984-986), the Grant Agency of Charles University in Prague (GAUK 676812), the Grant Agency of the Czech Republic (P304-12-G069), institutional support RVO: 67985823, and project PRVOUK P26/LF1/4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint CN, 2001, J EXP BIOL, V204, P4213; Balint CN, 2004, J EXP BIOL, V207, P3813, DOI 10.1242/jeb.01229; Bartussek J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1013; Bender JA, 2006, J EXP BIOL, V209, P3170, DOI 10.1242/jeb.02369; Bergou AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.148101; CRAVEN P, 1979, NUMER MATH, V31, P377, DOI 10.1007/BF01437407; DAVID CT, 1985, NATURE, V313, P48, DOI 10.1038/313048a0; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; Dickson WB, 2008, AIAA J, V46, P2150, DOI 10.2514/1.29862; Fod A, 2002, AUTON ROBOT, V12, P39, DOI 10.1023/A:1013254724861; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Frye MA, 2004, J EXP BIOL, V207, P123, DOI 10.1242/jeb.00725; Frye MA, 2001, NEURON, V32, P385, DOI 10.1016/S0896-6273(01)00490-1; Geurten BRH, 2010, J EXP BIOL, V213, P2461, DOI 10.1242/jeb.036079; Gotz K.G., 1983, Biona Report, V2, P21; Graetzel C. G., 2006, 1 IEEE RAS EMBS INT, V2006, P278, DOI [10.1109/BIOROB.2006.1639099, DOI 10.1109/BIOROB.2006.1639099]; Heide G, 1996, J EXP BIOL, V199, P1711; HEISENBERG M, 1988, J COMP PHYSIOL A, V163, P373, DOI 10.1007/BF00604013; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lehmann FO, 1998, J EXP BIOL, V201, P385; Riskin DK, 2008, J THEOR BIOL, V254, P604, DOI 10.1016/j.jtbi.2008.06.011; Sane SP, 2001, J EXP BIOL, V204, P2607; Sanger TD, 2000, J NEUROSCI, V20, P1066, DOI 10.1523/JNEUROSCI.20-03-01066.2000; Schilstra C, 1999, J EXP BIOL, V202, P1481; Springthorpe D, 2012, J EXP BIOL, V215, P1766, DOI 10.1242/jeb.067355; Stogbauer H, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066123; Tammero LF, 2002, J EXP BIOL, V205, P2785; Taylor GK, 2001, BIOL REV, V76, P449, DOI 10.1017/S1464793101005759; Truong TQ, 2014, J BIONIC ENG, V11, P36, DOI 10.1016/S1672-6529(14)60018-4; Victor JD, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051903; Wang HZ, 2008, J EXP BIOL, V211, P423, DOI 10.1242/jeb.011791; WILSON DM, 1961, J EXP BIOL, V38, P471; Young J, 2009, SCIENCE, V325, P1549, DOI 10.1126/science.1175928; ZANKER JM, 1988, PHYSIOL ENTOMOL, V13, P351, DOI 10.1111/j.1365-3032.1988.tb00485.x; ZANKER JM, 1990, PHILOS T ROY SOC B, V327, P45, DOI 10.1098/rstb.1990.0042; Zheng LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053060	41	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116813	10.1371/journal.pone.0116813	http://dx.doi.org/10.1371/journal.pone.0116813			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710715	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900017
J	Mo, JA; Lim, JH; Sul, AR; Lee, M; Youn, YC; Kim, HJ				Mo, Jin-A; Lim, Ju-Hee; Sul, Ah-Ram; Lee, Min; Youn, Young Chul; Kim, Hee-Jin			Cerebrospinal Fluid beta-Amyloid(1-42) Levels in the Differential Diagnosis of Alzheimer's Disease-Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PHOSPHORYLATED-TAU; CSF BIOMARKERS; A-BETA-42/A-BETA-40 RATIO; ASSOCIATION WORKGROUPS; AMYLOID BETA(1-42); NATIONAL INSTITUTE; A-BETA-42; DEMENTIA; RECOMMENDATIONS	Objectives The purpose of this study was to carry out systematic review of the literature and metaanalysis to evaluate the diagnostic utility of cerebrospinal fluid (CSF) levels of the 42 amino acid form of amyloid-beta (A beta(1-42)) as a biomarker for differentiating Alzheimer's disease (AD) from non-AD dementia. Methods Design. Systematic literature review was used to evaluate the effectiveness of the A beta for the diagnosis of AD. The Scottish Intercollegiate Guidelines Network (SIGN) tool was used to evaluate independently the quality of the studies. Data sources. The literature review covered from January 1, 2004, to October 22, 2013, and searched eight domestic databases including Korea Med and international databases including Ovid-MEDLINE, EMBASE, and Cochrane Library. Data Extraction and Synthesis. Primary criteria for inclusion were valid studies on (i) patients with mild cognitive impairment with confirmed or suspected AD and non-AD dementia, and (ii) assessment of A beta(1-42) levels using appropriate comparative tests. Results A total of 17 diagnostic evaluation studies were identified in which levels of CSF A beta(1-42) were assessed. Meta-analysis was performed on 11 robust studies that compared confirmed AD (n = 2211) with healthy individuals (n = 1030), 10 studies that compared AD with non-AD dementias (n = 627), and 5 studies that compared amnestic mild cognitive impairment (n = 1133) with non-amnestic type subjects (n = 1276). Overall, the CSF A beta(1-42) levels were reduced in AD compared to controls or non-AD dementia. The effectiveness of test was evaluated for diagnostic accuracy (pooled sensitivity, 0.80 (95% CI 0.78-0.82); pooled specificity, 0.76 (95% CI 0.74-0.78). Conclusions Reduced CSF A beta(1-42) levels are of potential utility in the differential diagnosis of AD versus non-AD dementias and controls. Diagnostic accuracy was high in AD versus healthy controls. However, differential diagnosis for MCI or non-AD might be evaluated by other biomarkers.	[Mo, Jin-A; Lim, Ju-Hee; Sul, Ah-Ram; Lee, Min] Natl Evidence Based Hlth Care Collaborating Agcy, Seoul, South Korea; [Mo, Jin-A] Inha Univ, Coll Med, Dept Nursing, Inchon, South Korea; [Youn, Young Chul] Chung Ang Univ, Coll Med, Dept Neurol, Seoul 156756, South Korea; [Kim, Hee-Jin] Hanyang Univ, Coll Med, Dept Neurol, Seoul 133791, South Korea	Inha University; Chung Ang University; Chung Ang University Hospital; Hanyang University	Kim, HJ (corresponding author), Hanyang Univ, Coll Med, Dept Neurol, Seoul 133791, South Korea.	hyumcbrain@hanyang.ac.kr	Youn, Young Chul/ABA-9938-2021; zhong, feng/G-4623-2015; Sul, Ah-Ram/G-1935-2017	Youn, Young Chul/0000-0002-2742-1759; Sul, Ah-Ram/0000-0003-0331-5529	Ministry of Health and Welfare; Hanyang University [HY-2012]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Hanyang University	This study was supported by research funds from the Ministry of Health and Welfare. This work was supported by the research fund of Hanyang University (HY-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal Rachna, 2011, Int J Alzheimers Dis, V2011, P503293, DOI 10.4061/2011/503293; Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Andreasen N, 1999, NEUROSCI LETT, V273, P5, DOI 10.1016/S0304-3940(99)00617-5; Andreasen N, 2003, ACTA NEUROL SCAND, V107, P47, DOI 10.1034/j.1600-0404.107.s179.9.x; Bateman RJ, 2007, NEUROLOGY, V68, P666, DOI 10.1212/01.wnl.0000256043.50901.e3; Becher B, 2005, PUBLICATION BIAS MET; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Buchhave P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006294; Buerger K, 2002, ARCH NEUROL-CHICAGO, V59, P1267, DOI 10.1001/archneur.59.8.1267; Buerger K, 2009, EXP GERONTOL, V44, P579, DOI 10.1016/j.exger.2009.06.003; COOPER J, 1995, BRIT J PSYCHIAT, V166, P4, DOI 10.1192/bjp.166.1.4; Cummings Jeffrey L, 2011, Alzheimers Dement, V7, pe13, DOI 10.1016/j.jalz.2010.06.004; del Campo M, 2012, BIOMARK MED, V6, P419, DOI [10.2217/bmm.12.46, 10.2217/BMM.12.46]; Dumurgier J, 2013, NEUROBIOL DIS, V54, P486, DOI 10.1016/j.nbd.2013.01.023; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Hampel H, 2004, MOL PSYCHIATR, V9, P705, DOI 10.1038/sj.mp.4001473; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hansson O, 2007, DEMENT GERIATR COGN, V23, P316, DOI 10.1159/000100926; Herukka SK, 2008, J ALZHEIMERS DIS, V14, P51; Herukka SK, 2005, NEUROLOGY, V64, P1294, DOI 10.1212/01.WNL.0000156914.16988.56; Holtzman DM, 2011, NEUROBIOL AGING, V32, pS4, DOI 10.1016/j.neurobiolaging.2011.09.003; Kang JH, 2013, CLIN CHEM, V59, P903, DOI 10.1373/clinchem.2013.202937; Kapaki E, 2005, INT J GERIATR PSYCH, V20, P722, DOI 10.1002/gps.1351; Kapaki EN, 2007, EUR J NEUROL, V14, P168, DOI 10.1111/j.1468-1331.2006.01593.x; Le Bastard N, 2013, J ALZHEIMERS DIS, V33, P117, DOI 10.3233/JAD-2012-121246; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Lewczuk P, 2008, NEUROBIOL AGING, V29, P812, DOI 10.1016/j.neurobiolaging.2006.12.010; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; Maruyama M, 2001, EXP NEUROL, V172, P433, DOI 10.1006/exnr.2001.7814; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mitchell AJ, 2009, J NEUROL NEUROSUR PS, V80, P966, DOI 10.1136/jnnp.2008.167791; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Orwin R, 1983, J ED STAT, V8, P3; Perneczky R, 2011, NEUROLOGY, V77, P35, DOI 10.1212/WNL.0b013e318221ad47; Reijn TSM, 2007, CLIN CHEM, V53, P859, DOI 10.1373/clinchem.2006.081679; Schoonenboom NSM, 2005, CLIN CHEM, V51, P189, DOI 10.1373/clinchem.2004.039735; Schoonenboom NSM, 2004, NEUROLOGY, V62, P1580, DOI 10.1212/01.WNL.0000123249.58898.E0; Smach MA, 2009, EUR NEUROL, V62, P349, DOI 10.1159/000241881; Song MS, 2007, J INT MED RES, V35, P301, DOI 10.1177/147323000703500303; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stefani A, 2005, J NEUROL SCI, V237, P83, DOI 10.1016/j.jns.2005.05.016; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Vos SJB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100784; Vos SJB, 2013, NEUROLOGY, V80, P1124, DOI 10.1212/WNL.0b013e318288690c; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	48	40	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116802	10.1371/journal.pone.0116802	http://dx.doi.org/10.1371/journal.pone.0116802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710596	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900016
J	Prime, T; Brown, JM; Plater, AJ				Prime, Thomas; Brown, Jennifer M.; Plater, Andrew J.			Physical and Economic Impacts of Sea-Level Rise and Low Probability Flooding Events on Coastal Communities	PLOS ONE			English	Article							CLIMATE-CHANGE; STORM SURGES; BIG-FLOOD; MODEL; DEFENSES; ESTUARY	Conventionally flood mapping typically includes only a static water level (e.g. peak of a storm tide) in coastal flood inundation events. Additional factors become increasingly important when increased water-level thresholds are met during the combination of a storm tide and increased mean sea level. This research incorporates factors such as wave overtopping and river flow in a range of flood inundation scenarios of future sea-level projections for a UK case study of Fleetwood, northwest England. With increasing mean sea level it is shown that wave overtopping and river forcing have an important bearing on the cost of coastal flood events. The method presented converts inundation maps into monetary cost. This research demonstrates that under scenarios of joint extreme surge-wave-river events the cost of flooding can be increased by up to a factor of 8 compared with an increase in extent of up to a factor of 3 relative to "surge alone" event. This is due to different areas being exposed to different flood hazards and areas with common hazard where flood waters combine non-linearly. This shows that relying simply on flood extent and volume can under-predict the actual economic impact felt by a coastal community. Additionally, the scenario inundation depths have been presented as "brick course" maps, which represent a new way of interpreting flood maps. This is primarily aimed at stakeholders to increase levels of engagement within the coastal community.	[Prime, Thomas] Univ Liverpool, Environm Sci, Liverpool L69 3BX, Merseyside, England; [Prime, Thomas; Brown, Jennifer M.] Natl Oceanog Ctr, Liverpool, Merseyside, England; [Plater, Andrew J.] Univ Liverpool, Geog, Liverpool L69 3BX, Merseyside, England	University of Liverpool; NERC National Oceanography Centre; University of Liverpool	Prime, T (corresponding author), Univ Liverpool, Environm Sci, Liverpool L69 3BX, Merseyside, England.	tprime@liv.ac.uk		Brown, Jennifer/0000-0002-3894-4651; Prime, Thomas/0000-0002-9638-009X	Engineering and Physical Sciences Research Council, Adapatation and Resilience of Coastal Energy Supply project [EP/103590/1]; EPSRC [EP/I035390/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I035390/1] Funding Source: researchfish; Natural Environment Research Council [noc010012] Funding Source: researchfish	Engineering and Physical Sciences Research Council, Adapatation and Resilience of Coastal Energy Supply project; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funded by the Engineering and Physical Sciences Research Council as part of the Adapatation and Resilience of Coastal Energy Supply project. Grant number EP/103590/1 (http://www.liv.ac.uk/geography-and-planning/research/adaptation-and-resilience-of-coastal-energy-supply/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, LAND COVER DATASET 2; Bates PD, 2010, J HYDROL, V387, P33, DOI 10.1016/j.jhydrol.2010.03.027; Bates PD, 2005, COAST ENG, V52, P793, DOI 10.1016/j.coastaleng.2005.06.001; Bates PD, 2000, J HYDROL, V236, P54, DOI 10.1016/S0022-1694(00)00278-X; Baxter PJ, 2005, PHILOS T R SOC A, V363, P1293, DOI 10.1098/rsta.2005.1569; Bowker P., 2007, FLOOD RESISTANCE RES; Bowker P., 2007, IMPROVING FLOOD PERF; Buijs F., 2007, PERFORMANCE RELIABIL; Burke R., 1983, FREE SURFACE FLOW SA; Chini N, 2012, COAST ENG, V65, P27, DOI 10.1016/j.coastaleng.2012.02.009; Chini N, 2010, COAST ENG, V57, P973, DOI 10.1016/j.coastaleng.2010.05.009; Dawson RJ, 2005, INT J WATER RESOUR D, V21, P577, DOI 10.1080/07900620500258380; Environment Agency, 2013, NW UK COAST DEF DAT; Environment Agency, 2009, PEAKS OV THRESH CSV; Environment Agency Geomatics, 2014, LIDAR DAT; Environment Agency Northwest Office, 2013, RIV WUR HYDR; FAS Wavenet, 2014, BLACKP WAV DAT; Galarneau TJ, 2013, MON WEATHER REV, V141, P4296, DOI 10.1175/MWR-D-13-00181.1; Gallien TW, 2014, COAST ENG, V91, P18, DOI 10.1016/j.coastaleng.2014.04.007; Gerritsen H, 2005, PHILOS T R SOC A, V363, P1271, DOI 10.1098/rsta.2005.1568; Gilles D., 2010, REV HYDRAULIC FLOOD; Green C, 2014, ROSSALL SEA DEFENCES; Halcrow, 2010, SHORELINE MANAGEMENT; Hall JW, 2006, PHILOS T R SOC A, V364, P1027, DOI 10.1098/rsta.2006.1752; HM Government, 2013, NAT AD PROGR MAK COU; HM Government, 2012, PROJ DELIV; Hoozemans F.M.J., 1993, GLOBAL VULNERABILITY; Jevrejeva S, 2012, GLOBAL PLANET CHANGE, V80-81, P14, DOI 10.1016/j.gloplacha.2011.09.006; Jonkman S., 2005, P SOL COAST DIS C AM, P8; Kates RW, 2006, P NATL ACAD SCI USA, V103, P14653, DOI 10.1073/pnas.0605726103; Leake J, 2009, RESPONSE MARINE CLIM; Lowe J., 2009, UK CLIMATE PROJECTIO; Lowe JA, 2001, CLIM DYNAM, V18, P179, DOI 10.1007/s003820100163; Maskell J, 2014, J COASTAL RES, V30, P248, DOI 10.2112/JCOASTRES-D-12-00221.1; McCabe MV, 2013, COAST ENG, V74, P33, DOI 10.1016/j.coastaleng.2012.11.010; Mcinnes KL, 2003, NAT HAZARDS, V30, P187, DOI 10.1023/A:1026118417752; McMillan A, 2011, COASTAL FLOOD BOUNDA; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Nicholls RJ, 2011, PHILOS T R SOC A, V369, P161, DOI 10.1098/rsta.2010.029; Ordnance Survey, 2013, ORDN SURV TOP DAT; Penning-Rowsell E., 2013, FLOOD COASTAL EROSIO, DOI [10.3390/jpm3040288, DOI 10.3390/JPM3040288]; PIETRUSZCZAK S, 1992, INT J SOLIDS STRUCT, V29, P531, DOI 10.1016/0020-7683(92)90052-U; Purvis MJ, 2008, COAST ENG, V55, P1062, DOI 10.1016/j.coastaleng.2008.04.008; Quinn N, 2013, J GEOPHYS RES-OCEANS, V118, P5887, DOI 10.1002/jgrc.20412; Smith RAE, 2012, ENVIRON MODELL SOFTW, V30, P35, DOI 10.1016/j.envsoft.2011.11.008; STEERS JA, 1979, GEOGR J, V145, P192, DOI 10.2307/634386; Stocker T F, 2013, CLIM CHANG 2013 PHYS; Wade S, 2008, SUPPLEMENTARY NOTE F, P1; Wadey MP, 2012, WATER-SUI, V4, P430, DOI 10.3390/w4020430; Wadey MP, 2014, OCEAN SCI DISCUSS, V11, P1995, DOI [10.5194/osd-11-1995-2014, DOI 10.5194/OSD-11-1995-2014]; Wolf J, 2005, PHILOS T R SOC A, V363, P1359, DOI 10.1098/rsta.2005.1572; Zong YQ, 2003, NAT HAZARDS, V29, P13, DOI 10.1023/A:1022942801531	52	33	33	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117030	10.1371/journal.pone.0117030	http://dx.doi.org/10.1371/journal.pone.0117030			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710497	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350683900021
J	Bessi, A; Coletto, M; Davidescu, GA; Scala, A; Caldarelli, G; Quattrociocchi, W				Bessi, Alessandro; Coletto, Mauro; Davidescu, George Alexandru; Scala, Antonio; Caldarelli, Guido; Quattrociocchi, Walter			Science vs Conspiracy: Collective Narratives in the Age of Misinformation	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; SOCIAL-INFLUENCE; MEDIA	The large availability of user provided contents on online social media facilitates people aggregation around shared beliefs, interests, worldviews and narratives. In spite of the enthusiastic rhetoric about the so called collective intelligence unsubstantiated rumors and conspiracy theories-e.g., chemtrails, reptilians or the Illuminati-are pervasive in online social networks (OSN). In this work we study, on a sample of 1.2 million of individuals, how information related to very distinct narratives-i.e. main stream scientific and conspiracy news-are consumed and shape communities on Facebook. Our results show that polarized communities emerge around distinct types of contents and usual consumers of conspiracy news result to be more focused and self-contained on their specific contents. To test potential biases induced by the continued exposure to unsubstantiated rumors on users' content selection, we conclude our analysis measuring how users respond to 4,709 troll information-i.e. parodistic and sarcastic imitation of conspiracy theories. We find that 77.92% of likes and 80.86% of comments are from users usually interacting with conspiracy stories.	[Bessi, Alessandro] IUSS Inst Adv Study, Pavia, Italy; [Scala, Antonio; Caldarelli, Guido] ISC CNR Uos Sapienza, Rome, Italy; [Quattrociocchi, Walter] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA	IUSS PAVIA; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Northeastern University		walter.quattrociocchi@imtlucca.it	Scala, Antonio/H-9153-2019; Scala, Antonio/GRS-5823-2022; Caldarelli, Guido/AAB-8206-2022; Caldarelli, Guido/A-5274-2010; Quattrociocchi, Walter/L-4550-2016	Scala, Antonio/0000-0002-3414-2686; Bessi, Alessandro/0000-0001-6260-4422; Caldarelli, Guido/0000-0001-9377-3616; Quattrociocchi, Walter/0000-0002-4374-9324	EU FET project MULTIPLEX [317532]; EU FET project SIMPOL [610704]	EU FET project MULTIPLEX; EU FET project SIMPOL	Funding for this work was provided by EU FET project MULTIPLEX nr. 317532 and SIMPOL nr. 610704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Allport GW, 1946, PUBLIC OPIN QUART, V10, P501, DOI 10.1086/265813; Ambrosetti G, 2013, FORCONI SENATO HA AP; [Anonymous], 2014, SLATE; Atran S, 2012, SCIENCE, V336, P855, DOI 10.1126/science.1216902; Ayers MS, 1998, PSYCHON B REV, V5, P1, DOI 10.3758/BF03209454; Bekkers V, 2011, INFORM SOC, V27, P209, DOI 10.1080/01972243.2011.583812; Ben-Naim E, 2003, PHYSICA A, V330, P99, DOI 10.1016/j.physa.2003.08.027; Bessi A, J TRUST MAN IN PRESS; Bessi A, 2014, LECT NOTES COMPUT SC, V8851, P259, DOI 10.1007/978-3-319-13734-6_18; Blondel V. D., 2008, FAST UNFOLDING COMMU; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Borge-Holthoefer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023883; Bruland K., 1997, RESISTANCE NEW TECHN, P125; Byford J, 2011, CONSPIRACY THEORIES: A CRITICAL INTRODUCTION, P1, DOI 10.1057/9780230349216; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cheng J, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P925, DOI 10.1145/2566486.2567997; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Epstein S, 1996, J PERS SOC PSYCHOL, V71, P390, DOI 10.1037/0022-3514.71.2.390; Facebook, 2013, US GRAPH AP; Fine G, SOCIAL IMPACT RUMOR; Frenda SJ, 2011, CURR DIR PSYCHOL SCI, V20, P20, DOI 10.1177/0963721410396620; Friggeri A, 2014, AAAI C WEBL SOC MED; Garrett R.K., 2013, P ACM 2013 C COMPUTE, P1047, DOI [10.1145/2441776.2441895, DOI 10.1145/2441776.2441895]; Global Polis, 2014, FAC TROLLS IT POL; Hannak A., 2014, P 8 INT AAAI C WEBL, P186; Hogg M, 2011, BLACK WELL CLAREMONT; Howell L, 2013, REPORT 2013; Joinson AN, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1027; Kleinberg J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0378; Koriat A, 2000, ANNU REV PSYCHOL, V51, P481, DOI 10.1146/annurev.psych.51.1.481; Kuklinski JH, 2000, J POLIT, V62, P790, DOI 10.1111/0022-3816.00033; Lewandowsky Stephan, 2013, Front Psychol, V4, P73, DOI 10.3389/fpsyg.2013.00073; Mann C, 2000, NEW TECHNOLOGIES SOC; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; McKelvey K, 2013, P CSCW 13; Meade ML, 2002, MEM COGNITION, V30, P995, DOI 10.3758/BF03194318; Mocanu D, 2014, COMPUTERS HUMAN BEHA; Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Paolucci M., 2009, SOCIAL KNOWLEDGE E G; Patrick J, 2013, BELIEFS CONSPIRACY T; Quattrociocchi W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04938; Quattrociocchi W, 2011, ADV COMPLEX SYST, V14, P567, DOI 10.1142/S0219525911003165; Quattrociocchi W, 2009, INT J KNOWL LEARN, V5, P457, DOI 10.1504/IJKL.2009.031509; Rojecki A, 2016, NEW MEDIA SOC, V18, P25, DOI 10.1177/1461444814535724; Shum SB, 2012, EUR PHYS J-SPEC TOP, V214, P109, DOI 10.1140/epjst/e2012-01690-3; simplyhumans, 2014, SIMPLY HUMANS BENEFI; simplyhumans, 2014, DIETA PERSONALIZZATA; Sunstein CR, 2009, J POLIT PHILOS, V17, P202, DOI 10.1111/j.1467-9760.2008.00325.x; Surowiecki J., 2005, WISDOM CROWDS WHY MA; Ugander  J., 2012, P NATL ACAD SCI; Viswanath B, 2009, 2ND ACM SIGCOMM WORKSHOP ON ONLINE SOCIAL NETWORKS (WOSN 09), P37; WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049; Welinder P., 2010, ADV NEURAL INFORM PR, V23, P2424; Zhu B, 2010, PERS INDIV DIFFER, V48, P889, DOI 10.1016/j.paid.2010.02.016	59	241	246	31	257	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118093	10.1371/journal.pone.0118093	http://dx.doi.org/10.1371/journal.pone.0118093			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706981	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350662100143
J	Gkantidis, N; Schauseil, M; Pazera, P; Zorkun, B; Katsaros, C; Ludwig, B				Gkantidis, Nikolaos; Schauseil, Michael; Pazera, Pawel; Zorkun, Berna; Katsaros, Christos; Ludwig, Bjoern			Evaluation of 3-Dimensional Superimposition Techniques on Various Skeletal Structures of the Head Using Surface Models	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; CRANIAL BASE; MAXILLARY PROTRACTION; CT; REGISTRATION; GROWTH; RECONSTRUCTION; RELIABILITY; AGREEMENT; IMPLANT	Objectives To test the applicability, accuracy, precision, and reproducibility of various 3D superimposition techniques for radiographic data, transformed to triangulated surface data. Methods Five superimposition techniques (3P: three-point registration; AC: anterior cranial base; AC + F: anterior cranial base + foramen magnum; BZ: both zygomatic arches; 1Z: one zygomatic arch) were tested using eight pairs of pre-existing CT data (pre-and post-treatment). These were obtained from non-growing orthodontic patients treated with rapid maxillary expansion. All datasets were superimposed by three operators independently, who repeated the whole procedure one month later. Accuracy was assessed by the distance (D) between superimposed datasets on three form-stable anatomical areas, located on the anterior cranial base and the foramen magnum. Precision and reproducibility were assessed using the distances between models at four specific landmarks. Non parametric multivariate models and Bland-Altman difference plots were used for analyses. Results There was no difference among operators or between time points on the accuracy of each superimposition technique (p>0.05). The AC + F technique was the most accurate (D<0.17 mm), as expected, followed by AC and BZ superimpositions that presented similar level of accuracy (D<0.5 mm). 3P and 1Z were the least accurate superimpositions (0.79<D<1.76 mm, p<0.005). Although there was no difference among operators or between time points on the precision of each superimposition technique (p>0.05), the detected structural changes differed significantly between different techniques (p<0.05). Bland-Altman difference plots showed that BZ superimposition was comparable to AC, though it presented slightly higher random error. Conclusions Superimposition of 3D datasets using surface models created from voxel data can provide accurate, precise, and reproducible results, offering also high efficiency and increased post-processing capabilities. In the present study population, the BZ superimposition was comparable to AC, with the added advantage of being applicable to scans with a smaller field of view.	[Gkantidis, Nikolaos; Pazera, Pawel; Katsaros, Christos] Univ Bern, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Schauseil, Michael] Univ Marburg, Dept Orthodont, Marburg, Germany; [Zorkun, Berna] Cumhuriyet Univ, Dept Orthodont, Sivas, Turkey; [Ludwig, Bjoern] Private Orthodont Off, Traben Trarbach, Germany; [Ludwig, Bjoern] Univ Saarland, Dept Orthodont, Homburg, Germany	University of Bern; Philipps University Marburg; Cumhuriyet University; Saarland University	Gkantidis, N (corresponding author), Univ Bern, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland.	nikosgant@yahoo.gr	Ludwig, Björn/P-5210-2019; Gkantidis, Nikolaos/ABC-4727-2020	Gkantidis, Nikolaos/0000-0002-3180-6272; Katsaros, Christos/0000-0001-5545-6740				AlHadidi A, 2011, DENTOMAXILLOFAC RAD, V40, P351, DOI 10.1259/dmfr/13993523; Almeida RC, 2011, INT J ORAL MAX SURG, V40, P353, DOI 10.1016/j.ijom.2010.11.018; AlSamak S, 2012, INT J ORAL MAX IMPL, V27, P875; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; [Anonymous], 2004, PERMDISP FORTRAN COM; Arat ZM, 2010, ANGLE ORTHOD, V80, P725, DOI 10.2319/080709-447.1; Bailey LTJ, 2004, AM J ORTHOD DENTOFAC, V126, P273, DOI 10.1016/j.ajodo.2004.06.003; Bastir M, 2006, J ANAT, V209, P637, DOI 10.1111/j.1469-7580.2006.00644.x; Benazzi S, 2011, J ORAL MAXIL SURG, V69, P1184, DOI 10.1016/j.joms.2010.02.028; BJORK A, 1983, EUR J ORTHODONT, V5, P1; Bjork A, 1977, Br J Orthod, V4, P53; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BUSCHANG PH, 1986, EUR J ORTHODONT, V8, P152, DOI 10.1093/ejo/8.3.152; Cevidanes LHC, 2010, AM J ORTHOD DENTOFAC, V137, pS120, DOI 10.1016/j.ajodo.2009.04.021; Cevidanes LHS, 2006, AM J ORTHOD DENTOFAC, V129, P611, DOI 10.1016/j.ajodo.2005.12.008; CHEN Y, 1991, 1991 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P2724, DOI 10.1109/ROBOT.1991.132043; Crum WR, 2003, NEUROIMAGE, V20, P1425, DOI 10.1016/j.neuroimage.2003.07.014; Danz JC, 2011, AM J ORTHOD DENTOFAC, V140, P274, DOI 10.1016/j.ajodo.2011.04.010; De Clerck H, 2010, AM J ORTHOD DENTOFAC, V138, P577, DOI 10.1016/j.ajodo.2009.10.037; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; Eggers G, 2008, MINIM INVAS NEUROSUR, V51, P15, DOI 10.1055/s-2007-1004559; Fortin M, 2012, PHYS THER, V92, P853, DOI 10.2522/ptj.20110380; FRANKEL R, 1980, AM J ORTHOD DENTOFAC, V77, P379, DOI 10.1016/0002-9416(80)90104-9; Gkantidis N, 2011, AM J ORTHOD DENTOFAC, V140, P346, DOI 10.1016/j.ajodo.2011.05.015; Gkantidis N, 2011, J ANAT, V218, P426, DOI 10.1111/j.1469-7580.2011.01346.x; Grauer D, 2009, AM J ORTHOD DENTOFAC, V136, P460, DOI 10.1016/j.ajodo.2009.04.016; Halazonetis DJ, 2012, AM J ORTHOD DENTOFAC, V141, P407, DOI 10.1016/j.ajodo.2012.02.010; Halazonetis DJ, 2005, AM J ORTHOD DENTOFAC, V127, P627, DOI 10.1016/j.ajodo.2005.01.004; Halazonetis DJ, 2004, AM J ORTHOD DENTOFAC, V125, P571, DOI 10.1016/j.ajodo.2003.05.013; Heymann GC, 2010, AM J ORTHOD DENTOFAC, V137, P274, DOI 10.1016/j.ajodo.2009.07.009; HILL DLG, 1991, BRIT J RADIOL, V64, P1030, DOI 10.1259/0007-1285-64-767-1030; HOUSTON WJB, 1985, EUR J ORTHODONT, V7, P127, DOI 10.1093/ejo/7.2.127; Kim G, 2012, J DIGIT IMAGING, V25, P486, DOI 10.1007/s10278-012-9458-6; Lagravere MO, 2010, DENTOMAXILLOFAC RAD, V39, P400, DOI 10.1259/dmfr/17319459; Lee JH, 2012, OR SURG OR MED OR PA, V114, P167, DOI 10.1016/j.tripleo.2011.06.003; Liang X, 2010, EUR J RADIOL, V75, P270, DOI 10.1016/j.ejrad.2009.04.016; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Ludlow JB, 2008, ORAL SURG ORAL MED O, V106, P106, DOI 10.1016/j.tripleo.2008.03.018; Ludwig B., 2009, KIEFERORTHOP, V23, P267; MELSEN B, 1975, AM J ORTHOD DENTOFAC, V68, P42, DOI 10.1016/0002-9416(75)90158-X; Metzger MC, 2007, ORAL SURG ORAL MED O, V104, pE1, DOI 10.1016/j.tripleo.2007.04.015; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Nada RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016520; Popat H, 2008, ORTHOD CRANIOFAC RES, V11, P216, DOI 10.1111/j.1601-6343.2008.00433.x; Rahmah NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018199; Rodriguez JM, 2012, CARIES RES, V46, P9, DOI 10.1159/000334786; Rodt T, 2006, DENTOMAXILLOFAC RAD, V35, P227, DOI 10.1259/dmfr/22989395; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Santler G, 1998, Comput Aided Surg, V3, P248, DOI 10.1002/(SICI)1097-0150(1998)3:5<248::AID-IGS4>3.0.CO;2-A; Shelly AD, 2000, AM J ORTHOD DENTOFAC, V117, P630, DOI 10.1016/S0889-5406(00)70171-5; Tai K, 2010, J CLIN PEDIATR DENT, V34, P361, DOI 10.17796/jcpd.34.4.w8n6321878105431; Tamm EP, 2011, RADIOGRAPHICS, V31, P1823, DOI 10.1148/rg.317115027; Trucco E, 1999, PATTERN RECOGN LETT, V20, P889, DOI 10.1016/S0167-8655(99)00055-0; Tsang ST, 2009, AM J ORTHOD DENTOFAC, V135, P66, DOI 10.1016/j.ajodo.2007.01.033; van Vlijmen OJC, 2011, CLIN ORAL INVEST, V15, P721, DOI 10.1007/s00784-010-0440-8; Yamauchi T, 2010, J CLIN NEUROSCI, V17, P756, DOI 10.1016/j.jocn.2009.09.037	58	53	54	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118810	10.1371/journal.pone.0118810	http://dx.doi.org/10.1371/journal.pone.0118810			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706151	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100206
J	Rossmann, FS; Laverde, D; Kropec, A; Romero-Saavedra, F; Meyer-Buehn, M; Huebner, J				Rossmann, Friederike S.; Laverde, Diana; Kropec, Andrea; Romero-Saavedra, Felipe; Meyer-Buehn, Melanie; Huebner, Johannes			Isolation of Highly Active Monoclonal Antibodies against Multiresistant Gram-Positive Bacteria	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ENTEROCOCCUS-FAECALIS; PROLONGED BACTEREMIA; BIOFILM; SAFETY; COLONIZATION; PAGIBAXIMAB; INFECTIONS; SET	Multiresistant nosocomial pathogens often cause life-threatening infections that are sometimes untreatable with currently available antibiotics. Staphylococci and enterococci are the predominant Gram-positive species associated with hospital-acquired infections. These infections often lead to extended hospital stay and excess mortality. In this study, a panel of fully human monoclonal antibodies was isolated from a healthy individual by selection of Bcells producing antibodies with high opsonic killing against E. faecalis 12030. Variable domains (VH and VL) of these immunoglobulin genes were amplified by PCR and cloned into an eukaryotic expression vector containing the constant domains of a human IgG1 molecule and the human lambda constant domain. These constructs were transfected into CHO cells and culture supernatants were collected and tested by opsonophagocytic assay against E. faecalis and S. aureus strains (including MRSA). At concentrations of 600 pg/ml, opsonic killing was between 40% and 70% against all strains tested. Monoclonal antibodies were also evaluated in a mouse sepsis model (using S. aureus LAC and E. faecium), a mouse peritonitis model (using S. aureus Newman and LAC) and a rat endocarditis model (using E. faecalis 12030) and were shown to provide protection in all models at a concentration of 4 mu g/kg per animal. Here we present a method to produce fully human IgG1 monoclonal antibodies that are opsonic in vitro and protective in vivo against several multiresistant Gram-positive bacteria. The monoclonal antibodies presented in this study are significantly more effective compared to another monoclonal antibody currently in clinical trials.	[Rossmann, Friederike S.; Laverde, Diana; Kropec, Andrea; Romero-Saavedra, Felipe; Huebner, Johannes] Univ Hosp, Dept Med, Div Infect Dis, Freiburg, Germany; [Rossmann, Friederike S.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Rossmann, Friederike S.; Meyer-Buehn, Melanie; Huebner, Johannes] Univ Munich, Dept Pediat, Dr von Hauner Childrens Hosp, Munich, Germany; [Rossmann, Friederike S.; Meyer-Buehn, Melanie; Huebner, Johannes] German Ctr Infect Res DZIF, Tubingen, Germany	University of Freiburg; University of Freiburg; University of Munich; German Center for Infection Research	Rossmann, FS (corresponding author), Univ Hosp, Dept Med, Div Infect Dis, Freiburg, Germany.	frierossmann@googlemail.com		Huebner, Johannes/0000-0003-1232-4646				BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC, P1; Chen QY, 2008, J IMMUNOL, V181, P8258, DOI 10.4049/jimmunol.181.12.8258; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; Fabretti F, 2005, INT J ARTIF ORGANS, V28, P1079, DOI 10.1177/039139880502801105; Flego M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-4; Greenberg JW, 1996, INFECT IMMUN, V64, P3318, DOI 10.1128/IAI.64.8.3318-3325.1996; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Guttormsen HK, 1996, J INFECT DIS, V173, P142, DOI 10.1093/infdis/173.1.142; Haller C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091863; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Heikens E, 2007, J BACTERIOL, V189, P8233, DOI 10.1128/JB.01205-07; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006; Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005; Laverde D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110953; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Pier GB, 2004, J IMMUNOL, V173, P5671, DOI 10.4049/jimmunol.173.9.5671; Preston MJ, 1998, INFECT IMMUN, V66, P4137; Reichmann Nathalie T., 2014, New Zealand Journal of Zoology, V41, P273, DOI 10.1111/mmi.12551; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Ryu S, 2014, INT J MOL SCI, V15, P8753, DOI 10.3390/ijms15058753; ter Meulen J, 2007, EXPERT OPIN EMERG DR, V12, P525, DOI 10.1517/14728214.12.4.525; Theilacker C, 2012, J INFECT DIS, V205, P1076, DOI 10.1093/infdis/jis022; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Tosato Giovanna, 2007, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0722s76; Weisman LE, 2011, PEDIATRICS, V128, P271, DOI 10.1542/peds.2010-3081; Weisman LE, 2009, ANTIMICROB AGENTS CH, V53, P2879, DOI 10.1128/AAC.01565-08; Weisman LE, 2009, INT IMMUNOPHARMACOL, V9, P639, DOI 10.1016/j.intimp.2009.02.008	35	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118405	10.1371/journal.pone.0118405	http://dx.doi.org/10.1371/journal.pone.0118405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706415	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100178
J	Walker, D; Shing, RNK; Jones, D; Gruss, HJ; Regula, J				Walker, Dave; Shing, Richard Ng Kwet; Jones, Deborah; Gruss, Hans-Jurgen; Regula, Jaroslaw			Challenges of Correlating pH Change with Relief of Clinical Symptoms in Gastro Esophageal Reflux Disease: A Phase III, Randomized Study of Zegerid versus Losec	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; GASTROESOPHAGEAL-REFLUX; ACID SUPPRESSION; PRESENTATIONS; ESOMEPRAZOLE; DIAGNOSIS; IMPEDANCE; ARTICLE; BILE	Background Zegerid (on demand immediate-release omeprazole and sodium bicarbonate combination therapy) has demonstrated earlier absorption and more rapid pH change compared with Losec (standard enteric coated omeprazole), suggesting more rapid clinical relief of heartburn. This Phase III, multicenter, double-blind, double-dummy, randomized study assessed the clinical superiority of Zegerid versus Losec for rapid relief of heartburn associated with gastro-esophageal reflux disease (GERD). Methods Patients with a history of frequent (2 3 days/week) uncomplicated GERD, were randomized to receive Zegerid (20mg) or Losec (20mg) with corresponding placebo. Study medication was self-administered on the first episode of heartburn, and could be taken for up to 3 days within a 14 day study period. Heartburn severity was self assessed up to 180 minutes post dose (9 point Likert scale). Primary endpoint was median time to sustained response (>= 3 point reduction in heartburn severity for >= 45 minutes). Results Of patients randomized to Zegerid (N=122) or Losec (N=117), 228/239 had recorded >= 1 evaluable heartburn episodes and were included in the modified intent-to-treat population. No significant between-group differences were observed for median time to sustained response (60.0 vs. 52.2 minutes, Zegerid [N=117] and Losec [N=111], respectively), sustained partial response (both, 37.5 minutes) and sustained total relief (both, 105 minutes). Significantly more patients treated with Zegerid reached sustained total relief within 0-30 minutes post dose in all analysis sets (p<0.05). Both treatments were well tolerated and did not raise any safety concerns. Conclusions Superiority of Zegerid over Losec for rapid heartburn relief was not demonstrated; both treatments were equally effective however the rapid onset of action of Losec was unexpected. Factors, including aspects of study design may have contributed to this. This study supports previously reported difficulty in correlating intra-gastric pH change with clinical effect in GERD therapy, highlighting the significance of several technical considerations for studies of this type.	[Walker, Dave; Shing, Richard Ng Kwet; Jones, Deborah] Norgine Ltd, Uxbridge, Middx, England; [Gruss, Hans-Jurgen] ICON Clin Res, Med & Safety Serv, Eastleigh, England; [Regula, Jaroslaw] Inst Oncol, Dept Gastroenterol, Warsaw, Poland; [Regula, Jaroslaw] Med Ctr Postgrad Educ, Warsaw, Poland	ICON plc; Maria Sklodowska-Curie National Research Institute of Oncology; Centre of Postgraduate Medical Education - Poland	Walker, D (corresponding author), Norgine Ltd, Uxbridge, Middx, England.	DWalker@norgine.com		Regula, Jaroslaw/0000-0001-7071-3151	Norgine Ltd, UK	Norgine Ltd, UK	This study was funded by Norgine Ltd, UK (www.norgine.com). The funder's representatives (DW, RNKS, DJ, HJG) were involved in the study design, data collection, analysis, decision to publish and preparation of the manuscript.	Armstrong D, 2004, ALIMENT PHARM THERAP, V20, P19, DOI 10.1111/j.1365-2036.2004.02140.x; Bautista JM, 2005, DIGEST DIS SCI, V50, P1909, DOI 10.1007/s10620-005-2960-7; BELL NJV, 1992, DIGESTION, V51, P59, DOI 10.1159/000200917; Bulat R, 1999, ALIMENT PHARM THERAP, V13, P805, DOI 10.1046/j.1365-2036.1999.00528.x; Charbel S, 2005, AM J GASTROENTEROL, V100, P283, DOI 10.1111/j.1572-0241.2005.41210.x; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Dent J, 2008, AM J GASTROENTEROL, V103, P20, DOI 10.1111/j.1572-0241.2007.01544.x; Diaz-Rubio M, 2004, ALIMENT PHARM THER, V19, P95, DOI 10.1046/j.1365-2036.2003.01769.x; European Medicines Agency Committee for Medicinal Products for Human Use, 2009, EMACHMPEWP3426912009; Grigoleit HG, 2005, PHYTOMEDICINE, V12, P601, DOI 10.1016/j.phymed.2004.10.005; Hatlebakk JG, 2000, ALIMENT PHARM THERAP, V14, P1267, DOI 10.1046/j.1365-2036.2000.00829.x; Herro E, 2010, DERMATITIS, V21, P327, DOI 10.2310/6620.2011.10080; HUNT RH, 1995, DIGEST DIS SCI, V40, pS24, DOI 10.1007/BF02214870; HUNT RH, 1995, ALIMENT PHARM THERAP, V9, P3; Kahrilas PJ, 2008, GASTROENTEROLOGY, V135, P1392, DOI 10.1053/j.gastro.2008.08.044; Kahrilas PJ, 2007, CLIN GASTROENTEROL H, V5, P1385, DOI 10.1016/j.cgh.2007.08.014; Karamanolis G, 2008, DIGEST DIS SCI, V53, P3128, DOI 10.1007/s10620-008-0301-3; Katz PO, 2011, J CLIN GASTROENTEROL, V45, P748, DOI 10.1097/MCG.0b013e318224d4ba; Mainie I, 2006, GUT, V55, P1398, DOI 10.1136/gut.2005.087668; Metz DC, 2007, AM J GASTROENTEROL, V102, P642, DOI 10.1111/j.1572-0241.2006.00998.x; Mohammed I, 2003, GUT, V52, P1085, DOI 10.1136/gut.52.8.1085; Pace F, 2007, ALIMENT PHARM THER, V26, P195, DOI 10.1111/j.1365-2036.2007.03381.x; Richter JE, 1996, GASTROENTEROL CLIN N, V25, P75, DOI 10.1016/S0889-8553(05)70366-6; Rodriguez-Stanley S, 2000, ALIMENT PHARM THER, V14, P129; SACHS G, 1995, ANNU REV PHARMACOL, V35, P277, DOI 10.1146/annurev.pa.35.040195.001425; Siddiqui A, 2005, DIGEST DIS SCI, V50, P81, DOI 10.1007/s10620-005-1282-0; Stedman CAM, 2000, ALIMENT PHARM THERAP, V14, P963, DOI 10.1046/j.1365-2036.2000.00788.x; Tack J, 2006, ALIMENT PHARM THER, V24, P10, DOI 10.1111/j.1365-2036.2006.03040.x; Terry P, 2000, NUTR CANCER, V38, P186, DOI 10.1207/S15327914NC382_7; Tutuian R, 2008, AM J GASTROENTEROL, V103, P1090, DOI 10.1111/j.1572-0241.2008.01791.x; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Vela MF, 2001, GASTROENTEROLOGY, V120, P1599, DOI 10.1053/gast.2001.24840; WATERFALL WE, 1986, CAN MED ASSOC J, V135, P1101; Zerbib F, 2006, AM J GASTROENTEROL, V101, P1956, DOI 10.1111/j.1572-0241.2006.00711.x	34	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116308	10.1371/journal.pone.0116308	http://dx.doi.org/10.1371/journal.pone.0116308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706883	gold, Green Submitted, Green Published			2022-12-27	WOS:000350662100032
J	Gomi, K; Arbelaez, V; Crystal, RG; Walters, MS				Gomi, Kazunori; Arbelaez, Vanessa; Crystal, Ronald G.; Walters, Matthew S.			Activation of NOTCH1 or NOTCH3 Signaling Skews Human Airway Basal Cell Differentiation toward a Secretory Pathway	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; STEM-CELLS; MUCOUS METAPLASIA; CLARA CELLS; IN-VITRO; EPITHELIUM; SMOKING; LUNG; FATE; REGENERATION	Airway basal cells (BC) function as stem/progenitor cells capable of differentiating into the luminal ciliated and secretory cells to replenish the airway epithelium during physiological turnover and repair. The objective of this study was to define the role of Notch signaling in regulating human airway BC differentiation into a pseudostratified mucociliated epithelium. Notch inhibition with gamma-secretase inhibitors demonstrated Notch activation is essential for BC differentiation into secretory and ciliated cells, but more so for the secretory lineage. Sustained cell autonomous ligand independent Notch activation via lentivirus expression of the intracellular domain of each Notch receptor (NICD1-4) demonstrated that the NOTCH2 and 4 pathways have little effect on BC differentiation into secretory and ciliated cells, while activation of the NOTCH1 or 3 pathways has a major influence, with persistent expression of NICD1 or 3 resulting in a skewing toward secretory cell differentiation with a parallel decrease in ciliated cell differentiation. These observations provide insights into the control of the balance of BC differentiation into the secretory vs ciliated cell lineage, a balance that is critical for maintaining the normal function of the airway epithelium in barrier defense against the inhaled environment.	[Gomi, Kazunori; Arbelaez, Vanessa; Crystal, Ronald G.; Walters, Matthew S.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA	Cornell University	Walters, MS (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu		Walters, Matthew/0000-0003-0010-8444	National Institutes of Health [R01HL107882, P50HL084936, UL1TR000457, UL1RR024143]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084936, R01HL107882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies are supported by the National Institutes of Health R01HL107882, P50HL084936, UL1TR000457 and UL1RR024143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Beasley MB, 2010, ADV ANAT PATHOL, V17, P270, DOI 10.1097/PAP.0b013e3181e3bf97; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Borggrefe T, 2012, CELL CYCLE, V11, P264, DOI 10.4161/cc.11.2.18995; Boucherat O, 2012, BIOL OPEN, V1, P677, DOI 10.1242/bio.20121701; Cole BB, 2010, AM J PATHOL, V177, P362, DOI 10.2353/ajpath.2010.090870; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Gerovac BJ, 2014, AM J RESP CELL MOL, V51, P516, DOI 10.1165/rcmb.2013-0237OC; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Hackett NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018378; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hajj R, 2007, STEM CELLS, V25, P139, DOI 10.1634/stemcells.2006-0288; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Ito T, 2000, DEVELOPMENT, V127, P3913; Kim V, 2008, COPD, V5, P329, DOI 10.1080/15412550802522445; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Li AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062215; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; LUMSDEN AB, 1984, THORAX, V39, P844, DOI 10.1136/thx.39.11.844; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Paul MK, 2014, CELL STEM CELL, V15, P199, DOI 10.1016/j.stem.2014.05.009; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Schoch KG, 2004, AM J PHYSIOL-LUNG C, V286, pL631, DOI 10.1152/ajplung.00112.2003; Shan L, 2007, AM J PHYSIOL-LUNG C, V292, pL500, DOI 10.1152/ajplung.00052.2006; Shaykhiev R, 2013, P NATL ACAD SCI USA, V110, P12102, DOI 10.1073/pnas.1303058110; Tam A, 2012, MED CLIN N AM, V96, P681, DOI 10.1016/j.mcna.2012.04.012; Tam Anthony, 2011, Ther Adv Respir Dis, V5, P255, DOI 10.1177/1753465810396539; Tata PR, 2013, AM J RESP CELL MOL, V49, P1048, DOI 10.1165/rcmb.2012-0412OC; Tilley AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022798; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Tsao PN, 2011, DEVELOPMENT, V138, P3533, DOI 10.1242/dev.063727; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Walters MS, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-135; Xing YM, 2012, STEM CELLS, V30, P946, DOI 10.1002/stem.1059; Xu KL, 2012, ADV EXP MED BIOL, V727, P89, DOI 10.1007/978-1-4614-0899-4_7; Zhang SB, 2013, DEV DYNAM, V242, P678, DOI 10.1002/dvdy.23965	47	43	44	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116507	10.1371/journal.pone.0116507	http://dx.doi.org/10.1371/journal.pone.0116507			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700162	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800010
J	Zuwala, K; Golda, A; Kabala, W; Burmistrz, M; Zdzalik, M; Nowak, P; Kedracka-Krok, S; Zarebski, M; Dobrucki, J; Florek, D; Zeglen, S; Wojarski, J; Potempa, J; Dubin, G; Pyrc, K				Zuwala, Kaja; Golda, Anna; Kabala, Wojciech; Burmistrz, Michal; Zdzalik, Michal; Nowak, Paulina; Kedracka-Krok, Sylwia; Zarebski, Miroslaw; Dobrucki, Jerzy; Florek, Dominik; Zeglen, Slawomir; Wojarski, Jacek; Potempa, Jan; Dubin, Grzegorz; Pyrc, Krzysztof			The Nucleocapsid Protein of Human Coronavirus NL63	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; INFECTIOUS-BRONCHITIS VIRUS; N-TERMINAL DOMAIN; DIFFERENTIAL SCANNING CALORIMETRY; DIMERIZATION DOMAIN; AMINOPEPTIDASE-N; DOWN-REGULATION; RNA-BINDING; LOCALIZATION; SEQUENCE	Human coronavirus (HCoV) NL63 was first described in 2004 and is associated with respiratory tract disease of varying severity. At the genetic and structural level, HCoV-NL63 is similar to other members of the Coronavirinae subfamily, especially human coronavirus 229E (HCoV-229E). Detailed analysis, however, reveals several unique features of the pathogen. The coronaviral nucleocapsid protein is abundantly present in infected cells. It is a multi-domain, multi-functional protein important for viral replication and a number of cellular processes. The aim of the present study was to characterize the HCoV-NL63 nucleocapsid protein. Biochemical analyses revealed that the protein shares characteristics with homologous proteins encoded in other coronaviral genomes, with the N-terminal domain responsible for nucleic acid binding and the C-terminal domain involved in protein oligomerization. Surprisingly, analysis of the subcellular localization of the N protein of HCoV-NL63 revealed that, differently than homologous proteins from other coronaviral species except for SARS-CoV, it is not present in the nucleus of infected or transfected cells. Furthermore, no significant alteration in cell cycle progression in cells expressing the protein was observed. This is in stark contrast with results obtained for other coronaviruses, except for the SARS-CoV.	[Zuwala, Kaja; Golda, Anna; Kabala, Wojciech; Burmistrz, Michal; Zdzalik, Michal; Nowak, Paulina; Florek, Dominik; Potempa, Jan; Dubin, Grzegorz; Pyrc, Krzysztof] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Kabala, Wojciech; Kedracka-Krok, Sylwia; Dubin, Grzegorz; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Kedracka-Krok, Sylwia] Jagiellonian Univ, Dept Phys Biochem, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Zarebski, Miroslaw; Dobrucki, Jerzy] Jagiellonian Univ, Div Cell Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Wojarski, Jacek] Silesian Ctr Heart Dis, Dept Cardiac Surg & Transplantol, PL-41800 Zabrze, Poland; [Potempa, Jan] Univ Louisville, Oral Hlth & Syst Dis Res Grp, Sch Dent, Louisville, KY 40292 USA	Jagiellonian University; Jagiellonian University; Jagiellonian University; Jagiellonian University; Silesian Center for Heart Diseases; University of Louisville	Pyrc, K (corresponding author), Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland.	k.a.pyrc@uj.edu.pl	Dubin, Grzegorz/J-8168-2014; Zuwala, Kaja/L-6124-2017; Burmistrz, Michal/AAQ-1027-2020; Potempa, Jan/AAA-6850-2021	Dubin, Grzegorz/0000-0002-5535-5760; Zuwala, Kaja/0000-0001-6585-4259; Nowak, Paulina/0000-0001-5786-2339; Potempa, Jan/0000-0002-3600-7461; Wojarski, Jacek/0000-0001-7724-8213; Pyrc, Krzysztof/0000-0002-3867-7688; Dobrucki, Jerzy/0000-0002-4432-1522	LIDER grant from the National Centre for Research and Development [Lider/27/55/L-2/10/2011]; Iuventus Plus grant from the Ministry of Science and Higher Education, Poland [IP 2010 033870, IP2011 044371]; National Science Center [UMO-2012/05/B/NZ4/02428, UMO-2011/01/D/NZ1/01169, UMO-2012/07/E/NZ6/01712]; European Union [POIG.02.01.00-12-064/08]	LIDER grant from the National Centre for Research and Development; Iuventus Plus grant from the Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); National Science Center(National Science Centre, Poland); European Union(European Commission)	This work was supported by the LIDER grant from the National Centre for Research and Development (Lider/27/55/L-2/10/2011) (KP) and Iuventus Plus grant from the Ministry of Science and Higher Education, Poland (IP 2010 033870 and IP2011 044371) (KP) and grants from the National Science Center (UMO-2012/05/B/NZ4/02428 (SKK), UMO-2011/01/D/NZ1/01169 (GD) and UMO-2012/07/E/NZ6/01712 (KP)). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08 - "Molecular biotechnology for health"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J D, 1967, J Gen Virol, V1, P175, DOI 10.1099/0022-1317-1-2-175; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cabeca TK, 2012, J CLIN VIROL, V53, P82, DOI 10.1016/j.jcv.2011.09.006; Cabeca TK, 2013, INFLUENZA OTHER RESP; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Chen HY, 2005, J VIROL, V79, P1164, DOI 10.1128/JVI.79.2.1164-1179.2005; DAVIES HA, 1981, J GEN VIROL, V53, P67, DOI 10.1099/0022-1317-53-1-67; Dijkman R, 2012, J GEN VIROL, V93, P1924, DOI 10.1099/vir.0.043919-0; Dijkman R, 2012, J CLIN VIROL, V53, P135, DOI 10.1016/j.jcv.2011.11.011; Dijkman R, 2009, J FORMOS MED ASSOC, V108, P270, DOI 10.1016/S0929-6646(09)60066-8; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan H, 2005, STRUCTURE, V13, P1859, DOI 10.1016/j.str.2005.08.021; Fields BN, 2013, FIELDS VIROLOGY, DOI [10.1016/j.jfo.2013.06.003, DOI 10.1016/J.JFO.2013.06.003]; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Golda A, 2011, J GEN VIROL, V92, P1358, DOI 10.1099/vir.0.028381-0; Grossoehme NE, 2009, J MOL BIOL, V394, P544, DOI 10.1016/j.jmb.2009.09.040; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Harrison SM, 2007, FEBS LETT, V581, P1275, DOI 10.1016/j.febslet.2007.02.039; HISCOX JA, 1995, VIRUS RES, V36, P119, DOI 10.1016/0168-1702(94)00108-O; Hiscox JA, 2001, J VIROL, V75, P506, DOI 10.1128/JVI.75.1.506-512.2001; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hon KL, 2012, HONG KONG MED J, V18, P60; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06; Jevsnik M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-365; Kedracka-Krok S, 2003, EUR J BIOCHEM, V270, P4564, DOI 10.1046/j.1432-1033.2003.03856.x; KENNEDY DA, 1976, INTERVIROLOGY, V6, P197; King A. M. Q, 2012, VIRUS TAXONOMY; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lo YS, 2013, FEBS LETT, V587, P120, DOI 10.1016/j.febslet.2012.11.016; Lu XL, 2011, VIRUS GENES, V42, P37, DOI 10.1007/s11262-010-0544-x; MACNAUGHTON MR, 1978, J GEN VIROL, V39, P545, DOI 10.1099/0022-1317-39-3-545; Mateos-Gomez PA, 2011, J VIROL, V85, P8968, DOI 10.1128/JVI.00869-11; MCINTOSH K, 1967, P NATL ACAD SCI USA, V58, P2268, DOI 10.1073/pnas.58.6.2268; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Narayanan K, 2003, VIRUS RES, V98, P131, DOI 10.1016/j.virusres.2003.08.021; Nelson GW, 2000, J GEN VIROL, V81, P181, DOI 10.1099/0022-1317-81-1-181; Oh Jin Sik, 2003, J Vet Sci, V4, P269; Oosterhof L, 2010, BONE MARROW TRANSPL, V45, P1115, DOI 10.1038/bmt.2009.292; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peitsch M C, 2000, Pharmacogenomics, V1, P257, DOI 10.1517/14622416.1.3.257; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Pyrc K., 2005, RECENT RES DEV INFEC, P25, DOI DOI 10.1016/J.TIG.2014.12.005; Pyrc K, 2007, EXPERT REV ANTI-INFE, V5, P245, DOI 10.1586/14787210.5.2.245; Pyrc K, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-7; Pyrc Krzysztof, 2008, V454, P73, DOI 10.1007/978-1-59745-181-9_7; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reed ML, 2007, J VIROL, V81, P4298, DOI 10.1128/JVI.02239-06; Rowland RRR, 2005, J VIROL, V79, P11507, DOI 10.1128/JVI.79.17.11507-11512.2005; Saikatendu KS, 2007, J VIROL, V81, P3913, DOI 10.1128/JVI.02236-06; Sanchez-Ruiz J M, 1995, Subcell Biochem, V24, P133; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Sheval EV, 2005, EUR J HISTOCHEM, V49, P117; STOHLMAN SA, 1988, J VIROL, V62, P4288, DOI 10.1128/JVI.62.11.4288-4295.1988; Sung JY, 2010, PEDIATR INFECT DIS J, V29, P822, DOI [10.1097/INF.0b013e3181e7c18d, 10.1097/INF.0b013e3181de9c2e]; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Surjit M, 2004, BIOCHEM J, V383, P13, DOI 10.1042/BJ20040984; Takeda M, 2008, J MOL BIOL, V380, P608, DOI 10.1016/j.jmb.2007.11.093; Tang TK, 2005, PROTEOMICS, V5, P925, DOI 10.1002/pmic.200401204; Timani KA, 2005, VIRUS RES, V114, P23, DOI 10.1016/j.virusres.2005.05.007; Tresnan DB, 1996, J VIROL, V70, P8669, DOI 10.1128/JVI.70.12.8669-8674.1996; TYRRELL DAJ, 1965, BMJ-BRIT MED J, V1, P1467, DOI 10.1136/bmj.1.5448.1467; van der Hoek L, 2005, PLOS MED, V2, P764, DOI 10.1371/journal.pmed.0020240; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Wang YL, 2004, BIOCHEMISTRY-US, V43, P11103, DOI 10.1021/bi049194b; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Wu PS, 2008, EUR J PEDIATR, V167, P75, DOI 10.1007/s00431-007-0429-8; Wurm T, 2001, J VIROL, V75, P9345, DOI 10.1128/JVI.75.19.9345-9356.2001; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; You JH, 2007, BIOCHEM BIOPH RES CO, V358, P1015, DOI 10.1016/j.bbrc.2007.05.036; You JW, 2005, J GEN VIROL, V86, P3303, DOI 10.1099/vir.0.81076-0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao G, 2006, CELL BIOL TOXICOL, V22, P313, DOI 10.1007/s10565-006-0077-1; Zhou B, 2008, J VIROL, V82, P6962, DOI 10.1128/JVI.00133-08; Zuniga S, 2007, VIROLOGY, V357, P215, DOI 10.1016/j.virol.2006.07.046; Zuniga S, 2010, J VIROL, V84, P2169, DOI 10.1128/JVI.02011-09	82	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117833	10.1371/journal.pone.0117833	http://dx.doi.org/10.1371/journal.pone.0117833			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700263	gold, Green Submitted, Green Published			2022-12-27	WOS:000349789800029
J	Bessonov, N; Levin, M; Morozova, N; Reinberg, N; Tosenberger, A; Volpert, V				Bessonov, Nikolai; Levin, Michael; Morozova, Nadya; Reinberg, Natalia; Tosenberger, Alen; Volpert, Vitaly			On a Model of Pattern Regeneration Based on Cell Memory	PLOS ONE			English	Article							MORPHOGENETIC FIELDS; ORGANIZATION; BEHAVIOR	We present here a new model of the cellular dynamics that enable regeneration of complex biological morphologies. Biological cell structures are considered as an ensemble of mathematical points on the plane. Each cell produces a signal which propagates in space and is received by other cells. The total signal received by each cell forms a signal distribution defined on the cell structure. This distribution characterizes the geometry of the cell structure. If a part of this structure is removed, the remaining cells have two signals. They keep the value of the signal which they had before the amputation (memory), and they receive a new signal produced after the amputation. Regeneration of the cell structure is stimulated by the difference between the old and the new signals. It is stopped when the two signals coincide. The algorithm of regeneration contains certain rules which are essential for its functioning, being the first quantitative model of cellular memory that implements regeneration of complex patterns to a specific target morphology. Correct regeneration depends on the form and the size of the cell structure, as well as on some parameters of regeneration.	[Bessonov, Nikolai; Reinberg, Natalia] Russian Acad Sci, Inst Problems Mech Engn, St Petersburg 199178, Russia; [Levin, Michael] Tufts Univ, Tufts Ctr Regenerat Dev Biol, Dept Biol, Medford, MA 02155 USA; [Morozova, Nadya] CEA, CNRS, Lab Epigenet & Canc, FRE 3377, F-91191 Saclay, France; [Morozova, Nadya; Tosenberger, Alen] Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France; [Volpert, Vitaly] Univ Lyon 1, CNRS, Inst Camille Jordan, UMR 5208, F-69622 Villeurbanne, France	Russian Academy of Sciences; Tufts University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet	Volpert, V (corresponding author), Univ Lyon 1, CNRS, Inst Camille Jordan, UMR 5208, F-69622 Villeurbanne, France.	volpert@math.univ-lyon1.fr	Levin, Michael/A-5918-2011; Volpert, Vitaly/E-2969-2019; Reinberg, Natalia/D-6201-2016	Levin, Michael/0000-0001-7292-8084; Reinberg, Natalia/0000-0002-9475-0632; Tosenberger, Alen/0000-0002-9255-7177	National Institutes of Health, NIH [R03 HD81401-01, 1R01HD081326-01]; G. Harold and Leila Y. Mathers Charitable Foundation; NSF [CDI EF-1124651]; Keck foundation; Agence National de la Recherch [ANR-2010-BLAN-0107-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081326, R03HD081401] Funding Source: NIH RePORTER	National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NSF(National Science Foundation (NSF)); Keck foundation(W.M. Keck Foundation); Agence National de la Recherch(French National Research Agency (ANR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	ML was supported by the National Institutes of Health, NIH R03 HD81401-01, 1R01HD081326-01; The G. Harold and Leila Y. Mathers Charitable Foundation; NSF CDI EF-1124651; W.M. Keck foundation. VV was supported by Agence National de la Recherch, ANR-2010-BLAN-0107-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applewhite P.B., 1975, Advances behav Biol, V13, P131; Astor JC, 2000, ARTIF LIFE, V6, P189, DOI 10.1162/106454600568834; Baddour JA, 2012, BIRTH DEFECTS RES C, V96, P1, DOI 10.1002/bdrc.21006; Badugu A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00991; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; BELINTSEV BN, 1987, J THEOR BIOL, V129, P369, DOI 10.1016/S0022-5193(87)80019-X; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Casadesus J, 2002, BIOESSAYS, V24, P512, DOI 10.1002/bies.10102; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Deutsch A, 2005, CELLULAR AUTOMATON M; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; Eisenstein E. M., 1975, ANEURAL ORGANISMS NE; Hamilton T.C., 1975, Advances behav Biol, V13, P111; Hampton AN, 2004, Artificial Life IX, P438; Kragl M, 2008, COLD SH Q B, V73, P583, DOI 10.1101/sqb.2008.73.034; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kusch I, 1996, J THEOR BIOL, V178, P333, DOI 10.1006/jtbi.1996.0029; Levin M, 2014, J PHYSL, V592, DOI [10.1113/jphysiol.2014, DOI 10.1113/JPHYSIOL.2014]; Levin M, 2012, BIOSYSTEMS, V109, P243, DOI 10.1016/j.biosystems.2012.04.005; Levin M, 2012, ANNU REV BIOMED ENG, V14, P295, DOI [10.1146/annurev-bioeng-071811-150114, 10.1146/annurev.bioeng-071811-150114]; Levin M, 2011, REGEN MED, V6, P667, DOI [10.2217/RME.11.69, 10.2217/rme.11.69]; Maden Malcolm, 2008, V461, P467, DOI 10.1007/978-1-60327-483-8_32; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Nakagaki T, 2001, RES MICROBIOL, V152, P767, DOI 10.1016/S0923-2508(01)01259-1; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; Rauch EM, 2004, J THEOR BIOL, V226, P401, DOI 10.1016/j.jtbi.2003.09.018; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Schiffmann Y, 2007, PROG BIOPHYS MOL BIO, V95, P50, DOI 10.1016/j.pbiomolbio.2007.03.001; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Vandenberg LN, 2012, DEV DYNAM, V241, P863, DOI 10.1002/dvdy.23770	30	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118091	10.1371/journal.pone.0118091	http://dx.doi.org/10.1371/journal.pone.0118091			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695252	Green Submitted, Green Published, gold			2022-12-27	WOS:000350062300041
J	Beurskens, R; Gollhofer, A; Muehlbauer, T; Cardinale, M; Granacher, U				Beurskens, Rainer; Gollhofer, Albert; Muehlbauer, Thomas; Cardinale, Marco; Granacher, Urs			Effects of Heavy-Resistance Strength and Balance Training on Unilateral and Bilateral Leg Strength Performance in Old Adults	PLOS ONE			English	Article							SKELETAL-MUSCLE; DEFICIT; YOUNG; CONTRACTIONS; ADAPTATIONS; TASK; EXPRESSIONS; INHIBITION; ACTIVATION; IMPACT	The term "bilateral deficit" (BLD) has been used to describe a reduction in performance during bilateral contractions when compared to the sum of identical unilateral contractions. In old age, maximal isometric force production (MIF) decreases and BLD increases indicating the need for training interventions to mitigate this impact in seniors. In a cross-sectional approach, we examined age-related differences in MIF and BLD in young (age: 20-30 years) and old adults (age: > 65 years). In addition, a randomized-controlled trial was conducted to investigate training-specific effects of resistance vs. balance training on MIF and BLD of the leg extensors in old adults. Subjects were randomly assigned to resistance training (n = 19), balance training (n = 14), or a control group (n = 20). Bilateral heavy-resistance training for the lower extremities was performed for 13 weeks (3 x /week) at 80% of the one repetition maximum. Balance training was conducted using predominately unilateral exercises on wobble boards, soft mats, and uneven surfaces for the same duration. Pre-and post-tests included uni-and bilateral measurements of maximal isometric leg extension force. At baseline, young subjects outperformed older adults in uni-and bilateral MIF (all p < .001; d = 2.61-3.37) and in measures of BLD (p < .001; d = 2.04). We also found significant increases in uni-and bilateral MIF after resistance training (all p < .001, d = 1.8-5.7) and balance training (all p < .05, d = 1.3-3.2). In addition, BLD decreased following resistance (p < .001, d = 3.4) and balance training (p < .001, d = 2.6). It can be concluded that both training regimens resulted in increased MIF and decreased BLD of the leg extensors (HRT-group more than BAL-group), almost reaching the levels of young adults.	[Beurskens, Rainer; Muehlbauer, Thomas; Granacher, Urs] Univ Potsdam, Div Training & Movement Sci, Potsdam, Germany; [Gollhofer, Albert] Univ Freiburg, Inst Sport & Sport Sci, D-79106 Freiburg, Germany; [Cardinale, Marco] ASPIRE Acad Sports Excellence, Doha, Qatar; [Cardinale, Marco] UCL, Inst Sports Exercise & Hlth, London, England	University of Potsdam; University of Freiburg; Aspire Academy for Sports Excellence; University of London; University College London	Beurskens, R (corresponding author), Univ Potsdam, Div Training & Movement Sci, Potsdam, Germany.	rainer.beurskens@uni-potsdam.de	Cardinale, Marco/N-3138-2019; Granacher, Urs/T-9900-2017; Granacher, Urs/N-1963-2019; Albert, Gollhofer/V-3291-2019; Granacher, Urs/GXM-3858-2022; Gollhofer, Albert/ABF-5766-2020	Cardinale, Marco/0000-0002-2777-8707; Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Beurskens, Rainer/0000-0002-4512-4491				Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P49, DOI 10.1111/j.1600-0838.2009.01084.x; Aune TK, 2013, HUM MOVEMENT SCI, V32, P436, DOI 10.1016/j.humov.2013.01.005; Beck S, 2007, BRAIN RES, V1179, P51, DOI 10.1016/j.brainres.2007.08.048; Bobbert MF, 2006, J APPL PHYSIOL, V100, P493, DOI 10.1152/japplphysiol.00637.2005; Christie A, 2014, AGE, V36, P749, DOI 10.1007/s11357-013-9577-0; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Frey I., 2002, EUR J SPORT SCI, V2, P1, DOI [DOI 10.1080/17461390200072406, 10.1080/17461390200072406]; FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Granacher U, 2007, DEUT Z SPORTMED, V58, P446; Granacher U, 2009, INT J SPORTS MED, V30, P652, DOI 10.1055/s-0029-1224178; Granacher U, 2010, STRENGTH COND, P399; Granacher U, 2011, SPORTS MED, V41, P377, DOI 10.2165/11539920-000000000-00000; Granacher U, 2010, AGING CLIN EXP RES, V22, P374, DOI [10.1007/BF03337733, 10.3275/6706]; Gruber M, 2004, EUR J APPL PHYSIOL, V92, P98, DOI 10.1007/s00421-004-1080-y; Gusi N, 2012, J PHYSIOTHER, V58, P97, DOI 10.1016/S1836-9553(12)70089-9; Haekkinen K, 2003, STRENGTH POWER SPORT, P409; Hakkinen K, 1997, Electromyogr Clin Neurophysiol, V37, P131; Hawley JA, 2002, CLIN EXP PHARMACOL P, V29, P218, DOI 10.1046/j.1440-1681.2002.03623.x; Hernandez JP, 2003, J GERONTOL A-BIOL, V58, P536; Hortobagyi T, 2003, J GERONTOL A-BIOL, V58, P453; HOWARD JD, 1991, J APPL PHYSIOL, V70, P306, DOI 10.1152/jappl.1991.70.1.306; Jakobi JM, 2001, CAN J APPL PHYSIOL, V26, P12, DOI 10.1139/h01-002; Janzen CL, 2006, EUR J APPL PHYSIOL, V97, P253, DOI 10.1007/s00421-006-0165-1; Kuruganti U, 2008, EUR J APPL PHYSIOL, V102, P721, DOI 10.1007/s00421-007-0651-0; Kuruganti U, 2006, EUR J APPL PHYSIOL, V97, P322, DOI 10.1007/s00421-006-0188-7; Latham NK, 2004, J GERONTOL A-BIOL, V59, P48; Lesinski M, 2014, SPORTS MED; Macaluso A, 2002, MUSCLE NERVE, V25, P858, DOI 10.1002/mus.10113; Magnus CRA, 2008, APPL PHYSIOL NUTR ME, V33, P1132, DOI 10.1139/H08-101; Narici MV, 2003, J APPL PHYSIOL, V95, P2229, DOI 10.1152/japplphysiol.00433.2003; Noble JW, 2014, EXP BRAIN RES, V232, P2785, DOI 10.1007/s00221-014-3963-4; Oda S, 1997, JPN J PHYSIOL, V47, P487, DOI 10.2170/jjphysiol.47.487; OHTSUKI T, 1983, BEHAV BRAIN RES, V7, P165, DOI 10.1016/0166-4328(83)90190-0; Owings TM, 1998, J GERONTOL A-BIOL, V53, pB425, DOI 10.1093/gerona/53A.6.B425; Post M, 2007, NEUROIMAGE, V35, P16, DOI 10.1016/j.neuroimage.2006.11.050; Puttemans V, 2005, J NEUROSCI, V25, P4270, DOI 10.1523/JNEUROSCI.3866-04.2005; Rejc E, 2010, EUR J APPL PHYSIOL, V108, P157, DOI 10.1007/s00421-009-1199-y; Schubert M, 2008, EUR J NEUROSCI, V27, P2007, DOI 10.1111/j.1460-9568.2008.06186.x; Seguin R, 2003, AM J PREV MED, V25, P141, DOI 10.1016/S0749-3797(03)00177-6; Taniguchi Y, 1998, EUR J APPL PHYSIOL O, V78, P226, DOI 10.1007/s004210050411; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; Taube W, 2012, DEUT Z SPORTMED, V63, P273, DOI 10.5960/dzsm.2012.030; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Vieluf S, 2013, EXP BRAIN RES, V231, P107, DOI 10.1007/s00221-013-3673-3; Yamauchi J, 2009, J BIOMECH, V42, P2151, DOI 10.1016/j.jbiomech.2009.05.032	48	19	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118535	10.1371/journal.pone.0118535	http://dx.doi.org/10.1371/journal.pone.0118535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695770	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300055
J	Jiang, Z; Li, C; Manuel, ML; Yuan, S; Kevil, CG; McCarter, KD; Lu, W; Sun, H				Jiang, Zheng; Li, Chun; Manuel, Morganne L.; Yuan, Shuai; Kevil, Christopher G.; McCarter, Kimberly D.; Lu, Wei; Sun, Hong			Role of Hydrogen Sulfide in Early Blood-Brain Barrier Disruption following Transient Focal Cerebral Ischemia	PLOS ONE			English	Article							NITRIC-OXIDE; SIGNALING MOLECULE; SYNTHASE CBS; H2S; VASORELAXANT; RELAXATION; INHIBITORS; PROTECTS; STROKE; INJURY	We determined the role of endogenous hydrogen sulfide (H2S) in cerebral vasodilation/hyperemia and early BBB disruption following ischemic stroke. A cranial window was prepared over the left frontal, parietal and temporal cortex in mice. Transient focal cerebral Ischemia was induced by directly ligating the middle cerebral artery (MCA) for two hours. Regional vascular response and cerebral blood flow (CBF) during ischemia and reperfusion were measured in real time. Early BBB disruption was assessed by Evans Blue (EB) and sodium fluorescein (Na-F) extravasation at 3 hours of reperfusion. Topical treatment with DL-pro-pargylglycine (PAG, an inhibitor for cystathionine. gamma-lyase (CSE)) and aspartate (ASP, inhibitor for cysteine aminotransferase/3-mercaptopyruvate sulfurtransferase (CAT/3-MST)), but not O-(Carboxymethyl) hydroxylamine hemihydrochloride (CHH, an inhibitor for cystathionine beta-synthase (CBS)), abolished postischemic cerebral vasodilation/hyperemia and prevented EB and Na-F extravasation. CSE knockout (CSE-/-) reduced postischemic cerebral vasodilation/hyperemia but only inhibited Na-F extravasation. An upregulated CBS was found in cerebral cortex of CSE-/- mice. Topical treatment with CHH didn't further alter postischemic cerebral vasodilation/hyperemia, but prevented EB extravasation in CSE-/- mice. In addition, L-cysteine-induced hydrogen sulfide (H2S) production similarly increased in ischemic side cerebral cortex of control and CSE-/- mice. Our findings suggest that endogenous production of H2S by CSE and CAT/3-MST during reperfusion may be involved in postischemic cerebral vasodilation/hyperemia and play an important role in early BBB disruption following transient focal cerebral ischemia.	[Jiang, Zheng; Li, Chun; Manuel, Morganne L.; Yuan, Shuai; McCarter, Kimberly D.; Lu, Wei; Sun, Hong] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Kevil, Christopher G.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Pathol, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Sun, H (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA.	hsun1@lsuhsc.edu	Yuan, Shuai/AAU-3108-2020; Yuan, Shuai/N-9282-2018	Yuan, Shuai/0000-0002-9590-6555; Yuan, Shuai/0000-0002-9590-6555; Kevil, Christopher/0000-0003-0863-7260	National Institutes of Health [HL113303]; Louisiana State University Health Sciences Center-Shreveport; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University Health Sciences Center-Shreveport; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a National Institutes of Health Grant (HL113303) to CGK, and by start-up funds from Louisiana State University Health Sciences Center-Shreveport to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bleilevens C, 2013, EXP BRAIN RES, V224, P155, DOI 10.1007/s00221-012-3296-0; Bucci M, 2009, EUR UROL, V56, P378, DOI 10.1016/j.eururo.2008.05.014; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Chitnis MK, 2013, EXP EYE RES, V116, P350, DOI 10.1016/j.exer.2013.10.004; Desilles JP, 2013, NEUROLOGY, V80, P844, DOI 10.1212/WNL.0b013e31828406de; Dufton N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00499; Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817; Gheibi S, 2014, J MOL NEUROSCIENCE M; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jiang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093134; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Liu X, 2010, NEUROL SCI, V31, P699, DOI 10.1007/s10072-010-0241-5; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Madden JA, 2012, J APPL PHYSIOL, V112, P411, DOI 10.1152/japplphysiol.01049.2011; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Perez-Asensio FJ, 2010, J CEREBR BLOOD F MET, V30, P638, DOI 10.1038/jcbfm.2009.237; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shibuya N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2371; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; TOMINAGA T, 1994, J CEREBR BLOOD F MET, V14, P715, DOI 10.1038/jcbfm.1994.92; Wang Y, 2014, J NEUROCHEMISTRY; Wang YF, 2008, CHINESE MED J-PEKING, V121, P420, DOI 10.1097/00029330-200803010-00010; Wong PTH, 2006, J NEUROPATH EXP NEUR, V65, P109, DOI 10.1097/01.jnen.0000199571.96472.c7; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Zhao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067322; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	39	35	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117982	10.1371/journal.pone.0117982	http://dx.doi.org/10.1371/journal.pone.0117982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695633	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300036
J	Tjelele, J; Ward, D; Dziba, L				Tjelele, Julius; Ward, David; Dziba, Luthando			The Effects of Seed Ingestion by Livestock, Dung Fertilization, Trampling, Grass Competition and Fire on Seedling Establishment of Two Woody Plant Species	PLOS ONE			English	Article							LARGE MAMMALIAN HERBIVORES; BUSH ENCROACHMENT; BRUCHID BEETLES; AFRICAN SAVANNA; ACACIA; TREE; RECRUITMENT; GERMINATION; DYNAMICS; GROWTH	The increasing rate of woody plant encroachment in grasslands or savannas remains a challenge to livestock farmers. The causes and control measures of woody plant encroachment are of common interest, especially where it negatively affects the objectives of an agricultural enterprise. The objectives of this study were to determine the effects of gut passage (goats, cattle), dung (nutrients), fire, grass competition and trampling on establishment of A. nilotica and D. cinerea seedlings. Germination trials were subjected to the following treatments: 1) seed passage through the gut of cattle and goats and unpassed/untreated seeds (i.e. not ingested), 2) dung and control (no dung), 3) grass and control (mowed grass), 4) fire and control (no fire), 5) trampling and control (no trampling). The interaction of animal species, grass and fire had an effect on seedling recruitment (P < 0.0052). Seeds retrieved from goats and planted with no grass and with fire (6.81% +/- 0.33) had a significant effect on seedling recruitment than seeds retrieved from goats and planted with grass and no fire (2.98% +/- 0.33). Significantly more D. cinerea and A. nilotica seeds germinated following seed ingestion by goats (3.59% +/- 0.16) than cattle (1.93% +/- 0.09) and control or untreated seeds (1.69% +/- 0.11). Less dense grass cover, which resulted in reduced grass competition with tree seedlings for light, space and water, and improved seed scarification due to gut passage were vital for emergence and recruitment of Acacia seedlings. These results will contribute considerably to the understanding of the recruitment phase of woody plant encroachment.	[Tjelele, Julius] Agr Res Council, Anim Prod Inst, ZA-0062 Irene, South Africa; [Tjelele, Julius; Ward, David] Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Life Sci, ZA-3209 Scottsville, South Africa; [Dziba, Luthando] CSIR Nat Resources & Environm, ZA-0001 Pretoria, South Africa	Agricultural Research Council of South Africa; Animal Production Research Institute, Agricultural Research Council; University of Kwazulu Natal; Council for Scientific & Industrial Research (CSIR) - South Africa	Tjelele, J (corresponding author), Agr Res Council, Anim Prod Inst, ZA-0062 Irene, South Africa.	jtjelele@arc.agric.za		Dziba, Luthando/0000-0001-6974-5578	International Foundation for Science [D/5131-1]; National Research Foundation [80709]	International Foundation for Science(International Foundation for Science); National Research Foundation	This work was supported by International Foundation for Science, Grant No. D/5131-1 (www.ifs.seTJ), and National Research Foundation, Grant No. 80709 (http://www.nrf.ac.za/TJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodmer Richard, 2006, Conservation Biology Series (Cambridge), V11, P232; Brown J, 2010, APPL SOIL ECOL, V46, P9, DOI 10.1016/j.apsoil.2010.05.010; BROWN JR, 1988, VEGETATIO, V73, P73, DOI 10.1007/BF00031854; BROWN N. A. C, 1967, S AFR J AGR SCI, V10, P659; BUSH JK, 1995, ECOLOGY, V76, P1603, DOI 10.2307/1938161; Campbell ML, 2006, AUSTRAL ECOL, V31, P1016, DOI 10.1111/j.1442-9993.2006.01660.x; COE M, 1987, S AFR J SCI, V83, P624; COFFIN DP, 1990, ECOL MODEL, V49, P229, DOI 10.1016/0304-3800(90)90029-G; COUGHENOUR MB, 1986, AFR J ECOL, V24, P203, DOI 10.1111/j.1365-2028.1986.tb00363.x; Cramer MD, 2007, J ECOL, V95, P1123, DOI 10.1111/j.1365-2745.2007.01285.x; Danell K, 2003, FOREST ECOL MANAG, V181, P67, DOI 10.1016/S0378-1127(03)00116-6; DINERSTEIN E, 1988, ECOLOGY, V69, P1768, DOI 10.2307/1941155; Frost PGH, 1986, BIOL INT SPEC ISSUE, V10, P1; GARDENER CJ, 1993, J APPL ECOL, V30, P63, DOI 10.2307/2404271; GIFFORD GF, 1983, J RANGE MANAGE, V36, P152, DOI 10.2307/3898150; Goheen JR, 2010, J ANIM ECOL, V79, P372, DOI 10.1111/j.1365-2656.2009.01644.x; Grellier S, 2012, PLANT ECOL, V213, P899, DOI 10.1007/s11258-012-0051-3; Henery ML, 2001, OIKOS, V92, P479, DOI 10.1034/j.1600-0706.2001.920309.x; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; Hoffman T., 2001, NATURE DIVIDED LAND; James JJ, 2011, J APPL ECOL, V48, P961, DOI 10.1111/j.1365-2664.2011.02009.x; JANZEN DH, 1984, AM NAT, V123, P338, DOI 10.1086/284208; Jeltsch F, 1996, J ECOL, V84, P583, DOI 10.2307/2261480; Kambatuku JR, 2011, J VEG SCI, V22, P225, DOI 10.1111/j.1654-1103.2010.01239.x; Kgosikoma O. E., 2012, African Journal of Agricultural Research, V7, P2312; KNOOP WT, 1985, J ECOL, V73, P235, DOI 10.2307/2259780; Kraaij T, 2006, PLANT ECOL, V186, P235, DOI 10.1007/s11258-006-9125-4; Kumbasli M, 2010, J ENVIRON BIOL, V31, P185; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; Little TM, 1972, STAT METHODS AGR RES; Maclean JE, 2011, ECOLOGY, V92, P1626, DOI 10.1890/10-2097.1; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Meyer SE, 2005, PLANT ECOL, V178, P171, DOI 10.1007/s11258-004-3038-x; MILLER MF, 1995, AFR J ECOL, V33, P194, DOI 10.1111/j.1365-2028.1995.tb00797.x; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Moles AT, 2002, OIKOS, V99, P241, DOI 10.1034/j.1600-0706.2002.990204.x; Mucina L., 2006, VEGETATION S AFRICA; OCONNOR TG, 1995, OECOLOGIA, V103, P214, DOI 10.1007/BF00329083; Or K, 2007, ENTOMOL EXP APPL, V122, P165, DOI 10.1111/j.1570-7458.2006.00509.x; Or K, 2003, AFR J ECOL, V41, P257, DOI 10.1046/j.1365-2028.2003.00451.x; Rodriguez-Perez J, 2011, OECOLOGIA, V167, P97, DOI 10.1007/s00442-011-1964-6; Rohner C, 1999, CONSERV BIOL, V13, P1162, DOI 10.1046/j.1523-1739.1999.97300.x; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; SAS Institute, 2002, SAS STAT US GUID VER, VSixth; SCHUPP EW, 1995, ECOSCIENCE, V2, P267, DOI 10.1080/11956860.1995.11682293; Schwinning S, 2002, OECOLOGIA, V130, P345, DOI 10.1007/s00442-001-0817-0; Seabloom EW, 2003, ECOL APPL, V13, P575, DOI 10.1890/1051-0761(2003)013[0575:CSLDAR]2.0.CO;2; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sharam G, 2006, BIOTROPICA, V38, P599, DOI 10.1111/j.1744-7429.2006.00195.x; SNEDECOR G W, 1980; Tjelele J, 2014, RANGELAND ECOL MANAG, V67, P423, DOI 10.2111/REM-D-13-00115.1; Tjelele JT, 2012, RANGELAND ECOL MANAG, V65, P105, DOI 10.2111/REM-D-09-00161.1; Traveset A, 2001, PLANT ECOL, V155, P29, DOI 10.1023/A:1013282313035; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; VALENTIN C, 1992, GEODERMA, V55, P225, DOI 10.1016/0016-7061(92)90085-L; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; WALTER HEINRICH, 1939, JAHRB WISS BOT, V87, P750; Ward D., 2005, African Journal of Range & Forage Science, V22, P101, DOI 10.2989/10220110509485867; Ward D, 2013, S AFR J BOT, V86, P141, DOI [10.1016/j.sajb.2013.02.016, 10.1007/s00442-012-2538-y]; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Wiegand K, 2006, PERSPECT PLANT ECOL, V7, P229, DOI 10.1016/j.ppees.2005.10.001; Wiegand K, 2005, J VEG SCI, V16, P311, DOI 10.1111/j.1654-1103.2005.tb02369.x; Wigley BJ, 2009, AFR J ECOL, V47, P62, DOI 10.1111/j.1365-2028.2008.01051.x; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Wilson TB, 1998, J ARID ENVIRON, V38, P541, DOI 10.1006/jare.1998.0362	66	20	21	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117788	10.1371/journal.pone.0117788	http://dx.doi.org/10.1371/journal.pone.0117788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695765	gold, Green Published, Green Submitted			2022-12-27	WOS:000350062300030
J	Han, SB; Yang, HK; Kim, J; Hong, K; Lee, B; Hwang, JM				Han, Sang Beom; Yang, Hee Kyung; Kim, Jonghyun; Hong, Keehoon; Lee, Byoungho; Hwang, Jeong-Min			New Stereoacuity Test Using a 3-Dimensional Display System in Children	PLOS ONE			English	Article							RANDOM-DOT STEREOTEST; RETINAL ILLUMINANCE; FIXATION DISPARITY; SPATIAL-FREQUENCY; STEREOPSIS; ACCOMMODATION; STIMULI	The previously developed 3-dimensional (3D) display stereoacuity tests were validated only at distance. We developed a new stereoacuity test using a 3D display that works both at near and distance and evaluated its validity in children with and without strabismus. Sixty children (age range, 6 to 18 years) with variable ranges of stereoacuity were included. Sideby- side randot images of 4 different simple objects (star, circle, rectangle, and triangle) with a wide range of crossed horizontal disparities (3000 to 20 arcsec) were randomly displayed on a 3D monitor with MATLAB (Matworks, Inc., Natick, MA, USA) and were presented to subjects wearing shutter glasses at 0.5 m and 3 m. The 3D image was located in front of (conventional) or behind (proposed) the background image on the 3D monitor. The results with the new 3D stereotest (conventional and proposed) were compared with those of the near and distance Randot stereotests. At near, the Bland-Altman plots of the conventional and proposed 3D stereotest did not show significant difference, both of which were poorer than the Randot test. At distance, the results of the proposed 3D stereotest were similar to the Randot test, but the conventional 3D stereotest results were better than those of the other two tests. The results of the proposed 3D stereotest and Randot stereotest were identical in 83.3% at near and 88.3% at distance. More than 95% of subjects showed concordance within 2 grades between the 2 tests at both near and distance. In conclusion, the newly proposed 3D stereotest shows good concordance with the Randot stereotests in children with and without strabismus.	[Han, Sang Beom] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Grad Sch Med, Dept Ophthalmol, Chunchon, South Korea; [Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Seoul, South Korea; [Kim, Jonghyun; Hong, Keehoon; Lee, Byoungho] Seoul Natl Univ, Sch Elect Engn, Seoul, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, B (corresponding author), Seoul Natl Univ, Sch Elect Engn, Seoul, South Korea.	byoungho@snu.ac.kr; hjm@snu.ac.kr		hong, keehoon/0000-0001-7325-1036	Interdisciplinary Research Initiatives Program by College of Engineering and College of Medicine, Seoul National University	Interdisciplinary Research Initiatives Program by College of Engineering and College of Medicine, Seoul National University	This work was supported by the Interdisciplinary Research Initiatives Program by College of Engineering and College of Medicine, Seoul National University (2012). The funder partly had a role in the development of the new stereoacuity test using a 3-dimensional display system, but had no other role in data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WE, 2005, BRIT J OPHTHALMOL, V89, P1438, DOI 10.1136/bjo.2005.071761; Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; Breyer A, 2006, INVEST OPHTH VIS SCI, V47, P4842, DOI 10.1167/iovs.06-0238; Chang YH, 2006, GRAEF ARCH CLIN EXP, V244, P1083, DOI 10.1007/s00417-005-0196-z; Fawcett SL, 2005, J AAPOS, V9, P572, DOI 10.1016/j.jaapos.2005.06.006; Fujikado T, 1998, JPN J OPHTHALMOL, V42, P101, DOI 10.1016/S0021-5155(97)00120-2; Fujikado T, 1996, ERGONOMICS, V39, P1315, DOI 10.1080/00140139608964551; Howard IP, 1995, BINOCULAR VISION STE; Jainta S, 2009, OPHTHAL PHYSL OPT, V29, P162, DOI 10.1111/j.1475-1313.2008.00624.x; Jaschinski W, 2001, VISION RES, V41, P923, DOI 10.1016/S0042-6989(00)00322-9; Kim J, J DISP TECH; Kim J, 2011, AM J OPHTHALMOL, V151, P1081, DOI 10.1016/j.ajo.2010.09.034; Kriegbaum-Stehberger B, 2008, GRAEF ARCH CLIN EXP, V246, P1, DOI 10.1007/s00417-007-0632-3; LEGGE GE, 1989, VISION RES, V29, P989, DOI 10.1016/0042-6989(89)90114-4; Leske DA, 2006, AM J OPHTHALMOL, V142, P699, DOI 10.1016/j.ajo.2006.04.065; LOVASIK JV, 1985, INVEST OPHTH VIS SCI, V26, P741; Okada Y, 2006, VISION RES, V46, P475, DOI 10.1016/j.visres.2005.07.014; SCHMIDT PP, 1994, OPTOMETRY VISION SCI, V71, P466, DOI 10.1097/00006324-199407000-00007; SIDEROV J, 1995, VISION RES, V35, P2329, DOI 10.1016/0042-6989(94)00307-8; Suzuki D, 2009, 2009 SID INTERNATIONAL SYMPOSIUM DIGEST OF TECHNICAL PAPERS, VOL XL, BOOKS I - III, P428; Wang JY, 2010, J AAPOS, V14, P142, DOI 10.1016/j.jaapos.2009.12.159; Woods A., 2010, 3 DIM SYST APPL C TO; Zaroff CM, 2003, INVEST OPHTH VIS SCI, V44, P891, DOI 10.1167/iovs.02-0361	23	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116626	10.1371/journal.pone.0116626	http://dx.doi.org/10.1371/journal.pone.0116626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693034	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500021
J	Wang, B; Wei, XP; Dong, J; Zhang, Q				Wang, Bin; Wei, Xiaopeng; Dong, Jing; Zhang, Qiang			Improved Lower Bounds of DNA Tags Based on a Modified Genetic Algorithm	PLOS ONE			English	Article							BARCODED PRIMERS; DESIGN; PERFORMANCE; ACCURACY; QUALITY	The well-known massively parallel sequencing method is efficient and it can obtain sequence data from multiple individual samples. In order to ensure that sequencing, replication, and oligonucleotide synthesis errors do not result in tags (or barcodes) that are unrecoverable or confused, the tag sequences should be abundant and sufficiently different. Recently, many design methods have been proposed for correcting errors in data using error-correcting codes. The existing tag sets contain small tag sequences, so we used a modified genetic algorithm to improve the lower bound of the tag sets in this study. Compared with previous research, our algorithm is effective for designing sets of DNA tags. Moreover, the GC content determined by existing methods includes an imprecise range. Thus, we improved the GC content determination method to obtain tag sets that control the GC content in a more precise range. Finally, previous studies have only considered perfect self-complementarity. Thus, we considered the crossover between different tags and introduced an improved constraint into the design of tag sets.	[Wang, Bin; Wei, Xiaopeng; Dong, Jing; Zhang, Qiang] Dalian Univ, Lab Adv Design & Intelligent Comp, Minist Educ, Dalian 116622, Peoples R China	Dalian University	Zhang, Q (corresponding author), Dalian Univ, Lab Adv Design & Intelligent Comp, Minist Educ, Dalian 116622, Peoples R China.	zhangq@dlu.edu.cn	wang, bin/B-5533-2011	wang, bin/0000-0002-8800-000X; Zhang, Qiang/0000-0003-3776-9799	National Science Foundation for Distinguished Young Scholars of China [61425002]; National Natural Science Foundation of China [61402066, 61402067]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1109]; Program for Liaoning Innovative Research Team in University [LT2011018]; Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for Liaoning Innovative Research Team in University; Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University	This work is supported by the National Science Foundation for Distinguished Young Scholars of China (No. 61425002), the National Natural Science Foundation of China (Nos. 61402066, 61402067), the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1109), the Program for Liaoning Innovative Research Team in University (No. LT2011018) and by the Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashlock D, 2002, IEEE C EVOL COMPUTAT, P1296, DOI 10.1109/CEC.2002.1004430; Ashlock D, 2009, CIBCB: 2009 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P38; Brenneman A, 2002, THEOR COMPUT SCI, V287, P39, DOI 10.1016/S0304-3975(02)00135-4; Buschmann T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-272; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Chen DH, 1999, NUCLEIC ACIDS RES, V27, P389, DOI 10.1093/nar/27.2.389; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Costea PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057521; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; Eckert K A, 1991, PCR Methods Appl, V1, P17; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gilar M, 2001, ANAL BIOCHEM, V298, P196, DOI 10.1006/abio.2001.5386; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Krishnan AR, 2011, ELECTRON LETT, V47, P236, DOI 10.1049/el.2010.3546; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Mali P, 2013, NAT METHODS, V10, P403, DOI [10.1038/nmeth.2407, 10.1038/NMETH.2407]; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Mitchell Melanie, 1998, INTRO GENETIC ALGORI; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pon RT, 1996, BIOTECHNIQUES, V21, P680; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schober S, 2012, IEEE INT WORK GENOM, P31, DOI 10.1109/GENSIPS.2012.6507719; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Zhang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072180; Zhang Q, 2010, IEEE T NANOBIOSCI, V9, P273, DOI 10.1109/TNB.2010.2069570	34	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0110640	10.1371/journal.pone.0110640	http://dx.doi.org/10.1371/journal.pone.0110640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693135	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500001
J	Zhang, L; Boeren, S; Hageman, JA; van Hooijdonk, T; Vervoort, J; Hettinga, K				Zhang, Lina; Boeren, Sjef; Hageman, Jos A.; van Hooijdonk, Toon; Vervoort, Jacques; Hettinga, Kasper			Bovine Milk Proteome in the First 9 Days: Protein Interactions in Maturation of the Immune and Digestive System of the Newborn	PLOS ONE			English	Article							CARBOXYL ESTER LIPASE; MAMMARY-GLAND; WHEY PROTEOME; COWS MILK; COLOSTRUM; COMPONENTS; COMPLEMENT; CD59; GENE; QUANTIFICATION	In order to better understand the milk proteome and its changes from colostrum to mature milk, samples taken at seven time points in the first 9 days from 4 individual cows were analyzed using proteomic techniques. Both the similarity in changes from day 0 to day 9 in the quantitative milk proteome, and the differences in specific protein abundance, were observed among four cows. One third of the quantified proteins showed a significant decrease in concentration over the first 9 days after calving, especially in the immune proteins (as much as 40 fold). Three relative high abundant enzymes (XDH, LPL, and RNASE1) and cell division and proliferation protein (CREG1) may be involved in the maturation of the gastro-intestinal tract. In addition, high correlations between proteins involved in complement and blood coagulation cascades illustrates the complex nature of biological interrelationships between milk proteins. The linear decrease of protease inhibitors and proteins involved in innate and adaptive immune system implies a protective role for protease inhibitor against degradation. In conclusion, the results found in this study not only improve our understanding of the role of colostrum in both host defense and development of the newborn calf but also provides guidance for the improvement of infant formula through better understanding of the complex interactions between milk proteins.	[Zhang, Lina; van Hooijdonk, Toon; Hettinga, Kasper] Wageningen Univ, Dairy Sci & Technol Food Qual & Design Grp, NL-6700 AP Wageningen, Netherlands; [Boeren, Sjef; Vervoort, Jacques] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands; [Hageman, Jos A.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Hageman, Jos A.] Wageningen Univ, Ctr BioSyst Gen, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Centre for BioSystems Genomics; Wageningen University & Research	Hettinga, K (corresponding author), Wageningen Univ, Dairy Sci & Technol Food Qual & Design Grp, NL-6700 AP Wageningen, Netherlands.	kasper.hettinga@wur.nl	Hageman, Jos/N-1221-2015	Hageman, Jos/0000-0002-5868-587X				BARNARD EA, 1969, ANNU REV BIOCHEM, V38, P677, DOI 10.1146/annurev.bi.38.070169.003333; Bjorge L, 1996, AM J REPROD IMMUNOL, V35, P43, DOI 10.1111/j.1600-0897.1996.tb00007.x; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Brooks HJL, 2006, FEMS IMMUNOL MED MIC, V48, P347, DOI 10.1111/j.1574-695X.2006.00151.x; Chowanadisai W, 2002, AM J CLIN NUTR, V76, P828, DOI 10.1093/ajcn/76.4.828; Cortese VS, 2009, VET CLIN N AM-FOOD A, V25, P221, DOI 10.1016/j.cvfa.2008.10.003; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Farrell HM, 2004, J DAIRY SCI, V87, P1641, DOI 10.3168/jds.S0022-0302(04)73319-6; Fritz H, 1979, Ciba Found Symp, P351; Godlewski M M, 2005, J Physiol Pharmacol, V56 Suppl 3, P7; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P37; Hammon HM, 2013, J ANIM SCI, V91, P685, DOI 10.2527/jas.2012-5758; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hettinga K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019433; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Jackson RM, 1999, PROTEIN SCI, V8, P603; Jensen GS, 2012, PREV MED, V54, pS124, DOI 10.1016/j.ypmed.2012.01.004; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; LARSON BL, 1980, J DAIRY SCI, V63, P665, DOI 10.3168/jds.S0022-0302(80)82988-2; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Le A, 2011, J PROTEOME RES, V10, P692, DOI 10.1021/pr100884z; Levieux D, 1999, J DAIRY RES, V66, P421, DOI 10.1017/S0022029999003581; LIDMER AS, 1995, GENOMICS, V29, P115, DOI 10.1006/geno.1995.1221; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lonnerdal B, 2010, J PEDIATR-US, V156, pS26, DOI 10.1016/j.jpeds.2009.11.017; Lu J, 2011, J PROTEOMICS, V75, P34, DOI 10.1016/j.jprot.2011.07.031; Moore M, 2005, JAVMA-J AM VET MED A, V226, P1375, DOI 10.2460/javma.2005.226.1375; Nissen A, 2012, PROTEOMICS, V12, P2866, DOI 10.1002/pmic.201200231; Pareek Ravi, 2005, Journal of Applied Genetics, V46, P171; Piantoni P, 2010, BIOINFORM BIOL INSIG, V4, P85; Purup S, 2007, J DAIRY RES, V74, P58, DOI 10.1017/S0022029906002093; QUIGLEY JD, 1995, J DAIRY SCI, V78, P1573, DOI 10.3168/jds.S0022-0302(95)76780-7; Rogers ML, 1996, J ENDOCRINOL, V151, P77, DOI 10.1677/joe.0.1510077; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Sacher M, 2005, P NATL ACAD SCI USA, V102, P18326, DOI 10.1073/pnas.0505071102; Sanderson-Smith ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/272148; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Senda A, 2011, ANIM SCI J, V82, P698, DOI 10.1111/j.1740-0929.2011.00886.x; Smolenski G, 2007, J PROTEOME RES, V6, P207, DOI 10.1021/pr0603405; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Ward RE, 2004, J NUTR, V134, p962S, DOI 10.1093/jn/134.4.962S; Wheeler TT, 2012, ANIMAL, V6, P415, DOI 10.1017/S1751731111002151; Wheeler TT, 2007, J MAMMARY GLAND BIOL, V12, P237, DOI 10.1007/s10911-007-9051-7; Yang YX, 2015, J SCI FOOD AGR, V95, P592, DOI 10.1002/jsfa.6791; Zabielski R, 2002, REGUL PEPTIDES, V103, P93, DOI 10.1016/S0167-0115(01)00362-7; Zhang LY, 2011, ASIAN AUSTRAL J ANIM, V24, P272, DOI 10.5713/ajas.2011.10122	50	44	45	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116710	10.1371/journal.pone.0116710	http://dx.doi.org/10.1371/journal.pone.0116710			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693162	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500022
J	Wittig, RM; Crockford, C; Weltring, A; Deschner, T; Zuberbuhler, K				Wittig, Roman M.; Crockford, Catherine; Weltring, Anja; Deschner, Tobias; Zuberbuehler, Klaus			Single Aggressive Interactions Increase Urinary Glucocorticoid Levels in Wild Male Chimpanzees	PLOS ONE			English	Article							POST-CONFLICT ANXIETY; COPING MECHANISMS; SOCIAL-DOMINANCE; PAN-TROGLODYTES; CORTISOL-LEVELS; STRESS; RECONCILIATION; BEHAVIOR; TESTOSTERONE; EXCRETION	A basic premise in behavioural ecology is the cost-benefit arithmetic, which determines both behavioural decisions and evolutionary processes. Aggressive interactions can be costly on an energetic level, demanding increased energy or causing injuries, and on a psychological level, in the form of increased anxiety and damaged relationships between opponents. Here we used urinary glucocorticoid (uGC) levels to assess the costs of aggression in wild chimpanzees of Budongo Forest, Uganda. We collected 169 urine samples from nine adult male chimpanzees following 14 aggressive interactions (test condition) and 10 resting events (control condition). Subjects showed significantly higher uGC levels after single aggressive interactions compared to control conditions, likely for aggressors as well as victims. Higher ranking males had greater increases of uGC levels after aggression than lower ranking males. In contrast, uGC levels showed no significant change in relation to aggression length or intensity, indicating that psychological factors might have played a larger role than mere energetic expenditure. We concluded that aggressive behaviour is costly for both aggressors and victims and that costs seem poorly explained by energetic demands of the interaction. Our findings are relevant for studies of post-conflict interactions, since we provide evidence that both aggressors and victims experience a stress response to conflict.	[Wittig, Roman M.; Crockford, Catherine; Weltring, Anja; Deschner, Tobias] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Wittig, Roman M.; Crockford, Catherine; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurobiol, St Andrews, Fife, Scotland; [Wittig, Roman M.; Crockford, Catherine; Zuberbuehler, Klaus] Budongo Conservat Field Stn, Masindi, Uganda; [Zuberbuehler, Klaus] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland	Max Planck Society; University of St Andrews; University of Neuchatel	Wittig, RM (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	wittig@eva.mpg.de; crockfor@eva.mpg.de	Crockford, Catherine/AAO-1482-2021; Zuberbühler, Klaus/A-9053-2011; Crockford, Catherine/A-5410-2011	Zuberbühler, Klaus/0000-0001-8378-088X; 	British Academy; Leakey Foundation; Leverhulm Trust; Max Planck Society; Royal Zoological Society of Scotland; Budongo Conservation Field Station; European Union [283871]	British Academy; Leakey Foundation; Leverhulm Trust(Leverhulme Trust); Max Planck Society(Max Planck SocietyFoundation CELLEX); Royal Zoological Society of Scotland; Budongo Conservation Field Station; European Union(European Commission)	Financial support was provided by British Academy [http://www.britac.ac.uk/] (CC), Leakey Foundation [http://www.leakeyfoundation.org/] (CC, RMW, TD), Leverhulm Trust [http://www.leverhulme.ac.uk/] (KZ), Max Planck Society [http://www.eva.mpg.de/] (AW, CC, RMW, TD) and the Royal Zoological Society of Scotland [http://www.rzss.org.uk/], in providing core funding for Budongo Conservation Field Station. This project has received additional funding from the European Union's Seventh Framework Program for research, technological development and demonstration [http://ec.europa.eu/research/fp7/index_en.cfm] under grant agreement no 283871. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AURELI F, 1991, ETHOLOGY, V89, P89; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; Beehner JC, 2005, ANIM BEHAV, V69, P1211, DOI 10.1016/j.anbehav.2004.08.014; Bergman TJ, 2005, ANIM BEHAV, V70, P703, DOI 10.1016/j.anbehav.2004.12.017; Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Butovskaya ML, 2008, BEHAVIOUR, V145, P1557, DOI 10.1163/156853908786131342; Castles DL, 1999, ANIM BEHAV, V58, P1207, DOI 10.1006/anbe.1999.1250; Cheney DL, 2009, ADV STUD BEHAV, V39, P1, DOI 10.1016/S0065-3454(09)39001-4; CHRISTIANSEN JS, 1991, J EXP ZOOL, V260, P149, DOI 10.1002/jez.1402600203; Cooper MA, 2007, ETHOLOGY, V113, P26, DOI 10.1111/j.1439-0310.2006.01287.x; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Creel SF, 2005, J MAMMAL, V86, P255, DOI 10.1644/BHE-002.1; Crockford C, 2008, HORM BEHAV, V53, P254, DOI 10.1016/j.yhbeh.2007.10.007; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DIJKSTRA H, 1992, PHYSIOL BEHAV, V51, P961, DOI 10.1016/0031-9384(92)90078-G; ELIAS M, 1981, AGGRESSIVE BEHAV, V7, P215, DOI 10.1002/1098-2337(1981)7:3<215::AID-AB2480070305>3.0.CO;2-M; ERB RE, 1970, J ANIM SCI, V30, P79, DOI 10.2527/jas1970.30179x; Fox J., 2019, R COMPANION APPL REG, V.; Fraser ON, 2009, COMMUN INTEGR BIOL, V2, P1; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Hauser B, 2008, J CHROMATOGR B, V862, P100, DOI 10.1016/j.jchromb.2007.11.009; KNAPP R, 1995, HORM BEHAV, V29, P85, DOI 10.1006/hbeh.1995.1007; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Maynard Smith J., 1982, pi; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Mitani JC, 2009, ANIM BEHAV, V77, P633, DOI 10.1016/j.anbehav.2008.11.021; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Muller MN, 2003, AM J PRIMATOL, V60, P161, DOI 10.1002/ajp.10103; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Overli O, 1999, BRAIN BEHAV EVOLUT, V54, P263, DOI 10.1159/000006627; Reynolds V., 2005, CHIMPANZEES BUDONGO; Romero T, 2009, AM J PRIMATOL, V71, P60, DOI 10.1002/ajp.20619; SACHSER N, 1991, PHYSIOL BEHAV, V50, P83, DOI 10.1016/0031-9384(91)90502-F; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schino G, 2007, ETHOLOGY, V113, P1081, DOI 10.1111/j.1439-0310.2007.01407.x; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Sobolewski M.E, 2012, THESIS U MICHIGAN; Suay F, 1999, PSYCHONEUROENDOCRINO, V24, P551, DOI 10.1016/S0306-4530(99)00011-6; Thompson ME, 2010, HORM BEHAV, V58, P440, DOI 10.1016/j.yhbeh.2010.05.009; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; Van Duyse E, 2004, BEHAVIOUR, V141, P451, DOI 10.1163/156853904323066739; Wallner B, 1999, GEN COMP ENDOCR, V113, P80, DOI 10.1006/gcen.1998.7183; Wittig RM, 2005, ETHOLOGY, V111, P736, DOI 10.1111/j.1439-0310.2005.01093.x; Wittig RM, 2003, BEHAV ECOL SOCIOBIOL, V54, P491, DOI 10.1007/s00265-003-0654-8; Wittig RM, 2008, HORM BEHAV, V54, P170, DOI 10.1016/j.yhbeh.2008.02.009; Wittig RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3155; Wittig RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3096; Wittig RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013995; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014	55	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118695	10.1371/journal.pone.0118695	http://dx.doi.org/10.1371/journal.pone.0118695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714095	Green Published, gold			2022-12-27	WOS:000350168700097
J	Bayarri-Olmos, R; Hansen, S; Henriksen, ML; Storm, L; Thiel, S; Garred, P; Munthe-Fog, L				Bayarri-Olmos, Rafael; Hansen, Soren; Henriksen, Maiken Lumby; Storm, Line; Thiel, Steffen; Garred, Peter; Munthe-Fog, Lea			Genetic Variation of COLEC10 and COLEC11 and Association with Serum Levels of Collectin Liver 1 (CL-L1) and Collectin Kidney 1 (CL-K1)	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; MISSENSE SUBSTITUTIONS; EVOLUTIONARY; PROTEIN; CL-11; POLYMORPHISMS; TRANSPORTER; MUTATIONS; PLAYERS; DEFECT	Collectin liver 1 (CL-L1, alias CL-10) and collectin kidney 1 (CL-K1, alias CL-11), encoded by the COLEC10 and COLEC11 genes, respectively, are highly homologous soluble pattern recognition molecules in the lectin pathway of complement. These proteins may be involved in anti-microbial activity and in tissue development as mutations in COLEC11 are one of the causes of the developmental defect syndrome 3MC. We studied variations in COLEC10 and COLEC11, the impact on serum concentration and to what extent CL-L1 and CL-K1 serum concentrations are correlated. We sequenced the promoter regions, exons and exon-intron boundaries of COLEC10 and COLEC11 in samples from Danish Caucasians and measured the corresponding serum levels of CL-L1 and CL-K1. The median concentration of CL-L1 and CL-K1 was 1.87 mu g/ml (1.00-4.14 mu g/ml) and 0.32 mu g/ml (0.11-0.69 mu g/ml), respectively. The level of CL-L1 strongly correlated with CL-K1 (rho = 0.7405, P <0.0001). Both genes were highly conserved with the majority of variations in the non-coding regions. Three non-synonymous variations were tested: COLEC10 Glu78Asp (rs150828850, minor allele frequency (MAF): 0.003), COLEC10 Arg125Trp (rs149331285, MAF: 0.007) and COLEC11 His219Arg (rs7567833, MAF: 0.033). Carriers of COLEC10 Arg125Trp had increased CL-L1 serum levels (P = 0.0478), whereas promoter polymorphism COLEC11-9570C>T (rs3820897) was associated with decreased levels of CL-K1 (P = 0.044). In conclusion, COLEC10 and COLEC11 are highly conserved, which may reflect biological importance of CL-L1 and CL-K1. Moreover, the strong inter individual correlation between the two proteins suggests that a major proportion are found as heterooligomers or subjected to the same regulatory mechanisms.	[Bayarri-Olmos, Rafael; Garred, Peter; Munthe-Fog, Lea] Univ Copenhagen, Rigshosp, Fac Hlth & Med Sci, Dept Clin Immunol,Lab Mol Med, DK-2100 Copenhagen, Denmark; [Hansen, Soren; Henriksen, Maiken Lumby] Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark; [Storm, Line; Thiel, Steffen] Aarhus Univ, Fac Hlth Sci, Dept Biomed, Aarhus, Denmark	Rigshospitalet; University of Copenhagen; University of Southern Denmark; Aarhus University	Munthe-Fog, L (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth & Med Sci, Dept Clin Immunol,Lab Mol Med, Sect 7631, DK-2100 Copenhagen, Denmark.	lea.munthe.fog@regionh.dk		Thiel, Steffen/0000-0002-4817-155X; Bayarri Olmos, Rafael/0000-0003-3202-9679; Garred, Peter/0000-0002-2876-8586; Munthe-Fog, Lea/0000-0003-1345-176X; Hansen, Soren/0000-0002-8186-4630	Danish Research Council for Independent Research; Novo Nordisk Research Foundation; Lundbeck Research Foundation; Svend Andersen Research Foundation; Rigshospitalet; University of Copenhagen; Novo Nordisk Fonden [NNF13OC0007989] Funding Source: researchfish	Danish Research Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Lundbeck Research Foundation(Lundbeckfonden); Svend Andersen Research Foundation; Rigshospitalet; University of Copenhagen; Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding was provided by The Danish Research Council for Independent Research, The Novo Nordisk Research Foundation, The Lundbeck Research Foundation, The Svend Andersen Research Foundation, Rigshospitalet and The University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Axelgaard E, 2013, J BIOL CHEM, V288, P23407, DOI 10.1074/jbc.M113.492603; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; BrownAugsburger P, 1996, J BIOL CHEM, V271, P13724, DOI 10.1074/jbc.271.23.13724; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; CARNEVALE F, 1989, AM J MED GENET, V33, P186, DOI 10.1002/ajmg.1320330210; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Hakansson K, 2000, PROTEIN SCI, V9, P1607, DOI 10.1110/ps.9.9.1607; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Hartshorn KL, 1996, BLOOD, V87, P3450, DOI 10.1182/blood.V87.8.3450.bloodjournal8783450; Henriksen ML, 2013, J IMMUNOL, V191, P6117, DOI 10.4049/jimmunol.1302121; HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Kakhki SA, 2013, MOL CELL BIOCHEM, V376, P145, DOI 10.1007/s11010-013-1562-5; Keshi H, 2006, MICROBIOL IMMUNOL, V50, P1001, DOI 10.1111/j.1348-0421.2006.tb03868.x; Kilpatrick DC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/138797; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Ma YJ, 2013, J INNATE IMMUN, V5, P242, DOI 10.1159/000345356; MALPUECH G, 1983, AM J MED GENET, V16, P475, DOI 10.1002/ajmg.1320160405; MICHELS VV, 1978, J PEDIATR-US, V93, P444, DOI 10.1016/S0022-3476(78)81154-8; Mingarelli R, 1996, J MED GENET, V33, P884, DOI 10.1136/jmg.33.10.884; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Ohtani K, 1999, J BIOL CHEM, V274, P13681, DOI 10.1074/jbc.274.19.13681; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Selman L, 2012, J IMMUNOL METHODS, V375, P182, DOI 10.1016/j.jim.2011.10.010; Selman L, 2012, IMMUNOBIOLOGY, V217, P851, DOI 10.1016/j.imbio.2011.12.008; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shu Y, 2003, P NATL ACAD SCI USA, V100, P5902, DOI 10.1073/pnas.0730858100; Takahashi K, 2014, J THROMB THROMBOLYS, V38, P331, DOI 10.1007/s11239-013-1042-5; Tang YQ, 2012, BBA-PROTEINS PROTEOM, V1824, P253, DOI 10.1016/j.bbapap.2011.05.021; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; van de Wetering JK, 2004, EUR J BIOCHEM, V271, P1229, DOI 10.1111/j.1432-1033.2004.04040.x; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Yoshizaki T, 2012, J BIOCHEM, V151, P57, DOI 10.1093/jb/mvr114	38	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0114883	10.1371/journal.pone.0114883	http://dx.doi.org/10.1371/journal.pone.0114883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710878	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900001
J	Dumortier, JG; David, NB				Dumortier, Julien G.; David, Nicolas B.			The TORC2 Component, Sin1, Controls Migration of Anterior Mesendoderm during Zebrafish Gastrulation	PLOS ONE			English	Article							MAMMALIAN TARGET; ACTIN CYTOSKELETON; BINDING PARTNER; CELL MOVEMENTS; SIGNAL RELAY; PHAS-I; MTOR; PATHWAY; RICTOR; CHEMOTAXIS	TORC2 is a serine-threonine kinase complex conserved through evolution that recently emerged as a new regulator of actin dynamics and cell migration. However, knockout in mice of its core components Sin1 and Rictor is embryonic lethal, which has limited in vivo analyses. Here, we analysed TORC2 function during early zebrafish development, using a morpholino-mediated loss of function of sin1. Sin1 appears required during gastrulation for migration of the prechordal plate, the anterior most mesoderm. In absence of Sin1, cells migrate both slower and less persistently, which can be correlated to a reduction in actin-rich protrusions and a randomisation of the remaining protrusions. These results demonstrate that, as established in vitro, the TORC2 component Sin1 controls actin dynamics and cell migration in vivo. We furthermore establish that Sin1 is required for protrusion formation downstream of PI3K, and is acting upstream of the GTPase Rac1, since expression of an activated form of Rac1 is sufficient to rescue sin1 loss of function.	[Dumortier, Julien G.; David, Nicolas B.] INSERM, U1024, Paris, France; [Dumortier, Julien G.; David, Nicolas B.] CNRS, UMR 8197, Paris, France; [Dumortier, Julien G.; David, Nicolas B.] Ecole Normale Super, Inst Biol, IBENS, F-75231 Paris, France; [Dumortier, Julien G.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Cambridge	David, NB (corresponding author), INSERM, U1024, Paris, France.	ndavid@biologie.ens.fr	Dumortier, Julien/M-7469-2013; David, Nicolas/A-1699-2008	Dumortier, Julien/0000-0002-1483-4028; David, Nicolas/0000-0003-1166-6732	Association pour la Recherche sur le Cancer [SFI20111203770, PJA 20131200143]; Ministere de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Association pour la Recherche sur le Cancer No SFI20111203770 and No PJA 20131200143. JGD was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. NBD was supported by the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Charest PG, 2010, DEV CELL, V18, P737, DOI 10.1016/j.devcel.2010.03.017; Daggett DF, 2004, CURR BIOL, V14, P1632, DOI 10.1016/j.cub.2004.08.024; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Dumortier JG, 2012, P NATL ACAD SCI USA, V109, P16945, DOI 10.1073/pnas.1205870109; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Glickman NS, 2003, DEVELOPMENT, V130, P873, DOI 10.1242/dev.00314; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleijn M, 1996, FEBS LETT, V396, P165, DOI 10.1016/0014-5793(96)01097-6; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Makino C, 2006, GENES CELLS, V11, P1239, DOI 10.1111/j.1365-2443.2006.01016.x; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; MORI H, 1994, MOL BRAIN RES, V27, P221, DOI 10.1016/0169-328X(94)90004-3; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pezeron G, 2008, CURR BIOL, V18, P276, DOI 10.1016/j.cub.2008.01.028; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schroder W, 2005, CELL SIGNAL, V17, P761, DOI 10.1016/j.cellsig.2004.10.015; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; SOLNICAKREZEL L, 1995, BIOESSAYS, V17, P931, DOI 10.1002/bies.950171106; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; Tahinci E, 2003, DEV BIOL, V259, P318, DOI 10.1016/S0012-1606(03)00206-9; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yonezawa K, 2004, BIOCHEM BIOPH RES CO, V313, P437, DOI 10.1016/j.bbrc.2003.07.018; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207	54	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118474	10.1371/journal.pone.0118474	http://dx.doi.org/10.1371/journal.pone.0118474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710382	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900059
J	Jaguin, M; Fardel, O; Lecureur, V				Jaguin, Marie; Fardel, Olivier; Lecureur, Valerie			Exposure to Diesel Exhaust Particle Extracts (DEPe) Impairs Some Polarization Markers and Functions of Human Macrophages through Activation of AhR and Nrf2	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; ENVIRONMENTAL CONTAMINANT BENZO(A)PYRENE; AIRWAY INFLAMMATORY RESPONSES; RAT ALVEOLAR MACROPHAGES; OXIDATIVE STRESS; ENHANCES SUSCEPTIBILITY; TRANSCRIPTION FACTOR; DEPENDENT INDUCTION; MICROARRAY ANALYSIS; NEGATIVE REGULATOR	Macrophages (M Phi), well-known to play an important role in immune response, also respond to environmental toxic chemicals such as diesel exhaust particles (DEP). Potential effects of DEPs towards M Phi polarization, a key hall-mark of M Phi physiology, remain however poorly documented. This study was therefore designed to evaluate the effects of a reference DEP extract (DEPe) on human M Phi polarization. Human blood monocytes-derived M Phi were incubated with IFN gamma+LPS or IL-4 to obtain M1 and M2 subtypes, respectively; a 24 h exposure of polarizing M Phi to 10 mu g/ml DEPe was found to impair expression of some macrophagic M1 and M2 markers, without however overall inhibition of M1 and M2 polarization processes. Notably, DEPe treatment increased the secretion of the M1 marker IL-8 and the M2 marker IL-10 in both M Phi subtypes, whereas it reduced lipopolysaccharide-induced IL-6 and IL-12p40 secretion in M1 M Phi. In M2 M Phi, DEPe exposure led to a reduction of CD200R expression and of CCL17, CCL18 and CCL22 secretion, associated with a lower chemotaxis of CCR4-positive cells. DEPe activated the Nrf2 and AhR pathways and induced expression of their reference target genes such as Hmox-1 and cytochrome P-4501B1 in M1 and M2 M Phi. Nrf2 or AhR silencing through RNA interference prevented DEPe-related down-regulation of IL-6. AhR silencing also inhibited the down-secretion of IL-12p40 and CCL18 in M1- and M2-DEPe-exposed M Phi, respectively. DEPs are therefore likely to alter expression of some M1 and M2 markers in an AhR- and Nrf2-dependent manner; such regulations may contribute to deleterious immune effects of atmospheric DEP.	[Jaguin, Marie; Fardel, Olivier; Lecureur, Valerie] Univ Rennes 1, IRSET, UMR INSERM U1085, F-35043 Rennes, France; [Fardel, Olivier] CHU Rennes, F-35033 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes	Lecureur, V (corresponding author), Univ Rennes 1, IRSET, UMR INSERM U1085, 2 Ave Pr Leon Bernard, F-35043 Rennes, France.	valerie.lecureur@univ-rennes1.fr	Fardel, Olivier/J-8560-2015; LECUREUR, Valérie/J-9095-2015		"Fondation Coeur et Arteres" (FCA) [09T3]; Institut National de la Sante et de la Recherche Medicale; University of Rennes 1; French Ministry of Research	"Fondation Coeur et Arteres" (FCA); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Rennes 1; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by "Fondation Coeur et Arteres" (FCA 09T3), Institut National de la Sante et de la Recherche Medicale and the University of Rennes 1. MJ is a recipient of a fellow from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amakawa K, 2003, EXP LUNG RES, V29, P149, DOI 10.1080/01902140303770; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; [Anonymous], 1997, Cardiovasc Res, V35, P2; Baulig A, 2003, AM J PHYSIOL-LUNG C, V285, pL671, DOI 10.1152/ajplung.00419.2002; Benson JM, 2011, TOXICOL SCI, V124, P327, DOI 10.1093/toxsci/kfr249; Bleck B, 2006, J IMMUNOL, V176, P7431, DOI 10.4049/jimmunol.176.12.7431; Bourdonnay E, 2009, J CELL BIOCHEM, V107, P537, DOI 10.1002/jcb.22155; Braun A, 2010, TOXICOL SCI, V113, P85, DOI 10.1093/toxsci/kfp239; Chan RCF, 2006, J ALLERGY CLIN IMMUN, V118, P455, DOI 10.1016/j.jaci.2006.06.006; Chao MW, 2012, TOXICOLOGY, V297, P34, DOI 10.1016/j.tox.2012.03.009; Chaudhuri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051107; Chenivesse C, 2012, J IMMUNOL, V189, P128, DOI 10.4049/jimmunol.1003616; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; De Nadai P, 2006, J IMMUNOL, V176, P6286, DOI 10.4049/jimmunol.176.10.6286; Fahy O, 2002, J IMMUNOL, V168, P5912, DOI 10.4049/jimmunol.168.11.5912; Fardel O, 2013, EXPERT OPIN DRUG MET, V9, P141, DOI 10.1517/17425255.2013.738194; Ghio AJ, 2012, CURR OPIN PULM MED, V18, P144, DOI 10.1097/MCP.0b013e32834f0e2a; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gowdy KM, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-34; Hatanaka N, 2001, CARCINOGENESIS, V22, P2033, DOI 10.1093/carcin/22.12.2033; Hiura TS, 1999, J IMMUNOL, V163, P5582; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Jeong SI, 2010, ARCH PHARM RES, V33, P1867, DOI 10.1007/s12272-010-1120-6; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Koike E, 2002, TOXICOL SCI, V67, P241, DOI 10.1093/toxsci/67.2.241; Kollert F, 2009, INFLAMMATION, V32, P163, DOI 10.1007/s10753-009-9115-5; Laupeze W, 2002, J IMMUNOL, V168, P2652, DOI 10.4049/jimmunol.168.6.2652; Lecureur V, 2005, FEBS LETT, V579, P1904, DOI 10.1016/j.febslet.2005.01.081; Li N, 2006, ANTIOXID REDOX SIGN, V8, P88, DOI 10.1089/ars.2006.8.88; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li N, 2000, J IMMUNOL, V165, P3393, DOI 10.4049/jimmunol.165.6.3393; Li YJ, 2008, CLIN IMMUNOL, V128, P366, DOI 10.1016/j.clim.2008.05.005; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Masuda K, 2011, INT IMMUNOL, V23, P637, DOI 10.1093/intimm/dxr072; Miller MR, 2012, FUTUR CARDIOL, V8, P577, DOI [10.2217/fca.12.43, 10.2217/FCA.12.43]; Miyata R, 2011, TOXICOL APPL PHARM, V257, P209, DOI 10.1016/j.taap.2011.09.007; Mo CF, 2014, ANTIOXID REDOX SIGN, V20, P574, DOI 10.1089/ars.2012.5116; Moller P, 2011, CRIT REV TOXICOL, V41, P339, DOI 10.3109/10408444.2010.533152; Moreau A, 2011, FUND CLIN PHARMACOL, V25, P743, DOI 10.1111/j.1472-8206.2010.00913.x; Morino-Koga S, 2013, J DERMATOL SCI, V72, P9, DOI 10.1016/j.jdermsci.2013.04.031; Mundandhara SD, 2006, TOXICOL IN VITRO, V20, P614, DOI 10.1016/j.tiv.2005.10.018; N'Diaye M, 2006, J BIOL CHEM, V281, P19906, DOI 10.1074/jbc.M601192200; Nguyen NT, 2013, INT IMMUNOL, V25, P335, DOI 10.1093/intimm/dxt011; Papaiahgari S, 2007, AM J RESP CRIT CARE, V176, P1222, DOI 10.1164/rccm.200701-060OC; Pi JB, 2007, FREE RADICAL BIO MED, V42, P1797, DOI 10.1016/j.freeradbiomed.2007.03.001; Podechard N, 2011, TOXICOL LETT, V206, P289, DOI 10.1016/j.toxlet.2011.07.024; Podechard N, 2008, TOXICOL LETT, V177, P130, DOI 10.1016/j.toxlet.2008.01.006; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Rebourcet D, 2010, INT J ANDROL, V33, P413, DOI 10.1111/j.1365-2605.2009.01020.x; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Sawyer K, 2010, J TOXICOL ENV HEAL A, V73, P41, DOI 10.1080/15287390903248901; Sparfel L, 2010, TOXICOL SCI, V114, P247, DOI 10.1093/toxsci/kfq007; Stenfors N, 2004, EUR RESPIR J, V23, P82, DOI 10.1183/09031936.03.00004603; Sun YV, 2004, NUCLEIC ACIDS RES, V32, P4512, DOI 10.1093/nar/gkh782; Taront S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-9; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374; Verheyen GR, 2004, TOXICOL IN VITRO, V18, P377, DOI 10.1016/j.tiv.2003.10.007; Vogel CFA, 2005, ENVIRON HEALTH PERSP, V113, P1536, DOI 10.1289/ehp.8094; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Vogel CFA, 2007, BIOCHEM BIOPH RES CO, V363, P722, DOI 10.1016/j.bbrc.2007.09.032; Williams MA, 2008, J IMMUNOL, V181, P4545, DOI 10.4049/jimmunol.181.7.4545; Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209766	69	31	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116560	10.1371/journal.pone.0116560	http://dx.doi.org/10.1371/journal.pone.0116560			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710172	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900010
J	Hata, A; Yonemoto, K; Shikama, Y; Aki, N; Kosugi, C; Tamura, A; Ichihara, T; Minagawa, T; Kuwamura, Y; Miyoshi, M; Nakao, T; Funaki, M				Hata, Akiko; Yonemoto, Koji; Shikama, Yosuke; Aki, Nanako; Kosugi, Chisato; Tamura, Ayako; Ichihara, Takako; Minagawa, Takako; Kuwamura, Yumi; Miyoshi, Masashi; Nakao, Takayuki; Funaki, Makoto			Cut-Off Value of Total Adiponectin for Managing Risk of Developing Metabolic Syndrome in Male Japanese Workers	PLOS ONE			English	Article							HIGH-MOLECULAR-WEIGHT; CORONARY-ARTERY-DISEASE; PANCREATIC BETA-CELLS; INSULIN-RESISTANCE; SERUM ADIPONECTIN; NITRIC-OXIDE; POPULATION; GLUCOSE; MEN; HYPOADIPONECTINEMIA	Aim To determine the optimal cut-off value of serum total adiponectin for managing the risk of developing metabolic syndrome (MetS) in male Japanese workers. Methods A total of 365 subjects without MetS aged 20-60 years were followed up prospectively for a mean of 3.1 years. The accelerated failure-time model was used to estimate time ratio (TR) and cut-off value for developing MetS. Results During follow-up, 45 subjects developed MetS. Age-adjusted TR significantly declined with decreasing total adiponectin level (<= 4.9, 5.0-6.6, 6.7-8.8 and >= 8.9 mu g/ml, P for trend = 0.003). In multivariate analyses, TR of MetS was 0.12 (95% CI 0.02-0.78; P = 0.03) in subjects with total adiponectin level of 5.0-6.6 mu g/ml, and 0.15 (95% CI 0.02-0.97; P = 0.047) in subjects with total adiponectin level <= 4.9 mu g/ml compared with those with total adiponectin level >= 8.9 mu g/ml. The accelerated failure-timemodel showed that the optimal cut-off value of total adiponectin for managing the risk of developing MetS was 6.2 mu g/ml. In the multivariate-adjusted model, the mean time to the development of MetS was 78% shorter for total adiponectin level <= 6.2 mu g/ml compared with > 6.2 mu g/ml (TR 0.22, 95% CI: 0.08-0.64, P = 0.005). Conclusion Our findings suggest that the cut-off value for managing the risk of developing MetS is 6.2 mu g/ml in male Japanese workers. Subjects with total adiponectin level <= 6.2 mu g/ml developed MetS more rapidly than did those with total adiponectin level > 6.2 mu g/ml.	[Hata, Akiko; Shikama, Yosuke; Aki, Nanako; Kosugi, Chisato; Funaki, Makoto] Tokushima Univ Hosp, Clin Res Ctr Diabet, Tokushima, Japan; [Yonemoto, Koji] Kurume Univ, Biostatt Ctr, Fukuoka, Japan; [Aki, Nanako] Univ Tokushima, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Tokushima 770, Japan; [Tamura, Ayako; Ichihara, Takako; Minagawa, Takako; Kuwamura, Yumi] Univ Tokushima, Grad Sch, Dept Nursing Sci, Inst Hlth Biosci, Tokushima 770, Japan; [Miyoshi, Masashi; Nakao, Takayuki] Tokushima Univ Hosp, Clin Lab, Tokushima, Japan	Tokushima University; Kurume University; Tokushima University; Tokushima University; Tokushima University	Hata, A (corresponding author), Tokushima Univ Hosp, Clin Res Ctr Diabet, Tokushima, Japan.	akiko-hata@tokushima-u.ac.jp			Knowledge Cluster Initiative (Tokushima Health and Medicine Cluster) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Tokushima Prefecture; Otsuka Pharmaceutical Company; Ministry of Education, Culture, Sports, Science and Technology of Japan [25860439]; Grants-in-Aid for Scientific Research [23244011] Funding Source: KAKEN	Knowledge Cluster Initiative (Tokushima Health and Medicine Cluster) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Tokushima Prefecture; Otsuka Pharmaceutical Company(Otsuka Pharmaceutical); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by The Knowledge Cluster Initiative (Tokushima Health and Medicine Cluster) (http://www.mext.go.jp/a_menu/kagaku/chiiki/cluster/index.htm) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MF), by Grants-in-Aid for research from Tokushima Prefecture (MF) (http://www.pref.tokushima.jp/), by Otsuka Pharmaceutical Company (http://www.otsuka.co.jp/en/) (MF), and by Grants-in-Aid for Young Scientists (B) (25860439) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (AH) (http://www.jsps.go.jp/english/index.html). The funders/sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2007, J CLIN ENDOCRINOL ME, V92, P4313; Calton EK, 2013, EUR J CLIN NUTR, V67, P485, DOI 10.1038/ejcn.2013.1; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Hata J, 2010, ATHEROSCLEROSIS, V210, P249, DOI 10.1016/j.atherosclerosis.2009.10.044; Hung J, 2008, INT J OBESITY, V32, P772, DOI 10.1038/sj.ijo.0803793; Jeong JE, 2014, ALCOHOL ALCOHOLISM, V49, pi58, DOI [10.1093/alcalc/agu054.27, DOI 10.1093/ALCALC/AGU054.27]; Jian L, 2013, HORM METAB RES, V45, P561, DOI 10.1055/s-0033-1341500; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kashyap SR, 2010, METAB SYNDR RELAT D, V8, P459, DOI 10.1089/met.2010.0018; Kim JY, 2013, DIABETES CARE, V36, P1547, DOI 10.2337/dc12-0223; Ko GTC, 2010, DIABETES METAB, V36, P192, DOI 10.1016/j.diabet.2009.11.007; Koh SB, 2010, METABOLISM, V59, P333, DOI 10.1016/j.metabol.2009.07.031; Komura N, 2008, CIRC J, V72, P23, DOI 10.1253/circj.72.23; Kotajima N, 2001, JPN J MED PHARM SCI, V46, P235; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; Nakashima R, 2011, J ENDOCRINOL INVEST, V34, P615, DOI 10.3275/7409; Nishida A, 1986, KITASATOIGAKU, V16, P393; Ogawa Y, 2005, HYPERTENS RES, V28, P51, DOI 10.1291/hypres.28.51; Onishi T, 1990, J CLIN LAB I REAG, V13, P929; Seino Y, 2009, METABOLISM, V58, P355, DOI 10.1016/j.metabol.2008.10.008; Singh RS, 2013, OPEN J STAT, V3, P155, DOI [10.4236/ojs.2013.32017, DOI 10.4236/OJS.2013.32017]; Tabara Y, 2008, J CLIN ENDOCR METAB, V93, P715, DOI 10.1210/jc.2007-0397; Tamura K, 2003, JPN J MED PHARM SCI, V49, P791; Tao C, 2014, BEST PRACT RES CL EN, V28, P43, DOI 10.1016/j.beem.2013.11.003; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Won WY, 2014, PSYCHIAT INVEST, V11, P173, DOI 10.4306/pi.2014.11.2.173; Woodward M, 2013, EPIDEMIOLOGY STUDY D; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yun JE, 2012, CIRC J, V76, P2443, DOI 10.1253/circj.CJ-12-0125	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118373	10.1371/journal.pone.0118373	http://dx.doi.org/10.1371/journal.pone.0118373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705909	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100175
J	Kojima, M; Sudo, H; Kawauchi, J; Takizawa, S; Kondou, S; Nobumasa, H; Ochiai, A				Kojima, Motohiro; Sudo, Hiroko; Kawauchi, Junpei; Takizawa, Satoko; Kondou, Satoshi; Nobumasa, Hitoshi; Ochiai, Atsushi			MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers	PLOS ONE			English	Article							EXPRESSION	It is difficult to detect pancreatic cancer or biliary-tract cancer at an early stage using current diagnostic technology. Utilizing microRNA (miRNA) markers that are stably present in peripheral blood, we aimed to identify pancreatic and biliary-tract cancers in patients. With "3D-Gene", a highly sensitive microarray, we examined comprehensive miRNA expression profiles in 571 serum samples obtained from healthy patients, patients with pancreatic, biliary-tract, or other digestive cancers, and patients with non-malignant abnormalities in the pancreas or biliary tract. The samples were randomly divided into training and test cohorts, and candidate miRNA markers were independently evaluated. We found 81 miRNAs for pancreatic cancer and 66 miRNAs for biliary-tract cancer that showed statistically different expression compared with healthy controls. Among those markers, 55 miRNAs were common in both the pancreatic and biliary-tract cancer samples. The previously reported miR125a-3p was one of the common markers; however, it was also expressed in other types of digestive-tract cancers, suggesting that it is not specific to cancer types. In order to discriminate the pancreato-biliary cancers from all other clinical conditions including the healthy controls, non-malignant abnormalities, and other types of cancers, we developed a diagnostic index using expression profiles of the 10 most significant miRNAs. A combination of eight miRNAs (miR-6075, miR-4294, miR-6880-5p, miR-6799-5p, miR-125a-3p, miR-4530, miR-6836-3p, and miR-4476) achieved a sensitivity, specificity, accuracy and AUC of 80.3%, 97.6%, 91.6% and 0.953, respectively. In contrast, CA19-9 and CEA gave sensitivities of 65.6% and 40.0%, specificities of 92.9% and 88.6%, and accuracies of 82.1% and 71.8%, respectively, in the same test cohort. This diagnostic index identified 18/21 operable pancreatic cancers and 38/48 operable biliary-tract cancers in the entire cohort. Our results suggest that the assessment of these miRNA markers is clinically valuable to identify patients with pancreato-biliary cancers who could benefit from surgical intervention.	[Kojima, Motohiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Dept Pathol, Kashiwa, Chiba, Japan; [Sudo, Hiroko; Kawauchi, Junpei; Takizawa, Satoko] Toray Industries Ltd, New Frontiers Res Labs, Kamakura, Kanagawa, Japan; [Kondou, Satoshi; Nobumasa, Hitoshi] Toray Industries Ltd, New Projects Dev Div, Kamakura, Kanagawa, Japan	National Cancer Center - Japan; Toray Industries, Inc.; Toray Industries, Inc.	Kojima, M (corresponding author), Natl Canc Ctr Hosp East, Dept Pathol, Kashiwa, Chiba, Japan.	mokojima@east.ncc.go.jp						Ali S, 2011, AM J TRANSL RES, V3, P28; Ballehaninna UK, 2012, J GASTROINTEST ONCOL, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Bartsch DK, 2012, NAT REV GASTRO HEPAT, V9, P445, DOI 10.1038/nrgastro.2012.111; Becker AE, 2014, WORLD J GASTROENTERO, V20, P11182, DOI 10.3748/wjg.v20.i32.11182; Brand B, 2000, SCAND J GASTROENTERO, V35, P1221; Challagundla KB, 2014, EXPERT REV MOL DIAGN, V14, P565, DOI 10.1586/14737159.2014.922879; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eklund A, 2013, BEESWARM BEE SWARM P; Ganepola GAP, 2014, WORLD J GASTRO ONCOL, V6, P22, DOI 10.4251/wjgo.v6.i1.22; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kosaka Nobuyoshi, 2013, Frontiers in Genetics, V4, P173, DOI 10.3389/fgene.2013.00173; Lee G, 2008, IEEE ACM T COMPUT BI, V5, P368, DOI 10.1109/TCBB.2008.36; Li AG, 2013, CLIN CANCER RES, V19, P3600, DOI 10.1158/1078-0432.CCR-12-3092; Liu JQ, 2012, INT J CANCER, V131, P683, DOI 10.1002/ijc.26422; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Morris-Stiff G, 2012, J GASTROINTEST ONCOL, V3, P88, DOI 10.3978/j.issn.2078-6891.2012.016; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Taguchi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066714; Venables WN., 2002, MODERN APPL STAT S 4	20	80	87	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118220	10.1371/journal.pone.0118220	http://dx.doi.org/10.1371/journal.pone.0118220			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706130	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100156
J	Shi, YH; Liu, PP; Guan, J; Lu, Y; Su, KM				Shi, Yuhua; Liu, Panpan; Guan, Jian; Lu, Yan; Su, Kaiming			Association between Glaucoma and Obstructive Sleep Apnea Syndrome: A Meta-Analysis and Systematic Review	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; FLOPPY EYELID SYNDROME; RISK-FACTOR; DIABETES-MELLITUS; OPTIC NEUROPATHY; HIGH PREVALENCE; DISEASE; STROKE	Background Obstructive sleep apnea syndrome (OSAS) is a common disease that increases the risk of diabetes, heart disease, and stroke. However, studies of an association between OSAS and glaucoma neuropathy have reported controversial findings. Objective The main purpose of this study was to evaluate whether a significant association exists between OSAS and glaucoma by performing a meta-analysis of previous studies. Methods A comprehensive literature search using the PubMed and Embase databases was performed to identify cross-sectional, case-control, and cohort studies related to the topic. We estimated a pooled odds ratio (OR) for the association between OSAS and glaucoma, by a fixed-or random-effects model. Results In total, 16 studies with 2,278,832 participants met the inclusion criteria: one retrospective cohort study reported an adjusted hazard ratio of glaucoma of 1.67 (95% CI = 1.30-2.17). Using a fixed-effects model, the pooled OR of six case-control studies was 1.96 (95% CI = 1.37 2.80). A significant association was also identified in a meta-analysis of nine cross-sectional studies using a random-effects model, which showed a pooled OR of 1.41 (95% CI = 1.11 1.79). However, the reported pooled estimates for case control studies and cross-sectional studies were based on unadjusted ORs. Conclusions Our results suggest that OSAS is associated with the prevalence of glaucoma. However, this result was based only on unadjusted estimates. Prospective cohort studies designed to take into consideration potential confounders, or examination of data from interventional trials to determine whether a reduction in OSAS status is associated with a reduced incidence of glaucoma, are needed to clarify whether OSAS is an independent risk factor for glaucoma.	[Shi, Yuhua; Lu, Yan] Nanjing Univ, Sch Med, Jinling Hosp, Dept Ophthalmol, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Panpan; Guan, Jian; Su, Kaiming] Shanghai Jiao Tong Univ, Otolaryngol Inst, Dept Otolaryngol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Nanjing University; Shanghai Jiao Tong University	Su, KM (corresponding author), Shanghai Jiao Tong Univ, Otolaryngol Inst, Dept Otolaryngol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	021china@sina.com			Fund of the Shanghai Municipal Health Bureau [20124450]; Science and Engineering Research Fund of Shanhai Jiaotong University of China [09XJ21004]; Project of the Shanghai Committee of Science and Technology [14DZ1940704]	Fund of the Shanghai Municipal Health Bureau; Science and Engineering Research Fund of Shanhai Jiaotong University of China; Project of the Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This study was supported by the Fund of the Shanghai Municipal Health Bureau (Grant No. 20124450), the Science and Engineering Research Fund of Shanhai Jiaotong University of China (Grant No. 09XJ21004), and the Project of the Shanghai Committee of Science and Technology (14DZ1940704).	Angheben JMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086868; Aptel F, 2014, SLEEP MED; Armstrong AW, 2013, JAMA DERMATOL, V149, P84, DOI 10.1001/2013.jamadermatol.406; Austeng ME, 2014, INT J PEDIAT OTORHIN; Banerjee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079521; Bendel RE, 2008, EYE, V22, P1105, DOI 10.1038/sj.eye.6702846; Bilgin G, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-27; Bilgin G, 2013, J NEURO-OPHTHALMOL, V33, P232, DOI 10.1097/WNO.0b013e31828eecbd; Boonyaleephan S, 2008, J MED HLTH SCI, V15, P87; Boyle-Walker Megan, 2011, ISRN Ophthalmol, V2011, P920767, DOI 10.5402/2011/920767; Faridi O, 2012, CLIN EXP OPHTHALMOL, V40, P408, DOI 10.1111/j.1442-9071.2012.02768.x; Geyer O, 2003, AM J OPHTHALMOL, V136, P1093, DOI 10.1016/S0002-9394(03)00709-8; Girkin CA, 2006, BRIT J OPHTHALMOL, V90, P679, DOI 10.1136/bjo.2005.086082; Hollo G, 2010, EUR J OPHTHALMOL, V20, P1000, DOI 10.1177/112067211002000620; Huerva V, 2014, SLEEP MED, V15, P724, DOI 10.1016/j.sleep.2013.12.017; Javaheri S, 2011, J CLIN SLEEP MED, V7, P399, DOI 10.5664/JCSM.1202; Kadyan A, 2010, EYE, V24, P843, DOI 10.1038/eye.2009.212; Kang IG, 2013, CLIN EXP OTORHINOLAR, V6, P68, DOI 10.3342/ceo.2013.6.2.68; Karakucuk S, 2008, GRAEF ARCH CLIN EXP, V246, P129, DOI 10.1007/s00417-007-0656-8; Khandgave TP, 2013, J CLIN DIAGN RES, V7, P1391, DOI 10.7860/JCDR/2013/5383.3147; Klemm M, 2014, KLIN MONATSBL AUGENH, V231, P116, DOI 10.1055/s-0033-1360143; Koehler U, 2014, NERVENARZT, V85, P35, DOI 10.1007/s00115-013-3890-9; Li M, 2014, INT J CARDIOL, V172, P466, DOI 10.1016/j.ijcard.2013.12.230; Lin CC, 2013, OPHTHALMOLOGY, V120, P1559, DOI 10.1016/j.ophtha.2013.01.006; Lin PW, 2011, J GLAUCOMA, V20, P553, DOI 10.1097/IJG.0b013e3181f3eb81; Manaviat MR, 2014, ZAHEDAN J RES MED SC, V16, P44; Mannarino MR, 2012, EUR J INTERN MED, V23, P586, DOI 10.1016/j.ejim.2012.05.013; Marcus DM, 2001, J GLAUCOMA, V10, P177, DOI 10.1097/00061198-200106000-00006; Marcus MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029724; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mojon DS, 1999, OPHTHALMOLOGY, V106, P1009, DOI 10.1016/S0161-6420(99)00525-4; Mojon DS, 2002, OPHTHALMOLOGICA, V216, P180, DOI 10.1159/000059625; Muniesa M, 2014, J GLAUCOMA, V23, pE81, DOI 10.1097/IJG.0b013e31829da19f; Ohana EB, 2010, EUR ANN OTORHINOLARY, V127, P159, DOI 10.1016/j.anorl.2010.07.003; Onen SH, 2000, ACTA OPHTHALMOL SCAN, V78, P638, DOI 10.1034/j.1600-0420.2000.078006638.x; Pajic B, 2011, CURR EYE RES, V36, P1129, DOI 10.3109/02713683.2011.608240; Pulixi EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096349; Roberts TV, 2009, J GLAUCOMA, V18, P114, DOI 10.1097/IJG.0b013e318179f80c; Sands-Lincoln M, 2013, J CLIN HYPERTENS, V15, P593, DOI 10.1111/jch.12144; Sergi M, 2007, J GLAUCOMA, V16, P42, DOI 10.1097/01.ijg.0000243472.51461.24; Stein JD, 2011, AM J OPHTHALMOL, V152, P989, DOI 10.1016/j.ajo.2011.04.030; Teramoto S, 2003, CIRCULATION, V107, pE40, DOI 10.1161/01.CIR.0000053956.46188.5F; Tothova L, 2013, SLEEP BREATH; Tsang CSL, 2006, EYE, V20, P38, DOI 10.1038/sj.eye.6701785; Zeng JG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053409, 10.1371/journal.pone.0082091]	46	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115625	10.1371/journal.pone.0115625	http://dx.doi.org/10.1371/journal.pone.0115625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705901	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100015
J	Smolarek, D; Hattab, C; Buczkowska, A; Kaczmarek, R; Jarzab, A; Cochet, S; de Brevern, AG; Lukasiewicz, J; Jachymek, W; Niedziela, T; Grodecka, M; Wasniowska, K; Colin Aronovicz, Y; Bertrand, O; Czerwinski, M				Smolarek, Dorota; Hattab, Claude; Buczkowska, Anna; Kaczmarek, Radoslaw; Jarzab, Anna; Cochet, Sylvie; de Brevern, Alexandre G.; Lukasiewicz, Jolanta; Jachymek, Wojciech; Niedziela, Tomasz; Grodecka, Magdalena; Wasniowska, Kazimiera; Colin Aronovicz, Yves; Bertrand, Olivier; Czerwinski, Marcin			Studies of a Murine Monoclonal Antibody Directed against DARC: Reappraisal of Its Specificity	PLOS ONE			English	Article							CARBOHYDRATE-MIMETIC PEPTIDE; DUFFY ANTIGEN RECEPTOR; PLASMODIUM-VIVAX; STD-NMR; STRUCTURAL-CHARACTERIZATION; CHEMOKINE BINDING; LIGAND-BINDING; PROTEIN; EPITOPE; ANTIGEN/RECEPTOR	Duffy Antigen Receptor for Chemokines (DARC) plays multiple roles in human health as a blood group antigen, a receptor for chemokines and the only known receptor for Plasmodium vivax merozoites. It is the target of the murine anti-Fy6 monoclonal antibody 2C3 which binds to the first extracellular domain (ECD1), but exact nature of the recognized epitope was a subject of contradictory reports. Here, using a set of complex experiments which include expression of DARC with amino acid substitutions within the Fy6 epitope in E. coli and K562 cells, ELISA, surface plasmon resonance (SPR) and flow cytometry, we have resolved discrepancies between previously published reports and show that the basic epitope recognized by 2C3 antibody is (FEDVW26)-F-22, with F-22 and W-26 being the most important residues. In addition, we demonstrated that Y-30 plays an auxiliary role in binding, particularly when the residue is sulfated. The STD-NMR studies performed using 2C3-derived Fab and synthetic peptide corroborated most of these results, and together with the molecular modelling suggested that V-25 is not involved in direct interactions with the antibody, but determines folding of the epitope backbone.	[Smolarek, Dorota; Buczkowska, Anna; Kaczmarek, Radoslaw; Grodecka, Magdalena; Wasniowska, Kazimiera; Czerwinski, Marcin] Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Glycoconjugate Immunochem, Wroclaw, Poland; [Lukasiewicz, Jolanta; Jachymek, Wojciech; Niedziela, Tomasz] Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Microbial Immunochem & Vaccines, Wroclaw, Poland; [Jarzab, Anna] Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Med Microbiol, Wroclaw, Poland; [Smolarek, Dorota; Hattab, Claude; Cochet, Sylvie; de Brevern, Alexandre G.; Colin Aronovicz, Yves; Bertrand, Olivier] INSERM, UMR S1134, F-75015 Paris, France; [Smolarek, Dorota; Hattab, Claude; Cochet, Sylvie; de Brevern, Alexandre G.; Colin Aronovicz, Yves; Bertrand, Olivier] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Buczkowska, Anna] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Wasniowska, Kazimiera; Czerwinski, Marcin] Opole Univ Technol, Inst Physiotherapy, Fac Phys Educ & Physiotherapy, Opole, Poland; [Hattab, Claude; Cochet, Sylvie; de Brevern, Alexandre G.; Colin Aronovicz, Yves; Bertrand, Olivier] Univ Paris Diderot, Sorbonne Paris Cite, F-15013 Paris, France; [Hattab, Claude; Cochet, Sylvie; de Brevern, Alexandre G.; Colin Aronovicz, Yves; Bertrand, Olivier] Lab Excellence GR Ex, Paris, France; [Smolarek, Dorota] Kings Coll London, Guys Hosp, MRC Ctr Transplantat, Div Transplantat Immunol & Mucosal Biol, London WC2R 2LS, England	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Opole University of Technology; UDICE-French Research Universities; Universite Paris Cite; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Czerwinski, M (corresponding author), Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Glycoconjugate Immunochem, Wroclaw, Poland.	czerwins@iitd.pan.wroc.pl	colin, yves/O-1910-2017; de Brevern, Alexandre G./B-4788-2009; Jarzab, Anna/HHN-6781-2022; Cochet, sylvie/I-2721-2015; Jarzab, Anna/AAK-5814-2021	colin, yves/0000-0001-5196-4254; de Brevern, Alexandre G./0000-0001-7112-5626; Jarzab, Anna/0000-0002-1059-9147; Lukasiewicz, Jolanta/0000-0001-8081-7261; Wasniowska, Kazimiera/0000-0001-7629-2589; Czerwinski, Marcin/0000-0003-2859-3699; Jachymek, Wojciech/0000-0001-8963-3020; Kaczmarek, Radoslaw/0000-0001-8084-1958; Niedziela, Tomasz/0000-0002-9333-3175	National Science Centre in Poland [N N 401 536640]	National Science Centre in Poland(National Science Centre, Poland)	This work was supported by a grant from National Science Centre in Poland (Grant No. N N 401 536640). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Batchelor JD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003869; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Bushnell RV, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-200; Carbonnet F, 2000, TRANSFUSION MED, V10, P145; Chen HW, 2009, INFECT IMMUN, V77, P2311, DOI 10.1128/IAI.01298-08; Chen Y, 2014, ARCH VIROL, V159, P1413, DOI 10.1007/s00705-013-1955-5; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; Czerwinski M, 1998, J IMMUNOL, V160, P4406; Czerwinski M, 2002, TRANSFUSION, V42, P257, DOI 10.1046/j.1537-2995.2002.00018.x; Czerwinski M, 2007, BIOCHEM BIOPH RES CO, V356, P816, DOI 10.1016/j.bbrc.2007.03.054; Enriquez-Navas PM, 2012, CHEMBIOCHEM, V13, P1357, DOI 10.1002/cbic.201200119; Enriquez-Navas PM, 2011, CHEM-EUR J, V17, P1547, DOI 10.1002/chem.201002519; Gardner L, 2004, BIOCHEM BIOPH RES CO, V321, P306, DOI 10.1016/j.bbrc.2004.06.146; Goddard T. D., 2001, SPARKY 3; Grodecka M, 2012, GLYCOCONJUGATE J, V29, P93, DOI 10.1007/s10719-011-9367-9; Grodecka M, 2010, ACTA BIOCHIM POL, V57, P49; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Huang LP, 2012, ARCH VIROL, V157, P1339, DOI 10.1007/s00705-012-1268-0; Johnson MA, 2004, BIOORGAN MED CHEM, V12, P295, DOI 10.1016/j.bmc.2003.09.041; Kulkarni H, 2009, BLOOD, V114, P2783, DOI 10.1182/blood-2009-04-215186; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; Lentsch AB, 2002, FASEB J, V16, P1093, DOI 10.1096/fj.02-0066hyp; Maupetit J, 2007, PROTEINS, V69, P394, DOI 10.1002/prot.21505; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mercereau-Puijalon O, 2010, TRANSFUS CLIN BIOL, V17, P176, DOI 10.1016/j.tracli.2010.06.005; Mesleh MF, 2007, J BIOL CHEM, V282, P6338, DOI 10.1074/jbc.M609816200; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Nibbs R, 2003, SEMIN IMMUNOL, V15, P287, DOI 10.1016/j.smim.2003.08.006; Niedziela T, 2005, INFECT IMMUN, V73, P7381, DOI 10.1128/IAI.73.11.7381-7389.2005; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plum M, 2011, J BIOL CHEM, V286, P43103, DOI 10.1074/jbc.M111.291823; Pogo AO, 2000, SEMIN HEMATOL, V37, P122, DOI 10.1016/S0037-1963(00)90037-4; Pons J, 2008, BIOCHEMISTRY-US, V47, P14, DOI 10.1021/bi7014212; Rasamoelisolo M, 1997, VOX SANG, V72, P185, DOI 10.1046/j.1423-0410.1997.7230185.x; Rot A, 2005, CYTOKINE GROWTH F R, V16, P687, DOI 10.1016/j.cytogfr.2005.05.011; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; Shen H, 2006, FASEB J, V20, P59, DOI 10.1096/fj.05-4764com; Smolarek D, 2010, CELL MOL LIFE SCI, V67, P3371, DOI 10.1007/s00018-010-0387-6; Sun GH, 2011, ACTA OTO-LARYNGOL, V131, P197, DOI 10.3109/00016489.2010.516012; Szczepina MG, 2011, CHEM-EUR J, V17, P11446, DOI 10.1002/chem.201100222; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Tournamille C, 2003, BRIT J HAEMATOL, V122, P1014, DOI 10.1046/j.1365-2141.2003.04533.x; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Walton RT, 2008, CELL HOST MICROBE, V4, P3, DOI 10.1016/j.chom.2008.06.006; Wasniowska K, 1996, MOL IMMUNOL, V33, P917; Wasniowska K, 2002, TRANSFUSION MED, V12, P205, DOI 10.1046/j.1365-3148.2002.00373.x; Yermakova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044317	51	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116472	10.1371/journal.pone.0116472	http://dx.doi.org/10.1371/journal.pone.0116472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706384	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100038
J	Zhang, LL; Chen, W; Burger, M; Yang, LJ; Gong, P; Wu, ZJ				Zhang, Lili; Chen, Wei; Burger, Martin; Yang, Lijie; Gong, Ping; Wu, Zhijie			Changes in Soil Carbon and Enzyme Activity As a Result of Different Long-Term Fertilization Regimes in a Greenhouse Field	PLOS ONE			English	Article							MICROBIAL BIOMASS CALIBRATION; FUMIGATION-EXTRACTION METHOD; NITROGEN-FERTILIZATION; ORGANIC-MATTER; BETA-GLUCOSIDASE; CROPPING SYSTEM; PLANT-GROWTH; MANURE; SEQUESTRATION; STABILIZATION	In order to discover the advantages and disadvantages of different fertilization regimes and identify the best management practice of fertilization in greenhouse fields, soil enzyme activities involved in carbon (C) transformations, soil chemical characteristics, and crop yields were monitored after long-term (20-year) fertilization regimes, including no fertilizer (CK), 300 kg N ha-1 and 600 kg N ha-1 as urea (N1 and N2), 75 Mg ha-1 horse manure compost (M), and M with either 300 or 600 kg N ha-1 urea (MN1 and MN2). Compared with CK, fertilization increased crop yields by 31% (N2) to 69% (MN1). However, compared with CK, inorganic fertilization (especially N2) also caused soil acidification and salinization. In the N2 treatment, soil total organic carbon (TOC) decreased from 14.1 +/- 0.27 g kg-1 at the beginning of the long-term experiment in 1988 to 12.6 +/- 0.11 g kg-1 (P<0.05). Compared to CK, N1 and N2 exhibited higher soil alpha-galactosidase and beta-galactosidase activities, but lower soil alpha-glucosidase and beta-glucosidase activities (P<0.05), indicating that inorganic fertilization had different impacts on these C transformation enzymes. Compared with CK, the M, MN1 and MN2 treatments exhibited higher enzyme activities, soil TOC, total nitrogen, dissolved organic C, and microbial biomass C and N. The fertilization regime of the MN1 treatment was identified as optimal because it produced the highest yields and increased soil quality, ensuring sustainability. The results suggest that inorganic fertilizer alone, especially in high amounts, in greenhouse fields is detrimental to soil quality.	[Zhang, Lili; Chen, Wei; Yang, Lijie; Gong, Ping; Wu, Zhijie] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Liaoning, Peoples R China; [Burger, Martin] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Chen, Wei; Yang, Lijie] Univ Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of California System; University of California Davis; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, ZJ (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Liaoning, Peoples R China.	llzhang@iae.ac.cn			National Natural Science Foundation of China [41101242]; Special Fund for Agro-scientific Research in the Public Interest [201303095-9]; National Science & Technology Pillar Program [2011BAD11B04, 2012BAD14B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Science & Technology Pillar Program	his work was supported by the National Natural Science Foundation of China (41101242), Special Fund for Agro-scientific Research in the Public Interest (201303095-9), the National Science & Technology Pillar Program (2011BAD11B04, 2012BAD14B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eliades LA, 2011, J BASIC MICROB, V51, P659, DOI 10.1002/jobm.201100163; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Allison VJ, 2007, SOIL BIOL BIOCHEM, V39, P1770, DOI 10.1016/j.soilbio.2007.02.006; ALVA AK, 1991, SOIL SCI SOC AM J, V55, P357, DOI 10.2136/sssaj1991.03615995005500020009x; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Belay A, 2002, BIOL FERT SOILS, V35, P420, DOI 10.1007/s00374-002-0489-x; Brar BS, 2013, SOIL TILL RES, V128, P30, DOI 10.1016/j.still.2012.10.001; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chen BM, 2004, PLANT SCI, V167, P635, DOI 10.1016/j.plantsci.2004.05.015; EIVAZI F, 1990, SOIL BIOL BIOCHEM, V22, P891, DOI 10.1016/0038-0717(90)90126-K; Eivazi F, 1988, SOIL BIOL BIOCHEM, V42, P2203; Ekenler M, 2003, BIOL FERT SOILS, V39, P51, DOI 10.1007/s00374-003-0664-8; Fonte SJ, 2009, SOIL SCI SOC AM J, V73, P961, DOI 10.2136/sssaj2008.0204; FRANKENBERGER WT, 1982, SOIL SCI SOC AM J, V46, P1173, DOI 10.2136/sssaj1982.03615995004600060011x; Garg S, 2008, BIORESOURCE TECHNOL, V99, P5773, DOI 10.1016/j.biortech.2007.10.063; Hamer U, 2009, APPL SOIL ECOL, V43, P226, DOI 10.1016/j.apsoil.2009.08.001; Hao XH, 2008, NUTR CYCL AGROECOSYS, V81, P17, DOI 10.1007/s10705-007-9145-z; HAYANO K, 1985, SOIL BIOL BIOCHEM, V17, P553, DOI 10.1016/0038-0717(85)90024-0; He FF, 2007, NUTR CYCL AGROECOSYS, V77, P1, DOI 10.1007/s10705-006-6275-7; He XM, 2004, J WOOD SCI, V50, P266, DOI 10.1007/s10086-003-0546-6; Hu YL, 2010, PLANT SOIL, V333, P81, DOI 10.1007/s11104-010-0321-6; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Jorquera MA, 2014, WORLD J MICROB BIOT, V30, P99, DOI 10.1007/s11274-013-1427-9; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Khan SA, 2007, J ENVIRON QUAL, V36, P1821, DOI 10.2134/jeq2007.0099; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Ladha JK, 2011, J ENVIRON QUAL, V40, P1756, DOI 10.2134/jeq2011.0064; Lammirato C, 2010, SOIL BIOL BIOCHEM, V42, P2203, DOI 10.1016/j.soilbio.2010.08.018; Lemke RL, 2010, AGR ECOSYST ENVIRON, V135, P42, DOI 10.1016/j.agee.2009.08.010; Liang B, 2012, PLANT SOIL, V353, P249, DOI 10.1007/s11104-011-1028-z; Liang WJ, 2009, SOIL BIOL BIOCHEM, V41, P883, DOI 10.1016/j.soilbio.2008.06.018; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Lopez-Bellido RJ, 2010, PLANT SOIL, V332, P247, DOI 10.1007/s11104-010-0289-2; Lou Y, 2011, SOIL USE MANAGE, V27, P163, DOI 10.1111/j.1475-2743.2010.00325.x; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Mandal A, 2007, BIORESOURCE TECHNOL, V98, P3585, DOI 10.1016/j.biortech.2006.11.027; Miao YX, 2011, AGRON SUSTAIN DEV, V31, P397, DOI 10.1051/agro/2010034; Pankhurst CE, 2001, BIOL FERT SOILS, V33, P204, DOI 10.1007/s003740000309; Pernes-Debuyser A, 2004, EUR J SOIL SCI, V55, P505, DOI 10.1111/j.1365-2389.2004.00614.x; Pietri JCA, 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI [10.1016/j.soilbio.2008.03.020, 10.1016/i.soilbio.2008.03.020]; Powlson DS, 2010, J ENVIRON QUAL, V39, P749, DOI 10.2134/jeq2010.0001le; QUIQUAMPOIX H, 1989, PROG COLL POL SCI S, V79, P59; Russell AE, 2005, SOIL SCI SOC AM J, V69, P413, DOI 10.2136/sssaj2005.0413; Shen WS, 2010, PLANT SOIL, V337, P137, DOI 10.1007/s11104-010-0511-2; Shi WM, 2009, NUTR CYCL AGROECOSYS, V83, P73, DOI 10.1007/s10705-008-9201-3; SINSABAUGH RL, 1994, SOIL BIOL BIOCHEM, V26, P1305, DOI 10.1016/0038-0717(94)90211-9; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Wang Ji-dong, 2012, Yingyong Shengtai Xuebao, V23, P1031; Yu HY, 2012, SOIL TILL RES, V124, P170, DOI 10.1016/j.still.2012.06.011; Zotarelli L, 2009, AGR WATER MANAGE, V96, P1247, DOI 10.1016/j.agwat.2009.03.019	53	61	66	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118371	10.1371/journal.pone.0118371	http://dx.doi.org/10.1371/journal.pone.0118371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706998	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100174
J	Zhao, FZ; Xu, M; Lei, HC; Zhou, ZQ; Wang, L; Li, P; Zhao, JF; Hu, PH				Zhao, Fengzhi; Xu, Meng; Lei, Honcho; Zhou, Ziqi; Wang, Liang; Li, Ping; Zhao, Jianfu; Hu, Penghui			Clinicopathological Characteristics of Patients with Non-Small-Cell Lung Cancer Who Harbor EML4-ALK Fusion Gene: A Meta-Analysis	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; CLINICAL-FEATURES; ALK REARRANGEMENTS; EGFR; MUTATIONS; ADENOCARCINOMA; CRIZOTINIB; GEFITINIB; SUBSET; MODEL	Background A novel fusion gene of echinoderm microtubule-associated protein-like 4 (EML4) and anaplastic lymphoma kinase (ALK) has been recently identified in non-small-cell lung cancers (NSCLCs). Patients with the EML4-ALK fusion gene demonstrate unique clinicopathological and physiological characteristics. Here we present a meta-analysis of large-scale studies to evaluate the clinicopathological characteristics of NSCLC patients harboring the EML4-ALK fusion gene. Methods Both English and Chinese databases were systematically used to search the materials of the clinicopathological characteristics of patients with NSCLC harboring the EML4-ALK fusion gene. Pooled relative risk (RR) estimates and the 95% confidence intervals (95% CI) were calculated with the fixed or random effect model. Publication bias and chi-square test were also calculated. Results 27 retrospective studies were included in our meta-analysis. These studies included a total of 6950 patients. The incidence rate of EML4-ALK fusion in NSCLC patients was found to be 6.8% (472/6950). The correlation of the EML4-ALK fusion gene and clinicopathological characteristics of NSCLC patients demonstrated a significant difference in smoking status, histological types, stage, and ethnic characteristics. The positive rate of the EML4-ALK fusion gene expression in females were slightly higher than that in males, but not significantly (P = 0.52). In addition, the EML4-ALK fusion gene was mutually exclusive of the EGFR and KRAS mutation genes (P = 0.00). Conclusion Our pooled analysis revealed that the EML4-ALK fusion gene was observed predominantly in adenocarcinoma, non-smoking and NSCLC patients, especially those diagnosed in the advanced clinical stage of NSCLC. Additionally, the EML4-ALK fusion gene was exclusive of the EGFR and KRAS mutation genes. We surmise that IHC assay is a valuable tool for the prescreening of patients with ALK fusion gene in clinical practice, and FISH assay can be performed as a confirmation method. These insights might be helpful in guiding the appropriate molecular target therapy for NSCLC.				xumengjinan@yahoo.com			National Natural Science Foundation of China [81273814]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81273814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Ettinger David S, 2006, J Natl Compr Canc Netw, V4, P548; Fallet V, 2014, EUR J CANCER, V50, P1239, DOI 10.1016/j.ejca.2014.02.001; Fang P, 2013, J MED RES, V42, P109; Giaccone G, 2002, LUNG CANCER-J IASLC, V38, pS29; Greene FL, 2002, J SURG ONCOL, V80, P119, DOI 10.1002/jso.10114; Han XH, 2013, VIRCHOWS ARCH, V463, P583, DOI 10.1007/s00428-013-1472-7; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin G, 2012, J KOREAN MED SCI, V27, P228, DOI 10.3346/jkms.2012.27.2.228; Jokoji R, 2010, J CLIN PATHOL, V63, P1066, DOI 10.1136/jcp.2010.081166; Kim HR, 2012, CANCER-AM CANCER SOC, V118, P729, DOI 10.1002/cncr.26311; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kuo YW, 2010, J THORAC ONCOL, V5, P2039, DOI 10.1097/JTO.0b013e3181f43274; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054369, 10.1371/journal.pone.0055108, 10.1371/journal.pone.0062036, 10.1371/journal.pone.0052093, 10.1371/journal.pone.0063648, 10.1371/journal.pone.0066567, 10.1371/journal.pone.0077685, 10.1371/journal.pone.0071994]; [林小梅 Lin Xiaomei], 2012, [中国病理生理杂志, Chinese Journal of Pathophysiology], V28, P1135; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Nalbandian A, 2009, ONCOGENE, V28, P1928, DOI 10.1038/onc.2009.32; Paik JH, 2012, LUNG CANCER, V76, P403, DOI 10.1016/j.lungcan.2011.11.008; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sanders HR, 2011, CANCER GENET-NY, V204, P45, DOI 10.1016/j.cancergencyto.2010.08.024; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shinmura K, 2008, LUNG CANCER, V61, P163, DOI 10.1016/j.lungcan.2007.12.013; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Solomon B, 2009, J THORAC ONCOL, V4, P1450, DOI 10.1097/JTO.0b013e3181c4dedb; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Takamochi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069794; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Tiseo M, 2011, LUNG CANCER, V71, P241, DOI 10.1016/j.lungcan.2010.11.014; Wang M, 2013, CLIN ONCOLOGY, V18, P688; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Wu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078203; Yang JJ, 2014, CLIN CANCER RES, V20, P1383, DOI 10.1158/1078-0432.CCR-13-0699; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056732; Zhong Shan, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P252, DOI 10.3760/cma.j.issn.0529-5807.2013.04.009	45	41	43	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117333	10.1371/journal.pone.0117333	http://dx.doi.org/10.1371/journal.pone.0117333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706305	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100077
J	Zhou, JP; Cheng, Y; Yin, MQ; Yang, EN; Gong, WP; Liu, C; Zheng, XL; Deng, KJ; Ren, ZL; Zhang, Y				Zhou, Jianping; Cheng, Yan; Yin, Meiqi; Yang, Ennian; Gong, Wenping; Liu, Cheng; Zheng, Xuelian; Deng, Kejun; Ren, Zhenglong; Zhang, Yong			Identification of Novel miRNAs and miRNA Expression Profiling in Wheat Hybrid Necrosis	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; SMALL RNAS; FLORAL DEVELOPMENT; MICRORNAS; GENES; ESTABLISHMENT; BIOGENESIS; METABOLISM; MIR166/165; CHLOROSIS	MicroRNAs (miRNAs) play essential roles in a vast array of biological processes, including growth and development, defense against viral infection, and responses to environmental changes in plant. Wheat hybrid necrosis is an interesting genetic phenomenon observed frequency and it is lethal or semi lethal, resulting in gradual death or loss of productivity. However, the molecular basis and mechanisms associated with hybrid necrosis in wheat are still not well understood. Here, we report the population and expression profiles of miRNAs in wheat hybrid necrosis. We identified a total of 57 conserved miRNA families as well as 182 putative novel miRNAs. Expression profiling revealed that expression of 49 known miRNAs and 165 novel miRNAs was changed in hybrid necrosis. And the expression levels of some miRNAs and their predicated targets have been confirmed by qRT-PCR. These results indicate that these miRNAs, especially miR159, miR166, miR167 and miR5072 could be involved in the extensive regulation of gene expression in response to hybrid necrosis.	[Zhou, Jianping; Cheng, Yan; Yin, Meiqi; Gong, Wenping; Liu, Cheng; Zheng, Xuelian; Deng, Kejun; Zhang, Yong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Yang, Ennian] Sichuan Acad Agr Sci, Crop Res Inst, Chengdu 610066, Peoples R China; [Ren, Zhenglong] Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu 611130, Peoples R China	University of Electronic Science & Technology of China; Sichuan Academy of Agricultural Sciences (SAAS); Sichuan Agricultural University	Zhang, Y (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	zhangyong916@uestc.edu.cn	Zhang, Yong/R-6789-2019	Zhang, Yong/0000-0003-3704-4835	National Natural Science Foundation of China [31271420, 31330017, 30800685]; National Transgenic Major Project [2014ZX0801003B-002]; Applied Fundamental Research Fund of Sichuan Province [2014JY0006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Major Project; Applied Fundamental Research Fund of Sichuan Province	This work was supported by the National Natural Science Foundation of China (No. 31271420, No.31330017 and No. 30800685), the National Transgenic Major Project (No. 2014ZX0801003B-002) and the Applied Fundamental Research Fund of Sichuan Province (No. 2014JY0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bizimungu B, 1998, CAN J PLANT SCI, V78, P239, DOI 10.4141/P96-185; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Caldwell RM, 1943, J HERED, V34, P67, DOI 10.1093/oxfordjournals.jhered.a105248; Chen XM, 2008, CURR TOP MICROBIOL, V320, P117; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chu CG, 2006, THEOR APPL GENET, V112, P1374, DOI 10.1007/s00122-006-0239-9; Dalal M, 1999, BIOCHEM BIOPH RES CO, V262, P109, DOI 10.1006/bbrc.1999.1149; Dalal M, 2001, PHYSIOL PLANTARUM, V111, P297, DOI 10.1034/j.1399-3054.2001.1110306.x; Dryanova A, 2008, GENOME, V51, P433, DOI 10.1139/G08-025; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HERMSEN JGT, 1967, EUPHYTICA, V16, P134, DOI 10.1007/BF00043448; Johnson C, 2007, NUCLEIC ACIDS RES, V35, pD829, DOI 10.1093/nar/gkl991; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Liu QL, 2009, PLANT J, V58, P27, DOI 10.1111/j.1365-313X.2008.03757.x; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Mica E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-558; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nishikawa K., 1974, Japanese Journal of Breeding (Ikushugaku Zasshi), V24, P277; Orr HA, 1996, GENETICS, V144, P1331; Ozhuner E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059543; Pei HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064290; Ramachandran V, 2008, TRENDS PLANT SCI, V13, P368, DOI 10.1016/j.tplants.2008.03.008; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Singh S, 2000, EUPHYTICA, V112, P95, DOI 10.1023/A:1003824910041; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-28; Tomar S. M. S., 1991, Wheat Information Service, P9; Tomar SMS, 1998, EUPHYTICA, V99, P1, DOI 10.1023/A:1018353816039; TSUNEWAKI K, 1992, GENOME, V35, P594, DOI 10.1139/g92-089; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048445; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yao YY, 2010, FUNCT INTEGR GENOMIC, V10, P187, DOI 10.1007/s10142-010-0163-6; Zeven A. C., 1972, Wheat Information Service, P4; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang L, 2009, PLOS GENET, V5; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107; Zuo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-7	68	15	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117507	10.1371/journal.pone.0117507	http://dx.doi.org/10.1371/journal.pone.0117507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706289	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100097
J	O'Loughlin, JL; Eucker, TP; Chavez, JD; Samuelson, DR; Neal-McKinney, J; Gourley, CR; Bruce, JE; Konkel, ME				O'Loughlin, Jason L.; Eucker, Tyson P.; Chavez, Juan D.; Samuelson, Derrick R.; Neal-McKinney, Jason; Gourley, Christopher R.; Bruce, James E.; Konkel, Michael E.			Analysis of the Campylobacter jejuni Genome by SMRT DNA Sequencing Identifies Restriction-Modification Motifs	PLOS ONE			English	Article							VIRULENCE GENE; REVEALS; INFECTION; DIVERSITY; ENTERITIS	Campylobacter jejuni is a leading bacterial cause of human gastroenteritis. The goal of this study was to analyze the C. jejuni F38011 strain, recovered from an individual with severe enteritis, at a genomic and proteomic level to gain insight into microbial processes. The C. jejuni F38011 genome is comprised of 1,691,939 bp, with a mol.% (G+C) content of 30.5%. PacBio sequencing coupled with REBASE analysis was used to predict C. jejuni F38011 genomic sites and enzymes that may be involved in DNA restriction-modification. A total of five putative methylation motifs were identified as well as the C. jejuni enzymes that could be responsible for the modifications. Peptides corresponding to the deduced amino acid sequence of the C. jejuni enzymes were identified using proteomics. This work sets the stage for studies to dissect the precise functions of the C. jejuni putative restrictionmodification enzymes. Taken together, the data generated in this study contributes to our knowledge of the genomic content, methylation profile, and encoding capacity of C. jejuni.	[O'Loughlin, Jason L.; Eucker, Tyson P.; Samuelson, Derrick R.; Neal-McKinney, Jason; Gourley, Christopher R.; Konkel, Michael E.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA; [Chavez, Juan D.; Bruce, James E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Washington State University; University of Washington; University of Washington Seattle	Konkel, ME (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.	konkel@vetmed.wsu.edu	Samuelson, Derrick/AAR-4230-2021; Samuelson, Derrick/AAC-9132-2019	Samuelson, Derrick/0000-0002-5356-1413; Chavez, Juan/0000-0001-8849-0304; Konkel, Michael/0000-0002-8950-0903	National Institutes of Health (NIH) [R56 AI088518-01A1, 5R01GM086688]; National Institutes of Health T32 Training program in Infectious Diseases and Microbial Immunology [5 T32 AI 7025-33]; National Institute of General Medical Sciences (NIGMS) [T32GM008336, T32GM083864]; NIGMS [T32GM083864]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025, R56AI088518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336, R01GM086688, T32GM083864] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health T32 Training program in Infectious Diseases and Microbial Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds awarded by the National Institutes of Health (NIH) to Michael E. Konkel (Award Number R56 AI088518-01A1). Jason L. O'Loughlin was supported, in part, by funds awarded by the National Institutes of Health T32 Training program in Infectious Diseases and Microbial Immunology (Award Number 5 T32 AI 7025-33). Tyson P. Eucker was supported, in part, by funds awarded by the National Institute of General Medical Sciences (NIGMS, Award Number T32GM008336 and T32GM083864). Derrick R. Samuelson was supported, in part, by funds awarded by NIGMS (T32GM083864). James E. Bruce and Juan D. Chavez were supported by funds awarded by the NIH (Award Number 5R01GM086688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa K, 2012, CURR GENOMICS, V13, P4, DOI 10.2174/138920212799034749; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; Biggs PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027121; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1979, ANN INTERN MED, V91, P179, DOI 10.7326/0003-4819-91-2-179; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Choe W, 2005, BIOCHEM BIOPH RES CO, V334, P1233, DOI 10.1016/j.bbrc.2005.07.017; Christensen JE, 2009, MOL MICROBIOL, V73, P650, DOI 10.1111/j.1365-2958.2009.06797.x; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Cooper KK, 2011, J BACTERIOL, V193, P1491, DOI 10.1128/JB.01475-10; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DEKEYSER P, 1972, J INFECT DIS, V125, P390, DOI 10.1093/infdis/125.4.390; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Duong T, 2009, CURR OPIN BIOTECH, V20, P158, DOI 10.1016/j.copbio.2009.03.004; Feng ZX, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002935; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gilbert M, 2007, CHEMBIOCHEM, V8, P625, DOI 10.1002/cbic.200600508; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Konkel M E, 2001, Curr Issues Intest Microbiol, V2, P55; KONKEL ME, 1992, J MED MICROBIOL, V37, P30, DOI 10.1099/00222615-37-1-30; Konkel ME, 1999, J CLIN MICROBIOL, V37, P510, DOI 10.1128/JCM.37.3.510-517.1999; Kramer JM, 2000, J FOOD PROTECT, V63, P1654, DOI 10.4315/0362-028X-63.12.1654; Krebes J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/nar/gkt1201; Malik-Kale P, 2008, J BACTERIOL, V190, P2286, DOI 10.1128/JB.01736-07; Malik-Kale P, 2007, APPL ENVIRON MICROB, V73, P3123, DOI 10.1128/AEM.01399-06; Miller WG, 2005, MICROBIOL-SGM, V151, P337, DOI 10.1099/mic.0.27327-0; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Poly F, 2005, J CLIN MICROBIOL, V43, P2330, DOI 10.1128/JCM.43.5.2330-2338.2005; Raphael BH, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P397; Ratel D, 2006, FEBS LETT, V580, P3179, DOI 10.1016/j.febslet.2006.04.074; Samuelson DR, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-79; Schwerer B, 2002, MICROBES INFECT, V4, P373, DOI 10.1016/S1286-4579(02)01550-2; SEBALD M, 1963, ANN I PASTEUR PARIS, V105, P897; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Weisbrod CR, 2013, J PROTEOMICS, V88, P109, DOI 10.1016/j.jprot.2013.04.009; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Wilson MK, 2009, MICROB ECOL, V58, P843, DOI 10.1007/s00248-009-9571-3; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Zhang MJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00256-13	45	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118533	10.1371/journal.pone.0118533	http://dx.doi.org/10.1371/journal.pone.0118533			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695747	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300054
J	Wang, J; Shapira, P				Wang, Jue; Shapira, Philip			Is There a Relationship between Research Sponsorship and Publication Impact? An Analysis of Funding Acknowledgments in Nanotechnology Papers	PLOS ONE			English	Article							INFORMATION-SCIENCE; BASIC RESEARCH; CITATION	This study analyzes funding acknowledgments in scientific papers to investigate relationships between research sponsorship and publication impacts. We identify acknowledgments to research sponsors for nanotechnology papers published in the Web of Science during a one-year sample period. We examine the citations accrued by these papers and the journal impact factors of their publication titles. The results show that publications from grant sponsored research exhibit higher impacts in terms of both journal ranking and citation counts than research that is not grant sponsored. We discuss the method and models used, and the insights provided by this approach as well as it limitations.	[Wang, Jue] Nanyang Technol Univ, Sch Humanities & Social Sci, Publ Policy & Global Affairs Program, Singapore 639798, Singapore; [Shapira, Philip] Univ Manchester, Manchester Business Sch, Manchester Inst Innovat Res, Manchester M13 9PL, Lancs, England; [Shapira, Philip] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Manchester; University System of Georgia; Georgia Institute of Technology	Shapira, P (corresponding author), Univ Manchester, Manchester Business Sch, Manchester Inst Innovat Res, Manchester M13 9PL, Lancs, England.	pshapira@mbs.ac.uk	Shapira, Philip/E-4638-2011; Wang, Jue/P-6168-2014	Shapira, Philip/0000-0003-2488-5985; Wang, Jue/0000-0002-3401-713X	Center for Nanotechnology in Society at Arizona State University (CNS-ASU) under National Science Foundation [0531194]; Manchester Institute of Innovation Research, at the Manchester Business School, University of Manchester	Center for Nanotechnology in Society at Arizona State University (CNS-ASU) under National Science Foundation; Manchester Institute of Innovation Research, at the Manchester Business School, University of Manchester	This research was supported in part by the Center for Nanotechnology in Society at Arizona State University (CNS-ASU) under National Science Foundation Grant No. 0531194. (http://www.nsf.gov) (PS JW). Additional support was provided by the Manchester Institute of Innovation Research, at the Manchester Business School, University of Manchester. (https://research.mbs.ac.uk/innovation/) (PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JD, 1998, ANN EC STAT, V49; Aksnes DW, 2003, RES EVALUAT, V12, P159, DOI 10.3152/147154403781776645; [Anonymous], 1974, EFFECTS R D PRODUCTI; [Anonymous], 2008, INT SCI ENG PARTN PR; Butler L, 2001, RES EVALUAT, V10, P59, DOI 10.3152/147154401781777141; Campbell D, 2010, AM J EVAL, V31, P66, DOI 10.1177/1098214009354774; Costas R, 2012, J AM SOC INF SCI TEC, V63, P1647, DOI 10.1002/asi.22692; Cronin B, 1999, J DOC, V55, P402, DOI 10.1108/EUM0000000007153; Decker RS, 2011, PROFILE FEDERAL GRAN; EPSRC, 2013, PEER REV PRINCP; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; Griliches Z, 1985, W1547 NBER; HARTER SP, 1992, J AM SOC INFORM SCI, V43, P583, DOI 10.1002/(SICI)1097-4571(199210)43:9<583::AID-ASI1>3.0.CO;2-O; HARTER SP, 1990, LIBR INFORM SCI RES, V12, P263; Huang Z, 2006, J NANOPART RES, V8, P859, DOI 10.1007/s11051-006-9147-9; KING J, 1987, J INFORM SCI, V13, P261, DOI 10.1177/016555158701300501; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Langfeldt L, 2001, SOC STUD SCI, V31, P820, DOI 10.1177/030631201031006002; Lewison G, 2003, INT J LANG COMM DIS, V38, P48; Lichtenberg FR, 1985, PAP COMM WORKSH FED, P115; Long J.S., 2006, REGRESSION MODELS CA; MACROBERTS MH, 1989, J AM SOC INFORM SCI, V40, P342, DOI 10.1002/(SICI)1097-4571(198909)40:5<342::AID-ASI7>3.0.CO;2-U; MANSFIELD E, 1980, AM ECON REV, V70, P863; MANSFIELD E, 1981, HARVARD BUS REV, V59, P98; Martin B.R., 1996, RELATIONSHIP PUBLICL; McAllister PR, 1983, IEEE T ENG MANAGE, VEM-30, P4; NARIN F, 1991, SCIENTOMETRICS, V21, P313, DOI 10.1007/BF02093973; National Science Foundation, 2014, PROGR SOL, P13; NIH, 2011, PEER REV PROC; NSF, 2013, 141 NSF, DOI 10.14802/jmd.14038; NSF, 2011, SCI SCI INN POL SCIS, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; OECD, 2011, MAIN SCI TECHN IND M, DOI [10.1787/msti-v2011-1-en-fr, DOI 10.1787/MSTI-V2011-1-EN-FR]; Paasi M, 1998, EC SYSTEMS, V22, P217; PAVITT K, 1991, RES POLICY, V20, P109, DOI 10.1016/0048-7333(91)90074-Z; Payne A.A., 2003, ADV EC ANAL POLICY, V3, P1, DOI [10.2202/1538-0637.1018, DOI 10.2202/1538-0637.1018]; Pendlebury DA, 2012, SCIENTOMETRICS, V92, P395, DOI 10.1007/s11192-012-0689-6; Porter AL, 2008, J NANOPART RES, V10, P715, DOI 10.1007/s11051-007-9266-y; RISTEX, 2011, R D PROGR SCI SCI TE; Sandstrom U, 2009, SCIENTOMETRICS, V79, P341, DOI 10.1007/s11192-009-0422-2; Shapira P, 2010, NATURE, V468, P627, DOI 10.1038/468627a; SOLOW RM, 1957, REV ECON STAT, V39, P312, DOI 10.2307/1926047; Terleckyj NE, 1985, PAP COMM WORKSH FED, P151; Thomson Reuters, 2012, J CITATION REPORTS J; Trochim WM, 2008, AM J EVAL, V29, P8, DOI 10.1177/1098214007309280; van Leeuwen TN, 2001, RES EVALUAT, V10, P195, DOI 10.3152/147154401781777015; Wang J, 2011, SCIENTOMETRICS, V87, P563, DOI 10.1007/s11192-011-0362-5; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th	47	83	83	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117727	10.1371/journal.pone.0117727	http://dx.doi.org/10.1371/journal.pone.0117727			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695739	Green Published, gold			2022-12-27	WOS:000350062300029
J	Samanas, NB; Commers, TW; Dennison, KL; Harenda, QE; Kurz, SG; Lachel, CM; Wavrin, KL; Bowler, M; Nijman, IJ; Guryev, V; Cuppen, E; Hubner, N; Sullivan, R; Vezina, CM; Shull, JD				Samanas, Nyssa Becker; Commers, Tessa W.; Dennison, Kirsten L.; Harenda, Quincy Eckert; Kurz, Scott G.; Lachel, Cynthia M.; Wavrin, Kristen Leland; Bowler, Michael; Nijman, Isaac J.; Guryev, Victor; Cuppen, Edwin; Hubner, Norbert; Sullivan, Ruth; Vezina, Chad M.; Shull, James D.			Genetic Etiology of Renal Agenesis: Fine Mapping of Renag1 and Identification of Kit as the Candidate Functional Gene	PLOS ONE			English	Article							INDUCED MAMMARY-CANCER; CONGENITAL BILATERAL ABSENCE; INDUCED PITUITARY GROWTH; COPENHAGEN RAT STRAINS; AFFECTED SIB-PAIRS; URINARY-TRACT; VESICOURETERAL REFLUX; VAS-DEFERENS; ACI RAT; UROGENITAL TRACT	Congenital anomalies of the kidney and urogenital tract (CAKUT) occur in approximately 0.5% of live births and represent the most frequent cause of end-stage renal disease in neonates and children. The genetic basis of CAKUT is not well defined. To understand more fully the genetic basis of one type of CAKUT, unilateral renal agenesis (URA), we are studying inbred ACI rats, which spontaneously exhibit URA and associated urogenital anomalies at an incidence of approximately 10%. URA is inherited as an incompletely dominant trait with incomplete penetrance in crosses between ACI and Brown Norway (BN) rats and a single responsible genetic locus, designated Renag1, was previously mapped to rat chromosome 14 (RNO14). The goals of this study were to fine map Renag1, identify the causal genetic variant responsible for URA, confirm that the Renag1 variant is the sole determinant of URA in the ACI rat, and define the embryologic basis of URA in this rat model. Data presented herein localize Renag1 to a 379 kilobase (kb) interval that contains a single protein coding gene, Kit (v-kit Hardy-Zukerman 4 feline sarcoma viral oncogene homolog); identify an endogenous retrovirus-derived long terminal repeat located within Kit intron 1 as the probable causal variant; demonstrate aberrant development of the nephric duct in the anticipated number of ACI rat embryos; and demonstrate expression of Kit and Kit ligand (Kitlg) in the nephric duct. Congenic rats that harbor ACI alleles at Renag1 on the BN genetic background exhibit the same spectrum of urogenital anomalies as ACI rats, indicating that Renag1 is necessary and sufficient to elicit URA and associated urogenital anomalies. These data reveal the first genetic link between Kit and URA and illustrate the value of the ACI rat as a model for defining the mechanisms and cell types in which Kit functions during urogenital development.	[Samanas, Nyssa Becker; Dennison, Kirsten L.; Harenda, Quincy Eckert; Wavrin, Kristen Leland; Bowler, Michael; Shull, James D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA; [Commers, Tessa W.; Kurz, Scott G.; Lachel, Cynthia M.; Wavrin, Kristen Leland; Shull, James D.] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Nijman, Isaac J.; Guryev, Victor; Cuppen, Edwin] Hubrecht Inst, Utrecht, Netherlands; [Hubner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany; [Sullivan, Ruth] Univ Wisconsin, Grad Sch, Res Anim Resources Ctr, Madison, WI 53706 USA; [Sullivan, Ruth; Vezina, Chad M.; Shull, James D.] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA; [Vezina, Chad M.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Nebraska System; University of Nebraska Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shull, JD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA.	shull@oncology.wisc.edu	Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; Vezina, Chad/GRO-2299-2022	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Vezina, Chad/0000-0001-7058-5399; Guryev, Victor/0000-0002-5810-6022	National Institutes of Health [DK070669, CA68529, CA77876]; Cancer Center Support, from the National Cancer Institute [P30-CA036727, P30-CA014520]; NATIONAL CANCER INSTITUTE [R01CA077876, R01CA068529, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK070669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support, from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK070669 (JDS), CA68529 (JDS) and CA77876 (JDS) from the National Institutes of Health (http://www.nih.gov/). Shared research resources at the University of Nebraska Medical Center and the University of Wisconsin-Madison were supported by Cancer Center Support Grants P30-CA036727 (JDS) and P30-CA014520 (JDS), respectively, from the National Cancer Institute (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler LL, 2011, JOVE-J VIS EXP, DOI 10.3791/2912; Abler LL, 2011, DEV DYNAM, V240, P2364, DOI 10.1002/dvdy.22730; Acien P, 2010, ACTA OBSTET GYN SCAN, V89, P1424, DOI 10.3109/00016349.2010.512067; Acien P, 2009, FERTIL STERIL, V91, P2369, DOI 10.1016/j.fertnstert.2008.01.079; Amakasu K, 2009, COMPARATIVE MED, V59, P249; ARFEEN S, 1993, AM J KIDNEY DIS, V21, P663, DOI 10.1016/S0272-6386(12)80041-2; ASHLEY DJB, 1960, J UROLOGY, V83, P211, DOI 10.1016/S0022-5347(17)65695-7; Ashraf S, 2010, NEPHROL DIAL TRANSPL, V25, P1496, DOI 10.1093/ndt/gfp650; AUGARTEN A, 1994, LANCET, V344, P1473, DOI 10.1016/S0140-6736(94)90292-5; Aveiro AC, 2011, BMJ CASE REP, V2011; BARAKAT AJ, 1991, UROLOGY, V38, P347, DOI 10.1016/0090-4295(91)80150-6; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Bellone RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078280; Bernex F, 1996, DEVELOPMENT, V122, P3023; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; Briggs CE, 2010, EUR J HUM GENET, V18, P245, DOI 10.1038/ejhg.2009.142; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; CARTER CO, 1979, J MED GENET, V16, P176, DOI 10.1136/jmg.16.3.176; Chia I, 2011, DEVELOPMENT, V138, P2089, DOI 10.1242/dev.056838; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Colletti JA, 2014, G3-GENES GENOM GENET, V4, P1385, DOI 10.1534/g3.114.011163; Conte ML, 2008, PEDIATR NEPHROL, V23, P587, DOI 10.1007/s00467-007-0675-z; CRAMER DV, 1975, TERATOLOGY, V12, P27, DOI 10.1002/tera.1420120104; Darlow JM, 2014, MOL GENET GENOM MED, V2, P7, DOI 10.1002/mgg3.22; DERINGER MK, 1956, P SOC EXP BIOL MED, V91, P312; Doray B, 1999, GENET COUNSEL, V10, P251; Feather SA, 2000, AM J HUM GENET, V66, P1420, DOI 10.1086/302864; FUJIKURA T, 1970, TERATOLOGY, V3, P245, DOI 10.1002/tera.1420030306; FUJITA K, 1979, LAB ANIM, V13, P325, DOI 10.1258/002367779780943323; Gholoum S, 2006, J PEDIATR SURG, V41, P987, DOI 10.1016/j.jpedsurg.2006.01.021; Gould KA, 2004, GENETICS, V168, P2113, DOI 10.1534/genetics.104.033878; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Kerecuk L, 2008, NAT CLIN PRACT NEPHR, V4, P312, DOI 10.1038/ncpneph0807; Kolettis PN, 2002, UROLOGY, V60, P1073, DOI 10.1016/S0090-4295(02)01973-8; Kuramoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043059; Kurz SG, 2014, MAMM GENOME, V25, P244, DOI 10.1007/s00335-014-9504-4; Lachel CM, 2003, COL SPRING HARB LAB, P83; Laulederkind SJF, 2013, BRIEF BIOINFORM, V14, P520, DOI 10.1093/bib/bbt007; Lawrence MG, 2012, ENDOCRINOLOGY, V153, P3199, DOI 10.1210/en.2012-1267; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; MANOVA K, 1991, DEV BIOL, V146, P312, DOI 10.1016/0012-1606(91)90233-S; Marchini GS, 2012, BJU INT, V109, P1709, DOI 10.1111/j.1464-410X.2011.10634.x; MARSHALL F F, 1978, Urology, V11, P58, DOI 10.1016/0090-4295(78)90201-7; MARSHALL FF, 1982, J UROLOGY, V127, P155, DOI 10.1016/S0022-5347(17)53651-4; McCallum TJ, 2001, HUM REPROD, V16, P282, DOI 10.1093/humrep/16.2.282; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; MIHARA M, 1992, ACTA PAEDIATR, V81, P326, DOI 10.1111/j.1651-2227.1992.tb12236.x; MORGAN WC, 1953, ANAT REC, V115, P635, DOI 10.1002/ar.1091150405; Nigam R, 2013, PHYSIOL GENOMICS, V45, P809, DOI 10.1152/physiolgenomics.00065.2013; NIWA Y, 1991, BLOOD, V78, P1936; Pohl M, 2002, KIDNEY INT, V61, P10, DOI 10.1046/j.1523-1755.2002.00086.x; Pye SM, 2008, BLOOD, V111, P5505, DOI 10.1182/blood-2007-10-114900; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.1002/cpp.1875, DOI 10.1002/CPP.1875]; ROODHOOFT M, 1984, NEW ENGL J MED, V310, P1341, DOI 10.1056/NEJM198405243102101; Rozen S, 2000, Methods Mol Biol, V132, P365; Saisawat P, 2012, KIDNEY INT, V81, P196, DOI 10.1038/ki.2011.315; Sanna-Cherchi S, 2013, NEW ENGL J MED, V369, P621, DOI 10.1056/NEJMoa1214479; Sanna-Cherchi S, 2007, PEDIATR NEPHROL, V22, P1675, DOI 10.1007/s00467-007-0479-1; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; Schaffer BS, 2006, CANCER RES, V66, P7793, DOI 10.1158/0008-5472.CAN-06-0143; Schaffer BS, 2013, CANCER PREV RES, V6, P59, DOI 10.1158/1940-6207.CAPR-12-0346-T; SCHIMKE RN, 1980, CLIN GENET, V18, P417; Schmidt-Ott KM, 2006, DEV BIOL, V299, P238, DOI 10.1016/j.ydbio.2006.07.026; Schwaderer AL, 2007, PEDIATR NEPHROL, V22, P52, DOI 10.1007/s00467-006-0295-z; SERIKAWA T, 1992, GENETICS, V131, P701; SHEIH CP, 1989, PEDIATRICS, V84, P1086; Shull JD, 2006, MAMM GENOME, V17, P751, DOI 10.1007/s00335-006-0004-z; SOLLEVELD H A, 1986, Toxicologic Pathology, V14, P168, DOI 10.1177/019262338601400204; Soofi A, 2012, DEV BIOL, V365, P241, DOI 10.1016/j.ydbio.2012.02.032; Spady TJ, 1999, ENDOCRINOLOGY, V140, P2828, DOI 10.1210/en.140.6.2828; SPRITZ RA, 1992, AM J MED GENET, V44, P492, DOI 10.1002/ajmg.1320440422; Strecker TE, 2005, GENETICS, V169, P2189, DOI 10.1534/genetics.104.039370; Torigoe D, 2011, J VET MED SCI, V73, P707, DOI 10.1292/jvms.10-0529; TSUJIMURA T, 1991, BLOOD, V78, P1942; Vercellini P, 2007, FERTIL STERIL, V87, P719, DOI 10.1016/j.fertnstert.2007.01.173; Wang X, 2014, J AM SOC NEPHROL; Wang YM, 2010, GENOME RES, V20, P19, DOI 10.1101/gr.100073.109; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Weng PL, 2009, J AM SOC NEPHROL, V20, P1633, DOI 10.1681/ASN.2008111199; Westland R, 2013, PEDIATRICS, V131, pE478, DOI 10.1542/peds.2012-2088; Westland R, 2012, NEPHROL DIAL TRANSPL, V27, P2603, DOI 10.1093/ndt/gfr625; Woods LCS, 2010, AM J PHYSIOL-RENAL, V298, pF1484, DOI 10.1152/ajprenal.00002.2010; YAMAMOTO Y, 1989, AM J MED GENET, V32, P520, DOI 10.1002/ajmg.1320320419; Yamashita S, 2005, CANCER RES, V65, P2610, DOI 10.1158/0008-5472.CAN-04-2932; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	91	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118147	10.1371/journal.pone.0118147	http://dx.doi.org/10.1371/journal.pone.0118147			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693193	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350061500103
J	Weiland, TJ; Jelinek, GA; Marck, CH; Hadgkiss, EJ; van der Meer, DM; Pereira, NG; Taylor, KL				Weiland, Tracey J.; Jelinek, George A.; Marck, Claudia H.; Hadgkiss, Emily J.; van der Meer, Dania M.; Pereira, Naresh G.; Taylor, Keryn L.			Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet	PLOS ONE			English	Article							QUALITY-OF-LIFE; ENVIRONMENTAL-FACTORS; PHYSICAL-ACTIVITY; NARCOMS-REGISTRY; DEPRESSION; DISEASE; DISABILITY; VALIDITY; BEHAVIOR; IMPACT	Background Fatigue contributes a significant burden of disease for people with multiple sclerosis (PwMS). Modifiable lifestyle factors have been recognized as having a role in a range of morbidity outcomes in PwMS. There is significant potential to prevent and treat fatigue in PwMS by addressing modifiable risk factors. Objectives To explore the associations between clinically significant fatigue and demographic factors, clinical factors (health-related quality of life, disability and relapse rate) and modifiable lifestyle, disease-modifying drugs (DMD) and supplement use in a large international sample of PwMS. Methods PwMS were recruited to the study via Web 2.0 platforms and completed a comprehensive survey measuring demographic, lifestyle and clinical characteristics, including health-related quality of life, disability, and relapse rate. Results Of 2469 participants with confirmed MS, 2138 (86.6%) completed a validated measure of clinically significant fatigue, the Fatigue Severity Scale. Participants were predominantly female from English speaking countries, with relatively high levels of education, and due to recruitment methods may have been highly pro-active about engaging in lifestyle management and self-help. Approximately two thirds of our sample (1402/2138; 65.6% 95% CI 63.7-67.7)) screened positive for clinically significant fatigue. Bivariate associations were present between clinically significant fatigue and several demographic, clinical, lifestyle, and medication variables. After controlling for level of disability and a range of stable socio-demographic variables, we found increased odds of fatigue associated with obesity, DMD use, poor diet, and reduced odds of fatigue with exercise, fish consumption, moderate alcohol use, and supplementation with vitamin D and flaxseed oil. Conclusion This study supports strong and significant associations between clinically significant fatigue and modifiable lifestyle factors. Longitudinal follow-up of this sample may help clarify the contribution of reverse causation to our findings. Further research is required to explore these associations including randomized controlled trials of lifestyle interventions that may	[Weiland, Tracey J.; Jelinek, George A.; Marck, Claudia H.; Hadgkiss, Emily J.; van der Meer, Dania M.] St Vincents Hosp, Emergency Practice Innovat Ctr, Melbourne, Vic, Australia; [Weiland, Tracey J.; Jelinek, George A.; Taylor, Keryn L.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Pereira, Naresh G.] Notre Dame Univ, Fac Med, Fremantle, WA 6959, Australia; [Taylor, Keryn L.] St Vincents Hosp Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Jelinek, George A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	St Vincent's Hospital Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; University of Notre Dame Australia; St Vincent's Hospital Melbourne; Monash University	Weiland, TJ (corresponding author), St Vincents Hosp, Emergency Practice Innovat Ctr, Melbourne, Vic, Australia.	Tracey.Weiland@svhm.org.au	Weiland, Tracey/Y-2029-2018	Weiland, Tracey/0000-0002-4053-5507; TAYLOR, KERYN/0000-0001-7543-4362; Jelinek, George/0000-0001-6157-0910; Marck, Claudia/0000-0002-3173-1522	Bloom Foundation; Horne Family Charitable Trust; Elizabeth Schefferle	Bloom Foundation; Horne Family Charitable Trust; Elizabeth Schefferle	The authors thank all the participants in the HOLISM study for taking the survey. The authors thank the Bloom Foundation, the Horne Family Charitable Trust, and Elizabeth Schefferle for their grants and donations supporting this study. Professor George Jelinek obtained the funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2001, MULT SCLER J, V7, P340, DOI 10.1191/135245801681138059; Asano M, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/798285; BLAKE RL, 1986, J FAM PRACTICE, V22, P82; Blikman LJ, 2013, ARCH PHYS MED REHAB, V94, P1360, DOI 10.1016/j.apmr.2013.01.025; Bol Y, 2010, J BEHAV MED, V33, P355, DOI 10.1007/s10865-010-9266-8; Bol Y, 2009, J PSYCHOSOM RES, V66, P3, DOI 10.1016/j.jpsychores.2008.05.003; Braley TJ, 2010, SLEEP, V33, P1061, DOI 10.1093/sleep/33.8.1061; Branas P., 2000, HLTH TECHNOL ASSESS, V4, P1, DOI [DOI 10.3310/HTA4270, 10.3310/hta4270]; Carter A, 2014, MULT SCLER J, V20, P1112, DOI 10.1177/1352458513519354; COLOSIMO C, 1995, ACTA NEUROL SCAND, V92, P353; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Ridder D, 2004, J PSYCHOSOM RES, V56, P341, DOI 10.1016/S0022-3999(03)00034-5; Feinstein A, 1999, CLIN NEUROPSYCHIATRY; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Flachenecker P, 2004, MULT SCLER J, V10, P165, DOI 10.1191/1352458504ms991oa; Flensner G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-224; Flensner G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-27; Ford H, 1998, J PSYCHOSOM RES, V45, P33, DOI 10.1016/S0022-3999(98)00004-X; FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135; Gold SM, 2003, MULT SCLER J, V9, P404, DOI 10.1191/1352458503ms927oa; Grossman P, 2010, NEUROLOGY, V75, P1141, DOI 10.1212/WNL.0b013e3181f4d80d; Hadgkiss EJ, 2014, NUTR NEUROSCI; Hadgkiss EJ, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/580596; Hadjimichael O, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-100; Heesen C, 2006, J NEUROL NEUROSUR PS, V77, P34, DOI 10.1136/jnnp.2005.065805; HIRSCH RL, 1985, J CLIN IMMUNOL, V5, P386, DOI 10.1007/BF00915335; Hohol MJ, 1999, MULT SCLER, V5, P349, DOI 10.1177/135245859900500508; Holper L, 2010, J NEUROL, V257, P103, DOI 10.1007/s00415-009-5282-4; Ingram G, 2010, MULT SCLER J, V16, P472, DOI 10.1177/1352458509358902; Janardhan V, 2002, J NEUROL SCI, V205, P51, DOI 10.1016/S0022-510X(02)00312-X; Kos D, 2008, NEUROREHAB NEURAL RE, V22, P91, DOI 10.1177/1545968306298934; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Krupp L, 2006, MULT SCLER J, V12, P367, DOI 10.1191/135248506ms1373ed; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KRUPP LB, 1988, ARCH NEUROL-CHICAGO, V45, P435, DOI 10.1001/archneur.1988.00520280085020; Lerdal A, 2007, EUR J NEUROL, V14, P1338, DOI 10.1111/j.1468-1331.2007.01974.x; Lerdal A, 2003, MULT SCLER J, V9, P509, DOI 10.1191/1352458503ms943oa; Marrie RA, 2007, MULT SCLER, V13, P770, DOI 10.1177/1352458506075031; Marrie RA, 2005, MULT SCLER, V11, P583, DOI 10.1191/1352458505ms1216oa; Marrie RA, 2011, NEUROL CLIN, V29, P323, DOI 10.1016/j.ncl.2010.12.004; McKellar S, 2008, AUSTR J PRIMARY HLTH; Minden SL, 2006, MULT SCLER J, V12, P24, DOI 10.1191/135248506ms1262oa; Moore P, 2013, MULT SCLER J, V19, P1647, DOI 10.1177/1352458513481396; Patrick E, 2009, MULT SCLER J, V15, P258, DOI 10.1177/1352458508097466; Penner IK, 2007, MULT SCLER, V13, P1161, DOI 10.1177/1352458507079267; Pittion-Vouyovitch S, 2006, J NEUROL SCI, V243, P39, DOI 10.1016/j.jns.2005.11.025; Ramagopalan SV, 2010, EUR J NEUROL, V17, P634, DOI 10.1111/j.1468-1331.2009.02850.x; Rocca MA, 2014, RADIOLOGY; Sangelaji B, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.17173; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Simioni S, 2007, SWISS MED WKLY, V137, P496; Sjonnesen K, 2012, POSTGRAD MED, V124, P69, DOI 10.3810/pgm.2012.09.2595; Smedal T, 2011, EUR J NEUROL, V18, P114, DOI 10.1111/j.1468-1331.2010.03090.x; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; TACHIBANA N, 1994, EUR NEUROL, V34, P320, DOI 10.1159/000117070; Taylor KL, 2014, LIFESTYLE FACTORS DE; Thomas PW, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-109; Trojan DA, 2007, MULT SCLER J, V13, P985, DOI 10.1177/1352458507077175; van der Mei IAF, 2011, NEUROL CLIN, V29, P233, DOI 10.1016/j.ncl.2010.12.007; van Kessel K, 2008, PSYCHOSOM MED, V70, P205, DOI 10.1097/PSY.0b013e3181643065; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Weikert M, 2010, J NEUROL SCI, V290, P6, DOI 10.1016/j.jns.2009.12.021; Weiland TJ, 2013, J NEUROL SCI, DOI [10.1016/j.ins.2013.12.037, DOI 10.1016/J.INS.2013.12.037]; Weiland TJ, 2014, J NEUROL SCI, V336, P211, DOI 10.1016/j.jns.2013.10.046; World Health Organization, 2006, GLOB DAT BOD MASS IN	65	82	82	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115541	10.1371/journal.pone.0115541	http://dx.doi.org/10.1371/journal.pone.0115541			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25692993	gold, Green Published			2022-12-27	WOS:000350061500010
J	Koper, T; Polit, A; Sobiecka-Szkatula, A; Wegrzyn, K; Scire, A; Figaj, D; Kadzinski, L; Zarzecka, U; Zurawa-Janicka, D; Banecki, B; Lesner, A; Tanfani, F; Lipinska, B; Skorko-Glonek, J				Koper, Tomasz; Polit, Agnieszka; Sobiecka-Szkatula, Anna; Wegrzyn, Katarzyna; Scire, Andrea; Figaj, Donata; Kadzinski, Leszek; Zarzecka, Urszula; Zurawa-Janicka, Dorota; Banecki, Bogdan; Lesner, Adam; Tanfani, Fabio; Lipinska, Barbara; Skorko-Glonek, Joanna			Analysis of the Link between the Redox State and Enzymatic Activity of the HtrA (DegP) Protein from Escherichia coli	PLOS ONE			English	Article							HEAT-SHOCK PROTEASE; PROTEOLYTIC ACTIVITY; DISULFIDE BONDS; CHAPERONE; FLUORESCENCE; EXPRESSION; GENE; THIOREDOXIN; REDUCTION; STABILITY	Bacterial HtrAs are proteases engaged in extracytoplasmic activities during stressful conditions and pathogenesis. A model prokaryotic HtrA (HtrA/DegP from Escherichia coli) requires activation to cleave its substrates efficiently. In the inactive state of the enzyme, one of the regulatory loops, termed LA, forms inhibitory contacts in the area of the active center. Reduction of the disulfide bond located in the middle of LA stimulates HtrA activity in vivo suggesting that this S-S bond may play a regulatory role, although the mechanism of this stimulation is not known. Here, we show that HtrA lacking an S-S bridge cleaved a model peptide substrate more efficiently and exhibited a higher affinity for a protein substrate. An LA loop lacking the disulfide was more exposed to the solvent; hence, at least some of the interactions involving this loop must have been disturbed. The protein without S-S bonds demonstrated lower thermal stability and was more easily converted to a dodecameric active oligomeric form. Thus, the lack of the disulfide within LA affected the stability and the overall structure of the HtrA molecule. In this study, we have also demonstrated that in vitro human thioredoxin 1 is able to reduce HtrA; thus, reduction of HtrA can be performed enzymatically.	[Koper, Tomasz; Sobiecka-Szkatula, Anna; Figaj, Donata; Zarzecka, Urszula; Zurawa-Janicka, Dorota; Lipinska, Barbara; Skorko-Glonek, Joanna] Univ Gdansk, Fac Biol, Dept Biochem, PL-80952 Gdansk, Poland; [Polit, Agnieszka] Jagiellonian Univ, Dept Phys Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Wegrzyn, Katarzyna; Kadzinski, Leszek; Banecki, Bogdan] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, PL-80952 Gdansk, Poland; [Wegrzyn, Katarzyna; Kadzinski, Leszek; Banecki, Bogdan] Med Univ Gdansk, Gdansk, Poland; [Scire, Andrea; Tanfani, Fabio] Univ Politecn Marche, Dept Life & Environm Sci, Ancona, Italy; [Lesner, Adam] Univ Gdansk, Fac Chem, Dept Biochem, PL-80952 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Jagiellonian University; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Marche Polytechnic University; Fahrenheit Universities; University of Gdansk	Skorko-Glonek, J (corresponding author), Univ Gdansk, Fac Biol, Dept Biochem, PL-80952 Gdansk, Poland.	joanna.skorko-glonek@biol.ug.edu.pl	Skorko-Glonek, Joanna/AAF-5516-2020; Lesner, Adam/M-2732-2019; Lipinska, Barbara/ABA-6124-2020; Scirè, Andrea/A-2961-2010; Zarzecka, Urszula/ABH-4987-2020	Skorko-Glonek, Joanna/0000-0002-8084-5251; Lipinska, Barbara/0000-0001-9510-4811; Scirè, Andrea/0000-0002-8288-6989; Wegrzyn, Katarzyna/0000-0002-3743-8597; Figaj, Donata/0000-0002-0625-2968; Banecki, Bogdan/0000-0003-3286-2388; Zarzecka, Urszula/0000-0003-4319-1639; Tanfani, Fabio/0000-0001-7685-4692; Kadzinski, Leszek/0000-0002-6052-5787; Lesner, Adam/0000-0001-8335-3431; Zurawa-Janicka, Dorota/0000-0001-5048-2245; Polit, Agnieszka/0000-0001-5811-9838	Ministry of Science and Higher Education (Poland) [0393/B/P01/2011/40]	Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland)	This work was supported by Ministry of Science and Higher Education (Poland) Grant 0393/B/P01/2011/40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANECKI B, 1992, J BIOL CHEM, V267, P25051; Berkmen M, 2012, PROTEIN EXPRES PURIF, V82, P240, DOI 10.1016/j.pep.2011.10.009; Betton JM, 1998, J BIOL CHEM, V273, P8897, DOI 10.1074/jbc.273.15.8897; CALHOUN D B, 1986, Proteins Structure Function and Genetics, V1, P109, DOI 10.1002/prot.340010202; Circu ML, 2012, BBA-MOL CELL RES, V1823, P1767, DOI 10.1016/j.bbamcr.2012.06.019; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Connolly L, 1997, GENE DEV, V11, P2012, DOI 10.1101/gad.11.15.2012; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; DERMAN AI, 1991, J BACTERIOL, V173, P7719, DOI 10.1128/jb.173.23.7719-7722.1991; Dworkin M, 2006, HDB BIOL BACTERIA, V6; Figaj D, 2014, J BIOL CHEM, V289, P15880, DOI 10.1074/jbc.M113.532895; Frees Dorte, 2013, Subcell Biochem, V66, P161, DOI 10.1007/978-94-007-5940-4_7; Ghelis C, 1982, PROTEIN FOLDING, P298; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; Harvey RA, 2005, LIPPINCOTTS ILLUSTRA, P1, DOI [10.1016/j.ygcen.2014.12.017, DOI 10.1016/J.YGCEN.2014.12.017]; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Jaeger SU, 2013, MUCOSAL IMMUNOL, V6, P1179, DOI 10.1038/mi.2013.17; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Lakowicz JR, 2006, PRINCIPALS FLUORESCE, P533; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis C, 2009, MICROBIOL-SGM, V155, P873, DOI 10.1099/mic.0.023754-0; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Maiti NR, 2001, J BIOL CHEM, V276, P2427, DOI 10.1074/jbc.M007862200; Matsuo Y, 2013, CYTOKINE GROWTH F R, V24, P345, DOI 10.1016/j.cytogfr.2013.01.001; Matyus L, 2006, J PHOTOCH PHOTOBIO B, V83, P223, DOI 10.1016/j.jphotobiol.2005.12.017; MERRILL AR, 1993, BIOCHEMISTRY-US, V32, P6974, DOI 10.1021/bi00078a023; Neidhardt FC, 1987, ESCHERICHIA COLI SAL, V2, P1334; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Redford P, 2006, INFECT IMMUN, V74, P4030, DOI 10.1128/IAI.01984-05; RUSSEL M, 1984, J BACTERIOL, V159, P1034, DOI 10.1128/JB.159.3.1034-1039.1984; SALOMAA P, 1964, J AM CHEM SOC, V86, P1, DOI 10.1021/ja01055a001; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342, DOI 10.1007/s004380051092; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; Skorko-Glonek J, 2006, ACTA BIOCHIM POL, V53, P585; Skorko-Glonek J, 2013, CURR PHARM DESIGN, V19, P977, DOI 10.2174/1381612811319060003; Skorko-Glonek J, 2008, MICROBIOL-SGM, V154, P3649, DOI 10.1099/mic.0.2008/020487-0; SkorkoGlonek J, 1997, J BIOL CHEM, V272, P8974; SKORKOGLONEK J, 1995, GENE, V163, P47, DOI 10.1016/0378-1119(95)00406-V; SKORKOGLONEK J, 1995, J BIOL CHEM, V270, P11140, DOI 10.1074/jbc.270.19.11140; Sobiecka-Szkatula A, 2009, BBA-PROTEINS PROTEOM, V1794, P1573, DOI 10.1016/j.bbapap.2009.07.002; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRYJEWSKI W, 1986, EUR J BIOCHEM, V158, P547, DOI 10.1111/j.1432-1033.1986.tb09789.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Wysocka M, 2012, ANAL CHEM, V84, P7241, DOI 10.1021/ac301684w; Wysocka M, 2010, ANAL BIOCHEM, V399, P196, DOI 10.1016/j.ab.2010.01.007; Zhang L, 2011, BIOTECHNOL ADV, V29, P923, DOI 10.1016/j.biotechadv.2011.07.013	57	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117413	10.1371/journal.pone.0117413	http://dx.doi.org/10.1371/journal.pone.0117413			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710793	Green Submitted, gold, Green Published			2022-12-27	WOS:000350683900033
J	Li, J; Krupka, T; Yao, JP; Wang, RH; Jiang, L; Zhou, Y; Zuo, GQ; Wang, ZB; Dai, LL; Ren, JL; Zheng, YY; Wang, D				Li, Juan; Krupka, Tianyi; Yao, Jinpeng; Wang, Ronghui; Jiang, Lin; Zhou, Yang; Zuo, Guoqing; Wang, Zhibiao; Dai, Lili; Ren, Jianli; Zheng, Yuanyi; Wang, Dong			Liquid-Solid Phase-Inversion PLGA Implant for the Treatment of Residual Tumor Tissue after HIFU Ablation	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; DRUG-DELIVERY; NONINVASIVE CHARACTERIZATION; CONTRAST AGENT; VX2 CARCINOMA; LYMPH-NODES; MICROBUBBLES; THERAPY; CANCER; TEMPERATURE	Background HIFU has been shown to be a more suitable alternative for the treatment of primary solid tumors and metastatic diseases than other focal heat ablation techniques due to its noninvasive and extracorporeal nature. However, similar to other focal heat ablation techniques, HIFU is still in need of refinements due to tumor recurrence. Methods In this work, we investigated the effectiveness of an adjunct treatment regimen using doxorubicin (DOX)-loaded, injectable, in situ-forming, and phase-inverting PLGA as the second line of defense after HIFU ablation to destroy detrimental residual tumors and to prevent tumor recurrence. All of the statistical analyses were performed using the Statistical Package for the Social Sciences 18.0(SPSS, Inc., Chicago, IL, USA), and p<0.05 was considered statistically significant. All of the results are presented as the means +/- STDEV (standard deviation). For multiple comparisons, ANOVA (differences in tumor volumes, growth rates, apoptosis, proliferation indexes, and Bcl-2 and Bax protein levels) was used when the data were normally distributed with homogenous variance, and rank sum tests were used otherwise. Once significant differences were detected, Student-t tests were used for comparisons between two groups. Results Our results revealed that DOX diffused beyond the ablated tissue regions and entered tumor cells that were not affected by the HIFU ablation. Our results also show that HIFU in concert with DOX-loaded PLGA led to a significantly higher rate of tumor cell apoptosis and a lower rate of tumor cell proliferation in the areas beyond the HIFU-ablated tissues and consequently caused significant tumor volume shrinkage (tumor volumes: 0.26 +/- 0.1,1.09 plusmn; 0.76, and 1.42 +/- 0.9cm(3) for treatment, sham, and no treatment control, respectively). Conclusions From these results, we concluded that the intralesional injection of DOX-loaded PLGA after HIFU ablation is significantly more effective than HIFU alone for the treatment of solid tumors.	[Li, Juan; Yao, Jinpeng; Wang, Ronghui; Jiang, Lin; Zhou, Yang; Zuo, Guoqing; Dai, Lili; Ren, Jianli; Zheng, Yuanyi] Chongqing Med Univ, Affiliated Hosp 2, Chongqing 400014, Peoples R China; [Li, Juan; Yao, Jinpeng; Wang, Ronghui; Jiang, Lin; Zhou, Yang; Zuo, Guoqing; Dai, Lili; Ren, Jianli; Zheng, Yuanyi] Chongqing Med Univ, Ultrasound Imaging Inst, Chongqing 400014, Peoples R China; [Krupka, Tianyi] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Wang, Zhibiao] Chongqing Med Univ, Coll Biomed Engn, Chongqing 400016, Peoples R China; [Wang, Dong] Chongqing Med Univ, Childrens Hosp, Dept Ultrasound, Minist Educ,Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China	Chongqing Medical University; Chongqing Medical University; Stanford University; Chongqing Medical University; Chongqing Medical University	Wang, D (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Ultrasound, Minist Educ,Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China.	wangketongtong@163.com			National Natural Science Foundation of China [81371579, 81270021, 81271598]; Chongqing Distinguished Young Scholars Foundation [cstc2013jcyjjq10004]; Natural Science Foundation of Chongqing [cstc2013jcyjA10002]; Key grant of Chinese Ministry of Education [[2012] 76]; Program for New Century Excellent Talents in University [NCET-2013]; Key Grant of the Education Department of Chongqing [KJ120328]; Postdoctoral Project of Chongqing [Xm2014054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Distinguished Young Scholars Foundation; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Key grant of Chinese Ministry of Education(Ministry of Education, China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Grant of the Education Department of Chongqing; Postdoctoral Project of Chongqing	This work was supported by the National Natural Science Foundation of China (81371579, 81270021, 81271598), the Chongqing Distinguished Young Scholars Foundation (cstc2013jcyjjq10004), the Natural Science Foundation of Chongqing (cstc2013jcyjA10002), the Key grant of Chinese Ministry of Education ([2012] 76), the Program for New Century Excellent Talents in University (NCET-2013), the Key Grant of the Education Department of Chongqing (KJ120328), and the Postdoctoral Project of Chongqing (Xm2014054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai K, 2006, SURG TODAY, V36, P1075, DOI 10.1007/s00595-006-3312-8; Brodbeck KJ, 1999, J CONTROL RELEASE, V62, P333, DOI 10.1016/S0168-3659(99)00159-5; Bummer PM, 2004, CRIT REV THER DRUG, V21, P1; Cerruto MA, 2012, UROLOG J, V79, P219, DOI 10.5301/RU.2012.9908; DesNoyer JR, 2003, J CONTROL RELEASE, V86, P15, DOI 10.1016/S0168-3659(02)00293-6; Gelet A, 2000, J ENDOUROL, V14, P519, DOI 10.1089/end.2000.14.519; Graham PD, 1999, J CONTROL RELEASE, V58, P233, DOI 10.1016/S0168-3659(98)00158-8; Ishiko O, 2001, ANTICANCER RES, V21, P2363; Iyer AK, 2013, ADV DRUG DELIVER REV, V65, P1784, DOI 10.1016/j.addr.2013.07.012; Ke S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-73; Niu CC, 2013, BIOMATERIALS, V34, P2307, DOI 10.1016/j.biomaterials.2012.12.003; Niu CC, 2012, CLIN BREAST CANCER, V12, P199, DOI 10.1016/j.clbc.2012.01.005; Patel RB, 2010, J BIOMED MATER RES A, V94A, P476, DOI 10.1002/jbm.a.32724; Roy HS, 2012, CLIN IMAG, V36, P577, DOI 10.1016/j.clinimag.2012.01.026; Solorio L, 2012, THERANOSTICS, V2, P1064, DOI 10.7150/thno.4181; Solorio L, 2010, J CONTROL RELEASE, V143, P183, DOI 10.1016/j.jconrel.2010.01.001; Sun Y, 2012, BIOMATERIALS, V33, P5854, DOI 10.1016/j.biomaterials.2012.04.062; TERHAAR G, 1991, PHYS MED BIOL, V36, P1495, DOI 10.1088/0031-9155/36/11/009; Visioli A G, 1999, Eur J Ultrasound, V9, P11, DOI 10.1016/S0929-8266(99)00009-9; Wang D, 2012, CLIN IMAG, V36, P717, DOI 10.1016/j.clinimag.2012.01.042; Wang D, 2010, CLIN IMAG, V34, P288, DOI 10.1016/j.clinimag.2010.02.009; Wu F, 2001, ULTRASOUND MED BIOL, V27, P1099, DOI 10.1016/S0301-5629(01)00389-1; Zheng YY, 2012, J MICROENCAPSUL, V29, P437, DOI 10.3109/02652048.2012.655333; Zhou Y, 2013, ADV MATER, V25, P4123, DOI 10.1002/adma.201301655	24	9	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117358	10.1371/journal.pone.0117358	http://dx.doi.org/10.1371/journal.pone.0117358			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710485	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900029
J	Li, XJ; Li, M; Zhou, Y; Hu, S; Hu, R; Chen, Y; Li, XB				Li, Xiao-Jie; Li, Mo; Zhou, Ying; Hu, Shan; Hu, Rong; Chen, Yun; Li, Xue-Bao			Overexpression of Cotton RAV1 Gene in Arabidopsis Confers Transgenic Plants High Salinity and Drought Sensitivity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ABSCISIC-ACID; NEGATIVE REGULATOR; DISEASE RESISTANCE; EXPRESSION; COLD; DEFENSE; PROTEIN; VIVIPAROUS-1; SENESCENCE	RAV (related to ABI3/VP1) protein containing an AP2 domain in the N-terminal region and a B3 domain in the C-terminal region, which belongs to AP2 transcription factor family, is unique in higher plants. In this study, a gene (GhRAV1) encoding a RAV protein of 357 amino acids was identified in cotton (Gossypium hirsutum). Transient expression analysis of the eGFP: GhRAV1 fusion genes in tobacco (Nicotiana tabacum) epidermal cells revealed that GhRAV1 protein was localized in the cell nucleus. Quantitative RT-PCR analysis indicated that expression of GhRAV1 in cotton is induced by abscisic acid (ABA), NaCl and polyethylene glycol (PEG). Overexpression of GhRAV1 in Arabidopsis resulted in plant sensitive to ABA, NaCl and PEG. With abscisic acid (ABA) treatment, seed germination and green seedling rates of the GhRAV1 transgenic plants were remarkably lower than those of wild type. In the presence of NaCl, the seed germination and seedling growth of the GhRAV1 transgenic lines were inhibited greater than those of wild type. And chlorophyll content and maximum photochemical efficiency of the transgenic plants were significantly lower than those of wild type. Under drought stress, the GhRAV1 transgenic plants displayed more severe wilting than wild type. Furthermore, expressions of the stress-related genes were altered in the GhRAV1 transgenic Arabidopsis plants under high salinity and drought stresses. Collectively, our data suggested that GhRAV1 may be involved in response to high salinity and drought stresses through regulating expressions of the stress-related genes during cotton development.	[Li, Xiao-Jie; Li, Mo; Zhou, Ying; Hu, Shan; Hu, Rong; Chen, Yun; Li, Xue-Bao] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China	Central China Normal University	Li, XB (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China.	xbli@mail.ccnu.edu.cn			National Natural Sciences Foundation of China [31171174]; project from the Ministry of Agriculture of China for transgenic research [2014ZX08009-27B]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); project from the Ministry of Agriculture of China for transgenic research	This work was supported by National Natural Sciences Foundation of China (Grant No. 31171174) and the project from the Ministry of Agriculture of China for transgenic research (Grant No. 2014ZX08009-27B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PLANT MOL BIOL, V60, P51; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Cadou A, 2010, MOL MICROBIOL, V77, P1186, DOI 10.1111/j.1365-2958.2010.07281.x; Chen XF, 2009, GENES GENET SYST, V84, P101, DOI 10.1266/ggs.84.101; Glazebrook J, 1999, CURR OPIN PLANT BIOL, V2, P280, DOI 10.1016/S1369-5266(99)80050-8; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Il Je B, 2010, PLANT CELL, V22, P1777, DOI 10.1105/tpc.109.069575; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Kagaya Y, 2009, GENES GENET SYST, V84, P95, DOI 10.1266/ggs.84.95; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Kruskopf M, 2006, NEW PHYTOL, V169, P525, DOI 10.1111/j.1469-8137.2005.01601.x; LANG V, 1992, PLANT MOL BIOL, V20, P951, DOI 10.1007/BF00027165; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Li CW, 2011, PLANT PHYSIOL, V156, P213, DOI 10.1104/pp.111.174268; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Osnato M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1810; Qin LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059115; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Saleh A., 2003, GENETIKA+, V35, P37, DOI DOI 10.2298/GENSR0301037S; Schwechheimer C, 1998, TRENDS PLANT SCI, V98, P1360; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Sohn KH, 2006, PLANT MOL BIOL, V61, P897, DOI 10.1007/s11103-006-0057-0; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; Swamy PM, 1999, CURR SCI INDIA, V76, P1220; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Wang G, 2012, ACTA PHYSIOL PLANT, V34, P107, DOI 10.1007/s11738-011-0809-6; Wang XL, 2009, PLANT J, V57, P473, DOI 10.1111/j.1365-313X.2008.03700.x; Woo HR, 2010, J EXP BOT, V61, P3947, DOI 10.1093/jxb/erq206; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; Zhao L, 2008, PLANTA, V227, P1389, DOI 10.1007/s00425-008-0711-7	43	28	32	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118056	10.1371/journal.pone.0118056	http://dx.doi.org/10.1371/journal.pone.0118056			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710493	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900046
J	Nagarajan, MB; Coan, P; Huber, MB; Diemoz, PC; Wismuller, A				Nagarajan, Mahesh B.; Coan, Paola; Huber, Markus B.; Diemoz, Paul C.; Wismueller, Axel			Integrating Dimension Reduction and Out-of-Sample Extension in Automated Classification of Ex Vivo Human Patellar Cartilage on Phase Contrast X-Ray Computed Tomography	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; QUANTITATIVE CHARACTERIZATION; AIDED DIAGNOSIS; SMALL LESIONS; BREAST CADX; GLYCOSAMINOGLYCAN	Phase contrast X-ray computed tomography (PCI-CT) has been demonstrated as a novel imaging technique that can visualize human cartilage with high spatial resolution and soft tissue contrast. Different textural approaches have been previously investigated for characterizing chondrocyte organization on PCI-CT to enable classification of healthy and osteoarthritic cartilage. However, the large size of feature sets extracted in such studies motivates an investigation into algorithmic feature reduction for computing efficient feature representations without compromising their discriminatory power. For this purpose, geometrical feature sets derived from the scaling index method (SIM) were extracted from 1392 volumes of interest (VOI) annotated on PCI-CT images of ex vivo human patellar cartilage specimens. The extracted feature sets were subject to linear and non-linear dimension reduction techniques as well as feature selection based on evaluation of mutual information criteria. The reduced feature set was subsequently used in a machine learning task with support vector regression to classify VOIs as healthy or osteoarthritic; classification performance was evaluated using the area under the receiver-operating characteristic (ROC) curve (AUC). Our results show that the classification performance achieved by 9-D SIM-derived geometric feature sets (AUC: 0.96 +/- 0.02) can be maintained with 2-D representations computed from both dimension reduction and feature selection (AUC values as high as 0.97 +/- 0.02). Thus, such feature reduction techniques can offer a high degree of compaction to large feature sets extracted from PCI-CT images while maintaining their ability to characterize the underlying chondrocyte patterns.	[Nagarajan, Mahesh B.; Huber, Markus B.; Wismueller, Axel] Univ Rochester, Med Ctr, Dept Imaging Sci, Rochester, NY 14627 USA; [Nagarajan, Mahesh B.; Huber, Markus B.; Wismueller, Axel] Univ Rochester, Med Ctr, Dept Biomed Engn, Rochester, NY 14627 USA; [Coan, Paola; Wismueller, Axel] Univ Munich, Fac Med, Munich, Germany; [Coan, Paola; Wismueller, Axel] Univ Munich, Inst Clin Radiol, Munich, Germany; [Coan, Paola; Diemoz, Paul C.] Univ Munich, Fac Phys, Munich, Germany; [Coan, Paola; Diemoz, Paul C.] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Rochester; University of Rochester; University of Munich; University of Munich; University of Munich; European Synchrotron Radiation Facility (ESRF)	Nagarajan, MB (corresponding author), Univ Rochester, Med Ctr, Dept Imaging Sci, Rochester, NY 14627 USA.	mahesh.nagarajan@rochester.edu	Coan, Paola/GPC-5718-2022; Coan, Paola/L-8804-2013	Coan, Paola/0000-0003-1399-2398; Coan, Paola/0000-0003-1399-2398; Diemoz, Paul Claude/0000-0001-5855-4848	National Institutes of Health (NIH) [R01-DA-034977]; Clinical and Translational Science Award within the Upstate New York Translational Research Network (UNYTRN) of the Clinical and Translational Science Institute (CTSI), University of Rochester [5-28527]; Center for Emerging and Innovative Sciences (CEIS), a NYSTAR-designated Center for Advanced Technology; DFG Cluster of Excellence Munich - Centre for Advanced Photonics (MAP), Munich, Germany; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034977] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award within the Upstate New York Translational Research Network (UNYTRN) of the Clinical and Translational Science Institute (CTSI), University of Rochester; Center for Emerging and Innovative Sciences (CEIS), a NYSTAR-designated Center for Advanced Technology; DFG Cluster of Excellence Munich - Centre for Advanced Photonics (MAP), Munich, Germany; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded in part by: 1. the National Institutes of Health (NIH) Award R01-DA-034977 (MBN MBH AW); 2. the Clinical and Translational Science Award 5-28527 within the Upstate New York Translational Research Network (UNYTRN) of the Clinical and Translational Science Institute (CTSI), University of Rochester (MBN MBH AW); 3. the Center for Emerging and Innovative Sciences (CEIS), a NYSTAR-designated Center for Advanced Technology (MBN MBH AW); and 4. the DFG Cluster of Excellence Munich - Centre for Advanced Photonics (MAP), Munich, Germany (PC PCD). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir A, 1997, RADIOLOGY, V205, P551, DOI 10.1148/radiology.205.2.9356644; Benninghoff A., 1925, Z ZELLFORSCH, V2, P783, DOI DOI 10.1007/BF00583443; Bravin A, 2003, J PHYS D APPL PHYS, V36, pA24, DOI 10.1088/0022-3727/36/10A/306; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; Bunte K, 2012, NEURAL NETWORKS, V26, P159, DOI 10.1016/j.neunet.2011.10.001; Bunte K, 2011, NEUROCOMPUTING, V74, P1340, DOI 10.1016/j.neucom.2010.11.027; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Coan P, 2006, J SYNCHROTRON RADIAT, V13, P260, DOI 10.1107/S0909049506008983; Coan P, 2010, INVEST RADIOL, V45, P437, DOI 10.1097/RLI.0b013e3181e193bd; Crema MD, 2011, RADIOGRAPHICS, V31, P37, DOI 10.1148/rg.311105084; Diemoz PC, 2012, OPT EXPRESS, V20, P27670, DOI 10.1364/OE.20.027670; Dilmanian FA, 2000, PHYS MED BIOL, V45, P933, DOI 10.1088/0031-9155/45/4/309; Drucker H, 1997, ADV NEUR IN, V9, P155; Duda R.O., 2000, PATTERN CLASSIFICATI; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Eckstein F, 2004, SEMIN MUSCULOSKEL R, V8, P329, DOI 10.1055/s-2004-861579; Eckstein F, 2012, NAT REV RHEUMATOL, V8, P622, DOI 10.1038/nrrheum.2012.113; Fiedler S, 2004, PHYS MED BIOL, V49, P175, DOI 10.1088/0031-9155/49/2/001; Glaser C, 2001, MAGN RESON IMAGING, V19, P177, DOI 10.1016/S0730-725X(01)00292-2; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; HOLM S, 1979, SCAND J STAT, V6, P65; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Hunter DJ, 2009, CURR OPIN RHEUMATOL, V21, P110, DOI 10.1097/BOR.0b013e3283235add; Jamieson AR, 2010, MED PHYS, V37, P4155, DOI 10.1118/1.3455704; Jamieson AR, 2010, MED PHYS, V37, P339, DOI 10.1118/1.3267037; Jamitzky F, 2001, ULTRAMICROSCOPY, V86, P241, DOI 10.1016/S0304-3991(00)00111-X; Lee JA, 2009, NEUROCOMPUTING, V72, P1431, DOI 10.1016/j.neucom.2008.12.017; MacLean CH, 1998, J RHEUMATOL, V25, P2213; Moody J, 1989, NEURAL COMPUT, V1, P281, DOI 10.1162/neco.1989.1.2.281; Nagarajan MB, 2014, ARTIF INTELL MED, V60, P65, DOI 10.1016/j.artmed.2013.11.003; Nagarajan MB, 2014, J DIGIT IMAGING, V27, P98, DOI 10.1007/s10278-013-9634-3; Nagarajan MB, 2013, IEEE T BIO-MED ENG, V60, P2896, DOI 10.1109/TBME.2013.2266325; Nagarajan MB, 2013, MACH VISION APPL, V24, P1371, DOI 10.1007/s00138-012-0456-y; Nagarajan MB, 2013, J MED BIOL ENG, V33, P59, DOI 10.5405/jmbe.1183; Rath C, 2002, MON NOT R ASTRON SOC, V337, P413, DOI 10.1046/j.1365-8711.2002.05829.x; Raya JG, 2012, RADIOLOGY, V262, P550, DOI 10.1148/radiol.11110821; Reddy R, 1997, MAGNET RESON MED, V38, P207, DOI 10.1002/mrm.1910380208; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schmitt B, 2011, RADIOLOGY, V260, P257, DOI 10.1148/radiol.11101841; Schneider P, 2009, NEURAL COMPUT, V21, P3532, DOI 10.1162/neco.2009.11-08-908; Shepard D., 1968, P 1968 23 ACM NATL C, P517, DOI [10.1145/800186.810616, DOI 10.1145/800186.810616]; Stahl R, 2009, EUR RADIOL, V19, P132, DOI 10.1007/s00330-008-1107-6; Tourassi GD, 2001, MED PHYS, V28, P2394, DOI 10.1118/1.1418724; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P13, DOI [10.1080/ 135062804440 0 0102, DOI 10.1080/13506280444000102]; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Venna J, 2010, J MACH LEARN RES, V11, P451; Vesanto J, 2000, P MATL DSP C, P35; Wismuller A, 2009, LECT NOTES COMPUT SC, V5629, P334, DOI 10.1007/978-3-642-02397-2_38; Wismuller A, 2009, LECT NOTES COMPUT SC, V5629, P344, DOI 10.1007/978-3-642-02397-2_39; Wismuller A, 2009, P SOC PHOTO-OPT INS, V7260; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Yelin E, 2003, J RHEUMATOL, V30, P8	53	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117157	10.1371/journal.pone.0117157	http://dx.doi.org/10.1371/journal.pone.0117157			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710875	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900025
J	Alnoch, RC; Martini, VP; Glogauer, A; Costa, ACD; Piovan, L; Muller-Santos, M; de Souza, EM; Pedrosa, FD; Mitchell, DA; Krieger, N				Alnoch, Robson Carlos; Martini, Viviane Paula; Glogauer, Arnaldo; dos Santos Costa, Allen Carolina; Piovan, Leandro; Muller-Santos, Marcelo; de Souza, Emanuel Maltempi; Pedrosa, Fabio de Oliveira; Mitchell, David Alexander; Krieger, Nadia			Immobilization and Characterization of a New Regioselective and Enantioselective Lipase Obtained from a Metagenomic Library	PLOS ONE			English	Article							BIODIESEL PRODUCTION; PSEUDOMONAS-CEPACIA; KINETIC RESOLUTION; PURIFICATION; ENZYMES; TRANSESTERIFICATION; IDENTIFICATION; STABILIZATION; BIOCATALYSIS; EXPRESSION	In previous work, a new lipase and its cognate foldase were identified and isolated from a metagenomic library constructed from soil samples contaminated with fat. This new lipase, called LipG9, is a true lipase that shows specific activities that are comparable to those of well-known industrially-used lipases with high activity against long-chain triglycerides. In the present work, LipG9 was co-expressed and co-immobilized with its foldase, on an inert hydrophobic support (Accurel MP1000). We studied the performance of this immobilized LipG9 (Im-LipG9) in organic media, in order to evaluate its potential for use in biocatalysis. Im-LipG9 showed good stability, maintaining a residual activity of more than 70% at 50 degrees C after incubation in n-heptane (log P 4.0) for 8 h. It was also stable in polar organic solvents such as ethanol (log P -0.23) and acetone (log P -0.31), maintaining more than 80% of its original activity after 8 h incubation at 30 degrees C. The synthesis of ethyl esters was tested with fatty acids of different chain lengths in n-heptane at 30 degrees C. The best conversions (90% in 3 h) were obtained for medium and long chain saturated fatty acids (C8, C14 and C16), with the maximum specific activity, 29 U per gram of immobilized preparation, being obtained with palmitic acid (C16). Im-LipG9 was sn-1,3-specific. In the transesterification of the alcohol (R, S)-1-phenylethanol with vinyl acetate and the hydrolysis of the analogous ester, (R, S)-1-phenylethyl acetate, Im-LipG9 showed excellent enantioselectivity for the R-isomer of both substrates (E> 200), giving an enantiomeric excess (ee) of higher than 95% for the products at 49% conversion. The results obtained in this work provide the basis for the development of applications of LipG9 in biocatalysis.	[Alnoch, Robson Carlos; Muller-Santos, Marcelo; de Souza, Emanuel Maltempi; Pedrosa, Fabio de Oliveira; Mitchell, David Alexander] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-81531980 Curitiba, Parana, Brazil; [Martini, Viviane Paula] Inst Fed Parana, BR-84500000 Irati, Parana, Brazil; [Glogauer, Arnaldo] Inst Tecnol Parana Tecpar, Dept Quim, BR-81350010 Curitiba, Parana, Brazil; [dos Santos Costa, Allen Carolina; Piovan, Leandro; Krieger, Nadia] Univ Fed Parana, Dept Quim, BR-81531980 Curitiba, Parana, Brazil	Universidade Federal do Parana; Instituto Federal do Parana; Universidade Federal do Parana	Krieger, N (corresponding author), Univ Fed Parana, Dept Quim, Cx P 19081 Ctr Politecn, BR-81531980 Curitiba, Parana, Brazil.	nkrieger@ufpr.br	Alnoch, Robson Carlos/AAA-9613-2019; Mitchell, David A/A-8935-2008; Müller-Santos, Marcelo/D-7272-2013; Piovan, Leandro/AAG-7796-2021; Krieger, Nadia/A-5749-2011; Pedrosa, Fabio 0/C-1938-2013	Alnoch, Robson Carlos/0000-0002-1999-2914; Mitchell, David A/0000-0001-9355-5520; Müller-Santos, Marcelo/0000-0001-9615-6007; Krieger, Nadia/0000-0003-0492-7308; 	Brazilian National Council for Scientific and Technological Development (CNPq); NK EMS FOP DAM VPM AG MMS; Pronex/Fundacao Araucaria EMS FOP; Coordination for the Development of Higher Education Personnel (CAPES): research scholaships: RCA ACS	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NK EMS FOP DAM VPM AG MMS; Pronex/Fundacao Araucaria EMS FOP; Coordination for the Development of Higher Education Personnel (CAPES): research scholaships: RCA ACS(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the following: Brazilian National Council for Scientific and Technological Development (CNPq) http://www.cnpq.br/; funding and research scholarships: NK EMS FOP DAM VPM AG MMS; Pronex/Fundacao Araucaria (Funding)(www.fappr.pr.gov.br/) EMS FOP; and Coordination for the Development of Higher Education Personnel (CAPES): research scholaships: RCA ACS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Duri B, 2000, BIOCHEM ENG J, V4, P207, DOI 10.1016/S1369-703X(99)00050-9; Bayramoglu G, 2011, PROCESS BIOCHEM, V46, P372, DOI 10.1016/j.procbio.2010.09.014; Brault G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091872; Salum TFC, 2010, PROCESS BIOCHEM, V45, P1348, DOI 10.1016/j.procbio.2010.05.004; CHEN CS, 1982, J AM CHEM SOC, V104, P7294, DOI 10.1021/ja00389a064; Chow J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047665; Cote A, 2010, J IND MICROBIOL BIOT, V37, P883, DOI 10.1007/s10295-010-0735-4; Couto GH, 2010, GENET MOL RES, V9, P514, DOI 10.4238/vol9-1gmr738; de Souza ROMA, 2009, J ORG CHEM, V74, P6157, DOI 10.1021/jo9010443; Dheeman DS, 2011, BIORESOURCE TECHNOL, V102, P3373, DOI 10.1016/j.biortech.2010.11.074; Dheeman DS, 2010, J IND MICROBIOL BIOT, V37, P1, DOI 10.1007/s10295-009-0643-7; Faoro H, 2011, ENV MICROBIOL REP, V3, P750, DOI 10.1111/j.1758-2229.2011.00295.x; Ghamgui H, 2007, BIOCHEM ENG J, V37, P34, DOI 10.1016/j.bej.2007.03.006; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8; Habulin M, 2009, J MOL CATAL B-ENZYM, V58, P24, DOI 10.1016/j.molcatb.2008.10.007; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Hernandez-Rodriguez B, 2009, J MOL CATAL B-ENZYM, V61, P136, DOI 10.1016/j.molcatb.2009.06.004; Jaeger KE, 2004, CURR OPIN BIOTECH, V15, P305, DOI 10.1016/j.copbio.2004.06.007; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jose C, 2011, J MOL CATAL B-ENZYM, V71, P95, DOI 10.1016/j.molcatb.2011.04.004; Kapoor M, 2012, PROCESS BIOCHEM, V47, P555, DOI 10.1016/j.procbio.2012.01.011; KAZLAUSKAS RJ, 1991, J ORG CHEM, V56, P2656, DOI 10.1021/jo00008a016; Kharrat N, 2011, PROCESS BIOCHEM, V46, P1083, DOI 10.1016/j.procbio.2011.01.029; Kim YH, 2010, BIOCHEM BIOPH RES CO, V393, P45, DOI 10.1016/j.bbrc.2010.01.070; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; KLIBANOV AM, 1979, ANAL BIOCHEM, V93, P1; Krieger N, 2004, FOOD TECHNOL BIOTECH, V42, P279; Lammle K, 2007, J BIOTECHNOL, V127, P575, DOI 10.1016/j.jbiotec.2006.07.036; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu CH, 2012, APPL ENERG, V100, P41, DOI 10.1016/j.apenergy.2012.05.053; Liu Y, 2010, PROCESS BIOCHEM, V45, P1176, DOI 10.1016/j.procbio.2010.03.023; Lotrakul P, 1997, J BIOTECHNOL, V54, P113, DOI 10.1016/S0168-1656(97)01696-9; LOWRY RR, 1976, J AM OIL CHEM SOC, V53, P470, DOI 10.1007/BF02636814; Madan B, 2010, APPL MICROBIOL BIOT, V85, P597, DOI 10.1007/s00253-009-2131-4; Martini VP, 2012, CARACTERIZACAO MOL B, DOI [10.1080/713663671.Self-image, DOI 10.1080/713663671.SELF-IMAGE]; Masomian M, 2010, WORLD J MICROB BIOT, V26, P1693, DOI 10.1007/s11274-010-0347-1; Mateo C, 2000, ENZYME MICROB TECH, V26, P509, DOI 10.1016/S0141-0229(99)00188-X; Matsumoto M, 2003, BIOCHEM ENG J, V14, P75, DOI 10.1016/S1369-703X(02)00138-9; Overmeyer A, 1999, BIOTECHNOL LETT, V21, P65, DOI 10.1023/A:1005422524509; Palomo JM, 2002, J MOL CATAL B-ENZYM, V19, P279, DOI 10.1016/S1381-1177(02)00178-9; Peng R, 2011, APPL BIOCHEM BIOTECH, V165, P926, DOI 10.1007/s12010-011-9309-9; Rahman RNZRA, 2005, ANAL BIOCHEM, V341, P267, DOI 10.1016/j.ab.2005.03.006; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Shimada Y, 2002, J MOL CATAL B-ENZYM, V17, P133, DOI 10.1016/S1381-1177(02)00020-6; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STUER W, 1986, J BACTERIOL, V168, P1070, DOI 10.1128/jb.168.3.1070-1074.1986; SUGIHARA A, 1992, J BIOCHEM, V112, P598, DOI 10.1093/oxfordjournals.jbchem.a123946; Tan TW, 2010, BIOTECHNOL ADV, V28, P628, DOI 10.1016/j.biotechadv.2010.05.012; Tirawongsaroj P, 2008, J BIOTECHNOL, V133, P42, DOI 10.1016/j.jbiotec.2007.08.046; Tiss A, 2001, ANAL BIOCHEM, V294, P36, DOI 10.1006/abio.2001.5095; Traub PC, 2001, APPL MICROBIOL BIOT, V55, P198, DOI 10.1007/s002530000492; Tutar H, 2009, INT J BIOL MACROMOL, V45, P315, DOI 10.1016/j.ijbiomac.2009.06.014; Wu JC, 2007, J MOL CATAL B-ENZYM, V45, P108, DOI 10.1016/j.molcatb.2007.01.003; Yadav GD, 2005, MICROPOR MESOPOR MAT, V86, P215, DOI 10.1016/j.micromeso.2005.07.018; Yang JH, 2000, J BACTERIOL, V182, P295, DOI 10.1128/JB.182.2.295-302.2000; Ye P, 2005, BIOMATERIALS, V26, P6394, DOI 10.1016/j.biomaterials.2005.04.019; ZAKS A, 1985, P NATL ACAD SCI USA, V82, P3192, DOI 10.1073/pnas.82.10.3192; Zheng XM, 2012, PROCESS BIOCHEM, V47, P643, DOI 10.1016/j.procbio.2012.01.005	60	25	25	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0114945	10.1371/journal.pone.0114945	http://dx.doi.org/10.1371/journal.pone.0114945			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706996	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100004
J	Diaz-Valencia, PA; Bougneres, P; Valleron, AJ				Diaz-Valencia, Paula Andrea; Bougneres, Pierre; Valleron, Alain-Jacques			Covariation of the Incidence of Type 1 Diabetes with Country Characteristics Available in Public Databases	PLOS ONE			English	Article							DQ HAPLOTYPES; HLA-DR; MELLITUS; LOCUS; DISEASE; SUSCEPTIBILITY; ASSOCIATION; PREVALENCE; GENETICS; TRENDS	Background The incidence of Type 1 Diabetes (T1D) in children varies dramatically between countries. Part of the explanation must be sought in environmental factors. Increasingly, public databases provide information on country-to-country environmental differences. Methods Information on the incidence of T1D and country characteristics were searched for in the 194 World Health Organization (WHO) member countries. T1D incidence was extracted from a systematic literature review of all papers published between 1975 and 2014, including the 2013 update from the International Diabetes Federation. The information on country characteristics was searched in public databases. We considered all indicators with a plausible relation with T1D and those previously reported as correlated with T1D, and for which there was less than 5% missing values. This yielded 77 indicators. Four domains were explored: Climate and environment, Demography, Economy, and Health Conditions. Bonferroni correction to correct false discovery rate (FDR) was used in bivariate analyses. Stepwise multiple regressions, served to identify independent predictors of the geographical variation of T1D. Findings T1D incidence was estimated for 80 WHO countries. Forty-one significant correlations between T1D and the selected indicators were found. Stepwise Multiple Linear Regressions performed in the four explored domains indicated that the percentages of variance explained by the indicators were respectively 35% for Climate and environment, 33% for Demography, 45% for Economy, and 46% for Health conditions, and 51% in the Final model, where all variables selected by domain were considered. Significant environmental predictors of the country-to-country variation of T1D incidence included UV radiation, number of mobile cellular subscriptions in the country, health expenditure per capita, hepatitis B immunization and mean body mass index (BMI). Conclusions The increasing availability of public databases providing information in all global environmental domains should allow new analyses to identify further geographical, behavioral, social and economic factors, or indicators that point to latent causal factors of T1D.	[Diaz-Valencia, Paula Andrea; Bougneres, Pierre; Valleron, Alain-Jacques] INSERM, U1169, F-94276 Le Kremlin Bicetre, France; [Diaz-Valencia, Paula Andrea; Valleron, Alain-Jacques] Univ Paris 06, Ecole Doctorale 393, F-75012 Paris, France; [Bougneres, Pierre] Hop Kremlin Bicetre, AP HP, Serv Endocrinol, F-94276 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Diaz-Valencia, PA (corresponding author), INSERM, U1169, F-94276 Le Kremlin Bicetre, France.	paula.diaz@inserm.fr		Diaz, Paula/0000-0001-8065-5629	Programme Hospitalier de Recherche Clinique; Colciencias; Administrative Department of Science, Technology and Innovation for Colombia	Programme Hospitalier de Recherche Clinique; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Administrative Department of Science, Technology and Innovation for Colombia	This work was supported by grants from the Programme Hospitalier de Recherche Clinique and from Colciencias, the Administrative Department of Science, Technology and Innovation for Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; [Anonymous], 2013, WORLD POP PROSP 2012; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Cardwell CR, 2007, DIABETIC MED, V24, P289, DOI 10.1111/j.1464-5491.2007.02080.x; Cardwell CR, 2006, DIABETOLOGIA, V49, P2074, DOI 10.1007/s00125-006-0342-0; Dahlquist G, 2000, ACTA PAEDIATR, V89, P1231, DOI 10.1080/080352500750027628; Di Ciauia A, 2014, ADV RES, V2, P409, DOI DOI 10.9734/air/2014/10071; Dorman JS, 1997, EPIDEMIOL REV, V19, P91, DOI 10.1093/oxfordjournals.epirev.a017950; Dorman JS, 2000, EPIDEMIOL REV, V22, P218, DOI 10.1093/oxfordjournals.epirev.a018034; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Evertsen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006873; Frongia O, 1997, ACTA DIABETOL, V34, P199, DOI 10.1007/s005920050074; GARANCINI P, 1991, EUR J EPIDEMIOL, V7, P55; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gopinath S, 2008, ANN NY ACAD SCI, V1150, P200, DOI 10.1196/annals.1447.057; Green A, 2000, LANCET, V355, P873; Harjutsalo V, 2013, JAMA-J AM MED ASSOC, V310, P427, DOI 10.1001/jama.2013.8399; Holmqvist BM, 2008, DIABETIC MED, V25, P255, DOI 10.1111/j.1464-5491.2007.02342.x; Huang J, 2014, HEPATITIS B VACCINAT; Kawabata Y, 2002, DIABETES, V51, P545, DOI 10.2337/diabetes.51.2.545; Maindonald JH, 2003, PACKAGE DAAG VERSION; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mohr SB, 2008, DIABETOLOGIA, V51, P1391, DOI 10.1007/s00125-008-1061-5; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Ogle G. D., 2001, Papua New Guinea Medical Journal, V44, P96; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 2001, DIABETOLOGIA, V44, pB9, DOI 10.1007/PL00002961; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pociot F, 2010, DIABETES, V59, P1561, DOI 10.2337/db10-0076; PODAR T, 1993, DIABETES METAB, V19, P361; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Pundziute-Lycka A, 2003, DIABETES CARE, V26, P671, DOI 10.2337/diacare.26.3.671; R Core Team, 2021, R LANGUAGE ENV STAT; Rewers M, 2012, DIABETES METAB J, V36, P90, DOI 10.4093/dmj.2012.36.2.90; Roach JC, 2006, AM J HUM GENET, V79, P614, DOI 10.1086/507876; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Sloka S, 2010, ACTA DIABETOL, V47, P73, DOI 10.1007/s00592-009-0100-0; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Soltesz G, 2009, DIABETES YOUNG GLOBA; Staples JA, 2003, ENVIRON HEALTH PERSP, V111, P518, DOI 10.1289/ehp.5941; Stayoussef M, 2009, CLIN VACCINE IMMUNOL, V16, P136, DOI 10.1128/CVI.00215-08; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Weisberg S., 2005, WILEY SERIES PROBABI; WEST R, 1979, DIABETES, V28, P690, DOI 10.2337/diabetes.28.7.690; World Health Organization, 2013, GLOB HLTH OBS DAT RE; Yang CY, 2013, CLIN REV ALLERGY IMM	48	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118298	10.1371/journal.pone.0118298	http://dx.doi.org/10.1371/journal.pone.0118298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706995	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100164
J	Kaul, S; Mittal, SK; Feigenbaum, L; Kruhlak, MJ; Roche, PA				Kaul, Sunil; Mittal, Sharad K.; Feigenbaum, Lionel; Kruhlak, Michael J.; Roche, Paul A.			Expression of the SNARE Protein SNAP-23 Is Essential for Cell Survival	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; PLATELET EXOCYTOSIS; GLUCOSE-UPTAKE; SYNTAXIN 2; DIFFERENTIATION; THYMOCYTES; PROMOTES; THYMUS	Members of the SNARE-family of proteins are known to be key regulators of the membrane-membrane fusion events required for intracellular membrane traffic. The ubiquitously expressed SNARE protein SNAP-23 regulates a wide variety of exocytosis events and is essential for mouse development. Germline deletion of SNAP-23 results in early embryonic lethality in mice, and for this reason we now describe mice and cell lines in which SNAP-23 can be conditionally-deleted using Cre-lox technology. Deletion of SNAP-23 in CD19-Cre expressing mice prevents B lymphocyte development and deletion of SNAP-23 using a variety of T lymphocyte-specific Cre mice prevents T lymphocyte development. Acute depletion of SNAP-23 in mouse fibroblasts leads to rapid apoptotic cell death. These data highlight the importance of SNAP-23 for cell survival and describe a mouse in which specific cell types can be eliminated by expression of tissue-specific Cre-recombinase.	[Kaul, Sunil; Mittal, Sharad K.; Kruhlak, Michael J.; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] Frederick Natl Lab Canc Res, Leidos Biomed Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roche, PA (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011035, ZICBC010915] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HA, 1998, J IMMUNOL, V160, P4850; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Carayannopoulos MO, 2000, P NATL ACAD SCI USA, V97, P7313, DOI 10.1073/pnas.97.13.7313; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108; Gegonne A, 2012, MOL CELL BIOL, V32, P1984, DOI 10.1128/MCB.06305-11; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Huang X, 2001, PANCREAS, V23; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; Martin-Martin B, 2000, BLOOD, V96, P2574; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Suh YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018444; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Vaidyanathan VV, 2001, J BIOL CHEM, V276, P25101, DOI 10.1074/jbc.M103536200; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Yang YP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng080; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	23	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118311	10.1371/journal.pone.0118311	http://dx.doi.org/10.1371/journal.pone.0118311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706117	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100166
J	Maeda, N; Tahata, S; Yagi, T; Tanaka, E; Masu, K; Sato, M; Haeno, S; Onaga, T; Yokota, H				Maeda, Naoyuki; Tahata, Sachi; Yagi, Takeshi; Tanaka, Emi; Masu, Kanae; Sato, Michiko; Haeno, Satoko; Onaga, Takenori; Yokota, Hiroshi			Assessment of Testicular Corticosterone Biosynthesis in Adult Male Rats	PLOS ONE			English	Article							LEYDIG-CELLS; IN-VIVO; 11-BETA-HYDROXYLASE; ALDOSTERONE; STRESS; BRAIN; 21-HYDROXYLATION; GLUCOCORTICOIDS; STIMULATION; EXPRESSION	Corticosterone is synthesized in the adrenal glands and is circulated throughout the body to perform regulatory functions in various tissues. The testis is known to synthesize and secrete testosterone and other androgens. We developed an accurate method to measure steroid content using liquid chromatography-mass spectrometry analysis. In the present study, significant levels of the precursor compounds of testosterone and corticosterone synthesis could be detected in rat testis using this method. After adrenalectomy, corticosterone remained in the blood and testicular tissue at approximately 1% of the amount present in the control testis. When the excised testicular tissue was washed and incubated with NADH, NADPH and progesterone, not only testosterone and its precursors but also 11-deoxycorticosterone and corticosterone were produced; the levels of 11-deoxycorticosterone and corticosterone increased with incubation time. The production rate of 11-deoxycorticosterone from progesterone was estimated to be approximately 1/20 that of 17-hydroxyprogesterone, and the corticosterone level was approximately 1/10 that of testosterone. These ratios coincided with those in the testicular tissue of the adrenalectomized rats, indicating that corticosterone was synthesized in the testis and not in the blood. A primary finding of this study was that corticosterone and testosterone were synthesized in a 1/10-20 ratio in the testis. It is concluded that corticosterone, which has various functions, such as the regulation of glycolysis and mediating spermatogenesis, is produced locally in the testis and that this the local production is convenient and functional to respond to local needs.	[Maeda, Naoyuki; Tahata, Sachi; Yagi, Takeshi; Sato, Michiko; Haeno, Satoko; Yokota, Hiroshi] Rakuno Gakuen Univ Ebetsu, Sch Vet Med, Vet Biochem Lab, Sapporo, Hokkaido, Japan; [Maeda, Naoyuki; Tanaka, Emi; Masu, Kanae] Japan Meat Sci & Technol Inst, Shibuya Ku, Tokyo, Japan; [Masu, Kanae; Onaga, Takenori] Rakuno Gakuen Univ Ebetsu, Sch Vet Med, Lab Vet Nutr, Sapporo, Hokkaido, Japan		Yokota, H (corresponding author), Rakuno Gakuen Univ Ebetsu, Sch Vet Med, Vet Biochem Lab, Sapporo, Hokkaido, Japan.	h-yokota@rakuno.ac.jp	Masu, Kazuya/E-5066-2014	Masu, Kazuya/0000-0002-7121-8440	Ministry of Education, Science, Sports and Culture and Technology in Japan	Ministry of Education, Science, Sports and Culture and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid and Support Project to Assist Private Universities in Developing Bases for Research from the Ministry of Education, Science, Sports and Culture and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2012, STRESS, V15, P74, DOI 10.3109/10253890.2011.585188; Contreras L N, 1996, Minerva Endocrinol, V21, P43; Croft AP, 2008, BRAIN RES, V1238, P12, DOI 10.1016/j.brainres.2008.08.009; Davies E, 2003, CLIN EXP PHARMACOL P, V30, P437, DOI 10.1046/j.1440-1681.2003.03867.x; Gao HB, 2002, ENDOCRINOLOGY, V143, P130, DOI 10.1210/en.143.1.130; Ge RS, 2005, MOL CELL ENDOCRINOL, V243, P35, DOI 10.1016/j.mce.2005.08.004; Gomes LG, 2009, J CLIN ENDOCR METAB, V94, P89, DOI 10.1210/jc.2008-1174; Gomez-Sanchez EP, 2005, AM J PHYSIOL-ENDOC M, V288, pE342, DOI 10.1152/ajpendo.00355.2004; Hardy MP, 2005, CELL TISSUE RES, V322, P147, DOI 10.1007/s00441-005-0006-2; Hazra R, 2014, ENDOCRINOLOGY, V155, P1120, DOI 10.1210/en.2013-1940; MacKenzie SM, 2000, J MOL ENDOCRINOL, V24, P321, DOI 10.1677/jme.0.0240321; MacKenzie SM, 2000, ENDOCR RES, V26, P531, DOI 10.3109/07435800009048566; Maeda N, 2013, J BIOCHEM, V153, P63, DOI 10.1093/jb/mvs121; MELLON SH, 1989, J CLIN INVEST, V84, P1497, DOI 10.1172/JCI114325; Miura S, 2008, ZOOL SCI, V25, P212, DOI 10.2108/zsj.25.212; MONDER C, 1994, STEROIDS, V59, P69, DOI 10.1016/0039-128X(94)90078-7; Schmidt KL, 2008, GEN COMP ENDOCR, V157, P266, DOI 10.1016/j.ygcen.2008.03.025; Sher L, 2006, THESCIENTIFICWORLDJO, V6, P1398, DOI 10.1100/tsw.2006.251; Taves MD, 2011, AM J PHYSIOL-ENDOC M, V301, pE11, DOI 10.1152/ajpendo.00100.2011; WADA A, 1992, J BIOL CHEM, V267, P22877; Wang GM, 2002, ENDOCRINOLOGY, V143, P621, DOI 10.1210/en.143.2.621; Whirledge S, 2010, MINERVA ENDOCRINOL, V35, P109	22	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117795	10.1371/journal.pone.0117795	http://dx.doi.org/10.1371/journal.pone.0117795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706382	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100118
J	Du, F; Babcock, JJ; Yu, HB; Zou, BY; Li, M				Du, Fang; Babcock, Joseph J.; Yu, Haibo; Zou, Beiyan; Li, Min			Global Analysis Reveals Families of Chemical Motifs Enriched for hERG Inhibitors	PLOS ONE			English	Article							POTASSIUM CHANNELS; LONG-QT; MODEL; COMPOUND; QSAR; CLASSIFICATION; PHARMACOPHORE; PREDICTION; DIVERSE; CARDIOTOXICITY	Promiscuous inhibition of the human ether-a-go-go-related gene (hERG) potassium channel by drugs poses a major risk for life threatening arrhythmia and costly drug withdrawals. Current knowledge of this phenomenon is derived from a limited number of known drugs and tool compounds. However, in a diverse, naive chemical library, it remains unclear which and to what degree chemical motifs or scaffolds might be enriched for hERG inhibition. Here we report electrophysiology measurements of hERG inhibition and computational analyses of >300,000 diverse small molecules. We identify chemical 'communities' with high hERG liability, containing both canonical scaffolds and structurally distinctive molecules. These data enable the development of more effective classifiers to computationally assess hERG risk. The resultant predictive models now accurately classify naive compound libraries for tendency of hERG inhibition. Together these results provide a more complete reference map of characteristic chemical motifs for hERG liability and advance a systematic approach to rank chemical collections for cardiotoxicity risk.	Johns Hopkins Univ, High Throughput Biol Ctr, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, JHICC, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Li, M (corresponding author), GSK, King Of Prussia, PA 19406 USA.	min.x.li@gsk.com			National Institutes of Health [GM078579, MH084691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078579, T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by grants to ML from the National Institutes of Health (GM078579, MH084691). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Aronov AM, 2006, J MED CHEM, V49, P6917, DOI 10.1021/jm060500o; Aronov AM, 2004, BIOORGAN MED CHEM, V12, P2307, DOI 10.1016/j.bmc.2004.02.003; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Bolton EE, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-32; Bolton EE, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-13; Braga RC, 2014, CURR TOP MED CHEM, V14, P1399, DOI 10.2174/1568026614666140506124442; Bridal TR, 2010, ASSAY DRUG DEV TECHN, V8, P755, DOI 10.1089/adt.2010.0267; Bridgland-Taylor M. H., 2006, Journal of Pharmacological and Toxicological Methods, V54, P189, DOI 10.1016/j.vascn.2006.02.003; Cavalli A, 2002, J MED CHEM, V45, P3844, DOI 10.1021/jm0208875; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Czodrowski P, 2013, J CHEM INF MODEL, V53, P2240, DOI 10.1021/ci400308z; Doddareddy MR, 2010, CHEMMEDCHEM, V5, P716, DOI 10.1002/cmdc.201000024; Drwal MN, 2014, NUCLEIC ACIDS RES, V42, pW53, DOI 10.1093/nar/gku401; Du F, 2011, ASSAY DRUG DEV TECHN, V9, P580, DOI 10.1089/adt.2011.0425; Du LP, 2004, BIOORG MED CHEM LETT, V14, P4771, DOI 10.1016/j.bmcl.2004.06.070; Ekins S, 2002, J PHARMACOL EXP THER, V301, P427, DOI 10.1124/jpet.301.2.427; Fanoe S, 2009, BRIT J CLIN PHARMACO, V67, P172, DOI 10.1111/j.1365-2125.2008.03327.x; Fowler JH, 2011, P NATL ACAD SCI USA, V108, P1993, DOI 10.1073/pnas.1011687108; Gavaghan CL, 2007, J COMPUT AID MOL DES, V21, P189, DOI 10.1007/s10822-006-9095-6; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Guha R, 2008, J COMPUT AID MOL DES, V22, P367, DOI 10.1007/s10822-008-9192-9; Guo Liang, 2005, Journal of Pharmacological and Toxicological Methods, V52, P123, DOI 10.1016/j.vascn.2005.04.002; Huang XP, 2010, ASSAY DRUG DEV TECHN, V8, P727, DOI 10.1089/adt.2010.0331; Hussain J, 2010, J CHEM INF MODEL, V50, P339, DOI 10.1021/ci900450m; Kannankeril PJ, 2007, CURR OPIN CARDIOL, V22, P39, DOI 10.1097/HCO.0b013e32801129eb; Kim S, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-26; Koes DR, 2011, J CHEM INF MODEL, V51, P1307, DOI 10.1021/ci200097m; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; Li QY, 2008, MOL PHARMACEUT, V5, P117, DOI 10.1021/mp700124e; Matyus P, 1998, INT J QUANTUM CHEM, V69, P21, DOI 10.1002/(SICI)1097-461X(1998)69:1<21::AID-QUA4>3.0.CO;2-Z; Morgan T K Jr, 1992, Prog Med Chem, V29, P65, DOI 10.1016/S0079-6468(08)70005-5; Papadatos G, 2010, J CHEM INF MODEL, V50, P1872, DOI 10.1021/ci100258p; Pearlstein RA, 2003, BIOORG MED CHEM LETT, V13, P1829, DOI 10.1016/S0960-894X(03)00196-3; Robinson RLM, 2011, MOL INFORM, V30, P443, DOI 10.1002/minf.201000159; Roche O, 2002, CHEMBIOCHEM, V3, P455, DOI 10.1002/1439-7633(20020503)3:5<455::AID-CBIC455>3.0.CO;2-L; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Seierstad M, 2006, CHEM BIOL DRUG DES, V67, P284, DOI 10.1111/j.1747-0285.2006.00379.x; Shen MY, 2011, CHEM RES TOXICOL, V24, P934, DOI 10.1021/tx200099j; Testai L, 2004, CURR MED CHEM, V11, P2691, DOI 10.2174/0929867043364351; Thai KM, 2009, MOL DIVERS, V13, P321, DOI 10.1007/s11030-009-9117-0; Thomas D, 2004, N-S ARCH PHARMACOL, V369, P462, DOI 10.1007/s00210-004-0931-8; Varin T, 2011, J CHEM INF MODEL, V51, P1528, DOI 10.1021/ci2000924; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wetzel S, 2009, NAT CHEM BIOL, V5, P581, DOI 10.1038/nchembio.187; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426; Zou BY, 2010, ASSAY DRUG DEV TECHN, V8, P743, DOI 10.1089/adt.2010.0339	51	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118324	10.1371/journal.pone.0118324	http://dx.doi.org/10.1371/journal.pone.0118324			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700001	Green Published, gold, Green Submitted			2022-12-27	WOS:000349789800038
J	Llarena, AK; Huneau, A; Hakkinen, M; Hanninen, ML				Llarena, Ann-Katrin; Huneau, Adeline; Hakkinen, Marjaana; Hanninen, Marja-Liisa			Predominant Campylobacter jejuni Sequence Types Persist in Finnish Chicken Production	PLOS ONE			English	Article							BROILER FLOCKS; SPP.; RISK; COLI; COLONIZATION; EPIDEMIOLOGY; ASSOCIATION; INFECTIONS; PREVALENCE; HUMANS	Consumption and handling of chicken meat are well-known risk factors for acquiring campylobacteriosis. This study aimed to describe the Campylobacter jejuni population in Finnish chickens and to investigate the distribution of C. jejuni genotypes on Finnish chicken farms over a period of several years. We included 89.8% of the total C. jejuni population recovered in Finnish poultry during 2004, 2006, 2007, 2008, and 2012 and used multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE) to characterize the 380 isolates. The typing data was combined with isolate information on collection-time and farm of origin. The C. jejuni prevalence in chicken slaughter batches was low (mean 3.0%, CI95% [1.8%, 4.2%]), and approximately a quarter of Finnish chicken farms delivered at least one positive chicken batch yearly. In general, the C. jejuni population was diverse as represented by a total of 63 sequence types (ST), but certain predominant MLST lineages were identified. ST-45 clonal complex (CC) accounted for 53% of the isolates while ST-21 CC and ST-677 CC covered 11% and 9% of the isolates, respectively. Less than half of the Campylobacter positive farms (40.3%) delivered C. jejuni-contaminated batches in multiple years, but the genotypes (ST and PFGE types) generally varied from year to year. Therefore, no evidence for a persistent C. jejuni source for the colonization of Finnish chickens emerged. Finnish chicken farms are infrequently contaminated with C. jejuni compared to other European Union (EU) countries, making Finland a valuable model for further epidemiological studies of the C. jejuni in poultry flocks.	[Llarena, Ann-Katrin; Hanninen, Marja-Liisa] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Huneau, Adeline] Anses, Ploufragan Plouzane Lab, F-22440 Ploufragan, France; [Hakkinen, Marjaana] Evira, Finnish Food Safety Author, Res & Lab Dept, Food & Feed Microbiol Res Unit, Helsinki, Finland	University of Helsinki; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Finnish Food Authority	Llarena, AK (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	ann-katrin.llarena@helsinki.fi		Llarena, Ann-Katrin/0000-0001-5278-7253; Huneau-Salaun, Adeline/0000-0002-2343-5176	Finnish Ministry of Agriculture and Forestry [MMM2054/312/11]; Coordination of European Research on Emerging and Major Infectious Diseases of Livestock (EMIDA ERA-NET) [Dnro 776/312/2012]	Finnish Ministry of Agriculture and Forestry; Coordination of European Research on Emerging and Major Infectious Diseases of Livestock (EMIDA ERA-NET)	This work was supported by Finnish Ministry of Agriculture and Forestry grant [No. MMM2054/312/11] and by Coordination of European Research on Emerging and Major Infectious Diseases of Livestock (EMIDA ERA-NET) (Dnro 776/312/2012) through the project entitled Biology and Control of Campylobacter in the Chicken Supply Chain (CamChain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agunos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104905; Allen VM, 2008, J FOOD PROTECT, V71, P264, DOI 10.4315/0362-028X-71.2.264; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1437; Blaser MJ, 2008, CAMPYLOBACTER, 3RD EDITION, P99; Bull SA, 2006, APPL ENVIRON MICROB, V72, P645, DOI 10.1128/AEM.72.1.645-652.2006; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; de Haan CPA, 2012, APPL ENVIRON MICROB, V78, P5550, DOI 10.1128/AEM.01023-12; de Haan CPA, 2014, CAMPYLOBACTER ECOLOG, P241; EFSA, 2011, EFSA J, V9, P2105, DOI DOI 10.2903/J.EFSA.2011.2105; EFSA (European Food Safety Authority), 2009, EFSA J, V7, P358, DOI [10.2903/j.efsa.2009.1438, DOI 10.2903/J.EFSA.2009.1438, 10.2903/j.efsa.2010.1496]; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Evira (Finnish Food Safety Authority), 2012, 35125 EV; Fajo-Pascual M, 2010, EUR J PUBLIC HEALTH, V20, P443, DOI 10.1093/eurpub/ckp206; French N., 2014, CAMPYLOBACTER ECOLOG, P221; Griekspoor P, 2013, MOL ECOL, V22, P1463, DOI 10.1111/mec.12144; Griekspoor P, 2010, VET MICROBIOL, V140, P180, DOI 10.1016/j.vetmic.2009.07.022; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Hakkinen M, 2007, APPL ENVIRON MICROB, V73, P3232, DOI 10.1128/AEM.02579-06; Hakkinen M, 2009, APPL ENVIRON MICROB, V75, P5244, DOI 10.1128/AEM.00374-09; Hald B, 2004, EMERG INFECT DIS, V10, P1490, DOI 10.3201/eid1008.040129; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansson I, 2007, J APPL MICROBIOL, V103, P640, DOI 10.1111/j.1365-2672.2007.03291.x; Hartnett E, 2001, EPIDEMIOL INFECT, V127, P195, DOI 10.1017/S0950268801005866; Hook H, 2005, VET MICROBIOL, V106, P109, DOI 10.1016/j.vetmic.2004.12.017; Hulkko T, 2008, THL RAPORTTI, V17, P1; Jaakola S, 2013, THL LAITOS, V10, P1; Jonsson ME, 2012, PREV VET MED, V107, P95, DOI 10.1016/j.prevetmed.2012.05.002; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P148, DOI 10.1128/AEM.01488-06; Klena JD, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P165; Korczak BM, 2009, J CLIN MICROBIOL, V47, P1996, DOI 10.1128/JCM.00237-09; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Llarena AK, 2015, ZOONOSES PUBLIC HLTH, V62, P209, DOI 10.1111/zph.12141; Maa-ja Metsatalousministerio, 2007, 10EEO2007 MAA JA MET; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; McCarthy ND, 2012, EPIDEMIOL INFECT, V140, P2247, DOI 10.1017/S0950268812000192; McDowell SWJ, 2008, PREV VET MED, V84, P261, DOI 10.1016/j.prevetmed.2007.12.010; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Niemi J, 2013, MAA JA ELINTARVIKETA, V114, P1; O'Mahony E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028490; Perko-Makela P, 2002, EPIDEMIOL INFECT, V129, P187, DOI 10.1017/S0950268802007367; Perko-Makela P, 2011, THESIS U HELSINKI; Pirinen P., 2012, FINN METEOROL I REP, V2012, P1; Revez J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-768; Ridley AM, 2011, APPL ENVIRON MICROB, V77, P98, DOI 10.1128/AEM.01388-10; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Schonberg-Norio D, 2004, EMERG INFECT DIS, V10, P1474, DOI 10.3201/eid1008.030924; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Tike, 2013, YB FARM STAT; Vidal A, 2014, CAMPYLOBACTER ECOLOG, P288	53	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116585	10.1371/journal.pone.0116585	http://dx.doi.org/10.1371/journal.pone.0116585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700264	gold, Green Published, Green Submitted			2022-12-27	WOS:000349789800011
J	Kalmar, Z; Cozma, V; Sprong, H; Jahfari, S; D'Amico, G; Marcutan, DI; Ionica, AM; Magdas, C; Modry, D; Mihalca, AD				Kalmar, Zsuzsa; Cozma, Vasile; Sprong, Hein; Jahfari, Setareh; D'Amico, Gianluca; Marcutan, Daniel I.; Ionica, Angela M.; Magdas, Cristian; Modry, David; Mihalca, Andrei D.			Transstadial Transmission of Borrelia turcica in Hyalomma aegyptium Ticks	PLOS ONE			English	Article							BURGDORFERI-SENSU-LATO; BORNE RELAPSING FEVER; ACARI IXODIDAE; LYME-DISEASE; IMPORTED REPTILES; IXODES-SCAPULARIS; 1ST ISOLATION; EXOTIC TICKS; HARD TICK; HUMANS	Borrelia turcica comprises the third major group of arthropod-transmitted borreliae and is phylogenetically divergent from other Borrelia groups. The novel group of Borrelia was initially isolated from Hyalomma aegyptium ticks in Turkey and it was recently found in blood and multiple organs of tortoises exported from Jordan to Japan. However, the ecology of these spirochetes and their development in ticks or the vertebrate hosts were not investigated in detail; our aims were to isolate the pathogen and to evaluate the possibility of transstadial transmission of Borrelia turcica by H. aegyptium ticks. Ticks were collected from Testudo graeca tortoises during the summer of 2013 from southeastern Romania. Engorged nymphs were successfully molted to the adult stage. Alive B. turcica was isolated from molted ticks by using Barbour-Stoenner-Kelly (BSK) II medium. Four pure cultures of spirochetes were obtained and analyzed by PCR and sequencing. Sequence analysis of glpQ, gyrB and flaB revealed 98%-100% similarities with B. turcica. H. aegyptium ticks collected from T. graeca tortoises were able to pass the infection with B. turcica via transstadial route, suggesting its vectorial capacity.	[Kalmar, Zsuzsa; Cozma, Vasile; D'Amico, Gianluca; Marcutan, Daniel I.; Ionica, Angela M.; Magdas, Cristian; Mihalca, Andrei D.] Univ Agr Sci & Vet Med Cluj Napoca, Dept Parasitol & Parasit Dis, Cluj Napoca, Romania; [Sprong, Hein; Jahfari, Setareh] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Modry, David] Univ Vet & Pharmaceut Sci, Fac Vet Med, Dept Pathol & Parasitol, Brno, Czech Republic; [Modry, David] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic	University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Netherlands National Institute for Public Health & the Environment; University of Veterinary Sciences Brno; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Cozma, V (corresponding author), Univ Agr Sci & Vet Med Cluj Napoca, Dept Parasitol & Parasit Dis, Cluj Napoca, Romania.	vasile.cozma@usamvcluj.ro	Kalmar, Zsuzsa/A-1791-2017; Ionica, Angela/HDM-8313-2022; Mihalca, Andrei Daniel/A-1561-2008; Modry, David/G-7815-2014; Cozma, Vasile/GVT-2461-2022; D'Amico, Gianluca/A-8708-2019; Kalmar, Zsuzsa/AAD-7178-2021	Mihalca, Andrei Daniel/0000-0001-6076-7914; Modry, David/0000-0001-9649-6255; Cozma, Vasile/0000-0002-8587-3753; Kalmar, Zsuzsa/0000-0002-4492-8383; Sprong, Hein/0000-0002-0218-4320; Ionica, Angela/0000-0002-1438-2498	European Social Fund, Human Resources Development Operational Programme [POSDRU/159/1.5/S/136893]; EurNegVec COST Action [TD1303];  [IDEI PCE 236/2011]	European Social Fund, Human Resources Development Operational Programme; EurNegVec COST Action(European Cooperation in Science and Technology (COST)); 	This paper was published under the frame of: 1. European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/S/136893 (http://www.usamvcluj.ro/POSDRU136893/); 2. Grant IDEI PCE 236/2011 (http://www.geo-parasite.org/about.html); 3. The work of ZK, GD, DIM, AMI, DM, HS, VC, ADM was done under the frame of EurNegVec COST Action TD1303 (http://www.eurnegvec.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeolu M, 2014, ANTON LEEUW INT J G, V105, P1049, DOI 10.1007/s10482-014-0164-x; ALGWAIZ LA, 1995, ANN SAUDI MED, V15, P165, DOI 10.5144/0256-4947.1995.165; Apanaskevich D. A., 2004, Parazitologiya (St. Petersburg), V38, P515; Bacon RM, 2004, J CLIN MICROBIOL, V42, P2326, DOI 10.1128/JCM.42.5.2326-2328.2004; Banerjee SN, 1998, J CLIN MICROBIOL, V36, P3505, DOI 10.1128/JCM.36.12.3505-3508.1998; Barbour AG, 2005, INFECT IMMUN, V73, P6165, DOI 10.1128/IAI.73.9.6165-6168.2005; Bitam I, 2009, CLIN MICROBIOL INFEC, V15, P253, DOI 10.1111/j.1469-0691.2008.02274.x; Burridge MJ, 2000, J PARASITOL, V86, P700, DOI 10.1645/0022-3395(2000)086[0700:IOPHVA]2.0.CO;2; Burridge MJ, 2011, NON NATIVE AND INVAS, P4; Burridge ML, 2003, VET PARASITOL, V113, P289, DOI 10.1016/S0304-4017(03)00060-8; Bursali A, 2010, J VECTOR ECOL, V35, P180, DOI 10.1111/j.1948-7134.2010.00045.x; Cutler SJ, 2006, EMERG INFECT DIS, V12, P369, DOI 10.3201/eid1203.050899; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Dolan MC, 1997, J MED ENTOMOL, V34, P128, DOI 10.1093/jmedent/34.2.128; Eisen L, 2002, LYME BORRELIOSIS BIO, P102; Elbir H, 2013, AM J TROP MED HYG, V89, P288, DOI 10.4269/ajtmh.12-0691; Feider Z, 1965, ARACHNIDA, VV, P2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Franke J, 2013, TICKS TICK-BORNE DIS, V4, P11, DOI 10.1016/j.ttbdis.2012.06.007; Gern L, 1998, WIEN KLIN WOCHENSCHR, V110, P856; Guner ES, 2004, INT J SYST EVOL MICR, V54, P1649, DOI 10.1099/ijs.0.03050-0; Guner ES, 2003, J MED MICROBIOL, V52, P807, DOI 10.1099/jmm.0.05205-0; Harris DJ, 2011, J PARASITOL, V97, P106, DOI 10.1645/GE-2470.1; Kalmar Z, 2014, PARASIT VECTORS SUPP, V7, P6; Kar S, 2013, EXP APPL ACAROL, V61, P349, DOI 10.1007/s10493-013-9698-2; Kar S, 2011, CLIN EXP HEALTH SCI, V1, P166; Kolonin GV, 1983, RODY HYALOMMA APONOM; Masuzawa T, 2004, JPN J INFECT DIS, V57, P229; Mihalca AD, 2012, EXP APPL ACAROL, V58, P183, DOI 10.1007/s10493-012-9566-5; Orkun O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003067; Paperna I, 2002, PARASITE, V9, P17, DOI 10.1051/parasite/200209117; Pastiu AI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-301; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; RAY HN, 1950, T ROY SOC TROP MED H, V44, P93, DOI 10.1016/0035-9203(50)90074-5; Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDERS FH, 1995, J MED ENTOMOL, V32, P402, DOI 10.1093/jmedent/32.4.402; Schwan TG, 2005, J CLIN MICROBIOL, V43, P3851, DOI 10.1128/JCM.43.8.3851-3859.2005; Schwan TG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001924; Siroky P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-101; Siroky P, 2011, EXP APPL ACAROL, V54, P277, DOI 10.1007/s10493-011-9442-8; Siroky P, 2010, PARASITOL RES, V107, P1515, DOI 10.1007/s00436-010-2037-1; Siroky P, 2009, J PARASITOL, V95, P728, DOI 10.1645/GE-1842.1; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Takano A, 2011, ENV MICROBIOL REP, V3, P632, DOI 10.1111/j.1758-2229.2011.00280.x; Takano A, 2012, TICKS TICK-BORNE DIS, V3, P259, DOI 10.1016/j.ttbdis.2012.06.003; Takano A, 2010, ENVIRON MICROBIOL, V12, P134, DOI 10.1111/j.1462-2920.2009.02054.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Dam AP, 1999, J CLIN MICROBIOL, V37, P2027, DOI 10.1128/JCM.37.6.2027-2030.1999; Vatansever Z, 2008, PARASITOL RES, V102, P551, DOI 10.1007/s00436-007-0809-z	52	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115520	10.1371/journal.pone.0115520	http://dx.doi.org/10.1371/journal.pone.0115520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695663	gold, Green Published, Green Submitted			2022-12-27	WOS:000350062300005
J	Krix, AC; Sauerland, M; Lorei, C; Rispens, I				Krix, Alana C.; Sauerland, Melanie; Lorei, Clemens; Rispens, Imke			Consistency across Repeated Eyewitness Interviews: Contrasting Police Detectives' Beliefs with Actual Eyewitness Performance	PLOS ONE			English	Article							STRATEGIC REGULATION; GRAIN-SIZE; MEMORY; ACCURACY; RECALL	In the legal system, inconsistencies in eyewitness accounts are often used to discredit witnesses' credibility. This is at odds with research findings showing that witnesses frequently report reminiscent details (details previously unrecalled) at an accuracy rate that is nearly as high as for consistently recalled information. The present study sought to put the validity of beliefs about recall consistency to a test by directly comparing them with actual memory performance in two recall attempts. All participants watched a film of a staged theft. Subsequently, the memory group (N = 84) provided one statement immediately after the film (either with the Self-Administered Interview or free recall) and one after a one-week delay. The estimation group (N = 81) consisting of experienced police detectives estimated the recall performance of the memory group. The results showed that actual recall performance was consistently underestimated. Also, a sharp decline of memory performance between recall attempts was assumed by the estimation group whereas actual accuracy remained stable. While reminiscent details were almost as accurate as consistent details, they were estimated to be much less accurate than consistent information and as inaccurate as direct contradictions. The police detectives expressed a great concern that reminiscence was the result of suggestive external influences. In conclusion, it seems that experienced police detectives hold many implicit beliefs about recall consistency that do not correspond with actual recall performance. Recommendations for police trainings are provided. These aim at fostering a differentiated view on eyewitness performance and the inclusion of more comprehensive classes on human memory structure.	[Krix, Alana C.; Sauerland, Melanie] Maastricht Univ, Forens Psychol Sect, NL-6200 MD Maastricht, Netherlands; [Lorei, Clemens] Univ Appl Sci Police & Adm Hesse, Wiesbaden, Germany; [Rispens, Imke] Police Acad Netherlands, Apeldoorn, Netherlands	Maastricht University	Krix, AC (corresponding author), Maastricht Univ, Forens Psychol Sect, NL-6200 MD Maastricht, Netherlands.	Alana.Krix@maastrichtuniversity.nl	Sauerland, Melanie/AAB-3877-2019; Sauerland, Melanie/ABD-9558-2020; Krix, Alana/AAU-4034-2021	Sauerland, Melanie/0000-0002-7401-1365; Krix, Alana/0000-0001-7905-8966	Studienstiftung des deutschen Volkes (German National Academic Foundation)	Studienstiftung des deutschen Volkes (German National Academic Foundation)	This research was supported by Studienstiftung des deutschen Volkes (German National Academic Foundation, http://www.studienstiftung.de) that provided AK with a PhD scholarship to cover the living expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1983, J VERB LEARN VERB BE, V22, P261, DOI 10.1016/S0022-5371(83)90201-3; Bornstein BH, 1998, APPL COGNITIVE PSYCH, V12, P119, DOI 10.1002/(SICI)1099-0720(199804)12:2<119::AID-ACP500>3.0.CO;2-4; Brainerd CJ, 2013, CURR DIR PSYCHOL SCI, V22, P335, DOI 10.1177/0963721413484468; Brewer N, 1999, APPL COGNITIVE PSYCH, V13, P297, DOI 10.1002/(SICI)1099-0720(199908)13:4<297::AID-ACP578>3.3.CO;2-J; Brock P, 1999, PSYCHOL CRIME LAW, V5, P29, DOI 10.1080/10683169908414992; Cohen J.E., 1988, STAT POWER ANAL BEHA; Erdelyi MH, 2010, AM PSYCHOL, V65, P623, DOI 10.1037/a0020440; Evans JR, 2011, APPL COGNITIVE PSYCH, V25, P501, DOI 10.1002/acp.1722; Fisher R.P., 2009, HDB PSYCHOL INVESTIG, P121, DOI DOI 10.1002/9780470747599.CH8; FISHER RP, 1991, J EXP PSYCHOL LEARN, V17, P722; Fisher RP, 1992, MEMORY ENHANCING TEC; Gabbert F, 2009, LAW HUMAN BEHAV, V33, P298, DOI 10.1007/s10979-008-9146-8; Gilbert JAE, 2006, APPL COGNITIVE PSYCH, V20, P723, DOI 10.1002/acp.1232; Goldsmith M, 2005, J MEM LANG, V52, P505, DOI 10.1016/j.jml.2005.01.010; Goldsmith M, 2002, J EXP PSYCHOL GEN, V131, P73, DOI 10.1037/0096-3445.131.1.73; Hope L, 2014, APPL COGNITIVE PSYCH, V28, P304, DOI 10.1002/acp.2984; Hope L, 2011, LEGAL CRIMINOL PSYCH, V16, P211, DOI 10.1111/j.2044-8333.2011.02015.x; Kebbell MR, 1998, J SOC PSYCHOL, V138, P323, DOI 10.1080/00224549809600384; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; Krix AC, 2014, PSYCHOL CRIME LAW, V20, P1005, DOI 10.1080/1068316X.2014.902456; La Rooy D, 2010, PSYCHOL PUBLIC POL L, V16, P373, DOI 10.1037/a0019909; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Odinot G, 2013, PSYCHOL CRIME LAW, V19, P629, DOI 10.1080/1068316X.2012.660152; Odinot G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076305; Oeberst A, 2012, LAW HUMAN BEHAV, V36, P266, DOI 10.1037/h0093966; Potter R., 1999, PSYCHIAT PSYCHOL LAW, V6, P97, DOI DOI 10.1080/13218719909524952; Sauerland M, 2014, MEM COGNITION, V42, P978, DOI 10.3758/s13421-014-0401-6; SCRIVNER E, 1988, J APPL PSYCHOL, V73, P371, DOI 10.1037/0021-9010.73.3.371; Sixth Circuit Pattern Criminal Jury Instruction Committee, 2014, 6 CIRC CRIM PATT JUR; Smeets T, 2004, AM J PSYCHOL, V117, P595, DOI 10.2307/4148994; Sporer S. L., 2011, RES METHODS FORENSIC, P43; TULVING E, 1975, PSYCHOL REV, V82, P261, DOI 10.1037/h0076782; UVILLER HR, 1993, DUKE LAW J, V42, P776, DOI 10.2307/1372715	33	21	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118641	10.1371/journal.pone.0118641	http://dx.doi.org/10.1371/journal.pone.0118641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695428	gold, Green Submitted, Green Published			2022-12-27	WOS:000350062300058
J	Li, GL; Zhang, JR; Guo, Q; Jiang, Y; Wei, JH; Zhao, LL; Zhao, XQ; Lu, JX; Wan, KL				Li, Guilian; Zhang, Jingrui; Guo, Qian; Jiang, Yi; Wei, Jianhao; Zhao, Li-li; Zhao, Xiuqin; Lu, Jianxin; Wan, Kanglin			Efflux Pump Gene Expression in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates	PLOS ONE			English	Article							INTRINSIC DRUG-RESISTANCE; ISONIAZID RESISTANCE; RIFAMPIN RESISTANCE; MICROARRAY ANALYSIS; GENOME SEQUENCE; MECHANISM; SMEGMATIS; SUSCEPTIBILITY; TRANSPORTERS; ETHAMBUTOL	Isoniazid (INH) and rifampicin (RIF) are the two most effective drugs in tuberculosis therapy. Understanding the molecular mechanisms of resistance to these two drugs is essential to quickly diagnose multidrug-resistant (MDR) tuberculosis and extensive drug-resistant tuberculosis. Nine clinical Mycobacterium tuberculosis isolates resistant to only INH and RIF and 10 clinical pan-sensitive isolates were included to evaluate the expression of 20 putative drug efflux pump genes and sequence mutations in rpoB (RIF), katG (INH), the inhA promoter (INH), and oxyR-ahpC (INH). Nine and three MDR isolates were induced to overexpress efflux pump genes by INH and RIF, respectively. Eight and two efflux pump genes were induced to overexpress by INH and RIF in MDR isolates, respectively. drrA, drrB, efpA, jefA (Rv2459), mmr, Rv0849, Rv1634, and Rv1250 were overexpressed under INH or RIF stress. Most efflux pump genes were overexpressed under INH stress in a MDR isolates that carried the wild-type katG, inhA, and oxyR-ahpC associated with INH resistance than in those that carried mutations. The expression levels of 11 genes (efpA, Rv0849, Rv1250, P55 (Rv1410c), Rv1634, Rv2994, stp, Rv2459, pstB, drrA, and drrB) without drug inducement were significantly higher (P < 0.05) in nine MDR isolates than in 10 pansensitive isolates. In conclusion, efflux pumps may play an important role in INH acquired resistance in MDR M. tuberculosis, especially in those strains having no mutations in genes associated with INH resistance; basal expression levels of some efflux pump genes are higher in MDR isolates than in pan-sensitive isolates and the basal expressional differences may be helpful to diagnose and treat resistant tuberculosis.	[Li, Guilian; Zhang, Jingrui; Guo, Qian; Jiang, Yi; Wei, Jianhao; Zhao, Li-li; Zhao, Xiuqin; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, TB Branch, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Li, Guilian; Zhang, Jingrui; Guo, Qian; Jiang, Yi; Wei, Jianhao; Zhao, Li-li; Zhao, Xiuqin; Wan, Kanglin] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jingrui; Wei, Jianhao; Lu, Jianxin] Wenzhou Med Coll, Key Lab Lab Med, Wenzhou 325035, Zhejiang, Peoples R China; [Zhang, Jingrui] Shijiazhuang Gynecol & Obstetr Hosp, Shijiazhuang 050000, Hebei, Peoples R China; [Guo, Qian] South China Univ, Pathogen Biol Inst, Hengyang 421001, Hunan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Wenzhou Medical University	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, TB Branch, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.	wankanglin@icdc.cn			National Key Programme of Mega Infectious Diseases [2013ZX10003002-001]; State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID104]	National Key Programme of Mega Infectious Diseases; State Key Laboratory for Infectious Disease Prevention and Control	This work was financially supported by projects 2013ZX10003002-001 of the National Key Programme of Mega Infectious Diseases and the key project 2014SKLID104 of the State Key Laboratory for Infectious Disease Prevention and Control. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Aslan G, 2008, JPN J INFECT DIS, V61, P255; Balganesh M, 2012, ANTIMICROB AGENTS CH, V56, P2643, DOI 10.1128/AAC.06003-11; Balganesh M, 2010, ANTIMICROB AGENTS CH, V54, P5167, DOI 10.1128/AAC.00610-10; Banerjee A, 1998, MICROBIOL-SGM, V144, P2697, DOI 10.1099/00221287-144-10-2697; Betts JC, 2003, ANTIMICROB AGENTS CH, V47, P2903, DOI 10.1128/AAC.47.9.2903-2913.2003; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Choudhuri BS, 2002, BIOCHEM J, V367, P279, DOI 10.1042/BJ20020615; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; De Rossi E, 1998, J BACTERIOL, V180, P6068, DOI 10.1128/JB.180.22.6068-6071.1998; De Rossi Edda, 2002, Molecular Medicine (Baltimore), V8, P714; DeMarco CE, 2007, ANTIMICROB AGENTS CH, V51, P3235, DOI 10.1128/AAC.00430-07; Doustdar F, 2008, MICROB DRUG RESIST, V14, P273, DOI 10.1089/mdr.2008.0842; Escribano I, 2007, CHEMOTHERAPY, V53, P397, DOI 10.1159/000109769; Fu LM, 2006, TUBERCULOSIS, V86, P134, DOI 10.1016/j.tube.2005.07.004; Gupta AK, 2010, INDIAN J MED RES, V132, P176; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Jiang X, 2008, MICROB DRUG RESIST, V14, P7, DOI 10.1089/mdr.2008.0772; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kiepiela P, 2000, TUBERCLE LUNG DIS, V80, P47, DOI 10.1054/tuld.1999.0231; Leonard B, 2008, J CLIN MICROBIOL, V46, P3526, DOI 10.1128/JCM.02083-07; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; McCammon MT, 2005, ANTIMICROB AGENTS CH, V49, P2200, DOI 10.1128/AAC.49.6.2200-2209.2005; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; Mokrousov I, 2002, ANTIMICROB AGENTS CH, V46, P1417, DOI 10.1128/AAC.46.5.1417-1424.2002; Mukaigawa Jun, 2005, Kansenshogaku Zasshi, V79, P388; Niederweis M, 2003, MOL MICROBIOL, V49, P1167, DOI 10.1046/j.1365-2958.2003.03662.x; Pang Y, 2013, ANTIMICROB AGENTS CH, V57, P893, DOI 10.1128/AAC.01024-12; Pasca MR, 2005, ANTIMICROB AGENTS CH, V49, P4775, DOI 10.1128/AAC.49.11.4775-4777.2005; Piddock LJV, 2000, J ANTIMICROB CHEMOTH, V45, P159, DOI 10.1093/jac/45.2.159; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Rodrigues L, 2012, INFECT GENET EVOL, V12, P695, DOI 10.1016/j.meegid.2011.08.009; Sacchettini JC, 1996, RES MICROBIOL, V147, P36, DOI 10.1016/0923-2508(96)80201-4; Sekiguchi J, 2007, J CLIN MICROBIOL, V45, P179, DOI 10.1128/JCM.00750-06; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Waddell SJ, 2004, TUBERCULOSIS, V84, P263, DOI 10.1016/j.tube.2003.12.005; World Health Organization, 2012, 2012 UPD CRIT CONC 1; World Health Organization, 2008, WHOHTMTB2008392; Zhang Jing-rui, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P379; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	45	66	70	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0119013	10.1371/journal.pone.0119013	http://dx.doi.org/10.1371/journal.pone.0119013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695504	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300059
J	McLellan, ML; McLellan, BN				McLellan, Michelle L.; McLellan, Bruce N.			Effect of Season and High Ambient Temperature on Activity Levels and Patterns of Grizzly Bears (Ursus arctos)	PLOS ONE			English	Article							BLACK BEARS; BODY-SIZE; CIRCADIAN-RHYTHMS; TIME BUDGETS; ECOLOGY; CONSTRAINTS; THIBETANUS; MOUNTAINS; SALMON; DIET	Understanding factors that influence daily and annual activity patterns of a species provides insights to challenges facing individuals, particularly when climate shifts, and thus is important in conservation. Using GPS collars with dual-axis motion sensors that recorded the number of switches every 5 minutes we tested the hypotheses: 1. Grizzly bears (Ursus arctos) increase daily activity levels and active bout lengths when they forage on berries, the major high-energy food in this ecosystem, and 2. Grizzly bears become less active and more nocturnal when ambient temperature exceeds 20 degrees C. We found support for hypothesis 1 with both male and female bears being active from 0.7 to 2.8 h longer in the berry season than in other seasons. Our prediction under hypothesis 2 was not supported. When bears foraged on berries on a dry, open mountainside, there was no relationship between daily maximum temperature (which varied from 20.4 to 40.1 degrees C) and the total amount of time bears were active, and no difference in activity levels during day or night between warm (20.4-27.3 degrees C) and hot (27.9-40.1 degrees C) days. Our results highlight the strong influence that food acquisition has on activity levels and patterns of grizzly bears and is a challenge to the heat dissipation limitation theory.	[McLellan, Michelle L.] South Coast Grizzly Bear Project, Nelson, BC, Canada; [McLellan, Bruce N.] British Columbia Fish Wildlife & Habitat Manageme, DArcy, BC, Canada		McLellan, ML (corresponding author), South Coast Grizzly Bear Project, Nelson, BC, Canada.	mclellan.wildlife.research@gmail.com			Habitat Conservation Trust Foundation; BC Hydro Fish and Wildlife Compensation Program; British Columbia Ministry of Forests, Lands, and Natural Resource Operations	Habitat Conservation Trust Foundation; BC Hydro Fish and Wildlife Compensation Program; British Columbia Ministry of Forests, Lands, and Natural Resource Operations	This work was supported by the following sources of funding (to BNM): Habitat Conservation Trust Foundation (http://www.hctf.ca/); BC Hydro Fish and Wildlife Compensation Program (www.bchydro.com/about/sustainability/environmental_responsibility/compensation_programs.html); and British Columbia Ministry of Forests, Lands, and Natural Resource Operations (http://www.gov.bc.ca/for/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacigalupe LD, 2003, J MAMMAL, V84, P311, DOI 10.1644/1545-1542(2003)084<0311:AASUBD>2.0.CO;2; Bacon E.S., 1976, IUCN Publs (New Series), VNo. 40, P27; BELOVSKY GE, 1986, OECOLOGIA, V70, P53, DOI 10.1007/BF00377110; du Toit JT, 2005, OECOLOGIA, V143, P317, DOI 10.1007/s00442-004-1789-7; Fortin JK, 2013, J MAMMAL, V94, P833, DOI 10.1644/12-MAMM-A-238.1; GARSHELIS DL, 1980, J MAMMAL, V61, P8, DOI 10.2307/1379952; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hwang MH, 2007, J ZOOL, V271, P203, DOI 10.1111/j.1469-7998.2006.00203.x; Klinka DR, 2002, CAN J ZOOL, V80, P1317, DOI 10.1139/Z02-123; Kozakai C, 2013, J MAMMAL, V94, P351, DOI 10.1644/11-MAMM-A-246.1; Kuznetsova A, 2014, LMERTEST TESTS RANDO; LARIVIERE S, 1994, J MAMMAL, V75, P613, DOI 10.2307/1382508; Mace RD, 1999, CONSERV BIOL, V13, P367, DOI 10.1046/j.1523-1739.1999.013002367.x; Machutchon AG, 1998, URSUS-SERIES, V10, P539; MacHutchon AG, 2001, URSUS-SERIES, V12, P189; McCann RK, 1991, ACTIVITY MEASURES FR; McLellan BN, 2011, CAN J ZOOL, V89, P546, DOI 10.1139/Z11-026; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; McLellan BN, 2001, J WILDLIFE MANAGE, V65, P92, DOI 10.2307/3803280; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Olson TL, 1987, URSUS, V10, P547; Owen-Smith N, 1998, J ZOOL, V246, P183, DOI 10.1111/j.1469-7998.1998.tb00147.x; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; REID D, 1991, MAMMALIA, V55, P221, DOI 10.1515/mamm.1991.55.2.221; Robbins CT, 2004, URSUS, V15, P161, DOI 10.2192/1537-6176(2004)015<0161:NEOUAR>2.0.CO;2; Rode KD, 2001, OECOLOGIA, V128, P62, DOI 10.1007/s004420100637; Rogers L., 1976, Transactions N Am Wildl nat Resour Conf, VNo. 41, P431; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P1628, DOI 10.2193/2009-571; Shrestha AK, 2014, INT J BIOMETEOROL, V58, P41, DOI 10.1007/s00484-012-0622-y; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Stelmock JJ, 1986, INT C BEAR RES MAN, V6, P155, DOI DOI 10.2307/3872820; Team RDC, 2010, R PROJECT STAT COMPU; van der Vinne V, 2014, PHYSIOL BEHAV, V128, P295, DOI 10.1016/j.physbeh.2014.01.019; Vieira EM, 2010, CAN J ZOOL, V88, P259, DOI 10.1139/Z09-142; Ware JV, 2012, AM J PHYSIOL-REG I, V303, pR890, DOI 10.1152/ajpregu.00313.2012; Welch CA, 1997, ECOLOGY, V78, P1105, DOI 10.2307/2265862; Yamazaki K, 2008, URSUS, V19, P154, DOI 10.2192/07GR009.1	39	21	23	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117734	10.1371/journal.pone.0117734	http://dx.doi.org/10.1371/journal.pone.0117734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692979	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500070
J	Patel, N; Itakura, T; Jeong, S; Liao, CP; Roy-Burman, P; Zandi, E; Groshen, S; Pinski, J; Coetzee, GA; Gross, ME; Fini, ME				Patel, Nitin; Itakura, Tatsuo; Jeong, Shinwu; Liao, Chun-Peng; Roy-Burman, Pradip; Zandi, Ebrahim; Groshen, Susan; Pinski, Jacek; Coetzee, Gerhard A.; Gross, Mitchell E.; Fini, M. Elizabeth			Expression and Functional Role of Orphan Receptor GPR158 in Prostate Cancer Growth and Progression	PLOS ONE			English	Article							ANDROGEN RECEPTOR; NEUROENDOCRINE DIFFERENTIATION; LNCAP CELLS; INDEPENDENT GROWTH; RNA INTERFERENCE; GENE; DEPRIVATION; PATHWAY; TRANSDIFFERENTIATION; ADENOCARCINOMA	Prostate cancer (PCa) is the second-leading cause of cancer-related mortality, after lung cancer, in men from developed countries. In its early stages, primary tumor growth is dependent on androgens, thus generally can be controlled by androgen deprivation therapy (ADT). Eventually however, the disease progresses to castration-resistant prostate cancer (CRPC), a lethal form in need of more effective treatments. G-protein coupled receptors (GPCRs) comprise a large clan of cell surface proteins that have been implicated as therapeutic targets in PCa growth and progression. The findings reported here provide intriguing evidence of a role for the newly characterized glutamate family member GPR158 in PCa growth and progression. We found that GPR158 promotes PCa cell proliferation independent of androgen receptor (AR) functionality and that this requires its localization in the nucleus of the cell. This suggests that GPR158 acts by mechanisms different from other GPCRs. GPR158 expression is stimulated by androgens and GPR158 stimulates AR expression, implying a potential to sensitize tumors to low androgen conditions during ADT via a positive feedback loop. Further, we found GPR158 expression correlates with a neuroendocrine (NE) differentiation phenotype and promotes anchorage-independent colony formation implying a role for GPR158 in therapeutic progression and tumor formation. GPR158 expression was increased at the invading front of prostate tumors that formed in the genetically defined conditional Pten knockout mouse model, and co-localized with elevated AR expression in the cell nucleus. Kaplan-Meier analysis on a dataset from the Memorial Sloan Kettering cancer genome portal showed that increased GPR158 expression in tumors is associated with lower disease-free survival. Our findings strongly suggest that pharmaceuticals targeting GPR158 activities could represent a novel and innovative approach to the prevention and management of CRPC.	[Patel, Nitin; Itakura, Tatsuo; Jeong, Shinwu; Liao, Chun-Peng; Gross, Mitchell E.; Fini, M. Elizabeth] Univ So Calif, Inst Med Genet, Los Angeles, CA 90089 USA; [Liao, Chun-Peng; Gross, Mitchell E.] Ctr Appl Mol Med, Los Angeles, CA USA; [Liao, Chun-Peng; Gross, Mitchell E.] Univ So Calif, Westside Prostate Canc Ctr, Los Angeles, CA USA; [Roy-Burman, Pradip; Zandi, Ebrahim; Groshen, Susan; Pinski, Jacek; Coetzee, Gerhard A.; Gross, Mitchell E.; Fini, M. Elizabeth] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Fini, M. Elizabeth] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Pinski, Jacek; Gross, Mitchell E.] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Zandi, Ebrahim] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Jeong, Shinwu; Fini, M. Elizabeth] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Roy-Burman, Pradip] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Groshen, Susan; Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Coetzee, Gerhard A.; Gross, Mitchell E.] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Patel, N (corresponding author), Univ So Calif, Inst Med Genet, Los Angeles, CA 90089 USA.	nitinpat@usc.edu	coetzee, Gerhard/AAT-6203-2020; Coetzee, Gerhard/AAG-8439-2019	Coetzee, Gerhard/0000-0001-8820-8364; Liao, Chun-Peng/0000-0001-8920-4322; Jeong, Shinwu/0000-0002-4847-813X; Gross, Mitchell/0000-0002-1691-921X	National Institutes of Health [R01-EY09828, R01-CA136924]; Robert E. and May R. Wright Foundation; NATIONAL CANCER INSTITUTE [R01CA136924] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert E. and May R. Wright Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants [R01-EY09828] to MEF and [R01-CA136924] to GAC. The Robert E. and May R. Wright Foundation award to NP and MEF also provided support for conducting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO;2-S; Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Agrawal P, 2010, CELL CYCLE, V9, P4908, DOI 10.4161/cc.9.24.14199; Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; Bjarndottir TK, 2005, GENE, V362, P70, DOI 10.1016/j.gene.2005.07.029; Bonkhoff H, 1998, PROSTATE, P18; Buchanan G, 2004, PROSTATE, V60, P352, DOI 10.1002/pros.20079; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; El-Haibi CP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-64; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; Gillies K, 2013, CELL PHYSIOL BIOCHEM, V32, P74, DOI 10.1159/000350126; Gioeli D, 1999, CANCER RES, V59, P279; Imberg-Kazdan K, 2013, GENOME RES, V23, P581, DOI 10.1101/gr.144774.112; Jongsma J, 2000, PROSTATE, V42, P34, DOI 10.1002/(SICI)1097-0045(20000101)42:1<34::AID-PROS5>3.0.CO;2-2; Jongsma J, 2000, CANCER RES, V60, P741; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Koivisto P, 1997, CANCER RES, V57, P314; KUIPER GGJM, 1992, J STEROID BIOCHEM, V41, P697, DOI 10.1016/0960-0760(92)90407-A; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; LABRIE F, 1993, CLIN INVEST MED, V16, P475; Lee JG, 2009, MOL CARCINOGEN, V48, P141, DOI 10.1002/mc.20462; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Li Z, 2013, ASIAN J ANDROL, V15, P328, DOI 10.1038/aja.2013.7; Liao CP, 2007, CANCER RES, V67, P7525, DOI 10.1158/0008-5472.CAN-07-0668; Linja MJ, 2001, CANCER RES, V61, P3550; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013500; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Mori R, 2009, PROSTATE, V69, P12, DOI 10.1002/pros.20851; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; Patel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057843; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Price DT, 1999, J UROLOGY, V162, P1537, DOI 10.1016/S0022-5347(05)68354-1; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rockstroh M MS, 2011, J INTEGR OMICS, V1, P135, DOI DOI 10.5584/JI0MICS; Sagnak L, 2011, CLIN GENITOURIN CANC, V9, P73, DOI 10.1016/j.clgc.2011.07.003; Salazar MD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2827; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Schayek H, 2012, HORM METAB RES, V44, P511, DOI 10.1055/s-0032-1311566; Shen R, 1997, Urol Oncol, V3, P67, DOI 10.1016/S1078-1439(97)00039-2; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Shiota M, 2011, J MOL ENDOCRINOL, V47, pR25, DOI 10.1530/JME-11-0018; Siddiqui EJ, 2006, J UROLOGY, V176, P1648, DOI 10.1016/j.juro.2006.06.087; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spans L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090002; Sun Y, 2009, AM J TRANSL RES, V1, P148; Taub JS, 2003, CANCER RES, V63, P2037; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thalmann GN, 2000, PROSTATE, V44, P91; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Wright ME, 2003, MOL ENDOCRINOL, V17, P1726, DOI 10.1210/me.2003-0031; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Wu JT, 2000, ANN CLIN LAB SCI, V30, P175; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zelivianski S, 2001, BBA-MOL CELL RES, V1539, P28, DOI 10.1016/S0167-4889(01)00087-8	71	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117758	10.1371/journal.pone.0117758	http://dx.doi.org/10.1371/journal.pone.0117758			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693195	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500073
J	Smith, TJS; Wolfson, JA; Jiao, D; Crupain, MJ; Rangan, U; Sapkota, A; Bleich, SN; Nachman, KE				Smith, Tyler J. S.; Wolfson, Julia A.; Jiao, Ding; Crupain, Michael J.; Rangan, Urvashi; Sapkota, Amir; Bleich, Sara N.; Nachman, Keeve E.			Caramel Color in Soft Drinks and Exposure to 4-Methylimidazole: A Quantitative Risk Assessment	PLOS ONE			English	Article							BEVERAGES	Caramel color is added to many widely-consumed beverages as a colorant. Consumers of these beverages can be exposed to 4-methylimidazole (4-MEI), a potential carcinogen formed during its manufacture. California's Proposition 65 law requires that beverages containing 4-MEI concentrations corresponding to exposures that pose excess cancer risks >1 case per 100,000 exposed persons (29 mu g 4-MEI/day) carry warning labels. Using ultrahigh-performance liquid chromatography-tandem mass spectrometry, we assessed 4-MEI concentrations in 12 beverages purchased in California and a geographically distant metropolitan area (New York) in which warning labels are not required. In addition, we characterized beverage consumption by age and race/ethnicity (using weighted means calculated from logistic regressions) and assessed 4-MEI exposure and resulting cancer risks and US population cancer burdens attributable to beverage consumption. Data on beverage consumption were obtained from the National Health and Nutrition Examination Survey, dose-response data for 4-MEI were obtained from the California Environmental Protection Agency Office of Environmental Health Hazards Assessment, and data on population characteristics were obtained from the U.S. Census Bureau. Of the 12 beverages, Malta Goya had the highest 4-MEI concentration (915.8 to 963.3 mu g/L), lifetime average daily dose (LADD - 8.04x10(-3) mg/kgBWday), lifetime excess cancer risk (1.93x10(-4)) and burden (5,011 cancer cases in the U.S. population over 70 years); Coca-Cola had the lowest value of each (4-MEI: 9.5 to 11.7 mu g/L; LADD: 1.01x10(-4) mg/kgBW-day; risk: 1.92x10(-6); and burden: 76 cases). 4-MEI concentrations varied considerably by soda and state/area of purchase, but were generally consistent across lots of the same beverage purchased in the same state/area. Routine consumption of certain beverages can result in 4-MEI exposures >29 mu g/day. State regulatory standards	[Smith, Tyler J. S.; Wolfson, Julia A.; Crupain, Michael J.; Nachman, Keeve E.] Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21205 USA; [Smith, Tyler J. S.; Nachman, Keeve E.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Wolfson, Julia A.; Bleich, Sara N.; Nachman, Keeve E.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Jiao, Ding; Crupain, Michael J.; Rangan, Urvashi] Consumer Reports, Food Safety & Sustainabil Ctr, Yonkers, NY USA; [Sapkota, Amir] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA; [Nachman, Keeve E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Risk Sci & Publ Policy Inst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nachman, KE (corresponding author), Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21205 USA.	knachman@jhu.edu	Sapkota, Amir/A-5968-2011; Wolfson, Julia/D-9854-2018	Nachman, Keeve/0000-0003-4925-4151; Wolfson, Julia/0000-0001-9155-2609; Smith, Tyler/0000-0003-4692-2206	Consumers Union; GRACE Communications Foundation; National Heart, Lung, and Blood Institute [1K01HL096409]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL096409] Funding Source: NIH RePORTER	Consumers Union; GRACE Communications Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	TJSS, AS and KEN were supported by a grant from Consumers Union (the grant was not given a specific number). TJSS and KEN are also funded by the GRACE Communications Foundation (who did not provide funding specific to this project) (URL: http://www.gracelinks.org/). JAW and SNB are funded by a grant from the National Heart, Lung, and Blood Institute (1K01HL096409). JAW is also a CLF-Lerner Doctoral Fellow. With the exception of MJC, UR and DJ, who are employees of Consumers Union and part of the study team, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubrey A, 2014, POTENTIAL CARCINOGEN; Aubrey A, 2013, COKE CHANGED CARAMEL; Bleich S. N., 2008, AM J CLIN NUTR; Centers for Disease Control and Prevention, 2014, 2009 2010 DAT DOC CO; Consumer Reports, 2014, CAR COL HLTH RISK MA; Folmer D, 2014, 206 REFINED EXPOSURE; International Agency for Research on Cancer, 2010, 4 METH; Kamuf W, 2003, CEREAL FOOD WORLD, V48, P64; Moon JK, 2011, J AGR FOOD CHEM, V59, P615, DOI 10.1021/jf104098a; National Toxicology Program, 2007, NTP TECHN REP TOX CA; Office of Environmental Health Hazard Assessment, 2011, PROP 65 PLAIN LANG; Office of Environmental Health Hazard Assessment, 2011, NO SIGN RISK LEV NSR; Schoeny R, 2008, ACCEPTABLE RISK LEVE; United States Census Bureau, 2013, NSTEST201201 US CENS; United States Environmental Protection Agency, 2014, TECHN TRANSF NETW 19; United States Food and Drug Administration, 2002, FED REGISTER, V67, P78172; United States Food and Drug Administration, 2014, QUEST ANSW CAR COL 4; United States Food and Drug Administration, 2014, COL ADD STAT LIST; US EPA, 2011, EXPOSURE FACTORS HDB, DOI DOI 10.2903/J.EFSA.2011.2392.2011.EPA/600/R-09/052F; Wang JY, 2012, J AGR FOOD CHEM, V60, P917, DOI 10.1021/jf204476x; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834	21	57	58	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118138	10.1371/journal.pone.0118138	http://dx.doi.org/10.1371/journal.pone.0118138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693062	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500101
J	Chakrabarti, S; Wu, JP				Chakrabarti, Subhadeep; Wu, Jianping			Milk-Derived Tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) Promote Adipocyte Differentiation and Inhibit Inflammation in 3T3-F442A Cells	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; KAPPA-B ACTIVATION; LOW-GRADE INFLAMMATION; INSULIN-RESISTANCE; METABOLIC SYNDROME; C-FOS; ARTERIAL-HYPERTENSION; BIOACTIVE PEPTIDES; GENE-EXPRESSION; DOWN-REGULATION	Milk derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) have shown promise as anti-hypertensive agents due to their inhibitory effects on angiotensin converting enzyme (ACE). Due to the key inter-related roles of hypertension, chronic inflammation and insulin resistance in the pathogenesis of metabolic syndrome, there is growing interest in investigating established anti-hypertensive agents for their effects on insulin sensitivity and inflammation. In this study, we examined the effects of IPP and VPP on 3T3-F442A murine preadipocytes, a widely used model for studying metabolic diseases. We found that both IPP and VPP induced beneficial adipogenic differentiation as manifested by intracellular lipid accumulation, upregulation of peroxisome proliferator-activated receptor gamma (PPAR gamma) and secretion of the protective lipid hormone adiponectin by these cells. The observed effects were similar to those induced by insulin, suggesting potential benefits in the presence of insulin resistance. IPP and VPP also inhibited cytokine induced pro-inflammatory changes such as reduction in adipokine levels and activation of the nuclear factor kappa B (NF-kappa B) pathway. Taken together, our findings suggest that IPP and VPP exert insulin-mimetic adipogenic effects and prevent inflammatory changes in adipocytes, which may offer protection against metabolic disease.	[Wu, Jianping] Univ Alberta, Dept Agr Food & Nutr Sci AFNS, Edmonton, AB, Canada; Univ Alberta, Cardiovasc Res Ctr CVRC, Edmonton, AB, Canada	University of Alberta; University of Alberta	Wu, JP (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci AFNS, Edmonton, AB, Canada.	jwu3@ualberta.ca	Wu, Jian/AAU-5221-2020; Chakrabarti, Subhadeep/AAD-1078-2022; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Alberta Livestock and Meat Agency (ALMA); Natural Sciences and Engineering Research Council (NSERC) of Canada	Alberta Livestock and Meat Agency (ALMA); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by grants from Alberta Livestock and Meat Agency (ALMA) and the Natural Sciences and Engineering Research Council (NSERC) of Canada to J. Wu. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aihara K, 2009, J ATHEROSCLER THROMB, V16, P594, DOI 10.5551/jat.729; Ayala-Sumuano JT, 2008, BIOCHEM BIOPH RES CO, V374, P720, DOI 10.1016/j.bbrc.2008.07.127; Beh JE, 2013, J ETHNOPHARMACOL, V150, P339, DOI 10.1016/j.jep.2013.09.001; Boelsma E, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-52; Chakrabarti S, 2009, J STEROID BIOCH MOL; Chakrabarti S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/608979; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Christensen KB, 2009, PHYTOTHER RES, V23, P1316, DOI 10.1002/ptr.2782; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coppack S, 2005, CARDIOVASCULAR DISEASE: DIET, NUTRITION AND EMERGING RISK FACTORS, P22; CRANDALL DL, 1993, METABOLISM, V42, P511, DOI 10.1016/0026-0495(93)90111-Z; Davis JE, 2009, HORM METAB RES, V41, P523, DOI 10.1055/s-0029-1202852; Dermitzaki E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097060; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; FitzGerald RJ, 2004, J NUTR, V134, p980S, DOI 10.1093/jn/134.4.980S; Fu YC, 2004, DIABETES, V53, pA79; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Gonzalez-Albarran O, 2009, DIABETOLOGIA, V52, pS467; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Guo W, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051204, DOI 10.1371/JOURNAL.PONE.0051204]; Guo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040958; GURLAND G, 1990, ENDOCRINOLOGY, V127, P3187, DOI 10.1210/endo-127-6-3187; Hamm JK, 1998, MOL BIOL CELL, V9, p317A; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Hatano T, 2014, BIOL PHARM BULL, V37, P1132, DOI 10.1248/bpb.b13-00989; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Hirota T, 2011, HEART VESSELS, V26, P549, DOI 10.1007/s00380-010-0096-y; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Ichikawa S, 2010, INT J FOOD SCI NUTR, V61, P52, DOI 10.3109/09637480903257711; Jauhiainena T, 2007, INT DAIRY J, V17, P1209, DOI 10.1016/j.idairyj.2007.03.002; Karagiannis A, 2007, EXPERT OPIN THER TAR, V11, P191, DOI 10.1517/14728222.11.2.191; Khan HMS, 2012, AFR J PHARM PHARMACO, V6, P1805, DOI 10.5897/AJPP12.684; Khanna A, 2008, CURR OPIN NEPHROL HY, V17, P477, DOI 10.1097/MNH.0b013e3283069d72; Li Z, 2013, J DAIRY SCI, V96, P4242, DOI 10.3168/jds.2012-6511; LIND L, 1993, J HYPERTENS, V11, pS11; Lu HL, 2006, WORLD J GASTROENTERO, V12, P1747, DOI 10.3748/wjg.v12.i11.1747; Maeda A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/946492; Majumder K, 2013, J AGR FOOD CHEM; Matsushita K, 2005, CIRCULATION, V112, pU342; Medvedev IN, 2007, RUSS J CARDIOL, P97; Meisel H, 2004, BIOFACTORS, V21, P55, DOI 10.1002/biof.552210111; Moller DE, 2003, INT J OBESITY, V27, pS17, DOI 10.1038/sj.ijo.0802494; Nakamura T, 2013, J MED FOOD, V16, P396, DOI 10.1089/jmf.2012.2541; Nakarai Hideo, 2012, Innate Immunity, V18, P164, DOI 10.1177/1753425910393370; Natali A, 2004, ENDOCRIN METAB CLIN, V33, P417, DOI 10.1016/j.ecl.2004.03.007; Ohara H, 2010, J DERMATOL, V37, P330, DOI 10.1111/j.1346-8138.2010.00827.x; Potenza MV, 2009, NUTR CLIN PRACT, V24, P560, DOI 10.1177/0884533609342436; Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011; Rekovets O, 2010, J HYPERTENS, V28, pE569, DOI 10.1097/01.hjh.0000379936.92800.4d; Rodrigues CEM, 2012, CLIN EXP RHEUMATOL, V30, P871; Roncal CA, 2009, AM J NEPHROL, V30, P399, DOI 10.1159/000235731; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Salazard B, 2004, CELL BIOL TOXICOL, V20, P375, DOI 10.1007/s10565-004-1471-1; Seppo L, 2003, AM J CLIN NUTR, V77, P326, DOI 10.1093/ajcn/77.2.326; Serne EH, 2006, ESSAYS BIOCHEM, V42, P163, DOI 10.1042/bse0420163; Sgarra L, 2012, AM J PHYSIOL-ENDOC M, V302, pE1171, DOI 10.1152/ajpendo.00038.2012; Shahidi F, 2008, J AOAC INT, V91, P914; Shigemura Y, 2009, J AGR FOOD CHEM, V57, P444, DOI 10.1021/jf802785h; Smorlesi A, 2012, OBES REV, V13, P83, DOI 10.1111/j.1467-789X.2012.01039.x; Sonnenberg GE, 2004, OBES RES, V12, P180, DOI 10.1038/oby.2004.24; Strowski MZ, 2004, ENDOCRINOLOGY, V145, P5259, DOI 10.1210/en.2004-0610; Sueta D, 2011, CIRCULATION, V124; SUMANTRAN VN, 1992, ENDOCRINOLOGY, V130, P2016, DOI 10.1210/en.130.4.2016; Taguchi I, 2013, HYPERTENS RES, V36, P608, DOI 10.1038/hr.2013.3; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; Taylor CT, 2014, BIOCHEM BIOPH RES CO, V447, P660, DOI 10.1016/j.bbrc.2014.04.062; Turpeinen AM, 2009, J FUNCT FOODS, V1, P260, DOI 10.1016/j.jff.2009.03.001; van Tienen FH, 2010, J CELL BIOCHEM, V111, P1575, DOI 10.1002/jcb.22889; Yamaguchi N, 2009, EUR J PHARMACOL, V620, P71, DOI 10.1016/j.ejphar.2009.08.005; Yamamoto Y, 2004, J CLIN ENDOCR METAB, V89, P87, DOI 10.1210/jc.2003-031163; Yan J, 2014, J ANIM PHYSIOL AN N, V98, P530, DOI 10.1111/jpn.12107; Yanagisawa M, 2012, MOL NUTR FOOD RES, V56, P1783, DOI 10.1002/mnfr.201200284; Zamboni M, 2007, INT J OBESITY, V31, P1104, DOI 10.1038/sj.ijo.0803563; Zarich Stuart W, 2005, Rev Cardiovasc Med, V6, P194	75	38	40	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117492	10.1371/journal.pone.0117492	http://dx.doi.org/10.1371/journal.pone.0117492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714093	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700034
J	Nojima, Y; Ito, K; Ono, H; Nakazato, T; Bono, H; Yokoyama, T; Sato, R; Suetsugu, Y; Nakamura, Y; Yamamoto, K; Satoh, JI; Tabunoki, H; Fugo, H				Nojima, Yosui; Ito, Katsuhiko; Ono, Hiromasa; Nakazato, Takeru; Bono, Hidemasa; Yokoyama, Takeshi; Sato, Ryoichi; Suetsugu, Yoshitaka; Nakamura, Yuki; Yamamoto, Kimiko; Satoh, Jun-ichi; Tabunoki, Hiroko; Fugo, Hajime			Superoxide Dismutases, SOD1 and SOD2, Play a Distinct Role in the Fat Body during Pupation in Silkworm Bombyx mori	PLOS ONE			English	Article							LARGE GENE LISTS; REACTIVE OXYGEN; DOMESTICATED SILKWORM; PROTEIN OXIDATION; HYPHANTRIA-CUNEA; JUVENILE-HORMONE; DROSOPHILA; SEQUENCE; GENOME; 20-HYDROXYECDYSONE	One way that aerobic biological systems counteract the generation of reactive oxygen species (ROS) is with superoxide dismutase proteins SOD1 and SOD2 that metabolize superoxide radicals to molecular oxygen and hydrogen peroxide or scavenge oxygen radicals produced by the extensive oxidation-reduction and electron-transport reactions that occur in mitochondria. We characterized SOD1 and SOD2 of Bombyx mori isolated from the fat body of larvae. Immunological analysis demonstrated the presence of BmSOD1 and BmSOD2 in the silk gland, midgut, fat body, Malpighian tubules, testis and ovary from larvae to adults. We found that BmSOD2 had a unique expression pattern in the fat body through the fifth instar larval developmental stage. The anti-oxidative functions of BmSOD1 and BmSOD2 were assessed by exposing larvae to insecticide rotenone or vasodilator isosorbide dinitrate, which is an ROS generator in BmN4 cells; however, exposure to these compounds had no effect on the expression levels of either BmSOD protein. Next, we investigated the physiological role of BmSOD1 and BmSOD2 under environmental oxidative stress, applied through whole-body UV irradiation and assayed using quantitative RTPCR, immunoblotting and microarray analysis. The mRNA expression level of both BmSOD1 and BmSOD2 was markedly increased but protein expression level was increased only slightly. To examine the differences in mRNA and protein level due to UV irradiation intensity, we performed microarray analysis. Gene set enrichment analysis revealed that genes in the insulin signaling pathway and PPAR signaling pathway were significantly up-regulated after 6 and 12 hours of UV irradiation. Taken together, the activities of BmSOD1 and BmSOD2 may be related to the response to UV irradiation stress in B. mori. These results suggest that BmSOD1 and BmSOD2 modulate environmental oxidative stress in the cell and have a specific role in fat body of B. mori during pupation.	[Nojima, Yosui; Ito, Katsuhiko; Yokoyama, Takeshi; Tabunoki, Hiroko; Fugo, Hajime] Tokyo Univ Agr & Technol, Fac Agr, Dept Biol Prod, Tokyo 1838509, Japan; [Nojima, Yosui; Satoh, Jun-ichi] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Tokyo 2048588, Japan; [Ono, Hiromasa; Nakazato, Takeru; Bono, Hidemasa] Res Org Informat & Syst, Database Ctr Life Sci DBCLS, Mishima, Shizuoka 4118540, Japan; [Sato, Ryoichi] Tokyo Univ Agr & Technol, Bioapplicat & Syst Engn, Tokyo 1848588, Japan; [Suetsugu, Yoshitaka; Nakamura, Yuki; Yamamoto, Kimiko] Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki 3058634, Japan	Tokyo University of Agriculture & Technology; Meiji Pharmaceutical University; Research Organization of Information & Systems (ROIS); Tokyo University of Agriculture & Technology; National Institute of Agrobiological Sciences - Japan	Tabunoki, H (corresponding author), Tokyo Univ Agr & Technol, Fac Agr, Dept Biol Prod, Saiwai Cho 3-5-8, Tokyo 1838509, Japan.	h_tabuno@cc.tuat.ac.jp	Ito, Katsuhiko/B-8861-2015; Nojima, Yosui/Y-9309-2019; Yokoyama, Takeshi/C-3854-2013; TABUNOKI, Hiroko/H-6593-2013; Sato, Ryoichi/G-1074-2013; Bono, Hidemasa/AAF-3649-2020; Nakazato, Takeru/H-2732-2013; Ono, Hiromasa/ABA-1412-2021	Ito, Katsuhiko/0000-0003-4464-1734; Nojima, Yosui/0000-0002-6821-0093; TABUNOKI, Hiroko/0000-0003-1823-9952; Bono, Hidemasa/0000-0003-4413-0651; Nakazato, Takeru/0000-0002-0706-2867; Ono, Hiromasa/0000-0001-8675-963X	Funds for Development of Human Resources in Science and Technology "Supporting positive activities for female researchers" from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS) [23300281]; National Bioscience Database Center (NBDC) of the Japan Science and the Technology Agency (JST)	Funds for Development of Human Resources in Science and Technology "Supporting positive activities for female researchers" from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Bioscience Database Center (NBDC) of the Japan Science and the Technology Agency (JST)	This work was supported by Funds for Development of Human Resources in Science and Technology "Supporting positive activities for female researchers" from the Ministry of Education, Culture, Sports, Science and Technology of Japan to H.T. H.F. was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research B (23300281). Support for this work was also provided by the National Bioscience Database Center (NBDC) of the Japan Science and the Technology Agency (JST) to H.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Bi ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090435; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dean RT, 1997, BIOCHEM J, V324, P1; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; HAYASHI Y, 1960, NATURE, V186, P1053, DOI 10.1038/1861053a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang TT, 1999, ANN NY ACAD SCI, V893, P95, DOI 10.1111/j.1749-6632.1999.tb07820.x; Isobe M, 2006, CHEMBIOCHEM, V7, P1590, DOI 10.1002/cbic.200600138; Jia HH, 2014, J INSECT PHYSIOL, V60, P68, DOI 10.1016/j.jinsphys.2013.11.004; Kamimura M, 2007, ARCH INSECT BIOCHEM, V65, P143, DOI 10.1002/arch.20186; Kim YI, 2010, COMP BIOCHEM PHYS B, V157, P343, DOI 10.1016/j.cbpb.2010.08.003; Kim YI, 2011, COMP BIOCHEM PHYS A, V159, P303, DOI 10.1016/j.cbpa.2011.03.022; Liu Y, 2010, J INSECT PHYSIOL, V56, P1436, DOI 10.1016/j.jinsphys.2010.02.011; Meng JY, 2009, J INSECT PHYSIOL, V55, P588, DOI 10.1016/j.jinsphys.2009.03.003; Miller AF, 2012, FEBS LETT, V586, P585, DOI 10.1016/j.febslet.2011.10.048; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mockett RJ, 2003, P NATL ACAD SCI USA, V100, P301, DOI 10.1073/pnas.0136976100; Morin B, 1998, BIOCHEM J, V330, P1059, DOI 10.1042/bj3301059; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Nation JL, 2008, INSECT PHYSL BIOCH, P123; Pani G, 2009, INT J BIOCHEM CELL B, V41, P1002, DOI 10.1016/j.biocel.2008.10.011; Parkes TL, 1999, NEUROBIOL AGING, V20, P531, DOI 10.1016/S0197-4580(99)00086-X; Vilela FMP, 2012, EUR J PHARM BIOPHARM, V80, P387, DOI 10.1016/j.ejpb.2011.10.005; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; Sims-Robinson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068011; Suetsugu Y, 2013, G3-GENES GENOM GENET, V3, P1481, DOI 10.1534/g3.113.006239; Suzuki T, 2008, J INSECT PHYSIOL, V54, P1168, DOI 10.1016/j.jinsphys.2008.06.005; Tabunoki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069130; Tabunoki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017683; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang F, 2013, MOL GENET GENOMICS, V288, P683, DOI 10.1007/s00438-013-0782-4; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yamamoto K, 2005, COMP BIOCHEM PHYS B, V142, P403, DOI 10.1016/j.cbpb.2005.09.002; Yamamoto K, 2005, BIOSCI BIOTECH BIOCH, V69, P507, DOI 10.1271/bbb.69.507; Yamamoto K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r21	40	25	27	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116007	10.1371/journal.pone.0116007	http://dx.doi.org/10.1371/journal.pone.0116007			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714339	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700008
J	Postnikova, OA; Hult, M; Shao, J; Skantar, A; Nemchinov, LG				Postnikova, Olga A.; Hult, Maria; Shao, Jonathan; Skantar, Andrea; Nemchinov, Lev G.			Transcriptome Analysis of Resistant and Susceptible Alfalfa Cultivars Infected With Root-Knot Nematode Meloidogyne incognita	PLOS ONE			English	Article							PLANTS; GENE; PROTEINS; SEQUENCE; REVEALS; DEFENSE; CULTURE; TOOL	Nematodes are one of the major limiting factors in alfalfa production. Root-knot nematodes (RKN, Meloidogyne spp.) are widely distributed and economically important sedentary endoparasites of agricultural crops and they may inflict significant damage to alfalfa fields. As of today, no studies have been published on global gene expression profiling in alfalfa infected with RKN or any other plant parasitic nematode. Very little information is available about molecular mechanisms that contribute to pathogenesis and defense responses in alfalfa against these pests and specifically against RKN. In this work, we performed root transcriptome analysis of resistant (cv. Moapa 69) and susceptible (cv. Lahontan) alfalfa cultivars infected with RKN Meloidogyne incognita, widespread root-knot nematode species and a major pest worldwide. A total of 1,701,622,580 pair-end reads were generated on an Illumina Hi-Seq 2000 platform from the roots of both cultivars and assembled into 45,595 and 47,590 transcripts in cvs Moapa 69 and Lahontan, respectively. Bioinformatic analysis revealed a number of common and unique genes that were differentially expressed in susceptible and resistant lines as a result of nematode infection. Although the susceptible cultivar showed a more pronounced defense response to the infection, feeding sites were successfully established in its roots. Characteristically, basal gene expression levels under normal conditions differed between the two cultivars as well, which may confer advantage to one of the genotypes toward resistance to nematodes. Differentially expressed genes were subsequently assigned to known Gene Ontology categories to predict their functional roles and associated biological processes. Real-time PCR validated expression changes in genes arbitrarily selected for experimental confirmation. Candidate genes that contribute to protection against M. incognita in alfalfa were proposed and alfalfa-nematode interactions with respect to resistance are discussed.	[Postnikova, Olga A.; Shao, Jonathan; Nemchinov, Lev G.] USDA ARS, Beltsville Agr Res Ctr, Mol Plant Pathol Lab, Beltsville, MD 20705 USA; [Hult, Maria; Skantar, Andrea] USDA ARS, Beltsville Agr Res Ctr, Nematol Lab, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Nemchinov, LG (corresponding author), USDA ARS, Beltsville Agr Res Ctr, Mol Plant Pathol Lab, Beltsville, MD 20705 USA.	Lev.Nemchinov@ars.usda.gov	Skantar, Andrea/V-1182-2018	Skantar, Andrea/0000-0001-8940-2580; Hult, Maria/0000-0002-6930-9810	United States Department of Agriculture, Agricultural Research Service	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the United States Department of Agriculture, Agricultural Research Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beneventi MA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-322; Castagnone-Sereno P, 2013, ANNU REV PHYTOPATHOL, V51, P203, DOI 10.1146/annurev-phyto-082712-102300; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dhandaydham M, 2008, J NEMATOL, V40, P46; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; GAMBORG OL, 1976, IN VITRO CELL DEV B, V12, P473; Griffin GD, 1991, STANDARD TESTS CHARA; GRIFFIN GD, 1990, COMPENDIUM ALFALFA D, P46; Hafez SL, 2009, P 2009 W ALF FOR C D; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Jurkowski GI, 2004, MOL PLANT MICROBE IN, V17, P511, DOI 10.1094/MPMI.2004.17.5.511; Lambert K., 2002, PLANT HLTH INSTRUCTO, V10, P1094, DOI [DOI 10.1094/PHI-I-2002-1218-01, 10.1094/PHI-I-2002-1218-01]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li XH, 2012, AGRONOMY-BASEL, V2, P40, DOI 10.3390/agronomy2010040; Mitkowski NA, 2003, INSTRUCTOR, DOI DOI 10.1094/PHI-I-2003-0917-01; Nakasugi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091776; Paal J, 2004, PLANT J, V38, P285, DOI 10.1111/j.1365-313X.2004.02047.x; Postnikova OA, 2014, MOL GENET GENOMICS, V289, P457, DOI 10.1007/s00438-014-0823-7; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Potenza C, 2001, PLANT SCI, V161, P289, DOI 10.1016/S0168-9452(01)00415-0; Potenza CL, 1996, J NEMATOL, V28, P475; Rosso MN, 2013, PARASITIC NEMATODES: MOLECULAR BIOLOGY, BIOCHEMISTRY AND IMMUNOLOGY, 2ND EDITION, P42, DOI 10.1079/9781845937591.0042; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sanseverino Walter, 2012, BMC Res Notes, V5, P678, DOI 10.1186/1756-0500-5-678; Sanseverino W, 2010, NUCLEIC ACIDS RES, V38, pD814, DOI 10.1093/nar/gkp978; Sasser J. N., 1987, Vistas on Nematology: A Commemoration of the Twenty-fifth Anniversary of the Society of Nematologists, P7; Schaff JE, 2007, PLANT PHYSIOL, V144, P1079, DOI 10.1104/pp.106.090241; Supramana S, 2002, NEMATROPICA, V32, P5; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williamson VM, 2006, TRENDS GENET, V22, P396, DOI 10.1016/j.tig.2006.05.003; Williamson VM, 2003, CURR OPIN PLANT BIOL, V6, P327, DOI 10.1016/S1369-5266(03)00059-1; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	38	41	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118269	10.1371/journal.pone.0118269	http://dx.doi.org/10.1371/journal.pone.0118269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710378	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900051
J	Yang, H; He, F; Wang, TH; Liu, Y; Shen, Y; Gong, J; Dai, W; Zhou, J; Gu, J; Tu, YM; Wang, TY; Shen, L; Wu, YM; Xia, XP; Xu, DH; Pan, ZG; Zhu, SZ				Yang, Hua; He, Fang; Wang, Tianhao; Liu, Yao; Shen, Yao; Gong, Jian; Dai, Wei; Zhou, Jing; Gu, Jie; Tu, Yimin; Wang, Tianying; Shen, Lei; Wu, Yumiao; Xia, Xiuping; Xu, Donghao; Pan, Zhigang; Zhu, Shanzhu			Health-Related Lifestyle Behaviors among Male and Female Rural-to-Urban Migrant Workers in Shanghai, China	PLOS ONE			English	Article							QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; PROSPECTIVE COHORT; CIGARETTE-SMOKING; COMBINED IMPACT; UNITED-STATES; RISK-FACTORS; FOLLOW-UP; MORTALITY; WOMEN	Background Lifestyle behaviors significantly impact health, yet remain poorly defined in Chinese rural-to-urban migrants. Methods In a cross-sectional study of health-related behaviors of 5484 rural-to-urban migrants who had worked in Shanghai for at least six months, we assessed the contribution of demographics and physical and mental health to lifestyle behaviors in male and female participants by multiple stepwise cumulative odds logistic regression. Results Respondents were 51.3% male. 9.9% exhibited abnormal blood pressure; 27.0% were overweight or obese; 11.2% reported abnormal mental health; 36.9% reported healthy lifestyle. Multiple stepwise cumulative odds logistic regression indicated that men working in manufacturing reported less unhealthy lifestyle than those in hospitality (cumulative odds ratio (COR) = 1.806, 95% CI 1.275-2.559) or recreation/leisure (COR = 3.248, 95% CI 2.379-4.435); and women working in manufacturing and construction reported less unhealthy lifestyle than those in all other sectors. Unhealthy lifestyle was associated with small workplaces for men (COR = 1.422, 95% CI 1.154-1.752), working more than 8 or 11 hours per day for women and men, respectively, and earning over 3500 RMB in women (COR = 1.618, 95% CI 1.137-2.303). Single women and women who had previously resided in three or more cities were more likely to report unhealthy lifestyle (COR = 2.023, 95% CI 1.664-2.461, and COR = 1.311, 95% CI 1.072-1.602, respectively). Abnormal mental status was also correlated with unhealthy lifestyle in men (COR = 3.105, 95% CI 2.454-3.930) and women (COR = 2.566, 95% CI 2.024-3.252). Conclusions There were different risk factors of unhealthy lifestyle score in male and female rural-to-urban migrants, especially in number of cities experienced, salary, marital status, work place scale. Several demographic groups: employment sectors (e.g. hospitality and recreation/leisure), working conditions (e.g. long hours) and abnormal mental status were associated with unhealthy lifestyle behaviors in Chinese rural-to-urban migrants, and health interventions should be targeted to these groups.	[Yang, Hua; Wang, Tianhao; Liu, Yao; Shen, Yao; Gong, Jian; Dai, Wei; Zhou, Jing; Gu, Jie; Pan, Zhigang; Zhu, Shanzhu] Fudan Univ, Zhongshan Hosp, Dept Gen Practice, Shanghai 200433, Peoples R China; [He, Fang] Xinjing Community Hlth Serv Ctr, Dept Gen Practice, Shanghai, Peoples R China; [Tu, Yimin] Yinhang Community Hlth Serv Ctr, Dept Gen Practice, Shanghai, Peoples R China; [Wang, Tianying] Sanlin Community Hlth Serv Ctr, Dept Gen Practice, Shanghai, Peoples R China; [Shen, Lei] Huaxin Community Hlth Serv Ctr, Dept Prevent Med, Shanghai, Peoples R China; [Wu, Yumiao] Changzheng Community Hlth Serv Ctr, Dept Gen Practice, Shanghai, Peoples R China; [Xia, Xiuping] Huangdu Community Hlth Serv Ctr, Dept Gen Practice, Shanghai, Peoples R China; [Xu, Donghao] Caohejing Community Hlth Serv Ctr, Dept Gen Practice, Shanghai, Peoples R China	Fudan University	Pan, ZG (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gen Practice, Shanghai 200433, Peoples R China.	zhigang_pan@163.com; zhu_shanzhu@126.com			Shanghai Charity Foundation WEALOVE Charity Funding	Shanghai Charity Foundation WEALOVE Charity Funding	This study was supported by Shanghai Charity Foundation WEALOVE Charity Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batty GD, 2008, ANN ONCOL, V19, P996, DOI 10.1093/annonc/mdm578; Best paper award, 2008, 315 SHANGHAI MIGRANT; Bradley KA, 2009, J GEN INTERN MED, V24, P881, DOI 10.1007/s11606-009-1014-9; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Carlsson AC, 2013, INT J CARDIOL, V168, P946, DOI 10.1016/j.ijcard.2012.10.045; Carlsson AC, 2010, EUR J EPIDEMIOL, V25, P547, DOI 10.1007/s10654-010-9472-2; Centers for Disease Control and Prevention, 2013, CHRONIC DISEASES AND; Chen FZ, 2014, PSYCHIAT RES, V216, P346, DOI 10.1016/j.psychres.2014.01.051; Chen XG, 2004, PREV MED, V39, P666, DOI 10.1016/j.ypmed.2004.02.033; Chinese center for disease control and prevention, 2013, CHINA CARDIOVASCULAR; Chinese Nutrition Society, 2008, THE DIETARY GUIDELIN; Cui XB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-979; de Vries H, 2008, PREV MED, V46, P203, DOI 10.1016/j.ypmed.2007.08.005; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; Eguchi E, 2012, EUR HEART J, V33, P467, DOI 10.1093/eurheartj/ehr429; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881; Hesketh T, 2008, PUBLIC HEALTH REP, V123, P189, DOI 10.1177/003335490812300211; Hesketh T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-29; [蒋善 Jiang Shah], 2007, [心理科学, Psychological Science], V30, P216; Jin H., 1986, CHIN J NERV MENT DIS, V12, P260; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Laaksonen M, 2001, EUR J PUBLIC HEALTH, V11, P294, DOI 10.1093/eurpub/11.3.294; Li L, 2007, SOC PSYCH PSYCH EPID, V42, P716, DOI 10.1007/s00127-007-0221-0; Li Xiaoming, 2006, World Health Popul, V8, P14; Li Y, 2013, QUAL HEALTH RES, V23, P1459, DOI 10.1177/1049732313507500; Lin DH, 2011, COMMUNITY MENT HLT J, V47, P171, DOI 10.1007/s10597-009-9278-4; Ma GuanSheng, 2009, Acta Nutrimenta Sinica, V31, P213; Ma YuXia, 2011, Chinese Journal of Prevention and Control of Chronic Diseases, V19, P9; Ministry of health disease Control department of the people's Republic of China, 2003, CHINESE ADULT OVERWE; Mou J, 2013, BRIT MED BULL, V106, P19, DOI 10.1093/bmb/ldt016; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Odegaard AO, 2011, CIRCULATION, V124, P2847, DOI 10.1161/CIRCULATIONAHA.111.048843; Piwonski J, 2010, KARDIOL POL, V68, P912; Prevention Ccfdca, 2011, 2010 NATIONAL DISEAS; Prochaska JJ, 2008, PREV MED, V46, P181, DOI 10.1016/j.ypmed.2008.02.001; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rubinsky AD, 2013, ALCOHOL CLIN EXP RES, V37, P1380, DOI 10.1111/acer.12092; Shanghai government affairs, 2011, 8 977 000 OF FOREIGN; Shanghai statistics, 2013, PARTICIPATING IN THE; Shanghai statistics, 2008, MORE THAN 400 MILLIO; Shanghai statistics, 2013, URBAN RESIDENTS PER; Shanghai statistics, 2013, MARITAL AND BIRTH ST; Shanghai statistics, 2013, LIVING CONDITIONS OF; Shi Yuhui, 2012, Environmental Health and Preventive Medicine, V17, P385, DOI 10.1007/s12199-012-0264-z; Singh GK, 2011, J COMMUN HEALTH, V36, P94, DOI 10.1007/s10900-010-9287-9; The central peoples government of the peoples republic of China, 2013, NATIONAL MIGRANT WOR; The central peoples government of the peoples republic of China, 2012, SHANGHAI ADJUST THE; Tobias M, 2007, AUST NZ J PUBL HEAL, V31, P155, DOI 10.1111/j.1753-6405.2007.00034.x; Tsai SY, 2012, INT J ENV RES PUB HE, V9, P3740, DOI 10.3390/ijerph9103740; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wang Z., 1984, SYMPTOM CHECKLIST SC, V2, P68, DOI DOI 10.32388/SG7B5L]; Xing Haiyan, 2008, THE RESEARCH OF HEAL; Yang T, 2009, PUBLIC HEALTH, V123, P743, DOI 10.1016/j.puhe.2009.09.021; Yang TZ, 2012, COMMUNITY MENT HLT J, V48, P342, DOI 10.1007/s10597-011-9395-8; Yang ZY, 2011, INT J BEHAV MED, V18, P295, DOI 10.1007/s12529-011-9187-0; Zhang L., 2014, HUM VACC IMMUNOTHER, V10, P10, DOI [DOI 10.1371/J0URNAL.P0NE.0111127, DOI 10.2147/NDT.S56020]; Zhong BL, 2013, SOC PSYCH PSYCH EPID, V48, P1569, DOI 10.1007/s00127-013-0672-4; Zhu CY, 2012, QUAL LIFE RES, V21, P495, DOI 10.1007/s11136-011-9950-3	63	12	12	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117946	10.1371/journal.pone.0117946	http://dx.doi.org/10.1371/journal.pone.0117946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IY	25710464	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900044
J	Billings, FT; Petracek, MR; Roberts, LJ; Pretorius, M				Billings, Frederic T.; Petracek, Michael R.; Roberts, L. Jackson, II; Pretorius, Mias			Perioperative Intravenous Acetaminophen Attenuates Lipid Peroxidation in Adults Undergoing Cardiopulmonary Bypass: A Randomized Clinical Trial	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; OXIDATIVE STRESS; CARDIAC-SURGERY; HEMOGLOBIN; QUANTIFICATION; ISOPROSTANES; HAPTOGLOBIN; HEMOLYSIS; OUTCOMES; INFANTS	Background Cardiopulmonary bypass ( CPB) lyses erythrocytes and induces lipid peroxidation, indicated by increasing plasma concentrations of free hemoglobin, F-2-isoprostanes, and isofurans. Acetaminophen attenuates hemeprotein-mediated lipid peroxidation, reduces plasma and urine concentrations of F-2-isoprostanes, and preserves kidney function in an animal model of rhabdomyolysis. Acetaminophen also attenuates plasma concentrations of isofurans in children undergoing CPB. The effect of acetaminophen on lipid peroxidation in adults has not been studied. This was a pilot study designed to test the hypothesis that acetaminophen attenuates lipid peroxidation in adults undergoing CPB and to generate data for a clinical trial aimed to reduce acute kidney injury following cardiac surgery. Methods and Results In a prospective double-blind placebo-controlled clinical trial, sixty adult patients were randomized to receive intravenous acetaminophen or placebo starting prior to initiation of CPB and for every 6 hours for 4 doses. Acetaminophen concentrations measured 30 min into CPB and post-CPB were 11.9 +/- 0.6 g/mu mL (78.9 +/- 3.9 mu M) and 8.7 +/- 0.3 mu g/mL (57.6 +/- 2.0 mu M), respectively. Plasma free hemoglobin increased more than 15-fold during CPB, and haptoglobin decreased 73%, indicating hemolysis. Plasma and urinary markers of lipid peroxidation also increased during CPB but returned to baseline by the first postoperative day. Acetaminophen reduced plasma isofuran concentrations over the duration of the study (P = 0.05), and the intraoperative plasma isofuran concentrations that corresponded to peak hemolysis were attenuated in those subjects randomized to acetaminophen (P = 0.03). Perioperative acetaminophen did not affect plasma concentrations of F-2-isoprostanes or urinary markers of lipid peroxidation. Conclusions Intravenous acetaminophen attenuates the increase in intraoperative plasma isofuran concentrations that occurs during CPB, while urinary markers were unaffected.	[Roberts, L. Jackson, II; Pretorius, Mias] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Petracek, Michael R.] Vanderbilt Univ, Sch Med, Dept Cardiac Surg, Nashville, TN 37212 USA; [Roberts, L. Jackson, II] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Billings, Frederic T.; Pretorius, Mias] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Pretorius, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA.	mias.pretorius@vanderbilt.edu		Pretorius, Mias/0000-0002-8777-3940; Billings, Josh/0000-0001-7135-7785	National Institutes of Health [P50 GM015431-43, K23 GM102676]; Center for Advancing Translational Sciences [2 UL1 TR000445-06]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM102676, P50GM015431, P01GM015431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes of Health (P50 GM015431-43 and K23 GM102676) and by the Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayash AI, 2013, TRENDS BIOTECHNOL, V31, P2, DOI 10.1016/j.tibtech.2012.10.003; Albers E, 2012, PEDIATR CARDIOL, V33, P562, DOI 10.1007/s00246-012-0166-2; Balaguer JM, 2013, CLIN PHARMACOL THER, V93, P326, DOI 10.1038/clpt.2012.249; Billings FT, 2014, CARDIORENAL MED, V4, P12, DOI 10.1159/000357871; Billings FT, 2012, J AM SOC NEPHROL, V23, P1221, DOI 10.1681/ASN.2011090940; Billings FT, 2011, FREE RADICAL BIO MED, V50, P1480, DOI 10.1016/j.freeradbiomed.2011.02.011; Boutaud O, 2010, P NATL ACAD SCI USA, V107, P2699, DOI 10.1073/pnas.0910174107; Candilio L, 2014, HEART; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; Fessel JP, 2002, P NATL ACAD SCI USA, V99, P16713, DOI 10.1073/pnas.252649099; Gallagher SM, 2014, KIDNEY INT; Kato GJ, 2009, J CLIN INVEST, V119, P2140, DOI 10.1172/JCI40258; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li C, 2014, ANESTHESIOLOGY, V121, P249, DOI 10.1097/ALN.0000000000000266; Lim YK, 2000, KIDNEY INT, V58, P1033, DOI 10.1046/j.1523-1755.2000.00261.x; Mamikonian LS, 2014, PEDIATR CRIT CARE ME, V15, pE111, DOI 10.1097/PCC.0000000000000047; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Morgan CJ, 2013, J PEDIATR-US, V162, P120, DOI 10.1016/j.jpeds.2012.06.054; Morrow JD, 2005, ARTERIOSCL THROM VAS, V25, P279, DOI 10.1161/01.ATV.0000152605.64964.c0; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Shin H, 2000, ARTIF ORGANS, V24, P450, DOI 10.1046/j.1525-1594.2000.06587.x; Simpson SA, 2014, PEDIATR CRIT CARE ME, V15, P503, DOI 10.1097/PCC.0000000000000149; Ulus AT, 2003, FREE RADICAL BIO MED, V34, P911, DOI 10.1016/S0891-5849(03)00030-3; Unger J, 2007, CLIN CHEM, V53, P1717, DOI 10.1373/clinchem.2007.091421; Vercaemst Leen, 2008, J Extra Corpor Technol, V40, P257	27	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117625	10.1371/journal.pone.0117625	http://dx.doi.org/10.1371/journal.pone.0117625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705899	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100105
J	Chien, CH; Lee, MJ; Liou, HC; Liou, HH; Fu, WM				Chien, Chia-Hung; Lee, Ming-Jen; Liou, Houng-Chi; Liou, Horng-Huei; Fu, Wen-Mei			Local Immunosuppressive Microenvironment Enhances Migration of Melanoma Cells to Lungs in DJ-1 Knockout Mice	PLOS ONE			English	Article							PARKINSONS-DISEASE; CANCER; INTERLEUKIN-1-BETA; INFLAMMATION; PROMOTES; IDENTIFICATION; TRANSCRIPTION; EXPRESSION; MICROGLIA; PHENOTYPE	DJ-1 is an oncoprotein that promotes survival of cancer cells through anti-apoptosis. However, DJ-1 also plays a role in regulating IL-1 beta expression, and whether inflammatory microenvironment built by dysregulated DJ-1 affects cancer progression is still unclear. This study thus aimed to compare the metastatic abilities of melanoma cells in wild-type (WT) and DJ-1 knockout (KO) mice, and to check whether inflammatory microenvironment built in DJ-1 KO mice plays a role in migration of cancer cells to lungs. First, B16F10 melanoma cells (at 6x10(4)) were injected into the femoral vein of mice, and formation of lung nodules, levels of lung IL-1 beta and serum cytokines, and accumulation of myeloid-derived suppressor cells (MDSCs) were compared between WT and DJ-1 KO mice. Second, the cancer-bearing mice were treated with an interleukin-1 beta (IL-1 beta) neutralizing antibody to see whether IL-1 beta is involved in the cancer migration. Finally, cultured RAW 264.7 macrophage and B16F10 melanoma cells were respectively treated with DJ-1 shRNA and recombinant IL-1 beta to explore underlying molecular mechanisms. Our results showed that IL-1 beta enhanced survival and colony formation of cultured melanoma cells, and that IL-1 beta levels were elevated both in DJ-1 KO mice and in cultured macrophage cells with DJ-1 knockdown. The elevated IL-1 beta correlated with higher accumulation of immunosuppressive MDSCs and formation of melanoma module in the lung of DJ-1 KO mice, and both can be decreased by treating mice with IL-1 beta neutralizing antibodies. Taken together, these results indicate that immunosuppressive tissue microenvironment built in DJ-1 KO mice can enhance lung migration of cancer, and IL-1 beta plays an important role in promoting the cancer migration.	[Chien, Chia-Hung; Fu, Wen-Mei] Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei 10764, Taiwan; [Lee, Ming-Jen; Liou, Horng-Huei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Liou, Houng-Chi; Liou, Horng-Huei; Fu, Wen-Mei] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan; [Lee, Ming-Jen; Liou, Horng-Huei; Fu, Wen-Mei] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Fu, WM (corresponding author), Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei 10764, Taiwan.	wenmei@ntu.edu.tw			Ministry of Science and Technology, Taiwan, R.O.C. [MOST 102-2321-B-002-016]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	The study was financially supported by the grant MOST 102-2321-B-002-016 from the Ministry of Science and Technology, Taiwan, R.O.C. to H.H.L. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bjorkdahl O, 1997, CANCER IMMUNOL IMMUN, V44, P273, DOI 10.1007/s002620050383; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Chen LC, 2012, EMBO MOL MED, V4, P1276, DOI 10.1002/emmm.201201569; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Denes A, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002006; Devine MJ, 2011, NAT REV CANCER, V11, P812, DOI 10.1038/nrc3150; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; GIAVAZZI R, 1990, CANCER RES, V50, P4771; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1; Kamp DW, 2011, ONCOLOGY-NY, V25, P400; Kim JH, 2013, NEUROBIOL DIS, V60, P1, DOI 10.1016/j.nbd.2013.08.007; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Li W, 2013, AGEING RES REV, V12, P1005, DOI 10.1016/j.arr.2013.05.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moore Darren J, 2006, Sci Aging Knowledge Environ, V2006, ppe2, DOI 10.1126/sageke.2006.2.pe2; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Narayan S, 2011, ARTHRITIS RHEUM-US, V63, P422, DOI 10.1002/art.30147; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Pardo M, 2006, INT J CANCER, V119, P1014, DOI 10.1002/ijc.21942; Persidsky Y, 2003, J LEUKOCYTE BIOL, V74, P691, DOI 10.1189/jlb.0503205; Plun-Favreau H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001257; Sekito A, 2005, INT J ONCOL, V26, P685; Shigeta A, 2008, BLOOD, V112, P4915, DOI 10.1182/blood-2008-04-153866; Sweet DG, 2001, ARCH DIS CHILD-FETAL, V84, pF168, DOI 10.1136/fn.84.3.F168; Trudler D, 2014, J NEUROCHEM, V129, P434, DOI 10.1111/jnc.12633; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Vegran F, 2014, NAT IMMUNOL, V15, P758, DOI 10.1038/ni.2925; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Yamanaka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104479	39	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115827	10.1371/journal.pone.0115827	http://dx.doi.org/10.1371/journal.pone.0115827			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706411	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100018
J	Field, SF; Beraldi, D; Bachman, M; Stewart, SK; Beck, S; Balasubramanian, S				Field, Sarah F.; Beraldi, Dario; Bachman, Martin; Stewart, Sabrina K.; Beck, Stephan; Balasubramanian, Shankar			Accurate Measurement of 5-Methylcytosine and 5-Hydroxymethylcytosine in Human Cerebellum DNA by Oxidative Bisulfite on an Array (OxBS-Array)	PLOS ONE			English	Article							TET; 5-CARBOXYLCYTOSINE; 5-FORMYLCYTOSINE; GLYCOSYLASE; CYTOSINE	The Infinium 450K Methylation array is an established tool for measuring methylation. However, the bisulfite (BS) reaction commonly used with the 450K array cannot distinguish between 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC). The oxidative-bisulfite assay disambiguates 5mC and 5hmC. We describe the use of oxBS in conjunction with the 450K array (oxBS-array) to analyse 5hmC/5mC in cerebellum DNA. The "methylation" level derived by the BS reaction is the combined level of 5mC and 5hmC at a given base, while the oxBS reaction gives the level of 5mC alone. The level of 5hmC is derived by subtracting the oxBS level from the BS level. Here we present an analysis method that distinguishes genuine positive levels of 5hmC at levels as low as 3%. We performed four replicates of the same sample of cerebellum and found a high level of reproducibility (average r for BS = 98.3, and average r for oxBS = 96.8). In total, 114,734 probes showed a significant positive measurement for 5hmC. The range at which we were able to distinguish 5hmC occupancy was between 3% and 42%. In order to investigate the effects of multiple replicates on 5hmC detection we also simulated fewer replicates and found that decreasing the number of replicates to two reduced the number of positive probes identified by > 50%. We validated our results using qPCR in conjunction with glucosylation of 5hmC sites followed by MspI digestion and we found good concordance with the array estimates (r = 0.94). This experiment provides a map of 5hmC in the cerebellum and a robust dataset for use as a standard in future 5hmC analyses. We also provide a novel method for validating the presence of 5hmC at low levels, and highlight some of the pitfalls associated with measuring 5hmC and 5mC.	[Field, Sarah F.; Beraldi, Dario; Bachman, Martin; Balasubramanian, Shankar] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Stewart, Sabrina K.; Beck, Stephan] UCL, UCL Canc Inst, Dept Canc Biol, London WC1E 6BT, England; [Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London; University of Cambridge	Balasubramanian, S (corresponding author), Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	sb10031@cam.ac.uk	Balasubramanian, Shankar/C-1671-2009; Bachman, Martin/V-4902-2019	Balasubramanian, Shankar/0000-0002-0281-5815; Bachman, Martin/0000-0003-3903-6492; Beraldi, Dario/0000-0003-1504-5212	CRUK; Cancer Research UK [12488] Funding Source: researchfish	CRUK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The Balasubramanian group received core institutional funding from CRUK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryee M, 2014, BIOINFORMATICS, P1, DOI [10.1186/1471-2105-15-1, DOI 10.1186/1471-2105-15-1]; Booth MJ, 2013, NAT PROTOC, V8, P1841, DOI 10.1038/nprot.2013.115; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Chopra P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-131; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P10203, DOI 10.1093/nar/gks845; HAYATSU H, 1970, BIOCHEMISTRY-US, V9, P2858, DOI 10.1021/bi00816a016; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu S, 2013, NUCLEIC ACIDS RES, V41, P6421, DOI 10.1093/nar/gkt360; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Mastroeni D, 2010, NEUROBIOL AGING, V31, P2025, DOI 10.1016/j.neurobiolaging.2008.12.005; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Pan H, 2012, EPIGENETICS-US, V7, P1173, DOI 10.4161/epi.22102; Robertson AB, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr051; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; SHAPIRO R, 1974, J AM CHEM SOC, V96, P906, DOI 10.1021/ja00810a043; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Stewart SK, EPIGENOMICS, DOI [10.2217/epi.14.89, DOI 10.2217/EPI.14.89]; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116	26	42	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118202	10.1371/journal.pone.0118202	http://dx.doi.org/10.1371/journal.pone.0118202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706862	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100151
J	Reynaud, Y; Millet, J; Couvin, D; Rastogi, N; Brown, C; Couppie, P; Legrand, E				Reynaud, Yann; Millet, Julie; Couvin, David; Rastogi, Nalin; Brown, Christopher; Couppie, Pierre; Legrand, Eric			Heterogeneity among Mycobacterium ulcerans from French Guiana Revealed by Multilocus Variable Number Tandem Repeat Analysis (MLVA)	PLOS ONE			English	Article							CAUSATIVE AGENT; MYCOLACTONE; EVOLUTION; SEQUENCE; IDENTIFICATION; MACROLIDE; MARINUM; IS2404; GENOME; LOCUS	Buruli ulcer is an emerging and neglected tropical disease caused by Mycobacterium ulcerans. Few cases have been reported so far in the Americas. With 250 cases reported since 1969, French Guiana is the only Buruli ulcer endemic area in the continent. Thus far, no genetic diversity studies of strains of M. ulcerans from French Guiana have been reported. Our goal in the present study was to examine the genetic diversity of M. ulcerans strains in this region by using the Multilocus Variable Number Tandem Repeat Analysis (MLVA) approach. A total of 23 DNA samples were purified from ulcer biopsies or derived from pure cultures. MVLA was used in the study of six previously-described Variable Number of Tandem Repeat (VNTR) markers. A total of three allelic combinations were characterized in our study: genotype I which has been described previously, genotype III which is very similar to genotype I, and genotype II which has distinctly different characteristics in comparison with the other two genotypes. This high degree of genetic diversity appears to be uncommon for M. ulcerans. Further research based on complete genome sequencing of strains belonging to genotypes I and II is in progress and should lead soon to a better understanding of genetic specificities of M. ulcerans strains from French Guiana.	[Reynaud, Yann; Legrand, Eric] Inst Pasteur, Cayenne, French Guiana; [Millet, Julie; Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, Pointe A Pitre, Guadeloupe, France; [Brown, Christopher] NOAA, Milford, CT USA; [Couppie, Pierre] Ctr Hosp Andre Rosemon, Cayenne, French Guiana	National Oceanic Atmospheric Admin (NOAA) - USA	Reynaud, Y (corresponding author), Inst Pasteur, Cayenne, French Guiana.	yreynaud@pasteur-guadeloupe.fr; Eric.legrand@pasteur.fr	Reynaud, Yann/ABD-7936-2021; RASTOGI, NALIN/AAP-1958-2020	RASTOGI, NALIN/0000-0002-7199-7747; Couppie, Pierre/0000-0002-4213-2867; Couvin, David/0000-0002-7897-9023; Reynaud, Yann/0000-0002-1966-7249; Legrand, Eric/0000-0003-4725-0712	European Commission [REGPOT-CT-2011-285837-STRONGER]; Agence Nationale de la Recherche, LabEx CEBA [ANR-10-LABX-25-01]	European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche, LabEx CEBA(French National Research Agency (ANR))	Sponsored by the European Commission. URL: www.cordis.europa.eu/fp7/. Grant number: REGPOT-CT-2011-285837-STRONGER. Received by YR and EL. Sponsored by the Agence Nationale de la Recherche, LabEx CEBA. URL: www.labex-ceba.fr. Grant number: ANR-10-LABX-25-01). Received by YR and EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablordey A, 2007, CLIN MICROBIOL INFEC, V13, P734, DOI 10.1111/j.1469-0691.2007.01716.x; Ablordey A, 2005, J CLIN MICROBIOL, V43, P5281, DOI 10.1128/JCM.43.10.5281-5284.2005; Ablordey A, 2005, J CLIN MICROBIOL, V43, P1546, DOI 10.1128/JCM.43.4.1546-1551.2005; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Doig KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-258; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Hilty M, 2006, J BACTERIOL, V188, P1462, DOI 10.1128/JB.188.4.1462-1465.2006; Kaser M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-177; Morris A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002660; Mve-Obiang A, 2005, INFECT IMMUN, V73, P3307, DOI 10.1128/IAI.73.6.3307-3312.2005; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; Ranger BS, 2006, INFECT IMMUN, V74, P6037, DOI 10.1128/IAI.00970-06; Roltgen K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000751; Stinear T, 1999, J CLIN MICROBIOL, V37, P1018, DOI 10.1128/JCM.37.4.1018-1023.1999; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Stragier P, 2006, EMERG INFECT DIS, V12, P844, DOI 10.3201/eid1205.051191; Stragier P, 2005, J BACTERIOL, V187, P1639, DOI 10.1128/JB.187.5.1639-1647.2005; Stragier P, 2007, SYST APPL MICROBIOL, V30, P525, DOI 10.1016/j.syapm.2007.06.001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobias NJ, 2013, J BACTERIOL, V195, P556, DOI 10.1128/JB.02132-12; Trott KA, 2004, COMPARATIVE MED, V54, P309; Yip MJ, 2007, J BACTERIOL, V189, P2021, DOI 10.1128/JB.01442-06	22	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118597	10.1371/journal.pone.0118597	http://dx.doi.org/10.1371/journal.pone.0118597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706942	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100193
J	Tsay, JCJ; Li, ZG; Yie, TA; Wu, F; Segal, L; Greenberg, AK; Leibert, E; Weiden, MD; Pass, H; Munger, J; Statnikov, A; Tchou-Wong, KM; Rom, WN				Tsay, Jun-Chieh J.; Li, Zhiguo; Yie, Ting-An; Wu, Feng; Segal, Leopoldo; Greenberg, Alissa K.; Leibert, Eric; Weiden, Michael D.; Pass, Harvey; Munger, John; Statnikov, Alexander; Tchou-Wong, Kam-Meng; Rom, William N.			Molecular Characterization of the Peripheral Airway Field of Cancerization in Lung Adenocarcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION; PROTEIN EXPRESSION; GENE-EXPRESSION; NEUROENDOCRINE DIFFERENTIATION; RESPIRATORY EPITHELIUM; CANCER; KINASE; CELLS; RECEPTOR; MIR-483-5P	Field of cancerization in the airway epithelium has been increasingly examined to understand early pathogenesis of non-small cell lung cancer. However, the extent of field of cancerization throughout the lung airways is unclear. Here we sought to determine the differential gene and microRNA expressions associated with field of cancerization in the peripheral airway epithelial cells of patients with lung adenocarcinoma. We obtained peripheral airway brushings from smoker controls (n=13) and from the lung contralateral to the tumor in cancer patients (n=17). We performed gene and microRNA expression profiling on these peripheral airway epithelial cells using Affymetrix GeneChip and TaqMan Array. Integrated gene and microRNA analysis was performed to identify significant molecular pathways. We identified 26 mRNAs and 5 miRNAs that were significantly (FDR <0.1) upregulated and 38 mRNAs and 12 miRNAs that were significantly down-regulated in the cancer patients when compared to smoker controls. Functional analysis identified differential transcriptomic expressions related to tumorigenesis. Integration of miRNA-mRNA data into interaction network analysis showed modulation of the extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) pathway in the contralateral lung field of cancerization. In conclusion, patients with lung adenocarcinoma have tumor related molecules and pathways in histologically normal appearing peripheral airway epithelial cells, a substantial distance from the tumor itself. This finding can potentially provide new biomarkers for early detection of lung cancer and novel therapeutic targets.	[Tsay, Jun-Chieh J.; Yie, Ting-An; Segal, Leopoldo; Greenberg, Alissa K.; Leibert, Eric; Weiden, Michael D.; Munger, John; Tchou-Wong, Kam-Meng; Rom, William N.] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10012 USA; [Li, Zhiguo; Statnikov, Alexander] NYU, Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Wu, Feng; Tchou-Wong, Kam-Meng; Rom, William N.] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Pass, Harvey] NYU, Sch Med, Dept Cardiothorac Surg, Div Thorac Surg, New York, NY USA; [Statnikov, Alexander] NYU, Sch Med, Dept Med, Div Translat Med, New York, NY USA	New York University; New York University; NYU Langone Medical Center; New York University; New York University; New York University	Tsay, JCJ (corresponding author), NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10012 USA.	tsayj01@nyumc.org		Tsay, Jun-Chieh/0000-0002-2282-2510; Segal, Leopoldo/0000-0003-3559-9431; Rom, William/0000-0002-8793-7028; Pass, Harvey/0000-0003-3222-3471; Munger, John/0000-0002-9679-2983	National Institutes of Health [T32 ES007267, UO1 CA086137, UL1 TR000038, RO1 HL090316, K24 AI080298A]; Stony-Wold Herbert Fund Fellowship; NATIONAL CANCER INSTITUTE [P30CA016087, U01CA086137] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony-Wold Herbert Fund Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	JJT is funded by National Institutes of Health grant T32 ES007267, UO1 CA086137, UL1 TR000038, and Stony-Wold Herbert Fund Fellowship (http://www.stonywoldherbertfund.com).WNR is funded by National Institutes of Health grant T32 ES007267, UO1 CA086137, UL1 TR000038, RO1 HL090316 and K24 AI080298A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Chen Y, 2014, J THORAC ONCOL, V9, P50, DOI 10.1097/JTO.0000000000000034; Dang XM, 2012, CANCER GENET-NY, V205, P113, DOI 10.1016/j.cancergen.2012.01.002; Franklin WA, 1997, J CLIN INVEST, V100, P2133, DOI 10.1172/JCI119748; Fukui S, 2013, TUMOR DORMANCY QUIES, V1, P270; Gaedcke J, 2012, CLIN CANCER RES, V18, P4919, DOI 10.1158/1078-0432.CCR-12-0016; Gkirtzimanaki K, 2013, P NATL ACAD SCI USA, V110, pE1470, DOI 10.1073/pnas.1215938110; Gomperts BN, 2013, CANCER PREV RES, V6, P4, DOI 10.1158/1940-6207.CAPR-12-0470; Grant JL, 2013, CANCER PREV RES PHIL; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; GUEDDARI N, 1993, BIOCHIMIE, V75, P811, DOI 10.1016/0300-9084(93)90132-C; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Gustafson AM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000251; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Hirota T, 2012, LUNG CANCER, V77, P16, DOI 10.1016/j.lungcan.2011.12.018; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jang JS, 2012, CLIN CANCER RES, V18, P3658, DOI 10.1158/1078-0432.CCR-11-2857; Kadara H, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju004; Kadara H, 2013, CANCER PREV RES, V6, P8, DOI 10.1158/1940-6207.CAPR-12-0290; Kang YJ, 2014, J CLIN PATHOL, V67, P86, DOI 10.1136/jclinpath-2013-201841; Kao DD, 2013, MOL CELL BIOCHEM, V382, P153, DOI 10.1007/s11010-013-1730-7; Kapur M, 2012, EMBO REP, V13, P1021, DOI 10.1038/embor.2012.140; Khatlani TS, 2007, ONCOGENE, V26, P2658, DOI 10.1038/sj.onc.1210050; Klein RM, 2009, CANCER RES, V69, P2224, DOI 10.1158/0008-5472.CAN-08-3201; Kosari F, 2014, ONCOGENE, V33, P3776, DOI 10.1038/onc.2013.359; Lee S, 2007, BIOCHEM BIOPH RES CO, V362, P853, DOI 10.1016/j.bbrc.2007.08.060; Li Y, 2012, AM J RESP CELL MOL, V47, P768, DOI 10.1165/rcmb.2012-0027OC; Lin C, 2014, ONCOGENE; Linnoila RI, 2000, CANCER RES, V60, P4005; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Nelson MA, 1996, CANCER LETT, V103, P115, DOI 10.1016/0304-3835(96)04202-4; Peng Y, 2013, PROCEEDINGS OF THE N; Perdomo C, 2013, P NATL ACAD SCI USA, V110, P18946, DOI 10.1073/pnas.1220319110; Perdomo C, 2011, MUTAT RES-FUND MOL M, V717, P32, DOI 10.1016/j.mrfmmm.2011.04.005; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; Powell CA, 1999, CLIN CANCER RES, V5, P2025; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Shen H, 2012, BIOMED PHARMACOTHER, V66, P89, DOI 10.1016/j.biopha.2011.09.013; Shen J, 2013, CANCER EPIDEM BIOMAR, V22, P2364, DOI 10.1158/1055-9965.EPI-13-0237; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Song QC, 2014, CANCER RES, V74, P3031, DOI 10.1158/0008-5472.CAN-13-2193; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Staudt MR, 2014, AM J RESP CRIT CARE, V190, P955, DOI 10.1164/rccm.201406-1167LE; Steiling K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005043; Tang XN, 2005, CANCER RES, V65, P7568, DOI 10.1158/0008-5472.CAN-05-1705; Tsay JJ, 2013, ANTICANCER RES, V33, P1247; Ueki K, 2002, P NATL ACAD SCI USA, V99, P419, DOI 10.1073/pnas.012581799; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vosa U, 2011, GENE CHROMOSOME CANC, V50, P812, DOI 10.1002/gcc.20902; Wang L, 2012, FEBS LETT, V586, P1312, DOI 10.1016/j.febslet.2012.03.035; Wang YQ, 2011, J BIOL CHEM, V286, P41095, DOI 10.1074/jbc.M111.296806; Wistuba II, 2000, CANCER RES, V60, P1949; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074	66	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118132	10.1371/journal.pone.0118132	http://dx.doi.org/10.1371/journal.pone.0118132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705890	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100145
J	Ungefroren, H; Hyder, A; Hinz, H; Groth, S; Lange, H; El-Sayed, KMF; Ehnert, S; Nussler, AK; Fandrich, F; Gieseler, F				Ungefroren, Hendrik; Hyder, Ayman; Hinz, Hebke; Groth, Stephanie; Lange, Hans; El-Sayed, Karim M. Fawzy; Ehnert, Sabrina; Nuessler, Andreas K.; Faendrich, Fred; Gieseler, Frank			Pluripotency Gene Expression and Growth Control in Cultures of Peripheral Blood Monocytes during Their Conversion into Programmable Cells of Monocytic Origin (PCMO): Evidence for a Regulatory Role of Autocrine Activin and TGF-beta	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HEPATOCYTE-LIKE CELLS; DIFFERENTIATION; SMAD2; TRANSPLANTATION; MAINTENANCE; SB-431542; INHIBITOR; INDUCTION; MARKERS	Previous studies have shown that peripheral blood monocytes can be converted in vitro to a stem cell-like cell termed PCMO as evidenced by the re-expression of pluripotency-associated genes, transient proliferation, and the ability to adopt the phenotype of hepatocytes and insulin-producing cells upon tissue-specific differentiation. However, the regulatory interactions between cultured cells governing pluripotency and mitotic activity have remained elusive. Here we asked whether activin(s) and TGF-beta(s), are involved in PCMO generation. De novo proliferation of PCMO was higher under adherent vs. suspended culture conditions as revealed by the appearance of a subset of Ki67-positive monocytes and correlated with down-regulation of p21(WAF1) beyond day 2 of culture. Realtime-PCR analysis showed that PCMO express ActRIIA, ALK4, T beta RII, ALK5 as well as TGF-beta 1 and the beta(A) subunit of activin. Interestingly, expression of ActRIIA and ALK4, and activin A levels in the culture super-natants increased until day 4 of culture, while levels of total and active TGF-beta 1 strongly declined. PCMO responded to both growth factors in an autocrine fashion with intracellular signaling as evidenced by a rise in the levels of phospho-Smad2 and a drop in those of phospho-Smad3. Stimulation of PCMO with recombinant activins (A, B, AB) and TGF-beta 1 induced phosphorylation of Smad2 but not Smad3. Inhibition of autocrine activin signaling by either SB431542 or follistatin reduced both Smad2 activation and Oct4A/Nanog upregulation. Inhibition of autocrine TGF-beta signaling by either SB431542 or anti-TGF-beta antibody reduced Smad3 activation and strongly increased the number of Ki67-positive cells. Furthermore, anti-TGF-beta antibody moderately enhanced Oct4A/Nanog expression. Our data show that during PCMO generation pluripotency marker expression is controlled positively by activin/Smad2 and negatively by TGF-beta/Smad3 signaling, while relief from growth inhibition is primarily the result of reduced TGF-beta/Smad3, and to a lesser extent, activin/Smad2 signaling.	[Ungefroren, Hendrik; Hyder, Ayman; Hinz, Hebke; Groth, Stephanie; Lange, Hans; Faendrich, Fred] UKSH, Clin Appl Cellular Med, Kiel, Germany; [Gieseler, Frank] UKSH, Dept Med 1, Lubeck, Germany; [El-Sayed, Karim M. Fawzy] Sch Dent Med, Clin Conservat Dent & Periodontol, Kiel, Germany; [Ehnert, Sabrina; Nuessler, Andreas K.] Univ Tubingen, BG Trauma Ctr, Siegfried Weller Inst Trauma Res, Tubingen, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Eberhard Karls University of Tubingen	Ungefroren, H (corresponding author), UKSH, Dept Med 1, Lubeck, Germany.	hendrik.ungefroren@uksh.de	Gieseler, Frank/E-8386-2012; El-Sayed, Karim M. Fawzy/F-7508-2011; Nussler, Andreas/H-3557-2019; Ehnert, Sabrina/AAE-8163-2019; Hyder, Ayman/I-6953-2017	Gieseler, Frank/0000-0001-6409-3822; El-Sayed, Karim M. Fawzy/0000-0002-6261-3609; Nussler, Andreas/0000-0002-6666-6791; Ehnert, Sabrina/0000-0003-4347-1702; Hyder, Ayman/0000-0003-3216-0431	"Bundesministerium fur Bildung und Forschung" [01 GN 0985]	"Bundesministerium fur Bildung und Forschung"(Federal Ministry of Education & Research (BMBF))	This work was supported in part by a grant (to HU) from the "Bundesministerium fur Bildung und Forschung" (Grant number: 01 GN 0985, URL: http://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ehnert S, 2011, CELL TRANSPLANT, V20, P1465, DOI 10.3727/096368910X550224; Ehnert S, 2010, ALCOHOL CLIN EXP RES, V34, P708, DOI 10.1111/j.1530-0277.2009.01140.x; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Frandsen U, 2007, BIOCHEM BIOPH RES CO, V362, P568, DOI 10.1016/j.bbrc.2007.07.200; Groth S, 2005, J BIOL CHEM, V280, P33190, DOI 10.1074/jbc.M504249200; Hyder A, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-23; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jafary H, 2008, CELL BIOL INT, V32, P278, DOI 10.1016/j.cellbi.2007.10.001; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kanatani Y, 1999, CELL GROWTH DIFFER, V10, P705; Kramer JL, 2002, BRIT J HAEMATOL, V117, P727, DOI 10.1046/j.1365-2141.2002.03498.x; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Kwak HB, 2005, BIOCHEM BIOPH RES CO, V330, P1080, DOI 10.1016/j.bbrc.2005.03.085; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee KL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002130; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Okahashi N, 2001, J CELL BIOCHEM, V80, P339, DOI 10.1002/1097-4644(20010301)80:3<339::AID-JCB60>3.0.CO;2-#; Park Kyung-Soon, 2011, Int J Stem Cells, V4, P18; Ruhnke M, 2005, GASTROENTEROLOGY, V128, P1774, DOI 10.1053/j.gastro.2005.03.029; Sakaki-Yumoto M, 2013, J BIOL CHEM, V288, P18546, DOI 10.1074/jbc.M112.446591; Seta N, 2010, EXP HEMATOL, V38, P557, DOI 10.1016/j.exphem.2010.03.015; Tesseur I, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-15; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V220, P59, DOI 10.1016/j.mce.2004.03.009; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Ungefroren H, 2010, STEM CELLS DEV, V19, P1769, DOI 10.1089/scd.2009.0351; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072505; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100	34	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118097	10.1371/journal.pone.0118097	http://dx.doi.org/10.1371/journal.pone.0118097			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25707005	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100144
J	Winzer, BM; Paratz, JD; Whitehead, JP; Whiteman, DC; Reeves, MM				Winzer, Brooke M.; Paratz, Jennifer D.; Whitehead, Jonathan P.; Whiteman, David C.; Reeves, Marina M.			The Feasibility of an Exercise Intervention in Males at Risk of Oesophageal Adenocarcinoma: A Randomized Controlled Trial	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; MOLECULAR-WEIGHT ADIPONECTIN; BODY-MASS INDEX; PHYSICAL-ACTIVITY; BARRETTS-ESOPHAGUS; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISING INCIDENCE; HISTOLOGIC TYPES; GASTRIC CARDIA	Objective To investigate the feasibility and safety of a 24-week exercise intervention, compared to control, in males with Barrett's oesophagus, and to estimate the effect of the intervention, compared to control, on risk factors associated with oesophageal adenocarcinoma development. Methods A randomized controlled trial of an exercise intervention (60 minutes moderate-intensity aerobic and resistance exercise five days/week over 24 weeks; one supervised and four unsupervised sessions) versus attention control (45 minutes stretching five days/week over 24 weeks; one supervised and four unsupervised sessions) in inactive, overweight/obese (25.0-34.9 kg/m(2)) males with Barrett's oesophagus, aged 18-70 years. Primary outcomes were obesity-associated hormones relevant to oesophageal adenocarcinoma risk (circulating concentrations of leptin, adiponectin, interleukin-6, tumour necrosis factor-alpha, C-reactive protein, and insulin resistance [HOMA]). Secondary outcomes included waist circumference, body composition, fitness, strength and gastro- oesophageal reflux symptoms. Outcomes were measured at baseline and 24-weeks. Intervention effects were analysed using generalised linear models, adjusting for baseline value. Results Recruitment was difficult in this population with a total of 33 participants recruited (target sample size: n = 80); 97% retention at 24-weeks. Adherence to the exercise protocol was moderate. No serious adverse events were reported. A statistically significant intervention effect (exercise minus control) was observed for waist circumference (-4.5 [95% CI -7.5, -1.4] cm; p < 0.01). Effects on primary outcomes were not statistically significant. Conclusion This small, exploratory trial provides important information to inform future trial development including recruitment rates and estimates of effect sizes on outcomes related to oesophageal adenocarcinoma risk. Future trials should investigate a combined dietary and exercise intervention to achieve greater weight loss in this population and relax inclusion criteria to maximize recruitment.	[Winzer, Brooke M.; Paratz, Jennifer D.] Univ Queensland, Sch Med, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia; [Whitehead, Jonathan P.] Univ Queensland, Mater Res Inst, Metab Med Grp, Brisbane, Qld, Australia; [Whiteman, David C.] QIMR Berghofer Med Res Inst, Canc Control Grp, Brisbane, Qld, Australia; [Reeves, Marina M.] Univ Queensland, Sch Publ Hlth, Canc Prevent Res Ctr, Brisbane, Qld, Australia	University of Queensland; Mater Research; University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland	Reeves, MM (corresponding author), Univ Queensland, Sch Publ Hlth, Canc Prevent Res Ctr, Brisbane, Qld, Australia.	m.reeves@sph.uq.edu.au	Reeves, Marina M/B-3813-2009; Whiteman, David C/P-2728-2014	Reeves, Marina M/0000-0003-3052-2013; Whiteman, David C/0000-0003-2563-9559; Whitehead, Jonathan/0000-0003-3978-3148	Wesley Research Institute [2009/3]; Queensland Health (Health Practitioners Grant); Australian Government Postgraduate Award; National Health and Medical Research Council (NHMRC) [511104]; Australian Research Council [FT0990987]; NHMRC [389500]; National Breast Cancer Foundation [ECF-1309]	Wesley Research Institute; Queensland Health (Health Practitioners Grant); Australian Government Postgraduate Award(Australian Government); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This study was funded by grants from The Wesley Research Institute (number 2009/3) and Queensland Health (Health Practitioners Grant) awarded to BMW, JDP and DCW. BMW was supported by an Australian Government Postgraduate Award; JPW was supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (number 511104); DCW was supported by a Future Fellowship (number FT0990987) from the Australian Research Council; and MMR was supported by Early Career Fellowships from the NHMRC (number 389500) and National Breast Cancer Foundation (number ECF-1309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JJB, 2006, NUTR TODAY, V41, P115; Beales ILP, 2007, MOL CELL ENDOCRINOL, V274, P60, DOI 10.1016/j.mce.2007.05.017; Beddy P, 2010, BRIT J SURG, V97, P1028, DOI 10.1002/bjs.7100; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Bluher M, 2007, DIABETES CARE, V30, P280, DOI 10.2337/dc06-1362; Booth M, 2000, RES Q EXERCISE SPORT, V71, pS114; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Borst SE, 2001, MED SCI SPORT EXER, V33, P648; Bouassida A, 2010, BRIT J SPORT MED, V44, P620, DOI 10.1136/bjsm.2008.046151; Byers T, 2011, DIABETES OBES METAB, V13, P1063, DOI 10.1111/j.1463-1326.2011.01464.x; CAMERON AJ, 1985, NEW ENGL J MED, V313, P857, DOI 10.1056/NEJM198510033131404; Corley DA, 2008, CANCER EPIDEM BIOMAR, V17, P352, DOI 10.1158/1055-9965.EPI-07-0748; Cornish BH, 1996, EUR J CLIN NUTR, V50, P159; Courneya KS, 2004, PSYCHO-ONCOL, V13, P857, DOI 10.1002/pon.802; Dekker MJ, 2007, METABOLISM, V56, P332, DOI 10.1016/j.metabol.2006.10.015; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Duggan C, 2013, CLIN GASTROENTEROL H, V11, P934, DOI 10.1016/j.cgh.2013.02.017; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Fatouros IG, 2005, J CLIN ENDOCR METAB, V90, P5970, DOI 10.1210/jc.2005-0261; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Friedenreich CM, 2012, CANCER PREV RES, V5, P98, DOI 10.1158/1940-6207.CAPR-11-0369; Friedenreich CM, 2011, ENDOCR-RELAT CANCER, V18, P357, DOI 10.1530/ERC-10-0303; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261; Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07; Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Hickman IJ, 2012, CURR MED CHEM, V19, P5427; Howard JM, 2010, OBES REV, V11, P863, DOI 10.1111/j.1467-789X.2010.00718.x; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Ibiebele TI, 2009, PUBLIC HEALTH NUTR, V12, P2359, DOI 10.1017/S1368980009005023; Jakicic JM, 2009, OBESITY, V17, pS34, DOI 10.1038/oby.2009.386; Jones R, 2007, ALIMENT PHARM THER, V25, P1451, DOI 10.1111/j.1365-2036.2007.03343.x; Katzmarzyk PT, 2003, MED SCI SPORT EXER, V35, P1703, DOI 10.1249/01.MSS.0000089337.73244.9B; Kendall BJ, 2008, GUT, V57, P448, DOI 10.1136/gut.2007.131243; Kendall BJ, 2006, AM J GASTROENTEROL, V101, P1178, DOI 10.1111/j.1572-0241.2006.00548.x; Kristal AR, 2005, CANCER EPIDEM BIOMAR, V14, P2377, DOI 10.1158/1055-9965.EPI-05-0158; Kubo A, 2006, CANCER EPIDEM BIOMAR, V15, P872, DOI 10.1158/1055-9965.EPI-05-0860; Leitzmann MF, 2009, AM J PREV MED, V36, P112, DOI 10.1016/j.amepre.2008.09.033; Lord RVN, 1998, J GASTROEN HEPATOL, V13, P356, DOI 10.1111/j.1440-1746.1998.tb00646.x; MacInnis RJ, 2006, INT J CANCER, V118, P2628, DOI 10.1002/ijc.21638; Huerta JM, 2010, CANCER CAUSE CONTROL, V21, P657, DOI 10.1007/s10552-009-9493-x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nelson AG, 2011, J PHYSIOTHER, V57, P173, DOI 10.1016/S1836-9553(11)70038-8; O'Leary VB, 2006, J APPL PHYSIOL, V100, P1584, DOI 10.1152/japplphysiol.01336.2005; Ogunwobi O, 2006, ENDOCRINOLOGY, V147, P4505, DOI 10.1210/en.2006-0224; Ogunwobi OO, 2008, MOL CELL ENDOCRINOL, V285, P43, DOI 10.1016/j.mce.2008.01.023; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Polednak AP, 2003, INT J CANCER, V105, P98, DOI 10.1002/ijc.11029; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Reseland JE, 2001, AM J CLIN NUTR, V73, P240; Semple RK, 2007, DIABETES, V56, P1712, DOI 10.2337/db06-1665; Shang JJ, 2012, CANCER NURS, V35, P312, DOI 10.1097/NCC.0b013e318236a3b3; Sharma P, 2004, GASTROENTEROLOGY, V127, P310, DOI 10.1053/j.gastro.2004.04.010; Shaw K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003817.pub3; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Somasundar P, 2003, AM J SURG, V186, P575, DOI 10.1016/j.amjsurg.2003.07.017; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Steffen A, 2009, CANCER EPIDEM BIOMAR, V18, P2079, DOI 10.1158/1055-9965.EPI-09-0265; Stein Hubert J., 1993, Dysphagia, V8, P276, DOI 10.1007/BF01354551; Thomas KS, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-153; Thompson OM, 2010, OBESITY, V18, P2204, DOI 10.1038/oby.2009.508; Thrift AP, 2012, ANN ONCOL, V23, P3155, DOI 10.1093/annonc/mds181; van Soest EM, 2005, GUT, V54, P1062, DOI 10.1136/gut.2004.063685; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; Vu V, 2007, DIABETES-METAB RES, V23, P600, DOI 10.1002/dmrr.778; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375; Winzer BM, 2011, CANCER CAUSE CONTROL, V22, P811, DOI 10.1007/s10552-011-9761-4; Winzer BM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-292; World Cancer Research Fund/ American Institute for Cancer Research, 2007, THE SECOND EXPERT RE	71	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117922	10.1371/journal.pone.0117922	http://dx.doi.org/10.1371/journal.pone.0117922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706622	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000350662100130
J	Imai, M; Miyazaki, M; Yeung, HH; Hidaka, S; Kantartzis, K; Okada, H; Kita, S				Imai, Mutsumi; Miyazaki, Michiko; Yeung, H. Henny; Hidaka, Shohei; Kantartzis, Katerina; Okada, Hiroyuki; Kita, Sotaro			Sound Symbolism Facilitates Word Learning in 14-Month-Olds	PLOS ONE			English	Article							PHONETIC DETAIL; LANGUAGE; CORRESPONDENCES; SPEECH; OBJECTS; ACCESS; SHAPE	Sound symbolism, or the nonarbitrary link between linguistic sound and meaning, has often been discussed in connection with language evolution, where the oral imitation of external events links phonetic forms with their referents (e.g., Ramachandran & Hubbard, 2001). In this research, we explore whether sound symbolism may also facilitate synchronic language learning in human infants. Sound symbolism may be a useful cue particularly at the earliest developmental stages of word learning, because it potentially provides a way of bootstrapping word meaning from perceptual information. Using an associative word learning paradigm, we demonstrated that 14-month-old infants could detect Khler-type (1947) shape-sound symbolism, and could use this sensitivity in their effort to establish a wordreferent association.	[Imai, Mutsumi] Keio Univ, Dept Environm & Informat Studies, Fujisawa, Kanagawa 2528520, Japan; [Miyazaki, Michiko] Otsuma Womens Univ, Sch Social Informat Studies, Tokyo 2068540, Japan; [Yeung, H. Henny] CNRS, Paris, France; [Yeung, H. Henny] Univ Paris 05, Sorbonne Paris Cite, Lab Psychol Percept, Paris, France; [Hidaka, Shohei] Japan Adv Inst Sci & Technol, Sch Knowledge Sci, Nomi, Ishikawa 9231292, Japan; [Kantartzis, Katerina] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Miyazaki, Michiko; Okada, Hiroyuki] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo 1948610, Japan; [Kita, Sotaro] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England	Keio University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Japan Advanced Institute of Science & Technology (JAIST); University of Birmingham; University of Warwick	Imai, M (corresponding author), Keio Univ, Dept Environm & Informat Studies, 5322 Endo, Fujisawa, Kanagawa 2528520, Japan.	imai@sfc.keio.ac.jp	Kita, Sotaro/B-2860-2008; Okada, HIroyuki/AAN-8999-2020	Kita, Sotaro/0000-0002-0088-3654; Yeung, Henny/0000-0003-4601-6924; Kantartzis, Katerina/0000-0002-8008-144X	JSPS KAKENHI [15300088, 22243043, 23300099]; MEXT (Ministry of Education, Culture, Sports, Science and Technology) [23120003, 25119510]; MEXT GCOE program to Tamagawa University; Biotechnology and Biological Sciences Research Council's Research Development Fellowship [BB/G023069/1]; BBSRC [BB/G023069/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023069/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [26580078, 25330176, 23300099] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT GCOE program to Tamagawa University; Biotechnology and Biological Sciences Research Council's Research Development Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI to MI (#15300088, #22243043), MEXT ( Ministry of Education, Culture, Sports, Science and Technology) Grant-in-Aid for Scientific Research on Innovative Areas to MI (#23120003), MEXT Grant-in-Aid for Scientific Research on Innovative Areas to MM (#25119510), JSPS KAKENHI to SH (#23300099), MEXT GCOE program to Tamagawa University, and Biotechnology and Biological Sciences Research Council's Research Development Fellowship [BB/G023069/1] to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 1996, BRIT J DEV PSYCHOL, V14, P79, DOI 10.1111/j.2044-835X.1996.tb00695.x; Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Asano M, CORTEX IN PRESS; DAVIS R, 1961, BRIT J PSYCHOL, V52, P259, DOI 10.1111/j.2044-8295.1961.tb00788.x; Farmer TA, 2006, P NATL ACAD SCI USA, V103, P12203, DOI 10.1073/pnas.0602173103; Fennell CT, 2010, CHILD DEV, V81, P1376, DOI 10.1111/j.1467-8624.2010.01479.x; Fennell CT, 2003, LANG SPEECH, V46, P245, DOI 10.1177/00238309030460020901; Fernald A, 2006, DEV PSYCHOL, V42, P98, DOI 10.1037/0012-1649.42.1.98; Firth J. R., 1935, T PHILOL SOC, V34, P36, DOI DOI 10.1111/J.1467-968X.1935.TB01254.X; Gogate LJ, 2010, PSYCHOL REV, V117, P496, DOI 10.1037/a0019049; Gogate LJ, 2000, STUDY MULTIMODAL MOT; Goldstein MH, 2010, INFANCY, V15, P362, DOI 10.1111/j.1532-7078.2009.00020.x; Gonzalez-Gomez PL, 2013, GEN COMP ENDOCR, V191, P1, DOI 10.1016/j.ygcen.2013.05.007; Hamano Shoko., 1998, SOUND SYMBOLIC SYSTE; HOLLAND MK, 1964, PERCEPT MOTOR SKILL, V19, P111, DOI 10.2466/pms.1964.19.1.111; Hollich G, 2007, DEV PSYCHOL, V43, P1051, DOI 10.1037/0012-1649.43.5.1051; Imai M, 1997, COGNITION, V62, P169, DOI 10.1016/S0010-0277(96)00784-6; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kantartzis K, 2011, JAPANESE SOUND SYMBO; Kelly SD, 2002, DEV NEUROPSYCHOL, V22, P323, DOI 10.1207/S15326942dn2201_1; Kita S, 1997, LINGUISTICS, V35, P379, DOI 10.1515/ling.1997.35.2.379; Kita S, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P206, DOI 10.1142/9789814295222_0027; [Китаев С.В. Kitayev S.V.], 2008, [Онкоурология, Onkourologiya], P25; Kohler W, 1929, GESTALT PSYCHOL INTR; Mani N, 2008, DEVELOPMENTAL SCI, V11, P53, DOI 10.1111/j.1467-7687.2007.00645.x; Markman E. M., 1989, CATEGORIZATION NAMIN; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Mazuka R., 2008, ORIGINS LANGUAGE UNR, P39; Monaghan P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0299; Monaghan P, 2012, J EXP PSYCHOL LEARN, V38, P1152, DOI 10.1037/a0027747; Monaghan P, 2011, J EXP PSYCHOL GEN, V140, P325, DOI 10.1037/a0022924; Mondloch CJ, 2004, COGN AFFECT BEHAV NE, V4, P133, DOI 10.3758/CABN.4.2.133; Ogura T, 2004, MACARTHUR COMMUNICAT; Ogura T, 2009, INFANTS RECEPTIVE VO; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791; Quine W. V. O., 1960, WORD OBJECT; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Saussure Ferdinandde., 1986, COURSE GEN LINGUISTI; Senghas A, 2004, SCIENCE, V305, P1779, DOI 10.1126/science.1100199; Smith L. B., 2002, BECOMING WORD LEARNE; Spiegel C, 2011, J EXP CHILD PSYCHOL, V109, P132, DOI 10.1016/j.jecp.2010.10.013; Stager CL, 1997, NATURE, V388, P381, DOI 10.1038/41102; Swingley D, 2002, PSYCHOL SCI, V13, P480, DOI 10.1111/1467-9280.00485; Tomasello M, 1995, CULTURAL ORIGINS HUM; Voeltz Friedrich K. Erhard, 2001, IDEOPHONES; Wagenmakers EJ, 2010, COGNITIVE PSYCHOL, V60, P158, DOI 10.1016/j.cogpsych.2009.12.001; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037/0012-1649.34.6.1289; Westbury C, 2005, BRAIN LANG, V93, P10, DOI 10.1016/j.bandl.2004.07.006; Woodward AL, 1999, CHILD DEV, V70, P65, DOI 10.1111/1467-8624.00006; Yoshida KA, 2009, DEVELOPMENTAL SCI, V12, P412, DOI 10.1111/j.1467-7687.2008.00789.x; Yurovsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047419; Zangl R, 2005, J COGN DEV, V6, P179, DOI 10.1207/s15327647jcd0602_2; Zesiger P, 2012, INFANCY, V17, P591, DOI 10.1111/j.1532-7078.2011.00111.x	55	37	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116494	10.1371/journal.pone.0116494	http://dx.doi.org/10.1371/journal.pone.0116494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695741	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000350062300014
J	Soares, RC; Zani, MB; Arruda, ACBB; de Arruda, LHF; Paulino, LC				Soares, Renan Cardoso; Zani, Marcelo Bergamin; Belini Bazan Arruda, Ana Carolina; Favaro de Arruda, Lucia Helena; Paulino, Luciana Campos			Malassezia Intra-Specific Diversity and Potentially New Species in the Skin Microbiota from Brazilian Healthy Subjects and Seborrheic Dermatitis Patients	PLOS ONE			English	Article							REAL-TIME PCR; ATOPIC-DERMATITIS; MOLECULAR ANALYSIS; DANDRUFF/SEBORRHOEIC DERMATITIS; PITYRIASIS-VERSICOLOR; QUANTITATIVE-ANALYSIS; CUTANEOUS MALASSEZIA; HUMAN KERATINOCYTES; PSORIATIC LESIONS; GENUS MALASSEZIA	Malassezia yeasts are part of the resident cutaneous microbiota, and are also associated with skin diseases such as seborrheic dermatitis (SD). The role these fungi play in skin diseases and why they are pathogenic for only some individuals remain unclear. This study aimed to characterize Malassezia microbiota from different body sites in healthy and SD subjects from Brazil. Scalp and forehead samples from healthy, mild SD and severe SD subjects were collected. Non-scalp lesions from severe SD patients were also sampled. 5.8S rDNA/ITS2 amplicons from Malassezia sp. were analyzed by RFLP and sequencing. Results indicate that Malassezia microbiota did not group according to health condition or body area. Phylogenetic analysis revealed that three groups of sequences did not cluster together with any formally described species, suggesting that they might belong to potential new species. One of them was found in high proportions in scalp samples. A large variety of Malassezia subtypes were detected, indicating intra-specific diversity. Higher Malassezia globosa proportions were found in non-scalp lesions from severe SD subjects compared with other areas, suggesting closer association of this species with SD lesions from areas other than scalp. Our results show the first panorama of Malassezia microbiota in Brazilian subjects using molecular techniques and provide new perspectives for further studies to elucidate the association between Malassezia microbiota and skin diseases.	[Soares, Renan Cardoso; Zani, Marcelo Bergamin; Paulino, Luciana Campos] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Belini Bazan Arruda, Ana Carolina; Favaro de Arruda, Lucia Helena] Hosp & Maternidade Celso Pierro, Campinas, SP, Brazil	Universidade Federal do ABC (UFABC)	Paulino, LC (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil.	luciana.paulino@ufabc.edu.br	PAULINO, LUCIANA CAMPOS/ABD-9425-2021; Paulino, Luciana Campos/R-4172-2019	PAULINO, LUCIANA CAMPOS/0000-0003-2421-5236; 	Sao Paulo Research Foundation (FAPESP); FAPESP research grant [2008/08183-9]; FAPESP scholarship [2011/16543-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP research grant(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP scholarship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP) (http://fapesp.br/en/). LCP was awarded a FAPESP research grant (2008/08183-9) and RCS received a FAPESP scholarship (2011/16543-8). No additional external funding source was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arsenijevic VSA, 2014, BMC DERMATOL, V14, DOI 10.1186/1471-5945-14-5; Ashbee HR, 2007, MED MYCOL, V45, P287, DOI 10.1080/13693780701191373; Ashbee HR, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P139, DOI 10.1007/978-3-642-03616-3_5; Baroni A, 2006, ARCH DERMATOL RES, V297, P280, DOI 10.1007/s00403-005-0594-4; Baroni A, 2004, J CUTAN PATHOL, V31, P35, DOI 10.1046/j.0303-6987.2004.0135.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cabanes FJ, 2011, MED MYCOL, V49, P40, DOI 10.3109/13693786.2010.493562; Cabanes FJ, 2007, FEMS YEAST RES, V7, P1064, DOI 10.1111/j.1567-1364.2007.00217.x; Castella G, 2014, MED MYCOL, V52, P99, DOI 10.3109/13693786.2013.815372; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clavaud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058203; Colwell RK, 2013, ESTIMATES STAT ESTIM; DeAngelis YM, 2005, J INVEST DERM SYMP P, V10, P295, DOI 10.1111/j.1087-0024.2005.10119.x; DeAngelis YM, 2007, J INVEST DERMATOL, V127, P2138, DOI 10.1038/sj.jid.5700844; Dessinioti C, 2013, CLIN DERMATOL, V31, P343, DOI 10.1016/j.clindermatol.2013.01.001; Duarte ER, 2010, MYCOSES, V53, P48, DOI 10.1111/j.1439-0507.2008.01658.x; Duarte ER, 1999, MED MYCOL, V37, P159, DOI 10.1046/j.1365-280X.1999.00212.x; Emtestam L, 2012, MYCOSES, V55, P393, DOI 10.1111/j.1439-0507.2011.02126.x; Faergemann J, 2001, BRIT J DERMATOL, V144, P549, DOI 10.1046/j.1365-2133.2001.04082.x; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Gaitanis G, 2013, CLIN DERMATOL, V31, P455, DOI 10.1016/j.clindermatol.2013.01.012; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gandra RF, 2008, MYCOPATHOLOGIA, V165, P21, DOI 10.1007/s11046-007-9079-7; Gemmer CM, 2002, J CLIN MICROBIOL, V40, P3350, DOI 10.1128/JCM.40.9.3350-3357.2002; Gioti A, 2013, MBIO, V4, DOI 10.1128/mBio.00572-12; Giusiano G, 2010, REV IBEROAM MICOL, V27, P71, DOI 10.1016/j.riam.2009.12.005; Gorley C.K., 2006, GETTING STARTED PRIM; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grimalt R, 2007, J INVEST DERM SYMP P, V12, P10, DOI 10.1038/sj.jidsymp.5650048; Gueho E, 1996, ANTON LEEUW INT J G, V69, P337, DOI 10.1007/BF00399623; Gueho-Kellermann E, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P17, DOI 10.1007/978-3-642-03616-3_2; GUILLOT J, 1995, ANTON LEEUW INT J G, V67, P297, DOI 10.1007/BF00873693; Gupta AK, 2000, J CLIN MICROBIOL, V38, P1869, DOI 10.1128/JCM.38.5.1869-1875.2000; Gupta AK, 2004, J AM ACAD DERMATOL, V51, P785, DOI 10.1016/j.jaad.2003.12.034; Hernandez Hernandez Francisca, 2003, Revista Iberoamericana de Micologia, V20, P141; Hirai A, 2004, INT J SYST EVOL MICR, V54, P623, DOI 10.1099/ijs.0.02776-0; Hiruma M, 2014, MYCOPATHOLOGIA, V177, P263, DOI 10.1007/s11046-014-9748-2; Juntachai W, 2011, MICROBIOL-SGM, V157, P3492, DOI 10.1099/mic.0.054528-0; Juntachai W, 2009, MED MYCOL, V47, P477, DOI 10.1080/13693780802314825; Kaga M, 2011, MYCOSES, V54, pE24, DOI 10.1111/j.1439-0507.2009.01821.x; Kerr K, 2011, ACTA DERM-VENEREOL, V91, P404, DOI 10.2340/00015555-1073; Kerr K, 2011, INT J DERMATOL, V50, P102, DOI 10.1111/j.1365-4632.2010.04629.x; Lee YW, 2011, ANN DERMATOL, V23, P156, DOI 10.5021/ad.2011.23.2.156; Lian CH, 2014, MYCOSES, DOI [10.1111/myc.12280, DOI 10.1111/MYC.12280]; Lyakhovitsky A, 2013, INT J DERMATOL, V52, P231, DOI [10.1111/j.1365-4632.2012.05595.x, 10.1111/ijd.12167]; Machado MLS, 2011, VET DERMATOL, V22, P46, DOI 10.1111/j.1365-3164.2010.00909.x; Machado MLS, 2010, MED MYCOL, V48, P889, DOI 10.3109/13693780903532080; Midgley G, 2000, MED MYCOL, V38, P9, DOI 10.1080/mmy.38.s1.9.16; Mills KJ, 2012, BRIT J DERMATOL, V166, P33, DOI 10.1111/j.1365-2133.2012.10863.x; Mokos ZB, 2012, ACTA DERMATOVENER CR, V20, P98; Munoz-Perez MA, 1998, BRIT J DERMATOL, V139, P33; Nagata R, 2012, PEDIATR INT, V54, P350, DOI 10.1111/j.1442-200X.2012.03563.x; Paulino LC, 2008, FEMS YEAST RES, V8, P460, DOI 10.1111/j.1567-1364.2008.00359.x; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Perkins MA, 2002, SKIN RES TECHNOL, V8, P187, DOI 10.1034/j.1600-0846.2002.20337.x; Petry V, 2011, AN BRAS DERMATOL, V86, P803, DOI 10.1590/S0365-05962011000400032; Rendic E, 2003, REV MED CHILE, V131, P1295; Rincón Sandra, 2005, Biomed., V25, P189; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Selene CED, 2007, ACTA VET HUNG, V55, P471, DOI 10.1556/AVet.55.2007.4.6; Sugita T, 2004, MICROBIOL IMMUNOL, V48, P579, DOI 10.1111/j.1348-0421.2004.tb03554.x; Sugita T, 2003, J CLIN MICROBIOL, V41, P4695, DOI 10.1128/JCM.41.10.4695-4699.2003; Sugita T, 2003, J CLIN MICROBIOL, V41, P3022, DOI 10.1128/JCM.41.7.3022-3027.2003; Sugita T, 2002, J CLIN MICROBIOL, V40, P1363, DOI 10.1128/JCM.40.4.1363-1367.2002; Sugita T, 2001, J CLIN MICROBIOL, V39, P3486, DOI [10.1128/JCM.39.10.3486-3490.2001, 10.3314/jjmm.42.217]; Sugita T, 2006, MICROBIOL IMMUNOL, V50, P549, DOI 10.1111/j.1348-0421.2006.tb03825.x; Tajima M, 2008, J INVEST DERMATOL, V128, P345, DOI 10.1038/sj.jid.5701017; Takahata Y, 2007, BRIT J DERMATOL, V157, P1178, DOI 10.1111/j.1365-2133.2007.08193.x; Takahata Y, 2007, BRIT J DERMATOL, V157, P670, DOI 10.1111/j.1365-2133.2007.08090.x; Trznadel-Grodzka E, 2012, POSTEP HIG MED DOSW, V66, P843, DOI 10.5604/17322693.1019642; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; Zhang H, 2013, MYCOPATHOLOGIA, V175, P83, DOI 10.1007/s11046-012-9606-z	75	25	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117921	10.1371/journal.pone.0117921	http://dx.doi.org/10.1371/journal.pone.0117921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695430	gold, Green Submitted, Green Published			2022-12-27	WOS:000350062300034
J	Czaczkes, TJ; Heinze, J; Ruther, J				Czaczkes, Tomer J.; Heinze, Juergen; Ruther, Joachim			Nest Etiquette-Where Ants Go When Nature Calls	PLOS ONE			English	Article							DIVISION-OF-LABOR; WASTE MANAGEMENT; BEHAVIOR; HYMENOPTERA; FORMICIDAE; SANITATION; DISEASE; BROOD	Sanitary behaviour is an important, but seldom studied, aspect of social living. Social insects have developed several strategies for dealing with waste and faecal matter, including dumping waste outside the nest and forming specialised waste-storage chambers. In some cases waste material and faeces are put to use, either as a construction material or as a long-lasting signal, suggesting that faeces and waste may not always be dangerous. Here we examine a previously undescribed behaviour in ants - the formation of well-defined faecal patches. Lasius niger ants were housed in plaster nests and provided with coloured sucrose solution. After two months, 1-4 well defined dark patches, the colour of the sucrose solution, formed within each of the plaster nests. These patches never contained other waste material such as uneaten food items, or nestmate corpses. Such waste was collected in waste piles outside the nest. The coloured patches were thus distinct from previously described 'kitchen middens' in ants, and are best described as 'toilets'. Why faeces is not removed with other waste materials is unclear. The presence of the toilets inside the nest suggests that they may not be an important source of pathogens, and may have a beneficial role.	[Czaczkes, Tomer J.; Heinze, Juergen; Ruther, Joachim] Univ Regensburg, D-93053 Regensburg, Bavaria, Germany	University of Regensburg	Czaczkes, TJ (corresponding author), Univ Regensburg, D-93053 Regensburg, Bavaria, Germany.	tomer.czaczkes@biologie.uni-regensburg.de	Ruther, Joachim/AAE-3568-2019	Czaczkes, Tomer/0000-0002-1350-4975; Ruther, Joachim/0000-0002-1295-347X	Alexander von Humboldt foundation	Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	This work was supported by the Alexander von Humboldt foundation, http://www.humboldt-foundation.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1974, SOCIAL BEHAV BEES; Arganda S, 2014, J INSECT PHYSL; Bailey L, 1955, ANN APPL BIOL, V43, P379, DOI 10.1111/j.1744-7348.1955.tb02488.x; Ballari S, 2007, J INSECT BEHAV, V20, P87, DOI 10.1007/s10905-006-9065-9; BEUGNON G, 1992, INSECT SOC, V39, P341, DOI 10.1007/BF01323954; BUCHER GE, 1957, CAN J MICROBIOL, V3, P695, DOI 10.1139/m57-077; Devigne C, 2002, INSECT SOC, V49, P357, DOI 10.1007/PL00012659; Diez L, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0306; Dussutour A, 2009, CURR BIOL, V19, P740, DOI 10.1016/j.cub.2009.03.015; Fernandez-Marin H, 2006, P ROY SOC B-BIOL SCI, V273, P1689, DOI 10.1098/rspb.2006.3492; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Hart AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P387, DOI 10.1007/s002650000312; HOLLDOBLER B, 1977, SCIENCE, V195, P900, DOI 10.1126/science.841318; Holldobler B., 1990, pi; HOLLDOBLER B, 1976, SCIENCE, V192, P912, DOI 10.1126/science.192.4242.912; Jarau S, 2009, CONTEMP TOP ENTOMOL, P1, DOI 10.1201/9781420075618; Kerr A. S., 1999, Revista Brasileira de Biologia, V59, P119, DOI 10.1590/S0034-71081999000100015; Korb J, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P349, DOI 10.1007/978-90-481-3977-4_13; Noirot C., 1970, P73; PEETERS C, 1994, INSECT SOC, V41, P211, DOI 10.1007/BF01240479; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Poulsen M, 2002, BEHAV ECOL SOCIOBIOL, V52, P151, DOI 10.1007/s00265-002-0489-8; Rettenmeyer C. W., 1963, Kansas University Science Bulletin, V44, P281; Rosengaus RB, 1998, J CHEM ECOL, V24, P1697, DOI 10.1023/A:1020872729671; Sato Y, 2003, ETHOLOGY, V109, P713, DOI 10.1046/j.1439-0310.2003.00905.x; Sato Y, 2006, ETHOLOGY, V112, P664, DOI 10.1111/j.1439-0310.2005.01184.x; Tragust S, 2013, CURR BIOL, V23, P76, DOI 10.1016/j.cub.2012.11.034; Tranter C, 2014, BEHAV ECOL SOCIOBIOL, V68, P499, DOI 10.1007/s00265-013-1664-9; Vencl FV, 1999, J CHEM ECOL, V25, P549, DOI 10.1023/A:1020905920952; Weiss MR, 2006, ANNU REV ENTOMOL, V51, P635, DOI 10.1146/annurev.ento.49.061802.123212; Weiss MR, 2003, ECOL LETT, V6, P361, DOI 10.1046/j.1461-0248.2003.00442.x; WILSON EO, 1984, INSECT SOC, V31, P408, DOI 10.1007/BF02223657	32	17	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118376	10.1371/journal.pone.0118376	http://dx.doi.org/10.1371/journal.pone.0118376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692971	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500120
J	Jiang, MJ; Wang, LS; Huang, SL; Xu, LB; Hu, C; Jiang, WZ				Jiang, Minjie; Wang, Lisheng; Huang, Shulin; Xu, Liba; Hu, Chao; Jiang, Weizhe			Pharmacokinetic Study of 14-(3-Methylbenzyl)matrine and 14-(4-Methylbenzyl)matrine in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometry	PLOS ONE			English	Article							ACTIVE METABOLITE MATRINE; DOG PLASMA; OXYMATRINE; SOPHORIDINE	A rapid, sensitive and selective high-performance liquid chromatography-tandem mass spectrometric method (HPLC-MS) was developed and validated to determine the 14-(3-methylbenzyl)matrine (3MBM) and 14-(4-methylbenzyl)matrine (4MBM) levels in rat plasma in the present study. The analytes were separated using a C18 column (1.9 mu m, 2.1 mm x 100 mm) equipped with a Security Guard C18 column (5 mu m, 2.1 mm x 10 mm), followed by detection via triple-quadrupole mass spectrometry using an electrospray ionization (ESI) source. Sample pretreatment involved one-step protein precipitation with isopropanol: ethyl acetate (v/v, 25:75), and pseudoephedrine hydrochloride was used as an internal standard. The method was linear in the concentration range of 5-2000 ng/ml for both compounds. The intra-day and inter-day relative standard deviations (RSDs) were less than 15%, and all relative errors (REs) were within 15%. The proposed method enables the unambiguous identification and quantification of these two compounds in vivo. This study is the first to determine the 3MBM and 4MBM levels in rat plasma after oral administration of these compounds. These results provide a meaningful basis for evaluating the clinical applications of these medicines.	[Jiang, Minjie; Wang, Lisheng] Guangxi Univ, Sch Chem & Chem Engn, Nanning 530004, Peoples R China; [Huang, Shulin; Xu, Liba; Hu, Chao; Jiang, Weizhe] Guangxi Med Univ, Sch Pharmaceut, Nanning 530021, Peoples R China	Guangxi University; Guangxi Medical University	Wang, LS (corresponding author), Guangxi Univ, Sch Chem & Chem Engn, 100 Daxue Rd, Nanning 530004, Peoples R China.	jiangminjietp@me.com; jiangweizhe6812@yahoo.com.cn			Natural Science Foundation of China [21262005]; Natural Science Foundation of Guangxi [2012GXNSFAA053158]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This work was supported by the Natural Science Foundation of China (No. 21262005) and the Natural Science Foundation of Guangxi (No. 2012GXNSFAA053158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Yong, 2005, Yaoxue Xuebao, V40, P740; Li YM, 2004, BIOMED CHROMATOGR, V18, P619, DOI 10.1002/bmc.348; Liu JY, 2007, INT IMMUNOPHARMACOL, V7, P816, DOI 10.1016/j.intimp.2007.02.003; Liu Mei, 2003, Zhongguo Zhongyao Zazhi, V28, P801; Liu XH, 2006, CHROMATOGRAPHIA, V63, P483, DOI 10.1365/s10337-006-0773-2; Long Yao, 2004, Hepatobiliary Pancreat Dis Int, V3, P69; Ran W, 2012, SYNTHESIS MATRINE DE; Sit DST, 2004, J CHROMATOGR B, V808, P209, DOI 10.1016/j.jchromb.2004.05.010; Wang LS, 2012, J GUANGXI U, V37, P12; Wang SJ, 2005, J CHROMATOGR B, V817, P319, DOI 10.1016/j.jchromb.2005.01.003; Wang X, 2007, ANAL CHIM ACTA, V594, P290, DOI 10.1016/j.aca.2007.05.024; Wang YQ, 2007, BIOMED CHROMATOGR, V21, P876, DOI 10.1002/bmc.834; Wei YH, 2006, J CHROMATOGR B, V843, P10, DOI 10.1016/j.jchromb.2006.05.023; Wu XL, 2006, J PHARMACEUT BIOMED, V41, P918, DOI 10.1016/j.jpba.2006.01.029; Wu YJ, 2005, ANAL BIOANAL CHEM, V382, P1595, DOI 10.1007/s00216-005-3316-z; Zhang XL, 2009, J CHROMATOGR B, V877, P3253, DOI 10.1016/j.jchromb.2009.08.026; Zhanga L, 2008, J PHARMACEUT BIOMED, V47, P892, DOI 10.1016/j.jpba.2008.03.019	17	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116010	10.1371/journal.pone.0116010	http://dx.doi.org/10.1371/journal.pone.0116010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714369	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700009
J	van de Leemput, IA; van Nes, EH; Scheffer, M				van de Leemput, Ingrid A.; van Nes, Egbert H.; Scheffer, Marten			Resilience of Alternative States in Spatially Extended Ecosystems	PLOS ONE			English	Article							SELF-ORGANIZATION; VEGETATION CHANGE; REGIME SHIFTS; SAVANNA; FOREST; THRESHOLDS; RECOVERY; SCALE; HETEROGENEITY; CONNECTIVITY	Alternative stable states in ecology have been well studied in isolated, well-mixed systems. However, in reality, most ecosystems exist on spatially extended landscapes. Applying existing theory from dynamic systems, we explore how such a spatial setting should be expected to affect ecological resilience. We focus on the effect of local disturbances, defining resilience as the size of the area of a strong local disturbance needed to trigger a shift. We show that in contrast to well-mixed systems, resilience in a homogeneous spatial setting does not decrease gradually as a bifurcation point is approached. Instead, as an environmental driver changes, the present dominant state remains virtually 'indestructible', until at a critical point (the Maxwell point) its resilience drops sharply in the sense that even a very local disturbance can cause a domino effect leading eventually to a landscape-wide shift to the alternative state. Close to this Maxwell point the travelling wave moves very slow. Under these conditions both states have a comparable resilience, allowing long transient co-occurrence of alternative states side-by-side, and also permanent co-existence if there are mild spatial barriers. Overall however, hysteresis may mostly disappear in a spatial context as one of both alternative states will always tend to be dominant. Our results imply that local restoration efforts on a homogeneous landscape will typically either fail or trigger a landscape-wide transition. For extensive biomes with alternative stable states, such as tundra, steppe and forest, our results imply that, as climatic change reduces the stability, the effect might be difficult to detect until a point where local disturbances inevitably induce a spatial cascade to the alternative state.	[van de Leemput, Ingrid A.; van Nes, Egbert H.; Scheffer, Marten] Wageningen Univ, Dept Environm Sci, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	van de Leemput, IA (corresponding author), Wageningen Univ, Dept Environm Sci, NL-6700 AP Wageningen, Netherlands.	ingrid.vandeleemput@wur.nl	van Nes, Egbert H/F-2681-2011	van Nes, Egbert/0000-0002-6345-104X	Ecoshape, Building with Nature [NTW 2.1]; European Research Council (ERC) [268732]	Ecoshape, Building with Nature; European Research Council (ERC)(European Research Council (ERC))	IvdL is supported by Ecoshape, Building with Nature, NTW 2.1(www.ecoshape.nl). IvdL, EvN, and MS are are supported by the European Research Council (ERC: http://erc.europa.eu/) under the ERC Grant Agreement no 268732. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri AH, 2007, AM NAT, V169, P195, DOI 10.1086/510603; Angelini C, 2012, ECOLOGY, V93, P101, DOI 10.1890/11-0557.1; Aronson D. G., 1975, LECT NOTES MATH, V446, P5, DOI DOI 10.1007/BFB0070595; Bel G, 2012, THEOR ECOL-NETH, V5, P591, DOI 10.1007/s12080-011-0149-6; Bertness MD, 2002, ECOLOGY, V83, P3434, DOI 10.1890/0012-9658(2002)083[3434:DASCSE]2.0.CO;2; Bowman AW, 1997, APPL SMOOTHING TECHN; Cottenie K, 2003, FRESHWATER BIOL, V48, P823, DOI 10.1046/j.1365-2427.2003.01050.x; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Donahue MJ, 2011, AM NAT, V178, P612, DOI 10.1086/662177; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; FIFE PC, 1979, ARCH RATION MECH AN, V70, P31, DOI 10.1007/BF00276380; Gagnon P, 2004, MAR BIOL, V144, P1191, DOI 10.1007/s00227-003-1270-x; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Handa IT, 2002, J ECOL, V90, P86, DOI 10.1046/j.0022-0477.2001.00635.x; Higgins SI, 2012, NATURE, V488, P209, DOI 10.1038/nature11238; Hilt S, 2011, OIKOS, V120, P766, DOI 10.1111/j.1600-0706.2010.18553.x; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holt RD, 2005, OIKOS, V108, P18, DOI 10.1111/j.0030-1299.2005.13147.x; Keitt TH, 2001, AM NAT, V157, P203, DOI 10.1086/318633; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; Kool JT, 2009, ECOL INFORM, V4, P136, DOI 10.1016/j.ecoinf.2009.06.002; MacDonald GM, 2008, PHILOS T R SOC B, V363, P2285, DOI 10.1098/rstb.2007.2200; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Petraitis PS, 1999, ECOLOGY, V80, P429, DOI 10.1890/0012-9658(1999)080[0429:TIOSIT]2.0.CO;2; POMEAU Y, 1986, PHYSICA D, V23, P3, DOI 10.1016/0167-2789(86)90104-1; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Robles CD, 2010, LANDSCAPE ECOL, V25, P745, DOI 10.1007/s10980-010-9450-9; SCHEFFER M, 1994, AQUAT BOT, V49, P193, DOI 10.1016/0304-3770(94)90038-8; Scheffer M, 1998, POPULATION COMMUNITY, V22, P1; Scheffer M, 2012, P NATL ACAD SCI USA, V109, P21384, DOI 10.1073/pnas.1219844110; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; SKEEL RD, 1990, SIAM J SCI STAT COMP, V11, P1, DOI 10.1137/0911001; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3; Sternberg LDL, 2001, GLOBAL ECOL BIOGEOGR, V10, P369, DOI 10.1046/j.1466-822X.2001.00243.x; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; van de Koppel J, 2005, AM NAT, V165, pE1; van de Koppel J, 2002, AM NAT, V159, P209, DOI 10.1086/324791; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; Van Geest GJ, 2003, FRESHWATER BIOL, V48, P440, DOI 10.1046/j.1365-2427.2003.01022.x; van Katwijk MM, 2009, MAR POLLUT BULL, V58, P179, DOI 10.1016/j.marpolbul.2008.09.028; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; van Wesenbeeck BK, 2008, ECOSYSTEMS, V11, P1133, DOI 10.1007/s10021-008-9184-6; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Warman L, 2009, LANDSCAPE ECOL, V24, P1, DOI 10.1007/s10980-008-9285-9; Weerman EJ, 2010, AM NAT, V176, pE15, DOI 10.1086/652991; Wilson WG, 1997, ECOLOGY, V78, P2004, DOI 10.2307/2265940; Wolken JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00288.1	55	46	46	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116859	10.1371/journal.pone.0116859	http://dx.doi.org/10.1371/journal.pone.0116859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714342	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700026
J	Durrer, C; Robinson, E; Wan, ZX; Martinez, N; Hummel, ML; Jenkins, NT; Kilpatrick, MW; Little, JP				Durrer, Cody; Robinson, Emily; Wan, Zhongxiao; Martinez, Nic; Hummel, Michelle L.; Jenkins, Nathan T.; Kilpatrick, Marcus W.; Little, Jonathan P.			Differential Impact of Acute High-Intensity Exercise on Circulating Endothelial Microparticles and Insulin Resistance between Overweight/Obese Males and Females	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ENDURANCE EXERCISE; GENDER-DIFFERENCES; INTERVAL EXERCISE; SPRINT INTERVAL; SHEAR-STRESS; SINGLE BOUT; BLOOD-FLOW; LOW-VOLUME; SENSITIVITY	Background An acute bout of exercise can improve endothelial function and insulin sensitivity when measured on the day following exercise. Our aim was to compare acute high-intensity continuous exercise (HICE) to high-intensity interval exercise (HIIE) on circulating endothelial microparticles (EMPs) and insulin sensitivity in overweight/obese men and women. Methods Inactive males (BMI = 30 +/- 3, 25 +/- 6 yr, n = 6) and females (BMI = 28 +/- 2, 21 +/- 3 yr, n = 7) participated in three experimental trials in a randomized counterbalanced crossover design: 1) No exercise control (Control); 2) HICE (20 min cycling @ just above ventilatory threshold); 3) HIIE (10 X 1-min @ similar to 90% peak aerobic power). Exercise conditions were matched for external work and diet was controlled post-exercise. Fasting blood samples were obtained similar to 18 hr after each condition. CD62E(+) and CD31(+)/CD42b(-) EMPs were assessed by flow cytometry and insulin resistance (IR) was estimated by homeostasis model assessment (HOMA-IR). Results There was a significant sex X exercise interaction for CD62E+ EMPs, CD31+/CD42b-EMPs, and HOMA-IR (all P < 0.05). In males, both HICE and HIIE reduced EMPs compared to Control (P <= 0.05). In females, HICE increased CD62E+ EMPs (P < 0.05 vs. Control) whereas CD31+/CD42b- EMPs were unaltered by either exercise type. There was a significant increase in HOMA-IR in males but a decrease in females following HIIE compared to Control (P < 0.05). Conclusions Overweight/obese males and females appear to respond differently to acute bouts of high-intensity exercise. A single session of HICE and HIIE reduced circulating EMPs measured on the morning following exercise in males but in females CD62E+ EMPs were increased following HICE. Next day HOMA-IR paradoxically increased in males but was reduced in females following HIIE. Future research is needed to investigate mechanisms responsible for potential differential responses between males and females.	[Durrer, Cody; Robinson, Emily; Wan, Zhongxiao; Little, Jonathan P.] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Martinez, Nic; Hummel, Michelle L.; Kilpatrick, Marcus W.] Univ S Florida, Coll Educ, Tampa, FL USA; [Jenkins, Nathan T.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA	University of British Columbia; State University System of Florida; University of South Florida; University System of Georgia; University of Georgia	Little, JP (corresponding author), Univ British Columbia, Sch Hlth & Exercise Sci, Okanagan Campus, Kelowna, BC, Canada.	jonathan.little@ubc.ca	Little, Jonathan P./T-4076-2019	Little, Jonathan P./0000-0002-9796-2008; Durrer, Cody/0000-0002-0046-1494	Natural Sciences and Engineering Research Council of Canada Discovery Grant; University of South Florida World Grant	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of South Florida World Grant	The work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to JPL and a University of South Florida World Grant to MWK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; Adams OP, 2013, DIABETES METAB SYNDR, V6, P113, DOI 10.2147/DMSO.S29222; Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Arteaga RB, 2006, AM J CARDIOL, V98, P70, DOI 10.1016/j.amjcard.2006.01.054; Augustine D, 2014, CIRC RES, V114, P109, DOI 10.1161/CIRCRESAHA.114.301904; Babbitt DM, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/538017; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brestoff JR, 2009, APPL PHYSIOL NUTR ME, V34, P25, DOI 10.1139/H08-126; Carroll S, 2004, SPORTS MED, V34, P371, DOI 10.2165/00007256-200434060-00004; Chaar V, 2011, CLIN HEMORHEOL MICRO, V47, P15, DOI 10.3233/CH-2010-1361; Cleland SJ, 1999, HYPERTENSION, V33, P554, DOI 10.1161/01.HYP.33.1.554; Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Earnest CP, 2009, CURRENT CARDIOVASCUL, V3, P296, DOI DOI 10.1007/S12170-009-0045-4; Esposito K, 2006, J CLIN ENDOCR METAB, V91, P3676, DOI 10.1210/jc.2006-0851; Feairheller DL, 2014, J CLIN HYPERTENS, V16, P504, DOI 10.1111/jch.12328; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Green DJ, 2008, J APPL PHYSIOL, V105, P766, DOI 10.1152/japplphysiol.01028.2007; Green DJ, 2009, EXERC SPORT SCI REV, V37, P196, DOI 10.1097/JES.0b013e3181b7b6e3; Guiraud T, 2013, CAN J CARDIOL, V29, P1285, DOI 10.1016/j.cjca.2013.03.024; Hallmark R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085450; Horowitz JF, 2007, EXERC SPORT SCI REV, V35, P192, DOI 10.1097/jes.0b013e318156e084; Houmard JA, 2004, J APPL PHYSIOL, V96, P101, DOI 10.1152/japplphysiol.00707.2003; Jenkins NT, 2013, HYPERTENSION, V61, P615, DOI 10.1161/HYPERTENSIONAHA.111.00561; Jenkins NT, 2011, J PHYSIOL-LONDON, V589, P5539, DOI 10.1113/jphysiol.2011.215277; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Kilpatrick M, 2007, MED SCI SPORT EXER, V39, P1417, DOI 10.1249/mss.0b013e31806ad73c; Kretzschmar J, 2014, MENOPAUSE, V21, P579, DOI [10.1097/gme.0000000000000133, 10.1097/GME.0000000000000133]; La Vignera S, 2012, J ANDROL, V33, P202, DOI 10.2164/jandrol.111.013136; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Little JP, 2011, J APPL PHYSL; Little JP, 2014, APPL PHYSIOL NUTR ME, V39, P1, DOI [10.1139/apnm-2013-0026, DOI 10.1139/APNM-2013-0026]; Magkos F, 2008, CLIN SCI, V114, P59, DOI 10.1042/CS20070134; Magkos F, 2010, EUR J ENDOCRINOL, V162, P61, DOI 10.1530/EJE-09-0756; Maric C, 2005, HYPERTENSION, V46, P475, DOI 10.1161/01.HYP.0000178600.88820.b2; Morel O, 2009, HAEMATOL-HEMATOL J, V94, P313, DOI 10.3324/haematol.2009.003657; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Newsom SA, 2013, DIABETES CARE, V36, P2516, DOI 10.2337/dc12-2606; Padilla J, 2006, EUR J APPL PHYSIOL, V98, P256, DOI 10.1007/s00421-006-0272-z; Roberts CK, 2013, MED SCI SPORT EXER, V45, P1868, DOI 10.1249/MSS.0b013e318295cdbb; Rynders CA, 2014, J CLIN ENDOCR METAB, V99, P220, DOI 10.1210/jc.2013-2687; Sader MA, 2002, CARDIOVASC RES, V53, P597, DOI 10.1016/S0008-6363(01)00473-4; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Sossdorf M, 2011, MED SCI SPORT EXER, V43, P1169, DOI 10.1249/MSS.0b013e3182068645; Tanaka H, 2006, MED SCI SPORT EXER, V38, P81, DOI 10.1249/01.mss.0000191166.81789.de; Thompson PD, 2001, MED SCI SPORT EXER, V33, pS438, DOI 10.1097/00005768-200106001-00012; Tinken TM, 2010, HYPERTENSION, V55, P312, DOI 10.1161/HYPERTENSIONAHA.109.146282; Tjonna AE, 2011, J STRENGTH COND RES, V25, P2552, DOI 10.1519/JSC.0b013e3181fb4809; Toth B, 2007, PLATELETS, V18, P515, DOI 10.1080/09537100701525843; Tyldum GA, 2009, J AM COLL CARDIOL, V53, P200, DOI 10.1016/j.jacc.2008.09.033; Vanhatalo A, 2011, INT J SPORT PHYSIOL, V6, P128, DOI 10.1123/ijspp.6.1.128; Viera AJ, 2012, J AM SOC HYPERTENS, V6, P243, DOI 10.1016/j.jash.2012.06.003; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wasserman K., 1999, PRINCIPLES EXERCISE; Weston K. S., 2013, BRIT J SPORTS MED; Wisloff U, 2009, EXERC SPORT SCI REV, V37, P139, DOI 10.1097/JES.0b013e3181aa65fc	59	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0115860	10.1371/journal.pone.0115860	http://dx.doi.org/10.1371/journal.pone.0115860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710559	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900006
J	Lokki, AI; Aalto-Viljakainen, T; Meri, S; Laivuori, H				Lokki, A. Inkeri; Aalto-Viljakainen, Tia; Meri, Seppo; Laivuori, Hannele			Genetic Analysis of Membrane Cofactor Protein (CD46) of the Complement System in Women with and without Preeclamptic Pregnancies	PLOS ONE			English	Article							ACTIVATION; MUTATIONS; MCP; RECEPTOR; SITES	Preeclampsia is a common disorder of pregnancy characterized by endothelial dysfunction. It may be life-threatening for the mother and fetus in severe cases. Dysregulation of the complement system has been suggested to predispose women to preeclampsia. Complement is part of the innate and adaptive immune systems and potentially capable of causing inflammation and tissue damage. Membrane cofactor protein MCP (CD46) is among the potent complement regulators that have recently been linked to a severe form of preeclampsia with or without an underlying autoimmune phenotype. Mutations in CD46 predispose to thrombotic microangiopathy with endothelial cell dysfunction. The exome of CD46 were sequenced in 95 Finnish women with severe preeclampsia. Genetic variations discovered in the full exome were compared to those observed in 95 control women who did not develop preeclampsia. Because A304V (rs35366573) was associated with preeclampsia in one previous study, we sequenced the transmembrane region including the A304V variant and part of the cytoplasmic tail in 95 additional controls. We did not discover any association between A304V or other CD46 SNPs and preeclampsia. This study describes a carefully characterized cohort of severely preeclamptic Finnish women and found no potentially predisposing variants in CD46. However, it is possible that other genetic components of the complement system may affect the pathogenesis of severe preeclampsia and related diseases.	[Lokki, A. Inkeri; Aalto-Viljakainen, Tia; Laivuori, Hannele] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Lokki, A. Inkeri; Meri, Seppo] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Lokki, A. Inkeri; Meri, Seppo] Univ Helsinki, Res Programs Unit, Immunobiol Res Program, Helsinki, Finland; [Aalto-Viljakainen, Tia; Laivuori, Hannele] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Aalto-Viljakainen, Tia; Laivuori, Hannele] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Lokki, AI (corresponding author), Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland.	inkeri.lokki@helsinki.fi	Lokki, A. Inkeri/H-4783-2019; Kere, Juha/A-9179-2008; Laivuori, Hannele/F-2953-2011	Lokki, A. Inkeri/0000-0003-4397-8415; Kere, Juha/0000-0003-1974-0271; Laivuori, Hannele/0000-0003-3212-7826; Kivinen, Katja/0000-0002-1135-7625; Meri, Seppo/0000-0001-9142-501X	Jane and Aatos Erkko Foundation; Paivikki and Sakari Sohlberg Foundation; Academy of Finland; Research Funds of the University of Helsinki; Special state subsidy for Health Sciences (EVO funding) at Helsinki and Uusimaa Hospital District; National Graduate School of Clinical Investigation (CLIGS); Novo Nordisk Foundation; Finnish Foundation for Pediatric Research; Emil Aaltonen Foundation; Sigrid Juselius Foundation	Jane and Aatos Erkko Foundation; Paivikki and Sakari Sohlberg Foundation; Academy of Finland(Academy of Finland); Research Funds of the University of Helsinki; Special state subsidy for Health Sciences (EVO funding) at Helsinki and Uusimaa Hospital District; National Graduate School of Clinical Investigation (CLIGS); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Finnish Foundation for Pediatric Research; Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The FINNPEC study was supported by Jane and Aatos Erkko Foundation, Paivikki and Sakari Sohlberg Foundation, Academy of Finland, Research Funds of the University of Helsinki, Special state subsidy for Health Sciences (EVO funding) at Helsinki and Uusimaa Hospital District, the National Graduate School of Clinical Investigation (CLIGS), Novo Nordisk Foundation, Finnish Foundation for Pediatric Research, Emil Aaltonen Foundation, and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andreson R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-172; Barilla-LaBarca ML, 2002, J IMMUNOL, V168, P6298, DOI 10.4049/jimmunol.168.12.6298; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Csomor P, 2010, EUR ARCH OTO-RHINO-L, V267, P219, DOI 10.1007/s00405-009-1042-4; Csuka D, 2010, J REPROD IMMUNOL, V87, P90, DOI 10.1016/j.jri.2010.07.004; Derzsy Z, 2010, MOL IMMUNOL, V47, P1500, DOI 10.1016/j.molimm.2010.01.021; Fang CJ, 2008, BLOOD, V111, P624, DOI 10.1182/blood-2007-04-084533; Fremeaux-Bacchi V, 2006, J AM SOC NEPHROL, V17, P2017, DOI 10.1681/ASN.2005101051; Hoffman MC, 2014, AM J REPROD IMMUNOL, V71, P55, DOI 10.1111/aji.12162; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Lopez-Jaramillo P, 2008, AM J THER, V15, DOI 10.1097/MJT.0b013e31818bed43; MANCHESTER M, 1995, P NATL ACAD SCI USA, V92, P2303, DOI 10.1073/pnas.92.6.2303; Mao DL, 2003, IMMUNITY, V19, P813, DOI 10.1016/S1074-7613(03)00321-2; Mazor-Dray E, 2009, J MATERN-FETAL NEO M, V22, P124, DOI 10.1080/14767050802488246; Mori Y, 2002, J VIROL, V76, P6750, DOI 10.1128/JVI.76.13.6750-6761.2002; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Pihkala J, 1989, Duodecim, V105, P1540; POST TW, 1991, J EXP MED, V174, P93, DOI 10.1084/jem.174.1.93; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Riley RC, 2002, MOL REPROD DEV, V62, P534, DOI 10.1002/mrd.10144; Riva A, 2002, BIOINFORMATICS, V18, P1681, DOI 10.1093/bioinformatics/18.12.1681; ROZEN S, BIOINFORMATICS METHO, P365; Salmon JE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001013; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Vergnes Jean-Noel, 2008, Evid Based Dent, V9, P46, DOI 10.1038/sj.ebd.6400580	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117840	10.1371/journal.pone.0117840	http://dx.doi.org/10.1371/journal.pone.0117840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710174	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900042
J	Otsubo, T; Okamura, T; Hagiwara, T; Ishizaka, Y; Dohi, T; Kawamura, YI				Otsubo, Takeshi; Okamura, Tadashi; Hagiwara, Teruki; Ishizaka, Yukihito; Dohi, Taeko; Kawamura, Yuki I.			Retrotransposition of Long Interspersed Nucleotide Element-1 Is Associated with Colitis but Not Tumors in a Murine Colitic Cancer Model	PLOS ONE			English	Article							L1 RETROTRANSPOSITION; TUMORIGENESIS; INFLAMMATION; PROGRESSION; SURVIVAL; LINE-1; CELLS; STAT3; IL-6	Long interspersed element-1 (L1) is a transposable element that can move within the genome, potentially leading to genome diversity and modified gene function. Although L1 activity in somatic cells is normally suppressed through DNA methylation, some L1s are activated in tumors including colorectal carcinoma. However, how L1-retrotransposition (L1-RTP) is involved in gastrointestinal disorders remains to be elucidated. We hypothesized that L1-RTP in somatic cells might contribute to colitis-associated cancer (CAC). To address this, we employed an experimental model of CAC using transgenic L1-reporter mice carrying a human L1-EGFP reporter gene. Mice were subjected to repeated cycles of colitis induced by administration of dextran sodium sulfate (DSS) in drinking water with injection of carcinogen azoxymethane (AOM). L1-RTP levels were measured by a quantitative polymerase chain reaction targeting the newly inserted reporter EGFP in various tissues and cell types, including samples obtained by laser microdissection and cell sorting with flow cytometry. DNA methylation levels of the human L1 promoter were analyzed by bisulfite pyrosequencing. AOM+DSS-treated mice exhibited significantly higher levels of L1-RTP in whole colon tissue during the acute phase of colitis when compared with control naive mice. L1-RTP levels in whole colon tissue were positively correlated with the histological severity of colitis and degree of neutrophil infiltration into the lamina propria (LP), but not with tumor development in the colon. L1-RTP was enriched in LP mesenchymal cells rather than epithelial cells (ECs), myeloid, or lymphoid cells. DNA methylation levels of the human L1 promoter region showed a negative correlation with L1-RTP levels. L1-RTP was absent from most tumors found in 22-week-old mice. In conclusion, we demonstrated that L1-RTP was induced in the mouse CAC mucosa in accordance with the acute inflammatory response; however, retrotransposition appears not to have direct relevance to colitis-induced cancer initiation.	[Otsubo, Takeshi; Hagiwara, Teruki; Dohi, Taeko; Kawamura, Yuki I.] Res Inst, Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Dept Gastroenterol, Ichikawa 2728516, Japan; [Okamura, Tadashi] Res Inst, Natl Ctr Global Hlth & Med, Dept Infect Dis, Sect Anim Models,Shinjuku Ku, Tokyo 1628655, Japan; [Ishizaka, Yukihito] Res Inst, Natl Ctr Global Hlth & Med, Dept Intractable Dis, Shinjuku Ku, Tokyo 1628655, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Dohi, T (corresponding author), Res Inst, Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Dept Gastroenterol, Ichikawa 2728516, Japan.	dohi@ri.ncgm.go.jp; kawamura@ri.ncgm.go.jp			Ministry of Education, Cultures, Sports, Science, and Technology; International Cooperation Research Grants from Ministry of Health, Labor, and Welfare; National Center for Global Health and Medicine [21-110, 22-205, 21-129, 23-101, 25-104, 26-110]; Ministry of Health, Labour, and Welfare of Japan [09156296]	Ministry of Education, Cultures, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Cooperation Research Grants from Ministry of Health, Labor, and Welfare; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was partly supported by grants from the programs Grants-in-Aid for Young Scientists; Grants-in-Aid for Scientific Research (C); Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Cultures, Sports, Science, and Technology; International Cooperation Research Grants from Ministry of Health, Labor, and Welfare; and the National Center for Global Health and Medicine (21-110, 22-205, 21-129, 23-101, 25-104, 26-110); and Grant-in-Aid for Research from the Ministry of Health, Labour, and Welfare of Japan (09156296).	Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goodier JL, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-11; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Iijima K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-83; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Nakkuntod J, 2013, J HUM GENET, V58, P241, DOI 10.1038/jhg.2013.6; Nakkuntod J, 2011, CLIN CHIM ACTA, V412, P1457, DOI 10.1016/j.cca.2011.04.002; Nasuno M, 2014, STEM CELLS, V32, P913, DOI 10.1002/stem.1594; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Okudaira N, 2013, ONCOGENE, V32, P4903, DOI 10.1038/onc.2012.516; Okudaira N, 2014, J BIOL CHEM; Okudaira N, 2011, CANCER SCI, V102, P2000, DOI 10.1111/j.1349-7006.2011.02060.x; Okudaira N, 2010, P NATL ACAD SCI USA, V107, P18487, DOI 10.1073/pnas.1001252107; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116072	10.1371/journal.pone.0116072	http://dx.doi.org/10.1371/journal.pone.0116072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710700	gold, Green Submitted, Green Published			2022-12-27	WOS:000350683900007
J	Szelag, M; Czerwoniec, A; Wesoly, J; Bluyssen, HAR				Szelag, Malgorzata; Czerwoniec, Anna; Wesoly, Joanna; Bluyssen, Hans A. R.			Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; HIGH-ACCURACY; ACTIVATION; PROTEINS; CELLS; PHOSPHORYLATION; INFLAMMATION; DIMERIZATION; RECOGNITION; APOPTOSIS	Signal transducers and activators of transcription (STATs) facilitate action of cytokines, growth factors and pathogens. STAT activation is mediated by a highly conserved SH2 domain, which interacts with phosphotyrosine motifs for specific STAT-receptor contacts and STAT dimerization. The active dimers induce gene transcription in the nucleus by binding to a specific DNA-response element in the promoter of target genes. Abnormal activation of STAT signaling pathways is implicated in many human diseases, like cancer, inflammation and auto-immunity. Searches for STAT-targeting compounds, exploring the phosphotyrosine (pTyr)-SH2 interaction site, yielded many small molecules for STAT3 but sparsely for other STATs. However, many of these inhibitors seem not STAT3-specific, thereby questioning the present modeling and selection strategies of SH2 domain-based STAT inhibitors. We generated new 3D structure models for all human (h) STATs and developed a comparative in silico docking strategy to obtain further insight into STAT-SH2 cross-binding specificity of a selection of previously identified STAT3 inhibitors. Indeed, by primarily targeting the highly conserved pTyr-SH2 binding pocket the majority of these compounds exhibited similar binding affinity and tendency scores for all STATs. By comparative screening of a natural product library we provided initial proof for the possibility to identify STAT1 as well as STAT3-specific inhibitors, introducing the 'STAT-comparative binding affinity value' and ` ligand binding pose variation' as selection criteria. In silico screening of a multi-million clean leads (CL) compound library for binding of all STATs, likewise identified potential specific inhibitors for STAT1 and STAT3 after docking validation. Based on comparative virtual screening and docking validation, we developed a novel STAT inhibitor screening tool that allows identification of specific STAT1 and STAT3 inhibitory compounds. This could increase our understanding of the functional role of these STATs in different diseases and benefit the clinical need for more drugable STAT inhibitors with high specificity, potency and excellent bioavailability.	[Szelag, Malgorzata; Bluyssen, Hans A. R.] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Dept Human Mol Genet, PL-61614 Poznan, Poland; [Wesoly, Joanna] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Lab High Throughput Technol, PL-61614 Poznan, Poland; [Czerwoniec, Anna] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Bioinformat Lab, PL-61614 Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University; Adam Mickiewicz University	Bluyssen, HAR (corresponding author), Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Dept Human Mol Genet, Umultowska 89, PL-61614 Poznan, Poland.	h.bluyss@amu.edu.pl		Bluyssen, Hans/0000-0002-4568-6259	National Science Centre Poland [UMO-2012/07/B/NZ1/02710, UMO-2012/07/N/NZ2/01359]; Poznan Supercomputer Centre (PCSS) [128]; KNOW RNA Research Centre in Poznan [01/KNOW2/2014]; PL-Grid Infrastructure	National Science Centre Poland(National Science Centre, Poland); Poznan Supercomputer Centre (PCSS); KNOW RNA Research Centre in Poznan; PL-Grid Infrastructure	This publication was supported by grants UMO-2012/07/B/NZ1/02710 (to HB), UMO-2012/07/N/NZ2/01359 (to MS) from National Science Centre Poland, and No 128 from the Poznan Supercomputer Centre (PCSS) (to MS). This work was supported by the KNOW RNA Research Centre in Poznan (No. 01/KNOW2/2014) and in part by PL-Grid Infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Bill MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040724; Bill MA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-165; Boniecki M, 2003, J COMPUT AID MOL DES, V17, P725, DOI 10.1023/B:JCAM.0000017486.83645.a0; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Chen HJ, 2013, EUR J MED CHEM, V62, P498, DOI 10.1016/j.ejmech.2013.01.023; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Furqan M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-90; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gunning PT, 2007, BIOORG MED CHEM LETT, V17, P1875, DOI 10.1016/j.bmcl.2007.01.077; Hildebrand PW, 2009, NUCLEIC ACIDS RES, V37, pW571, DOI 10.1093/nar/gkp338; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Kamran MZ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/421821; Kim MJ, 2013, CANCER LETT, V335, P145, DOI 10.1016/j.canlet.2013.02.010; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Larsson P, 2009, PROTEINS, V77, P167, DOI 10.1002/prot.22476; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin JP, 2009, J MOL GRAPH MODEL, V28, P347, DOI 10.1016/j.jmgm.2009.08.013; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Ma DL, 2014, ANGEW CHEM INT EDIT, V53, P9178, DOI 10.1002/anie.201404686; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Matsuno K, 2010, ACS MED CHEM LETT, V1, P371, DOI 10.1021/ml1000273; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; Park In-Hee, 2011, J Mol Recognit, V24, P254, DOI 10.1002/jmr.1047; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Read RJ, 2007, PROTEINS, V69, P27, DOI 10.1002/prot.21662; Sadreyev RI, 2003, PROTEIN SCI, V12, P2262, DOI 10.1110/ps.03197403; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanseverino I, 2012, CHEM BIOL, V19, P1213, DOI 10.1016/j.chembiol.2012.08.021; Scalmani G., 2016, GAUSSIAN 09; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Sikorski K, 2011, CYTOKINE GROWTH F R, V22, P211, DOI 10.1016/j.cytogfr.2011.06.003; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Sun JZ, 2005, ONCOGENE, V24, P3236, DOI 10.1038/sj.onc.1208470; Szelag M, 2014, EUR J PHARMACOL, V740, P417, DOI 10.1016/j.ejphar.2014.05.047; Szelag M, 2013, EUR J PHARMACOL, V720, P38, DOI 10.1016/j.ejphar.2013.10.055; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tu SP, 2012, CANCER PREV RES, V5, P205, DOI 10.1158/1940-6207.CAPR-11-0247; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Wallner B, 2005, BIOINFORMATICS, V21, P4248, DOI 10.1093/bioinformatics/bti702; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang Y, 2012, NANO, V7, DOI 10.1142/S1793292012500427; Xu XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004783; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zemla A, 1999, PROTEINS, P22; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001; Zhao J, 2007, NEW PHYTOL, V175, P215, DOI 10.1111/j.1469-8137.2007.02109.x	69	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116688	10.1371/journal.pone.0116688	http://dx.doi.org/10.1371/journal.pone.0116688			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710482	gold, Green Submitted, Green Published			2022-12-27	WOS:000350683900013
J	Belcher, JD; Chen, CS; Nguyen, J; Abdulla, F; Nguyen, P; Nguyen, M; Okeley, NM; Benjamin, DR; Senter, PD; Vercellotti, GM				Belcher, John D.; Chen, Chunsheng; Nguyen, Julia; Abdulla, Fuad; Nguyen, Phong; Nguyen, Minh; Okeley, Nicole M.; Benjamin, Dennis R.; Senter, Peter D.; Vercellotti, Gregory M.			The Fucosylation Inhibitor, 2-Fluorofucose, Inhibits Vaso-Occlusion, Leukocyte-Endothelium Interactions and NF-kappa B Activation in Transgenic Sickle Mice	PLOS ONE			English	Article							CELL P-SELECTIN; ERYTHROCYTES; INFLAMMATION; NEUTROPHILS; MONOCYTES; MODULATOR; ADHESION; RELEASE; LIGANDS; BINDING	2-Fluorofucose (2FF) blocks the fucosylation and the tethering of sialyl-Lewis(x) tetrasaccharide and structural variants on leukocytes and red blood cells to P- and E-selectins on activated endothelial cell surfaces. Because P-and E-selectin are required for vaso-occlusion in murine sickle cell disease (SCD), we investigated whether 2FF would inhibit vaso-occlusion in SCD mice. Microvascular stasis was measured in subcutaneous venules in NY1DD and HbSS-Townes SCD mice with dorsal skin-fold chambers after infusion of hemoglobin or exposure to hypoxia/reoxygenation. 2FF in drinking water or administered by gavage inhibited stasis in sickle mice in a dose-responsive manner. Significant inhibitory effects on stasis were seen 1 day post-treatment. 2FF treatment of SCD mice also significantly reduced leukocyte rolling and adhesion along the vessel walls of SCD mice and the static adhesion of neutrophils and sickle red blood cells isolated from 2FF-treated SCD mice to resting and activated endothelial cells. Total white blood cell counts increased in response to 2FF. NF-kappa B activation and VCAM-1 and E-selectin expression were inhibited in the livers of SCD mice consistent with an overall decrease in vascular inflammation and ischemia-reperfusion physiology. Pretreatment with 2FF completely eliminated heme-induced lethality in HbSS-Townes mice, consistent with the observed anti-inflammatory and anti-adhesive properties of 2FF in SCD mice. These data suggest that 2FF may be beneficial for preventing or treating vaso-occlusive crises in SCD patients.	[Belcher, John D.; Chen, Chunsheng; Nguyen, Julia; Abdulla, Fuad; Nguyen, Phong; Nguyen, Minh; Vercellotti, Gregory M.] Vasc Biol Ctr, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; [Okeley, Nicole M.; Benjamin, Dennis R.; Senter, Peter D.] Seattle Genet Inc, Bothell, WA USA	Seattle Genetics	Belcher, JD (corresponding author), Vasc Biol Ctr, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA.	belcher@umn.edu	Abdulla, Fuad/A-3337-2015; Abdulla, Fuad/AHB-7032-2022		Seattle Genetics, Inc.; National Institute of Health's Heart, Lung and Blood Institute [HL115467-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114567] Funding Source: NIH RePORTER	Seattle Genetics, Inc.; National Institute of Health's Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Seattle Genetics, Inc., and the National Institute of Health's Heart, Lung and Blood Institute (HL115467-01). Seattle Genetics, Inc., provided support in the form of salaries for authors NMO, DRB, and PDS, study design, 2-fluorofucose reagent, plasma 2-fluorofucose analysis, and preparation of the manuscript. The funders did not have any additional roles in the data collection and analysis or decision to publish.	BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Belcher John D, 2013, ISRN Oxidative Med, V2013; Belcher JD, 2013, BLOOD, V122, P2757, DOI 10.1182/blood-2013-02-486282; Brittain JE, 2008, BRIT J HAEMATOL, V141, P872, DOI 10.1111/j.1365-2141.2008.07056.x; Brown RA, 2003, BRIT J PHARMACOL, V139, P845, DOI 10.1038/sj.bjp.0705291; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713; FABRY ME, 1992, P NATL ACAD SCI USA, V89, P12150, DOI 10.1073/pnas.89.24.12150; Ghosh S, 2013, J CLIN INVEST, V123, P4809, DOI 10.1172/JCI64578; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Kalambur VS, 2004, AM J HEMATOL, V77, P117, DOI 10.1002/ajh.20143; Kaul DK, 2006, AM J PHYSIOL-CELL PH, V291, pC922, DOI 10.1152/ajpcell.00639.2005; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Lowe JB, 1996, SELECTINS INITIATORS; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955; Okeley NM, 2013, P NATL ACAD SCI USA, V110, P5404, DOI 10.1073/pnas.1222263110; Osarogiagbon UR, 2000, BLOOD, V96, P314, DOI 10.1182/blood.V96.1.314.013k39_314_320; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Telen MJ, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.776.776; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Wood KC, 2004, AM J PHYSIOL-HEART C, V286, pH1608, DOI 10.1152/ajpheart.01056.2003; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zennadi R, 2008, BLOOD, V112, P3474, DOI 10.1182/blood-2008-01-134346	32	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117772	10.1371/journal.pone.0117772	http://dx.doi.org/10.1371/journal.pone.0117772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706118	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100116
J	Benedyk, M; Byrne, DP; Glowczyk, I; Potempa, J; Olczak, M; Olczak, T; Smalley, JW				Benedyk, Malgorzata; Byrne, Dominic P.; Glowczyk, Izabela; Potempa, Jan; Olczak, Mariusz; Olczak, Teresa; Smalley, John W.			Pyocycanin, a Contributory Factor in Haem Acquisition and Virulence Enhancement of Porphyromonas gingivalis in the Lung	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA PYOCYANIN; IRON PROTOPORPHYRIN IX; BACTEROIDES-GINGIVALIS; SUPEROXIDE-DISMUTASE; PREVOTELLA-INTERMEDIA; ANAEROBIC-BACTERIA; HEMOGLOBIN; GINGIPAINS; MECHANISM; HEMOLYSIN	Several recent studies show that the lungs infected with Pseudomonas aeruginosa are often co-colonised by oral bacteria including black-pigmenting anaerobic (BPA) Porphyromonas species. The BPAs have an absolute haem requirement and their presence in the infected lung indicates that sufficient haem, a virulence up-regulator in BPAs, must be present to support growth. Haemoglobin from micro-bleeds occurring during infection is the most likely source of haem in the lung. Porphyromonas gingivalis displays a novel haem acquisition paradigm whereby haemoglobin must be firstly oxidised to methaemoglobin, facilitating haem release, either by gingipain proteolysis or capture via the haem-binding haemophore HmuY. P. aeruginosa produces the blue phenazine redox compound, pyocyanin. Since phenazines can oxidise haemoglobin, it follows that pyocyanin may also facilitate haem acquisition by promoting methaemoglobin production. Here we show that pyocyanin at concentrations found in the CF lung during P. aeruginosa infections rapidly oxidises oxyhaemoglobin in a dose-dependent manner. We demonstrate that methaemoglobin formed by pyocyanin is also susceptible to proteolysis by P. gingivalis Kgp gingipain and neutrophil elastase, thus releasing haem. Importantly, co-incubation of oxyhaemoglobin with pyocyanin facilitates haem pickup from the resulting methemoglobin by the P. gingivalis HmuY haemophore. Mice intra-tracheally challenged with viable P. gingivalis cells plus pyocyanin displayed increased mortality compared to those administered P. gingivalis alone. Pyocyanin significantly elevated both methaemoglobin and total haem levels in homogenates of mouse lungs and increased the level of arginine-specific gingipain activity from mice inoculated with viable P. gingivalis cells plus pyocyanin compared with mice inoculated with P. gingivalis only. These findings indicate that pyocyanin, by promoting haem availability through methaemoglobin formation and stimulating of gingipain production, may contribute to virulence of P. gingivalis and disease severity when co-infecting with P. aeruginosa in the lung.	[Smalley, John W.] Univ Liverpool, Sch Dent, Liverpool L69 3BX, Merseyside, England; [Benedyk, Malgorzata; Glowczyk, Izabela; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland; [Byrne, Dominic P.] Univ Liverpool, Inst Integrat Biol, Dept Biochem & Cell Biol, Liverpool L69 3BX, Merseyside, England; [Olczak, Mariusz; Olczak, Teresa] Univ Wroclaw, Fac Biotechnol, Biochem Lab, PL-50138 Wroclaw, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA	University of Liverpool; Jagiellonian University; University of Liverpool; University of Wroclaw; University of Louisville	Smalley, JW (corresponding author), Univ Liverpool, Sch Dent, Liverpool L69 3BX, Merseyside, England.	josmall@liv.ac.uk	Potempa, Jan/AAA-6850-2021	Potempa, Jan/0000-0002-3600-7461	Wroclaw Research Center EIT+ under the project "Biotechnologies and Advanced Medical Technologies-BioMed" - European Regional Development Fund [POIG 01.01.02-02-003/08/ 00]; US NIH [DE 09761, DE 022597]; European Commission [FP7-HEALTH-2010-261460, FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-F3-2012-306029]; Foundation for Polish Science [DPS/424-329/10]; National Science Center Krakow, Poland [2011/01/B/NZ6/00268, 2012/04/A/NZ1/00051]; Polish Ministry of Science and Higher Education [137/7. PREU/ 2011/2]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022597, R01DE009761] Funding Source: NIH RePORTER	Wroclaw Research Center EIT+ under the project "Biotechnologies and Advanced Medical Technologies-BioMed" - European Regional Development Fund; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); National Science Center Krakow, Poland(National Science Centre, Poland); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	TO is grateful for grant support from the Wroclaw Research Center EIT+ under the project "Biotechnologies and Advanced Medical Technologies-BioMed" (POIG 01.01.02-02-003/08/00) financed by the European Regional Development Fund (Operational Program Innovative Economy, 1.1.2), www.eitplus.pl. JP acknowledges grant support from the following: the US NIH (DE 09761 and DE 022597), http://www.nih.gov/; the European Commission (FP7-HEALTH-2010-261460 "Gums & Joints", FP7-PEOPLE-2011-ITN-290246 "RAPID" and FP7-HEALTH-F3-2012- 306029 " TRIGGER"), http://ec.europa.eu/index; the Foundation for Polish Science (FNP, TEAM project DPS/424-329/10), http://www.fnp.org.pl; the National Science Center Krakow, Poland (2011/01/B/NZ6/00268 and 2012/04/A/NZ1/00051) http://www.ncn.gov.pl; and the Polish Ministry of Science and Higher Education (project 137/7. PREU/ 2011/2), http://www.nauka.gov.pl/home/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO A, 1992, INFECT IMMUN, V60, P712, DOI 10.1128/IAI.60.2.712-714.1992; Armstrong DS, 1997, AM J RESP CRIT CARE, V156, P1197, DOI 10.1164/ajrccm.156.4.96-11058; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; BROOK I, 1994, FEMS MICROBIOL REV, V13, P65, DOI 10.1016/0168-6445(94)90101-5; Byrne DP, 2013, MOL ORAL MICROBIOL, V28, P219, DOI 10.1111/omi.12018; Byrne DP, 2010, BIOCHEM J, V425, P257, DOI 10.1042/BJ20090343; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Cosgrove S, 2011, J BIOL CHEM, V286, P7692, DOI 10.1074/jbc.M110.183863; COX CD, 1986, INFECT IMMUN, V52, P263, DOI 10.1128/IAI.52.1.263-270.1986; CRUMPTON MJ, 1965, J MOL BIOL, V11, P722, DOI 10.1016/S0022-2836(65)80030-4; Deshpande RG, 1999, FEMS MICROBIOL LETT, V176, P387, DOI 10.1016/S0378-1097(99)00255-4; Dias IHK, 2008, INFECT IMMUN, V76, P317, DOI 10.1128/IAI.00618-07; Diaz PI, 2004, ORAL MICROBIOL IMMUN, V19, P88, DOI 10.1046/j.0902-0055.2003.00121.x; FINEGOLD SM, 1993, FEMS IMMUNOL MED MIC, V6, P77; Finnan S, 2004, J CLIN MICROBIOL, V42, P5783, DOI 10.1128/JCM.42.12.5783-5792.2004; Fothergill JL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-45; FUJITA K, 1988, INFECT IMMUN, V56, P1385, DOI 10.1128/IAI.56.5.1385-1387.1988; Graves DT, 2000, CURR OPIN INFECT DIS, V13, P227, DOI 10.1097/00001432-200006000-00005; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hart CA, 2002, BRIT MED BULL, V61, P81, DOI 10.1093/bmb/61.1.81; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; KANTHAKUMAR K, 1993, INFECT IMMUN, V61, P2848, DOI 10.1128/IAI.61.7.2848-2853.1993; KARUNAKARAN T, 1993, MICROB PATHOGENESIS, V15, P37, DOI 10.1006/mpat.1993.1055; KAWAHARA K, 1965, BIOCHEMISTRY-US, V4, P1203, DOI 10.1021/bi00883a001; KIMURA H, 1976, PHYSIOL CHEM PHYS M, V8, P101; KIMURA H, 1975, J BIOCHEM-TOKYO, V77, P909, DOI 10.1093/oxfordjournals.jbchem.a130814; Kolpen M, 2010, THORAX, V65, P57, DOI 10.1136/thx.2009.114512; KOSAKA H, 1979, BIOCHIM BIOPHYS ACTA, V581, P184, DOI 10.1016/0005-2795(79)90235-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Li N, 2010, MOL MICROBIOL, V76, P861, DOI 10.1111/j.1365-2958.2010.07123.x; Li Q, 2014, MICROBES INFECT, V16, P17, DOI 10.1016/j.micinf.2013.10.006; Lourbakos A, 1998, FEBS LETT, V435, P45, DOI 10.1016/S0014-5793(98)01036-9; MARSH PD, 1994, MICROBIOL-UK, V140, P861, DOI 10.1099/00221287-140-4-861; MARSH PD, 1988, FEMS MICROBIOL LETT, V55, P87, DOI 10.1016/0378-1097(88)90156-5; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; Mikolajczyk-Pawlinska J, 1998, FEBS LETT, V440, P282, DOI 10.1016/S0014-5793(98)01461-6; Minas T, 1991, MICROB ECOL HEALTH D, V4, P311; MINETTI M, 1993, ARCH BIOCHEM BIOPHYS, V302, P233, DOI 10.1006/abbi.1993.1205; MINHAS T, 1993, MICROBIOS, V76, P105; Moelants EAV, 2014, INFECT IMMUN, V82, P2511, DOI 10.1128/IAI.01624-14; Mydel P, 2006, PLOS PATHOG, V2, P712, DOI 10.1371/journal.ppat.0020076; NAKAYAMA K, 1994, J BACTERIOL, V176, P1939, DOI 10.1128/jb.176.7.1939-1943.1994; Nemec A, 2009, EXP LUNG RES, V35, P605, DOI 10.1080/01902140902783381; O'Malley YQ, 2003, AM J PHYSIOL-LUNG C, V284, pL420, DOI 10.1152/ajplung.00316.2002; Olczak T, 2008, ARCH MICROBIOL, V189, P197, DOI 10.1007/s00203-007-0309-7; Pan YP, 2009, MICROB PATHOGENESIS, V46, P73, DOI 10.1016/j.micpath.2008.10.012; Pandey AV, 1999, ANAL BIOCHEM, V268, P159, DOI 10.1006/abio.1998.2997; PIKE R, 1994, J BIOL CHEM, V269, P406; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Reszka KJ, 2004, FREE RADICAL BIO MED, V36, P1448, DOI 10.1016/j.freeradbiomed.2004.03.011; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Sabra W, 2002, MICROBIOL-SGM, V148, P3195, DOI 10.1099/00221287-148-10-3195; Scannapieco FA, 1999, J PERIODONTOL, V70, P793, DOI 10.1902/jop.1999.70.7.793; SCHMEKEL B, 1990, INFLAMMATION, V14, P447, DOI 10.1007/BF00914095; Schobert M, 2010, INT J MED MICROBIOL, V300, P549, DOI 10.1016/j.ijmm.2010.08.007; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Smalley JW, 2008, BIOL CHEM, V389, P1235, DOI 10.1515/BC.2008.140; Smalley JW, 2007, ARCH BIOCHEM BIOPHYS, V465, P44, DOI 10.1016/j.abb.2007.05.011; Smalley JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017182; SMALLEY JW, 1991, FEMS MICROBIOL LETT, V90, P63, DOI 10.1016/0378-1097(91)90647-S; Smalley JW, 2000, FEMS MICROBIOL LETT, V183, P159, DOI 10.1111/j.1574-6968.2000.tb08951.x; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; Smalley JW, 2003, MICROBIOL-SGM, V149, P1711, DOI 10.1099/mic.0.26258-0; Smalley JW, 2002, BIOCHEM J, V362, P239, DOI 10.1042/0264-6021:3620239; Smith L, 2006, J MED MICROBIOL, V55, P1641, DOI 10.1099/jmm.0.46845-0; Sugio S, 2000, EUR J BIOCHEM, V267, P3487, DOI 10.1046/j.1432-1327.2000.01373.x; Suzuki N, 2012, ANAEROBE, V18, P350, DOI 10.1016/j.anaerobe.2012.04.005; Tan L, 2014, J PERIODONTAL RES, V49, P760, DOI 10.1111/jre.12159; Tsuruga M, 1997, BIOCHIM BIOPHYS ACTA, V133, P96; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Ulrich M, 2010, THORAX, V65, P978, DOI 10.1136/thx.2010.137745; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; VASIL ML, 1982, J BACTERIOL, V152, P431; Voynow JA, 2008, INT J BIOCHEM CELL B, V40, P1238, DOI 10.1016/j.biocel.2008.03.003; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; WILSON R, 1987, J CLIN INVEST, V79, P221, DOI 10.1172/JCI112787; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988; WINTERBOURN CC, 1976, BIOCHEM J, V155, P493, DOI 10.1042/bj1550493; Wojtowicz H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000419; Wojtowicz H, 2009, BIOCHEM BIOPH RES CO, V383, P178, DOI 10.1016/j.bbrc.2009.03.148; Worlitzsch D, 2009, CLIN MICROBIOL INFEC, V15, P454, DOI 10.1111/j.1469-0691.2008.02659.x; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; ZHANG L, 1991, J BIOL CHEM, V266, P24698	96	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118319	10.1371/journal.pone.0118319	http://dx.doi.org/10.1371/journal.pone.0118319			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706529	Green Published, gold			2022-12-27	WOS:000350662100169
J	Busbee, PB; Nagarkatti, M; Nagarkatti, PS				Busbee, Philip B.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.			Natural Indoles, Indole-3-Carbinol (I3C) and 3,3 '-Diindolylmethane (DIM), Attenuate Staphylococcal Enterotoxin B-Mediated Liver Injury by Downregulating miR-31 Expression and Promoting Caspase-2-Mediated Apoptosis	PLOS ONE			English	Article							CANCER CELLS; INFLAMMATION; CONTRIBUTES; ACTIVATION; MECHANISMS; RESISTANCE; PATHWAYS; WARFARE; TARGETS; RICIN	Staphylococcal enterotoxin B (SEB) is a potent superantigen capable of inducing inflammation characterized by robust immune cell activation and proinflammatory cytokine release. Exposure to SEB can result in food poisoning as well as fatal conditions such as toxic shock syndrome. In the current study, we investigated the effect of natural indoles including indole- 3-carbinol (I3C) and 3,3'-diindolylmethane (DIM) on SEB-mediated liver injury. Injection of SEB into D-galactosamine-sensitized female C57BL/6 mice resulted in liver injury as indicated by an increase in enzyme aspartate transaminase (AST) levels, induction of inflammatory cytokines, and massive infiltration of immune cells into the liver. Administration of I3C and DIM (40mg/kg), by intraperitonal injection, attenuated SEB-induced acute liver injury, as evidenced by decrease in AST levels, inflammatory cytokines and cellular infiltration in the liver. I3C and DIM triggered apoptosis in SEB-activated T cells primarily through activation of the intrinsic mitochondrial pathway. In addition, inhibitor studies involving caspases revealed that I3C and DIM-mediated apoptosis in these activated cells was dependent on caspase-2 but independent of caspase-8, 9 and 3. In addition, I3C and DIM caused a decrease in Bcl-2 expression. Both compounds also down-regulated miR-31, which directly targets caspase-2 and influences apoptosis in SEB-activated cells. Our data demonstrate for the first time that indoles can effectively suppress acute hepatic inflammation caused by SEB and that this may be mediated by decreased expression of miR-31 and consequent caspase-2-dependent apoptosis in T cells.	[Busbee, Philip B.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Nagarkatti, Mitzi] WJB Dorn Vet Affairs Med Ctr, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Nagarkatti, PS (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	prakash@mailbox.sc.edu	Busbee, Philip/AAE-9840-2020	Busbee, Philip/0000-0002-7029-2403; Nagarkatti, Mitzi/0000-0002-5977-5615; Nagarkatti, Prakash/0000-0003-2663-0759	National Institutes of Health National Center for Complementary and Alternative Medicine [R01-AT006888, P01-AT003961]; National Institutes of Health National Institute of Environmental Health Sciences [R01-ES019313]; National Institutes of Health National Institute of Mental Health [R01-MH094755]; National Institutes of Health National Center for Research Resources [P20-GM103641]; VA Merit Award [1I01-BX001357]; National Center for Complementary & Integrative Health [R01AT006888, P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	National Institutes of Health National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine); National Institutes of Health National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Award(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded in part by the National Institutes of Health National Center for Complementary and Alternative Medicine [Grants R01-AT006888 and P01-AT003961]; the National Institutes of Health National Institute of Environmental Health Sciences [Grant R01-ES019313]; the National Institutes of Health National Institute of Mental Health [Grant R01-MH094755]; the National Institutes of Health National Center for Research Resources [Grant P20-GM103641]; and a VA Merit Award [1I01-BX001357]. The funding agencies had no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993; Ahmad A, 2010, CURR DRUG TARGETS, V11, P652, DOI 10.2174/138945010791170923; Assenmacher M, 1998, EUR J IMMUNOL, V28, P1534, DOI 10.1002/(SICI)1521-4141(199805)28:05<1534::AID-IMMU1534>3.0.CO;2-R; Auborn KJ, 2003, J NUTR, V133, P3610, DOI 10.1093/jn/133.11.3610; Baker MD, 2004, INT J MED MICROBIOL, V293, P529, DOI 10.1078/1438-4221-00298; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; Busbee PB, 2014, TOXICOL APPL PHARM, V274, P7, DOI 10.1016/j.taap.2013.10.022; Busbee PB, 2013, NUTR REV, V71, P353, DOI 10.1111/nure.12024; Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Dong Z, 2014, CANCER LETT, V343, P249, DOI 10.1016/j.canlet.2013.09.034; Exon JH, 2000, J TOXICOL ENV HEAL A, V59, P271, DOI 10.1080/009841000156934; Fava LL, 2012, J CELL SCI, V125, P5911, DOI 10.1242/jcs.115105; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hegde VL, 2013, J BIOL CHEM, V288, P36810, DOI 10.1074/jbc.M113.503037; Hegde VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018281; Heidemann SM, 2011, EXP LUNG RES, V37, P563, DOI 10.3109/01902148.2011.611963; Henghold WB, 2004, DERMATOL CLIN, V22, P257, DOI 10.1016/j.det.2004.03.004; Hwang IS, 2011, BIOL PHARM BULL, V34, P1602, DOI 10.1248/bpb.34.1602; Jiang J, 2013, FOOD CHEM TOXICOL, V57, P256, DOI 10.1016/j.fct.2013.03.040; Kim EJ, 2007, J NUTR, V137, P31, DOI 10.1093/jn/137.1.31; Kim HW, 2014, TOXICOL SCI, V137, P158, DOI 10.1093/toxsci/kft240; Kim YH, 2009, INFLAMM BOWEL DIS, V15, P1164, DOI 10.1002/ibd.20917; Korner C, 2013, J BIOL CHEM, V288, P8750, DOI 10.1074/jbc.M112.414128; Krakauer T, 2010, MIL MED, V175, P917, DOI 10.7205/MILMED-D-10-00148; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Ler SG, 2006, J CHROMATOGR A, V1133, P1, DOI 10.1016/j.chroma.2006.08.078; Lombard C, 2005, LEUKEMIA RES, V29, P915, DOI 10.1016/j.leukres.2005.01.014; Madsen JM, 2001, CLIN LAB MED, V21, P593; MARRACK P, 1990, SCIENCE, V248, P1066; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Mohan J, 2006, J BIOL CHEM, V281, P17599, DOI 10.1074/jbc.M602641200; Nagarkatti M, 2010, METHODS MOL BIOL, V598, P241, DOI 10.1007/978-1-60761-401-2_18; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Peter ME, 1998, CURR OPIN IMMUNOL, V10, P545, DOI 10.1016/S0952-7915(98)80222-7; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pinchuk IV, 2010, TOXINS, V2, P2177, DOI 10.3390/toxins2082177; Rahman KMW, 2005, CANCER RES, V65, P364; Rahman KW, 2004, NUTR CANCER, V48, P84, DOI 10.1207/s15327914nc4801_12; Rao R, 2014, INFECT IMMUN, V82, P2971, DOI 10.1128/IAI.01666-14; Reider SA, 2013, INFECT IMMUN, V79, P1305; Rouse M, 2013, BRIT J PHARMACOL, V169, P1305, DOI 10.1111/bph.12205; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Sung WS, 2007, BIOL PHARM BULL, V30, P1865, DOI 10.1248/bpb.30.1865; Swanton E, 1999, ONCOGENE, V18, P1781, DOI 10.1038/sj.onc.1202490; VanOosten RL, 2007, APOPTOSIS, V12, P561, DOI 10.1007/s10495-006-0009-9	48	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118506	10.1371/journal.pone.0118506	http://dx.doi.org/10.1371/journal.pone.0118506			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706292	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100187
J	Gatto, M; de Abreu, MM; Tasca, KI; Golim, MD; da Silva, LDM; Simao, JC; Fortaleza, CMCB; Soares, AMVD; Calvi, SA				Gatto, Mariana; de Abreu, Mariana Miziara; Tasca, Karen Ingrid; Golim, Marjorie de Assis; Mendes da Silva, Laura Denise; Simao, Jose Cludio; Castelo Branco Fortaleza, Carlos Magno; Victoriano de Campos Soares, Angela Maria; Calvi, Sueli Aparecida			The Involvement of TLR2 and TLR4 in Cytokine and Nitric Oxide Production in Visceral Leishmaniasis Patients before and after Treatment with Anti-Leishmanial Drugs	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; RESPONSE IN-VITRO; INTERFERON-GAMMA; DONOVANI INFECTION; CUTANEOUS LEISHMANIASIS; CHAGASI INFECTION; IMMUNE-RESPONSE	Toll-like receptors (TLRs) have significant involvement in Leishmania infection, although little is known about the relationship between these receptors, cytokines and nitric oxide (NO) in patients with visceral leishmaniasis (VL) before or after treatment with anti-leishmanial drugs. The goal of this study was to evaluate the expression of TLR2 and TLR4 in CD3(+) and CD14(+) cells and the production of TNF-alpha, IFN-gamma, IL-17, IL-10, TGF-beta and NO in peripheral blood mononuclear cells (PBMCs) from VL patients pre- and post-treatment with anti-leishmanial drugs. In addition, we investigated whether these receptors were involved in the production of these cytokines and NO. In the active VL patients, increased TLR2 and TLR4 expression in lymphocytes and monocytes, increased production of TNF-alpha, IL-10 and TGF-beta and decreased production of IFN-gamma, IL-17 and NO were observed. After treatment, TLR2 and TLR4 were still expressed in lymphocytes and monocytes, the TNF-alpha and IL-10 levels were lower, the production of IFN-gamma, IL-17 and NO was higher, and the TGF-beta level remained high. Before treatment, the production of TNF-alpha and NO was associated with TLR2 and TLR4 expression, while IL-10 production was only associated with TLR2 expression. After treatment, both receptors were associated with the production of TNF-alpha, IFN-gamma, IL-10 and NO, while the production of IL-17 was associated only with TLR4 expression. The results presented in this study suggest that both TLR2 and TLR4 participate in the modulation of cytokine and NO production in VL patients, contributing to the pathogenesis of VL prior to treatment and the protective immune response after treatment.	[Gatto, Mariana; de Abreu, Mariana Miziara; Tasca, Karen Ingrid; Mendes da Silva, Laura Denise; Castelo Branco Fortaleza, Carlos Magno; Calvi, Sueli Aparecida] UNESP, Botucatu Sch Med, Dept Trop Dis, Botucatu, SP, Brazil; [Golim, Marjorie de Assis] UNESP, Botucatu Sch Med, Hemocenter, Flow Cytometry Lab, Botucatu, SP, Brazil; [Simao, Jose Cludio] State Hosp Bauru, Ward Infect Dis, Bauru, SP, Brazil; [Victoriano de Campos Soares, Angela Maria] UNESP, Biosci Inst, Dept Microbiol & Immunol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Gatto, M (corresponding author), UNESP, Botucatu Sch Med, Dept Trop Dis, Botucatu, SP, Brazil.	marianagatto11@hotmail.com	Tasca, Karen Ingrid/L-5062-2014; Fortaleza, Carlos Magno C. B./C-3807-2013; Simão, José Cláudio/ACJ-9666-2022; Gatto, Mariana/M-4755-2018	Tasca, Karen Ingrid/0000-0002-3664-3978; Fortaleza, Carlos Magno C. B./0000-0003-4120-1258; Simão, José Cláudio/0000-0002-3864-5264; Gatto, Mariana/0000-0002-3115-0795; de Assis Golim, Marjorie/0000-0002-4824-9441	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/13922-5, 2012/16289-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (www.fapesp.br); Scholarship: 2010/13922-5; Funding research: 2012/16289-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, ARTHRITIS RHEUM, V58, P3753, DOI 10.1002/art.24127; Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Amato VS, 2007, AM J TROP MED HYG, V77, P266, DOI 10.4269/ajtmh.2007.77.266; Costa ASA, 2012, MEM I OSWALDO CRUZ, V107, P735, DOI 10.1590/S0074-02762012000600005; Ansari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017; Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515; Bacellar O, 2009, J INFECT DIS, V200, P75, DOI 10.1086/599380; BARRAL A, 1993, P NATL ACAD SCI USA, V90, P3442, DOI 10.1073/pnas.90.8.3442; BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Berman JD, 1997, CLIN INFECT DIS, V24, P684, DOI 10.1093/clind/24.4.684; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0; BOGDAN C, 1993, ANN NY ACAD SCI, V685, P713, DOI 10.1111/j.1749-6632.1993.tb35934.x; BOUTARD V, 1995, J IMMUNOL, V155, P2077; de Oliveira LRC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088572; Chandra D, 2008, CLIN EXP IMMUNOL, V154, P224, DOI 10.1111/j.1365-2249.2008.03741.x; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; Das S, 2012, J ANTIMICROB CHEMOTH, V67, P2373, DOI 10.1093/jac/dks220; Das S, 2012, IMMUNOL CELL BIOL, V90, P640, DOI 10.1038/icb.2011.80; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Desjeux P, 1999, CLIN DERMATOL, V17, P317, DOI 10.1016/S0738-081X(99)00050-4; Duthie MS, 2014, EUR J CLIN MICROBIOL, V33, P639, DOI 10.1007/s10096-013-1999-1; Engwerda CR, 2004, AM J PATHOL, V165, P2123, DOI 10.1016/S0002-9440(10)63262-2; Flandin JF, 2006, EUR J IMMUNOL, V36, P411, DOI 10.1002/eji.200535079; Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461; GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570; Ghosh K, 2013, J INFECT DIS, V207, P1016, DOI 10.1093/infdis/jis771; Cezario GAG, 2011, MEM I OSWALDO CRUZ, V106, P573, DOI 10.1590/S0074-02762011000500010; Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; HOLADAY BJ, 1993, J CLIN INVEST, V92, P2626, DOI 10.1172/JCI116878; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Kavoosi G, 2009, PARASITOLOGY, V136, P1193, DOI 10.1017/S0031182009990473; Khalil EAG, 2005, CLIN EXP IMMUNOL, V140, P349, DOI 10.1111/j.1365-2249.2005.02768.x; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Kropf P, 2004, INFECT IMMUN, V72, P1920, DOI 10.1128/IAI.72.4.1920-1928.2004; Kropf P, 2004, J LEUKOCYTE BIOL, V76, P48, DOI 10.1189/jlb.1003484; Kumar R, 2001, CLIN EXP IMMUNOL, V124, P262, DOI 10.1046/j.1365-2249.2001.01551.x; Lachaud L, 2009, CLIN INFECT DIS, V48, pE16, DOI 10.1086/595710; Lapara NJ, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-8; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Guedes PMM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001630; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; Medeiros IM, 2000, CLIN MICROBIOL INFEC, V6, P34, DOI 10.1046/j.1469-0691.2000.00011.x; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Ministerio da Saude, 2005, GUIA VIG EP A, DOI [10.1016/j.smrv.2014.10.006, DOI 10.1016/J.SMRV.2014.10.006]; Ministerio da Saude, 2006, LEISHM VISC GRAV NOR, DOI [10.1016/j.scitotenv.2014.10.047, DOI 10.1016/J.SCITOTENV.2014.10.047]; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mukherjee AK, 2012, INT IMMUNOPHARMACOL, V12, P565, DOI 10.1016/j.intimp.2012.02.002; Murray HW, 2013, INFECT IMMUN, V81, P2318, DOI 10.1128/IAI.01468-12; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Nascimento MS, 2014, IL 17 ACTS SYNERGIST; Nylen S, 2003, CLIN EXP IMMUNOL, V131, P457, DOI 10.1046/j.1365-2249.2003.02096.x; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; Packiam M, 2012, MUCOSAL IMMUNOL, V5, P19, DOI 10.1038/mi.2011.38; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Paul J, 2012, EUR J IMMUNOL, V42, P2087, DOI 10.1002/eji.201242428; Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Prabha C, 2008, IMMUNOL LETT, V117, P26, DOI 10.1016/j.imlet.2007.11.002; Ray M, 2000, J INFECT DIS, V181, P1121, DOI 10.1086/315330; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020; ROACH TIA, 1991, INFECT IMMUN, V59, P3935, DOI 10.1128/IAI.59.11.3935-3944.1991; Rodrigues OR, 2009, IMMUNOBIOLOGY, V214, P101, DOI 10.1016/j.imbio.2008.07.001; Saran M, 1999, FREE RADICAL BIO MED, V26, P482, DOI 10.1016/S0891-5849(98)00187-7; Singh S, 2006, INDIAN J MED RES, V123, P311; STENGER S, 1994, J EXP MED, V180, P783, DOI 10.1084/jem.180.3.783; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P327, DOI 10.1111/j.1348-0421.2003.tb03404.x; Taylor AP, 1997, J EXP MED, V185, P1231, DOI 10.1084/jem.185.7.1231; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x; TUMANG MCT, 1994, J IMMUNOL, V153, P768; Tuon FF, 2008, INFECT IMMUN, V76, P866, DOI 10.1128/IAI.01090-07; *UNICEF UNDP WORLD, SPEC PROGR RES TRAIN; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; Wang JP, 2010, APMIS, V118, P261, DOI 10.1111/j.1600-0463.2010.02586.x; Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9; Wilhelm P, 2001, J IMMUNOL, V166, P4012, DOI 10.4049/jimmunol.166.6.4012; WU JY, 1993, J IMMUNOL, V151, P4325; Zarnbrano-Villa S, 2002, TRENDS PARASITOL, V18, P272, DOI 10.1016/S1471-4922(02)02289-4; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; ZIJLSTRA EE, 1995, J INFECT DIS, V171, P498, DOI 10.1093/infdis/171.2.498	88	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117977	10.1371/journal.pone.0117977	http://dx.doi.org/10.1371/journal.pone.0117977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706930	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100133
J	Karim, MR; Dong, HJ; Li, TY; Yu, FC; Li, DZ; Zhang, LX; Li, JQ; Wang, RJ; Li, SY; Li, XF; Rume, FI; Ning, CS				Karim, Md Robiul; Dong, Haiju; Li, Tongyi; Yu, Fuchang; Li, Dezhong; Zhang, Longxian; Li, Junqiang; Wang, Rongjun; Li, Shouyi; Li, Xiaofeng; Rume, Farzana Islam; Ning, Changshen			Predomination and New Genotypes of Enterocytozoon bieneusi in Captive Nonhuman Primates in Zoos in China: High Genetic Diversity and Zoonotic Significance	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GIARDIA-DUODENALIS; HOST-SPECIFICITY; MICROSPORIDIA; PREVALENCE; SEQUENCE; ANIMALS; SWINE; CATS	To appreciate the genetic diversity and zoonotic implications of Enterocytozoon bieneusi in nonhuman primates (NHPs) in zoos, we genotyped E. bieneusi in captive NHPs in seven zoos located at six major cities in China, using ribosomal internal transcribed spacer (ITS)based PCR and sequence analyses. A total of 496 fecal specimens from 36 NHP species under nine families were analyzed and E. bieneusi was detected in 148 (29.8%) specimens of 25 NHP species from six families, including Cercopithecidae (28.7%), Cebidae (38.0%), Aotidae (75.0%), Lemuridae (26.0%), Hylobatidae (50.0%) and Hominidae (16.2%) (P = 0.0605). The infection rates were 29.0%, 15.2%, 18.2%, 37.3%, 29.2%, 37.7% and 44.8% in Shijiazhuang Zoo, Wuhan Zoo, Taiyuan Zoo, Changsha Wild Animal Zoo, Beijing Zoo, Shanghai Zoo and Shanghai Wild Animal Park, respectively (P = 0.0146). A total of 25 ITS genotypes were found: 14 known (D, O, EbpC, EbpA, Type IV, Henan-IV, BEB6, BEB4, Peru8, PigEBITS5, EbpD, CM1, CM4 and CS-1) and 11 new (CM8 to CM18). Genotype D was the most prevalent one (40/148), followed by CM4 (20/148), CM1 (15/148), O (13/148), CM16 (13/148), EbpC (11/148). Of them, genotypes D, EbpC, CM4 and O were widely distributed in NHPs (seen in 9 to 12 species) whereas genotypes CM1 and CM16 were restricted to one to three NHP species. In phylogenetic analysis, 20 genotypes (121/148, 81.8%), excluding genotypes BEB4, BEB6, CM9, CM4 and CM18, belonged to group 1 with zoonotic potential. New genotype CM9 clustered in group 2 with BEB4 and BEB6. The remaining two genotypes CM4 and CM18 formed new cluster (group 9) in between two other genotypic clusters found in primates. The findings of high diversity in E. bieneusi genotypes and their zoonotic potentiality concluded the importance of captive NHPs as reservoir hosts for human microsporidiosis.	[Karim, Md Robiul; Dong, Haiju; Yu, Fuchang; Zhang, Longxian; Li, Junqiang; Wang, Rongjun; Li, Shouyi; Li, Xiaofeng; Ning, Changshen] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou 450002, Peoples R China; [Li, Tongyi; Li, Dezhong] Zhengzhou Zoo, Zhengzhou 45000, Peoples R China; [Rume, Farzana Islam] Patuakhali Sci & Technol Univ, Dept Microbiol, Patuakhali 8602, Bangladesh	Henan Agricultural University	Zhang, LX (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou 450002, Peoples R China.	zhanglx8999@gmail.com	Li, Junqiang/AAG-2200-2020; Zhang, Longxian/I-9223-2019; Zhang, Longxian/HGE-1918-2022; Yu, Fuchang/T-3390-2017; Zhang, Longxian/R-7799-2019; Yu, Fuchang/ABF-4800-2021	Zhang, Longxian/0000-0002-5706-131X; Yu, Fuchang/0000-0003-0031-1549; Yu, Fuchang/0000-0003-0031-1549; Karim, Md Robiul/0000-0002-0712-5573	Innovation Scientists and Technicians Troop Construction Projects of Henan Province [134200510012]; State Key Program of National Natural Science Foundation of China [31330079]; Key National Science and Technology Specific Projects [2012ZX10004220]; Program for Science and Technology Innovative Research Team in University of Henan Province [012IRTSTHN005]	Innovation Scientists and Technicians Troop Construction Projects of Henan Province; State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National Science and Technology Specific Projects; Program for Science and Technology Innovative Research Team in University of Henan Province	This study was supported in part by Innovation Scientists and Technicians Troop Construction Projects of Henan Province (134200510012, http://www.hnkjt.gov.cn/new/index.eiip), the State Key Program of National Natural Science Foundation of China (No. 31330079, http://npd.nsfc.gov.cn/), the Key National Science and Technology Specific Projects (No. 2012ZX10004220, http://www.nmp.gov.cn/), the Program for Science and Technology Innovative Research Team in University of Henan Province (012IRTSTHN005, http://est.haedu.gov.cn/Article/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbo FO, 2012, AM J TROP MED HYG, V86, P441, DOI 10.4269/ajtmh.2012.11-0548; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Ghosh Kaya, 2009, Interdiscip Perspect Infect Dis, V2009, P926521, DOI 10.1155/2009/926521; Guo YQ, 2014, APPL ENVIRON MICROB, V80, P218, DOI 10.1128/AEM.02997-13; Henriques-Gil N, 2010, APPL ENVIRON MICROB, V76, P3333, DOI 10.1128/AEM.03026-09; Karim MR, 2014, J CLIN MICROBIOL, V52, P3297, DOI 10.1128/JCM.01352-14; Karim MR, 2014, PARASITOL RES, V113, P3041, DOI 10.1007/s00436-014-3967-9; Karim MR, 2014, APPL ENVIRON MICROB, V80, P1893, DOI 10.1128/AEM.03845-13; Karim MR, 2014, VET PARASITOL, V200, P13, DOI 10.1016/j.vetpar.2013.12.004; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097623; Li W, 2014, PARASITOL RES, V113, P1147, DOI 10.1007/s00436-014-3752-9; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Lores B, 2002, MEM I OSWALDO CRUZ, V97, P941, DOI 10.1590/S0074-02762002000700003; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Mori H, 2013, VET PARASITOL, V197, P696, DOI 10.1016/j.vetpar.2013.07.025; Mori H, 2013, PARASITE, V20, DOI 10.1051/parasite/2013014; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Santin M, 2010, J PARASITOL, V96, P157, DOI 10.1645/GE-2184.1; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Wagnerova P, 2012, VET PARASITOL, V190, P573, DOI 10.1016/j.vetpar.2012.07.013; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Ye JB, 2014, PARASITOL INT, V63, P132, DOI 10.1016/j.parint.2013.10.007; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhang X, 2011, J CLIN MICROBIOL, V49, P2006, DOI 10.1128/JCM.00372-11; Zhao W, 2014, APPL ENVIRON MICROB, V80, P3699, DOI 10.1128/AEM.00807-14	31	93	96	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117991	10.1371/journal.pone.0117991	http://dx.doi.org/10.1371/journal.pone.0117991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705879	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100135
J	Kim, MS; Horst, A; Blinka, S; Stamm, K; Mahnke, D; Schuman, J; Gundry, R; Tomita-Mitchell, A; Lough, J				Kim, Min-Su; Horst, Audrey; Blinka, Steven; Stamm, Karl; Mahnke, Donna; Schuman, James; Gundry, Rebekah; Tomita-Mitchell, Aoy; Lough, John			Activin-A and Bmp4 Levels Modulate Cell Type Specification during CHIR-Induced Cardiomyogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PROMOTES CARDIAC DIFFERENTIATION; PRIMITIVE STREAK FORMATION; DEFINITIVE ENDODERM; WNT/BETA-CATENIN; CARDIOMYOCYTE DIFFERENTIATION; SMALL-MOLECULE; MOUSE; PROGENITORS; POPULATION	The use of human pluripotent cell progeny for cardiac disease modeling, drug testing and therapeutics requires the ability to efficiently induce pluripotent cells into the cardiomyo-genic lineage. Although direct activation of the Activin-A and/or Bmp pathways with growth factors yields context-dependent success, recent studies have shown that induction of Wnt signaling using low molecular weight molecules such as CHIR, which in turn induces the Activin-A and Bmp pathways, is widely effective. To further enhance the reproducibility of CHIR-induced cardiomyogenesis, and to ultimately promote myocyte maturation, we are using exogenous growth factors to optimize cardiomyogenic signaling downstream of CHIR induction. As indicated by RNA-seq, induction with CHIR during Day 1 (Days 0-1) was followed by immediate expression of Nodal ligands and receptors, followed later by Bmp ligands and receptors. Co-induction with CHIR and high levels of the Nodal mimetic ActivinA (50-100 ng/ml) during Day 0-1 efficiently induced definitive endoderm, whereas CHIR supplemented with Activin-A at low levels (10 ng/ml) consistently improved cardiomyogenic efficiency, even when CHIR alone was ineffective. Moreover, co-induction using CHIR and low levels of Activin-A apparently increased the rate of cardiomyogenesis, as indicated by the initial appearance of rhythmically beating cells by Day 6 instead of Day 8. By contrast, co-induction with CHIR plus low levels (3-10 ng/ml) of Bmp4 during Day 0-1 consistently and strongly inhibited cardiomyogenesis. These findings, which demonstrate that cardiomyogenic efficacy is improved by optimizing levels of CHIR-induced growth factors when applied in accord with their sequence of endogenous expression, are consistent with the idea that Nodal (Activin-A) levels toggle the entry of cells into the endodermal or mesodermal lineages, while Bmp levels regulate subsequent allocation into mesodermal cell types.	[Kim, Min-Su; Horst, Audrey; Blinka, Steven; Schuman, James; Lough, John] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Stamm, Karl; Mahnke, Donna; Tomita-Mitchell, Aoy] Med Coll Wisconsin, Dept Surg, Div Cardiothorac Surg, Milwaukee, WI 53226 USA; [Gundry, Rebekah] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Tomita-Mitchell, Aoy; Lough, John] Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Lough, J (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	jlough@mcw.edu	Gundry, Rebekah/K-6080-2019	Stamm, Karl/0000-0002-7844-7326; Blinka, Steven/0000-0002-0776-5677; Gundry, Rebekah L./0000-0002-9263-833X	National Institutes of Health Heart Lung and Blood Institute [089471]; Wolfe Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL094708] Funding Source: NIH RePORTER	National Institutes of Health Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wolfe Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health Heart Lung and Blood Institute Grant #089471 (JWL), Wolfe Family Foundation (ATM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041627; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Lough J, 2000, DEV DYNAM, V217, P327, DOI 10.1002/(SICI)1097-0177(200004)217:4<327::AID-DVDY1>3.3.CO;2-B; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Minami I, 2012, CELL REP, V2, P1448, DOI 10.1016/j.celrep.2012.09.015; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Puceat M, 2008, METHODS, V45, P168, DOI 10.1016/j.ymeth.2008.03.003; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Rivera-Perez JA, 2005, DEV BIOL, V288, P363, DOI 10.1016/j.ydbio.2005.09.012; Rudy-Reil D, 2004, CIRC RES, V94, pE107, DOI 10.1161/01.RES.0000134852.12783.6e; Sepac A, 2010, ANESTHESIOLOGY, V113, P906, DOI 10.1097/ALN.0b013e3181eff6b7; Si-Tayeb K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-81; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Van Orman JR, 2012, STEM CELLS DEV, V21, P987, DOI 10.1089/scd.2011.0161; Wang INE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038328; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yamauchi K, 2010, GENES CELLS, V15, P1216, DOI 10.1111/j.1365-2443.2010.01455.x; Yang C, 2014, CHEMMEDCHEM, V9, P537, DOI 10.1002/cmdc.201300478; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zhang JH, 2012, CIRC RES, V111, P1125, DOI 10.1161/CIRCRESAHA.112.273144; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	41	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118670	10.1371/journal.pone.0118670	http://dx.doi.org/10.1371/journal.pone.0118670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706534	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100199
J	Kratz, JE; Strasser, C				Kratz, John Ernest; Strasser, Carly			Researcher Perspectives on Publication and Peer Review of Data	PLOS ONE			English	Article							ATTITUDES	Data "publication" seeks to appropriate the prestige of authorship in the peer-reviewed literature to reward researchers who create useful and well-documented datasets. The scholarly communication community has embraced data publication as an incentive to document and share data. But, numerous new and ongoing experiments in implementation have not yet resolved what a data publication should be, when data should be peer-reviewed, or how data peer review should work. While researchers have been surveyed extensively regarding data management and sharing, their perceptions and expectations of data publication are largely unknown. To bring this important yet neglected perspective into the conversation, we surveyed similar to 250 researchers across the sciences and social sciences-asking what expectations"data publication" raises and what features would be useful to evaluate the trustworthiness, evaluate the impact, and enhance the prestige of a data publication. We found that researcher expectations of data publication center on availability, generally through an open database or repository. Few respondents expected published data to be peer-reviewed, but peer-reviewed data enjoyed much greater trust and prestige. The importance of adequate metadata was acknowledged, in that almost all respondents expected data peer review to include evaluation of the data's documentation. Formal citation in the reference list was affirmed by most respondents as the proper way to credit dataset creators. Citation count was viewed as the most useful measure of impact, but download count was seen as nearly as valuable. These results offer practical guidance for data publishers seeking to meet researcher expectations and enhance the value of published data.				John.Kratz@ucop.edu		Strasser, Carly/0000-0001-9592-2339; Kratz, John/0000-0002-9610-5370	Council on Library and Information Resources/Digital Library Foundation - California Digital Library; Alfred P. Sloan Foundation	Council on Library and Information Resources/Digital Library Foundation - California Digital Library; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	JK is supported by a Council on Library and Information Resources/Digital Library Foundation Postdoctoral Fellowship in Data Curation for the Sciences and Social Sciences (http://www.clir.org/ fellowships/postdoc/info/dc-science) funded by the California Digital Library (http://www.cdlib.org/) and the Alfred P. Sloan Foundation (http://www.sloan.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Allan R, 2014, GEOSCI DATA J, V1, P1, DOI 10.1002/gdj3.3; Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; [Anonymous], 2003, FINAL NIH STATEMENT; [Anonymous], 2011, 111 NSF, P11; Atici L, 2013, J ARCHAEOL METHOD TH, V20, P663, DOI 10.1007/s10816-012-9132-9; Aydinoglu AU, 2014, ASTROBIOLOGY, V14, P451, DOI 10.1089/ast.2013.1127; Blankman D, 2003, ECOLOGICAL METADATA; Bobrow M, 2014, TECHNICAL REPORT; Borenstein M., 2009, INTRO METAANALYSIS; Callaghan S., 2012, INT J DIGIT CURATION, V7, P107, DOI [10.2218/ijdc.v7i1.218, DOI 10.2218/IJDC.V7I1.218]; Callaghan S, 2013, INT J DIGITAL CURATI, V8, P193, DOI [10.2218/ijdc.v8i1.253, DOI 10.2218/IJDC.V8I1.253]; CECI SJ, 1988, SCI TECHNOL HUM VAL, V13, P45, DOI 10.1177/0162243988013001-206; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Costello MJ, 2009, BIOSCIENCE, V59, P418, DOI 10.1525/bio.2009.59.5.9; Cramr H, 1999, MATH METHODS STAT, V9; Drew BT, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001636; Editors, 2013, THE ECONOMIST; Enke N, 2012, ECOL INFORM, V11, P25, DOI 10.1016/j.ecoinf.2012.03.004; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FORCE11 Data Citation Synthesis Group, 2014, JOINT DECL DAT CIT P; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Harley D, 2010, TECHNICAL REPORT; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kansa EC, 2013, J EAST MEDITERR ARCH, V1, P88; Kim Y., 2012, J COMPUTATIONAL SCI, V3, P47, DOI DOI 10.22369/ISSN.2153-4136/3/1/6; Kratz J, 2014, DATA PUBLICATION CON; Kratz J, 2014, RES PERSPECTIVES PUB; Lawrence B., 2011, INT J DIGITAL CURATI, V6, P4, DOI DOI 10.2218/IJDC.V6I2.205; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; Mobley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063221; Mooney H, 2012, J LIBRARIANSHIP SCHO, V1, DOI [10.7710/2162-3309.1035, DOI 10.7710/2162-3309.1035]; Mooney H, 2011, LEARN PUBL, V24, P99, DOI 10.1087/20110204; Newman P, 2009, INT J ROBOT RES, V28, P587, DOI 10.1177/0278364909104283; Obama B, 2013, MAKING OPEN MACHINE; Parsons MA., 2010, EOS T AM GEOPHYS UN, V91, P297, DOI [10.1029/2010EO340001, DOI 10.1029/2010E0340001, DOI 10.1029/2010EO340001]; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Scaramozzino JM, 2012, COLL RES LIBR, V73, P349, DOI 10.5860/crl-255; Sieber PJE, 1995, SCI ENG ETHICS, V1, P11, DOI [10.1007/BF02628694, DOI 10.1007/BF02628694]; Stewart G, 2010, BIOL LETTERS, V6, P78, DOI 10.1098/rsbl.2009.0546; Strasser C, 2014, DATAUP TOOL HELP RES; Swan A, 2008, TECHNICAL REPORT; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Weaver R, 2012, DATA ACCEPTANCE PLAN; Westra B, 2010, DATA SERVICES SCI NE; Zimmer C, 2012, NY TIMES	53	36	38	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117619	10.1371/journal.pone.0117619	http://dx.doi.org/10.1371/journal.pone.0117619			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706992	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100104
J	Mendoza, JP; Wielhouwer, JL				Mendoza, Juan P.; Wielhouwer, Jacco L.			Only the Carrot, Not the Stick: Incorporating Trust into the Enforcement of Regulation	PLOS ONE			English	Article							TAX COMPLIANCE GAME; ORGANIZATIONAL TRUST; INTERPERSONAL-TRUST; INTEGRATIVE MODEL; FOLK THEOREM; INFORMATION; REPUTATION; EVASION; RECIPROCITY; PUNISHMENT	New enforcement strategies allow agents to gain the regulator's trust and consequently face a lower audit probability. Prior research suggests that, in order to prevent lower compliance, a reduction in the audit probability (the "carrot") must be compensated with the introduction of a higher penalty for non- compliance (the "stick"). However, such carrot-and-stick strategies reflect neither the concept of trust nor the strategies observed in practice. In response to this, we definetrust-based regulation as a strategy that incorporates rules that allow trust to develop, and using a generic (non- cooperative) game of tax compliance, we examine whether trust-based regulation is feasible (i.e., whether, in equilibrium, a reduction in the audit probability, without ever increasing the penalty for non- compliance, does not lead to reduced compliance). The model shows that trust-based regulation is feasible when the agent sufficiently values the future. In line with the concept of trust, this strategy is feasible when the regulator is uncertain about the agent's intentions. Moreover, the model shows that (i) introducing higher penalties makes trust-based regulation less feasible, and (ii) combining trust and forgiveness can lead to a lower audit probability for both trusted and distrusted agents. Policy recommendations often point toward increasing deterrence. This model shows that the opposite can be optimal.	[Mendoza, Juan P.; Wielhouwer, Jacco L.] Vrije Univ Amsterdam, Accounting Dept, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Mendoza, JP (corresponding author), Vrije Univ Amsterdam, Accounting Dept, Amsterdam, Netherlands.	j.mendozarodriguez@vu.nl		Wielhouwer, Jacco/0000-0002-0509-0602; Mendoza, Juan P./0000-0002-4666-924X				ALLINGHAM M. G., 1972, J PUBLIC ECON, V1, P323, DOI 10.1016/0047-2727(72)90010-2; Alm J, 2004, J ECON BEHAV ORGAN, V54, P297, DOI 10.1016/j.jebo.2003.02.003; Andreoni J, 1998, J ECON LIT, V36, P818; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bernasconi M, 1998, J PUBLIC ECON, V67, P123, DOI 10.1016/S0047-2727(97)00051-0; CAMERER C, 1988, ECONOMETRICA, V56, P1, DOI 10.2307/1911840; Castelfranchi C., 2008, INT REV EC, V55, P45, DOI [DOI 10.1007/S12232-008-0041-X, 10.1007/s12232-008-0041-x]; Chang LJ, 2010, COGNITIVE PSYCHOL, V61, P87, DOI 10.1016/j.cogpsych.2010.03.001; Cherney A., 1997, CURRENT ISSUES CRIMI, V9, P71; Clark J, 2004, ECON INQ, V42, P69, DOI 10.1093/ei/cbh045; Cox JC, 2004, GAME ECON BEHAV, V46, P260, DOI 10.1016/S0899-8256(03)00119-2; CRASWELL R, 1993, J LAW ECON, V36, P487, DOI 10.1086/467285; Crocker KJ, 2005, J PUBLIC ECON, V89, P1593, DOI 10.1016/j.jpubeco.2004.08.003; ERARD B, 1994, RAND J ECON, V25, P1, DOI 10.2307/2555850; Feld L.P., 2002, ECON GOV, V3, P87, DOI [10.1007/s101010100032, DOI 10.1007/S101010100032]; Friesen L, 2003, J ENVIRON ECON MANAG, V46, P72, DOI 10.1016/S0095-0696(02)00033-5; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; FUDENBERG D, 1994, ECONOMETRICA, V62, P997, DOI 10.2307/2951505; Graetz M.J., 1986, J LAW ECON ORGAN, V2, P1; GREENBERG J, 1984, J ECON THEORY, V32, P1, DOI 10.1016/0022-0531(84)90071-1; HARRINGTON W, 1988, J PUBLIC ECON, V37, P29, DOI 10.1016/0047-2727(88)90003-5; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kirchler E., 2007, EC PSYCHOL TAX BEHAV; Kramer RM, 1999, ANNU REV PSYCHOL, V50, P569, DOI 10.1146/annurev.psych.50.1.569; KREPS DM, 1982, J ECON THEORY, V27, P253, DOI 10.1016/0022-0531(82)90030-8; Kreps DM, 1995, PERSPECTIVES POSITIV, P90; LANDSBERGER M, 1982, J PUBLIC ECON, V19, P333, DOI 10.1016/0047-2727(82)90060-3; Lange B, 2010, SCI TOTAL ENVIRON, V408, P5235, DOI 10.1016/j.scitotenv.2010.07.052; Lewicki RJ, 2006, J MANAGE, V32, P991, DOI 10.1177/0149206306294405; MAYER RC, 1995, ACAD MANAGE REV, V20, P709, DOI 10.2307/258792; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; OECD, 2009, FOR TAX ADM COMPL MA; OECD, 2013, COOP COMPL FRAM; OEM, 2009, DEB PLAN BUS REG; Ostrom E., 2003, TRUST RECIPROCITY IN; Polinsky AM, 2000, J ECON LIT, V38, P45, DOI 10.1257/jel.38.1.45; RADNER R, 1985, ECONOMETRICA, V53, P1173, DOI 10.2307/1911017; Raymond M, 1999, J PUBLIC ECON, V73, P289, DOI 10.1016/S0047-2727(98)00106-6; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Sandmo A, 2005, NATL TAX J, V58, P643, DOI 10.17310/ntj.2005.4.02; SANSING RC, 1993, ACCOUNT REV, V68, P874; Schoorman FD, 2007, ACAD MANAGE REV, V32, P344, DOI 10.5465/AMR.2007.24348410; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Srinivasan T. N., 1973, J PUBLIC ECON, V2, P339, DOI [10.1016/0047-2727(73)90024-8, DOI 10.1016/0047-2727(73)90024-8]; WEIGELT K, 1988, STRATEGIC MANAGE J, V9, P443, DOI 10.1002/smj.4250090505; WILLIAMSON OE, 1993, J LAW ECON, V36, P453, DOI 10.1086/467284; xBelastingdienst, 2008, DUTCH TAX CUST ADM B; Zaheer A, 1998, ORGAN SCI, V9, P141, DOI 10.1287/orsc.9.2.141	50	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117212	10.1371/journal.pone.0117212	http://dx.doi.org/10.1371/journal.pone.0117212			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25705898	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100065
J	Rachid, CTCC; Balieiro, FC; Fonseca, ES; Peixoto, RS; Chaer, GM; Tiedje, JM; Rosado, AS				Rachid, Caio T. C. C.; Balieiro, Fabiano C.; Fonseca, Eduardo S.; Peixoto, Raquel Silva; Chaer, Guilherme M.; Tiedje, James M.; Rosado, Alexandre S.			Intercropped Silviculture Systems, a Key to Achieving Soil Fungal Community Management in Eucalyptus Plantations	PLOS ONE			English	Article							MIXED-SPECIES PLANTATIONS; ECTOMYCORRHIZAL FUNGI; NITROGEN-FIXATION; ACACIA-MANGIUM; GROWTH; GLOBULUS; DIVERSITY; NUTRITION; RICHNESS; LITTER	Fungi are ubiquitous and important contributors to soil nutrient cycling, playing a vital role in C, N and P turnover, with many fungi having direct beneficial relationships with plants. However, the factors that modulate the soil fungal community are poorly understood. We studied the degree to which the composition of tree species affected the soil fungal community structure and diversity by pyrosequencing the 28S rRNA gene in soil DNA. We were also interested in whether intercropping (mixed plantation of two plant species) could be used to select fungal species. More than 50,000 high quality sequences were analyzed from three treatments: monoculture of Eucalyptus; monoculture of Acacia mangium; and a mixed plantation with both species sampled 2 and 3 years after planting. We found that the plant type had a major effect on the soil fungal community structure, with 75% of the sequences from the Eucalyptus soil belonging to Basidiomycota and 19% to Ascomycota, and the Acacia soil having a sequence distribution of 28% and 62%, respectively. The intercropping of Acacia mangium in a Eucalyptus plantation significantly increased the number of fungal genera and the diversity indices and introduced or increased the frequency of several genera that were not found in the monoculture cultivation samples. Our results suggest that management of soil fungi is possible by manipulating the composition of the plant community, and intercropped systems can be a means to achieve that.	[Rachid, Caio T. C. C.; Fonseca, Eduardo S.; Peixoto, Raquel Silva; Rosado, Alexandre S.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil; [Balieiro, Fabiano C.] EMBRAPA, Embrapa Solos, Rio De Janeiro, Brazil; [Chaer, Guilherme M.] EMBRAPA, Embrapa Agrobiol, Rio De Janeiro, Brazil; [Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Universidade Federal do Rio de Janeiro; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Michigan State University	Rachid, CTCC (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.	caiorachid@micro.ufrj.br; asrosado@micro.ufrj.br	Rosado, Alexandre Soares/G-1955-2012; Rachid, Caio TCC/J-5001-2016; Balieiro, Fabiano/AAQ-5915-2020; Peixoto, Raquel/V-2554-2019; Balieiro, Fabiano C/J-4390-2017; Chaer, Guilherme Montandon/B-1241-2013	Rosado, Alexandre Soares/0000-0001-5135-1394; Rachid, Caio TCC/0000-0003-3115-5702; Balieiro, Fabiano C/0000-0002-0229-6672; Chaer, Guilherme Montandon/0000-0003-0734-2866; Peixoto, Raquel/0000-0002-9536-3132	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp) [2010/16623-9]; DOE Great Lakes Bioenergy Research Center (DOE Office of Science BER ) [DE-FC02-07ER64494]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); DOE Great Lakes Bioenergy Research Center (DOE Office of Science BER )(United States Department of Energy (DOE))	This work received funding from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp, no 2010/16623-9), and the DOE Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAF, 2012, YB STAT ABRAF 2012 B; Akutse KS, 2013, FUNGAL ECOL, V6, P293, DOI 10.1016/j.funeco.2013.01.003; Balieiro FD, 2008, REV BRAS CIENC SOLO, V32, P1253, DOI 10.1590/S0100-06832008000300033; Binkley D, 2003, FOREST ECOL MANAG, V182, P93, DOI [10.1016/S0378-1127(03)00028-8, 10.1016/s0378-1127(03)00028-8]; Binkley D., 2004, IUFRO C 2004 AV P AV, P11; BIONDINI ME, 1985, VEGETATIO, V60, P25, DOI 10.1007/BF00053909; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Bristow M, 2006, FOREST ECOL MANAG, V233, P285, DOI 10.1016/j.foreco.2006.05.019; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Chifflot V, 2009, AGR ECOSYST ENVIRON, V131, P32, DOI 10.1016/j.agee.2008.11.010; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; CUBETA MA, 1991, PHYTOPATHOLOGY, V81, P1395, DOI 10.1094/Phyto-81-1395; da Silva EV, 2009, PLANT SOIL, V325, P305, DOI 10.1007/s11104-009-9980-6; Diagne N, 2013, SOIL BIOL BIOCHEM, V57, P468, DOI 10.1016/j.soilbio.2012.08.030; Ducousso M., 2012, INT J FOR RES, V2012, P450715, DOI DOI 10.1155/2012/450715; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Duponnois R, 2005, FOREST ECOL MANAG, V207, P351, DOI 10.1016/j.foreco.2004.10.060; Ford E.D., 1984, NUTR PLANTATION FORE, P17; Forrester DI, 2007, TREE PHYSIOL, V27, P1319, DOI 10.1093/treephys/27.9.1319; Forrester DI, 2006, FOREST ECOL MANAG, V233, P211, DOI 10.1016/j.foreco.2006.05.012; Forrester DI, 2010, FOREST ECOL MANAG, V259, P1761, DOI 10.1016/j.foreco.2009.07.036; Forrester DI, 2005, CAN J FOREST RES, V35, P2942, DOI 10.1139/X05-214; Forrester DI, 2005, FOREST ECOL MANAG, V209, P147, DOI 10.1016/j.foreco.2005.01.012; Franco AA, 1997, SOIL BIOL BIOCHEM, V29, P897, DOI 10.1016/S0038-0717(96)00229-5; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hinchee M, 2009, IN VITRO CELL DEV-PL, V45, P619, DOI 10.1007/s11627-009-9235-5; Khanna PK, 1997, FOREST ECOL MANAG, V94, P105, DOI 10.1016/S0378-1127(96)03971-0; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Laclau JP, 2008, FOREST ECOL MANAG, V255, P3905, DOI 10.1016/j.foreco.2007.10.049; Li YF, 2009, PLANT SOIL, V315, P285, DOI 10.1007/s11104-008-9751-9; Liu Hua, 2010, Journal of Sustainable Development, V3, P197; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mather P. M., 1976, COMPUTATIONAL METHOD; Parrotta JA, 1999, RESTOR ECOL, V7, P103, DOI 10.1046/j.1526-100X.1999.72001.x; Plassard C, 2010, TREE PHYSIOL, V30, P1129, DOI 10.1093/treephys/tpq063; Prescott CE, 2013, FOREST ECOL MANAG, V309, P19, DOI 10.1016/j.foreco.2013.02.034; Rachid CTCC, 2013, SOIL BIOL BIOCHEM, V66, P146, DOI 10.1016/j.soilbio.2013.07.005; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Satter M. A., 2007, BANGLADESH J MICROBI, V24, P9; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Souza EL, 2013, BRAZILIAN J IN PRESS; STEFFEN R.B., 2010, CIENCIA NATURA, V32, P25, DOI DOI 10.1016/J.EJ0GRB.2014.09.037; Strauss SY, 2001, AUSTRAL ECOL, V26, P447, DOI 10.1046/j.1442-9993.2001.01136.x; Tedersoo L, 2014, MOL ECOL, V23, P992, DOI 10.1111/mec.12660; Tedersoo L, 2013, NEW PHYTOL, V199, P822, DOI 10.1111/nph.12328; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Voigtlaender M, 2012, PLANT SOIL, V352, P99, DOI 10.1007/s11104-011-0982-9; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xiang W, 2007, AUST J BOT, V55, P576, DOI 10.1071/BT06083; Gonzalez JAZ, 2009, REV BRAS CIENC SOLO, V33, P555, DOI 10.1590/S0100-06832009000300007	52	34	37	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118515	10.1371/journal.pone.0118515	http://dx.doi.org/10.1371/journal.pone.0118515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706388	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100188
J	Zhang, XT; Rosen, BD; Tang, HB; Krishnakumar, V; Town, CD				Zhang, Xingtan; Rosen, Benjamin D.; Tang, Haibao; Krishnakumar, Vivek; Town, Christopher D.			Polyribosomal RNA-Seq Reveals the Decreased Complexity and Diversity of the Arabidopsis Translatome	PLOS ONE			English	Article							GLUTATHIONE-TRANSFERASES; REFERENCE GENOME; MESSENGER-RNA; PLANTS; ALIGNMENT; CODONS	Recent RNA-seq studies reveal that the transcriptomes in animals and plants are more complex than previously thought, leading to the inclusion of many more splice isoforms in annotated genomes. However, it is possible that a significant proportion of the transcripts are spurious isoforms that do not contribute to functional proteins. One of the current hypotheses is that commonly used mRNA extraction methods isolate both pre-mature (nuclear) mRNA and mature (cytoplasmic) mRNA, and these incompletely spliced pre-mature mRNAs may contribute to a large proportion of these spurious transcripts. To investigate this, we compared a traditional RNA-seq dataset (total RNA-seq) and a ribosome-bound RNA-seq dataset (polyribosomal RNA-seq) from Arabidopsis thaliana. An integrative framework that combined de novo assembly and genome-guided assembly was applied to reconstruct transcriptomes for the two datasets. Up to 44.8% of the de novo assembled transcripts in total RNA-seq sample were of low abundance, whereas only 0.09% in polyribosomal RNA-seq de novo assembly were of low abundance. The final round of assembly using PASA (Program to Assemble Spliced Alignments) resulted in more transcript assemblies in the total RNA-seq than those in polyribosomal sample. Comparison of alternative splicing (AS) patterns between total and polyribosomal RNA-seq showed a significant difference (G-test, p-value<0.01) in intron retention events: 46.4% of AS events in the total sample were intron retention, whereas only 23.5% showed evidence of intron retention in the polyribosomal sample. It is likely that a large proportion of retained introns in total RNA-seq result from incompletely spliced pre-mature mRNA. Overall, this study demonstrated that polyribosomal RNA-seq technology decreased the complexity and diversity of the coding transcriptome by eliminating pre-mature mRNAs, especially those of low abundance.	[Zhang, Xingtan; Rosen, Benjamin D.; Tang, Haibao; Krishnakumar, Vivek; Town, Christopher D.] J Craig Venter Inst, Rockville, MD 20850 USA; [Zhang, Xingtan] Chongqing Univ, Sch Life Sci, Chongqing 630044, Peoples R China	J. Craig Venter Institute; Chongqing University	Town, CD (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.	cdtown@jcvi.org	Tang, Haibao/A-6715-2011; Krishnakumar, Vivek/C-7204-2015	Tang, Haibao/0000-0002-3460-8570; Krishnakumar, Vivek/0000-0002-5227-0200	US National Science Foundation [0821966, 1262414]; China Scholarship Council	US National Science Foundation(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council)	The work was supported by grants from the US National Science Foundation (0821966 and 1262414, http://www.nsf.gov) and a scholarship from the China Scholarship Council (http://en.csc.edu.cn) to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry S, 2014, PLANT J, V78, P659, DOI 10.1111/tpj.12502; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hori K, 2007, PLANT CELL PHYSIOL, V48, P1072, DOI 10.1093/pcp/pcm075; Iida K, 2006, MOL BIOL EVOL, V23, P1085, DOI 10.1093/molbev/msj118; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Juntawong P, 2014, P NATL ACAD SCI USA, V111, pE203, DOI 10.1073/pnas.1317811111; Krajewski MP, 2013, PHYTOCHEMISTRY, V91, P198, DOI 10.1016/j.phytochem.2012.04.016; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Reynoso MA, 2012, PLANT J, DOI [10.1111/tpj.12055, DOI 10.1111/TPJ.12055]; Savaldi-Goldstein S, 2000, PLANT J, V21, P91, DOI 10.1046/j.1365-313x.2000.00657.x; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Zanetti ME, 2005, PLANT PHYSIOL, V138, P624, DOI 10.1104/pp.105.059477	28	15	15	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117699	10.1371/journal.pone.0117699	http://dx.doi.org/10.1371/journal.pone.0117699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706651	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100110
J	Souza, AMR; Fillenbaum, GG; Blay, SL				Souza, Adelle M. R.; Fillenbaum, Gerda G.; Blay, Sergio L.			Prevalence and Correlates of Physical Inactivity among Older Adults in Rio Grande do Sul, Brazil	PLOS ONE			English	Article							HEALTH; MORTALITY; DISEASES; LIFE	Background Current information on the epidemiology of physical inactivity among older adults is lacking, making it difficult to target the inactive and to plan for interventions to ameliorate adverse effects. Objectives To present statewide representative findings on the prevalence of physical inactivity among older community residents, its correlates and associated health service use. Methods A representative non-institutionalized random sample of 6963 individuals in Rio Grande do Sul, Brazil, aged >= 60 years, was interviewed face-to-face. Information was obtained on demographic characteristics, social resources, health conditions and behaviors, health service use, and physical inactivity. Controlled logistic regression was used to determine the association of physical inactivity with these characteristics. Results Overall, 62% reported no regular physical activity. Physical inactivity was significantly more prevalent among women, older persons, those with lower education and income, Afro-Brazilians (73%; White: 61%; "other": 64%), those no longer married, and was associated with multiple individual health conditions and impaired activities of daily living (ADL). In adjusted analyses, associations remained for sociodemographic characteristics, social participation, impaired self-rated health, ADL, vision, and depression (odds ratios (OR) 1.2-1.7). Physically inactive respondents were less likely to report outpatient visits (OR 0.81), but more likely to be hospitalized (OR 1.41). Conclusions Physical inactivity is highly prevalent, particularly among Afro -Brazilians. It is associated with adverse sociodemographic characteristics; lack of social interaction; and poor self-rated health, ADL, vision, and depression; although not with other health conditions. Self-care may be neglected, resulting in hospitalization.	[Souza, Adelle M. R.; Blay, Sergio L.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Psychiat, Sao Paulo, Brazil; [Fillenbaum, Gerda G.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA	Universidade Federal de Sao Paulo (UNIFESP); Duke University	Blay, SL (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Psychiat, Sao Paulo, Brazil.	blay@uol.com.br	Pinto, Guilherme/AAT-5848-2021		National Council for Scientific and Technological Development (CNPq; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Bolsista de Produtividade em Pesquisa [306156/2011-3]; Bolsista CNPq/CAPES - Mestrado; National Institute on Aging [1P30 AG028716]; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	National Council for Scientific and Technological Development (CNPq; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Bolsista de Produtividade em Pesquisa; Bolsista CNPq/CAPES - Mestrado; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from National Council for Scientific and Technological Development (CNPq; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) to SLB, research grant (Bolsista de Produtividade em Pesquisa: 306156/2011-3) to AMRS, research grant (Bolsista CNPq/CAPES - Mestrado), and National Institute on Aging grant number 1P30 AG028716 to GGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetti Tânia R Bertoldo, 2008, Rev. Saúde Pública, V42, P302, DOI 10.1590/S0034-89102008005000007; Bernstein M, 2001, SOZ PRAVENTIV MED, V46, P49, DOI 10.1007/BF01318798; Blay SL, 2007, AM J GERIAT PSYCHIAT, V15, P790, DOI 10.1097/JGP.0b013e3180654179; BLAY SL, 1988, J AM GERIATR SOC, V36, P687, DOI 10.1111/j.1532-5415.1988.tb07169.x; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Brasil Vigitel, 2006, VIG FAT RISC PROT DO; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Clemson L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4547; Conselho Estadual do Idoso, 1997, OS ID RIO GRAND EST; Dias-da-Costa Juvenal Soares, 2005, Cad. Saúde Pública, V21, P275, DOI 10.1590/S0102-311X2005000100030; Zaitune MPD, 2010, CAD SAUDE PUBLICA, V26, P1606, DOI 10.1590/S0102-311X2010000800014; Dogra S, 2011, J AGING PHYS ACTIV, V19, P322, DOI 10.1123/japa.19.4.322; Eurobarometer, 2003, SPEC EUR PHYS ACT; Ferreira MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-690; Friedenreich CM, 2011, RECENT RESULTS CANC, V188, P125, DOI 10.1007/978-3-642-10858-7_11; Gobbi Sebastiao, 2012, J Aging Res, V2012, P685190, DOI 10.1155/2012/685190; Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E; Hallal Pedro C., 2005, Cad. Saúde Pública, V21, P573, DOI 10.1590/S0102-311X2005000200024; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Ingram DK, 2000, MED SCI SPORT EXER, V32, P1623; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lima-Costa M F, 2001, Rev Panam Salud Publica, V9, P219, DOI 10.1590/S1020-49892001000400003; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Link BG, 2002, AM J PUBLIC HEALTH, V92, P730, DOI 10.2105/AJPH.92.5.730; Liu-Ambrose TYL, 2010, BRIT J SPORT MED, V44, P1024, DOI 10.1136/bjsm.2008.046458; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Monteiro Carlos A., 2003, Rev Panam Salud Publica, V14, P246, DOI 10.1590/S1020-49892003000900005; Pucci GCMF, 2012, REV SAUDE PUBL, V46, P166, DOI 10.1590/S0034-89102012000100021; National center for health statistics, 2011, SPEC FEAT DEATH DYIN; Ng SW, 2014, OBES REV, V15, P27, DOI 10.1111/obr.12127; Nielsen Company, 2010, GLOB TEL AUD MEAS; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Saffer H, 2011, 17413 NAT BUR EC RES; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Siqueira FV, 2008, CAD SAUDE PUBLICA, V24, P39, DOI 10.1590/S0102-311X2008000100005; Tribess Sheilla, 2009, Rev. salud pública, V11, P39; United Nations, 2002, WORLD POPULATION AGE; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; Woolcott JC, 2010, BRIT J SPORT MED, V44, P902, DOI 10.1136/bjsm.2008.057216; World Health Organization, WORLD HLTH REP 2012	45	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117060	10.1371/journal.pone.0117060	http://dx.doi.org/10.1371/journal.pone.0117060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB7EQ	25700161	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800016
J	Gray, C; Vickers, MH; Segovia, SA; Zhang, XD; Reynolds, CM				Gray, Clint; Vickers, Mark H.; Segovia, Stephanie A.; Zhang, Xiaohuan D.; Reynolds, Clare M.			A Maternal High Fat Diet Programmes Endothelial Function and Cardiovascular Status in Adult Male Offspring Independent of Body Weight, Which is Reversed by Maternal Conjugated Linoleic Acid (CLA) Supplementation	PLOS ONE			English	Article							ATHEROSCLEROSIS; APOE(-/-); RESPONSES; OBESITY	Maternal high fat intake during pregnancy and lactation can result in obesity and adverse cardio-metabolic status in offspring independent of postnatal diet. While it is clear that maternal high fat intake can cause hypertension in adult offspring, there is little evidence regarding the role of dietary interventions in terms of reversing these adverse effects. Conjugated linoleic acid (CLA) is an omega 6 fatty acid with beneficial effects in obesity and metabolic status. However, the impact of CLA supplementation in the context of pregnancy disorders and high fat diet-induced developmental programming of offspring cardio-metabolic dysfunction has not been investigated. We have utilised a model of maternal overnutrition to examine the effects of CLA supplementation on programmed endothelial dysfunction during adulthood. Female Sprague-Dawley rats were fed either a purified control diet (CON) or purified control diet supplemented with 1% CLA (of total fat), a purified high fat (HF) diet (45% kcal from fat) and a purified HF diet supplemented with 1% CLA (of total fat) (HFCLA). All dams were fed ad libitum throughout pregnancy and lactation. Offspring were fed a standard chow diet from weaning (day 21) until the end of the study (day 150). Systolic blood pressure (SBP) was measured at day 85 and 130 by tail cuff plethysmography. At day 150, offspring mesenteric vessels were mounted on a pressure myograph and vascular responses to agonist-induced constriction and endothelium-dependent vasodilators were investigated. SBP was increased at day 85 and 130 in HF and HFCLA adult male offspring compared to CON and CLA groups with no effect of CLA supplementation. An overall effect of a maternal HF diet was observed in adult male vessels with a reduced vasoconstrictor response to phenylephrine and blunted vasodilatory response to acetylcholine (ACh). Furthermore, HF and HFCLA offspring displayed a reduction in nitric oxide pathway function and an increased compensatory EDHF function when compared to CON and CLA groups. These data suggest that a maternal HF diet causes a developmental programming of endothelial dysfunction and hypertension in male offspring which can be partially improved by maternal CLA supplementation, independent of offspring body weight.	[Gray, Clint] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland 1, New Zealand	University of Auckland; University of Auckland	Gray, C (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	c.gray@auckland.ac.nz		Vickers, Mark/0000-0003-4876-9356; Reynolds, Clare/0000-0001-5782-6303	Gravida: National Centre for Growth and Development; Kelliher Trust; Auckland Medical Research Foundation; Lottery Health Research Fellowship	Gravida: National Centre for Growth and Development; Kelliher Trust; Auckland Medical Research Foundation; Lottery Health Research Fellowship	The authors acknowledge the technical support from Angelica Bernal, Rachna Patel (Liggins Institute) and the Vernon Jansen Unit, University of Auckland. This work was supported by Gravida: National Centre for Growth and Development, the Kelliher Trust and the Auckland Medical Research Foundation and Lottery Health Research Fellowship.	Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Atkinson RL, 1999, ADV CONJUGATED LINOL, V1, P328; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bassaganya-Riera J, 2010, CURR OPIN CLIN NUTR, V13, P569, DOI 10.1097/MCO.0b013e32833b648e; Fan L, 2013, INT J OBESITY, V37, P254, DOI 10.1038/ijo.2012.42; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Gebauer SK, 2011, ADV NUTR, V2, P332, DOI 10.3945/an.111.000521; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Gray C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053505; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Jelinska M, 2014, BBA-MOL BASIS DIS, V1842, P2230, DOI 10.1016/j.bbadis.2014.08.013; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Li ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076961; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Moloney F, 2007, DIABETES, V56, P574, DOI 10.2337/db06-0384; Penedo LA, 2013, J NUTR BIOCHEM, V24, P2144, DOI 10.1016/j.jnutbio.2013.08.006; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; Reynolds CM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12110; Reynolds CM, 2013, J NUTR BIOCHEM, V24, P401, DOI 10.1016/j.jnutbio.2011.12.006; Taylor JSW, 2006, ARTERIOSCL THROM VAS, V26, P307, DOI 10.1161/01.ATV.0000199679.40501.ac; Teng KT, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-12; Tonkiss J, 1998, HYPERTENSION, V32, P108, DOI 10.1161/01.HYP.32.1.108; Toomey S, 2003, BIOCHEM SOC T, V31, P1075, DOI 10.1042/BST0311075; Toomey S, 2006, ATHEROSCLEROSIS, V187, P40, DOI 10.1016/j.atherosclerosis.2005.08.024; Torrens C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050671	26	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115994	10.1371/journal.pone.0115994	http://dx.doi.org/10.1371/journal.pone.0115994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695432	gold, Green Submitted, Green Published			2022-12-27	WOS:000350062300010
J	Humplik, JF; Bergougnoux, V; Jandova, M; Simura, J; Pencik, A; Tomanec, O; Rolcik, J; Novaak, O; Fellner, M				Humplik, Jan F.; Bergougnoux, Veronique; Jandova, Michaela; Simura, Jan; Pencik, Ales; Tomanec, Ondrej; Rolcik, Jakub; Novak, Ondrej; Fellner, Martin			Endogenous Abscisic Acid Promotes Hypocotyl Growth and Affects Endoreduplication during Dark-Induced Growth in Tomato (Solanum lycopersicum L.)	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; DEFICIENT MUTANT SITIENS; ARABIDOPSIS-THALIANA; SHOOT GROWTH; GENE-EXPRESSION; WATER RELATIONS; WILTY MUTANTS; ROOT-GROWTH; PROTEIN-KINASE; DE-ETIOLATION	Dark-induced growth (skotomorphogenesis) is primarily characterized by rapid elongation of the hypocotyl. We have studied the role of abscisic acid (ABA) during the development of young tomato (Solanum lycopersicum L.) seedlings. We observed that ABA deficiency caused a reduction in hypocotyl growth at the level of cell elongation and that the growth in ABA-deficient plants could be improved by treatment with exogenous ABA, through which the plants show a concentration dependent response. In addition, ABA accumulated in dark-grown tomato seedlings that grew rapidly, whereas seedlings grown under blue light exhibited low growth rates and accumulated less ABA. We demonstrated that ABA promotes DNA endoreduplication by enhancing the expression of the genes encoding inhibitors of cyclin-dependent kinases SIKRP1 and SIKRP3 and by reducing cytokinin levels. These data were supported by the expression analysis of the genes which encode enzymes involved in ABA and CK metabolism. Our results show that ABA is essential for the process of hypocotyl elongation and that appropriate control of the endogenous level of ABA is required in order to drive the growth of etiolated seedlings.	[Humplik, Jan F.; Simura, Jan; Pencik, Ales; Rolcik, Jakub; Novak, Ondrej; Fellner, Martin] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Humplik, Jan F.; Simura, Jan; Pencik, Ales; Rolcik, Jakub; Novak, Ondrej; Fellner, Martin] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Chem Biol & Genet, CR-77147 Olomouc, Czech Republic; [Humplik, Jan F.; Simura, Jan; Pencik, Ales; Rolcik, Jakub; Novak, Ondrej; Fellner, Martin] Inst Expt Bot ASCR, Olomouc, Czech Republic; [Bergougnoux, Veronique] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Mol Biol, CR-77147 Olomouc, Czech Republic; [Jandova, Michaela] Palacky Univ, Fac Sci, Dept Bot, CR-77147 Olomouc, Czech Republic; [Tomanec, Ondrej] Palacky Univ, Dept Phys Chem, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Humplik, JF (corresponding author), Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic.	jan.humplik@upol.cz	Humplik, Jan F./H-4444-2019; NOVAK, Ondrej/F-7031-2014; Pencik, Ales/D-4488-2018; Simura, Jan/I-3560-2014; Fellner, Martin/B-2068-2010; Bergougnoux, Veronique/GZK-3304-2022	Humplik, Jan F./0000-0002-8915-4369; NOVAK, Ondrej/0000-0003-3452-0154; Pencik, Ales/0000-0002-1314-2249; Simura, Jan/0000-0002-1567-2278; Bergougnoux, Veronique/0000-0003-0681-311X	Ministry of Education, Youth and Sports of the Czech Republic (National Program of Sustainability) [LO1204, LO1305]; Operational Programs Education for Competitiveness - European Social Fund [CZ.1.07/2.3.00/20.0165, CZ.1.07/2.3.00/30.0004]; Palacky University [IGA-PrF-2013-003, IGA-PrF-2014001]	Ministry of Education, Youth and Sports of the Czech Republic (National Program of Sustainability); Operational Programs Education for Competitiveness - European Social Fund; Palacky University	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic grants no. LO1204 and LO1305 (National Program of Sustainability). V. Bergougnoux and M. Fellner were supported by the Operational Programs Education for Competitiveness - European Social Fund, project no. CZ.1.07/2.3.00/20.0165 and project no. CZ.1.07/2.3.00/30.0004, respectively. M. Jandova was supported by internal grants from Palacky University (IGA-PrF-2013-003; IGA-PrF-2014001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2008, PLANT J, V53, P324, DOI 10.1111/j.1365-313X.2007.03346.x; Aroca R, 2008, MICROB ECOL, V56, P704, DOI 10.1007/s00248-008-9390-y; Arsovski Andrej A, 2012, Arabidopsis Book, V10, pe0147, DOI 10.1199/tab.0147; Assmann SM, 2010, PLANT HORMONES BIOSY, P339; Barrero JM, 2005, J EXP BOT, V56, P2071, DOI 10.1093/jxb/eri206; Barrero JM, 2008, PLANT CELL ENVIRON, V31, P227, DOI 10.1111/j.1365-3040.2007.01759.x; Bergougnoux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045255; Bisbis B, 2006, J BIOL CHEM, V281, P7374, DOI 10.1074/jbc.M506587200; Brocard-Gifford I, 2004, PLANT CELL, V16, P406, DOI 10.1105/tpc.018077; Brugiere N, 2003, PLANT PHYSIOL, V132, P1228, DOI 10.1104/pp.102.017707; Burbidge A, 1999, PLANT J, V17, P427, DOI 10.1046/j.1365-313X.1999.00386.x; Castellano MD, 2004, PLANT CELL, V16, P2380, DOI 10.1105/tpc.104.022400; Chen H, 2008, P NATL ACAD SCI USA, V105, P4495, DOI 10.1073/pnas.0710778105; CREELMAN RA, 1990, PLANT PHYSIOL, V92, P205, DOI 10.1104/pp.92.1.205; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Dolezal K, 2006, BIOORGAN MED CHEM, V14, P875, DOI 10.1016/j.bmc.2005.09.004; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; GROOT SPC, 1991, PHYSIOL PLANTARUM, V81, P73, DOI 10.1111/j.1399-3054.1991.tb01715.x; Guan CM, 2014, PLANT PHYSIOL, V164, P1515, DOI 10.1104/pp.113.234740; Hansen H, 2000, PLANT PHYSIOL, V124, P1437, DOI 10.1104/pp.124.3.1437; Hayashi Y, 2014, PLANT CELL PHYSIOL, V55, P845, DOI 10.1093/pcp/pcu028; Hoyerova K, 2006, PHYTOCHEMISTRY, V67, P1151, DOI 10.1016/j.phytochem.2006.03.010; JONES HG, 1987, J EXP BOT, V38, P1848, DOI 10.1093/jxb/38.11.1848; Kitahata N, 2011, J PLANT RES, V124, P549, DOI 10.1007/s10265-011-0415-0; KRAEPIEL Y, 1994, PLANT J, V6, P665, DOI 10.1046/j.1365-313X.1994.6050665.x; LeNoble ME, 2004, J EXP BOT, V55, P237, DOI 10.1093/jxb/erh031; Leung J, 1998, ANN REV PLANT PHYSL; Makela P, 2003, PHYSIOL PLANTARUM, V117, P58, DOI 10.1034/j.1399-3054.2003.1170107.x; Munns R, 1996, PLANT SOIL, V185, P33, DOI 10.1007/BF02257563; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nafati M, 2010, NEW PHYTOL, V188, P136, DOI 10.1111/j.1469-8137.2010.03364.x; NAGEL OW, 1994, PHYSIOL PLANTARUM, V92, P102, DOI 10.1111/j.1399-3054.1994.tb06661.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; NEILL SJ, 1985, J EXP BOT, V36, P1222, DOI 10.1093/jxb/36.8.1222; Nitsch LMC, 2009, PLANTA, V229, P1335, DOI 10.1007/s00425-009-0913-7; Parks BM, 1999, P NATL ACAD SCI USA, V96, P14142, DOI 10.1073/pnas.96.24.14142; Parks BM, 1998, PLANT PHYSIOL, V118, P609, DOI 10.1104/pp.118.2.609; Pencik A, 2009, TALANTA, V80, P651, DOI 10.1016/j.talanta.2009.07.043; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Pettko-Szandtner A, 2006, PLANT J, V46, P111, DOI 10.1111/j.1365-313X.2006.02677.x; Quarrie S., 1987, HORMONE ACTION PLANT, P89, DOI [10.1016/B978-0-408-00796-2.50011-6, DOI 10.1016/B978-0-408-00796-2.50011-6]; Rai MK, 2011, PLANT CELL TISS ORG, V106, P179, DOI 10.1007/s11240-011-9923-9; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; SAAB IN, 1990, PLANT PHYSIOL, V93, P1329, DOI 10.1104/pp.93.4.1329; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scofield S, 2013, PLANT J, V75, P53, DOI 10.1111/tpj.12198; Sharp RE, 2000, J EXP BOT, V51, P1575, DOI 10.1093/jexbot/51.350.1575; Sharp RE, 2002, PLANT CELL ENVIRON, V25, P211, DOI 10.1046/j.1365-3040.2002.00798.x; SINDHU RK, 1988, PLANT PHYSIOL, V88, P178, DOI 10.1104/pp.88.1.178; Svacinova J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-17; Symons GM, 2003, PLANTA, V216, P422, DOI 10.1007/s00425-002-0860-z; Taiz L, 2006, PLANT PHYSIOL, P485, DOI [10.1016/j.ijsu.2006.06.025, DOI 10.1016/J.IJSU.2006.06.025]; TAKAHASHI K, 1972, NATURE-NEW BIOL, V238, P92, DOI 10.1038/newbio238092a0; Takahashi N, 2013, CURR BIOL, V23, P1812, DOI 10.1016/j.cub.2013.07.051; TAL M, 1973, BIOCHEM GENET, V8, P291, DOI 10.1007/BF00486182; TAYLOR IB, 1988, PLANT CELL ENVIRON, V11, P739, DOI 10.1111/j.1365-3040.1988.tb01158.x; Thompson AJ, 2004, PLANT CELL ENVIRON, V27, P459, DOI 10.1111/j.1365-3040.2003.01164.x; Traas J, 1998, CURR OPIN PLANT BIOL, V1, P498, DOI 10.1016/S1369-5266(98)80042-3; Valente P, 1998, PLANT SCI, V134, P207, DOI 10.1016/S0168-9452(98)00062-4; WAKABAYASHI K, 1989, PHYSIOL PLANTARUM, V75, P151, DOI 10.1111/j.1399-3054.1989.tb06162.x; Wang H, 1998, PLANT J, V15, P501, DOI 10.1046/j.1365-313X.1998.00231.x; Weatherwax SC, 1996, PLANT PHYSIOL, V111, P363, DOI 10.1104/pp.111.2.363; Wen B, 2013, J EXP BOT, V64, P1135, DOI 10.1093/jxb/ert009; Yamburenko MV, 2013, J EXP BOT, V64, P4491, DOI 10.1093/jxb/ert258; ZHANG JH, 1990, J EXP BOT, V41, P1125, DOI 10.1093/jxb/41.9.1125	70	14	14	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117793	10.1371/journal.pone.0117793	http://dx.doi.org/10.1371/journal.pone.0117793			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695830	Green Submitted, Green Published, gold			2022-12-27	WOS:000350062300031
J	Lowe, AS; Walton, JP				Lowe, Andrea S.; Walton, Joseph P.			Alterations in Peripheral and Central Components of the Auditory Brainstem Response: A Neural Assay of Tinnitus	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; SALICYLATE-INDUCED TINNITUS; SENSORINEURAL HEARING-LOSS; INFERIOR COLLICULUS; BEHAVIORAL PARADIGM; DETECTION DEFICITS; EVOKED POTENTIALS; STARTLE PARADIGM; TEMPORAL ACUITY; C57BL/6 MOUSE	Chronic tinnitus, or "ringing of the ears", affects upwards of 15% of the adult population. Identifying a cost-effective and objective measure of tinnitus is needed due to legal concerns and disability issues, as well as for facilitating the effort to assess neural biomarkers. We developed a modified gap-in-noise (GIN) paradigm to assess tinnitus in mice using the auditory brainstem response (ABR). We then compared the commonly used acoustic startle reflex gap-prepulse inhibition (gap-PPI) and the ABR GIN paradigm in young adult CBA/CaJ mice before and after administrating sodium salicylate (SS), which is known to reliably induce a 16 kHz tinnitus percept in rodents. Post-SS, gap-PPI was significantly reduced at 12 and 16 kHz, consistent with previous studies demonstrating a tinnitus-induced gap-PPI reduction in this frequency range. ABR audiograms indicated thresholds were significantly elevated post-SS, also consistent with previous studies. There was a significant increase in the peak 2 (P2) to peak 1 (P1) and peak 4 (P4) to P1 amplitude ratios in the mid-frequency range, along with decreased latency of P4 at higher intensities. For the ABR GIN, peak amplitudes of the response to the second noise burst were calculated as a percentage of the first noise burst response amplitudes to quantify neural gap processing. A significant decrease in this ratio (i.e. recovery) was seen only at 16 kHz for P1, indicating the presence of tinnitus near this frequency. Thus, this study demonstrates that GIN ABRs can be used as an efficient, non-invasive, and objective method of identifying the approximate pitch and presence of tinnitus in a mouse model. This technique has the potential for application in human subjects and also indicates significant, albeit different, deficits in temporal processing in peripheral and brainstem circuits following drug induced tinnitus.	[Walton, Joseph P.] Univ S Florida, Dept Commun Sci & Disorders, Tampa, FL 33606 USA; [Lowe, Andrea S.; Walton, Joseph P.] Univ S Florida, Dept Chem & Biomed Engn, Tampa, FL USA; [Lowe, Andrea S.; Walton, Joseph P.] Univ S Florida, Global Ctr Hearing & Speech Res, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Walton, JP (corresponding author), Univ S Florida, Dept Commun Sci & Disorders, Tampa, FL 33606 USA.	jwalton1@usf.edu		Vanneste, Sven/0000-0003-1513-5752; Walton, Joseph/0000-0002-3059-1695	National Institutes of Health - National Institute on Aging [P01 AG009524]; NATIONAL INSTITUTE ON AGING [P01AG009524] Funding Source: NIH RePORTER	National Institutes of Health - National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health - National Institute on Aging P01 AG009524 under JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1979, J COMP NEUROL, V183, P519, DOI 10.1002/cne.901830305; Baizer JS, 2012, BRAIN RES, V1485, P40, DOI 10.1016/j.brainres.2012.03.044; Boettcher FA, 1996, HEARING RES, V102, P167, DOI 10.1016/S0378-5955(96)90016-7; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Campolo J, 2013, NOISE HEALTH, V15, P398, DOI 10.4103/1463-1741.121232; Chen GD, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/658741; Chen GD, 2013, HEARING RES, V295, P100, DOI 10.1016/j.heares.2012.11.016; Chen GD, 2012, BRAIN RES, V1485, P63, DOI 10.1016/j.brainres.2012.03.016; Chen GD, 2010, HEARING RES, V265, P63, DOI 10.1016/j.heares.2010.02.010; Coomber B, 2014, EUR J NEUROSCI; Dehmel S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00042; Dehmel S, 2012, J NEUROSCI, V32, P1660, DOI 10.1523/JNEUROSCI.4608-11.2012; Deng AC, 2010, BRAIN RES, V1344, P96, DOI 10.1016/j.brainres.2010.04.077; Eggermont JJ, 2012, OBJECTIVE ASSESSMENT; Eggermont JJ, 2012, NEUROSCIENCE TINNITU; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Fournier P, 2013, HEARING RES, V295, P16, DOI 10.1016/j.heares.2012.05.011; Gu JW, 2012, JARO-J ASSOC RES OTO, V13, P819, DOI 10.1007/s10162-012-0344-1; Hall JW, 2007, NEW HDB AUDITORY EVO, Vc2007, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Henry KS, 2011, HEARING RES, V280, P236, DOI 10.1016/j.heares.2011.06.002; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; ISON JR, 1982, J COMP PHYSIOL PSYCH, V96, P945, DOI 10.1037/0735-7036.96.6.945; JASTREBOFF PJ, 1986, ARCH OTOLARYNGOL, V112, P1050; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kurata K, 1997, J VET MED SCI, V59, P9, DOI 10.1292/jvms.59.9; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Liu XP, 2012, BRAIN RES, V1485, P88, DOI 10.1016/j.brainres.2012.04.048; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Longenecker RJ, 2012, BRAIN RES, V1485, P54, DOI 10.1016/j.brainres.2012.02.067; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Lu J, 2011, NEUROSCIENCE, V189, P187, DOI 10.1016/j.neuroscience.2011.04.073; Mehdizade Gilani Vahid, 2013, Iran J Otorhinolaryngol, V25, P221; Moller AR, 2011, TEXTBOOK OF TINNITUS, P29, DOI 10.1007/978-1-60761-145-5_5; Musiek FE, 2007, AUDITORY SYSTEM ANAT, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; NIST/SEMATECH, 2012, E HDB STAT METHODS; Nouvian R, 2012, COCHLEA AUDITORY NER, P83; PARHAM K, 1990, BEHAV NEUROSCI, V104, P831, DOI 10.1037/0735-7044.104.6.831; PHARM K, 1988, BEHAV NEUROSCI, V102, P881; Ralli M, 2010, OTOL NEUROTOL, V31, P823, DOI 10.1097/MAO.0b013e3181de4662; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Stolzberg D, 2011, NEUROSCIENCE, V180, P157, DOI 10.1016/j.neuroscience.2011.02.005; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; U. S. Department of Veterans Affairs Veterans Benefits Administration, 2012, ANN BEN REP FISC YEA; Walton JP, 2008, JARO-J ASSOC RES OTO, V9, P90, DOI 10.1007/s10162-007-0101-z; WALTON JP, 1995, HEARING RES, V88, P19, DOI 10.1016/0378-5955(95)00093-J; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Willott JF, 2001, HDB MOUSE AUDITORY R; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107	53	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117228	10.1371/journal.pone.0117228	http://dx.doi.org/10.1371/journal.pone.0117228			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695496	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300019
J	Rajala, N; Hensen, F; Wessels, HJCT; Ives, D; Gloerich, J; Spelbrink, JN				Rajala, Nina; Hensen, Fenna; Wessels, Hans J. C. T.; Ives, Daniel; Gloerich, Jolein; Spelbrink, Johannes N.			Whole Cell Formaldehyde Cross-Linking Simplifies Purification of Mitochondrial Nucleoids and Associated Proteins Involved in Mitochondrial Gene Expression	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; MTDNA REPLICATION; MASS-SPECTROMETRY; DNA NUCLEOIDS; RNA; MEMBRANE; IDENTIFICATION; MUTATIONS; TWINKLE; MAINTENANCE	Mitochondrial DNA/protein complexes (nucleoids) appear as discrete entities inside the mitochondrial network when observed by live-cell imaging and immunofluorescence. This somewhat trivial observation in recent years has spurred research towards isolation of these complexes and the identification of nucleoid-associated proteins. Here we show that whole cell formaldehyde crosslinking combined with affinity purification and tandem mass-spectrometry provides a simple and reproducible method to identify potential nucleoid associated proteins. The method avoids spurious mitochondrial isolation and subsequent multifarious nucleoid enrichment protocols and can be implemented to allow for label-free quantification (LFQ) by mass-spectrometry. Using expression of a Flag-tagged Twinkle helicase and appropriate controls we show that this method identifies many previously identified nucleoid associated proteins. Using LFQ to compare HEK293 cells with and without mtDNA, but both expressing Twinkle-FLAG, identifies many proteins that are reduced or absent in the absence of mtDNA. This set not only includes established mtDNA maintenance proteins but also many proteins involved in mitochondrial RNA metabolism and translation and therefore represents what can be considered an mtDNA gene expression proteome. Our data provides a very valuable resource for both basic mitochondrial researchers as well as clinical geneticists working to identify novel disease genes on the basis of exome sequence data.	[Rajala, Nina; Spelbrink, Johannes N.] BioMediTech, Mitochondrial DNA Maintenance Grp, FI-33014 Tampere, Finland; [Hensen, Fenna; Wessels, Hans J. C. T.; Gloerich, Jolein; Spelbrink, Johannes N.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Wessels, Hans J. C. T.; Gloerich, Jolein] Radboud Univ Nijmegen, Med Ctr, Radboud Prote Ctr, Dept Lab Med,Lab Genet Endocrine & Metab Disorder, NL-6500 HB Nijmegen, Netherlands; [Ives, Daniel] Natl Inst Med Res, MRC, London NW7 1AA, England	Radboud University Nijmegen; Radboud University Nijmegen; MRC National Institute for Medical Research	Spelbrink, JN (corresponding author), BioMediTech, Mitochondrial DNA Maintenance Grp, FI-33014 Tampere, Finland.	hans.spelbrink@radboudumc.nl	Hensen, Fenna/P-5719-2015; Gloerich, Jolein/L-4327-2015; Spelbrink, Johannes N/L-4661-2015; Wessels, Hans J/P-6248-2015	Gloerich, Jolein/0000-0001-5976-8426; Spelbrink, Johannes N/0000-0002-9756-2602; Wessels, Hans J/0000-0001-5957-3127	Academy of Finland; Netherlands Organization for Scientific Research [NWO: VICI] [865.10.004]	Academy of Finland(Academy of Finland); Netherlands Organization for Scientific Research [NWO: VICI](Netherlands Organization for Scientific Research (NWO))	This work was supported by the Academy of Finland [Centre of Excellence funding to JNS] http://www.aka.fi/en-GB/A/Programmes-andcooperation/Centres-of-Excellence-/; the Netherlands Organization for Scientific Research [NWO: VICI grant 865.10.004 to JNS] http://www.nwo.nl/financiering/onze-financieringsinstrumenten/nwo/vernieuwingsimpuls/vici/index. html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; BARAT M, 1985, EXP CELL RES, V157, P207, DOI 10.1016/0014-4827(85)90163-6; Boesch P, 2010, NUCLEIC ACIDS RES, V38, P1478, DOI 10.1093/nar/gkp1143; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Busch KB, 2014, PHILOS T R SOC LON B, V369, DOI [10.1098/rstb.2014.0022, DOI 10.1098/RSTB.2014.0022]; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalla Rosa I, 2014, NUCLEIC ACIDS RES, V42, P8500, DOI 10.1093/nar/gku513; Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Fukuoh A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145117; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Hensen F, 2014, BIOCHIMIE, V100, P219, DOI 10.1016/j.biochi.2013.09.017; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Lee KW, 2013, J BIOL CHEM, V288, P31386, DOI 10.1074/jbc.M113.515692; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; MacAlpine DM, 2000, EMBO J, V19, P767, DOI 10.1093/emboj/19.4.767; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; MIGNOTTE B, 1986, NUCLEIC ACIDS RES, V14, P5969, DOI 10.1093/nar/14.15.5969; NASS MMK, 1969, J MOL BIOL, V42, P521, DOI 10.1016/0022-2836(69)90240-X; NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052; Richman TR, 2014, NUCLEIC ACIDS RES, V42, P5483, DOI 10.1093/nar/gku179; Richter R, 2010, EMBO J, V29, P1116, DOI 10.1038/emboj.2010.14; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576; Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014; SCHATZ G, 1964, BIOCHEM BIOPH RES CO, V15, P127, DOI 10.1016/0006-291X(64)90311-0; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029; VANTUYLE GC, 1981, J BIOL CHEM, V256, P2772; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Wessels HJCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068340; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	58	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116726	10.1371/journal.pone.0116726	http://dx.doi.org/10.1371/journal.pone.0116726			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695250	gold, Green Published, Green Submitted			2022-12-27	WOS:000350062300017
J	Jarczok, MN; Kleber, ME; Koenig, J; Loerbroks, A; Herr, RM; Hoffmann, K; Fischer, JE; Benyamini, Y; Thayer, JF				Jarczok, Marc N.; Kleber, Marcus E.; Koenig, Julian; Loerbroks, Adrian; Herr, Raphael M.; Hoffmann, Kristina; Fischer, Joachim E.; Benyamini, Yael; Thayer, Julian F.			Investigating the Associations of Self-Rated Health: Heart Rate Variability Is More Strongly Associated than Inflammatory and Other Frequently Used Biomarkers in a Cross Sectional Occupational Sample	PLOS ONE			English	Article							OVERNIGHT URINARY NOREPINEPHRINE; OLDER-ADULTS; NEUROVISCERAL INTEGRATION; NEURAL REGULATION; GLYCEMIC STATUS; GLUCOSE; MORTALITY; MODEL; STIMULATION; STRESS	The present study aimed to investigate the possible mechanisms linking a single-item measure of global self-rated health (SRH) with morbidity by comparing the association strengths between SRH with markers of autonomic nervous system (ANS) function, inflammation, blood glucose and blood lipids. Cross-sectional comprehensive health-check data of 3947 working adults (age 42 +/- 11) was used to calculate logistic regressions, partial correlations and compare correlation strength using Olkins Z. Adjusted logistic regression models showed a negative association between SRH (higher values indicating worse health) and measures of heart rate variability (HRV). Glycemic markers were positively associated with poor SRH. No adjusted association was found with inflammatory markers, BP or lipids. In both unadjusted and adjusted linear models Pearson's correlation strength was significantly higher between SRH with HRV measures compared to SRH with other biomarkers. This is the first study investigating the association of ANS function and SRH. We showed that a global measure of SRH is associated with HRV, and that all measures of ANS function were significantly more strongly associated with SRH than any other biomarker. The current study supports the hypothesis that the extent of brain-body communication, as indexed by HRV, is associated with self-rated health.	[Jarczok, Marc N.; Kleber, Marcus E.; Herr, Raphael M.; Hoffmann, Kristina; Fischer, Joachim E.; Thayer, Julian F.] Heidelberg Univ, Mannheim Med Fac, Mannheim Inst Publ Hlth Social & Prevent Med, Mannheim, Germany; [Koenig, Julian; Thayer, Julian F.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Loerbroks, Adrian] Univ Dusseldorf, Fac Med, Inst Occupat & Social Med, Dusseldorf, Germany; [Herr, Raphael M.] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Benyamini, Yael] Tel Aviv Univ, Bob Shapell Sch Social Work, IL-69978 Tel Aviv, Israel	Ruprecht Karls University Heidelberg; University System of Ohio; Ohio State University; Heinrich Heine University Dusseldorf; University of Amsterdam; Tel Aviv University	Koenig, J (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	Koenig.393@osu.edu	Koenig, Julian/J-8863-2017; Thayer, Julian/AAA-1161-2020; Jarczok, Marc N/A-2383-2014; Jarczok, M/GZN-2543-2022; Benyamini, Yael/G-8367-2012; Herr, Raphael/GYU-5115-2022	Koenig, Julian/0000-0003-1009-9625; Thayer, Julian/0000-0001-9385-3421; Jarczok, Marc N/0000-0002-6055-385X; Benyamini, Yael/0000-0001-5110-8212; Herr, Raphael/0000-0003-0079-2792; Kleber, Marcus/0000-0003-0663-7275	Mannheim Institute of Public Health (Heidelberg University); Humboldt Senior Research Award	Mannheim Institute of Public Health (Heidelberg University); Humboldt Senior Research Award	The work was supported by internal funds of the Mannheim Institute of Public Health (Heidelberg University). The Director of this Institute JEF is co-author of the manuscript and as such played a role in preparation and approval of this manuscript. He had no role in study design, analysis and decision to publish the manuscript. Julian F. Thayer was supported by a Humboldt Senior Research Award. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner JM, 2011, AM J EPIDEMIOL, V173, P882, DOI 10.1093/aje/kwq445; Barger SD, 2007, HEALTH PSYCHOL, V26, P85, DOI 10.1037/0278-6133.26.1.85; Benyamini Y, 1999, RES AGING, V21, P477, DOI 10.1177/0164027599213007; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Benyamini Y, 2014, HEALTH PSYCHOL, V33, P317, DOI 10.1037/a0031371; Benyamini Y, 2011, PSYCHOL HEALTH, V26, P1407, DOI 10.1080/08870446.2011.621703; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Camm AJ, 1996, CIRCULATION, V93, P1043; Chapman BP, 2006, J GERONTOL B-PSYCHOL, V61, pP362, DOI 10.1093/geronb/61.6.P362; Christian LM, 2011, PSYCHONEUROENDOCRINO, V36, P1495, DOI 10.1016/j.psyneuen.2011.04.003; DeSalvo KB, 2006, QUAL LIFE RES, V15, P191, DOI 10.1007/s11136-005-0887-2; Dowd JB, 2010, ANN EPIDEMIOL, V20, P743, DOI 10.1016/j.annepidem.2010.06.007; Fagundes CP, 2011, PSYCHONEUROENDOCRINO, V36, P1137, DOI 10.1016/j.psyneuen.2011.02.005; Geiger SD, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/518263; Goldman N, 2004, ANN EPIDEMIOL, V14, P49, DOI 10.1016/S1047-2797(03)00077-2; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Hall M, 2004, PSYCHOSOM MED, V66, P56, DOI 10.1097/01.PSY.0000106884.58744.09; Haring R, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-103; Haseli-Mashhadi N, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-130, 10.1186/1471-2458-9-368]; Henderson LA, 2007, PAIN, V128, P20, DOI 10.1016/j.pain.2006.08.013; Hillebrand S, 2013, EUROPACE, V15, P742, DOI 10.1093/europace/eus341; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Janszky I, 2005, BRAIN BEHAV IMMUN, V19, P555, DOI 10.1016/j.bbi.2005.01.001; Jarczok MN, 2014, J INTERN MED, V276, P667, DOI 10.1111/joim.12295; Jarczok MN, 2013, INT J CARDIOL, V168, P3025, DOI 10.1016/j.ijcard.2013.04.147; Jarczok MN, 2013, NEUROSCI BIOBEHAV R, V37, P1810, DOI 10.1016/j.neubiorev.2013.07.004; Jarczok MN, 2013, INT J CARDIOL, V167, P855, DOI 10.1016/j.ijcard.2012.02.002; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Jylha M, 2006, J CLIN EPIDEMIOL, V59, P465, DOI 10.1016/j.jclinepi.2005.12.004; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kim JH, 2013, J CLIN SLEEP MED, V9, P1057, DOI 10.5664/jcsm.3082; Kissler HJ, 2005, METABOLISM, V54, P881, DOI 10.1016/j.metabol.2005.01.036; Koenig J, 2014, EUR J PAIN, V18, P301, DOI 10.1002/j.1532-2149.2013.00379.x; Lane RD, 2009, NEUROIMAGE, V47, P1135, DOI 10.1016/j.neuroimage.2009.06.013; Li J, 2013, INT J BEHAV MED, V20, P495, DOI 10.1007/s12529-012-9255-0; Li J, 2012, AM J IND MED, V55, P808, DOI 10.1002/ajim.22018; Lima-Costa MF, 2012, AM J EPIDEMIOL, V175, P228, DOI 10.1093/aje/kwr290; Loerbroks A, 2010, J PSYCHOSOM RES, V69, P151, DOI 10.1016/j.jpsychores.2010.03.004; Luft FC, 2012, J AM SOC HYPERTENS, V6, P23, DOI 10.1016/j.jash.2011.09.006; Mantyselka PT, 2003, JAMA-J AM MED ASSOC, V290, P2435, DOI 10.1001/jama.290.18.2435; Martinez DJ, 2010, J GERONTOL B-PSYCHOL, V65, P715, DOI 10.1093/geronb/gbp115; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; Page KA, 2011, J CLIN INVEST, V121, P4161, DOI 10.1172/JCI57873; Pereira EAC, 2007, STEREOT FUNCT NEUROS, V85, P175, DOI 10.1159/000101296; Pinquart M, 2001, PSYCHOL AGING, V16, P414, DOI 10.1037//0882-7974.16.3.414; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Schmidt B, 2014, INT J BEHAV MED, V21, P750, DOI 10.1007/s12529-013-9345-7; Schnittker J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084933; Shirom A, 2008, HEALTH PSYCHOL, V27, P567, DOI 10.1037/0278-6133.27.5.567; Singh-Manoux A, 2006, J EPIDEMIOL COMMUN H, V60, P364, DOI 10.1136/jech.2005.039883; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Thayer JF, 2009, J INTERN MED, V265, P439, DOI 10.1111/j.1365-2796.2008.02023.x; Thayer J.F., 2004, CRIT PERSPECT, P567; Thayer JF, 2002, SCAND J PSYCHOL, V43, P123, DOI 10.1111/1467-9450.00277; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Thayer JF, 2013, INT J CARDIOL, V162, P240, DOI 10.1016/j.ijcard.2011.05.058; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2011, RESP PHYSIOL NEUROBI, V178, P387, DOI 10.1016/j.resp.2011.05.016; Thayer JF, 2010, BRAIN BEHAV IMMUN, V24, P1223, DOI 10.1016/j.bbi.2010.07.247; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Wagner DC, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130241; Weiss T, 2008, NEUROIMAGE, V41, P1372, DOI 10.1016/j.neuroimage.2008.03.047; Wittling A, 2014, ANS EXPLORER; Yamada Chizumi, 2012, Environmental Health and Preventive Medicine, V17, P457, DOI 10.1007/s12199-012-0274-x	72	60	60	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117196	10.1371/journal.pone.0117196	http://dx.doi.org/10.1371/journal.pone.0117196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25693164	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500042
J	Zhang, L; Chen, P; Chen, L; Weng, TJ; Zhang, SC; Zhou, X; Zhang, B; Liu, LC				Zhang, Li; Chen, Peng; Chen, Lin; Weng, Tujun; Zhang, Shichang; Zhou, Xia; Zhang, Bo; Liu, Luchuan			Inhibited Wnt Signaling Causes Age-Dependent Abnormalities in the Bone Matrix Mineralization in the Apert Syndrome FGFR2(S252W/+) Mice	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; FRIZZLED-RELATED PROTEIN-1; FIBROBLAST GROWTH-FACTORS; MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; PARATHYROID-HORMONE; FGFR2 MUTATIONS; MOUSE MODEL; MASS; CRANIOSYNOSTOSIS	Apert syndrome (AS) is a type of autosomal dominant disease characterized by premature fusion of the cranial sutures, severe syndactyly, and other abnormalities in internal organs. Approximately 70% of AS cases are caused by a single mutation, S252W, in fibroblast growth factor receptor 2 (FGFR2). Two groups have generated FGFR2 knock-in mice Fgfr2 (S252W/+) that exhibit features of AS. During the present study of AS using the Fgfr2 (S252W/+) mouse model, an age-related phenotype of bone homeostasis was discovered. The long bone mass was lower in 2 month old mutant mice than in age-matched controls but higher in 5 month old mutant mice. This unusual phenotype suggested that bone marrow-derived mesenchymal stem cells (BMSCs), which are vital to maintain bone homeostasis, might be involved. BMSCs were isolated from Fgfr2 (S252W/+) mice and found that S252W mutation could impair osteogenic differentiation BMSCs but enhance mineralization of more mature osteoblasts. A microarray analysis revealed that Wnt pathway inhibitors SRFP1/2/4 were up-regulated in mutant BMSCs. This work provides evidence to show that the Wnt/beta-catenin pathway is inhibited in both mutant BMSCs and osteoblasts, and differentiation defects of these cells can be ameliorated by Wnt3a treatment. The present study suggested that the bone abnormalities caused by deregulation of Wnt pathway may underlie the symptoms of AS.	[Zhang, Li; Chen, Lin; Zhou, Xia; Liu, Luchuan] Third Mil Med Univ, Daping Hosp, Dept Stomatol, Chongqing 400042, Peoples R China; [Zhang, Li; Chen, Lin; Zhou, Xia; Liu, Luchuan] Third Mil Med Univ, Inst Surg Res, Chongqing 400042, Peoples R China; [Zhang, Li; Chen, Peng; Weng, Tujun; Zhang, Shichang; Zhang, Bo] Third Mil Med Univ, Daping Hosp, Dept 4, State Key Lab Trauma Burns & Combined Injury, Chongqing 400042, Peoples R China; [Zhang, Li; Chen, Peng; Weng, Tujun; Zhang, Shichang; Zhang, Bo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing 400042, Peoples R China; [Chen, Peng] PLA 324 Hosp, Dept Neurosurg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Zhang, B (corresponding author), Third Mil Med Univ, Daping Hosp, Dept 4, State Key Lab Trauma Burns & Combined Injury, Chongqing 400042, Peoples R China.	zhangbo67184@163.com; liuluchuan1957@126.com	Zhang, Shichang/K-1715-2019	Zhang, Shichang/0000-0002-6587-2518	Special Funds for Major State Basic Research Program of China (973 program) [2011CB964701]; Natural Science Foundation Project of CQ CSTC [cstc2012jjA0427]	Special Funds for Major State Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	The work was supported by the Special Funds for Major State Basic Research Program of China (973 program) (No. 2011CB964701), Natural Science Foundation Project of CQ CSTC (No. cstc2012jjA0427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Cho HY, 2010, BONE, V47, P263, DOI 10.1016/j.bone.2010.05.010; Cohen Jr MM, 2000, CRANIOSYNOSTOSIS DIA, P331; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Eijken M, 2008, J CELL BIOCHEM, V104, P568, DOI 10.1002/jcb.21651; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fragale A, 1999, AM J PATHOL, V154, P1465, DOI 10.1016/S0002-9440(10)65401-6; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hehr U, 1999, MOL GENET METAB, V68, P139, DOI 10.1006/mgme.1999.2915; Holmes G, 2009, DEV BIOL, V328, P273, DOI 10.1016/j.ydbio.2009.01.026; Hurley MM, 2006, BIOCHEM BIOPH RES CO, V341, P989, DOI 10.1016/j.bbrc.2006.01.044; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Jilka RL, 2013, J GERONTOL A-BIOL, V68, P1209, DOI 10.1093/gerona/glt046; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lemonnier J, 2001, AM J PATHOL, V158, P1833, DOI 10.1016/S0002-9440(10)64139-9; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Lomri A, 1998, J CLIN INVEST, V101, P1310; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Miraoui H, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146re9; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Nuckolls GH, 1999, CLEFT PALATE-CRAN J, V36, P12, DOI 10.1597/1545-1569(1999)036<0012:PTUCM>2.3.CO;2; Ornitz DM, 2001, GENOME BIOL, V2; PARK WJ, 1995, AM J HUM GENET, V57, P321; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Slaney SF, 1996, AM J HUM GENET, V58, P923; So N, 2008, BIOCHEM BIOPH RES CO, V376, P454, DOI 10.1016/j.bbrc.2008.08.165; Su N, 2010, HUM MOL GENET, V19, P1199, DOI 10.1093/hmg/ddp590; Takeda S, 2003, ANNU REV NUTR, V23, P403, DOI 10.1146/annurev.nutr.23.011702.073312; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; von Gernet S, 2000, CLIN GENET, V57, P137, DOI 10.1034/j.1399-0004.2000.570208.x; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Yao W, 2010, J BONE MINER RES, V25, P190, DOI 10.1359/jbmr.090719; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536; Zhou X, 2013, AM J MED GENET A, V161A, P983, DOI 10.1002/ajmg.a.35824	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e112716	10.1371/journal.pone.0112716	http://dx.doi.org/10.1371/journal.pone.0112716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693202	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500003
J	Chen, JP; Lei, X; Zhang, L; Peng, B				Chen, Jiangpeng; Lei, Xun; Zhang, Li; Peng, Bin			Using Extreme Value Theory Approaches to Forecast the Probability of Outbreak of Highly Pathogenic Influenza in Zhejiang, China	PLOS ONE			English	Article								Background Influenza is a contagious disease with high transmissibility to spread around the world with considerable morbidity and mortality and presents an enormous burden on worldwide public health. Few mathematical models can be used because influenza incidence data are generally not normally distributed. We developed a mathematical model using Extreme Value Theory (EVT) to forecast the probability of outbreak of highly pathogenic influenza. Methods The incidence data of highly pathogenic influenza in Zhejiang province from April 2009 to November 2013 were retrieved from the website of Health and Family Planning Commission of Zhejiang Province. MATLAB "VIEM" toolbox was used to analyze data and modelling. In the present work, we used the Peak Over Threshold (POT) model, assuming the frequency as a Poisson process and the intensity to be Pareto distributed, to characterize the temporal variability of the long-term extreme incidence of highly pathogenic influenza in Zhejiang, China. Results The skewness and kurtosis of the incidence of highly pathogenic influenza in Zhejiang between April 2009 and November 2013 were 4.49 and 21.12, which indicated a "fat tail" distribution. A QQ plot and a mean excess plot were used to further validate the features of the distribution. After determining the threshold, we modeled the extremes and estimated the shape parameter and scale parameter by the maximum likelihood method. The results showed that months in which the incidence of highly pathogenic influenza is about 4462/2286/1311/487 are predicted to occur once every five/three/two/one year, respectively. Conclusions Despite the simplicity, the present study successfully offers the sound modeling strategy and a methodological avenue to implement forecasting of an epidemic in the midst of its course.	[Chen, Jiangpeng; Lei, Xun; Zhang, Li; Peng, Bin] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China	Chongqing Medical University	Peng, B (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China.	pengbin@cqmu.edu.cn			Department for International Development (DFID) [201400] Funding Source: researchfish	Department for International Development (DFID)		[Anonymous], 2014, INFL FACT SHEET; [Anonymous], 1958, STAT EXTREMES, DOI DOI 10.7312/GUMB92958; Fisher RA, 1928, P CAMB PHILOS SOC, V24, P180, DOI 10.1017/S0305004100015681; Gnedenko B, 1943, ANN MATH, V44, P423, DOI 10.2307/1968974; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Kim EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069305; Lee HC, 2007, CTR GEOSCIENCES GEOS, DOI [10.1021/jp204223t, DOI 10.1021/JP204223T]; McNeil A. J., 2005, QUANTITATIVE RISK MA; Mugglin AS, 2002, STAT MED, V21, P2703, DOI 10.1002/sim.1217; Patie P, 2000, TALKS FINANCIAL INSU; PICKANDS J, 1975, ANN STAT, V3, P119; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Songchitruksa P, 2006, ACCIDENT ANAL PREV, V38, P811, DOI 10.1016/j.aap.2006.02.003; Sumi Ayako, 2012, Environmental Health and Preventive Medicine, V17, P98, DOI 10.1007/s12199-011-0223-0; Xu L, 2010, AGRIC AGRIC SCI PROC, V1, P251, DOI 10.1016/j.aaspro.2010.09.031; Zhao X, 2010, THESIS U CENTERBURY; Zheng L, 2014, ACCIDENT ANAL PREV, V62, P32, DOI 10.1016/j.aap.2013.09.006	17	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118521	10.1371/journal.pone.0118521	http://dx.doi.org/10.1371/journal.pone.0118521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710503	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900061
J	Demarque, DP; Fitts, SMF; Boaretto, AG; da Silva, JCL; Vieira, MC; Franco, VNP; Teixeira, CB; Toffoli-Kadri, MC; Carollo, CA				Demarque, Daniel P.; Fitts, Sonia Maria F.; Boaretto, Amanda G.; Leite da Silva, Julio Cesar; Vieira, Maria C.; Franco, Vanessa N. P.; Teixeira, Caroline B.; Toffoli-Kadri, Monica C.; Carollo, Carlos A.			Optimization and Technological Development Strategies of an Antimicrobial Extract from Achyrocline alata Assisted by Statistical Design	PLOS ONE			English	Article							ACCELERATED SOLVENT-EXTRACTION; KINASE-C ACTIVATORS; KUNTH DC.; ANTIOXIDANT; DERIVATIVES; MECHANISMS; EXPRESSION; ASTERACEAE; FRUCTUS; SOUTH	Achyrocline alata, known as Jatei-ka-ha, is traditionally used to treat several health problems, including inflammations and infections. This study aimed to optimize an active extract against Streptococcus mutans, the main bacteria that causes caries. The extract was developed using an accelerated solvent extraction and chemometric calculations. Factorial design and response surface methodologies were used to determine the most important variables, such as active compound selectivity. The standardized extraction recovered 99% of the four main compounds, gnaphaliin, helipyrone, obtusifolin and lepidissipyrone, which represent 44% of the extract. The optimized extract of A. alata has a MIC of 62.5 mu g/mL against S. mutans and could be used in mouth care products.	[Demarque, Daniel P.; Boaretto, Amanda G.; Carollo, Carlos A.] Univ Fed Mato Grosso do Sul, Lab Farmacognosia, Ctr Ciencias Biol & Saude, Campo Grande, MS, Brazil; [Fitts, Sonia Maria F.; Teixeira, Caroline B.] Univ Fed Mato Grosso do Sul, Lab Microbiol, Ctr Ciencias Biol & Saude, Campo Grande, MS, Brazil; [Leite da Silva, Julio Cesar] Univ Fed Mato Grosso do Sul, Fac Odontol, Campo Grande, MS, Brazil; [Vieira, Maria C.] Fundacao Univ Fed Grande Dourados, Fac Ciencias Agr, Dourados, MS, Brazil; [Franco, Vanessa N. P.; Toffoli-Kadri, Monica C.] Univ Fed Mato Grosso do Sul, Lab Farmacol & Inflamacao, Ctr Ciencias Biol & Saude, Setor Biofisiofarmacol, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Federal da Grande Dourados; Universidade Federal de Mato Grosso do Sul	Carollo, CA (corresponding author), Univ Fed Mato Grosso do Sul, Lab Farmacognosia, Ctr Ciencias Biol & Saude, Campo Grande, MS, Brazil.	carlos.carollo@ufms.br	Demarque, Daniel Pecoraro/K-7325-2014; Kadri, Mônica/AAH-4495-2021; Toffoli-Kadri, Mônica C/D-4972-2014	Demarque, Daniel Pecoraro/0000-0002-3576-5148; Kadri, Mônica/0000-0003-4160-4444; Toffoli-Kadri, Mônica C/0000-0003-4160-4444	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Instituto Nacional de Areas Umidas (INAU)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Instituto Nacional de Areas Umidas (INAU)	The authors express their gratitude to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) and Instituto Nacional de Areas Umidas (INAU) for their support in carrying out the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Adedapo AA, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-21; Aiyegoro OA, 2009, INT J MOL SCI, V10, P4990, DOI 10.3390/ijms10114990; [Anonymous], 2003, M7A6 CLSI, V23, P2; BOHLMANN F, 1980, PHYTOCHEMISTRY, V19, P2475, DOI 10.1016/S0031-9422(00)91058-6; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P89, DOI 10.1080/10408440590917044; Carlos IZ, 2009, REV BRAS FARMACOGN, V19, P847, DOI 10.1590/S0102-695X2009000600009; Cotoras M, 2011, MOLECULES, V16, P3885, DOI 10.3390/molecules16053885; Czaika VA, 2013, MYCOSES, V56, P16, DOI 10.1111/myc.12055; de Souza GC, 2004, J ETHNOPHARMACOL, V90, P135, DOI 10.1016/j.jep.2003.09.039; DING AH, 1988, J IMMUNOL, V141, P2407; Amorim Crystiane Venditi Gomes do, 2004, Braz. oral res., V18, P242, DOI 10.1590/S1806-83242004000300012; Gao FY, 2013, FOOD CHEM, V141, P1962, DOI 10.1016/j.foodchem.2013.05.013; Grassi-Zampieron R, 2010, REV BRAS FARMACOGN, V20, P575, DOI 10.1590/S0102-695X2010000400017; Grassi-Zampieron RF, 2009, REV BRAS FARMACOGN, V19, P572, DOI 10.1590/S0102-695X2009000400011; HANSEL R, 1970, Z NATURFORSCH PT B, VB 25, P989, DOI 10.1515/znb-1970-0916; Herald TJ, 2012, J SCI FOOD AGR, V92, P2326, DOI 10.1002/jsfa.5633; Herrero M, 2005, FOOD CHEM, V93, P417, DOI 10.1016/j.foodchem.2004.09.037; Hossain MB, 2011, FOOD CHEM, V126, P339, DOI 10.1016/j.foodchem.2010.10.076; ICH-4, 1994, METHODOLOGY; JAKUPOVIC J, 1989, PHYTOCHEMISTRY, V28, P1119, DOI 10.1016/0031-9422(89)80195-5; LINNER KM, 1993, J PHARMACOL EXP THER, V267, P1566; Liu J, 2012, ANTIMICROB AGENTS CH, V56, P4532, DOI 10.1128/AAC.00885-12; Lopes FCM, 2011, NAT PROD RES, V25, P1796, DOI 10.1080/14786419.2010.488624; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nothnick WB, 1998, AM J REPROD IMMUNOL, V40, P364; OFLAHERTY JT, 1990, J IMMUNOL, V144, P1909; OFLAHERTY JT, 1989, J BIOL CHEM, V264, P6836; OPITZ L, 1970, TETRAHEDRON LETT, P3369; Palombo EA, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep067; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Pezzuto JM, 1997, BIOCHEM PHARMACOL, V53, P121, DOI 10.1016/S0006-2952(96)00654-5; PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3; Raynie DE, 2010, ANAL CHEM, V82, P4911, DOI 10.1021/ac101223c; Richter BE, 1996, ANAL CHEM, V68, P1033, DOI 10.1021/ac9508199; RIOS JL, 1991, J ETHNOPHARMACOL, V33, P51, DOI 10.1016/0378-8741(91)90160-F; Sala A, 2003, EUR J PHARMACOL, V461, P53, DOI 10.1016/S0014-2999(02)02953-9; Schorr K, 2005, PHYTOCHEM ANALYSIS, V16, P161, DOI 10.1002/pca.836; Sohn HY, 2004, PHYTOMEDICINE, V11, P666, DOI 10.1016/j.phymed.2003.09.005; Toffoli-Kadri MC, 2014, J ETHNOPHARMACOL, V153, P461, DOI 10.1016/j.jep.2014.03.008; Tsuchiya H, 2000, PHYTOMEDICINE, V7, P161, DOI 10.1016/S0944-7113(00)80089-6; Vilkhu K, 2008, INNOV FOOD SCI EMERG, V9, P161, DOI 10.1016/j.ifset.2007.04.014; Yan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064000; Zhao LC, 2012, MOLECULES, V17, P3618, DOI 10.3390/molecules17043618	44	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118574	10.1371/journal.pone.0118574	http://dx.doi.org/10.1371/journal.pone.0118574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710523	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900062
J	Angoa-Perez, M; Herrera-Mundo, N; Kane, MJ; Sykes, CE; Anneken, JH; Francescutti, DM; Kuhn, DM				Angoa-Perez, Mariana; Herrera-Mundo, Nieves; Kane, Michael J.; Sykes, Catherine E.; Anneken, John H.; Francescutti, Dina M.; Kuhn, Donald M.			Brain Serotonin Signaling Does Not Determine Sexual Preference in Male Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRYPTOPHAN-HYDROXYLASE; P-CHLOROPHENYLALANINE; COPULATORY-BEHAVIOR; DEVELOPMENTAL ROLE; MOUNTING BEHAVIOR; AGGRESSION; 5-HT; DEPLETION; MODEL	It was reported recently that male mice lacking brain serotonin (5-HT) lose their preference for females (Liu et al., 2011, Nature, 472, 95-100), suggesting a role for 5-HT signaling in sexual preference. Regulation of sex preference by 5-HT lies outside of the well established roles in this behavior established for the vomeronasal organ (VNO) and the main olfactory epithelium (MOE). Presently, mice with a null mutation in the gene for tryptophan hydroxylase 2(TPH2), which are depleted of brain 5-HT, were tested for sexual preference. When presented with inanimate (urine scents from male or estrous female) or animate (male or female mouse in estrus) sexual stimuli, TPH2-/- males show a clear preference for female over male stimuli. When a TPH2-/- male is offered the simultaneous choice between an estrous female and a male mouse, no sexual preference is expressed. However, when confounding behaviors that are seen among 3 mice in the same cage are controlled, TPH2-/- mice, like their TPH2+/+ counterparts, express a clear preference for female mice. Female TPH2-/- mice are preferred by males over TPH2+/+ females but this does not lead to increased pregnancy success. In fact, if one or both partners in a mating pair are TPH2-/- in genotype, pregnancy success rates are significantly decreased. Finally, expression of the VNO-specific cation channel TRPC2 and of CNGA2 in the MOE of TPH2-/- mice is normal, consistent with behavioral findings that sexual preference of TPH2-/- males for females is intact. In conclusion, 5-HT signaling in brain does not determine sexual preference in male mice. The use of pharmacological agents that are non-selective for the 5-HT neuronal system and that have serious adverse effects may have contributed historically to the stance that 5-HT regulates sexual behavior, including sex partner preference.	[Angoa-Perez, Mariana; Herrera-Mundo, Nieves; Kane, Michael J.; Sykes, Catherine E.; Anneken, John H.; Francescutti, Dina M.; Kuhn, Donald M.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA; [Angoa-Perez, Mariana; Herrera-Mundo, Nieves; Kane, Michael J.; Sykes, Catherine E.; Anneken, John H.; Francescutti, Dina M.; Kuhn, Donald M.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA	Wayne State University	Kuhn, DM (corresponding author), John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA.	donald.kuhn@wayne.edu			Department of Veterans Affairs [5IO1RX000458]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA039667] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000458] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by a grant to DMK from the Department of Veterans Affairs (5IO1RX000458). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Amireault P, 2005, BIOL REPROD, V73, P358, DOI 10.1095/biolreprod.104.039313; Angoa Perez M, 2010, NEUROSCIENCE, V2010; Angoa-Perez M, 2012, J NEUROCHEM, V121, P974, DOI 10.1111/j.1471-4159.2012.07739.x; Basu B, 2008, REPRODUCTION, V135, P657, DOI 10.1530/REP-07-0577; Blier P, 2013, J CLIN PSYCHIAT, V74, P19, DOI 10.4088/JCP.12084su1c.04; Bortolato M, 2013, NEUROSCIENCE, V236, P160, DOI 10.1016/j.neuroscience.2013.01.015; Bourin M, 1996, FUNDAM CLIN PHARM, V10, P450, DOI 10.1111/j.1472-8206.1996.tb00600.x; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Dailly E, 2006, J NEUROSCI METH, V150, P111, DOI 10.1016/j.jneumeth.2005.06.008; FERGUSON J, 1970, SCIENCE, V168, P499, DOI 10.1126/science.168.3930.499; Fidalgo S, 2013, BIOGERONTOLOGY, V14, P21, DOI 10.1007/s10522-012-9406-3; Fineberg NA, 2012, INT J NEUROPSYCHOPH, V15, P1173, DOI 10.1017/S1461145711001829; Fligny C, 2009, BIOESSAYS, V31, P935, DOI 10.1002/bies.200800217; FRATTA W, 1977, LIFE SCI, V21, P379, DOI 10.1016/0024-3205(77)90518-5; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gaspar P, 2012, PHILOS T R SOC B, V367, P2382, DOI 10.1098/rstb.2011.0378; Griebel G, 2013, NAT REV DRUG DISCOV, V12, P667, DOI 10.1038/nrd4075; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Gutknecht L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043157; Hedge S S, 1994, J Pharmacol Exp Ther, V271, P741; Hickner S, 2014, J APPL PHYSIOL, V116, P240, DOI 10.1152/japplphysiol.01197.2013; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; Jimenez-Trejo F, 2012, REPRODUCTION, V144, P677, DOI 10.1530/REP-12-0145; Kane MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048975; KIM KS, 1991, MOL BRAIN RES, V9, P277; Klempin F, 2013, J NEUROSCI, V33, P8270, DOI 10.1523/JNEUROSCI.5855-12.2013; Kriegebaum C, 2010, NEUROCHEM INT, V57, P512, DOI 10.1016/j.neuint.2010.06.015; Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003; LAUDER JM, 1990, ANN NY ACAD SCI, V600, P297, DOI 10.1111/j.1749-6632.1990.tb16891.x; Lesch KP, 2012, PHILOS T R SOC B, V367, P2426, DOI 10.1098/rstb.2012.0039; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; LICHTENSTEIGER W, 1967, J NEUROCHEM, V14, P489, DOI 10.1111/j.1471-4159.1967.tb09548.x; Liu Y, 2011, NATURE, V472, P95, DOI 10.1038/nature09822; MALMNAS CO, 1971, NATURE, V232, P398, DOI 10.1038/232398a0; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Migliarini S, 2012, MOL PSYCHIATR, DOI [10.1038/mp.2012.176, DOI 10.1038/MP.2012.176]; Monti JM, 2011, SLEEP MED REV, V15, P269, DOI 10.1016/j.smrv.2010.11.003; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Murillo-Rodriguez Eric, 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P38; Narboux-Neme N, 2013, ACS CHEM NEUROSCI, V4, P171, DOI 10.1021/cn300165x; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; SALIS PJ, 1971, NATURE, V232, P400, DOI 10.1038/232400a0; Sanger GJ, 2000, BRIT J PHARMACOL, V130, P706, DOI 10.1038/sj.bjp.0703367; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Simon KR, 2013, BIOCHEM CELL BIOL, V91, P319, DOI 10.1139/bcb-2013-0023; SLOVITER RS, 1978, J PHARMACOL EXP THER, V206, P339; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TAGLIAMONTE A, 1969, SCIENCE, V166, P1433, DOI 10.1126/science.166.3911.1433; Thomas DM, 2010, J NEUROCHEM, V115, P595, DOI 10.1111/j.1471-4159.2010.06950.x; Trowbridge S, 2011, ANAT REC, V294, P1615, DOI 10.1002/ar.21248; VANDEPOLL NE, 1977, EUR J PHARMACOL, V41, P225, DOI 10.1016/0014-2999(77)90214-X; Waider J, 2013, HISTOCHEM CELL BIOL, V139, P267, DOI 10.1007/s00418-012-1029-x; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; WHALEN RE, 1970, SCIENCE, V169, P1000, DOI 10.1126/science.169.3949.1000; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Zhang SS, 2013, P NATL ACAD SCI USA, V110, P9968, DOI 10.1073/pnas.1220712110	63	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118603	10.1371/journal.pone.0118603	http://dx.doi.org/10.1371/journal.pone.0118603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706994	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100194
J	Brendel, M; Jaworska, A; Grieinger, E; Rtzer, C; Burgold, S; Gildehaus, FJ; Carlsen, J; Cumming, P; Baumann, K; Haass, C; Steiner, H; Bartenstein, P; Herms, J; Rominger, A				Brendel, Matthias; Jaworska, Anna; Grieinger, Eric; Rtzer, Christina; Burgold, Steffen; Gildehaus, Franz-Josef; Carlsen, Janette; Cumming, Paul; Baumann, Karlheinz; Haass, Christian; Steiner, Harald; Bartenstein, Peter; Herms, Jochen; Rominger, Axel			Cross-Sectional Comparison of Small Animal [F-18]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; PLAQUE-FORMATION; MEMORY DEFICITS; IMAGING AGENTS; NEURON LOSS; BETA; MICE; BRAIN; DEPOSITION	We aimed to compare [F-18]-florbetaben PET imaging in four transgenic mouse strains modelling Alzheimer's disease (AD), with the main focus on APPswe/PS2 mice and C57Bl/6 mice serving as controls (WT). A consistent PET protocol (N = 82 PET scans) was used, with cortical standardized uptake value ratio (SUVR) relative to cerebellum as the endpoint. We correlated methoxy-X04 staining of beta-amyloid with PET results, and undertook ex vivo autoradiography for further validation of a partial volume effect correction (PVEC) of PET data. The SUVR in APPswe/PS2 increased from 0.95 +/- 0.04 at five months (N = 5) and 1.04 +/- 0.03 (p < 0.05) at eight months (N = 7) to 1.07 +/- 0.04 (p < 0.005) at ten months (N = 6), 1.28 +/- 0.06 (p < 0.001) at 16 months (N = 6) and 1.39 +/- 0.09 (p < 0.001) at 19 months (N = 6). SUVR was 0.95 +/- 0.03 in WT mice of all ages (N = 22). In APPswe/PS1G384A mice, the SUVR was 0.93/0.98 at five months (N = 2) and 1.11 at 16 months (N = 1). In APPswe/PS1dE9 mice, the SUVR declined from 0.96/0.96 at 12 months (N = 2) to 0.91/0.92 at 24 months (N = 2), due to beta-amyloid plaques in cerebellum. PVEC reduced the discrepancy between SUVR-PET and autoradiography from -22% to +2% and increased the differences between young and aged transgenic animals. SUVR and plaque load correlated highly between strains for uncorrected (R = 0.94, p < 0.001) and PVE-corrected (R = 0.95, p < 0.001) data. We find that APPswe/PS2 mice may be optimal for longitudinal amyloid-PET monitoring in planned interventions studies.	[Brendel, Matthias; Rtzer, Christina; Gildehaus, Franz-Josef; Carlsen, Janette; Bartenstein, Peter; Rominger, Axel] Univ Munich, Dept Nucl Med, Munich, Germany; [Jaworska, Anna; Grieinger, Eric; Burgold, Steffen; Herms, Jochen] Univ Munich, Dept Translat Res 1, German Ctr Neurodegenerat Dis DZNE Site Munich, Munich, Germany; [Jaworska, Anna] Int Inst Mol & Cell Biol, Lab Neurodegenerat, Warsaw, Poland; [Cumming, Paul] Univ Erlangen Nurnberg, Dept Nucl Med, D-91054 Erlangen, Germany; [Cumming, Paul] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Baumann, Karlheinz] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland; [Haass, Christian; Steiner, Harald] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Haass, Christian; Steiner, Harald] DZNE German Ctr Neurodegenerat Dis, Munich, Germany; [Haass, Christian; Bartenstein, Peter; Herms, Jochen; Rominger, Axel] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Erlangen Nuremberg; University of Copenhagen; Roche Holding; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Rominger, A (corresponding author), Univ Munich, Dept Nucl Med, Munich, Germany.	axel.rominger@med.uni-muenchen.de	Rominger, Axel/K-5891-2019	GRIESSINGER, Emmanuel/0000-0001-7529-4187; Cumming, Paul/0000-0002-0257-9621; Rominger, Axel/0000-0002-1954-736X	SyNergy Cluster, Core 2 Project; GE; Piramal Imaging; F. Hoffmann-La Roche	SyNergy Cluster, Core 2 Project; GE(General Electric); Piramal Imaging; F. Hoffmann-La Roche(Hoffmann-La Roche)	The study was financially supported by the SyNergy Cluster, Core 2 Project. During this study, K. B. received funding in the form of salary from F. Hoffmann-La Roche. P. B. received consultant fees from GE and Piramal Imaging, as well as honoraria from Siemens. A. R. received consultant fees from Piramal Imaging and GE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann N, 2011, J NEUROSCI, V31, P1023, DOI 10.1523/JNEUROSCI.4936-10.2011; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Brendel M, 2014, NEUROIMAGE, V84, P843, DOI 10.1016/j.neuroimage.2013.09.017; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Fodero-Tavoletti MT, 2012, NUCL MED BIOL, V39, P1042, DOI 10.1016/j.nucmedbio.2012.03.001; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Horgan J, 2007, J ALZHEIMERS DIS, V12, P115; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Johnson KA, 2013, J NUCL MED, V54, P476, DOI 10.2967/jnumed.113.120618; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Kuntner C, 2009, MOL IMAGING BIOL, V11, P236, DOI 10.1007/s11307-009-0198-z; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Maeda J, 2011, J NEUROSCI, V31, P4720, DOI 10.1523/JNEUROSCI.3076-10.2011; Manook A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031310; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ozmen L, 2009, NEURODEGENER DIS, V6, P29, DOI 10.1159/000170884; Poisnel G, 2012, NEUROBIOL AGING, V33, P2561, DOI 10.1016/j.neurobiolaging.2011.12.024; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Richards JG, 2003, J NEUROSCI, V23, P8989; Rojas S, 2013, NEUROBIOL AGING, V34, P1790, DOI 10.1016/j.neurobiolaging.2012.12.027; Rominger A, 2013, J NUCL MED, V54, P1127, DOI 10.2967/jnumed.112.114660; Rousset OG, 1998, J NUCL MED, V39, P904; Rousset OG, 2008, J NUCL MED, V49, P1097, DOI 10.2967/jnumed.107.048330; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schneider Lon S, 2013, Continuum (Minneap Minn), V19, P339, DOI 10.1212/01.CON.0000429180.60095.d0; Snellman A, 2013, J NUCL MED, V54, P1434, DOI 10.2967/jnumed.112.110163; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Toyama H, 2005, EUR J NUCL MED MOL I, V32, P593, DOI 10.1007/s00259-005-1780-5; Virdee K, 2012, NEUROSCI BIOBEHAV R, V36, P1188, DOI 10.1016/j.neubiorev.2012.01.009; von Reutern B, 2013, MOL IMAGING BIOL, V15, P576, DOI 10.1007/s11307-013-0625-z; Willuweit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007931; Xiong HQ, 2011, NEUROSCI BULL, V27, P221, DOI 10.1007/s12264-011-1015-7; Zhang W, 2005, NUCL MED BIOL, V32, P799, DOI 10.1016/j.nucmedbio.2005.06.001; Zhang W, 2005, J MED CHEM, V48, P5980, DOI 10.1021/jm050166g	39	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116678	10.1371/journal.pone.0116678	http://dx.doi.org/10.1371/journal.pone.0116678			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706990	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100044
J	Cao, DN; Wu, HY; Li, QY; Sun, YM; Liu, TX; Fei, J; Zhao, YF; Wu, S; Hu, XX; Li, N				Cao, Dainan; Wu, Hanyu; Li, Qingyuan; Sun, Yingmin; Liu, Tongxin; Fei, Jing; Zhao, Yaofeng; Wu, Sen; Hu, Xiaoxiang; Li, Ning			Expression of Recombinant Human Lysozyme in Egg Whites of Transgenic Hens	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; HIGH-LEVEL EXPRESSION; OVIDUCT-SPECIFIC EXPRESSION; CHICKENS; GENE; MILK; TRANSMISSION; LACTOFERRIN; PROTEINS; KNOCKOUT	Chicken egg lysozyme (cLY) is an enzyme with 129 amino acid (AA) residue enzyme. This enzyme is present not only in chicken egg white but also in mucosal secretions such as saliva and tears. The antibacterial properties of egg white can be attributed to the presence of lysozyme, which is used as an anti-cancer drug and for the treatment of human immunodeficiency virus (HIV) infection. In this study, we constructed a lentiviral vector containing a synthetic cLY signal peptide and a 447 bp synthetic human lysozyme (hLY) cDNA sequence driven by an oviduct-specific ovalbumin promoter, and microinjected into the subgerminal cavity of stage X chick embryos to generate transgenic chicken. The transgene inserted in the chicken chromosomes directs the synthesis and secretion of hLY which has three times higher specific activity than cLY. Three G(1) transgenic chickens were identified, the only female of which expressed recombinant human lysozyme (rhLY) at 57.66 +/- 4.10 mu g/ ml in the egg white and the G(2) transgenic hens of the G(1) transgenic cock A011 expressed rhLY at 48.72 +/- 1.54 mu g/ ml. This experiment demonstrated that transgenic hens with stable oviduct-specific expression of recombinant human lysozyme proteins can be created by microinjection of lentiviral vectors. The results of this research could be contribute to the technological development using transgenic hens as a cost-effective alternative to other mammalian systems, such as cow, sheep and goats, for the production of therapeutic proteins and other applications.	[Cao, Dainan; Wu, Hanyu; Li, Qingyuan; Sun, Yingmin; Liu, Tongxin; Fei, Jing; Zhao, Yaofeng; Wu, Sen; Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	China Agricultural University	Hu, XX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	xiaoxiang.hu@gmail.com		Cao, Dainan/0000-0001-6119-9357	National High Technology Research and Development Program of China [2011AA100301]; National Key Technologies RD Program [2011BAD28B03]; Science and Technology Planning Project of Guangdong Province, China [2012A020800005]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Technologies RD Program(National Key Technology R&D Program); Science and Technology Planning Project of Guangdong Province, China	work was financially supported by National High Technology Research and Development Program of China (2011AA100301), National Key Technologies R&D Program (2011BAD28B03) and Science and Technology Planning Project of Guangdong Province, China (2012A020800005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artymiuk P, 1979, CRYSTALLOGRAPHIC STU; Beintema J, 1995, LYSOZYMES MODEL ENZY, P75; BOSSELMAN RA, 1989, SCIENCE, V243, P533, DOI 10.1126/science.2536194; Fastrez J, 1995, LYSOZYMES MODEL ENZY, V75, P35; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Harvey AJ, 2002, POULTRY SCI, V81, P202, DOI 10.1093/ps/81.2.202; Huang JM, 2002, MOL BREEDING, V10, P83, DOI 10.1023/A:1020355511981; JIGAMI Y, 1986, GENE, V43, P273, DOI 10.1016/0378-1119(86)90216-7; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kaleri HA, 2011, GENET MOL RES, V10, P3046, DOI 10.4238/2011.December.8.1; Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005; Kodama D, 2008, BIOCHEM BIOPH RES CO, V367, P834, DOI 10.1016/j.bbrc.2008.01.020; Lee-Huang S, 1999, P NATL ACAD SCI USA, V96, P2678, DOI 10.1073/pnas.96.6.2678; Lee-Huang S, 2005, BIOCHEMISTRY-US, V44, P4648, DOI 10.1021/bi0477081; LI YM, 1995, NAT MED, V1, P1057, DOI 10.1038/nm1095-1057; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Liu S, 2012, TRANSGENIC RES, V21, P407, DOI 10.1007/s11248-011-9536-4; LOVE J, 1994, BIO-TECHNOL, V12, P60, DOI 10.1038/nbt0194-60; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Maga EA, 1998, J FOOD PROTECT, V61, P52, DOI 10.4315/0362-028X-61.1.52; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Mozdziak PE, 2003, DEV DYNAM, V226, P439, DOI 10.1002/dvdy.10234; Nakajima H, 1997, PLANT CELL REP, V16, P674, DOI 10.1007/s002990050300; Nakamura Y, 2010, BIOL REPROD, V83, P130, DOI 10.1095/biolreprod.110.083923; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; PETERS CWB, 1989, EUR J BIOCHEM, V182, P507, DOI 10.1111/j.1432-1033.1989.tb14857.x; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; Rapp JC, 2003, TRANSGENIC RES, V12, P569, DOI 10.1023/A:1025854217349; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Tong J, 2011, TRANSGENIC RES, V20, P417, DOI 10.1007/s11248-010-9409-2; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; TSUCHIYA K, 1992, APPL MICROBIOL BIOT, V38, P109; Wang SY, 2005, BIOCHEM BIOPH RES CO, V327, P820, DOI 10.1016/j.bbrc.2004.12.077; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yang DC, 2003, PLANTA, V216, P597, DOI 10.1007/s00425-002-0919-x; Yu Z, 2006, J DAIRY SCI, V89, P2911, DOI 10.3168/jds.S0022-0302(06)72563-2; Zhu L, 2005, NAT BIOTECHNOL, V23, P1159, DOI 10.1038/nbt1132	41	26	31	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118626	10.1371/journal.pone.0118626	http://dx.doi.org/10.1371/journal.pone.0118626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706123	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100196
J	Erinosho, TO; Pinard, CA; Nebeling, LC; Moser, RP; Shaikh, AR; Resnicow, K; Oh, AY; Yaroch, AL				Erinosho, Temitope O.; Pinard, Courtney A.; Nebeling, Linda C.; Moser, Richard P.; Shaikh, Abdul R.; Resnicow, Ken; Oh, April Y.; Yaroch, Amy L.			Development and Implementation of the National Cancer Institute's Food Attitudes and Behaviors Survey to Assess Correlates of Fruit and Vegetable Intake in Adults	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; DIETARY CHANGE; PSYCHOLOGICAL-FACTORS; PSYCHOSOCIAL FACTORS; CONSUMPTION; HEALTH; MOTIVATION; EAT; RELIABILITY; MEDIATION	Background Low fruit and vegetable (FV) intake is a leading risk factor for chronic disease globally as well as in the United States. Much of the population does not consume the recommended servings of FV daily. This paper describes the development of psychosocial measures of FV intake for inclusion in the U.S. National Cancer Institute's 2007 Food Attitudes and Behaviors Survey. Methods This was a cross-sectional study among 3,397 adults from the United States. Scales included conventional constructs shown to be correlated with fruit and vegetable intake (FVI) in prior studies (e.g., self-efficacy, social support), and novel constructs that have been measured in few-to-no studies (e.g., views on vegetarianism, neophobia). FVI was assessed with an eight-item screener. Exploratory factor analysis, Cronbach's alpha, and regression analyses were conducted. Results Psychosocial scales with Cronbach's alpha >= 0.68 were self-efficacy, social support, perceived barriers and benefits of eating FVs, views on vegetarianism, autonomous and controlled motivation, and preference for FVs. Conventional scales that were associated (p<0.05) with FVI were self-efficacy, social support, and perceived barriers to eating FVs. Novel scales that were associated (p<0.05) with FVI were autonomous motivation, and preference for vegetables. Other single items that were associated (p<0.05) with FVI included knowledge of FV recommendations, FVI "while growing up", and daily water consumption. Conclusion These findings may inform future behavioral interventions as well as further exploration of other potential factors to promote and support FVI.	[Erinosho, Temitope O.] Univ N Carolina, Chapel Hill, NC USA; [Pinard, Courtney A.; Yaroch, Amy L.] Gretchen Swanson Ctr Nutr, Omaha, NE 68114 USA; [Nebeling, Linda C.; Moser, Richard P.; Shaikh, Abdul R.] US Natl Canc Inst, Rockville, MD USA; [Resnicow, Ken] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Oh, April Y.] SAIC Frederick Inc, Clin Monitoring Res Program, Natl Canc Inst Frederick, Frederick, MD USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Pinard, CA (corresponding author), Gretchen Swanson Ctr Nutr, Omaha, NE 68114 USA.	cpinard@centerfornutrition.org						Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; [Anonymous], 2002, P SECT HLTH POL STAT; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura Albert, 1977, SOCIAL LEARNING THEO; Baranowski T, 2006, J NUTR EDUC BEHAV, V38, P340, DOI 10.1016/j.jneb.2006.06.005; Bazzano LA, 2002, AM J CLIN NUTR, V76, P93; Blanck HM, 2011, PREV CHRONIC DIS, V8; Blanck HM, 2009, HEALTH EDUC BEHAV, V36, P289, DOI 10.1177/1090198107303308; BRUG J, 1995, APPETITE, V25, P285, DOI 10.1006/appe.1995.0062; Caldwell EM, 2009, PUBLIC HEALTH NUTR, V12, P1743, DOI 10.1017/S1368980008004308; Campbell MK, 2008, ANN BEHAV MED, V35, P49, DOI 10.1007/s12160-007-9002-y; Carter P, 2010, BMJ, V341; Caspi CE, 2012, SOC SCI MED, V75, P1254, DOI 10.1016/j.socscimed.2012.05.014; Deci EL, 2008, CAN PSYCHOL, V49, P182, DOI 10.1037/a0012801; Erinosho TO, 2012, APPETITE, V59, P155, DOI 10.1016/j.appet.2012.04.010; Erinosho Temitope O, 2012, Prev Chronic Dis, V9, pE10; Fahimi Mansour, 2008, Prev Chronic Dis, V5, pA80; Fischbein M., 1967, READINGS ATTITUDE TH, P477; Fruits and Veggies-More Matters (FVVM), WHAT PERC AM AR AW T; Fuemmeler BF, 2006, HEALTH PSYCHOL, V25, P474, DOI 10.1037/0278-6133.25.4.474; Goodman AB, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120248; Guenther PM, 2006, J AM DIET ASSOC, V106, P1371, DOI 10.1016/j.jada.2006.06.002; Havas S, 1998, J AM DIET ASSOC, V98, P1141, DOI 10.1016/S0002-8223(98)00264-8; Judkins DR, 1997, P STAT CAN S; KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121; Kimmons Joel, 2009, Medscape J Med, V11, P26; Ko LK, 2011, MIL MED, V176, P1281, DOI 10.7205/MILMED-D-11-00021; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; KREBSSMITH SM, 1995, AM J HEALTH PROMOT, V10, P98, DOI 10.4278/0890-1171-10.2.98; Krenzke Tom, 2007, P SECT SURV RES METH, P3211; Ling AMC, 1999, AM J HEALTH PROMOT, V13, P290, DOI 10.4278/0890-1171-13.5.290; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Mikkila V, 2004, EUR J CLIN NUTR, V58, P1038, DOI 10.1038/sj.ejcn.1601929; National Cancer Institute, FOOD ATT BEH FAB SUR; National Cancer Institute, FRUIT VEG SCREEN EAT; Nezami E, 2003, SUBST USE MISUSE, V38, P25, DOI 10.1081/JA-120016564; Norman GJ, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-56; Obayashi S, 2003, J NUTR EDUC BEHAV, V35, P83, DOI 10.1016/S1499-4046(06)60044-4; Patrick H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-18; Piesse A, 2005, P SECT SURV RES METH; Piesse A, 2005, P SECT SURV RES METH, P3476; Resnicow K, 2000, J CANCER EDUC, V15, P156; Resnicow K, 1998, J AM DIET ASSOC, V98, P785, DOI 10.1016/S0002-8223(98)00177-1; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Satia JA, 2001, PUBLIC HEALTH NUTR, V4, P953, DOI 10.1079/PHN2001157; Satia JA, 2007, AM J HEALTH BEHAV, V31, P643, DOI 10.5993/AJHB.31.6.9; Shaikh AR, 2008, AM J PREV MED, V34, P535, DOI 10.1016/j.amepre.2007.12.028; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Townsend MS, 2005, J NUTR EDUC BEHAV, V37, P170, DOI 10.1016/S1499-4046(06)60243-1; US Department of Agriculture US Department of Health and Human Services, 2020, DIET GUID AM 2020 20; Van Duyn MAS, 2001, AM J HEALTH PROMOT, V16, P69, DOI 10.4278/0890-1171-16.2.69; Watters JL, 2007, PUBLIC HEALTH NUTR, V10, P701, DOI 10.1017/S1368980007662284; Williams GC, 2011, CONTEMP CLIN TRIALS, V32, P535, DOI 10.1016/j.cct.2011.03.002; Williams L, 2010, APPETITE, V55, P441, DOI 10.1016/j.appet.2010.08.004; Yaroch AL, 2012, J ACAD NUTR DIET, V112, P1570, DOI 10.1016/j.jand.2012.06.002; Yeh MC, 2010, J NUTR EDUC BEHAV, V42, P321, DOI 10.1016/j.jneb.2009.08.004	56	27	27	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115017	10.1371/journal.pone.0115017	http://dx.doi.org/10.1371/journal.pone.0115017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706120	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100006
J	Heisel, T; Podgorski, H; Staley, CM; Knights, D; Sadowsky, MJ; Gale, CA				Heisel, Timothy; Podgorski, Heather; Staley, Christopher M.; Knights, Dan; Sadowsky, Michael J.; Gale, Cheryl A.			Complementary Amplicon-Based Genomic Approaches for the Study of Fungal Communities in Humans	PLOS ONE			English	Article							CANDIDA-ALBICANS; GUT MICROBIOTA; BACTERIAL; SEQUENCE; DIVERSITY; INFANTS; COLONIZATION; INFLAMMATION; MODULATION; DATABASE	Recent studies highlight the importance of intestinal fungal microbiota in the development of human disease. Infants, in particular, are an important population in which to study intestinal microbiomes because microbial community structure and dynamics during this formative window of life have the potential to influence host immunity and metabolism. When compared to bacteria, much less is known about the early development of human fungal communities, owing partly to their lower abundance and the relative lack of established molecular and taxonomic tools for their study. Herein, we describe the development, validation, and use of complementary amplicon-based genomic strategies to characterize infant fungal communities and provide quantitative information about Candida, an important fungal genus with respect to intestinal colonization and human disease. Fungal communities were characterized from 11 infant fecal samples using primers that target the internal transcribed spacer (ITS) 2 locus, a region that provides taxonomic discrimination of medically relevant fungi. Each sample yielded an average of 27,553 fungal sequences and Candida albicans was the most abundant species identified by sequencing and quantitative PCR (qPCR). Low numbers of Candida krusei and Candida parapsilosis sequences were observed in several samples, but their presence was detected by species-specific qPCR in only one sample, highlighting a challenge inherent in the study of low-abundance organisms. Overall, the sequencing results revealed that infant fecal samples had fungal diversity comparable to that of bacterial communities in similar-aged infants, which correlated with the relative abundance of C. albicans. We conclude that targeted sequencing of fungal ITS2 amplicons in conjunction with qPCR analyses of specific fungi provides an informative picture of fungal community structure in the human intestinal tract. Our data suggests that the infant intestine harbors diverse fungal species and is consistent with prior culture-based analyses showing that the predominant fungus in the infant intestine is C. albicans.	[Heisel, Timothy; Podgorski, Heather; Gale, Cheryl A.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55454 USA; [Staley, Christopher M.; Knights, Dan; Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Knights, Dan] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Gale, Cheryl A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Gale, CA (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55454 USA.	galex012@umn.edu	Sadowsky, Michael/J-2507-2016; Staley, Christopher/K-1142-2019	Sadowsky, Michael/0000-0001-8779-2781; Staley, Christopher/0000-0002-2309-0083	Minnesota Medical Foundation; Minnesota Viking Children's Fund; National Institutes of Health (NIH) [R21AI091907]; Minnesota Environment and Natural Resources Trust Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091907] Funding Source: NIH RePORTER	Minnesota Medical Foundation; Minnesota Viking Children's Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Environment and Natural Resources Trust Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Minnesota Medical Foundation (http://www.mmf.umn.edu/) and Minnesota Viking Children's Fund (http://www.vikings.com/outreach/vikings-childrens-fund.html) research awards to CAG, and by National Institutes of Health (NIH) R21AI091907 and Minnesota Environment and Natural Resources Trust Fund (as recommended by the Legislative-Citizen Commission on Minnesota Resources (http://www.lccmr.leg.mn/)) awards to MJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Bates ST, 2013, STAND GENOMIC SCI, V8, P118, DOI 10.4056/sigs.3737409; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bendel CM, 1994, SEMIN PEDIAT INFECT, V5, P35; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Bougnoux ME, 2006, J CLIN MICROBIOL, V44, P1810, DOI 10.1128/JCM.44.5.1810-1820.2006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cao YP, 2013, WATER RES, V47, P6862, DOI 10.1016/j.watres.2013.02.061; Carvalho A, 2007, MED MYCOL, V45, P619, DOI 10.1080/13693780701501787; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Charlson ES, 2012, AM J RESP CRIT CARE, V186, P536, DOI 10.1164/rccm.201204-0693OC; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Coates EW, 2005, PEDIATRICS, V116, pE241, DOI 10.1542/peds.2004-2537; Cole GT, 1996, CLIN INFECT DIS, V22, pS73, DOI 10.1093/clinids/22.Supplement_2.S73; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; CUTLER JE, 1991, ANNU REV MICROBIOL, V45, P187, DOI 10.1146/annurev.mi.45.100191.001155; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Falgier C, 2011, PEDIATR RES, V69, P384, DOI 10.1203/PDR.0b013e31821269d5; FINEGOLD SM, 1974, AM J CLIN NUTR, V27, P1456, DOI 10.1093/ajcn/27.12.1456; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; GRAHAM JH, 1961, PHYTOPATHOLOGY, V51, P680; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Li QR, 2014, J CLIN GASTROENTEROL, V48, P513, DOI 10.1097/MCG.0000000000000035; Li SS, 2010, INT J FOOD MICROBIOL, V138, P85, DOI 10.1016/j.ijfoodmicro.2010.01.009; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; Macia L, 2012, IMMUNOL REV, V245, P164, DOI 10.1111/j.1600-065X.2011.01080.x; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mukherjee PK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003996; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nam YD, 2008, J MICROBIOL, V46, P491, DOI 10.1007/s12275-008-0199-7; Nguyen NH, 2015, NEW PHYTOL, V205, P1389, DOI 10.1111/nph.12923; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Nucci M, 2001, CLIN INFECT DIS, V33, P1959, DOI 10.1086/323759; ODDS FC, 1994, J AM ACAD DERMATOL, V31, pS2, DOI 10.1016/S0190-9622(08)81257-1; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Petersen L, 2005, CHEMOMETR INTELL LAB, V77, P261, DOI 10.1016/j.chemolab.2004.09.013; Pfaller MA, 2002, J CLIN MICROBIOL, V40, P852, DOI 10.1128/JCM.40.3.852-856.2002; Pierro A, 1996, ARCH SURG-CHICAGO, V131, P176; Ragouilliaux CJ, 2007, PEDIATRICS, V120, pE1458, DOI 10.1542/peds.2006-2804; Romeo O, 2011, MYCOSES, V54, P475, DOI 10.1111/j.1439-0507.2010.01939.x; RUSTCHENKO EP, 1993, J BACTERIOL, V175, P7189, DOI 10.1128/JB.175.22.7189-7199.1993; Saiman L, 2000, PEDIATR INFECT DIS J, V19, P319, DOI 10.1097/00006454-200004000-00011; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Sandven P, 1999, J CLIN MICROBIOL, V37, P3731, DOI 10.1128/JCM.37.11.3731-3732.1999; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulze J, 2009, DTSCH ARZTEBL INT, V106, P837, DOI 10.3238/arztebl.2009.0837; Sherman F, 1991, METHOD ENZYMOL; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; STAPLETON A, 1991, GENETICS, V127, P39; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van het Hoog M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r52; Warnock David W, 2007, Nihon Ishinkin Gakkai Zasshi, V48, P1, DOI 10.3314/jjmm.48.1; Xiao M, 2014, J CLIN MICROBIOL, V52, P3044, DOI 10.1128/JCM.00246-14	73	39	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116705	10.1371/journal.pone.0116705	http://dx.doi.org/10.1371/journal.pone.0116705			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706290	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100047
J	Li, T; Guo, F; Wang, Q; Fang, HL; Li, Z; Wang, DH; Wang, H				Li, Tao; Guo, Feng; Wang, Qin; Fang, Huali; Li, Zhan; Wang, Dehui; Wang, Hui			N-Terminus Three Residues Deletion Mutant of Human Beta-Defensin 3 with Remarkably Enhanced Salt-Resistance	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-3	In this study, we designed and synthesized three N-terminal deletion analogs of human beta-defensin 3 (hBD-3), namely, hBD-3 Delta 4, hBD-3 Delta 7, and hBD-3 Delta 10, to determine the effect of N-terminal residues on the antibacterial activity and salt resistance of these peptides. The antibacterial activities and salt resistance of hBD-3 and its analogs were tested against a broad range of standard and clinically isolated strains. The deletion of nine N-terminal residues significantly reduced the antibacterial activity of hBD-3 against most of tested strains, particularly Klebsiella pneumonia. Compared with hBD-3 and other analogs, the analog with a deletion of three residues, hBD-3 Delta 4, exhibited significantly higher antimicrobial activity against almost all the tested strains, especially Escherichia coli and Enterococcus faecium, at high NaCl concentrations. Given its broad spectrum of antimicrobial activity and high salt resistance, hBD-3 Delta 4 could serve as a promising template for new therapeutic antimicrobial agents.	[Li, Tao; Guo, Feng; Wang, Qin; Fang, Huali; Li, Zhan; Wang, Dehui; Wang, Hui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Wang, H (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	geno0109@vip.sina.com			National Science and Technology Major Project [2013ZX09304101]; National Key Basic Research Program (973) project [2015CB554202]; National Natural Science Foundation of China [81401643]	National Science and Technology Major Project; National Key Basic Research Program (973) project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Science and Technology Major Project, Grant Number 2013ZX09304101, Grant Recipient Hui Wang; National Key Basic Research Program (973) project, Grant Number 2015CB554202, Grant Recipient Hui Wang; and National Natural Science Foundation of China, Grant Number 81401643, Grant Recipient Tao Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Conejo-Garcia JR, 2001, FASEB J, V15, P1819, DOI DOI 10.1096/FJ.00-0865FJE; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Jung S, 2011, ANTIMICROB AGENTS CH, V55, P954, DOI 10.1128/AAC.00872-10; Lee IH, 1997, INFECT IMMUN, V65, P2898, DOI 10.1128/IAI.65.7.2898-2903.1997; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; Park IY, 2004, J BIOL CHEM, V279, P13896, DOI 10.1074/jbc.M311418200; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Scudiero O, 2010, ANTIMICROB AGENTS CH, V54, P2312, DOI 10.1128/AAC.01550-09; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Tomita T, 2000, MICROBIOL IMMUNOL, V44, P749, DOI 10.1111/j.1348-0421.2000.tb02559.x; Yu QT, 2000, J BIOL CHEM, V275, P3943, DOI 10.1074/jbc.275.6.3943	18	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117913	10.1371/journal.pone.0117913	http://dx.doi.org/10.1371/journal.pone.0117913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706284	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100127
J	Maekawa, S; Takabayashi, A; Reyes, TH; Yamamoto, H; Tanaka, A; Sato, T; Yamaguchi, J				Maekawa, Shugo; Takabayashi, Atsushi; Reyes, Thais Huarancca; Yamamoto, Hiroko; Tanaka, Ayumi; Sato, Takeo; Yamaguchi, Junji			Pale-Green Phenotype of atl31 atl6 Double Mutant Leaves Is Caused by Disruption of 5-Aminolevulinic Acid Biosynthesis in Arabidopsis thaliana	PLOS ONE			English	Article							TRANSFER-RNA REDUCTASE; CHLOROPLAST DEVELOPMENT; CHLOROPHYLL BIOSYNTHESIS; 14-3-3 PROTEINS; PHOTOSYSTEM-II; TETRAPYRROLE BIOSYNTHESIS; UBIQUITIN LIGASE; GENE-EXPRESSION; PHYTOCHROME; FAMILY	Arabidopsis ubiquitin ligases ATL31 and homologue ATL6 control the carbon/nitrogen nutrient and pathogen responses. A mutant with the loss-of-function of both atl31 and atl6 developed light intensity-dependent pale-green true leaves, whereas the single knockoutmutants did not. Plastid ultrastructure and Blue Native-PAGE analyses revealed that pale-green leaves contain abnormal plastid structure with highly reduced levels of thylakoid proteins. In contrast, the pale-green leaves of the atl31/atl6 mutant showed normal Fv/Fm. In the pale-green leaves of the atl31/atl6, the expression of HEMA1, which encodes the key enzyme for 5-aminolevulinic acid synthesis, the rate-limiting step in chlorophyll biosynthesis, was markedly down-regulated. The expression of key transcription factor GLK1, which directly promotes HEMA1 transcription, was also significantly decreased in atl31/atl6 mutant. Finally, application of 5-aminolevulinic acid to the atl31/atl6 mutants resulted in recovery to a green phenotype. Taken together, these findings indicate that the 5-aminolevulinic acid biosynthesis step was inhibited through the down-regulation of chlorophyll biosynthesis-related genes in the pale-green leaves of atl31/atl6 mutant.	[Maekawa, Shugo; Reyes, Thais Huarancca; Yamamoto, Hiroko; Sato, Takeo; Yamaguchi, Junji] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 060, Japan; [Maekawa, Shugo; Reyes, Thais Huarancca; Yamamoto, Hiroko; Sato, Takeo; Yamaguchi, Junji] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 060, Japan; [Takabayashi, Atsushi; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Yamaguchi, J (corresponding author), Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 060, Japan.	jjyama@sci.hokudai.ac.jp	Yamaguchi, Junji/AAG-9118-2021; Huarancca Reyes, Thais/ABI-2552-2020; Takabayashi, Atsushi/AAH-6025-2020; Takabayashi, Atsushi/G-1998-2011; Tanaka, Ayumi/D-9003-2012	Huarancca Reyes, Thais/0000-0003-2988-0980; Takabayashi, Atsushi/0000-0003-1100-7462; Takabayashi, Atsushi/0000-0003-1100-7462; Maekawa, Shugo/0000-0002-6021-505X	Nara Institute of Science and Technology by The Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists;  [23380198];  [24114701];  [25112501]; Grants-in-Aid for Scientific Research [26850034] Funding Source: KAKEN	Nara Institute of Science and Technology by The Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research to JY [No. 23380198, 24114701 and 25112501] and by a Grant in-Aid to SM for Scientific Research for a Plant Graduate Student from the Nara Institute of Science and Technology (2009) by The Ministry of Education, Culture, Sports, Science and Technology of Japan. SM was also supported by Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (2010-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2011, PLANT MOL BIOL, V76, P221, DOI 10.1007/s11103-010-9693-5; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anderson JM, 2008, PHOTOSYNTH RES, V98, P575, DOI 10.1007/s11120-008-9381-3; Apitz J, 2014, PLANT CELL PHYSIOL, V55, P645, DOI 10.1093/pcp/pcu016; Chow WS, 2005, PHOTOCH PHOTOBIO SCI, V4, P1081, DOI 10.1039/b507310n; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-5; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Fu A, 2007, P NATL ACAD SCI USA, V104, P15947, DOI 10.1073/pnas.0707851104; Guzman P, 2012, PLANT SIGNAL BEHAV, V7, P1014, DOI 10.4161/psb.20851; Hedtke B, 2007, PLANT MOL BIOL, V64, P733, DOI 10.1007/s11103-007-9194-3; Helliwell C, 2003, METHODS, V30, P289, DOI 10.1016/S1046-2023(03)00036-7; Huang XZ, 2009, CELL RES, V19, P1205, DOI 10.1038/cr.2009.84; ILAG LL, 1994, PLANT CELL, V6, P265, DOI 10.1105/tpc.6.2.265; Kumar AM, 1996, PLANT MOL BIOL, V30, P419, DOI 10.1007/BF00049321; Kumar AM, 2000, PLANT PHYSIOL, V122, P49, DOI 10.1104/pp.122.1.49; Maekawa S, 2014, PLANT PHYSIOL, V164, P879, DOI 10.1104/pp.113.230995; Maekawa S, 2012, PLANT MOL BIOL, V79, P217, DOI 10.1007/s11103-012-9907-0; Mayfield JD, 2007, PLANT PHYSIOL, V145, P1692, DOI 10.1104/pp.107.108654; Mayfield JD, 2012, J EXP BOT, V63, P3061, DOI 10.1093/jxb/ers022; McCormac AC, 2002, PLANT PHYSIOL, V130, P402, DOI 10.1104/pp.003806; McCormac AC, 2001, PLANT J, V25, P549, DOI 10.1046/j.1365-313x.2001.00986.x; Morita-Yamamuro C, 2005, PLANT CELL PHYSIOL, V46, P902, DOI 10.1093/pcp/pci095; Nagane T, 2010, PLANTA, V231, P939, DOI 10.1007/s00425-010-1099-8; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qiao JW, 2013, PLANT CELL PHYSIOL, V54, P2071, DOI 10.1093/pcp/pct148; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Sakuraba Y, 2012, PLANT CELL PHYSIOL, V53, P505, DOI 10.1093/pcp/pcs006; Sato T, 2011, PLANT J, V68, P137, DOI 10.1111/j.1365-313X.2011.04673.x; Sato T, 2009, PLANT J, V60, P852, DOI 10.1111/j.1365-313X.2009.04006.x; Schwenkert S, 2006, J BIOL CHEM, V281, P34227, DOI 10.1074/jbc.M604888200; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Takabayashi A, 2011, PLANT CELL PHYSIOL, V52, P2103, DOI 10.1093/pcp/pcr138; TANAKA A, 1991, PLANT CELL PHYSIOL, V32, P195, DOI 10.1093/oxfordjournals.pcp.a078064; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Ujwal ML, 2002, PLANT MOL BIOL, V50, P83, DOI 10.1023/A:1016081114758; Waters MT, 2008, PLANT J, V56, P432, DOI 10.1111/j.1365-313X.2008.03616.x; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Yasuda S, 2014, J BIOL CHEM, V289, P15179, DOI 10.1074/jbc.M113.533133; Zheng B, 2006, PLANTA, V224, P1103, DOI 10.1007/s00425-006-0292-2	42	17	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117662	10.1371/journal.pone.0117662	http://dx.doi.org/10.1371/journal.pone.0117662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706562	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100109
J	Mohades, SG; Van Schuerbeek, P; Rosseel, Y; De Craen, PV; Luypaert, R; Baeken, C				Mohades, Seyede Ghazal; Van Schuerbeek, Peter; Rosseel, Yves; De Craen, Piet Van; Luypaert, Robert; Baeken, Chris			White-Matter Development is Different in Bilingual and Monolingual Children: A Longitudinal DTI Study	PLOS ONE			English	Article							CORPUS-CALLOSUM; LANGUAGE LATERALIZATION; PROCESSING SPEED; HUMAN BRAIN; ORBITOFRONTAL CORTEX; ARCUATE FASCICULUS; COGNITIVE CONTROL; INTEGRITY; CHILDHOOD; AGE	Although numerous people grow up speaking more than one language, the impact of bilingualism on brain developing neuroanatomy is still poorly understood. This study aimed to determine whether the changes in the mean fractional-anisotropy (MFA) of language pathways are different between bilingual and monolingual children. Simultaneous-bilinguals, sequential-bilinguals and monolingual, male and female 10-13 years old children participated in this longitudinal study over a period of two years. We used diffusion tensor tractography to obtain mean fractional-anisotropy values of four language related pathways and one control bundle: 1-left-inferior-occipitofrontal fasciculus/IIFOF, 2-left-arcuate fasciculus/IAF/ISLF, 3-bundle arising from the anterior part of corpus-callosum and projecting to orbital lobe/AC-OL, 4-fibres emerging from anterior-midbody of corpus-callosum (CC) to motor cortices/AMB-PMC, 5-right-inferior-occipitofrontal fasciculus rIFOF as the control pathway unrelated to language. These values and their rate of change were compared between 3 groups. FA-values did not change significantly over two years for IAF/ISLF and AC-OL. Sequential- bilinguals had the highest degree of change in the MFA value of IIFOF, and AMBPMC did not present significant group differences. The comparison of MFA of IIFOF yielded a significantly higher FA-value in simultaneous bilinguals compared to monolinguals. These findings acknowledge the existing difference of the development of the semantic processing specific pathway between children with different semantic processing procedure. These also support the hypothesis that age of second language acquisition affects the maturation and myelination of some language specific white-matter pathways.	[Mohades, Seyede Ghazal; De Craen, Piet Van; Luypaert, Robert] Vrije Univ Brussel, Brussels, Belgium; [Van Schuerbeek, Peter; Luypaert, Robert] Univ Ziekenhuis Brussel UZBrussel, Radiol, Brussels, Belgium; [Baeken, Chris] Univ Hosp, Dept Psychiat, Brussels, Belgium; [Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium; [Rosseel, Yves] Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Ghent University; Ghent University	Mohades, SG (corresponding author), Vrije Univ Brussel, Brussels, Belgium.	smohades@vub.ac.be	Baeken, Chris/D-6790-2013	Rosseel, Yves/0000-0002-4129-4477; Van Schuerbeek, Peter/0000-0003-3647-4446	Onderzoeksraad (OZR) Research council of Vrij universiteit Brussel	Onderzoeksraad (OZR) Research council of Vrij universiteit Brussel	This research was supported by de Onderzoeksraad (OZR) Research council of Vrij universiteit Brussel under the project: Project: A semi-longitudinal, multidisciplinary, neuroscientific study of bilingualism in development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; Acton QA, 2012, ADV CER RES APPL, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; [Anonymous], 2012, DUAL LANG LEARN DLL; Ashtari M, 2012, DEV MED CHILD NEUROL, V54, P6, DOI 10.1111/j.1469-8749.2011.04122.x; Balsamo LM, 2002, ARCH NEUROL-CHICAGO, V59, P1168, DOI 10.1001/archneur.59.7.1168; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bergen D., 2002, ROLE PRETEND PLAY CH; Bethmann A, 2007, BRAIN RES, V1133, P145, DOI 10.1016/j.brainres.2006.11.057; Bialystok E, 2005, NEUROIMAGE, V24, P40, DOI 10.1016/j.neuroimage.2004.09.044; Bialystok E, 2012, TRENDS COGN SCI, V16, P240, DOI 10.1016/j.tics.2012.03.001; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Bretherton I., 1984, SYMBOLIC PLAY DEV SO; Butler Y., 2008, HDB BILINGUALISM EDI, P114; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Christley R.M., 2010, OPEN EPIDEMIOL J, V3, P16, DOI DOI 10.2174/1874297101003010016; Coggins PE, 2004, BRAIN LANG, V89, P69, DOI 10.1016/S0093-934X(03)00299-2; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Cummine J, 2013, BRAIN STRUCT FUNCT, V218, P595, DOI 10.1007/s00429-012-0466-6; Darki F, 2014, CEREB CORTEX; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Emmorey K, 2008, PSYCHOL SCI, V19, P1201, DOI 10.1111/j.1467-9280.2008.02224.x; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Han Z, 2013, BRAIN; Hoeft F, 2011, P NATL ACAD SCI USA, V108, P361, DOI 10.1073/pnas.1008950108; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Hull R, 2006, LATERALITY, V11, P436, DOI 10.1080/13576500600691162; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Josse G, 2008, J NEUROSCI, V28, P14132, DOI 10.1523/JNEUROSCI.4383-08.2008; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Kim EY, 2007, INT J DEV NEUROSCI, V25, P409, DOI 10.1016/j.ijdevneu.2007.05.005; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kroll JF, 2008, ACTA PSYCHOL, V128, P416, DOI 10.1016/j.actpsy.2008.02.001; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Leclercq D, 2010, J NEUROSURG, V112, P503, DOI 10.3171/2009.8.JNS09558; Liu Y, 2012, AM J NEURORADIOL, V33, P839, DOI 10.3174/ajnr.A2872; Luders E, 2010, J NEUROSCI, V30, P10985, DOI 10.1523/JNEUROSCI.5122-09.2010; Luk G, 2011, J NEUROSCI, V31, P16808, DOI 10.1523/JNEUROSCI.4563-11.2011; Madden DJ, 2009, J COGNITIVE NEUROSCI, V21, P289, DOI 10.1162/jocn.2009.21047; Mandonnet E, 2007, BRAIN, V130, P623, DOI 10.1093/brain/awl361; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Meuter RFI, 2007, THE 6TH INTERNATIONA; Mohades SG, 2012, BRAIN RES, V1435, P72, DOI 10.1016/j.brainres.2011.12.005; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mummery CJ, 1999, BRAIN, V122, P61, DOI 10.1093/brain/122.1.61; Ortibus E, 2012, DEV MED CHILD NEUROL, V54, P38, DOI 10.1111/j.1469-8749.2011.04147.x; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Penke L, 2010, J NEUROSCI, V30, P7569, DOI 10.1523/JNEUROSCI.1553-10.2010; Plaza M, 2008, CEREB CORTEX, V18, P1253, DOI 10.1093/cercor/bhm169; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Putnam MC, 2008, J NEUROSCI, V28, P2912, DOI 10.1523/JNEUROSCI.2295-07.2008; Rauschecker AM, 2009, NEUROPSYCHOLOGIA, V47, P180, DOI 10.1016/j.neuropsychologia.2008.08.011; RESCORLA L, 1992, J SPEECH HEAR RES, V35, P1290, DOI 10.1044/jshr.3506.1290; Rodrigo S, 2007, AM J NEURORADIOL, V28, P1526, DOI 10.3174/ajnr.A0584; Rodrigo S, 2008, EPILEPSIA, V49, P1367, DOI 10.1111/j.1528-1167.2008.01607.x; Rutherford MD, 2007, J AUTISM DEV DISORD, V37, P1024, DOI 10.1007/s10803-006-0240-9; Schweizer TA, 2012, CORTEX, V48, P991, DOI 10.1016/j.cortex.2011.04.009; Segura B, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-64; Smith LB, 2011, DEVELOPMENTAL SCI, V14, P1142, DOI 10.1111/j.1467-7687.2011.01065.x; Tabors PO, 1997, ONE CHILD 2 LANG GUI; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Toppelberg CO, 2005, J AM ACAD CHILD PSY, V44, P592, DOI 10.1097/01.chi.0000157549.87078.f8; Treit S, 2013, J NEUROSCI, V33, P10098, DOI 10.1523/JNEUROSCI.5004-12.2013; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Vikingstad EM, 2000, J NEUROL SCI, V175, P17, DOI 10.1016/S0022-510X(00)00269-0; Wahl M, 2010, NEUROIMAGE, V51, P531, DOI 10.1016/j.neuroimage.2010.02.072; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Yeatman JD, 2012, P NATL ACAD SCI USA, V109, pE3045, DOI 10.1073/pnas.1206792109	82	43	43	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117968	10.1371/journal.pone.0117968	http://dx.doi.org/10.1371/journal.pone.0117968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706865	gold, Green Published			2022-12-27	WOS:000350662100132
J	Romand, R; Ripp, R; Poidevin, L; Boeglin, M; Geffers, L; Dolle, P; Poch, O				Romand, Raymond; Ripp, Raymond; Poidevin, Laetitia; Boeglin, Marcel; Geffers, Lars; Dolle, Pascal; Poch, Olivier			Integrated Annotation and Analysis of In Situ Hybridization Images Using the ImAnno System: Application to the Ear and Sensory Organs of the Fetal Mouse	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; DATABASE; CYTOSCAPE; PROFILES; BRAIN; ATLAS	An in situ hybridization (ISH) study was performed on 2000murine genes representing around 10% of the protein-coding genes present in the mouse genome using data generated by the EURExpress consortium. This study was carried out in 25 tissues of late gestation embryos (E14.5), with a special emphasis on the developing ear and on five distinct developing sensory organs, including the cochlea, the vestibular receptors, the sensory retina, the olfactory organ, and the vibrissae follicles. The results obtained from an analysis of more than 11,000 micrographs have been integrated in a newly developed knowledgebase, called ImAnno. In addition to managing the multilevel micrograph annotations performed by human experts, ImAnno provides public access to various integrated databases and tools. Thus, it facilitates the analysis of complex ISH gene expression patterns, as well as functional annotation and interaction of gene sets. It also provides direct links to human pathways and diseases. Hierarchical clustering of expression patterns in the 25 tissues revealed three main branches corresponding to tissues with common functions and/or embryonic origins. To illustrate the integrative power of ImAnno, we explored the expression, function and disease traits of the sensory epithelia of the five presumptive sensory organs. The study identified 623 genes (out of 2000) concomitantly expressed in the five embryonic epithelia, among which many (similar to 12%) were involved in human disorders. Finally, various multilevel interaction networks were characterized, highlighting differential functional enrichments of directly or indirectly interacting genes. These analyses exemplify an under-represention of "sensory" functions in the sensory gene set suggests that E14.5 is a pivotal stage between the developmental stage and the functional phase that will be fully reached only after birth.	[Romand, Raymond; Ripp, Raymond; Dolle, Pascal] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, Dev Biol & Stem Cells Dept, CNRS,INSERM, F-67404 Illkirch Graffenstaden, France; [Ripp, Raymond; Poidevin, Laetitia; Poch, Olivier] Univ Strasbourg, ICube Lab, LBGI Bioinformat & Genom Integrat, Strasbourg, France; [Ripp, Raymond; Poidevin, Laetitia; Poch, Olivier] Univ Strasbourg, Strasbourg Federat Translat Med FMTS, Strasbourg, France; [Ripp, Raymond; Poidevin, Laetitia; Poch, Olivier] CNRS, Strasbourg, France; [Boeglin, Marcel] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, Imaging & Microscopy Platform,INSERM, F-67404 Illkirch Graffenstaden, France; [Geffers, Lars] Max Planck Inst Biophys Chem, Dept Genes & Behav, D-37077 Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Max Planck Society	Poch, O (corresponding author), Univ Strasbourg, ICube Lab, LBGI Bioinformat & Genom Integrat, Strasbourg, France.	olivier.poch@unistra.fr	Dolle, Pascal/A-8037-2010	Dolle, Pascal/0000-0002-9294-9090; Geffers, Lars/0000-0001-6800-4305	European Union [LSHG-CT-2004512003]; Agence Nationale de la Recherche (ANR); Fondation pour la Recherche Medicale (Equipe FRM); ANR [BIPBIP: ANR-10BINF-03-05]; CNRS; INSERM; Universite de Strasbourg; Federation de Medecine Translationnelle de Strasbourg; Region Alsace	European Union(European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; Federation de Medecine Translationnelle de Strasbourg; Region Alsace(Region Grand-Est)	The present work was funded by the grants from the European Union (6th Framework Program, EURExpress integrated project, LSHG-CT-2004512003), the Agence Nationale de la Recherche (ANR Neurosciences 2007 and Programme blanc 2011), Fondation pour la Recherche Medicale (Equipe FRM 2007) (to P. D.); ANR BIPBIP: ANR-10BINF-03-05 (to O.P.) and the CNRS, INSERM, Universite de Strasbourg, Federation de Medecine Translationnelle de Strasbourg, Region Alsace. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Carson JP, 2002, CURR OPIN NEUROBIOL, V12, P562, DOI 10.1016/S0959-4388(02)00356-2; Christiansen JH, 2006, NUCLEIC ACIDS RES, V34, pD637, DOI 10.1093/nar/gkj006; Deng M, 2010, DEV BIOL, V338, P38, DOI 10.1016/j.ydbio.2009.11.003; Desper R, 2006, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi0603s15, DOI 10.1002/0471250953.BI0603S15]; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Duquette PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013232; Eichele G, 2011, METHODS, V53, P417, DOI 10.1016/j.ymeth.2010.12.020; Geffers L, 2012, MAMM GENOME, V23, P525, DOI 10.1007/s00335-012-9413-3; Kim SJ, 2006, ANN CLIN LAB SCI, V36, P115; Lindsay S, 2005, TRENDS GENET, V21, P586, DOI 10.1016/j.tig.2005.08.011; Liu XY, 2012, PATHOL ONCOL RES, V18, P17, DOI 10.1007/s12253-011-9410-y; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Maguschak KA, 2011, J NEUROSCI, V31, P13057, DOI 10.1523/JNEUROSCI.3248-11.2011; Maienschein-Cline M, 2012, BIOINFORMATICS, V28, P206, DOI 10.1093/bioinformatics/btr628; Mallo M, 2003, CURR TOP DEV BIOL, V57, P85, DOI 10.1016/S0070-2153(03)57003-X; Nickell MD, 2012, J COMP NEUROL, V520, P2608, DOI 10.1002/cne.23052; Roelfsema Jeroen H., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000415; ROMAND R, 1987, HEARING RES, V28, P1, DOI 10.1016/0378-5955(87)90148-1; ROSSANT J, 2002, MOUSE DEV PATTERNING; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith CM, 2007, NUCLEIC ACIDS RES, V35, pD618, DOI 10.1093/nar/gkl1003; Stansberg C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-94; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tian HK, 2008, DEV NEUROBIOL, V68, P476, DOI 10.1002/dneu.20612; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wicker N, 2001, MOL BIOL EVOL, V18, P1435, DOI 10.1093/oxfordjournals.molbev.a003929; Wurdak H, 2005, GENE DEV, V19, P530, DOI 10.1101/gad.317405; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	34	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118024	10.1371/journal.pone.0118024	http://dx.doi.org/10.1371/journal.pone.0118024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706271	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100137
J	Thoke, HS; Tobiesen, A; Brewer, J; Hansen, PL; Stock, RP; Olsen, LF; Bagatolli, LA				Thoke, Henrik Seir; Tobiesen, Asger; Brewer, Jonathan; Hansen, Per Lyngs; Stock, Roberto P.; Olsen, Lars F.; Bagatolli, Luis A.			Tight Coupling of Metabolic Oscillations and Intracellular Water Dynamics in Saccharomyces cerevisiae	PLOS ONE			English	Article							GENERALIZED POLARIZATION; GLYCOLYTIC OSCILLATIONS; LAURDAN; PROTEIN; CYTOPLASM; SOLVENT; YEAST; MITOCHONDRIAL; FLUCTUATIONS; FLUORESCENCE	We detected very strong coupling between the oscillating concentration of ATP and the dynamics of intracellular water during glycolysis in Saccharomyces cerevisiae. Our results indicate that: i) dipolar relaxation of intracellular water is heterogeneous within the cell and different from dilute conditions, ii) water dipolar relaxation oscillates with glycolysis and in phase with ATP concentration, iii) this phenomenon is scale-invariant from the subcellular to the ensemble of synchronized cells and, iv) the periodicity of both glycolytic oscillations and dipolar relaxation are equally affected by D2O in a dose-dependent manner. These results offer a new insight into the coupling of an emergent intensive physicochemical property of the cell, i.e. cell-wide water dipolar relaxation, and a central metabolite (ATP) produced by a robustly oscillating metabolic process.	[Thoke, Henrik Seir; Tobiesen, Asger; Brewer, Jonathan; Bagatolli, Luis A.] Univ Southern Denmark, Dept Biochem & Mol Biol, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense M, Denmark; [Hansen, Per Lyngs] Univ Southern Denmark, Dept Phys Chem & Pharm, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense M, Denmark; [Stock, Roberto P.] Univ Nacl Autonoma Mexico IBt UNAM, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico; [Olsen, Lars F.] Univ Southern Denmark, Dept Biochem & Mol Biol, CelCom Grp, DK-5230 Odense M, Denmark	University of Southern Denmark; University of Southern Denmark; Universidad Nacional Autonoma de Mexico; University of Southern Denmark	Bagatolli, LA (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, MEMPHYS Ctr Biomembrane Phys, Campusvej 55, DK-5230 Odense M, Denmark.	bagatolli@memphys.sdu.dk	Brewer, Jonathan/C-7079-2012; Bagatolli, Luis/L-5159-2016	Brewer, Jonathan/0000-0002-3444-1715; Thoke, Henrik Seir/0000-0003-2660-5860; Olsen, Lars Folke/0000-0001-7391-2340; Bagatolli, Luis/0000-0002-4727-8611	Danish Research Council (FNU) [0602-02507B]; Villum Fonden [00007292, 00007268] Funding Source: researchfish	Danish Research Council (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Villum Fonden(Villum Fonden)	This work is supported by a grant from the Danish Research Council (FNU, 0602-02507B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AZ, 2007, YEAST, V24, P731, DOI 10.1002/yea.1508; Bagatolli L.A., 2013, FLUORESCENT METHODS, P3, DOI DOI 10.1007/4243_2012_42; Brewer J, 2013, J INVEST DERMATOL, V133, P1260, DOI 10.1038/jid.2012.461; CLEGG JS, 1984, AM J PHYSIOL, V246, pR133, DOI 10.1152/ajpregu.1984.246.2.R133; Fels J, 2009, BIOPHYS J, V96, P4276, DOI 10.1016/j.bpj.2009.02.038; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; Frauenfelder H, 2006, P NATL ACAD SCI USA, V103, P15469, DOI 10.1073/pnas.0607168103; Frauenfelder H, 2008, NAT CHEM BIOL, V4, P21, DOI 10.1038/nchembio0108-21; Frauenfelder H, 2007, IUBMB LIFE, V59, P506, DOI 10.1080/15216540701194113; Goldbeter A., 1996, BIOCH OSCILLATIONS C; HAZLEWOOD CF, 1974, BIOPHYS J, V14, P583, DOI 10.1016/S0006-3495(74)85937-0; Jaeger J, 2001, J THEOR BIOL, V213, P171, DOI 10.1006/jtbi.2001.2414; Kiser PF, 1998, NATURE, V394, P459, DOI 10.1038/28822; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Leterrier JF, 2001, CELL MOL BIOL, V47, P901; Ling G.N., 1962, PHYS THEORY LIVING S; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Murray DB, 2014, SYSTEMS BIOL METABOL; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Olsen LF, 2009, BIOPHYS J, V96, P3850, DOI 10.1016/j.bpj.2009.02.026; Ozalp VC, 2010, CHEMBIOCHEM, V11, P2538, DOI 10.1002/cbic.201000500; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; Poulsen AK, 2004, FEMS MICROBIOL LETT, V236, P261, DOI 10.1016/j.femsle.2004.05.044; Reijenga KA, 2001, BIOPHYS J, V80, P626, DOI 10.1016/S0006-3495(01)76043-2; Richard P, 1996, YEAST, V12, P731; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Roenneberg T, 2005, P NATL ACAD SCI USA, V102, P7742, DOI 10.1073/pnas.0501884102; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; Spitzer J, 2011, MICROBIOL MOL BIOL R, V75, P491, DOI 10.1128/MMBR.00010-11; Stark BC, 2011, J BIOL CHEM, V286, P30384, DOI 10.1074/jbc.M111.262899; Thomson J.F., 1963, BIOL EFFECTS DEUTERI; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Yoo H, 2011, J PHYS CHEM LETT, V2, P532, DOI 10.1021/jz200057g; Young RD, 2011, BBA-PROTEINS PROTEOM, V1814, P916, DOI 10.1016/j.bbapap.2011.05.005; Zasetsky AY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.117601; ZENG JW, 1995, BIOPHYS J, V68, P567, DOI 10.1016/S0006-3495(95)80218-3	41	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117308	10.1371/journal.pone.0117308	http://dx.doi.org/10.1371/journal.pone.0117308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705902	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100075
J	Wu, J; Li, L; Sun, Y; Huang, S; Tang, J; Yu, P; Wang, GL				Wu, Jie; Li, Lian; Sun, Yu; Huang, Shuai; Tang, Juan; Yu, Pan; Wang, Genlin			Altered Molecular Expression of the TLR4/NF-kappa B Signaling Pathway in Mammary Tissue of Chinese Holstein Cattle with Mastitis	PLOS ONE			English	Article							EPITHELIAL-CELLS; TNF-ALPHA; STAPHYLOCOCCUS-AUREUS; KAPPA-B; ACTIVATION; LIPOPOLYSACCHARIDE; NEUTROPHIL; PATHOGENS; MARKER; GLAND	Toll-like receptor 4 (TLR4) mediated activation of the nuclear transcription factor.B (NF-kappa B) signaling pathway by mastitis initiates expression of genes associated with inflammation and the innate immune response. In this study, the profile of mastitis-induced differential gene expression in the mammary tissue of Chinese Holstein cattle was investigated by Gene-Chip microarray and bioinformatics. The microarray results revealed that 79 genes associated with the TLR4/NF-kappa B signaling pathway were differentially expressed. Of these genes, 19 were up-regulated and 29 were down-regulated in mastitis tissue compared to normal, healthy tissue. Statistical analysis of transcript and protein level expression changes indicated that 10 genes, namely TLR4, MyD88, IL-6, and IL-10, were up-regulated, while, CD14, TNF-alpha, MD-2, IL-beta, NF-kappa B, and IL-12 were significantly down-regulated in mastitis tissue in comparison with normal tissue. Analyses using bioinformatics database resources, such as the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and the Gene Ontology Consortium (GO) for term enrichment analysis, suggested that these differently expressed genes implicate different regulatory pathways for immune function in the mammary gland. In conclusion, our study provides new evidence for better understanding the differential expression and mechanisms of the TLR4/NF-kappa B signaling pathway in Chinese Holstein cattle with mastitis.	[Wu, Jie; Li, Lian; Sun, Yu; Huang, Shuai; Tang, Juan; Yu, Pan; Wang, Genlin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, GL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	glwang@njau.edu.cn	LI, Lian/HHS-4918-2022		National Natural Science Foundation of China [31372290]; Science and Technology Sustentation Project of China [2011BAD28B02, 2012BAD12B00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Sustentation Project of China	This work was supported by the National Natural Science Foundation of China No. 31372290, the Science and Technology Sustentation Project of China (2011BAD28B02, 2012BAD12B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alain K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-444; Bhatt V. D., 2012, Korean Journal of Veterinary Research, V52, P231; Blasi E, 2007, MICROB PATHOGENESIS, V42, P80, DOI 10.1016/j.micpath.2006.11.002; Cao WJ, 2011, INT IMMUNOPHARMACOL, V11, P172, DOI 10.1016/j.intimp.2010.11.012; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Daly KA, 2009, VET IMMUNOL IMMUNOP, V129, P36, DOI 10.1016/j.vetimm.2008.12.001; De Ketelaere A, 2006, J DAIRY SCI, V89, P4066, DOI 10.3168/jds.S0022-0302(06)72450-X; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fu YH, 2013, VET IMMUNOL IMMUNOP, V155, P245, DOI 10.1016/j.vetimm.2013.08.003; Gilbert FB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-40; Griesbeck-Zilch B, 2009, J DAIRY SCI, V92, P4621, DOI 10.3168/jds.2008-1954; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hoeben D, 2000, J DAIRY RES, V67, P503, DOI 10.1017/S0022029900004489; Ibeagha-Awemu EM, 2008, VET RES, V39, DOI 10.1051/vetres:2007047; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Krishnamoorthy P, 2013, INDIAN J VET PATHOLO, V37; Kuhn H, 2014, RESPIROLOGY, V19, P67, DOI 10.1111/resp.12149; Liu SL, 2009, J IMMUNOL, V183, P5537, DOI 10.4049/jimmunol.0900083; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loor JJ, 2011, J MAMMARY GLAND BIOL, V16, P305, DOI 10.1007/s10911-011-9232-2; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Paape M, 2002, J MAMMARY GLAND BIOL, V7, P109, DOI 10.1023/A:1020343717817; Putra ABN, 2014, MOL IMMUNOL, V58, P32, DOI 10.1016/j.molimm.2013.11.003; Rinaldi M, 2010, VET IMMUNOL IMMUNOP, V138, P267, DOI 10.1016/j.vetimm.2010.10.005; Sipka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085579; Sohn EJ, 2007, VET RES, V38, P95, DOI 10.1051/vetres:2006052; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Wei Z, 2014, INT IMMUNOPHARMACOL, DOI DOI 10.1016/J.INTIMP.2014;09.004; Wei ZK, 2014, MICROB PATHOGENESIS, P1; Wellnitz O, 2012, VET J, V192, P148, DOI 10.1016/j.tvjl.2011.09.013; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yang J, 2008, INFLAMMATION, V31, P304, DOI 10.1007/s10753-008-9079-x	39	26	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118458	10.1371/journal.pone.0118458	http://dx.doi.org/10.1371/journal.pone.0118458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706977	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100183
J	Astakhova, LN; Zatsepina, OG; Funikov, SY; Zelentsova, ES; Schostak, NG; Orishchenko, KE; Evgen'ev, MB; Garbuz, DG				Astakhova, Lyubov N.; Zatsepina, Olga G.; Funikov, Sergei Yu.; Zelentsova, Elena S.; Schostak, Natalia G.; Orishchenko, Konstantin E.; Evgen'ev, Michael B.; Garbuz, David G.			Activity of Heat Shock Genes' Promoters in Thermally Contrasting Animal Species	PLOS ONE			English	Article							GAGA-FACTOR; DROSOPHILA GENES; FACTOR-BINDING; IN-VIVO; TRANSCRIPTION; EXPRESSION; PROTEIN; POLYMERASE; CHROMATIN; CELLS	Heat shock gene promoters represent a highly conserved and universal system for the rapid induction of transcription after various stressful stimuli. We chose pairs of mammalian and insect species that significantly differ in their thermoresistance and constitutive levels of Hsp70 to compare hsp promoter strength under normal conditions and after heat shock (HS). The first pair includes the HSPA1 gene promoter of camel (Camelus dromedarius) and humans. It was demonstrated that the camel HSPA1A and HSPA1L promoters function normally in vitro in human cell cultures and exceed the strength of orthologous human promoters under basal conditions. We used the same in vitro assay for Drosophila melanogaster Schneider- 2 (S2) cells to compare the activity of the hsp70 and hsp83 promoters of the second species pair represented by Diptera, i.e., Stratiomys singularior and D. melanogaster, which dramatically differ in thermoresistance and the pattern of Hsp70 accumulation. Promoter strength was also monitored in vivo in D. melanogaster strains transformed with constructs containing the S. singularior hsp70 ORF driven either by its own promoter or an orthologous promoter from the D. melanogaster hsp70Aa gene. Analysis revealed low S. singularior hsp70 promoter activity in vitro and in vivo under basal conditions and after HS in comparison with the endogenous promoter in D. melanogaster cells, which correlates with the absence of canonical GAGA elements in the promoters of the former species. Indeed, the insertion of GAGA elements into the S. singularior hsp70 regulatory region resulted in a dramatic increase in promoter activity in vitro but only modestly enhanced the promoter strength in the larvae of the transformed strains. In contrast with hsp70 promoters, hsp83 promoters from both of the studied Diptera species demonstrated high conservation and universality.	[Astakhova, Lyubov N.; Zatsepina, Olga G.; Funikov, Sergei Yu.; Zelentsova, Elena S.; Schostak, Natalia G.; Evgen'ev, Michael B.; Garbuz, David G.] RAS, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Evgen'ev, Michael B.] RAS, Inst Cell Biophys, Pushchino 142290, Moscow Region, Russia; [Orishchenko, Konstantin E.] RAS, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Evgen'ev, MB (corresponding author), RAS, Engelhardt Inst Mol Biol, Vavilov Str 32, Moscow 119991, Russia.	misha672011@yahoo.com	Orishchenko, Konstantin/AFR-5367-2022; Funikov, Sergei/F-7161-2017; Orishchenko, Konstantin/Q-6630-2016; Garbuz, David/Q-7522-2016	Funikov, Sergei/0000-0002-3336-6119; 	Russian Academy of Sciences; RFFI [12-04-00810-a, 12-04-00069-a, N14Z50.31.0014]	Russian Academy of Sciences(Russian Academy of Sciences); RFFI(Russian Foundation for Basic Research (RFBR))	The work was supported by a grant from the Russian Academy of Sciences (Cell and Molecular Biology Program to M. E.) and RFFI grants 12-04-00810-a and 12-04-00069-a, and MGrant N14Z50.31.0014 to M. E. The funders had no role in the study, design, data collection and analysis, decision to publish or preparation of the manuscript.	Adkins NL, 2006, BIOCHEM CELL BIOL, V84, P559, DOI 10.1139/O06-062; AMIN J, 1987, MOL CELL BIOL, V7, P1055, DOI 10.1128/MCB.7.3.1055; Astakhova LN, 2013, INSECT MOL BIOL, V22, P284, DOI 10.1111/imb.12020; ATKINSON PW, 1992, INSECT BIOCHEM MOLEC, V22, P423, DOI 10.1016/0965-1748(92)90137-4; BERGER EM, 1985, SOMAT CELL MOLEC GEN, V11, P371, DOI 10.1007/BF01534414; Bevilacqua A, 2000, DEVELOPMENT, V127, P1541; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; Chen B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020308; CORCES V, 1981, P NATL ACAD SCI-BIOL, V78, P7038, DOI 10.1073/pnas.78.11.7038; ENENSTEIN J, 1984, J CELL BIOL, V99, P464, DOI 10.1083/jcb.99.2.464; Evgen'ev MB, 2007, J BIOSCIENCES, V32, P489, DOI 10.1007/s12038-007-0048-6; Garbuz DG, 2008, MOL ECOL, V17, P4763, DOI 10.1111/j.1365-294X.2008.03947.x; Garbuz DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027205; Garbuz DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-74; Georgel PT, 2005, BIOCHEM CELL BIOL, V83, P555, DOI 10.1139/O05-060; GILMOUR DS, 1989, SCIENCE, V245, P1487, DOI 10.1126/science.2781290; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; GRANOK H, 1995, CURR BIOL, V5, P238, DOI 10.1016/S0960-9822(95)00048-0; Guertin MJ, 2010, COLD SH Q B, V75, P1, DOI 10.1101/sqb.2010.75.039; Guertin MJ, 2013, CURR OPIN GENET DEV, V23, P116, DOI 10.1016/j.gde.2012.11.008; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; JUDD BH, 1995, GENETICS, V141, P245; Kalosaka K, 2006, INSECT MOL BIOL, V15, P373, DOI 10.1111/j.1365-2583.2006.00650.x; Lebedeva LA, 2005, P NATL ACAD SCI USA, V102, P18087, DOI 10.1073/pnas.0509063102; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Lefevre G., 1976, GENET BIOL DROSOPHIL, P31; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Lim JK, 1993, DROSOPHILA INFORMATI, V72, P73; LIS J, 1982, HEAT SHOCK BACTERIA, P57; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; MCMAHON AP, 1984, P NATL ACAD SCI-BIOL, V81, P7490, DOI 10.1073/pnas.81.23.7490; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; OBRIEN T, 1995, GENE DEV, V9, P1098, DOI 10.1101/gad.9.9.1098; Omelina ES, 2011, COMPUT BIOL CHEM, V35, P363, DOI 10.1016/j.compbiolchem.2011.10.008; PELHAM HRB, 1982, EMBO J, V1, P1473, DOI 10.1002/j.1460-2075.1982.tb01340.x; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010669; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Uhlirova M, 2002, DEV GENES EVOL, V212, P145, DOI 10.1007/s00427-002-0221-8; ULMASOV HA, 1993, COMP BIOCHEM PHYS B, V106, P867, DOI 10.1016/0305-0491(93)90043-5; VOELLMY R, 1982, P NATL ACAD SCI-BIOL, V79, P1776, DOI 10.1073/pnas.79.6.1776; Wang YV, 2005, MOL CELL BIOL, V25, P3543, DOI 10.1128/MCB.25.9.3543-3552.2005; Widlak W, 2007, ACTA BIOCHIM POL, V54, P107; Wilkerson DC, 2009, REPRODUCTION, V137, P923, DOI 10.1530/REP-09-0015; Wilkins RC, 1998, NUCLEIC ACIDS RES, V26, P2672, DOI 10.1093/nar/26.11.2672; Wilkins RC, 1997, NUCLEIC ACIDS RES, V25, P3963, DOI 10.1093/nar/25.20.3963	53	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0115536	10.1371/journal.pone.0115536	http://dx.doi.org/10.1371/journal.pone.0115536			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700087	gold, Green Published, Green Submitted			2022-12-27	WOS:000349789800003
J	de Vos, AF; Dessing, MC; Lammers, AJJ; de Porto, APNA; Florquin, S; de Boer, OJ; de Beer, R; Terpstra, S; Bootsma, HJ; Hermans, PW; Veer, C; van der Poll, T				de Vos, Alex F.; Dessing, Mark C.; Lammers, Adriana J. J.; de Porto, Alexander P. N. A.; Florquin, Sandrine; de Boer, Onno J.; de Beer, Regina; Terpstra, Sanne; Bootsma, Hester J.; Hermans, Peter W.; Veer, Cornelis van 't; van der Poll, Tom			The Polysaccharide Capsule of Streptococcus pneumonia Partially Impedes MyD88-Mediated Immunity during Pneumonia in Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; COMMUNITY-ACQUIRED PNEUMONIA; LIPOTEICHOIC ACID LTA; PNEUMOCOCCAL PNEUMONIA; INFLAMMATORY RESPONSE; ANTIBACTERIAL DEFENSE; EPITHELIAL-CELLS; INFECTION; TOLL-LIKE-RECEPTOR-2; COLONIZATION	Toll-like receptors (TLR) and the downstream adaptor protein MyD88 are considered crucial for protective immunity during bacterial infections. Streptococcus (S.) pneumoniae is a human respiratory pathogen and a large majority of clinical pneumococcal isolates expresses an external polysaccharide capsule. We here sought to determine the role of pneumococcal capsule in MyD88-mediated antibacterial defense during S. pneumonia pneumonia. Wild type (WT) and Myd88(-/-) mice were inoculated intranasally with serotype 2 S. pneumoniae D39 or with an isogenic capsule locus deletion mutant (D39 Delta cps), and analysed for bacterial outgrowth and inflammatory responses in the lung. As compared to WT mice, Myd88(-/-) mice infected with D39 demonstrated a modestly impaired bacterial clearance accompanied by decreased inflammatory responses in the lung. Strikingly, while WT mice rapidly cleared D39 Delta cps, Myd88(-/-) mice showed 10(5)-fold higher bacterial burdens in their lungs and dissemination to blood 24 hours after infection. These data suggest that the pneumococcal capsule impairs recognition of TLR ligands expressed by S. pneumoniae and thereby partially impedes MyD88-mediated antibacterial defense.	[de Vos, Alex F.; Dessing, Mark C.; Lammers, Adriana J. J.; de Porto, Alexander P. N. A.; de Beer, Regina; Terpstra, Sanne; Veer, Cornelis van 't; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [de Vos, Alex F.; Dessing, Mark C.; Lammers, Adriana J. J.; de Porto, Alexander P. N. A.; de Beer, Regina; Terpstra, Sanne; Veer, Cornelis van 't; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Dessing, Mark C.; Florquin, Sandrine; de Boer, Onno J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Bootsma, Hester J.; Hermans, Peter W.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen	de Vos, AF (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.f.devos@amc.uva.nl	Hermans, Peter W.M./H-8042-2014	de Boer, Onno/0000-0001-8844-1326; Florquin, Sandrine/0000-0002-9676-1722; de Porto, Alexander/0000-0002-1201-0754				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Bernstein JM, 1999, CHEST, V115, p9S, DOI 10.1378/chest.115.suppl_1.9S; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Dessing MC, 2008, CELL MICROBIOL, V10, P237, DOI 10.1111/j.1462-5822.2007.01035.x; Dessing MC, 2008, J INFECT DIS, V197, P245, DOI 10.1086/524873; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; KELLY T, 1994, INFECT IMMUN, V62, P1813, DOI 10.1128/IAI.62.5.1813-1819.1994; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Lammers AJ, 2011, IMMUNOBIOLOGY, V216, P863, DOI 10.1016/j.imbio.2011.02.004; Littmann M, 2009, EMBO MOL MED, V1, P211, DOI 10.1002/emmm.200900025; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Melin M, 2010, INFECT IMMUN, V78, P5262, DOI 10.1128/IAI.00740-10; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Paterson GK, 2006, MICROBIOL-SGM, V152, P285, DOI 10.1099/mic.0.28551-0; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Wilson RP, 2008, CELL MICROBIOL, V10, P876, DOI 10.1111/j.1462-5822.2007.01090.x; Wu MF, 2009, INFECT IMMUN, V77, P615, DOI 10.1128/IAI.00931-08; Yoshimura A, 1999, J IMMUNOL, V163, P1	38	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118181	10.1371/journal.pone.0118181	http://dx.doi.org/10.1371/journal.pone.0118181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700108	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800033
J	Ortiz, MTL; Rosario, PBL; Luna-Nevarez, P; Gamez, AS; Martinez-del Campo, A; Del Rio, G				Lara Ortiz, Maria Teresa; Leon Rosario, Pablo Benjamn; Luna-Nevarez, Pablo; Savin Gamez, Alba; Martinez-del Campo, Ana; Del Rio, Gabriel			Quality Control Test for Sequence-Phenotype Assignments	PLOS ONE			English	Article							CRITICAL RESIDUES; PROTEIN; PREDICTION; NETWORK; SET	Relating a gene mutation to a phenotype is a common task in different disciplines such as protein biochemistry. In this endeavour, it is common to find false relationships arising from mutations introduced by cells that may be depurated using a phenotypic assay; yet, such phenotypic assays may introduce additional false relationships arising from experimental errors. Here we introduce the use of high-throughput DNA sequencers and statistical analysis aimed to identify incorrect DNA sequence-phenotype assignments and observed that 10-20% of these false assignments are expected in large screenings aimed to identify critical residues for protein function. We further show that this level of incorrect DNA sequence-phenotype assignments may significantly alter our understanding about the structure-function relationship of proteins. We have made available an implementation of our method at http://bis.ifc.unam.mx/en/software/chispas.	[Lara Ortiz, Maria Teresa; Leon Rosario, Pablo Benjamn; Savin Gamez, Alba; Del Rio, Gabriel] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biochem & Struct Biol, Mexico City 04510, DF, Mexico; [Luna-Nevarez, Pablo] Sonora Inst Technol, Dept Agron Sci & Vet, Obregon City 85000, Mexico; [Martinez-del Campo, Ana] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Del Rio, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biochem & Struct Biol, Mexico City 04510, DF, Mexico.	gdelrio@ifc.unam.mx			PAPIIT [IN205911]; Instituto de fisiologia celular from UNAM	PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Instituto de fisiologia celular from UNAM	This work was supported by PAPIIT (IN205911) and the Instituto de fisiologia celular from UNAM to GDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Aguirre B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021035; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Cusack MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000421; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Lin XY, 2013, BIOSTATISTICS, V14, P667, DOI 10.1093/biostatistics/kxt006; Lindsey JK, 1999, STAT MED, V18, P2223, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2223::AID-SIM251>3.0.CO;2-6; Lindsey JK, 1998, STAT MED, V17, P59, DOI 10.1002/(SICI)1097-0258(19980115)17:1<59::AID-SIM733>3.3.CO;2-Z; Ma BY, 2001, CURR OPIN STRUC BIOL, V11, P364, DOI 10.1016/S0959-440X(00)00216-5; Marco Ambriz-Rivas NP, 2012, PROTEIN INTERACTIONS; Martinez MA, 1996, EMBO J, V15, P1203, DOI 10.1002/j.1460-2075.1996.tb00461.x; POULSEN LK, 1989, MOL MICROBIOL, V3, P1463, DOI 10.1111/j.1365-2958.1989.tb00131.x; POULSEN LK, 1991, MOL MICROBIOL, V5, P1627, DOI 10.1111/j.1365-2958.1991.tb01910.x; Quezada H, 2008, MICROBIOL-SGM, V154, P1656, DOI 10.1099/mic.0.2008/017103-0; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; SHORTLE D, 1992, Q REV BIOPHYS, V25, P205, DOI 10.1017/S0033583500004674; Somarowthu S, 2012, BIOINFORMATICS, V28, P2078, DOI 10.1093/bioinformatics/bts321; Thibert B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-213	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118288	10.1371/journal.pone.0118288	http://dx.doi.org/10.1371/journal.pone.0118288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700273	Green Submitted, gold, Green Published			2022-12-27	WOS:000349789800035
J	Assi, J; Srivastava, G; Matta, A; MacMillan, C; Ralhan, R; Walfish, PG				Assi, Jasmeet; Srivastava, Gunjan; Matta, Ajay; MacMillan, Christina; Ralhan, Ranju; Walfish, Paul G.			Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in "Low Risk" Prostate Adenocarcinomas	PLOS ONE			English	Article							IMMUNOTHERAPEUTIC TARGET; MESENCHYMAL TRANSITION; EPCAM ANTIBODY; BREAST-CANCER; CAM; OVEREXPRESSION; PROGRESSION; SURVIVAL; MARKER; COLON	Introduction Molecular markers for predicting prostate cancer (PCa) that would have poor prognosis are urgently needed for a more personalized treatment for patients. Regulated intramembrane proteolysis of Epithelial cell adhesion molecule results in shedding of the extracellular domain (EpEx) and release of its intracellular domain (Ep-ICD) which triggers oncogenic signaling and might correlate to tumor aggressiveness. This study aimed to explore the potential of Ep-ICD and EpEx to identify PCa that have poor prognosis. Methods Immunohistochemical analysis of Ep-ICD and EpEx was carried out in normal prostate tissues (n = 100), benign prostate hyperplasia (BPH, n = 83), and prostate cancer (n = 249) using domain specific antibodies. The expression of Ep-ICD and EpEx was correlated with clinico-pathological parameters and disease free survival (DFS). Results Reduced expression of nuclear Ep-ICD and membrane EpEx was observed in PCa in comparison with BPH and normal prostate tissues (p = 0.006, p < 0.001 respectively). For patients who had PCa with Gleason Score less than 7, preserved nuclear Ep-ICD emerged as the most significant marker in multivariate analysis for prolonged DFS, where these patients did not have recurrence during follow up of up to 12 years (p = 0.001). Conclusion Reduced expression of nuclear Ep-ICD was associated with shorter disease free survival in patients with a Gleason Score less than 7 and may be useful in identifying patients likely to have aggressive tumors with poor prognosis. Furthermore, nuclear Ep-ICD can differentiate between normal and prostate cancer tissues for ambiguous cases.	[Assi, Jasmeet; Srivastava, Gunjan; Matta, Ajay; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON, Canada; [MacMillan, Christina; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON, Canada; [MacMillan, Christina] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON, Canada; [Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Toronto, ON, Canada; [Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Ralhan, R (corresponding author), Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, 600 Univ Ave, Toronto, ON, Canada.	rralhan@mtsinai.on.ca; pwalfish@mtsinai.on.ca	MATTA, AJAY/AFT-2977-2022		Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics; Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Oncology; Mount Sinai Hospital Department of Medicine Research Fund	Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics(Canadian Institutes of Health Research (CIHR)); Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Oncology; Mount Sinai Hospital Department of Medicine Research Fund	The financial support of this work from the Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics (RR), Mount Sinai Foundation of Toronto Da Vinci Gala Fundraiser, Alex and Simona Shnaider Chair in Thyroid Oncology, and the Mount Sinai Hospital Department of Medicine Research Fund (PGW) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anose BM, 2008, ADV EXP MED BIOL, V617, P541, DOI 10.1007/978-0-387-69080-3_55; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Benko G, 2013, UROL ONCOL-SEMIN ORI, V31, P468, DOI 10.1016/j.urolonc.2011.03.007; Carpenter G, 2009, CANCER CELL, V15, P165, DOI 10.1016/j.ccr.2009.02.005; Chaudry MA, 2007, BRIT J CANCER, V96, P1013, DOI 10.1038/sj.bjc.6603505; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Resende MF, 2013, TUMOR BIOL, V34, P2665, DOI 10.1007/s13277-013-0817-9; Ensinger C, 2006, J IMMUNOTHER, V29, P569, DOI 10.1097/01.cji.0000211303.52503.da; Epstein JI, 2006, J UROLOGY, V175, P820, DOI 10.1016/S0022-5347(05)00337-X; Epstein JI, 2004, MODERN PATHOL, V17, P307, DOI 10.1038/modpathol.3800050; Epstein JI, 2002, PROSTATE BIOPSY INTE, Vxiii; Fields ALA, 2009, J CLIN ONCOL, V27, P1941, DOI 10.1200/JCO.2008.18.5710; Fong D, 2013, HISTOPATHOLOGY; Fujita K, 2009, J UROLOGY, V182, P2664, DOI 10.1016/j.juro.2009.08.044; Gadalla SE, 2013, BIOCHEM BIOPH RES CO, V439, P203, DOI 10.1016/j.bbrc.2013.08.059; Gastl G, 2000, LANCET, V356, P1981, DOI 10.1016/S0140-6736(00)03312-2; Gires O, 2010, J CLIN ONCOL, V28, pE239, DOI 10.1200/JCO.2009.26.8540; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Hu CY, 2014, J BUON, V19, P215; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kawamoto K, 2007, CLIN CANCER RES, V13, P2541, DOI 10.1158/1078-0432.CCR-06-2225; Kisner H J, 1998, Clin Lab Manage Rev, V12, P277; Koochekpour S, 2012, CLIN CANCER RES, V18, P5888, DOI 10.1158/1078-0432.CCR-12-1308; Lin CW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386235; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mukherjee S, 2009, AM J PATHOL, V175, P2277, DOI 10.2353/ajpath.2009.090013; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Ni J, 2012, CANCER METAST REV, V31, P779, DOI 10.1007/s10555-012-9389-1; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Poczatek RB, 1999, J UROLOGY, V162, P1462, DOI 10.1016/S0022-5347(05)68341-3; Ralhan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014130; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Riethmuller G, 1998, J CLIN ONCOL, V16, P1788, DOI 10.1200/JCO.1998.16.5.1788; Saadatmand S, 2013, BRIT J SURG, V100, P252, DOI 10.1002/bjs.8980; Schmidt M, 2012, ANN ONCOL, V23, P2306, DOI 10.1093/annonc/mdr625; Schmidt M, 2010, ANN ONCOL, V21, P275, DOI 10.1093/annonc/mdp314; Schmoll HJ, 2009, J CLIN ONCOL, V27, P1926, DOI 10.1200/JCO.2008.20.6284; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simon M, 2013, EXPERT OPIN DRUG DEL, V10, P451, DOI 10.1517/17425247.2013.759938; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Soysal SD, 2013, BRIT J CANCER, V108, P1480, DOI 10.1038/bjc.2013.80; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Tripathi SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019213; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varga M, 2004, CLIN CANCER RES, V10, P3131, DOI 10.1158/1078-0432.CCR-03-0528; Wang J, 2013, ASIAN PAC J CANCER P, V14, P2023, DOI 10.7314/APJCP.2013.14.3.2023; Wang L, 2013, PROSTATE CANCER P D, V16, P301, DOI 10.1038/pcan.2013.25; Warneke VS, 2013, BRIT J CANCER, V109, P2217, DOI 10.1038/bjc.2013.536; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zellweger T, 2005, INT J CANCER, V113, P619, DOI 10.1002/ijc.20615; Zhao ZG, 2004, JPN J CLIN ONCOL, V34, P414, DOI 10.1093/jjco/hyh073	57	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0107586	10.1371/journal.pone.0107586	http://dx.doi.org/10.1371/journal.pone.0107586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695234	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300001
J	Ehsan, AM; Geurden, T; Casaert, S; Parvin, SM; Islam, TM; Ahmed, UM; Levecke, B; Vercruysse, J; Claerebout, E				Ehsan, Amimul M.; Geurden, Thomas; Casaert, Stijn; Parvin, Sonia M.; Islam, Taohidul M.; Ahmed, Uddin M.; Levecke, Bruno; Vercruysse, Jozef; Claerebout, Edwin			Assessment of Zoonotic Transmission of Giardia and Cryptosporidium between Cattle and Humans in Rural Villages in Bangladesh	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SURFACE-WATER; ASSEMBLAGE-A; DUODENALIS; DIARRHEA; PREVALENCE; INDIA; IDENTIFICATION; EPIDEMIOLOGY; INFECTIONS	Giardia and Cryptosporidium are important causes of diarrhoea in Bangladesh. The high prevalence of both parasites in humans and cattle in rural Bangladesh and the common use of water ponds by village inhabitants and their animals suggest a potential for zoonotic transmission. Direct transmission of Giardia and Cryptosporidium between cattle and their handlers and indirect transmission through water ponds was investigated. Faecal/stool samples were collected from 623 calves and 125 calf handlers in a cross-sectional survey. In two villages, water samples were collected monthly from water ponds and faecal/stool samples were collected monthly from inhabitants and their cattle. Giardia cysts and Cryptosporidium oocysts were detected in water samples and in faecal/stool samples and positive samples were genotyped, to determine their human or animal origin. The prevalence of Giardia and Cryptosporidium in calves was 22% and 5% respectively. In calf handlers, the prevalence of Giardia and Cryptosporidium was 11.2% and 3.2% respectively. Both in the cross-sectional survey and in the longitudinal study in the villages, G. duodenalis assemblage E was most prevalent in calves, while in humans assemblage AII, BIII and BIV were found. In cattle, Cryptosporidium parvum, C. bovis and C. andersoni were identified, but no Cryptosporidium sequences were obtained from humans. Giardia and Cryptosporidium were detected in 14/24 and 12/24 water samples respectively. G. duodenalis assemblage E and BIV (-like), as well as C. andersoni and C. hominis were identified. Although the presence of Giardia and Cryptosporidium in both water ponds suggests that water-borne transmission of Giardia and Cryptosporidium is possible, the genotyping results indicate that there is no significant direct or indirect (water-borne) transmission of Giardia between cattle and people in this area of rural Bangladesh. No conclusions could be drawn for Cryptosporidium, because of the low number of sequences that were obtained from human and water samples.	[Ehsan, Amimul M.; Geurden, Thomas; Casaert, Stijn; Levecke, Bruno; Vercruysse, Jozef; Claerebout, Edwin] Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Ehsan, Amimul M.; Parvin, Sonia M.; Islam, Taohidul M.; Ahmed, Uddin M.] Bangladesh Agr Univ, Dept Med, Mymensingh, Bangladesh	Ghent University; Bangladesh Agricultural University (BAU)	Claerebout, E (corresponding author), Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	edwin.claerebout@ugent.be	Islam, Md. Taohidul/AAL-3539-2020	Islam, Md. Taohidul/0000-0003-4213-2784; Claerebout, Edwin/0000-0002-8292-2791; Levecke, Bruno/0000-0001-8912-5595	Ghent University [01W05309]	Ghent University(Ghent University)	AME was supported by a doctoral scholarship for candidates from developing countries from Ghent University (grant No 01W05309) (http://www.ugent.be/en/research/funding/phd/bof/dos/docos.htm). BL is a postdoctoral fellow of the Fund for Scientific Research-Flanders (Belgium) (F.W.O.-Vlaanderen) (http://www.fwo.be/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayaz S, 2012, AFR J MICROBIOL RES, V6, P5383, DOI 10.5897/AJMR12.697; Caccio SM, 2005, TRENDS PARASITOL, V21, P430, DOI 10.1016/j.pt.2005.06.013; Cringoli G, 2002, VET PARASITOL, V108, P137, DOI 10.1016/S0304-4017(02)00183-8; Elwin K, 2012, INT J PARASITOL, V42, P675, DOI 10.1016/j.ijpara.2012.04.016; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Geurden T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/j.ijpara.2007.07.016; Geurden T, 2004, INT J PARASITOL, V34, P1121, DOI 10.1016/j.ijpara.2004.05.007; Gormley FJ, 2011, EMERG INFECT DIS, V17, P151, DOI 10.3201/eid1701.100902; Haque R, 2005, J INFECT DIS, V192, P2171, DOI 10.1086/498169; Haque R, 2009, CLIN INFECT DIS, V48, P1191, DOI 10.1086/597580; Hasan KZ, 2006, J HEALTH POPUL NUTR, V24, P25; Karn SK, 2001, ENVIRON MANAGE, V28, P483; Khan SM, 2011, VET PARASITOL, V178, P342, DOI 10.1016/j.vetpar.2011.01.029; Khan WA, 2004, AM J TROP MED HYG, V71, P412, DOI 10.4269/ajtmh.2004.71.412; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Laishram S, 2012, EPIDEMIOL INFECT, V140, P2023, DOI 10.1017/S0950268811002767; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Levecke B, 2009, INT J PARASITOL, V39, P1595, DOI 10.1016/j.ijpara.2009.05.013; McCuin RM, 2003, APPL ENVIRON MICROB, V69, P267, DOI 10.1128/AEM.69.1.267-274.2003; Morgan UM, 2001, INT J PARASITOL, V31, P289, DOI 10.1016/S0020-7519(00)00164-8; Paul S, 2008, VET PARASITOL, V153, P143, DOI 10.1016/j.vetpar.2008.01.044; Peng MM, 2001, J EUKARYOT MICROBIOL, p28S; Quilez J, 1996, VET PARASITOL, V66, P139, DOI 10.1016/S0304-4017(96)01015-1; Rahman AKMA, 2013, PREV VET MED, V110, P242, DOI 10.1016/j.prevetmed.2012.11.029; RAHMAN ASMH, 1985, INDIAN J MED RES, V82, P510; RAHMAN M, 1990, AM J TROP MED HYG, V42, P127, DOI 10.4269/ajtmh.1990.42.127; Rahman S, 2008, WATER RESOUR MANAG, V22, P377, DOI 10.1007/s11269-007-9167-y; Robertson LJ, 2010, VET PARASITOL, V171, P140, DOI 10.1016/j.vetpar.2010.03.014; Roy SS, 2006, VET PARASITOL, V141, P330, DOI 10.1016/j.vetpar.2006.06.017; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003; Smith HV, 2007, VET PARASITOL, V149, P29, DOI 10.1016/j.vetpar.2007.07.015; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Thompson RCA, 2011, VET PARASITOL, V182, P70, DOI 10.1016/j.vetpar.2011.07.016; World Health Organisation, 2005, WORLD HLTH REP MAK E; Xiao LH, 2001, APPL ENVIRON MICROB, V67, P1097, DOI 10.1128/AEM.67.3.1097-1101.2001; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	38	27	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118239	10.1371/journal.pone.0118239	http://dx.doi.org/10.1371/journal.pone.0118239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695662	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300045
J	Lu, J; He, Q; Huang, LY; Cai, XF; Guo, WW; He, J; Zhang, LL; Li, AY				Lu, Jin; He, Qiang; Huang, Luyao; Cai, Xiaofeng; Guo, Wenwen; He, Jing; Zhang, Lili; Li, Aiying			Accumulation of a Bioactive Benzoisochromanequinone Compound Kalafungin by a Wild Type Antitumor-Medermycin-Producing Streptomycete Strain	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; ACTINORHODIN; ANTIBIOTICS; EXPRESSION; KETOREDUCTASE; DISCOVERY; AM-7161; SYSTEMS; CLONING	Medermycin and kalafungin, two antibacterial and antitumor antibiotics isolated from different streptomycetes, share an identical polyketide skeleton core. The present study reported the discovery of kalafungin in a medermycin-producing streptomycete strain for the first time. A mutant strain obtained through UV mutagenesis showed a 3-fold increase in the production of this antibiotic, compared to the wild type strain. Heterologous expression experiments suggested that its production was severely controlled by the gene cluster for medermycin biosynthesis. In all, these findings suggested that kalafungin and medermycin could be accumulated by the same streptomycete and share their biosynthetic pathway to some extent in this strain.	[Lu, Jin; Li, Aiying] Shandong Univ, Shandong Univ Helmholtz Joint Inst Biotechnol, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Lu, Jin; Li, Aiying] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [He, Qiang; Huang, Luyao; Cai, Xiaofeng; Guo, Wenwen; Li, Aiying] Cent China Normal Univ, Sch Life Sci, Wuhan 430079, Peoples R China; [He, Jing] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Zhang, Lili] Tarim Univ, Xinjiang Prod & Construct Corps, Key Lab Protect & Utilizat Biol Resources Tarim B, Alar 843300, Xinjiang, Peoples R China	Shandong University; Shandong University; Central China Normal University; Huazhong Agricultural University; Tarim University	Li, AY (corresponding author), Shandong Univ, Shandong Univ Helmholtz Joint Inst Biotechnol, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	ayli@sdu.edu.cn	He, Jing/ABB-7225-2020		National Natural Science Foundation of China [31170050, 30770036]; Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin [BRZD1401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin	The authors got financial support from (1) National Natural Science Foundation of China (URL: http://www.nsfc.gov.cn/) (No. 31170050 and 30770036); (2) Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin (URL: http://lab.taru.edu.cn/)( No. BRZD1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Deng HQ, 2010, J BASIC MICROB, V50, P299, DOI 10.1002/jobm.200900240; Donner CD, 2013, TETRAHEDRON, V69, P377, DOI 10.1016/j.tet.2012.10.012; Ichinose K, 2003, MICROBIOL-SGM, V149, P1633, DOI 10.1099/mic.0.26310-0; Ichinose K., 1998, ACTINOMYCETOL, V12, P99; JOHNSON LE, 1968, APPL MICROBIOL, V16, P1815, DOI 10.1128/AEM.16.12.1815-1821.1968; KAKINUMA S, 1990, J ANTIBIOT, V43, P391, DOI 10.7164/antibiotics.43.391; KAKINUMA S, 1991, J ANTIBIOT, V44, P995, DOI 10.7164/antibiotics.44.995; KAKINUMA S, 1995, J ANTIBIOT, V48, P484, DOI 10.7164/antibiotics.48.484; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Li AY, 2005, BIOORGAN MED CHEM, V13, P6856, DOI 10.1016/j.bmc.2005.07.060; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Metsa-Ketela M, 2013, CURR OPIN CHEM BIOL, V17, P562, DOI 10.1016/j.cbpa.2013.06.032; Moore BS, 2002, NAT PROD REP, V19, P70, DOI 10.1039/b003939j; OCHI K, 1990, J BACTERIOL, V172, P4008, DOI 10.1128/jb.172.7.4008-4016.1990; Okamoto S, 2009, CHEM BIOL, V16, P226, DOI 10.1016/j.chembiol.2009.01.015; Sambrook J., 2001, MOL CLONING LAB MANU; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Sun Rui, 2012, Weishengwu Xuebao, V52, P60; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; TAKANO S, 1976, J ANTIBIOT, V29, P765, DOI 10.7164/antibiotics.29.765; Toral-Barza L, 2007, MOL CANCER THER, V6, P3028, DOI 10.1158/1535-7163.MCT-07-0211; TSUJIBO H, 1990, CHEM PHARM BULL, V38, P2299, DOI 10.1248/cpb.38.2299; Zaburannyi N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-97; Zhang HY, 2012, FEMS MICROBIOL LETT, V332, P105, DOI 10.1111/j.1574-6968.2012.02582.x; Zhou Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S8	28	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117690	10.1371/journal.pone.0117690	http://dx.doi.org/10.1371/journal.pone.0117690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695632	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300028
J	Rommler, F; Hammel, M; Waldhuber, A; Muller, T; Jurk, M; Uhlmann, E; Wagner, H; Vollmer, J; Miethke, T				Roemmler, Franziska; Hammel, Monika; Waldhuber, Anna; Mueller, Tina; Jurk, Marion; Uhlmann, Eugen; Wagner, Hermann; Vollmer, Joerg; Miethke, Thomas			Guanine-Modified Inhibitory Oligonucleotides Efficiently Impair TLR7-and TLR9-Mediated Immune Responses of Human Immune Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; NUCLEIC-ACIDS; I INTERFERON; CPG; TLR9; IDENTIFICATION; UNC93B1; RNA; TOLL-LIKE-RECEPTOR-7	Activation of TLR7 and TLR9 by endogenous RNA-or DNA-containing ligands, respectively, is thought to contribute to the complicated pathophysiology of systemic lupus erythematosus (SLE). These ligands induce the release of type-I interferons by plasmacytoid dendritic cells and autoreactive antibodies by B-cells, both responses being key events in perpetuating SLE. We recently described the development of inhibitory oligonucleotides (INH-ODN), which are characterized by a phosphorothioate backbone, a CC(T) XXX(3-5)GGG motif and a chemical modification of the G-quartet to avoid the formation of higher order structures via intermolecular G-tetrads. These INH-ODNs were equally or significantly more efficient to impair TLR7- and TLR9-stimulated murine B-cells, macrophages, conventional and plasmacytoid dendritic cells than the parent INH-ODN 2088, which lacks G-modification. Here, we evaluate the inhibitory/therapeutic potential of our set of G-modified INH-ODN on human immune cells. We report the novel finding that G-modified INH-ODNs efficiently inhibited the release of IFN-alpha by PBMC stimulated either with the TLR7-ligand oligoribonucleotide (ORN) 22075 or the TLR9-ligand CpG-ODN 2216. G-modification of INH-ODNs significantly improved inhibition of IL-6 release by PBMCs and purified human B-cells stimulated with the TLR7-ligand imiquimod or the TLR9-ligand CpG-ODN 2006. Furthermore, inhibition of B-cell activation analyzed by expression of activation markers and intracellular ATP content was significantly improved by G-modification. As observed with murine B-cells, high concentrations of INH-ODN 2088 but not of G-modified INH-ODNs stimulated IL-6 secretion by PBMCs in the absence of TLR-ligands thus limiting its blocking efficacy. In summary, G-modification of INH-ODNs improved their ability to impair TLR7- and TLR9-mediated signaling in those human immune cells which are considered as crucial in the pathophysiology of SLE.	[Roemmler, Franziska; Hammel, Monika; Waldhuber, Anna; Mueller, Tina; Wagner, Hermann] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-80290 Munich, Germany; [Jurk, Marion] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Uhlmann, Eugen] Adiutide Pharmaceut GmbH, Frankfurt, Germany; [Vollmer, Joerg] Nexigen GmbH, Cologne, Germany; [Miethke, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Med Microbiol & Hyg, Mannheim, Germany	Technical University of Munich; Miltenyi Biotec; Ruprecht Karls University Heidelberg	Miethke, T (corresponding author), Heidelberg Univ, Med Fac Mannheim, Inst Med Microbiol & Hyg, Mannheim, Germany.	Thomas.Miethke@medma.uni-heidelberg.de			Coley Pharmaceutical GmbH; Bundesministerium fur Bildung und Forschung (BMBF) [01EX1022Q]; Nexigen GmbH	Coley Pharmaceutical GmbH; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Nexigen GmbH	This project was integrated into the m4 cluster in Munich, and funded by Coley Pharmaceutical GmbH and the Bundesministerium fur Bildung und Forschung (BMBF, grant 01EX1022Q). The funders had no role in study design, data collection and analysis, decision to publish, or in the preparation of the manuscript. Coauthor Marion Jurk is employed by Miltenyi Biotec GmbH. Co-author Eugen Uhlmann is employed by Adiutide Pharmaceuticals GmbH and co-author Jorg Vollmer is employed by Nexigen GmbH. Miltenyi Biotec GmbH, Adiutide Pharmaceuticals GmbH and Nexigen GmbH provided support in the form of salaries for authors MJ, EU and JV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section..	Armstrong DL, 2009, GENES IMMUN, V10, P446, DOI 10.1038/gene.2009.38; Ashman RF, 2011, INT IMMUNOPHARMACOL, V11, P1032, DOI 10.1016/j.intimp.2011.02.023; Ashman RF, 2011, INT IMMUNOL, V23, P203, DOI 10.1093/intimm/dxq473; AUSTIN HA, 1986, NEW ENGL J MED, V314, P614, DOI 10.1056/NEJM198603063141004; Avalos AM, 2011, EUR J IMMUNOL, V41, P2820, DOI 10.1002/eji.201141563; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Duramad O, 2005, J IMMUNOL, V174, P5193, DOI 10.4049/jimmunol.174.9.5193; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jurk M, 2006, EUR J IMMUNOL, V36, P1815, DOI 10.1002/eji.200535806; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koh YT, 2013, J IMMUNOL, V190, P4982, DOI 10.4049/jimmunol.1202986; Kono DH, 2013, CURR OPIN IMMUNOL, V25, P720, DOI 10.1016/j.coi.2013.10.006; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lenert P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2710; Lenert PS, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/986596; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peter M, 2008, IMMUNOLOGY, V123, P118, DOI 10.1111/j.1365-2567.2007.02718.x; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Rommler F, 2013, J IMMUNOL, V191, P3240, DOI 10.4049/jimmunol.1300706; Rovin BH, 2014, AM J KIDNEY DIS; Sasai M, 2011, IMMUNITY, V35, P3, DOI 10.1016/j.immuni.2011.07.006; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stunz LL, 2002, EUR J IMMUNOL, V32, P1212, DOI 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO;2-D; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	44	21	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116703	10.1371/journal.pone.0116703	http://dx.doi.org/10.1371/journal.pone.0116703			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695778	Green Published, gold			2022-12-27	WOS:000350062300016
J	Maxwell, L; Devries, K; Zionts, D; Alhusen, JL; Campbell, J				Maxwell, Lauren; Devries, Karen; Zionts, Danielle; Alhusen, Jeanne L.; Campbell, Jacquelyn			Estimating the Effect of Intimate Partner Violence on Women's Use of Contraception: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SOUTH-AFRICAN WOMEN; DOMESTIC VIOLENCE; PREGNANCY; HIV; PREVALENCE; PREVENTION; HEALTH; RISK; HETEROGENEITY; EXPERIENCES	Background Intimate partner violence (IPV) is an important global public health problem. While there is a growing literature on the association between IPV and women's reproductive health (RH) outcomes, most studies are cross-sectional-which weakens inference about the causal effect of IPV on women's RH. This systematic review synthesizes existing evidence from the strongest study designs to estimate the impact of IPV on women's use of contraception. Methods We searched 11 electronic databases from January of 1980 to 3 December 2013 and reviewed reference lists from systematic reviews for studies examining IPV and contraceptive use. To be able to infer causality, we limited our review to studies that had longitudinal measures of either IPV or women's use of contraception. Results Of the 1,574 articles identified by the search, we included 179 articles in the full text review and extracted data from 12 studies that met our inclusion criteria. We limited the meta-analysis to seven studies that could be classified as subject to low or moderate levels of bias. Women's experience of IPV was associated with a significant reduction in the odds of using contraception (n = 14,866; OR: 0.47; 95% CI: 0.25, 0.85; I-2 = 92%; 95% CII2 2: 87%, 96%). Restricting to studies that measured the effect of IPV on women's use of partner dependent contraceptive methods was associated with a reduction in the heterogeneity of the overall estimate. In the three studies that examined women's likelihood of using male condoms with their partners, experience of IPV was associated with a significant decrease in condom use (OR: 0.48; 95% CIOR: 0.32, 0.72; I-2 = 51%; 95% CI(I)2: 0%, 86%). Conclusions IPV is associated with a reduction in women's use of contraception; women who experience IPV are less likely to report using condoms with their male partners. Family planning and HIV prevention programs should consider women's experiences of IPV.	[Maxwell, Lauren; Zionts, Danielle] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Devries, Karen] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Social & Math Epidemiol Grp, London WC1, England; [Devries, Karen] London Sch Hyg & Trop Med, Gender Violence & Hlth Ctr, Dept Global Hlth & Dev, London WC1, England; [Alhusen, Jeanne L.; Campbell, Jacquelyn] Johns Hopkins Univ, Sch Nursing, Dept Community Publ Hlth, Baltimore, MD USA	McGill University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University	Maxwell, L (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	lauren.maxwell@mail.mcgill.ca	Devries, Karen/K-1083-2016	Devries, Karen/0000-0001-8935-2181; Alhusen, Jeanne/0000-0001-9492-1932; Maxwell, Lauren/0000-0002-0777-2092	Maternal and Child Health Equity Project (MACHEquity) - Canadian Institutes of Health Research	Maternal and Child Health Equity Project (MACHEquity) - Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding support for the preparation of this manuscript was provided by the Maternal and Child Health Equity Project (MACHEquity), funded by the Canadian Institutes of Health Research. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Alio AP, 2009, INT J GYNECOL OBSTET, V107, P35, DOI 10.1016/j.ijgo.2009.05.002; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; [Anonymous], 2013, Obstet Gynecol, V121, P411, DOI 10.1097/01.AOG.0000426427.79586.3b; Baker WL, 2009, INT J CLIN PRACT, V63, P1426, DOI 10.1111/j.1742-1241.2009.02168.x; Borenstein M., 2009, INTRO METAANALYSIS; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Chamberlain L., 2013, ADDRESSING INTIMATE, V3rd; Clark LE, 2013, AM J OBSTET GYNECOL, DOI [10.1097/IGC.0000000000000339, DOI 10.1097/IGC.0000000000000339]; Coggins Margi, 2003, Issues Ment Health Nurs, V24, P723; Coker AL, 2007, TRAUMA VIOLENCE ABUS, V8, P149, DOI 10.1177/1524838007301162; Commodity Security Branch UNPF, 2011, NIC COUNTR PROF; de Bocanegra HT, 2010, VIOLENCE AGAINST WOM, V16, P601, DOI 10.1177/1077801210366965; Deeks J, 2011, COCHRANE HDB SYSTEMA, V5; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Dude AM, 2011, AIDS BEHAV, V15, P142, DOI 10.1007/s10461-009-9526-1; Dutton Mary Ann, 2005, Violence Vict, V20, P483, DOI 10.1891/088667005780927520; Egger M, 1998, BRIT MED J, V316, P140; El-Bassel N, 2005, SOC SCI MED, V61, P171, DOI 10.1016/j.socscimed.2004.11.035; Ellsberg M, 2002, LANCET, V359, P1599, DOI 10.1016/S0140-6736(02)08521-5; Ellsberg M, 2001, STUD FAMILY PLANN, V32, P1, DOI 10.1111/j.1728-4465.2001.00001.x; Ely GE, 2011, J INTERPERS VIOLENCE, V26, P3248, DOI 10.1177/0886260510393004; Fanslow J, 2008, AUST NZ J OBSTET GYN, V48, P83, DOI 10.1111/j.1479-828X.2007.00805.x; Fantasia HC, 2012, CONTRACEPTION, V86, P530, DOI 10.1016/j.contraception.2012.03.005; Field A. P., 2003, UNDERSTANDING STAT, V2, P105, DOI DOI 10.1207/S15328031US0202_02; Gee RE, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.048; Gracia E, 2004, J EPIDEMIOL COMMUN H, V58, P536, DOI 10.1136/jech.2003.019604; Hall M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001581; Hathaway Jeanne E, 2005, J Am Med Womens Assoc (1972), V60, P42; Friedman SH, 2007, J WOMENS HEALTH, V16, P471, DOI 10.1089/jwh.2006.0115; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hindin M.J., 2008, INTIMATE PARTNER VIO; Howards PP, 2012, AM J EPIDEMIOL, V176, P506, DOI 10.1093/aje/kws127; Hung KJ, 2012, OBSTET GYNECOL, V119, P975, DOI 10.1097/AOG.0b013e31824fc9a0; Ioannidis JPA, 2008, J EVAL CLIN PRACT, V14, P951, DOI 10.1111/j.1365-2753.2008.00986.x; Jacoby M, 1999, AM J PREV MED, V16, P318, DOI 10.1016/S0749-3797(99)00029-X; Jewkes R, 2000, REPROD HEALTH MATTER, V8, P93, DOI 10.1016/S0968-8080(00)90010-7; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024256; Jones DL, 2013, AIDS CARE, V25, P702, DOI 10.1080/09540121.2013.772280; Kacanek D, 2013, JAIDS-J ACQ IMM DEF, V64, P400, DOI 10.1097/QAI.0b013e3182a6b0be; Kouyoumdjian FG, 2013, AIDS, V27, P1331, DOI 10.1097/QAD.0b013e32835fd851; McCarraher DR, 2006, J BIOSOC SCI, V38, P169, DOI 10.1017/S0021932005025897; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Miller E, 2007, AMBUL PEDIATR, V7, P360, DOI 10.1016/j.ambp.2007.05.007; Miller E, 2014, CONTRACEPTION, V89, P122, DOI 10.1016/j.contraception.2013.10.011; Miller E, 2010, CONTRACEPTION, V81, P316, DOI 10.1016/j.contraception.2009.12.004; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moore AM, 2010, SOC SCI MED, V70, P1737, DOI 10.1016/j.socscimed.2010.02.009; Organization WH, 2013, SUMM RESP INT PARTN; Orsini N., 2006, HETEROGI STATA MODUL; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Raneri LG, 2007, PERSPECT SEX REPRO H, V39, P39, DOI 10.1363/3903907; Reeves S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub2; Salazar M, 2012, J FAM PLAN REPROD H, V38, P221, DOI 10.1136/jfprhc-2011-000043; Schunemann HJ, 2011, COCHRANE HDB SYSTEMA; Scribano PV, 2013, MATERN CHILD HLTH J, V17, P307, DOI 10.1007/s10995-012-0986-y; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Steichen T., 2001, ECONPAPERS; Stephenson R, 2013, J INTERPERS VIOLENCE, V28, P1020, DOI 10.1177/0886260512459379; Stupp PW, 2007, REPROD MATERNAL CHIL; Teitelman AM, 2008, JOGNN-J OBST GYN NEO, V37, P219, DOI 10.1111/j.1552-6909.2008.00231.x; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3; Van der Wijden C, 2003, COCHRANE DATABASE SY, V4; Van Horne BS, 2009, AM J PUBLIC HEALTH, V99, pS417, DOI 10.2105/AJPH.2007.131870; Weed DL, 2000, INT J EPIDEMIOL, V29, P387, DOI 10.1093/ije/29.3.387; Williams CM, 2008, VIOLENCE AGAINST WOM, V14, P1382, DOI 10.1177/1077801208325187; Wingood GM, 2006, AM J PUBLIC HEALTH, V96, P1085, DOI 10.2105/AJPH.2004.053595; World Health Organization, 2021, VIOL WOM PREV EST 20	75	89	91	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118234	10.1371/journal.pone.0118234	http://dx.doi.org/10.1371/journal.pone.0118234			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25693056	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000350061500111
J	Thompson, PL; Davies, TJ; Gonzalez, A				Thompson, Patrick L.; Davies, T. Jonathan; Gonzalez, Andrew			Ecosystem Functions across Trophic Levels Are Linked to Functional and Phylogenetic Diversity	PLOS ONE			English	Article							TOP-DOWN CONTROL; SPECIES RICHNESS; BIODIVERSITY; PRODUCTIVITY; COMMUNITIES; ECOLOGY; LAKES; COMPLEMENTARITY; PHYTOPLANKTON; EXTINCTION	In experimental systems, it has been shown that biodiversity indices based on traits or phylogeny can outperform species richness as predictors of plant ecosystem function. However, it is unclear whether this pattern extends to the function of food webs in natural ecosystems. Here we tested whether zooplankton functional and phylogenetic diversity explains the functioning of 23 natural pond communities. We used two measures of ecosystem function: (1) zooplankton community biomass and (2) phytoplankton abundance (Chl a). We tested for diversity-ecosystem function relationships within and across trophic levels. We found a strong correlation between zooplankton diversity and ecosystem function, whereas local environmental conditions were less important. Further, the positive diversity- ecosystem function relationships were more pronounced for measures of functional and phylogenetic diversity than for species richness. Zooplankton and phytoplankton biomass were best predicted by different indices, suggesting that the two functions are dependent upon different aspects of diversity. Zooplankton community biomass was best predicted by zooplankton trait-based functional richness, while phytoplankton abundance was best predicted by zooplankton phylogenetic diversity. Our results suggest that the positive relationship between diversity and ecosystem function can extend across trophic levels in natural environments, and that greater insight into variation in ecosystem function can be gained by combining functional and phylogenetic diversity measures.	[Thompson, Patrick L.; Davies, T. Jonathan; Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Thompson, PL (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	patrick.thompson@mail.mcgill.ca	Thompson, Patrick L/B-6213-2012; Gonzalez, Andrew/F-2247-2010	Thompson, Patrick L/0000-0002-5278-9045; Gonzalez, Andrew/0000-0001-6075-8081	NSERC Postgraduate Fellowship; Vineberg Fellowship in Freshwater/Limnology; NSERC Discovery Grant; Canada Research Chair program; Quebec Centre for Biodiversity Science	NSERC Postgraduate Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vineberg Fellowship in Freshwater/Limnology; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); Quebec Centre for Biodiversity Science	PLT was supported by an NSERC Postgraduate Fellowship (http://www.nserc-crsng.gc.ca) and a Vineberg Fellowship in Freshwater/Limnology (http://biology.mcgill.ca/grad/grad_gen_awards&scholarsh.html). AG was supported by an NSERC Discovery Grant (http://www.nserc-crsng.gc.ca), the Canada Research Chair program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx), and the Quebec Centre for Biodiversity Science (http://qcbs.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, COPEPOD EVOLUTION; Barnett AJ, 2007, FRESHWATER BIOL, V52, P796, DOI 10.1111/j.1365-2427.2007.01733.x; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Brandl Z, 1998, J MARINE SYST, V15, P87, DOI 10.1016/S0924-7963(97)00042-0; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Cadotte MW, 2013, P NATL ACAD SCI USA, V110, P8996, DOI 10.1073/pnas.1301685110; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Clark CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052821; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; Grace JB., 2015, STRUCTURAL EQUATION; Griffin JN, 2013, ECOLOGY, V94, P2180, DOI 10.1890/13-0179.1; Haney J. F, 2010, AN IMAGE BASED KEY Z; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Laliberte E., 2014, FD MEASURING FUNCTIO; Legendre P, 2013, LMODEL2 MODEL 2 REGR; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Lumley T., 2009, LEAPS REGRESSION SUB; McCauley E., 1984, IBP HDB, P228; MCQUEEN DJ, 1986, CAN J FISH AQUAT SCI, V43, P1571, DOI 10.1139/f86-195; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Oksanen J., 2016, R PACKAG; Orme D., 2018, R PACKAGE VERSION, V5, P1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pavoine S, 2013, J VEG SCI, V24, P781, DOI 10.1111/jvs.12051; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2009, BIODIVERSITY ECOSYST, DOI [10.1093/acprof:oso/9780199547951.003.0004, DOI 10.1093/ACPROF:OSO/9780199547951.003.0004]; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Schmitz OJ, 2009, ECOLOGY, V90, P2339, DOI 10.1890/08-1919.1; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wetzel RG., 1979, LIMNOLOGICAL ANAL; Ye L, 2013, J ANIM ECOL, V82, P1052, DOI 10.1111/1365-2656.12067; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	57	54	57	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117595	10.1371/journal.pone.0117595	http://dx.doi.org/10.1371/journal.pone.0117595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693188	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500063
J	Wallis, BA; Watt, K; Franklin, RC; Nixon, JW; Kimble, RM				Wallis, Belinda A.; Watt, Kerrianne; Franklin, Richard C.; Nixon, James W.; Kimble, Roy M.			Drowning Mortality and Morbidity Rates in Children and Adolescents 0-19yrs: A Population-Based Study in Queensland, Australia	PLOS ONE			English	Article							ACCIDENTS INVOLVING CHILDREN; IMMERSION ACCIDENTS; CHILDHOOD; BRISBANE	Objective To redress the lack of Queensland population incidence mortality and morbidity data associated with drowning in those aged 0-19yrs, and to understand survival and patient care. Design, Setting and Participants Retrospective population-based study used data linkage to capture both fatal and non-fatal drowning cases (N = 1299) among children aged 0-19years in Queensland, from 2002-2008 inclusive. Patient data were accessed from pre-hospital, emergency department, hospital admission and death data, and linked manually to collate data across the continuum of care. Main Outcome Measures Incidence rates were calculated separately by age group and gender for events resulting in death, hospital admission, and non-admission. Trends over time were analysed. Results Drowning death to survival ratio was 1: 10, and two out of three of those who survived were admitted to hospital. Incidence rates for fatal and non-fatal drowning increased over time, primarily due to an increase in non-fatal drowning. There were non-significant reductions in fatal and admission rates. Rates for non-fatal drowning that did not result in hospitalisation more than doubled over the seven years. Children aged 5-9yrs and 10-14yrs incurred the lowest incidence rates 6.38 and 4.62 (expressed as per 100,000), and the highest rates were among children aged 0-4yrs (all drowning events 43.90; fatal 4.04; non-fatal 39.85-comprising admission 26.69 and non-admission 13.16). Males were over-represented in all age groups except 10-14yrs. Total male drowning events increased 44% over the seven years (P<0.001). Conclusion This state-wide data collection has revealed previously unknown incidence and survival ratios. Increased trends in drowning survival rates may be viewed as both positive and challenging for drowning prevention and the health system. Males are over-represented, and although infants and toddlers did not have increased fatality rates, they had the greatest drowning burden demonstrating the need for continued drowning prevention efforts.	[Wallis, Belinda A.; Watt, Kerrianne; Franklin, Richard C.; Nixon, James W.; Kimble, Roy M.] Univ Queensland, Queensland Childrens Med Res Inst, Ctr Childrens Burns & Trauma Res, Brisbane, Qld, Australia; [Wallis, Belinda A.; Kimble, Roy M.] Royal Childrens Hosp, Paediat Burns & Trauma Network, Brisbane, Qld, Australia; [Watt, Kerrianne; Franklin, Richard C.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia; [Franklin, Richard C.] Royal Life Saving Soc Australia, Sydney, NSW, Australia	University of Queensland; Royal Children's Hospital Brisbane; James Cook University	Wallis, BA (corresponding author), Univ Queensland, Queensland Childrens Med Res Inst, Ctr Childrens Burns & Trauma Res, Brisbane, Qld, Australia.	belinda.wallis@uqconnect.edu.au	Franklin, Richard Charles/H-1731-2012; Watt, Kerrianne/G-2520-2010; Wallis, Belinda/F-6449-2010	Franklin, Richard Charles/0000-0003-1864-4552; Watt, Kerrianne/0000-0002-2275-081X; Wallis, Belinda/0000-0001-8137-7915; Kimble, Roy/0000-0002-2449-7707	Queensland Injury Prevention Council (QIPC) [00.01/01]	Queensland Injury Prevention Council (QIPC)	This work was supported by the Queensland Injury Prevention Council (QIPC) Grant #00.01/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS Australian Bureau of Statistics, 2012, 4730D0032006 ABS; AWSC Australian Water Safety Council, 2012, AUSTR WAT SAF STRAT; Branche C., 2008, WORLD REPORT CHILD I; Cass DT, 1996, MED J AUSTRALIA, V165, P610, DOI 10.5694/j.1326-5377.1996.tb138663.x; CCYPCG, 2009, ANN REP DEATHS CHILD; CDC Centers for Disease Control and Prevention, 2014, WISQARS 2002 2008 US; Edmond KM, 2001, MED J AUSTRALIA, V175, P605, DOI 10.5694/j.1326-5377.2001.tb143744.x; Franklin RC, 2010, MED J AUSTRALIA, V192, P123, DOI 10.5694/j.1326-5377.2010.tb03448.x; Henley G, 2009, INJURY DEATHS AUSTR; Idris AH, 2003, RESUSCITATION, V59, P45, DOI 10.1016/j.resuscitation.2003.09.003; Kreisfeld R, 2008, DEATHS HOSPITALISATI; NIXON J, 1986, ACCIDENT ANAL PREV, V18, P199, DOI 10.1016/0001-4575(86)90003-5; Peam J, 1977, MED J AUSTRALIA, V2, P770; PEARN J, 1978, RESUSCITATION, V6, P271, DOI 10.1016/0300-9572(78)90008-4; PEARN J, 1976, MED J AUSTRALIA, V2, P942, DOI 10.5694/j.1326-5377.1976.tb115532.x; PEARN JH, 1979, ACCIDENT ANAL PREV, V11, P173, DOI 10.1016/0001-4575(79)90002-2; Peden M, 2002, INJURY CHART BOOK GR; PITT WR, 1986, MED J AUSTRALIA, V144, P683, DOI 10.5694/j.1326-5377.1986.tb113695.x; PITT WR, 1991, MED J AUSTRALIA, V154, P661, DOI 10.5694/j.1326-5377.1991.tb121253.x; RLSSA, 2013, NAT DROWN REP 2013; RLSSA Royal Life Saving Association Australia, 2012, NAT DROWN REP 2012; Scott Ian, 2003, Inj Control Saf Promot, V10, P227, DOI 10.1076/icsp.10.4.227.16783; Steenkamp M, 2002, PERSISTING MORBIDITY; Thompson D, 2000, COCHRANE DB SYST REV; van Beeck EF, 2005, B WORLD HEALTH ORGAN, V83, P853; WHO, 2004, FACTS INJ DROWN; World Health Organization, 2008, GLOB BURD DIS 2004 U	27	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117948	10.1371/journal.pone.0117948	http://dx.doi.org/10.1371/journal.pone.0117948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714360	Green Accepted, gold, Green Published			2022-12-27	WOS:000350168700045
J	Romanets-Korbut, O; Najakshin, AM; Yurchenko, M; Malysheva, TA; Kovalevska, L; Shlapatska, LM; Zozulya, YA; Taranin, AV; Horvat, B; Sidorenko, SP				Romanets-Korbut, Olga; Najakshin, Alexander M.; Yurchenko, Mariya; Malysheva, Tatyana A.; Kovalevska, Larysa; Shlapatska, Larysa M.; Zozulya, Yuriy A.; Taranin, Alexander V.; Horvat, Branka; Sidorenko, Svetlana P.			Expression of CD150 in Tumors of the Central Nervous System: Identification of a Novel Isoform	PLOS ONE			English	Article							LYMPHOCYTIC ACTIVATION MOLECULE; MEASLES-VIRUS STRAINS; MONOCLONAL-ANTIBODIES; CELLULAR RECEPTOR; DENDRITIC CELLS; SLAM; SAP; CDW150; IPO-3	CD150 (IPO3/SLAM) belongs to the SLAM family of receptors and serves as a major entry receptor for measles virus. CD150 is expressed on normal and malignant cells of the immune system. However, little is known about its expression outside the hematopoietic system, especially tumors of the central nervous system (CNS). Although CD150 was not found in different regions of normal brain tissues, our immunohistochemical study revealed its expression in 77.6% of human CNS tumors, including glioblastoma, anaplastic astrocytoma, diffuse astrocytoma, ependymoma, and others. CD150 was detected in the cytoplasm, but not on the cell surface of glioma cell lines, and it was colocalized with the endoplasmic reticulum and Golgi complex markers. In addition to the full length mRNA of the mCD150 splice isoform, in glioma cells we found a highly expressed novel CD150 transcript (nCD150), containing an 83 bp insert. The insert is derived from a previously unrecognized exon designated Cyt-new, which is located 510 bp downstream of the transmembrane region exon, and is a specific feature of primate SLAMF1. Both mCD150 and nCD150 cDNA variants did not contain any mutations and had the leader sequence. The nCD150 transcript was also detected in normal and malignant B lymphocytes, primary T cells, dendritic cells and macrophages; however, in glioma cells nCD150 was found to be the predominant CD150 isoform. Similarly to mCD150, cell surface expression of nCD150 allows wild type measles virus entry to the cell. Our data indicate that CD150 expression in CNS tumors can be considered a new diagnostic marker and potential target for novel therapeutic approaches.	[Romanets-Korbut, Olga; Yurchenko, Mariya; Kovalevska, Larysa; Shlapatska, Larysa M.; Sidorenko, Svetlana P.] NAS Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Lab Signal Transduct Pathways, Kiev, Ukraine; [Romanets-Korbut, Olga; Horvat, Branka] Univ Lyon, CIRI, Int Ctr Infectiol Res, IbIV Team, Lyon, France; [Romanets-Korbut, Olga; Horvat, Branka] INSERM, U1111, F-69008 Lyon, France; [Romanets-Korbut, Olga; Malysheva, Tatyana A.; Horvat, Branka] CNRS, UMR5308, Lyon, France; [Romanets-Korbut, Olga; Horvat, Branka] Univ Lyon 1, F-69365 Lyon, France; [Romanets-Korbut, Olga; Horvat, Branka] Ecole Normale Super Lyon, F-69364 Lyon, France; [Najakshin, Alexander M.; Taranin, Alexander V.] SB RAS, Inst Mol & Cellular Biol, Immunogenet Lab, Novosibirsk, Russia; [Zozulya, Yuriy A.] NAMS Ukraine, AP Romodanov Inst Neurosurg, Neuropathomorphol Dept, Kiev, Ukraine; [Taranin, Alexander V.] Novosibirsk State Univ, Novosibirsk 630090, Russia	National Academy of Sciences Ukraine; Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology of NASU; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Russian Academy of Sciences; National Academy of Medical Sciences of Ukraine; Romodanov Neurosurgery Institute; Novosibirsk State University	Sidorenko, SP (corresponding author), NAS Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Lab Signal Transduct Pathways, Kiev, Ukraine.	svitasyd@yahoo.com	Horvat, Branka/M-3504-2014; Najakshin, Alexander M/N-7968-2015; Malysheva, Tatyana A./C-4793-2017; Taranin, Alexander/N-5136-2015	Horvat, Branka/0000-0003-0578-7765; Malysheva, Tatyana A./0000-0003-4071-8327; Taranin, Alexander/0000-0002-9184-4238; Yurchenko, Maria/0000-0002-0516-4747; Kovalevska, Larysa/0000-0002-7550-9392; Sidorenko, Svetlana/0000-0001-8281-8006; Zozulya, Yuriy/0000-0002-0573-2740	National Academy of Sciences of Ukraine [0113U001436]; INSERM; Ligue contre le Cancer; Ministere des affaires Etrangeres; Partenariat Curien Franco-Ukrainien "Dnipro"; FEBS Summer and Collaborative Fellowships	National Academy of Sciences of Ukraine; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue contre le Cancer(Ligue nationale contre le cancer); Ministere des affaires Etrangeres; Partenariat Curien Franco-Ukrainien "Dnipro"; FEBS Summer and Collaborative Fellowships	The work was supported by the grant no. 0113U001436 of the National Academy of Sciences of Ukraine (SPS), INSERM (BH), Ligue contre le Cancer (BH), Ministere des affaires Etrangeres (BH), Partenariat Curien Franco-Ukrainien "Dnipro" (SPS, BH), FEBS Summer and Collaborative Fellowships (ORK), Bourse de Gouvernement Francais and "AccueilDoc" from Region Rhone Alpes (ORK), Collaborative program of the NAS of Ukraine and the Siberian Department of RAS (SPS, AVT) and the Grant 6.23 from the RAS program Molecular and Cellular Biology (AVT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2008, MOL THER, V16, P1556, DOI 10.1038/mt.2008.152; Avota E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001290; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Bleharski JR, 2001, J IMMUNOL, V167, P3174, DOI 10.4049/jimmunol.167.6.3174; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Dumitru CA, 2009, J CELL PHYSIOL, V221, P688, DOI 10.1002/jcp.21907; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Fielding AK, 2005, REV MED VIROL, V15, P135, DOI 10.1002/rmv.455; Galanis E, 2010, CLIN PHARMACOL THER, V88, P620, DOI 10.1038/clpt.2010.211; Herold-Mende C, 1999, LAB INVEST, V79, P1573; Kruse M, 2001, J IMMUNOL, V167, P1989, DOI 10.4049/jimmunol.167.4.1989; Ma CY, 2012, J BIOL CHEM, V287, P18359, DOI 10.1074/jbc.M112.367060; Mavaddat N, 2000, J BIOL CHEM, V275, P28100; Miest TS, 2013, MOL THER, V21, P2019, DOI 10.1038/mt.2013.171; Mikhalap SV, 2004, BLOOD, V104, P4063, DOI 10.1182/blood-2004-04-1273; Minagawa H, 2001, J GEN VIROL, V82, P2913, DOI 10.1099/0022-1317-82-12-2913; Moskal JR, 2009, EXPERT REV NEUROTHER, V9, P1529, DOI [10.1586/ern.09.105, 10.1586/ERN.09.105]; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Paraskevakou G, 2007, MOL THER, V15, P677, DOI 10.1038/sj.mt.6300105; PINCHOUK VG, 1988, ANTICANCER RES, V8, P1377; Punnonen J, 1997, J EXP MED, V185, P993, DOI 10.1084/jem.185.6.993; Reynders E, 2011, GLYCOBIOLOGY, V21, P853, DOI 10.1093/glycob/cwq179; Riboni L, 2002, GLIA, V39, P105, DOI 10.1002/glia.10087; Schneider-Schaulies J, 2003, J NEUROVIROL, V9, P247, DOI 10.1080/13550280390193993; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; SIDORENKO SP, 1992, NEOPLASMA, V39, P3; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Weller M, 2013, LANCET ONCOL, V14, pE370, DOI 10.1016/S1470-2045(13)70168-2; Yurchenko MY, 2005, EXP ONCOL, V27, P24; Yurchenko OV, 2003, EXP ONCOL, V25, P186	37	8	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118302	10.1371/journal.pone.0118302	http://dx.doi.org/10.1371/journal.pone.0118302			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710480	gold, Green Submitted, Green Published			2022-12-27	WOS:000350683900053
J	Aguilera, M; Barandiaran, XE; Bedia, MG; Seron, F				Aguilera, Miguel; Barandiaran, Xabier E.; Bedia, Manuel G.; Seron, Francisco			Self-Organized Criticality, Plasticity and Sensorimotor Coupling. Explorations with a Neurorobotic Model in a Behavioural Preference Task	PLOS ONE			English	Article							SCALE-FREE; INTERACTION-DOMINANT; HUMAN COGNITION; 1/F NOISE; DYNAMICS; BRAIN; SYNCHRONIZATION; CONSCIOUSNESS; ROBOTICS	During the last two decades, analysis of 1/f noise in cognitive science has led to a considerable progress in the way we understand the organization of our mental life. However, there is still a lack of specific models providing explanations of how 1/f noise is generated in coupled brain-body-environment systems, since existing models and experiments typically target either externally observable behaviour or isolated neuronal systems but do not address the interplay between neuronal mechanisms and sensorimotor dynamics. We present a conceptual model of a minimal neurorobotic agent solving a behavioural task that makes it possible to relate mechanistic (neurodynamic) and behavioural levels of description. The model consists of a simulated robot controlled by a network of Kuramoto oscillators with homeostatic plasticity and the ability to develop behavioural preferences mediated by sensorimotor patterns. With only three oscillators, this simple model displays self-organized criticality in the form of robust 1/f noise and a wide multifractal spectrum. We show that the emergence of self-organized criticality and 1/f noise in our model is the result of three simultaneous conditions: a) non-linear interaction dynamics capable of generating stable collective patterns, b) internal plastic mechanisms modulating the sensorimotor flows, and c) strong sensorimotor coupling with the environment that induces transient metastable neurodynamic regimes. We carry out a number of experiments to show that both synaptic plasticity and strong sensorimotor coupling play a necessary role, as constituents of self-organized criticality, in the generation of 1/f noise. The experiments also shown to be useful to test the robustness of 1/f scaling comparing the results of different techniques. We finally discuss the role of conceptual models as mediators between nomothetic and mechanistic models and how they can inform future experimental research where self-organized critically includes sensorimotor coupling among the essential interaction-dominant process giving rise to 1/f noise.	[Aguilera, Miguel; Bedia, Manuel G.; Seron, Francisco] Univ Zaragoza, Dept Comp Sci & Engn Syst, Zaragoza, Spain; [Barandiaran, Xabier E.] Univ Basque Country, UPV EHU, Univ Sch Social Work, Dept Philosophy, Vitoria, Spain; [Barandiaran, Xabier E.] Univ Basque Country, UPV EHU, IAS Res Ctr Life Mind & Soc, Dept Log & Philosophy Sci, Donostia San Sebastian, Spain	University of Zaragoza; University of Basque Country; University of Basque Country	Aguilera, M (corresponding author), Univ Zaragoza, Dept Comp Sci & Engn Syst, Zaragoza, Spain.	miguel.academic@maguilera.net	Aguilera, Miguel/Q-9512-2019; Barandiaran, Xabier E/A-6172-2011; Aguilera, Miguel/GPX-1756-2022; Seron Arbeloa, Francisco Jose/L-3146-2014	Aguilera, Miguel/0000-0002-3366-4706; Barandiaran, Xabier E/0000-0002-4763-6845; Seron Arbeloa, Francisco Jose/0000-0003-1683-4694	Spanish 'Ministerio de Educacion' [AP-2010-6036]; Spanish 'Ministerio de Ciencia e Innovacion' [TIN2011-24660]; FP7 project eSMCs [IST-270212]; Spanish Government [FFI2011-25665]; Basque Government [IT590-13]	Spanish 'Ministerio de Educacion'(Spanish Government); Spanish 'Ministerio de Ciencia e Innovacion'(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FP7 project eSMCs; Spanish Government(Spanish GovernmentEuropean Commission); Basque Government(Basque Government)	Miguel Aguilera holds a FPU predoctoral fellowship from the Spanish 'Ministerio de Educacion' with reference AP-2010-6036. Miguel Aguilera, Manuel Bedia and Francisco Seron were supported in part by the project TIN2011-24660 funded by the Spanish 'Ministerio de Ciencia e Innovacion'. Dr. Xabier E. Barandiaran currently benefits from funding from the FP7 project eSMCs IST-270212 (EU 7th Framework through 'ICT: Cognitive Systems and Robotics'), also from research project 'Au-tonomia y Niveles de Organizacion' financed by the Spanish Government (ref. FFI2011-25665) and IAS-Research group funding IT590-13 from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; [Anonymous], 1969, GEN SYSTEM THEORY FD; Ashby W.R., 1941, DESIGN BRAIN, V4, P859; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barandiaran X., 2006, ARTIF LIFE, P513; Barandiaran XE, 2009, ADAPT BEHAV, V17, P287, DOI 10.1177/1059712309340847; Chemero A, 2009, BRADFORD BOOKS, P1; Chialvo DR, 2006, BRAIN NEAR EDGE; Di Paolo EA, 2000, SIMULATION MODELS OP; Di Paolo EA, 2008, BIOSYSTEMS, V91, P409, DOI 10.1016/j.biosystems.2007.05.016; Dixon JA, 2012, TOP COGN SCI, V4, P51, DOI 10.1111/j.1756-8765.2011.01162.x; Dotov DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009433; Edelman G., 2001, UNIVERSE CONSCIOUSNE; Edelman GM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00004; Freeman WJ, 2005, BIOL CYBERN, V92, P350, DOI 10.1007/s00422-005-0563-1; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; GOUPILLAUD P, 1984, GEOEXPLORATION, V23, P85, DOI 10.1016/0016-7142(84)90025-5; Hardstone R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00450; Harvey I, 2005, ARTIF LIFE, V11, P79, DOI 10.1162/1064546053278991; Hausdorff JM, 1996, PHYS REV E, V54, P2154, DOI 10.1103/PhysRevE.54.2154; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Ihlen EAF, 2010, J EXP PSYCHOL GEN, V139, P436, DOI 10.1037/a0019098; Iizuka H, 2008, LECT NOTES ARTIF INT, V5040, P1; Iizuka H, 2007, ADAPT BEHAV, V15, P359, DOI 10.1177/1059712307084687; Jensen H.J., 1998, SELF ORG CRITICALITY; Kaplan DM, 2011, TOP COGN SCI, V3, P438, DOI 10.1111/j.1756-8765.2011.01147.x; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kloos H, 2010, MIND MATTER, V8, P19; Kugler P.N., 1980, ADV PSYCHOL, P3, DOI [10.1016/S0166-4115, DOI 10.1016/S0166-4115, 10.1016/S0166-4115(08)61936]; Le Van Quyen M, 2003, BIOL RES, V36, P67, DOI 10.4067/S0716-97602003000100006; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Peng CK, 2000, SELF ORG BIOL DYNAMI; Rohde M, 2006, 584 U SUSS; Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038; Rybarsch M, 2012, 12123106 ARXIV; Scott D. W., 2012, HDB COMPUTATIONAL ST, P549, DOI DOI 10.1007/978-3-642-21551-3_19; Seth AK, 2006, P NATL ACAD SCI USA, V103, P10799, DOI 10.1073/pnas.0604347103; Silberstein M, 2011, HUMANA MENTE, P1; Silberstein M, 2012, TOP COGN SCI, V4, P35, DOI 10.1111/j.1756-8765.2011.01168.x; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stepp N, 2011, TOP COGN SCI, V3, P425, DOI 10.1111/j.1756-8765.2011.01143.x; Thelen Esther, 1996, DYNAMIC SYSTEMS APPR; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Tognoli E, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00122; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Torre K, 2009, HUM MOVEMENT SCI, V28, P297, DOI 10.1016/j.humov.2009.01.001; USHER M, 1995, PHYS REV LETT, V74, P326, DOI 10.1103/PhysRevLett.74.326; Van Orden GC, 2005, J EXP PSYCHOL GEN, V134, P117, DOI 10.1037/0096-3445.134.1.117; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Varela Francisco J., 1995, Biological Research, V28, P81; von Bertalanffy Ludwig, 1950, BRIT J PHILOS SCI, V1, P134, DOI [DOI 10.1093/BJPS/I.2.134, 10.1093/bjps/I.2.134]; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; Wagenmakers EJ, 2012, TOP COGN SCI, V4, P87, DOI 10.1111/j.1756-8765.2011.01164.x; Ward LM, 2011, CONSCIOUS COGN, V20, P464, DOI 10.1016/j.concog.2011.01.007; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001; Wijnants ML, 2009, NONLIN DYNAM PSYCHOL, V13, P79	60	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117465	10.1371/journal.pone.0117465	http://dx.doi.org/10.1371/journal.pone.0117465			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706744	Green Published, gold			2022-12-27	WOS:000350662100091
J	El Najjar, F; Lampe, L; Baker, ML; Wang, LF; Dutch, RE				El Najjar, Farah; Lampe, Levi; Baker, Michelle L.; Wang, Lin-Fa; Dutch, Rebecca Ellis			Analysis of Cathepsin and Furin Proteolytic Enzymes Involved in Viral Fusion Protein Activation in Cells of the Bat Reservoir Host	PLOS ONE			English	Article							EBOLA-VIRUS GLYCOPROTEIN; TRANS-GOLGI NETWORK; RESPIRATORY SYNDROME CORONAVIRUS; SUBTILISIN-LIKE ENDOPROTEASE; PROPROTEIN CONVERTASE FURIN; MULTIPLE SEQUENCE ALIGNMENT; HENDRA-VIRUS; NIPAH-VIRUS; CLEAVAGE SITE; FRUIT BAT	Bats of different species play a major role in the emergence and transmission of highly pathogenic viruses including Ebola virus, SARS-like coronavirus and the henipaviruses. These viruses require proteolytic activation of surface envelope glycoproteins needed for entry, and cellular cathepsins have been shown to be involved in proteolysis of glycoproteins from these distinct virus families. Very little is currently known about the available proteases in bats. To determine whether the utilization of cathepsins by bat-borne viruses is related to the nature of proteases in their natural hosts, we examined proteolytic processing of several viral fusion proteins in cells derived from two fruit bat species, Pteropus alecto and Rousettus aegyptiacus. Our work shows that fruit bat cells have homologs of cathepsin and furin proteases capable of cleaving and activating both the cathepsin-dependent Hendra virus F and the furin-dependent parainfluenza virus 5 F proteins. Sequence analysis comparing Pteropus alecto furin and cathepsin L to proteases from other mammalian species showed a high degree of conservation; however significant amino acid variation occurs at the C-terminus of Pteropus alecto furin. Further analysis of furin-like proteases from fruit bats revealed that these proteases are catalytically active and resemble other mammalian furins in their response to a potent furin inhibitor. However, kinetic analysis suggests that differences may exist in the cellular localization of furin between different species. Collectively, these results indicate that the unusual role of cathepsin proteases in the life cycle of bat-borne viruses is not due to the lack of active furin-like proteases in these natural reservoir species; however, differences may exist between furin proteases present in fruit bats compared to furins in other mammalian species, and these differences may impact protease usage for viral glycoprotein processing.	[El Najjar, Farah; Lampe, Levi; Dutch, Rebecca Ellis] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Baker, Michelle L.; Wang, Lin-Fa] CSIRO, Australian Anim Hlth Lab, East Geelong, Vic, Australia; [Wang, Lin-Fa] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore, Singapore	University of Kentucky; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National University of Singapore	Dutch, RE (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	rdutc2@uky.edu	wang, lili/HDL-7210-2022; wang, lin/HHM-2225-2022; Baker, Michelle/AAX-9171-2020; Baker, Michelle L/C-9694-2013; wang, lin/GSE-3040-2022	Baker, Michelle/0000-0002-7993-9971; Baker, Michelle L/0000-0002-7993-9971; Wang, Lin-Fa/0000-0003-2752-0535	NIH from the National Center for Research Resources [R01AI051517, 2P20 RR020171]; Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, R56AI051517, R01AI051517] Funding Source: NIH RePORTER	NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Southeastern Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01AI051517, 2P20 RR020171 from the National Center for Research Resources, and # U54 AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense to R.E.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGLIKER H, 1993, BIOCHEM J, V293, P75, DOI 10.1042/bj2930075; Bolt G, 1998, VIROLOGY, V252, P387, DOI 10.1006/viro.1998.9464; Bossart KN, 2002, J VIROL, V76, P11186, DOI 10.1128/JVI.76.22.11186-11198.2002; Bossart KN, 2001, VIROLOGY, V290, P121, DOI 10.1006/viro.2001.1158; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; Bourne GL, 2011, J IMMUNOL METHODS, V364, P101, DOI 10.1016/j.jim.2010.11.008; Breed AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028816; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Clayton BA, 2013, ZOONOSES PUBLIC HLTH, V60, P69, DOI 10.1111/j.1863-2378.2012.01501.x; Craft WW, 2005, VIROLOGY, V341, P130, DOI 10.1016/j.virol.2005.07.004; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Diederich S, 2005, J BIOL CHEM, V280, P29899, DOI 10.1074/jbc.M504598200; Diederich S, 2012, J VIROL, V86, P3736, DOI 10.1128/JVI.06628-11; Diederich S, 2009, VIRUS RES, V145, P300, DOI 10.1016/j.virusres.2009.07.020; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Du LY, 2013, J VIROL, V87, P9939, DOI 10.1128/JVI.01048-13; DUBAY JW, 1995, J VIROL, V69, P4675, DOI 10.1128/JVI.69.8.4675-4682.1995; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Field H, 2012, CURR TOP MICROBIOL, V359, P11, DOI 10.1007/82_2012_214; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Fraser GC, 1996, EMERG INFECT DIS, V2, P327, DOI 10.3201/eid0204.960408; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; GOTOH B, 1992, J VIROL, V66, P6391, DOI 10.1128/JVI.66.11.6391-6397.1992; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Harris SL, 2007, VET REC, V161, P384, DOI 10.1136/vr.161.11.384; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Iwasaki T, 2004, ARCH VIROL, V149, P1139, DOI 10.1007/s00705-003-0271-x; Johara MY, 2001, EMERG INFECT DIS, V7, P439; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Jordan I, 2009, VIRUS RES, V145, P54, DOI 10.1016/j.virusres.2009.06.007; Krahling V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000802; Kruger N, 2013, J VIROL, V87, P13889, DOI 10.1128/JVI.02458-13; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Kurth A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038688; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li ZJ, 1998, J VIROL, V72, P3789, DOI 10.1128/JVI.72.5.3789-3795.1998; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Mahalingam S, 2012, LANCET INFECT DIS, V12, P799, DOI 10.1016/S1473-3099(12)70158-5; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Meulendyke KA, 2005, J VIROL, V79, P12643, DOI 10.1128/JVI.79.20.12643-12649.2005; Michalski WP, 2000, VIRUS RES, V69, P83, DOI 10.1016/S0168-1702(00)00169-6; Moll M, 2004, J VIROL, V78, P9705, DOI 10.1128/JVI.78.18.9705-9712.2004; ORTMANN D, 1994, J VIROL, V68, P2772, DOI 10.1128/JVI.68.4.2772-2776.1994; Pager CT, 2006, VIROLOGY, V346, P251, DOI 10.1016/j.virol.2006.01.007; Pager CT, 2005, J VIROL, V79, P12714, DOI 10.1128/JVI.79.20.12714-12720.2005; Pager CT, 2004, J VIROL, V78, P9154, DOI 10.1128/JVI.78.17.9154-9163.2004; Papenfuss AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-261; PATERSON RG, 1989, J VIROL, V63, P1293, DOI 10.1128/JVI.63.3.1293-1301.1989; Peel AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030346; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Plaimauer B, 2001, BIOCHEM J, V354, P689, DOI 10.1042/0264-6021:3540689; Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005; Popa A, 2012, J VIROL, V86, P3014, DOI 10.1128/JVI.05826-11; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; SCHAFER W, 1995, EMBO J, V14, P2424, DOI 10.1002/j.1460-2075.1995.tb07240.x; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Smith EC, 2012, J VIROL, V86, P3003, DOI 10.1128/JVI.05762-11; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Smith I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025275; Sotomayor-Bonilla J, 2014, AM J TROP MED HYG, V91, P129, DOI 10.4269/ajtmh.13-0524; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Sugrue RJ, 2001, J GEN VIROL, V82, P1375, DOI 10.1099/0022-1317-82-6-1375; Sun T, 2010, INT J BIOL SCI, V6, P89; Sun XM, 2013, CELL REP, V3, P769, DOI 10.1016/j.celrep.2013.01.025; TAKAHASHI S, 1995, J BIOL CHEM, V270, P28397; Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06; Taniguchi S, 2011, EMERG INFECT DIS, V17, P1559, DOI 10.3201/eid1708.101693; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson NN, 2014, ZOONOSES PUBLIC HLTH, DOI [10.1111/zph.12175, DOI 10.1111/ZPH.12175]; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Vogt C, 2005, J VIROL, V79, P3865, DOI 10.1128/JVI.79.6.3865-3872.2005; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8; Weis M, 2014, J GEN VIROL, V95, P539, DOI 10.1099/vir.0.060632-0; WILCOX D, 1992, BIOCHEM J, V285, P495, DOI 10.1042/bj2850495; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Yadav PD, 2012, AM J TROP MED HYG, V87, P576, DOI 10.4269/ajtmh.2012.11-0416; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835	101	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115736	10.1371/journal.pone.0115736	http://dx.doi.org/10.1371/journal.pone.0115736			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706132	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100016
J	Hu, J; Xie, YM; Shu, Z; Yang, W; Zhan, SY				Hu, Jing; Xie, Yanming; Shu, Zheng; Yang, Wei; Zhan, Siyan			Trends in the Use of Guideline-Recommended Medications and In-Hospital Mortality of Patients with Acute Myocardial Infarction in a Chinese Population	PLOS ONE			English	Article							TEMPORAL TRENDS; ASSOCIATION; RISK; PREVENTION; MANAGEMENT; PATTERNS; OUTCOMES; EVENTS; GAP	Objective Current practice guidelines recommend the routine use of several cardiac medications early in the course of acute myocardial infarction (AMI). Our objective was to analyze temporal trends in medication use and in-hospital mortality of AMI patients in a Chinese population. Methods This is a retrospective observational study using electronic medical records from the hospital information system (HIS) of 14 Chinese hospitals. We identified 5599 patients with AMI between 2005 and 2011. Factors associated with medication use and in-hospital mortality were explored by using hierarchical logistic regression. Results The use of several guideline-recommended medications all increased during the study period: statins (57.7%-90.1%), clopidogrel (61.8%-92.3%), beta-Blockers (45.4%-65.1%), ACEI/ARB (46.7%-58.7%), aspirin (81.9%-92.9%), and the combinations thereof increased from 24.9% to 42.8% (P<0.001 for all). Multivariate analyses showed statistically significant increases in all these medications. The in-hospital mortality decreased from 15.9% to 5.7% from 2005 to 2011 (P<0.001). After multivariate adjustment, admission year was still a significant factor (OR = 0.87, 95% CI 0.79-0.96, P = 0.007), the use of aspirin (OR = 0.64, 95% CI 0.46-0.87), clopidogrel (OR = 0.44, 95% CI 0.31-0.61), ACEI/ARB (OR = 0.73, 95% CI 0.56-0.94) and statins (OR = 0.54, 95% CI 0.40-0.73) were associated with a decrease in in-hospital mortality. Patients with older age, cancer and renal insufficiency had higher in-hospital mortality, while they were generally less likely to receive all these medications. Conclusion Use of guideline-recommended medications early in the course of AMI increased between 2005 and 2011 in a Chinese population. During this same time, there was a decrease in in-hospital mortality.	[Hu, Jing; Zhan, Siyan] Peking Univ, Sch Publ Hlth, Evidence Based Med Ctr, Beijing 100191, Peoples R China; [Hu, Jing] Capital Med Univ, Inst Tradit Chinese Med, Beijing Tradit Chinese Med Hosp, Beijing 100010, Peoples R China; [Xie, Yanming; Yang, Wei] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing 100700, Peoples R China; [Shu, Zheng] STATinMED Beijing Int Healthcare Technol Assessme, Ctr Hlth Econ & Epidemiol Assessment, Beijing 100025, Peoples R China; [Zhan, Siyan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China	Peking University; Capital Medical University; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; Peking University	Zhan, SY (corresponding author), Peking Univ, Sch Publ Hlth, Evidence Based Med Ctr, Beijing 100191, Peoples R China.	siyan-zhan@bjmu.edu.cn			Significant Drug Research and Development in Important State Science and Technology Specific and Key Technique Research in Chin [2009ZX09502-030]	Significant Drug Research and Development in Important State Science and Technology Specific and Key Technique Research in Chin	The study is supported by Significant Drug Research and Development in Important State Science and Technology Specific and Key Technique Research in China( No. 2009ZX09502-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MH, 2006, INT J CARDIOL, V111, P189, DOI 10.1016/j.ijcard.2005.11.003; Al-Jarallah M, 2011, OPEN CARDIOVASC MED, V5, P171, DOI 10.2174/1874192401105010171; Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P295; Cardiovascular Diseases Branch of Chinese Medical Association, 2001, CHINESE J CARDIOLOGY, V29, P710; Chen ZM, 2005, LANCET, V366, P1622; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Cho KH, 2010, AM J CARDIOL, V106, P1061, DOI 10.1016/j.amjcard.2010.06.009; Dharmarajan K, 2013, CIRC-CARDIOVASC QUAL, V6, P732, DOI 10.1161/CIRCOUTCOMES.113.000441; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; Fu M., 2007, EXPT STUDY CELLULAR; Gao R, 2008, HEART, V94, P554, DOI 10.1136/hrt.2007.119750; Gierlotka M, 2012, AM J CARDIOL, V109, P779, DOI 10.1016/j.amjcard.2011.10.041; Guidelines for the diagnosis, 2010, CHIN J CARDIOVASC DI, P675; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; LaBresh Kenneth A, 2007, Crit Pathw Cardiol, V6, P98, DOI 10.1097/HPC.0b013e31812da7ed; Liu Hong-xu, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P306; McAlister FA, 2007, ARCH INTERN MED, V167, P1019, DOI 10.1001/archinte.167.10.1019; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Motivala AA, 2011, J AM COLL CARDIOL, V58, P1760, DOI 10.1016/j.jacc.2011.06.050; National Center for Cardiovascular Disease China, 2011, REP CARD DIS CHIN 20; Niu SL, 2009, AM HEART J, V157, P709, DOI 10.1016/j.ahj.2008.12.009; Ortolani P, 2013, AM HEART J, V166, P846, DOI 10.1016/j.ahj.2013.08.026; *UN HLTH PARTN GRO, 2005, HLTH SIT ASS PEOPL R; Wang TY, 2009, CLIN CARDIOL, V32, pE22, DOI 10.1002/clc.20518; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhang B, 2012, CHINESE MED J-PEKING, V125, P1915, DOI 10.3760/cma.j.issn.0366-6999.2012.11.014	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118777	10.1371/journal.pone.0118777	http://dx.doi.org/10.1371/journal.pone.0118777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706944	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100203
J	Joo, NS; Evans, IAT; Cho, HJ; Park, IH; Engelhardt, JF; Wine, JJ				Joo, Nam Soo; Evans, Idil Apak T.; Cho, Hyung-Ju; Park, Il-Ho; Engelhardt, John F.; Wine, Jeffrey J.			Proteomic Analysis of Pure Human Airway Gland Mucus Reveals a Large Component of Protective Proteins	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; VASOACTIVE-INTESTINAL-PEPTIDE; TRACHEAL SUBMUCOSAL GLANDS; EXOSOME-LIKE VESICLES; CYSTIC-FIBROSIS; EPITHELIAL-CELLS; ANTIMICROBIAL PEPTIDE; INNATE DEFENSE; HISTONE H2A; STREPTOCOCCUS-PYOGENES	Airway submucosal glands contribute to innate immunity and protect the lungs by secreting mucus, which is required for mucociliary clearance and which also contains antimicrobial, anti-inflammatory, anti-proteolytic and anti-oxidant proteins. We stimulated glands in tracheal trimmings from three lung donors and collected droplets of uncontaminated mucus as they formed at the gland orifices under an oil layer. We analyzed the mucus using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Analysis identified 5486 peptides and 441 proteins from across the 3 samples (269-319 proteins per subject). We focused on 269 proteins common to at least 2 0f 3 subjects, of which 102 (38%) had protective or innate immunity functions. While many of these have long been known to play such roles, for many others their cellular protective functions have only recently been appreciated in addition to their well-studied biologic functions (e.g. annexins, apolipoproteins, gelsolin, hemoglobin, histones, keratins, and lumican). A minority of the identified proteins are known to be secreted via conventional exocytosis, suggesting that glandular secretion occurs via multiple mechanisms. Two of the observed protective proteins, major vault protein and prohibitin, have not been observed in fluid from human epithelial cultures or in fluid from nasal or bronchoalveolar lavage. Further proteomic analysis of pure gland mucus may help clarify how healthy airways maintain a sterile environment.	[Joo, Nam Soo; Cho, Hyung-Ju; Park, Il-Ho; Wine, Jeffrey J.] Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA; [Evans, Idil Apak T.; Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	Stanford University; University of Iowa	Joo, NS (corresponding author), Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA.	nsjoo@stanford.edu	Park, Il-Ho/AAI-1394-2019	Park, Il-Ho/0000-0002-7011-6071; Engelhardt, John/0000-0003-2389-9277	Cystic Fibrosis Foundation [JOO11GO, WINE13GO]; Cystic Fibrosis Foundation Therapeutics [WINE07XX0]; Center for Gene Therapy from National Institute of Health [DK047967, HL108902, DK054759]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047967, P30DK054759, R01DK047967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Center for Gene Therapy from National Institute of Health(Ohio State University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by JOO11GO (to NSJ) from Cystic Fibrosis Foundation (http://www.cff.org); WINE07XX0 (to JJW) from Cystic Fibrosis Foundation Therapeutics (http://www.cff.org); WINE13GO (to JJW) from Cystic Fibrosis Foundation (http://www.cff.org); DK047967, HL108902 and DK054759-the Center for Gene Therapy from National Institute of Health (http://www.nih.gov) (to JFE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal Gopi, 2003, Journal of Medical and Dental Sciences, V50, P195; Ballard ST, 1999, AM J PHYSIOL-LUNG C, V277, pL694, DOI 10.1152/ajplung.1999.277.4.L694; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bartlett JA, 2013, AM J PHYSIOL-LUNG C, V305, P1256, DOI 10.1152/ajplung.00056.2013; BASBAUM CB, 1990, ANNU REV PHYSIOL, V52, P97; Bucki R, 2004, ANTIMICROB AGENTS CH, V48, P1526, DOI 10.1128/AAC.48.5.1526-1533.2004; Candiano G, 2007, AM J PHYSIOL-LUNG C, V292, pL185, DOI 10.1152/ajplung.00085.2006; Canny G, 2002, P NATL ACAD SCI USA, V99, P3902, DOI 10.1073/pnas.052533799; Casado B, 2005, PROTEOMICS, V5, P2949, DOI 10.1002/pmic.200401172; Chen JZ, 2008, PROTEOM CLIN APPL, V2, P585, DOI 10.1002/prca.200780006; Cho HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024424; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; Chu Y, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-44; Clarke LL, 2004, AM J PHYSIOL-GASTR L, V286, pG1050, DOI 10.1152/ajpgi.00393.2003; Dajani R, 2005, AM J RESP CELL MOL, V32, P548, DOI 10.1165/rcmb.2005-0059OC; Davoodian K, 1997, BIOCHEMISTRY-US, V36, P9637, DOI 10.1021/bi9711487; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; EATON JW, 1982, SCIENCE, V215, P691, DOI 10.1126/science.7036344; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; ENGELHARDT JF, 1994, AM J PHYSIOL, V267, pC491, DOI 10.1152/ajpcell.1994.267.2.C491; ETHERTON JE, 1979, J ANAT, V129, P305; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gharib SA, 2010, EUR RESPIR J, V35, P1388, DOI 10.1183/09031936.00089409; Guo YR, 2005, PROTEOMICS, V5, P4608, DOI 10.1002/pmic.200500052; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; HELMINEN HJ, 1968, J ULTRA MOL STRUCT R, V25, P193, DOI 10.1016/S0022-5320(68)80069-3; HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925; HOBSON D, 1958, J EXP MED, V107, P167, DOI 10.1084/jem.107.2.167; Horwitz AH, 1999, ANTIMICROB AGENTS CH, V43, P2314, DOI 10.1128/AAC.43.9.2314; Ianowski JP, 2007, J PHYSIOL-LONDON, V580, P301, DOI 10.1113/jphysiol.2006.123653; Inglis SK, 1997, AM J PHYSIOL-LUNG C, V272, pL203, DOI 10.1152/ajplung.1997.272.2.L203; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; Joo NS, 2004, J BIOL CHEM, V279, P38854, DOI 10.1074/jbc.M407077200; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Kim HS, 1996, BIOCHEM BIOPH RES CO, V229, P381, DOI 10.1006/bbrc.1996.1814; Kim HS, 2002, J IMMUNOL, V168, P2356, DOI 10.4049/jimmunol.168.5.2356; Kim HS, 2000, J IMMUNOL, V165, P3268, DOI 10.4049/jimmunol.165.6.3268; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kosanam H, 2012, CLIN BIOCHEM, V45, P223, DOI 10.1016/j.clinbiochem.2011.11.015; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Lee DY, 2009, J INVEST DERMATOL, V129, P2489, DOI 10.1038/jid.2009.106; Ligtenberg AJM, 2010, INT J MOL SCI, V11, P5213, DOI 10.3390/ijms1112521; Lilly EA, 2010, MOL ORAL MICROBIOL, V25, P293, DOI 10.1111/j.2041-1014.2010.00579.x; Liman N, 2013, ANAT REC, V296, P504, DOI 10.1002/ar.22645; Lindahl M, 2001, ELECTROPHORESIS, V22, P1795, DOI 10.1002/1522-2683(200105)22:9<1795::AID-ELPS1795>3.0.CO;2-J; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; Magi B, 2002, ELECTROPHORESIS, V23, P3434, DOI 10.1002/1522-2683(200210)23:19<3434::AID-ELPS3434>3.0.CO;2-R; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Merkel D, 2005, PROTEOMICS, V5, P2972, DOI 10.1002/pmic.200401180; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Ogawa Y, 2011, BIOL PHARM BULL, V34, P13, DOI 10.1248/bpb.34.13; PACK RJ, 1980, CELL TISSUE RES, V208, P65; Parish CA, 2001, BIOORGAN MED CHEM, V9, P377; Park IY, 1998, FEBS LETT, V437, P258, DOI 10.1016/S0014-5793(98)01238-1; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Plymoth A, 2006, CLIN CHEM, V52, P671, DOI 10.1373/clinchem.2005.060715; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Shao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054765; Shao HJ, 2012, J BIOL CHEM, V287, P35860, DOI 10.1074/jbc.M112.380550; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Swisher JFA, 2007, J LEUKOCYTE BIOL, V82, P1174, DOI 10.1189/jlb.0307154; TADA N, 1993, MOL CELL BIOCHEM, V119, P171, DOI 10.1007/BF00926868; Tam C, 2012, J CLIN INVEST, V122, P3665, DOI 10.1172/JCI64416; Tamada T, 2001, Nihon Kokyuki Gakkai Zasshi, V39, P157; Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033; Tomazic PV, 2014, J ALLERGY CLIN IMMUN, V133, P741, DOI 10.1016/j.jaci.2013.09.040; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Vos JB, 2005, PHYSIOL GENOMICS, V21, P324, DOI 10.1152/physiolgenomics.00289.2004; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Wu J, 2005, MOL CELL PROTEOMICS, V4, P1251, DOI 10.1074/mcp.M500041-MCP200; YANG FM, 1995, LAB INVEST, V73, P433	88	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116756	10.1371/journal.pone.0116756	http://dx.doi.org/10.1371/journal.pone.0116756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706550	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100049
J	Judd, TM; Teal, PEA; Hernandez, EJ; Choudhury, T; Hunt, JH				Judd, Timothy M.; Teal, Peter E. A.; Hernandez, Edgar Javier; Choudhury, Talbia; Hunt, James H.			Quantitative Differences in Nourishment Affect Caste-Related Physiology and Development in the Paper Wasp Polistes metricus	PLOS ONE			English	Article							FUSCATUS HYMENOPTERA-VESPIDAE; SOCIAL WASP; JUVENILE-HORMONE; GENE-EXPRESSION; MISCHOCYTTARUS-MASTIGOPHORUS; EVOLUTIONARY IMPLICATIONS; EUSOCIAL WASPS; APIS-MELLIFERA; COLD-HARDINESS; PREY QUANTITY	The distinction between worker and reproductive castes of social insects is receiving increased attention from a developmental rather than adaptive perspective. In the wasp genus Polistes, colonies are founded by one or more females, and the female offspring that emerge in that colony are either non-reproducing workers or future reproductives of the following generation (gynes). A growing number of studies now indicate that workers emerge with activated reproductive physiology, whereas the future reproductive gynes do not. Low nourishment levels for larvae during the worker-rearing phase of the colony cycle and higher nourishment levels for larvae when gynes are reared are now strongly suspected of playing a major role in this difference. Here, we present the results of a laboratory rearing experiment in which Polistes metricus single foundresses were held in environmental conditions with a higher level of control than in any previously published study, and the amount of protein nourishment made available to feed larvae was the only input variable. Three experimental feeding treatments were tested: restricted, unrestricted, and hand-supplemented. Analysis of multiple response variables shows that wasps reared on restricted protein nourishment, which would be the case for wasps reared in field conditions that subsequently become workers, tend toward trait values that characterize active reproductive physiology. Wasps reared on unrestricted and hand-supplemented protein, which replicates higher feeding levels for larvae in field conditions that subsequently become gynes, tend toward trait values that characterize inactive reproductive physiology. Although the experiment was not designed to test for worker behavior per se, our results further implicate activated reproductive physiology as a developmental response to low larval nourishment as a fundamental aspect of worker behavior in Polistes.	[Judd, Timothy M.] SE Missouri State Univ, Dept Biol, Cape Girardeau, MO 63701 USA; [Teal, Peter E. A.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32604 USA; [Hernandez, Edgar Javier] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Choudhury, Talbia; Hunt, James H.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Hunt, James H.] N Carolina State Univ, WM Keck Ctr Behav Biol, Dept Entomol, Raleigh, NC 27695 USA	United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Saint Louis; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Judd, TM (corresponding author), SE Missouri State Univ, Dept Biol, Cape Girardeau, MO 63701 USA.	tjudd@semo.edu		Hernandez, Edgar/0000-0003-1455-8251				Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Anderson Kirk E., 2008, Myrmecological News, V11, P119; [Anonymous], 1982, WASPS GENUS TRYPOXYL; Armitage KB, 1996, ETHOL ECOL EVOL, V8, P67, DOI 10.1080/08927014.1996.9522936; BOHM M K, 1977, Journal of the Kansas Entomological Society, V50, P275; BOHM MK, 1972, J INSECT PHYSIOL, V18, P1875, DOI 10.1016/0022-1910(72)90158-8; BOURKE AFG, 1988, Q REV BIOL, V63, P291, DOI 10.1086/415930; Bourke FG, 1995, SOCIAL EVOLUTION ANT; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y; Carbaugh JR, 2011, SOCIOBIOLOGY, V58, P457; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Corona M, 1999, J EXP BIOL, V202, P929; DANI FR, 1992, ETHOL ECOL EVOL NOV, P49; DEWILDE J, 1982, ADV INSECT PHYSIOL, V16, P167; EICKWORT K, 1969, INSECT SOC, V16, P67, DOI 10.1007/BF02224464; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; FUKATSU T, 1992, J INSECT PHYSIOL, V38, P1033, DOI 10.1016/0022-1910(92)90012-3; Gadagkar R., 1991, P149; GIBO DL, 1976, CAN ENTOMOL, V108, P801, DOI 10.4039/Ent108801-8; Giray T, 2005, P NATL ACAD SCI USA, V102, P3330, DOI 10.1073/pnas.0409560102; Hepperle C, 2001, NATURWISSENSCHAFTEN, V88, P113, DOI 10.1007/s001140000196; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Hunt JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026641; Hunt JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010674; HUNT JH, 1984, INSECT SOC, V31, P452, DOI 10.1007/BF02223659; Hunt JH, 2003, J INSECT PHYSIOL, V49, P785, DOI 10.1016/S0022-1910(03)00115-X; Hunt JH, 1998, ANN ENTOMOL SOC AM, V91, P466, DOI 10.1093/aesa/91.4.466; Hunt JH, 2002, ECOL ENTOMOL, V27, P467, DOI 10.1046/j.1365-2311.2002.00369.x; HUNT JH, 1982, EVOLUTION, V36, P1318, DOI 10.1111/j.1558-5646.1982.tb05501.x; Hunt JH, 2007, EVOLUTION SOCIAL WAS; Jandt JM, 2014, BIOL REV, V89, P48, DOI 10.1111/brv.12042; Jandt JM, 2014, 17 C INT UN STUD SOC; Judd TM, 2010, J INSECT PHYSIOL, V56, P42, DOI 10.1016/j.jinsphys.2009.09.002; Judd TM, 2006, ANN ENTOMOL SOC AM, V99, P398, DOI 10.1603/0013-8746(2006)099[0398:RBFSAF]2.0.CO;2; Karsai I, 2002, ENVIRON ENTOMOL, V31, P99, DOI 10.1603/0046-225X-31.1.99; Kudo K, 2002, SOCIOBIOLOGY, V39, P243; LaFage J.P., 1978, PRODUCTION ECOLOGY A, P165; Lenz Michael, 1994, P159; Marchal P., 1896, ARCH ZOOL EXP GEN, V4, P1; Marchal P, 1987, CR HEBD ACAD SCI, V10, P556; Markiewicz DA, 2001, J COMP PHYSIOL A, V187, P327, DOI 10.1007/s003590100204; Matzkin LM, 2011, J NUTR, V141, P1127, DOI 10.3945/jn.111.138438; MEAD F, 1995, INSECT SOC, V42, P385, DOI 10.1007/BF01242167; MIYANO S, 1980, RES POPUL ECOL, V22, P69, DOI 10.1007/BF02513536; Molina Y, 2008, ETHOL ECOL EVOL, V20, P125, DOI 10.1080/08927014.2008.9522533; Nadeau H, 2003, ECOL ENTOMOL, V28, P328, DOI 10.1046/j.1365-2311.2003.00514.x; Nalepa Christine A., 1994, P57; Naumann I.D., 1991, P916; NIJHOUT HF, 1982, Q REV BIOL, V57, P109, DOI 10.1086/412671; Noriega FG, 2004, INSECT BIOCHEM MOLEC, V34, P687, DOI 10.1016/j.ibmb.2004.03.021; O'Donnell S, 1998, BEHAV ECOL SOCIOBIOL, V43, P327, DOI 10.1007/s002650050498; O'Donnell S, 1998, ANNU REV ENTOMOL, V43, P323, DOI 10.1146/annurev.ento.43.1.323; PAGE RE, 1989, AM NAT, V134, P731, DOI 10.1086/285008; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; PARDI L, 1948, PHYSIOL ZOOL, V21, P1; REED HC, 1988, J KANSAS ENTOMOL SOC, V61, P453; Reeve H.K., 1991, P99; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROSSI AM, 1988, ECOL ENTOMOL, V13, P437, DOI 10.1111/j.1365-2311.1988.tb00376.x; Seal JN, 2004, INSECT SOC, V51, P239, DOI 10.1007/s00040-004-0733-5; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; SOLIS CR, 1990, FUNCT ECOL, V4, P531, DOI 10.2307/2389321; Stamp NE, 2001, ECOL ENTOMOL, V26, P292, DOI 10.1046/j.1365-2311.2001.00325.x; Strambi A, 1985, CASTE DIFFERENTIATIO, P371; STRASSMANN JE, 1983, ANIM BEHAV, V31, P431, DOI 10.1016/S0003-3472(83)80063-3; STRASSMANN JE, 1984, INSECT SOC, V31, P291, DOI 10.1007/BF02223613; STRASSMANN JE, 1981, BEHAV ECOL SOCIOBIOL, V8, P55, DOI 10.1007/BF00302844; Suryanarayanan S, 2008, ETHOLOGY, V114, P1201, DOI 10.1111/j.1439-0310.2008.01561.x; Suryanarayanan S, 2011, CURR BIOL, V21, P231, DOI 10.1016/j.cub.2011.01.003; SUZUKI T, 1985, ANN ENTOMOL SOC AM, V78, P736, DOI 10.1093/aesa/78.6.736; Tibbetts EA, 2010, AM NAT, V176; Tibbetts EA, 2011, J INSECT PHYSIOL, V57, P995, DOI 10.1016/j.jinsphys.2011.04.016; Toth AL, 2009, INSECT SOC, V56, P77, DOI 10.1007/s00040-008-1041-2; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; TURILLAZZI S, 1981, MONIT ZOOL ITAL, V15, P275; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P302; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; Wheeler Diana E., 1994, P245; YAMAMOTO RT, 1969, J ECON ENTOMOL, V62, P1427, DOI 10.1093/jee/62.6.1427	81	25	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116199	10.1371/journal.pone.0116199	http://dx.doi.org/10.1371/journal.pone.0116199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706417	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100028
J	Wang, R; Sun, Q; Chang, QR				Wang, Rui; Sun, Quan; Chang, Qingrui			Soil Types Effect on Grape and Wine Composition in Helan Mountain Area of Ningxia	PLOS ONE			English	Article							CABERNET-SAUVIGNON; GROWING REGIONS; RED WINES; PHENOLIC-COMPOUNDS; CANADIAN TERROIR; AROMA COMPOUNDS; VINEYARD SOILS; MERLOT WINES; ANTHOCYANINS; MATURITY	Different soil types can significantly affect the composition of wine grapes and the final wine product. In this study, the effects of soil types on the composition of Cabernet Sauvignon grapes and wine produced in the Helan Mountains were evaluated. Three different representative soil types-aeolian, sierozem and irrigation silting soil were studied. The compositions of grapes and wines were measured, and in addition, the weights of 100-berry samples were determined. The grapes that grown on the aeolian and sierozem soils matured sooner than those grown on the irrigation silting soil. The highest sugar content, total soluble solids content, sugar to acid ratio and anthocyanin content were found in the grapes that grown on the aeolian soil. The wine produced from this soil had improved chroma and tone and higher-quality phenols. The grapes grown on the sierozem soil had the highest total phenol and tannin contents, which affected the wine composition. The grapes grown on the irrigation silting soil had higher acidities, but the remaining indices were lower. In addition, the grapes grown on the aeolian soil resulted in wines with better chroma and aroma. The sierozem soil was beneficial for the formation of wine tannins and phenols and significantly affected the wine composition. The quality of the grapes from the irrigation silting soil was relatively low, resulting in lower-quality wine.	[Wang, Rui; Chang, Qingrui] Northwest A&F Univ, Coll Resource & Environm, Yangling 712100, Shaanxi, Peoples R China; [Wang, Rui; Sun, Quan] Ningxia Univ, Educ Minist, Grape & Wine Engn Res Ctr, Ningxia 750021, Peoples R China	Northwest A&F University - China; Ningxia University	Chang, QR (corresponding author), Northwest A&F Univ, Coll Resource & Environm, Yangling 712100, Shaanxi, Peoples R China.	changqingruixn@sina.com			National Natural Science Foundation of China [31160417]; National Key Technology R&D Program in the 12th Five year Plan of China [2013BAD09B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program in the 12th Five year Plan of China(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (31160417) and National Key Technology R&D Program in the 12th Five year Plan of China (2013BAD09B02).	Bramley RGV, 2011, AUST J GRAPE WINE R, V17, P217, DOI 10.1111/j.1755-0238.2011.00136.x; BUTTROSE MS, 1971, AM J ENOL VITICULT, V22, P71; Conradie W. J., 2002, South African Journal of Enology and Viticulture, V23, P78; Cortell JM, 2008, AM J ENOL VITICULT, V59, P1; de Andres-de Prado R, 2007, J AGR FOOD CHEM, V55, P779, DOI 10.1021/jf062446q; Douglas D, 2001, FOOD RES INT, V34, P559, DOI 10.1016/S0963-9969(01)00071-0; Gambelli L, 2004, J FOOD COMPOS ANAL, V17, P613, DOI 10.1016/j.jfca.2003.09.010; Gawel R., 1998, AUST J GRAPE WINE R, V4, P74, DOI DOI 10.1111/J.1755-0238.1998.TB00137.X; Goldberg DM, 1998, AM J ENOL VITICULT, V49, P23; Gomez-Miguez MJ, 2007, J FOOD ENG, V79, P758, DOI 10.1016/j.jfoodeng.2006.02.038; Gonzalez-San Jose M. L., 1990, J FOOD COMPOS ANAL, V3, P54, DOI [10.1016/0889-1575(90)90009-B, DOI 10.1016/0889-1575(90)90009-B]; Harbertson JF, 2003, AM J ENOL VITICULT, V54, P301; Fernandez-Marin MI, 2013, J FOOD COMPOS ANAL, V31, P191, DOI 10.1016/j.jfca.2013.05.009; JACKSON DI, 1993, AM J ENOL VITICULT, V44, P409; Jiang B, 2013, FOOD RES INT, V51, P482, DOI 10.1016/j.foodres.2013.01.001; Jiang B, 2012, MOLECULES, V17, P8804, DOI 10.3390/molecules17088804; Kennedy JA, 2002, AM J ENOL VITICULT, V53, P268; Kontkanen D, 2005, FOOD RES INT, V38, P417, DOI 10.1016/j.foodres.2004.10.010; Lesschaeve I, 2005, AM J CLIN NUTR, V81, p330S, DOI 10.1093/ajcn/81.1.330S; Li H., 2008, VITICULTURE; Li JM, 2013, LIQUOR MAKING SCI TE, V7, P37; Li WenChao, 2012, Journal of Fruit Science, V29, P837; Li Z, 2011, FOOD CHEM, V125, P77, DOI 10.1016/j.foodchem.2010.08.039; McDonald MS, 1998, J AGR FOOD CHEM, V46, P368, DOI 10.1021/jf970677e; Mendez-Costabel MP, 2013, AM J ENOL VITICULT, V64, P430, DOI 10.5344/ajev.2013.12109; Orak HH, 2007, SCI HORTIC-AMSTERDAM, V111, P235, DOI 10.1016/j.scienta.2006.10.019; Rapisarda P, 1999, J AGR FOOD CHEM, V47, P4718, DOI 10.1021/jf990111l; Rastija V, 2009, FOOD CHEM, V115, P54, DOI 10.1016/j.foodchem.2008.11.071; Reynolds AG, 2013, AM J ENOL VITICULT, V64, P180, DOI 10.5344/ajev.2013.12092; Roullier-Gall C, 2014, FOOD CHEM, V152, P100, DOI 10.1016/j.foodchem.2013.11.056; SEGUIN G, 1986, EXPERIENTIA, V42, P861, DOI 10.1007/BF01941763; Soleas GJ, 2002, CLIN BIOCHEM, V35, P119, DOI 10.1016/S0009-9120(02)00275-8; Tramontini S, 2013, PLANT SOIL, V368, P215, DOI 10.1007/s11104-012-1507-x; van Leeuwen C, 2010, WOODHEAD PUBL FOOD S, P273, DOI 10.1533/9781845699284.3.273; Wang HG, 2013, SINO OVERSEAS GRAPEV, V4, P24; Wang LN, 2011, NO HORTICULTURE, V3, P4; [王秀芹 WANG Xiuqin], 2006, [食品科学, Food Science], V27, P791; Willwerth J. J., 2010, PROGRES AGRICOLE VIT, V8, P159; [徐淑伟 XU Shu-wei], 2009, [土壤, Soils], V41, P790; Yokotsuka K, 1999, AM J ENOL VITICULT, V50, P1; Zou JF, 2012, AM J ENOL VITICULT, V63, P232, DOI 10.5344/ajev.2012.11087	41	34	37	14	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116690	10.1371/journal.pone.0116690	http://dx.doi.org/10.1371/journal.pone.0116690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706126	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100046
J	Wang, XF; Zhang, RW; Gu, LQ; Zhang, YY; Zhao, X; Bi, KS; Chen, XH				Wang, Xiaofan; Zhang, Ruowen; Gu, Liqiang; Zhang, Yuanyuan; Zhao, Xu; Bi, Kaishun; Chen, Xiaohui			Cell-Based Screening Identifies the Active Ingredients from Traditional Chinese Medicine Formula Shixiao San as the Inhibitors of Atherosclerotic Endothelial Dysfunction	PLOS ONE			English	Article							NF-KAPPA-B; HYDROGEN-PEROXIDE; NITRIC-OXIDE; EXPRESSION; FLAVONOIDS; CONSTITUENTS; ACTIVATION; APOPTOSIS; OXIDATION; EXTRACTS	In this study, we performed a phenotypic screening in human endothelial cells exposed to oxidized low density lipoprotein (an in vitro model of atherosclerotic endothelial dysfunction) to identify the effective compounds in Shixiao San. After investigating the suitability and reliability of the cell-based screening method using atorvastatin as the positive control drug, this method was applied in screening Shixiao San and its extracts. The treatment of n-butanol fraction on endothelial cells exhibited stronger healing effects against oxidized low density lipoprotein-induced insult when compared with other fractions. Cell viability, the level of nitric oxide, endothelial nitric oxide synthase and endothelin-1 were measured, respectively. The assays revealed n-butanol fraction significantly elevated the survival ratio of impaired cells in culture. In parallel, n-butanol fraction exhibited the highest inhibition of inflammation. The generation of prostaglandin-2 and adhesion molecule (soluble intercellular adhesion molecule-1) was obviously declined. Furthermore, n-butanol fraction suppressed the production of reactive oxygen species and malondialdehyde, and restored the activity of superoxide dismutase. Compounds identification of the n-butanol fraction was carried out by ultra high liquid chromatography coupled to quadrupole time-of-flight tandem mass spectrometry. The active ingredients including quercetin-3-O-(2(G)-alpha-l-rhamnosyl)-rutinoside, quercetin-3-O-neohesperidoside, isorhamnetin-3-O-neohesperidoside and isorhamnetin-3-O-rutinoside revealed the ability of anti-atherosclerosis after exposing on endothelial cells. The current work illustrated the pharmacology effect of Shixiao San and clearly indicated the major active components in Shixiao San. More importantly, the proposed cell-based screening method might be particularly suitable for fast evaluating the anti-atherosclerosis efficacy of Traditional Chinese Medicines and screening out the interesting ingredients of Traditional Chinese Medicines.	[Wang, Xiaofan; Gu, Liqiang; Zhang, Yuanyuan; Bi, Kaishun; Chen, Xiaohui] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China; [Zhang, Ruowen] Univ N Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58201 USA; [Zhao, Xu] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Shenyang, Peoples R China	Shenyang Pharmaceutical University; University of North Dakota Grand Forks; Shenyang Pharmaceutical University	Chen, XH (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China.	cxh_syphu@hotmail.com	chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; zhang, yuanyuan/GYA-4428-2022	Zhang, Ruowen/0000-0003-1403-2356				Ahmadi N, 2010, AM J CARDIOL, V105, P459, DOI 10.1016/j.amjcard.2009.09.052; Boudjeltia KZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038810; Bouhlel I, 2010, J APPL TOXICOL, V30, P551, DOI 10.1002/jat.1525; Bouhlel I, 2009, DRUG CHEM TOXICOL, V32, P258, DOI 10.1080/01480540902882192; Chao CY, 2011, J AGR FOOD CHEM, V59, P5263, DOI 10.1021/jf104003y; Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Chunye C, 2011, CELL BIOCH BIOPHYS, V61, P337, DOI [10.1007/s12013-011-9216-2, DOI 10.1007/S12013-011-9216-2]; Fang X, 1998, CIRC RES, V82, P1289, DOI 10.1161/01.RES.82.12.1289; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Guo S, 2012, CIRC RES, V110, P948, DOI 10.1161/CIRCRESAHA.111.263715; Haendeler J, 1999, VITAM HORM, V57, P49; Heizter T, 2000, CIRC RES, V86, P36; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Iljin K, 2009, CLIN CANCER RES, V15, P6070, DOI 10.1158/1078-0432.CCR-09-1035; Jia LQ, 2012, J ETHNOPHARMACOL, V143, P100, DOI 10.1016/j.jep.2012.06.007; Jiang Y, 2010, ANAL CHIM ACTA, V657, P9, DOI 10.1016/j.aca.2009.10.024; Kang YH, 2001, MOL CELL BIOCHEM, V216, P37, DOI 10.1023/A:1011040026620; Kuruppu S, 2012, FEBS LETT, V586, P2212, DOI 10.1016/j.febslet.2012.06.020; Li HG, 2000, J PATHOL, V190, P244, DOI 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8; Lopez-Alarcon C, 2013, ANAL CHIM ACTA, V763, P1, DOI 10.1016/j.aca.2012.11.051; MARSDEN PA, 1992, AM J PHYSIOL, V262, pC854, DOI 10.1152/ajpcell.1992.262.4.C854; Minuz P, 2006, BRIT J CLIN PHARMACO, V61, P774, DOI 10.1111/j.1365-2125.2006.02681.x; Morales AI, 2006, TOXICOL APPL PHARM, V210, P128, DOI 10.1016/j.taap.2005.09.006; Non AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094474; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Seto Y, 2010, J PHARMACEUT BIOMED, V52, P781, DOI 10.1016/j.jpba.2010.02.029; Shibano M, 2008, J NAT MED-TOKYO, V62, P349, DOI 10.1007/s11418-008-0244-1; Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022; Tian Long, 2004, Zhonghua Yi Xue Za Zhi, V84, P954; Tsakadze NL, 2004, AM J PHYSIOL-CELL PH, V287, pC55, DOI 10.1152/ajpcell.00585.2003; Wakabayashi I, 2000, EUR J PHARMACOL, V406, P477, DOI 10.1016/S0014-2999(00)00695-6; Wang X, 2014, ASIAN J PHARM SCI, V9, P17, DOI 10.1016/j.ajps.2013.11.008; Wang XF, 2014, J CHROMATOGR B, V953, P1, DOI 10.1016/j.jchromb.2014.01.042; Wang YK, 2005, PHARMACOL RES, V52, P174, DOI 10.1016/j.phrs.2005.02.023; Weller CL, 2007, P NATL ACAD SCI USA, V104, P11712, DOI 10.1073/pnas.0701700104; Wolfrum S, 2003, ARTERIOSCL THROM VAS, V23, P729, DOI 10.1161/01.ATV.0000063385.12476.A7; Xue X, 2013, J CHROMATOGR A, V1280, P75, DOI 10.1016/j.chroma.2013.01.033; Yan XT, 2014, BIOORG MED CHEM LETT, V24, P1397, DOI 10.1016/j.bmcl.2014.01.028; Yi L, 2011, INT J MOL SCI, V12, P5471, DOI 10.3390/ijms12095471; Zheng ZG, 2013, J PHARMACEUT BIOMED, V77, P44, DOI 10.1016/j.jpba.2013.01.003; Zhou W, 2010, MOLECULES, V15, P6217, DOI 10.3390/molecules15096217; Zhu Z, 2011, PLOS ONE, V6, DOI [10.1371/ journal. pone. 0023554, DOI 10.1371/J0URNAL.P0NE.0023554]	44	13	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116601	10.1371/journal.pone.0116601	http://dx.doi.org/10.1371/journal.pone.0116601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699522	Green Published, gold, Green Submitted			2022-12-27	WOS:000349789800012
J	Yao, Y; Zhang, B; Dong, CJ; Du, Y; Jiang, L; Liu, JY				Yao, Yuan; Zhang, Bing; Dong, Chun-Juan; Du, Ying; Jiang, Lin; Liu, Jin-Yuan			Comparative Proteomic and Biochemical Analyses Reveal Different Molecular Events Occurring in the Process of Fiber Initiation between Wild-Type Allotetraploid Cotton and Its Fuzzless-Lintless Mutant	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM L.; EXPRESSED PROTEINS; HYDROGEN-PEROXIDE; CELL INITIATION; PLANT-TISSUES; OXYGEN; ELONGATION; SYNTHASE; SUCROSE; GENE	To explore lint fiber initiation-related proteins in allotetraploid cotton (Gossypium hirsutum L.), a comparative proteomic analysis was performed between wild-type cotton (Xu-142) and its fuzzless-lintless mutant (Xu-142-fl) at five developmental time points for lint fiber initiation from -3 to +3 days post-anthesis (dpa). Using two-dimensional gel electrophoresis (2-DE) combined with mass spectrometry (MS) analyses, 91 differentially accumulated protein (DAP) species that are related to fiber initiation were successfully identified, of which 58 preferentially accumulated in the wild-type and 33 species in the fl mutant. These DAPs are involved in various cellular and metabolic processes, mainly including important energy/carbohydrate metabolism, redox homeostasis, amino acid and fatty acid biosynthesis, protein quality control, cytoskeleton dynamics, and anthocyanidin metabolism. Further physiological and biochemical experiments revealed dynamic changes in the carbohydrate flux and H2O2 levels in the cotton fiber initiation process. Compared with those in the fl mutant, the contents of glucose and fructose in wild-type ovules sharply increased after anthesis with a relatively higher rate of amino acid biosynthesis. The relative sugar starvation and lower rate of amino acid biosynthesis in the fl mutant ovules may impede the carbohydrate/energy supply and cell wall synthesis, which is consistent with the proteomic results. However, the H2O2 burst was only observed in the wild-type ovules on the day of anthesis. Cotton boll injection experiments in combination with electron microscope observation collectively indicated that H2O2 burst, which is negatively regulated by ascorbate peroxidases (APx), plays an important role in the fiber initiation process. Taken together, our study demonstrates a putative network of DAP species related to fiber initiation in cotton ovules and provides a foundation for future studies on the specific functions of these proteins in fiber development.	[Yao, Yuan; Zhang, Bing; Dong, Chun-Juan; Du, Ying; Jiang, Lin; Liu, Jin-Yuan] Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Plant Mol Biol Lab, Beijing 100084, Peoples R China	Tsinghua University	Liu, JY (corresponding author), Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Plant Mol Biol Lab, Beijing 100084, Peoples R China.	liujy@mail.tsinghua.edu.cn			State Key Basic Research and Development Plan [2010CB126003]; National Transgenic Animals and Plants Research Project [2011ZX08005-003, 2011ZX08009-003]	State Key Basic Research and Development Plan; National Transgenic Animals and Plants Research Project	This work was supported by grants from the State Key Basic Research and Development Plan (2010CB126003) and the National Transgenic Animals and Plants Research Project (2011ZX08005-003 and 2011ZX08009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAKO K, 1994, PLANT CELL PHYSIOL, V35, P497; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Azevedo RA, 2001, AMINO ACIDS, V20, P261, DOI 10.1007/s007260170043; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Craig S, 1996, J MICROSC-OXFORD, V182, P102, DOI 10.1046/j.1365-2818.1996.128409.x; Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917; Du SJ, 2013, J PROTEOMICS, V82, P113, DOI 10.1016/j.jprot.2013.02.020; DUERRE JA, 1981, BIOCHIM BIOPHYS ACTA, V678, P275, DOI 10.1016/0304-4165(81)90217-8; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fath A, 2001, PLANT PHYSIOL, V126, P156, DOI 10.1104/pp.126.1.156; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; GEIGENBERGER P, 1993, PLANTA, V189, P329, DOI 10.1007/BF00194429; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; Kato Y, 1997, PLANT CELL PHYSIOL, V38, P173, DOI 10.1093/oxfordjournals.pcp.a029149; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee JJ, 2006, PLANTA, V223, P418, DOI 10.1007/s00425-005-0098-7; Liu K, 2012, J PROTEOMICS, V75, P845, DOI 10.1016/j.jprot.2011.09.025; Ma QF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-466; Macheroux P, 1999, PLANTA, V207, P325, DOI 10.1007/s004250050489; McInnis SM, 2006, NEW PHYTOL, V172, P221, DOI 10.1111/j.1469-8137.2006.01875.x; Moffatt BA, 2002, PLANT PHYSIOL, V128, P812, DOI 10.1104/pp.010880; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; NELSON R J, 1992, Current Biology, V2, P487, DOI 10.1016/0960-9822(92)90673-X; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Obiadalla-Ali H, 2004, PHYSIOL PLANTARUM, V120, P196, DOI 10.1111/j.0031-9317.2004.0167.x; OKUDA T, 1991, PLANT PHYSIOL, V97, P1265, DOI 10.1104/pp.97.3.1265; Rong JK, 2005, THEOR APPL GENET, V111, P1137, DOI 10.1007/s00122-005-0041-0; Ruan YL, 1998, PLANT PHYSIOL, V118, P399, DOI 10.1104/pp.118.2.399; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Ruan YL, 2001, PLANT CELL, V13, P47, DOI 10.1105/tpc.13.1.47; SEAGULL RW, 1990, PROTOPLASMA, V159, P44, DOI 10.1007/BF01326634; SHARGOOL PD, 1988, PHYTOCHEMISTRY, V27, P1571, DOI 10.1016/0031-9422(88)80404-7; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Tenhaken R, 1996, PLANT PHYSIOL, V112, P1127, DOI 10.1104/pp.112.3.1127; Turley RB, 2002, J HERED, V93, P359, DOI 10.1093/jhered/93.5.359; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wang HH, 2010, PLANT MOL BIOL, V72, P397, DOI 10.1007/s11103-009-9578-7; Wilkins T., 2005, Pflanzenschutz-Nachrichten Bayer, V58, P119; WISE RR, 1987, PLANT PHYSIOL, V83, P278, DOI 10.1104/pp.83.2.278; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Yao Y, 2006, ELECTROPHORESIS, V27, P4559, DOI 10.1002/elps.200600111; Yu XH, 2000, SCI CHINA SER C, V43, P623, DOI 10.1007/BF02882283; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058758; Zhang B, 2013, PROTEOMICS, V13, P1159, DOI 10.1002/pmic.201200176; Zhao GR, 2002, BBA-GENE STRUCT EXPR, V1574, P370, DOI 10.1016/S0167-4781(01)00311-6; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t	51	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117049	10.1371/journal.pone.0117049	http://dx.doi.org/10.1371/journal.pone.0117049			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700002	gold, Green Submitted, Green Published			2022-12-27	WOS:000349789800014
J	Simpson, MJ				Simpson, Matthew J.			Exact Solutions of Linear Reaction-Diffusion Processes on a Uniformly Growing Domain: Criteria for Successful Colonization	PLOS ONE			English	Article							NEURAL CREST CELLS; PATTERN-FORMATION; MIGRATION; GROWTH; MODELS; TIME; EMBRYO	Many processes during embryonic development involve transport and reaction of molecules, or transport and proliferation of cells, within growing tissues. Mathematical models of such processes usually take the form of a reaction-diffusion partial differential equation (PDE) on a growing domain. Previous analyses of such models have mainly involved solving the PDEs numerically. Here, we present a framework for calculating the exact solution of a linear reaction-diffusion PDE on a growing domain. We derive an exact solution for a general class of one-dimensional linear reaction-diffusion process on 0<x<L(t), where L(t) is the length of the growing domain. Comparing our exact solutions with numerical approximations confirms the veracity of the method. Furthermore, our examples illustrate a delicate interplay between: (i) the rate at which the domain elongates, (ii) the diffusivity associated with the spreading density profile, (iii) the reaction rate, and (iv) the initial condition. Altering the balance between these four features leads to different outcomes in terms of whether an initial profile, located near x = 0, eventually overcomes the domain growth and colonizes the entire length of the domain by reaching the boundary where x = L(t).	Queensland Univ Technol, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Simpson, MJ (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	matthew.simpson@qut.edu.au		Simpson, Matthew/0000-0001-6254-313X	Australian Research Council [FT130100148]	Australian Research Council(Australian Research Council)	The author acknowledges the support from the Australian Research Council (FT130100148) (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PRINCIPLES DEV; Baker RE, 2010, B MATH BIOL, V72, P719, DOI 10.1007/s11538-009-9467-x; Binder BJ, 2009, J THEOR BIOL, V259, P541, DOI 10.1016/j.jtbi.2009.04.025; Chisholm RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012857; Crampin EJ, 2002, B MATH BIOL, V64, P747, DOI 10.1006/bulm.2002.0295; Crampin EJ, 1999, B MATH BIOL, V61, P1093, DOI 10.1006/bulm.1999.0131; Crank J., 1975, MATH DIFFUSION; Ellery AJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041135; Farlow S.J., 1982, PARTIAL DIFFERENTIAL; Gershon Michael D, 2004, Semin Pediatr Surg, V13, P224, DOI 10.1053/j.sempedsurg.2004.10.019; Haberman R, 2004, APPL PARTIAL DIFFERE; Hickson RI, 2011, INT J HEAT MASS TRAN, V54, P2642, DOI 10.1016/j.ijheatmasstransfer.2011.01.019; Hywood JD, 2013, ANZIAM J, V55, P93, DOI 10.1017/S1446181113000369; Jazaei F, 2014, J HYDROL, V519, P1642, DOI 10.1016/j.jhydrol.2014.09.018; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kulesa PM, 1998, DEV BIOL, V204, P327, DOI 10.1006/dbio.1998.9082; Landman K. A., 2000, J APPL MATH DECIS SC, V4, P125, DOI [10.155/S1173912600000092, DOI 10.1155/S1173912600000092]; Landman KA, 2003, B MATH BIOL, V65, P235, DOI 10.1016/S0092-8240(02)00098-8; Landman KA, 1997, AICHE J, V43, P3147, DOI 10.1002/aic.690431204; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; Meinhardt H., 1982, MODELS BIOL PATTERN; Murray, 2002, MATH BIOL I INTRO IN; Newgreen DF, 1996, ACTA ANAT, V157, P105; NEWGREEN DF, 1986, INT REV CYTOL, V103, P89, DOI 10.1016/S0074-7696(08)60834-7; Newgreen DF, 2013, DEV BIOL, V382, P305, DOI 10.1016/j.ydbio.2013.06.029; Painter KJ, 1999, P NATL ACAD SCI USA, V96, P5549, DOI 10.1073/pnas.96.10.5549; Simpson MJ, 2006, J COMPUT APPL MATH, V192, P282, DOI 10.1016/j.cam.2005.05.003; Simpson MJ, 2014, J HYDROL, V513, P7, DOI 10.1016/j.jhydrol.2014.03.035; Simpson MJ, 2013, J HYDROL, V501, P241, DOI 10.1016/j.jhydrol.2013.08.005; Simpson MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0007; Sun YW, 1999, TRANSPORT POROUS MED, V37, P327, DOI 10.1023/A:1006507514019; Swanson KR, 2008, MATH COMPUT MODEL, V47, P638, DOI 10.1016/j.mcm.2007.02.024; Thompson RN, 2012, B MATH BIOL, V74, P2793, DOI 10.1007/s11538-012-9779-0; Witelski TP, 2005, ADV WATER RESOUR, V28, P1133, DOI 10.1016/j.advwatres.2004.06.006; Yates CA, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021921; Young HM, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-23	36	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117949	10.1371/journal.pone.0117949	http://dx.doi.org/10.1371/journal.pone.0117949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693183	Green Submitted, gold, Green Published			2022-12-27	WOS:000350061500082
J	Ben Maamar, M; Lesne, L; Desdoits-Lethimonier, C; Coiffec, I; Lassurguere, J; Lavoue, V; Deceuninck, Y; Antignac, JP; Le Bizec, B; Perdu, E; Zalko, D; Pineau, C; Chevrier, C; Dejucq-Rainsford, N; Mazaud-Guittot, S; Jegou, B				Ben Maamar, Millissia; Lesne, Laurianne; Desdoits-Lethimonier, Christele; Coiffec, Isabelle; Lassurguere, Julie; Lavoue, Vincent; Deceuninck, Yoann; Antignac, Jean-Philippe; Le Bizec, Bruno; Perdu, Elisabeth; Zalko, Daniel; Pineau, Charles; Chevrier, Cecile; Dejucq-Rainsford, Nathalie; Mazaud-Guittot, Severine; Jegou, Bernard			An Investigation of the Endocrine-Disruptive Effects of Bisphenol A in Human and Rat Fetal Testes	PLOS ONE			English	Article							SERUM TESTOSTERONE CONCENTRATION; INSULIN-LIKE FACTOR-3; IN-UTERO; LACTATIONAL EXPOSURE; LUTEINIZING-HORMONE; ANOGENITAL DISTANCE; PERINATAL EXPOSURE; PRENATAL EXPOSURE; SPRAGUE-DAWLEY; HUMAN HEALTH	Few studies have been undertaken to assess the possible effects of bisphenol A (BPA) on the reproductive hormone balance in animals or humans with often contradictory results. We investigated possible direct endocrine disruption by BPA of the fetal testes of 2 rat strains (14.5-17.5 days post-coitum) and humans (8-12 gestational weeks) and under different culture conditions. BPA concentrations of 10(-8)M and 10(-5)M for 72h reduced testosterone production by the Sprague-Dawley fetal rat testes, while only 10(-5)M suppressed it in the Wistar strain. The suppressive effects at 10(-5)M were seen as early as 24h and 48h in both strains. BPA at 10(-7)-10(-5)M for 72h suppressed the levels of fetal rat Leydig cell insulin-like factor 3 (INSL3). BPA exposure at 10(-8)M, 10(-7)M, and 10(-5)M for 72h inhibited testosterone production in fetal human testes. For the lowest doses, the effects observed occurred only when no gonadotrophin was added to the culture media and were associated with a poorly preserved testicular morphology. We concluded that (i) BPA can display antiandrogenic effects both in rat and human fetal testes; (ii) it is essential to ascertain that the divergent effects of endocrine disruptors between species in vitro do not result from the culture conditions used, and/or the rodent strain selected; (iii) the optimization of each in vitro assay for a given species should be a major objective rather than the search of an hypothetical trans-species consensual model-system, as the organization of the testis is intrinsically different between mammalian species; (iv) due to the uncertainty existing on the internal exposure of the human fetal testis to BPA, and the insufficient number of epidemiological studies on the endocrine disruptive effects of BPA, caution should be taken in the extrapolation of our present results to the human reproductive health after fetal exposure to BPA.	[Ben Maamar, Millissia; Lesne, Laurianne; Desdoits-Lethimonier, Christele; Coiffec, Isabelle; Lassurguere, Julie; Pineau, Charles; Chevrier, Cecile; Dejucq-Rainsford, Nathalie; Mazaud-Guittot, Severine; Jegou, Bernard] INSERM, IRSET, SFR Biosit, U1085, Rennes, France; [Ben Maamar, Millissia; Lesne, Laurianne; Desdoits-Lethimonier, Christele; Coiffec, Isabelle; Lassurguere, Julie; Pineau, Charles; Chevrier, Cecile; Dejucq-Rainsford, Nathalie; Mazaud-Guittot, Severine; Jegou, Bernard] Univ Rennes 1, Rennes, France; [Lavoue, Vincent] CHU Rennes, Serv Gynecol & Obstet, Rennes, France; [Deceuninck, Yoann; Antignac, Jean-Philippe; Le Bizec, Bruno] ONIRIS, LABERCA, USC 1329, Nantes, France; [Perdu, Elisabeth; Zalko, Daniel] INRA, TOXALIM, UMR 1331, F-31931 Toulouse, France; [Jegou, Bernard] EHESP, Sch Publ Hlth, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Ecole des Hautes Etudes en Sante Publique (EHESP)	Jegou, B (corresponding author), INSERM, IRSET, SFR Biosit, U1085, Campus Beaulieu, Rennes, France.	bernard.jegou@inserm.fr	Chevrier, Cecile/J-9170-2015; DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; Pineau, Charles G/D-9185-2013; Maamar, Millissia Ben/Z-5134-2019; Mazaud-Guittot, Severine/I-4694-2015; , Protim/C-4687-2012; Lesne, Laurianne/AAD-6180-2019; Desdoits-Lethimonier, Christele/I-2744-2015; Jégou, Bernard/I-4742-2015; LAVOUE, Vincent/L-5644-2017; Ben Maamar, Millissia/D-8094-2015	Chevrier, Cecile/0000-0003-3101-8222; Pineau, Charles G/0000-0002-7461-5433; Mazaud-Guittot, Severine/0000-0003-0566-4124; Lesne, Laurianne/0000-0003-3165-9986; Desdoits-Lethimonier, Christele/0000-0003-4232-2107; LAVOUE, Vincent/0000-0002-4682-2806; JEGOU, Bernard/0000-0003-0623-3609; ANTIGNAC, Jean-Philippe/0000-0001-9512-9314; LE BIZEC, Bruno/0000-0002-0600-5895; Ben Maamar, Millissia/0000-0002-2022-922X; Dejucq-Rainsford, Nathalie/0000-0002-1788-2690	Inserm (Institut National de la Sante et de la Recherche Medicale); Ministere de l'Enseignement Superieur et de la Recherche; EHESP - School of Public Health; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES) [EST-2010/2/046, EST-2012/2/171]; Agence Nationale de la Recherche (ANR) [ANR-13-CESA-0012-03]; Ministere de l'Ecologie, du Developpement Durable et de l'Energie (MEDDE) [13-MRES-PNRPE-5-CUS-047]	Inserm (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council); EHESP - School of Public Health; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES)(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere de l'Ecologie, du Developpement Durable et de l'Energie (MEDDE)	This work was funded by Inserm (Institut National de la Sante et de la Recherche Medicale), Ministere de l'Enseignement Superieur et de la Recherche, EHESP - School of Public Health, Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES; grant#EST-2010/2/046 (BPATESTIS); grant#EST-2012/2/171 (CHEMIX)), Agence Nationale de la Recherche (ANR; grant#ANR-13-CESA-0012-03 (NEWPLAST)) and Ministere de l'Ecologie, du Developpement Durable et de l'Energie (MEDDE; grant# 13-MRES-PNRPE-5-CUS-047 (BPACTIONS)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert O, 2014, HUM REPROD UPDATE, V20, P231, DOI 10.1093/humupd/dmt050; Angenard G, 2011, REPROD TOXICOL, V31, P470, DOI 10.1016/j.reprotox.2010.12.058; Aris A, 2014, REPROD TOXICOL, V45, P8, DOI 10.1016/j.reprotox.2013.12.006; Audebert M, 2011, ARCH TOXICOL, V85, P1463, DOI 10.1007/s00204-011-0721-2; Balakrishnan B, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.025; Bay K, 2005, J CLIN ENDOCR METAB, V90, P3410, DOI 10.1210/jc.2004-2257; Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366; Brucker-Davis F, 2011, THYROID, V21, P1133, DOI 10.1089/thy.2010.0459; Bursztyka J, 2008, TOXICOL IN VITRO, V22, P1595, DOI 10.1016/j.tiv.2008.06.013; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Calafat AM, 2009, ENVIRON HEALTH PERSP, V117, P639, DOI 10.1289/ehp.0800265; Chauvigne F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027172; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; Chevrier J, 2013, ENVIRON HEALTH PERSP, V121, P138, DOI 10.1289/ehp.1205092; Choi J, 2014, MOL CELL ENDOCRINOL, V383, P203, DOI 10.1016/j.mce.2013.12.009; Deceuninck Y, 2014, J CHROMATOGR A, V1362, P241, DOI 10.1016/j.chroma.2014.07.105; Delfosse V, 2014, VITAM HORM, V94, P229, DOI 10.1016/B978-0-12-800095-3.00009-2; Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069; Dhooge W, 2006, ANAL BIOANAL CHEM, V386, P1419, DOI 10.1007/s00216-006-0669-x; Farabollini F, 1999, PHARMACOL BIOCHEM BE, V64, P687, DOI 10.1016/S0091-3057(99)00136-7; Fenichel P, 2012, HUM REPROD, V27, P983, DOI 10.1093/humrep/der451; HABERT R, 1990, BIOL NEONATE, V58, P24; Hallmark N, 2007, ENVIRON HEALTH PERSP, V115, P390, DOI 10.1289/ehp.9490; Harley KG, 2013, ENVIRON HEALTH PERSP, V121, P514, DOI 10.1289/ehp.1205548; Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487; Howdeshell KL, 2008, TOXICOL SCI, V102, P371, DOI 10.1093/toxsci/kfm306; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Huang Jie, 2013, Wei Sheng Yan Jiu, V42, P543; Huhtaniemi I, 1996, LEYDIG CELL, P365; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Ivell R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00006; Kabuto H, 2004, LIFE SCI, V74, P2931, DOI 10.1016/j.lfs.2003.07.060; Kawai K, 2003, ENVIRON HEALTH PERSP, V111, P175, DOI 10.1289/ehp.5440; Kobayashi K, 2002, IND HEALTH, V40, P375, DOI 10.2486/indhealth.40.375; Kristensen DM, 2012, INT J ANDROL, V35, P377, DOI 10.1111/j.1365-2605.2012.01282.x; Kristensen DM, 2011, HUM REPROD, V26, P235, DOI 10.1093/humrep/deq323; Kuroda N, 2003, J PHARMACEUT BIOMED, V30, P1743, DOI 10.1016/S0731-7085(02)00516-2; Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146; Lassurguere J, 2003, TOXICOL SCI, V73, P160, DOI 10.1093/toxsci/kfg065; Lee YJ, 2008, REPROD TOXICOL, V25, P413, DOI 10.1016/j.reprotox.2008.05.058; Mazaud-Guittot S, 2013, J CLIN ENDOCR METAB, V98, pE1757, DOI 10.1210/jc.2013-2531; Miao MH, 2011, BIRTH DEFECTS RES A, V91, P867, DOI 10.1002/bdra.22845; Murray TJ, 2007, REPROD TOXICOL, V23, P383, DOI 10.1016/j.reprotox.2006.10.002; N'Tumba-Byn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051579; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Snijder CA, 2013, ENVIRON HEALTH PERSP, V121, P393, DOI 10.1289/ehp.1205296; Staples CA, 2000, CHEMOSPHERE, V40, P521, DOI 10.1016/S0045-6535(99)00288-X; Tanaka M, 2006, HUM EXP TOXICOL, V25, P369, DOI 10.1191/0960327106ht638oa; Teeguarden J, 2013, FOOD CHEM TOXICOL, V62, P949, DOI 10.1016/j.fct.2013.08.001; Tyl RW, 2014, SEMIN FETAL NEONAT M, V19, P195, DOI 10.1016/j.siny.2013.11.010; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vandenberg LN, 2010, CIENC SAUDE COLETIVA, V17, P407; Vrijheid M, 2003, OCCUP ENVIRON MED, V60, P543, DOI 10.1136/oem.60.8.543; Wilson VS, 2007, TOXICOL LETT, V170, P177, DOI 10.1016/j.toxlet.2007.03.004; Ye LP, 2011, TOXICOL LETT, V207, P137, DOI 10.1016/j.toxlet.2011.09.001; Zhang XW, 2011, TOXICOL SCI, V121, P320, DOI 10.1093/toxsci/kfr061	62	35	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117226	10.1371/journal.pone.0117226	http://dx.doi.org/10.1371/journal.pone.0117226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706302	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100067
J	Charpentier, MS; Tandon, P; Trincot, CE; Koutleva, EK; Conlon, FL				Charpentier, Marta S.; Tandon, Panna; Trincot, Claire E.; Koutleva, Elitza K.; Conlon, Frank L.			A Distinct Mechanism of Vascular Lumen Formation in Xenopus Requires EGFL7	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MOUSE YOLK-SAC; ENDOTHELIAL-CELLS; IN-VIVO; TUBE FORMATION; ZEBRAFISH EMBRYO; CAPILLARY LUMEN; MOLECULAR-BASIS; VESSEL FUSION; DORSAL AORTA	During vertebrate blood vessel development, lumen formation is the critical process by which cords of endothelial cells transition into functional tubular vessels. Here, we use Xenopus embryos to explore the cellular and molecular mechanisms underlying lumen formation of the dorsal aorta and the posterior cardinal veins, the primary major vessels that arise via vasculogenesis within the first 48 hours of life. We demonstrate that endothelial cells are initially found in close association with one another through the formation of tight junctions expressing ZO-1. The emergence of vascular lumens is characterized by elongation of endothelial cell shape, reorganization of junctions away from the cord center to the periphery of the vessel, and onset of Claudin-5 expression within tight junctions. Furthermore, unlike most vertebrate vessels that exhibit specialized apical and basal domains, we show that early Xenopus vessels are not polarized. Moreover, we demonstrate that in embryos depleted of the extracellular matrix factor Epidermal Growth Factor-Like Domain 7 (EGFL7), an evolutionarily conserved factor associated with vertebrate vessel development, vascular lumens fail to form. While Claudin-5 localizes to endothelial tight junctions of EGFL7-depleted embryos in a timely manner, endothelial cells of the aorta and veins fail to undergo appropriate cell shape changes or clear junctions from the cell-cell contact. Taken together, we demonstrate for the first time the mechanisms by which lumens are generated within the major vessels in Xenopus and implicate EGFL7 in modulating cell shape and cell-cell junctions to drive proper lumen morphogenesis.	[Charpentier, Marta S.; Tandon, Panna; Trincot, Claire E.; Koutleva, Elitza K.; Conlon, Frank L.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27514 USA; [Charpentier, Marta S.; Tandon, Panna; Trincot, Claire E.; Conlon, Frank L.] UNC CH, Dept Genet & Mol Biol, Chapel Hill, NC USA; [Koutleva, Elitza K.; Conlon, Frank L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Conlon, Frank L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Conlon, FL (corresponding author), Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27514 USA.	frank_conlon@med.unc.edu	Ariel, Pablo/AGJ-4118-2022	Trincot, Claire/0000-0002-5125-2297	National Institutes of Health, National Heart, Lung, and Blood Institute [RO1 DE018825, RO1 HL089641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018825] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by grants to F.L.C. from National Institutes of Health, National Heart, Lung, and Blood Institute (RO1 DE018825 and RO1 HL089641).	Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Campagnolo L, 2005, AM J PATHOL, V167, P275, DOI 10.1016/S0002-9440(10)62972-0; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Charpentier MS, 2013, DEV CELL, V25, P132, DOI 10.1016/j.devcel.2013.03.003; Charpentier MS, 2013, BIOESSAYS; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Ciau-Uitz A, 2013, DEVELOPMENT, V140, P2632, DOI 10.1242/dev.090829; Cleaver O, 2000, DEVELOPMENT, V127, P869; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Cleaver O, 1997, DEV DYNAM, V210, P66, DOI 10.1002/(SICI)1097-0177(199709)210:1<66::AID-AJA7>3.3.CO;2-S; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Doherty JR, 2007, DEV DYNAM, V236, P2808, DOI 10.1002/dvdy.21321; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Fan C, 2013, INT J BIOL MARKER, V28, P71, DOI 10.5301/JBM.2013.10568; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Helker CS, 2013, DEVELOPMENT; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Iden S, 2006, EMBO REP, V7, P1239, DOI 10.1038/sj.embor.7400819; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Johnson L, 2013, J CLIN INVEST, V123, P3997, DOI 10.1172/JCI67892; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; KAU CL, 1983, J IMMUNOL, V131, P2262; Kucera T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004132; Lammert E, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006619; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; Levine AJ, 2003, DEV BIOL, V254, P50, DOI 10.1016/S0012-1606(02)00029-5; Lizama CO, 2013, EXP CELL RES, V319, P1247, DOI 10.1016/j.yexcr.2013.03.028; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Mandel EM, 2010, DEVELOPMENT, V137, P1919, DOI 10.1242/dev.043588; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Meadows KL, 2012, COLD SPRING HARB PER, V2; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nichol D, 2012, BLOOD, V119, P1345, DOI 10.1182/blood-2011-10-322446; Nichol D, 2010, BLOOD, V116, P6133, DOI 10.1182/blood-2010-03-274860; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nikolic Iva, 2010, J Angiogenes Res, V2, P9, DOI 10.1186/2040-2384-2-9; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sato Y, 2008, DEV CELL, V14, P890, DOI 10.1016/j.devcel.2008.03.024; Showell C, 2006, DEV DYNAM, V235, P1623, DOI 10.1002/dvdy.20714; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Strilic B, 2010, CURR BIOL, V20, P2003, DOI 10.1016/j.cub.2010.09.061; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tandon P, 2013, DEVELOPMENT, V140, P2409, DOI 10.1242/dev.093385; Tandon P, 2012, METHODS MOL BIOL, V843, P29, DOI 10.1007/978-1-61779-523-7_4; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; Udan RS, 2013, DEVELOPMENT, V140, P4041, DOI 10.1242/dev.096255; Udan RS, 2013, WIRES DEV BIOL, V2, P327, DOI 10.1002/wdev.91; Vokes SA, 2002, DEVELOPMENT, V129, P775; Walmsley M, 2002, DEVELOPMENT, V129, P5683, DOI 10.1242/dev.00169; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Xu K, 2011, SEMIN CELL DEV BIOL; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; Zhong HB, 2011, CELL RES, V21, P1080, DOI 10.1038/cr.2011.41	86	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116086	10.1371/journal.pone.0116086	http://dx.doi.org/10.1371/journal.pone.0116086			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705891	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100025
J	Dinter, J; Muhlhaus, J; Wienchol, CL; Yi, CX; Nurnberg, D; Morin, S; Gruters, A; Kohrle, J; Schoneberg, T; Tschop, M; Krude, H; Kleinau, G; Biebermann, H				Dinter, Juliane; Muehlhaus, Jessica; Wienchol, Carolin Leonie; Yi, Chun-Xia; Nuernberg, Daniela; Morin, Silke; Grueters, Annette; Koehrle, Josef; Schoeneberg, Torsten; Tschoep, Matthias; Krude, Heiko; Kleinau, Gunnar; Biebermann, Heike			Inverse Agonistic Action of 3-Iodothyronamine at the Human Trace Amine-Associated Receptor 5	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HORMONE DERIVATIVE 3-IODOTHYRONAMINE; ADIPOSE-TISSUE THERMOGENESIS; THYROID-HORMONE; OLFACTORY SUBSYSTEM; HYPOTHALAMIC AMPK; MOLECULAR-BASIS; METABOLISM; EXPRESSION; CELLS	Application of 3-iodothyronamine (3-T(1)AM) results in decreased body temperature and body weight in rodents. The trace amine-associated receptor (TAAR) 1, a family A G protein-coupled receptor, is a target of 3-T(1)AM. However, 3-T(1)AM effects still persist in mTaar1 knockout mice, which suggest so far unknown further receptor targets that are of physiological relevance. TAAR5 is a highly conserved TAAR subtype among mammals and we here tested TAAR5 as a potential 3-T(1)AM target. First, we investigated mouse Taar5 (mTaar5) expression in several brain regions of the mouse in comparison to mTaar1. Secondly, to unravel the full spectrum of signaling capacities, we examined the distinct G(s)-, G(i/o)-, G(12/13)-, G(q/11)- and MAP kinase-mediated signaling pathways of mouse and human TAAR5 under ligand-independent conditions and after application of 3-T(1)AM. We found overlapping localization of mTaar1 and mTaar5 in the amygdala and ventromedial hypothalamus of the mouse brain. Second, the murine and human TAAR5 (hTAAR5) display significant basal activity in the G(q/11) pathway but show differences in the basal activity in G(s) and MAP kinase signaling. In contrast to mTaar5, 3-T(1)AM application at hTAAR5 resulted in significant reduction in basal IP3 formation and MAP kinase signaling. In conclusion, our data suggest that the human TAAR5 is a target for 3-T(1)AM, exhibiting inhibitory effects on IP3 formation and MAP kinase signaling pathways, but does not mediate Gs signaling effects as observed for TAAR1. This study also indicates differences between TAAR5 orthologs with respect to their signaling profile. In consequence, 3-T(1)AM-mediated effects may differ between rodents and humans.	[Dinter, Juliane; Muehlhaus, Jessica; Wienchol, Carolin Leonie; Nuernberg, Daniela; Grueters, Annette; Krude, Heiko; Kleinau, Gunnar; Biebermann, Heike] Charite, Inst Expt Padiat Endokrinol, D-13353 Berlin, Germany; [Yi, Chun-Xia; Morin, Silke] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Diabet & Obes, Munich, Germany; [Koehrle, Josef; Tschoep, Matthias] Charite, Inst Expt Endocrinol, D-13353 Berlin, Germany; [Schoeneberg, Torsten] Univ Leipzig, Fak Med, Inst Biochem, Mol Biochem, D-04109 Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Biebermann, H (corresponding author), Charite, Inst Expt Padiat Endokrinol, D-13353 Berlin, Germany.	heike.biebermann@charite.de	Kleinau, Gunnar/GPX-6330-2022; Köhrle, Josef/AAH-6438-2020; Yi, Chun-Xia/J-4068-2016	Köhrle, Josef/0000-0002-9187-9078; Yi, Chun-Xia/0000-0003-1184-4615; Biebermann, Heike/0000-0002-2024-7778; Tschoep, Matthias/0000-0002-4744-371X	Deutsche Forschungsgemeinschaft (DFG) [SPP1629, BI 893/5-1, KO 922/16-1, STA 1265/1-1, 1208-2, KL 2334/2-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) project SPP1629 Thyroid Trans Act BI 893/5-1, KO 922/16-1, STA 1265/1-1, Graduate College 1208-2: Hormonal Regulation of Energy Metabolism, Body Weight and Growth, TP1 and TP3, and KL 2334/2-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babusyte A, 2013, J LEUKOCYTE BIOL, V93, P387, DOI 10.1189/jlb.0912433; Bakker RA, 2000, EUR J PHARMACOL, V387, pR5, DOI 10.1016/S0014-2999(99)00803-1; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Braulke LJ, 2008, J COMP PHYSIOL B, V178, P167, DOI 10.1007/s00360-007-0208-x; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Carnicelli V, 2010, CHEMOSENS PERCEPT, V3, P99, DOI 10.1007/s12078-010-9075-z; CODY V, 1984, ENDOCR RES, V10, P91, DOI 10.3109/07435808409035410; D'Andrea G, 2003, NEUROSCI LETT, V346, P89, DOI 10.1016/S0304-3940(03)00573-1; Dhillo WS, 2009, DIABETES OBES METAB, V11, P251, DOI 10.1111/j.1463-1326.2008.00935.x; Doyle KP, 2007, STROKE, V38, P2569, DOI 10.1161/STROKEAHA.106.480277; EASON MG, 1992, J BIOL CHEM, V267, P15795; Ferrero DM, 2012, ACS CHEM BIOL, V7, P1184, DOI 10.1021/cb300111e; Frascarelli S, 2011, CARDIOVASC DRUG THER, V25, P307, DOI 10.1007/s10557-011-6320-x; Galli E, 2012, J CLIN ENDOCR METAB, V97, pE69, DOI 10.1210/jc.2011-1115; Ghelardoni S, 2014, J ENDOCRINOL, V221, P101, DOI 10.1530/JOE-13-0311; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gompf HS, 2010, BRAIN RES, V1351, P130, DOI 10.1016/j.brainres.2010.06.067; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grandy DK, 2007, PHARMACOL THERAPEUT, V116, P355, DOI 10.1016/j.pharmthera.2007.06.007; Hackenmueller SA, 2012, J CHROMATOGR A, V1256, P89, DOI 10.1016/j.chroma.2012.07.052; Hart ME, 2006, J MED CHEM, V49, P1101, DOI 10.1021/jm0505718; Haviland JA, 2013, OBESITY, V21, P2538, DOI 10.1002/oby.20391; Hoefig CS, 2011, J CLIN ENDOCR METAB, V96, P1864, DOI 10.1210/jc.2010-2680; James TD, 2013, HORM BEHAV, V64, P81, DOI 10.1016/j.yhbeh.2013.05.004; Johnson MA, 2012, P NATL ACAD SCI USA, V109, P13410, DOI 10.1073/pnas.1206724109; JONES SVP, 1991, MOL PHARMACOL, V40, P242; Kenakin T, 2005, TRENDS PHARMACOL SCI, V26, P603, DOI 10.1016/j.tips.2005.10.007; Khilnani G, 2011, INDIAN J PHARMACOL, V43, P492, DOI 10.4103/0253-7613.84947; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kleinau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027073; Klieverik LP, 2009, J ENDOCRINOL, V201, P377, DOI 10.1677/JOE-09-0043; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Maack C, 2000, BRIT J PHARMACOL, V130, P1131, DOI 10.1038/sj.bjp.0703400; Manni ME, 2013, BRIT J PHARMACOL, V168, P354, DOI 10.1111/j.1476-5381.2012.02137.x; Manni ME, 2012, BRIT J PHARMACOL, V166, P650, DOI 10.1111/j.1476-5381.2011.01823.x; de Morentin PBM, 2014, CELL METAB, V20, P41, DOI 10.1016/j.cmet.2014.03.031; Millan MJ, 2012, J PHARMACOL EXP THER, V340, P750, DOI 10.1124/jpet.111.187468; Miller GM, 2005, J PHARMACOL EXP THER, V313, P983, DOI 10.1124/jpet.105.084459; Musilli C, 2014, BRIT J PHARMACOL, V171, P3476, DOI 10.1111/bph.12697; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Panas HN, 2010, J NEUROSCI RES, V88, P1962, DOI 10.1002/jnr.22367; Panas MW, 2012, J NEUROIMMUNE PHARM, V7, P866, DOI 10.1007/s11481-011-9321-4; RAYMOND JR, 1995, AM J PHYSIOL-RENAL, V269, pF141, DOI 10.1152/ajprenal.1995.269.2.F141; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Saba A, 2010, ENDOCRINOLOGY, V151, P5063, DOI 10.1210/en.2010-0491; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Sotnikova TD, 2009, MOL PHARMACOL, V76, P229, DOI 10.1124/mol.109.055970; Staubert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011133; Vallender EJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-51; Vanti WB, 2003, BIOCHEM BIOPH RES CO, V305, P67, DOI 10.1016/S0006-291X(03)00709-5; Wainscott DB, 2007, J PHARMACOL EXP THER, V320, P475, DOI 10.1124/jpet.106.112532; Wallrabenstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054950; Wasik AM, 2012, LEUKEMIA RES, V36, P245, DOI 10.1016/j.leukres.2011.10.002; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wolinsky TD, 2007, GENES BRAIN BEHAV, V6, P628, DOI 10.1111/j.1601-183X.2006.00292.x; Zhang JJ, 2013, J NEUROSCI, V33, P3228, DOI 10.1523/JNEUROSCI.4299-12.2013; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zucchi R, 2006, BRIT J PHARMACOL, V149, P967, DOI 10.1038/sj.bjp.0706948	64	56	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117774	10.1371/journal.pone.0117774	http://dx.doi.org/10.1371/journal.pone.0117774			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706283	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100117
J	Rockstroh, D; Landgraf, K; Wagner, IV; Gesing, J; Tauscher, R; Lakowa, N; Kiess, W; Buhligen, U; Wojan, M; Till, H; Bluher, M; Korner, A				Rockstroh, Denise; Landgraf, Kathrin; Wagner, Isabel Viola; Gesing, Julia; Tauscher, Roy; Lakowa, Nicole; Kiess, Wieland; Buehligen, Ulf; Wojan, Magdalena; Till, Holger; Blueher, Matthias; Koerner, Antje			Direct Evidence of Brown Adipocytes in Different Fat Depots in Children	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUES; ADULT HUMANS; BEIGE ADIPOCYTES; DISTINCT; OBESITY; TRANSDIFFERENTIATION; THERMOGENESIS; INFILTRATION; PREVALENCE; ACTIVATION	Recent studies suggested the persistence of brown adipocytes in adult humans, as opposed to being exclusively present in infancy. In this study, we investigated the presence of brown-like adipocytes in adipose tissue (AT) samples of children and adolescents aged 0 to 18 years and evaluated the association with age, location, and obesity. For this, we analysed AT samples from 131 children and 23 adults by histological, immunohistochemical and expression analyses. We detected brown-like and UCP1 positive adipocytes in 10.3% of 87 lean children (aged 0.3 to 10.7 years) and in one overweight infant, whereas we did not find brown adipocytes in obese children or adults. In our samples, the brown-like adipocytes were interspersed within white AT of perirenal, visceral and also subcutaneous depots. Samples with brown-like adipocytes showed an increased expression of UCP1 (>200fold), PRDM16 (2.8fold), PGC1 alpha and CIDEA while other brown/beige selective markers, such as PAT2, P2RX5, ZIC1, LHX8, TMEM26, HOXC9 and TBX1 were not significantly different between UCP1 positive and negative samples. We identified a positive correlation between UCP1 and PRDM16 within UCP1 positive samples, but not with any other brown/beige marker. In addition, we observed significantly increased PRDM16 and PAT2 expression in subcutaneous and visceral AT samples with high UCP1 expression in adults. Our data indicate that brown-like adipocytes are present well beyond infancy in subcutaneous depots of non-obese children. The presence was not restricted to typical perirenal locations, but they were also interspersed within WAT of visceral and subcutaneous depots.	[Rockstroh, Denise; Landgraf, Kathrin; Wagner, Isabel Viola; Gesing, Julia; Tauscher, Roy; Kiess, Wieland; Koerner, Antje] Univ Leipzig, Ctr Pediat Res Leipzig, Univ Hosp Children & Adolescents, Dept Womens & Child Hlth, D-04109 Leipzig, Germany; [Rockstroh, Denise; Landgraf, Kathrin; Lakowa, Nicole; Till, Holger; Blueher, Matthias; Koerner, Antje] Univ Leipzig, Integrated Res & Treatment Ctr IFB, D-04109 Leipzig, Germany; [Lakowa, Nicole; Blueher, Matthias] Univ Leipzig, Dept Med, Div Endocrinol, D-04109 Leipzig, Germany; [Buehligen, Ulf] Univ Leipzig, Dept Pediat Surg, D-04109 Leipzig, Germany; [Wojan, Magdalena] Univ Leipzig, Dept Orthopaed Surg, D-04109 Leipzig, Germany; [Till, Holger] Med Univ Graz, Dept Pediat & Adolescent Surg, Graz, Austria	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Medical University of Graz	Korner, A (corresponding author), Univ Leipzig, Ctr Pediat Res Leipzig, Univ Hosp Children & Adolescents, Dept Womens & Child Hlth, D-04109 Leipzig, Germany.	antje.koerner@medizin.uni-leipzig.de	Körner, Antje/B-3988-2015; Frielitz, Fabian/ABH-2518-2020; Landgraf, Kathrin/J-4937-2016	Körner, Antje/0000-0001-6001-0356; Landgraf, Kathrin/0000-0002-6878-6033	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]; German Research Council (DFG) [CRC1052/1 C05]; European Community's 7th Framework Programme (FP7) project Beta-JUDO [279153]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); German Research Council (DFG)(German Research Foundation (DFG)); European Community's 7th Framework Programme (FP7) project Beta-JUDO	This work was supported by grants from the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001 (IFB AdiposityDiseases), the German Research Council (DFG) for the Clinical Research Center "Obesity Mechanisms" CRC1052/1 C05 and the European Community's 7th Framework Programme (FP7/2007-2013) project Beta-JUDO under grant agreement no 279153 to A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerril S, 2013, HISTOL HISTOPATHOL, V28, P1411, DOI 10.14670/HH-28.1411; Bluher M, 2009, J CLIN ENDOCR METAB, V94, P2507, DOI 10.1210/jc.2009-0002; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2009, P NUTR SOC, V68, P340, DOI 10.1017/S0029665109990140; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Drubach LA, 2011, J PEDIATR-US, V159, P939, DOI 10.1016/j.jpeds.2011.06.028; EMERY JL, 1978, ARCH DIS CHILD, V53, P154, DOI 10.1136/adc.53.2.154; Enerback S, 2009, NEW ENGL J MED, V360, P2021, DOI 10.1056/NEJMcibr0809610; Garcia CA, 2006, MOL IMAGING BIOL, V8, P24, DOI 10.1007/s11307-005-0030-3; Gilsanz V, 2013, PEDIATR RES, V73, P3, DOI 10.1038/pr.2012.141; Gilsanz V, 2012, J PEDIATR-US, V160, P604, DOI 10.1016/j.jpeds.2011.09.035; Gilsanz V, 2011, J PEDIATR-US, V158, P722, DOI 10.1016/j.jpeds.2010.11.020; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HEATON JM, 1972, J ANAT, V112, P35; HIMMSHAGEN J, 1979, CAN MED ASSOC J, V121, P1361; Hu HCH, 2013, J MAGN RESON IMAGING, V38, P885, DOI 10.1002/jmri.24053; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Korner A, 2007, PEDIATR RES, V61, P640, DOI 10.1203/01.pdr.0000262638.48304.ef; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Landgraf K, 2014, DIABETES DB; LEAN MEJ, 1986, CLIN SCI, V71, P291, DOI 10.1042/cs0710291; Lee P, 2011, J CLIN ENDOCR METAB, V96, P2450, DOI 10.1210/jc.2011-0487; Lee P, 2010, AM J PHYSIOL-ENDOC M, V299, pE601, DOI 10.1152/ajpendo.00298.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Liu WY, 2013, J CELL SCI, V126, P3527, DOI 10.1242/jcs.124321; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; MERKLIN RJ, 1974, ANAT REC, V178, P637, DOI 10.1002/ar.1091780311; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Symonds ME, 2012, DIABETOLOGIA, V55, P1597, DOI 10.1007/s00125-012-2505-5; Tam CS, 2012, J CLIN ENDOCR METAB, V97, P1320, DOI 10.1210/jc.2011-2806; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Ussar S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008490; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	46	44	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117841	10.1371/journal.pone.0117841	http://dx.doi.org/10.1371/journal.pone.0117841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706927	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100123
J	Xiao, FC; Wu, HC; Sun, HS; Pan, SW; Xu, JP; Song, YH				Xiao, Fucheng; Wu, Hengchao; Sun, Hansong; Pan, Shiwei; Xu, Jianping; Song, Yunhu			Effect of Preoperatively Continued Aspirin Use on Early and Mid-Term Outcomes in Off-Pump Coronary Bypass Surgery: A Propensity Score-Matched Study of 1418 Patients	PLOS ONE			English	Article							ON-PUMP; MORTALITY; THERAPY; GUIDELINE; SOCIETY	Background To date, effect of preoperatively continued aspirin administration in off-pump coronary artery bypass grafting (CABG) is less known. We aimed to assess the effect of preoperatively continued aspirin use on early and mid-term outcomes in patients receiving off-pump CABG. Methods From October 2009 to September 2013 at the Fuwai Hospital, 709 preoperative aspirin users were matched with unique 709 nonaspirin users using propensity score matching to obtain risk-adjusted outcome comparisons between the two groups. Early outcomes were in-hospital death, stroke, intra- and post-operative blood loss, reoperation for bleeding and blood product transfusion. Major adverse cardiac events (death, myocardial infarction or repeat revascularization), angina recurrence and cardiogenic readmission were considered as mid-term endpoints. Results There were no significant differences among the groups in baseline characteristics after propensity score matching. The median intraoperative blood loss (600 ml versus 450 ml, P = 0.56), median postoperative blood loss (800 ml versus 790 ml, P = 0.60), blood transfusion requirements (25.1% versus 24.4%, P = 0.76) and composite outcome of in-hospital death, stroke and reoperation for bleeding (2.8% versus 1.6%, P = 0.10) were similar in aspirin and nonaspirin use group. At about 4 years follow-up, no significant difference was observed among the aspirin and nonaspirin use group in major adverse cardiac events free survival estimates (95.7% versus 91.5%, P = 0.23) and freedom from cardiogenic readmission (88.5% versus 85.3%, P = 0.77) whereas the angina recurrence free survival rates was 83.7% and 73.9% in the aspirin and nonaspirin use group respectively (P = 0.02), with odd ratio for preoperative aspirin estimated at 0.71 (95% confidence interval, 0.49-1.04, P = 0.08). Conclusions Preoperatively continued aspirin use was not associated with increased risk of intra- and post-operative blood loss, blood transfusion requirements and composite outcome of in-hospital death, stroke and reoperation for bleeding in off-pump CABG. Preoperative aspirin use tended to decrease the hazard of mid-term angina recurrence.	[Xiao, Fucheng; Wu, Hengchao; Sun, Hansong; Pan, Shiwei; Xu, Jianping; Song, Yunhu] Fu Wai Hosp, Dept Cardiovasc Surg, State Key Lab Cardiovasc Dis, Beijing, Peoples R China; [Xiao, Fucheng; Wu, Hengchao; Sun, Hansong; Pan, Shiwei; Xu, Jianping; Song, Yunhu] Peking Union Med Coll, Cardiovasc Inst, Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China; [Xiao, Fucheng; Wu, Hengchao; Sun, Hansong; Pan, Shiwei; Xu, Jianping; Song, Yunhu] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Sun, HS (corresponding author), Fu Wai Hosp, Dept Cardiovasc Surg, State Key Lab Cardiovasc Dis, Beijing, Peoples R China.; Sun, HS (corresponding author), Peking Union Med Coll, Cardiovasc Inst, Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China.; Sun, HS (corresponding author), Chinese Acad Med Sci, Beijing 100730, Peoples R China.	drsunhs@sina.com						[Anonymous], 2008, STS GEN THORACIC DAT; Ballotta A, 2007, J THORAC CARDIOV SUR, V134, P132, DOI 10.1016/j.jtcvs.2007.01.055; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805; Cao LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030094; Cao LH, 2012, ANN SURG, V255, P399, DOI 10.1097/SLA.0b013e318234313b; CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201; Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0; Deja MA, 2012, J THORAC CARDIOV SUR, V144, P204, DOI 10.1016/j.jtcvs.2012.04.004; Ferraris VA, 2012, ANN THORAC SURG, V94, P1761, DOI 10.1016/j.athoracsur.2012.07.086; GOLDMAN S, 1988, CIRCULATION, V77, P1324, DOI 10.1161/01.CIR.77.6.1324; Gulbins H, 2009, THORAC CARDIOV SURG, V57, P18, DOI 10.1055/s-2008-1038791; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Hirai Shinji, 2003, Ann Thorac Cardiovasc Surg, V9, P365; Jacob M, 2011, CIRCULATION, V123, P577, DOI 10.1161/CIRCULATIONAHA.110.957373; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Ma XC, 2014, J CARDIOVASC PHARM T, V19, P97, DOI 10.1177/1074248413509026; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; Mariani MA, 1999, ANN THORAC SURG, V67, P1370, DOI 10.1016/S0003-4975(99)00265-9; Ms RM, 2012, J CARDIOTHOR VASC AN, V26, P245, DOI 10.1053/j.jvca.2011.09.024; Parsons, 2001, P 26 ANN SAS US GROU; Quigley RL, 2003, HEART SURG FORUM, V6, P94; SETHI GK, 1990, J AM COLL CARDIOL, V15, P15, DOI 10.1016/0735-1097(90)90168-O; Sezai Yukiyasu, 2007, Ann Thorac Cardiovasc Surg, V13, P220; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Srinivasan AK, 2003, ANN THORAC SURG, V76, P41, DOI 10.1016/S0003-4975(03)00182-6; Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104; Taggart DP, 2012, EUR HEART J, V33, P1181, DOI 10.1093/eurheartj/ehr374; WOODMAN RC, 1990, BLOOD, V76, P1680; Yao L, 2014, ANN SURG, V90, P1	30	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116311	10.1371/journal.pone.0116311	http://dx.doi.org/10.1371/journal.pone.0116311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706957	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100033
J	Zhao, L; Feng, CH; Hou, CT; Hu, LY; Wang, QC; Wu, YF				Zhao, Lei; Feng, Chaohong; Hou, Caiting; Hu, Lingyun; Wang, Qiaochun; Wu, Yunfeng			First Discovery of Acetone Extract from Cottonseed Oil Sludge as a Novel Antiviral Agent against Plant Viruses	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; BETA-SITOSTEROL; ANTIBACTERIAL ACTIVITY; CANCER CELLS; GOSSYPOL; DERIVATIVES; CHEMISTRY; APOPTOSIS; RATS; ROOT	A novel acetone extract from cottonseed oil sludge was firstly discovered against plant viruses including Tobacco mosaic virus (TMV), Rice stripe virus (RSV) and Southern rice black streaked dwarf virus (SRBSDV). Gossypol and beta-sitosterol separated from the acetone extract were tested for their effects on anti-TMV and analysed by nuclear magnetic resonance (NMR) assay. In vivo and field trials in different geographic distributions and different host varieties declared that this extract mixture was more efficient than the commercial agent Ningnanmycin with a broad spectrum of anti-plant-viruses activity. No phytotoxic activity was observed in the treated plants and environmental toxicology showed that this new acetone extract was environmentally friendly, indicating that this acetone extract has potential application in the control of plant virus in the future.	[Zhao, Lei; Hou, Caiting; Wu, Yunfeng] Northwest A&F Univ, Minist Educ, Coll Plant Protect,Minist Agr,Key Lab Plant Protec, State Key Lab Crop Stress Biol Arid Areas,Key Lab, Yangling, Shaanxi, Peoples R China; [Feng, Chaohong; Hu, Lingyun; Wang, Qiaochun] Northwest A&F Univ, Minist Educ, Coll Hort,Minist Agr,Key Lab Plant Protect Resourc, State Key Lab Crop Stress Biol Arid Areas,Key Lab, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Wu, YF (corresponding author), Northwest A&F Univ, Minist Educ, Coll Plant Protect,Minist Agr,Key Lab Plant Protec, State Key Lab Crop Stress Biol Arid Areas,Key Lab, Yangling, Shaanxi, Peoples R China.	qiaochunwang@nwsuaf.edu.cn; wuyf@nwsuaf.edu.cn			Special Fund for Agro-scientific Research in the Public Interest [200903052]; Education Ministry of China [B07049]	Special Fund for Agro-scientific Research in the Public Interest; Education Ministry of China(Ministry of Education, China)	The study was supported by the Special Fund for Agro-scientific Research in the Public Interest (No. 200903052) and the 111 Project from the Education Ministry of China (No. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An T, 2012, ANTIVIR RES, V94, P276, DOI 10.1016/j.antiviral.2012.02.014; Awad AB, 2000, INT J MOL MED, V5, P541; Baskar AA, 2012, J MED FOOD, V15, P335, DOI 10.1089/jmf.2011.1780; Bauer JA, 2005, MOL CANCER THER, V4, P1096, DOI 10.1158/1535-7163.MCT-05-0081; Beltrame FL, 2002, BRAZ ARCH BIOL TECHN, V45, P21, DOI 10.1590/S1516-89132002000100004; Bouic PJD, 1996, INT J IMMUNOPHARMACO, V18, P693, DOI 10.1016/S0192-0561(97)85551-8; Cheng ZB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-307; Chou CH, 1999, CRIT REV PLANT SCI, V18, P609, DOI 10.1016/S0735-2689(99)00393-7; Gebre-Mariam T, 2006, J ETHNOPHARMACOL, V104, P182, DOI 10.1016/j.jep.2005.08.071; GOODING GV, 1967, PHYTOPATHOLOGY, V57, P1285; Hari V, 1998, PLANT VIRUS DISEASE CONTROL, P417; Huang HungChang, 2005, Plant Pathology Bulletin, V14, P1; JANERO DR, 1988, BIOCHEM PHARMACOL, V37, P3335, DOI 10.1016/0006-2952(88)90647-8; Karen-Beth G, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, DOI 10.1111/J.1364-3703.2011.00752.X]; Keller PA, 2003, J MOL GRAPH MODEL, V21, P365, DOI 10.1016/S1093-3263(02)00183-3; Lall N, 2000, J ETHNOPHARMACOL, V72, P313, DOI 10.1016/S0378-8741(00)00231-2; Lin CW, 2005, ANTIVIR RES, V68, P36, DOI 10.1016/j.antiviral.2005.07.002; LIN TS, 1993, BIOCHEM PHARMACOL, V46, P251, DOI 10.1016/0006-2952(93)90411-O; Ouyang MA, 2007, J AGR FOOD CHEM, V55, P6460, DOI 10.1021/jf0709808; Park C, 2007, BIOL PHARM BULL, V30, P1317, DOI 10.1248/bpb.30.1317; Peres MTLP, 1997, J ETHNOPHARMACOL, V56, P223, DOI 10.1016/S0378-8741(97)00039-1; Prieto JM, 2006, B LATINOAM CARIBE PL, V5, P57; Qian XH, 2010, J AGR FOOD CHEM, V58, P2613, DOI 10.1021/jf904098w; Scholthof KBG, 2004, ANNU REV PHYTOPATHOL, V42, P13, DOI 10.1146/annurev.phyto.42.040803.140322; Seiber JN, 2011, J AGR FOOD CHEM, V59, P1, DOI 10.1021/jf1046078; SUGANO M, 1977, J NUTR, V107, P2011, DOI 10.1093/jn/107.11.2011; Vivancos M, 2005, FREE RADICAL BIO MED, V39, P91, DOI 10.1016/j.freeradbiomed.2005.02.025; Wang ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052933; Wei TY, 2009, J GEN VIROL, V90, P1025, DOI 10.1099/vir.0.006858-0; Yang JQ, 2010, J AGR FOOD CHEM, V58, P2730, DOI 10.1021/jf902861m; Yang J, 2012, BIOORG MED CHEM LETT, V22, P1415, DOI 10.1016/j.bmcl.2011.12.076; Yasuhara-Bell J, 2010, ANTIVIR RES, V86, P231, DOI 10.1016/j.antiviral.2010.03.009; Zak A, 1990, Cas Lek Cesk, V129, P1320	33	13	15	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117496	10.1371/journal.pone.0117496	http://dx.doi.org/10.1371/journal.pone.0117496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705894	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100095
J	Gong, S; Miao, YL; Jiao, GZ; Sun, MJ; Li, H; Lin, J; Luo, MJ; Tan, JH				Gong, Shuai; Miao, Yi-Long; Jiao, Guang-Zhong; Sun, Ming-Ju; Li, Hong; Lin, Juan; Luo, Ming-Jiu; Tan, Jing-He			Dynamics and Correlation of Serum Cortisol and Corticosterone under Different Physiological or Stressful Conditions in Mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; RESTRAINT STRESS; ESTROUS-CYCLE; PLASMA-CORTICOSTERONE; BIOMEDICAL-RESEARCH; RESTRICTION STRESS; IN-VITRO; MOUSE; RAT; ADRENOCORTICOTROPIN	Although plasma corticosterone is considered the main glucocorticoid involved in regulation of stress responses in rodents, the presence of plasma cortisol and whether its level can be used as an indicator for rodent activation of stress remain to be determined. In this study, effects of estrous cycle stage, circadian rhythm, and acute and chronic (repeated or unpredictable) stressors of various severities on dynamics and correlation of serum cortisol and corticosterone were examined in mice. A strong (r = 0.6-0.85) correlation between serum cortisol and corticosterone was observed throughout the estrous cycle, all day long, and during acute or repeated restraints, chronic unpredictable stress and acute forced swimming or heat stress. Both hormones increased to the highest level on day 1 of repeated-restraint or unpredictable stresses, but after that, whereas the concentration of cortisol did not change, that of corticosterone showed different dynamics. Thus, whereas corticosterone declined dramatically during repeated restraints, it remained at the high level during unpredictable stress. During forced swimming or heat stress, whereas cortisol increased to the highest level within 3 min., corticosterone did not reach maximum until 40 min. of stress. Analysis with HPLC and HPLC-MS further confirmed the presence of cortisol in mouse serum. Taken together, results (i) confirmed the presence of cortisol in mouse serum and (ii) suggested that mouse serum cortisol and corticosterone are closely correlated in dynamics under different physiological or stressful conditions, but, whereas corticosterone was a more adaptation-related biomarker than cortisol during chronic stress, cortisol was a quicker responder than corticosterone during severe acute stress.	[Gong, Shuai; Miao, Yi-Long; Jiao, Guang-Zhong; Sun, Ming-Ju; Li, Hong; Lin, Juan; Luo, Ming-Jiu; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An 271018, Shandong, Peoples R China	Shandong Agricultural University	Tan, JH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An 271018, Shandong, Peoples R China.	tanjh@sdau.edu.cn	Luo, Mingjiu/AAU-8570-2021		National Basic Research Program of China [2014CB138503, 2012CB944403]; China National Natural Science Foundation [31272444, 30972096]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (Nos. 2014CB138503 and 2012CB944403) and the China National Natural Science Foundation (Nos. 31272444 and 30972096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson HC, 2006, J NEUROENDOCRINOL, V18, P526, DOI 10.1111/j.1365-2826.2006.01444.x; Atkinson HC, 1997, ENDOCRINOLOGY, V138, P3842, DOI 10.1210/en.138.9.3842; Ayada K, 2002, PHYSIOL BEHAV, V77, P161, DOI 10.1016/S0031-9384(02)00844-2; Bhat MS, 2007, EVID-BASED COMPL ALT, V4, P35, DOI 10.1093/ecam/nel049; BINGEL AS, 1969, J REPROD FERTIL, V19, P215; CAREY MP, 1995, J ENDOCRINOL, V144, P311, DOI 10.1677/joe.0.1440311; Cavigelli SA, 2003, P NATL ACAD SCI USA, V100, P16131, DOI 10.1073/pnas.2535721100; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; Champlin AK, 1969, THESIS U ROCHESTER R; Chen Y, 2005, J ETHNOPHARMACOL, V96, P451, DOI 10.1016/j.jep.2004.09.033; Cheng Yiyong, 2004, Wei Sheng Yan Jiu, V33, P179; CHOURAQUI J, 1970, ACTA ENDOCRINOL-COP, V65, P650, DOI 10.1530/acta.0.0650650; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; FAZEKAS G, 1966, ENDOKRINOLOGIE, V50, P130; FEVOLD HR, 1969, BIOCHEMISTRY-US, V8, P3433, DOI 10.1021/bi00836a045; GLAVIN GB, 1994, NEUROSCI BIOBEHAV R, V18, P223, DOI 10.1016/0149-7634(94)90027-2; Golub MS, 2004, BIRTH DEFECTS RES B, V71, P26, DOI 10.1002/bdrb.10058; Hafez E. S. E., 1993, P94; Ide S, 2010, NEUROPHARMACOLOGY, V58, P241, DOI 10.1016/j.neuropharm.2009.07.005; IUDAEV N A, 1965, Probl Endokrinol Gormonoter, V11, P81; IUDAEV N A, 1960, Probl Endokrinol Gormonoter, V6, P19; KASS EH, 1954, P SOC EXP BIOL MED, V85, P583; Kim JY, 2008, NEUROREPORT, V19, P1373, DOI 10.1097/WNR.0b013e32830e4c1d; KITAY JI, 1961, NATURE, V192, P358, DOI 10.1038/192358b0; Koren L, 2012, GEN COMP ENDOCR, V177, P113, DOI 10.1016/j.ygcen.2012.02.020; KRUM AA, 1964, P SOC EXP BIOL MED, V118, P255; Liu Y, 2013, PHARMACOL BIOCHEM BE, V103, P474, DOI 10.1016/j.pbb.2012.09.009; Magiakou M A, 1994, Curr Ther Endocrinol Metab, V5, P120; Mizobe K, 1997, J NEUROIMMUNOL, V73, P81, DOI 10.1016/S0165-5728(96)00169-5; NAKAMURA K, 1990, J NEUROIMMUNOL, V30, P23, DOI 10.1016/0165-5728(90)90049-S; NAKAMURA K, 1989, SCAND J GASTROENTERO, V24, P47, DOI 10.3109/00365528909091122; NICHOLS DJ, 1981, EXPERIENTIA, V37, P319, DOI 10.1007/BF01991678; Ovejero R, 2013, J EXP ZOOL PART A, V319, P539, DOI 10.1002/jez.1833; PARE WP, 1986, NEUROSCI BIOBEHAV R, V10, P339, DOI 10.1016/0149-7634(86)90017-5; Podsevatkin V. G., 2008, Eksperimental'naya i Klinicheskaya Farmakologiya, V71, P22; SNELL GD, 1941, BIOL LAB MOUSE, P53; Taves MD, 2014, ENDOCRINOLOGY; THURSTON JH, 1989, METAB BRAIN DIS, V4, P177, DOI 10.1007/BF01000294; Walker QD, 2001, J PHARMACOL EXP THER, V297, P291; WON SJ, 1995, J APPL PHYSIOL, V79, P732, DOI 10.1152/jappl.1995.79.3.732; Wu LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052331; Yin YY, 2007, CHINESE MED J-PEKING, V120, P1088, DOI 10.1097/00029330-200706020-00011; Zhang SY, 2011, BIOL REPROD, V84, P672, DOI 10.1095/biolreprod.110.087890	43	238	245	9	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117503	10.1371/journal.pone.0117503	http://dx.doi.org/10.1371/journal.pone.0117503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699675	Green Submitted, gold, Green Published			2022-12-27	WOS:000349789800025
J	Sinke, C; Schmidt, K; Forkmann, K; Bingel, U				Sinke, Christopher; Schmidt, Katharina; Forkmann, Katarina; Bingel, Ulrike			Phasic and Tonic Pain Differentially Impact the Interruptive Function of Pain	PLOS ONE			English	Article							STEREOTYPE THREAT; CATASTROPHIC THINKING; ATTENTION; PERFORMANCE; CONNECTIVITY; INFORMATION; SENSITIVITY; MODULATION; NETWORK; PLACEBO	The interruptive effect of painful experimental stimulation on cognitive processes is a well-known phenomenon. This study investigated the influence of pain duration on the negative effects of pain on cognition. Thirty-four healthy volunteers performed a rapid serial visual presentation task (RSVP) in which subjects had to detect (visual detection task) and count the occurrence of a target letter (working memory task) in two separate sessions while being stimulated on the left volar forearm with either short (2 sec) or long (18 sec) painful heat stimuli of equal subjective intensity. The results show that subjects performed significantly worse in the long pain session as indexed by decreased detection and counting performance. Interestingly, this effect on performance was also observed during control trials of the long pain session in which participants did not receive any painful stimulation. Moreover, subjects expected long painful stimulation to have a greater impact on their performance and individual expectation correlated with working memory performance. These findings suggest that not only the length of painful stimulation but also its expected ability to impair cognitive functioning might influence the interruptive function of pain. The exact relevance of expectation for the detrimental effects of pain on cognitive processes needs to be explored in more detail in future studies.	[Sinke, Christopher; Schmidt, Katharina; Bingel, Ulrike] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Schmidt, Katharina; Forkmann, Katarina; Bingel, Ulrike] Essen Univ Hosp, Dept Neurol, Essen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen	Bingel, U (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	Ulrike.Bingel@uk-essen.de	Sinke, Christopher/U-8412-2017	Sinke, Christopher/0000-0003-1716-6229	German Research Foundation [SFB936/A4]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation, SFB936/A4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber SJ, 2013, PSYCHOL SCI, V24, P2522, DOI 10.1177/0956797613497023; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; Colagiuri B, 2011, PSYCHON B REV, V18, P399, DOI 10.3758/s13423-010-0041-1; Crombez G, 1998, PAIN, V75, P187, DOI 10.1016/S0304-3959(97)00219-4; Crombez G, 2002, Pain Res Manag, V7, P31; CROMBEZ G, 1994, BEHAV RES THER, V32, P611, DOI 10.1016/0005-7967(94)90015-9; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; ECCLESTON C, 1995, BEHAV RES THER, V33, P391, DOI 10.1016/0005-7967(94)00057-Q; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Forkmann K, 2013, J NEUROSCI, V33, P2571, DOI 10.1523/JNEUROSCI.2994-12.2013; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Grisart J, 2007, BEHAV RES THER, V45, P1077, DOI 10.1016/j.brat.2006.05.002; Grisart JM, 1999, EUR J PAIN-LONDON, V3, P325, DOI 10.1016/S1090-3801(99)90014-9; Kahneman D., 1973, ATTENTION EFFORT; Keogh E, 2001, J ANXIETY DISORD, V15, P299, DOI 10.1016/S0887-6185(01)00065-2; Keogh E, 2001, PAIN, V91, P91, DOI 10.1016/S0304-3959(00)00422-X; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Kuhajda MC, 2002, PAIN, V97, P213, DOI 10.1016/S0304-3959(01)00488-2; Lautenbacher S, 2009, CLIN J PAIN, V25, P92, DOI 10.1097/AJP.0b013e3181850dce; Laux L, 1992, STATE TRAIT ANGSTINV; Legrain V, 2009, J NEUROPHYSIOL, V102, P2423, DOI 10.1152/jn.00372.2009; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; Moore DJ, 2013, PAIN, V154, P82, DOI 10.1016/j.pain.2012.09.009; Moore DJ, 2012, Q J EXP PSYCHOL, V65, P565, DOI 10.1080/17470218.2011.626865; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Oosterman JM, 2012, PAIN RES MANAG, V17, P159, DOI 10.1155/2012/962786; PATIL PG, 1995, PHYSIOL BEHAV, V58, P1281, DOI 10.1016/0031-9384(95)02071-3; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Seminowicz DA, 2004, PAIN, V112, P48, DOI 10.1016/j.pain.2004.07.027; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tiemann L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035068; Tiemann L, 2010, PAIN, V150, P302, DOI 10.1016/j.pain.2010.05.014; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Van Damme S, 2004, PAIN, V107, P70, DOI 10.1016/j.pain.2003.09.023; Vancleef LMG, 2006, J PAIN, V7, P23, DOI 10.1016/j.jpain.2005.04.003; Walter B, 2002, SCHMERZ, V16, P83; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	45	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118363	10.1371/journal.pone.0118363	http://dx.doi.org/10.1371/journal.pone.0118363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695254	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300049
J	Bei, YH; Zhou, QL; Fu, SY; Lv, DC; Chen, P; Chen, YY; Wang, F; Xiao, JJ				Bei, Yihua; Zhou, Qiulian; Fu, Siyi; Lv, Dongchao; Chen, Ping; Chen, Yuanyuan; Wang, Fei; Xiao, Junjie			Cardiac Telocytes and Fibroblasts in Primary Culture: Different Morphologies and Immunophenotypes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SKELETAL-MUSCLE INTERSTITIUM; ELECTRON-MICROSCOPE EVIDENCE; LUNG TELOCYTES; MYOCARDIAL-INFARCTION; SYSTEMIC-SCLEROSIS; LAMINA PROPRIA; STROMAL CELLS; DISTINCT TYPE; MOUSE LUNG	Telocytes (TCs) are a peculiar type of interstitial cells with very long prolongations termed telopodes. TCs have previously been identified in different anatomic structures of the heart, and have also been isolated and cultured from heart tissues in vitro. TCs and fibroblasts, both located in the interstitial spaces of the heart, have different morphologies and functionality. However, other than microscopic observation, a reliable means to make differential diagnosis of cardiac TCs from fibroblasts remains unclear. In the present study, we isolated and cultured cardiac TCs and fibroblasts from heart tissues, and observed their different morphological features and immunophenotypes in primary culture. Morphologically, TCs had extremely long and thin telopodes with moniliform aspect, stretched away from cell bodies, while cell processes of fibroblasts were short, thick and cone shaped. Furthermore, cardiac TCs were positive for CD34/c-kit, CD34/vimentin, and CD34/PDGFR-beta, while fibroblasts were only vimentin and PDGFR-beta positive. In addition, TCs were also different from pericytes as TCs were CD34 positive and alpha-SMA weak positive while pericytes were CD34 negative but alpha-SMA positive. Besides that, we also showed cardiac TCs were homogenously positive for mesenchymal marker CD29 but negative for hematopoietic marker CD45, indicating that TCs could be a source of cardiac mesenchymal cells. The differences in morphological features and immunophenotypes between TCs and fibroblasts will provide more compelling evidence to differentiate cardiac TCs from fibroblasts.	[Bei, Yihua; Zhou, Qiulian; Fu, Siyi; Lv, Dongchao; Chen, Ping; Chen, Yuanyuan; Xiao, Junjie] Shanghai Univ, Expt Ctr Life Sci, Regenerat & Ageing Lab, Shanghai 200444, Peoples R China; [Bei, Yihua; Zhou, Qiulian; Fu, Siyi; Lv, Dongchao; Chen, Ping; Chen, Yuanyuan; Xiao, Junjie] Shanghai Univ, Innovat Drug Res Ctr, Sch Life Sci, Shanghai 200444, Peoples R China; [Bei, Yihua; Xiao, Junjie] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai 200444, Peoples R China; [Wang, Fei; Xiao, Junjie] Tongji Univ, Tongji Hosp, Sch Med, Digest Dis Inst,Div Gastroenterol & Hepatol, Shanghai 200065, Peoples R China	Shanghai University; Shanghai University; Shanghai University; Tongji University	Xiao, JJ (corresponding author), Shanghai Univ, Expt Ctr Life Sci, Regenerat & Ageing Lab, Shanghai 200444, Peoples R China.	junjiexiao@shu.edu.cn	Chen, Yuanyuan/GXG-2130-2022		National Natural Science Foundation of China [81200169]; Innovation Program of Shanghai Municipal Education Commission [13YZ014]; Foundation for University Young Teachers by Shanghai Municipal Education Commission; Shanghai University [sdcx2012038]; Shanghai Municipal Education Commission	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Foundation for University Young Teachers by Shanghai Municipal Education Commission; Shanghai University(Shanghai University); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the grants from National Natural Science Foundation of China (81200169 to J. Xiao), Innovation Program of Shanghai Municipal Education Commission (13YZ014 to J. Xiao), Foundation for University Young Teachers by Shanghai Municipal Education Commission (year 2012, to J. Xiao), Innovation fund from Shanghai University (sdcx2012038 to J. Xiao), and Program for the integration of production, teaching and research for University Teachers supported by Shanghai Municipal Education Commission (year 2014, to J. Xiao).	Bani D, 2010, J CELL MOL MED, V14, P2531, DOI 10.1111/j.1582-4934.2010.01119.x; Bojin FM, 2011, J CELL MOL MED, V15, P2269, DOI 10.1111/j.1582-4934.2011.01386.x; Bosco C, 2013, AUTON NEUROSCI-BASIC, V177, P224, DOI 10.1016/j.autneu.2013.05.002; Campeanu RA, 2014, LASER MED SCI, V29, P1867, DOI 10.1007/s10103-014-1589-1; Carmona IC, 2011, J CELL MOL MED, V15, P26, DOI 10.1111/j.1582-4934.2010.01207.x; Cantarero I, 2011, J CELL MOL MED, V15, P2594, DOI 10.1111/j.1582-4934.2011.01312.x; Ceafalan L, 2012, J CELL MOL MED, V16, P1405, DOI 10.1111/j.1582-4934.2012.01580.x; Chen L, 2014, BIOSCI TRENDS, V8, P111, DOI 10.5582/bst.8.111; Chen XK, 2013, J CELL MOL MED, V17, P1506, DOI 10.1111/jcmm.12149; Cismasiu VB, 2011, J CELL MOL MED, V15, P1071, DOI 10.1111/j.1582-4934.2011.01325.x; Corradi LS, 2013, J CELL MOL MED, V17, P398, DOI 10.1111/jcmm.12021; Cretoiu D, 2012, HISTOL HISTOPATHOL, V27, P1067, DOI 10.14670/HH-27.1067; Cretoiu SM, 2013, REPRODUCTION, V145, P357, DOI 10.1530/REP-12-0369; Diaz-Flores L, 2014, HISTOL HISTOPATHOL, V29, P831, DOI 10.14670/HH-29.831; Edelstein L, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00041; Faussone Pellegrini MS, 2011, BIOMOL CONCEPTS, V2, P481, DOI DOI 10.1515/BMC.2011.039; Faussone-Pellegrini MS, 2010, J CELL MOL MED, V14, P1061, DOI 10.1111/j.1582-4934.2010.01074.x; Galiger C, 2014, J CELL MOL MED, V18, P1321, DOI 10.1111/jcmm.12295; Gherghiceanu M, 2012, CELL TISSUE RES, V348, P265, DOI 10.1007/s00441-012-1333-8; Gherghiceanu M, 2011, J CELL MOL MED, V15, P1005, DOI 10.1111/j.1582-4934.2011.01299.x; Gherghiceanu M, 2010, J CELL MOL MED, V14, P2330, DOI 10.1111/j.1582-4934.2010.01133.x; Gherghiceanu M, 2010, J CELL MOL MED, V14, P871, DOI 10.1111/j.1582-4934.2010.01060.x; Hatta K, 2012, J CELL MOL MED, V16, P1392, DOI 10.1111/j.1582-4934.2012.01583.x; HE Q, 1995, J MOL CELL CARDIOL, V27, P1173, DOI 10.1016/0022-2828(95)90053-5; Hinescu ME, 2011, CELL TISSUE RES, V343, P389, DOI 10.1007/s00441-010-1095-0; Luesma MJ, 2013, J CELL MOL MED, V17, P1016, DOI 10.1111/jcmm.12111; Kostin S, 2009, J CELL MOL MED, V13, P295, DOI 10.1111/j.1582-4934.2008.00668.x; Kostin S, 2010, J CELL MOL MED, V14, P1917, DOI 10.1111/j.1582-4934.2010.01111.x; Li H, 2014, J CELL MOL MED, V18, P975, DOI 10.1111/jcmm.12337; Li LP, 2014, J CELL MOL MED, V18, P1144, DOI 10.1111/jcmm.12274; Manetti M, 2014, J CELL MOL MED, V18, P253, DOI 10.1111/jcmm.12228; Manetti M, 2013, J CELL MOL MED, V17, P482, DOI 10.1111/jcmm.12028; Manole CG, 2011, J CELL MOL MED, V15, P2284, DOI 10.1111/j.1582-4934.2011.01449.x; Milia AF, 2013, J CELL MOL MED, V17, P1525, DOI 10.1111/jcmm.12177; Nicolescu MI, 2012, PANCREAS, V41, P949, DOI 10.1097/MPA.0b013e31823fbded; Nicolescu MI, 2012, ANAT REC, V295, P378, DOI 10.1002/ar.21540; Popescu BO, 2012, NEUROSCI LETT, V516, P265, DOI 10.1016/j.neulet.2012.04.006; Popescu LM, 2013, RESIDENT STEM CELLS AND REGENERATIVE THERAPY, P205, DOI 10.1016/B978-0-12-416012-5.00011-6; Popescu LM, 2011, J CELL MOL MED, V15, P1379, DOI 10.1111/j.1582-4934.2011.01330.x; Popescu LM, 2010, J CELL MOL MED, V14, P2085, DOI 10.1111/j.1582-4934.2010.01129.x; Popescu LM, 2010, J CELL MOL MED, V14, P729, DOI 10.1111/j.1582-4934.2010.01059.x; Popescu LM, 2011, CELL TISSUE RES, V345, P391, DOI 10.1007/s00441-011-1229-z; Qi GS, 2012, J CELL MOL MED, V16, P3116, DOI 10.1111/j.1582-4934.2012.01582.x; Rusu MC, 2012, ANN ANAT, V194, P359, DOI 10.1016/j.aanat.2011.11.007; Rusu MC, 2012, J CELL MOL MED, V16, P401, DOI 10.1111/j.1582-4934.2011.01465.x; Rusu MC, 2011, ANN ANAT, V193, P403, DOI 10.1016/j.aanat.2011.06.005; Rusu MC, 2012, CELL BIOL INT, V36, P1079, DOI 10.1042/CBI20120007; Suciu L, 2010, J CELL MOL MED, V14, P2687, DOI 10.1111/j.1582-4934.2010.01185.x; Suciu L, 2010, CELLS TISSUES ORGANS, V192, P325, DOI 10.1159/000319467; Suciu LC, 2012, J CELL MOL MED, V16, P701, DOI 10.1111/j.1582-4934.2011.01505.x; Sun XR, 2014, J CELL MOL MED, V18, P801, DOI 10.1111/jcmm.12302; Vannucchi MG, 2013, J CELL MOL MED, V17, P1099, DOI 10.1111/jcmm.12134; Wang F, 2014, J CELL MOL MED, V18, P1720, DOI 10.1111/jcmm.12355; Xiao JJ, 2013, J CELL MOL MED, V17, P1537, DOI 10.1111/jcmm.12195; Yang Y, 2014, J CELL MOL MED, V18, P759, DOI 10.1111/jcmm.12285; Zhao BY, 2014, J CELL MOL MED, V18, P780, DOI 10.1111/jcmm.12259; Zhao BY, 2013, J CELL MOL MED, V17, P123, DOI 10.1111/j.1582-4934.2012.01655.x; Zheng Y, 2011, J CELL MOL MED, V15, P2262, DOI 10.1111/j.1582-4934.2011.01404.x; Zheng YH, 2014, J CELL MOL MED, V18, P568, DOI 10.1111/jcmm.12290; Zheng YH, 2013, J CELL MOL MED, V17, P567, DOI 10.1111/jcmm.12052; Zheng YH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-188; Zhou J, 2010, J CELL MOL MED, V14, P2641, DOI 10.1111/j.1582-4934.2010.01186.x; Zhou Y, 2010, J HISTOCHEM CYTOCHEM, V58, P309, DOI 10.1369/jhc.2009.955146	63	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115991	10.1371/journal.pone.0115991	http://dx.doi.org/10.1371/journal.pone.0115991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693182	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500012
J	Li, Y; Li, XH; Huang, ZJ; Yang, GP; Zhang, GG; Zhao, SP; Guo, Y; Lu, SJ; Ma, JL; Meng, FB; Chen, P; Yuan, H				Li, Ying; Li, Xiao-hui; Huang, Zhi-jun; Yang, Guo-ping; Zhang, Guo-gang; Zhao, Shui-ping; Guo, Ying; Lu, Shi-juan; Ma, Jian-lin; Meng, Fan-bo; Chen, Ping; Yuan, Hong			A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Trial of Allisartan Isoproxil in Essential Hypertensive Population at Low- Medium Risk	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; BLOOD-PRESSURE; LOSARTAN POTASSIUM; PREVALENCE; ANTAGONIST; ASSOCIATION; CHOLESTEROL; MORTALITY; PARALLEL; SAFETY	Background Angiotensin II receptor blockers (ARBs) is a well-tolerated class of antihypertensive agents, exhibiting effective antihypertensive and cardiovascular protective function. The objective of the study was to examine the efficacy and safety of Allisartan Isoproxil, a newly developed, selective, nonpeptide blocker of the angiotensin II type 1 receptor (AT1R), in essential hypertensive patients at low-medium risk.	[Li, Ying; Huang, Zhi-jun; Yang, Guo-ping; Yuan, Hong] Cent South Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha, Hunan, Peoples R China; [Li, Xiao-hui] Cent South Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Hunan, Peoples R China; [Zhang, Guo-gang] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China; [Zhao, Shui-ping] Cent South Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China; [Guo, Ying] Hunan Prov Peoples Hosp, Dept Cardiol, Changsha, Hunan, Peoples R China; [Lu, Shi-juan] Haikou City Peoples Hosp, Dept Cardiol, Haikou, Peoples R China; [Ma, Jian-lin] Hainan Prov Peoples Hosp, Dept Cardiol, Haikou, Peoples R China; [Meng, Fan-bo] Jilin Univ, China Japan Union Hosp, Dept Cardiol, Changchun 130023, Peoples R China; [Chen, Ping] Shantou Cent Hosp, Dept Cardiol, Shantou, Peoples R China	Central South University; Central South University; Central South University; Central South University; Jilin University	Yuan, H (corresponding author), Cent South Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha, Hunan, Peoples R China.	yuanhongxy3@163.com			Shenzhen Salubris Pharmaceuticals Co., Ltd.; Shenzhen Salubris Pharmaceuticals Co., Ltd	Shenzhen Salubris Pharmaceuticals Co., Ltd.; Shenzhen Salubris Pharmaceuticals Co., Ltd	This Trial is funded by Shenzhen Salubris Pharmaceuticals Co., Ltd. All clinical investigators received support budgets from Shenzhen Salubris Pharmaceuticals Co., Ltd for the conduct of the clinical trial. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hangzhou Tigermed Co. Ltd is independently in charge of data collection and statistical analysis.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Alperovitch A, 2009, ARCH INTERN MED, V169, P75, DOI 10.1001/archinternmed.2008.512; BONAA KH, 1991, CIRCULATION, V83, P1305, DOI 10.1161/01.CIR.83.4.1305; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; CASTELLI WP, 1986, AM J MED, V80, P23, DOI 10.1016/0002-9343(86)90157-9; Cheng J, 2014, JAMA INTERN MED, V174, P773, DOI 10.1001/jamainternmed.2014.348; Chiolero Arnaud, 2013, Front Public Health, V1, P29, DOI 10.3389/fpubh.2013.00029; Crigui MH, 1986, CIRCULATION, V73, P140; Frishman WH, 2006, AM J HYPERTENS, V19, P388, DOI 10.1016/j.amjhyper.2005.10.007; GOLDBERG AI, 1995, AM J CARDIOL, V75, P793, DOI 10.1016/S0002-9149(99)80413-5; GRADMAN AH, 1995, HYPERTENSION, V25, P1345, DOI 10.1161/01.HYP.25.6.1345; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; HJERMANN I, 1978, J EPIDEMIOL COMMUN H, V32, P117, DOI 10.1136/jech.32.2.117; Holwerda NJ, 1996, J HYPERTENS, V14, P1147, DOI 10.1097/00004872-199609000-00016; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; LAURENZI M, 1990, J HYPERTENS, V8, pS7, DOI 10.1097/00004872-199003001-00003; Li Y, 2014, J CARDIOVASC PHARM, V63, P252, DOI 10.1097/FJC.0000000000000042; Li Y, 2012, CARDIOVASC DIAGN THE, V2, P56, DOI 10.3978/j.issn.2223-3652.2012.02.02; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; Puig JG, 2009, CLIN THER, V31, P2839, DOI 10.1016/j.clinthera.2009.12.006; Punzi HA, 2012, ADV THER, V29, P524, DOI 10.1007/s12325-012-0029-5; SMITH RD, 1992, ANNU REV PHARMACOL, V32, P135; SWEET CS, 1994, AM J HYPERTENS, V7, P1035, DOI 10.1093/ajh/7.12.1035; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; van Vark LC, 2012, EUR HEART J, V33, P2088, DOI 10.1093/eurheartj/ehs075; Wen ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067242; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; WONG PC, 1990, J PHARMACOL EXP THER, V255, P211; Wu MY, 2009, ACTA PHARMACOL SIN, V30, P307, DOI 10.1038/aps.2009.11; Xu FC, 2009, CURR MED CHEM, V16, P3841, DOI 10.2174/092986709789178046; Yaguchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064724; Zavaroni I, 1989, N ENGL MED, V320	33	14	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117560	10.1371/journal.pone.0117560	http://dx.doi.org/10.1371/journal.pone.0117560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693004	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500061
J	Bucay, I; O'Brien, ET; Wulfe, SD; Superfine, R; Wolberg, AS; Falvo, MR; Hudson, NE				Bucay, Igal; O'Brien, E. Tim, III; Wulfe, Steven D.; Superfine, Richard; Wolberg, Alisa S.; Falvo, Michael R.; Hudson, Nathan E.			Physical Determinants of Fibrinolysis in Single Fibrin Fibers	PLOS ONE			English	Article							PLASMINOGEN-BINDING SITES; ALPHA-C-DOMAINS; ELECTRON-MICROSCOPY; MODELING FIBRINOLYSIS; MOLECULAR-MECHANISMS; CLOT STRUCTURE; TPA-BINDING; NETWORKS; EXTENSIBILITY; ELASTICITY	Fibrin fibers form the structural backbone of blood clots; fibrinolysis is the process in which plasmin digests fibrin fibers, effectively regulating the size and duration of a clot. To understand blood clot dissolution, the influence of clot structure and fiber properties must be separated from the effects of enzyme kinetics and perfusion rates into clots. Using an inverted optical microscope and fluorescently-labeled fibers suspended between micropatterned ridges, we have directly measured the lysis of individual fibrin fibers. We found that during lysis 64 +/- 6% of fibers were transected at one point, but 29 +/- 3% of fibers increase in length rather than dissolving or being transected. Thrombin and plasmin dose-response experiments showed that the elongation behavior was independent of plasmin concentration, but was instead dependent on the concentration of thrombin used during fiber polymerization, which correlated inversely with fiber diameter. Thinner fibers were more likely to lyse, while fibers greater than 200 +/- 30 nm in diameter were more likely to elongate. Because lysis rates were greatly reduced in elongated fibers, we hypothesize that plasmin activity depends on fiber strain. Using polymer physics-and continuum mechanics-based mathematical models, we show that fibers polymerize in a strained state and that thicker fibers lose their prestrain more rapidly than thinner fibers during lysis, which may explain why thick fibers elongate and thin fibers lyse. These results highlight how subtle differences in the diameter and prestrain of fibers could lead to dramatically different lytic susceptibilities.	[Bucay, Igal; O'Brien, E. Tim, III; Wulfe, Steven D.; Superfine, Richard; Falvo, Michael R.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC USA; [Wolberg, Alisa S.] UNC Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Hudson, Nathan E.] Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; [Hudson, Nathan E.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Hudson, NE (corresponding author), Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA.	hudson@crystal.harvard.edu	Superfine, Richard/A-1968-2012	Superfine, Richard/0000-0002-2569-071X; Wulfe, Steven/0000-0003-3309-7614; Hudson, Nathan/0000-0003-0573-7661	National Institutes of Health [P41-EB002025]; National Science Foundation grant [CMMI-1030640]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grant P41-EB002025 http://www.nih.gov/; and by National Science Foundation grant CMMI-1030640 http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannish BE, 2014, MATH MED BIOL, V31, P17, DOI 10.1093/imammb/dqs029; Bannish BE, 2014, MATH MED BIOL, V31, P45, DOI 10.1093/imammb/dqs030; Blinc A, 2000, FIBRINOLYSIS PROTEOL, V14, P288, DOI 10.1054/fipr.2000.0085; CARR ME, 1978, MACROMOLECULES, V11, P46, DOI 10.1021/ma60061a009; CARROLL RC, 1981, BLOOD, V57, P44; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Collet JP, 2005, BLOOD, V106, P3824, DOI 10.1182/blood-2005-05-2150; Collet JP, 2003, J BIOL CHEM, V278, P21331, DOI 10.1074/jbc.M212734200; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; DIAMOND SL, 1993, BIOPHYS J, V65, P2622, DOI 10.1016/S0006-3495(93)81314-6; DING ZY, 1991, J POLYM SCI POL PHYS, V29, P1035, DOI 10.1002/polb.1991.090290815; Duval C, 2014, THROMB HAEMOSTASIS, V111, P842, DOI 10.1160/TH13-10-0855; FLEURY V, 1991, BIOCHEMISTRY-US, V30, P7630, DOI 10.1021/bi00244a035; Flory PJ, 1943, J CHEM PHYS, V11, P512, DOI 10.1063/1.1723791; FLORY PJ, 1950, J AM CHEM SOC, V72, P5052, DOI 10.1021/ja01167a064; GABRIEL DA, 1992, J BIOL CHEM, V267, P24259; Houser JR, 2010, BIOPHYS J, V99, P3038, DOI 10.1016/j.bpj.2010.08.060; Hudson NE, 2013, BIOPHYS J, V104, P2671, DOI 10.1016/j.bpj.2013.04.052; Hudson NE, 2010, BIOPHYS J, V98, P1632, DOI 10.1016/j.bpj.2009.12.4312; Lam WA, 2011, NAT MATER, V10, P61, DOI 10.1038/NMAT2903; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317; LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341; Lugovskoi E V, 2009, Bioorg Khim, V35, P437; Medved L, 2003, THROMB HAEMOSTASIS, V89, P409; Medved L, 2001, ANN NY ACAD SCI, V936, P185; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Nieuwenhuizen W, 2001, ANN NY ACAD SCI, V936, P237; O'Brien ET, 2008, P NATL ACAD SCI USA, V105, P19438, DOI 10.1073/pnas.0804865105; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Scott EM, 2004, ARTERIOSCL THROM VAS, V24, P1558, DOI 10.1161/01.ATV.0000136649.83297.bf; THORSEN S, 1992, ANN NY ACAD SCI, V667, P52, DOI 10.1111/j.1749-6632.1992.tb51597.x; Tsurupa G, 2001, BIOCHEMISTRY-US, V40, P801, DOI 10.1021/bi001789t; Tsurupa G, 2009, BIOCHEMISTRY-US, V48, P12191, DOI 10.1021/bi901640e; Varju I, 2011, J THROMB HAEMOST, V9, P979, DOI 10.1111/j.1538-7836.2011.04203.x; Veklich Y, 1998, BLOOD, V92, P4721, DOI 10.1182/blood.V92.12.4721.424k13_4721_4729; Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x; Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963; WEISEL JW, 1987, P NATL ACAD SCI USA, V84, P8991, DOI 10.1073/pnas.84.24.8991; WEISEL JW, 1994, J MOL BIOL, V235, P1117, DOI 10.1006/jmbi.1994.1061; WILLIAMS RC, 1983, P NATL ACAD SCI-BIOL, V80, P1570, DOI 10.1073/pnas.80.6.1570; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Wolberg AS, 2003, BLOOD, V101, P3008, DOI 10.1182/blood-2002-08-2527; Yakovlev S, 2000, BIOCHEMISTRY-US, V39, P15730, DOI 10.1021/bi001847a	45	32	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116350	10.1371/journal.pone.0116350	http://dx.doi.org/10.1371/journal.pone.0116350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714359	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700017
J	Lorkiewicz, W; Ploszaj, T; Jedrychowska-Danska, K; Zadzinska, E; Strapagiel, D; Haduch, E; Szczepanek, A; Grygiel, R; Witas, HW				Lorkiewicz, Wieslaw; Ploszaj, Tomasz; Jedrychowska-Danska, Krystyna; Zadzinska, Elzbieta; Strapagiel, Dominik; Haduch, Elzbieta; Szczepanek, Anita; Grygiel, Ryszard; Witas, Henryk W.			Between the Baltic and Danubian Worlds: The Genetic Affinities of a Middle Neolithic Population from Central Poland	PLOS ONE			English	Article							DEMIC DIFFUSION; MITOCHONDRIAL-DNA; HUNTER-GATHERERS; ANCIENT DNA; FARMERS; GENOME; ADMIXTURE; ANCESTRY; ORIGINS; HISTORY	For a long time, anthropological and genetic research on the Neolithic revolution in Europe was mainly concentrated on the mechanism of agricultural dispersal over different parts of the continent. Recently, attention has shifted towards population processes that occurred after the arrival of the first farmers, transforming the genetically very distinctive early Neolithic Linear Pottery Culture (LBK) and Mesolithic forager populations into present-day Central Europeans. The latest studies indicate that significant changes in this respect took place within the post-Linear Pottery cultures of the Early and Middle Neolithic which were a bridge between the allochthonous LBK and the first indigenous Neolithic culture of north-central Europe-the Funnel Beaker culture (TRB). The paper presents data on mtDNA haplotypes of a Middle Neolithic population dated to 4700/4600-4100/4000 BC belonging to the Brzesc Kujawski Group of the Lengyel culture (BKG) from the Kuyavia region in north-central Poland. BKG communities constituted the border of the "Danubian World" in this part of Europe for approx. seven centuries, neighboring foragers of the North European Plain and the southern Baltic basin. MtDNA haplogroups were determined in 11 individuals, and four mtDNA macrohaplogroups were found (H, U5, T, and HV0). The overall haplogroup pattern did not deviate from other post-Linear Pottery populations from central Europe, although a complete lack of N1a and the presence of U5a are noteworthy. Of greatest importance is the observed link between the BKG and the TRB horizon, confirmed by an independent analysis of the craniometric variation of Mesolithic and Neolithic populations inhabiting central Europe. Estimated phylogenetic pattern suggests significant contribution of the post-Linear BKG communities to the origin of the subsequent Middle Neolithic cultures, such as the TRB.	[Lorkiewicz, Wieslaw; Zadzinska, Elzbieta] Univ Lodz, Fac Biol & Environm Protect, Dept Anthropol, PL-90131 Lodz, Poland; [Ploszaj, Tomasz; Jedrychowska-Danska, Krystyna; Witas, Henryk W.] Med Univ Lodz, Dept Mol Biol, Lodz, Poland; [Strapagiel, Dominik] Univ Lodz, Fac Biol & Environm Protect, Dept Mol Biophys, Biobank Lab, PL-90131 Lodz, Poland; [Haduch, Elzbieta; Szczepanek, Anita] Jagiellonian Univ, Fac Biol & Earth Sci, Dept Anthropol, Krakow, Poland; [Grygiel, Ryszard] Museum Archaeol & Ethnog Lodz, Lodz, Poland	University of Lodz; Medical University Lodz; University of Lodz; Jagiellonian University	Lorkiewicz, W (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Anthropol, PL-90131 Lodz, Poland.	wlorkiew@biol.uni.lodz.pl	Strapagiel, Dominik/AAD-4351-2020; Ploszaj, Tomasz/S-9849-2016; Witas, Henryk Wlodzimierz/S-9450-2016; Strapagiel, Dominik/L-3247-2013	Strapagiel, Dominik/0000-0001-9752-4270; Ploszaj, Tomasz/0000-0002-9503-278X; Witas, Henryk Wlodzimierz/0000-0002-8402-2084; Jedrychowska-Danska, Krystyna/0000-0001-9262-4010; Zadzinska, Elzbieta/0000-0003-1001-7319; Lorkiewicz, Wieslaw/0000-0003-0754-5161	National Science Centre/Ministry of Science and Higher Education, Poland [N N303 335436]	National Science Centre/Ministry of Science and Higher Education, Poland	The project was funded by the National Science Centre/Ministry of Science and Higher Education, Poland, grant no. N N303 335436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; BACH A, 1978, NEOLITISCHE POPULATI; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Barbujani G, 2001, P NATL ACAD SCI USA, V98, P22, DOI 10.1073/pnas.98.1.22; Barbujani G, 2012, CURR BIOL, V22, pR631, DOI 10.1016/j.cub.2012.06.033; Belle EMS, 2006, P ROY SOC B-BIOL SCI, V273, P1595, DOI 10.1098/rspb.2006.3494; Bocquet-Appel JP, 2002, CURR ANTHROPOL, V43, P637, DOI 10.1086/342429; BOGUCKI P, 1987, CURR ANTHROPOL, V28, P1, DOI 10.1086/203488; Bogucki P., 2008, ANALECTA PRAEHISTORI, P51; Bogucki P., 2000, EUROPES 1 FARMERS, P197, DOI DOI 10.1017/CBO9780511607851.009; Bogucki P, 2011, J WORLD PREHIST, V24, P107, DOI 10.1007/s10963-011-9047-5; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Casalotti R, 1999, P ROY SOC B-BIOL SCI, V266, P1959, DOI 10.1098/rspb.1999.0873; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Collins M., 1998, ANCIENT BIOMOLECULES, V2, P209; Domanska L., 1995, GENEZA KRZEMIENIARST; Dupanloup I, 2004, MOL BIOL EVOL, V21, P1361, DOI 10.1093/molbev/msh135; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farruggia J.-P., 2002, ARCHEOL ROZHL, V54, P44, DOI DOI 10.4317/JCED.51476; Fix AG, 1996, J ROY ANTHROPOL INST, V2, P625, DOI 10.2307/3034300; Fu QM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032473; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; GRYGIEL R, 1986, J FIELD ARCHAEOL, V13, P121, DOI 10.1179/009346986791535762; Grygiel R, 1997, J FIELD ARCHAEOL, V24, P161, DOI 10.1179/009346997792208186; Grygiel R, 2008, NEOLITHIC EARLY BRON, V2; Grygiel R., 1981, J FIELD ARCHAEOL, V8, P9, DOI [10.1179/009346981791505201, DOI 10.1179/009346981791505201]; Grygiel Ryszard, 2004, NEOLITHIC EARLY BRON, V1; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hill T., 2007, STAT METHODS APPL; Jazdzewski K., 1938, WIADOMOSCI ARCHEOLOG, V15, P1, DOI [10.5603/KP.a2014.0244, DOI 10.5603/KP.A2014.0244]; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kruk J., 1980, BAR INT SERIES, V93; Lorkiewicz W, 2012, BIOL WCZESNOROLNICZY; Lorkiewicz W, 2011, ROUTLEDGE HANDBOOK OF ARCHAEOLOGICAL HUMAN REMAINS LEGISLATION: AN INTERNATIONAL GUIDE TO LAWS AND PRACTICE IN THE EXCAVATION AND TREATMENT OF ARCHAEOLOGICAL HUMAN REMAINS, P331; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Melchior L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011898; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Midgley M, 1992, TRB CULTURE 1 FARMER; Nowak M., 2013, INTERDISCIP ARCHAEOL, V4, P85, DOI [10.1371/journal.pone.0113856, DOI 10.1371/JOURNAL.PONE.0113856]; Pilloud MA, 2011, AM J PHYS ANTHROPOL, V145, P519, DOI 10.1002/ajpa.21520; Pinhasi R, 2004, CURR ANTHROPOL, V45, pS59, DOI 10.1086/422085; Pinhasi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006747; Price TD, 2000, EUROPES 1 FARMERS, P260, DOI [10.1016/j.scitotenv.2015.01.008, DOI 10.1017/CBO9780511607851.011]; REYNOLDS J, 1983, GENETICS, V105, P767; Richards M, 2000, Am J Hum Genet, V67, P1251; Richards M, 2003, ANNU REV ANTHROPOL, V32, P135, DOI 10.1146/annurev.anthro.32.061002.093207; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Shennan S, 2007, J ARCHAEOL SCI, V34, P1339, DOI 10.1016/j.jas.2006.10.031; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Sverrisdottir OO, 2014, MOL BIOL EVOL, V31, P975, DOI 10.1093/molbev/msu049; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; von Cramon-Taubadel N, 2011, P ROY SOC B-BIOL SCI, V278, P2874, DOI 10.1098/rspb.2010.2678; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Winters M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021247; Witas HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073682; Zvelebil M, 2006, J ANTHROPOL ARCHAEOL, V25, P178, DOI 10.1016/j.jaa.2005.11.003	63	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118316	10.1371/journal.pone.0118316	http://dx.doi.org/10.1371/journal.pone.0118316			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CC2IM	25714361	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700063
J	Guo, Y; Zhu, CH; Gan, LJ; Ng, D; Xia, K				Guo, Yue; Zhu, Changhua; Gan, Lijun; Ng, Denny; Xia, Kai			Effects of Exogenous Gibberellic Acid(3) on Iron and Manganese Plaque Amounts and Iron and Manganese Uptake in Rice	PLOS ONE			English	Article							ORYZA-SATIVA L.; RETARDANT (E)-1-(4-CHLOROPHENYL)-4,4-DIMETHYL-2-(1,2,4-TRIAZOL-1-YL)-1-PENTEN-3-OL S-3307; TYPHA-LATIFOLIA; PHRAGMITES-AUSTRALIS; PLANT-RESPONSES; NUTRIENT-UPTAKE; ROOTS; GROWTH; ACCUMULATION; PHOSPHATE	Gibberellins (GA) regulate various components of plant development. Iron and Mn plaque result from oxiding and hydroxiding Fe and Mn, respectively, on the roots of aquatic plant species such as rice (Oryza sativa L.). In this study, we found that exogenous gibberellic acid(3) (GA(3)) spray decreased Fe plaque, but increased Mn plaque, with applications of Kimura B nutrient solution. Similar effects from GA(3), leading to reduced Fe plaque and increased Mn plaque, were also found by scanning electron microscopy and energy dispersive X-ray spectrometric microanalysis. Reduced Fe plaque was observed after applying GA(3) to the groups containing added Fe2+ (17 and 42 mg center dot L-1) and an increasing trend was detected in Mn plaques of the Mn2+ (34 and 84 mg center dot L-1) added treatments. In contrast, an inhibitor of GA(3), uniconazole, reversed the effects of GA(3). The uptake of Fe or Mn in rice plants was enhanced after GA(3) application and Fe or Mn plaque production. Strong synergetic effects of GA(3) application on Fe plaque production were detected. However, no synergetic effects on Mn plaque production were detected.	[Guo, Yue; Zhu, Changhua; Gan, Lijun; Xia, Kai] Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China; [Ng, Denny] CP Bio Inc, Chino, CA 91710 USA	Nanjing Agricultural University	Xia, K (corresponding author), Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China.	zhish@njau.edu.cn			National Natural Science Foundation of China [30871460]; CP Bio, Inc	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CP Bio, Inc	This work was supported by a grant from the National Natural Science Foundation of China (30871460). CP Bio, Inc, provided support in the form of a salary for author DN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the Author Contributions section.	ANDO T, 1983, PLANT SOIL, V72, P57, DOI 10.1007/BF02185094; Armstrong J, 2005, ANN BOT-LONDON, V96, P625, DOI 10.1093/aob/mci215; Armstrong W., 1979, Advances in Botanical Research, V7, P225, DOI 10.1016/S0065-2296(08)60089-0; Asahina M, 2002, PLANT PHYSIOL, V129, P201, DOI 10.1104/pp.010886; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; BACHA RE, 1977, SOIL SCI SOC AM J, V41, P931, DOI 10.2136/sssaj1977.03615995004100050025x; Batty LC, 2002, ANN BOT-LONDON, V89, P443, DOI 10.1093/aob/mcf067; Batty LC, 2000, ANN BOT-LONDON, V86, P647, DOI 10.1006/anbo.2000.1191; Chabbi A, 1999, NEW PHYTOL, V144, P133, DOI 10.1046/j.1469-8137.1999.00503.x; Chabbi A, 2000, AM J BOT, V87, P1081, DOI 10.2307/2656644; CHEN CC, 1980, SOIL SCI SOC AM J, V44, P1113, DOI 10.2136/sssaj1980.03615995004400050046x; Chen JG, 1996, J PLANT GROWTH REGUL, V15, P173, DOI 10.1007/BF00190581; Chen L, 2001, PLANT CELL ENVIRON, V24, P469, DOI 10.1046/j.1365-3040.2001.00688.x; Chen RF, 2006, ANN BOT-LONDON, V98, P389, DOI 10.1093/aob/mcl110; Christensen KK, 1998, CAN J BOT, V76, P2158, DOI 10.1139/b98-181; COHEN JD, 1987, PLANT PHYSIOL, V84, P982, DOI 10.1104/pp.84.4.982; CROWDER AA, 1993, J PLANT NUTR, V16, P589, DOI 10.1080/01904169309364559; Crowder AA, 1991, TRENDS SOIL SCI, V1, P15; Cui DY, 2005, J EXP BOT, V56, P1327, DOI 10.1093/jxb/eri133; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; Franco-Zorrilla JM, 2004, J EXP BOT, V55, P285, DOI 10.1093/jxb/erh009; GREIPSSON S, 1994, COMMUN SOIL SCI PLAN, V25, P2761, DOI 10.1080/00103629409369223; GREIPSSON S, 1995, J PLANT NUTR, V18, P1659, DOI 10.1080/01904169509365011; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Hansel CM, 2001, ENVIRON SCI TECHNOL, V35, P3863, DOI 10.1021/es0105459; Hartweck LM, 2008, PLANTA, V229, P1, DOI 10.1007/s00425-008-0830-1; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; IZUMI K, 1984, PLANT CELL PHYSIOL, V25, P611; IZUMI K, 1985, PLANT CELL PHYSIOL, V26, P821; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Jordan-Meille L, 2008, PLANT SOIL, V304, P157, DOI 10.1007/s11104-007-9534-8; Jung JY, 2009, PLANT CELL, V21, P607, DOI 10.1105/tpc.108.063099; KANNAN S, 1970, PLANT PHYSIOL, V45, P206, DOI 10.1104/pp.45.2.206; Kopriva S, 2006, ANN BOT-LONDON, V97, P479, DOI 10.1093/aob/mcl006; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; LEVAN MA, 1986, PLANT SOIL, V95, P33, DOI 10.1007/BF02378850; Liu WJ, 2004, J EXP BOT, V55, P1707, DOI 10.1093/jxb/erh205; Liu WJ, 2004, NEW PHYTOL, V162, P481, DOI 10.1111/j.1469-8137.2004.01035.x; Ma JF, 1996, PHYSIOL PLANTARUM, V97, P609, DOI 10.1111/j.1399-3054.1996.tb00522.x; Marschner H., 1996, MINERAL NUTR HIGHER; Matsukura C, 1998, PLANTA, V205, P145, DOI 10.1007/s004250050306; Matsuoka K, 2014, PLANT CELL PHYSIOL, V55, P87, DOI 10.1093/pcp/pct160; MCLAUGHLIN BE, 1985, PLANT SOIL, V85, P433, DOI 10.1007/BF02220198; MITSUI S., 1962, Soil and Plant Food, V8, P25; Moller CL, 2008, NEW PHYTOL, V179, P848, DOI 10.1111/j.1469-8137.2008.02506.x; Nozoye T, 2011, J BIOL CHEM, V286, P5446, DOI 10.1074/jbc.M110.180026; Oda A, 2003, PLANT PHYSIOL, V133, P1779, DOI 10.1104/pp.103.030742; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; OTTE ML, 1989, NEW PHYTOL, V111, P309, DOI 10.1111/j.1469-8137.1989.tb00694.x; Ragni L, 2011, PLANT CELL, V23, P1322, DOI 10.1105/tpc.111.084020; REEVE DR, 1974, J EXP BOT, V25, P431, DOI 10.1093/jxb/25.2.431; Rubio V, 2009, PLANT MOL BIOL, V69, P361, DOI 10.1007/s11103-008-9380-y; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Sekimoto H., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P150; SMITH EW, 1976, PLANT PHYSIOL, V58, P143, DOI 10.1104/pp.58.2.143; Stout PR, 1939, AM J BOT, V26, P144, DOI 10.2307/2436530; TAYLOR GJ, 1983, AM J BOT, V70, P1254, DOI 10.2307/2443295; TAYLOR GJ, 1983, CAN J BOT, V61, P63, DOI 10.1139/b83-005; TAYLOR GJ, 1984, AM J BOT, V71, P666, DOI 10.2307/2443363; Ticconi CA, 2004, TRENDS PLANT SCI, V9, P548, DOI 10.1016/j.tplants.2004.09.003; VONWIREN N, 1994, PLANT PHYSIOL, V106, P71, DOI 10.1104/pp.106.1.71; WAKHLOO JL, 1970, PLANTA, V91, P190, DOI 10.1007/BF00385477; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562; Xie YJ, 2008, PLANT CELL ENVIRON, V31, P1864, DOI 10.1111/j.1365-3040.2008.01888.x; Yabuta T., 1938, J AGR CHEM SOC JAPAN, V14, P1526, DOI DOI 10.1271/NOGEIKAGAKU1924.14.12_1526; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Ye ZH, 1998, AQUAT BOT, V61, P55, DOI 10.1016/S0304-3770(98)00057-6; Ye ZH, 2001, CAN J BOT, V79, P314, DOI 10.1139/cjb-79-3-314; Ye ZH, 1997, NEW PHYTOL, V136, P481, DOI 10.1046/j.1469-8137.1997.00758.x; Yin CX, 2007, J EXP BOT, V58, P2441, DOI 10.1093/jxb/erm077; Yizong H., 2009, ACTA ECOL SIN, V29, P320, DOI [10.1016/j.chnaes.2009.09.011, DOI 10.1016/J.CHNAES.2009.09.011]; ZELITCH I, 1957, J BIOL CHEM, V224, P251; Zelitch I, 1971, PHOTOSYNTHESIS PHOTO, P127; Zhang HM, 2007, J EXP BOT, V58, P2329, DOI 10.1093/jxb/erm114; Zhang XK, 1999, PLANT SOIL, V209, P187, DOI 10.1023/A:1004505431879; Zhang XK, 1998, PLANT SOIL, V202, P33, DOI 10.1023/A:1004322130940	80	7	7	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118177	10.1371/journal.pone.0118177	http://dx.doi.org/10.1371/journal.pone.0118177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710173	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900050
J	Weng, LL; Menczer, F				Weng, Lilian; Menczer, Filippo			Topicality and Impact in Social Media: Diverse Messages, Focused Messengers	PLOS ONE			English	Article							PREDICTION; WORLD	We have a limited understanding of the factors that make people influential and topics popular in social media. Are users who comment on a variety of matters more likely to achieve high influence than those who stay focused? Do general subjects tend to be more popular than specific ones? Questions like these demand a way to detect the topics hidden behind messages associated with an individual or a keyword, and a gauge of similarity among these topics. Here we develop such an approach to identify clusters of similar hashtags in Twitter by detecting communities in the hashtag co-occurrence network. Then the topical diversity of a user's interests is quantified by the entropy of her hashtags across different topic clusters. A similar measure is applied to hashtags, based on co-occurring tags. We find that high topical diversity of early adopters or co-occurring tags implies high future popularity of hashtags. In contrast, low diversity helps an individual accumulate social influence. In short, diverse messages and focused messengers are more likely to gain impact.	[Weng, Lilian; Menczer, Filippo] Indiana Univ, Ctr Complex Networks & Syst Res, Sch Informat & Comp, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Weng, LL (corresponding author), Indiana Univ, Ctr Complex Networks & Syst Res, Sch Informat & Comp, Bloomington, IN 47405 USA.	weng@umail.iu.edu			James S. McDonnell Foundation [2011022]; National Science Foundation [CCF-1101743]; Defense Advanced Research Projects Agency [W911NF-12-1-0037]; Direct For Computer & Info Scie & Enginr [1101743] Funding Source: National Science Foundation	James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The work is supported in part by the James S. McDonnell Foundation complex systems grant on contagion of ideas in online social networks (https://www.jsmf.org/grants/2011022/), the National Science Foundation grant CCF-1101743 (http://nsf.gov/awardsearch/showAward?AWD_ID=1101743), and the Defense Advanced Research Projects Agency grant W911NF-12-1-0037 (http://www.darpa.mil/Opportunities/Contract_Management/Grants_and_Cooperative_Agreements.aspx).	Agarwal MK, 2012, PROC VLDB ENDOW, V5, P980, DOI 10.14778/2336664.2336671; Aggarwal C. C., 2012, P 2012 SIAM INT C DA, P624, DOI DOI 10.1137/1.9781611972825.54; Aiello LM, 2012, ACM T WEB, V6, DOI 10.1145/2180861.2180866; An J., 2011, P 5 INT AAAI C WEBL, P18; Aral S, 2011, MANAGE SCI, V57, P1623, DOI 10.1287/mnsc.1110.1421; Bakshy E., 2011, P 4 ACM INT C WEB SE, P65, DOI DOI 10.1145/1935826.1935845; Berger J, 2012, J MARKETING RES, V49, P192, DOI 10.1509/jmr.10.0353; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cha M., 2010, ICWSM, P10, DOI DOI 10.1093/JSCR/2010.10.10; Chen JL, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1185; Cheng J, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P925, DOI 10.1145/2566486.2567997; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; Davison B. D., 2000, SIGIR Forum, V34, P272; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Ferrara E, 2013, 2013 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P554; GOFFMAN W, 1964, NATURE, V204, P225, DOI 10.1038/204225a0; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Goldberg K, 2001, INFORM RETRIEVAL, V4, P133, DOI 10.1023/A:1011419012209; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Haveliwala TH, 2003, IEEE T KNOWL DATA EN, V15, P784, DOI 10.1109/TKDE.2003.1208999; Ienco D, 2010, IEEE INT C DAT MIN W, P328; Java Akshay, 2007, P JOINT 9 WEBKDD 1 S, P56, DOI 10.1145/1348549.1348556; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lerman K, 2007, IEEE INTERNET COMPUT, V11, P16, DOI 10.1109/MIC.2007.136; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Lin Y.R., 2013, P 7 INT C WEBL SOC M, P370; Menczer F, 2004, J AM SOC INF SCI TEC, V55, P1261, DOI 10.1002/asi.20081; Menczer F., 1998, Proceedings of the Second International Conference on Autonomous Agents, P157, DOI 10.1145/280765.280794; Michelson M., 2010, P 4 WORKSH AN NOIS U, P73, DOI DOI 10.1145/1871840.1871852; Michlmayr E., 2007, P WORKSH TAGG MET SO, P1; Moreno Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066130; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Phelan O., 2009, P 3 ACM C REC SYST, P385, DOI DOI 10.1145/1639714.1639794; Quigley JM, 1998, J ECON PERSPECT, V12, P127, DOI 10.1257/jep.12.2.127; Romero  D.M., 2013, ICWSM; Romero D. M., 2011, P 20 INT C COMP WORL, P113, DOI DOI 10.1145/1963192.1963250; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Schifanella Rossano, 2010, P 3 ACM INT C WEB SE, P271, DOI DOI 10.1145/1718487.1718521; Serrano MA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.078701; Simmons M. P., 2011, ICWSM, P17; Suh B, 2010, 2010 IEEE 2 INT C SO, V2, P177, DOI [10.1109/SocialCom.2010.33, DOI 10.1109/SOCIALCOM.2010.33]; Szabo G, 2010, COMMUN ACM, V53, P80, DOI 10.1145/1787234.1787254; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Weng J., 2010, P 3 ACM INT C WEB SE, P261, DOI [10.1145/1718487.1718520, DOI 10.1145/1718487.1718520]; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335; Weng L, 2014, P AAAI INT C WEBL SO, P623; Weng L., 2014, P 8 INT AAAI C WEBL, P535; Weng LL, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P356; Weng LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02522; Xie L., 2011, P 19 ACM INT C MULT, P53, DOI DOI 10.1145/2072298.2072307; Yang L., 2012, P 21 INT C WORLD WID, P261, DOI [DOI 10.1145/2187836.2187872, 10.1145/2187836.2187872]; Zhiheng Xu, 2011, 2011 IEEE/WIC/ACM International Joint Conferences on Web Intelligence (WI) and Intelligent Agent Technologies, P422, DOI 10.1109/WI-IAT.2011.47	56	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118410	10.1371/journal.pone.0118410	http://dx.doi.org/10.1371/journal.pone.0118410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IY	25710685	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900056
J	Fu, S; Chen, C; Xiao, L; He, HM; Xue, FS				Fu, Shu; Chen, Chao; Xiao, Liang; He, Haimin; Xue, Fangsen			Inheritance of Diapause in Crosses between the Northernmost and the Southernmost Strains of the Asian Corn Borer Ostrinia furnacalis	PLOS ONE			English	Article							CONTROLLING LARVAL DIAPAUSE; DISTINCT VOLTINE ECOTYPES; 2-SPOTTED SPIDER-MITE; GEOGRAPHICAL VARIATION; TETRANYCHUS-URTICAE; CALLIPHORA-VICINA; PUPAL DIAPAUSE; PINK-BOLLWORM; BLOW FLY; INDUCTION	The northernmost Harbin strain (N strain) of the Asian corn borer, Ostrinia furnacalis enters facultative diapause as fully grown larvae in response to short daylengths; whereas the southernmost Ledong strain (S strain) exhibits almost no diapause under the same light conditions. In the present study, we examined the inheritance of diapause induction and termination by crossing the two strains under a range of environmental conditions. The N strain showed a typical long-day response with a critical daylength of approximately 15.88 h at 22 degrees C, 15.72 h at 25 degrees C and 15.14 h at 28 degrees C, whereas the S strain showed a weak photoperiodic response at 22 degrees C. The F1 progeny also showed a long-day response at 22, 25 and 28 degrees C. However, the critical daylengths in S female x N male crosses were significantly longer than those in N female x S male crosses, indicating a sex linkage in the inheritance of diapause induction, with the male parent having more influence on the following F1 progeny. The incidence of diapause in S female x N male crosses was the same as in the N strain under short daylengths of 11-13 h, indicating that diapause trait is completely dominant over the non-diapause trait. The critical daylength in backcross to N was significantly longer than it was in backcross to S, showing a grandfather gene effect. Whether the inheritance of diapause fits an additive hypothesis or not was dependent on the rearing photoperiod, and the capacity for diapause was transmitted genetically in the manner of incomplete dominance. The duration of diapause for the reciprocal crosses under different diapause-terminating conditions showed different patterns of inheritance. The results in this study reveal that genetic and genetic-environmental interactions are involved in diapause induction and termination in O. furnacalis.	[Fu, Shu; Chen, Chao; Xiao, Liang; He, Haimin; Xue, Fangsen] Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University	Xue, FS (corresponding author), Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China.	xue_fangsen@hotmail.com			National Natural Science Foundation of the People's Republic of China [31260430]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC))	The research was supported by a grant from National Natural Science Foundation of the People's Republic of China to FSX (31260430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck S.D., 1980, INSECT PHOTOPERIODIS, DOI 10.1016/b978-0-120-84380-0.x5001-7; Chen C, 2014, B ENTOMOL RES, V104, P586, DOI 10.1017/S0007485314000352; Chen C, 2012, J INSECT PHYSIOL, V58, P1582, DOI 10.1016/j.jinsphys.2012.09.013; Danks HV, 1987, INSECT DORMANCY ECOL; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; GOTOH T, 1981, JPN J APPL ENTOMOL Z, V25, P113, DOI 10.1303/jjaez.25.113; HENRICH VC, 1983, J HERED, V74, P371, DOI 10.1093/oxfordjournals.jhered.a109813; Huang LL, 2013, PHYSIOL ENTOMOL, V38, P126, DOI 10.1111/phen.12009; Ikten C, 2011, ANN ENTOMOL SOC AM, V104, P567, DOI 10.1603/AN09149; Kawakami Y, 2010, J HERED, V101, P20, DOI 10.1093/jhered/esp085; KIMURA MT, 1988, ENTOMOL EXP APPL, V47, P81, DOI 10.1007/BF00186719; Kuang XJ, 2011, J INSECT PHYSIOL, V57, P614, DOI 10.1016/j.jinsphys.2011.01.004; KURAHASHI H, 1977, EXPERIENTIA, V33, P186, DOI 10.1007/BF02124056; Lu X., 1995, J MAIZE SCI, V2, P75; McWatters HG, 1997, J INSECT PHYSIOL, V43, P709, DOI 10.1016/S0022-1910(97)00051-6; McWatters HG, 1996, J INSECT PHYSIOL, V42, P721, DOI 10.1016/0022-1910(96)00030-3; Nylin S, 2013, PHYSIOL ENTOMOL, V38, P96, DOI 10.1111/phen.12014; Qiao Li, 2008, Journal of Northwest A & F University - Natural Science Edition, V36, P109; RAINA AK, 1981, INSECT SCI APPL, V1, P231, DOI 10.1017/S1742758400000461; RAINA AK, 1974, ANN ENTOMOL SOC AM, V67, P685, DOI 10.1093/aesa/67.4.685; Robinson R, 1971, LEPIDIPTERA GENETICS; Saunders DS, 2002, INSECT CLOCKS; Showers W.B., 1981, P97; SHOWERS WB, 1990, ENVIRON ENTOMOL, V19, P1311, DOI 10.1093/ee/19.5.1311; SIMS SR, 1983, HEREDITY, V51, P495, DOI 10.1038/hdy.1983.60; Soderlind L, 2011, PHYSIOL ENTOMOL, V36, P8, DOI 10.1111/j.1365-3032.2010.00756.x; Suwa A, 2006, J APPL ENTOMOL, V130, P329, DOI 10.1111/j.1439-0418.2006.01050.x; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Wang ZY., 2000, J SHENYANG AGR U, V31, P402; Xia QW, 2012, PHYSIOL ENTOMOL, V37, P185, DOI 10.1111/j.1365-3032.2011.00810.x; Zhou DR, 1995, ASIAN CORN BORER ITS	31	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118186	10.1371/journal.pone.0118186	http://dx.doi.org/10.1371/journal.pone.0118186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706525	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100149
J	Shanmugam, M; Gopal, P; El Abbar, F; Schreiner, HC; Kaplan, JB; Fine, DH; Ramasubbu, N				Shanmugam, Mayilvahanan; Gopal, Prerna; El Abbar, Faiha; Schreiner, Helen C.; Kaplan, Jeffrey B.; Fine, Daniel H.; Ramasubbu, Narayanan			Role of Exopolysaccharide in Aggregatibacter actinomycetemcomitans-Induced Bone Resorption in a Rat Model for Periodontal Disease	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN/HEMAGGLUTININ; MEDIATES BIOFILM FORMATION; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; STAPHYLOCOCCUS-EPIDERMIDIS; RESISTANCE; PATHOGENESIS; INFECTION; ADHERENCE; GENES; CELLS	Aggregatibacter actinomycetemcomitans a causative agent of periodontal disease in humans, forms biofilm on biotic and abiotic surfaces. A. actinomycetemcomitans biofilm is heterogeneous in nature and is composed of proteins, extracellular DNA and exopolysaccharide. To explore the role played by the exopolysaccharide in the colonization and disease progression, we employed genetic reduction approach using our rat model of A. actinomycetemcomitans-induced periodontitis. To this end, a genetically modified strain of A. actinomycetemcomitans lacking the pga operon was compared with the wild-type strain in the rat infection model. The parent and mutant strains were primarily evaluated for bone resorption and disease. Our study showed that colonization, bone resorption/disease and antibody response were all elevated in the wild-type fed rats. The bone resorption/disease caused by the pga mutant strain, lacking the exopolysaccharide, was significantly less (P < 0.05) than the bone resorption/disease caused by the wild-type strain. Further analysis of the expression levels of selected virulence genes through RT-PCR showed that the decrease in colonization, bone resorption and antibody titer in the absence of the exopolysaccharide might be due to attenuated levels of colonization genes, flp-1, apiA and aae in the mutant strain. This study demonstrates that the effect exerted by the exopolysaccharide in A. actinomycetemcomitans-induced bone resorption has hitherto not been recognized and underscores the role played by the exopolysaccharide in A. actinomycetemcomitans-induced disease.	[Shanmugam, Mayilvahanan; Gopal, Prerna; El Abbar, Faiha; Schreiner, Helen C.; Kaplan, Jeffrey B.; Fine, Daniel H.; Ramasubbu, Narayanan] Rutgers Sch Dent Med, Dept Oral Biol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Ramasubbu, N (corresponding author), Rutgers Sch Dent Med, Dept Oral Biol, Newark, NJ 07103 USA.	ramasun1@sdm.rutgers.edu			United States Public Health Service [DE022544]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022544] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the United States Public Health Service DE022544 (NR HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; CHANG KM, 1994, J PERIODONTAL RES, V29, P242, DOI 10.1111/j.1600-0765.1994.tb01218.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; CRAWFORD JM, 1978, J PERIODONTAL RES, V13, P316, DOI 10.1111/j.1600-0765.1978.tb00186.x; Fine DH, 2009, J CLIN PERIODONTOL, V36, P106, DOI 10.1111/j.1600-051X.2008.01353.x; GONCHAROFF P, 1993, ORAL MICROBIOL IMMUN, V8, P105, DOI 10.1111/j.1399-302X.1993.tb00554.x; Haubek D, 1997, J CLIN MICROBIOL, V35, P3037, DOI 10.1128/JCM.35.12.3037-3042.1997; HAUBEK D, 1995, J CLIN MICROBIOL, V33, P395, DOI 10.1128/JCM.33.2.395-401.1995; Henderson B, 2002, J MED MICROBIOL, V51, P1013, DOI 10.1099/0022-1317-51-12-1013; Izano EA, 2007, J DENT RES, V86, P618, DOI 10.1177/154405910708600707; Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kaplan JB, 2001, INFECT IMMUN, V69, P5375, DOI 10.1128/IAI.69.9.5375-5384.2001; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Perez BA, 2006, J BACTERIOL, V188, P6361, DOI 10.1128/JB.00496-06; Ramsey MM, 2009, P NATL ACAD SCI USA, V106, P1578, DOI 10.1073/pnas.0809533106; Rupp ME, 1999, INFECT IMMUN, V67, P2656, DOI 10.1128/IAI.67.5.2656-2659.1999; Rupp ME, 1999, INFECT IMMUN, V67, P2627, DOI 10.1128/IAI.67.5.2627-2632.1999; Rupp ME, 2001, METHOD ENZYMOL, V336, P206, DOI 10.1016/S0076-6879(01)36591-6; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Schreiner H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069382; Shaddox L, 2010, J DENT RES, V89, P143, DOI 10.1177/0022034509353397; Subashchandrabose S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003788; Venketaraman V, 2008, MICROB PATHOGENESIS, V45, P173, DOI 10.1016/j.micpath.2008.05.007; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Yue G, 2007, INFECT IMMUN, V75, P4440, DOI 10.1128/IAI.02020-06; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117487	10.1371/journal.pone.0117487	http://dx.doi.org/10.1371/journal.pone.0117487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706999	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100094
J	Simon, SL; Field, J; Miller, LE; DiFrancesco, M; Beebe, DW				Simon, Stacey L.; Field, Julie; Miller, Lauren E.; DiFrancesco, Mark; Beebe, Dean W.			Sweet/Dessert Foods Are More Appealing to Adolescents after Sleep Restriction	PLOS ONE			English	Article							BODY-MASS INDEX; ENERGY-EXPENDITURE; MENSTRUAL-CYCLE; DURATION; METAANALYSIS; CHILDREN; OBESITY	Study Objective Examine the effect of experimental sleep restriction (SR) on adolescents' subjective hunger and perceived appeal of sweet/dessert foods versus other foods. A secondary goal was to replicate previous findings on the effects of SR on dietary intake. Design Randomized cross-over sleep restriction-extension paradigm. Setting Sleep was obtained and monitored at home. Outcome measures were gathered during office visits. Participants 31 typically-developing adolescents aged 14-17 years. Interventions The three-week protocol consisted of a baseline week, followed randomly by five consecutive nights of SR (6.5 hours in bed) versus healthy sleep duration (HS; 10 hours in bed), a 2-night wash-out period, and a 5-night cross-over. Measurements Sleep was monitored via actigraphy. The morning after each experimental condition, teens rated their hunger, underwent a 24-hour diet recall interview, and rated the appeal of a series of pictures of sweet/dessert foods (e.g., ice cream, candy) and non-sweets (meat, eggs, fruits, vegetables). Results Teens rated pictures of sweet/dessert foods to be more appealing after SR than after HS (Cohen's d = .41, t = 2.07, p = .045). The sleep manipulation did not affect self-reported hunger or the appeal of non-sweet foods ( p >.10). Consistent with our prior work, intake of overall calories was 11% higher and consumption of sweet/dessert servings was 52% greater during SR than HS. Conclusions Adolescent SR appears to increase the subjective appeal of sweet/dessert foods, indicating a potential mechanism by which SR might contribute to weight gain and the risk for obesity and chronic illness.	[Simon, Stacey L.] Childrens Hosp Colorado, Aurora, CO 80011 USA; [Simon, Stacey L.] Univ Colorado, Sch Med, Aurora, CO USA; [Field, Julie; DiFrancesco, Mark; Beebe, Dean W.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Miller, Lauren E.] Univ Connecticut, Dept Psychol, Storrs, CT USA; [Beebe, Dean W.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Cincinnati Children's Hospital Medical Center; University of Connecticut; University System of Ohio; University of Cincinnati	Simon, SL (corresponding author), Childrens Hosp Colorado, Aurora, CO 80011 USA.	stacey.simon@childrenscolorado.org	DiFrancesco, Mark William/AAE-6138-2020; Simon, Stacey/G-9882-2016	DiFrancesco, Mark William/0000-0001-8002-0332; Simon, Stacey/0000-0003-4755-8151	National Institutes of Health [R01 HL092149, UL1 RR026314]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (R01 HL092149, UL1 RR026314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberga AS, 2012, PEDIATR OBES, V7, P261, DOI 10.1111/j.2047-6310.2011.00046.x; Baker FC, 2007, SLEEP MED, V8, P613, DOI 10.1016/j.sleep.2006.09.011; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Beebe DW, 2013, SLEEP, V36, P827, DOI 10.5665/sleep.2704; Brondel L, 2010, AM J CLIN NUTR, V91, P1550, DOI 10.3945/ajcn.2009.28523; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Carr Katelyn A, 2011, Curr Drug Abuse Rev, V4, P190; Carskadon MA, 2011, PEDIATR CLIN N AM, V58, P637, DOI 10.1016/j.pcl.2011.03.003; Cohen C, 1988, STAT POWER ANAL BEHA; Craigie AM, 2009, OBESITY FACTS, V2, P150, DOI 10.1159/000218092; Johnson RK, 1996, J AM DIET ASSOC, V96, P1140, DOI 10.1016/S0002-8223(96)00293-3; Markwald RR, 2013, P NATL ACAD SCI USA, V110, P5695, DOI 10.1073/pnas.1216951110; MARTINI MC, 1994, AM J CLIN NUTR, V60, P895, DOI 10.1093/ajcn/60.6.895; O'Dea JA, 2012, PEDIATR OBES, V7, P295, DOI 10.1111/j.2047-6310.2012.00054.x; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Spaeth AM, 2013, SLEEP, V36, P981, DOI 10.5665/sleep.2792; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; St-Onge MP, 2013, J CLIN SLEEP MED, V9, P73, DOI 10.5664/jcsm.2348; St-Onge MP, 2012, AM J CLIN NUTR, V95, P818, DOI 10.3945/ajcn.111.027383; St-Onge MP, 2011, AM J CLIN NUTR, V94, P410, DOI 10.3945/ajcn.111.013904	21	62	62	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115434	10.1371/journal.pone.0115434	http://dx.doi.org/10.1371/journal.pone.0115434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706861	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100012
J	Zhu, DQ; Liu, F; Sun, Y; Yang, LM; Xin, L; Meng, XC				Zhu, De-Quan; Liu, Fei; Sun, Yu; Yang, Li-Mei; Xin, Li; Meng, Xiang-Chen			Genome-Wide Identification of Small RNAs in Bifidobacterium animalis subsp lactis KLDS 2.0603 and Their Regulation Role in the Adaption to Gastrointestinal Environment	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; TRANSCRIPTIONAL REGULATOR; LISTERIA-MONOCYTOGENES; EXPRESSION; PROTECTION; GROWTH	Objective Bifidobacteria are one of the predominant bacterial species in the human gastrointestinal tract (GIT) and play a vital role in the host's health by acting as probiotics. However, how they regulate themselves to adapt to GIT of their host remains unknown. Methods Eighteen bifidobacterial strains were used to analyze their adaptive capacities towards simulated GIT environment. The strain with highest survival rate and adhesion ability was selected for comparative genome as well as transcriptomic analysis. Results The Bifidobacterium animalis subsp. lactis KLDS 2.0603 strain was demonstrated to have the highest survival rate and adhesion ability in simulated GIT treatments. The comparative genome analysis revealed that the KLDS 2.0603 has most similar whole genome sequence compared with BB-12 strain. Eleven intergenic sRNAs were identified after genomes prediction and transcriptomic analysis of KLDS 2.0603. Transcriptomic analysis also showed that genes (mainly sRNAs targeted genes) and sRNAs were differentially expressed in different stress conditions, suggesting that sRNAs might play a crucial role in regulating genes involved in the stress resistance of this strain towards environmental changes. Conclusions This study first provided deep and comprehensive insights into the regulation of KLDS 2.0603 strain at transcription and post-transcription level towards environmental.				mengxach@163.com			National Natural Science Foundation of China [31171719/C200204]; Ministry of Education, Outstanding Youth Scientists Foundation of Harbin City [2014RFYXJ006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Outstanding Youth Scientists Foundation of Harbin City	This work was supported by the National Natural Science Foundation of China (No.31171719/C200204). The key technology research projects of the Ministry of Education, Outstanding Youth Scientists Foundation of Harbin City (2014RFYXJ006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 2012, RNA, V18, P530, DOI 10.1261/rna.027359.111; Allen JP, 2011, INFECT IMMUN, V79, P4638, DOI 10.1128/IAI.05567-11; Andrews S., 2010, FASTQC QUALITY CONTR; Barmpalia-Davis IM, 2009, FOOD MICROBIOL, V26, P483, DOI 10.1016/j.fm.2009.02.011; Barrangou R, 2009, J BACTERIOL, V191, P4144, DOI 10.1128/JB.00155-09; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bradley ES, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002126; Champagne CP, 2005, CRIT REV FOOD SCI, V45, P61, DOI 10.1080/10408690590900144; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Khalf M, 2010, BIORESOURCE TECHNOL, V101, P7966, DOI 10.1016/j.biortech.2010.05.053; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Langmead B, 2010, CURRENT PROTOCOL S32, P1171; Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin TH, 2012, J BACTERIOL, V194, P6758, DOI 10.1128/JB.01258-12; Mandin P, 2010, EMBO J, V29, P3094, DOI 10.1038/emboj.2010.179; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Mayo B, 2010, BIFIDOBACTERIA: GENOMICS AND MOLECULAR ASPECTS, P1; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Nijeholt JALA, 2013, FEBS LETT, V587, P3083, DOI 10.1016/j.febslet.2013.07.046; O'May GA, 2005, J CLIN MICROBIOL, V43, P3059, DOI 10.1128/JCM.43.7.3059-3065.2005; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pessi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072939; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Pinzone Marilia Rita, 2012, Int J Microbiol, V2012, P694629, DOI 10.1155/2012/694629; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Ruiz L, 2012, APPL ENVIRON MICROB, V78, P1123, DOI 10.1128/AEM.06060-11; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stubben CJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-385; Sun XY, 2013, SCI CHINA LIFE SCI, V56, P467, DOI 10.1007/s11427-013-4480-6; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tasanapak K, 2013, J MICROBIOL, V51, P783, DOI 10.1007/s12275-013-2619-6; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421; Weiss G, 2010, J MOL MICROB BIOTECH, V18, P206, DOI 10.1159/000316421; Yanagihara S, 2012, J BIOSCI BIOENG, V114, P582, DOI 10.1016/j.jbiosc.2012.07.001	43	9	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117373	10.1371/journal.pone.0117373	http://dx.doi.org/10.1371/journal.pone.0117373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706951	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100083
J	Blaisdell, GK; Roy, BA; Pfeifer-Meister, L; Bridgham, SD				Blaisdell, G. Kai; Roy, Bitty A.; Pfeifer-Meister, Laurel; Bridgham, Scott D.			An Exploration of Hypotheses that Explain Herbivore and Pathogen Attack in Restored Plant Communities	PLOS ONE			English	Article							VEGETATIONAL DIVERSITY; SPECIES-DIVERSITY; POPULATION-DYNAMICS; NITROGEN DEPOSITION; ECOLOGY; DISEASE; LEAF; DOMINANCE; SUSCEPTIBILITY; CONSEQUENCES	Many hypotheses address the associations of plant community composition with natural enemies, including: (i) plant species diversity may reduce enemy attack, (ii) attack may increase as host abundance increases, (iii) enemy spillover may lead to increased attack on one host species due to transmission from another host species, or enemy dilution may lead to reduced attack on a host that would otherwise have more attack, (iv) physical characteristics of the plant community may influence attack, and (v) plant vigor may affect attack. Restoration experiments with replicated plant communities provide an exceptional opportunity to explore these hypotheses. To explore the relative predictive strengths of these related hypotheses and to investigate the potential effect of several restoration site preparation techniques, we surveyed arthropod herbivore and fungal pathogen attack on the six most common native plant species in a restoration experiment. Multi-model inference revealed a weak but consistent negative correlation with pathogen attack and host diversity across the plant community, and no correlation between herbivory and host diversity. Our analyses also revealed host species-specific relationships between attack and abundance of the target host species, other native plant species, introduced plant species, and physical community characteristics. We found no relationship between enemy attack and plant vigor. We found minimal differences in plant community composition among several diverse site preparation techniques, and limited effects of site preparation techniques on attack. The strongest associations of community characteristics with attack varied among plant species with no community-wide patterns, suggesting that no single hypothesis successfully predicts the dominant community-wide trends in enemy attack.	[Blaisdell, G. Kai; Roy, Bitty A.; Pfeifer-Meister, Laurel; Bridgham, Scott D.] Univ Oregon, Dept Biol, Inst Ecol & Evolut, Eugene, OR 97403 USA	University of Oregon	Blaisdell, GK (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	blaisdell@berkeley.edu	Bridgham, Scott/R-1557-2017	Bridgham, Scott/0000-0003-0614-2678; Roy, Bitty A./0000-0003-1666-5624	National Science Foundation [NSF DEB-0515777, DGE-0742540]; United States Environmental Protection Agency (EPA); City of Eugene; EPA-STAR fellowship	National Science Foundation(National Science Foundation (NSF)); United States Environmental Protection Agency (EPA)(United States Environmental Protection Agency); City of Eugene; EPA-STAR fellowship(United States Environmental Protection Agency)	This study was conducted on property owned by the City of Eugene, Oregon, United States of America, in collaboration with the West Eugene Wetlands Partnership, and Lane Council of Governments. Support for this study came from the National Science Foundation, grant number NSF DEB-0515777 granted to BAR (http://www.nsf.gov/div/index.jsp?div=DEB). Funding for the restoration experiment was provided by a wetland program development grant from the United States Environmental Protection Agency (EPA) to SDB, BAR, and B. Johnson, with matching funds provided by the City of Eugene, and by an EPA-STAR fellowship granted to LPM (http://water.epa.gov/grants_funding/wetlands/grantguidelines/, http://www.epa.gov/ncer/). GKB was supported by the National Science Foundation Graduate STEM Fellows in K-12 Education program under Grant No. DGE-0742540 (http://pages.uoregon.edu/msiuo/GK12/Overview.html). The West Eugene Wetlands Partnership and Lane Council of Governments were involved in selection and implementation of the restoration techniques that were used in the restoration experiment. Beyond this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Alexander H. M., 1992, The fungal community: its organization and role in the ecosystem., P481; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Beckstead J, 2010, J ECOL, V98, P168, DOI 10.1111/j.1365-2745.2009.01599.x; Blaisdell GK, 2011, THESIS U OREGON; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Bradley DJ, 2003, AM J BOT, V90, P857, DOI 10.3732/ajb.90.6.857; Burdon JJ., 1987, DIS PLANT POPULATION; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cobb RC, 2010, ECOLOGY, V91, P327, DOI 10.1890/09-0680.1; COLLINGE SK, 1988, OECOLOGIA, V75, P559, DOI 10.1007/BF00776420; Cornelissen T, 2008, OIKOS, V117, P1121, DOI 10.1111/j.0030-1299.2008.16588.x; DEJONG TM, 1975, OIKOS, V26, P222, DOI 10.2307/3543712; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Dizney LJ, 2009, EMERG INFECT DIS, V15, P1012, DOI [10.3201/eid1507.081621, 10.3201/eid1507.081083]; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fitzpatrick G. S., 2004, TECHNIQUES RESTORING; Folgarait PJ, 1995, ENVIRON ENTOMOL, V24, P1487, DOI 10.1093/ee/24.6.1487; Gaborcik N, 2003, PHOTOSYNTHETICA, V41, P285, DOI 10.1023/B:PHOT.0000011963.43628.15; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Harmon JP, 2003, POPUL ECOL, V45, P75, DOI 10.1007/s10144-003-0146-8; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; JOSHI J, 2004, INSECTS ECOSYSTEM FU; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; KRANZ J, 1990, NEW PHYTOL, V116, P383, DOI 10.1111/j.1469-8137.1990.tb00525.x; Krokene P, 2012, PLANT PATHOL, V61, P57, DOI 10.1111/j.1365-3059.2011.02487.x; Lau JA, 2008, ECOLOGY, V89, P226, DOI 10.1890/07-0423.1; LETOURNEAU DK, 1987, ECOLOGY, V68, P1616, DOI 10.2307/1939853; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Malmstrom CM, 2007, J ECOL, V95, P1153, DOI 10.1111/j.1365-2745.2007.01307.x; Mazerolle MJ, 2006, AMPHIBIA-REPTILIA, V27, P169, DOI 10.1163/156853806777239922; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Neumann S, 2004, PLANT PATHOL, V53, P725, DOI 10.1111/j.1365-3059.2004.01107.x; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pagan I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002796; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Pfeifer-Meister L, 2008, THESIS U OREGON; Pfeifer-Meister L, 2012, PLANT ECOL, V213, P637, DOI 10.1007/s11258-012-0028-2; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Ricciardi A, 2006, SCIENCE, V313, DOI 10.1126/science.1128946; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; Rizzo DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.1890/1540-9295(2003)001[0197:SODECA]2.0.CO;2; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roy BA, 2011, ECOLOGY, V92, P665, DOI 10.1890/09-2006.1; Schellhorn NA, 1997, OECOLOGIA, V111, P233, DOI 10.1007/s004420050230; Seabloom EW, 2009, J ECOL, V97, P1264, DOI 10.1111/j.1365-2745.2009.01550.x; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Stanton ML, 2004, AM NAT, V164, P736, DOI 10.1086/425331; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; WHITE TCR, 1974, OECOLOGIA, V16, P279, DOI 10.1007/BF00344738; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilson HE, 2014, MYCOLOGIA, V106, P22, DOI 10.3852/12-330; YODER BJ, 1995, REMOTE SENS ENVIRON, V53, P199, DOI 10.1016/0034-4257(95)00135-N; Young WC, 1999, AGRON J, V91, P671, DOI 10.2134/agronj1999.914671x; Yukawa J, 2000, POPUL ECOL, V42, P105, DOI 10.1007/PL00011989; Zehnder CB, 2008, ECOL ENTOMOL, V33, P24, DOI 10.1111/j.1365-2311.2007.00945.x	64	0	0	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116650	10.1371/journal.pone.0116650	http://dx.doi.org/10.1371/journal.pone.0116650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699672	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800013
J	Chen, JP; Han, MM; Liao, ZJ; Dai, ZZ; Liu, L; Chen, H; Wen, XY; Hu, S; Que, P; Wen, W; Peng, B				Chen, Jiang-Peng; Han, Ming-Ming; Liao, Zi-Jun; Dai, Zhen-Zhen; Liu, Liang; Chen, Hua; Wen, Xiao-Yan; Hu, Shan; Que, Ping; Wen, Wen; Peng, Bin			HIV-Related Behaviors, Social Support and Health-Related Quality of Life among Men Who Have Sex with Men and Women (MSMW): A Cross-Sectional Study in Chongqing, China	PLOS ONE			English	Article							WENCHUAN EARTHQUAKE SURVIVORS; BLACK-MEN; RISK BEHAVIOR; CONDOM USE; PREVALENCE; WHOQOL; CITY; DEPRESSION; MODERATOR; SYPHILIS	Background Health-related quality of life (HRQOL) has become commonly used both as a concept and as a field of research. However, little is known about the HRQOL of men who have sex with men and women (MSMW). The aim of this study was to examine HIV-related behaviors, social support, and HRQOL status and explore its predictors among MSMW. Methods An anonymous cross-sectional study was conducted by snowball sampling method in 2013. A total of 563 Chinese MSM completed a structured questionnaire. The HRQOL and social support were measured with the Chinese version of the World Health Organization Quality of Life Scale (WHOQOL-BRFE) and the Social Support Rating Scale (SSRS), respectively. Results Of the 563 MSM analyzed, 77 (13.68%) were MSMW who had a higher proportion of in-marriage and preference for an insertive role as compared with the men who have sex with men only (MSMO) (P<0.05). As high as 70.13% of MSMW had no regular sex partners and 72.73% of MSMW reported engaging in unprotected anal sex in the last six months. 36.36% had tested for HIV, while only 12.99% had accepted HIV voluntary counseling and testing (VCT) services. The scores of objective support and subjective support in MSMW were significantly higher than that of MSMO (P<0.05). No statistically significant difference was found in scores of all the four domains of the HRQOL between MSMW and MSMO. When comparing the HRQOL scores of MSMW with the Chinese general population reference group, the scores of MSMW were significantly lower in physical health domain. In a multivariate regression model, age, monthly income, sexual role, VCT acceptability, subjective support were associated with variability in HRQOL. Conclusions To improve the HRQOL among MSMW, more attention needs to be paid to those with low social support, low-income, the old and those prefer a receptive role during anal sex populations.	[Chen, Jiang-Peng; Han, Ming-Ming; Dai, Zhen-Zhen; Chen, Hua; Wen, Xiao-Yan; Hu, Shan; Que, Ping; Wen, Wen; Peng, Bin] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China; [Liao, Zi-Jun] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing 100871, Peoples R China; [Liu, Liang] Beichuan Ctr Dis Control & Prevent, Mianyang, Sichuan Provinc, Peoples R China	Chongqing Medical University; Peking University	Peng, B (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China.	pengbin@cqmu.edu.cn						Ayala G, 2012, AM J PUBLIC HEALTH, V102, pS242, DOI 10.2105/AJPH.2011.300641; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041062; Chow EPF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-549; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; D'Anna LH, 2012, AIDS CARE, V24, P1028, DOI 10.1080/09540121.2012.668285; Deng MH, 2013, TUMOR BIOL, V34, P2809, DOI 10.1007/s13277-013-0839-3; Dodge B, 2008, ARCH SEX BEHAV, V37, P683, DOI 10.1007/s10508-008-9356-7; Fang, 2000, MEASUREMENT APPL QUA; Hoff CC, 2012, AIDS PATIENT CARE ST, V26, P738, DOI 10.1089/apc.2012.0198; Jin MH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1101; Jung YE, 2012, QUAL LIFE RES, V21, P967, DOI 10.1007/s11136-011-0006-5; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lau JTF, 2013, PREV MED, V57, P813, DOI 10.1016/j.ypmed.2013.09.005; Lin LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109567; Mimiaga MJ, 2013, AIDS CARE, V25, P1109, DOI 10.1080/09540121.2012.749340; Nedjat S, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-61; Nglazi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-676; Okaka E I, 2014, West Afr J Med, V33, P125; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Skevington SM, 2002, QUAL LIFE RES, V11, P135, DOI 10.1023/A:1015013312456; Soares GB, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-28; Tieu HV, 2012, AIDS CARE, V24, P1111, DOI 10.1080/09540121.2012.672723; Vyavaharkar M, 2007, AIDS PATIENT CARE ST, V21, P667, DOI 10.1089/apc.2006.0131; Wang KL, 2012, INT J EPIDEMIOL, V41, P423, DOI 10.1093/ije/dyr182; Williams CT, 2009, J URBAN HEALTH, V86, pS93, DOI 10.1007/s11524-009-9367-2; Wilson PA, 2014, HEALTH PSYCHOL, V33, P681, DOI 10.1037/a0035405; World Health Organization [WHO], 1996, WHOQOL BREF INTR ADM; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Xu J, 2014, PUBLIC HEALTH, V128, P430, DOI 10.1016/j.puhe.2014.03.002; Zeng G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/602719; Zhang B., 2000, CHIN J STD AIDS PREV, V3, P155; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhao CY, 2013, QUAL LIFE RES, V22, P733, DOI 10.1007/s11136-012-0197-4; Zheng Y, 2009, CLIN RHEUMATOL, V28, P265, DOI 10.1007/s10067-008-1033-7; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919	35	18	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118651	10.1371/journal.pone.0118651	http://dx.doi.org/10.1371/journal.pone.0118651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB7EQ	25700107	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800039
J	Bein, O; Livneh, N; Reggev, N; Gilead, M; Goshen-Gottstein, Y; Maril, A				Bein, Oded; Livneh, Neta; Reggev, Niv; Gilead, Michael; Goshen-Gottstein, Yonatan; Maril, Anat			Delineating the Effect of Semantic Congruency on Episodic Memory: The Role of Integration and Relatedness	PLOS ONE			English	Article							COMPLEMENTARY LEARNING-SYSTEMS; SPREADING ACTIVATION THEORY; PRIOR KNOWLEDGE; EVENT CONGRUENCY; RETRIEVAL; FAMILIARITY; NOVELTY; SCHEMA; ASSOCIATIONS; ELABORATION	A fundamental challenge in the study of learning and memory is to understand the role of existing knowledge in the encoding and retrieval of new episodic information. The importance of prior knowledge in memory is demonstrated in the congruency effect-the robust finding wherein participants display better memory for items that are compatible, rather than incompatible, with their pre-existing semantic knowledge. Despite its robustness, the mechanism underlying this effect is not well understood. In four studies, we provide evidence that demonstrates the privileged explanatory power of the elaboration-integration account over alternative hypotheses. Furthermore, we question the implicit assumption that the congruency effect pertains to the truthfulness/sensibility of a subject-predicate proposition, and show that congruency is a function of semantic relatedness between item and context words.	[Bein, Oded; Livneh, Neta; Reggev, Niv; Maril, Anat] Hebrew Univ Jerusalem, Dept Cognit Sci, Jerusalem, Israel; [Maril, Anat] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [Gilead, Michael; Goshen-Gottstein, Yonatan] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University	Maril, A (corresponding author), Hebrew Univ Jerusalem, Dept Cognit Sci, Jerusalem, Israel.	anat.maril@mail.huji.ac.il	gilead, michael/GMW-9288-2022; Reggev, Niv/F-5284-2010	Reggev, Niv/0000-0002-5734-7457; Bein, Oded/0000-0003-0522-4217	Israel Science Foundation [350/10]	Israel Science Foundation(Israel Science Foundation)	This work was supported by The Israel Science Foundation (grant No. 350/10 to A.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBA JW, 1983, PSYCHOL BULL, V93, P203, DOI 10.1037/0033-2909.93.2.203; Alberca-Reina E, 2014, NEUROBIOL LEARN MEM, V110, P27, DOI 10.1016/j.nlm.2014.01.012; Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; ANDERSON JR, 1983, J VERB LEARN VERB BE, V22, P261, DOI 10.1016/S0022-5371(83)90201-3; ANDERSON JR, 1974, COGNITIVE PSYCHOL, V6, P451, DOI 10.1016/0010-0285(74)90021-8; Atienza M, 2011, J COGNITIVE NEUROSCI, V23, P75, DOI 10.1162/jocn.2009.21358; BAKER L, 1977, MEM COGNITION, V5, P151, DOI 10.3758/BF03209207; Biederman I, 2006, AM SCI, V94, P247, DOI 10.1511/2006.3.247; BRANSFORD JD, 1972, J VERB LEARN VERB BE, V11, P717, DOI 10.1016/S0022-5371(72)80006-9; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Craik F. I. M., 1979, PERSPECTIVES MEMORY, P145; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; De Houwer J, 2009, LEARN BEHAV, V37, P1, DOI 10.3758/LB.37.1.1; DEGRAEF P, 1990, PSYCHOL RES-PSYCH FO, V52, P317, DOI 10.1007/BF00868064; DeWitt MR, 2012, PSYCHON B REV, V19, P251, DOI 10.3758/s13423-011-0196-4; EPSTEIN ML, 1975, J EXP PSYCHOL-HUM L, V104, P149; FISHER RP, 1980, MEM COGNITION, V8, P400, DOI 10.3758/BF03211136; Frost R., 2005, WORD FREQUENCY DATAB; Ghosh VE, 2014, NEUROPSYCHOLOGIA, V53, P104, DOI 10.1016/j.neuropsychologia.2013.11.010; Glisky EL, 2001, J EXP PSYCHOL LEARN, V27, P1131, DOI 10.1037//0278-7393.27.5.1131; GOSHENGOTTSTEIN Y, 1995, J EXP PSYCHOL LEARN, V21, P1229, DOI 10.1037/0278-7393.21.5.1229; Greve A, 2014, NEUROPSYCHOLOGIA, V60, P52, DOI 10.1016/j.neuropsychologia.2014.05.011; HALL DM, 1980, J EXP PSYCHOL-HUM L, V6, P778; HASHTROUDI S, 1983, MEM COGNITION, V11, P476, DOI 10.3758/BF03196984; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; JOHNSONLAIRD PN, 1978, MEM COGNITION, V6, P372, DOI 10.3758/BF03197468; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kormi-Nouri R, 2005, SCAND J PSYCHOL, V46, P133, DOI 10.1111/j.1467-9450.2005.00443.x; Kumaran D, 2009, NEURON, V63, P889, DOI 10.1016/j.neuron.2009.07.030; Long DL, 2002, J EXP PSYCHOL LEARN, V28, P1073, DOI 10.1037//0278-7393.28.6.1073; Maril A, 2011, NEUROPSYCHOLOGIA, V49, P3036, DOI 10.1016/j.neuropsychologia.2011.07.004; MATHEWS RC, 1981, J GEN PSYCHOL, V105, P311, DOI 10.1080/00221309.1981.9921084; McClelland JL, 2013, J EXP PSYCHOL GEN, V142, P1190, DOI 10.1037/a0033812; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCDANIEL MA, 1986, J EXP PSYCHOL LEARN, V12, P54, DOI 10.1037/0278-7393.12.1.54; Medin D. L., 2005, CAMBRIDGE HDB THINKI, V137, P37, DOI 10.1093/oxfordhb/9780199734689.013.0011; Mickes L, 2013, J MEM LANG, V68, P333, DOI 10.1016/j.jml.2013.01.001; MORRIS CD, 1978, MEM COGNITION, V6, P354, DOI 10.3758/BF03197466; MOSCOVITCH M, 1976, J VERB LEARN VERB BE, V15, P447, DOI 10.1016/S0022-5371(76)90040-2; Mudrik L, 2011, PSYCHOL SCI, V22, P764, DOI 10.1177/0956797611408736; Naghavi HR, 2011, NEUROSCI LETT, V505, P191, DOI 10.1016/j.neulet.2011.10.022; Nelson DL, 1998, PSYCHOL REV, V105, P299, DOI 10.1037/0033-295X.105.2.299; Poppenk J, 2010, J EXP PSYCHOL LEARN, V36, P1321, DOI 10.1037/a0019900; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Reder LM, 2013, PSYCHOL SCI, V24, P363, DOI 10.1177/0956797612457396; Reder LM, 2007, PSYCHOL LEARN MOTIV, V48, P271, DOI 10.1016/S0079-7421(07)48007-0; Riefer DM, 1998, PSYCHON B REV, V5, P312, DOI 10.3758/BF03212957; ROEDIGER HL, 1990, AM PSYCHOL, V45, P1043, DOI 10.1037/0003-066X.45.9.1043; SCHACTER DL, 1986, J EXP PSYCHOL LEARN, V12, P432, DOI 10.1037/0278-7393.12.3.432; SCHULMAN AI, 1974, MEM COGNITION, V2, P47, DOI 10.3758/BF03197491; Silberman Y, 2007, COGNITIVE SCI, V31, P645, DOI 10.1080/15326900701399921; Staresina BP, 2009, CEREB CORTEX, V19, P1198, DOI 10.1093/cercor/bhn165; Taylor JR, 2012, NEUROPSYCHOLOGIA, V50, P3027, DOI 10.1016/j.neuropsychologia.2012.07.029; THOMSON DM, 1972, J VERB LEARN VERB BE, V11, P497, DOI 10.1016/S0022-5371(72)80033-1; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; TULVING E, 1989, AM SCI, V77, P361; TULVING E, 1995, PSYCHON B REV, V2, P387, DOI 10.3758/BF03210977; Underwood G, 2008, CONSCIOUS COGN, V17, P159, DOI 10.1016/j.concog.2006.11.008; van Kesteren MTR, 2013, NEUROPSYCHOLOGIA, V51, P2352, DOI 10.1016/j.neuropsychologia.2013.05.027; van Kesteren MTR, 2012, TRENDS NEUROSCI, V35, P211, DOI 10.1016/j.tins.2012.02.001; van Kesteren MTR, 2010, J NEUROSCI, V30, P15888, DOI 10.1523/JNEUROSCI.2674-10.2010; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; Wixted JT, 2013, PERSPECT PSYCHOL SCI, V8, P104, DOI 10.1177/1745691612469022; Yonelinas AP, 2010, HIPPOCAMPUS, V20, P1178, DOI 10.1002/hipo.20864; Yonelinas AP, 1998, NEUROPSYCHOLOGY, V12, P323, DOI 10.1037/0894-4105.12.3.323; Zeithamova D, 2012, NEURON, V75, P168, DOI 10.1016/j.neuron.2012.05.010	67	38	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115624	10.1371/journal.pone.0115624	http://dx.doi.org/10.1371/journal.pone.0115624			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695759	Green Submitted, Green Published, gold			2022-12-27	WOS:000350062300006
J	Rugman-Jones, PF; Seybold, SJ; Graves, AD; Stouthamer, R				Rugman-Jones, Paul F.; Seybold, Steven J.; Graves, Andrew D.; Stouthamer, Richard			Phylogeography of the Walnut Twig Beetle, Pityophthorus juglandis, the Vector of Thousand Cankers Disease in North American Walnut Trees	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; THYSANOPTERA THRIPIDAE; POPULATION-GENETICS; MAXIMUM-LIKELIHOOD; FUNGUS SYMBIOSES; BARK; COLEOPTERA; GEOSMITHIA; INSECTS; ASSOCIATIONS	Thousand cankers disease (TCD) of walnut trees (Juglans spp.) results from aggressive feeding in the phloem by the walnut twig beetle (WTB), Pityophthorus juglandis, accompanied by inoculation of its galleries with a pathogenic fungus, Geosmithia morbida. In 1960, WTB was only known from four U.S. counties (in Arizona, California, and New Mexico), but the species has now (2014) invaded over 115 counties, representing much of the western USA, and at least six states in the eastern USA. The eastern expansion places TCD in direct proximity to highly valuable (> $500 billion) native timber stands of eastern black walnut, Juglans nigra. Using mitochondrial DNA sequences, from nearly 1100 individuals, we examined variation among 77 samples of WTB populations across its extended range in the USA, revealing high levels of polymorphism and evidence of two divergent lineages. The highest level of genetic diversity for the different lineages was found in the neighboring Madrean Sky Island and Western New Mexico regions, respectively. Despite their proximity, there was little evidence of mixing between these regions, with only a single migrant detected among 179 beetles tested. Indeed, geographic overlap of the two lineages was only common in parts of Colorado and Utah. Just two haplotypes, from the same lineage, predominated over the vast majority of the recently expanded range. Tests for Wolbachia proved negative suggesting it plays no role in "driving" the spread of particular haplotypes, or in maintaining deep levels of intraspecific divergence in WTB. Genotyping of ribosomal RNA corroborated the mitochondrial lineages, but also revealed evidence of hybridization between them. Hybridization was particularly prevalent in the sympatric areas, also apparent in all invaded areas, but absent from the most haplotype-rich area of each mitochondrial lineage. Hypotheses about the specific status of WTB, its recent expansion, and potential evolutionary origins of TCD are discussed.	[Rugman-Jones, Paul F.; Stouthamer, Richard] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Seybold, Steven J.] USDA, Forest Serv, Pacific Southwest Res Stn, Davis, CA USA; [Graves, Andrew D.] USDA, Forest Serv, Forest Hlth Protect, Albuquerque, NM USA	University of California System; University of California Riverside; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Rugman-Jones, PF (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	paul.rugman-jones@ucr.edu			USDA Forest Service; Pacific Southwest Research Station; USDA Forest Service, Washington Office Forest Health Protection; USDA APHIS CPHST [10-CA-11272172-058]	USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Pacific Southwest Research Station; USDA Forest Service, Washington Office Forest Health Protection; USDA APHIS CPHST	Funding for this work was provided by the USDA Forest Service, Pacific Southwest Research Station, and by grants from the USDA Forest Service, Washington Office Forest Health Protection and USDA APHIS CPHST administered by Mary Louise Flint through cooperative agreement #10-CA-11272172-058 between the USDA FS PSW Station and the UC-Riverside Department of Entomology. The authors are especially grateful to Bruce Moltzan for facilitating the funding from the USDA FS and to David Lance for facilitating the funding from USDA APHIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arthofer W, 2009, ENVIRON MICROBIOL, V11, P1923, DOI 10.1111/j.1462-2920.2009.01914.x; ATKINSON TH, 1993, FLA ENTOMOL, V76, P608, DOI 10.2307/3495794; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bright D. E., 2014, Insecta Mundi, P1; BRIGHT DE, 1985, GREAT BASIN NAT, V45, P476; Bright DE, 1981, MEMOIRS ENTOMOLOGICA, V118; Campbell B., 2000, P59; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; Carolin V.M., 1977, MISCELLANEOUS PUBLIC, P1; CDFA, 2014, CAL AGR STAT REV 201, DOI 10.1016/j.jad; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Cranshaw W, 2008, PEST ALERT WALNUT TW; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dowton M, 2004, GENETICS, V167, P1027, DOI 10.1534/genetics.103.024885; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flint ML, 2010, CAPCA ADVISOR MAGAZI, V8, P36; Forgan AH, 2007, PHYTOPATHOLOGY, V97, P650, DOI 10.1094/PHYTO-97-5-0650; Graves AD, 2011, MONITORING WALNUT HL; Graves AD, 2009, UC IPM WEBSITE PUBLI; Graves AD, 2010, 1000 CANKERS DIS WAL; Griffin JR, 1972, PSW82 USDA FOR SERV; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson RR, 2000, GENETICS, V155, P2011; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jordal BH, 2014, MOL ECOL RESOUR, V14, P7, DOI 10.1111/1755-0998.12150; Kolarik M, 2011, MYCOLOGIA, V103, P325, DOI 10.3852/10-124; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu M, 2011, ECOLOGY, V92, P2013, DOI 10.1890/11-0687.1; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; Montecchio L, 2014, PLANT DIS, V98, P696, DOI 10.1094/PDIS-10-13-1027-PDN; Newton L, 2009, PATHWAY ASSESSMENT G, V1; Ogawa H, 1997, MYCOLOGIA, V89, P756, DOI 10.2307/3761132; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rugman-Jones PF, 2012, B ENTOMOL RES, V102, P698, DOI 10.1017/S0007485312000302; Rugman-Jones PF, 2010, J ECON ENTOMOL, V103, P877, DOI 10.1603/EC09300; Seybold SJ, 2013, U.S Patent Publication, Patent No. [2013/0014428 A1, 20130014428]; Seybold SJ, 2013, DETECTING IDENTIFYIN; Seybold SJ, 2013, NAPR0210 USDA FOR SE; Seybold SJ, 2010, USDA FOR SERV N RES, V75, P55; Seybold SJ, 2012, PAN-PAC ENTOMOL, V88, P277, DOI 10.3956/2012-32.1; Shao RF, 2003, MOL BIOL EVOL, V20, P1612, DOI 10.1093/molbev/msg176; Simoes PM, 2011, MOL ECOL RESOUR, V11, P567, DOI 10.1111/j.1755-0998.2010.02955.x; Six DL, 2013, J CHEM ECOL, V39, P989, DOI 10.1007/s10886-013-0318-8; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1992, GENETICS, V132, P619; Tisserat N., 2011, Plant Health Progress, pPHP; Tisserat N, 2009, PHYTOPATHOLOGY, V99, pS128; Turcotte RM, 2013, ENTOMOL NEWS, V123, P311, DOI 10.3157/021.123.0404; USDA Forest Service, 2002, SW REG FOR FOR HLTH; Utley C, 2013, PLANT DIS, V97, P601, DOI 10.1094/PDIS-07-12-0636-RE; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Wiggins GJ, 2014, FORESTS, V5, P1185, DOI 10.3390/f5061185; Wingfield Michael J., 2010, New Zealand Journal of Forestry Science, V40, pS95; Wood SL, 1992, GREAT BASIN NAT, V13, P1005; Wood SL, 2007, BARK AMBROSIA BEETLE, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Zerillo MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112847	70	35	38	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118264	10.1371/journal.pone.0118264	http://dx.doi.org/10.1371/journal.pone.0118264			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695760	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300046
J	West, AM; Kumar, S; Wakie, T; Brown, CS; Stohlgren, TJ; Laituri, M; Bromberg, J				West, Amanda M.; Kumar, Sunil; Wakie, Tewodros; Brown, Cynthia S.; Stohlgren, Thomas J.; Laituri, Melinda; Bromberg, Jim			Using High-Resolution Future Climate Scenarios to Forecast Bromus tectorum Invasion in Rocky Mountain National Park	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; SAMPLE-SIZE; DISTRIBUTIONS; PERFORMANCE; HABITAT; SCALE; PREDICTIONS; EVOLUTION; ELEVATION; VARIABLES	National Parks are hallmarks of ecosystem preservation in the United States. The introduction of alien invasive plant species threatens protection of these areas. Bromus tectorum L. (commonly called downy brome or cheatgrass), which is found in Rocky Mountain National Park (hereafter, the Park), Colorado, USA, has been implicated in early spring competition with native grasses, decreased soil nitrogen, altered nutrient and hydrologic regimes, and increased fire intensity. We estimated the potential distribution of Bromus tectorum in the Park based on occurrence records (n = 211), current and future climate, and distance to roads and trails. An ensemble of six future climate scenarios indicated the habitable area of Bromus tectorum may increase from approximately 5.5% currently to 20.4% of the Park by the year 2050. Using ordination methods we evaluated the climatic space occupied by Bromus tectorum in the Park and how this space may shift given future climate change. Modeling climate change at a small extent (1,076 km2) and at a fine spatial resolution (90 m) is a novel approach in species distribution modeling, and may provide inference for microclimates not captured in coarse-scale models. Maps from our models serve as high-resolution hypotheses that can be improved over time by land managers to set priorities for surveys and removal of invasive species such as Bromus tectorum.	[West, Amanda M.; Kumar, Sunil; Wakie, Tewodros; Stohlgren, Thomas J.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [West, Amanda M.; Brown, Cynthia S.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [West, Amanda M.; Kumar, Sunil; Wakie, Tewodros; Brown, Cynthia S.; Laituri, Melinda] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Laituri, Melinda] Colorado State Univ, Dept Ecosystem Sci & Sustainabil, Ft Collins, CO 80523 USA; [Laituri, Melinda] Rocky Mt Natl Pk, Estes Pk, CO USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University	West, AM (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	amanda.west@colostate.edu	Kumar, Sunil/A-6730-2009	West, Amanda/0000-0002-9318-7139; Brown, Cynthia/0000-0001-8486-7119	National Institute of Food and Agriculture, U.S. Department of Agriculture [2010-03280]; Rocky Mountain Club Foundation Fellowship	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Rocky Mountain Club Foundation Fellowship	AW and TW received funding from the National Institute of Food and Agriculture, U.S. Department of Agriculture (Award No. -2010-03280), http://www.csrees.usda.gov/fo/nationalneedsgraduatefellowships.cfm. AW received funding from Rocky Mountain Club Foundation Fellowship (no award #), http://www.cmc.org/About/CMCFoundation.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; [Anonymous], [No title captured]; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Ashcroft MB, 2009, GLOBAL CHANGE BIOL, V15, P656, DOI 10.1111/j.1365-2486.2008.01762.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Ball DA, 2004, WEED SCI, V52, P518, DOI 10.1614/WS-03-067; Banks ER, 2011, NAT AREA J, V31, P377, DOI 10.3375/043.031.0408; Bradford JB, 2006, J VEG SCI, V17, P693, DOI 10.1111/j.1654-1103.2006.tb02493.x; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P196, DOI 10.1111/j.1365-2486.2008.01709.x; Bremond L, 2012, GLOBAL CHANGE BIOL, V18, P2324, DOI 10.1111/j.1365-2486.2012.02690.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Bromberg JE, 2011, INVAS PLANT SCI MANA, V4, P173, DOI 10.1614/IPSM-D-10-00022.1; Clements DR, 2011, WEED RES, V51, P227, DOI 10.1111/j.1365-3180.2011.00850.x; Compagnoni A, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00047.1; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ellstrand NC, 2006, EUPHYTICA, V148, P35, DOI 10.1007/s10681-006-5939-3; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Flory AR, 2012, J APPL ECOL, V49, P680, DOI 10.1111/j.1365-2664.2012.02129.x; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Gillingham PK, 2012, DIVERS DISTRIB, V18, P990, DOI 10.1111/j.1472-4642.2012.00933.x; Gillingham PK, 2012, ECOGRAPHY, V35, P831, DOI 10.1111/j.1600-0587.2011.07434.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jarnevich CS, 2009, BIOL INVASIONS, V11, P1373, DOI 10.1007/s10530-008-9345-8; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Leger EA, 2009, MOL ECOL, V18, P4366, DOI 10.1111/j.1365-294X.2009.04357.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Miller ME, 2006, PLANT SOIL, V288, P1, DOI 10.1007/s11104-006-0058-4; NOVAK SJ, 1993, CAN J BOT, V71, P1441, DOI 10.1139/b93-174; Paruelo JM, 1996, ECOL APPL, V6, P1212, DOI 10.2307/2269602; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2007, SYNTH AM MUS NAT HIS, V50; Pederson GT, 2013, GEOPHYS RES LETT, V40, P1811, DOI 10.1002/grl.50424; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Shabani F, 2014, AGR ECOSYST ENVIRON, V197, P96, DOI 10.1016/j.agee.2014.08.005; Shabani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048021; Sheppard CS, 2013, WEED RES, V53, P259, DOI 10.1111/wre.12021; Stanton JC, 2012, METHODS ECOL EVOL, V3, P349, DOI 10.1111/j.2041-210X.2011.00157.x; STOHLGREN TJ, 1995, VEGETATIO, V117, P113, DOI 10.1007/BF00045503; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Upadhyaya, 1986, CAN J PLANT SCI, V66, P689; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zelikova TJ, 2013, ECOL EVOL, V3, P1374, DOI 10.1002/ece3.542	64	29	32	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117893	10.1371/journal.pone.0117893	http://dx.doi.org/10.1371/journal.pone.0117893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695255	Green Published, gold			2022-12-27	WOS:000350062300033
J	Dryden-Peterson, S; Bennett, K; Hughes, MD; Veres, A; John, O; Pradhananga, R; Boyer, M; Brown, C; Sakyi, B; van Widenfelt, E; Keapoletswe, K; Mine, M; Moyo, S; Asmelash, A; Siedner, M; Mmalane, M; Shapiro, RL; Lockman, S				Dryden-Peterson, Scott; Bennett, Kara; Hughes, Michael D.; Veres, Adrian; John, Oaitse; Pradhananga, Rosina; Boyer, Matthew; Brown, Carolyn; Sakyi, Bright; van Widenfelt, Erik; Keapoletswe, Koona; Mine, Madisa; Moyo, Sikhulile; Asmelash, Aida; Siedner, Mark; Mmalane, Mompati; Shapiro, Roger L.; Lockman, Shahin			An Augmented SMS Intervention to Improve Access to Antenatal CD4 Testing and ART Initiation in HIV-Infected Pregnant Women: A Cluster Randomized Trial	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TO-CHILD TRANSMISSION; CARE; OUTCOMES; DECENTRALIZATION; PREVENTION	Background Less than one-third of HIV-infected pregnant women eligible for combination antiretroviral therapy (ART) globally initiate treatment prior to delivery, with lack of access to timely CD4 results being a principal barrier. We evaluated the effectiveness of an SMS-based intervention to improve access to timely antenatal ART. Methods We conducted a stepped-wedge cluster randomized trial of a low-cost programmatic intervention in 20 antenatal clinics in Gaborone, Botswana. From July 2011-April 2012, 2 clinics were randomly selected every 4 weeks to receive an ongoing clinic-based educational intervention to improve CD4 collection and to receive CD4 results via an automated SMS platform with active patient tracing. CD4 testing before 26 weeks gestation and ART initiation before 30 weeks gestation were assessed. Results Three-hundred-sixty-six ART-naive women were included, 189 registering for antenatal care under Intervention and 177 under Usual Care periods. Of CD4-eligible women, 100 (59.2%) women under Intervention and 79 (50.6%) women under Usual Care completed CD4 phlebotomy before 26 weeks gestation, adjusted odds ratio (aOR, adjusted for time that a clinic initiated Intervention) 0.87 (95% confidence interval [CI]0.47-1.63, P = 0.67). The SMS-based platform reduced time to clinic receipt of CD4 test result from median of 16 to 6 days (P<0.001), was appreciated by clinic staff, and was associated with reduced operational cost. However, rates of ART initiation remained low, with 56 (36.4%) women registering under Intervention versus 37 (24.2%) women under Usual Care initiating ART prior to 30 weeks gestation, aOR 1.06 (95% CI 0.53-2.13, P = 0.87). Conclusions The augmented SMS-based intervention delivered CD4 results more rapidly and efficiently, and this type of SMS- based results delivery platform may be useful for a variety of tests and settings. However, the intervention did not appear to improve access to timely antenatal CD4 testing or ART initiation, as obstacles other than CD4 impeded ART initiation during pregnancy.	[Dryden-Peterson, Scott; Siedner, Mark; Lockman, Shahin] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Dryden-Peterson, Scott; John, Oaitse; van Widenfelt, Erik; Asmelash, Aida; Mmalane, Mompati; Shapiro, Roger L.; Lockman, Shahin] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Dryden-Peterson, Scott; Shapiro, Roger L.; Lockman, Shahin] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Dryden-Peterson, Scott; Veres, Adrian; Siedner, Mark; Shapiro, Roger L.; Lockman, Shahin] Harvard Univ, Sch Med, Boston, MA USA; [Bennett, Kara] Bennett Stat Consulting Inc, New York, NY USA; [Hughes, Michael D.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Pradhananga, Rosina] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Boyer, Matthew] Marshall Univ, Joan C Edwards Sch Med, Huntington, WV USA; [Brown, Carolyn] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Sakyi, Bright; Keapoletswe, Koona; Mine, Madisa] Minist Hlth, Gaborone, Botswana; [Shapiro, Roger L.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Marshall University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Beth Israel Deaconess Medical Center	Dryden-Peterson, S (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	scott_peterson@post.harvard.edu	Moyo, Sikhulile/E-1464-2015	Moyo, Sikhulile/0000-0003-3821-4592; Veres, Adrian/0000-0002-3849-3475; Dryden-Peterson, Scott/0000-0002-8487-9731	National Institutes of Health [3R01HD044391-06S1, K23AI091434]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI091434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH099916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (3R01HD044391-06S1, K23AI091434). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Belzer ME, 2014, AIDS BEHAV, V18, P686, DOI 10.1007/s10461-013-0661-3; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Botswana Ministry of Health, 2012, 2012 BOTSW NAT HIV A, DOI [10.1016/j.mjafi.2012.08.017, DOI 10.1016/J.MJAFI.2012.08.017]; Botswana Ministry of Health, 2011, PREV MOTH TO CHILD T, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Botswana Ministry of Health, 2008, BOTSW 2008 NAT HIV A; Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Caldwell A, 2011, IEEE PULSE, V2, P63, DOI 10.1109/MPUL.2011.941459; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Chen JY, 2010, JAIDS-J ACQ IMM DEF, V54, P102, DOI 10.1097/QAI.0b013e3181c080bf; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Dorenbaum A, 2002, JAMA-J AM MED ASSOC, V288, P189, DOI 10.1001/jama.288.2.189; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Gaolathe T, 2008, 4 IAS C HIV TREATM P; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Interagency Task Team World Health Organization UNICEF, 2013, EXP SIMPL TREATM PRE, DOI [10.1016/j.mgene.2013.11.003, DOI 10.1016/J.MGENE.2013.11.003]; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Killam WP, 2010, AIDS, V24, P85, DOI 10.1097/QAD.0b013e32833298be; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Kuhn L, 2010, AIDS, V24, P1374, DOI 10.1097/QAD.0b013e3283394f5b; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rodrigues R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040723; Seidenberg P, 2012, B WORLD HEALTH ORGAN, V90, P348, DOI 10.2471/BLT.11.100032; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Siedner MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039894; Sterling TR, 2003, J INFECT DIS, V188, P1659, DOI 10.1086/379741; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; van der Merwe K, 2006, JAIDS-J ACQ IMM DEF, V43, P577; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Whittaker R, 2012, J HEALTH COMMUN, V17, P11, DOI 10.1080/10810730.2011.649103; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; World Health Organization, 2011, MHEALTH NEW HOR HLTH, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; World Health Organization, 2013, CONS GUID US ANT DRU, DOI [10.1016/j.mgene.2013.11.003, DOI 10.1016/J.MGENE.2013.11.003]	44	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117181	10.1371/journal.pone.0117181	http://dx.doi.org/10.1371/journal.pone.0117181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693050	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500041
J	Zhang, FQ; Wang, JP; Kim, J; Parrish, T; Wong, PCM				Zhang, Fengqing; Wang, Ji-Ping; Kim, Jieun; Parrish, Todd; Wong, Patrick C. M.			Decoding Multiple Sound Categories in the Human Temporal Cortex Using High Resolution fMRI	PLOS ONE			English	Article							MULTIVARIATE-ANALYSIS; PATTERN-ANALYSIS; GENE SELECTION; NATURAL IMAGES; CLASSIFICATION; REPRESENTATION; SIMILARITY; SPEECH	Perception of sound categories is an important aspect of auditory perception. The extent to which the brain's representation of sound categories is encoded in specialized subregions or distributed across the auditory cortex remains unclear. Recent studies using multivariate pattern analysis (MVPA) of brain activations have provided important insights into how the brain decodes perceptual information. In the large existing literature on brain decoding using MVPA methods, relatively few studies have been conducted on multi-class categorization in the auditory domain. Here, we investigated the representation and processing of auditory categories within the human temporal cortex using high resolution fMRI and MVPA methods. More importantly, we considered decoding multiple sound categories simultaneously through multi-class support vector machine-recursive feature elimination (MSVM-RFE) as our MVPA tool. Results show that for all classifications the model MSVM-RFE was able to learn the functional relation between the multiple sound categories and the corresponding evoked spatial patterns and classify the unlabeled sound-evoked patterns significantly above chance. This indicates the feasibility of decoding multiple sound categories not only within but across subjects. However, the across-subject variation affects classification performance more than the within-subject variation, as the across-subject analysis has significantly lower classification accuracies. Sound category-selective brain maps were identified based on multi-class classification and revealed distributed patterns of brain activity in the superior temporal gyrus and the middle temporal gyrus. This is in accordance with previous studies, indicating that information in the spatially distributed patterns may reflect a more abstract perceptual level of representation of sound categories. Further, we show that the across-subject classification performance can be significantly improved by averaging the fMRI images over items, because the irrelevant variations between different items of the same sound category are reduced and in turn the proportion of signals relevant to sound categorization increases.	[Zhang, Fengqing; Wang, Ji-Ping] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [Zhang, Fengqing] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; [Kim, Jieun; Wong, Patrick C. M.] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; [Parrish, Todd] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Wong, Patrick C. M.] Chinese Univ Hong Kong, Dept Linguist & Modern Languages, Shatin, Hong Kong, Peoples R China; [Wong, Patrick C. M.] Northwestern Univ, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA	Northwestern University; Drexel University; Northwestern University; Northwestern University; Feinberg School of Medicine; Chinese University of Hong Kong; Northwestern University	Wong, PCM (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	pwong@northwestern.edu		Wong, Patrick/0000-0002-6105-5027; Parrish, Todd/0000-0002-1184-1572	National Science Foundation [BCS-1125144]; National Institutes of Health [R01DC008333]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008333] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors would like to acknowledge the financial support of grants from the National Science Foundation (BCS-1125144) and the National Institutes of Health (R01DC008333) awarded to P.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Boersma Paul, 2002, GLOT INT, V5, P341; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; Clithero JA, 2011, NEUROIMAGE, V56, P699, DOI 10.1016/j.neuroimage.2010.03.057; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crammer K., 2000, P 13 ANN C COMP LEAR, P35; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Dubois D, 2006, ACTA ACUST UNITED AC, V92, P865; Etzel JA, 2011, NEUROIMAGE, V54, P1159, DOI 10.1016/j.neuroimage.2010.08.050; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Formisano E, 2008, MAGN RESON IMAGING, V26, P921, DOI 10.1016/j.mri.2008.01.052; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Gygi B, 2007, PERCEPT PSYCHOPHYS, V69, P839, DOI 10.3758/BF03193921; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Kaplan JT, 2012, NEUROIMAGE, V60, P204, DOI 10.1016/j.neuroimage.2011.12.059; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kumar S, 2012, J NEUROSCI, V32, P13348, DOI 10.1523/JNEUROSCI.3812-12.2012; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Ley A, 2012, J NEUROSCI, V32, P13273, DOI 10.1523/JNEUROSCI.0584-12.2012; McDermott JH, 2013, NAT NEUROSCI, V16, P493, DOI 10.1038/nn.3347; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Meyer K, 2010, NAT NEUROSCI, V13, P667, DOI 10.1038/nn.2533; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Raizada RDS, 2010, INT J IMAG SYST TECH, V20, P31, DOI 10.1002/ima.20225; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Shinkareva SV, 2011, NEUROIMAGE, V54, P2418, DOI 10.1016/j.neuroimage.2010.10.042; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Tice B, 1997, TONE; Tong F, 2012, ANNU REV PSYCHOL, V63, P483, DOI 10.1146/annurev-psych-120710-100412; Vapnik V., 1998, STAT LEARNING THEORY; Weil RS, 2010, CURR OPIN NEUROL, V23, P649, DOI 10.1097/WCO.0b013e32834028c7; Witten DM, 2011, J R STAT SOC B, V73, P753, DOI 10.1111/j.1467-9868.2011.00783.x; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036	40	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117303	10.1371/journal.pone.0117303	http://dx.doi.org/10.1371/journal.pone.0117303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692885	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500049
J	Martins-Bach, AB; Malheiros, J; Matot, B; Martins, PCM; Almeida, CF; Caldeira, W; Ribeiro, AF; de Sousa, PL; Azzabou, N; Tannsus, A; Carlier, PG; Vainzof, M				Martins-Bach, Aurea B.; Malheiros, Jackeline; Matot, Beatrice; Martins, Poliana C. M.; Almeida, Camila F.; Caldeira, Waldir; Ribeiro, Alberto F.; de Sousa, Paulo Loureiro; Azzabou, Noura; Tannsus, Alberto; Carlier, Pierre G.; Vainzof, Mariz			Quantitative T2 Combined with Texture Analysis of Nuclear Magnetic Resonance Images Identify Different Degrees of Muscle Involvement in Three Mouse Models of Muscle Dystrophy: mdx, Large(myd) and mdx/Large(myd)	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NEUROMUSCULAR DISEASES; SKELETAL; TISSUE; GENE; BOYS; MRI; QUANTIFICATION; CLASSIFICATION; DYSTROGLYCAN	Quantitative nuclear magnetic resonance imaging (MRI) has been considered a promising non-invasive tool for monitoring therapeutic essays in small size mouse models of muscular dystrophies. Here, we combined MRI (anatomical images and transverse relaxation time constant-T2-measurements) to texture analyses in the study of four mouse strains covering a wide range of dystrophic phenotypes. Two still unexplored mouse models of muscular dystrophies were analyzed: The severely affected Large(myd) mouse and the recently generated and worst double mutant mdx/Large(myd) mouse, as compared to the mildly affected mdx and normal mice. The results were compared to histopathological findings. MRI showed increased intermuscular fat and higher muscle T2 in the three dystrophic mouse models when compared to the wild-type mice (T2: mdx/Large(myd): 37.6 +/- 2.8 ms; mdx: 35.2 +/- 4.5 ms; Large(myd): 36.6 +/- 4.0 ms; wild-type: 29.1 +/- 1.8 ms, p<0.05), in addition to higher muscle T2 in the mdx/Large(myd) mice when compared to mdx (p<0.05). The areas with increased muscle T2 in the MRI correlated spatially with the identified histopathological alterations such as necrosis, inflammation, degeneration and regeneration foci. Nevertheless, muscle T2 values were not correlated with the severity of the phenotype in the 3 dystrophic mouse strains, since the severely affected Large(myd) showed similar values than both the mild mdx and worst mdx/Large(myd) lineages. On the other hand, all studied mouse strains could be unambiguously identified with texture analysis, which reflected the observed differences in the distribution of signals in muscle MRI. Thus, combined T2 intensity maps and texture analysis is a powerful approach for the characterization and differentiation of dystrophic muscles with diverse genotypes and phenotypes. These new findings provide important noninvasive tools in the evaluation of the efficacy of new therapies, and most importantly, can be directly applied in human translational research.	[Martins-Bach, Aurea B.; Martins, Poliana C. M.; Almeida, Camila F.; Vainzof, Mariz] Univ Sao Paulo, IB, Dept Genet & Biol Evolut, Ctr Estudos Genoma Humano, BR-09500900 Sao Paulo, SP, Brazil; [Malheiros, Jackeline; Tannsus, Alberto] Univ Sao Paulo, IFSC, Ctr Imagens & Espectroscopia In Vivo Ressonancia, BR-09500900 Sao Paulo, SP, Brazil; [Malheiros, Jackeline] Univ Fed Sao Paulo UNIFESP, Dept Fisiol, Sao Paulo, SP, Brazil; [Caldeira, Waldir; Ribeiro, Alberto F.] Univ Sao Paulo, IB, Dept Genet & Biol Evolut, Lab Microscopia Eletron, BR-09500900 Sao Paulo, SP, Brazil; [de Sousa, Paulo Loureiro] Univ Strasbourg, CNRS, ICube UMR 7357, FMTS, Strasbourg, France; [Martins-Bach, Aurea B.; Matot, Beatrice; de Sousa, Paulo Loureiro; Azzabou, Noura; Carlier, Pierre G.] Inst Myol, NMR Lab, Paris, France; [Matot, Beatrice; de Sousa, Paulo Loureiro; Azzabou, Noura; Carlier, Pierre G.] CEA, I2BM, MIRCen, NMR Lab, Paris, France	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Vainzof, M (corresponding author), Univ Sao Paulo, IB, Dept Genet & Biol Evolut, Ctr Estudos Genoma Humano, BR-09500900 Sao Paulo, SP, Brazil.	mvainzof@usp.br	Malheiros, Jackeline/F-3069-2014; Vainzof, Mariz/J-7150-2012; Ribeiro, Alberto F./E-6839-2016; Tannús, Alberto/B-9821-2012; Vainzof, Mariz/Q-4787-2019; de Freitas Almeida, Camila/L-6601-2013	Malheiros, Jackeline/0000-0001-8512-3111; Vainzof, Mariz/0000-0002-2797-0782; Tannús, Alberto/0000-0002-1675-1971; Vainzof, Mariz/0000-0002-2797-0782; de Freitas Almeida, Camila/0000-0003-2652-2205; Martins Bach, Aurea/0000-0002-7378-0867	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa; Inovacao e Difusao - FAPESP-CEPID [1998/14254-2, 2013/08028-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq-INCT [573633/2008-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Comite Francais d'Evaluation on de la Cooperation Universitaire et Scientifique avec le Bresil (CAPES-COFECUB) [725/11, 4419/11-1]; Association Francaise contre les Myopathies (AFM); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa; Inovacao e Difusao - FAPESP-CEPID; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq-INCT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Comite Francais d'Evaluation on de la Cooperation Universitaire et Scientifique avec le Bresil (CAPES-COFECUB); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Centro de Pesquisa, Inovacao e Difusao - FAPESP-CEPID, grant numbers 1998/14254-2 and 2013/08028-1 (http://cepid.fapesp.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq-INCT, grant number 573633/2008-8 (http://inct.cnpq.br/), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Comite Francais d'Evaluation on de la Cooperation Universitaire et Scientifique avec le Bresil (CAPES-COFECUB, Grant numbers 725/11 and 4419/11-1, http://www.capes.gov.br/cooperacao-internacional/franca/cofecub and http://www.campusfrance.org/fr/capes-cofecub), Association Francaise contre les Myopathies (AFM - http://www.afm-telethon.com/) and Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA - http://www.cea.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo ECA, 2014, BIOPHYS J, V106, P2267, DOI 10.1016/j.bpj.2014.04.010; Arpan I, 2013, NMR BIOMED, V26, P320, DOI 10.1002/nbm.2851; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Buckland KF, 2014, ADV DRUG DELIVER REV, V73, P162, DOI 10.1016/j.addr.2014.02.010; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Dubowitz V, 2004, NEUROMUSCULAR DISORD, V14, P451, DOI 10.1016/j.nmd.2004.06.002; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fan Z, 2014, NEUROMUSCULAR DISORD, V24, P178, DOI 10.1016/j.nmd.2013.10.005; Fischmann A, 2013, J NEUROL, V260, P969, DOI 10.1007/s00415-012-6733-x; Gaeta M, 2012, SKELETAL RADIOL, V41, P955, DOI 10.1007/s00256-011-1301-5; Gatehouse PD, 2003, CLIN RADIOL, V58, P1, DOI 10.1053/crad.2003.1157; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hsieh TJ, 2009, J COMPUT ASSIST TOMO, V33, P150, DOI 10.1097/RCT.0b013e318168f735; Kabaeva Z, 2011, HUM MOL GENET, V20, P3346, DOI 10.1093/hmg/ddr240; Kim HK, 2010, RADIOLOGY, V255, P899, DOI 10.1148/radiol.10091547; Kinali M, 2011, NEUROLOGY, V76, P346, DOI 10.1212/WNL.0b013e318208811f; Mahmoud-Ghoneim D, 2006, MAGN RESON IMAGING, V24, P167, DOI 10.1016/j.mri.2005.10.002; Marden FA, 2005, SKELETAL RADIOL, V34, P140, DOI 10.1007/s00256-004-0825-3; Martins PCM, 2013, DIS MODEL MECH, V6, P1167, DOI 10.1242/dmm.011700; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; McIntosh LM, 1998, BIOCHEM CELL BIOL, V76, P532; MUNTONI F, 1993, J NEUROL SCI, V120, P71, DOI 10.1016/0022-510X(93)90027-V; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; Nketiah G, 2014, SCAND J MED IN PRESS; Pacak CA, 2007, MOL THER, V15, P1775, DOI 10.1038/sj.mt.6300246; Papoti D, 2006, THESIS; Pratt Stephen J P, 2013, BMC Res Notes, V6, P262, DOI 10.1186/1756-0500-6-262; Quijano-Roy S, 2012, NEUROMUSCULAR DISORD, V22, pS68, DOI 10.1016/j.nmd.2012.08.003; Saab G, 1999, MAGNET RESON MED, V42, P150, DOI 10.1002/(SICI)1522-2594(199907)42:1<150::AID-MRM20>3.0.CO;2-5; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Salimena M, 2004, HISTOCHEM CELL BIOL, V122, P435, DOI 10.1007/s00418-004-0707-8; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Skoch A, 2004, MAGN RESON MATER PHY, V16, P259, DOI 10.1007/s10334-004-0032-1; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Strzelecki M, 2013, NUCL INSTRUM METH A, V702, P137, DOI 10.1016/j.nima.2012.09.006; Szczypinski PM, 2007, 2007 INTERNATIONAL SYMPOSIUM ON INFORMATION TECHNOLOGY CONVERGENCE, PROCEEDINGS, P245, DOI 10.1109/ISITC.2007.15; Szczypinski PM, 2009, COMPUT METH PROG BIO, V94, P66, DOI 10.1016/j.cmpb.2008.08.005; Tardif-de Gery S, 2000, NEUROMUSCULAR DISORD, V10, P507, DOI 10.1016/S0960-8966(00)00122-X; Torriani M, 2012, SKELETAL RADIOL, V41, P437, DOI 10.1007/s00256-011-1240-1; Tosetti M, 2011, MUSCLE NERVE, V44, P816, DOI 10.1002/mus.22181; Walter G, 2005, MAGN RESON MED, V54, P1369, DOI 10.1002/mrm.20721; Wang JH, 2013, INT J COMPUT ASS RAD, V8, P763, DOI 10.1007/s11548-012-0810-6; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; Willcocks RJ, 2014, NEUROMUSCULAR DISORD, V24, P393, DOI 10.1016/j.nmd.2013.12.012; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732	53	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117835	10.1371/journal.pone.0117835	http://dx.doi.org/10.1371/journal.pone.0117835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710816	gold, Green Published, Green Submitted			2022-12-27	WOS:000350683900041
J	Perez-Nanclares, G; Velayos, T; Vela, A; Munoz-Torres, M; Castano, L				Perez-Nanclares, Gustavo; Velayos, Teresa; Vela, Amaya; Munoz-Torres, Manuel; Castano, Luis			Pseudohypoparathyroidism Type Ib Associated with Novel Duplications in the GNAS Locus	PLOS ONE			English	Article							ALBRIGHTS HEREDITARY OSTEODYSTROPHY; IMPRINTING CONTROL ELEMENT; GS-ALPHA GENE; EPIGENETIC DEFECTS; HORMONE RESISTANCE; DELETION; MUTATIONS; A/B; DISORDERS; SUBUNIT	Context Pseudohypoparathyroidism type 1b (PHP-Ib) is characterized by renal resistance to PTH (and, sometimes, a mild resistance to TSH) and absence of any features of Albright's hereditary osteodystrophy. Patients with PHP-Ib suffer of defects in the methylation pattern of the complex GNAS locus. PHP-Ib can be either sporadic or inherited in an autosomal dominant pattern. Whereas familial PHP-Ib is well characterized at the molecular level, the genetic cause of sporadic PHP-Ib cases remains elusive, although some molecular mechanisms have been associated with this subtype. Objective The aim of the study was to investigate the molecular and imprinting defects in the GNAS locus in two unrelated patients with PHP-Ib. Design We have analyzed the GNAS locus by direct sequencing, Methylation-Specific Multiplex Ligation-dependent Probe Amplification, microsatellites, Quantitative Multiplex PCR of Short Fluorescent fragments and array-Comparative Genomic Hybridization studies in order to characterize two unrelated families with clinical features of PHP-Ib. Results We identified two duplications in the GNAS region in two patients with PHP-Ib: one of them, comprising similar to 320 kb, occurred 'de novo' in the patient, whereas the other one, of similar to 179 kb in length, was inherited from the maternal allele. In both cases, no other known genetic cause was observed. Conclusion In this article, we describe the to-our-knowledge biggest duplications reported so far in the GNAS region. Both are associated to PHP-Ib, one of them occurring 'de novo' and the other one being maternally inherited.	[Perez-Nanclares, Gustavo; Velayos, Teresa; Vela, Amaya; Castano, Luis] Univ Basque Country, CIBERDEM, CIBERER, Endocrinol & Diabet Res Grp,Hosp Univ Cruces,BioC, Baracaldo, Basque Country, Spain; [Munoz-Torres, Manuel] Hosp Univ San Cecilio, Clin Management Unit Endocrinol & Nutr, Inst Invest Biosanitaria Granada, Granada, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBERER; Hospital Universitario Cruces; University of Basque Country; Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada	Castano, L (corresponding author), Univ Basque Country, CIBERDEM, CIBERER, Endocrinol & Diabet Res Grp,Hosp Univ Cruces,BioC, Baracaldo, Basque Country, Spain.	lcastano@osakidetza.net	Torres, Manuel Muñoz/O-2330-2016	Torres, Manuel Muñoz/0000-0002-9645-3260; Perez de Nanclares, Gustavo/0000-0002-1692-8976; Castano, Luis/0000-0003-0437-9401	Basque Department of Education [IT-795-13, IT-472-07]; FPI Program of the University of Basque Country (UPVEHU)	Basque Department of Education; FPI Program of the University of Basque Country (UPVEHU)	This work was partially supported by Grants IT-795-13 and IT-472-07 from the Basque Department of Education (http://www.hezkuntza.ejgv.euskadi.net/r43-2591/es). TV is supported by the FPI Program of the University of Basque Country (UPVEHU, http://www.ehu.es/p200-home/es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright F, 1942, ENDOCRINOLOGY, V30, P922; Aldred MA, 2002, AM J MED GENET, V113, P167, DOI 10.1002/ajmg.10751; Alsum Z, 2010, GENET TEST MOL BIOMA, V14, P135, DOI 10.1089/gtmb.2009.0092; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bastepe M, 2011, BONE, V48, P659, DOI 10.1016/j.bone.2010.10.168; Begemann M, 2012, J MED GENET, V49, P547, DOI 10.1136/jmedgenet-2012-100967; Cai GQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-50; Chillambhi S, 2010, J CLIN ENDOCR METAB, V95, P3993, DOI 10.1210/jc.2009-2205; de Nanclares GP, 2007, J CLIN ENDOCR METAB, V92, P2370, DOI 10.1210/jc.2006-2287; Elli FM, 2014, J CLIN ENDOCR METAB, V99, pE724, DOI 10.1210/jc.2013-3704; Fernandez-Rebollo E, 2008, CLIN ENDOCRINOL, V69, P705, DOI 10.1111/j.1365-2265.2008.03255.x; Fernandez-Rebollo E, 2011, J BONE MINER RES, V26, P1854, DOI 10.1002/jbmr.408; Fernandez-Rebollo E, 2010, J CLIN ENDOCR METAB, V95, P765, DOI 10.1210/jc.2009-1581; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; Kunishima S, 2009, BLOOD, V113, P458, DOI 10.1182/blood-2008-06-162610; Linglart A, 2005, AM J HUM GENET, V76, P804, DOI 10.1086/429932; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Mantovani G, 2012, HORM METAB RES, V44, P716, DOI 10.1055/s-0032-1314842; Mantovani G, 2013, EUR J HUM GENET, V21, DOI 10.1038/ejhg.2012.211; Mantovani G, 2011, J CLIN ENDOCR METAB, V96, P3020, DOI 10.1210/jc.2011-1048; Mantovani G, 2010, J CLIN ENDOCR METAB, V95, P651, DOI 10.1210/jc.2009-0176; Mariot V, 2008, J CLIN ENDOCR METAB, V93, P661, DOI 10.1210/jc.2007-0927; Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254; Ouchida M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044095; Richard N, 2012, J CLIN ENDOCR METAB, V97, pE863, DOI 10.1210/jc.2011-2804; Robson JE, 2012, RNA, V18, P135, DOI 10.1261/rna.029561.111; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Spiegel AM, 1999, J PEDIATR ENDOCR MET, V12, P303; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024967; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; WILSON LC, 1994, J MED GENET, V31, P835, DOI 10.1136/jmg.31.11.835; WINTER JSD, 1980, CAN MED ASSOC J, V123, P26; Zazo C, 2011, J BONE MINER RES, V26, P1864, DOI 10.1002/jbmr.369	35	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117691	10.1371/journal.pone.0117691	http://dx.doi.org/10.1371/journal.pone.0117691			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710380	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900035
J	Beran, MJ; Heimbauer, LA				Beran, Michael J.; Heimbauer, Lisa A.			A Longitudinal Assessment of Vocabulary Retention in Symbol-Competent Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							PROSPECTIVE MEMORY; LANGUAGE-SKILLS; SIGN-LANGUAGE; COMMUNICATION; SPEECH; DELAY; FOOD; GRATIFICATION; PERCEPTION; JUDGMENTS	A number of studies from the 1960s to 1990s assessed the symbolic competence of great apes and other animals. These studies provided varying forms of evidence that some species were capable of symbolically representing their worlds, both through productive symbol use and comprehension of symbolic stimuli. One such project at the Language Research Center involved training chimpanzees (Pan troglodytes) to use lexigram symbols (geometric visual stimuli that represented objects, actions, locations, and individuals). Those studies now are more than 40 years old, and only a few of the apes involved in those studies are still alive. Three of these chimpanzees (and a fourth, control chimpanzee) were assessed across a 10-year period from 1999 to 2008 for their continued knowledge of lexigram symbols and, in the case of one chimpanzee, the continued ability to comprehend human speech. This article describes that longitudinal assessment and outlines the degree to which symbol competence was retained by these chimpanzees across that decade-long period. All chimpanzees showed retention of lexigram vocabularies, although there were differences in the number of words that were retained across the individuals. One chimpanzee also showed continual retention of human speech perception. These retained vocabularies largely consisted of food item names, but also names of inedible objects, locations, individuals, and some actions. Many of these retained words were for things that are not common in the daily lives of the chimpanzees and for things that are rarely requested by the chimpanzees. Thus, the early experiences of these chimpanzees in symbol-rich environments have produced long-lasting memories for symbol meaning, and those competencies have benefited research in a variety of topics in comparative cognition.	[Beran, Michael J.] Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA; [Heimbauer, Lisa A.] Penn State Univ, Dept Psychol, State Coll, PA USA	University System of Georgia; Georgia State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Beran, MJ (corresponding author), Georgia State Univ, Language Res Ctr, Univ Plaza, Atlanta, GA 30303 USA.	mjberan@yahoo.com	Beran, Michael J./ABY-1786-2022; Beran, Michael J./M-8743-2016	Beran, Michael J./0000-0002-2504-0338; Beran, Michael J./0000-0002-2504-0338	National Institutes of Child Health and Human Development [HD-06016, HD-38051, HD-060563]; College of Arts and Sciences at Georgia State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD060563] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038051] Funding Source: NIH RePORTER	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); College of Arts and Sciences at Georgia State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for this research project, and for care of the chimpanzees throughout the project, was provided by the National Institutes of Child Health and Human Development through grants HD-06016, HD-38051, and HD-060563, as well as from the College of Arts and Sciences at Georgia State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, [No title captured]; Bard KA, 2014, ANNU REV ANTHROPOL, V43, P183, DOI 10.1146/annurev-anthro-102313-030223; Beran MJ, 2007, J GEN PSYCHOL, V134, P217, DOI 10.3200/GENP.134.2.217-228; Beran MJ, 2014, ANIM COGN, V17, P197, DOI 10.1007/s10071-013-0652-9; Beran MJ, 2013, PSYCHOL SCI, V24, P660, DOI 10.1177/0956797612458936; Beran MJ, 2012, LEARN MOTIV, V43, P192, DOI 10.1016/j.lmot.2012.05.002; Beran MJ, 2012, AM J PRIMATOL, V74, P864, DOI 10.1002/ajp.22042; Beran MJ, 2012, J EXP PSYCHOL-ANIM B, V38, P23, DOI 10.1037/a0024965; Beran MJ, 2011, ANIM COGN, V14, P637, DOI 10.1007/s10071-011-0398-1; Beran MJ, 2010, BEHAV PROCESS, V83, P287, DOI 10.1016/j.beproc.2010.01.009; Beran MJ, 1999, DEV PSYCHOBIOL, V34, P119, DOI 10.1002/(SICI)1098-2302(199903)34:2<119::AID-DEV5>3.0.CO;2-P; Beran MJ, 2000, ANIM LEARN BEHAV, V28, P201, DOI 10.3758/BF03200255; Beran MJ, 2004, PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2004.01502004.x; Beran MJ, 2002, J EXP ANAL BEHAV, V78, P497, DOI 10.1901/jeab.2002.78-497; Beran MJ., 2001, ANIM COGN, V4, P81, DOI DOI 10.1007/S100710100098; Beran MJ, 1998, EVOLUTION COMMUNICAT, V2, P171; Bodamer MD, 2002, J COMP PSYCHOL, V116, P12, DOI 10.1037//0735-7036.116.1.12; Brakke KE, 1996, LANG COMMUN, V16, P361, DOI 10.1016/S0271-5309(96)00018-3; BRAKKE KE, 1995, LANG COMMUN, V15, P121, DOI 10.1016/0271-5309(95)00001-7; Brosnan SF, 2009, J COMP PSYCHOL, V123, P181, DOI 10.1037/a0015092; CORKIN S, 1984, SEMIN NEUROL, V4, P249, DOI 10.1055/s-2008-1041556; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Flemming TM, 2008, J COMP PSYCHOL, V122, P176, DOI 10.1037/0735-7036.122.2.176; Fragaszy DM, 2009, ANIM COGN, V12, P491, DOI 10.1007/s10071-008-0210-z; GARDNER BT, 1975, J EXP PSYCHOL GEN, V104, P244, DOI 10.1037/0096-3445.104.3.244; GARDNER BT, 1971, BEHAVIOR NONHUMAN PR, V4, P117; GARDNER BT, 1974, MINNESOTA S CHILD PS, V8, P3; GARDNER RA, 1969, SCIENCE, V165, P664, DOI 10.1126/science.165.3894.664; GARDNER RA, 1984, J COMP PSYCHOL, V98, P381, DOI 10.1037/0735-7036.98.4.381; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Hartmann J. Q, 2011, INT J COMP PSYCHOL, V24, P177; Hayes KJ, 1951, J COMP PHYSIOL PSYCH, V46, P470; Heimbauer LA, 2011, CURR BIOL, V21, P1210, DOI 10.1016/j.cub.2011.06.007; Jensvold MLA, 2000, J COMP PSYCHOL, V114, P335, DOI 10.1037/0735-7036.114.4.335; Kellogg W.N., 1933, APE CHILD, DOI [10.1097/00006324-193311000-00009, DOI 10.1097/00006324-193311000-00009]; KLATT DH, 1974, J ACOUST SOC AM, V55, P822, DOI 10.1121/1.1914607; Leeds CA, 2013, PRAGMAT COGN, V21, P224, DOI 10.1075/pc.21.1.10lee; Matsuzawa T, 2003, ANIM COGN, V6, P199, DOI 10.1007/s10071-003-0199-2; Matsuzawa T., 2001, PRIMATE ORIGINS HUMA; Menzel CR, 1999, J COMP PSYCHOL, V113, P426, DOI 10.1037/0735-7036.113.4.426; Menzel CR, 2002, INT J PRIMATOL, V23, P601, DOI 10.1023/A:1014925802015; Miles H.L.W., 1990, P511, DOI 10.1017/CBO9780511665486.021; Parrish AE, 2014, BEHAV PROCESS, V103, P184, DOI 10.1016/j.beproc.2013.12.011; Parrish AE, 2014, ANIM COGN, V17, P427, DOI 10.1007/s10071-013-0674-3; Patterson F., 1981, ED KOKO; Pepperberg I.M., 2002, ALEX STUDIES COGNITI; Pepperberg IM, 2010, BRAIN LANG, V115, P81, DOI 10.1016/j.bandl.2009.11.002; Perdue BM, 2014, ANIM COGN, V17, P287, DOI 10.1007/s10071-013-0661-8; Premack D., 1983, MIND APE; RALLS K, 1985, CAN J ZOOL, V63, P1050, DOI 10.1139/z85-157; RICHARDSON WK, 1990, BEHAV RES METH INSTR, V22, P127, DOI 10.3758/BF03203132; Rivas E, 2005, J COMP PSYCHOL, V119, P404, DOI 10.1037/0735-7036.119.4.404; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; Rumbaugh D. M., 2003, INTELLIGENCE APES OT; Rumbaugh DM., 1977, LANGUAGE LEARNING CH; Rumbaugh Duane M., 1994, P307; Savage-Rumbaugh E.S., 1986, APE LANGUAGE CONDITI, DOI DOI 10.7312/SAVA90374; Savage-Rumbaugh E. Sue, 1991, P209; Savage-Rumbaugh ES, 1990, ADVANCES INFANCY RES, V6, P221; Savage-Rumbaugh ES, 1993, MONOGR SOC RES CHILD, V58; Savage-Rumbaugh ES, J EXP PSYCHOL GEN, V115, P211; SAVAGERUMBAUGH ES, 1978, SCIENCE, V201, P641, DOI 10.1126/science.675251; SAVAGERUMBAUGH ES, 1980, SCIENCE, V210, P922, DOI 10.1126/science.7434008; SAVAGERUMBAUGH ES, 1983, J EXP PSYCHOL GEN, V112, P457, DOI 10.1037/0096-3445.112.4.457; SAVAGERUMBAUGH S, 1988, CHILD DEV, V59, P617, DOI 10.2307/1130561; Stoeger AS, 2012, CURR BIOL, V22, P2144, DOI 10.1016/j.cub.2012.09.022; Terrace Herbert S., 1979, NIM CHIMPANZEE WHO L	67	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118408	10.1371/journal.pone.0118408	http://dx.doi.org/10.1371/journal.pone.0118408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706561	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100179
J	Goll, JC; Charlesworth, G; Scior, K; Stott, J				Goll, Johanna C.; Charlesworth, Georgina; Scior, Katrina; Stott, Joshua			Barriers to Social Participation among Lonely Older Adults: The Influence of Social Fears and Identity	PLOS ONE			English	Article							LONELINESS; HEALTH; PEOPLE; INTERVENTION; INDEPENDENCE; ENGAGEMENT; NETWORKS; SUPPORT; RISK; LIFE	Introduction Loneliness among older adults is a major public health problem that may be associated with processes of social participation and identity. This study therefore sought to examine the relationship between social participation and identity in a sample of lonely older adults living independently in London, England. Method An inductive qualitative approach, based on semi-structured interviews and thematic analysis, was employed. Results Participants commonly spoke of barriers to social participation that have been reported elsewhere, including illness/disability, loss of contact with friends/relatives, lack of a supportive community, and lack of acceptable social opportunities. However, novel findings were also derived. In particular, participants commonly minimised the difficulties they faced alone, and described attempts to avoid social opportunities. These behaviours were linked to fears about engaging in social participation opportunities, including fears of social rejection and/or exploitation, and fears of losing valued aspects of identity. Discussion It is concluded that social participation amongst lonely older people will not improve through the removal of previously reported barriers alone; instead, older peoples' beliefs, fears and identities must be addressed. Suggestions for implementing these findings within community organisations are provided.	[Goll, Johanna C.; Charlesworth, Georgina; Scior, Katrina; Stott, Joshua] Univ Coll London UCL, Res Dept Clin Educ & Hlth Psychol, London, England	University of London; University College London	Goll, JC (corresponding author), Univ Coll London UCL, Res Dept Clin Educ & Hlth Psychol, London, England.	j.goll@ucl.ac.uk	stott, josh/AAX-6275-2021	Stott, Joshua/0000-0003-1361-053X; Scior, Katrina/0000-0002-4679-0090; Charlesworth, Georgina/0000-0002-5278-1756				Aartsen M, 2011, EUR J AGEING, V8, P31, DOI 10.1007/s10433-011-0175-7; Age UK, 2013, AG LAT LIF 2013 IMPR; [Anonymous], 1973, UNEXPECTED COMMUNITY; Bangee M, 2014, PERS INDIV DIFFER, V63, P16, DOI 10.1016/j.paid.2014.01.039; Barnes LL, 2004, J GERONTOL B-PSYCHOL, V59, pS146, DOI 10.1093/geronb/59.3.S146; Bowling A, 2000, REV CLIN GERONTOL, V10, P407, DOI DOI 10.1017/S0959259800104101; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Breheny M, 2009, AGEING SOC, V29, P1295, DOI 10.1017/S0144686X09990134; Bukov A, 2002, J GERONTOL B-PSYCHOL, V57, pP510, DOI 10.1093/geronb/57.6.P510; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Campbell C, 2002, SOC SCI MED, V55, P643, DOI 10.1016/S0277-9536(01)00193-9; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; Charmaz K., 2006, CONSTRUCTING GROUNDE, DOI [10.1093/geront/gns046, DOI 10.1093/GERONT/GNS046]; Dedoose, 2013, DED WEB APPL MAN AN; DEJONGGIERVELD J, 1985, APPL PSYCH MEAS, V9, P289, DOI 10.1177/014662168500900307; Department of Health, 2012, AD SOC CAR OUTC FRAM; Department of Health, 2012, CAR OUR FUT REF CAR; Desrosiers J, 2004, AGING CLIN EXP RES, V16, P406; Dickens AP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-218; DUCK S, 1994, J SOC PERS RELAT, V11, P253, DOI 10.1177/0265407594112006; Dykstra PA, 2005, RES AGING, V27, P725, DOI 10.1177/0164027505279712; Fealy G, 2012, AGEING SOC, V32, P85, DOI 10.1017/S0144686X11000092; Fine M, 2005, AGEING SOC, V25, P601, DOI 10.1017/S0144686X05003600; Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478; Glass TA, 2006, J AGING HEALTH, V18, P604, DOI 10.1177/0898264306291017; Glei DA, 2005, INT J EPIDEMIOL, V34, P864, DOI 10.1093/ije/dyi049; Greenfield EA, 2004, J GERONTOL B-PSYCHOL, V59, pS258, DOI 10.1093/geronb/59.5.S258; Haslam S.A., 2012, SOCIAL CURE IDENTITY, P157, DOI [10.4324/9780203813195, DOI 10.4324/9780203813195]; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Heaven B, 2013, MILBANK Q, V91, P222, DOI 10.1111/milq.12013; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hurd LC, 1999, J AGING STUD, V13, P419, DOI 10.1016/S0890-4065(99)00019-5; Jetten J., 2012, SOCIAL CURE IDENTITY; Kessler EM, 2007, PSYCHOL AGING, V22, P690, DOI 10.1037/0882-7974.22.4.690; KITE ME, 1988, PSYCHOL AGING, V3, P233, DOI 10.1037/0882-7974.3.3.233; Lefrancois R., 1998, Activities, Adaptation & Aging, V22, P15, DOI 10.1300/J016v22n04_03; Levasseur M, 2011, ARCH PHYS MED REHAB, V92, P1979, DOI 10.1016/j.apmr.2011.06.035; Levine M, 2005, PERS SOC PSYCHOL B, V31, P443, DOI 10.1177/0146167204271651; Lindstrom M, 2005, SOC SCI MED, V60, P1527, DOI 10.1016/j.socscimed.2004.08.015; Lund A, 2008, AGEING SOC, V28, P675, DOI 10.1017/S0144686X07006988; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Maier Heiner, 2005, Eur J Ageing, V2, P31, DOI 10.1007/s10433-005-0018-5; Martinson M, 2011, J AGING STUD, V25, P427, DOI 10.1016/j.jaging.2011.04.003; Masi CM, 2011, PERS SOC PSYCHOL REV, V15, P219, DOI 10.1177/1088868310377394; Nelson T. D., 2002, AGEISM STEREOTYPING; Office for National Statistics, 2012, ETHN NAT ID ENGL WAL; Office for National Statistics, 2010, STAND OCC CLASS 2010, V1-3; Office for National Statistics, 2010, BEN DAT IND WORK AG; Ormsby J, 2010, HEALTH SOC CARE COMM, V18, P607, DOI 10.1111/j.1365-2524.2010.00932.x; Pinquart M, 2001, BASIC APPL SOC PSYCH, V23, P245, DOI 10.1207/S15324834BASP2304_2; Rozanova J, 2012, CAN J AGING, V31, P25, DOI 10.1017/S0714980811000675; Schoenmakers EC, 2012, AGING MENT HEALTH, V16, P353, DOI 10.1080/13607863.2011.630373; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; St Claire L, 2009, APPL PSYCHOL-INT REV, V58, P24, DOI 10.1111/j.1464-0597.2008.00380.x; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Thoits PA, 2001, J HEALTH SOC BEHAV, V42, P115, DOI 10.2307/3090173; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turner J.C., 1987, REDISCOVERING SOCIAL; Victor CR, 2012, J CROSS-CULT GERONTO, V27, P65, DOI 10.1007/s10823-012-9161-6; Victor CR, 2012, J PSYCHOL, V146, P85, DOI 10.1080/00223980.2011.613875; Victor CR, 2005, AGEING SOC, V25, P357, DOI 10.1017/S0144686X04003332; Walker J, 2013, AGEING SOC, V33, P938, DOI 10.1017/S0144686X12000402; Walker RB, 2007, SOC SCI MED, V65, P1154, DOI 10.1016/j.socscimed.2007.04.031; WENGER GC, 1991, J AGING STUD, V5, P147, DOI 10.1016/0890-4065(91)90003-B; Westbrook D., 2011, INTRO COGNITIVE BEHA; Wilkie R, 2007, QUAL LIFE RES, V16, P1147, DOI 10.1007/s11136-007-9221-5; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234; Winningham RG, 2007, AGING MENT HEALTH, V11, P716, DOI 10.1080/13607860701366228; World Medical Association, 2013, DECL HELS ETH PRINC	69	105	108	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116664	10.1371/journal.pone.0116664	http://dx.doi.org/10.1371/journal.pone.0116664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706933	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100043
J	Haryadi, R; Ho, S; Kok, YJ; Pu, HX; Zheng, L; Pereira, NA; Li, B; Bi, XZ; Goh, LT; Yang, YS; Song, ZW				Haryadi, Ryan; Ho, Steven; Kok, Yee Jiun; Pu, Helen X.; Zheng, Lu; Pereira, Natasha A.; Li, Bin; Bi, Xuezhi; Goh, Lin-Tang; Yang, Yuansheng; Song, Zhiwei			Optimization of Heavy Chain and Light Chain Signal Peptides for High Level Expression of Therapeutic Antibodies in CHO Cells	PLOS ONE			English	Article							RECOGNITION PARTICLE; MAMMALIAN-CELLS; ENDOPLASMIC-RETICULUM; SECRETION; LUCIFERASE; MECHANISM; SEQUENCES; PROTEINS	Translocation of a nascent protein from the cytosol into the ER mediated by its signal peptide is a critical step in protein secretion. The aim of this work was to develop a platform technology to optimize the signal peptides for high level production of therapeutic antibodies in CHO cells. A database of signal peptides from a large number of human immunoglobulin (Ig) heavy chain (HC) and kappa light chain (LC) was generated. Most of the HC signal peptides contain 19 amino acids which can be divided into three domains and the LC signal peptides contain 22 amino acids. The signal peptides were then clustered according to sequence similarity. Based on the clustering, 8 HC and 2 LC signal peptides were analyzed for their impacts on the production of 5-top selling antibody therapeutics, namely, Herceptin, Avastin, Remicade, Rituxan, and Humira. The best HC and LC signal peptides for producing these 5 antibodies were identified. The optimized signal peptides for Rituxan is 2-fold better compared to its native signal peptides which are available in the public database. Substitution of a single amino acid in the optimized HC signal peptide for Avastin reduced its production significantly. Mass spectrometry analyses revealed that all optimized signal peptides are accurately removed in the mature antibodies. The results presented in this report are particularly important for the production of these 5 antibodies as biosimilar drugs. They also have the potential to be the best signal peptides for the production of new antibodies in CHO cells.	[Haryadi, Ryan; Ho, Steven; Kok, Yee Jiun; Pu, Helen X.; Zheng, Lu; Pereira, Natasha A.; Li, Bin; Bi, Xuezhi; Goh, Lin-Tang; Yang, Yuansheng; Song, Zhiwei] ASTAR, Bioproc Technol Inst, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI)	Song, ZW (corresponding author), ASTAR, Bioproc Technol Inst, Singapore, Singapore.	song_zhiwei@bti.a-star.edu.sg	Bi, Xuezhi/A-8532-2015; Kok, Yee Jiun/HCH-9659-2022	Bi, Xuezhi/0000-0001-6702-0805; Kok, Yee Jiun/0000-0001-6875-8262	Biomedical Research Council of Agency for Science, Technology and Research (A*STAR), Singapore	Biomedical Research Council of Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clemons WM, 1999, J MOL BIOL, V292, P697, DOI 10.1006/jmbi.1999.3090; De Jesus M, 2011, EUR J PHARM BIOPHARM, V78, P184, DOI 10.1016/j.ejpb.2011.01.005; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Futatsumori-Sugai M, 2010, BIOCHEM BIOPH RES CO, V391, P931, DOI 10.1016/j.bbrc.2009.11.167; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Ho SCL, 2013, J BIOTECHNOL, V165, P157, DOI 10.1016/j.jbiotec.2013.03.019; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Klatt S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-97; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Kober L, 2013, BIOTECHNOL BIOENG, V110, P1164, DOI 10.1002/bit.24776; Kotia RB, 2010, ANAL BIOCHEM, V399, P190, DOI 10.1016/j.ab.2010.01.008; Liu JX, 1997, GENE, V203, P141, DOI 10.1016/S0378-1119(97)00505-2; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nicchitta CV, 2002, CURR TOP MEMBR, V52, P483; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Reisinger H, 2008, APPL MICROBIOL BIOT, V81, P701, DOI 10.1007/s00253-008-1701-1; Saraogi I, 2011, TRAFFIC, V12, P535, DOI 10.1111/j.1600-0854.2011.01171.x; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; Yang YS, 2009, BIOTECHNOL BIOENG, V102, P1152, DOI 10.1002/bit.22152; Ying H, 2007, IMMUNOL LETT, V111, P66, DOI 10.1016/j.imlet.2007.05.002; Yu XC, 2009, ANAL CHEM, V81, P9282, DOI 10.1021/ac901541h; Zhang L, 2005, J GENE MED, V7, P354, DOI 10.1002/jgm.677	30	60	71	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116878	10.1371/journal.pone.0116878	http://dx.doi.org/10.1371/journal.pone.0116878			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706993	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100054
J	Lemoine, NP				Lemoine, Nathan P.			Climate Change May Alter Breeding Ground Distributions of Eastern Migratory Monarchs (Danaus plexippus) via Range Expansion of Asclepias Host Plants	PLOS ONE			English	Article							BUTTERFLIES; SHIFTS; LEPIDOPTERA; TEMPERATURE; PERFORMANCE; PREDICTION; PREFERENCE; RESPONSES; MILKWEED; IMPACTS	Climate change can profoundly alter species' distributions due to changes in temperature, precipitation, or seasonality. Migratory monarch butterflies (Danaus plexippus) may be particularly susceptible to climate-driven changes in host plant abundance or reduced overwintering habitat. For example, climate change may significantly reduce the availability of overwintering habitat by restricting the amount of area with suitable microclimate conditions. However, potential effects of climate change on monarch northward migrations remain largely unknown, particularly with respect to their milkweed (Asclepias spp.) host plants. Given that monarchs largely depend on the genus Asclepias as larval host plants, the effects of climate change on monarch northward migrations will most likely be mediated by climate change effects on Asclepias. Here, I used MaxEnt species distribution modeling to assess potential changes in Asclepias and monarch distributions under moderate and severe climate change scenarios. First, Asclepias distributions were projected to extend northward throughout much of Canada despite considerable variability in the environmental drivers of each individual species. Second, Asclepias distributions were an important predictor of current monarch distributions, indicating that monarchs may be constrained as much by the availability of Asclepias host plants as environmental variables per se. Accordingly, modeling future distributions of monarchs, and indeed any tightly coupled plant-insect system, should incorporate the effects of climate change on host plant distributions. Finally, MaxEnt predictions of Asclepias and monarch distributions were remarkably consistent among general circulation models. Nearly all models predicted that the current monarch summer breeding range will become slightly less suitable for Asclepias and monarchs in the future. Asclepias, and consequently monarchs, should therefore undergo expanded northern range limits in summer months while encountering reduced habitat suitability throughout the northern migration.	Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Lemoine, NP (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	nlemo001@fiu.edu			Smithsonian Predoctoral Fellowship; FIU Dissertation Evidence Acquisition Grant; FIU Dissertation Year Fellowship; Florida International University Open Access Publishing Fund	Smithsonian Predoctoral Fellowship(Smithsonian Institution); FIU Dissertation Evidence Acquisition Grant; FIU Dissertation Year Fellowship; Florida International University Open Access Publishing Fund	Funding for this project was provided by a Smithsonian Predoctoral Fellowship, an FIU Dissertation Evidence Acquisition Grant, and an FIU Dissertation Year Fellowship. Publication of this article was funded in part by Florida International University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Bartholomew CS, 2001, J KANSAS ENTOMOL SOC, V74, P211; Batalden RV, 2007, ENVIRON ENTOMOL, V36, P1365, DOI 10.1603/0046-225X(2007)36[1365:ENISGO]2.0.CO;2; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Berzitis EA, 2014, GLOBAL CHANGE BIOL, V20, P2778, DOI 10.1111/gcb.12557; Brindza LJ, 2008, J LEPID SOC, V62, P189; Brower LP, 2012, INSECT CONSERV DIVER, V5, P95, DOI 10.1111/j.1752-4598.2011.00142.x; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; Davis Andrew K., 2005, Journal of the Lepidopterists' Society, V59, P1; Diamond SE, 2012, ECOLOGY, V93, P2305, DOI 10.1890/11-2296.1; DiTommaso A, 2003, ENTOMOL EXP APPL, V108, P205, DOI 10.1046/j.1570-7458.2003.00089.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Feeley KJ, 2013, GLOBAL CHANGE BIOL, V19, P3472, DOI 10.1111/gcb.12300; Flockhart DTT, 2015, J ANIM ECOL, V84, P155, DOI 10.1111/1365-2656.12253; Flockhart DTT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1087; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Goehring L, 2002, ECOL ENTOMOL, V27, P674, DOI 10.1046/j.1365-2311.2002.00454.x; Guerra PA, 2013, CURR BIOL, V23, P419, DOI 10.1016/j.cub.2013.01.052; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Ladner DT, 2005, ENTOMOL EXP APPL, V116, P9, DOI 10.1111/j.1570-7458.2005.00308.x; Mattila HR, 2003, ENTOMOL EXP APPL, V107, P193, DOI 10.1046/j.1570-7458.2003.00049.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Oberhauser K, 2003, P NATL ACAD SCI USA, V100, P14063, DOI 10.1073/pnas.2331584100; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pateman RM, 2012, SCIENCE, V336, P1028, DOI 10.1126/science.1216980; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Reppert SM, 2010, TRENDS NEUROSCI, V33, P399, DOI 10.1016/j.tins.2010.04.004; Saenz-Romero C, 2012, FOREST ECOL MANAG, V275, P98, DOI 10.1016/j.foreco.2012.03.004; Sheldon KS, 2014, ECOLOGY, V95, P2134, DOI 10.1890/13-1703.1; Sheldon KS, 2011, ECOL LETT, V14, P1191, DOI 10.1111/j.1461-0248.2011.01689.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Tao LL, 2014, FUNCT ECOL, V28, P190, DOI 10.1111/1365-2435.12163; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; WOODSON ROBERT E., 1954, ANN MISSOURI BOT GARD, V41, P1, DOI 10.2307/2394652; Yeargan KV, 2005, J KANSAS ENTOMOL SOC, V78, P247, DOI 10.2317/0407.40.1; York HA, 2002, J KANSAS ENTOMOL SOC, V75, P290; Zalucki MR, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P219; Zipkin EF, 2012, GLOBAL CHANGE BIOL, V18, P3039, DOI 10.1111/j.1365-2486.2012.02751.x	48	57	59	11	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118614	10.1371/journal.pone.0118614	http://dx.doi.org/10.1371/journal.pone.0118614			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705876	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100195
J	Roy, HK; Brendler, CB; Subramanian, H; Zhang, D; Maneval, C; Chandler, J; Bowen, L; Kaul, KL; Helfand, BT; Wang, CH; Quinn, M; Petkewicz, J; Paterakos, M; Backman, V				Roy, Hemant K.; Brendler, Charles B.; Subramanian, Hariharan; Zhang, Di; Maneval, Charles; Chandler, John; Bowen, Leah; Kaul, Karen L.; Helfand, Brian T.; Wang, Chi-Hsiung; Quinn, Margo; Petkewicz, Jacqueline; Paterakos, Michael; Backman, Vadim			Nanocytological Field Carcinogenesis Detection to Mitigate Overdiagnosis of Prostate Cancer: A Proof of Concept Study	PLOS ONE			English	Article							GENE-EXPRESSION; RISK; LUNG; CANCERIZATION; TISSUES; TIME; MEN	Purpose To determine whether nano-architectural interrogation of prostate field carcinogenesis can be used to predict prognosis in patients with early stage (Gleason 6) prostate cancer (PCa), which is mostly indolent but frequently unnecessarily treated. Materials and Methods We previously developed partial wave spectroscopic microscopy (PWS) that enables quantification of the nanoscale intracellular architecture (20-200nm length scale) with remarkable accuracy. We adapted this technique to assess prostate needle core biopsies in a case control study from men with Gleason 6 disease who either progressed (n = 20) or remained indolent (n = 18) over a similar to 3 year follow up. We measured the parameter disorder strength (Ld) characterizing the spatial heterogeneity of the nanoscale cellular structure and nuclear morphology from the microscopically normal mucosa similar to 150 histologically normal epithelial cells. Results There was a profound increase in nano-architectural disorder between progressors and non-progressors. Indeed, the Ld from future progressors was dramatically increased when compared to future non-progressors (1 +/- 0.065 versus 1.30 +/- 0.0614, respectively p = 0.002). The area under the receiver operator characteristic curve (AUC) was 0.79, yielding a sensitivity of 88% and specificity of 72% for discriminating between progressors and non-progressors. This was not confounded by demographic factors (age, smoking status, race, obesity), thus supporting the robustness of the approach. Conclusions We demonstrate, for the first time, that nano-architectural alterations occur in prostate cancer field carcinogenesis and can be exploited to predict prognosis of early stage PCa. This approach has promise in addressing the clinically vexing dilemma of management of Gleason 6 PCa and may provide a paradigm for dealing with the larger issue of cancer overdiagnosis.	[Roy, Hemant K.] Boston Univ, Med Ctr, Dept Med, Boston, MA 02215 USA; [Brendler, Charles B.; Helfand, Brian T.; Wang, Chi-Hsiung; Quinn, Margo; Petkewicz, Jacqueline] NorthShore Univ HealthSyst, Dept Surg, Evanston, IL USA; [Subramanian, Hariharan; Zhang, Di; Maneval, Charles; Chandler, John; Bowen, Leah; Backman, Vadim] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Kaul, Karen L.; Paterakos, Michael] NorthShore Univ HealthSyst, Dept Pathol, Evanston, IL USA	Boston University; NorthShore University Health System; Northwestern University; NorthShore University Health System	Roy, HK (corresponding author), Boston Univ, Med Ctr, Dept Med, Boston, MA 02215 USA.	hkroy@bu.edu	Backman, Vadim/B-6689-2009; Roy, Hemant/AAC-9096-2020	Chandler, John/0000-0002-0104-5409	National Institutes of Health [U01CA111257, R01CA156186, R01CA165309, R01CA128641, R01CA155284, R42CA168055]; John and Carol Walter Center for Urological Health; NATIONAL CANCER INSTITUTE [R01CA128641, U01CA111257, R01CA156186, R01CA165309, R01CA155284, R42CA168055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John and Carol Walter Center for Urological Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by National Institutes of Health U01CA111257 HR, VB, http://nih.gov/; National Institutes of Health R01CA156186, HR, VB, http://nih.gov/; National Institutes of Health R01CA165309, HR, VB, http://nih.gov/; National Institutes of Health R01CA128641, HR, VB, http://nih.gov/; National Institutes of Health R01CA155284, HR, VB, http://nih.gov/; National Institutes of Health R42CA168055, HR, VB, http://nih.gov/; and John and Carol Walter Center for Urological Health, CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Backman V, 2013, J CANCER, V4, P251, DOI 10.7150/jca.5838; Backman V, 2011, GASTROENTEROLOGY, V140, P35, DOI 10.1053/j.gastro.2010.11.023; Campos-Fernandes JL, 2009, EUR UROL, V55, P600, DOI 10.1016/j.eururo.2008.06.043; Carter HB, 2013, BJU INT, V112, P543, DOI 10.1111/bju.12318; Chen LC, 2004, CANCER RES, V64, P3694, DOI 10.1158/0008-5472.CAN-03-3264; Damania D, 2013, INT J CANCER, V133, P1143, DOI 10.1002/ijc.28122; Damania D, 2012, CANCER RES, V72, P2720, DOI 10.1158/0008-5472.CAN-11-3807; Damania D, 2010, BIOPHYS J, V99, P989, DOI 10.1016/j.bpj.2010.05.023; Dotto GP, 2014, J CLIN INVEST, V124, P1446, DOI 10.1172/JCI72589; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Fillmore RA, 2014, EXP BIOL MED, V239, P793, DOI 10.1177/1535370214539091; Ganz PA, 2012, ANN INTERN MED, V156, P591, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00010]; Gong ZH, 2007, CANCER-AM CANCER SOC, V109, P1192, DOI 10.1002/cncr.22534; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Irshad S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006408; Jalloh M, 2014, EUR UROL; Kenfield SA, 2011, JAMA-J AM MED ASSOC, V305, P2548, DOI 10.1001/jama.2011.879; Konda VJA, 2013, ENDOSCOPY, V45, P983, DOI 10.1055/s-0033-1344617; Kosari F, 2012, AM J PATHOL, V181, P34, DOI 10.1016/j.ajpath.2012.03.043; Latini DM, 2007, J UROLOGY, V178, P826, DOI 10.1016/j.juro.2007.05.039; Lochhead P, 2014, MOD PATHOL; Luo JH, 2013, AM J PATHOL, V182, P2028, DOI 10.1016/j.ajpath.2013.02.040; Montironi R, 2000, VIRCHOWS ARCH, V437, P625, DOI 10.1007/s004280000290; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Parr R, 2013, DISCOV MED, V15, P213; Roy HK, 2011, FUTURE ONCOL, V7, P1, DOI [10.2217/fon.10.176, 10.2217/FON.10.176]; Roy HK, 2010, CANCER RES, V70, P7748, DOI 10.1158/0008-5472.CAN-10-1686; Sartori DA, 2014, CURR OPIN ONCOL, V26, P259, DOI 10.1097/CCO.0000000000000065; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Steiling K, 2008, CANCER PREV RES, V1, P396, DOI 10.1158/1940-6207.CAPR-08-0174; Subramanian H, 2009, CANCER RES, V69, P5357, DOI 10.1158/0008-5472.CAN-08-3895; Subramanian H, 2008, P NATL ACAD SCI USA, V105, P20118, DOI 10.1073/pnas.0804723105; Sundi D, 2014, J UROLOGY, V191, P60, DOI 10.1016/j.juro.2013.06.021; Tiwari AK, 2013, GASTROENTEROLOGY, V144, P1; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; Vickers AJ, 2014, UROLOGY, V83, P592, DOI 10.1016/j.urology.2013.09.075; Walsh PC, 2007, NEW ENGL J MED, V357, P2696, DOI 10.1056/NEJMcp0706784; Zhang Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-129; Zlotta AR, 2013, JNCI-J NATL CANCER I, V105, P1050, DOI 10.1093/jnci/djt151	41	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115999	10.1371/journal.pone.0115999	http://dx.doi.org/10.1371/journal.pone.0115999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706755	Green Published, gold			2022-12-27	WOS:000350662100021
J	Huynh, HN; Pradana, A; Chew, LY				Huynh, Hoai Nguyen; Pradana, Andri; Chew, Lock Yue			The Complexity of Sequences Generated by the Arc-Fractal System	PLOS ONE			English	Article							SYMBOLIC DYNAMICS	We study properties of the symbolic sequences extracted from the fractals generated by the arc-fractal system introduced earlier by Huynh and Chew. The sequences consist of only a few symbols yet possess several nontrivial properties. First using an operator approach, we show that the sequences are not periodic, even though they are constructed from very simple rules. Second by employing the epsilon-machine approach developed by Crutchfield and Young, we measure the complexity and randomness of the sequences and show that they are indeed complex, i.e. neither periodic nor random, with the value of complexity measure being significant as compared to the known example of logistic map at the edge of chaos. The complexity and randomness of the sequences are then discussed in relation with the properties of associated fractal objects, such as their fractal dimension, symmetry and orientations of the arcs.	[Huynh, Hoai Nguyen; Chew, Lock Yue] Nanyang Technol Univ, Complex Inst, Singapore 639798, Singapore; [Pradana, Andri; Chew, Lock Yue] Nanyang Technol Univ, Div Phys & Appl Phys, Sch Phys & Math Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chew, LY (corresponding author), Nanyang Technol Univ, Complex Inst, Singapore 639798, Singapore.	lockyue@ntu.edu.sg	Pradana, Andri/W-2725-2018	Pradana, Andri/0000-0002-9749-8882; Huynh, Nguyen/0000-0002-8432-7435; Chew, Lock Yue/0000-0003-1366-8205				Barnsley M, 1993, FRACTALS EVERYWHERE; Bennett CH, 1985, EMERGING SYNTHESES S, P297; CHAITIN GJ, 1966, J ACM, V13, P547, DOI 10.1145/321356.321363; Crutchfield JP, 2012, NAT PHYS, V8, P17, DOI 10.1038/nphys2190; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; CRUTCHFIELD JP, 1982, INT J THEOR PHYS, V21, P433, DOI 10.1007/BF02650178; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012256; FEIGENBAUM MJ, 1978, J STAT PHYS, V19, P25, DOI 10.1007/BF01020332; Gordon DM, 2002, COMPLEXITY, V8, P43, DOI [10.1002/cplx.10048, DOI 10.1002/CPLX.10048]; GRANOVSKAYA RM, 1980, PATTERN RECOGN, V12, P17, DOI 10.1016/0031-3203(80)90050-3; GRASSBERGER P, 1986, INT J THEOR PHYS, V25, P907, DOI 10.1007/BF00668821; Huynh HN, 2011, FRACTALS, V19, P141, DOI 10.1142/S0218348X11005178; Huynh HN, 2013, THESIS NANYANG TECHN; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; KOLMOGOROV AN, 1959, DOKL AKAD NAUK SSSR+, V124, P754; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; LLOYD S, 1988, ANN PHYS-NEW YORK, V188, P186, DOI 10.1016/0003-4916(88)90094-2; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; McElroy M.W., 2000, J KNOWL MANAG, V4, P195, DOI [10.1108/13673270010377652, DOI 10.1108/13673270010377652]; Metropolis N., 1973, Journal of Combinatorial Theory, Series A, V15, P25, DOI 10.1016/0097-3165(73)90033-2; Pastor G, 1998, PHYSICA A, V256, P369, DOI 10.1016/S0378-4371(98)00083-1; Rasband SN., 1990, CHAOTIC DYNAMICS NON; Ribeiro HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040689; Rogers James, 2011, Journal of Logic, Language and Information, V20, P329, DOI 10.1007/s10849-011-9140-2; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shiner JS, 1999, PHYS REV E, V59, P1459, DOI 10.1103/PhysRevE.59.1459; SHORT KM, 1993, J COMPUT PHYS, V104, P162, DOI 10.1006/jcph.1993.1018; SINAI I, 1959, DOKL AKAD NAUK SSSR+, V124, P768; Sterling D, 1999, PHYSICA D, V134, P153, DOI 10.1016/S0167-2789(99)00125-6; Xiao FH, 2004, ACTA PHYS SIN-CH ED, V53, P2877, DOI 10.7498/aps.53.2876	30	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117365	10.1371/journal.pone.0117365	http://dx.doi.org/10.1371/journal.pone.0117365			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700034	Green Published, gold			2022-12-27	WOS:000349789800021
J	Nanri, A; Mizoue, T; Kurotani, K; Goto, A; Oba, S; Noda, M; Sawada, N; Tsugane, S				Nanri, Akiko; Mizoue, Tetsuya; Kurotani, Kayo; Goto, Atsushi; Oba, Shino; Noda, Mitsuhiko; Sawada, Norie; Tsugane, Shoichiro		Japan Public Hlth Ctr-Based Prospe	Low-Carbohydrate Diet and Type 2 Diabetes Risk in Japanese Men and Women: The Japan Public Health Center-Based Prospective Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; FOLLOW-UP SURVEY; FATTY-ACIDS; COHORT-I; JPHC; REPRODUCIBILITY; METAANALYSIS; VALIDITY; PROTEIN; SCORE	Objective Evidence is sparse and contradictory regarding the association between low-carbohydrate diet score and type 2 diabetes risk, and no prospective study examined the association among Asians, who consume greater amount of carbohydrate. We prospectively investigated the association of low-carbohydrate diet score with type 2 diabetes risk. Methods Participants were 27,799 men and 36,875 women aged 45-75 years who participated in the second survey of the Japan Public Health Center-Based Prospective Study and who had no history of diabetes. Dietary intake was ascertained by using a validated food-frequency questionnaire, and low-carbohydrate diet score was calculated from total carbohydrate, fat, and protein intake. The scores for high animal protein and fat or for high plant protein and fat were also calculated. Odds ratios of self-reported, physician-diagnosed type 2 diabetes over 5-year were estimated by using logistic regression. Results During the 5-year period, 1191 new cases of type 2 diabetes were self-reported. Low-carbohydrate diet score for high total protein and fat was significantly associated with a decreased risk of type 2 diabetes in women (P for trend < 0.001); the multivariable-adjusted odds ratio of type 2 diabetes for the highest quintile of the score were 0.63 (95% confidence interval 0.46-0.84), compared with those for the lowest quintile. Additional adjustment for dietary glycemic load attenuated the association (odds ratio 0.75, 95% confidence interval 0.45-1.25). When the score separated for animal and for plant protein and fat, the score for high animal protein and fat was inversely associated with type 2 diabetes in women, whereas the score for high plant protein and fat was not associated in both men and women. Discussion Low-carbohydrate diet was associated with decreased risk of type 2 diabetes in Japanese women and this association may be partly attributable to high intake of white rice. The association for animal-based and plant-based low-carbohydrate diet warrants further investigation.	[Nanri, Akiko; Mizoue, Tetsuya; Kurotani, Kayo] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Goto, Atsushi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan; [Oba, Shino] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama 3510197, Japan; [Sawada, Norie; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 104, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Institute of Public Health - Japan; National Cancer Center - Japan	Nanri, A (corresponding author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.	nanri@ri.ncgm.go.jp	Oba, Shino/AAC-5473-2021; Noda, Mitsuhiko/W-3905-2019; Tsugane, Shoichiro/A-2424-2015	Oba, Shino/0000-0002-7388-5861; Noda, Mitsuhiko/0000-0003-0413-4631; Tsugane, Shoichiro/0000-0003-4105-2774; Goto, Atsushi/0000-0003-0669-654X	National Cancer Center Research and Development Fund [23-A-31[toku], 26-A-2]; Ministry of Health, Labour and Welfare of Japan	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by National Cancer Center Research and Development Fund (23-A-31[toku] and 26-A-2) (since 2011) and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010). The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Alhazmi A, 2012, J AM COLL NUTR, V31, P243, DOI 10.1080/07315724.2012.10720425; COLDITZ GA, 1992, AM J CLIN NUTR, V55, P1018, DOI 10.1093/ajcn/55.5.1018; de Koning L, 2011, AM J CLIN NUTR, V93, P844, DOI 10.3945/ajcn.110.004333; Ericson U, 2013, BRIT J NUTR, V109, P1143, DOI 10.1017/S0007114512003017; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Halton TL, 2008, AM J CLIN NUTR, V87, P339, DOI 10.1093/ajcn/87.2.339; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hu EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1454; Huxley R, 2008, EPIDEMIOLOGY DIABETE, P57; Ishihara J, 2003, J EPIDEMIOL, V13, pS134; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003; Kurotani K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064758; Ministry of Health Labour and Walfare, 2012, NAT HLTH NUTR SURV J; Ministry of Health Labour and Walfare, 2011, NAT HLTH NUTR SURV J; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Nakamura Y, 2014, BRIT J NUTR, V112, P916, DOI 10.1017/S0007114514001627; Nanri A, 2010, AM J CLIN NUTR, V92, P1468, DOI 10.3945/ajcn.2010.29512; Noto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055030; O'Neil CE, 2012, NUTRIENTS, V4, P2097, DOI 10.3390/nu4122097; Oba S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-165; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Sasaki S, 2003, J EPIDEMIOL, V13, pS115; Sasaki S, 2003, J EPIDEMIOL, V13, pS13; Schulze MB, 2008, BRIT J NUTR, V99, P1107, DOI 10.1017/S0007114507853360; Simila ME, 2012, EUR J CLIN NUTR, V66, P716, DOI 10.1038/ejcn.2012.24; Sluijs I, 2010, DIABETES CARE, V33, P43, DOI 10.2337/dc09-1321; Tsugane S, 2003, J EPIDEMIOL, V13, pS51; Tsugane S, 2001, J Epidemiol, V11, pS24; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wright Jacqueline D, 2010, NCHS Data Brief, P1; Wu JHY, 2012, BRIT J NUTR, V107, pS214, DOI 10.1017/S0007114512001602	34	45	47	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118377	10.1371/journal.pone.0118377	http://dx.doi.org/10.1371/journal.pone.0118377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695497	Green Submitted, Green Published, gold			2022-12-27	WOS:000350062300051
J	Wang, XL; He, YX; Guo, BS; Tsang, MC; Tu, FJ; Dai, Y; Yao, ZH; Zheng, LZ; Xie, XH; Wang, N; Yao, XS; Zhang, G; Qin, L				Wang, Xinluan; He, Yixin; Guo, Baosheng; Tsang, Man-Ching; Tu, Fengjuan; Dai, Yi; Yao, Zhihong; Zheng, Lizhen; Xie, Xinhui; Wang, Nan; Yao, Xinsheng; Zhang, Ge; Qin, Ling			In Vivo Screening for Anti-Osteoporotic Fraction from Extract of Herbal Formula Xianlinggubao in Ovariectomized Mice	PLOS ONE			English	Article							POSTMENOPAUSAL OSTEOPOROSIS; BONE LOSS; BIOCHEMICAL MARKERS; CONTROLLED TRIAL; TOTAL SAPONINS; RADIX-DIPSACI; RATS; FLAVONOIDS; DIFFERENTIATION; IDENTIFICATION	Background and Objectives Traditional Chinese Medicine (TCM) Fufang or formula Xianlinggubao (XLGB) is a prescribed TCM drug in China registered for prevention and treatment of osteoporosis. Fufang in TCM is comprised of a group of herbal compounds contributing in group to the treatment efficacy. The present study aims to identify the bioactive fraction(s) in XLGB extract that account(s) dominantly for its osteogenic effects. Methods The extract of XLGB formula was separated into three fractions using chromatography, i.e., XLGB-A, XLGB-B and XLGB-C. They were administrated to 4-month old ovariectomized (OVX) mice for 6 weeks to determine which bioactive fraction(s) were more effective for preventing OVX-induced bone loss evaluated by microCT, biomechanical testing and biochemical markers. The main peaks of the key fraction were identified using reference compounds isolated from the fraction. In addition, the effects of the composite compounds in XLGB-B on osteoblasts' proliferation and mineralization were evaluated in UMR 106 cells. Results XLGB-B with a yield of 13.0% from herbal Fufang XLGB was identified as the most potential one among the three fractions for prevention of OVX-induced bone loss confirmed with bone mass, bonemicroarchitecture, bone strength and bone turnover markers. Nine compounds in HPLC fingerprint were identified in the XLGB-B fraction, including phenylpropanoids from Herba Epimedii, terpenes from Radix Dipsaci and coumarins from Fructus Psoraleae. In addition, the identified compounds effectively promoted proliferation and/or mineralization of osteoblast-like UMR 106 cells in vitro. Conclusion XLGB-B with defined phytochemical structures was screened as the key fraction that demonstrated preventive effects on OVX-induced bone loss in mice. The present study laid down a foundation towards a new generation of herbal Fufang characterized with "less herbal materials for achieving equal treatment efficacy" in development strategy of TCM for prevention of OVX-induced osteoporosis.	[Wang, Xinluan; Wang, Nan; Qin, Ling] Chinese Acad Sci, Translat Med R&D Ctr, Shenzhen Inst Adv Technol, Inst Biomed Engn & Hlth Tec, Shenzhen 518000, Peoples R China; [Wang, Xinluan; He, Yixin; Guo, Baosheng; Tsang, Man-Ching; Zheng, Lizhen; Xie, Xinhui; Zhang, Ge; Qin, Ling] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China; [Tu, Fengjuan; Dai, Yi; Yao, Zhihong; Yao, Xinsheng] Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Guangdong, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong; Jinan University	Yao, XS (corresponding author), Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Guangdong, Peoples R China.	tyaoxs@jnu.edu.cn; zhangge@hkbu.edu.hk; lingqin@cuhk.edu.hk	Qin, Ling/J-9047-2018; Guo, Baosheng/ABD-4800-2021; GUO, Baosheng/M-6023-2013; Wang, Nan/GRY-3150-2022; Zhang, Ge/K-9118-2019	Qin, Ling/0000-0001-6173-6167; Guo, Baosheng/0000-0002-4510-5418; Zhang, Ge/0000-0002-7807-7695	Ministry of Science and Technology of the People's Republic of China [2011ZX09201-201-01]; National Natural Science Foundation of China [81220108028]; Ministry of Education of the People's Republic of China [B13038]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of the People's Republic of China(Ministry of Education, China)	The work was supported by Ministry of Science and Technology of the People's Republic of China (2011ZX09201-201-01, Prof. Ling Qin), National Natural Science Foundation of China (81220108028, Prof. Xinsheng Yao) and Ministry of Education of the People's Republic of China (B13038, Prof. Xinsheng Yao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WF, 2011, BRIT J NUTR, V105, P180, DOI 10.1017/S0007114510003247; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; Cremers S, 2006, DRUGS, V66, P2031, DOI 10.2165/00003495-200666160-00001; Deng WM, 2012, J BONE MINER METAB, V30, P517, DOI 10.1007/s00774-012-0351-7; Don MJ, 2012, PHYTOMEDICINE, V19, P551, DOI 10.1016/j.phymed.2012.01.006; Dong GC, 2008, J BIOMED MATER RES A, V84A, P167, DOI 10.1002/jbm.a.31261; Gao XZ, 2010, ASIA PAC TRADIT MED, V6, P142; Guan XY, 2011, J PHARMACEUT BIOMED, V55, P923, DOI 10.1016/j.jpba.2011.03.021; Gui Li, 2007, Zhongguo Xinyao yu Linchuang Zazhi, V26, P619; Hu CX, 2000, CHINESE TRADITIONAL, V22, P246; Huang J., 2004, CHIN J CLIN PHARM TH, V09, P1069; Li QQ, 2010, CHIN MOD MED, V17, P96; [李晓龙 Li Xiaolong], 2010, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V30, P891; Li Y, 2014, CHIN J NAT MEDICINES, V12, P204, DOI 10.1016/S1875-5364(14)60034-0; Lim SH, 2009, BRIT J NUTR, V101, P1031, DOI 10.1017/S0007114508066750; Liu CM, 2003, CHEM J CHINESE U, V24, P2215; Liu MJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-67; Liu YW, 2012, J ETHNOPHARMACOL, V139, P194, DOI 10.1016/j.jep.2011.11.004; Liu ZG, 2009, J ETHNOPHARMACOL, V123, P74, DOI 10.1016/j.jep.2009.02.025; Lock CA, 2006, OSTEOPOROSIS INT, V17, P20, DOI 10.1007/s00198-005-1942-0; Luo GA, 1997, TRADITIONAL CHINESE, V19, P44; Malaval L, 1998, J BONE MINER RES, V13, P175, DOI 10.1359/jbmr.1998.13.2.175; [茅月娟 MAO Yuejuan], 2006, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V23, P416; Mok SK, 2010, BRIT J PHARMACOL, V159, P939, DOI 10.1111/j.1476-5381.2009.00593.x; Niu YB, 2012, OSTEOPOROSIS INT, V23, P2649, DOI 10.1007/s00198-012-1932-y; Notelovitz M, 1997, AM J MED SCI, V313, P2, DOI 10.1097/00000441-199701000-00002; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park CK, 2008, BIOCHEM PHARMACOL, V75, P2175, DOI 10.1016/j.bcp.2008.03.007; Qin L, 2005, J BONE MINER METAB, V23, P55, DOI 10.1007/BF03026324; Qin L, 2014, J ORTHOP TRANSL, V2, P43, DOI 10.1016/j.jot.2013.12.001; Reginster JY, 2011, DRUGS, V71, P65, DOI 10.2165/11587570-000000000-00000; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P155, DOI 10.1007/s00223-007-9101-6; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Songlin P, 2009, BONE, V45, P534, DOI [DOI 10.1016/J.B0NE.2009.05.022, 10.1016/j.bone.2009.05.022]; Sorensen MG, 2007, BIOMARKERS, V12, P266, DOI 10.1080/13547500601070842; Tan W, 2012, INT J BIOL MACROMOL, V50, P59, DOI 10.1016/j.ijbiomac.2011.09.019; [陶玲 TAO Ling], 2009, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V29, P1431; Tsai MH, 2007, AM J CHINESE MED, V35, P669, DOI 10.1142/S0192415X07005168; Varea O, 2010, STEROIDS, V75, P565, DOI 10.1016/j.steroids.2009.09.006; Wang N, 2014, J ORTHOPAEDIC TRANSL, V2, P218; Wang N, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-17; Wang XL, 2008, CHEM PHARM BULL, V56, P46, DOI 10.1248/cpb.56.46; Wang XL, 2011, PHYTOMEDICINE, V18, P868, DOI 10.1016/j.phymed.2011.01.022; Wong RWK, 2010, PHYTOTHER RES, V24, pS155, DOI 10.1002/ptr.3049; Wong RWK, 2007, PHYTOTHER RES, V21, P596, DOI 10.1002/ptr.2126; Wu Huichao, 2011, Zhongguo Zhong Yao Za Zhi, V36, P992; Xiao HH, 2011, BRIT J NUTR, V106, P1802, DOI 10.1017/S0007114511002546; Yang Z, 2012, MENOPAUSE, V19, P1156, DOI 10.1097/gme.0b013e3182507e18; Zhang G, 2006, BONE, V38, P818, DOI 10.1016/j.bone.2005.11.019; Zhang G, 2007, J BONE MINER RES, V22, P1072, DOI 10.1359/JBMR.070405; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhang RX, 2008, J ETHNOPHARMACOL, V117, P199, DOI 10.1016/j.jep.2008.02.018; Zhu HM, 2012, OSTEOPOROSIS INT, V23, P1317, DOI 10.1007/s00198-011-1577-2; Zhu ZY, 2007, RAPID COMMUN MASS SP, V21, P1855, DOI 10.1002/rcm.3023	54	34	37	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118184	10.1371/journal.pone.0118184	http://dx.doi.org/10.1371/journal.pone.0118184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695519	Green Submitted, Green Published, gold			2022-12-27	WOS:000350062300044
J	Green, ML; Herzing, DL; Baldwin, JD				Green, Michelle L.; Herzing, Denise L.; Baldwin, John D.			Molecular Assessment of Mating Strategies in a Population of Atlantic Spotted Dolphins	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MALE REPRODUCTIVE SUCCESS; STENELLA-FRONTALIS; SOCIAL-STRUCTURE; TURSIOPS-TRUNCATUS; COMPUTER-PROGRAM; NORTH-ATLANTIC; MICROSATELLITE MARKERS; PATERNITY INFERENCE; NATURAL-POPULATIONS	Similar to other small cetacean species, Atlantic spotted dolphins (Stenella frontalis) have been the object of concentrated behavioral study. Although mating and courtship behaviors occur often and the social structure of the population is well-studied, the genetic mating system of the species is unknown. To assess the genetic mating system, we genotyped females and their progeny at ten microsatellite loci. Genotype analysis provided estimates of the minimum number of male sires necessary to account for the allelic diversity observed among the progeny. Using the estimates of male sires, we determined whether females mated with the same or different males during independent estrus events. Using GERUD2.0, a minimum of two males was necessary to account for the genetic variation seen among progeny arrays of all tested females. ML-RELATE assigned the most likely relationship between offspring pairs; half or full sibling. Relationship analysis supported the conservative male estimates of GERUD2.0 but in some cases, half or full sibling relationships between offspring could not be fully resolved. Integrating the results from GERUD2.0, ML-RELATE with previous observational and paternity data, we constructed two-, three-, and four-male pedigree models for each genotyped female. Because increased genetic diversity of offspring may explain multi-male mating, we assessed the internal genetic relatedness of each offspring's genotype to determine whether parent pairs of offspring were closely related. We found varying levels of internal relatedness ranging from unrelated to closely related (range -0.136-0.321). Because there are several hypothesized explanations for multi-male mating, we assessed our data to determine the most plausible explanation for multi-male mating in our study system. Our study indicated females may benefit from mating with multiple males by passing genes for long-term viability to their young.	[Green, Michelle L.; Baldwin, John D.] Florida Atlantic Univ, Dept Biol, Davie, FL 33314 USA; [Herzing, Denise L.] Wild Dolphin Project, Jupiter, FL 33468 USA; [Herzing, Denise L.] Florida Atlantic Univ, Dept Biol, Dept Psychol, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Green, ML (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Dept Anim Sci, 1503 S Maryland Dr, Urbana, IL 61801 USA.	mgreen31@gmail.com						Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Adams LD, 2006, MAR BIOL, V148, P671, DOI 10.1007/s00227-005-0094-2; AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Birkhead TR, 2000, PROMISCUITY, DOI [10.1007/BF02879286, DOI 10.1007/BF02879286]; Bossart Gregory D., 2005, Aquatic Mammals, V31, P473, DOI 10.1578/AM.31.4.2005.473; Caldwell M, 2002, MOL ECOL NOTES, V2, P393, DOI 10.1046/j.1471-8286.2002.00270.x; Cerchio S, 2005, ANIM BEHAV, V70, P267, DOI 10.1016/j.anbehav.2004.10.028; Clapham PJ, 1997, P ROY SOC B-BIOL SCI, V264, P95, DOI 10.1098/rspb.1997.0014; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Cohas A, 2007, J ANIM ECOL, V76, P771, DOI 10.1111/j.1365-2656.2007.01253.x; Coltman DW, 1999, MOL ECOL, V8, P1199, DOI 10.1046/j.1365-294x.1999.00683.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Connor RC, 1996, BEHAVIOUR, V133, P37, DOI 10.1163/156853996X00026; Connor RC, 2000, CETACEAN SOCIETIES, P247; Connor RC, 2000, CETACEAN SOCIETIES, P91; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; De Waal Frans B. M., 1992, P1; Dearolf JL, 2000, J MORPHOL, V244, P203, DOI 10.1002/(SICI)1097-4687(200006)244:3<203::AID-JMOR5>3.0.CO;2-V; Duffield Deborah A., 2002, P3; Dunn DG, 2002, J WILDLIFE DIS, V38, P505, DOI 10.7589/0090-3558-38.3.505; Elliser CR, 2014, MAR MAMMAL SCI, V30, P308, DOI 10.1111/mms.12039; Elliser CR, 2014, MAR MAMMAL SCI, V30, P329, DOI 10.1111/mms.12038; Elliser CR, 2012, MAR MAMMAL SCI, V00, P1; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Frasier TR, 2007, MOL ECOL, V16, P5277, DOI 10.1111/j.1365-294X.2007.03570.x; Nery MF, 2009, MAR MAMMAL SCI, V25, P450, DOI 10.1111/j.1748-7692.2008.00275.x; GERLOFF U, 1995, MOL ECOL, V4, P515, DOI 10.1111/j.1365-294X.1995.tb00247.x; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Green ML, 2007, MOL ECOL NOTES, V7, P1287, DOI 10.1111/j.1471-8286.2007.01858.x; Green ML, 2011, CAN J ZOOL, V89, P239, DOI 10.1139/Z10-111; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Herzing D. L., 1997, Aquatic Mammals, V23, P85; Herzing D. L., 1997, Aquatic Mammals, V23, P155; Herzing Denise L., 1996, Aquatic Mammals, V22, P61; Herzing DL, 1997, MAR MAMMAL SCI, V13, P576, DOI 10.1111/j.1748-7692.1997.tb00085.x; Herzing DL., 2013, INT J COMP PSYCHOL, V26, P124, DOI [10.46867/ijcp.2013.26.02.04, DOI 10.5811/WESTJEM.2011.5.6700]; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Hughes C, 1998, ECOLOGY, V79, P383, DOI 10.1890/0012-9658(1998)079[0383:IMTWFM]2.0.CO;2; Isvaran K, 2007, P ROY SOC B-BIOL SCI, V274, P219, DOI 10.1098/rspb.2006.3723; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Krutzen M, 2004, MOL ECOL, V13, P1975, DOI 10.1111/j.1365-294X.2004.02192.x; Krutzen M, 2003, P ROY SOC B-BIOL SCI, V270, P497, DOI 10.1098/rspb.2002.2229; MacLeod CD, 1998, J ZOOL, V244, P71, DOI 10.1017/S0952836998001083; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Miquel C, 2006, MOL ECOL NOTES, V6, P985, DOI 10.1111/j.1471-8286.2006.01413.x; Murphy S, 2005, J MAMMAL, V86, P1247, DOI 10.1644/1545-1542(2005)86[1247:MSITMC]2.0.CO;2; Nielsen R, 2001, GENETICS, V157, P1673; Owen ECG, 2003, THESIS, P326; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Parsons KM, 2006, MAR MAMMAL SCI, V22, P276, DOI 10.1111/j.1748-7692.2006.00019.x; Parsons KM, 2003, ANIM BEHAV, V66, P185, DOI 10.1006/anbe.2003.2186; Patterson IAP, 1998, P ROY SOC B-BIOL SCI, V265, P1167, DOI 10.1098/rspb.1998.0414; PERRIN WF, 1969, ZOOLOGICA-N Y, V54, P135; Perrin WF, 2003, MAR MAMMAL SCI, V19, P462, DOI 10.1111/j.1748-7692.2003.tb01315.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RALLS K, 1979, SCIENCE, V206, P1101, DOI 10.1126/science.493997; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reynolds JD, 1996, TRENDS ECOL EVOL, V11, pA68, DOI 10.1016/0169-5347(96)81045-7; Rogers CA, 2004, MAR MAMMAL SCI, V20, P688, DOI 10.1111/j.1748-7692.2004.tb01188.x; Rosas FCW, 2002, J MAMMAL, V83, P507; Rosel PE, 2005, MOL ECOL NOTES, V5, P830, DOI 10.1111/j.1471-8286.2005.01078.x; Shinohara M, 1997, MOL ECOL, V6, P695, DOI 10.1046/j.1365-294X.1997.00231.x; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; SLOOTEN E, 1994, J MAMMAL, V75, P956, DOI 10.2307/1382477; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Horn RC, 2008, ANIM BEHAV, V75, P1173, DOI 10.1016/j.anbehav.2007.08.027; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VanBressem MF, 1996, DIS AQUAT ORGAN, V26, P1, DOI 10.3354/dao026001; Vanpe C, 2009, BIOL J LINN SOC, V97, P128, DOI 10.1111/j.1095-8312.2009.01196.x; VANWAEREBEEK K, 1994, J MAMMAL, V75, P1054, DOI 10.2307/1382489; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; Wells RS, 1991, DOLPHIN SOC DISCOVER, P198; Wells RS, 2000, BIOL MARINE MAMMALS, P324; Welsh LS, 2007, BIOL SCI MASTERS, P35; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009	85	4	4	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118227	10.1371/journal.pone.0118227	http://dx.doi.org/10.1371/journal.pone.0118227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692972	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500110
J	Hsu, JL; Chen, WH; Bai, CH; Leu, JG; Hsu, CY; Viergever, MA; Leemans, A				Hsu, Jung-Lung; Chen, Wei-Hung; Bai, Chyi-Huey; Leu, Jyu-Gang; Hsu, Chien-Yeh; Viergever, Max A.; Leemans, Alexander			Microstructural White Matter Tissue Characteristics Are Modulated by Homocysteine: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; ELEVATED HOMOCYSTEINE; MEAN DIFFUSIVITY; RISK PROFILE; BRAIN; VOLUME; DISEASE; LEUKOARAIOSIS; STROKE; MRI	Homocysteine level can lead to adverse effects on the brain white matter through endothelial dysfunction, microstructural inflammation, and neurotoxin effects. Despite previously observed associations between elevated homocysteine and macroscopic structural brain changes, it is still unknown whether microstructural associations of homocysteine on brain tissue properties can be observed in healthy subjects with routine MRI. To this end, we investigated potential relationships between homocysteine levels and microstructural measures computed with diffusion tensor imaging (DTI) in a cohort of 338 healthy participants. Significant positive correlations were observed between homocysteine levels and diffusivity measures in the bilateral temporal WM, the brainstem, and the bilateral cerebellar peduncle. This is the first study demonstrating that DTI is sufficiently sensitive to relate microstructural WM properties to homocysteine levels in healthy subjects.	[Hsu, Jung-Lung; Hsu, Chien-Yeh] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Hsu, Jung-Lung] Chang Gung Mem Hosp, Dept Neurol, Sect Dementia & Cognit Impairment, Linkou, Taiwan; [Hsu, Jung-Lung; Viergever, Max A.; Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Chen, Wei-Hung] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan; [Bai, Chyi-Huey] Taipei Med Univ, Coll Med, Dept Publ Hlth, Taipei, Taiwan; [Leu, Jyu-Gang] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Utrecht University; Utrecht University Medical Center; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Fu Jen Catholic University	Hsu, JL (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan.	tulu@ms36.hinet.net	Leemans, Alexander/A-1784-2011; Viergever, Max A/J-1215-2014	Leemans, Alexander/0000-0002-9306-6126; 	National Science Council [NSC 101-2221-E-038 -006]; Netherlands Organization for Scientific Research (NWO) [639.072.411]	National Science Council(Ministry of Science and Technology, Taiwan); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the National Science Council (NSC 101-2221-E-038 -006). The research of A.L. is supported by VIDI Grant 639.072.411 from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; [Anonymous], 2009, P INT SOC MAGN RESON; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Atmaca M, 2005, PSYCHIAT CLIN NEUROS, V59, P616, DOI 10.1111/j.1440-1819.2005.01425.x; Ayesa-Arriola R, 2012, EUR ARCH PSY CLIN N, V262, P557, DOI 10.1007/s00406-012-0302-2; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Blom HJ, 2011, J INHERIT METAB DIS, V34, P75, DOI 10.1007/s10545-010-9177-4; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; da Cunha AA, 2010, METAB BRAIN DIS, V25, P199, DOI 10.1007/s11011-010-9188-8; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; Della Nave R, 2007, AM J NEURORADIOL, V28, P1313, DOI 10.3174/ajnr.A0555; Deprez S, 2013, BRAIN IMAGING BEHAV, V7, P409, DOI 10.1007/s11682-012-9220-1; Feng L, 2013, AM J GERIAT PSYCHIAT, V21, P164, DOI 10.1016/j.jagp.2012.10.017; Ford AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033345; Geller V, 2013, PSYCHIAT RES, V210, P769, DOI 10.1016/j.psychres.2013.08.016; Harold P, 2005, HDB CEREBROVASCULAR; Hooshmand B, 2013, BRAIN, V136, P2707, DOI 10.1093/brain/awt206; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Kim SR, 2009, J CLIN NEUROL, V5, P85, DOI 10.3988/jcn.2009.5.2.85; Leemans A, 2005, LEC NOTES COMPUT SCI, P3708; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Maillard P, 2011, STROKE, V42, P1917, DOI 10.1161/STROKEAHA.110.609768; McCully KS, 2009, ANN CLIN LAB SCI, V39, P219; Moreto F, 2013, INFLAMMATION, V36, P15, DOI 10.1007/s10753-012-9515-9; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Newton LAA, 2010, EXPERT REV MOL DIAGN, V10, P489, DOI 10.1586/ERM.10.19; O'Dwyer L, 2011, J ALZHEIMERS DIS, V26, P667, DOI 10.3233/JAD-2011-110137; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pikula A, 2012, CIRCULATION, V125, P2100, DOI 10.1161/CIRCULATIONAHA.110.989145; Rajagopalan P, 2011, NEUROREPORT, V22, P391, DOI 10.1097/WNR.0b013e328346bf85; Ruef A, 2012, J PSYCHIATR NEUROSCI, V37, P305, DOI 10.1503/jpn.110057; Sachdev P, 2004, J NEUROL SCI, V226, P25, DOI 10.1016/j.jns.2004.09.006; Sachdev P, 2004, ARCH NEUROL-CHICAGO, V61, P1369, DOI 10.1001/archneur.61.9.1369; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Van Hecke W, 2008, NEUROIMAGE, V43, P69, DOI 10.1016/j.neuroimage.2008.07.006; Van Hecke W, 2007, IEEE T MED IMAGING, V26, P1598, DOI 10.1109/TMI.2007.906786; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Weinstock RS, 2013, DIABETES CARE, V36, P1758, DOI 10.2337/dc12-2388; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Willette AA, 2012, NEUROBIOL AGING, V33, P670, DOI 10.1016/j.neurobiolaging.2010.06.003; Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wong A, 2006, J NEUROL, V253, P441, DOI 10.1007/s00415-005-0022-x; Wright CB, 2005, STROKE, V36, P1207, DOI 10.1161/01.STR.0000165923.02318.22; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032	59	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116330	10.1371/journal.pone.0116330	http://dx.doi.org/10.1371/journal.pone.0116330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693199	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500013
J	Lee, BH; Kim, MH; Lee, JH; Seliktar, D; Cho, NJ; Tan, LP				Lee, Bae Hoon; Kim, Myung Hee; Lee, Jae Ho; Seliktar, Dror; Cho, Nam-Joon; Tan, Lay Poh			Modulation of Huh7.5 Spheroid Formation and Functionality Using Modified PEG-Based Hydrogels of Different Stiffness	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; CELL-LINE; PRIMARY HEPATOCYTES; COLLAGEN SANDWICH; STEM-CELLS; CULTURE; MATRIX; PLATFORM; MODEL; ENCAPSULATION	Physical cues, such as cell microenvironment stiffness, are known to be important factors in modulating cellular behaviors such as differentiation, viability, and proliferation. Apart from being able to trigger these effects, mechanical stiffness tuning is a very convenient approach that could be implemented readily into smart scaffold designs. In this study, fibrinogen-modified poly(ethylene glycol)-diacrylate (PEG-DA) based hydrogels with tunable mechanical properties were synthesized and applied to control the spheroid formation and liver-like function of encapsulated Huh7.5 cells in an engineered, three-dimensional liver tissue model. By controlling hydrogel stiffness (0.1-6 kPa) as a cue for mechanotransduction representing different stiffness of a normal liver and a diseased cirrhotic liver, spheroids ranging from 50 to 200 mu m were formed over a three week time-span. Hydrogels with better compliance (i.e. lower stiffness) promoted formation of larger spheroids. The highest rates of cell proliferation, albumin secretion, and CYP450 expression were all observed for spheroids in less stiff hydrogels like a normal liver in a healthy state. We also identified that the hydrogel modification by incorporation of PEGylated-fibrinogen within the hydrogel matrix enhanced cell survival and functionality possibly owing to more binding of autocrine fibronectin. Taken together, our findings establish guidelines to control the formation of Huh7.5 cell spheroids in modified PEGDA based hydrogels. These spheroids may serve as models for applications such as screening of pharmacological drug candidates.	[Lee, Bae Hoon; Kim, Myung Hee; Lee, Jae Ho; Cho, Nam-Joon; Tan, Lay Poh] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Seliktar, Dror] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Technion Israel Institute of Technology	Cho, NJ (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	NJCho@ntu.edu.sg; LPTan@ntu.edu.sg	Tan, LP/A-2229-2011; Cho, Nam-Joon/J-7816-2012	Tan, LP/0000-0002-0172-1569; Cho, Nam-Joon/0000-0002-8692-8955; Seliktar, Dror/0000-0001-6964-8567	National Research Foundation (NRF) Competitive Research Programme grant in Singapore [NRF-CRP10-2012-07]	National Research Foundation (NRF) Competitive Research Programme grant in Singapore	This research is financially supported by the National Research Foundation (NRF) Competitive Research Programme (NRF-CRP10-2012-07) grant in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan A, 2014, MOL PHARMACEUT, V11, P2106, DOI 10.1021/mp500063y; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cho NJ, 2009, BIOMED MATER, V4, DOI [10.1088/1748-6041/4/1/011001, 10.1088/1748-6041/25/1/011001]; Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038; Donato MT, 2008, CELL TRANSPLANT, V17, P1211, DOI 10.3727/096368908787236620; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; DUNN JCY, 1993, BIOTECHNOL BIOENG, V41, P593, DOI 10.1002/bit.260410512; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fey SJ, 2012, TOXICOL SCI, V127, P403, DOI 10.1093/toxsci/kfs122; Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Hou YT, 2010, J BIOSCI BIOENG, V110, P208, DOI 10.1016/j.jbiosc.2010.01.016; Ivascu A, 2007, INT J ONCOL, V31, P1403; Kamphues C, 2012, ROFO-FORTSCHR RONTG, V184, P1013, DOI 10.1055/s-0032-1313126; Khaitan D, 2006, EXPERT OPIN DRUG DIS, V1, P663, DOI 10.1517/17460441.1.7.663; Klatt D, 2010, BIORHEOLOGY, V47, P133, DOI 10.3233/BIR-2010-0565; Lam CRI, 2014, MOL PHARMACEUT, V11, P2016, DOI 10.1021/mp500059q; Lee BH, 2014, J BIOMAT SCI-POLYM E, V25, P394, DOI 10.1080/09205063.2013.862401; Lee W, 2010, P NATL ACAD SCI USA, V107, P20709, DOI 10.1073/pnas.1005211107; Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052; Li C.Y., 2014, TISSUE ENG A; Liang Y, 2011, BIOMATERIALS, V32, P9308, DOI 10.1016/j.biomaterials.2011.08.045; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Lin TY, 2014, BIOMATERIALS, V35, P6898, DOI 10.1016/j.biomaterials.2014.04.118; Mahou R, 2012, J MATER SCI-MATER M, V23, P171, DOI 10.1007/s10856-011-4512-3; Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x; Molina-Jimenez F, 2012, VIROLOGY, V425, P31, DOI 10.1016/j.virol.2011.12.021; Mueller S, 2010, HEPATIC MED-EVID RES, V2, P49; Nakazawa K, 2002, INT J ARTIF ORGANS, V25, P51, DOI 10.1177/039139880202500109; Napolitano AP, 2007, TISSUE ENG, V13, P2087, DOI 10.1089/ten.2006.0190; Nelson LJ, 2010, CELLS TISSUES ORGANS, V192, P125, DOI 10.1159/000308893; Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8; Tran NM, 2013, TISSUE ENG PT A, V19, P103, DOI [10.1089/ten.TEA.2012.0139, 10.1089/ten.tea.2012.0139]; Peshwa MV, 1996, IN VITRO CELL DEV-AN, V32, P197; Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574; Ringel M, 2005, TOXICOLOGY, V206, P153, DOI 10.1016/j.tox.2004.07.017; Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528; Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328; Semler EJ, 2001, BIOTECHNOL BIOENG, V75, P510, DOI 10.1002/bit.10113; STAMATOGLOU SC, 1987, J CELL BIOL, V105, P2417, DOI 10.1083/jcb.105.5.2417; Subramanian K, 2014, STEM CELLS DEV, V23, P124, DOI 10.1089/scd.2013.0097; Tay CY, 2011, SMALL, V7, P1416, DOI 10.1002/smll.201002298; Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Weber LM, 2006, ACTA BIOMATER, V2, P1, DOI 10.1016/j.actbio.2005.10.005; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Williams CM, 2011, TISSUE ENG PT A, V17, P1055, DOI [10.1089/ten.tea.2010.0398, 10.1089/ten.TEA.2010.0398]; Yu HY, 2013, ADV HEALTHC MATER, V2, P442, DOI 10.1002/adhm.201200142	53	46	47	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118123	10.1371/journal.pone.0118123	http://dx.doi.org/10.1371/journal.pone.0118123			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692976	Green Published, gold			2022-12-27	WOS:000350061500100
J	Cayla, T; Batailler, B; Le Hir, R; Revers, F; Anstead, JA; Thompson, GA; Grandjean, O; Dinant, S				Cayla, Thibaud; Batailler, Brigitte; Le Hir, Rozenn; Revers, Frederic; Anstead, James A.; Thompson, Gary A.; Grandjean, Olivier; Dinant, Sylvie			Live Imaging of Companion Cells and Sieve Elements in Arabidopsis Leaves	PLOS ONE			English	Article							TOBACCO ETCH VIRUS; PHLOEM LECTIN; RIBONUCLEOPROTEIN COMPLEX; SUCROSE SYNTHASE; HIGH-MANNOSE; PROTEIN; THALIANA; TUBES; EXPRESSION; TRANSPORT	The phloem is a complex tissue composed of highly specialized cells with unique subcellular structures and a compact organization that is challenging to study in vivo at cellular resolution. We used confocal scanning laser microscopy and subcellular fluorescent markers in companion cells and sieve elements, for live imaging of the phloem in Arabidopsis leaves. This approach provided a simple framework for identifying phloem cell types unambiguously. It highlighted the compactness of the meshed network of organelles within companion cells. By contrast, within the sieve elements, unknown bodies were observed in association with the PP2-A1:GFP, GFP:RTM1 and RTM2:GFP markers at the cell periphery. The phloem lectin PP2-A1:GFP marker was found in the parietal ground matrix. Its location differed from that of the P-protein filaments, which were visualized with SEOR1:GFP and SEOR2:GFP. PP2-A1:GFP surrounded two types of bodies, one of which was identified as mitochondria. This location suggested that it was embedded within the sieve element clamps, specific structures that may fix the organelles to each another or to the plasma membrane in the sieve tubes. GFP:RTM1 was associated with a class of larger bodies, potentially corresponding to plastids. PP2-A1:GFP was soluble in the cytosol of immature sieve elements. The changes in its subcellular localization during differentiation provide an in vivo blueprint for monitoring this process. The subcellular features obtained with these companion cell and sieve element markers can be used as landmarks for exploring the organization and dynamics of phloem cells in vivo.	[Cayla, Thibaud; Le Hir, Rozenn; Dinant, Sylvie] INRA AgroParisTech, Inst Jean Pierre Bourgin, UMR1318, ERL CNRS 3559,Saclay Plant Sci, Versailles, France; [Batailler, Brigitte] Univ Bordeaux 2, CNRS, INSERM, Bordeaux Imaging Ctr,UMS 3420, F-33076 Bordeaux, France; [Batailler, Brigitte; Revers, Frederic] Univ Bordeaux, INRA, Biol Fruit & Pathol UMR1332, Villenave Dornon, France; [Anstead, James A.; Thompson, Gary A.] Penn State Univ, Coll Agr Sci, University Pk, PA 16802 USA; [Grandjean, Olivier] INRA AgroParisTech, UMR1318, Versailles, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Dinant, S (corresponding author), INRA AgroParisTech, Inst Jean Pierre Bourgin, UMR1318, ERL CNRS 3559,Saclay Plant Sci, Versailles, France.	sylvie.dinant@versailles.inra.fr	, LE HIR Rozenn/M-9111-2016; Revers, Frederic/A-9732-2009	, LE HIR Rozenn/0000-0001-6076-5863; Revers, Frederic/0000-0002-6167-192X; Dinant, Sylvie/0000-0001-6150-995X	Institut National de la Recherche Agronomique; Doctoral School ED145 "Sciences du vegetal", Paris -Sud XI University	Institut National de la Recherche Agronomique; Doctoral School ED145 "Sciences du vegetal", Paris -Sud XI University	This work was supported by the Institut National de la Recherche Agronomique. TC was supported by a PhD fellowship from Doctoral School ED145 "Sciences du vegetal", Paris -Sud XI University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstead JA, 2012, PLANT CELL PHYSIOL, V53, P1033, DOI 10.1093/pcp/pcs046; Batailler B, 2012, PLANT CELL ENVIRON, V35, P1258, DOI 10.1111/j.1365-3040.2012.02487.x; Behnke HD, 1990, SIEVE ELEMENTS COMP; Beneteau J, 2010, PLANT PHYSIOL, V153, P1345, DOI 10.1104/pp.110.153882; Busse JS, 1999, INT J PLANT SCI, V160, P1, DOI 10.1086/314098; Chisholm ST, 2001, PLANT PHYSIOL, V127, P1667, DOI 10.1104/pp.010479; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dannenhoffer JM, 1997, PLANTA, V201, P405, DOI 10.1007/s004250050083; Dinant S, 2003, PLANT PHYSIOL, V131, P114, DOI 10.1104/pp.013086; Ehlers K, 2000, PROTOPLASMA, V214, P80, DOI 10.1007/BF02524265; ELEFTHERIOU EP, 1990, SIEVE ELEMENTS, P139; ESAU K, 1969, P505; EVERT RF, 1990, SIEVE ELEMENTS, P103; Froelich DR, 2011, PLANT CELL, V23, P4428, DOI 10.1105/tpc.111.093179; Furuta KM, 2014, SCIENCE, V345, P933, DOI 10.1126/science.1253736; GEIGENBERGER P, 1993, PLANTA, V190, P446, DOI 10.1007/BF00224782; Gomez G, 2004, J VIROL, V78, P10104, DOI 10.1128/JVI.78.18.10104-10110.2004; Hafke JB, 2005, PLANT PHYSIOL, V138, P1527, DOI 10.1104/pp.104.058511; Hafke JB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00274; Hafke JB, 2013, PLANT PHYSIOL, V162, P707, DOI 10.1104/pp.113.216218; Ham BK, 2009, PLANT CELL, V21, P197, DOI 10.1105/tpc.108.061317; Haritatos E, 2000, PLANTA, V211, P105, DOI 10.1007/s004250000268; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Itaya A, 2000, PROTOPLASMA, V213, P165, DOI 10.1007/BF01282154; Jekat SB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00225; Knoblauch M, 1998, PLANT CELL, V10, P35, DOI 10.1105/tpc.10.1.35; Knoblauch M, 2001, PLANT CELL, V13, P1221, DOI 10.1105/tpc.13.5.1221; Knoblauch M, 2014, J EXP BOT, V65, P1879, DOI 10.1093/jxb/eru071; Knoblauch M, 2010, PLANT CELL ENVIRON, V33, P1439, DOI 10.1111/j.1365-3040.2010.02177.x; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kulikova AL, 2002, RUSS J PLANT PHYSL+, V49, P54, DOI 10.1023/A:1013708210811; Lannoo N, 2006, FEBS LETT, V580, P6329, DOI 10.1016/j.febslet.2006.10.044; Lee JR, 2014, BIOCHEM BIOPH RES CO, V443, P18, DOI 10.1016/j.bbrc.2013.11.034; Liesche J, 2008, PLANT SIGNAL BEHAV, V3, P1136, DOI 10.4161/psb.3.12.7096; Lin MK, 2009, MOL CELL PROTEOMICS, V8, P343, DOI 10.1074/mcp.M800420-MCP200; Martens HJ, 2006, PLANT PHYSIOL, V142, P471, DOI 10.1104/pp.106.085803; NOLTE KD, 1993, PLANT PHYSIOL, V101, P899, DOI 10.1104/pp.101.3.899; OPARKA KJ, 1994, PLANT J, V6, P759, DOI 10.1046/j.1365-313X.1994.6050759.x; Ruping B, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-219; Schobert C, 1998, PLANTA, V206, P245, DOI 10.1007/s004250050396; Sjolund RD, 1997, PLANT CELL, V9, P1137, DOI 10.1105/tpc.9.7.1137; Taoka K, 2007, PLANT CELL, V19, P1866, DOI 10.1105/tpc.107.052522; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Truernit E, 2014, J EXP BOT, V65, P1681, DOI 10.1093/jxb/ert445; TURGEON R, 1989, ANNU REV PLANT PHYS, V40, P119, DOI 10.1146/annurev.pp.40.060189.001003; TURGEON R, 1975, PROTOPLASMA, V83, P217, DOI 10.1007/BF01282555; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Van Bel AJE, 2003, PLANT CELL ENVIRON, V26, P125, DOI 10.1046/j.1365-3040.2003.00963.x; van Dongen JT, 2003, PLANT PHYSIOL, V131, P1529, DOI 10.1104/pp.102.017202; Walz C, 2002, PLANT J, V31, P189, DOI 10.1046/j.1365-313X.2002.01348.x; Whitham SA, 2000, PLANT CELL, V12, P569, DOI 10.1105/tpc.12.4.569	52	33	33	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118122	10.1371/journal.pone.0118122	http://dx.doi.org/10.1371/journal.pone.0118122			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714357	gold, Green Submitted, Green Published			2022-12-27	WOS:000350168700054
J	Del Vesco, AP; Gasparino, E; Grieser, DO; Zancanela, V; Voltolini, DM; Khatlab, AS; Guimaraes, SF; Soares, MM; Neto, ARO				Del Vesco, Ana Paula; Gasparino, Eliane; Grieser, Daiane Oliveira; Zancanela, Vittor; Voltolini, Debora Marques; Khatlab, Angelica Souza; Guimaraes, Simoneeliza Facioni; Menck Soares, Maria Amelia; Oliveira Neto, Adhemar Rodrigues			Effects of Methionine Supplementation on the Expression of Protein Deposition-Related Genes in Acute Heat Stress-Exposed Broilers	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; OXIDATIVE STRESS; ENVIRONMENTAL-TEMPERATURE; IGF-I; GROWTH; CHICKENS; MTOR; ACID; ATROGIN-1; TURNOVER	The objective of this study was to evaluate the effect of heat stress and methionine supplementation on the gene expression of insulin-like growth factor I (IGF-I), growth hormone receptor (GHR), phosphatidylinositol 3-kinase, and regulatory 1 (PI3KR1) in the liver, as well as the expression of the atrogin 1 and cathepsin L2 (CTSL2) genes in the breast muscle of broilers. Broilers from 1-21 and 22-42 days of age were divided into three treatments related to methionine supplementation as follows: without methionine supplementation (MD), recommended level of methionine (DL1), and excess supplementation of methionine (DL2). The animals were either maintained at a thermal comfort temperature or exposed to heat stress (HS) (38 degrees C for 24 hours, starting on day 20 or day 41 for experiments 1 and 2, respectively). The heat stress increased the body temperature at both ages. Starter period: The HS animals presented increased plasma creatinine content (P < 0.0001) and the highest CTSL2 gene expression (P < 0.0001). The methionine supplementation increased the IGF-I (P = 0.0144) and GHR (P = 0.0011) gene expression and decreased the CTSL2 (P = 0.0004) and atrogin 1 (P = 0.0012) gene expression. Grower period: Significant effects for the interaction between supplementation and environment were observed for GHR (P = 0.0252) and CTSL2 (P = 0.0011) gene expression. The highest GHR expression was observed in animals that remained in thermal comfort on the DL2 diet, and the lowest expression occurred in the HS animals fed the MD diet. For CTSL2, the HS animals fed the MD diet presented the highest CTSL2 gene expression, and the lowest expression was observed in the animals maintained at thermal comfort on DL1 and DL2 diets. Only methionine supplementation had effect on atrogin-1 gene expression (P < 0.0001), with higher methionine content in the diet lower atrogin-1 gene expression was observed. Our results suggest that heat stress induces greater protein degradation and that methionine supplementation could induce protein deposition because methionine increased the expression of genes related to protein synthesis and decreased the expression of genes related to protein breakdown.	[Del Vesco, Ana Paula; Gasparino, Eliane; Grieser, Daiane Oliveira; Zancanela, Vittor; Voltolini, Debora Marques; Khatlab, Angelica Souza] Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil; [Guimaraes, Simoneeliza Facioni] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Menck Soares, Maria Amelia] Univ Fed Rural Rio de Janeiro, Dept Genet, Rio de Janeiro, Brazil; [Oliveira Neto, Adhemar Rodrigues] Evonik Degussa, Sao Paulo, SP, Brazil	Universidade Estadual de Maringa; Universidade Federal de Vicosa; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Evonik Industries	Del Vesco, AP (corresponding author), Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil.	apaulavesco@gmail.com; egasparino@uem.br	Del Vesco, Ana/AAW-5174-2021; SOARES, MARIA AMELIA MENCK/AAQ-5097-2020; Grieser, Daiane/AAE-1904-2020; Del+Vesco, Ana/AAT-5956-2021; facioni guimaraes, simone eliza/HHZ-5341-2022	Del Vesco, Ana/0000-0002-0145-7817; SOARES, MARIA AMELIA MENCK/0000-0002-8268-3065; de Oliveira Grieser, Daiane/0000-0003-4890-9048; facioni guimaraes, simone eliza/0000-0003-3704-8131	Brazilian National Council for Research-CNPq [483751/2012-0]	Brazilian National Council for Research-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported and funded by the Brazilian National Council for Research-CNPq (No 483751/2012-0). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K. L., 2001, PRINCIPLES PRACTICE, V3rd; Biolo G, 1998, MINER ELECTROL METAB, V24, P267, DOI 10.1159/000057380; Del Vesco AP, 2013, GENET MOL RES, V12, P6414, DOI 10.4238/2013.December.10.2; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Geraert PA, 1996, BRIT J NUTR, V75, P205, DOI 10.1079/BJN19960125; Gomes-Marcondes MCC, 2002, CANCER LETT, V180, P69, DOI 10.1016/S0304-3835(02)00006-X; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MITCHELL MA, 1992, COMP BIOCHEM PHYS A, V101, P137, DOI 10.1016/0300-9629(92)90641-3; Morand C, 1997, J NUTR BIOCHEM, V8, P246, DOI 10.1016/S0955-2863(97)89661-1; Nakashima K, 2006, BIOSCI BIOTECH BIOCH, V70, P2775, DOI 10.1271/bbb.60274; Neto ARD, 2000, REV BRAS ZOOTECN, V29, P183; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Rostagno HS, 2011, BRAZILIAN TABLES BIR; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Scanes CG, 2009, GEN COMP ENDOCR, V163, P24, DOI 10.1016/j.ygcen.2009.04.013; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Stubbs AK, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740335; Temim S, 2000, J NUTR, V130, P813, DOI 10.1093/jn/130.4.813; Tesseraud S, 2007, BIOCHEM BIOPH RES CO, V357, P181, DOI 10.1016/j.bbrc.2007.03.131; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Willemsen H, 2011, POULTRY SCI, V90, P2311, DOI 10.3382/ps.2011-01353; Wu G, 2013, AMINO ACIDS: BIOCHEMISTRY AND NUTRITION, P1, DOI 10.1201/b14661; Yoon MS, 2013, MOL BIOL CELL, V24, P3754, DOI 10.1091/mbc.E13-06-0353; Yunianto VD, 1997, BRIT J NUTR, V77, P897, DOI 10.1079/BJN19970088	29	39	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0115821	10.1371/journal.pone.0115821	http://dx.doi.org/10.1371/journal.pone.0115821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714089	gold, Green Published, Green Submitted			2022-12-27	WOS:000350168700007
J	Leighty, KA; Valuska, AJ; Grand, AP; Bettinger, TL; Mellen, JD; Ross, SR; Boyle, P; Ogden, JJ				Leighty, Katherine A.; Valuska, Annie J.; Grand, Alison P.; bettinger, Tamara L.; Mellen, Jill D.; Ross, Stephen R.; Boyle, Paul; Ogden, Jacqueline J.			Impact of Visual Context on Public Perceptions of Non-Human Primate Performers	PLOS ONE			English	Article								Prior research has shown that the use of apes, specifically chimpanzees, as performers in the media negatively impacts public attitudes of their conservation status and desirability as a pet, yet it is unclear whether these findings generalize to other non-human primates (specifically non-ape species). We evaluated the impact of viewing an image of a monkey or prosimian in an anthropomorphic or naturalistic setting, either in contact with or in the absence of a human. Viewing the primate in an anthropomorphic setting while in contact with a person significantly increased their desirability as a pet, which also correlated with increased likelihood of believing the animal was not endangered. The majority of viewers felt that the primates in all tested images were "nervous." When shown in contact with a human, viewers felt they were "sad" and "scared", while also being less "funny." Our findings highlight the potential broader implications of the use of non-human primate performers by the entertainment industry.	[Leighty, Katherine A.; Valuska, Annie J.; bettinger, Tamara L.; Mellen, Jill D.; Ogden, Jacqueline J.] Walt Disney World, Disneys Anim Sci & Environm, Lake Buena Vista, FL 32830 USA; [Grand, Alison P.] Lemur Conservat Fdn, Myakka City, FL 34251 USA; [Ross, Stephen R.] Lincoln Pk Zoo, Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA; [Boyle, Paul] Assoc Zoos & Aquariums, Silver Spring, MD 20910 USA	Walt Disney Company	Leighty, KA (corresponding author), Walt Disney World, Disneys Anim Sci & Environm, Lake Buena Vista, FL 32830 USA.	katherine.leighty@disney.com			Walt Disney World; Association of Zoos and Aquariums	Walt Disney World; Association of Zoos and Aquariums	The authors received no specific funding for this work. Co-authors KAL, AJV, TLB, JDM and JJO are employed by Walt Disney World. Co-author PB is employed by the Association of Zoos and Aquariums. Walt Disney World and the Association of Zoos and Aquariums provided support in the form of salaries for authors KAL, AJV, TLB, JDM and JJO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Beatty P., 1995, P SECT SURV RES METH; Freeman HD, 2014, PEERJ, V2, DOI 10.7717/peerj.579; Lancendorfer KM, 2008, J BUS RES, V61, P384, DOI 10.1016/j.jbusres.2006.08.011; Ross SR, 2008, SCIENCE, V319, P1487, DOI 10.1126/science.1154490; Ross SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022050; RUBIN DB, 1995, J AM STAT ASSOC, V90, P822, DOI 10.2307/2291315; Schroepfer KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026048; Soulsbury CD, 2009, J APPL ANIM WELF SCI, V12, P1, DOI 10.1080/10888700802536483; Tomkovick C, 2001, J MARK COMMUN, V7, P89, DOI 10.1080/135272601750255171	9	29	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118487	10.1371/journal.pone.0118487	http://dx.doi.org/10.1371/journal.pone.0118487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714101	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700079
J	Pokharel, KP; Ludwig, T; Storch, I				Pokharel, Krishna Prasad; Ludwig, Tobias; Storch, Ilse			Spatial Niche Partitioning in Sub-Tropical Solitary Ungulates: Four-Horned Antelope and Barking Deer in Nepal	PLOS ONE			English	Article							ECOLOGICAL SURVEY; TROPICAL FORESTS; WILDLIFE-RESERVE; PANTHERA-PARDUS; INDIAN MUNTJAC; NATIONAL-PARK; MULE-DEER; DISTRIBUTIONS; POPULATION; PREDICTION	Differential resource use allows a diversity of species to co-exist in a particular area by specializing in individual ecological niches. Four-horned antelope Tetracerus quadricornis is endemic to the Indian subcontinent and has a restricted distribution in Nepal and India; however, the barking deer Muntiacus vaginalis is relatively common throughout its wide distribution range. We wanted a better understanding of their habitats and how these two similarly sized solitary ungulates manage to coexist in lowland Nepal. We used fecal pellet belt transect surveys in the Babai valley, Bardia National Park to study the habitat associations of both species. We found empirical evidence that four-horned antelope prefer hill sal forest and deciduous hill forest at higher elevations, whereas barking deer preferred riverine and sal forest in lower elevations. We found a clear niche differentiation of four-horned antelope and barking deer that made the coexistence of these similarly sized solitary ungulates possible. Hence, resource partitioning is the key to coexistence of these solitary ungulates, and the fine-grained habitat mosaic of different forest types in the study landscape appears to be the underlying feature. Therefore, maintaining the habitat mosaic and preserving valuable hill sal and deciduous hill forests will facilitate the coexistence of herbivores in subtropical regions.	[Pokharel, Krishna Prasad; Ludwig, Tobias; Storch, Ilse] Univ Freiburg, Fac Environm & Nat Resources, Wildlife Ecol & Management, D-79106 Freiburg, Germany	University of Freiburg	Pokharel, KP (corresponding author), Univ Freiburg, Fac Environm & Nat Resources, Wildlife Ecol & Management, Hugstetter Str 55, D-79106 Freiburg, Germany.	kp.pokharel@gmail.com	Storch, Ilse/N-7478-2019; Ludwig, Tobias/P-2011-2019; /AAD-2189-2020; Ludwig, Tobias/H-4430-2019; Storch, Ilse/P-6806-2019; Ludwig, Tobias/K-2979-2012	Ludwig, Tobias/0000-0001-8409-9359; /0000-0003-4335-9630; Storch, Ilse/0000-0002-3252-2036; Ludwig, Tobias/0000-0001-8409-9359	Rufford Foundation [9748-1]; PhD scholarship from state graduate funding (LGFG) through International Graduate Academy (IGA) of the University of Freiburg; German Research Foundation (DFG); Albert Ludwigs University Freiburg in the funding programme Open Access Publishing	Rufford Foundation; PhD scholarship from state graduate funding (LGFG) through International Graduate Academy (IGA) of the University of Freiburg; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg in the funding programme Open Access Publishing	KPP received partial funding from The Rufford Foundation (Ref. No. 9748-1; http://www.rufford.org) for the field work and was supported by a PhD scholarship from state graduate funding (LGFG) through International Graduate Academy (IGA) of the University of Freiburg. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrestani FS, 2011, BASIC APPL ECOL, V12, P634, DOI 10.1016/j.baae.2011.08.008; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; BARRETTE C, 1977, MAMMALIA, V41, P1, DOI 10.1515/mamm.1977.41.1.1; Barton K., 2014, MUMIN MULTIMODEL INF; Baskaran N., 2009, J SCI T ENV TECHNOL, V2, P139, DOI 10.20894/STET.116.002.003.005; Baskaran N, 2011, MAMM BIOL, V76, P741, DOI 10.1016/j.mambio.2011.06.010; Brodie JF, 2009, ECOL RES, V24, P1251, DOI 10.1007/s11284-009-0610-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chillo V, 2010, ACTA OECOL, V36, P611, DOI 10.1016/j.actao.2010.09.006; COLLINS WB, 1981, J WILDLIFE MANAGE, V45, P969, DOI 10.2307/3808105; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; DINERSTEIN E, 1979, BIOL CONSERV, V15, P127, DOI 10.1016/0006-3207(79)90030-2; DINERSTEIN E, 1980, BIOL CONSERV, V18, P5, DOI 10.1016/0006-3207(80)90063-4; DINERSTEIN E, 1989, BIOTROPICA, V21, P214, DOI 10.2307/2388646; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Freeman EA, 2008, J STAT SOFTW, V23, P1; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Heinze E, 2011, FOREST ECOL MANAG, V261, P288, DOI 10.1016/j.foreco.2010.10.022; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jnawali S. R., 2011, STATUS NEPAL MAMMALS; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; KARANTH KU, 1992, J TROP ECOL, V8, P21, DOI 10.1017/S0266467400006040; Khan JA, 1996, J TROP ECOL, V12, P149, DOI 10.1017/S0266467400009366; Krishna YC, 2008, J ZOOL, V276, P63, DOI 10.1111/j.1469-7998.2008.00470.x; Leslie David M. Jr., 2009, Mammalian Species, P1, DOI 10.1644/843.1; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Mallon D.P., 2001, ANTELOPES 4, P231; Mallon D. P., 2008, IUCN RED LIST THREAT; Mansson J, 2011, EUR J WILDLIFE RES, V57, P1017, DOI 10.1007/s10344-011-0512-3; McCullagh P, 1989, GEN LINEAR MODELS; Moe SR, 1997, J TROP ECOL, V13, P279, DOI 10.1017/S0266467400010452; NEFF DJ, 1968, J WILDLIFE MANAGE, V32, P597, DOI 10.2307/3798941; Odden M, 2007, ZOOLOGY, V110, P261, DOI 10.1016/j.zool.2007.03.003; Odden M, 2009, ACTA THERIOL, V54, P23, DOI 10.1007/BF03193134; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Pokharel K., 2010, Nepal Journal of Science and Technology, V11, P223; Pokharel Krishna, 2012, Gnusletter, V30, P13; Prater S.H., 1971, BOOK INDIAN ANIMALS, V3rd; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Ridgeway G., 2013, GBM GEN BOOSTED REGR; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Sharma Koustubh, 2009, Journal of the Bombay Natural History Society, V106, P72; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Steinheim G, 2005, J ZOOL, V265, P377, DOI 10.1017/S0952836905006448; Stewart KM, 2003, ECOSCIENCE, V10, P297, DOI 10.1080/11956860.2003.11682777; Teng LW, 2004, ECOL RES, V19, P675, DOI 10.1111/j.1440-1703.2004.00683.x; Timmins R., 2008, IUCN RED LIST THREAT; United States Geological Survey, 2004, SHUTTL RAD TOP MISS; Wegge P, 2009, BIOL CONSERV, V142, P189, DOI 10.1016/j.biocon.2008.10.020	61	11	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117917	10.1371/journal.pone.0117917	http://dx.doi.org/10.1371/journal.pone.0117917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714092	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700043
J	Turner, AH				Turner, Alan H.			A Review of Shamosuchus and Paralligator (Crocodyliformes, Neosuchia) from the Cretaceous of Asia	PLOS ONE			English	Review							PHYLOGENETIC-RELATIONSHIPS; VERTEBRATE ASSEMBLAGE; CRANIAL ANATOMY; MESOEUCROCODYLIA; CROCODYLOMORPHA; ATOPOSAURIDAE; THERIOSUCHUS; MORPHOLOGY; ARCHOSAURIA; ORIGIN	The crocodyliform Shamosuchus is known from numerous Late Cretaceous localities in southern and eastern Mongolia and fragmentary remains from Uzbekistan. Seven species of Shamosuchus have been named from six localities in Mongolia and three in Uzbekistan. Six species originally described as Paralligator were later referred to Shamosuchus. Only the type species, Shamosuchus djadochtaensis has been examined in detail. Many of the named species of Shamosuchus show striking similarity in size and cranial morphology but most are based on partial remains suggesting that the true species diversity is overestimated. A review of all species referred to Shamosuchus recognizes three valid taxa: Shamosuchus djadochtaensis, S. gradilifrons, and S. major. Shamosuchus sungaricus, S. borealis, and S. karakalpakensis are nomena dubia, whereas S. ancestralis, S. ulgicus, S. tersus, and S. ulanicus are junior subjective synonyms of S. gradilifrons. Phylogenetic analysis of 318 phenotypic characters recovers a Paralligatoridae clade consisting of Shamosuchus, Rugosuchus, Batrachomimus, Glen Rose Form, and Wannchampsus. Shamosuchus is non-monophyletic: S. djadochtaensis is near the base of Paralligatoridae whereas S. gradilifrons + S. major are the most deeply nested. The name Paralligator is resurrected for this clade. Rugosuchus and Batrachomimus are sister taxa to Paralligator. Paralligatoridae is closely related to Theriosuchus, hylaeochampsids and a speciose Allodaposuchus clade, which together are the sister group of Borealosuchus plus Crocodylia. These results support the presence of a diverse clade in eastern Asia and western North America throughout the Cretaceous with origins in the Late Jurassic.	SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Turner, AH (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.	alan.turner@stonybrook.edu			Research Foundation of State University of New York; National Science Foundation [NSF DEB 1257485]	Research Foundation of State University of New York; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Research Foundation of the State University of New York and by a grant from the National Science Foundation (NSF DEB 1257485) to AHT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TL, 2014, J PALEONTOL, V88, P1031, DOI 10.1666/12-089; Adams TL, 2013, J VERTEBR PALEONTOL, V33, P85, DOI 10.1080/02724634.2012.713277; Averianov A, 2012, CRETACEOUS RES, V34, P284, DOI 10.1016/j.cretres.2011.11.009; Benton M.J., 1988, Systematics Association Special Volume Series, P295; Bever GS, 2005, J VERTEBR PALEONTOL, V25, P548, DOI 10.1671/0272-4634(2005)025[0548:VITION]2.0.CO;2; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brinkmann W., 1992, BERLINER GEOWISSENSC, V5, P1; Brochu CA, 1997, SYST BIOL, V46, P479, DOI 10.2307/2413693; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brochu C, 2011, J VERTEBR PALEONTOL, V31, P78; Brochu CA, 2012, EARTH ENV SCI T R SO, V103, P521, DOI 10.1017/S1755691013000200; Buffetaut E., 1982, ME MOIRES SOCIE TE G, V142, P1, DOI DOI 10.1016/S0016-6995(83)80048-5; Buscalioni A.D., 1990, Journal of Vertebrate Paleontology, V10, P244; Buscalioni AD, 2001, J VERTEBR PALEONTOL, V21, P74, DOI 10.1671/0272-4634(2001)021[0074:AROTCA]2.0.CO;2; Clark J. M., 1986, THESIS U CHICAGO CHI; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; CODDINGTON J, 1994, CLADISTICS, V10, P415; Dashzeveg D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)498[0001:NSSDEA]2.0.CO;2; DASHZEVEG D, 1995, NATURE, V374, P446, DOI 10.1038/374446a0; Dingus L, 2008, AM MUS NOVIT, P1, DOI 10.1206/442.1; Efimov M.B., 1975, Paleontological J, V9, P417; Efimov M.B., 1988, T SOVMESTNOY SOVETSK, V36, P1; Efimov MB, 1982, PALEONTOLOGICHESKII, V2, P146; EFIMOV MB, 1983, T SOVMESTNOI SOVESTS, V24, P76; EFIMOV MB, 1981, T SOVMESTNOI SOVETSK, V15, P26; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Halliday TJD, 2015, ACTA PALAEONTOL POL, V60, P291, DOI 10.4202/app.2013.0018; Iordansky N.N., 1973, P201; Joffe J., 1967, Palaeontology, V10, P629; Jouve S, 2006, ZOOL J LINN SOC-LOND, V148, P603, DOI 10.1111/j.1096-3642.2006.00241.x; Jouve S, 2009, J VERTEBR PALEONTOL, V29, P88, DOI 10.1080/02724634.2009.10010364; Kalin J, 1955, TRAITE PALEONTOL, V5, P695; Konzhukova E.D., 1954, T PALEONTOLOGICHESKO, V48, P171; Langston W. Jr., 1974, Geoscience Man, V8, P77; Langston W. Jr., 1973, P263; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Lauprasert K, 2011, PALAEONTOL Z, V85, P37, DOI 10.1007/s12542-010-0071-z; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Macrini TE, 2009, J VERTEBR PALEONTOL, V29, P1199, DOI 10.1671/039.029.0413; Martin JE, 2014, J PALEONTOL, V88, P444, DOI 10.1666/13-106; Martin JE, 2010, NATURWISSENSCHAFTEN, V97, P845, DOI 10.1007/s00114-010-0702-y; Montefeltro FC, 2013, NATURWISSENSCHAFTEN, V100, P835, DOI 10.1007/s00114-013-1083-9; Mook C.C., 1924, AM MUS NOVIT, V117, P1; MOOK CHARLES C., 1934, JOUR GEOL, V42, P295; Nesbitt SJ, 2008, J VERTEBR PALEONTOL, V28, P1063, DOI 10.1671/0272-4634-28.4.1063; NESOV LA, 1989, SESSII VSESOYUZNOGO, V33, P144; Nesov LA, 1995, DINOSAURIA N EURASIA; Nestler JH, 2012, THESIS; NORELL M A, 1990, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V60, P115; O'Leary M.A., 2007, MORPHOBANK 2 5 WEB A; Owen R., 1879, PALAEONTOGRAPHICAL S, V33, P1; Pol D, 2004, CRETACEOUS RES, V25, P603, DOI 10.1016/j.cretres.2004.05.002; Pol D, 2009, B AM MUS NAT HIST, P1; Pritchard AC, 2013, AM MUS NOVIT, P1; Puertolas-Pascual E, 2014, HIST BIOL, V26, P91, DOI 10.1080/08912963.2012.763034; Rogers JV, 2003, J VERTEBR PALEONTOL, V23, P128, DOI 10.1671/0272-4634(2003)23[128:PTANPC]2.0.CO;2; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Salisbury SW, 2002, SPEC PAP PALAEONTOL, P121; Schwarz D, 2005, GEOBIOS-LYON, V38, P779, DOI 10.1016/j.geobios.2004.04.005; Steel R., 1973, HDB PALEOHERPETOLOGI, V16; Storrs Glenn W., 2000, P402; Sun A., 1958, Vertebrata Palasiatica, V2, P277; SUN AL, 1992, CHINESE FOSSIL REPTI; Turner A. H., 2010, J VERTEBRATE PALE S3, V30, p179A, DOI [10.13140/2.1.5127.3928, DOI 10.13140/2.1.5127.3928]; Turner AH, 2011, J VERTEBRATE PALE S3, V31, p110A, DOI DOI 10.1080/02724634.2011.550359; Turner AH, 2008, J VERTEBR PALEONTOL, V28, P382, DOI 10.1671/0272-4634(2008)28[382:MICMCA]2.0.CO;2; Turner AH, 2010, J VERTEBR PALEONTOL, V30, P177, DOI 10.1080/02724634.2010.532348; Wu XC, 1996, CAN J EARTH SCI, V33, P599, DOI 10.1139/e96-044; Wu XC, 2001, CAN J EARTH SCI, V38, P1653, DOI 10.1139/e01-055	74	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118116	10.1371/journal.pone.0118116	http://dx.doi.org/10.1371/journal.pone.0118116			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714338	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700053
J	Erives, AJ; Fassler, JS				Erives, Albert J.; Fassler, Jan S.			Metabolic and Chaperone Gene Loss Marks the Origin of Animals: Evidence for Hsp104 and Hsp78 Chaperones Sharing Mitochondrial Enzymes as Clients	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; ALPHA-AMINOADIPATE PATHWAY; SHOCK TRANSCRIPTION FACTOR; CLPB HOMOLOG HSP78; SACCHAROMYCES-CEREVISIAE; CELL-DIFFERENTIATION; NETWORK INTEGRATION; LYSINE BIOSYNTHESIS; MAXIMUM-LIKELIHOOD; PROTEIN	The evolution of animals involved acquisition of an emergent gene repertoire for gastrulation. Whether loss of genes also co-evolved with this developmental reprogramming has not yet been addressed. Here, we identify twenty-four genetic functions that are retained in fungi and choanoflagellates but undetectable in animals. These lost genes encode: (i) sixteen distinct biosynthetic functions; (ii) the two ancestral eukaryotic ClpB disaggregases, Hsp78 and Hsp104, which function in the mitochondria and cytosol, respectively; and (iii) six other assorted functions. We present computational and experimental data that are consistent with a joint function for the differentially localized ClpB disaggregases, and with the possibility of a shared client/chaperone relationship between the mitochondrial Fe/S homoaconitase encoded by the lost LYS4 gene and the two ClpBs. Our analyses lead to the hypothesis that the evolution of gastrulation-based multicellularity in animals led to efficient extraction of nutrients from dietary sources, loss of natural selection for maintenance of energetically expensive biosynthetic pathways, and subsequent loss of their attendant ClpB chaperones.	[Erives, Albert J.; Fassler, Jan S.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Erives, AJ (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	albert-erives@uiowa.edu; jan-fassler@uiowa.edu			National Science Foundation [1239673]	National Science Foundation(National Science Foundation (NSF))	This study was funded by the National Science Foundation, award: 1239673 (AE), www.nsf.gov/ios. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1987, MOL CELL BIOL, V7, P1055, DOI 10.1128/MCB.7.3.1055; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; BONNER JJ, 1994, MOL CELL BIOL, V14, P501, DOI 10.1128/MCB.14.1.501; Dayel MJ, 2011, DEV BIOL, V357, P73, DOI 10.1016/j.ydbio.2011.06.003; Degnan BM, 2009, CURR OPIN GENET DEV, V19, P591, DOI 10.1016/j.gde.2009.09.008; Degnan BM, 2005, INTEGR COMP BIOL, V45, P335, DOI 10.1093/icb/45.2.335; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Eliyahu E, 2012, FEBS LETT, V586, P64, DOI 10.1016/j.febslet.2011.11.025; Fairclough SR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r15; Fazius F, 2012, MOL MICROBIOL, V86, P1508, DOI 10.1111/mmi.12076; Fondi M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S3; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Guberman Jonathan M, 2011, Database (Oxford), V2011, pbar041, DOI 10.1093/database/bar041; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hashikawa N, 2007, J BIOL CHEM, V282, P10333, DOI 10.1074/jbc.M609708200; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanneganti V, 2011, MOL BIOL CELL, V22, P1648, DOI 10.1091/mbc.E10-11-0878; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; KOBAYASHI N, 1993, MOL CELL BIOL, V13, P248, DOI 10.1128/MCB.13.1.248; Kominek J, 2013, GENOME BIOL EVOL, V5, P2460, DOI 10.1093/gbe/evt192; Kosuge T, 1999, J BIOSCI BIOENG, V88, P672, DOI 10.1016/S1389-1723(00)87099-1; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; Kryndushkin DS, 2002, J BIOL CHEM, V277, P23702, DOI 10.1074/jbc.M111547200; Krzewska J, 2001, FEBS LETT, V489, P92, DOI 10.1016/S0014-5793(00)02423-6; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Lee S, 2000, MOL BIOL CELL, V11, P1753, DOI 10.1091/mbc.11.5.1753; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LEONHARDT SA, 1993, MOL CELL BIOL, V13, P6304, DOI 10.1128/MCB.13.10.6304; Lewandowska A, 2006, BBA-MOL CELL RES, V1763, P141, DOI 10.1016/j.bbamcr.2006.01.007; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Lian HY, 2007, J BIOL CHEM, V282, P11931, DOI 10.1074/jbc.M606856200; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Mah JL, 2014, EVOL DEV, V16, P25, DOI 10.1111/ede.12060; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; MOCZKO M, 1995, J MOL BIOL, V254, P538, DOI 10.1006/jmbi.1995.0636; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nakanishi N, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-26; Neuwald AF, 1999, GENOME RES, V9, P27; Nielsen C, 2008, EVOL DEV, V10, P241, DOI 10.1111/j.1525-142X.2008.00231.x; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Py B, 2011, CURR OPIN MICROBIOL, V14, P218, DOI 10.1016/j.mib.2011.01.004; Quezada H, 2011, MOL MICROBIOL, V82, P578, DOI 10.1111/j.1365-2958.2011.07832.x; Rakwalska M, 2004, MOL CELL BIOL, V24, P9186, DOI 10.1128/MCB.24.20.9186-9197.2004; Richards GS, 2009, COLD SH Q B, V74, P81, DOI 10.1101/sqb.2009.74.028; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rottgers K, 2002, J BIOL CHEM, V277, P45829, DOI 10.1074/jbc.M207152200; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schmitt M, 1996, J CELL BIOL, V134, P1375, DOI 10.1083/jcb.134.6.1375; Sebe-Pedros A, 2011, MOL BIOL EVOL, V28, P1241, DOI 10.1093/molbev/msq309; Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas C, 2009, REDOX REP, V14, P102, DOI 10.1179/135100009X392566; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; Tkach JM, 2008, TRAFFIC, V9, P39, DOI 10.1111/j.1600-0854.2007.00666.x; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; Yu RC, 2008, IET SYST BIOL, V2, P222, DOI 10.1049/iet-syb:20080127; Zarin T, 2014, YEAST	85	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117192	10.1371/journal.pone.0117192	http://dx.doi.org/10.1371/journal.pone.0117192			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710177	gold, Green Submitted, Green Published			2022-12-27	WOS:000350683900026
J	Carbajosa, NAL; Corradi, G; Verrilli, MAL; Guil, MJ; Vatta, MS; Gironacci, MM				Longo Carbajosa, Nadia A.; Corradi, Gerardo; Lopez Verrilli, Maria A.; Guil, Maria J.; Vatta, Marcelo S.; Gironacci, Mariela M.			Tyrosine Hydroxylase Is Short-Term Regulated by the Ubiquitin-Proteasome System in PC12 Cells and Hypothalamic and Brainstem Neurons from Spontaneously Hypertensive Rats: Possible Implications in Hypertension	PLOS ONE			English	Article							PROTEIN-DEGRADATION; GENE-EXPRESSION; IN-VIVO; PATHWAY; PHOSPHORYLATION; MECHANISM; ENZYME; LINE	Aberrations in the ubiquitin-proteasome system (UPS) are implicated in the pathogenesis of various diseases. Tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamines biosynthesis, is involved in hypertension development. In this study we investigated whether UPS regulated TH turnover in PC12 cells and hypothalamic and brainstem neurons from spontaneously hypertensive rats (SHR) and whether this system was impaired in hypertension. PC12 cells were exposed to proteasome or lysosome inhibitors and TH protein level evaluated by Western blot. Lactacystin, a proteasome inhibitor, induced an increase of 86 +/- 15% in TH levels after 30 min of incubation, then it started to decrease up to 6 h to reach control levels and finally it rose up to 35.2 +/- 8.5% after 24 h. Bafilomycin, a lysosome inhibitor, did not alter TH protein levels during short times, but it increased TH by 92 +/- 22% above basal after 6 h treatment. Before degradation proteasome substrates are labeled by conjugation with ubiquitin. Efficacy of proteasome inhibition on TH turnover was evidenced by accumulation of ubiquitinylated TH after 30 min. Further, the inhibition of proteasome increased the quantity of TH phosphorylated at Ser40, which is essential for TH activity, by 2.7 +/- 0.3 fold above basal. TH protein level was upregulated in neurons from hypothalami and brainstem of SHR when the proteasome was inhibited during 30 min, supporting that neuronal TH is also short-term regulated by the proteasome. Since the increased TH levels reported in hypertension may result from proteasome dysfunction, we evaluate proteasme activity. Proteasome activity was significantly reduced by 67 +/- 4% in hypothalamic and brainstem neurons from SHR while its protein levels did not change. Present findings show that TH is regulated by the UPS. The impairment in proteasome activity observed in SHR neurons may be one of the causes of the increased TH protein levels reported in hypertension.	[Longo Carbajosa, Nadia A.; Corradi, Gerardo; Lopez Verrilli, Maria A.; Gironacci, Mariela M.] Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB CONICET, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Guil, Maria J.; Vatta, Marcelo S.] Univ Buenos Aires, Fac Farm & Bioquim, IQUIMEFA CONICET, Catedra Fisiol, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Gironacci, MM (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB CONICET, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina.	mariela@qb.ffyb.uba.ar		Corradi, Gerardo Raul/0000-0003-0354-7709; Gironacci, Mariela/0000-0002-8189-0388	Universidad de Buenos Aires [UBACyT 20020120100194]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 11220110101097]; Agencia Nacional de Promocion Cientificay Tecnologica [PICT 2010-1998]	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientificay Tecnologica(ANPCyT)	This work was supported by by the following agencies and organisations: Universidad de Buenos Aires (grant UBACyT 20020120100194), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (grant PIP 11220110101097) and Agencia Nacional de Promocion Cientificay Tecnologica (grant PICT 2010-1998). GC, MV and MMG are career researchers from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptista MS, 2012, CELL MOL LIFE SCI, V69, P2691, DOI 10.1007/s00018-012-0946-0; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Ciechanover A, 2012, NEURODEGENER DIS, V10, P7, DOI 10.1159/000334283; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Doskeland AP, 2002, EUR J BIOCHEM, V269, P1561, DOI 10.1046/j.1432-1033.2002.02808.x; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fernandez E, 1999, J NEUROCHEM, V73, P169, DOI 10.1046/j.1471-4159.1999.0730169.x; Fujisawa H, 2005, BIOCHEM BIOPH RES CO, V338, P271, DOI 10.1016/j.bbrc.2005.07.183; Gironacci MM, 2011, HYPERTENSION, V58, P176, DOI 10.1161/HYPERTENSIONAHA.111.173344; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goncharov S V, 2009, Fiziol Zh, V55, P3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Kisselev AF, 1999, MOL CELL, V4, P395, DOI 10.1016/S1097-2765(00)80341-X; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lehmann IT, 2006, J BIOL CHEM, V281, P17644, DOI 10.1074/jbc.M512194200; Verrilli MAL, 2009, J NEUROCHEM, V109, P326, DOI 10.1111/j.1471-4159.2009.05912.x; Ludwig A, 2009, J MOL MED, V87, P793, DOI 10.1007/s00109-009-0469-9; Marfella R, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-35; Nakashima A, 2011, BIOCHEM BIOPH RES CO, V407, P343, DOI 10.1016/j.bbrc.2011.03.020; Ong LK, 2012, NEUROCHEM RES, V37, P1938, DOI 10.1007/s11064-012-0812-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Rao F, 2007, CIRCULATION, V116, P993, DOI 10.1161/CIRCULATIONAHA.106.682302; Reja V, 2002, HYPERTENSION, V40, P342, DOI 10.1161/01.HYP.0000027684.06638.63; Sakamoto K, 2009, OBESITY, V17, P1044, DOI 10.1038/oby.2008.612; Schlossarek S, 2011, CURR OPIN CARDIOL, V26, P190, DOI 10.1097/HCO.0b013e32834598fe; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Stangl K, 2010, CARDIOVASC RES, V85, P281, DOI 10.1093/cvr/cvp315; TANK AW, 1986, MOL PHARMACOL, V30, P486; Tayebati SK, 2012, J NEUROL SCI, V322, P241, DOI 10.1016/j.jns.2012.05.047; ULUDAG H, 1990, BIOMATERIALS, V11, P708, DOI 10.1016/0142-9612(90)90032-L; WU DK, 1994, J NEUROCHEM, V62, P863; Yang LL, 2008, PAIN, V140, P472, DOI 10.1016/j.pain.2008.09.028; Yu K, 1996, ENDOCRINOLOGY, V137, P3566, DOI 10.1210/en.137.8.3566; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	40	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116597	10.1371/journal.pone.0116597	http://dx.doi.org/10.1371/journal.pone.0116597			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710381	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900011
J	Bauer, JS; Noel, PB; Vollhardt, C; Much, D; Degirmenci, S; Brunner, S; Rummeny, EJ; Hauner, H				Bauer, Jan Stefan; Noel, Peter Benjamin; Vollhardt, Christiane; Much, Daniela; Degirmenci, Saliha; Brunner, Stefanie; Rummeny, Ernst Josef; Hauner, Hans			Accuracy and Reproducibility of Adipose Tissue Measurements in Young Infants by Whole Body Magnetic Resonance Imaging	PLOS ONE			English	Article							FAT DISTRIBUTION; NEWBORN-INFANTS; BIRTH-WEIGHT; MRI; QUANTIFICATION; GROWTH; LIFE; SEGMENTATION; OVERWEIGHT; LACTATION	Purpose MR might be well suited to obtain reproducible and accurate measures of fat tissues in infants. This study evaluates MR-measurements of adipose tissue in young infants in vitro and in vivo. Material and Methods MR images of ten phantoms simulating subcutaneous fat of an infant's torso were obtained using a 1.5T MR scanner with and without simulated breathing. Scans consisted of a cartesian water-suppression turbo spin echo (wsTSE) sequence, and a PROPELLER wsTSE sequence. Fat volume was quantified directly and by MR imaging using k-means clustering and threshold-based segmentation procedures to calculate accuracy in vitro. Whole body MR was obtained in sleeping young infants (average age 67 +/- 30 days). This study was approved by the local review board. All parents gave written informed consent. To obtain reproducibility in vivo, cartesian and PROPELLER wsTSE sequences were repeated in seven and four young infants, respectively. Overall, 21 repetitions were performed for the cartesian sequence and 13 repetitions for the PROPELLER sequence. Results In vitro accuracy errors depended on the chosen segmentation procedure, ranging from 5.4% to 76%, while the sequence showed no significant influence. Artificial breathing increased the minimal accuracy error to 9.1%. In vivo reproducibility errors for total fat volume of the sleeping infants ranged from 2.6% to 3.4%. Neither segmentation nor sequence significantly influenced reproducibility. Conclusion With both cartesian and PROPELLER sequences an accurate and reproducible measure of body fat was achieved. Adequate segmentation was mandatory for high accuracy.	[Bauer, Jan Stefan] Tech Univ Munich, Dept Neuroradiol, D-80290 Munich, Germany; [Noel, Peter Benjamin; Degirmenci, Saliha; Rummeny, Ernst Josef] Tech Univ Munich, Dept Radiol, D-80290 Munich, Germany; [Vollhardt, Christiane; Much, Daniela; Brunner, Stefanie; Hauner, Hans] Tech Univ Munich, Else Kroner Fresenius Ctr Nutr Med, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Bauer, JS (corresponding author), Tech Univ Munich, Dept Neuroradiol, D-80290 Munich, Germany.	jsb@tum.de	Kirschke, Jan/E-2550-2012	Kirschke, Jan/0000-0002-7557-0003; Noel, Peter/0000-0002-9671-6171	German Research Foundation (DFG); Technische Universitat Munchen within the funding programme 'Open Access Publishing'; Research grants for the INFAT Study from BMBF (German Ministry of Research and Education); EARNEST-Consortium of EU; International Unilever Foundation; Danone Baby Nutrition	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen within the funding programme 'Open Access Publishing'; Research grants for the INFAT Study from BMBF (German Ministry of Research and Education)(Federal Ministry of Education & Research (BMBF)); EARNEST-Consortium of EU; International Unilever Foundation(Unilever); Danone Baby Nutrition(Danone Nutricia)	The study was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme 'Open Access Publishing' and by Research grants for the INFAT Study from BMBF (German Ministry of Research and Education, http://www.gesundheitsforschung-bmbf.de), EARNEST-Consortium of EU (http://www.project-earlynutrition.eu), International Unilever Foundation (http://www.unilever.com/aboutus/foundation) and Danone Baby Nutrition (www.danone.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonekamp S, 2008, INT J OBESITY, V32, P100, DOI 10.1038/sj.ijo.0803696; Butte NF, 2000, PEDIATR RES, V47, P578, DOI 10.1203/00006450-200005000-00004; Darge K, 2011, RADIOLOGY, V261, P12, DOI 10.1148/radiol.11101922; Forbes KPN, 2001, J MAGN RESON IMAGING, V14, P215, DOI 10.1002/jmri.1176; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Harrington TAM, 2004, PEDIATR RES, V55, P437, DOI 10.1203/01.PDR.0000111202.29433.2D; Harrington TAM, 2002, LIPIDS, V37, P95, DOI 10.1007/s11745-002-0868-4; Hauner H, 2009, ANN NUTR METAB, V54, P97, DOI 10.1159/000209267; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; Hauner H, 2012, AM J CLIN NUTR, V95, P383, DOI 10.3945/ajcn.111.022590; KABIR N, 1993, PEDIATR RES, V34, P448, DOI 10.1203/00006450-199310000-00013; Kramer MS, 2002, J PEDIATR-US, V141, P538, DOI 10.1067/mpd.2002.128029; Kullberg J, 2007, INT J OBESITY, V31, P1806, DOI 10.1038/sj.ijo.0803671; Kullberg J, 2009, BRIT J RADIOL, V82, P123, DOI 10.1259/bjr/80083156; Kurth BM, 2007, BUNDESGESUNDHEITSBLA, V50, P736, DOI 10.1007/s00103-007-0235-5; Lane BF, 2011, AM J ROENTGENOL, V197, pW307, DOI 10.2214/AJR.10.5918; Ludescher B, 2009, INVEST RADIOL, V44, P712, DOI 10.1097/RLI.0b013e3181afbb1e; Modi N, 2006, PEDIATR RES, V60, P345, DOI 10.1203/01.pdr.0000232732.93000.52; Modi N, 2009, PEDIATR RES, V65, P584, DOI 10.1203/01.pdr.0000350364.10602.33; Muller HP, 2011, NMR BIOMED, V24, P17, DOI 10.1002/nbm.1549; Noel PB, 2012, ROFO-FORTSCHR RONTG, V184, P548, DOI 10.1055/s-0031-1299376; Odlind V, 2003, ACTA OBSTET GYN SCAN, V82, P516, DOI 10.1034/j.1600-0412.2003.00112.x; Olhager E, 2003, PEDIATR RES, V54, P906, DOI 10.1203/01.PDR.0000088064.63106.5E; Olhager E, 1998, PEDIATR RES, V44, P572, DOI 10.1203/00006450-199810000-00017; Peng Q, 2007, J MAGN RESON IMAGING, V26, P738, DOI 10.1002/jmri.21040; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; ROSS R, 1991, J APPL PHYSIOL, V70, P2164, DOI 10.1152/jappl.1991.70.5.2164; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; THOMAS LW, 1962, Q J EXP PHYSIOL CMS, V47, P179, DOI 10.1113/expphysiol.1962.sp001589; Wurslin C, 2010, J MAGN RESON IMAGING, V31, P430, DOI 10.1002/jmri.22036; Yoon DY, 2008, ACAD RADIOL, V15, P62, DOI 10.1016/j.acra.2007.07.013	31	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117127	10.1371/journal.pone.0117127	http://dx.doi.org/10.1371/journal.pone.0117127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706876	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100062
J	Grobe, N; Leiva, O; Morris, M; Elased, KM				Grobe, Nadja; Leiva, Orly; Morris, Mariana; Elased, Khalid M.			Loss of Prolyl Carboxypeptidase in Two-Kidney, One-Clip Goldblatt Hypertensive Mice	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; BRAIN-SELECTIVE OVEREXPRESSION; INDUCED CARDIAC DYSFUNCTION; RENOVASCULAR HYPERTENSION; BLOOD-PRESSURE; PROLYLCARBOXYPEPTIDASE GENE; KIDNEY-DISEASE; ACE2 ACTIVITY; RECEPTOR; IDENTIFICATION	It is well documented that angiotensin (Ang) II contributes to kidney disease progression. The protease prolyl carboxypeptidase (PRCP) is highly expressed in the kidney and may be renoprotective by degrading Ang II to Ang-(1-7). The aim of the study was to investigate whether renal PRCP protein expression and activity are altered in two-kidney, one-clip (2K1C) Goldblatt hypertensive mice. Left renal artery was constricted by using 0.12 mm silver clips. Blood pressure was measured using telemetry over the eleven weeks of study period and revealed an immediate increase in 2K1C animals during the first week of clip placement which was followed by a gradual decrease to baseline blood pressure. Similarly, urinary albumin excretion was significantly increased one week after 2K1C and returned to baseline levels during the following weeks. At 2 weeks and at the end of the study, renal pathologies were exacerbated in the 2K1C model as revealed by a significant increase in mesangial expansion and renal fibrosis. Renal PRCP expression and activity were significantly reduced in clipped kidneys. Immunofluorescence revealed the loss of renal tubular PRCP but not glomerular PRCP. In contrast, expression of prolyl endopeptidase, another enzyme capable of converting Ang II into Ang-(1-7), was not affected, while angiotensin converting enzyme was elevated in unclipped kidneys and renin was increased in clipped kidneys. Results suggest that PRCP is suppressed in 2K1C and that this downregulation may attenuate renoprotective effects via impaired Ang II degradation by PRCP.	[Grobe, Nadja; Leiva, Orly; Elased, Khalid M.] Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA; [Morris, Mariana] Nova SE Univ, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA	Wright State University Dayton; Nova Southeastern University	Grobe, N (corresponding author), Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA.	nadja.grobe@wright.edu		Leiva, Orly/0000-0002-3006-6380	National Institutes of Health [R25 GM090122, R01 HL093567, F32 DK093226-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK093226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM090122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R25 GM090122 (OL), R01 HL093567 (KME and MM), and F32 DK093226-01 (NG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GN, 2013, BLOOD, DOI [10.1182/blood-2012-12-473777, DOI 10.1182/BLOOD-2012-12-473777]; Adams GN, 2011, BLOOD, V117, P3929, DOI 10.1182/blood-2010-11-318527; Alghamri MS, 2013, J CARDIOVASC PHARM T, V18, P138, DOI 10.1177/1074248412460124; Bernstein KE, 2001, CONTRIB NEPHROL, V135, P16; Bindom SM, 2010, DIABETES, V59, P2540, DOI 10.2337/db09-0782; Brosius FC, 2013, KIDNEY INT, V83, P996, DOI 10.1038/ki.2013.58; BROWN JJ, 1976, LANCET, V1, P1219; CARRETERO OA, 1978, KLIN WOCHENSCHR, V56, P113, DOI 10.1007/BF01477462; Cervenka L, 2002, HYPERTENSION, V40, P735, DOI 10.1161/01.HYP.0000036452.28493.74; Cervenka L, 2008, J HYPERTENS, V26, P1379, DOI 10.1097/HJH.0b013e3282fe6eaa; Chaudhary K, 2010, CURR DIABETES REP, V10, P37, DOI 10.1007/s11892-009-0080-z; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cote I, 2001, J HUM HYPERTENS, V15, P143, DOI 10.1038/sj.jhh.1001145; da Silveira KD, 2010, CLIN SCI, V119, P385, DOI 10.1042/CS20090554; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Elased KM, 2005, HYPERTENSION, V46, P953, DOI 10.1161/01.HYP.0000174601.30793.b1; Feng YM, 2010, CIRC RES, V106, P373, DOI 10.1161/CIRCRESAHA.109.208645; Fujino T, 2004, J CLIN INVEST, V114, P805, DOI 10.1172/JCI200421382; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Giani JF, 2011, AM J PHYSIOL-RENAL, V300, pF272, DOI 10.1152/ajprenal.00278.2010; Giani JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE262, DOI 10.1152/ajpendo.90678.2008; GIROLAMI JP, 1983, EUR HEART J, V4, P67, DOI 10.1093/eurheartj/4.suppl_G.67; Goldblatt H, 1934, J EXP MED, V59, P347, DOI 10.1084/jem.59.3.347; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Grobe N, 2013, AM J PHYSIOL-CELL PH, V304, pC945, DOI 10.1152/ajpcell.00346.2012; Grobe N, 2012, AM J PHYSIOL-ENDOC M, V302, pE1016, DOI 10.1152/ajpendo.00515.2011; Gurley SB, 2008, EXP PHYSIOL, V93, P538, DOI 10.1113/expphysiol.2007.040014; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Gwathmey TM, 2010, HYPERTENSION, V55, P166, DOI 10.1161/HYPERTENSIONAHA.109.141622; Huentelman MJ, 2005, EXP PHYSIOL, V90, P783, DOI 10.1113/expphysiol.2005.031096; HULTHEN UL, 1977, ACTA MED SCAND, V202, P189; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; Jeong JK, 2013, TRENDS ENDOCRIN MET, V24, P61, DOI 10.1016/j.tem.2012.11.001; Jerums G, 2009, NAT REV NEPHROL, V5, P397, DOI 10.1038/nrneph.2009.91; Keddis MT, 2010, NEPHROL DIAL TRANSPL, V25, P3615, DOI 10.1093/ndt/gfq269; KOST CK, 1994, J PHARMACOL EXP THER, V270, P1063; Lavoz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040490; Lazartigues E, 2004, CIRC RES, V95, P523, DOI 10.1161/01.RES.0000140892.86313.c2; Liu CX, 2010, MOL MED, DOI [10.2119/molmed.2010.00204, DOI 10.2119/MOLMED.2010.00204]; Lorenz JN, 2011, AM J PHYSIOL-RENAL, V301, pF615, DOI 10.1152/ajprenal.00158.2011; Marut W, 2013, ARTHRITIS RHEUM, DOI [10.1002/art.38169, DOI 10.1002/ART.38169]; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Monteiro MB, 2008, HYPERTENSION, V52, pE91; Moreira CR, 2002, FEBS LETT, V523, P167, DOI 10.1016/S0014-5793(02)02980-0; Mottl AK, 2013, J DIABETES COMPLICAT, V27, P123, DOI 10.1016/j.jdiacomp.2012.09.010; Nadarajah R, 2012, KIDNEY INT, V82, P292, DOI 10.1038/ki.2012.83; Navar LG, 1998, NEWS PHYSIOL SCI, V13, P170; Nomura M, 2005, AM J HYPERTENS, V18, P538, DOI 10.1016/j.amjhyper.2004.11.010; ODYA CE, 1981, METHOD ENZYMOL, V80, P460; ODYA CE, 1978, J BIOL CHEM, V253, P5927; Pliquett Rainer U., 2014, BMC Physiology, V14, P4, DOI 10.1186/1472-6793-14-4; Prieto MC, 2011, AM J PHYSIOL-RENAL, V300, pF749, DOI 10.1152/ajprenal.00383.2009; Qin XP, 2009, CLIN EXP PHARMACOL P, V36, P319, DOI 10.1111/j.1440-1681.2008.05079.x; Ren YL, 2002, HYPERTENSION, V39, P799, DOI 10.1161/hy0302.104673; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; Ruiz-Ortega M, 2001, HYPERTENSION, V38, P1382, DOI 10.1161/hy1201.100589; Santiago NM, 2010, HYPERTENSION, V55, P889, DOI 10.1161/HYPERTENSIONAHA.110.149815; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Shah A, 2012, AM J PHYSIOL-HEART C, V302, pH2372, DOI 10.1152/ajpheart.00846.2011; Shariat-Madar Z, 2004, BLOOD, V103, P4554, DOI 10.1182/blood-2003-07-2510; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; TAN FL, 1993, J BIOL CHEM, V268, P16631; Verma A, 2012, MOL THER, V20, P28, DOI 10.1038/mt.2011.155; Wallingford N, 2009, J CLIN INVEST, V119, P2291, DOI 10.1172/JCI37209; Wang L, 2006, AM J OBSTET GYNECOL, V195, P162, DOI 10.1016/j.ajog.2006.01.079; WELCHES WR, 1993, LIFE SCI, V52, P1461, DOI 10.1016/0024-3205(93)90108-F; Wysocki J, 2006, DIABETES, V55, P2132, DOI 10.2337/db06-0033; Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; Xu SY, 2012, CLIN CHEM, V58, P1110, DOI 10.1373/clinchem.2011.179291; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; YAMAMOTO K, 1992, HYPERTENSION, V19, P692, DOI 10.1161/01.HYP.19.6.692; Yamazato Y, 2009, HYPERTENSION, V54, P365, DOI 10.1161/HYPERTENSIONAHA.108.125468; YANG HYT, 1970, BIOCHEM PHARMACOL, V19, P1201, DOI 10.1016/0006-2952(70)90380-1; Yatabe J, 2011, ENDOCRINOLOGY, V152, P1582, DOI 10.1210/en.2010-1070; Ye MH, 2004, HYPERTENSION, V43, P1120, DOI 10.1161/01.HYP.0000126192.27644.76; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Zhang Y, 2009, CHINESE MED J-PEKING, V122, P2461, DOI 10.3760/cma.j.issn.0366-6999.2009.20.012; Zhao YQ, 2001, AM J PHYSIOL-HEART C, V280, pH1821, DOI 10.1152/ajpheart.2001.280.4.H1821; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244; Zhu LP, 2010, HYPERTENSION, V56, P384, DOI 10.1161/HYPERTENSIONAHA.110.155051; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	82	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117899	10.1371/journal.pone.0117899	http://dx.doi.org/10.1371/journal.pone.0117899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706121	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100126
J	Park, SS; Kim, DH; Nam, IC; Lee, IH; Hwang, JW				Park, Soo Seog; Kim, Dong-Hyun; Nam, In-Chul; Lee, Il-Hwan; Hwang, Jae-Woong			The Effectiveness of Pregabalin for Post-Tonsillectomy Pain Control: A Randomized Controlled Trial	PLOS ONE			English	Article							POSTOPERATIVE PAIN; SURGERY; PHARMACOLOGY; GABAPENTIN; ADULTS	Background Although various analgesics have been used, postoperative pain remains one of the most troublesome aspects of tonsillectomy for patients. Objective The aim of the present study was to evaluate the effectiveness of premedication using pregabalin compared with placebo (diazepam) on postoperative pain control in patients undergoing tonsillectomy. Methods Forty-eight adult patients were randomly divided into a control group and a pregabalin group. Preoperatively, patients in the control group received 4 mg diazepam orally as placebo, whereas those in the pregabalin group received 300 mg pregabalin orally. All participants were provided with patient-controlled analgesia using fentanyl for 24 hours after surgery. Postoperative pain treatment included acetaminophen 650 mg three times daily for 8 postoperative days. The primary outcome measure was the total amount of patient-controlled fentanyl consumption after tonsillectomy. Secondary outcome measures were the number of injections of ketorolac tromethamine (each 30 mg) requested by patients, pain scores, overall satisfaction scores, drowsiness, nausea, dizziness, headache, and vomiting after the surgery. P < 0.05 was considered statistically significant. Results The total amount of fentanyl demanded decreased significantly in the pregabalin group (P < 0.001). There were no significant differences in the number of ketorolac tromethamine injections, pain scores, overall satisfaction scores, drowsiness, nausea, dizziness, headache, and vomiting between the two groups. Conclusion Administration of 300 mg pregabalin prior to tonsillectomy decreases fentanyl consumption compared with that after 4 mg diazepam, without an increased incidence of adverse effects.	[Park, Soo Seog; Hwang, Jae-Woong] Catholic Univ Korea, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Kim, Dong-Hyun; Nam, In-Chul; Lee, Il-Hwan] Catholic Univ Korea, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, DH (corresponding author), Catholic Univ Korea, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	monolithkim@catholic.ac.kr			Incheon St. Mary's Hospital of the Catholic University of Korea, through the Clinical Research Laboratory Foundation Program	Incheon St. Mary's Hospital of the Catholic University of Korea, through the Clinical Research Laboratory Foundation Program	This study was supported by the Incheon St. Mary's Hospital of the Catholic University of Korea, through the Clinical Research Laboratory Foundation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, BRIT J ANAESTH, V101, P700, DOI 10.1093/bja/aen244; Ben-Menachem E, 2004, EPILEPSIA, V45, P13, DOI 10.1111/j.0013-9580.2004.455003.x; Bryans JS, 1999, MED RES REV, V19, P149, DOI 10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B; Dooley DJ, 2000, J PHARMACOL EXP THER, V295, P1086; Gajraj NM, 2007, ANESTH ANALG, V105, P1805, DOI 10.1213/01.ane.0000287643.13410.5e; Hill CM, 2001, EUR J PAIN, V5, P119, DOI 10.1053/eujp.2001.0235; Jokela R, 2008, BRIT J ANAESTH, V100, P834, DOI 10.1093/bja/aen098; Jokela R, 2008, PAIN, V134, P106, DOI 10.1016/j.pain.2007.04.002; Judkins JH, 1996, ARCH OTOLARYNGOL, V122, P937; LIISTRO G, 1992, AM REV RESPIR DIS, V146, P581, DOI 10.1164/ajrccm/146.3.581; Mathiesen O, 2011, ACTA ANAESTH SCAND, V55, P297, DOI 10.1111/j.1399-6576.2010.02389.x; Mikkelsen S, 2006, ACTA ANAESTH SCAND, V50, P809, DOI 10.1111/j.1399-6576.2006.01057.x; Moiniche S, 2003, ANESTH ANALG, V96, P68, DOI 10.1213/01.ANE.0000040583.65135.57; Paech MF, 2007, ANESTH ANALG, V105, P1449, DOI 10.1213/01.ane.0000286227.13306.d7; Parsons SP, 2006, OTOLARYNG HEAD NECK, V134, P106, DOI 10.1016/j.otohns.2005.09.027; Reuben SS, 2006, ANESTH ANALG, V103, P1271, DOI 10.1213/01.ane.0000237279.08847.2d; Salonen A, 2002, LARYNGOSCOPE, V112, P94, DOI 10.1097/00005537-200201000-00017; White PF, 2009, ANESTH ANALG, V108, P1140, DOI 10.1213/ane.0b013e31818d40ce	18	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117161	10.1371/journal.pone.0117161	http://dx.doi.org/10.1371/journal.pone.0117161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706948	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100063
J	Rodriguez, JM; Marchicio, J; Lopez, M; Ziblat, A; Elias, F; Flo, J; Lopez, RA; Horn, D; Zorzopulos, J; Montaner, AD				Rodriguez, Juan M.; Marchicio, Jose; Lopez, Mariela; Ziblat, Andrea; Elias, Fernanda; Flo, Juan; Lopez, Ricardo A.; Horn, David; Zorzopulos, Jorge; Montaner, Alejandro D.			PyNTTTTGT and CpG Immunostimulatory Oligonucleotides: Effect on Granulocyte/Monocyte Colony-Stimulating Factor (GM-CSF) Secretion by Human CD56(+) (NK and NKT) Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; INTERFERON-ALPHA; BACTERIAL-DNA; INDUCTION; IMT504; RESPONSES; ADJUVANT; IFN; OLIGODEOXYNUCLEOTIDES; ACTIVATION	CD56(+) cells have been recognized as being involved in bridging the innate and acquired immune systems. Herein, we assessed the effect of two major classes of immunostimulatory oligonucleotides (ODNs), PyNTTTTGT and CpG, on CD56(+) cells. Incubation of human peripheral blood mononuclear cells (hPBMC) with some of these ODNs led to secretion of significant amounts of interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and granulocyte/monocyte colony-stimulating factor (GM-CSF), but only if interleukin 2 (IL2) was present. IMT504, the prototype of the PyNTTTTGT ODN class, was the most active. GM-CSF secretion was very efficient when non-CpG ODNs with high T content and PyNTTTTGT motifs lacking CpGs were used. On the other hand, CpG ODNs and IFN alpha inhibited this GM-CSF secretion. Selective cell type removal from hPBMC indicated that CD56(+) cells were responsible for GM-CSF secretion and that plasmacytoid dendritic cells (PDCs) regulate this process. In addition, PyNTTTTGT ODNs inhibited the IFNa secretion induced by CpG ODNs in PDCs by interference with the TLR9 signaling pathway. Since IFNa is essential for CD56(+) stimulation by CpG ODNs, there is a reciprocal interference of CpG and PyNTTTTGT ODNs when acting on this cell population. This suggests that these synthetic ODNs mimic different natural alarm signals for activation of the immune system.				zorzopul@hotmail.com	Corchado Rodríguez, Juan/D-3229-2013	Corchado Rodríguez, Juan/0000-0002-2829-1829; Ziblat, Andrea/0000-0003-1469-8836	Immunotech S.A.; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyTMinCyT) [PICT 2008-0970]; National Research Council (CONICET) from Argentina; David Horn LLC	Immunotech S.A.; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyTMinCyT); National Research Council (CONICET) from Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); David Horn LLC	This work was supported by Immunotech S.A. and additionally by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyTMinCyT) (grant number PICT 2008-0970 to ADM) and the National Research Council (CONICET) from Argentina. Immunotech S.A. and David Horn LLC provided support in the form of salaries for authors JM, ML, AZ, FE, JF, RAL, JZ and DH respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abel K, 2005, CLIN DIAGN LAB IMMUN, V12, P606, DOI 10.1128/CDLI.12.5.606-621.2005; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bessoles S, 2008, J LEUKOCYTE BIOL, V84, P224, DOI 10.1189/jlb.1007669; Bianchi MS, 2010, DIABETOLOGIA, V53, P1184, DOI 10.1007/s00125-010-1694-z; Brigl M, 2011, NAT IMMUNOL, V12, P1202, DOI [10. 1038/ ni. 2143, DOI 10.1038/NI.2143]; Coronel MF, 2008, NEUROSCI LETT, V444, P69, DOI 10.1016/j.neulet.2008.07.045; Montaner AD, 2011, NUCLEIC ACID THER, V21, P265, DOI 10.1089/nat.2011.0284; Elias F, 2005, VACCINE, V23, P3597, DOI 10.1016/j.vaccine.2004.12.030; Elias F, 2003, J IMMUNOL, V171, P3697, DOI 10.4049/jimmunol.171.7.3697; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Horowitz A, 2010, J IMMUNOL, V185, P2808, DOI 10.4049/jimmunol.1000844; Insua A., 2007, TOP TISSUE ENG, V3, P1; Insua AH, 2007, STEM CELLS, V25, P1047, DOI 10.1634/stemcells.2006-0479; Issazadeh-Navikas S, 2012, J MOL CELL BIOL, V4, P70, DOI 10.1093/jmcb/mjr035; Jurk M, 2004, IMMUNOBIOLOGY, V209, P141, DOI 10.1016/j.imbio.2004.02.006; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2001, CURR OPIN MOL THER, V3, P15; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Landrigan A, 2011, J IMMUNOL, V187, P3033, DOI 10.4049/jimmunol.1003414; Lee IF, 2011, J IMMUNOL, V187, P2898, DOI 10.4049/jimmunol.1002551; LEVITT LJ, 1991, J CLIN INVEST, V88, P67, DOI 10.1172/JCI115306; Liu YC, 2010, J IMMUNOL, V184, P3367, DOI 10.4049/jimmunol.0903079; Marshall JD, 2006, IMMUNOLOGY, V117, P38, DOI 10.1111/j.1365-2567.2005.02261.x; Montaner AD, 2012, WORLD J VACCINE, V2, P182, DOI DOI 10.4236/WJV.2012.24025; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Novak J, 2011, CYTOKINE, V53, P263, DOI 10.1016/j.cyto.2010.11.001; Paget C, 2012, J BIOL CHEM, V287, P8816, DOI 10.1074/jbc.M111.304758; Scheiermann J, 2014, VACCINE, V32, P6377, DOI 10.1016/j.vaccine.2014.06.065; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; Urban EM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-50; Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Zhao G, 2009, VIRAL IMMUNOL, V22, P131, DOI 10.1089/vim.2008.0073	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117484	10.1371/journal.pone.0117484	http://dx.doi.org/10.1371/journal.pone.0117484			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706946	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100093
J	Barca, L; Pezzulo, G				Barca, Laura; Pezzulo, Giovanni			Tracking Second Thoughts: Continuous and Discrete Revision Processes during Visual Lexical Decision	PLOS ONE			English	Article							MODELS; MEMORY; MIND	We studied the dynamics of lexical decisions by asking participants to categorize lexical and nonlexical stimuli and recording their mouse movements toward response buttons during the choice. In a previous report we revealed greater trajectory curvature and attraction to competitors for Low Frequency words and Pseudowords. This analysis did not clarify whether the trajectory curvature in the two conditions was due to a continuous dynamic competition between the response alternatives or if a discrete revision process (a "change of mind") took place during the choice from an initially selected response to the opposite one. To disentangle these two possibilities, here we analyse the velocity and acceleration profiles of mouse movements during the choice. Pseudowords' peak movement velocity occurred with 100ms delay with respect to words and Letters Strings. Acceleration profile for High and Low Frequency words and Letters Strings exhibited a butterfly plot with one acceleration peak at 400ms and one deceleration peak at 650ms. Differently, Pseudowords' acceleration profile had double positive peaks (at 400 and 600ms) followed by movement deceleration, in correspondence with changes in the decision from lexical to nonlexical response buttons. These results speak to different online processes during the categorization of Low Frequency words and Pseudowords, with a continuous competition process for the former and a discrete revision process for the latter.	[Barca, Laura; Pezzulo, Giovanni] CNR, Inst Cognit Sci & Technol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Barca, L (corresponding author), CNR, Inst Cognit Sci & Technol, Rome, Italy.	laura.barca@istc.cnr.it	Pezzulo, Giovanni/AAY-3586-2020; Barca, Laura/J-8274-2018	Pezzulo, Giovanni/0000-0001-6813-8282; Barca, Laura/0000-0002-8553-7717	European Community Seventh Framework Programme [PERG02-GA-2007-224919, FP7-270108]	European Community Seventh Framework Programme(European Commission)	The research leading to these results was funded by the European Community Seventh Framework Programme (FP7/2007-2013) under grant agreement no. PERG02-GA-2007-224919 (WoRHD) to Laura Barca and no. FP7-270108 (Goal-Leaders) to Giovanni Pezzulo.	Bangert AS, 2012, PSYCHON B REV, V19, P513, DOI 10.3758/s13423-012-0234-x; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barca L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035932; Barca L, 2010, READ WRIT, V23, P569, DOI 10.1007/s11145-009-9192-8; Bruhn P, 2014, J EXP PSYCHOL HUMAN, V40, P525, DOI 10.1037/a0034365; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Cisek P, 2012, CURR OPIN NEUROBIOL, V22, P927, DOI 10.1016/j.conb.2012.05.007; COLES MGH, 1985, J EXP PSYCHOL HUMAN, V11, P529, DOI 10.1037/0096-1523.11.5.529; Cos I, 2011, J NEUROPHYSIOL, V105, P3022, DOI 10.1152/jn.00975.2010; Freeman JB, 2014, PSYCHON B REV, V21, P85, DOI 10.3758/s13423-013-0470-8; Freeman JB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00059; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Lepora N, EMBODIED CH IN PRESS; Lepora NF, 2012, NEURAL COMPUT, V24, P2924, DOI 10.1162/NECO_a_00360; Marcos E., 2013, BMC NEUROSCI, V14, P408, DOI [10.1186/1471-2202-14-S1-P408, DOI 10.1186/1471-2202-14-S1-P408]; McKinstry C, 2008, PSYCHOL SCI, V19, P22, DOI 10.1111/j.1467-9280.2008.02041.x; Pagliuca G, 2008, LANG COGNITIVE PROC, V23, P422, DOI 10.1080/01690960701626036; Pezzulo G, 2012, MOTOR CONTROL, V16, P386, DOI 10.1123/mcj.16.3.386; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Quinton JC, 2013, IEEE T CYBERNETICS, V44, P539, DOI [10.1109/TCYB.2013.2259230, DOI 10.1109/TCYB.2013.2259230]; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Rigoux L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002716; Shiffrin RM, 1997, PSYCHON B REV, V4, P145, DOI 10.3758/BF03209391; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Spivey M. J., 2007, CONTINUITY MIND; Spivey MJ, 2010, J EXP PSYCHOL HUMAN, V36, P251, DOI 10.1037/a0017170; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Tipper SP, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P223; Tsetsos K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00063; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; van der Wel RPRD, 2009, J EXP PSYCHOL HUMAN, V35, P588, DOI 10.1037/0096-1523.35.2.588; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007	36	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116193	10.1371/journal.pone.0116193	http://dx.doi.org/10.1371/journal.pone.0116193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB7EQ	25699992	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800008
J	Nie, HT; Long, KH; Ma, J; Yue, D; Liu, JG				Nie, Haitao; Long, Kehui; Ma, Jun; Yue, Dan; Liu, Jinguo			Using an Improved SIFT Algorithm and Fuzzy Closed-Loop Control Strategy for Object Recognition in Cluttered Scenes	PLOS ONE			English	Article							INVARIANT FEATURE TRANSFORM; TRACKING; SCALE; LOGIC	Partial occlusions, large pose variations, and extreme ambient illumination conditions generally cause the performance degradation of object recognition systems. Therefore, this paper presents a novel approach for fast and robust object recognition in cluttered scenes based on an improved scale invariant feature transform (SIFT) algorithm and a fuzzy closed-loop control method. First, a fast SIFT algorithm is proposed by classifying SIFT features into several clusters based on several attributes computed from the sub-orientation histogram (SOH), in the feature matching phase only features that share nearly the same corresponding attributes are compared. Second, a feature matching step is performed following a prioritized order based on the scale factor, which is calculated between the object image and the target object image, guaranteeing robust feature matching. Finally, a fuzzy closed-loop control strategy is applied to increase the accuracy of the object recognition and is essential for autonomous object manipulation process. Compared to the original SIFT algorithm for object recognition, the result of the proposed method shows that the number of SIFT features extracted from an object has a significant increase, and the computing speed of the object recognition processes increases by more than 40%. The experimental results confirmed that the proposed method performs effectively and accurately in cluttered scenes.	[Nie, Haitao; Long, Kehui; Ma, Jun; Yue, Dan; Liu, Jinguo] Chinese Acad Sci, Changchun Inst Opt Fine Mech & Phys, Changchun, Peoples R China; [Nie, Haitao; Yue, Dan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Optics, Fine Mechanics & Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Nie, HT (corresponding author), Chinese Acad Sci, Changchun Inst Opt Fine Mech & Phys, Changchun, Peoples R China.	niehaitaokelek2@gmail.com			Changchun Institute of Optics, Fine Mechanics and Physics of Chinese Academy of Sciences, Innovation Fund [Y2CX1SS125]	Changchun Institute of Optics, Fine Mechanics and Physics of Chinese Academy of Sciences, Innovation Fund	This work was supported by Changchun Institute of Optics, Fine Mechanics and Physics of Chinese Academy of Sciences, Innovation Fund No. Y2CX1SS125 (http://www.ciomp.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi A, 2000, IEEE T COMMUN, V48, P7, DOI 10.1109/26.818866; Babuska R, 1996, CONTROL ENG PRACT, V4, P1593, DOI 10.1016/0967-0661(96)00175-X; Bonato V, 2008, IEEE T CIRC SYST VID, V18, P1703, DOI 10.1109/TCSVT.2008.2004936; BOWLES JB, 1995, P IEEE, V83, P435, DOI 10.1109/5.364489; Chariot A, 2008, INT C PATT RECOG, P3185; Cheng MM, 2011, PROC CVPR IEEE, P409, DOI 10.1109/CVPR.2011.5995344; Chum O, 2008, IEEE T PATTERN ANAL, V30, P1472, DOI 10.1109/TPAMI.2007.70787; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Dong Hwan Kim, 2014, 2014 IEEE International Conference on Consumer Electronics (ICCE), P388, DOI 10.1109/ICCE.2014.6776053; DROST B, 2010, PROC CVPR IEEE, P998, DOI DOI 10.1109/CVPR.2010.5540108; Hagras H, 2007, IEEE COMPUT INTELL M, V2, P30, DOI 10.1109/MCI.2007.357192; Hartley R., 2008, P 2008 IEEE C COMP V, P1, DOI DOI 10.1109/CVPR.2008.4587638; He KM, 2012, PROC CVPR IEEE, P111, DOI 10.1109/CVPR.2012.6247665; Ke Y, 2004, PROC CVPR IEEE, P506; Krystian M, 2003, IMAGE DATABASE; Kwon OS, 2010, IEEE T CONSUM ELECTR, V56, P792, DOI 10.1109/TCE.2010.5506003; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; MAMDANI EH, 1994, IEEE EXPERT, V9, P27; PAPPIS CP, 1977, IEEE T SYST MAN CYB, V7, P707, DOI 10.1109/TSMC.1977.4309605; Rathi Y, 2007, IEEE T PATTERN ANAL, V29, P1470, DOI 10.1109/TPAMI.2007.1081; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Schmid C, 1996, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, PROCEEDINGS - VOL II, P781, DOI 10.1109/ICIP.1996.561020; Shen Y, 2009, IEEE T CONSUM ELECTR, V55, P1714, DOI 10.1109/TCE.2009.5278047; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116, DOI 10.1109/TSMC.1985.6313399; Tzafestas SG, 1999, MACH INTELL, V1, P27; Wang BF, 1998, IEEE T PARALL DISTR, V9, P186, DOI 10.1109/71.663884; Wiskott L, 1997, IEEE T PATTERN ANAL, V19, P775, DOI 10.1109/34.598235; Xu WC, 2010, IEEE T SIGNAL PROCES, V58, P522, DOI 10.1109/TSP.2009.2032448; Xu Y, 2008, IEEE INT S PAR DISTR, P1, DOI [DOI 10.1109/IPDPS.2008.4536131, 10.1109/IPDPS.2008.4536131]; Zhao T, 2004, IEEE T PATTERN ANAL, V26, P1208, DOI 10.1109/TPAMI.2004.73; Zhou SHK, 2004, IEEE T IMAGE PROCESS, V13, P1491, DOI 10.1109/TIP.2004.836152	31	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116323	10.1371/journal.pone.0116323	http://dx.doi.org/10.1371/journal.pone.0116323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714094	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700016
J	Pedone, C; Roshanravan, B; Scarlata, S; Patel, KV; Ferrucci, L; Incalzi, RA				Pedone, Claudio; Roshanravan, Baback; Scarlata, Simone; Patel, Kushang V.; Ferrucci, Luigi; Incalzi, Raffaele Antonelli			Longitudinal Association between Serum Leptin Concentration and Glomerular Filtration Rate in Humans	PLOS ONE			English	Article							BODY-MASS INDEX; CHRONIC KIDNEY-DISEASE; METABOLIC SYNDROME; RENAL-FUNCTION; OBESITY; RISK; MICROALBUMINURIA; CKD; INTERLEUKIN-6; EPIDEMIOLOGY	Background Obesity is a risk factor for decline in glomerular filtration rate (GFR). One proposed mechanism leading to glomerulopathy is an increase in leptin levels. However, the association between leptin and GFR has never been demonstrated. The aim of this study is to verify whether higher levels of leptin are associated with longitudinal changes of estimated GFR (eGFR). Methods and findings We selected 744 participants in the InCHIANTI study (416 women). The association between eGFR and leptin changes over a 6-years follow-up was assessed using random effect models including leptin as a time-varying covariate and adjusted for potential confounders. We also compared the proportion of patients with rapid decline of renal function across tertiles of change in serum leptin between baseline and 6-years follow-up. Mean baseline eGFR was 82.2 ml/min/1.73 m, 78.7 ml/min/1.73 m, and 75.4 ml/min/1.73 m in the first, second and third tertile of baseline serum leptin concentration, respectively. After adjustment for potential confounders, leptin concentration was inversely associated with changes of eGFR over time (beta for log-leptin: -1.288, 95% CI: -2.079 - -0.497). Relative to baseline levels, the estimated change in eGFR for unit-increase in log-leptin was -1.9% (95% CI: -2.977 - -0.761). After stratification by sex, the results were confirmed in women only. In women we also found an association between increasing leptin concentration over time and rapid decline of renal function. Conclusions In women, serum leptin may contribute to eGFR decline independently from obesity and diabetes mellitus, although a cause-effect relationship cannot be established due to the observational nature of our study. A better characterization of adipokine profile of obese individuals may shed light on the accelerated renal function decline reported in a proportion of high-risk obese individuals.	[Pedone, Claudio; Scarlata, Simone; Incalzi, Raffaele Antonelli] Campus Biomed Univ, Unit Geriatr, Rome, Italy; [Roshanravan, Baback] Univ Washington, Dept Med, Div Nephrol, Kidney Res Inst, Seattle, WA 98195 USA; [Patel, Kushang V.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Ferrucci, Luigi] NIA, Longitudinal Study Sect, Clin Res Branch, Baltimore, MD 21224 USA; [Incalzi, Raffaele Antonelli] S Raffaele Cittadella Carita Fdn, Taranto, Italy	University Campus Bio-Medico - Rome Italy; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Pedone, C (corresponding author), Campus Biomed Univ, Unit Geriatr, Rome, Italy.	c.pedone@unicampus.it	Scarlata, Simone/G-6490-2010; Pedone, Claudio/F-9488-2010	Scarlata, Simone/0000-0002-2704-2708; Pedone, Claudio/0000-0003-1847-9032; Antonelli Incalzi, Raffaele/0000-0003-2100-2075	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK099442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG001050] Funding Source: NIH RePORTER; NIDDK NIH HHS [L30 DK099909, K23 DK099442] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bemelmans MHA, 1996, CRIT REV IMMUNOL, V16, P1; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; de Jong PE, 2002, INT J OBESITY, V26, pS21, DOI 10.1038/sj.ijo.0802213; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; Esler M, 2001, AM J HYPERTENS, V14, p304S, DOI 10.1016/S0895-7061(01)02236-1; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Griffin KA, 2008, AM J PHYSIOL-RENAL, V294, pF695, DOI 10.1152/ajprenal.00324.2007; Hall JE, 2003, CURR OPIN NEPHROL HY, V12, P195, DOI 10.1097/00041552-200303000-00011; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Ikezumi Y, 2008, BIOCHEM BIOPH RES CO, V376, P706, DOI 10.1016/j.bbrc.2008.09.049; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kastarinen H, 2009, SCAND J CLIN LAB INV, V69, P401, DOI 10.1080/00365510802706645; Klausen KP, 2009, CLIN ENDOCRINOL, V71, P40, DOI 10.1111/j.1365-2265.2008.03427.x; Kohler KA, 2000, AM J KIDNEY DIS, V36, P903, DOI 10.1053/ajkd.2000.19080; Komura Hiroshi, 2013, BMC Res Notes, V6, P463, DOI 10.1186/1756-0500-6-463; Kramer H, 2005, AM J KIDNEY DIS, V46, P587, DOI 10.1053/j.ajkd.2005.06.007; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Mathew AV, 2011, CURR DIABETES REV, V7, P41, DOI 10.2174/157339911794273928; Mohan S, 2012, OBES SURG, V22, P375, DOI 10.1007/s11695-011-0437-7; Munkhaugen J, 2009, AM J KIDNEY DIS, V54, P638, DOI 10.1053/j.ajkd.2009.03.023; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P1565, DOI 10.2215/CJN.02250409; Odagiri K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088873; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Patel NSA, 2005, J PHARMACOL EXP THER, V312, P1170, DOI 10.1124/jpet.104.078659; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Praga M, 2010, KIDNEY INT, V78, P633, DOI 10.1038/ki.2010.221; Rifkin DE, 2008, ARCH INTERN MED, V168, P2212, DOI 10.1001/archinte.168.20.2212; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Sharma K, 1997, KIDNEY INT, V51, P1980, DOI 10.1038/ki.1997.269; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Wolf G, 2006, CONTRIB NEPHROL, V151, P175, DOI 10.1159/000095328	42	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117828	10.1371/journal.pone.0117828	http://dx.doi.org/10.1371/journal.pone.0117828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710704	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900040
J	Eschler, A; Ender, SA; Schiml, K; Mittlmeier, T; Gradl, G				Eschler, Anica; Ender, Stephan Albrecht; Schiml, Katharina; Mittlmeier, Thomas; Gradl, Georg			Bony Healing of Unstable Thoracolumbar Burst Fractures in the Elderly Using Percutaneously Applied Titanium Mesh Cages and a Transpedicular Fixation System with Expandable Screws	PLOS ONE			English	Article							VERTEBRAL COMPRESSION FRACTURES; BALLOON KYPHOPLASTY; OSTEOPOROTIC FRACTURES; VERTEBROPLASTY; MANAGEMENT; EFFICACY; CEMENT; DISABILITY; RISK	Introduction There is a high incidence of vertebral burst fractures following low velocity trauma in the elderly. Treatment of unstable vertebral burst fractures using the same principles like in stable vertebral burst fractures may show less favourable results in terms of fracture reduction, maintenance of reduction and cement leakage. In order to address these shortcomings this study introduces cementless fixation of unstable vertebral burst fractures using internal fixators and expandable intravertebral titanium mesh cages in a one-stage procedure via minimum- invasive techniques. Material and Methods A total of 16 consecutive patients (median age 76 years, range 58-94) with unstable thoracolumbar burst fractures and concomitant osteoporosis were treated by an internal fixator inserted via minimum invasive technique one level above and below the fractured vertebra. Fracture reduction was achieved and maintained by transpedicular placement of two titanium mesh cages into the fractured vertebral body during the same procedure. Intra-and postoperative safety of the procedure as well as analysis of reduction quality was analysed by 3D C-arm imaging or CT, respectively. Clinical and radiographic follow-up averaged 10.4 months (range 4.5-24.5). Results Stabilization of the collapsed vertebral body was achieved in all 16 cases without any intraoperative complication. Surgical time averaged 102 +/- 6.6 minutes (71-194). The postoperative kyphotic angle (KA) and Cobb angle revealed significant improvements (KA 13.7 degrees to 7.4 degrees, p<0.001; Cobb 9.6 degrees to 6.0 degrees, p<0.002) with partial loss of reduction at final follow-up (KA 8.3 degrees, Cobb 8.7 degrees). VAS (Visual Analogue Scale) improved from 7.6 to 2.6 (p<0.001). Adjacent fractures were not observed. One minor (malposition of pedicle screw) complication was encountered. Conclusion Cementless fixation of osteoporotic burst fractures revealed substantial pain relief, adequate maintenance of reduction and a low complication rate. Bony healing after unstable osteoporotic burst fractures is possible.	[Eschler, Anica; Ender, Stephan Albrecht; Schiml, Katharina; Mittlmeier, Thomas; Gradl, Georg] Univ Rostock, Med Ctr, Dept Trauma Hand & Reconstruct Surg, D-18057 Rostock, Germany	University of Rostock	Eschler, A (corresponding author), Univ Rostock, Med Ctr, Dept Trauma Hand & Reconstruct Surg, Schillingallee 35, D-18057 Rostock, Germany.	anica.eschler@med.uni-rostock.de	Mittlmeier, Thomas/R-5741-2019	Mittlmeier, Thomas/0000-0002-0536-8045	Alphatec Spine	Alphatec Spine	The authors of the article declare that they did not receive any payment or services from a third party for this study, nor are they shareholders or participants in intellectual property with Alphatec Spine. One author received research support from Alphatec Spine irrespective to this study, the same author is related with speaker and teaching activities for the company. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Adams MA, 2011, ARCH ORTHOP TRAUM SU, V131, P1703, DOI 10.1007/s00402-011-1355-9; [Anonymous], 2009, OSTEOLOGIE, V4, P304; Berlemann U, 2002, J BONE JOINT SURG BR, V84B, P748, DOI 10.1302/0301-620X.84B5.11841; Blondel B, 2011, ORTHOP TRAUMATOL-SUR, V97, P527, DOI 10.1016/j.otsr.2011.03.020; Boonen S, 2011, OSTEOPOROSIS INT, V22, P2915, DOI 10.1007/s00198-011-1639-5; Bouza C, 2006, EUR SPINE J, V15, P1050, DOI 10.1007/s00586-005-0048-x; Bula P, 2010, Z ORTHOP UNFALLCHIR, V148, P646, DOI 10.1055/s-0030-1250379; Campbell PG, 2008, CURR REV MUSCULOSKE, V1, P61, DOI 10.1007/s12178-007-9007-y; Chang MC, 2013, J SPINAL DISORD TECH, V26, P305, DOI 10.1097/BSD.0b013e318246ae8a; COHEN LD, 1990, ORTHOP CLIN N AM, V21, P143; Dansie DM, 2005, AM J NEURORADIOL, V26, P1595; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Felder-Puig R, 2009, ORTHOPADE, V38, P606, DOI 10.1007/s00132-009-1446-2; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Fribourg D, 2004, SPINE, V29, P2270, DOI 10.1097/01.brs.0000142469.41565.2a; Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002; Ghofrani H, 2010, SPINE, V35, pE768, DOI 10.1097/BRS.0b013e3181d260bf; Heyde CE, 2006, MAN MED, V44, P504, DOI 10.1007/s00337-006-0486-5; Hofstaetter JG, 2012, J ORTHOP RES, V30, P1089, DOI 10.1002/jor.22026; Hulme PA, 2006, SPINE, V31, P1983, DOI 10.1097/01.brs.0000229254.89952.6b; Jung HJ, 2012, J KOREAN NEUROSURG S, V52, P353, DOI 10.3340/jkns.2012.52.4.353; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Kasperk C, 2010, J VASC INTERV RADIOL, V21, P701, DOI 10.1016/j.jvir.2010.01.003; Kim C, 2007, J SPINAL DISORD TECH, V20, P604, DOI 10.1097/BSD.0b013e318040ad73; Kim SH, 2004, ACTA RADIOL, V45, P440, DOI 10.1080/02841850410005615; Komemushi A, 2006, CARDIOVASC INTER RAD, V29, P580, DOI 10.1007/s00270-005-0138-5; Korovessis Panagiotis, 2014, Eur J Orthop Surg Traumatol, V24 Suppl 1, pS183, DOI 10.1007/s00590-013-1296-9; Li XG, 2012, J SPINAL DISORD TECH, V25, P142, DOI 10.1097/BSD.0b013e318213c113; Lin EP, 2004, AM J NEURORADIOL, V25, P175; Lin WC, 2008, EUR SPINE J, V17, P592, DOI 10.1007/s00586-007-0564-y; McGirt MJ, 2009, SPINE J, V9, P501, DOI 10.1016/j.spinee.2009.01.003; Murata K, 2012, J NEUROSURG-SPINE, V17, P469, DOI 10.3171/2012.7.SPINE122; Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2; Omidi-Kashani F, 2013, J OSTEOPOROS, V2013, DOI 10.1155/2013/690329; Paik H, 2012, SPINE J, V12, P417, DOI 10.1016/j.spinee.2012.03.020; Pflugmacher R, 2005, ROFO-FORTSCHR RONTG, V177, P1670, DOI 10.1055/s-2005-858631; Phillips FM, 2002, SPINE, V27, P2173, DOI 10.1097/00007632-200210010-00018; Rajasekaran S, 2010, EUR SPINE J, V19, P40, DOI 10.1007/s00586-009-1122-6; Robinson Y, 2008, PATIENT SAF SURG, V2, P1, DOI 10.1186/1754-9493-2-2; Rollinghoff M, 2010, MINERVA CHIR, V65, P429; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rotter R, 2010, EUR SPINE J, V19, P916, DOI 10.1007/s00586-010-1341-x; Seibel MJ, 2001, DTSCH ARZTEBL, V98, pA1681; Taylor RS, 2007, EUR SPINE J, V16, P1085, DOI 10.1007/s00586-007-0308-z; Taylor RS, 2006, SPINE, V31, P2747, DOI 10.1097/01.brs.0000244639.71656.7d; Tohmeh AG, 1999, SPINE, V24, P1772, DOI 10.1097/00007632-199909010-00004; Trout AT, 2006, AM J NEURORADIOL, V27, P217; United Nations Publisher, 2004, WORLD POPULATION PRO, P43; Vallejo R., 2010, TECH REG ANESTH PAIN, V14, P133; Voggenreiter G, 2008, UNFALLCHIRURG, V111, P403, DOI 10.1007/s00113-008-1453-5; Walter J, 2012, ACTA NEUROCHIR, V154, P313, DOI 10.1007/s00701-011-1239-3; Wiener JM, 2002, INT J EPIDEMIOL, V31, P776, DOI 10.1093/ije/31.4.776; Wilhelm K, 2003, ROFO-FORTSCHR RONTG, V175, P1690; Wu J, 2013, INDIAN J ORTHOP, V47, P230, DOI 10.4103/0019-5413.111496; Xing D, 2013, J CLIN NEUROSCI, V20, P795, DOI 10.1016/j.jocn.2012.05.038; Xu Shao-wen, 2003, Chin J Traumatol, V6, P160; Zdichavsky M., 2004, EUR J TRAUMA, V30, P234, DOI DOI 10.1007/S00068-004-1422-9; Zhao Li-lai, 2013, Zhongguo Gu Shang, V26, P429	58	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117122	10.1371/journal.pone.0117122	http://dx.doi.org/10.1371/journal.pone.0117122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706642	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100060
J	Kim, S; Ka, SO; Lee, Y; Park, BH; Fei, X; Jung, JK; Seo, SY; Bae, EJ				Kim, Sora; Ka, Sun-O; Lee, Youngyi; Park, Byung-Hyun; Fei, Xiang; Jung, Jae-Kyung; Seo, Seung-Yong; Bae, Eun Ju			The New 4-O-Methylhonokiol Analog GS12021 Inhibits Inflammation and Macrophage Chemotaxis: Role of AMP-Activated Protein Kinase a Activation	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; KAPPA-B ACTIVATION; INSULIN-RESISTANCE; P21-MEDIATED SUPPRESSION; TUMOR-GROWTH; HONOKIOL; MCP-1; CELLS; PATHWAY; EXPRESSION	Preventing pathologic tissue inflammation is key to treating obesity-induced insulin resistance and type 2 diabetes. Previously, we synthesized a series of methylhonokiol analogs and reported that compounds with a carbamate structure had inhibitory function against cyclooxygenase-2 in a cell-free enzyme assay. However, whether these compounds could inhibit the expression of inflammatory genes inmacrophages has not been investigated. Here, we found that a new 4-O-methylhonokiol analog, 3',5-diallyl-4'-methoxy-[ 1,1'-biphenyl]-2-yl morpholine-4-carboxylate (GS12021) inhibited LPS-or TNFa-stimulated inflammation in macrophages and adipocytes, respectively. LPS-induced phosphorylation of nuclear factorkappa B (NF-kappa B)/p65 was significantly decreased, whereas NF-kappa B luciferase activities were slightly inhibited, by GS12021 treatment in RAW264.7 cells. Either mitogen-activated protein kinase phosphorylation or AP-1 luciferase activity was not altered by GS12021. GS12021 increased the phosphorylation of AMP-activated protein kinase (AMPK) alpha and the expression of sirtuin (SIRT) 1. Inhibition of mRNA expression of inflammatory genes by GS12021 was abolished in AMPKa1-knockdown cells, but not in SIRT1 knockout cells, demonstrating that GS12021 exerts anti-inflammatory effects through AMPK alpha activation. The transwell migration assay results showed that GS12021 treatment of macrophages prevented the cell migration promoted by incubation with conditioned medium obtained from adipocytes. GS12021 suppression of p65 phosphorylation and macrophage chemotaxis were preserved in AMPK alpha 1-knockdown cells, indicating AMPK is not required for these functions of GS12021. Identification of this novel methylhonokiol analog could enable studies of the structure-activity relationship of this class of compounds and further evaluation of its in vivo potential for the treatment of insulin-resistant states and other chronic inflammatory diseases.	[Kim, Sora; Lee, Youngyi; Bae, Eun Ju] Woosuk Univ, Coll Pharm, Wanju Gun, Jeollabuk Do, South Korea; [Ka, Sun-O; Park, Byung-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561756, Jeollabuk Do, South Korea; [Ka, Sun-O; Park, Byung-Hyun] Chonbuk Natl Univ, Diabet Res Ctr, Jeonju 561756, Jeollabuk Do, South Korea; [Fei, Xiang; Seo, Seung-Yong] Gachon Univ, Coll Pharm, Inchon, South Korea; [Jung, Jae-Kyung] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea	Woosuk University; Jeonbuk National University; Jeonbuk National University; Gachon University; Chungbuk National University	Seo, SY (corresponding author), Gachon Univ, Coll Pharm, Inchon, South Korea.	syseo@gachon.ac.kr; ejbae@woosuk.ac.kr	Fei, Xiang/Z-1378-2019	Fei, Xiang/0000-0001-9637-1989; Jung, Jae-Kyung/0000-0002-0490-9663	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012R1A1A1014527]; Pioneer Research Center Program through the NRF - Ministry of Science, ICT & Future Planning [2014M3C1A3001556]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Pioneer Research Center Program through the NRF - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012R1A1A1014527) and the Pioneer Research Center Program through the NRF funded by the Ministry of Science, ICT & Future Planning (2014M3C1A3001556). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2006, MOL CANCER RES, V4, P621, DOI 10.1158/1541-7786.MCR-06-0076; Arora S, 2012, CURR MOL MED, V12, P1244, DOI 10.2174/156652412803833508; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Bai AP, 2010, J PHARMACOL EXP THER, V333, P717, DOI 10.1124/jpet.109.164954; BOSSINK AWJ, 1995, BLOOD, V86, P3841, DOI 10.1182/blood.V86.10.3841.bloodjournal86103841; Chen YJ, 2014, J ORTHOP RES, V32, P573, DOI 10.1002/jor.22577; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Fan SL, 2014, INFLAMMATION, V37, P17, DOI 10.1007/s10753-013-9707-y; Gaskin FS, 2011, AM J PHYSIOL-HEART C, V300, pH1352, DOI 10.1152/ajpheart.00944.2010; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hattori Y, 2006, HYPERTENSION, V47, P265, DOI 10.1161/01.HYP.0000198425.21604.aa; Hayashida K, 2001, ARTHRITIS RES, V3, P118, DOI 10.1186/ar149; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Kanamori H, 2007, BIOCHEM BIOPH RES CO, V360, P772, DOI 10.1016/j.bbrc.2007.06.148; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Kim YJ, 2013, MOL NUTR FOOD RES, V57, P1988, DOI 10.1002/mnfr.201300113; Kusano KF, 2004, CIRC J, V68, P671, DOI 10.1253/circj.68.671; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lee B, 2012, BIOORGAN MED CHEM, V20, P2860, DOI 10.1016/j.bmc.2012.03.028; Lee NJ, 2013, BRIT J PHARMACOL, V168, P1133, DOI 10.1111/j.1476-5381.2012.02235.x; Lee YJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-35; Nagalingam A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3128; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Oh JH, 2012, J NUTR BIOCHEM, V23, P706, DOI 10.1016/j.jnutbio.2011.03.013; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sanchez-Valdepenas C, 2007, CELL SIGNAL, V19, P528, DOI 10.1016/j.cellsig.2006.08.002; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Takahashi M, 2009, J IMMUNOL, V183, P3463, DOI 10.4049/jimmunol.0802812; Tei N, 2013, J NEUROSCI RES, V91, P681, DOI 10.1002/jnr.23202; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhang ZG, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/965954; Zhu XY, 2014, ACTA HISTOCHEM, V116, P588, DOI 10.1016/j.acthis.2013.11.005	39	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117120	10.1371/journal.pone.0117120	http://dx.doi.org/10.1371/journal.pone.0117120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706552	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100059
J	Kong, SY; Park, MH; Lee, M; Kim, JO; Lee, HR; Han, BW; Svendsen, CN; Sung, SH; Kim, HJ				Kong, Sun-Young; Park, Min-Hye; Lee, Mina; Kim, Jae-Ouk; Lee, Ha-Rim; Han, Byung Woo; Svendsen, Clive N.; Sung, Sang Hyun; Kim, Hyun-Jung			Kuwanon V Inhibits Proliferation, Promotes Cell Survival and Increases Neurogenesis of Neural Stem Cells	PLOS ONE			English	Article							CULTIVATED MULBERRY TREE; CORTEX RADICIS MORACEAE; MORUS-ALBA L.; PROGENITOR CELLS; ROOT BARK; NEURONAL DIFFERENTIATION; PRENYLATED FLAVONOIDS; IN-VITRO; DEATH; PATHWAY	Neural stem cells (NSCs) have the ability to proliferate and differentiate into neurons and glia. Regulation of NSC fate by small molecules is important for the generation of a certain type of cell. The identification of small molecules that can induce new neurons from NSCs could facilitate regenerative medicine and drug development for neurodegenerative diseases. In this study, we screened natural compounds to identify molecules that are effective on NSC cell fate determination. We found that Kuwanon V (KWV), which was isolated from the mulberry tree (Morus bombycis) root, increased neurogenesis in rat NSCs. In addition, during NSC differentiation, KWV increased cell survival and inhibited cell proliferation as shown by 5-bromo-2-deoxyuridine pulse experiments, Ki67 immunostaining and neurosphere forming assays. Interestingly, KWV enhanced neuronal differentiation and decreased NSC proliferation even in the presence of mitogens such as epidermal growth factor and fibroblast growth factor 2. KWV treatment of NSCs reduced the phosphorylation of extracellular signal-regulated kinase 1/2, increased mRNA expression levels of the cyclin-dependent kinase inhibitor p21, down-regulated Notch/Hairy expression levels and up-regulated microRNA miR-9, miR-29a and miR-181a. Taken together, our data suggest that KWV modulates NSC fate to induce neurogenesis, and it may be considered as a new drug candidate that can regenerate or protect neurons in neurodegenerative diseases.	[Kong, Sun-Young; Park, Min-Hye; Lee, Ha-Rim; Kim, Hyun-Jung] Chung Ang Univ, Coll Pharm, Lab Mol & Stem Cell Pharmacol, Seoul 156756, South Korea; [Lee, Mina; Han, Byung Woo; Sung, Sang Hyun] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Mina; Han, Byung Woo; Sung, Sang Hyun] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Lee, Mina] Sunchon Natl Univ, Coll Pharm, Sunchon, Jeollanam Do, South Korea; [Kim, Jae-Ouk] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea; [Svendsen, Clive N.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA	Chung Ang University; Seoul National University (SNU); Seoul National University (SNU); Sunchon National University; International Vaccine Institute; Cedars Sinai Medical Center	Kim, HJ (corresponding author), Chung Ang Univ, Coll Pharm, Lab Mol & Stem Cell Pharmacol, Seoul 156756, South Korea.	hyunjungkim@cau.ac.kr			Chung-Ang University Research Scholarship; National Research Foundation [NRF-2014R1A1A1002607]	Chung-Ang University Research Scholarship; National Research Foundation	This research was supported by the Chung-Ang University Research Scholarship Grants in 2013 and the National Research Foundation (NRF-2014R1A1A1002607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu Masahiko, 2006, Curr Stem Cell Res Ther, V1, P267, DOI 10.2174/157488806776956887; Anacker C, 2011, MOL PSYCHIATR, V16, P738, DOI 10.1038/mp.2011.26; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bonev B, 2012, CELL REPORTS, V2, P10, DOI 10.1016/j.celrep.2012.05.017; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Cavanagh JFR, 1997, CEREB CORTEX, V7, P293, DOI 10.1093/cercor/7.4.293; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chang DJ, 2011, BIOORG MED CHEM LETT, V21, P7050, DOI 10.1016/j.bmcl.2011.09.099; CHEN FJ, 1995, YAKUGAKU ZASSHI, V115, P476, DOI 10.1248/yakushi1947.115.6_476; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; Dat NT, 2009, J NAT PROD, V72, P39, DOI 10.1021/np800491u; Du J, 2003, PHYTOCHEMISTRY, V62, P1235, DOI 10.1016/S0031-9422(02)00753-7; Duan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097684; Duc MH, 2009, BIOORG MED CHEM LETT, V19, P6759, DOI 10.1016/j.bmcl.2009.09.102; Ebert AD, 2010, NAT REV DRUG DISCOV, V9, P1, DOI 10.1038/nrd3000; El-Beshbishy HA, 2006, LIFE SCI, V78, P2724, DOI 10.1016/j.lfs.2005.10.010; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Go HS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-48; Ham A, 2012, PHYTOTHER RES, V26, P620, DOI 10.1002/ptr.3592; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; IKUTA J, 1986, CHEM PHARM BULL, V34, P2471; Jin YS, 2007, PHYTOTHER RES, V21, P605, DOI 10.1002/ptr.2121; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Jung GA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-66; Kim HJ, 2007, EXP NEUROL, V203, P394, DOI 10.1016/j.expneurol.2006.08.029; Kim HJ, 2010, ARCH PHARM RES, V33, P1355, DOI 10.1007/s12272-010-0909-7; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Kim HJ, 2012, KOREAN J PHYSIOL PHA, V16, P1, DOI 10.4196/kjpp.2012.16.1.1; Kim HJ, 2011, BBA-MOL BASIS DIS, V1812, P1, DOI 10.1016/j.bbadis.2010.08.006; Kim HJ, 2009, STEM CELLS, V27, P390, DOI 10.1634/stemcells.2007-1047; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kim W, 2013, KOREAN J PHYSIOL PHA, V17, P23, DOI 10.4196/kjpp.2013.17.1.23; Laeng P, 2004, J NEUROCHEM, V91, P238, DOI 10.1111/j.1471-4159.2004.02725.x; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee HJ, 2012, ARCH PHARM RES, V35, P163, DOI 10.1007/s12272-012-0118-7; Lee HJ, 2011, ARCH PHARM RES, V34, P1373, DOI 10.1007/s12272-011-0818-4; Spohr TCLDE, 2010, J NEUROSCI RES, V88, P530, DOI 10.1002/jnr.22218; Liu JW, 2007, J NAT PROD, V70, P1329, DOI 10.1021/np070135j; Longo Frank M., 2006, Current Alzheimer Research, V3, P5, DOI 10.2174/156720506775697089; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma DK, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-16; Mancini M, 2012, AGING-US, V4, P843, DOI 10.18632/aging.100508; Marcussen AB, 2008, ACTA NEUROL SCAND, V117, P94, DOI 10.1111/j.1600-0404.2007.00910.x; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; NOMURA T, 1978, CHEM PHARM BULL, V26, P1394; Peng ZW, 2012, PROG NEURO-PSYCHOPH, V36, P183, DOI 10.1016/j.pnpbp.2011.08.014; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Pouton CW, 2005, ADV DRUG DELIVER REV, V57, P1918, DOI 10.1016/j.addr.2005.08.003; Roshan R, 2014, RNA, V20, P1287, DOI 10.1261/rna.044008.113; Rosser AE, 1997, DEV BRAIN RES, V98, P291, DOI 10.1016/S0165-3806(96)00189-7; Saxe JP, 2007, CHEM BIOL, V14, P1019, DOI 10.1016/j.chembiol.2007.07.016; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Shindler KS, 1997, J NEUROSCI, V17, P3112; Singa ANB, 2005, J ETHNOPHARMACOL, V100, P333, DOI 10.1016/j.jep.2005.03.013; Sohn HY, 2004, PHYTOMEDICINE, V11, P666, DOI 10.1016/j.phymed.2003.09.005; Sun AX, 2013, CURR OPIN CELL BIOL, V25, P215, DOI 10.1016/j.ceb.2012.12.007; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tan SL, 2012, GENES CELLS, V17, P952, DOI 10.1111/gtc.12009; Taupin Philippe, 2010, Recent Pat CNS Drug Discov, V5, P253, DOI 10.2174/157488910793362377; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang B, 2009, NEUROSCI LETT, V461, P252, DOI 10.1016/j.neulet.2009.06.020; Wen S, 2009, CELL ADHES MIGR, V3, P107, DOI 10.4161/cam.3.1.7602; Weng MS, 2011, J AGR FOOD CHEM, V59, P1031, DOI 10.1021/jf104263s; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Xu C, 2014, STEM CELLS, V32, P2961, DOI 10.1002/stem.1774; Yang WM, 2008, NEUROSCI LETT, V443, P104, DOI 10.1016/j.neulet.2008.07.020; Yoo DY, 2011, PHYTOTHER RES, V25, P809, DOI 10.1002/ptr.3337; Yoon HJ, 2013, BIOORGAN MED CHEM, V21, P7165, DOI 10.1016/j.bmc.2013.08.066; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	76	33	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118188	10.1371/journal.pone.0118188	http://dx.doi.org/10.1371/journal.pone.0118188			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706719	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100150
J	Park, M; Chung, YE; Kim, KA; Chung, WS; Lee, HS; Han, KH; Kim, MJ; Kim, KW				Park, Mina; Chung, Yong Eun; Kim, Kyung Ah; Chung, Woo-Suk; Lee, Hye Sun; Han, Kyung Hwa; Kim, Myeong-Jin; Kim, Ki Whang			Added Value of Arterial Enhancement Fraction Color Maps for the Characterization of Small Hepatic Low-Attenuating Lesions in Patients with Colorectal Cancer	PLOS ONE			English	Article							LIVER METASTASES; GADOXETIC ACID; HEPATOCELLULAR-CARCINOMA; PERFUSION INDEX; CT; MR; EPIDEMIOLOGY; RECURRENT; CM	Objective To assess the added value of arterial enhancement fraction (AEF) color maps for the differentiation of small metastases from hepatic benign lesions. Subjects and Methods We retrospectively analyzed 46 patients with colorectal cancer who underwent multiphasic liver CT imaging and had low-attenuating liver lesions smaller than 3 cm (123 total lesions; metastasis: benign = 32: 91). AEF color maps of the liver were created from multiphasic liver CT images using dedicated software. Two radiologists independently reviewed multiphasic CT image sets alone and in combination with image sets with AEF color maps using a five-point scale. The additional diagnostic value of the color maps was assessed by means of receiver-operating characteristic (ROC) analysis. Results The area under the ROC curve (Az) increased when multiphasic CT images were combined with AEF color map analysis as compared with evaluation based only on multiphasic CT images (from 0.698 to 0.897 for reader 1, and from 0.825 to 0.945 for reader 2; P < 0.001 and 0.002, respectively). The increase Az was especially significant for lesions less than 1 cm (from 0.702 to 0.888 for reader 1, and from 0.768 to 0.958 for reader 2; P = 0.001 and P = 0.001, respectively). The mean AEF of tumor-adjacent parenchyma (35.07 +/- 27.2) was significantly higher than that of tumor-free liver parenchyma (27.3 +/- 20.6) (P = 0.04). Conclusions AEF color mapping can improve the diagnostic performance for small hepatic metastases from colorectal cancer and may allow for the elimination of additional examinations.	[Park, Mina; Chung, Yong Eun; Kim, Myeong-Jin; Kim, Ki Whang] Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul, South Korea; [Kim, Kyung Ah] Catholic Univ Korea, St Vincents Hosp, Dept Radiol, Suwon, South Korea; [Chung, Woo-Suk] Konyang Univ, Coll Med, Dept Radiol, Taejon, South Korea; [Han, Kyung Hwa] Yonsei Univ, Coll Med, Med Res Ctr, Biostat Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System; Catholic University of Korea; Konyang University; Konyang University Hospital; Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul, South Korea.	yelv@yuhs.ac	Lee, Hye Sun/J-2154-2015; Kim, Myeong-Jin/E-1623-2011	Lee, Hye Sun/0000-0001-6328-6948; Kim, Myeong-Jin/0000-0001-7949-5402; Han, Kyunghwa/0000-0002-5687-7237; Chung, Yong Eun/0000-0003-0811-9578; PARK, MINA/0000-0002-2005-7560				Chung WS, 2011, J MAGN RESON IMAGING, V34, P345, DOI 10.1002/jmri.22671; Holalkere NS, 2006, J COMPUT ASSIST TOMO, V30, P591, DOI 10.1097/00004728-200607000-00007; Horton KM, 1999, RADIOGRAPHICS, V19, P431, DOI 10.1148/radiographics.19.2.g99mr04431; Joo I, 2011, EUROPEAN J RADIOLOGY, DOI [10.1016/j.ejrad.2011.11.029, DOI 10.1016/J.EJRAD.2011.11.029]; Kim KW, 2004, AM J ROENTGENOL, V182, P1233, DOI 10.2214/ajr.182.5.1821233; Kim KW, 2011, AM J ROENTGENOL, V196, P102, DOI 10.2214/AJR.09.3971; Kim KW, 2009, RADIOLOGY, V250, P425, DOI 10.1148/radiol.2501072196; Kim YK, 2012, INVEST RADIOL, V47, P159, DOI 10.1097/RLI.0b013e31823a1495; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Lee DH, 2013, KOREAN J RADIOL, V14, P51, DOI 10.3348/kjr.2013.14.1.51; Lee KH, 2013, KOREAN J RADIOL, V14, P894, DOI 10.3348/kjr.2013.14.6.894; Lee WS, 2008, J CLIN GASTROENTEROL, V42, P945, DOI 10.1097/MCG.0b013e318064e752; Mainenti PP, 2010, ABDOM IMAGING, V35, P511, DOI 10.1007/s00261-009-9555-2; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; McMillan DC, 2007, SURG ONCOL, V16, P3, DOI 10.1016/j.suronc.2007.04.008; Meijerink MR, 2008, EUR RADIOL, V18, P2345, DOI 10.1007/s00330-008-0996-8; Ogunbiyi OA, 1997, ANN SURG ONCOL, V4, P613, DOI 10.1007/BF02303744; Pandharipande PV, 2005, RADIOLOGY, V234, P661, DOI 10.1148/radiol.2343031362; PERKINS AC, 1987, NUCL MED COMMUN, V8, P982, DOI 10.1097/00006231-198712000-00006; Platt JF, 1997, RADIOLOGY, V205, P49, DOI 10.1148/radiology.205.1.9314961; Platt JF, 1997, J COMPUT ASSIST TOMO, V21, P348, DOI 10.1097/00004728-199705000-00003; Schwartz LH, 1999, RADIOLOGY, V210, P71, DOI 10.1148/radiology.210.1.r99ja0371; Shimada K, 2010, EUR RADIOL, V20, P2690, DOI 10.1007/s00330-010-1842-3; Sica GT, 2000, AM J ROENTGENOL, V174, P691, DOI 10.2214/ajr.174.3.1740691; Tan CH, 2011, AM J CLIN ONCOL-CANC, V34, P411, DOI 10.1097/COC.0b013e3181e84e1a; Wang W, 2006, STAT MED, V25, P2215, DOI 10.1002/sim.2332; Warren HW, 1998, BRIT J SURG, V85, P1708	27	1	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0114819	10.1371/journal.pone.0114819	http://dx.doi.org/10.1371/journal.pone.0114819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706878	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100002
J	Sawe, FK; Obiero, E; Yegon, P; Langat, RC; Aoko, A; Tarus, J; Kiptoo, I; Langat, RK; Maswai, J; Bii, M; Khamadi, S; Shikuku, KP; Close, N; Sinei, S; Shaffer, DN				Sawe, Fredrick K.; Obiero, Eunice; Yegon, Peter; Langat, Rither C.; Aoko, Appolonia; Tarus, Jemutai; Kiptoo, Ignatius; Langat, Raphael K.; Maswai, Jonah; Bii, Margaret; Khamadi, Samoel; Shikuku, Kibet P.; Close, Nicole; Sinei, Samuel; Shaffer, Douglas N.			Kericho CLinic-Based ART Diagnostic Evaluation (CLADE): Design, Accrual, and Baseline Characteristics of a Randomized Controlled Trial Conducted in Predominately Rural, District-Level, HIV Clinics of Kenya	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT FAILURE; VIROLOGICAL FAILURE; VIRAL LOAD; CELL COUNT; THERAPY; ADULTS; CRITERIA; UTILITY	Background Prospective clinical trial data regarding routine HIV-1 viral load (VL) monitoring of antiretroviral therapy (ART) in non-research clinics of Sub-Saharan Africa are needed for policy makers. Methods CLinic-based ART Diagnostic Evaluation (CLADE) is a randomized, controlled trial (RCT) evaluating feasibility, superiority, and cost-effectiveness of routine VL vs. standard of care (clinical and immunological) monitoring in adults initiating dual nucleoside reverse transcriptase inhibitor (NRTI)+non-NRTI ART. Participants were randomized (1:1) at 7 predominately rural, non-research, district-level clinics of western Kenya. Descriptive statistics present accrual patterns and baseline cohort characteristics. Results Over 15 months, 820 adults enrolled at 7 sites with 86-152 enrolled per site. Monthly site enrollment ranged from 2-92 participants. Full (100%) informed consent compliance was independently documented. Half (49.9%) had HIV diagnosed through voluntary counseling and testing. Study arms were similar: mostly females (57.6%) aged 37.6 (SD = 9.0) years with low CD4 (166 [SD = 106]) cells/m(3)). Notable proportions had WHO Stage III or IV disease (28.7%), BMI < 18.5 kg/m(2) (23.1%), and a history of tuberculosis (5.6%) or were receiving tuberculosis treatment (8.2%) at ART initiation. In the routine VL arm, 407/409 (99.5%) received baseline VL (234,577 SD = 151,055 copies/ml). All participants received lamivudine; 49.8% started zidovudine followed by 38.4% stavudine and 11.8% tenofovir; and, 64.4% received nevirapine as nNRTI (35.6% efavirenz). Conclusions A RCT can be enrolled successfully in rural, non-research, resource limited, district-level clinics in western Kenya. Many adults presenting for ART have advanced HIV/AIDS, emphasizing the importance of universal HIV testing and linkage-to-care campaigns.	[Sawe, Fredrick K.; Yegon, Peter; Langat, Rither C.; Aoko, Appolonia; Tarus, Jemutai; Kiptoo, Ignatius; Langat, Raphael K.; Maswai, Jonah; Bii, Margaret; Khamadi, Samoel; Shikuku, Kibet P.; Sinei, Samuel; Shaffer, Douglas N.] Kenya Govt Med Res Ctr, Walter Reed Project, Kericho, Kenya; [Sawe, Fredrick K.; Shaffer, Douglas N.] US Mil HIV Res Program, Walter Reed Army Inst Res, Silver Spring, MD USA; [Sawe, Fredrick K.] Henry M Jackson Fdn Adv Mil Med, Rockville, MD USA; [Obiero, Eunice] Kenya Minist Publ Hlth & Sanitat, Kericho Dist Hosp, Kericho, Kenya; [Yegon, Peter; Langat, Rither C.; Aoko, Appolonia; Tarus, Jemutai; Langat, Raphael K.; Maswai, Jonah; Bii, Margaret; Khamadi, Samoel; Sinei, Samuel] HJF Med Res Int Inc, Kericho, Kenya; [Close, Nicole] EmpiriStat, Mt Airy, MD USA	Kenya Medical Research Institute; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Sawe, FK (corresponding author), Kenya Govt Med Res Ctr, Walter Reed Project, Kericho, Kenya.	Fredrick.Sawe@usamru-k.org	Khamadi, Samoel Ashimosi/GXZ-6071-2022		U.S. Office of the Global AIDS Coordinator [KE-07-0044]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067, W81XWH-07-2-0065]; Kenya Medical Research Institute [W81XWH-07-2-0065]	U.S. Office of the Global AIDS Coordinator; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); Kenya Medical Research Institute	The Clinic-based ART Diagnostic Evaluation (CLADE) trial is sponsored by the U.S. Office of the Global AIDS Coordinator (#KE-07-0044). This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). Funding was also received through a cooperative agreement (W81XWH-07-2-0065) between the Kenya Medical Research Institute and the U.S. Department of Defense (DOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUID ANT THER KEN; Badri M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-89; Clinic-based ART Diagnostic Evaluation (CLADE), WALT REED ARM I RES; Division of Leprosy Tuberculosis and Lung Diseases (DLTLD) Ministry of Public Health and Sanitation, 2009, GUID MAN LEPR TUB; Educational Testing Service, 2012, GUID DOC PSYCH DIS A; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Eisenhut M, 2008, INT J INFECT DIS, V12, P565, DOI 10.1016/j.ijid.2008.02.002; European AIDS Clinical Society (EACS), 2012, GUID V6 1; Foglia G, 2008, EPIDEMIOL INFECT, V136, P694, DOI 10.1017/S0950268807009028; Gibb DM, 2013, LANCET, V381, P1391, DOI 10.1016/S0140-6736(12)62198-9; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Kenya Ministry of Public Health and Sanitation and Ministry of Medical Services, 2010, OP MAN IMPL PROV IN; Koethe JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009680; Larson BA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18026; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; National AIDS and STD Control Programme (NASCOP) Minstry of Health, 2008, NAT MAN MAN HIV RLEA; National AIDS and STI Control Programme (NASCOP), 2010, GUID HIV TEST COUNS; National AIDS and STI Control Programme (NASCOP), 2007, KEN NAT CLIN MAN ART; National AIDS and STI Control Programme (NASCOP) Ministry of Health Kenya, 2008, NAT GUID HIV TEST CO; Office of Human Research Protections (OHRP), 2013, WALT REED ARM I RES; Office of Human Research Protections (OHRP), 2013, TENW HOSP; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V56, P199, DOI 10.1097/QAI.0b013e31820bb448; Republic of Kenya, 2009, KEN AIDS IND SURV; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Rono K, 16 INT C AIDS STIS A; Shaffer DN, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/238012; Shaffer DN, 2010, JAIDS-J ACQ IMM DEF, V53, P514, DOI 10.1097/QAI.0b013e3181bcdae0; Smith DM, 2008, CLIN INFECT DIS, V46, P1598, DOI 10.1086/587110; US Department of State, 2013, PRES BUDG REQ REFL S; US Department of State, 2013, PRES EM PLAN AIDS RE; WHO, 2013, CONS GUID US ANTR DR; WHO, 2010, ANT THER HIV INF AD; World Health Organization (WHO), 2006, ANT THEARP HIV INF A	39	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116299	10.1371/journal.pone.0116299	http://dx.doi.org/10.1371/journal.pone.0116299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706652	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100030
J	Schofield, D; Cunich, M; Kelly, S; Passey, ME; Shrestha, R; Callander, E; Tanton, R; Veerman, L				Schofield, Deborah; Cunich, Michelle; Kelly, Simon; Passey, Megan E.; Shrestha, Rupendra; Callander, Emily; Tanton, Robert; Veerman, Lennert			The Impact of Diabetes on the Labour Force Participation, Savings and Retirement Income of Workers Aged 45-64 Years in Australia	PLOS ONE			English	Article							TIME PREFERENCE; PRODUCTIVITY; DISABILITY; EMPLOYMENT; POVERTY; BURDEN; WEALTH; PANEL	Background Diabetes is a debilitating and costly condition. The costs of reduced labour force participation due to diabetes can have severe economic impacts on individuals by reducing their living standards during working and retirement years. Methods A purpose-built microsimulation model of Australians aged 45-64 years in 2010, Health&WealthMOD2030, was used to estimate the lost savings at age 65 due to premature exit from the labour force because of diabetes. Regression models were used to examine the differences between the projected savings and retirement incomes of people at age 65 for those currently working full or part time with no chronic health condition, full or part time with diabetes, and people not in the labour force due to diabetes. Results All Australians aged 45-65 years who are employed full time in 2010 will have accumulated some savings at age 65; whereas only 90.5% of those who are out of the labour force due to diabetes will have done so. By the time they reach age 65, those who retire from the labour force early due to diabetes have a median projected savings of less than $35,000. This is far lower than the median value of total savings for those who remained in the labour force full time with no chronic condition, projected to have $638,000 at age 65. Conclusions Not only does premature retirement due to diabetes limit the immediate income available to individuals with this condition, but it also reduces their long-term financial capacity by reducing their accumulated savings and the income these savings could generate in retirement. Policies designed to support the labour force participation of those with diabetes, or interventions to prevent the onset of the disease itself, should be a priority to preserve living standards comparable with others who do not suffer from this condition.	[Schofield, Deborah; Cunich, Michelle; Shrestha, Rupendra; Callander, Emily] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Kelly, Simon; Tanton, Robert] Univ Canberra, Natl Ctr Social & Econ Modelling, Canberra, ACT 2601, Australia; [Passey, Megan E.] Univ Sydney, Sch Publ Hlth, Univ Ctr Rural Hlth North Coast, Sydney, NSW 2006, Australia; [Veerman, Lennert] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of Sydney; University of Canberra; University of Sydney; University of Queensland	Cunich, M (corresponding author), Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia.	michelle.cunich@ctc.usyd.edu.au	Passey, Megan/AAC-7062-2019; Callander, Emily/M-5679-2017; Kelly, Simon/X-7282-2018; Veerman, Lennert/A-9973-2011	Passey, Megan/0000-0001-5766-0235; Callander, Emily/0000-0001-7233-6804; Kelly, Simon/0000-0002-8245-0181; Shrestha, Rupendra/0000-0001-5455-0735; Cunich, Michelle/0000-0002-0163-3665; Veerman, Lennert/0000-0002-3206-8232; Schofield, Deborah/0000-0002-1658-494X; Tanton, Robert/0000-0001-6825-7353	Australian Research Council Linkage Grant [LP100100158]; Pfizer Australia	Australian Research Council Linkage Grant(Australian Research Council); Pfizer Australia(PfizerPfizer Australia)	The authors declare that the development of the microsimulation model used in this research, Health&WealthMOD2030, was funded by an Australian Research Council Linkage Grant (Grant number LP100100158), with Pfizer Australia as the commercial partner to the grant. All authors are independent from the funding source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2009, CONS PRIC IND AUSTR; Access Economics, 2008, ACC EC GROW COST OB; Australian Bureau of Statistics, 2005, INF PAP BAS CONF UNI; Australian Bureau of Statistics, 2011, INF PAP DIS AG CAR; Australian Bureau of Statistics, 2009, AV WEEKL EARN AUSTR; Australian Government, 2004, AUSTR DEM CHALL; Bastida E, 2002, HEALTH ECON, V11, P403, DOI 10.1002/hec.676; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bell P., 2000, GREGWT TABLE MACROS; Cagetti M, 2003, J BUS ECON STAT, V21, P339, DOI 10.1198/073500103288619007; Caner A, 2004, REV INCOME WEALTH, P493; Colagiuri S, 2008, HEALTH AFFAIR, V27, P256, DOI 10.1377/hlthaff.27.1.256; Costello P, 2007, INTERGENERATIONAL RE; Diabetes Australia, 2013, NAT DIAB SERV SCHEM; Diabetes UK, 2010, DIAB UK 2010 KEY STA; Dvornak N, 2007, ECON REC, V83, P117, DOI 10.1111/j.1475-4932.2007.00388.x; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Gray E., 2011, INFLUENCE TIME PREFE; Hayes AJ, 2013, J DIABETES COMPLICAT, V27, P351, DOI 10.1016/j.jdiacomp.2012.12.006; Headey B, 2008, FAMILIES INCOMES JOB; Heller PS, 1989, 8913 IMF FISC AFF DE; HUSE DM, 1989, JAMA-J AM MED ASSOC, V262, P2708, DOI 10.1001/jama.262.19.2708; International Diabetes Federation, DIAB PREV; JULIUS U, 1993, DIABETES METAB, V19, P202; Keegan M., 2009, APPSIM DYNAMIC MICRO; Kelly SJ, 2012, ECON REC, V88, P576, DOI 10.1111/j.1475-4932.2012.00845.x; Komlos J, 2004, J BIOSOC SCI, V36, P209, DOI 10.1017/S0021932003006205; Lavigne JE, 2003, PHARMACOECONOMICS, V21, P1123, DOI 10.2165/00019053-200321150-00006; Lawless L., 2013, AGR FOOD ECON, V1, P1; Mayfield JA, 1999, DIABETES CARE, V22, P1105, DOI 10.2337/diacare.22.7.1105; Miles D, 1999, ECON J, V109, P1, DOI 10.1111/1468-0297.00389; Ng YC, 2001, DIABETES CARE, V24, P257, DOI 10.2337/diacare.24.2.257; Orchard T., 2012, LIFE EXPECTANCY INCR; Organisation for Economic Co- operation and Development, 2007, LAB FORC STAT 1986 2; Rassler S., 2002, STAT MATCHING FREQUE; Ray NF, 1998, DIABETES CARE, V21, P296; Schofield D., 2011, INT J MICROSIMULATIO, V4, P32; Schofield D, 2014, INT J MICROSIMULATIO, V7, P94; Schofield DJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-418; Sloan FA, 2009, HEALTH SERV RES, V44, P1068, DOI 10.1111/j.1475-6773.2009.00957.x; Smith P, 2014, AGEING SOC, V34, P1730, DOI 10.1017/S0144686X13000457; Szukalska A, 2000, FINANCIAL DISADVANTA; Tanton R, 2009, ECON PAP, V28, P102, DOI 10.1111/j.1759-3441.2009.00022.x; Tunceli K, 2005, DIABETES CARE, V28, P2662, DOI 10.2337/diacare.28.11.2662; Valdmanis V, 2001, AM J PUBLIC HEALTH, V91, P129, DOI 10.2105/AJPH.91.1.129; Vijan S, 2004, HEALTH SERV RES, V39, P1653, DOI 10.1111/j.1475-6773.2004.00311.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yassin AS, 2002, J OCCUP ENVIRON MED, V44, P136, DOI 10.1097/00043764-200202000-00008	48	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116860	10.1371/journal.pone.0116860	http://dx.doi.org/10.1371/journal.pone.0116860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706941	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100053
J	Won, EJ; Shin, JH; Choi, MJ; Lee, WG; Park, YJ; Uh, Y; Kim, SY; Lee, MK; Kim, SH; Shin, MG; Suh, SP; Ryang, DW				Won, Eun Jeong; Shin, Jong Hee; Choi, Min Ji; Lee, Wee Gyo; Park, Yeon-Joon; Uh, Young; Kim, Shine-Young; Lee, Mi-Kyung; Kim, Soo Hyun; Shin, Myung Geun; Suh, Soon Pal; Ryang, Dong Wook			Antifungal Susceptibilities of Bloodstream Isolates of Candida Species from Nine Hospitals in Korea: Application of New Antifungal Breakpoints and Relationship to Antifungal Usage	PLOS ONE			English	Article							BROTH MICRODILUTION METHODS; FLUCONAZOLE; RESISTANCE; AGENTS; SURVEILLANCE; NATIONWIDE; FUNGEMIA; EUCAST; IMPACT; CLSI	We applied the new clinical breakpoints (CBPs) of the Clinical and Laboratory Standards Institute (CLSI) to a multicenter study to determine the antifungal susceptibility of bloodstream infection (BSI) isolates of Candida species in Korea, and determined the relationship between the frequency of antifungal-resistant Candida BSI isolates and antifungal use at hospitals. Four hundred and fifty BSI isolates of Candida species were collected over a 1-year period in 2011 from nine hospitals. The susceptibilities of the isolates to four antifungal agents were determined using the CLSI M27 broth microdilution method. By applying the species-specific CBPs, non-susceptibility to fluconazole was found in 16.4% (70/428) of isolates, comprising 2.6% resistant and 13.8% susceptible-dose dependent isolates. However, non-susceptibility to voriconazole, caspofungin, or micafungin was found in 0% (0/370), 0% (0/437), or 0.5% (2/437) of the Candida BSI isolates, respectively. Of the 450 isolates, 72 (16.0%) showed decreased susceptibility to fluconazole [minimum inhibitory concentration (MIC) >= 4 mu g/ml]. The total usage of systemic antifungals varied considerably among the hospitals, ranging from 190.0 to 7.7 defined daily dose per 1,000 patient days, and fluconazole was the most commonly prescribed agent (46.3%). By Spearman's correlation analysis, fluconazole usage did not show a significant correlation with the percentage of fluconazole resistant isolates at hospitals. However, fluconazole usage was significantly correlated with the percentage of fluconazole non-susceptible isolates (r = 0.733; P = 0.025) or the percentage of isolates with decreased susceptibility to fluconazole (MIC >= 4 mu g/ml) (r = 0.700; P = 0.036) at hospitals. Our work represents the first South Korean multicenter study demonstrating an association between antifungal use and antifungal resistance among BSI isolates of Candida at hospitals using the new CBPs of the CLSI.	[Won, Eun Jeong; Shin, Jong Hee; Choi, Min Ji; Kim, Soo Hyun; Shin, Myung Geun; Suh, Soon Pal; Ryang, Dong Wook] Chonnam Natl Univ, Sch Med, Dept Lab Med, Kwangju, South Korea; [Lee, Wee Gyo] Ajou Univ, Sch Med, Dept Lab Med, Suwon 441749, South Korea; [Park, Yeon-Joon] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea; [Uh, Young] Yonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea; [Kim, Shine-Young] Pusan Natl Univ Hosp, Dept Lab Med, Pusan, South Korea; [Lee, Mi-Kyung] Chung Ang Univ, Coll Med, Dept Lab Med, Seoul 156756, South Korea	Chonnam National University; Ajou University; Catholic University of Korea; Yonsei University; Pusan National University; Pusan National University Hospital; Chung Ang University; Chung Ang University Hospital	Shin, JH (corresponding author), Chonnam Natl Univ, Sch Med, Dept Lab Med, Kwangju, South Korea.	shinjh@chonnam.ac.kr	Won, Eun Jeong/AGX-7670-2022		Research of Korea Centers for Disease Control and Prevention [2013-E44001-00]	Research of Korea Centers for Disease Control and Prevention	This study was supported by a fund (2013-E44001-00) by Research of Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup MC, 2013, CLIN MICROBIOL INFEC, V19, pE343, DOI 10.1111/1469-0691.12212; Asmundsdottir LR, 2013, J CLIN MICROBIOL, V51, P841, DOI 10.1128/JCM.02566-12; Chow JK, 2008, CLIN INFECT DIS, V46, P1206, DOI 10.1086/529435; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI, VM27-S4; CLSI, 1908, M27A3 CLSI; Fothergill AW, 2014, J CLIN MICROBIOL, V52, P994, DOI 10.1128/JCM.03044-13; Jang MJ, 2013, ANN LAB MED, V33, P167, DOI 10.3343/alm.2013.33.3.167; Marcos-Zambrano LJ, 2014, ANTIMICROB AGENTS CH, V58, P4565, DOI 10.1128/AAC.02670-14; Jung SI, 2010, MED MYCOL, V48, P669, DOI 10.3109/13693780903410386; Kim MN, 2009, CLIN INFECT DIS, V48, pe57, DOI 10.1086/597108; Kim SH, 2009, MED MYCOL, V47, P296, DOI 10.1080/13693780802291445; Lai CC, 2012, INT J ANTIMICROB AG, V40, P349, DOI 10.1016/j.ijantimicag.2012.05.024; Lortholary O, 2011, ANTIMICROB AGENTS CH, V55, P532, DOI 10.1128/AAC.01128-10; Merlo J, 1996, EUR J CLIN PHARMACOL, V50, P27, DOI 10.1007/s002280050064; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2846, DOI 10.1128/JCM.00937-12; Pfaller MA, 2010, DRUG RESIST UPDATE, V13, P180, DOI 10.1016/j.drup.2010.09.002; Pfaller MA, 2004, DIAGN MICR INFEC DIS, V48, P101, DOI 10.1016/j.diagmicrobio.2003.09.009; Pfaller MA, 2014, DIAGN MICR INFEC DIS, V79, P198, DOI 10.1016/j.diagmicrobio.2014.03.004; Pfaller MA, 2011, J CLIN MICROBIOL, V49, P396, DOI 10.1128/JCM.01398-10; Shah DN, 2012, ANTIMICROB AGENTS CH, V56, P3239, DOI 10.1128/AAC.00019-12	21	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118770	10.1371/journal.pone.0118770	http://dx.doi.org/10.1371/journal.pone.0118770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706866	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100202
J	Liu, YF; Yang, AJ; Liu, W; Wang, CY; Wang, M; Zhang, LH; Wang, DC; Dong, JF; Li, M				Liu, Yan-fei; Yang, Aijun; Liu, Wei; Wang, Chenyu; Wang, Min; Zhang, Lihan; Wang, Dongcang; Dong, Jing-fei; Li, Min			NME2 Reduces Proliferation, Migration and Invasion of Gastric Cancer Cells to Limit Metastasis	PLOS ONE			English	Article							DIPHOSPHATE KINASE; MESSENGER-RNA; INVERSE CORRELATION; SUPPRESSOR NM23-H2; N-MYC; EXPRESSION; GENE; LINE; OVEREXPRESSION; CARCINOMA	Gastric cancer is one of the most common malignancies and has a high rate of metastasis. We hypothesize that NME2 (Nucleoside Diphosphate Kinase 2), which has previously been considered as an anti-metastatic gene, plays a role in the invasiveness of gastric cancer cells. Using a tissue chip technology and immunohistochemistry, we demonstrated that NME2 expression was associated with levels of differentiation of gastric cancer cells and their metastasis into the lymph nodes. When the NME2 gene product was over-expressed by; in vitro stable transfection, cells from BGC823 and MKN45 gastric cancer cell lines had reduced rates of proliferation, migration, and invasion through the collagen matrix, suggesting an inhibitory activity of NME2 in the propagation and invasion of gastric cancer. NME2 could, therefore, severe as a risk marker for gastric cancer invasiveness and a potential new target for gene therapy to enhance or induce NME2 expression.	[Liu, Yan-fei; Yang, Aijun; Liu, Wei; Wang, Chenyu; Wang, Min; Zhang, Lihan; Wang, Dongcang; Li, Min] Lanzhou Univ, Sch Basic Med Sci, Inst Pathol, Lanzhou 730000, Peoples R China; [Liu, Yan-fei] Xian Childrens Hosp, Dept Pathol, Xian, Peoples R China; [Dong, Jing-fei] Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Dong, Jing-fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Li, Min] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University; Puget Sound Blood Center; University of Washington; University of Washington Seattle; Lanzhou University	Li, M (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Inst Pathol, Lanzhou 730000, Peoples R China.	limin@lzu.edu.cn	min, Li/GQQ-2169-2022		program supports for Chang-Jiang Scholars and Innovative Research Team in University [PCSIRT:IRT1137]; Basic Research Funds for the Central Universities [lzujbky-2013-ct06]	program supports for Chang-Jiang Scholars and Innovative Research Team in University; Basic Research Funds for the Central Universities	This study was supported by the program supports for Chang-Jiang Scholars and Innovative Research Team in University (PCSIRT:IRT1137) and the Basic Research Funds for the Central Universities (lzujbky-2013-ct06). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Aktary Z, 2010, ONCOGENE, V29, P2118, DOI 10.1038/onc.2009.495; ARAI T, 1993, AM J PATHOL, V142, P1938; BABA H, 1995, CANCER RES, V55, P1977; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Chen DQ, 2013, INT J ONCOL, V42, P1763, DOI 10.3892/ijo.2013.1872; FLORENES VA, 1992, CANCER RES, V52, P6088; Fukuda M, 1996, INT J CANCER, V65, P531, DOI 10.1002/(SICI)1097-0215(19960208)65:4<531::AID-IJC23>3.0.CO;2-B; Godfried MB, 2002, ONCOGENE, V21, P2097, DOI 10.1038/sj.onc.1205259; HENNESSY C, 1991, J NATL CANCER I, V83, P281, DOI 10.1093/jnci/83.4.281; Huang B, 2013, ONCOLOGY REPORTS; IIZUKA N, 1995, CANCER RES, V55, P652; Kar A, 2012, NUCLEIC ACIDS RES, V40, P2554, DOI 10.1093/nar/gkr1109; Lee MJ, 2012, EXP MOL MED, V44, P214, DOI 10.3858/emm.2012.44.3.016; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; LEONE A, 1993, ONCOGENE, V8, P2325; LEONE A, 1993, ONCOGENE, V8, P855; MANDAI M, 1994, CANCER RES, V54, P1825; Marone M, 1996, BRIT J CANCER, V74, P1063, DOI 10.1038/bjc.1996.490; MARTINEZ JA, 1995, GUT, V37, P712, DOI 10.1136/gut.37.5.712; Miyazaki H, 1999, CLIN CANCER RES, V5, P4301; Oda Y, 2000, HUM PATHOL, V31, P709, DOI 10.1053/hupa.2000.8230; PARHAR RS, 1995, INT J CANCER, V60, P204; Polanski R, 2011, CARCINOGENESIS, V32, P1133, DOI 10.1093/carcin/bgr070; Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430; Saitoh T, 2001, INT J ONCOL, V19, P1187; STAHL JA, 1991, CANCER RES, V51, P445; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Tagashira H, 1998, INT J MOL MED, V2, P65; Thakur RK, 2011, N-S ARCH PHARMACOL, V384, P397, DOI 10.1007/s00210-011-0631-0; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Valentijn LJ, 2005, CANCER RES, V65, P3136, DOI 10.1158/0008-5472.CAN-04-2469; WATANABE J, 1995, BRIT J CANCER, V72, P1469, DOI 10.1038/bjc.1995.531	34	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0115968	10.1371/journal.pone.0115968	http://dx.doi.org/10.1371/journal.pone.0115968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700270	gold, Green Submitted, Green Published			2022-12-27	WOS:000349789800005
J	Zhang, W; Wang, LM; Zhou, P; Song, GC; Shen, M; Gan, SQ; Shi, GQ				Zhang, Wei; Wang, Limin; Zhou, Ping; Song, Guangchao; Shen, Min; Gan, Shangquan; Shi, Guoqing			Identification and Analysis of Genetic Variations in Pri-MiRNAs Expressed Specifically or at a High Level in Sheep Skeletal Muscle	PLOS ONE			English	Article							CANCER RISK; MICRORNA; BINDING; SNPS; PROLIFERATION; POLYMORPHISMS; ASSOCIATION; BIOGENESIS; SURVIVAL; TARGETS	MicroRNAs (miRNAs) are key regulators in miRNA-mediated gene regulatory networks and play important roles in many biological processes, such as growth and development of mammals. In this study, we used microarrays to detect 261 miRNAs that are expressed in sheep skeletal muscle. We found 22 miRNAs that showed high levels of expression and equated to 89% of the total miRNA. Genetic variations in these 22 pri-miRNAs were further investigated using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) and sequencing. A total of 49 genetic variations, which included 41 single nucleotide polymorphisms (SNPs) and 8 deletions/insertions, were identified in four sheep breeds. Three variations were further researched in a larger sample set, including five sheep breeds with different meat production performances. We found that the genotype and allele frequencies of the CCC deletion/insertion in pri-miR-133a were significantly related to the sheep meat production trait. Finally, cell assays and quantitative reverse transcription PCR (qRT-PCR) were employed to investigate the effect of pri-miRNA genetic variation on the miRNA biogenesis process. The results confirmed that genetic variations can influence miRNA biogenesis and increase or decrease the levels of mature miRNAs, in accordance with the energy and stability change of hair-pin secondary structures. Our findings will help to further the understanding of the functions of genetic variations in sheep pri-miRNAs in skeletal muscle growth and development.	[Zhang, Wei; Song, Guangchao; Shi, Guoqing] Shihezi Univ, Coll Anim Sci & Technol, Shihezi 832003, Peoples R China; [Zhang, Wei; Wang, Limin; Zhou, Ping; Song, Guangchao; Shen, Min; Gan, Shangquan; Shi, Guoqing] Xinjiang Acad Agr & Reclamat Sci, Inst Anim Husb & Vet Med, Shihezi 832000, Peoples R China	Shihezi University	Gan, SQ (corresponding author), Xinjiang Acad Agr & Reclamat Sci, Inst Anim Husb & Vet Med, Shihezi 832000, Peoples R China.	shangquangan@163.com; nkkxyxms@163.com		Gan, Shangquan/0000-0003-2880-7677	Natural Science Foundation of China [31160452]; National Basic Research Program of China (973 Program) [2012CB723002]; Guide Plan of Xinjiang Academy of Agricultural and Reclamation Sciences [YYD2010-9]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Guide Plan of Xinjiang Academy of Agricultural and Reclamation Sciences	This work was supported by the Natural Science Foundation of China (31160452), and grants from the National Basic Research Program of China (973 Program, 2012CB723002) and the Guide Plan of Xinjiang Academy of Agricultural and Reclamation Sciences (YYD2010-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bensen JT, 2013, CANCER CAUSE CONTROL, V24, P1099, DOI 10.1007/s10552-013-0187-z; Bizuayehu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061378; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dikeakos P, 2014, MOL BIOL REP, V41, P1075, DOI 10.1007/s11033-013-2953-0; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Ehrenreich IM, 2008, PLANT PHYSIOL, V146, P1974, DOI 10.1104/pp.108.116582; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Hong JS, 2012, GENE, V506, P211, DOI 10.1016/j.gene.2012.06.050; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Kim MC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093662, 10.1371/journal.pone.0101486]; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee JS, 2013, ANIM GENET, V44, P101, DOI 10.1111/j.1365-2052.2012.02362.x; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu QP, 2013, RICE, V6, DOI 10.1186/1939-8433-6-10; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; McDaneld TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042039; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Muroya S, 2013, J ANIM SCI, V91, P90, DOI 10.2527/jas.2012-5371; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Silvia M, 2013, BMC GENOMICS, V14, P1, DOI DOI 10.1186/1471-2164-14-1; Solda G, 2012, HUM MOL GENET, V21, P577, DOI 10.1093/hmg/ddr493; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Sun GL, 2012, PLANT MOL BIOL, V80, P17, DOI 10.1007/s11103-011-9817-6; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Wei W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.184; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200	39	6	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117327	10.1371/journal.pone.0117327	http://dx.doi.org/10.1371/journal.pone.0117327			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699993	Green Submitted, Green Published, gold			2022-12-27	WOS:000349789800020
J	Bozic, I; Savic, D; Laketa, D; Bjelobaba, I; Milenkovic, I; Pekovic, S; Nedeljkovic, N; Lavrnja, I				Bozic, Iva; Savic, Danijela; Laketa, Danijela; Bjelobaba, Ivana; Milenkovic, Ivan; Pekovic, Sanja; Nedeljkovic, Nadezda; Lavrnja, Irena			Benfotiamine Attenuates Inflammatory Response in LPS Stimulated BV-2 Microglia	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; EXTRACELLULAR ATP; TERMINAL KINASES; DOWN-REGULATION; NITRIC-OXIDE; CELLS; ACTIVATION; THIAMINE; EXPRESSION	Microglial cells are resident immune cells of the central nervous system (CNS), recognized as key elements in the regulation of neural homeostasis and the response to injury and repair. As excessive activation of microglia may lead to neurodegeneration, therapeutic strategies targeting its inhibition were shown to improve treatment of most neurodegenerative diseases. Benfotiamine is a synthetic vitamin B1 (thiamine) derivate exerting potentially anti-inflammatory effects. Despite the encouraging results regarding benfotiamine potential to alleviate diabetic microangiopathy, neuropathy and other oxidative stress-induced pathological conditions, its activities and cellular mechanisms during microglial activation have yet to be elucidated. In the present study, the anti-inflammatory effects of benfotiamine were investigated in lipopolysaccharide (LPS)-stimulated murine BV-2 microglia. We determined that benfotiamine remodels activated microglia to acquire the shape that is characteristic of non-stimulated BV-2 cells. In addition, benfotiamine significantly decreased production of pro-inflammatory mediators such as inducible form of nitric oxide synthase (iNOS) and NO; cyclooxygenase-2 (COX-2), heat-shock protein 70 (Hsp70), tumor necrosis factor alpha a (TNF-alpha), interleukin-6 (IL-6), whereas it increased anti-inflammatory interleukin-10 (IL-10) production in LPS stimulated BV-2 microglia. Moreover, benfotiamine suppressed the phosphorylation of extracellular signal-regulated kinases 1/2 (ERK1/2), c-Jun N-terminal kinases (JNK) and protein kinase B Akt/PKB. Treatment with specific inhibitors revealed that benfotiamine-mediated suppression of NO production was via JNK1/2 and Akt pathway, while the cytokine suppression includes ERK1/2, JNK1/2 and Akt pathways. Finally, the potentially protective effect is mediated by the suppression of translocation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) in the nucleus. Therefore, benfotiamine may have therapeutic potential for neurodegenerative diseases by inhibiting inflammatory mediators and enhancing anti-inflammatory factor production in activated microglia.	[Bozic, Iva; Savic, Danijela; Bjelobaba, Ivana; Pekovic, Sanja; Lavrnja, Irena] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Neurobiol, Belgrade, Serbia; [Laketa, Danijela; Nedeljkovic, Nadezda] Univ Belgrade, Fac Biol, Inst Physiol & Biochem, Belgrade, Serbia; [Milenkovic, Ivan] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol, Leipzig, Germany	University of Belgrade; University of Belgrade; Leipzig University	Lavrnja, I (corresponding author), Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Neurobiol, Belgrade, Serbia.	irenam@ibiss.bg.ac.rs	Lavrnja, Irena/ABA-1558-2020; Bjelobaba, Ivana/ABA-1538-2020; Savic, Danijela/I-7471-2019	Lavrnja, Irena/0000-0002-0607-5594; Bjelobaba, Ivana/0000-0002-7649-0304; Savic, Danijela/0000-0001-7411-4527; Bozic, Iva/0000-0002-8550-0359; Nedeljkovic, Nadezda/0000-0003-3046-0983	Ministry of Education, Science and Technological Development of the Republic of Serbia [III 41014]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was supported by Ministry of Education, Science and Technological Development of the Republic of Serbia Grant III 41014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Basset E, 2000, MED PRIN PRACT, V9, P81, DOI 10.1159/000026123; Abd-El-Basset EM, 2004, MED PRIN PRACT, V13, P325, DOI 10.1159/000080469; Ba A, 2008, CELL MOL NEUROBIOL, V28, P923, DOI 10.1007/s10571-008-9297-7; Bajic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076383; Balakumar P, 2010, PHARMACOL RES, V61, P482, DOI 10.1016/j.phrs.2010.02.008; BECKER JT, 1990, NEUROPSYCHOLOGIA, V28, P171, DOI 10.1016/0028-3932(90)90099-A; Berrone E, 2006, J BIOL CHEM, V281, P9307, DOI 10.1074/jbc.M600418200; BITSCH R, 1991, ANN NUTR METAB, V35, P292, DOI 10.1159/000177659; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bordt EA, 2014, FREE RADICAL BIO MED, V76, P34, DOI 10.1016/j.freeradbiomed.2014.07.033; Ceylan-Isik AF, 2006, J APPL PHYSIOL, V100, P150, DOI 10.1152/japplphysiol.00988.2005; Eggen BJL, 2013, J NEUROIMMUNE PHARM, V8, P807, DOI 10.1007/s11481-013-9490-4; ENOMOTO KI, 1985, BRAIN RES, V358, P316, DOI 10.1016/0006-8993(85)90976-X; Fiebich BL, 2002, J NEUROIMMUNOL, V132, P18, DOI 10.1016/S0165-5728(02)00279-5; FUJIWARA M, 1964, J VITAMINOL, V10, P79, DOI 10.5925/jnsv1954.10.79; FUJIWARA M, 1954, J BIOCHEM-TOKYO, V41, P273, DOI 10.1093/oxfordjournals.jbchem.a126438; Gertig U, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00101; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gunzl P, 2010, J LEUKOCYTE BIOL, V88, P1259, DOI 10.1189/jlb.0110001; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Huang WC, 2009, IMMUNOLOGY, V128, pe275, DOI 10.1111/j.1365-2567.2008.02959.x; Jhala SS, 2011, NEUROCHEM INT, V58, P248, DOI 10.1016/j.neuint.2010.11.019; Ji Z, 2014, J IMMUNOL, V193, P2157, DOI 10.4049/jimmunol.1302702; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim YH, 2010, INT IMMUNOPHARMACOL, V10, P1560, DOI 10.1016/j.intimp.2010.09.007; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lee JY, 2006, NEUROSCI LETT, V396, P1, DOI 10.1016/j.neulet.2005.11.004; Luo XG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-9; Manzardo AM, 2013, DRUG ALCOHOL DEPEN, V133, P562, DOI 10.1016/j.drugalcdep.2013.07.035; McCarty MF, 2006, MED HYPOTHESES, V67, P251, DOI 10.1016/j.mehy.2006.01.013; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Nakamichi K, 2007, NEUROSCI LETT, V414, P222, DOI 10.1016/j.neulet.2006.12.058; Nam KN, 2008, NEUROPHARMACOLOGY, V55, P819, DOI 10.1016/j.neuropharm.2008.06.065; Ohsawa K, 2012, J NEUROCHEM, V121, P217, DOI 10.1111/j.1471-4159.2012.07693.x; Pacal L, 2014, WORLD J DIABETES, V5, P288, DOI 10.4239/wjd.v5.i3.288; Pan XL, 2010, BRAIN, V133, P1342, DOI 10.1093/brain/awq069; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Saponaro C, 2012, IMMUNOPHARM IMMUNOT, V34, P858, DOI 10.3109/08923973.2012.665461; Savic D, 2014, IMMUNOPHARM IMMUNOT, V36, P433, DOI 10.3109/08923973.2014.971962; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Seo DR, 2004, NEUROREPORT, V15, P1157, DOI 10.1097/00001756-200405190-00015; Shafer LL, 2002, NEUROIMMUNOMODULAT, V10, P295, DOI 10.1159/000069973; Shoeb M, 2012, FREE RADICAL BIO MED, V52, P182, DOI 10.1016/j.freeradbiomed.2011.10.444; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Sun XJ, 2012, NEUROSCI BULL, V28, P561, DOI 10.1007/s12264-012-1264-0; Svensson C, 2010, BRAIN RES, V1322, P1, DOI 10.1016/j.brainres.2010.01.082; Volvert Marie-Laure, 2008, BMC Pharmacology, V8, P10, DOI 10.1186/1471-2210-8-10; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Waetzig V, 2004, NEUROSCI LETT, V361, P64, DOI 10.1016/j.neulet.2004.02.041; Wang DM, 2010, BIOCHEM BIOPH RES CO, V402, P123, DOI 10.1016/j.bbrc.2010.09.128; Watters JJ, 2002, J BIOL CHEM, V277, P9077, DOI 10.1074/jbc.M104385200; Wen J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-38; Woelk H, 1998, ALCOHOL ALCOHOLISM, V33, P631, DOI 10.1093/alcalc/33.6.631; Wu S, 2006, NEUROSCI LETT, V394, P158, DOI 10.1016/j.neulet.2005.10.022; Yadav UCS, 2010, FREE RADICAL BIO MED, V48, P1423, DOI 10.1016/j.freeradbiomed.2010.02.031; Yadav UCS, 2009, INVEST OPHTH VIS SCI, V50, P2276, DOI 10.1167/iovs.08-2816; Zhao H, 2014, J MOL NEUROSCI, V52, P186, DOI 10.1007/s12031-013-0120-7	72	62	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118372	10.1371/journal.pone.0118372	http://dx.doi.org/10.1371/journal.pone.0118372			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695433	gold, Green Published, Green Submitted			2022-12-27	WOS:000350062300050
J	NDong, C; Tate, JA; Kett, WC; Batra, J; Demidenko, E; Lewis, LD; Hoopes, PJ; Gerngross, TU; Griswold, KE				NDong, Christian; Tate, Jennifer A.; Kett, Warren C.; Batra, Jaya; Demidenko, Eugene; Lewis, Lionel D.; Hoopes, P. Jack; Gerngross, Tillman U.; Griswold, Karl E.			Tumor Cell Targeting by Iron Oxide Nanoparticles Is Dominated by Different Factors In Vitro versus In Vivo	PLOS ONE			English	Article							MAGNETIC FLUID HYPERTHERMIA; BREAST-CANCER; SUPERPARAMAGNETIC NANOPARTICLES; MULTIFUNCTIONAL NANOPARTICLES; BIOMEDICAL APPLICATIONS; ANTIBODY; DELIVERY; THERAPY; MRI; EFFICIENCY	Realizing the full potential of iron oxide nanoparticles (IONP) for cancer diagnosis and therapy requires selective tumor cell accumulation. Here, we report a systematic analysis of two key determinants for IONP homing to human breast cancers: (i) particle size and (ii) active vs passive targeting. In vitro, molecular targeting to the HER2 receptor was the dominant factor driving cancer cell association. In contrast, size was found to be the key determinant of tumor accumulation in vivo, where molecular targeting increased tumor tissue concentrations for 30 nm but not 100 nm IONP. Similar to the in vitro results, PEGylation did not influence in vivo IONP biodistribution. Thus, the results reported here indicate that the in vitro advantages of molecular targeting may not consistently extend to pre-clinical in vivo settings. These observations may have important implications for the design and clinical translation of advanced, multifunctional, IONP platforms.	[NDong, Christian; Tate, Jennifer A.; Kett, Warren C.; Batra, Jaya; Gerngross, Tillman U.; Griswold, Karl E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Demidenko, Eugene; Lewis, Lionel D.; Hoopes, P. Jack] Geisel Sch Med Dartmouth, Dept Biostat & Med, Lebanon, NH USA; [Griswold, Karl E.] Program Mol & Cellular Biol, Hanover, NH USA; [Gerngross, Tillman U.; Griswold, Karl E.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Gerngross, Tillman U.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Griswold, KE (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	karl.e.griswold@dartmouth.edu			NCI [1U54CA151662-01]; NATIONAL CANCER INSTITUTE [P30CA023108, U54CA151662] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant number 1U54CA151662-01.	Bergey EJ, 2002, BIOMED MICRODEVICES, V4, P293, DOI 10.1023/A:1020906307053; Chen HW, 2013, INT J NANOMED, V8, P3781, DOI 10.2147/IJN.S49069; Chen TJ, 2009, J BIOL INORG CHEM, V14, P253, DOI 10.1007/s00775-008-0445-9; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013; Corsi F, 2011, ACS NANO, V5, P6383, DOI 10.1021/nn201570n; DeNardo SJ, 2007, J NUCL MED, V48, P437; DeNardo SJ, 2005, CLIN CANCER RES, V11, p7087S, DOI 10.1158/1078-0432.CCR-1004-0022; Douziech-Eyrolles L, 2007, INT J NANOMED, V2, P541; Fiandra L, 2013, ACS NANO, V7, P6092, DOI 10.1021/nn4018922; GILCHRIST RK, 1957, ANN SURG, V146, P596, DOI 10.1097/00000658-195710000-00007; Giustini AJ, 2010, NANO LIFE, V1, P17, DOI 10.1142/S1793984410000067; Gong XW, 2007, TALANTA, V71, P381, DOI 10.1016/j.talanta.2006.04.010; Hadjipanayis CG, 2010, CANCER RES, V70, P6303, DOI 10.1158/0008-5472.CAN-10-1022; Hilger I, 2002, INVEST RADIOL, V37, P580, DOI 10.1097/00004424-200210000-00008; Hilger I, 2006, J PHYS-CONDENS MAT, V18, pS2951, DOI 10.1088/0953-8984/18/38/S28; Hilger I, 2012, NANOMEDICINE-UK, V7, P1443, DOI 10.2217/NNM.12.112; Ito A, 2004, CANCER LETT, V212, P167, DOI 10.1016/j.canlet.2004.03.038; Jain TK, 2008, MOL PHARMACEUT, V5, P316, DOI 10.1021/mp7001285; Johannsen M, 2005, PROSTATE, V64, P283, DOI 10.1002/pros.20213; Jones SK, 2002, INT J HYPERTHER, V18, P117, DOI 10.1080/02656730110103519; Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8; Kievit FM, 2011, ACCOUNTS CHEM RES, V44, P853, DOI 10.1021/ar2000277; Kievit FM, 2012, ACS NANO, V6, P2591, DOI 10.1021/nn205070h; Kikumori T, 2009, BREAST CANCER RES TR, V113, P435, DOI 10.1007/s10549-008-9948-x; Liu DF, 2011, ADV FUNCT MATER, V21, P1498, DOI 10.1002/adfm.201001658; Lu RM, 2011, BIOMATERIALS, V32, P3265, DOI 10.1016/j.biomaterials.2010.12.061; Minamimura T, 2000, INT J ONCOL, V16, P1153; Modi S, 2006, CURR PHARM DESIGN, V12, P4785, DOI 10.2174/138161206779026272; Moroz P, 2002, INT J HYPERTHER, V18, P267, DOI 10.1080/02656730110108785; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Prasad NK, 2007, J MATER CHEM, V17, P5042, DOI 10.1039/b708156a; Ramchand CN, 2001, INDIAN J PURE AP PHY, V39, P683; Roger J, 1999, EUR PHYS J-APPL PHYS, V5, P321, DOI 10.1051/epjap:1999144; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rosen JE, 2012, NANOMED-NANOTECHNOL, V8, P275, DOI 10.1016/j.nano.2011.08.017; Shang L, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-5; Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018; Toraya-Brown S, 2013, INTEGR BIOL-UK, V5, P159, DOI 10.1039/c2ib20180a; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Varanda LC, 2008, IEEE T MAGN, V44, P4448, DOI 10.1109/TMAG.2008.2002250; Villanueva A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115103; Wahajuddin, 2012, INT J NANOMED, V7, P3445, DOI 10.2147/IJN.S30320; Yan SY, 2005, J NANOSCI NANOTECHNO, V5, P1185, DOI 10.1166/jnn.2005.219; Yang LL, 2009, SMALL, V5, P235, DOI 10.1002/smll.200800714; Yu MK, 2012, THERANOSTICS, V2, P3, DOI 10.7150/thno.3463; Zhang JP, 2011, INT J HYPERTHER, V27, P682, DOI 10.3109/02656736.2011.609863	50	39	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115636	10.1371/journal.pone.0115636	http://dx.doi.org/10.1371/journal.pone.0115636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695795	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300008
J	Sakuma, K; Komatsu, H; Maruyama, M; Imaichi, S; Habata, Y; Mori, M				Sakuma, Kensuke; Komatsu, Hidetoshi; Maruyama, Minoru; Imaichi, Sachiko; Habata, Yugo; Mori, Masaaki			Temporal and Spatial Transcriptional Fingerprints by Antipsychotic or Propsychotic Drugs in Mouse Brain	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; DOPAMINE-RECEPTOR; STRIATAL NEURONS; MESSENGER-RNA; FOS EXPRESSION; NMDA CURRENTS; GROWTH-FACTOR; AMPHETAMINE; ACTIVATION; ARC	Various types of antipsychotics have been developed for the treatment of schizophrenia since the accidental discovery of the antipsychotic activity of chlorpromazine. Although all clinically effective antipsychotic agents have common properties to interact with the dopamine D2 receptor (D2R) activation, their precise mechanisms of action remain elusive. Antipsychotics are well known to induce transcriptional changes of immediate early genes (IEGs), raising the possibility that gene expressions play an essential role to improve psychiatric symptoms. Here, we report that while different classes of antipsychotics have complex pharmacological profiles against D2R, they share common transcriptome fingerprint (TFP) profile of IEGs in the murine brain in vivo by quantitative real-time PCR (qPCR). Our data showed that various types of antipsychotics with a profound interaction of D2R including haloperidol (antagonist), olanzapine (antagonist), and aripiprazole (partial agonist) all share common spatial TFPs closely homologous to those of D2R antagonist sulpiride, and elicited greater transcriptional responses in the striatum than in the nucleus accumbens. Meanwhile, D2R agonist quinpirole and propsychotic NMDA antagonists such as MK-801 and phencyclidine (PCP) exhibited the contrasting TFP profiles. Clozapine and propsychotic drug methamphetamine (MAP) displayed peculiar TFPs that reflect their unique pharmacological property. Our results suggest that transcriptional responses are conserved across various types of antipsychotics clinically effective in positive symptoms of schizophrenia and also show that temporal and spatial TFPs may reflect the pharmacological features of the drugs. Thus, we propose that a TFP approach is beneficial to evaluate novel drug candidates for antipsychotic development.	[Sakuma, Kensuke; Maruyama, Minoru; Habata, Yugo; Mori, Masaaki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Komatsu, Hidetoshi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cent Nervous Syst Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Imaichi, Sachiko] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Integrated Technol Res Labs, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Sakuma, K (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cardiovasc & Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	kensuke.sakuma@takeda.com		Maruyama, Minoru/0000-0002-1478-9415; Komatsu, Hidetoshi/0000-0003-1630-0537	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. The authors as employees of Takeda played their roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Beazely MA, 2006, J NEUROCHEM, V98, P1657, DOI 10.1111/j.1471-4159.2006.04064.x; Benturquia N, 2008, BRAIN RES, V1211, P1, DOI 10.1016/j.brainres.2008.03.016; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Boulay D, 2010, NEUROPSYCHOPHARMACOL, V35, P416, DOI 10.1038/npp.2009.144; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; Coba MP, 2008, J BIOL CHEM, V283, P34101, DOI 10.1074/jbc.M804951200; Coyle Joseph T, 2010, Dialogues Clin Neurosci, V12, P359; DEUTCH AY, 1992, MOL CELL NEUROSCI, V3, P332, DOI 10.1016/1044-7431(92)90030-6; Ferguson SM, 2003, J NEUROCHEM, V86, P33, DOI 10.1046/j.1471-4159.2003.01815.x; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Gunduz-Bruce H, 2009, BRAIN RES REV, V60, P279, DOI 10.1016/j.brainresrev.2008.07.006; Haleem Darakshan J, 2002, Med Sci Monit, V8, pBR354; Hirose Tsuyoshi, 2005, J Med Invest, V52 Suppl, P284, DOI 10.2152/jmi.52.284; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Ito T, 2007, INT J NEUROPSYCHOPH, V10, P717, DOI 10.1017/S1461145707007882; Jacobson C, 2004, P NATL ACAD SCI USA, V101, P12218, DOI 10.1073/pnas.0404240101; Kantrowitz J, 2012, CURR OPIN PSYCHIATR, V25, P96, DOI 10.1097/YCO.0b013e32835035b2; Konradi C, 1996, J NEUROSCI, V16, P4231; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Laruelle M, 2005, CLIN THER, V27, pS16, DOI 10.1016/j.clinthera.2005.07.017; Leslie JH, 2011, PROG NEUROBIOL, V94, P223, DOI 10.1016/j.pneurobio.2011.05.002; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Ma M, 2013, PHARMACOL BIOCHEM BE, V110, P98, DOI 10.1016/j.pbb.2013.06.005; Manji Husseini K, 2003, Sci STKE, V2003, ppe49; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; Panenka WJ, 2013, DRUG ALCOHOL DEPEN, V129, P167, DOI 10.1016/j.drugalcdep.2012.11.016; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pratt J, 2012, NAT REV DRUG DISCOV, V11, P560, DOI 10.1038/nrd3649; Robbins MJ, 2008, J PSYCHOPHARMACOL, V22, P536, DOI 10.1177/0269881107081521; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; Sharp FR, 2001, TRENDS NEUROSCI, V24, P330, DOI 10.1016/S0166-2236(00)01817-8; Stahl S.M., 2021, ESSENTIAL PSYCHOPHAR; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Wirtshafter D, 2003, BRAIN RES BULL, V62, P77, DOI 10.1016/j.brainresbull.2003.09.002; Wood S, 2014, PHARMACOL REV, V66, P193, DOI 10.1124/pr.112.007054; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Yamagata K, 2000, ANN NY ACAD SCI, V914, P22, DOI 10.1111/j.1749-6632.2000.tb05180.x; Yui K, 2000, ANN NY ACAD SCI, V914, P1, DOI 10.1111/j.1749-6632.2000.tb05178.x	55	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118510	10.1371/journal.pone.0118510	http://dx.doi.org/10.1371/journal.pone.0118510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693194	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500123
J	Mansfeldt, CB; Logsdon, BA; Debs, GE; Richardson, RE				Mansfeldt, Cresten B.; Logsdon, Benjamin A.; Debs, Garrett E.; Richardson, Ruth E.			SPINE: SParse eIgengene NEtwork Linking Gene Expression Clusters in Dehalococcoides mccartyi to Perturbations in Experimental Conditions	PLOS ONE			English	Article							ETHENOGENES STRAIN 195; REDUCTIVE DEHALOGENASE; RESPIRATION RATES; TETRACHLOROETHENE; TRICHLOROETHENE; DEHALORESPIRATION; METHYLGLYOXAL; BIOINDICATORS; METABOLISM; TRANSITION	We present a statistical model designed to identify the effect of experimental perturbations on the aggregate behavior of the transcriptome expressed by the bacterium Dehalococcoides mccartyi strain 195. Strains of Dehalococcoides are used in sub-surface bioremediation applications because they organohalorespire tetrachloroethene and trichloroethene (common chlorinated solvents that contaminate the environment) to non-toxic ethene. However, the biochemical mechanism of this process remains incompletely described. Additionally, the response of Dehalococcoides to stress-inducing conditions that may be encountered at field-sites is not well understood. The constructed statistical model captured the aggregate behavior of gene expression phenotypes by modeling the distinct eigengenes of 100 transcript clusters, determining stable relationships among these clusters of gene transcripts with a sparse network-inference algorithm, and directly modeling the effect of changes in experimental conditions by constructing networks conditioned on the experimental state. Based on the model predictions, we discovered new response mechanisms for DMC, notably when the bacterium is exposed to solvent toxicity. The network identified a cluster containing thirteen gene transcripts directly connected to the solvent toxicity condition. Transcripts in this cluster include an iron-dependent regulator (DET0096-97) and a methylglyoxal synthase (DET0137). To validate these predictions, additional experiments were performed. Continuously fed cultures were exposed to saturating levels of tetrachloethene, thereby causing solvent toxicity, and transcripts that were predicted to be linked to solvent toxicity were monitored by quantitative reverse-transcription polymerase chain reaction. Twelve hours after being shocked with saturating levels of tetrachloroethene, the control transcripts (encoding for a key hydrogenase and the 16S rRNA) did not significantly change. By contrast, transcripts for DET0137 and DET0097 displayed a 46.8 +/- 11.5 and 14.6 +/- 9.3 fold up-regulation, respectively, supporting the model. This is the first study to identify transcripts in Dehalococcoides that potentially respond to tetrachloroethene solvent-toxicity conditions that may be encountered near contamination source zones in sub-surface environments.	[Mansfeldt, Cresten B.; Richardson, Ruth E.] Cornell Univ, Dept Civil & Environm Engn, Ithaca, NY 14853 USA; [Logsdon, Benjamin A.] Sage Bionetworks, Seattle, WA 98109 USA; [Debs, Garrett E.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA	Cornell University; Cornell University	Logsdon, BA (corresponding author), Sage Bionetworks, Seattle, WA 98109 USA.	blogsdon@uw.edu	Richardson, Ruth E/B-8265-2017	Logsdon, Benjamin A/0000-0002-0572-2569; Mansfeldt, Cresten/0000-0002-5656-6463	Department of Defense Army Research Office [W911NF-07-1-0249]; National Science Foundation CBET Program [CBET-0731169]; NSF Graduate Research Fellowship Program; Department of Energy's Office of Biological and Environmental Research	Department of Defense Army Research Office(United States Department of Defense); National Science Foundation CBET Program; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE))	The authors would like to thank our funding sources, the Department of Defense Army Research Office (W911NF-07-1-0249) and the National Science Foundation CBET Program (CBET-0731169), for supporting this work. Additionally, the authors would like to thank the NSF Graduate Research Fellowship Program for funding Cresten Mansfeldt and Cornell Universitya(sic)(TM) s Engineering Learning Initiative for funding Garrett Debs in this research. A portion of this research was performed using EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian L, 2007, APPL ENVIRON MICROB, V73, P7717, DOI 10.1128/AEM.01649-07; Booth IR, 2003, BIOCHEM SOC T, V31, P1406; Brune I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-21; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Fung JM, 2007, APPL ENVIRON MICROB, V73, P4439, DOI 10.1128/AEM.00215-07; Heavner GLW, 2013, ENVIRON SCI TECHNOL, V47, P3724, DOI 10.1021/es303517s; Johnson DR, 2008, APPL ENVIRON MICROB, V74, P2864, DOI 10.1128/AEM.02208-07; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee PKH, 2012, APPL ENVIRON MICROB, V78, P1424, DOI 10.1128/AEM.06792-11; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Loffler FE, 2013, INT J SYST EVOL MICR, V63, P625, DOI 10.1099/ijs.0.034926-0; Logsdon BA, 2015, NUCLEIC ACIDS RES, V43, P1332, DOI 10.1093/nar/gku1290; Logsdon BA, 2012, BIOINFORMATICS, V28, P1738, DOI 10.1093/bioinformatics/bts261; Logsdon BA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-53; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Major DW, 2002, ENVIRON SCI TECHNOL, V36, P5106, DOI 10.1021/es0255711; Mansfeldt CB, 2014, APPL ENVIRON MICROB, V80, P6062, DOI 10.1128/AEM.02130-14; Maphosa F, 2010, TRENDS BIOTECHNOL, V28, P308, DOI 10.1016/j.tibtech.2010.03.005; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Morris RM, 2007, APPL ENVIRON MICROB, V73, P320, DOI 10.1128/AEM.02129-06; Nijenhuis I, 2005, APPL ENVIRON MICROB, V71, P1664, DOI 10.1128/AEM.71.3.1664-1667.2005; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Rahm BG, 2008, ENVIRON SCI TECHNOL, V42, P5099, DOI 10.1021/es702912t; Rahm BG, 2008, ENVIRON SCI TECHNOL, V42, P416, DOI 10.1021/es071455s; Richardson RE, 2013, CURR OPIN BIOTECH, V24, P498, DOI 10.1016/j.copbio.2013.02.014; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rowe AR, 2012, ENVIRON SCI TECHNOL, V46, P9388, DOI 10.1021/es300996c; Seshadri R, 2005, SCIENCE, V307, P105, DOI 10.1126/science.1102226; Tang SQ, 2013, APPL ENVIRON MICROB, V79, P974, DOI 10.1128/AEM.01873-12; Tang YJJ, 2009, J BACTERIOL, V191, P5224, DOI 10.1128/JB.00085-09; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Werner JJ, 2009, ENVIRON MICROBIOL, V11, P2687, DOI 10.1111/j.1462-2920.2009.01996.x; Zinder S. H., 2010, HDB HYDROCARBON LIPI, P2049	38	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118404	10.1371/journal.pone.0118404	http://dx.doi.org/10.1371/journal.pone.0118404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714365	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700072
J	Rodriguez-Lozano, P; Verkaik, I; Rieradevall, M; Prat, N				Rodriguez-Lozano, Pablo; Verkaik, Iraima; Rieradevall, Maria; Prat, Narcis			Small but Powerful: Top Predator Local Extinction Affects Ecosystem Structure and Function in an Intermittent Stream	PLOS ONE			English	Article							INTRAGUILD PREDATION; FISH PREDATION; COMMUNITY STRUCTURE; BIOTIC INTERACTIONS; FLOW INTERMITTENCY; BIOLOGICAL-CONTROL; PREY RATIOS; FRESH-WATER; DIVERSITY; BIODIVERSITY	Top predator loss is a major global problem, with a current trend in biodiversity loss towards high trophic levels that modifies most ecosystems worldwide. Most research in this area is focused on large-bodied predators, despite the high extinction risk of small-bodied freshwater fish that often act as apex consumers. Consequently, it remains unknown if intermittent streams are affected by the consequences of top-predators' extirpations. The aim of our research was to determine how this global problem affects intermittent streams and, in particular, if the loss of a small-bodied top predator (1) leads to a 'mesopredator release', affects primary consumers and changes whole community structures, and (2) triggers a cascade effect modifying the ecosystem function. To address these questions, we studied the top-down effects of a small endangered fish species, Barbus meridionalis (the Mediterranean barbel), conducting an enclosure/exclosure mesocosm experiment in an intermittent stream where B. meridionalis became locally extinct following a wildfire. We found that top predator absence led to 'mesopredator release', and also to 'prey release' despite intraguild predation, which contrasts with traditional food web theory. In addition, B. meridionalis extirpation changed whole macroinvertebrate community composition and increased total macroinvertebrate density. Regarding ecosystem function, periphyton primary production decreased in apex consumer absence. In this study, the apex consumer was functionally irreplaceable; its local extinction led to the loss of an important functional role that resulted in major changes to the ecosystem's structure and function. This study evidences that intermittent streams can be affected by the consequences of apex consumers' extinctions, and that the loss of small-bodied top predators can lead to large ecosystem changes. We recommend the reintroduction of small-bodied apex consumers to systems where they have been extirpated, to restore ecosystem structure and function.	[Rodriguez-Lozano, Pablo; Verkaik, Iraima; Rieradevall, Maria; Prat, Narcis] Univ Barcelona, Dept Ecol, Fac Biol, Freshwater Ecol & Management FEM Res Grp, E-08028 Barcelona, Spain	University of Barcelona	Rodriguez-Lozano, P (corresponding author), Univ Barcelona, Dept Ecol, Fac Biol, Freshwater Ecol & Management FEM Res Grp, E-08028 Barcelona, Spain.	pablorodriguezlozano@gmail.com	GARCIA, SERGIO ERICK/X-9320-2018; Rodríguez-Lozano, Pablo/AAA-8873-2020	Verkaik, Iraima/0000-0002-7432-525X; Rodriguez-Lozano, Pablo/0000-0002-5130-8107	Ministerio de Economia y Competitividad, Gobierno de Espana [CGL2008-03388/BOS]; FPU (Formacion de Profesorado Universitario) from Ministerio de Educacion, Cultura y Deporte, Gobierno de Espana [FPU2009-1470]	Ministerio de Economia y Competitividad, Gobierno de Espana(Spanish Government); FPU (Formacion de Profesorado Universitario) from Ministerio de Educacion, Cultura y Deporte, Gobierno de Espana(German Research Foundation (DFG))	This research was funded by the Ministerio de Economia y Competitividad, Gobierno de Espana, through the project CGL2008-03388/BOS (FURIMED-2; http://www.mineco.gob.es/portal/site/mineco/). PRL was supported by a FPU contract-fellowship (Formacion de Profesorado Universitario) from Ministerio de Educacion, Cultura y Deporte, Gobierno de Espana (ref: FPU2009-1470; http://www.mecd.gob.es/portada-mecd/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan D, 2007, STREAM ECOLOGY STRUC, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; [Anonymous], 2006, BIOL TEMPORARY WATER; Benejam L, 2010, FRESHWATER BIOL, V55, P628, DOI 10.1111/j.1365-2427.2009.02299.x; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Bogan MT, 2013, FRESHWATER BIOL, V58, P1016, DOI 10.1111/fwb.12105; Bonada N, 2007, HYDROBIOLOGIA, V589, P91, DOI 10.1007/s10750-007-0723-5; Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; Borrvall C, 2006, ECOL LETT, V9, P435, DOI 10.1111/j.1461-0248.2006.00893.x; BOULTON AJ, 1992, FRESHWATER BIOL, V27, P123, DOI 10.1111/j.1365-2427.1992.tb00528.x; Brashares Justin S., 2010, P221; Brown LE, 2011, J ANIM ECOL, V80, P884, DOI 10.1111/j.1365-2656.2011.01814.x; Cardillo M, 2003, ANIM CONSERV, V6, P63, DOI 10.1017/S1367943003003093; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; CASWELL H, 1978, AM NAT, V112, P127, DOI 10.1086/283257; Chalcraft DR, 2003, ECOLOGY, V84, P2407, DOI 10.1890/02-0550; Closs GP, 1996, AUST J ECOL, V21, P217, DOI 10.1111/j.1442-9993.1996.tb00601.x; COHEN JE, 1977, NATURE, V270, P165, DOI 10.1038/270165a0; Compte J, 2012, J EXP MAR BIOL ECOL, V418, P1, DOI 10.1016/j.jembe.2012.03.004; COOPER SD, 1990, ECOLOGY, V71, P1503, DOI 10.2307/1938287; Diaz S, 2003, TRENDS ECOL EVOL, V18, P140, DOI 10.1016/S0169-5347(03)00007-7; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Elton C., 1927, ANIMAL ECOLOGY; Ernest SKM, 2001, SCIENCE, V292, P101; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Finke DL, 2005, ECOL LETT, V8, P1299, DOI 10.1111/j.1461-0248.2005.00832.x; Gagnon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028061; Garcia-Roger EM, 2011, AQUAT SCI, V73, P567, DOI 10.1007/s00027-011-0218-3; Gido KB, 2010, AM FISH S S, V73, P593; GILLIAM JF, 1989, ECOLOGY, V70, P445, DOI 10.2307/1937549; Godwin CM, 2008, AQUAT ECOL, V42, P583, DOI 10.1007/s10452-007-9133-z; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; Henke SE, 1999, J WILDLIFE MANAGE, V63, P1066, DOI 10.2307/3802826; Holomuzki JR, 2010, J N AM BENTHOL SOC, V29, P220, DOI 10.1899/08-044.1; Holt RD, 2007, ECOLOGY, V88, P2706, DOI 10.1890/06-1525.1; Hurlbert SH, 1971, ECOLOGY; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jeffries MJ, 2002, J ANIM ECOL, V71, P173, DOI 10.1046/j.1365-2656.2002.00587.x; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Kotliar NB, 1999, ENVIRON MANAGE, V24, P177, DOI 10.1007/s002679900225; LAMBERTI GA, 1993, J N AM BENTHOL SOC, V12, P313, DOI 10.2307/1467618; LANCASTER J, 1991, J ANIM ECOL, V60, P625, DOI 10.2307/5302; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Love JW, 2005, HYDROBIOLOGIA, V543, P113, DOI 10.1007/s10750-004-6948-7; Ludlam JP, 2010, HYDROBIOLOGIA, V644, P127, DOI 10.1007/s10750-010-0102-5; Marshall KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029723; Mas-Marti E, 2010, HYDROBIOLOGIA, V657, P167, DOI 10.1007/s10750-010-0292-x; Merritt R.W., 1996, INTRO AQUATIC INSECT; Meyer JL, 2007, J AM WATER RESOUR AS, V43, P86, DOI 10.1111/j.1752-1688.2007.00008.x; Nikolaidis NP, 2013, WATER POLICY, V15, P830, DOI 10.2166/wp.2013.158; Olden JD, 2007, GLOBAL ECOL BIOGEOGR, V16, P694, DOI 10.1111/j.1466-8238.2007.00337.x; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; R Core Team, 2021, R LANGUAGE ENV STAT; REICE SR, 1991, J N AM BENTHOL SOC, V10, P42, DOI 10.2307/1467763; Reich P, 2010, RIVER RES APPL, V26, P529, DOI 10.1002/rra.1265; Rieradevall Maria, 1999, Limnetica, V17, P45; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rosenfeld J, 2000, CAN J FISH AQUAT SCI, V57, P1369, DOI 10.1139/cjfas-57-7-1369; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; Rudolf VHW, 2007, ECOLOGY, V88, P2697, DOI 10.1890/06-1266.1; Saddlier S, 2013, MAR FRESHWATER RES, V64, P874, DOI 10.1071/MF12260; Saterberg T, 2013, NATURE, V499, P468, DOI 10.1038/nature12277; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schneider FD, 2013, J ANIM ECOL, V82, P64, DOI 10.1111/1365-2656.12010; Shulman RS, 2007, OIKOS, V116, P1581, DOI 10.1111/j.2007.0030-1299.14690.x; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Snyder WE, 2001, ECOLOGY, V82, P705, DOI 10.1890/0012-9658(2001)082[0705:GPDBCB]2.0.CO;2; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; Staddon P, 2010, ECOL LETT, V13, P543, DOI 10.1111/j.1461-0248.2010.01450.x; STANLEY EH, 1994, AM MIDL NAT, V131, P288, DOI 10.2307/2426255; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Tachet H, 2010, INVERTEBRES EAU DOUC, P607; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1; Verkaik I, 2013, INT REV HYDROBIOL, V98, P271, DOI 10.1002/iroh.201201618; Vila-Escale M, 2007, WATER RES, V41, P2171, DOI 10.1016/j.watres.2006.07.029; Vila-Gispert A, 2001, J FISH BIOL, V59, P824, DOI 10.1111/j.1095-8649.2001.tb00153.x; WARREN PH, 1992, PHILOS T R SOC B, V338, P113, DOI 10.1098/rstb.1992.0135; Wesner JS, 2013, FRESHW SCI, V32, P438, DOI 10.1899/12-124.1; Williams DD, 1996, J N AM BENTHOL SOC, V15, P634, DOI 10.2307/1467813; Williams LR, 2003, T AM FISH SOC, V132, P120, DOI 10.1577/1548-8659(2003)132<0120:IOFPOA>2.0.CO;2; Wilson JB, 1996, OECOLOGIA, V106, P272, DOI 10.1007/BF00328608; Woodward G, 2008, OIKOS, V117, P683, DOI 10.1111/j.0030-1299.2008.16500.x	87	27	29	7	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117630	10.1371/journal.pone.0117630	http://dx.doi.org/10.1371/journal.pone.0117630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714337	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700035
J	Moura, AS; Cardoso, AF; Costa-da-Silva, AL; Winter, CE; Bijovsky, AT				Moura, Alexandre S.; Cardoso, Andre F.; Costa-da-Silva, Andre L.; Winter, Carlos E.; Tania Bijovsky, A.			Two Cathepsins B Are Responsible for the Yolk Protein Hydrolysis in Culex quinquefasciatus	PLOS ONE			English	Article							WEST-NILE-VIRUS; AMINO-ACID-SEQUENCES; COTTON BOLL WORM; CYSTEINE PROTEINASE; MOLECULAR-CLONING; VECTOR COMPETENCE; PIPIENS DIPTERA; AEDES-AEGYPTI; MOSQUITO; CULICIDAE	Despite the established role of Culex quinquefasciatus as a vector of various neurotropic viruses, such as the Rift Valley and West Nile viruses, as well as lymphatic filariasis, little is known regarding the organism's reproductive physiology. As in other oviparous animals, vitellogenin, the most important source of nutrients for the embryo development, is digested by intracellular proteases. Using mass spectrometry, we have identified two cathepsin B homologues partially purified by self-proteolysis of Cx. quinquefasciatus total egg extract. The transcriptional profile of these two cathepsin B homologues was determined by quantitative RT-PCR, and the enzymatic activity associated with the peptidase was determined in ovaries after female engorgement. According to the VectorBase (vectorbase.org) annotation, both cathepsin B homologues shared approximately 66% identity in their amino acid sequences. The two cathepsin B genes are expressed simultaneously in the fat body of the vitellogenic females, and enzymatic activity was detected within the ovaries, suggesting an extra-ovarian origin. Similar to the transcriptional profile of vitellogenin, cathepsin B transcripts were shown to accumulate post-blood meal and reached their highest expression at 36 h PBM. However, while vitellogenin expression decreased drastically at 48 h PBM, the expression of the cathepsins increased until 84 h PBM, at which time the females of our colony were ready for oviposition. The similarity between their transcriptional profiles strongly suggests a role for the cathepsin B homologues in vitellin degradation.	[Moura, Alexandre S.; Cardoso, Andre F.; Costa-da-Silva, Andre L.; Winter, Carlos E.; Tania Bijovsky, A.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, SP, Brazil; [Costa-da-Silva, Andre L.] INCT EM, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo	Bijovsky, AT (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, SP, Brazil.	bijovsky@gmail.com	Costa-da-Silva, Andre Luis/F-7874-2012; Costa-Da-Silva, André Luis/J-8913-2019; Winter, Carlos/A-3085-2008	Costa-da-Silva, Andre Luis/0000-0002-7615-7376; Costa-Da-Silva, André Luis/0000-0002-7615-7376; Winter, Carlos/0000-0002-0055-2484	FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/51241-0, 2013/09211-4]	FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/) (Grant numbers: 2010/51241-0; 2013/09211-4). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bracco JE, 1999, MEM I OSWALDO CRUZ, V94, P115, DOI 10.1590/S0074-02761999000100022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cardoso AF, 2010, MEM I OSWALDO CRUZ, V105, P254, DOI 10.1590/S0074-02762010000300003; Cho WL, 1999, J BIOL CHEM, V274, P13311, DOI 10.1074/jbc.274.19.13311; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; Dunkov Boris C, 2002, J Insect Sci, V2, P7; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu XD, 1996, J BIOL CHEM, V271, P33344, DOI 10.1074/jbc.271.52.33344; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEDINA M, 1988, ARCH BIOCHEM BIOPHYS, V263, P355, DOI 10.1016/0003-9861(88)90646-7; MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W; NEURATH H, 1967, SCIENCE, V158, P1638, DOI 10.1126/science.158.3809.1638; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Okuda K, 2002, TISSUE CELL, V34, P210, DOI 10.1016/S0040-8166(02)00032-0; Okuda K, 2007, J INSECT PHYSIOL, V53, P1307, DOI 10.1016/j.jinsphys.2007.07.005; Oliveira DMP, 2008, J INSECT PHYSIOL, V54, P883, DOI 10.1016/j.jinsphys.2008.04.005; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Rey L., 2008, PARASITOLOGIA, V4; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; RIBOLLA PEM, 1993, INSECT BIOCHEM MOLEC, V23, P217, DOI 10.1016/0965-1748(93)90002-A; RIBOLLA PEM, 1995, INSECT BIOCHEM MOLEC, V25, P1011, DOI 10.1016/0965-1748(95)00036-U; Richards SL, 2014, TROP MED INT HEALTH, V19, P610, DOI 10.1111/tmi.12277; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; Sais TD, 2003, ARTHROPOD STRUCT DEV, V32, P219, DOI 10.1016/S1467-8039(03)00035-5; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shimeld SM, 1999, SEMIN CELL DEV BIOL, V10, P549, DOI 10.1006/scdb.1999.0336; Snigirevskaya ES, 1997, CELL TISSUE RES, V290, P129, DOI 10.1007/s004410050915; TAKAHASHI SY, 1993, J BIOCHEM, V114, P267, DOI 10.1093/oxfordjournals.jbchem.a124165; Takahashi SY, 1996, INVERTEBR REPROD DEV, V30, P265, DOI 10.1080/07924259.1996.9672553; Takahashi SY, 1997, BIOCHEM MOL BIOL INT, V42, P591; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uchida K, 2004, J INSECT PHYSIOL, V50, P903, DOI 10.1016/j.jinsphys.2004.07.002; Uchida K, 2001, DEV BIOL, V237, P68, DOI 10.1006/dbio.2001.0357; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589; VANESSEN PHA, 1994, MED VET ENTOMOL, V8, P63, DOI 10.1111/j.1365-2915.1994.tb00387.x; Vargas HCM, 2014, J INSECT PHYSIOL, V62, P54, DOI 10.1016/j.jinsphys.2014.02.001; YAMAMOTO Y, 1994, J BIOCHEM, V116, P1330, DOI 10.1093/oxfordjournals.jbchem.a124683; YAMAMOTO Y, 1993, COMP BIOCHEM PHYS B, V106, P35, DOI 10.1016/0305-0491(93)90004-O; Yamamoto Y, 2000, J INSECT PHYSIOL, V46, P783, DOI 10.1016/S0022-1910(99)00167-5; Zhao XF, 2005, PROTEIN J, V24, P219, DOI 10.1007/s10930-005-6714-3; Zhao XF, 2002, INSECT MOL BIOL, V11, P567, DOI 10.1046/j.1365-2583.2002.00366.x; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0	50	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118736	10.1371/journal.pone.0118736	http://dx.doi.org/10.1371/journal.pone.0118736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710877	gold, Green Submitted, Green Published			2022-12-27	WOS:000350683900065
J	Farrington, HL; Edwards, CE; Guan, X; Carr, MR; Baerwaldt, K; Lance, RF				Farrington, Heather L.; Edwards, Christine E.; Guan, Xin; Carr, Matthew R.; Baerwaldt, Kelly; Lance, Richard F.			Mitochondrial Genome Sequencing and Development of Genetic Markers for the Detection of DNA of Invasive Bighead and Silver Carp (Hypophthalmichthys nobilis and H. molitrix) in Environmental Water Samples from the United States	PLOS ONE			English	Article							EDNA; INFORMATION; PERSISTENCE	Invasive Asian bighead and silver carp (Hypophthalmichthys nobilis and H. molitrix) pose a substantial threat to North American aquatic ecosystems. Recently, environmental DNA (eDNA), genetic material shed by organisms into their environment that can be detected by non-invasive sampling strategies and genetic assays, has gained recognition as a tool for tracking the invasion front of these species toward the Great Lakes. The goal of this study was to develop new species-specific conventional PCR (cPCR) and quantitative (qPCR) markers for detection of these species in North American surface waters. We first generated complete mitochondrial genome sequences from 33 bighead and 29 silver carp individuals collected throughout their introduced range. These sequences were aligned with those from other common and closely related fish species from the Illinois River watershed to identify and design new species-specific markers for the detection of bighead and silver carp DNA in environmental water samples. We then tested these genetic markers in the laboratory for species-specificity and sensitivity. Newly developed markers performed well in field trials, did not have any false positive detections, and many markers had much higher detection rates and sensitivity compared to the markers currently used in eDNA surveillance programs. We also explored the use of multiple genetic markers to determine whether it would improve detection rates, results of which showed that using multiple highly sensitive markers should maximize detection rates in environmental samples. The new markers developed in this study greatly expand the number of species-specific genetic markers available to track the invasion front of bighead and silver carp and will improve the resolution of these assays. Additionally, the use of the qPCR markers developed in this study may reduce sample processing time and cost of eDNA monitoring for these species.	[Farrington, Heather L.; Edwards, Christine E.; Guan, Xin; Carr, Matthew R.; Lance, Richard F.] United States Army, Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS 39183 USA; [Baerwaldt, Kelly] United States Army, Corps Engn, Rock Isl, IL USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); United States Department of Defense; United States Army; U.S. Army Corps of Engineers	Lance, RF (corresponding author), United States Army, Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS 39183 USA.	richard.f.lance@usace.army.mil	Edwards, Christine/P-1324-2014	Edwards, Christine/0000-0001-8837-4872	Asian Carp Regional Coordinating Committee	Asian Carp Regional Coordinating Committee	Funding for this project was provided to KB and RFL by the Asian Carp Regional Coordinating Committee (http://asiancarp.us). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asian Carp Regional Coordinating Committee Monitoring and Rapid Response Workgroup, 2013, FY 2013 AS CARP CONT; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farrington HL, 2014, ERDCTNEMRRPRQ02 US A; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Freedman J.A., 2012, FOR MIGR GLOB ENV CH; Freeze M., 1982, North American Journal of Fisheries Management, V2, P197, DOI 10.1577/1548-8659(1982)2<197:DASOTB>2.0.CO;2; Garvey JE, 2012, FISHING DOWN BIGHEAD; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Lamer JT, 2014, MOL ECOL RESOUR, V14, P79, DOI 10.1111/1755-0998.12152; Lance RF, 2012, ANSRP122 ERDCTN US A, DOI [10.1016/j.chemosphere.2013.08.061, DOI 10.1016/J.CHEMOSPHERE.2013.08.061]; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Oldham AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051931; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Roche Applied Science, 2011, NUCL AC IS PUR, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Rozen S, 2000, BIOINFORMATICS METHO; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Tucker JK, 1996, J FRESHWATER ECOL, V11, P241, DOI 10.1080/02705060.1996.9663484; United States Army Corps of Engineers, 2014, ENV DNA; United States Army Corps of Engineers, 2012, QUAL ASS PROJ PLAN E; United States Fish and Wildlife Service, 2014, EDNA RES WAT; Wahl DH, 2011, HYDROBIOLOGIA, V678, P49, DOI 10.1007/s10750-011-0820-3	34	32	34	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117803	10.1371/journal.pone.0117803	http://dx.doi.org/10.1371/journal.pone.0117803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706532	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100119
J	Goltstein, PM; Montijn, JS; Pennartz, CMA				Goltstein, Pieter M.; Montijn, Jorrit S.; Pennartz, Cyriel M. A.			Effects of Isoflurane Anesthesia on Ensemble Patterns of Ca2+ Activity in Mouse V1: Reduced Direction Selectivity Independent of Increased Correlations in Cellular Activity	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; RAPID EYE-MOVEMENTS; IN-VIVO; ORIENTATION SELECTIVITY; RECEPTIVE-FIELDS; THALAMIC NEURONS; FUNCTIONAL SPECIALIZATION; RESPONSE PROPERTIES; NOISE CORRELATIONS; CORTICAL-NEURONS	Anesthesia affects brain activity at the molecular, neuronal andnetwork level, but it is not well-understood how tuning properties of sensory neurons and network connectivity change under its influence. Using in vivo two-photon calcium imaging we matched neuron identity across episodes of wakefulness and anesthesia in the same mouse and recorded spontaneous and visually evoked activity patterns of neuronal ensembles in these two states. Correlations in spontaneous patterns of calcium activity between pairs of neurons were increased under anesthesia. While orientation selectivity remained unaffected by anesthesia, this treatment reduced direction selectivity, which was attributable to an increased response to the null-direction. As compared to anesthesia, populations of V1 neurons coded more mutual information on opposite stimulus directions during wakefulness, whereas information on stimulus orientation differences was lower. Increases in correlations of calcium activity during visual stimulation were correlated with poorer population coding, which raised the hypothesis that the anesthesia-induced increase in correlations may be causal to degrading directional coding. Visual stimulation under anesthesia, however, decorrelated ongoing activity patterns to a level comparable to wakefulness. Because visual stimulation thus appears to 'break' the strength of pairwise correlations normally found in spontaneous activity under anesthesia, the changes in correlational structure cannot explain the awake-anesthesia difference in direction coding. The population-wide decrease in coding for stimulus direction thus occurs independently of anesthesia-induced increments in correlations of spontaneous activity.	[Goltstein, Pieter M.; Montijn, Jorrit S.; Pennartz, Cyriel M. A.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Goltstein, Pieter M.; Montijn, Jorrit S.; Pennartz, Cyriel M. A.] Univ Amsterdam, Res Prior Program Brain & Cognit, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Pennartz, CMA (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands.	C.M.A.Pennartz@UvA.nl	Goltstein, Pieter/GVU-3883-2022; Montijn, Jorrit S/AAD-6634-2022; Pennartz, Cyriel/B-7508-2015	Montijn, Jorrit S/0000-0002-5621-090X; Pennartz, Cyriel/0000-0001-8328-1175	SenterNovem BSIK [03053]; NWO VICI [918.46.609]; EU [FP7-ICT-270108]	SenterNovem BSIK; NWO VICI(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	This work was supported by SenterNovem BSIK Grant 03053, NWO VICI Grant 918.46.609 and EU grant FP7-ICT-270108 to CMAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; Ch'ng YH, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00020; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crunelli V, 2012, PFLUG ARCH EUR J PHY, V463, P73, DOI 10.1007/s00424-011-1011-9; Dai SP, 2012, ANESTHESIOLOGY, V116, P816, DOI 10.1097/ALN.0b013e31824be0e3; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; Detsch O, 2002, BRIT J ANAESTH, V89, P294, DOI 10.1093/bja/aef170; Detsch O, 2002, NEUROSCI LETT, V317, P9, DOI 10.1016/S0304-3940(01)02419-3; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; Ecker AS, 2014, NEURON, V82, P235, DOI 10.1016/j.neuron.2014.02.006; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P218, DOI 10.1016/0166-2236(92)90039-B; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gentet LJ, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00052; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Goltstein PM, 2013, J NEUROSCI, V33, P11540, DOI 10.1523/JNEUROSCI.1341-12.2013; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Guo K, 2004, EUR J NEUROSCI, V19, P1055, DOI 10.1111/j.1460-9568.2004.03212.x; GUYTON AC, 1947, AM J PHYSIOL, V150, P70, DOI 10.1152/ajplegacy.1947.150.1.70; Haider B, 2012, NATURE; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Hofer SB, 2010, NEURAL NETWORKS, V23, P728, DOI 10.1016/j.neunet.2010.04.007; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; IKEDA H, 1974, EXP BRAIN RES, V20, P471; JONES MV, 1993, J NEUROPHYSIOL, V70, P1339, DOI 10.1152/jn.1993.70.4.1339; Josic K, 2009, NEURAL COMPUT, V21, P2774, DOI 10.1162/neco.2009.10-08-879; Kameda H, 2012, EUR J NEUROSCI, V35, P838, DOI 10.1111/j.1460-9568.2012.08027.x; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; KONIG P, 1995, CURR OPIN NEUROBIOL, V5, P511, DOI 10.1016/0959-4388(95)80013-1; Kreuzer M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-122; Kuhn B, 2008, P NATL ACAD SCI USA, V105, P7588, DOI 10.1073/pnas.0802462105; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lee SH, 2014, NATURE, V508, pE1, DOI 10.1038/nature13128; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Lee U, 2009, CONSCIOUS COGN, V18, P56, DOI 10.1016/j.concog.2008.10.005; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Liachenko S, 1999, BRIT J PHARMACOL, V127, P131, DOI 10.1038/sj.bjp.0702543; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Magri C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-81; MANDL G, 1980, BRAIN RES, V193, P401, DOI 10.1016/0006-8993(80)90173-0; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Mazurek M, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00092; Milton PL, 2012, RESPIRATION, V83, P253, DOI 10.1159/000330586; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Montani F, 2007, J NEUROSCI, V27, P2338, DOI 10.1523/JNEUROSCI.3417-06.2007; Movshon JA, 2003, NAT NEUROSCI, V6, P3, DOI 10.1038/nn0103-3a; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Oizumi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003588; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Oram MW, 2011, J NEUROPHYSIOL, V105, P942, DOI 10.1152/jn.00711.2009; Pack CC, 2003, NAT NEUROSCI, V6, P3, DOI 10.1038/nn0103-3b; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Paxinos G, 2004, MOUSE BRAIN STEREOTA; PENNARTZ CMA, 1990, VISION RES, V30, P1223, DOI 10.1016/0042-6989(90)90177-M; Ranson A, 2012, P NATL ACAD SCI USA, V109, P1311, DOI 10.1073/pnas.1112204109; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Sakatani T, 2004, NEUROSCI RES, V49, P123, DOI 10.1016/j.neures.2004.02.002; Sakatani T, 2007, NEUROSCI RES, V58, P324, DOI 10.1016/j.neures.2007.04.003; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1320; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; SOMOGYI P, 1989, P RET RES F, V2, P35; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Tan AYY, 2014, NATURE, V509, P226, DOI 10.1038/nature13159; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; TREVES A, 1991, NETWORK-COMP NEURAL, V2, P371, DOI 10.1088/0954-898X/2/4/004; Vahle-Hinz C, 2001, ANESTH ANALG, V92, P1578, DOI 10.1097/00000539-200106000-00046; Vahle-Hinz C, 2007, EXP BRAIN RES, V176, P159, DOI 10.1007/s00221-006-0604-6; Vaiceliunaite A, 2013, J NEUROPHYSIOL, V110, P964, DOI 10.1152/jn.00138.2013; van Alphen B, 2010, INVEST OPHTH VIS SCI, V51, P623, DOI 10.1167/iovs.09-4072; Veselis RA, 2004, ANESTH ANALG, V99, P399, DOI 10.1213/01.ANE.0000131971.92180.DF; VIDYASAGAR TR, 1986, NEUROSCIENCE, V17, P49, DOI 10.1016/0306-4522(86)90224-1; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Vizuete JA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00090; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; Wallace DJ, 2013, NATURE, V498, P65, DOI 10.1038/nature12153; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; WORGOTTER F, 1991, J NEUROSCI, V11, P1959; Xie Z, 2013, J NEUROPHYSIOL, V109, P758, DOI 10.1152/jn.00666.2012; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126; Zoccolan D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00193	121	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118277	10.1371/journal.pone.0118277	http://dx.doi.org/10.1371/journal.pone.0118277			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706867	Green Published, gold			2022-12-27	WOS:000350662100162
J	Harte, J; Kitzes, J				Harte, John; Kitzes, Justin			Inferring Regional-Scale Species Diversity from Small-Plot Censuses	PLOS ONE			English	Article							MAXIMUM-ENTROPY; BETA-DIVERSITY; UNIVERSALITY; GEOMETRY; BIOLOGY; SIZE	Estimation of the number of species at spatial scales too large to census directly is a long-standing ecological challenge. A recent comprehensive census of tropical arthropods and trees in Panama provides a unique opportunity to apply an inference procedure for up-scaling species richness and thereby make progress toward that goal. Confidence in the underlying theory is first established by showing that the method accurately predicts the species abundance distribution for trees and arthropods, and in particular accurately captures the rare tail of the observed distributions. The rare tail is emphasized because the shape of the species-area relationship is especially influenced by the numbers of rare species. The inference procedure is then applied to estimate the total number of arthropod and tree species at spatial scales ranging from a 6000 ha forest reserve to all of Panama, with input data only from censuses in 0.04 ha plots. The analysis suggests that at the scale of the reserve there are roughly twice as many arthropod species as previously estimated. For the entirety of Panama, inferred tree species richness agrees with an accepted empirical estimate, while inferred arthropod species richness is significantly below a previous published estimate that has been criticized as too high. An extension of the procedure to estimate species richness at continental scale is proposed.	[Harte, John; Kitzes, Justin] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kitzes, J (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.	jkitzes@berkeley.edu		Kitzes, Justin/0000-0001-7839-3594	U. S. National Science Foundation; Gordon and Betty Moore Foundation; Emerging Frontiers [1137685] Funding Source: National Science Foundation	U. S. National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the U. S. National Science Foundation and by the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2003, EVOL ECOL RES, V5, P493; Basset Yves, 2007, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V77, P39; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Chapman MG, 2009, ECOLOGY, V90, P754, DOI 10.1890/08-0650.1; Condit R., 2010, TREES PANAMA COSTA R; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Godfray HCJ, 1999, PHILOS T R SOC B, V354, P1811, DOI 10.1098/rstb.1999.0523; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Harte J, 2008, ECOLOGY, V89, P2700, DOI 10.1890/07-1369.1; Harte J, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199593415.001.0001; Harte J, 2014, TRENDS ECOL EVOL, V29, P384, DOI 10.1016/j.tree.2014.04.009; Harte J, 2013, AM NAT, V181, P282, DOI 10.1086/668821; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; Hubbell Stephen P., 2001, V32, pi; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Rosindell J, 2009, ECOLOGY, V90, P1743, DOI 10.1890/08-0661.1; Sizling AL, 2011, AM NAT, V178, P602, DOI 10.1086/662176; Storch D, 2008, FOLIA GEOBOT, V43, P329, DOI 10.1007/s12224-008-9015-8; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Ulrich W, 2010, OIKOS, V119, P1149, DOI 10.1111/j.1600-0706.2009.18236.x; White EP, 2012, ECOLOGY, V93, P1772, DOI 10.1890/11-2177.1	24	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117527	10.1371/journal.pone.0117527	http://dx.doi.org/10.1371/journal.pone.0117527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706536	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100099
J	Larsen, SL; Laenkholm, AV; Duun-Henriksen, AK; Bak, M; Lykkesfeldt, AE; Kirkegaard, T				Larsen, Sarah L.; Laenkholm, Anne-Vibeke; Duun-Henriksen, Anne Katrine; Bak, Martin; Lykkesfeldt, Anne E.; Kirkegaard, Tove			Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment	PLOS ONE			English	Article							C-SRC; PURE ANTIESTROGEN; FACTOR RECEPTOR; ENDOCRINE RESISTANCE; PROTEIN EXPRESSION; FAMILY KINASES; ACTIVATION; DASATINIB; SURVIVAL; ER	The underlying mechanisms leading to antiestrogen resistance in estrogen-receptor a (ER)-positive breast cancer is still poorly understood. The aim of this study was therefore to identify biomarkers and novel treatments for antiestrogen resistant breast cancer. We performed a kinase inhibitor screen on antiestrogen responsive T47D breast cancer cells and T47D-derived tamoxifen and fulvestrant resistant cell lines. We found that dasatinib, a broad-spectrum kinase inhibitor, inhibited growth of the antiestrogen resistant cells compared to parental T47D cells. Furthermore western blot analysis showed increased expression and phosphorylation of Src in the resistant cells and that dasatinib inhibited phosphorylation of Src and also signaling via Akt and Erk in all cell lines. Immunoprecipitation revealed Src: ER complexes only in the parental T47D cells. In fulvestrant resistant cells, Src formed complexes with the Human Epidermal growth factor Receptor (HER) 1 and HER2. Neither HER receptors nor ER were co-precipitated with Src in the tamoxifen resistant cell lines. Compared to treatment with dasatinib alone, combined treatment with dasatinib and fulvestrant had a stronger inhibitory effect on tamoxifen resistant cell growth, whereas dasatinib in combination with tamoxifen had no additive inhibitory effect on fulvestrant resistant growth. When performing immunohistochemical staining on 268 primary tumors from breast cancer patients who had received tamoxifen as first line endocrine treatment, we found that membrane expression of Src in the tumor cells was significant associated with reduced disease-free and overall survival. In conclusion, Src was identified as target for treatment of antiestrogen resistant T47D breast cancer cells. For tamoxifen resistant T47D cells, combined treatment with dasatinib and fulvestrant was superior to treatment with dasatinib alone. Src located at the membrane has potential as a new biomarker for reduced benefit of tamoxifen.	[Larsen, Sarah L.; Lykkesfeldt, Anne E.; Kirkegaard, Tove] Danish Canc Soc, Res Ctr, Breast Canc Grp, Copenhagen, Denmark; [Laenkholm, Anne-Vibeke] Slagelse Hosp, Dept Pathol, Slagelse, Denmark; [Duun-Henriksen, Anne Katrine] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Bak, Martin] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark	Danish Cancer Society; Danish Cancer Society; University of Southern Denmark; Odense University Hospital	Kirkegaard, T (corresponding author), Danish Canc Soc, Res Ctr, Breast Canc Grp, Copenhagen, Denmark.	tki@cancer.dk	Bak, Martin/D-1392-2012	Laenkholm, Anne-Vibeke/0000-0003-2166-8686	A Race Against Breast Cancer; Danish Bank Foundation; Engineer Bent Boegh and wife Inge Boeghs Foundation; Else and Mogens Wedel-Wedellborgs Foundation; Edith and Olfert Dines Hansens grant	A Race Against Breast Cancer; Danish Bank Foundation; Engineer Bent Boegh and wife Inge Boeghs Foundation; Else and Mogens Wedel-Wedellborgs Foundation; Edith and Olfert Dines Hansens grant	The study was supported by A Race Against Breast Cancer, Danish Bank Foundation, Engineer Bent Boegh and wife Inge Boeghs Foundation, Else and Mogens Wedel-Wedellborgs Foundation, and Edith and Olfert Dines Hansens grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo J, 2010, CANCER TREAT REV, V36, P492, DOI 10.1016/j.ctrv.2010.02.015; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Campbell EJ, 2008, BRIT J CANCER, V99, P1769, DOI 10.1038/sj.bjc.6604768; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Elias D, 2014, ONCOGENE, DOI [10.1038/onc.2014.138, DOI 10.1038/0NC.2014.138]; Elsberger B, 2012, J CANCER RES CLIN, V138, P327, DOI 10.1007/s00432-011-1096-8; Elsberger B, 2010, BRIT J CANCER, V103, P899, DOI 10.1038/sj.bjc.6605829; Elsberger B, 2014, CRIT REV ONCOL HEMAT, V89, P343, DOI 10.1016/j.critrevonc.2013.12.009; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Frogne T, 2005, ENDOCR-RELAT CANCER, V12, P599, DOI 10.1677/erc.1.00946; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Frogne T, 2009, BREAST CANCER RES TR, V114, P263, DOI 10.1007/s10549-008-0011-8; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Henriksen KL, 2007, J CLIN PATHOL, V60, P397, DOI 10.1136/jcp.2005.034447; Henriksen K, 2009, ACTA ONCOL, V48, P522, DOI 10.1080/02841860802676383; Hiscox S, 2009, BREAST CANCER RES TR, V115, P57, DOI 10.1007/s10549-008-0058-6; Hiscox S, 2007, CLIN EXP METASTAS, V24, P157, DOI 10.1007/s10585-007-9065-y; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Hiscox S, 2010, EUR J CANCER, V46, P2187, DOI 10.1016/j.ejca.2010.04.012; Hochhaus A, 2013, J CANCER RES CLIN, V139, P1971, DOI 10.1007/s00432-013-1488-z; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Kirkegaard T, 2006, HISTOPATHOLOGY, V48, P787, DOI 10.1111/j.1365-2559.2006.02412.x; Kirkegaard T, 2014, CANCER LETT, V344, P90, DOI 10.1016/j.canlet.2013.10.014; Liu S, 2014, ONCOTARGET; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lundholt BK, 2001, BREAST CANCER RES TR, V67, P199, DOI 10.1023/A:1017977406429; McClelland RA, 2001, ENDOCRINOLOGY, V142, P2776, DOI 10.1210/en.142.7.2776; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Morgan L, 2009, CANCER BIOL THER, V8, P1550, DOI 10.4161/cbt.8.16.8954; Nicholson RI, 2001, ENDOCR-RELAT CANCER, V8, P175, DOI 10.1677/erc.0.0080175; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Pedersen AM, 2014, INT J ONCOL, V45, P2167, DOI 10.3892/ijo.2014.2619; Pinhel IF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2719; Sommer A, 2003, J STEROID BIOCHEM, V85, P33, DOI 10.1016/S0960-0760(03)00139-0; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Thrane S, 2014, ONCOGENE, DOI [10.1038/onc.2014.351, DOI 10.1038/0NC.2014.351]; Thrane S, 2013, BREAST CANCER RES TR, V139, P71, DOI 10.1007/s10549-013-2485-2; Valachis A, 2010, CRIT REV ONCOL HEMAT, V73, P220, DOI 10.1016/j.critrevonc.2009.03.006; Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N; WAKELING AE, 1991, CANCER RES, V51, P3867; Wilson GR, 2006, BRIT J CANCER, V95, P1410, DOI 10.1038/sj.bjc.6603444; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	46	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118346	10.1371/journal.pone.0118346	http://dx.doi.org/10.1371/journal.pone.0118346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706943	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100173
J	Takahashi, S; Monda, K; Negi, J; Konishi, F; Ishikawa, S; Hashimoto-Sugimoto, M; Goto, N; Iba, K				Takahashi, Sho; Monda, Keina; Negi, Juntaro; Konishi, Fumitaka; Ishikawa, Shinobu; Hashimoto-Sugimoto, Mimi; Goto, Nobuharu; Iba, Koh			Natural Variation in Stomatal Responses to Environmental Changes among Arabidopsis thaliana Ecotypes	PLOS ONE			English	Article							ABSCISIC-ACID; SIGNAL-TRANSDUCTION; ION CHANNELS; WILD-TYPE; MUTANTS; CO2; IDENTIFICATION; THERMOGRAPHY; RESISTANCE; SLAC1	Stomata are small pores surrounded by guard cells that regulate gas exchange between plants and the atmosphere. Guard cells integrate multiple environmental signals and control the aperture width to ensure appropriate stomatal function for plant survival. Leaf temperature can be used as an indirect indicator of stomatal conductance to environmental signals. In this study, leaf thermal imaging of 374 Arabidopsis ecotypes was performed to assess their stomatal responses to changes in environmental CO2 concentrations. We identified three ecotypes, Koln (Kl-4), Gabelstein (Ga-0), and Chisdra (Chi-1), that have particularly low responsiveness to changes in CO2 concentrations. We next investigated stomatal responses to other environmental signals in these selected ecotypes, with Col-0 as the reference. The stomatal responses to light were also reduced in the three selected ecotypes when compared with Col-0. In contrast, their stomatal responses to changes in humidity were similar to those of Col-0. Of note, the responses to abscisic acid, a plant hormone involved in the adaptation of plants to reduced water availability, were not entirely consistent with the responses to humidity. This study demonstrates that the stomatal responses to CO2 and light share closely associated signaling mechanisms that are not generally correlated with humidity signaling pathways in these ecotypes. The results might reflect differences between ecotypes in intrinsic response mechanisms to environmental signals.	[Takahashi, Sho; Monda, Keina; Negi, Juntaro; Konishi, Fumitaka; Ishikawa, Shinobu; Hashimoto-Sugimoto, Mimi; Iba, Koh] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Goto, Nobuharu] RIKEN BioResource Ctr, Tsukuba, Ibaraki, Japan	Kyushu University; RIKEN	Iba, K (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	iba.koh.727@m.kyushu-u.ac.jp	Hashimoto-Sugimoto, Mimi/AAJ-6411-2021		Ministry of Education, Culture, Sports, Science, and Technology of Japan [21114002, 26221103]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Ares ( Nos. 21114002 and 26221103) to K.I. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann SM, 2000, PLANT CELL ENVIRON, V23, P387, DOI 10.1046/j.1365-3040.2000.00551.x; Borevitz JO, 2003, PLANT PHYSIOL, V132, P718, DOI 10.1104/pp.103.023549; Brosche M, 2010, PLANT CELL ENVIRON, V33, P914, DOI 10.1111/j.1365-3040.2010.02116.x; Chen XW, 2006, MOL PLANT PATHOL, V7, P391, DOI 10.1111/j.1364-3703.2006.00349.x; Christman MA, 2008, PLANT CELL ENVIRON, V31, P1170, DOI 10.1111/j.1365-3040.2008.01833.x; Fan LM, 2004, CURR OPIN PLANT BIOL, V7, P537, DOI 10.1016/j.pbi.2004.07.009; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; GOTOW K, 1985, PLANT PHYSIOL, V79, P829, DOI 10.1104/pp.79.3.829; Granier C, 2014, CURR OPIN PLANT BIOL, V18, P96, DOI 10.1016/j.pbi.2014.02.009; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hashimoto-Sugimoto M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3215; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Jones HG, 1999, PLANT CELL ENVIRON, V22, P1043, DOI 10.1046/j.1365-3040.1999.00468.x; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Costa JM, 2013, J EXP BOT, V64, P3937, DOI 10.1093/jxb/ert029; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Monda K, 2011, PLANTA, V234, P555, DOI 10.1007/s00425-011-1424-x; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Negi J, 2014, PLANT CELL PHYSIOL, V55, P241, DOI 10.1093/pcp/pct145; Pandey S, 2002, NEW PHYTOL, V153, P517, DOI 10.1046/j.0028-646X.2001.00329.x; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Roelfsema MRG, 2002, PLANT J, V32, P65, DOI 10.1046/j.1365-313X.2002.01403.x; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Yamaji Y, 2012, PLANT CELL, V24, P778, DOI 10.1105/tpc.111.093658	32	22	22	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117449	10.1371/journal.pone.0117449	http://dx.doi.org/10.1371/journal.pone.0117449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706630	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100090
J	Toth, A; Brozik, A; Szakacs, G; Sarkadi, B; Hegedus, T				Toth, Attila; Brozik, Anna; Szakacs, Gergely; Sarkadi, Balazs; Hegedus, Tamas			A Novel Mathematical Model Describing Adaptive Cellular Drug Metabolism and Toxicity in the Chemoimmune System	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; ENZYMES; BIOLOGY; TRANSPORTERS; CANCER; ARSENIC(III); HEPATOCYTES; MECHANISM; PATHWAY; SBML	Cells cope with the threat of xenobiotic stress by activating a complex molecular network that recognizes and eliminates chemically diverse toxic compounds. This "chemoimmune system" consists of cellular Phase I and Phase II metabolic enzymes, Phase 0 and Phase III ATP Binding Cassette (ABC) membrane transporters, and nuclear receptors regulating these components. In order to provide a systems biology characterization of the chemoimmune network, we designed a reaction kinetic model based on differential equations describing Phase 0-III participants and regulatory elements, and characterized cellular fitness to evaluate toxicity. In spite of the simplifications, the model recapitulates changes associated with acquired drug resistance and allows toxicity predictions under variable protein expression and xenobiotic exposure conditions. Our simulations suggest that multidrug ABC transporters at Phase 0 significantly facilitate the defense function of successive network members by lowering intracellular drug concentrations. The model was extended with a novel toxicity framework which opened the possibility of performing in silico cytotoxicity assays. The alterations of the in silico cytotoxicity curves show good agreement with in vitro cell killing experiments. The behavior of the simplified kinetic model suggests that it can serve as a basis for more complex models to efficiently predict xenobiotic and drug metabolism for human medical applications.	[Toth, Attila; Sarkadi, Balazs; Hegedus, Tamas] Hungarian Acad Sci, MTA SE Mol Biophys Res Grp, H-1094 Budapest, Hungary; [Toth, Attila; Sarkadi, Balazs; Hegedus, Tamas] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1094 Budapest, Hungary; [Toth, Attila; Brozik, Anna; Szakacs, Gergely; Sarkadi, Balazs] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1113 Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Hegedus, T (corresponding author), Hungarian Acad Sci, MTA SE Mol Biophys Res Grp, H-1094 Budapest, Hungary.	hegedus@hegelab.org	Szakacs, Gergely/A-2580-2009; Hegedus, Tamas/P-8625-2015; Sarkadi, Balazs/I-5024-2013	Szakacs, Gergely/0000-0002-9311-7827; Hegedus, Tamas/0000-0002-5195-749X; 	Momentum ("Lendulet") Program of the Hungarian Academy of Sciences; Hungarian Scientific Research Fund [OTKA 83533, OTKA 111678]; Hungarian Research and Technology Innovation Fund ("Kutatasi es Technologiai Innovacios Alap") [KTIA-AIK-12-2012-0025]	Momentum ("Lendulet") Program of the Hungarian Academy of Sciences; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Research and Technology Innovation Fund ("Kutatasi es Technologiai Innovacios Alap")	This work was supported by Momentum ("Lendulet") Program of the Hungarian Academy of Sciences (http://mta.hu/articles/momentum-program-of-the-hungarian-academy-of-sciences-130009; GS), the Hungarian Scientific Research Fund (http://www.otka.hu/en; OTKA 83533 to BS; OTKA 111678 to TH), and the Hungarian Research and Technology Innovation Fund ("Kutatasi es Technologiai Innovacios Alap"; KTIA-AIK-12-2012-0025; http://ktia.kormany.hu/; TH). TH is a Bolyai Fellow of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Chen J, 2006, DRUG METAB DISPOS, V34, P1650, DOI 10.1124/dmd.106.009837; Chen YK, 2012, BIOCHEM PHARMACOL, V83, P1112, DOI 10.1016/j.bcp.2012.01.030; Corsini A, 2013, J CLIN PHARMACOL, V53, P463, DOI 10.1002/jcph.23; Csermely P, 2013, STRUCTURE DYNAMICS M; Elsherbiny ME, 2011, DRUG METAB REV, V43, P457, DOI 10.3109/03602532.2011.596204; Emoto C, 2013, CURR DRUG METAB, V14, P239; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Li HY, 2012, HEPATO-GASTROENTEROL, V59, P2238, DOI 10.5754/hge11781; Lotsch J, 2001, CLIN PHARMACOKINET, V40, P485; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sarkadi B, 2010, NAT REV DRUG DISCOV, V9, DOI 10.1038/nrd3187-c1; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; SLADEK NE, 1988, PHARMACOL THERAPEUT, V37, P301, DOI 10.1016/0163-7258(88)90004-6; Stamatelos SK, 2013, J THEOR BIOL, V317, P244, DOI 10.1016/j.jtbi.2012.09.019; Stamatelos SK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-16; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vuilhorgne M, 1994, TAXANE ANTICANCER AG, P98; Wang D, 2012, ACTA PHARM SIN B, V2, P107, DOI 10.1016/j.apsb.2012.02.004; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n; Zhang Q, 2007, PLOS COMPUT BIOL, V3, P345, DOI 10.1371/journal.pcbi.0030024; Zhang Q, 2009, TOXICOL APPL PHARM, V237, P345, DOI 10.1016/j.taap.2009.04.005	33	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0115533	10.1371/journal.pone.0115533	http://dx.doi.org/10.1371/journal.pone.0115533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699998	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000349789800002
J	Feeney, SJ; McGrath, MJ; Sriratana, A; Gehrig, SM; Lynch, GS; D'Arcy, CE; Price, JT; McLean, CA; Tupler, R; Mitchell, CA				Feeney, Sandra J.; McGrath, Meagan J.; Sriratana, Absorn; Gehrig, Stefan M.; Lynch, Gordon S.; D'Arcy, Colleen E.; Price, John T.; McLean, Catriona A.; Tupler, Rossella; Mitchell, Christina A.			FHL1 Reduces Dystrophy in Transgenic Mice Overexpressing FSHD Muscular Dystrophy Region Gene 1 (FRG1)	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; REGION GENE-1 FRG1; ACTIN-BUNDLING PROTEIN; HUMAN-CHROMOSOME 4Q35; SKELETAL-MUSCLE; SATELLITE CELL; MYOGENIC DIFFERENTIATION; MYOTONIC-DYSTROPHY; MYOBLAST FUSION; CANDIDATE GENE	Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal-dominant disease with no effective treatment. The genetic cause of FSHD is complex and the primary pathogenic insult underlying the muscle disease is unknown. Several disease candidate genes have been proposed including DUX4 and FRG1. Expression analysis studies of FSHD report the deregulation of genes which mediate myoblast differentiation and fusion. Transgenic mice overexpressing FRG1 recapitulate the FSHD muscular dystrophy phenotype. Our current study selectively examines how increased expression of FRG1 may contribute to myoblast differentiation defects. We generated stable C2C12 cell lines overexpressing FRG1, which exhibited a myoblast fusion defect upon differentiation. To determine if myoblast fusion defects contribute to the FRG1 mouse dystrophic phenotype, this strain was crossed with skeletal muscle specific FHL1-transgenic mice. We previously reported that FHL1 promotes myoblast fusion in vitro and FHL1-transgenic mice develop skeletal muscle hypertrophy. In the current study, FRG1 mice overexpressing FHL1 showed an improvement in the dystrophic phenotype, including a reduced spinal kyphosis, increased muscle mass and myofiber size, and decreased muscle fibrosis. FHL1 expression in FRG1 mice, did not alter satellite cell number or activation, but enhanced myoblast fusion. Primary myoblasts isolated from FRG1 mice showed a myoblast fusion defect that was rescued by FHL1 expression. Therefore, increased FRG1 expression may contribute to a muscular dystrophy phenotype resembling FSHD by impairing myoblast fusion, a defect that can be rescued by enhanced myoblast fusion via expression of FHL1.	[Feeney, Sandra J.; McGrath, Meagan J.; Sriratana, Absorn; D'Arcy, Colleen E.; Price, John T.; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Gehrig, Stefan M.; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Melbourne, Vic 3010, Australia; [Price, John T.] Victoria Univ, Ctr Chron Dis Prevent & Management, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia; [McLean, Catriona A.] Alfred Hosp, Dept Anat Pathol, Prahran, Vic 3004, Australia; [McLean, Catriona A.] Monash Univ, Cent Clin Sch, Dept Med, Clayton, Vic 3800, Australia; [Tupler, Rossella] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01655 USA; [Tupler, Rossella] Univ Modena & Reggio Emilia, Dipartimento Sci Vita, I-41125 Modena, Italy	Monash University; University of Melbourne; Victoria University; Florey Institute of Neuroscience & Mental Health; Monash University; University of Massachusetts System; University of Massachusetts Worcester; Universita di Modena e Reggio Emilia	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Tupler, Rossella/C-9500-2015; Lynch, Gordon/G-9553-2015	Tupler, Rossella/0000-0002-3797-1789; Lynch, Gordon/0000-0001-9220-9810; McGrath, Meagan/0000-0002-9414-6558; Mitchell, Christina A/0000-0001-9372-3192; McLean, Catriona/0000-0002-0302-5727; Price, John/0000-0002-8244-1023	FSHD Global Research Foundation Ltd Australian Research Grants; National Institute of Health (NIAMS) [RO1AR056129]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056129] Funding Source: NIH RePORTER	FSHD Global Research Foundation Ltd Australian Research Grants; National Institute of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the FSHD Global Research Foundation Ltd Australian Research Grants (to C.A.M. and M.J.M.; http://www.fshdglobal.org/); and the National Institute of Health (NIAMS, RO1AR056129 to R.T; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavner A, 2005, NUCLEIC ACIDS RES, V33, P3561, DOI 10.1093/nar/gki667; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Chatterjee S, 2013, J CELL SCI, V126, P2213, DOI 10.1242/jcs.120519; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Chen SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019780; Cohen TV, 2012, NEUROMUSCULAR DISORD, V22, P648, DOI 10.1016/j.nmd.2012.03.002; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; D'Arcy CE, 2014, HUM MOL GENET, V23, P618, DOI 10.1093/hmg/ddt449; Dandapat A, 2014, CELL REP, V8, P1484, DOI 10.1016/j.celrep.2014.07.056; Deenen JCW, 2014, NEUROLOGY, V83, P1056, DOI 10.1212/WNL.0000000000000797; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Ferri G, 2014, HUM MOL GENET, P1; Flanigan KM, 2001, NEUROMUSCULAR DISORD, V11, P525, DOI 10.1016/S0960-8966(01)00201-2; Fu WX, 2014, P NATL ACAD SCI USA, V111, P9151, DOI 10.1073/pnas.1323265111; Furling D, 2001, NEUROMUSCULAR DISORD, V11, P728, DOI 10.1016/S0960-8966(01)00226-7; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Ge XJ, 2011, CELL RES, V21, P1591, DOI 10.1038/cr.2011.72; Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Grewal PK, 1998, GENE, V216, P13, DOI 10.1016/S0378-1119(98)00334-5; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Hanel ML, 2011, DIFFERENTIATION, V81, P107, DOI 10.1016/j.diff.2010.09.185; Hanel ML, 2009, DEV DYNAM, V238, P1502, DOI 10.1002/dvdy.21830; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Jorgensen LH, 2007, AM J PATHOL, V171, P1599, DOI 10.2353/ajpath.2007.070435; Joven A, 2013, J COMP NEUROL, V521, P3913, DOI 10.1002/cne.23385; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Kobayashi N, 2013, J COMP NEUROL, V521, P2987, DOI 10.1002/cne.23326; Krom YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003415; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Liu Q, 2010, J CELL SCI, V123, P1116, DOI 10.1242/jcs.058958; Loh KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037218; Masny PS, 2010, EUR J HUM GENET, V18, P448, DOI 10.1038/ejhg.2009.183; Mastroyiannopoulos NP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051204, DOI 10.1371/JOURNAL.PONE.0051204]; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Minetti GC, 2014, MOL CELL BIOL, V34, P619, DOI 10.1128/MCB.00957-13; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Mitsuhashi H, 2013, HUM MOL GENET, V22, P568, DOI 10.1093/hmg/dds467; Mostacciuolo ML, 2009, CLIN GENET, V75, P550, DOI 10.1111/j.1399-0004.2009.01158.x; Neguembor MV, 2013, J MOL CELL BIOL, V5, P294, DOI 10.1093/jmcb/mjt018; Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; PADBERG GW, 1995, MUSCLE NERVE, pS81, DOI 10.1002/mus.880181315; Pandey SN, 2012, BIOL OPEN, V1, P629, DOI 10.1242/bio.20121305; Pavlath GK, 2003, CELL CYCLE, V2, P420, DOI 10.4161/cc.2.5.497; Pistoni M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003186; Quinn LS, 2007, AM J PHYSIOL-ENDOC M, V293, pE1538, DOI 10.1152/ajpendo.00160.2007; Quinzi CM, 2008, AM J HUM GENET, V82, P208, DOI 10.1016/j.ajhg.2007.09.013; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; Sancisi V, 2014, AM J PHYSIOL-REG I, V306, pR124, DOI 10.1152/ajpregu.00379.2013; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Springer ML, 2002, CURR PROTOC HUM GENE; Storbeck CJ, 2004, HUM MOL GENET, V13, P589, DOI 10.1093/hmg/ddh064; Sun CYJ, 2011, J MOL BIOL, V411, P397, DOI 10.1016/j.jmb.2011.06.014; Tassin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051865; Tawil R, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-12; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van Koningsbruggen S, 2007, CHROMOSOMA, V116, P53, DOI 10.1007/s00412-006-0083-3; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Wang CH, 2012, NEUROMUSCULAR DISORD, V22, P331, DOI 10.1016/j.nmd.2011.10.018; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I; Wilding BR, 2014, J CELL SCI, V127, P2269, DOI 10.1242/jcs.140905; Windpassinger C, 2008, AM J HUM GENET, V82, P88, DOI 10.1016/j.ajhg.2007.09.004; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Wuebbles RD, 2009, DIS MODEL MECH, V2, P267, DOI 10.1242/dmm.002261; Xynos A, 2013, J CELL SCI, V126, P2236, DOI 10.1242/jcs.121533; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	91	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117665	10.1371/journal.pone.0117665	http://dx.doi.org/10.1371/journal.pone.0117665			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695429	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000350062300026
J	Iacono, V; Ellenbogen, MA; Wilson, AL; Desormeau, P; Nijjar, R				Iacono, Vanessa; Ellenbogen, Mark A.; Wilson, Alexa L.; Desormeau, Philip; Nijjar, Rami			Inhibition of Personally-Relevant Angry Faces Moderates the Effect of Empathy on Interpersonal Functioning	PLOS ONE			English	Article							IRRELEVANT FACIAL EXPRESSIONS; EMOTIONAL INFORMATION; PSYCHOMETRIC ANALYSIS; SELECTIVE ATTENTION; SOCIAL-NEUROSCIENCE; QUOTIENT; CHILDREN; DEPRESSION; DISORDER; ADOLESCENTS	While empathy is typically assumed to promote effective social interactions, it can sometimes be detrimental when it is unrestrained and overgeneralized. The present study explored whether cognitive inhibition would moderate the effect of empathy on social functioning. Eighty healthy young adults underwent two assessments six months apart. Participants' ability to suppress interference from distracting emotional stimuli was assessed using a Negative Affective Priming Task that included both generic and personally-relevant (i.e., participants' intimate partners) facial expressions of emotion. The UCLA Life Stress Interview and Empathy Quotient were administered to measure interpersonal functioning and empathy respectively. Multilevel modeling demonstrated that higher empathy was associated with worse concurrent interpersonal outcomes for individuals who showed weak inhibition of the personally-relevant depictions of anger. The effect of empathy on social functioning might be dependent on individuals' ability to suppress interference from meaningful emotional distractors in their environment.	[Iacono, Vanessa; Ellenbogen, Mark A.; Wilson, Alexa L.; Desormeau, Philip; Nijjar, Rami] Concordia Univ, Ctr Res Human Dev, Montreal, PQ, Canada	Concordia University - Canada	Ellenbogen, MA (corresponding author), Concordia Univ, Ctr Res Human Dev, Montreal, PQ, Canada.	mark.ellenbogen@concordia.ca		Ellenbogen, Mark/0000-0001-8928-5492	Social Sciences and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This project was funded by the Social Sciences and Humanities Research Council of Canada (http://www.sshrc-crsh.gc.ca/home-accueileng.aspx). This funding was awarded to ME. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Allison C, 2011, PERS INDIV DIFFER, V51, P829, DOI 10.1016/j.paid.2011.07.005; Amir N, 2009, J ABNORM PSYCHOL, V118, P28, DOI 10.1037/a0012589; Antshel KM, 2003, J CLIN CHILD ADOLESC, V32, P153, DOI 10.1207/S15374424JCCP3201_14; Arsalidou M, 2010, BRAIN COGNITION, V74, P47, DOI 10.1016/j.bandc.2010.06.003; BARGH JA, 1982, J PERS SOC PSYCHOL, V43, P425, DOI 10.1037/0022-3514.43.3.425; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BARSALOU LW, 1982, MEM COGNITION, V10, P82, DOI 10.3758/BF03197629; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Batson CD, 1991, ALTRUISM QUESTION SO, P128, DOI [10.1007/BF03192197, DOI 10.1007/BF03192197]; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bestgen Y, 2002, CURR PSYCHOL COGN, V19, P287; Cacioppo JT, 2003, CURR DIR PSYCHOL SCI, V12, P71, DOI 10.1111/1467-8721.01232; Clifton A, 2005, PSYCHOL ASSESSMENT, V17, P123, DOI 10.1037/1040-3590.17.2.123; Costa PT, 2007, REVISED NEO PERSONAL; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J., 2007, SOC NEUROSCI-UK, P246; Decety J, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-22; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2011, EMOT REV, V3, P92, DOI 10.1177/1754073910374662; Decety J, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P199; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Eisenberg N, 1996, DEV PSYCHOL, V32, P195, DOI 10.1037/0012-1649.32.2.195; Eisenberg N, 2004, SOCIAL PSYCHOL GOOD, P386; Eisenberg N, 1992, J PERS SOC PSYCHNOL, V66, P776; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Ekman P., 2002, MANUAL INVESTIGATORS; Ellenbogen MA, 2013, PSYCHONEUROENDOCRINO, V38, P387, DOI 10.1016/j.psyneuen.2012.06.016; Ellenbogen MA, 2009, BEHAV RES THER, V47, P128, DOI 10.1016/j.brat.2008.10.021; Elsenberg N, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P71; First MB, 2002, STRUCTURED CLIN INTE; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Goeleven E, 2006, J AFFECT DISORDERS, V93, P149, DOI 10.1016/j.jad.2006.03.007; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Hammen C, 2003, J AM ACAD CHILD PSY, V42, P571, DOI 10.1097/01.CHI.0000046829.95464.E5; Hammen C, 2002, J AFFECT DISORDERS, V72, P145, DOI 10.1016/S0165-0327(01)00455-4; Harkness KL, 2011, PSYCHIAT RES, V189, P91, DOI 10.1016/j.psychres.2011.06.007; Hasher L, 1999, ATTENTION PERFORM, V17, P653; Heck RH, 2010, QUANT METH SER, P1; Hofelich AJ, 2012, COGNITION EMOTION, V26, P119, DOI 10.1080/02699931.2011.559192; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; IBM Corp, 2010, IBM SPSS STAT WIND V; Joormann J, 2004, COGNITION EMOTION, V18, P125, DOI 10.1080/02699930244000480; Joormann J, 2007, J ABNORM PSYCHOL, V116, P135, DOI 10.1037/0021-843X.116.1.135; Joormann J, 2006, COGNITIVE THER RES, V30, P149, DOI 10.1007/s10608-006-9035-8; Joormann J, 2010, CURR DIR PSYCHOL SCI, V19, P161, DOI 10.1177/0963721410370293; Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179; Laible DJ, 2004, J ADOLESCENCE, V27, P703, DOI 10.1016/j.adolescence.2004.05.005; Lange T.M., 2011, NEW SCH PSYCHOL B, V8, P83; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lovett BJ, 2007, CLIN PSYCHOL REV, V27, P1, DOI 10.1016/j.cpr.2006.03.003; Lundqvist D., 1998, KAROLINSKA DIRECTED; Lundqvist D., 2005, EMOTION CONSCIOUSNES, P97; MacLeod CM, 2003, PSYCHOL LEARN MOTIV, V43, P163, DOI 10.1016/S0079-7421(03)01014-4; Mayer J., 2002, MAYER SALOVEY CARUSO; Mayer J., 2000, HDB EMOTIONAL INTELL, P92; McDonald MJ, 2003, PSYCHOL REP, V93, P371, DOI 10.2466/PR0.93.6.371-377; Muncer SJ, 2006, PERS INDIV DIFFER, V40, P1111, DOI 10.1016/j.paid.2005.09.020; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; O'Connor LE, 2007, EMPATHY IN MENTAL ILLNESS, P49, DOI 10.1017/CBO9780511543753.005; Ostiguy CS, 2012, DEV PSYCHOPATHOL, V24, P573, DOI 10.1017/S095457941200017X; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Preston SD, 2008, COGN AFFECT BEHAV NE, V8, P54, DOI 10.3758/CABN.8.1.54; Raes F, 2006, J ABNORM PSYCHOL, V115, P699, DOI 10.1037/0021-843X.115.4.699; Salzer S, 2008, J PERS ASSESS, V90, P292, DOI 10.1080/00223890701885076; Schlosser N, 2011, J NERV MENT DIS, V199, P696, DOI 10.1097/NMD.0b013e318229d6cf; Seeman TE, 2000, AM J HEALTH PROMOT, V14, P362, DOI 10.4278/0890-1171-14.6.362; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Taylor MJ, 2009, HUM BRAIN MAPP, V30, P2008, DOI 10.1002/hbm.20646; Taylor VA, 2011, BIOL PSYCHOL, V86, P17, DOI 10.1016/j.biopsycho.2010.10.001; Thoma P, 2011, PSYCHIAT RES, V189, P373, DOI 10.1016/j.psychres.2011.07.030; Thompson-Schill SL, 2009, CURR DIR PSYCHOL SCI, V18, P259, DOI 10.1111/j.1467-8721.2009.01648.x; Tipper SP, 2001, Q J EXP PSYCHOL-A, V54, P321, DOI 10.1080/02724980042000183; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P591, DOI 10.1080/14640748508400921; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; Wingenfeld K, 2006, PSYCHOL REP, V99, P781, DOI 10.2466/PR0.99.3.781-793	82	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0112990	10.1371/journal.pone.0112990	http://dx.doi.org/10.1371/journal.pone.0112990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695426	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000350062300002
J	Uehara, F; Hiroshima, Y; Miwa, S; Tome, Y; Yano, S; Yamamoto, M; Matsumoto, Y; Maehara, H; Tanaka, K; Bouvet, M; Kanaya, F; Hoffman, RM				Uehara, Fuminari; Hiroshima, Yukihiko; Miwa, Shinji; Tome, Yasunori; Yano, Shuya; Yamamoto, Mako; Matsumoto, Yasunori; Maehara, Hiroki; Tanaka, Kazuhiro; Bouvet, Michael; Kanaya, Fuminori; Hoffman, Robert M.			Fluorescence-Guided Surgery of Retroperitoneal-Implanted Human Fibrosarcoma in Nude Mice Delays or Eliminates Tumor Recurrence and Increases Survival Compared to Bright-Light Surgery	PLOS ONE			English	Article							HUMAN COLON-CANCER; ANTI-CEA ANTIBODY; FLUOROPHORE-CONJUGATED ANTIBODY; METASTATIC PANCREATIC-CANCER; SOFT-TISSUE SARCOMA; COMPLETE RESECTION; MOUSE MODELS; PROTEIN; PATIENT; GFP	The aim of this study is to determine if fluorescence-guided surgery (FGS) can eradicate human fibrosarcoma growing in the retroperitoneum of nude mice. One week after retroperitoneal implantation of human HT1080 fibrosarcoma cells, expressing green fluorescent protein (GFP) (HT-1080-GFP), in nudemice, bright-light surgery (BLS) was performed on all tumorbearing mice (n = 22). After BLS, mice were randomized into 2 treatment groups; BLS-only (n = 11) or the combination of BLS + FGS (n = 11). The residual tumors remaining after BLS were resected with FGS using a hand-held portable imaging systemunder fluorescence navigation. The average residual tumor area after BLS + FGS was significantly smaller than after BLS-only (0.4 +/- 0.4 mm(2) and 10.5 +/- 2.4 mm(2), respectively; p = 0.006). Five weeks after surgery, the fluorescent-tumor areas of BLS-and BLS + FGS-treated mice were 379 +/- 147 mm(2) and 11.7 +/- 6.9 mm(2), respectively, indicating that FGS greatly inhibited tumor recurrence compared to BLS. The combination of BLS + FGS significantly decreased fibrosarcoma recurrence compared to BLS-only treated mice (p < 0.001). Mice treated with BLS + FGS had a significantly higher disease-free survival rate than mice treated with BLS-only at five weeks after surgery. These results suggest that combination of BLS + FGS significantly reduced the residual fibrosarcoma volume after BLS and improved disease-free survival.	[Uehara, Fuminari; Hiroshima, Yukihiko; Miwa, Shinji; Tome, Yasunori; Yano, Shuya; Yamamoto, Mako; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Uehara, Fuminari; Hiroshima, Yukihiko; Miwa, Shinji; Tome, Yasunori; Yano, Shuya; Matsumoto, Yasunori; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Uehara, Fuminari; Tome, Yasunori; Maehara, Hiroki; Tanaka, Kazuhiro; Kanaya, Fuminori] Univ Ryukyus, Grad Sch Med, Dept Orthoped Surg, Nishihara, Okinawa 9030125, Japan	Anti Cancer Inc; University of California System; University of California San Diego; University of the Ryukyus	Hoffman, RM (corresponding author), AntiCancer Inc, 7917 Ostrow St, San Diego, CA 92111 USA.	all@anticancer.com	TOME, YASUNORI/K-4319-2019; Yano, Shuya/AAL-8028-2020; matsumoto, yasunori/GQP-9823-2022; Miwa, Shinji/AAI-9309-2020; Matsumoto, Yasunori/AAX-4135-2021	matsumoto, yasunori/0000-0002-6239-6691; Miwa, Shinji/0000-0002-5962-8287; Matsumoto, Yasunori/0000-0002-6239-6691; TOME, YASUNORI/0000-0002-3716-1866; UEHARA, FUMINARI/0000-0001-6567-2113; MAEHARA, HIROKI/0000-0001-5897-9213	National Cancer Institute [CA142669]; NATIONAL CANCER INSTITUTE [R01CA142669] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute grant CA142669. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonvalot S, 2009, J CLIN ONCOL, V27, P31, DOI 10.1200/JCO.2008.18.0802; Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Glinsky GV, 2013, J CLIN INVEST, V123, P2350, DOI 10.1172/JCI69268; Hiroshima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099977; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; JAQUES DP, 1990, ANN SURG, V212, P51, DOI 10.1097/00000658-199007000-00008; KARAKOUSIS CP, 1995, ARCH SURG-CHICAGO, V130, P1104; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Kimura H, 2010, CELL PROLIFERAT, V43, P41, DOI 10.1111/j.1365-2184.2009.00652.x; Kimura H, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3526356; Kimura H, 2010, J CELL BIOCHEM, V110, P1439, DOI 10.1002/jcb.22693; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Kishimoto H, 2009, MOL CANCER THER, V8, P3001, DOI 10.1158/1535-7163.MCT-09-0556; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Lewis JJ, 1998, ANN SURG, V228, P355, DOI 10.1097/00000658-199809000-00008; Maawy AA, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.101504; Maawy AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097965; Maawy AA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126016; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Metildi CA, 2014, J AM COLL SURGEONS, V219, P132, DOI 10.1016/j.jamcollsurg.2014.02.021; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Metildi CA, 2014, ANN SURG ONCOL, V21, P1405, DOI 10.1245/s10434-014-3495-y; Metildi CA, 2013, ANN SURG ONCOL, V20, pS693, DOI 10.1245/s10434-013-3172-6; Metildi CA, 2013, J SURG RES, V179, P87, DOI 10.1016/j.jss.2012.08.052; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Metildi CA, 2012, J AM COLL SURGEONS, V214, P997, DOI 10.1016/j.jamcollsurg.2012.02.009; Miwa S, 2014, J SURG RES, V192, P124, DOI 10.1016/j.jss.2014.05.049; Miwa S, 2014, ONCOTARGET, V5, P7119, DOI 10.18632/oncotarget.2226; Momiyama M, 2013, ANTICANCER RES, V33, P107; Momiyama M, 2012, J SURG RES, V178, P280, DOI 10.1016/j.jss.2012.03.020; Strauss DC, 2010, BRIT J SURG, V97, P698, DOI 10.1002/bjs.6994; Wu JZ, 2013, ANTICANCER RES, V33, P419; Yamamoto N, 2003, CANCER RES, V63, P7785; Yamamoto N, 2003, CLIN EXP METASTAS, V20, P181, DOI 10.1023/A:1022662927574; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116865	10.1371/journal.pone.0116865	http://dx.doi.org/10.1371/journal.pone.0116865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710463	gold, Green Published, Green Submitted			2022-12-27	WOS:000350683900020
J	Wu, SC; Chen, WTL; Muo, CH; Ke, TW; Fang, CW; Sung, FC				Wu, Shih-Chi; Chen, William Tzu-Liang; Muo, Chih-Hsin; Ke, Tao-Wei; Fang, Chu-Wen; Sung, Fung-Chang			Association between Appendectomy and Subsequent Colorectal Cancer Development: An Asian Population Study	PLOS ONE			English	Article							ULCERATIVE-COLITIS; COLON-CANCER; LARGE-BOWEL; INTESTINAL INFLAMMATION; FUSOBACTERIUM-VARIUM; ACUTE APPENDICITIS; CROHNS-DISEASE; GUT MICROBIOTA; RISK-FACTORS; CELLS	Objectives The appendix may modulate colon microbiota and bowel inflammation. We investigated whether appendectomy alters colorectal cancer risk. Methods We identified a cohort of 75979 patients who underwent appendectomy between 1997 and 1999 based on the insurance claims of Taiwan. A comparison cohort of 303640 persons without appendectomy was selected randomly, frequency matched by age, sex, comorbidity and entry year was also selected. We monitored subsequent colorectal cancer development in both cohorts. Results The overall colorectal cancer incidence was 14% higher in the appendectomy patients than in the comparison cohort (p < 0.05): the highest incidence was observed for rectal cancer, and the lowest incidence was observed for cancer of the cecum-ascending colon for both cohorts. Men were at higher risk than women. Subjects >= 60 years had an HR of 12.8 compared to those < 60 years. The incidence of colorectal cancer was much higher in 1.5-3.5 years post appendectomy follow-up than for the comparisons (HR of 2.13). Patients who received an incidental appendectomy had an HR of 2.90 when compared to the comparisons. Conclusions Results of our study suggest that appendectomy in patients with appendicitis is likely associated with the development of colorectal cancer in the post-surgery period.	[Wu, Shih-Chi] China Med Univ Hosp, Trauma & Emergency Ctr, Taichung, Taiwan; [Wu, Shih-Chi; Chen, William Tzu-Liang] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, William Tzu-Liang; Ke, Tao-Wei] China Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taichung, Taiwan; [Muo, Chih-Hsin; Sung, Fung-Chang] China Med Univ & Hosp, Management Off Hlth Data, Taichung, Taiwan; [Fang, Chu-Wen] Changhua Christian Hosp, Dept Surg, Changhua, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Inst Clin Med Sci, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Changhua Christian Hospital; China Medical University Taiwan	Sung, FC (corresponding author), China Med Univ & Hosp, Management Off Hlth Data, Taichung, Taiwan.	fcsung1008@yahoo.com	Chen, William Tzu-Liang/ABA-5673-2021		Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH 100-TD-B-111-004]; Cancer Research Center for Excellence [DOH102-TD-C-111-005]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; China Medical University Hospital [1MS1]; National Sciences Council, Executive Yuan [NSC 100-2621-M-039-001]	Taiwan Department of Health Clinical Trial and Research Center of Excellence; Cancer Research Center for Excellence; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; National Sciences Council, Executive Yuan	The study was supported by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH 100-TD-B-111-004) and Cancer Research Center for Excellence (DOH102-TD-C-111-005), Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), China Medical University Hospital (grant number 1MS1), and the National Sciences Council, Executive Yuan (grant number NSC 100-2621-M-039-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson RE, 2003, GASTROENTEROLOGY, V124, P40, DOI 10.1053/gast.2003.50021; Andersson RE, 2001, NEW ENGL J MED, V344, P808, DOI 10.1056/NEJM200103153441104; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Atreya I, 2008, EXPERT REV ANTICANC, V8, P561, DOI 10.1586/14737140.8.4.561; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bellavia M, 2013, MED MICROBIOL IMMUN, V202, P393, DOI 10.1007/s00430-013-0305-2; BERNDT H, 1970, DIGESTION, V3, P187, DOI 10.1159/000197030; BIERMAN HR, 1968, CANCER, V21, P109, DOI 10.1002/1097-0142(196801)21:1<109::AID-CNCR2820210117>3.0.CO;2-#; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Bollinger RR, 2007, GUT, V56, P1481; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Cai YK, 2012, HEPATO-GASTROENTEROL, V59, P1819, DOI 10.5754/hge10781; Canavan C, 2006, ALIMENT PHARM THER, V23, P1097, DOI 10.1111/j.1365-2036.2006.02854.x; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Castiglione F, 2012, J CROHNS COLITIS, V6, P324, DOI 10.1016/j.crohns.2011.09.003; Cheluvappa R, 2011, CLIN EXP IMMUNOL, V165, P393, DOI 10.1111/j.1365-2249.2011.04434.x; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Correale C, 2013, GASTROENTEROLOGY, V144, P346, DOI [10.1053/j.gastro.2012.10.040, 10.1053/j.gastro.2012.12.016]; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Feagins LA, 2009, NAT REV GASTRO HEPAT, V6, P297, DOI 10.1038/nrgastro.2009.44; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Gallimore AM, 2013, NEW ENGL J MED, V368, P282, DOI 10.1056/NEJMcibr1212341; Gold JS, 2004, ARCH SURG-CHICAGO, V139, P760, DOI 10.1001/archsurg.139.7.760; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; HOWIE JGR, 1966, CANCER-AM CANCER SOC, V19, P1138, DOI 10.1002/1097-0142(196608)19:8<1138::AID-CNCR2820190814>3.0.CO;2-V; HYAMS L, 1968, J CHRON DIS, V21, P391, DOI 10.1016/0021-9681(68)90003-9; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lai HW, 2006, J GASTROEN HEPATOL, V21, P1693, DOI 10.1111/j.1440-1746.2006.04426.x; Lakatos PL, 2008, WORLD J GASTROENTERO, V14, P3937, DOI 10.3748/wjg.14.3937; Mai V, 2004, NUTR REV, V62, P235, DOI [10.1111/j.1753-4887.2004.tb00045.x, 10.1301/nr2004.jun235-242]; Makivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; McIntosh GH, 1999, NUTR CANCER, V35, P153, DOI 10.1207/S15327914NC352_9; MCVAY JR, 1964, CANCER, V17, P929, DOI 10.1002/1097-0142(196407)17:7<929::AID-CNCR2820170713>3.0.CO;2-O; Minami M, 2009, FEMS IMMUNOL MED MIC, V56, P67, DOI 10.1111/j.1574-695X.2009.00550.x; MOERTEL CG, 1974, SURG GYNECOL OBSTET, V138, P549; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; Nakamura J, 2002, MICROBIOL IMMUNOL, V46, P487, DOI 10.1111/j.1348-0421.2002.tb02723.x; Nakao SK, 2013, SURG ENDOSC, V27, P768, DOI 10.1007/s00464-012-2543-6; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Rastall RA, 2004, J NUTR, V134, p2022S, DOI 10.1093/jn/134.8.2022S; Ray Katrina, 2011, Nat Rev Gastroenterol Hepatol, V8, P662, DOI 10.1038/nrgastro.2011.208; Roblin X, 2012, GUT, V61, P635, DOI 10.1136/gutjnl-2011-300576; Rowland IR, 1996, NUTR CANCER, V26, P37, DOI 10.1080/01635589609514461; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Solana R, 2000, VACCINE, V18, P1613, DOI 10.1016/S0264-410X(99)00495-8; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; Swidsinski A, 2012, SAUDI J GASTROENTERO, V18, P55, DOI 10.4103/1319-3767.91734; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tiihonen K, 2010, AGEING RES REV, V9, P107, DOI 10.1016/j.arr.2009.10.004; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; VOBECKY J, 1983, CANCER, V51, P1958, DOI 10.1002/1097-0142(19830515)51:10<1958::AID-CNCR2820511036>3.0.CO;2-W; Wong C, 2013, CURR OPIN IMMUNOL, V25, P535, DOI 10.1016/j.coi.2013.05.016; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zhu QC, 2013, TUMOR BIOL, V34, P1285, DOI 10.1007/s13277-013-0684-4; Zhu YM, 2011, CANCER LETT, V309, P119, DOI 10.1016/j.canlet.2011.06.004	68	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118411	10.1371/journal.pone.0118411	http://dx.doi.org/10.1371/journal.pone.0118411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710790	gold, Green Submitted, Green Published			2022-12-27	WOS:000350683900057
J	Zohdi, V; Whelan, DR; Wood, BR; Pearson, JT; Bambery, KR; Black, MJ				Zohdi, Vladislava; Whelan, Donna R.; Wood, Bayden R.; Pearson, James T.; Bambery, Keith R.; Black, M. Jane			Importance of Tissue Preparation Methods in FTIR Micro-Spectroscopical Analysis of Biological Tissues: 'Traps for New Users'	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; DIFFERENT FIXATION PROTOCOLS; SPECTRAL CYTOPATHOLOGY; SECONDARY STRUCTURE; RAT-HEART; PROTEINS; COLLAGEN; CANCER; CELLS	Fourier Transform Infrared (FTIR) micro-spectroscopy is an emerging technique for the biochemical analysis of tissues and cellular materials. It provides objective information on the holistic biochemistry of a cell or tissue sample and has been applied in many areas of medical research. However, it has become apparent that how the tissue is handled prior to FTIR micro-spectroscopic imaging requires special consideration, particularly with regards to methods for preservation of the samples. We have performed FTIR micro-spectroscopy on rodent heart and liver tissue sections (two spectroscopically very different biological tissues) that were prepared by desiccation drying, ethanol substitution and formalin fixation and have compared the resulting spectra with that of fully hydrated freshly excised tissues. We have systematically examined the spectra for any biochemical changes to the native state of the tissue caused by the three methods of preparation and have detected changes in infrared (IR) absorption band intensities and peak positions. In particular, the position and profile of the amide I, key in assigning protein secondary structure, changes depending on preparation method and the lipid absorptions lose intensity drastically when these tissues are hydrated with ethanol. Indeed, we demonstrate that preserving samples through desiccation drying, ethanol substitution or formalin fixation significantly alters the biochemical information detected using spectroscopic methods when compared to spectra of fresh hydrated tissue. It is therefore imperative to consider tissue preparative effects when preparing, measuring, and analyzing samples using FTIR spectroscopy.	[Zohdi, Vladislava; Black, M. Jane] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Whelan, Donna R.; Wood, Bayden R.; Bambery, Keith R.] Monash Univ, Ctr Biospect, Clayton, Vic 3800, Australia; [Whelan, Donna R.; Wood, Bayden R.; Bambery, Keith R.] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; [Pearson, James T.] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University; Monash University	Black, MJ (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.	jane.black@monash.edu	Bambery, Keith/S-2686-2019; Wood, Bayden R./E-4984-2011; Pearson, James T/B-4631-2012	Bambery, Keith/0000-0002-8489-1749; Wood, Bayden R./0000-0003-3581-447X; Pearson, James T/0000-0002-3318-5406; Black, Mary Jane/0000-0002-9253-3773; Whelan, Donna/0000-0002-7078-5443	Australian Postgraduate Research Award; Australian Research Council (ARC) Future Fellowship [FT120100926]; Australian Research Discovery Grant [DP0878464]; Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE)	Australian Postgraduate Research Award; Australian Research Council (ARC) Future Fellowship(Australian Research Council); Australian Research Discovery Grant(Australian Research Council); Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE)	VZ was supported by an Australian Postgraduate Research Award whilst conducting this study. BRW was supported by an Australian Research Council (ARC) Future Fellowship (FT120100926) and an Australian Research Discovery Grant (DP0878464). This work was supported by the Multi-modal Australian ScienceS Imaging and Visualisation Environment (MASSIVE) (http://www.massive.org.au) (KRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argov S, 2004, BIOPOLYMERS, V75, P384, DOI 10.1002/bip.20154; Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8; Bassan P, 2010, ANALYST, V135, P268, DOI 10.1039/b921056c; Bassan P, 2009, ANALYST, V134, P1586, DOI 10.1039/b904808a; Bonnier F, 2006, BBA-BIOMEMBRANES, V1758, P968, DOI 10.1016/j.bbamem.2006.05.018; Carter Elizabeth A, 2009, Biophys Rev, V1, P95, DOI 10.1007/s12551-009-0012-9; DEVOR AW, 1966, ANAL BIOCHEM, V14, P237, DOI 10.1016/0003-2697(66)90131-X; Diem M, 2004, ANALYST, V129, P880, DOI 10.1039/b408952a; Fung MFK, 1996, BIOSPECTROSCOPY, V2, P155, DOI 10.1002/(SICI)1520-6343(1996)2:3<155::AID-BSPY2>3.3.CO;2-F; Garnjanagoonchorn W, 2007, CHEM ENG PROCESS, V46, P465, DOI 10.1016/j.cep.2006.05.019; Gazi E, 2010, VIB SPECTROSC, P59; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Gough KM, 2010, VIB SPECTROSC, V53, P71, DOI 10.1016/j.vibspec.2010.01.015; Gough KM, 2003, ANAL BIOCHEM, V316, P232, DOI 10.1016/S0003-2697(03)00039-3; Gu Li, 2004, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V21, P449; JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V; Liu KZ, 1996, BBA-MOL BASIS DIS, V1315, P73, DOI 10.1016/0925-4439(95)00118-2; Lyman DJ, 1999, J BIOMED MATER RES, V48, P172, DOI 10.1002/(SICI)1097-4636(1999)48:2<172::AID-JBM12>3.3.CO;2-O; Malek K., 2014, OPTICAL SPECTROSCOPY, V14, DOI DOI 10.1007/978-94-007-7832-0_15; Mariani MM, 2009, ANALYST, V134, P1154, DOI 10.1039/b822408k; Mazur AI, 2012, ANAL CHEM, V84, P8265, DOI 10.1021/ac3017407; Mazur AI, 2012, ANAL CHEM, V84, P1259, DOI 10.1021/ac202046d; O Faolain E, 2005, VIB SPECTROSC, V38, P121, DOI 10.1016/j.vibspec.2005.02.013; PLESHKO NL, 1992, CALCIFIED TISSUE INT, V51, P72, DOI 10.1007/BF00296221; Potter K, 2001, ARTHRITIS RHEUM, V44, P846, DOI 10.1002/1529-0131(200104)44:4<846::AID-ANR141>3.0.CO;2-E; Rubin S, 2008, BIOPOLYMERS, V89, P160, DOI 10.1002/bip.20882; Salman A, 2001, CELL MOL BIOL; Specht A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/646257; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Taylor KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056181; Toyran N, 2007, ARCH BIOCHEM BIOPHYS, V458, P184, DOI 10.1016/j.abb.2006.12.012; Toyran N, 2006, BIOCHEM J, V397, P427, DOI 10.1042/BJ20060171; Verdonck M, 2013, ANALYST, V138, P4083, DOI 10.1039/c3an00246b; Whelan DR, 2013, ANALYST, V138, P3891, DOI 10.1039/c3an00316g; Wood BR, 2008, ANAL CHEM, V80, P9065, DOI 10.1021/ac8015483; Wood BR, 2004, GYNECOL ONCOL, V93, P59, DOI 10.1016/j.ygyno.2003.12.028; Wu JG, 2001, BIOPOLYMERS, V62, P185, DOI 10.1002/bip.1013; Zakout YMA, 2010, BIOTECH HISTOCHEM, V85, P93, DOI 10.3109/10520290903126883	38	72	72	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116491	10.1371/journal.pone.0116491	http://dx.doi.org/10.1371/journal.pone.0116491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710811	Green Submitted, gold, Green Published			2022-12-27	WOS:000350683900008
J	Abriata, LA; Palzkill, T; Dal Peraro, M				Abriata, Luciano A.; Palzkill, Timothy; Dal Peraro, Matteo			How Structural and Physicochemical Determinants Shape Sequence Constraints in a Functional Enzyme	PLOS ONE			English	Article							BETA-LACTAMASE STRUCTURE; DIRECTED EVOLUTION; PROTEIN EVOLUTION; TERTIARY STRUCTURE; HIGH-RESOLUTION; SOLVENT ACCESSIBILITY; NATURAL EVOLUTION; STABILITY; MUTATIONS; LANDSCAPE	The need for interfacing structural biology and biophysics to molecular evolution is being increasingly recognized. One part of the big problem is to understand how physics and chemistry shape the sequence space available to functional proteins, while satisfying the needs of biology. Here we present a quantitative, structure-based analysis of a high-resolution map describing the tolerance to all substitutions in all positions of a functional enzyme, namely a TEM lactamase previously studied through deep sequencing of mutants growing in competition experiments with selection against ampicillin. Substitutions are rarely observed within 7 angstrom of the active site, a stringency that is relaxed slowly and extends up to 15-20 20 angstrom, with buried residues being especially sensitive. Substitution patterns in over one third of the residues can be quantitatively modeled by monotonic dependencies on amino acid descriptors and predictions of changes in folding stability. Amino acid volume and steric hindrance shape constraints on the protein core; hydrophobicity and solubility shape constraints on hydrophobic clusters underneath the surface, and on salt bridges and polar networks at the protein surface together with charge and hydrogen bonding capacity. Amino acid solubility, flexibility and conformational descriptors also provide additional constraints at many locations. These findings provide fundamental insights into the chemistry underlying protein evolution and design, by quantitating links between sequence and different protein traits, illuminating subtle and unexpected sequence-trait relationships and pinpointing what traits are sacrificed upon gain-of-function mutation.	[Abriata, Luciano A.; Dal Peraro, Matteo] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Biomol Modeling, Lausanne, Switzerland; [Abriata, Luciano A.; Dal Peraro, Matteo] Ecole Polytech Fed Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Baylor College of Medicine	Abriata, LA (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Biomol Modeling, Lausanne, Switzerland.	luciano.abriata@epfl.ch			EMBO long-term fellowship; National Institutes of Health [AI32956, AI106863]; Swiss National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032956, R01AI032956, R01AI106863] Funding Source: NIH RePORTER	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	LAA was funded by an EMBO long-term fellowship during this work (http://www.embo.org); TP was funded by the National Institutes of Health grants AI32956 and AI106863 (http://www.nih.gov); MDP was funded by the Swiss National Science Foundation (http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriata LA, 2012, FEBS LETT, V586, P3330, DOI 10.1016/j.febslet.2012.07.010; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Bloom JD, 2014, MOL BIOL EVOL, DOI [10.1093/molbev/msu220, DOI 10.1093/M0LBEV/MSU220]; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng ZF, 2012, J MOL BIOL, V424, P150, DOI 10.1016/j.jmb.2012.09.014; Drawz SM, 2009, BIOCHEMISTRY-US, V48, P4557, DOI 10.1021/bi9003292; Firnberg E, 2014, MOL BIOL EVOL, V31, P1581, DOI 10.1093/molbev/msu081; FONZE E, 1995, ACTA CRYSTALLOGR D, V51, P682, DOI 10.1107/S0907444994014496; Fornasari MS, 2007, MOL BIOL EVOL, V24, P349, DOI 10.1093/molbev/msl181; Fornili A, 2012, METHODS MOL BIOL, V819, P375, DOI 10.1007/978-1-61779-465-0_23; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Galan JC, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00009; Goldman N, 1998, GENETICS, V149, P445; Gonzalez LJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003817; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hecht M, 2013, J MOL BIOL, V425, P3937, DOI 10.1016/j.jmb.2013.07.028; Hietpas R, 2012, NAT PROTOC, V7, P1382, DOI 10.1038/nprot.2012.069; Huang F, 2003, ANGEW CHEM INT EDIT, V42, P2269, DOI 10.1002/anie.200250684; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; Jacquier H, 2013, P NATL ACAD SCI USA, V110, P13067, DOI 10.1073/pnas.1215206110; Kaltenbach M, 2014, J EXP ZOOL PART B, V322, P468, DOI 10.1002/jez.b.22562; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Liberles DA, 2012, PROTEIN SCI, V21, P769, DOI 10.1002/pro.2071; Marshall NM, 2009, NATURE, V462, P113, DOI 10.1038/nature08551; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; Meyer AG, 2013, MOL BIOL EVOL, V30, P36, DOI 10.1093/molbev/mss217; Morgada MN, 2014, ANGEW CHEM INT EDIT, V53, P6188, DOI 10.1002/anie.201402083; Novais A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000735; Parisi G, 2005, GENE, V345, P45, DOI 10.1016/j.gene.2004.11.025; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Robinson DM, 2003, MOL BIOL EVOL, V20, P1692, DOI 10.1093/molbev/msg184; Rodrigue N, 2005, GENE, V347, P207, DOI 10.1016/j.gene.2004.12.011; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Roscoe BP, 2013, J MOL BIOL, V425, P1363, DOI 10.1016/j.jmb.2013.01.032; Salverda MLM, 2010, FEMS MICROBIOL REV, V34, P1015, DOI 10.1111/j.1574-6976.2010.00222.x; Starita LM, 2013, P NATL ACAD SCI USA, V110, pE1263, DOI 10.1073/pnas.1303309110; Thai QK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-390; Thorne JL, 2007, MOL BIOL EVOL, V24, P1667, DOI 10.1093/molbev/msm085; Thorne JL, 2007, CURR OPIN STRUC BIOL, V17, P337, DOI 10.1016/j.sbi.2007.05.006; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tomatis PE, 2005, P NATL ACAD SCI USA, V102, P13761, DOI 10.1073/pnas.0503495102; Traxlmayr MW, 2012, J MOL BIOL, V423, P397, DOI 10.1016/j.jmb.2012.07.017; Widmann M, 2012, ANTIMICROB AGENTS CH, V56, P3481, DOI 10.1128/AAC.00255-12; Yu JY, 2006, J MOL EVOL, V62, P682, DOI 10.1007/s00239-005-0107-2	51	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118684	10.1371/journal.pone.0118684	http://dx.doi.org/10.1371/journal.pone.0118684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706742	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100201
J	Baurand, PE; Pedrini-Martha, V; de Vaufleury, A; Niederwanger, M; Capelli, N; Scheifler, R; Dallinger, R				Baurand, Pierre-Emmanuel; Pedrini-Martha, Veronika; de Vaufleury, Annette; Niederwanger, Michael; Capelli, Nicolas; Scheifler, Renaud; Dallinger, Reinhard			Differential Expression of Metallothionein Isoforms in Terrestrial Snail Embryos Reflects Early Life Stage Adaptation to Metal Stress	PLOS ONE			English	Article							MESSENGER-RNA; HELIX-POMATIA; CRASSOSTREA-VIRGINICA; CADMIUM TOXICITY; DIFFERENT ORGANS; GENE; COPPER; CD; EMBRYOGENESIS; ACCUMULATION	The aim of this study was to analyze the expression of three metallothionein (MT) isoform genes (CdMT, CuMT and Cd/CuMT), already known from adults, in the Early Life Stage (ELS) of Cantareus aspersus. This was accomplished by detection of the MT isoform-specific transcription adopting Polymerase Chain Reaction (PCR) amplification and quantitative Real Time (qRT)-PCR of the three MT genes. Freshly laid eggs were kept for 24 hours under control conditions or exposed to three cadmium (Cd) solutions of increasing concentration (5, 10, and 15 mg Cd/L). The transcription of the three MT isoform genes was detected via PCR in 1, 6 and 12-day-old control or Cd-exposed embryos. Moreover, the transcription of this isoform genes during development was followed by qRT-PCR in 6 and 12-day-old embryos. Our results showed that the CdMT and Cd/CuMT genes, but not the CuMT gene, are expressed in embryos at the first day of development. The transcription of the 3 MT genes in control embryos increased with development time, suggesting that the capacities of metal regulation and detoxification may have gradually increased throughout embryogenesis. However in control embryos, the most highly expressed MT gene was that of the Cd/CuMT isoform, whose transcription levels greatly exceeded those of the other two MT genes. This contrasts with the minor significance of this gene in adult snails and suggests that in embryos, this isoform may play a comparatively more important role in metal physiology compared to adult individuals. This function in adult snails appears not to be related to Cd detoxification. Instead, snail embryos responded to Cd exposure by over-expression of the CdMT gene in a concentration-dependent manner, whereas the expression of the Cd/CuMT gene remained unaffected. Moreover, our study demonstrates the ability of snail embryos to respond very early to Cd exposure by up-regulation of the CdMT gene.	[Baurand, Pierre-Emmanuel; de Vaufleury, Annette; Capelli, Nicolas; Scheifler, Renaud] Univ Franche Comte, Chronoenvironm, UMR 6249, F-25030 Besancon, France; [Pedrini-Martha, Veronika; Niederwanger, Michael; Dallinger, Reinhard] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [de Vaufleury, Annette] Dept Hlth Safety Environm, F-70003 Vesoul, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; University of Innsbruck	de Vaufleury, A (corresponding author), Univ Franche Comte, Chronoenvironm, UMR 6249, 16 Route Gray, F-25030 Besancon, France.	annette.devaufleury@univ-fcomte.fr	Scheifler, Renaud/H-2971-2014	Scheifler, Renaud/0000-0002-9620-0204; Pedrini-Martha, Veronika/0000-0003-0941-8174; Niederwanger, Michael/0000-0002-7229-4146	Austrian Science Foundation [P 23635-B20]; Conseil Regional de Franche-Comte; Ecole Doctorale Environnement-Sante; University of Franche-Comte; Austrian Science Fund (FWF) [P 23635] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Conseil Regional de Franche-Comte(Region Bourgogne-Franche-Comte); Ecole Doctorale Environnement-Sante; University of Franche-Comte; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by project No. P 23635-B20 granted by the Austrian Science Foundation to R. Dallinger and the Conseil Regional de Franche-Comte, the Ecole Doctorale Environnement-Sante and the University of Franche-Comte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SK, 2006, BIOCHEM J, V394, P275, DOI 10.1042/BJ20051143; Baurand PE, 2014, ECOTOX ENVIRON SAFE, V110, P89, DOI 10.1016/j.ecoenv.2014.08.017; Baurand PE, 2013, ENVIRON SCI TECHNOL, V47, P9505, DOI 10.1021/es4021519; Blindauer CA, 2010, NAT PROD REP, V27, P720, DOI 10.1039/b906685n; Chabicovsky M, 2004, ENVIRON TOXICOL CHEM, V23, P648, DOI 10.1897/02-617; Chabicovsky M, 2003, TOXICOL APPL PHARM, V190, P25, DOI 10.1016/S0041-008X(03)00148-0; DALLINGER R, 1993, EUR J BIOCHEM, V216, P739, DOI 10.1111/j.1432-1033.1993.tb18193.x; Dallinger R, 2005, AM J PHYSIOL-REG I, V289, pR1185, DOI 10.1152/ajpregu.00052.2005; Dallinger R, 1996, COMP BIOCHEM PHYS C, V113, P125, DOI 10.1016/0742-8413(95)02078-0; Dallinger R, 1997, NATURE, V388, P237, DOI 10.1038/40785; DALLINGER R, 1984, COMP BIOCHEM PHYS C, V79, P117, DOI 10.1016/0742-8413(84)90173-7; DALLINGER R, 1989, MOL CELL BIOCHEM, V85, P135, DOI 10.1007/BF00577109; Druart C, 2012, APPL SOIL ECOL, V53, P56, DOI 10.1016/j.apsoil.2011.11.006; Druart C, 2010, J HAZARD MATER, V184, P26, DOI 10.1016/j.jhazmat.2010.07.099; Durliat M, 1999, INT J DEV BIOL, V43, P575; Egg M, 2009, MOL ECOL, V18, P2426, DOI 10.1111/j.1365-294X.2009.04191.x; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; ENSERINK L, 1990, AQUAT TOXICOL, V17, P15, DOI 10.1016/0166-445X(90)90009-E; Fu CJ, 2006, PROTIST, V157, P193, DOI 10.1016/j.protis.2006.02.006; Geffard O, 2002, ECOTOXICOLOGY, V11, P403, DOI 10.1023/A:1021024415695; Hispard F, 2008, ENVIRON TOXICOL CHEM, V27, P1533, DOI 10.1897/07-232.1; Hockner M, 2011, BIOMETALS, V24, P1079, DOI 10.1007/s10534-011-9466-x; KAGI JHR, 1993, ADV LIF SCI, P29; KAGI JHR, 1991, METHOD ENZYMOL, V205, P613; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Lemoine S, 2000, MAR BIOTECHNOL, V2, P195; Meistertzheim AL, 2009, COMP BIOCHEM PHYS A, V152, P234, DOI 10.1016/j.cbpa.2008.10.004; OLSSON PE, 1990, EUR J BIOCHEM, V193, P229, DOI 10.1111/j.1432-1033.1990.tb19327.x; Palacios O, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-4; Roesijadi G, 1996, TOXICOL APPL PHARM, V140, P356, DOI 10.1006/taap.1996.0231; Roesijadi G, 1997, COMP BIOCHEM PHYS C, V118, P171, DOI 10.1016/S0742-8413(97)00085-6; Roesijadi G, 1997, AQUAT TOXICOL, V39, P185, DOI 10.1016/S0166-445X(97)00037-4; Russo R, 2003, CELL STRESS CHAPERON, V8, P232, DOI 10.1379/1466-1268(2003)008<0232:STCMBM>2.0.CO;2; Russo R, 2013, GENE, V519, P305, DOI 10.1016/j.gene.2013.01.063; Salice CJ, 2002, ENVIRON TOXICOL CHEM, V21, P1398, DOI [10.1002/etc.5620210710, 10.1897/1551-5028(2002)021&lt;1398:RTCAPI&gt;2.0.CO;2]; Scheifler R, 2002, ECOTOX ENVIRON SAFE, V53, P148, DOI 10.1006/eesa.2002.2216; Simoniello P, 2010, J EXP ZOOL PART A, V313A, P410, DOI 10.1002/jez.611	37	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116004	10.1371/journal.pone.0116004	http://dx.doi.org/10.1371/journal.pone.0116004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706953	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100023
J	Berges, A; Bullman, J; Bates, S; Krull, D; Williams, N; Chen, C				Berges, Alienor; Bullman, Jonathan; Bates, Stewart; Krull, David; Williams, Nicola; Chen, Chao			Ozanezumab Dose Selection for Amyotrophic Lateral Sclerosis by Pharmacokinetic-Pharmacodynamic Modelling of Immunohistochemistry Data from Patient Muscle Biopsies	PLOS ONE			English	Article							NOGO; EXPRESSION; CYTOMETRY; MARKER	Amyotrophic Lateral Sclerosis (ALS) is a rare and fatal neurodegenerative disease with a high unmet medical need. In this context, a potential therapy should be brought to patients in the most expeditious way and early exploration of pharmacology is highly beneficial. Ozanezumab, a humanised IgG monoclonal antibody against Nogo-A protein which is an inhibitor of neurite outgrowth, is currently under development for the treatment of ALS and has been recently assessed in 76 patients in a first-in-human study. Inadequate target engagement has been recognised as a major contributing reason for drug trial failures. In this work, we describe the development of a pharmacokinetic-pharmacodynamic (PKPD) model using immunohistochemistry (IHC) data of co-localization of ozanezumab with Nogo-A in skeletal muscle as a surrogate measure of target engagement. The rich plasma concentration data and the sparse IHC data after one or two intravenous doses of ozanezumab were modelled simultaneously using a non-linear mixed-effect approach. The final PKPD model was a two-compartment PK model combined with an effect compartment PD model that accounted for the delay in ozanezumab concentrations to reach the site of action which is skeletal muscle. Diagnostic plots showed a satisfactory fit of both PK and IHC data. The model was used as a simulation tool to design a dose regimen for sustained drug-target co-localization in a phase II study.				nchao.c.chen@gsk.com						AARONS L, 1991, BRIT J CLIN PHARMACO, V32, P669; Beal S, 1989, NONMEM USERS GUIDES; Beghi E, 2007, CURR MED CHEM, V14, P3185, DOI 10.2174/092986707782793862; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Borasio GD, 2001, NEUROL CLIN, V19, P829, DOI 10.1016/S0733-8619(05)70049-9; Cao YG, 2013, J PHARMACOKINET PHAR, V40, P597, DOI 10.1007/s10928-013-9332-2; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Dupuis L, 2002, NEUROBIOL DIS, V10, P358, DOI 10.1006/nbdi.2002.0522; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Hooker AC, 2007, PHARM RES, V24, P2187, DOI 10.1007/s11095-007-9361-x; Jokic N, 2005, ANN NEUROL, V57, P553, DOI 10.1002/ana.20420; Jonsson EN, 1998, PHARMACEUT RES, V15, P1463, DOI 10.1023/A:1011970125687; Jonsson EN, 2002, CLIN PHARMACOL THER, V72, P603, DOI 10.1067/mcp.2002.129307; Karlsson MO, 2007, CLIN PHARMACOL THER, V82, P17, DOI 10.1038/sj.clpt.6100241; Karlsson MO, 1995, J PHARMACOKINET BIOP, V23, P651, DOI 10.1007/BF02353466; Krull DL, 2011, METHOD CELL BIOL, V102, P291, DOI 10.1016/B978-0-12-374912-3.00011-0; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lindbom L, 2004, COMPUT METH PROG BIO, V75, P85, DOI 10.1016/j.cmpb.2003.11.003; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Meininger V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097803; Miller RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub3; Peterson RA, 2008, TOXICOL PATHOL, V36, P117, DOI 10.1177/0192623307312704; Pradat PF, 2012, NEURODEGENER DIS, V9, P38, DOI 10.1159/000329723; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; SHEINER LB, 1979, CLIN PHARMACOL THER, V25, P358; Sheiner LB, 2000, ANNU REV PHARMACOL, V40, P67, DOI 10.1146/annurev.pharmtox.40.1.67; Soetaert K, 2010, JOURNAL OF STATISTIC, V33; Tabrizi M, 2010, AAPS J, V12, P33, DOI 10.1208/s12248-009-9157-5; Talbot Kevin, 2009, Pract Neurol, V9, P303, DOI 10.1136/jnnp.2009.188151	30	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117355	10.1371/journal.pone.0117355	http://dx.doi.org/10.1371/journal.pone.0117355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706882	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100082
J	Chae, MP; Smoll, NR; Hunter-Smith, DJ; Rozen, WM				Chae, Michael P.; Smoll, Nicolas R.; Hunter-Smith, David J.; Rozen, Warren Mattew			Establishing the Natural History and Growth Rate of Ameloblastoma with Implications for Management: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							NONVASCULARIZED BONE-GRAFTS; RECURRENT AMELOBLASTOMA; UNICYSTIC AMELOBLASTOMA; DESMOPLASTIC AMELOBLASTOMA; MANDIBULAR RECONSTRUCTION; MAXILLARY AMELOBLASTOMA; GIGANTIC AMELOBLASTOMA; GIANT AMELOBLASTOMA; HUGE AMELOBLASTOMA; ILIAC CREST	Background Ameloblastoma is the second most common odontogenic tumor, known to be slow-growing, persistent, and locally aggressive. Recent data suggests that ameloblastoma is best treated with wide resection and adequate margins. Following primary excision, bony reconstruction is often necessary for a functional and aesthetically satisfactory outcome, making early diagnosis paramount. Despite earlier diagnosis potentially limiting the extent of resection and reconstruction, an understanding of the growth rate and natural history of ameloblastoma has been notably lacking from the literature. Method A systematic review of the literature was conducted by reviewing relevant articles from PubMed and Web of Science databases. Each article's level of evidence was formally appraised according to the Centre of Evidence Based Medicine (CEBM), with data from each utilized in a meta-analysis of growth rates for ameloblastoma. Results Literature regarding the natural history of ameloblastoma is limited since the tumor is immediately acted upon at its initial detection, unless the patient voluntarily refuses a surgical intervention. From the limited data, it is derived that the highest estimated growth rate is associated with solid, multicystic type and the lowest rate with peripheral ameloblastomas. After meta-analysis, the calculated mean specific grow rate is 87.84% per year. Conclusion The growth rate of ameloblastoma has been demonstrated, offering prognostic and management information, particularly in cases where a delay in management is envisaged.	[Chae, Michael P.; Smoll, Nicolas R.; Hunter-Smith, David J.; Rozen, Warren Mattew] Frankston Hosp, Peninsula Hlth, Dept Plast & Reconstruct Surg, Frankston, Vic, Australia; [Chae, Michael P.; Smoll, Nicolas R.; Hunter-Smith, David J.; Rozen, Warren Mattew] Monash Univ, Dept Surg, Clayton, Vic, Australia; [Chae, Michael P.; Smoll, Nicolas R.; Hunter-Smith, David J.; Rozen, Warren Mattew] Monash Univ, Plast & Reconstruct Surg Unit, Peninsula Clin Sch, Frankston, Vic, Australia; [Rozen, Warren Mattew] James Cook Univ, Sch Clin, Dept Surg, Townsville, Qld 4811, Australia	Frankston Hospital; Monash University; Monash University; James Cook University	Chae, MP (corresponding author), Frankston Hosp, Peninsula Hlth, Dept Plast & Reconstruct Surg, Frankston, Vic, Australia.	mpc25@me.com	Rozen, Warren Matthew/AAE-6296-2022; Hunter-Smith, David James/U-7055-2019; Smoll, Nicolas/D-3322-2013	Rozen, Warren Matthew/0000-0002-4092-182X; Smoll, Nicolas/0000-0002-6923-9701; Hunter-Smith, David/0000-0001-8544-1531; Hunter-Smith, David James/0000-0001-5660-0572				Acharya S, 2011, J CLIN EXP DENT, V3, pe343; ACKERMANN GL, 1988, J ORAL PATHOL MED, V17, P541, DOI 10.1111/j.1600-0714.1988.tb01331.x; ADEKEYE EO, 1986, J MAXILLOFAC SURG, V14, P153, DOI 10.1016/S0301-0503(86)80282-X; BREDENKAMP JK, 1989, ARCH OTOLARYNGOL, V115, P99; Carlson ER, 2006, J ORAL MAXIL SURG, V64, P484, DOI 10.1016/j.joms.2005.11.032; Carlson ER, 2004, J ORAL MAXIL SURG, V62, P1103, DOI 10.1016/j.joms.2004.05.114; Catherine Z, 2013, REV STOMATOL CHIR, V114, P97, DOI 10.1016/j.revsto.2013.01.005; Chauhan DS, 2011, J CLIN IMAG SCI, V1, DOI 10.4103/2156-7514.91134; Curi MM, 1997, ORAL SURG ORAL MED O, V84, P339, DOI 10.1016/S1079-2104(97)90028-7; Dandriyal Ramakant, 2011, Natl J Maxillofac Surg, V2, P22, DOI 10.4103/0975-5950.85849; DARAMOLA JO, 1980, PLAST RECONSTR SURG, V65, P577, DOI 10.1097/00006534-198005000-00006; DAVID DJ, 1988, PLAST RECONSTR SURG, V82, P792, DOI 10.1097/00006534-198811000-00011; De Silva I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047897; Dunn JL, 1997, RADIOGRAPHICS, V17, P531, DOI 10.1148/radiographics.17.2.9084089; Effiom OA, 2011, ORAL SURG ORAL MED O, V111, pE27, DOI 10.1016/j.tripleo.2010.06.021; Escande C, 2009, J CRANIO MAXILL SURG, V37, P363, DOI 10.1016/j.jcms.2009.05.001; Feinberg SE, 1996, ORAL SURG ORAL MED O, V81, P383, DOI 10.1016/S1079-2104(96)80012-6; Forrest LA, 1997, AM J OTOLARYNG, V18, P396; Frantz VK, 1932, ARCH SURG-CHICAGO, V25, P890, DOI 10.1001/archsurg.1932.01160230073006; GARDNER DG, 1980, CANCER, V46, P2514, DOI 10.1002/1097-0142(19801201)46:11<2514::AID-CNCR2820461133>3.0.CO;2-9; GARDNER DG, 1977, CANCER, V39, P1625, DOI 10.1002/1097-0142(197704)39:4<1625::AID-CNCR2820390437>3.0.CO;2-V; Gardner DG, 1996, ORAL SURG ORAL MED O, V82, P660, DOI 10.1016/S1079-2104(96)80441-0; Goletta D, 2006, LANCET ONCOL, V7, P272, DOI 10.1016/S1470-2045(06)70620-9; Gordy F M, 1996, Spec Care Dentist, V16, P199, DOI 10.1111/j.1754-4505.1996.tb00860.x; Handschel J, 2011, IN VIVO, V25, P795; Hata H, 2008, INT J ORAL MAX SURG, V37, P866, DOI 10.1016/j.ijom.2008.04.001; Hayter JP, 1996, INT J ORAL MAX SURG, V25, P3, DOI 10.1016/S0901-5027(96)80004-X; HAYWARD JR, 1973, J ORAL SURG, V31, P368; Hertog D, 2011, ORAL ONCOL, V47, P145, DOI 10.1016/j.oraloncology.2010.11.008; HIDALGO DA, 1995, PLAST RECONSTR SURG, V96, P585, DOI 10.1097/00006534-199509000-00010; HOLLAND PS, 1981, INT J ORAL MAXILLOF, V10, P32; Hong J, 2007, INT J ORAL MAX SURG, V36, P283, DOI 10.1016/j.ijom.2006.11.003; HUFFMAN GG, 1974, J ORAL SURG, V32, P850; Hughes CA, 1999, ENT-EAR NOSE THROAT, V78, P570; Hunasgi S, 2013, CASE REP DENT, V2013, DOI 10.1155/2013/372781; HUVOS AG, 1985, CANCER-AM CANCER SOC, V55, P1244, DOI 10.1002/1097-0142(19850315)55:6<1244::AID-CNCR2820550617>3.0.CO;2-1; KAHN MA, 1989, ORAL SURG ORAL MED O, V67, P706, DOI 10.1016/0030-4220(89)90013-3; KOMISAR A, 1984, HEAD NECK SURG, V7, P172, DOI 10.1002/hed.2890070213; KUNZE E, 1985, PATHOL RES PRACT, V180, P526, DOI 10.1016/S0344-0338(85)80017-0; Li TJ, 2000, AM J SURG PATHOL, V24, P1385, DOI 10.1097/00000478-200010000-00008; Luo DY, 2012, J CRANIO MAXILL SURG, V40, pE470, DOI 10.1016/j.jcms.2012.03.006; MARX RE, 1993, J ORAL MAXIL SURG, V51, P304, DOI 10.1016/S0278-2391(10)80180-6; MEHLISCH DR, 1972, J ORAL SURG, V30, P9; Mehrara E, 2011, BRIT J CANCER, V105, P682, DOI 10.1038/bjc.2011.276; Mehrara E, 2007, CANCER RES, V67, P3970, DOI 10.1158/0008-5472.CAN-06-3822; Mendenhall WM, 2007, AM J CLIN ONCOL-CANC, V30, P645, DOI 10.1097/COC.0b013e3181573e59; Mijiti A, 2013, J PLAST RECONSTR AES, V66, P1440, DOI 10.1016/j.bjps.2013.04.051; MILLARD DR, 1969, AM J SURG, V118, P726, DOI 10.1016/0002-9610(69)90219-0; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mukhopadhyay S, 2005, INDIAN J OTOLARYNGOL, V57, P247, DOI 10.1007/BF03008023; MULLER H, 1985, J MAXILLOFAC SURG, V13, P79, DOI 10.1016/S0301-0503(85)80021-7; Nakamura N, 2002, ORAL SURG ORAL MED O, V93, P13, DOI 10.1067/moe.2002.119517; NAKASATO S, 1991, J ORAL MAXIL SURG, V49, P764, DOI 10.1016/S0278-2391(10)80246-0; NASTRI AL, 1995, BRIT J ORAL MAX SURG, V33, P28, DOI 10.1016/0266-4356(95)90082-9; Odukoya O, 2008, Niger Postgrad Med J, V15, P1; OKA K, 1986, CLIN NEUROL NEUROSUR, V88, P303, DOI 10.1016/S0303-8467(86)80051-8; Ony NRN, 2012, CLIN IMAG, V36, P146, DOI 10.1016/j.clinimag.2011.06.009; OSAKI T, 1985, INT J ORAL MAXILLOF, V14, P302, DOI 10.1016/S0300-9785(85)80045-4; Ota Y, 2012, J ORAL MAXIL SURG, V70, P1380, DOI 10.1016/j.joms.2011.06.003; Philipsen HP, 1998, ORAL ONCOL, V34, P317, DOI 10.1016/S1368-8375(98)00012-8; Pogrel MA, 2009, INT J ORAL MAX SURG, V38, P807, DOI 10.1016/j.ijom.2009.02.018; POGREL MA, 1993, J ORAL MAXIL SURG, V51, P269; Pogrel MA, 1997, J ORAL MAXIL SURG, V55, P1200, DOI 10.1016/S0278-2391(97)90165-8; PRAMULIO T H S, 1985, Australasian Radiology, V29, P308, DOI 10.1111/j.1440-1673.1985.tb01720.x; RAMBO VB, 1977, JAMA-J AM MED ASSOC, V238, P418; REICHART PA, 1995, ORAL ONCOL, V31B, P86; ROBINSON L, 1977, CANCER, V40, P2278, DOI 10.1002/1097-0142(197711)40:5<2278::AID-CNCR2820400539>3.0.CO;2-L; Ruiz Valero CA, 2013, J ORAL MAXILLOFAC SU, DOI [10.1016/j.joms.2013.11.012, DOI 10.1016/J.JOMS.2013.11.012]; SALMASSY DA, 1995, J ORAL MAXIL SURG, V53, P784, DOI 10.1016/0278-2391(95)90333-X; Sampson DE, 1999, J ORAL MAXIL SURG, V57, P1074, DOI 10.1016/S0278-2391(99)90328-2; SEHDEV MK, 1974, CANCER-AM CANCER SOC, V33, P324, DOI 10.1002/1097-0142(197402)33:2<324::AID-CNCR2820330205>3.0.CO;2-U; SERAFIN D, 1977, BRIT J PLAST SURG, V30, P263, DOI 10.1016/0007-1226(77)90113-8; Simon ENM, 2013, INT J ORAL MAX SURG, V42, P106, DOI 10.1016/j.ijom.2012.07.010; Stoelinga PJW, 2005, J ORAL MAXIL SURG, V63, P1662, DOI 10.1016/j.joms.2005.08.007; SULLIVAN MJ, 1989, ARCH OTOLARYNGOL, V115, P1334; TAYLOR GI, 1982, ANN PLAS SURG, V9, P361, DOI 10.1097/00000637-198211000-00003; UENO S, 1989, J ORAL MAXIL SURG, V47, P11, DOI 10.1016/0278-2391(89)90116-X; UEYAMA Y, 1995, J CRANIO MAXILL SURG, V23, P47, DOI 10.1016/S1010-5182(05)80255-0; van Gemert JTM, 2009, J ORAL MAXIL SURG, V67, P1446, DOI 10.1016/j.joms.2008.12.052; VAUGHAN ED, 1994, INT J ORAL MAX SURG, V23, P194, DOI 10.1016/S0901-5027(05)80370-4; Vu DD, 2008, J ORAL MAXIL SURG, V66, P1856, DOI 10.1016/j.joms.2008.04.021; Yilmaz M, 2008, J CRANIOFAC SURG, V19, P227, DOI 10.1097/scs.0b013e31815c942c	82	25	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117241	10.1371/journal.pone.0117241	http://dx.doi.org/10.1371/journal.pone.0117241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706407	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000350662100068
J	McGrath-Morrow, SA; Hayashi, M; Aherrera, A; Lopez, A; Malinina, A; Collaco, JM; Neptune, E; Klein, JD; Winickoff, JP; Breysse, P; Lazarus, P; Chen, G				McGrath-Morrow, Sharon A.; Hayashi, Madoka; Aherrera, Angela; Lopez, Armando; Malinina, Alla; Collaco, Joseph M.; Neptune, Enid; Klein, Jonathan D.; Winickoff, Jonathan P.; Breysse, Patrick; Lazarus, Philip; Chen, Gang			The Effects of Electronic Cigarette Emissions on Systemic Cotinine Levels, Weight and Postnatal Lung Growth in Neonatal Mice	PLOS ONE			English	Article							TOBACCO EXPOSURE; SMOKING; VAPORS; IMPACT	Background/Objective Electronic cigarette (E-cigarettes) emissions present a potentially new hazard to neonates through inhalation, dermal and oral contact. Exposure to nicotine containing E-cigarettes may cause significant systemic absorption in neonates due to the potential for multi-route exposure. Systemic absorption of nicotine and constituents of E-cigarette emissions may adversely impact weight and lung development in the neonate. To address these questions we exposed neonatal mice to E-cigarette emissions and measured systemic cotinine levels and alveolar lung growth. Methods/Main Results Neonatal mice were exposed to E-cigarettes for the first 10 days of life. E-cigarette cartridges contained either 1.8% nicotine in propylene glycol (PG) or PG vehicle alone. Daily weights, plasma and urine cotinine levels and lung growth using the alveolar mean linear intercept (MLI) method were measured at 10 days of life and compared to room air controls. Mice exposed to 1.8% nicotine/PG had a 13.3% decrease in total body weight compared to room air controls. Plasma cotinine levels were found to be elevated in neonatal mice exposed to 1.8% nicotine/PG E-cigarettes (mean 62.34 +/- 3.3 ng/ml). After adjusting for sex and weight, the nicotine exposed mice were found to have modestly impaired lung growth by MLI compared to room air control mice (p<.054 trial 1; p<.006 trial 2). These studies indicate that exposure to E-cigarette emissions during the neonatal period can adversely impact weight gain. In addition exposure to nicotine containing E-cigarettes can cause detectable levels of systemic cotinine, diminished alveolar cell proliferation and a modest impairment in postnatal lung growth.	[McGrath-Morrow, Sharon A.; Hayashi, Madoka; Aherrera, Angela; Lopez, Armando; Collaco, Joseph M.] Johns Hopkins Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD 21209 USA; [McGrath-Morrow, Sharon A.; Collaco, Joseph M.; Klein, Jonathan D.; Winickoff, Jonathan P.; Breysse, Patrick] Amer Acad Pediat, Julius B Richmond Ctr Excellence, Elk Grove Village, IL USA; [Lopez, Armando; Malinina, Alla; Neptune, Enid] Johns Hopkins Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Winickoff, Jonathan P.] Massachusetts Gen Hosp, Div Gen Pediat, Boston, MA 02114 USA; [Winickoff, Jonathan P.] Harvard Univ, Sch Med, Boston, MA USA; [Breysse, Patrick] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lazarus, Philip; Chen, Gang] Washington State Univ, Dept Pharmacol, Spokane, WA USA	Johns Hopkins University; Johns Hopkins Medicine; American Academy of Pediatrics; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Washington State University	McGrath-Morrow, SA (corresponding author), Johns Hopkins Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD 21209 USA.	smcgrath@jhmi.edu		Klein, Jonathan/0000-0003-4185-1998	Center of Excellence Grant from the Flight Attendant Medical Research Institute; NIH [RHL114800A]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025460] Funding Source: NIH RePORTER	Center of Excellence Grant from the Flight Attendant Medical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by a Center of Excellence Grant to the American Academy of Pediatrics from the Flight Attendant Medical Research Institute and NIH RHL114800A (Sharon McGrath-Morrow). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadori B, 2013, MED HYPOTHESES, V81, P582, DOI [10.1016/j.mehy.2013.07.007, 10.1016/j.mehy.]; Ballbe M, 2014, ENVIRON RES, V135, P76, DOI 10.1016/j.envres.2014.09.005; Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P15; Czogala J, 2014, NICOTINE TOB RES, V16, P655, DOI 10.1093/ntr/ntt203; Dempsey D, 2000, CLIN PHARMACOL THER, V67, P458, DOI 10.1067/mcp.2000.106129; Drummond M Bradley, 2014, Ann Am Thorac Soc, V11, P236, DOI 10.1513/AnnalsATS.201311-391FR; Flouris AD, 2013, INHAL TOXICOL, V25, P91, DOI 10.3109/08958378.2012.758197; Goniewicz ML, 2014, NICOTINE TOB RES; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; HALBOWER AC, 1994, LAB INVEST, V71, P149; Heller DS, 2003, INT J GYNECOL CANCER, V13, P303, DOI 10.1046/j.1525-1438.2003.13201.x; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Ijomone Omamuyovwi Meashack, 2014, Pathophysiology, V21, P185, DOI 10.1016/j.pathophys.2014.08.003; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Lambers DS, 1996, SEMIN PERINATOL, V20, P115, DOI 10.1016/S0146-0005(96)80079-6; Li SS, 2012, J ASTHMA, V49, P895, DOI 10.3109/02770903.2012.724129; Mancini AJ, 2004, PEDIATRICS, V113, P1114; Maritz GS, 2011, EXP LUNG RES, V37, P57, DOI 10.3109/01902148.2010.515650; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; McMillen Robert C., 2014, NICOTINE TOB RES; Miller MD, 2010, ENVIRON HEALTH PERSP, V118, P1155, DOI 10.1289/ehp.0901856; Mund SI, 2008, DEV DYNAM, V237, P2108, DOI 10.1002/dvdy.21633; Murphy SE, 2013, J EXPO SCI ENV EPID, V23, P513, DOI 10.1038/jes.2013.7; Petre MA, 2011, INT J TOXICOL, V30, P244, DOI 10.1177/1091581810395332; Roosli M, 2011, PROG BIOPHYS MOL BIO, V107, P315, DOI 10.1016/j.pbiomolbio.2011.08.006; SCHULTEHOBEIN B, 1992, ACTA PAEDIATR, V81, P550, DOI 10.1111/j.1651-2227.1992.tb12293.x; Sly PD, 2008, ANN NY ACAD SCI, V1140, P163, DOI 10.1196/annals.1454.017; Spector LG, 2014, PEDIATRICS, V133, pE1632, DOI 10.1542/peds.2013-3118; Valcke M, 2011, REGUL TOXICOL PHARM, V59, P258, DOI 10.1016/j.yrtph.2010.10.008; Wall DM, 2014, CELL MICROBIOL, V16, P1746, DOI 10.1111/cmi.12368; Xue JP, 2007, RISK ANAL, V27, P411, DOI 10.1111/j.1539-6924.2007.00893.x; Zhang YP, 2013, NICOTINE TOB RES, V15, P501, DOI 10.1093/ntr/nts165	33	105	107	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118344	10.1371/journal.pone.0118344	http://dx.doi.org/10.1371/journal.pone.0118344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706869	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100172
J	Vanthournout, B; Hendrickx, F				Vanthournout, Bram; Hendrickx, Frederik			Endosymbiont Dominated Bacterial Communities in a Dwarf Spider	PLOS ONE			English	Article							MALE-KILLING BACTERIA; WOLBACHIA-PIPIENTIS; BROWN SPIDER; SEX-RATIO; INSECTS; INFECTIONS; CHLAMYDIAE; DIVERSITY; PATHOGEN; SEQUENCE	The microbial community of spiders is little known, with previous studies focussing primarily on the medical importance of spiders as vectors of pathogenic bacteria and on the screening of known cytoplasmic endosymbiont bacteria. These screening studies have been performed by means of specific primers that only amplify a selective set of endosymbionts, hampering the detection of unreported species in spiders. In order to have a more complete overview of the bacterial species that can be present in spiders, we applied a combination of a cloning assay, DGGE profiling and high-throughput sequencing on multiple individuals of the dwarf spider Oedothorax gibbosus. This revealed a co-infection of at least three known (Wolbachia, Rickettsia and Cardinium) and the detection of a previously unreported endosymbiont bacterium (Rhabdochlamydia) in spiders. 16S rRNA gene sequences of Rhabdochlamydia matched closely with those of Candidatus R. porcellionis, which is currently only reported as a pathogen from a woodlouse and with Candidatus R. crassificans reported from a cockroach. Remarkably, this bacterium appears to present in very high proportions in one of the two populations only, with all investigated females being infected. We also recovered Acinetobacter in high abundance in one individual. In total, more than 99% of approximately 4.5M high-throughput sequencing reads were restricted to these five bacterial species. In contrast to previously reported screening studies of terrestrial arthropods, our results suggest that the bacterial communities in this spider species are dominated by, or even restricted to endosymbiont bacteria. Given the high prevalence of endosymbiont species in spiders, this bacterial community pattern could be widespread in the Araneae order.	[Vanthournout, Bram] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Hendrickx, Frederik] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Hendrickx, Frederik] Univ Ghent, Dept Biol, Terr Ecol Unit TEREC, B-9000 Ghent, Belgium	Aarhus University; Royal Belgian Institute of Natural Sciences; Ghent University	Vanthournout, B (corresponding author), Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark.	bvthourn@bios.au.dk	Hendrickx, Frederik/F-3149-2013	Vanthournout, Bram/0000-0001-6198-9092	agency for Innovation by Science and Technology (IWT grant) [73344]; Belgian Science Policy (BELSPO) [MO/36/O25]	agency for Innovation by Science and Technology (IWT grant)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office)	Bram Vanthournout is holder of a PhD scholarship grant from the agency for Innovation by Science and Technology (IWT grant no 73344). Additional financial support was received from the Belgian Science Policy (BELSPO, research project MO/36/O25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhoundi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050259; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Baxtrom C, 2006, J MED ENTOMOL, V43, P962, DOI 10.1603/0022-2585(2006)43[962:CHSANL]2.0.CO;2; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Corsaro D, 2007, SYST APPL MICROBIOL, V30, P221, DOI 10.1016/j.syapm.2006.06.001; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Cowdry EV, 1923, J EXP MED, V37, P431, DOI 10.1084/jem.37.4.431; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Duron O, 2008, MOL ECOL, P1, DOI [10.1111/j.1365-294X.2007, DOI 10.1111/J.1365-294X.2007]; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Engelstadter J, 2007, GENETICS, V175, P245, DOI 10.1534/genetics.106.060921; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Gaver-Wainwright MM, 2011, J MED ENTOMOL, V48, P382, DOI 10.1603/ME09224; Geiger A, 2009, INFECT GENET EVOL, V9, P1364, DOI 10.1016/j.meegid.2009.09.013; Goodacre SL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-32; Goodacre SL, 2006, MOL ECOL, V15, P517, DOI 10.1111/j.1365-294X.2005.02802.x; Gunnarsson B, 2009, BIOL J LINN SOC, V98, P181, DOI 10.1111/j.1095-8312.2009.01247.x; Haupt J, 2002, FUNGAL RICKETTSIAL I; Hirsch J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S6; Hollants J, 2010, SYMBIOSIS, V51, P131, DOI 10.1007/s13199-010-0068-0; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 2000, GENETICS, V156, P699; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kostanjsek R, 2004, INT J SYST EVOL MICR, V54, P543, DOI 10.1099/ijs.0.02802-0; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin OY, 2009, J ARACHNOL, V37, P106, DOI 10.1636/SH08-05.1; Mascarelli PE, 2013, PARASITES VECTORS, V6; Monteiro CLB, 2002, TOXICON, V40, P409, DOI 10.1016/S0041-0101(01)00209-4; Curley CM, 2007, ANN ENTOMOL SOC AM, V100, P345, DOI 10.1603/0013-8746(2007)100[345:EFFEOG]2.0.CO;2; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; MOREL G, 1976, J INVERTEBR PATHOL, V28, P167, DOI 10.1016/0022-2011(76)90118-X; MOREL G, 1977, ANN INST PASTEUR MIC, VA128, P49; MOREL G, 1978, EXPERIENTIA, V34, P344, DOI 10.1007/BF01923025; Murrell A, 2003, PARASITOL RES, V89, P326, DOI 10.1007/s00436-002-0722-4; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3111, DOI 10.1093/nar/13.9.3111; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; OSAKI H, 1973, Acta Arachnologica, V25, P23, DOI 10.2476/asjaa.25.23; Palavesam A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049493, 10.1371/journal.pone.0044390]; Reid NM, 2011, APPL ENVIRON MICROB, V77, P7000, DOI 10.1128/AEM.05609-11; Rowley SM, 2004, CURR MICROBIOL, V49, P208, DOI 10.1007/s00284-004-4346-z; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; Silvestre FG, 2005, TOXICON, V46, P927, DOI 10.1016/j.toxicon.2005.09.002; Smith JE, 2009, PARASITOLOGY, V136, P1901, DOI 10.1017/S0031182009991818; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor M, 2012, FEMS IMMUNOL MED MIC, V64, P21, DOI 10.1111/j.1574-695X.2011.00916.x; Temmerman R, 2003, APPL ENVIRON MICROB, V69, P220, DOI 10.1128/AEM.69.1.220-226.2003; Thao ML, 2003, CURR MICROBIOL, V47, P46, DOI 10.1007/s00284-002-3953-9; Towner KJ, 1991, FEMS S; Unckless RL, 2009, P ROY SOC B-BIOL SCI, V276, P2805, DOI 10.1098/rspb.2009.0287; Vanthournout B, 2014, J ARACHNOL, V42, P24, DOI 10.1636/Hi12-37.1; Vanthournout B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-15; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JA, 2011, BIOESSAYS, V33, P823, DOI 10.1002/bies.201100095; Zheng LY, 2013, J MED ENTOMOL, V50, P647, DOI 10.1603/ME12199; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388	67	26	29	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117297	10.1371/journal.pone.0117297	http://dx.doi.org/10.1371/journal.pone.0117297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706947	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100073
J	Lyu, Y; Su, XY; Deng, JN; Liu, SX; Zou, LQ; Zhao, XJ; Wei, SN; Geng, B; Xu, GH				Lyu, Ying; Su, Xueying; Deng, Jingna; Liu, Shangxin; Zou, Liangqiang; Zhao, Xiaojing; Wei, Suning; Geng, Bin; Xu, Guoheng			Defective Differentiation of Adipose Precursor Cells from Lipodystrophic Mice Lacking Perilipin 1	PLOS ONE			English	Article							FAMILIAL PARTIAL LIPODYSTROPHY; PRIMARY RAT ADIPOCYTES; LIPID DROPLETS; IN-VIVO; GENERALIZED LIPODYSTROPHY; PROGENITOR CELLS; GENE-EXPRESSION; UP-REGULATION; TISSUE; LIPOLYSIS	Perilipin 1 (Plin1) localizes at the surface of lipid droplets to regulate triglyceride storage and hydrolysis in adipocytes. Plin1 defect leads to low adiposity in mice and partial lipodystrophy in human. This study investigated the roles of Plin1 in adipocyte differentiation. Plin1 null (-/-) mice showed plenty of multilocular adipocytes and small unilocular adipocytes in adipose tissue, along with lack of a subpopulation of adipose progenitor cells capable of in vivo adipogenesis and along with downregulation of adipogenic pathway. Before initiation of differentiation, adipose stromal-vascular cells (SVCs) from Plin1-/-mice already accumulated numerous tiny lipid droplets, which increased in number and size during the first 12-h induction but thereafter became disappeared at day 1 of differentiation. The adipogenic signaling was dysregulated despite protein level of PPAR. was near normal in Plin1-/-SVCs like in Plin1-/-adipose tissue. Heterozygous Plin1+/-SVCs were able to develop lipid droplets, with both the number and size more than in Plin1-/-SVCs but less than in Plin1+/+ SVCs, indicating that Plin1 haploinsufficiency accounts for attenuated adipogenesis. Aberrant lipid droplet growth and differentiation of Plin1-/-SVCs were rescued by adenoviral Plin1 expression and were ameliorated by enhanced or prolonged adipogenic stimulation. Our finding suggests that Plin1 plays an important role in adipocyte differentiation and provides an insight into the pathology of partial lipodystrophy in patients with Plin1 mutation.	[Lyu, Ying; Su, Xueying; Deng, Jingna; Liu, Shangxin; Zou, Liangqiang; Zhao, Xiaojing; Wei, Suning; Geng, Bin; Xu, Guoheng] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China	Peking University	Xu, GH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China.	xug@bjmu.edu.cn	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710	National Natural Science Foundation of China [91439119]; Beijing Natural Science Foundation [7152080]; National Basic Research Program of China [2012CB517505, 2012CB517806]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China [91439119] (to GX) and by Beijing Natural Science Foundation [7152080 to GX] and by the National Basic Research Program of China [2012CB517505 to GX, 2012CB517806 to BG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Castro-Chavez F, 2003, DIABETES, V52, P2666, DOI 10.2337/diabetes.52.11.2666; Chen WQ, 2009, ENDOCRINOLOGY, V150, P4552, DOI 10.1210/en.2009-0236; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Fei WH, 2011, TRENDS ENDOCRIN MET, V22, P204, DOI 10.1016/j.tem.2011.02.004; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Garg Abhimanyu, 2006, Clin Cornerstone, V8 Suppl 4, pS7, DOI 10.1016/S1098-3597(06)80039-6; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Hausman Dorothy B., 2008, V456, P201, DOI 10.1007/978-1-59745-245-8_15; He JH, 2006, BBA-MOL CELL BIOL L, V1761, P247, DOI 10.1016/j.bbalip.2006.02.001; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037, DOI 10.1152/ajpendo.2001.281.5.E1037; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-446; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Maumus M, 2008, J CLIN ENDOCR METAB, V93, P4098, DOI 10.1210/jc.2008-0044; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sawada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014006; SPIEGELMAN BM, 1980, J BIOL CHEM, V255, P8811; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Wang SM, 2003, HISTOCHEM CELL BIOL, V120, P285, DOI 10.1007/s00418-003-0575-7; WIEDERER O, 1987, J LIPID RES, V28, P649; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Zhai W, 2010, HORM METAB RES, V42, P247, DOI 10.1055/s-0029-1243599; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	51	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117536	10.1371/journal.pone.0117536	http://dx.doi.org/10.1371/journal.pone.0117536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695774	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300023
J	He, XG; Zou, HD; Lu, L; Zhao, R; Zhao, HJ; Li, QQ; Zhu, JF				He, Xiangui; Zou, Haidong; Lu, Lina; Zhao, Rong; Zhao, Huijuan; Li, Qiangqiang; Zhu, Jianfeng			Axial Length/Corneal Radius Ratio: Association with Refractive State and Role on Myopia Detection Combined with Visual Acuity in Chinese Schoolchildren	PLOS ONE			English	Article							OCULAR COMPONENTS; CHILDHOOD MYOPIA; RISK-FACTORS; CHILDREN; LENGTH; EYE; PREVALENCE; ERROR; PARAMETERS; ONSET	Purpose To evaluate the association between the AL/CR ratio and refractive state and explore the effectiveness of this ratio in the assessment of myopia, especially when combined with uncorrected visual acuity in schoolchildren among whom myopia is common. Methods Cross sectional study. 4686 children from 6 primary schools, aged from 6 to 12 years were selected using the clusteredstratified random sampling method. Uncorrected visual acuity (UCVA), axial length (AL), corneal radius of curvature (CR), and cycloplegic refraction were tested. Refraction was measured as the spherical equivalent (SE). Results 3922 children were included in the analysis. The mean AL/CR ratio was 2.973 +/- 0.002, increased with age, and different in gender. The coefficients of correlations of the SE with the AL/CR ratio, AL, and CR were -0.811, -0.657, and 0.095, respectively. Linear regression showed a 10.72 D shift towards myopia with every 1 unit increase in the AL/CR ratio (P <0.001, r(2) = 66.4%). The estimated SE values obtained by substituting the AL/CR ratio and gender back to the regression model that were within a difference of +/- 0.50 D in ATE/LER (allowable total error and limits for erroneous results) zones compared to the actual measured values was 51%. The area under the ROC curve of the AL/CR ratio, AL, and UCVA for myopia detection were 0.910, 0.822, and 0.889, respectively, and the differences between each pair were statistically significant (P <0.01). At a specificity of 90%, the sensitivities were 72.98%, 50.50%, 71.99%, and 82.96%, respectively, for the AL/CR ratio, AL, UCVA, and the combination of the AL/CR ratio and UCVA. Conclusions The AL/CR ratio was found to explain the total variance in SE better than AL alone. The effectiveness of the AL/CR ratio was statistically significantly better than UCVA for detecting myopia in children, and combining the two produced increased sensitivity without significantly decreasing specificity.	[He, Xiangui; Zou, Haidong; Lu, Lina; Zhao, Rong; Zhu, Jianfeng] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Eye Dis Prevent, Shanghai, Peoples R China; [Zou, Haidong] Affiliated Shanghai Jiaotong Univ, Shanghai Peoples 1, Dept Ophthalmol, Shanghai, Peoples R China; [Zhao, Huijuan; Li, Qiangqiang] Baoshan Ctr Dis Prevent & Control, Dept Sch Hlth, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zhu, JF (corresponding author), Shanghai Eye Dis Prevent & Treatment Ctr, Dept Eye Dis Prevent, Shanghai, Peoples R China.	jfzhu1974@hotmail.com		Zou, Haidong/0000-0002-6831-7560	Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System [2011-15]; Shanghai Municipal Health Bureau [2010Y113]	Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System; Shanghai Municipal Health Bureau	This study was supported by Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System (2011-2013) (Grant NO. 2011-15) and Research Fund for Young Medical Staff (Grant NO. 2010Y113) from Shanghai Municipal Health Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMIN B, 1957, Spec Rep Ser Med Res Counc (G B), V11, P1; Cheng SCK, 2013, OPHTHAL PHYSL OPT, V33, P652, DOI 10.1111/opo.12082; Chu Ren-Yuan, 2009, Zhonghua Yan Ke Za Zhi, V45, P577; COOK RC, 1951, AM J OPHTHALMOL, V34, P1407, DOI 10.1016/0002-9394(51)90481-3; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; Blanco FG, 2008, OPTOMETRY VISION SCI, V85, P89, DOI 10.1097/OPX.0b013e3181622602; GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785; Goss DA, 1995, OPTOMETRY VISION SCI, V72, P870, DOI 10.1097/00006324-199512000-00005; GROSVENOR T, 1994, OPTOMETRY VISION SCI, V71, P573, DOI 10.1097/00006324-199409000-00005; GROSVENOR T, 1988, AM J OPTOM PHYS OPT, V65, P689; Grosvenor T, 1998, OPTOMETRY VISION SCI, V75, P132, DOI 10.1097/00006324-199802000-00017; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; Hamasaki I, 2007, JPN J OPHTHALMOL, V51, P111, DOI 10.1007/s10384-006-0400-7; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2009, OPTOMETRY VISION SCI, V86, P40, DOI 10.1097/OPX.0b013e3181940719; Hiraoka T, 2012, INVEST OPHTH VIS SCI, V53, P3913, DOI 10.1167/iovs.11-8453; Ip JM, 2008, EYE, V22, P649, DOI 10.1038/sj.eye.6702701; Ip JM, 2007, INVEST OPHTH VIS SCI, V48, P4846, DOI 10.1167/iovs.07-0101; Iribarren R, 2012, INVEST OPHTH VIS SCI, V53, P5124, DOI 10.1167/iovs.12-9637; Iyamu Eghosasere, 2011, ISRN Ophthalmol, V2011, P138941, DOI 10.5402/2011/138941; Jones LA, 2005, INVEST OPHTH VIS SCI, V46, P2317, DOI 10.1167/iovs.04-0945; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Kimura S, 2007, JPN J OPHTHALMOL, V51, P105, DOI 10.1007/s10384-006-0410-5; Lai YH, 2013, OPHTHALMOLOGY, V120, P271, DOI 10.1016/j.ophtha.2012.08.009; LARSEN JS, 1971, ACTA OPHTHALMOL, V49, P873; Leone JF, 2010, ARCH OPHTHALMOL-CHIC, V128, P894, DOI 10.1001/archophthalmol.2010.134; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Ma YY, 2013, OPTOMETRY VISION SCI, V90, P1479, DOI 10.1097/OPX.0000000000000095; Manny RE, 2001, INVEST OPHTH VIS SCI, V42, P1728; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; MUTTI DO, 1995, VISION RES, V35, P1345, DOI 10.1016/0042-6989(94)00225-B; Mutti DO, 2007, INVEST OPHTH VIS SCI, V48, P2510, DOI 10.1167/iovs.06-0562; Mutti DO, 2012, OPTOMETRY VISION SCI, V89, P251, DOI 10.1097/OPX.0b013e3182418213; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; O'Donoghue L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034441; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P4424, DOI 10.1167/iovs.05-0077; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P2748, DOI 10.1167/iovs.04-1324; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P361, DOI 10.1111/j.1600-0420.2006.00847.x; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Schmidt P, 2004, OPHTHALMOLOGY, V111, P637, DOI 10.1016/j.ophtha.2004.01.022; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Song YY, 2011, J OCUL PHARMACOL TH, V27, P361, DOI 10.1089/jop.2011.0017; STENSTROM SOLVE, 1948, AMER JOUR OPTOM, V25, P218; Twelker JD, 2009, OPTOMETRY VISION SCI, V86, P918, DOI 10.1097/OPX.0b013e3181b2f903; van ALPHEN G, 1961, Opt Acta (Lond), V142(Suppl), P1; Vision in Preschoolers (VIP) Study Group, 2005, INVEST OPHTH VIS SCI, V46; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Xiang F, 2012, OPHTHALMOLOGY, V119, P1478, DOI 10.1016/j.ophtha.2012.01.017; Yebra-Pimentel E, 2004, Arch Soc Esp Oftalmol, V79, P317; Zadnik K, 1999, INVEST OPHTH VIS SCI, V40, P1936; ZADNIK K, 1993, OPTOMETRY VISION SCI, V70, P750, DOI 10.1097/00006324-199309000-00012; Zadnik K, 2003, OPTOMETRY VISION SCI, V80, P226, DOI 10.1097/00006324-200303000-00012; Zhang J, 2011, ARCH OPHTHALMOL-CHIC, V129, P63, DOI 10.1001/archophthalmol.2010.323; Zhou YH, 2011, J CLIN LAB ANAL, V25, P83, DOI 10.1002/jcla.20437	60	46	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0111766	10.1371/journal.pone.0111766	http://dx.doi.org/10.1371/journal.pone.0111766			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693186	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500002
J	Hoskins, AJ; Costa, DP; Arnould, JPY				Hoskins, Andrew J.; Costa, Daniel P.; Arnould, John P. Y.			Utilisation of Intensive Foraging Zones by Female Australian Fur Seals	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; SOUTHERN ELEPHANT SEALS; LIONS PHOCARCTOS-HOOKERI; AEROBIC DIVE LIMIT; OPTIMAL PATCH USE; 1ST PASSAGE TIME; MARINE PREDATOR; DIVING BEHAVIOR; 1ST-PASSAGE TIME; HABITAT USE	Within a heterogeneous environment, animals must efficiently locate and utilise foraging patches. One way animals can achieve this is by increasing residency times in areas where foraging success is highest (area-restricted search). For air-breathing diving predators, increased patch residency times can be achieved by altering both surface movements and diving patterns. The current study aimed to spatially identify the areas where female Australian fur seals allocated the most foraging effort, while simultaneously determining the behavioural changes that occur when they increase their foraging intensity. To achieve this, foraging behaviour was successfully recorded with a FastLoc GPS logger and dive behaviour recorder from 29 individual females provisioning pups. Females travelled an average of 118 +/- 50 km from their colony during foraging trips that lasted 7.3 +/- 3.4 days. Comparison of two methods for calculating foraging intensity (first-passage time and first-passage time modified to include diving behaviour) determined that, due to extended surface intervals where individuals did not travel, inclusion of diving behaviour into foraging analyses was important for this species. Foraging intensity 'hot spots' were found to exist in a mosaic of patches within the Bass Basin, primarily to the south-west of the colony. However, the composition of benthic habitat being targeted remains unclear. When increasing their foraging intensity, individuals tended to perform dives around 148 s or greater, with descent/ascent rates of approximately 1.9 m.s(-1) or greater and reduced postdive durations. This suggests individuals were maximising their time within the benthic foraging zone. Furthermore, individuals increased tortuosity and decreased travel speeds while at the surface to maximise their time within a foraging location. These results suggest Australian fur seals will modify both surface movements and diving behaviour to maximise their time within a foraging patch.	[Hoskins, Andrew J.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia; [Costa, Daniel P.] Univ Calif Santa Cruz, Ctr Ocean Hlth, Santa Cruz, CA 95060 USA	Deakin University; University of California System; University of California Santa Cruz	Hoskins, AJ (corresponding author), Deakin Univ, Sch Life & Environm Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia.	Andrew.Hoskins@csiro.au	Hoskins, Andrew/T-2694-2019; Costa, Daniel/E-2616-2013	Hoskins, Andrew/0000-0001-8907-6682; Costa, Daniel/0000-0002-0233-5782	Australian Research Council; Winnifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment	Australian Research Council(Australian Research Council); Winnifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment	This project was support by research funding received from the Australian Research Council, Winnifred Violet Scott Charitable Trust and the Holsworth Wildlife Research Endowment. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, BIOSPHERE CONSERVATI; Arnould JPY, 2006, LOW WAKE FI, P309; Arnould JPY, 2011, MAR ECOL PROG SER, V422, P291, DOI 10.3354/meps08933; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Auge AA, 2011, CAN J ZOOL, V89, P1195, DOI 10.1139/Z11-098; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bailleul F, 2010, ECOL MODEL, V221, P1665, DOI 10.1016/j.ecolmodel.2010.04.001; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Barry J.P., 1991, Ecological Studies, P270; Baylis AMM, 2008, CAN J ZOOL, V86, P774, DOI 10.1139/Z08-055; Bhattacharyya A, 1946, SANKHYA, V7, P401; BOVET P, 1991, ANIM BEHAV, V42, P57, DOI 10.1016/S0003-3472(05)80605-0; BOYD IL, 1991, J ANIM ECOL, V60, P577, DOI 10.2307/5299; BOYD IL, 1994, J ANIM ECOL, V63, P703, DOI 10.2307/5235; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Chilvers BL, 2009, NEW ZEAL J ECOL, V33, P106; Cook TR, 2008, ANIM BEHAV, V76, P565, DOI 10.1016/j.anbehav.2008.02.010; Costa DP, 2001, COMP BIOCHEM PHYS A, V129, P771, DOI 10.1016/S1095-6433(01)00346-4; Costa DP, 2000, J EXP BIOL, V203, P3655; de Bruyn PJN, 2009, MAR ECOL PROG SER, V394, P263, DOI 10.3354/meps08292; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dorville N, 2013, THESIS; Dragon AC, 2010, PROG OCEANOGR, V87, P61, DOI 10.1016/j.pocean.2010.09.025; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; FELDKAMP SD, 1987, J EXP BIOL, V131, P117; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Gales NJ, 1998, MAR MAMMAL SCI, V14, P355, DOI 10.1111/j.1748-7692.1998.tb00727.x; Goldsworthy SD, 2010, MAR ECOL PROG SER, V409, P255, DOI 10.3354/meps08611; Hoskins AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079484; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; KASPARI M, 1991, OIKOS, V60, P307, DOI 10.2307/3545072; Kirkwood R, 2008, MAR ECOL PROG SER, V369, P297, DOI 10.3354/meps07633; Kirkwood R, 2011, AUST J ZOOL, V59, P216, DOI 10.1071/ZO11080; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; KREBS JR, 1974, ANIM BEHAV, V22, P953, DOI 10.1016/0003-3472(74)90018-9; Lander ME, 2009, ECOL APPL, V19, P1645, DOI 10.1890/08-0159.1; Lea MA, 2002, MAR ECOL PROG SER, V245, P281, DOI 10.3354/meps245281; Leung ES, 2013, NEW ZEAL J MAR FRESH, V47, P38, DOI 10.1080/00288330.2012.732584; Lowther AD, 2011, MAR ECOL PROG SER, V443, P249, DOI 10.3354/meps09392; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McKenzie H, 2009, B MATH BIOL, V71, P107, DOI 10.1007/s11538-008-9354-x; Mori Y, 1998, J ZOOL, V245, P279, DOI 10.1111/j.1469-7998.1998.tb00102.x; Mori Y, 2002, J EVOLUTION BIOL, V15, P269, DOI 10.1046/j.1420-9101.2002.00382.x; Mori Y, 1998, J THEOR BIOL, V190, P187, DOI 10.1006/jtbi.1997.0550; Mori Y, 1999, BEHAV ECOL, V10, P155, DOI 10.1093/beheco/10.2.155; Orians G.H., 1979, P155; Passlow V., 2006, SEDIMENTS BENTHIC BI; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; R Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; Riet-Sapriza FG, 2012, DEEP SEA RES 2; Robinson PW, 2007, DEEP-SEA RES PT II, V54, P356, DOI 10.1016/j.dsr2.2006.11.020; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Rosen DAS, 2007, PHILOS T R SOC B, V362, P2151, DOI 10.1098/rstb.2007.2108; Sigler MF, 2004, CAN J FISH AQUAT SCI, V61, P1475, DOI 10.1139/F04-086; Sigler MF, 2009, MAR ECOL PROG SER, V388, P243, DOI 10.3354/meps08144; SIH A, 1982, AM NAT, V120, P666, DOI 10.1086/284019; Simmons SE, 2007, MAR ECOL PROG SER, V346, P265, DOI 10.3354/meps07014; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Thums M, 2013, J ANIM ECOL, V82, P72, DOI 10.1111/j.1365-2656.2012.02021.x; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Trillmich F, 1986, ATTENDANCE DIVING BE; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Walsh PD, 1996, J THEOR BIOL, V183, P351, DOI 10.1006/jtbi.1996.0227; Warneke R.M., 1985, P53; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Werner R, 1995, CAN J ZOOL, V73, P1975, DOI 10.1139/z95-232; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822; Zuur Alain F., 2009, P1	76	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117997	10.1371/journal.pone.0117997	http://dx.doi.org/10.1371/journal.pone.0117997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692978	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500090
J	Garitaonandia, I; Amir, H; Boscolo, FS; Wambua, GK; Schultheisz, HL; Sabatini, K; Morey, R; Waltz, S; Wang, YC; Tran, H; Leonardo, TR; Nazor, K; Slavin, I; Lynch, C; Li, YC; Coleman, R; Romero, IG; Altun, G; Reynolds, D; Dalton, S; Parast, M; Loring, JF; Laurent, LC				Garitaonandia, Ibon; Amir, Hadar; Boscolo, Francesca Sesillo; Wambua, Gerald K.; Schultheisz, Heather L.; Sabatini, Karen; Morey, Robert; Waltz, Shannon; Wang, Yu-Chieh; Tran, Ha; Leonardo, Trevor R.; Nazor, Kristopher; Slavin, Ileana; Lynch, Candace; Li, Yingchun; Coleman, Ronald; Romero, Irene Gallego; Altun, Gulsah; Reynolds, David; Dalton, Stephen; Parast, Mana; Loring, Jeanne F.; Laurent, Louise C.			Increased Risk of Genetic and Epigenetic Instability in Human Embryonic Stem Cells Associated with Specific Culture Conditions	PLOS ONE			English	Article							COPY NUMBER; BCL-XL; PLURIPOTENCY; 20Q11.21; LINES; EXPRESSION; MUTATIONS; GAIN	The self-renewal and differentiation capacities of human pluripotent stem cells ( hPSCs) make them a promising source of material for cell transplantation therapy, drug development, and studies of cellular differentiation and development. However, the large numbers of cells necessary for many of these applications require extensive expansion of hPSC cultures, a process that has been associated with genetic and epigenetic alterations. We have performed a combinatorial study on both hESCs and hiPSCs to compare the effects of enzymatic vs. mechanical passaging, and feeder-free vs. mouse embryonic fibroblast feeder substrate, on the genetic and epigenetic stability and the phenotypic characteristics of hPSCs. In extensive experiments involving over 100 continuous passages, we observed that both enzymatic passaging and feeder-free culture were associated with genetic instability, higher rates of cell proliferation, and persistence of OCT4/POU5F1-positive cells in teratomas, with enzymatic passaging having the stronger effect. In all combinations of culture conditions except for mechanical passaging on feeder layers, we noted recurrent deletions in the genomic region containing the tumor suppressor gene TP53, which was associated with decreased mRNA expression of TP53, as well as alterations in the expression of several downstream genes consistent with a decrease in the activity of the TP53 pathway. Among the hESC cultures, we also observed culture-associated variations in global gene expression and DNA methylation. The effects of enzymatic passaging and feeder-free conditions were also observed in hiPSC cultures. Our results highlight the need for careful assessment of the effects of culture conditions on cells intended for clinical therapies.	[Garitaonandia, Ibon; Boscolo, Francesca Sesillo; Wambua, Gerald K.; Schultheisz, Heather L.; Sabatini, Karen; Morey, Robert; Waltz, Shannon; Wang, Yu-Chieh; Tran, Ha; Leonardo, Trevor R.; Nazor, Kristopher; Slavin, Ileana; Lynch, Candace; Coleman, Ronald; Altun, Gulsah; Loring, Jeanne F.; Laurent, Louise C.] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Amir, Hadar; Boscolo, Francesca Sesillo; Sabatini, Karen; Morey, Robert; Laurent, Louise C.] UCSD Healthcare, Dept Reprod Med, San Diego, CA 92093 USA; [Li, Yingchun; Parast, Mana] UCSD Healthcare, Dept Pathol, La Jolla, CA 92093 USA; [Romero, Irene Gallego] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Reynolds, David; Dalton, Stephen] Univ Georgia, Paul D Coverdell Ctr Biomed & Hlth Sci, Ctr Mol Med, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Scripps Research Institute; University of California System; University of California San Diego; University of Chicago; University System of Georgia; University of Georgia	Loring, JF (corresponding author), Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	jloring@scripps.edu; llaurent@ucsd.edu	; Loring, Jeanne/A-1620-2011	Gallego Romero, Irene/0000-0003-1613-8998; Loring, Jeanne/0000-0001-6226-9767; Dalton, Stephen/0000-0002-3450-1263; Laurent, Louise/0000-0002-2095-7534	California Institute for Regenerative Medicine; NIH; Marie Mayer Foundation; Autism Speaks Foundation; Pew Charitable Trust; Hartwell Foundation; Millipore Foundation; Esther O'Keeffe Foundation; Wellcome Trust; UCSD Department of Reproductive Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087925] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Mayer Foundation; Autism Speaks Foundation; Pew Charitable Trust; Hartwell Foundation; Millipore Foundation; Esther O'Keeffe Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); UCSD Department of Reproductive Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	California Institute for Regenerative Medicine, NIH, Marie Mayer Foundation, Autism Speaks Foundation, Pew Charitable Trust, Hartwell Foundation, Millipore Foundation, Esther O'Keeffe Foundation, Wellcome Trust, UCSD Department of Reproductive Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; [Anonymous], 2014, ILLUMINA TECHNICAL N; Avery S, 2013, STEM CELL REP, V1, P379, DOI 10.1016/j.stemcr.2013.10.005; Bai Q, 2014, STEM CELLS DEV, DOI [10.1089/scd.2014.0374, DOI 10.1089/SCD.2014.0374]; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Ben-Yosef D, 2013, CELL REP, V4, P1288, DOI 10.1016/j.celrep.2013.08.009; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fox JL, 2008, NAT BIOTECHNOL, V26, P598, DOI 10.1038/nbt0608-598; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Nguyen HT, 2014, MOL HUM REPROD, V20, P168, DOI 10.1093/molehr/gat077; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865	25	83	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118307	10.1371/journal.pone.0118307	http://dx.doi.org/10.1371/journal.pone.0118307			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714340	gold, Green Published			2022-12-27	WOS:000350168700062
J	Michaelsen, S; Schaefer, J; Peterson, MS				Michaelsen, Savannah; Schaefer, Jacob; Peterson, Mark S.			Fluctuating Asymmetry in Menidia beryllina before and after the 2010 Deepwater Horizon Oil Spill	PLOS ONE			English	Article							CRUDE-OIL; DEVELOPMENTAL INSTABILITY; INLAND SILVERSIDES; FISHES; FITNESS; STRESS; GROWTH; COPE	Assessing the impacts of the Deepwater Horizon oil spill with a dependable baseline comparison can provide reliable insight into environmental stressors on organisms that were potentially affected by the spill. Fluctuating asymmetry (small, non-random deviations from perfect bilateral symmetry) is an informative metric sensitive to contaminants that can be used to assess environmental stress levels. For this study, the well-studied and common Gulf of Mexico estuarine fish, Menidia beryllina, was used with pre and post-oil spill collections. Comparisons of fluctuating asymmetry in three traits (eye diameter, pectoral fin length, and pelvic fin length) were made pre and post-oil spill across two sites (Old Fort Bayou and the Pascagoula River), as well as between years of collection (2011, 2012)-one and two years, respectfully, after the spill in 2010. We hypothesized that fluctuating asymmetry would be higher in post-Deepwater Horizon samples, and that this will be replicated in both study areas along the Mississippi Gulf coast. We also predicted that fluctuating asymmetry would decrease through time after the oil spill as the oil decomposed and/or was removed. Analyses performed on 1135 fish (220 pre and 915 post Deepwater Horizon) showed significantly higher post spill fluctuating asymmetry in the eye but no difference for the pectoral or pelvic fins. There was also higher fluctuating asymmetry in one of the two sites both pre and post-spill, indicating observed asymmetry may be the product of multiple stressors. Fluctuating asymmetry decreased in 2012 compared to 2011. Fluctuating asymmetry is a sensitive measure of sub lethal stress, and the observed variability in this study (pre vs. post-spill or between sites) could be due to a combination of oil, dispersants, or other unknown stressors.	[Michaelsen, Savannah; Schaefer, Jacob] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Michaelsen, Savannah] SE Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA; [Peterson, Mark S.] Univ So Mississippi, Dept Coastal Sci, Ocean Springs, MS 39564 USA	University of Southern Mississippi; University of Louisiana System; Southeastern Louisiana University; University of Southern Mississippi	Schaefer, J (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	jake.schaefer@usm.edu			B. P. Exploration and Production Inc.	B. P. Exploration and Production Inc.	Funding for this project was provided by B. P. Exploration and Production Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenbach DM, 2011, REV FISH BIOL FISHER, V21, P355, DOI 10.1007/s11160-010-9178-2; Almeida D, 2008, AQUACULTURE, V279, P120, DOI 10.1016/j.aquaculture.2008.04.003; BENGTSON DA, 1984, MAR ECOL PROG SER, V18, P21, DOI 10.3354/meps018021; Brette F, 2014, SCIENCE, V343, P772, DOI 10.1126/science.1242747; CLARKE GM, 1995, CONSERV BIOL, V9, P18, DOI 10.1046/j.1523-1739.1995.09010018.x; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; De Coster G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057966; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Dubansky B, 2013, ENVIRON SCI TECHNOL, V47, P5074, DOI 10.1021/es400458p; Edwards BR, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035301; Eriksen MS, 2008, ENVIRON BIOL FISH, V81, P87, DOI 10.1007/s10641-006-9174-5; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; Gleason TR, 1996, T AM FISH SOC, V125, P860, DOI 10.1577/1548-8659(1996)125<0860:SSMOIS>2.3.CO;2; Godet JP, 2012, ECOL INDIC, V23, P130, DOI 10.1016/j.ecolind.2012.03.018; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Gundersen DT, 1996, ARCH ENVIRON CON TOX, V31, P1; Huber M, 1999, J EXP MAR BIOL ECOL, V240, P285, DOI 10.1016/S0022-0981(99)00064-7; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; Klingenberg Christian Peter, 2003, P14; Kristoffersen JB, 2009, J FISH BIOL, V75, P2723, DOI 10.1111/j.1095-8649.2009.02473.x; LEARY RF, 1989, TRENDS ECOL EVOL, V4, P214, DOI 10.1016/0169-5347(89)90077-3; Lee DS, 1980, ATLAS N AM FRESHWATE; Lytle TF, 1985, MSAGS82038, P124; MACDONALD IR, 1993, J GEOPHYS RES-OCEANS, V98, P16351, DOI 10.1029/93JC01289; Mariano AJ, 2011, DYNAM ATMOS OCEANS, V52, P322, DOI 10.1016/j.dynatmoce.2011.06.001; McCrea-Strub A, 2011, FISHERIES, V36, P332, DOI 10.1080/03632415.2011.589334; MERILA J, 1995, SYST BIOL, V44, P97, DOI 10.2307/2413486; MIDDAUGH DP, 1992, COPEIA, P53; Middaugh DP, 1996, ARCH ENVIRON CON TOX, V31, P410; Moller AP, 1998, ADV STUD BEHAV, V27, P181; Moody RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058376; Morris MR, 2012, FUNCT ECOL, V26, P723, DOI 10.1111/j.1365-2435.2012.01983.x; Murawski SA, 2014, T AM FISH SOC, V143, P1084, DOI 10.1080/00028487.2014.911205; Nijhout H. F., 2003, P3; Partyka ML, 2008, J COASTAL RES, V24, P1570, DOI 10.2112/07-0937.1; Peterson CH, 2012, BIOSCIENCE, V62, P461, DOI 10.1525/bio.2012.62.5.7; Peterson MS, 2007, AQUAT CONSERV, V17, P602, DOI 10.1002/aqc.823; Peterson MS, 2005, WETLANDS, V25, P112, DOI 10.1672/0277-5212(2005)025[0112:TOONNT]2.0.CO;2; PETERSON MS, 1991, ESTUAR COAST SHELF S, V33, P467, DOI 10.1016/0272-7714(91)90085-P; R Development Core, 2012, R LANG ENV STAT COMP; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Roark SA, 2005, ENVIRON TOXICOL CHEM, V24, P726, DOI 10.1897/03-688.1; Ross S. T., 2000, INLAND FISHES MISSIS; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; SOLANGI MA, 1982, J FISH DIS, V5, P13, DOI 10.1111/j.1365-2761.1982.tb00453.x; TEAL JM, 1984, ENVIRON MANAGE, V8, P27, DOI 10.1007/BF01867871; Weber LP, 2003, J FISH BIOL, V63, P637, DOI 10.1046/j.1095-8649.2003.00178.x; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x; Wurtsbaugh W, 1985, LIMNOL OCEANOGR, V30; Young WP, 2009, AQUACULTURE, V289, P13, DOI 10.1016/j.aquaculture.2008.12.031	53	5	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118742	10.1371/journal.pone.0118742	http://dx.doi.org/10.1371/journal.pone.0118742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714356	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700098
J	Reeves, AB; Smith, MM; Meixell, BW; Fleskes, JP; Ramey, AM				Reeves, Andrew B.; Smith, Mathew M.; Meixell, Brandt W.; Fleskes, Joseph P.; Ramey, Andrew M.			Genetic Diversity and Host Specificity Varies across Three Genera of Blood Parasites in Ducks of the Pacific Americas Flyway	PLOS ONE			English	Article							AVIAN MALARIA; HAEMOSPORIDA; LEUCOCYTOZOON; HAEMOPROTEUS; PREVALENCE; HEMATOZOA	Birds of the order Anseriformes, commonly referred to as waterfowl, are frequently infected by Haemosporidia of the genera Haemoproteus, Plasmodium, and Leucocytozoon via dipteran vectors. We analyzed nucleotide sequences of the Cytochrome b (Cytb) gene from parasites of these genera detected in six species of ducks from Alaska and California, USA to characterize the genetic diversity of Haemosporidia infecting waterfowl at two ends of the Pacific Americas Flyway. In addition, parasite Cytb sequences were compared to those available on a public database to investigate specificity of genetic lineages to hosts of the order Anseriformes. Haplotype and nucleotide diversity of Haemoproteus Cytb sequences was lower than was detected for Plasmodium and Leucocytozoon parasites. Although waterfowl are presumed to be infected by only a single species of Leucocytozoon, L. simondi, diversity indices were highest for haplotypes from this genus and sequences formed five distinct clades separated by genetic distances of 4.9%-7.6%, suggesting potential cryptic speciation. All Haemoproteus and Leucocytozoon haplotypes derived from waterfowl samples formed monophyletic clades in phylogenetic analyses and were unique to the order Anseriformes with few exceptions. In contrast, waterfowl-origin Plasmodium haplotypes were identical or closely related to lineages found in other avian orders. Our results suggest a more generalist strategy for Plasmodium parasites infecting North American waterfowl as compared to those of the genera Haemoproteus and Leucocytozoon.	[Reeves, Andrew B.; Smith, Mathew M.; Meixell, Brandt W.; Ramey, Andrew M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Fleskes, Joseph P.] US Geol Survey, Western Ecol Res Ctr, Dixon Field Stn, Dixon, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Reeves, AB (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	areeves@usgs.gov		Ramey, Andrew/0000-0002-3601-8400; Meixell, Brandt/0000-0002-6738-0349	USGS through the Wildlife Program of the Ecosystem Mission Area; U. S. Fish and Wildlife Service through the Central Valley Joint Venture and Avian Health and Disease Program; California Department of Fish and Wildlife via California Waterfowl Association	USGS through the Wildlife Program of the Ecosystem Mission Area; U. S. Fish and Wildlife Service through the Central Valley Joint Venture and Avian Health and Disease Program; California Department of Fish and Wildlife via California Waterfowl Association	This work was funded by the USGS through the Wildlife Program of the Ecosystem Mission Area, the U. S. Fish and Wildlife Service through the Central Valley Joint Venture and Avian Health and Disease Program and the California Department of Fish and Wildlife via a contract with California Waterfowl Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON J. R., 1962, ZOONOSES RES, V1, P155; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Bellrose F. C., 1976, DUCKS GEESE SWANS N; BENNETT GF, 1993, J NAT HIST, V27, P993, DOI 10.1080/00222939300770621; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Cumming GS, 2013, PARASITOLOGY, V140, P193, DOI 10.1017/S0031182012001461; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FALLIS A. M., 1954, CANADIAN JOUR ZOOL, V32, P120, DOI 10.1139/z54-013; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; HERMAN C M, 1975, Journal of Wildlife Diseases, V11, P404; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Matta NE, 2014, PARASITOL RES, V113, P2991, DOI 10.1007/s00436-014-3961-2; Oakgrove KS, 2014, INT J PARASITOL, V44, P717, DOI 10.1016/j.ijpara.2014.04.011; Outlaw DC, 2014, PARASITOLOGY, V141, P1223, DOI 10.1017/S0031182014000560; Ramey AM, 2014, CAN J ZOOL, V92, P699, DOI 10.1139/cjz-2014-0041; Ramey Andrew M., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P102, DOI 10.1016/j.ijppaw.2013.02.001; Ramey AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045789; Sehgal RNM, 2006, J PARASITOL, V92, P375, DOI 10.1645/GE-656R.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valki<umacron>nas G, 2005, AVIAN MALARIA PARASI; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Wood MJ, 2013, J AVIAN BIOL, V44, P347, DOI 10.1111/j.1600-048X.2013.00091.x; Yoshimura A, 2014, J WILDLIFE DIS, V50, P235, DOI 10.7589/2013-03-071	25	26	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116661	10.1371/journal.pone.0116661	http://dx.doi.org/10.1371/journal.pone.0116661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710468	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900012
J	Zhang, ZH				Zhang, Zhongheng			Antipyretic Therapy in Critically Ill Patients with Established Sepsis: A Trial Sequential Analysis	PLOS ONE			English	Article							MODERATE HYPOTHERMIA; BODY-TEMPERATURE; FEBRILE PATIENTS; METAANALYSIS; PHYSIOLOGY; IBUPROFEN; FEVER; BIAS	Background and objective antipyretic therapy for patients with sepsis has long been debated. The present study aimed to explore the beneficial effect of antipyretic therapy for ICU patients with sepsis. Design systematic review and trial sequential analysis of randomized controlled trials. Database Pubmed, Scopus, EBSCO and EMBASE were searched from inception to August 5, 2014. Methods Mortality was dichotomized as binary outcome variable and odds ratio (OR) was chosen to be the summary statistic. Pooled OR was calculated by using DerSimonian and Laird method. Statistical heterogeneity was assessed by using the statistic I-2. Trial sequential analysis was performed to account for the small number of trials and patients. Main results A total of 6 randomized controlled trials including 819 patients were included into final analysis. Overall, there was no beneficial effect of antipyretic therapy on mortality risk in patients with established sepsis (OR: 1.02, 95% CI: 0.50-2.05). The required information size (IS) was 2582 and our analysis has not yet reached half of the IS. The Z-curve did not cross the O'Brien-Fleming alpha-spending boundary or reach the futility, indicating that the non-significant result was probably due to lack of statistical power. Conclusion our study fails to identify any beneficial effect of antipyretic therapy on ICU patients with established diagnosis of sepsis. Due to limited number of total participants, more studies are needed to make a conclusive and reliable analysis.	Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhang, ZH (corresponding author), Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China.	zh_zhang1984@hotmail.com	Zhang, Zhongheng/E-1282-2011; zhang, zh/GWV-4677-2022	Zhang, Zhongheng/0000-0002-2336-5323; 				Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; BERNARD GR, 1991, AM REV RESPIR DIS, V144, P1095, DOI 10.1164/ajrccm/144.5.1095; Borm GF, 2009, J CLIN EPIDEMIOL, V62, P825, DOI 10.1016/j.jclinepi.2008.08.010; Cavaillon JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11237; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimopoulos G, 2009, INFECT DIS CLIN N AM, V23, P471, DOI 10.1016/j.idc.2009.04.001; Drewry AM, 2013, CHEST, V144, P1098, DOI 10.1378/chest.13-0918; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GRAHAM NMH, 1990, J INFECT DIS, V162, P1277, DOI 10.1093/infdis/162.6.1277; Hasday JD, 2000, MICROBES INFECT, V2, P1891, DOI 10.1016/S1286-4579(00)01337-X; HAUPT MT, 1991, CRIT CARE MED, V19, P1339, DOI 10.1097/00003246-199111000-00006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kluger MJ, 1996, INFECT DIS CLIN N AM, V10, P1, DOI 10.1016/S0891-5520(05)70282-8; Launey Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10097; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Memis D, 2004, CRIT CARE, V8, pR474, DOI 10.1186/cc2969; Mohr NM, 2013, CHEST, V144, P1096, DOI 10.1378/chest.13-0916; Niven DJ, 2013, J CRIT CARE, V28, P303, DOI 10.1016/j.jcrc.2012.09.009; Pogue J, 1998, LANCET, V351, P47, DOI 10.1016/S0140-6736(97)08461-4; Pogue JM, 1997, CONTROL CLIN TRIALS, V18, P580, DOI 10.1016/S0197-2456(97)00051-2; Sahuquillo J, 2009, INTENS CARE MED, V35, P890, DOI 10.1007/s00134-008-1357-4; Schmutzhard E, 2002, CRIT CARE MED, V30, P2481, DOI 10.1097/00003246-200211000-00013; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Schulman Carl I, 2005, Surg Infect (Larchmt), V6, P369; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Yang YL, 2013, CHINESE MED J-PEKING, V126, P1809, DOI 10.3760/cma.j.issn.0366-6999.20121880; Young PJ, 2014, CRIT CARE, V18, DOI 10.1186/cc13773	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117279	10.1371/journal.pone.0117279	http://dx.doi.org/10.1371/journal.pone.0117279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710375	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900027
J	Arat, S; Bullerjahn, GS; Laubenbacher, R				Arat, Seda; Bullerjahn, George S.; Laubenbacher, Reinhard			A Network Biology Approach to Denitrification in Pseudomonas aeruginosa	PLOS ONE			English	Article							NITROUS-OXIDE REDUCTASE; DISSOLVED SUBSTANCES; ESCHERICHIA-COLI; DISCRETE MODELS; LAKE-ERIE; GENE; PHOSPHORUS; PHOSPHATE; WATER; EMISSIONS	Pseudomonas aeruginosa is a metabolically flexible member of the Gammaproteobacteria. Under anaerobic conditions and the presence of nitrate, P. aeruginosa can perform (complete) denitrification, a respiratory process of dissimilatory nitrate reduction to nitrogen gas via nitrite (NO2), nitric oxide (NO) and nitrous oxide (N2O). This study focuses on understanding the influence of environmental conditions on bacterial denitrification performance, using a mathematical model of a metabolic network in P. aeruginosa. To our knowledge, this is the first mathematical model of denitrification for this bacterium. Analysis of the long-term behavior of the network under changing concentration levels of oxygen (O-2), nitrate (NO3), and phosphate (PO4) suggests that PO4 concentration strongly affects denitrification performance. The model provides three predictions on denitrification activity of P. aeruginosa under various environmental conditions, and these predictions are either experimentally validated or supported by pertinent biological literature. One motivation for this study is to capture the effect of PO4 on a denitrification metabolic network of P. aeruginosa in order to shed light on mechanisms for greenhouse gas N2O accumulation during seasonal oxygen depletion in aquatic environments such as Lake Erie (Laurentian Great Lakes, USA). Simulating the microbial production of greenhouse gases in anaerobic aquatic systems such as Lake Erie allows a deeper understanding of the contributing environmental effects that will inform studies on, and remediation strategies for, other hypoxic sites worldwide.	[Arat, Seda] Virginia Tech, Dept Math, Blacksburg, VA 24061 USA; [Arat, Seda] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Bullerjahn, George S.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Laubenbacher, Reinhard] Univ Connecticut, Ctr Hlth, Ctr Quantitat Med, Farmington, CT 06030 USA; [Laubenbacher, Reinhard] Jackson Lab Genom Med, Farmington, CT USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University System of Ohio; Bowling Green State University; University of Connecticut; Jackson Laboratory	Laubenbacher, R (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Quantitat Med, Farmington, CT 06030 USA.	laubenbacher@uchc.edu	Bullerjahn, George S/F-4428-2010	Bullerjahn, George/0000-0001-5319-7896; Arat, Seda/0000-0002-3988-1947	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NSF [OCE-0927277]	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Experimental work was supported by NSF award OCE-0927277. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JS, 1995, BIOTECHNOL BIOENG, V46; Arai H, 2003, MICROBIOL-SGM, V149, P29, DOI 10.1099/mic.0.25936-0; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Bakken LR, 2012, PHILOS T R SOC B, V367, P1226, DOI 10.1098/rstb.2011.0321; Bootsma H, 2006, NATURALLY OCCURRING; Dybas CL, 2005, BIOSCIENCE, V55, P552, DOI 10.1641/0006-3568(2005)055[0552:DZSIWO]2.0.CO;2; Elsbury KE, 2009, ENVIRON SCI TECHNOL, V43, P3108, DOI 10.1021/es8034126; Fennel K, 2009, BIOGEOCHEMISTRY, V93, P159, DOI 10.1007/s10533-008-9270-z; FILLOUX A, 1988, MOL GEN GENET, V212, P510, DOI 10.1007/BF00330857; Finlay JC, 2013, SCIENCE, V342, P247, DOI 10.1126/science.1242575; Fujiwara T, 1996, J BACTERIOL, V178, P1866, DOI 10.1128/jb.178.7.1866-1871.1996; Galan-Vasquez Edgardo, 2011, Microb Inform Exp, V1, P3, DOI 10.1186/2042-5783-1-3; Giardina G, 2008, J MOL BIOL, V378, P1002, DOI 10.1016/j.jmb.2008.03.013; Groffman PM, 2009, BIOGEOCHEMISTRY, V93, P1, DOI 10.1007/s10533-009-9285-0; GROISMAN EA, 1992, J BACTERIOL, V174, P486, DOI 10.1128/jb.174.2.486-491.1992; HECKY RE, 1993, LIMNOL OCEANOGR, V38, P709, DOI 10.4319/lo.1993.38.4.0709; Hinkelmann F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-295; HULSE CL, 1988, ANAL BIOCHEM, V172, P420, DOI 10.1016/0003-2697(88)90464-2; Jayakumar A, 2009, MICROB ECOL, V58, P350, DOI 10.1007/s00248-009-9487-y; Kampschreur MJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00370; KIER LD, 1979, J BACTERIOL, V138, P155, DOI 10.1128/JB.138.1.155-161.1979; KRISTJANSSON JK, 1980, J BIOL CHEM, V255, P704; Kupchella CE, 1989, ECOLOGY; Laubenbacher R, 2004, J THEOR BIOL, V229, P523, DOI 10.1016/j.jtbi.2004.04.037; Loladze I, 2011, ECOL LETT, V14, P244, DOI 10.1111/j.1461-0248.2010.01577.x; Makarewicz JC, 2000, J GREAT LAKES RES, V26, P82, DOI 10.1016/S0380-1330(00)70675-7; Mampaey KE, 2013, ENVIRON TECHNOL, V34, P1555, DOI 10.1080/09593330.2012.758666; Marzan LW, 2013, ARCH MICROBIOL, V195, P161, DOI 10.1007/s00203-012-0861-7; McCarthy MJ, 2007, J GREAT LAKES RES, V33, P219, DOI 10.3394/0380-1330(2007)33[219:EOHFRO]2.0.CO;2; Mortimer CH, 1942, J ECOL, V30, P147, DOI 10.2307/2256691; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; Murrugarra D, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-5; Palsson B, 2011, SYSTEMS BIOL SIMULAT; Pan YT, 2013, ENVIRON SCI TECHNOL, V47, P11083, DOI 10.1021/es402348n; Philippot L, 2011, GLOBAL CHANGE BIOL, V17, P1497, DOI 10.1111/j.1365-2486.2010.02334.x; Philippot L, 2009, ENVIRON MICROBIOL, V11, P1518, DOI 10.1111/j.1462-2920.2009.01879.x; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Salles JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00209; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Toyofuku Masanori, 2012, Int J Microbiol, V2012, P405191, DOI 10.1155/2012/405191; Veliz-Cuba A, 2010, BIOINFORMATICS, V26, P1637, DOI 10.1093/bioinformatics/btq240; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Wilhelm SW, 2006, J GREAT LAKES RES, V32, P657, DOI 10.3394/0380-1330(2006)32[657:SHATGD]2.0.CO;2; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	47	26	26	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118235	10.1371/journal.pone.0118235	http://dx.doi.org/10.1371/journal.pone.0118235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706405	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100158
J	Arnold, A; Sajitz-Hermstein, M; Nikoloski, Z				Arnold, Anne; Sajitz-Hermstein, Max; Nikoloski, Zoran			Effects of Varying Nitrogen Sources on Amino Acid Synthesis Costs in Arabidopsis thaliana under Different Light and Carbon-Source Conditions	PLOS ONE			English	Article							ESCHERICHIA-COLI; CENTRAL METABOLISM; PLANT-METABOLISM; GROWTH; NITRATE; DIOXIDE; LEAVES; FRUCTOSE-2,6-BISPHOSPHATE; PHOTOSYNTHESIS; RECONSTRUCTION	Plants as sessile organisms cannot escape their environment and have to adapt to any changes in the availability of sunlight and nutrients. The quantification of synthesis costs of metabolites, in terms of consumed energy, is a prerequisite to understand trade-offs arising from energetic limitations. Here, we examine the energy consumption of amino acid synthesis in Arabidopsis thaliana. To quantify these costs in terms of the energy equivalent ATP, we introduce an improved cost measure based on flux balance analysis and apply it to three state-of-the-art metabolic reconstructions to ensure robust results. We present the first systematic in silico analysis of the effect of nitrogen supply (nitrate/ammonium) on individual amino acid synthesis costs as well as of the effect of photoautotrophic and heterotrophic growth conditions, integrating day/night-specific regulation. Our results identify nitrogen supply as a key determinant of amino acid costs, in agreement with experimental evidence. In addition, the association of the determined costs with experimentally observed growth patterns suggests that metabolite synthesis costs are involved in shaping regulation of plant growth. Finally, we find that simultaneous uptake of both nitrogen sources can lead to efficient utilization of energy source, which may be the result of evolutionary optimization.	[Arnold, Anne] Jacobs Univ Bremen, Sch Engn & Sci, D-28759 Bremen, Germany; [Arnold, Anne; Sajitz-Hermstein, Max; Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol, Syst Biol & Math Modeling Grp, D-14476 Potsdam, Germany	Jacobs University; Max Planck Society	Sajitz-Hermstein, M (corresponding author), Max Planck Inst Mol Plant Physiol, Syst Biol & Math Modeling Grp, D-14476 Potsdam, Germany.	sajitz@mpimp-golm.mpg.de		Grimbs, Anne/0000-0001-7836-7572; Nikoloski, Zoran/0000-0003-2671-6763				Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Arnold A, 2014, PLANT PHYSIOL, V165, P1380, DOI 10.1104/pp.114.235358; Barton MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011935; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Craig CL, 1998, MOL BIOL EVOL, V15, P774, DOI 10.1093/oxfordjournals.molbev.a025981; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Eichelmann H, 2011, J EXP BOT, V62, P2205, DOI 10.1093/jxb/erq428; Geigenberger P, 2005, J EXP BOT, V56, P1469, DOI 10.1093/jxb/eri178; GEIGER DR, 1994, ANNU REV PLANT PHYS, V45, P235, DOI 10.1146/annurev.pp.45.060194.001315; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; Geiger M, 1999, PLANT CELL ENVIRON, V22, P1177, DOI 10.1046/j.1365-3040.1999.00466.x; Gibon Y, 2009, PLANT CELL ENVIRON, V32, P859, DOI 10.1111/j.1365-3040.2009.01965.x; Heinrich R., 1996, REGULATION CELLULAR; Heizer EM, 2006, MOL BIOL EVOL, V23, P1670, DOI 10.1093/molbev/msl029; Helali SM, 2010, PLANT SOIL, V336, P65, DOI 10.1007/s11104-010-0445-8; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Kaleta C, 2013, BIOTECHNOL J, V8, P1105, DOI 10.1002/biot.201200267; Kirchsteiger K, 2012, PLANT CELL, V24, P1534, DOI 10.1105/tpc.111.092304; Kronzucker HJ, 1999, PLANT PHYSIOL, V119, P1041, DOI 10.1104/pp.119.3.1041; Masakapalli SK, 2013, PLANT J, V74, P569, DOI 10.1111/tpj.12142; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; Miller AJ, 2005, PLANT SOIL, V274, P1, DOI 10.1007/s11104-004-0965-1; Mooney BP, 2006, PHYSIOL PLANTARUM, V128, P237, DOI 10.1111/j.1399-3054.2006.00746.x; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Nielsen TH, 2004, TRENDS PLANT SCI, V9, P556, DOI 10.1016/j.tplants.2004.09.004; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Penning de Vries FW, 1974, J THEOR BIOL, V45, P339, DOI [10.1016/0022-5193(74)90119-2, DOI 10.1016/0022-5193(74)90119-2]; Piques M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.68; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Reed JL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002662; Ruelland E, 1999, TRENDS PLANT SCI, V4, P136, DOI 10.1016/S1360-1385(99)01391-6; Sajitz-Hermstein M, 2010, BIOINFORMATICS, V26, pi582, DOI 10.1093/bioinformatics/btq390; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; SICHER RC, 1987, PLANT PHYSIOL, V83, P768, DOI 10.1104/pp.83.4.768; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; STITT M, 1990, ANNU REV PLANT PHYS, V41, P153, DOI 10.1146/annurev.pp.41.060190.001101; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Sweetlove LJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00038; Tschoep H, 2009, PLANT CELL ENVIRON, V32, P300, DOI 10.1111/j.1365-3040.2008.01921.x; von Wiren N, 2000, CURR OPIN PLANT BIOL, V3, P254, DOI 10.1016/S1369-5266(00)00073-X	48	20	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116536	10.1371/journal.pone.0116536	http://dx.doi.org/10.1371/journal.pone.0116536			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706533	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100039
J	Cohen, C; Walaza, S; Moyes, J; Groome, M; Tempia, S; Pretorius, M; Hellferscee, O; Dawood, H; Haffejee, S; Variava, E; Kahn, K; Tshangela, A; von Gottberg, A; Wolter, N; Cohen, AL; Kgokong, B; Venter, M; Madhi, SA				Cohen, Cheryl; Walaza, Sibongile; Moyes, Jocelyn; Groome, Michelle; Tempia, Stefano; Pretorius, Marthi; Hellferscee, Orienka; Dawood, Halima; Haffejee, Summaya; Variava, Ebrahim; Kahn, Kathleen; Tshangela, Akhona; von Gottberg, Anne; Wolter, Nicole; Cohen, Adam L.; Kgokong, Babatyi; Venter, Marietjie; Madhi, Shabir A.			Epidemiology of Severe Acute Respiratory Illness (SARI) among Adults and Children Aged >= 5 Years in a High HIV-Prevalence Setting, 2009-2012	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; INVASIVE PNEUMOCOCCAL DISEASE; INFECTED ADULTS; SOUTH-AFRICA; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL PNEUMONIA; CONJUGATE VACCINE; RISK-FACTORS; ETIOLOGY; KENYA	Objective There are few published studies describing severe acute respiratory illness ( SARI) epidemiology amongst older children and adults from high HIV-prevalence settings. We aimed to describe SARI epidemiology amongst individuals aged >= 5 years in South Africa. Methods We conducted prospective surveillance for individuals with SARI from 2009-2012. Using polymerase chain reaction, respiratory samples were tested for ten viruses, and blood for pneumococcal DNA. Cumulative annual SARI incidence was estimated at one site with population denominators. Findings We enrolled 7193 individuals, 9% (621/7067) tested positive for influenza and 9%(600/6519) for pneumococcus. HIV-prevalence was 74% (4663/6334). Among HIV-infected individuals with available data, 41% of 2629 were receiving antiretroviral therapy (ART). The annual SARI hospitalisation incidence ranged from 325-617/100,000 population. HIV-infected individuals experienced a 13-19 times greater SARI incidence than HIV-uninfected individuals (p<0.001). On multivariable analysis, compared to HIV-uninfected individuals, HIV-infected individuals were more likely to be receiving tuberculosis treatment (odds ratio (OR): 1.7; 95% CI:1.1-2.7), have pneumococcal infection (OR 2.4; 95% CI: 1.7-3.3) be hospitalised for >7 days rather than <2 days (OR1.7; 95% CI: 1.2-2.2) and had a higher case-fatality ratio (8% vs 5%; OR1.7; 95% CI: 1.2-2.3), but were less likely to be infected with influenza (OR 0.6; 95% CI: 0.5-0.8). On multivariable analysis, independent risk indicators associated with death included HIV infection (OR 1.8; 95% CI: 1.3-2.4), increasing age-group, receiving mechanical ventilation (OR 6.5; 95% CI: 1.3-32.0) and supplemental-oxygen therapy (OR 2.6; 95% CI: 2.1-3.2). Conclusion The burden of hospitalized SARI amongst individuals aged >= 5 years is high in South Africa. HIV-infected individuals are the most important risk group for SARI hospitalization and mortality in this setting.	[Cohen, Cheryl; Walaza, Sibongile; Moyes, Jocelyn; Pretorius, Marthi; Hellferscee, Orienka; Tshangela, Akhona; von Gottberg, Anne; Wolter, Nicole; Kgokong, Babatyi; Venter, Marietjie; Madhi, Shabir A.] Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Natl Inst Communicable Dis, Johannesburg, South Africa; [Cohen, Cheryl; Walaza, Sibongile; Moyes, Jocelyn] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Groome, Michelle; von Gottberg, Anne; Wolter, Nicole; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Resp & Meningeal Pathogens Res Unit, Med Res Council, Johannesburg, South Africa; [Groome, Michelle; Madhi, Shabir A.] Univ Witwatersrand, Natl Res Fdn Vaccine Prevent Dis, Dept Sci & Technol, Johannesburg, South Africa; [Tempia, Stefano; Cohen, Adam L.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Tempia, Stefano; Cohen, Adam L.] Ctr Dis Control & Prevent South Africa, Influenza Programme, Pretoria, South Africa; [Dawood, Halima] Pietermaritzburg Metropolitan Hosp, Dept Med, Pietermaritzburg, South Africa; [Dawood, Halima] Univ KwaZulu Natal, Pietermaritzburg, South Africa; [Haffejee, Summaya] Univ KwaZulu Natal, Sch Pathol, Pietermaritzburg, South Africa; [Variava, Ebrahim] Klerksdorp Tshepong Hosp, Dept Med, Klerksdorp, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Johannesburg, South Africa; [Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Kahn, Kathleen] Umea Univ, Ctr Global Hlth Res, Umea, Sweden; [Kahn, Kathleen] INDEPTH Network, Accra, Ghana; [Venter, Marietjie] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, ZA-0002 Pretoria, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; South African Medical Research Council; University of Witwatersrand; University of Witwatersrand; Centers for Disease Control & Prevention - USA; University of Kwazulu Natal; University of Kwazulu Natal; University of Witwatersrand; University of Witwatersrand; Umea University; INDEPTH Network; University of Pretoria	Cohen, C (corresponding author), Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Natl Inst Communicable Dis, Johannesburg, South Africa.	cherylc@nicd.ac.za; shabirm@nicd.ac.za	Moyes, Jocelyn/AAF-7882-2019; Variava, Ebrahim/AAO-5717-2020; Hellferscee, Orienka/AAN-6202-2020; Venter, Marietjie/P-9604-2016; Dawood, Halima/AAO-6963-2020; Groome, Michelle Jennifer/AAI-9967-2021; Dawood, Halima/AAF-6045-2020	Variava, Ebrahim/0000-0003-2888-789X; Hellferscee, Orienka/0000-0001-9246-8927; Venter, Marietjie/0000-0003-2696-824X; Dawood, Halima/0000-0001-8180-6791; Groome, Michelle Jennifer/0000-0001-5893-3725; Pretorius, Marthi/0000-0003-2163-6158; Cohen, Cheryl/0000-0003-0376-2302; von Gottberg, Anne/0000-0002-0243-7455; Malope-Kgokong, Babatyi/0000-0001-7446-7664; Kahn, Kathleen/0000-0003-3339-3931	NICD/NHLS; United States Centers for Disease Control and Prevention (CDC), Atlanta; Pandemic Influenza in South Africa [U51/IP000155-04]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U51IP000155] Funding Source: NIH RePORTER	NICD/NHLS; United States Centers for Disease Control and Prevention (CDC), Atlanta; Pandemic Influenza in South Africa; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study received funding from the NICD/NHLS and was supported in part by funds from the United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia Preparedness and Response to Avian and Pandemic Influenza in South Africa (Cooperative Agreement Number: U51/IP000155-04). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. The funders had no role in study design, implementation,	Actuarial Society of South A, 2011, AIDS DEM MOD 2008; Albrich WC, 2014, J CLIN MICROBIOL, V52, P4224, DOI 10.1128/JCM.01553-14; Azzari C, 2011, J MED MICROBIOL, V60, P710, DOI 10.1099/jmm.0.028357-0; Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Charalambous S, 2003, AIDS, V17, P1531, DOI 10.1097/00002030-200307040-00014; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Day C, 2013, S AFRICAN HLTH REV; FANG GD, 1990, MEDICINE, V69, P307, DOI 10.1097/00005792-199009000-00004; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Feldman Charles, 2005, Curr Opin Infect Dis, V18, P165, DOI 10.1097/01.qco.0000160907.79437.5a; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Johnson LF, 2012, S AFR J HIV MED, P22; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; KoullaShiro S, 1996, TUBERCLE LUNG DIS, V77, P47, DOI 10.1016/S0962-8479(96)90075-1; MACFARLANE JT, 1982, LANCET, V2, P255; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; MUNDY LM, 1995, AM J RESP CRIT CARE, V152, P1309, DOI 10.1164/ajrccm.152.4.7551387; National Department of H, 2003, OP PLAN COMPR HIV AI; Olsen SJ, 2006, INT J INFECT DIS, V10, P439, DOI 10.1016/j.ijid.2006.06.004; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Resti M, 2010, CLIN INFECT DIS, V51, P1042, DOI 10.1086/656579; Rouphael N, 2011, DIAGN MICR INFEC DIS, V70, P452, DOI 10.1016/j.diagmicrobio.2010.09.006; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Singh E., 2008, COMMUNICABLE DIS SUR, V6, P16; Statistics South A, 2011, STAT REL P030903 MOR; Statistics South A, 2008, STATSSA MID POP EST; Tornheim JA, 2007, INT J INFECT DIS, V11, P536, DOI 10.1016/j.ijid.2007.03.006; Vong S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-97; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2011, WHO GLOB TECHN CONS	39	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117716	10.1371/journal.pone.0117716	http://dx.doi.org/10.1371/journal.pone.0117716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706880	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100112
J	Johnston, SC; Briese, T; Bell, TM; Pratt, WD; Shamblin, JD; Esham, HL; Donnelly, GC; Johnson, JC; Hensley, LE; Lipkin, WI; Honko, AN				Johnston, Sara C.; Briese, Thomas; Bell, Todd M.; Pratt, William D.; Shamblin, Joshua D.; Esham, Heather L.; Donnelly, Ginger C.; Johnson, Joshua C.; Hensley, Lisa E.; Lipkin, W. Ian; Honko, Anna N.			Detailed Analysis of the African Green Monkey Model of Nipah Virus Disease	PLOS ONE			English	Article							ENCEPHALITIS OUTBREAK; FLYING-FOXES; TRANSMISSION; HENIPAVIRUS; INFECTION; BANGLADESH; PATHOLOGY; MALAYSIA; HENDRA; BATS	Henipaviruses are implicated in severe and frequently fatal pneumonia and encephalitis in humans. There are no approved vaccines or treatments available for human use, and testing of candidates requires the use of well-characterized animal models that mimic human disease. We performed a comprehensive and statistically-powered evaluation of the African green monkey model to define parameters critical to disease progression and the extent to which they correlate with human disease. African green monkeys were inoculated by the intratracheal route with 2.5x10(4) plaque forming units of the Malaysia strain of Nipah virus. Physiological data captured using telemetry implants and assessed in conjunction with clinical pathology were consistent with shock, and histopathology confirmed widespread tissue involvement associated with systemic vasculitis in animals that succumbed to acute disease. In addition, relapse encephalitis was identified in 100% of animals that survived beyond the acute disease phase. Our data suggest that disease progression in the African green monkey is comparable to the variable outcome of Nipah virus infection in humans.	[Johnston, Sara C.; Pratt, William D.; Shamblin, Joshua D.; Esham, Heather L.; Donnelly, Ginger C.; Johnson, Joshua C.; Hensley, Lisa E.; Lipkin, W. Ian; Honko, Anna N.] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Briese, Thomas] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA; [Bell, Todd M.] US Army, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA	Columbia University	Honko, AN (corresponding author), Natl Inst Allergy & Infect Dis, Integrated Res Facil, 8200 Res Plaza, Ft Detrick, MD 21702 USA.	anna.honko@nih.gov	Honko, Anna/H-9539-2019; Lipkin, W. Ian/ABE-6216-2020	Honko, Anna/0000-0001-9165-148X; Lipkin, W. Ian/0000-0002-8768-9386; Hensley, Lisa/0000-0003-1188-4342; Johnson, Joshua/0000-0002-5677-3841	Northeast Biodefense Center [AI57158]; USAMRIID [1882367]	Northeast Biodefense Center; USAMRIID	This work was supported by AI57158 (Northeast Biodefense Center) and performed under USAMRIID project number 1882367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop Kimberly A., 2008, V8, P155; Bossart KN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004241; Bossart KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000642; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Chua KB, 2001, J INFECTION, V42, P40, DOI 10.1053/jinf.2000.0782; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; de Wit E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001432; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690; Gurley ES, 2007, INFECT CONT HOSP EP, V28, P740, DOI 10.1086/516665; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Lam SK, 2002, CLIN INFECT DIS, V34, pS48, DOI 10.1086/338818; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Maisner A, 2009, THROMB HAEMOSTASIS, V102, P1014, DOI 10.1160/TH09-05-0310; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; Porotto M, 2009, J VIROL, V83, P5148, DOI 10.1128/JVI.00164-09; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Tan CT, 2002, ANN NEUROL, V51, P703, DOI 10.1002/ana.10212; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P1065, DOI 10.1001/archneurol.2009.189; Weingartl HM, 2009, VET J, V181, P211, DOI 10.1016/j.tvjl.2008.10.016; Williamson MM, 2010, VET PATHOL, V47, P871, DOI 10.1177/0300985810378648; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8	30	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117817	10.1371/journal.pone.0117817	http://dx.doi.org/10.1371/journal.pone.0117817			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706617	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100120
J	Konok, V; Kosztolanyi, A; Rainer, W; Mutschler, B; Halsband, U; Miklosi, A				Konok, Veronika; Kosztolanyi, Andras; Rainer, Wohlfarth; Mutschler, Bettina; Halsband, Ulrike; Miklosi, Adam			Influence of Owners' Attachment Style and Personality on Their Dogs' (Canis familiaris) Separation-Related Disorder	PLOS ONE			English	Article							ADULT ATTACHMENT; MATERNAL SENSITIVITY; RISK-FACTORS; PARENTAL RESPONSIVENESS; RELATIONSHIP QUALITY; ANXIETY DISORDERS; WORKING MODELS; PET DOGS; BEHAVIOR; SECURITY	Previous research has suggested that owners' attitude to their family dogs may contribute to a variety of behaviour problems in the dog, and authors assume that dogs with separation- related disorder (SRD) attach differently to the owner than typical dogs do. Our previous research suggested that these dogs may have an insecure attachment style. In the present study we have investigated whether owners' attachment style, personality traits and the personality of the dog influence the occurrence of SRD in the dog. In an internetbased survey 1508 (1185 German and 323 Hungarian) dog-owners filled in five questionnaires: Demographic questions, Separation Behaviour Questionnaire (to determine SRD), Human and Dog Big Five Inventory and Adult Attachment Scale. We found that with owners' higher score on attachment avoidance the occurrence of SRD in the dog increases. Dogs scoring higher on the neuroticism scale were more prone to develop SRD. Our results suggest that owners' attachment avoidance may facilitate the development of SRD in dogs. We assume that avoidant owners are less responsive to the dog's needs and do not provide a secure base for the dog when needed. As a result dogs form an insecure attachment and may develop SRD. However, there may be alternative explanations of our findings that we also discuss.	[Konok, Veronika; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, H-1117 Budapest, Hungary; [Kosztolanyi, Andras] Univ Debrecen, Dept Evolutionary Zool & Human Biol, MTA DE Lendlet Behav Ecol Res Grp, H-4012 Debrecen, Hungary; [Rainer, Wohlfarth] Freiburg Univ Educ, Dept Publ Hlth Hlth Educ, Freiburg, Germany; [Rainer, Wohlfarth; Mutschler, Bettina] Freiburg Inst Anim Assisted Therapy, Freiburg, Germany; [Halsband, Ulrike] Univ Freiburg, Dept Psychol, D-79106 Freiburg, Germany; [Miklosi, Adam] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand University; University of Debrecen; Freiburg University of Education; University of Freiburg; University of Freiburg; MTA-ELTE Comparative Ethology Research Group	Konok, V (corresponding author), Eotvos Lorand Univ, Dept Ethol, Pazmany P S 1-C, H-1117 Budapest, Hungary.	konokvera@gmail.com	Kosztolanyi, Andras/B-8008-2016; Konok, Veronika/AAF-3889-2020; Miklosi, Adam/N-5147-2017	Kosztolanyi, Andras/0000-0002-9109-5871; Miklosi, Adam/0000-0003-4831-8985	EU FP7 [ICT-215554 LIREC]; Hungarian Academy of Sciences [MTA 01 031]	EU FP7(European Commission); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the EU FP7 ICT-215554 LIREC (http://lirec.eu/) and the Hungarian Academy of Sciences (MTA 01 031) (http://mta.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2004, CHILD DEV, V75, P110, DOI 10.1111/j.1467-8624.2004.00657.x; Ainsworth M., 1978, PATTERNS ATTACHMENT; Ainsworth M, 1971, ORIG HUM SOC RELATIO; AINSWORTH MD, 1969, CHILD DEV, V40, P969, DOI 10.1111/j.1467-8624.1969.tb04561.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Appleby D, 2003, VET CLIN N AM-SMALL, V33, P321, DOI 10.1016/S0195-5616(02)00101-8; Archer J, 2011, ANTHROZOOS, V24, P249, DOI 10.2752/175303711X13045914865060; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; BERRYMAN JC, 1985, VET REC, V117, P659, DOI 10.1136/vr.117.25-26.659; Biederman J, 2001, AM J PSYCHIAT, V158, P49, DOI 10.1176/appi.ajp.158.1.49; Borkenau P., 2008, NEO FFI NEO FUNF FAK, V2.; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Bowlby J., 1988, SECURE BASE PARENT C, P137; Brennan K., 1998, ATTACHMENT THEORY CL, P46; BYRNE D, 1967, J PERS SOC PSYCHOL, V5, P82, DOI 10.1037/h0021198; Byrne D., 1971, ATTRACTION PARADIGM, V1st ed.; Carver CS, 1997, PERS SOC PSYCHOL B, V23, P865, DOI 10.1177/0146167297238007; Cassidy J., 1984, FRONTIERS INFANT PSY, VVolume 2, P132; COLLINS NL, 1990, J PERS SOC PSYCHOL, V58, P644, DOI 10.1037/0022-3514.58.4.644; Collins NL, 1996, J PERS SOC PSYCHOL, V71, P810, DOI 10.1037/0022-3514.71.4.810; COPPINGER R, 1987, ETHOLOGY, V75, P89; COSTA PT, 1988, J PERS SOC PSYCHOL, V55, P258, DOI 10.1037/0022-3514.55.2.258; CROCKENBERG SB, 1981, CHILD DEV, V52, P857, DOI 10.2307/1129087; Dallaire DH, 2005, ATTACH HUM DEV, V7, P393, DOI 10.1080/14616730500365894; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; Dozier M, 1998, ATTACHMENT THEORY CL, P221; Edelstein RS, 2004, ATTACH HUM DEV, V6, P31, DOI 10.1080/146167303100001659584; Estes HR., 1956, AM J PSYCHOTHER; Fischer-Mamblona H, 2000, Attach Hum Dev, V2, P8, DOI 10.1080/146167300361291; Flannigan G, 2001, J AM VET MED ASSOC, V219, P460, DOI 10.2460/javma.2001.219.460; Gacsi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058475; Gaultier E, 2005, VET REC, V156, P533, DOI 10.1136/vr.156.17.533; George C, 1996, INF MENTAL HLTH J, V17, P198, DOI 10.1002/(SICI)1097-0355(199623)17:3<198::AID-IMHJ2>3.0.CO;2-L; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; GRIFFIN D, 1994, J PERS SOC PSYCHOL, V67, P430, DOI 10.1037/0022-3514.67.3.430; Gunnar MR, 1996, DEV PSYCHOBIOL, V29, P191, DOI 10.1002/(SICI)1098-2302(199604)29:3<191::AID-DEV1>3.3.CO;2-T; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Horn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065296; Jagoe A, 1996, APPL ANIM BEHAV SCI, V47, P31, DOI 10.1016/0168-1591(95)01008-4; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; John Oliver P., 1990, HDB PERSONAL THEORY; Kearney CA, 2004, BEHAV MODIF, V28, P147, DOI 10.1177/0145445503259263; Kelly G., 1955, PSYCHOL PERSONAL CON; King JN, 2000, APPL ANIM BEHAV SCI, V67, P255, DOI 10.1016/S0168-1591(99)00127-6; Kobelt AJ, 2003, APPL ANIM BEHAV SCI, V82, P137, DOI 10.1016/S0168-1591(03)00062-5; Kochanska G, 2004, J PERS SOC PSYCHOL, V86, P744, DOI 10.1037/0022-3514.86.5.744; Konok V, 2011, APPL ANIM BEHAV SCI, V135, P300, DOI 10.1016/j.applanim.2011.10.011; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Kurdek LA, 2009, J FAM PSYCHOL, V23, P439, DOI 10.1037/a0014979; Lang FR, 2001, DIAGNOSTICA, V47, P111, DOI 10.1026//0012-1924.47.3.111; Leerkes EM, 2011, INFANT BEHAV DEV, V34, P443, DOI 10.1016/j.infbeh.2011.04.006; Luo SH, 2005, J PERS SOC PSYCHOL, V88, P304, DOI 10.1037/0022-3514.88.2.304; Lynch M, 2002, FAM PROCESS, V41, P519, DOI 10.1111/j.1545-5300.2002.41314.x; MANASSIS K, 1994, J AM ACAD CHILD PSY, V33, P1106, DOI 10.1097/00004583-199410000-00006; MCCRAVE EA, 1991, VET CLIN N AM-SMALL, V21, P247, DOI 10.1016/S0195-5616(91)50030-9; McGreevy PD, 2008, APPL ANIM BEHAV SCI, V109, P320, DOI 10.1016/j.applanim.2007.04.001; Meins E, 2001, J CHILD PSYCHOL PSYC, V42, P637, DOI 10.1111/1469-7610.00759; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Metsapelto RL, 2003, EUR J PERSONALITY, V17, P59, DOI 10.1002/per.468; Mills-Koonce WR, 2011, INFANT MENT HEALTH J, V32, P277, DOI 10.1002/imhj.20296; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; New J. C. Jr., 2000, Journal of Applied Animal Welfare Science, V3, P179, DOI 10.1207/S15327604JAWS0303_1; Noftle EE, 2006, J RES PERS, V40, P179, DOI 10.1016/j.jrp.2004.11.003; NORMAN WT, 1963, J ABNORM PSYCHOL, V66, P574, DOI 10.1037/h0040291; OFarrell V, 1997, APPL ANIM BEHAV SCI, V52, P205, DOI 10.1016/S0168-1591(96)01123-9; Overall KL, 2001, J AM VET MED ASSOC, V219, P467, DOI 10.2460/javma.2001.219.467; Palmer R, 2008, APPL ANIM BEHAV SCI; Parthasarathy V, 2006, J VET BEHAV, V1, P109, DOI 10.1016/j.jveb.2006.09.005; Podberscek AL, 1997, VET REC, V141, P73, DOI 10.1136/vr.141.3.73; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Prinzie P, 2009, J PERS SOC PSYCHOL, V97, P351, DOI 10.1037/a0015823; Rozsa S, 2006, MAGY PSZICHOL SZLE, V26, P57; Schmidt S, 2004, PSYCHOTHER PSYCH MED, V54, P375, DOI 10.1055/s-2003-815000; Scott JP., 1965, GENETICS SOCIAL BEHA; SHAVER PR, 1992, PERS SOC PSYCHOL B, V18, P536, DOI 10.1177/0146167292185003; Sherman BL, 2008, COMPENDIUM, V30, P27; Storengen LM, 2014, APPL ANIM BEHAV SCI, V159, P82, DOI 10.1016/j.applanim.2014.07.006; Takeuchi Y, 2001, APPL ANIM BEHAV SCI, V70, P297, DOI 10.1016/S0168-1591(00)00156-8; Thundershirt, 2011, DOG ANX SURV; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Turcsan B, 2012, APPL ANIM BEHAV SCI, V140, P154, DOI 10.1016/j.applanim.2012.06.004; VAN IJZENDOORN MH, 1995, PSYCHOL BULL, V117, P387, DOI 10.1037/0033-2909.117.3.387; Voith V, 1985, COMPEND CONTIN ED PR, P7; Warren SL, 1997, J AM ACAD CHILD PSY, V36, P637, DOI 10.1097/00004583-199705000-00014; Whipple N, 2011, DEV PSYCHOL, V47, P396, DOI 10.1037/a0021310; Wilsson E, 1997, APPL ANIM BEHAV SCI, V54, P235, DOI 10.1016/S0168-1591(96)01175-6; Wolchik SA, 2002, J ABNORM CHILD PSYCH, V30, P401, DOI 10.1023/A:1015722109114; Zilcha-Mano S, 2011, J RES PERS, V45, P345, DOI 10.1016/j.jrp.2011.04.001	90	42	43	8	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118375	10.1371/journal.pone.0118375	http://dx.doi.org/10.1371/journal.pone.0118375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706147	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100176
J	Li, YX; Zhang, L; Simayi, DLX; Zhang, N; Tao, L; Yang, L; Zhao, J; Chen, YZ; Li, F; Zhang, WJ				Li, Yi Xin; Zhang, Lei; Simayi, Dilixia; Zhang, Nan; Tao, Lin; Yang, Lan; Zhao, Jin; Chen, Yun Zhao; Li, Feng; Zhang, Wen Jie			Human Papillomavirus Infection Correlates with Inflammatory Stat3 Signaling Activity and IL-17 Level in Patients with Colorectal Cancer	PLOS ONE			English	Article							T-CELLS; LUNG-CANCER; SUPPRESSOR-CELLS; UP-REGULATION; RISK; DNA; PREVALENCE; EXPRESSION; TH17; VACCINATION	Background Colorectal cancer (CRC) is a major burden of public health and healthcare worldwide. Microbiota has been suggested in promoting chronic inflammation in the intestine which, in turn, promotes tumor development. This study focuses on possible correlations of human papillomavirus (HPV) infection with proinflammatory Stat3 signaling activities and the resulting levels of its downstream proinflammatory cytokine IL-17 in CRC patients. Methods HPV was examined using HPV Genotyping Chip technology and constitutively active Stat3 (p-Stat3) and IL-17 levels were tested using immunohistochemistry (IHC) in paraffinembedded cancerous and adjacent normal tissues (ANT) from a cohort of 95 CRC patients. Correlation analyses were performed between HPV infection and clinicopathological characteristics, Stat3 activities and IL-17 levels among these CRC patients. Results Three major findings were observed: (1) HPV infection existed in a high rate of CRC cases (48.4%, 46/ 95), of which 45 cases (45/ 46, 97.8%) were high-risk HPV16-positive and only one case was HPV53-positive. (2) HPV infection correlated with poorer clinical stages (III+ IV) of CRC. (3) HPV infection strongly correlated with both constitutively higher Stat3 activities (P< 0.01) and higher IL-17 levels (P< 0.01) only in CRC tissues but not in ANT tissues. Conclusions HPV infection is common in CRC patients suggesting potentially preventive effectiveness of HPV vaccination among high-risk young individuals. We have for the first time revealed a tri-lateral relationship among HPV infection, constitutive Stat3 activity and IL-17 level, whose collaborative act may orchestrate a proinflammatory microenvironment in the colorectum that, in turn, may promote carcinogenesis and possibly facilitate progression of CRC.	[Li, Yi Xin; Zhang, Lei; Simayi, Dilixia; Zhang, Nan; Tao, Lin; Yang, Lan; Zhao, Jin; Chen, Yun Zhao; Li, Feng; Zhang, Wen Jie] Shihezi Univ, Sch Med, Dept Pathol, Key Labs Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Tao, Lin; Yang, Lan; Zhao, Jin; Chen, Yun Zhao; Li, Feng; Zhang, Wen Jie] Shihezi Univ, Sch Med, Dept Pathol, Affiliated Hosp 1, Shihezi, Xinjiang, Peoples R China; [Zhang, Lei] Changzhou Childrens Hosp, Changzhou, Jiangsu, Peoples R China; [Simayi, Dilixia] Xinjiang Med Univ, Key Lab, Chinese Minist Educ, Urumqi, Xinjiang, Peoples R China	Shihezi University; Shihezi University; Xinjiang Medical University	Zhang, WJ (corresponding author), Shihezi Univ, Sch Med, Dept Pathol, Key Labs Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China.	zhangwj82@yahoo.com			Oasis Scholar Fund of Shihezi University [LZXZ201023]; National Natural Science Foundation of China (NSFC) [81160301, 81260301]	Oasis Scholar Fund of Shihezi University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Oasis Scholar Fund of Shihezi University (LZXZ201023), the National Natural Science Foundation of China (NSFC Nos. 81160301 and 81260301). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abudukadeer A, 2010, EUR J GYNAECOL ONCOL, V31, P315; Alizadeh D, 2014, CANCER RES, V74, P104, DOI 10.1158/0008-5472.CAN-13-1545; Antonic V, 2013, J CANCER, V4, P227, DOI 10.7150/jca.5835; Baandrup L, 2014, EUR J CANCER, V50, P1446, DOI 10.1016/j.ejca.2014.01.019; Benevides L, 2013, EUR J IMMUNOL, V43, P1518, DOI 10.1002/eji.201242951; Cason J, 2005, J CLIN VIROL, V32, pS52, DOI 10.1016/j.jcv.2004.12.007; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chang YH, 2010, CANCER-AM CANCER SOC, V116, P4800, DOI 10.1002/cncr.25224; Chen ACH, 2009, J MED VIROL, V81, P1792, DOI 10.1002/jmv.21592; Chen TH, 2012, WORLD J GASTROENTERO, V18, P4051, DOI 10.3748/wjg.v18.i30.4051; Chiou HL, 2003, CANCER, V97, P1558, DOI 10.1002/cncr.11191; Couto JP, 2012, P NATL ACAD SCI USA, V109, pE2361, DOI 10.1073/pnas.1201232109; Damin DC, 2013, COLORECTAL DIS, V15, pe420, DOI 10.1111/codi.12257; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Egner JR, 2010, JAMA-J AM MED ASSOC, V304, P1726, DOI DOI 10.1001/JAMA.2010.1525; de Oliveira DE, 2007, CANCER LETT, V247, P182, DOI 10.1016/j.canlet.2006.05.010; Ferlay J, 2013, IARC CANCERBASE; Gagliani N, 2014, CELL, V157, P776, DOI 10.1016/j.cell.2014.03.006; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guirnalda PD, 2012, ONCOIMMUNOLOGY, V1, P822, DOI 10.4161/onci.20491; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li BH, 2012, CELL SIGNAL, V24, P718, DOI 10.1016/j.cellsig.2011.11.005; Li N, 2011, J INFECT DIS, V204, P217, DOI 10.1093/infdis/jir248; Li N, 2011, BREAST CANCER RES TR, V126, P515, DOI 10.1007/s10549-010-1128-0; Lv L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018219; MCGREGOR B, 1993, AM J SURG, V166, P738, DOI 10.1016/S0002-9610(05)80690-7; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Mukherjee S, 2012, SHOCK, V38, P515, DOI 10.1097/SHK.0b013e31826f862c; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Shukla S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-282; Sobti RC, 2009, MOL CELL BIOCHEM, V330, P193, DOI 10.1007/s11010-009-0133-2; Svahn MF, 2014, ACTA OBSTET GYN SCAN, V93, P6, DOI 10.1111/aogs.12254; Syrjanen K, 2012, ANTICANCER RES, V32, P3235; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0; Wu D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/436307; Yavuzer D, 2011, MED ONCOL, V28, P127, DOI 10.1007/s12032-010-9416-4; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang WJ, 2013, NAT BIOTECHNOL, V31, P590, DOI 10.1038/nbt.2631; Zhang ZX, 2012, CHINESE J LAB DIAGNO, V2; Zhu Y, 2012, INT J STD AIDS, V23, pE1, DOI [10.1258/ijsa.2009.009015, 10.1258/ijsa.2009.009396]; Zhuang Y, 2012, GASTROENTEROLOGY, V143, P951, DOI 10.1053/j.gastro.2012.06.010	49	33	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118391	10.1371/journal.pone.0118391	http://dx.doi.org/10.1371/journal.pone.0118391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706309	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100177
J	Pi, BR; Yu, DL; Dai, FW; Song, XM; Zhu, CY; Li, HY; Yu, YS				Pi, Borui; Yu, Dongliang; Dai, Fangwei; Song, Xiaoming; Zhu, Congyi; Li, Hongye; Yu, Yunsong			A Genomics Based Discovery of Secondary Metabolite Biosynthetic Gene Clusters in Aspergillus ustus	PLOS ONE			English	Article							NIDULANS; PROTEIN; VIRIDICATUMTOXIN; IDENTIFICATION; FUMIGATUS; SEQUENCE; BINDING; AFLR	Secondary metabolites (SMs) produced by Aspergillus have been extensively studied for their crucial roles in human health, medicine and industrial production. However, the resulting information is almost exclusively derived from a few model organisms, including A. nidulans and A. fumigatus, but little is known about rare pathogens. In this study, we performed a genomics based discovery of SM biosynthetic gene clusters in Aspergillus ustus, a rare human pathogen. A total of 52 gene clusters were identified in the draft genome of A. ustus 3.3904, such as the sterigmatocystin biosynthesis pathway that was commonly found in Aspergillus species. In addition, several SM biosynthetic gene clusters were firstly identified in Aspergillus that were possibly acquired by horizontal gene transfer, including the vrt cluster that is responsible for viridicatumtoxin production. Comparative genomics revealed that A. ustus shared the largest number of SM biosynthetic gene clusters with A. nidulans, but much fewer with other Aspergilli like A. niger and A. oryzae. These findings would help to understand the diversity and evolution of SM biosynthesis pathways in genus Aspergillus, and we hope they will also promote the development of fungal identification methodology in clinic.	[Pi, Borui; Yu, Yunsong] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Infect Dis, Hangzhou 310016, Zhejiang, Peoples R China; [Yu, Dongliang] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China; [Dai, Fangwei] Zhejiang Acad Med Sci, Ctr Expt Anim, Hangzhou 310013, Zhejiang, Peoples R China; [Song, Xiaoming] Hangzhou Normal Univ, Lab Anim Ctr, Hangzhou 310036, Zhejiang, Peoples R China; [Zhu, Congyi; Li, Hongye] Zhejiang Univ, Inst Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Normal University; Zhejiang Academy of Medical Sciences; Hangzhou Normal University; Zhejiang University	Li, HY (corresponding author), Zhejiang Univ, Inst Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China.	hyli@zju.edu.cn; yvys119@163.com	Yu, Dongliang/ABA-1393-2021; Li, Hong-Ye/AAX-2736-2020	Li, Hong-Ye/0000-0001-7427-0706	National Foundation of Natural Science of China [31300131, 31371691]; China Agriculture Research System [CARS-27]; Hangzhou Normal University	National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Hangzhou Normal University	This work was in part supported by the National Foundation of Natural Science of China (31300131 and 31371691), the China Agriculture Research System (CARS-27) and grants from Hangzhou Normal University.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artigot MP, 2009, MICROBIOL-SGM, V155, P1738, DOI 10.1099/mic.0.024836-0; Balajee SA, 2007, STUD MYCOL, P39, DOI 10.3114/sim.2007.59.05; Cabada MM, 2010, J HEART LUNG TRANSPL, V29, P900, DOI 10.1016/j.healun.2010.04.016; Chooi YH, 2010, CHEM BIOL, V17, P483, DOI 10.1016/j.chembiol.2010.03.015; Ehrlich KC, 1999, GENE, V230, P249, DOI 10.1016/S0378-1119(99)00075-X; Fedorova Natalie D, 2012, Methods Mol Biol, V944, P23, DOI 10.1007/978-1-62703-122-6_2; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Florescu DF, 2009, CLIN TRANSPLANT, V23, P116, DOI 10.1111/j.1399-0012.2008.00895.x; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Inglis DO, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-91; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Krimitzas A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/260395; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Oleinikova GK, 2012, CHEM NAT COMPD+, V48, P467, DOI 10.1007/s10600-012-0276-3; Olorunnipa Olushola, 2010, Hand (N Y), V5, P102, DOI 10.1007/s11552-009-9211-x; Osbourn A, 2010, TRENDS GENET, V26, P449, DOI 10.1016/j.tig.2010.07.001; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Sun XP, 2013, FEMS MICROBIOL LETT, V348, P11, DOI 10.1111/1574-6968.12235; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vagefi PA, 2008, J HEART LUNG TRANSPL, V27, P131, DOI 10.1016/j.healun.2007.09.020; Wang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098110; Weber T, 2014, INT J MED MICROBIOL, V304, P230, DOI 10.1016/j.ijmm.2014.02.001; Zheng CJ, 2008, J ANTIBIOT, V61, P633, DOI 10.1038/ja.2008.84; Zhu QY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-717	30	21	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116089	10.1371/journal.pone.0116089	http://dx.doi.org/10.1371/journal.pone.0116089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706180	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100026
J	Tu, H; Shen, GJ; Li, HX; Xie, F; Granger, DE				Tu, Hua; Shen, Guanjun; Li, Haixu; Xie, Fei; Granger, Darryl E.			Al-26/Be-10 Burial Dating of Xujiayao-Houjiayao Site in Nihewan Basin, Northern China	PLOS ONE			English	Article							HUMAN-EVOLUTION; PLEISTOCENE; AGE; AL-26; CAVE	The Xujiayao-Houjiayao site in Nihewan Basin is among the most important Paleolithic sites in China for having provided a rich collection of hominin and mammalian fossils and lithic artifacts. Based on biostratigraphical correlation and exploratory results from a variety of dating methods, the site has been widely accepted as early Upper Pleistocene in time. However, more recent paleomagnetic analyses assigned a much older age of similar to 500 ka (thousand years). This paper reports the application of Al-26/Be-10 burial dating as an independent check. Two quartz samples from a lower cultural horizon give a weighted mean age of 0.24 +/- 0.05 Ma (million years, 1 sigma). The site is thus younger than 340 ka at 95% confidence, which is at variance with the previous paleomagnetic results. On the other hand, our result suggests an age of older than 140 ka for the site's lower cultural deposits, which is consistent with recent post-infrared infrared stimulated luminescence (pIR-IRSL) dating at 160-220 ka.	[Tu, Hua; Shen, Guanjun; Li, Haixu] Nanjing Normal Univ, Coll Geog Sci, Nanjing, Jiangsu, Peoples R China; [Xie, Fei] Hebei Prov Inst Cultural Rel, Shijiazhuang, Peoples R China; [Granger, Darryl E.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Li, Haixu] Zhangjiakou Univ, Dept Nat Sci, Zhangjiakou, Peoples R China	Nanjing Normal University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Zhangjiakou University	Shen, GJ (corresponding author), Nanjing Normal Univ, Coll Geog Sci, Nanjing, Jiangsu, Peoples R China.	gjshen@njnu.edu.cn			National Natural Science Foundation of China [41273067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China 41273067 to Shen http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argento DC, 2013, NUCL INSTRUM METH B, V294, P464, DOI 10.1016/j.nimb.2012.05.022; Bae CJ, 2010, AM J PHYS ANTHROPOL, P75, DOI 10.1002/ajpa.21442; Balco G, 2008, AM J SCI, V308, P1083, DOI 10.2475/10.2008.02; CHEN T, 1982, ACTA ANTHR SINICA, V1, P91; Chen T., 1984, ACTA ANTHR SINICA, V3, P259, DOI DOI 10.1177/0959683611405244; Chen TM, 1984, WEN WU, P92; Erlanger ED, 2012, GEOLOGY, V40, P1019, DOI 10.1130/G33172.1; Etler DA, 1996, ANNU REV ANTHROPOL, V25, P275, DOI 10.1146/annurev.anthro.25.1.275; Granger DE, 2006, GEOL SOC AM SPEC PAP, V415, P1, DOI 10.1130/2006.2415(01); Granger DE, 1997, GEOLOGY, V25, P107, DOI 10.1130/0091-7613(1997)025<0107:QDROTN>2.3.CO;2; Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; Hayase R., 2012, BASIC STUDIES PALEOE, P89; Huang W.W., 2000, ACTA ARCHAEOLOGICA S, V19, P269; [浑凌云 Hun Lingyun], 2011, [第四纪研究, Quaternary Sciences], V31, P951; Institute of Archaeology of the Chinese Academy of Social Sciences, 1991, RAD DAT CHIN ARCH 19; Jia L.P., 1976, ARCHAEOL B, V2, P97; JIA LP, 1979, VERTEBRAT PALASIATIC, V17, P277; Li CR, 1994, WORLD ANTIQ, P103; Li ZT, 2014, QUATERN INT, V349, P42, DOI 10.1016/j.quaint.2014.06.003; Liu C., 1992, SCI GEOL SINICA, V1, P87; Liu Y, 2013, QUATERN INT, V295, P204, DOI 10.1016/j.quaint.2012.01.015; Lovlie R, 2001, QUATERNARY SCI REV, V20, P1341, DOI 10.1016/S0277-3791(00)00159-1; [王喜生 Wang Xisheng], 2002, [第四纪研究, Quaternary Sciences], V22, P451; Nagatomo T., 2009, ACTA ANTHR SINICA, V28, P276; Norton CJ, 2008, J HUM EVOL, V55, P164, DOI 10.1016/j.jhevol.2008.02.006; [樊行昭 Fan Xingzhao], 2002, [地层学杂志, Journal of Stratigraphy], V26, P248; Rightmire GP, 1998, EVOL ANTHROPOL, V6, P218, DOI 10.1002/(SICI)1520-6505(1998)6:6<218::AID-EVAN4>3.0.CO;2-6; Shen GJ, 2004, QUATERNARY RES, V62, P208, DOI 10.1016/j.yqres.2004.06.004; Shen GJ, 2004, J ARCHAEOL SCI, V31, P337, DOI 10.1016/j.jas.2003.09.004; Shen GJ., 1991, ACTA ANTHROPOL SIN, V10, P65; Shen GJ, 2014, QUAT GEOCHRONOL, V23, P56, DOI 10.1016/j.quageo.2014.06.004; Shen GJ, 2010, QUATERN INT, V211, P24, DOI 10.1016/j.quaint.2009.02.020; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Su P, 2000, CHINESE J GEOPHYS-CH, V43, P223; Wang F.G., 2008, STORIES RELICS, V5, P23; Wang FG, 2012, BASIC STUDIES PALEOE, P61; Wang XS, 2008, PALAEOGEOGR PALAEOCL, V260, P452, DOI 10.1016/j.palaeo.2007.12.006; Watanabe M, 2012, BASIC STUDIES PALEOE, P73; Wei Q, 2012, ACTA ANTHR SIN, V19, P269; Wei Q, 2010, WENWUCHUNQIU, V6, P3, DOI [10.1093/jscr/2010.6.3, DOI 10.1093/JSCR/2010.6.3]; Wei Qi, 2011, Journal of Stratigraphy, V35, P193; Wu Maolin, 1986, Acta Anthropologica Sinica, V5, P220; WU ML, 1980, VERTEBRAT PALASIATIC, V18, P229; Wu XJ, 2015, INT J OSTEOARCHAEOL, V25, P245, DOI 10.1002/oa.2283; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Wu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059587; Xie F, 2011, CHINESE CULTURA 0930; Xie F, 2008, CHINESE CULTURA 0523; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Zhang L., 2007, SE CULT, P54; Zhao H, 2010, QUAT GEOCHRONOL, V5, P159, DOI 10.1016/j.quageo.2009.03.008	51	16	21	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118315	10.1371/journal.pone.0118315	http://dx.doi.org/10.1371/journal.pone.0118315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706272	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100167
J	Wang, YH; Ma, CY; Zhang, Y; Guan, ZY; Liu, S; Li, YL; Yang, J				Wang, Yonghuai; Ma, Chunyan; Zhang, Yan; Guan, Zhengyu; Liu, Shuang; Li, Yuling; Yang, Jun			Assessment of Left and Right Ventricular Diastolic and Systolic Functions Using Two-Dimensional Speckle-Tracking Echocardiography in Patients with Coronary Slow-Flow Phenomenon	PLOS ONE			English	Article							EJECTION FRACTION; ANGINA-PECTORIS; STRAIN; DYSFUNCTION; STENOSIS; ASSOCIATION; ARTERIES; DISEASE; ABSENCE	Objective Coronary slow-flow phenomenon (CSFP) is an angiographic diagnosis characterised by a low rate of flow of contrast agent in the normal or near-normal epicardial coronary arteries. Many of the patients with CSFP may experience recurrent acute coronary syndromes. However, current clinical practice tends to underestimate the impact of CSFP due to the yet unknown effect on the cardiac function. This study was performed to evaluate left ventricular (LV) and right ventricular (RV) diastolic and systolic functions, using two-dimensional (2D) longitudinal strain and strain rate, in patients with CSFP, and to determine the relationships between the thrombolysis in myocardial infarction (TIMI) frame count (TFC) and LV and RV diastolic and systolic functions. Methods Sixty-three patients with CSFP and 45 age-and sex-matched controls without CSFP were enrolled in the study. Diagnosis of CSFP was made by TFC. LV and RV diastolic and systolic functions were assessed by 2D speckle-tracking echocardiography. Results LV peak early diastolic longitudinal strain rate (LSRe) was lower in patients with CSFP than in controls (P = 0.01). LV peak systolic longitudinal strain (LS) and LV peak systolic longitudinal strain rate (LSRs) were lower in patients with CSFP than in controls (P = 0.004 and P = 0.03, respectively). There was no difference in LV ejection fraction. RV peak early diastolic longitudinal strain rate (RSRe) was lower in patients with CSFP than in controls (P = 0.03). There were no differences in RV peak systolic longitudinal strain (RS), RV peak systolic longitudinal strain rate (RSRs), or RV fractional area change among the groups. The mean TFC correlated negatively with LSRe and RSRe in patients with CSFP (r = -0.26, P = 0.04 and r = -0.32, P = 0.01, respectively). Conclusions LV diastolic and systolic functions were impaired in patients with CSFP. CSFP also affected RV diastolic function, but not RV systolic function.	[Wang, Yonghuai; Ma, Chunyan; Zhang, Yan; Guan, Zhengyu; Liu, Shuang; Yang, Jun] China Med Univ, Dept Cardiovasc Ultrasound, Hosp 1, Shenyang, Liaoning, Peoples R China; [Li, Yuling] China Med Univ, Dept Cardiol, Hosp 1, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Ma, CY (corresponding author), China Med Univ, Dept Cardiovasc Ultrasound, Hosp 1, Shenyang, Liaoning, Peoples R China.	mcy_echo@163.com	Wang, Yonghuai/AAJ-6778-2021					Altunkas F, 2014, MED PRIN PRACT, V23, P34, DOI 10.1159/000355471; Balci MM, 2013, ACTA CARDIOL, V68, P161, DOI 10.1080/AC.68.2.2967273; Baykan M, 2009, ECHOCARDIOGR-J CARD, V26, P1167, DOI 10.1111/j.1540-8175.2009.00939.x; BELLAMY RF, 1980, AM J PHYSIOL, V238, pH481, DOI 10.1152/ajpheart.1980.238.4.H481; Beltrame JF, 2004, J AM COLL CARDIOL, V44, P57, DOI 10.1016/j.jacc.2004.03.055; Beltrame JF, 2003, AM HEART J, V146, P84, DOI 10.1016/S0002-8703(03)00124-8; Beltrame JF, 2002, CARDIOLOGY, V97, P197, DOI 10.1159/000063121; Bian XM, 2000, J MOL CELL CARDIOL, V32, P345, DOI 10.1006/jmcc.1999.1077; Biswas M, 2013, ECHOCARDIOGR-J CARD, V30, P88, DOI 10.1111/echo.12079; Blessberger H, 2010, HEART, V96, P716, DOI 10.1136/hrt.2007.141002; Celebi H, 2008, CARDIOVASC REVASCULA, V9, P144, DOI 10.1016/j.carrev.2007.11.002; Chow PC, 2008, HEART, V94, P855, DOI 10.1136/hrt.2007.131862; Cin VG, 2003, JPN HEART J, V44, P907, DOI 10.1536/jhj.44.907; Dandel M, 2009, INT J CARDIOL, V132, P11, DOI 10.1016/j.ijcard.2008.06.091; Edvardsen T, 2006, PROG CARDIOVASC DIS, V49, P207, DOI 10.1016/j.pcad.2006.08.008; Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879; GOLDSTEIN JA, 1992, J AM COLL CARDIOL, V19, P704, DOI 10.1016/S0735-1097(10)80296-7; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; Hawkins BM, 2012, CIRC J, V76, P936, DOI 10.1253/circj.CJ-11-0959; Hurlburt HM, 2007, ECHOCARDIOGR-J CARD, V24, P723, DOI 10.1111/j.1540-8175.2007.00460.x; Kakouros N, 2010, POSTGRAD MED J, V86, P719, DOI 10.1136/pgmj.2010.103887; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li JJ, 2007, CLIN CHIM ACTA, V385, P43, DOI 10.1016/j.cca.2007.05.024; Mangieri E, 1996, CATHETER CARDIO DIAG, V37, P375, DOI 10.1002/(SICI)1097-0304(199604)37:4<375::AID-CCD7>3.0.CO;2-8; Marechaux S, 2013, ARCH CARDIOVASC DIS, V106, P629, DOI 10.1016/j.acvd.2013.10.001; Mor-Avi V, 2011, EUR J ECHOCARDIOGR, V12, P167, DOI 10.1093/ejechocard/jer021; MOSSERI M, 1986, CIRCULATION, V74, P964, DOI 10.1161/01.CIR.74.5.964; Ng ACT, 2011, EUR HEART J, V32, P1542, DOI 10.1093/eurheartj/ehr084; Nie SP, 2010, CHINESE MED J-PEKING, V123, P3529, DOI 10.3760/cma.j.issn.0366-6999.2010.24.005; Nurkalem Z, 2009, INT J CARDIOVAS IMAG, V25, P25, DOI 10.1007/s10554-008-9341-1; Pasqui AL, 2005, NUTR METAB CARDIOVAS, V15, P56, DOI 10.1016/j.numecd.2004.05.001; Pekdemir H, 2004, ACTA CARDIOL, V59, P127, DOI 10.2143/AC.59.2.2005166; Saya S, 2008, CLIN CARDIOL, V31, P352, DOI 10.1002/clc.20266; Serne EH, 2007, HYPERTENSION, V50, P204, DOI 10.1161/HYPERTENSIONAHA.107.089680; TAMBE AA, 1972, AM HEART J, V84, P66, DOI 10.1016/0002-8703(72)90307-9; Vargas-Barron J, 2007, REV ESP CARDIOL, V60, P51, DOI 10.1016/S1885-5857(07)60106-6; Yang B, 2013, INT HEART J, V54, P266, DOI 10.1536/ihj.54.266; Yuda S, 2003, J AM SOC ECHOCARDIOG, V16, P1163, DOI 10.1067/S0894-7317(03)00647-3	38	19	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117979	10.1371/journal.pone.0117979	http://dx.doi.org/10.1371/journal.pone.0117979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706989	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100134
J	Weininger, A; Weininger, S				Weininger, Arthur; Weininger, Susan			Using Common Spatial Distributions of Atoms to Relate Functionally Divergent Influenza Virus N10 and N11 Protein Structures to Functionally Characterized Neuraminidase Structures, Toxin Cell Entry Domains, and Non-Influenza Virus Cell Entry Domains	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SPECIFICITY; COMPLEXES; SIALIDASE	The ability to identify the functional correlates of structural and sequence variation in proteins is a critical capability. We related structures of influenza A N10 and N11 proteins that have no established function to structures of proteins with known function by identifying spatially conserved atoms. We identified atoms with common distributed spatial occupancy in PDB structures of N10 protein, N11 protein, an influenza A neuraminidase, an influenza B neuraminidase, and a bacterial neuraminidase. By superposing these spatially conserved atoms, we aligned the structures and associated molecules. We report spatially and sequence invariant residues in the aligned structures. Spatially invariant residues in the N6 and influenza B neuraminidase active sites were found in previously unidentified spatially equivalent sites in the N10 and N11 proteins. We found the corresponding secondary and tertiary structures of the aligned proteins to be largely identical despite significant sequence divergence. We found structural precedent in known non-neuraminidase structures for residues exhibiting structural and sequence divergence in the aligned structures. In N10 protein, we identified staphylococcal enterotoxin I-like domains. In N11 protein, we identified hepatitis E E2S-like domains, SARS spike protein-like domains, and toxin components shared by alpha-bungarotoxin, staphylococcal enterotoxin I, anthrax lethal factor, clostridium botulinum neurotoxin, and clostridium tetanus toxin. The presence of active site components common to the N6, influenza B, and S. pneumoniae neuraminidases in the N10 and N11 proteins, combined with the absence of apparent neuraminidase function, suggests that the role of neuraminidases in H17N10 and H18N11 emerging influenza A viruses may have changed. The presentation of E2S-like, SARS spike protein-like, or toxin-like domains by the N10 and N11 proteins in these emerging viruses may indicate that H17N10 and H18N11 sialidase-facilitated cell entry has been supplemented or replaced by sialidase-independent receptor binding to an expanded cell population that may include neurons and T-cells.	[Weininger, Arthur; Weininger, Susan] Weininger Works Inc, Thornhill, ON, Canada		Weininger, A (corresponding author), Weininger Works Inc, Thornhill, ON, Canada.	weiningerworks@gmail.com						Chan MCW, 2013, LANCET RESP MED, V1, P534, DOI 10.1016/S2213-2600(13)70138-3; Cosby MT, 2013, PLOS ONE, DOI [10.1371/journal.pone.0082089, DOI 10.1371/J0URNAL.P0NE.0082089]; Dapat IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036455; Emsley P, 2000, J BIOL CHEM, V275, P8889, DOI 10.1074/jbc.275.12.8889; Fernandez MM, 2006, J BIOL CHEM, V281, P25356, DOI 10.1074/jbc.M603969200; Gayen A, 2011, BBA-BIOMEMBRANES, V1808, P127, DOI 10.1016/j.bbamem.2010.09.023; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Hsiao YS, 2009, BIOCHEM BIOPH RES CO, V380, P467, DOI 10.1016/j.bbrc.2009.01.108; Li Q, 2012, P NATL ACAD SCI USA, V109, P18897, DOI 10.1073/pnas.1211037109; LOVE RA, 1986, PROTEIN ENG, V1, P37, DOI 10.1093/protein/1.1.37; Masuyer G, 2011, ACTA CRYSTALLOGR F, V67, P1466, DOI 10.1107/S1744309111034671; Nishikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045371; Ottmann M, 2010, ANTIVIR THER, V15, P721, DOI 10.3851/IMP1576; Parker RB, 2012, ACS CHEM BIOL, V7, P1509, DOI 10.1021/cb300241v; Rudino-Pinera E, 2004, PROTEIN DATA BANK ID; Schrauwen EJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059889; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Taylor NR, 1998, J MED CHEM, V41, P798, DOI 10.1021/jm9703754; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Wibawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083417; Zhu XY, 2012, P NATL ACAD SCI USA, V109, P18903, DOI 10.1073/pnas.1212579109	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117499	10.1371/journal.pone.0117499	http://dx.doi.org/10.1371/journal.pone.0117499			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706124	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100096
J	Chancey, ST; Bai, XH; Kumar, N; Drabek, EF; Daugherty, SC; Colon, T; Ott, S; Sengamalay, N; Sadzewicz, L; Tallon, LJ; Fraser, CM; Tettelin, H; Stephens, DS				Chancey, Scott T.; Bai, Xianhe; Kumar, Nikhil; Drabek, Elliott F.; Daugherty, Sean C.; Colon, Thomas; Ott, Sandra; Sengamalay, Naomi; Sadzewicz, Lisa; Tallon, Luke J.; Fraser, Claire M.; Tettelin, Herve; Stephens, David S.			Transcriptional Attenuation Controls Macrolide Inducible Efflux and Resistance in Streptococcus pneumoniae and in Other Gram-Positive Bacteria Containing mef/mel (msr(D)) Elements	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; BACILLUS-SUBTILIS; SECONDARY STRUCTURE; GENE-EXPRESSION; ERYTHROMYCIN; SEQUENCE; ENTEROCOCCI; PYOGENES; ERMK; LICHENIFORMIS	Macrolide resistance, emerging in Streptococcus pneumoniae and other Gram-positive bacteria, is increasingly due to efflux pumps encoded by mef/mel(msr) operons found on discrete mobile genetic elements. The regulation of mef/mel(msr) in these elements is not well understood. We identified the mef(E)/mel transcriptional start, localized the mef(E)/mel promoter, and demonstrated attenuation of transcription as a mechanism of regulation of macrolide-inducible mef-mediated macrolide resistance in S. pneumoniae. The mef(E)/mel transcriptional start site was a guanine 327 bp upstream of mef(E). Consensus pneumococcal promoter -10 (5 '-TATACT-3 ') and -35 (5 '-TTGAAC-3 ') boxes separated by 17 bp were identified 7 bp upstream of the start site. Analysis of the predicted secondary structure of the 327 5' region identified four pairs of inverted repeats R1-R8 predicted to fold into stem-loops, a small leader peptide [MTASMRLR, (Mef(E) L)] required for macrolide induction and a Rho-independent transcription terminator. RNA-seq analyses provided confirmation of transcriptional attenuation. In addition, expression of mef(E) L was also influenced by mef(E) L-dependent mRNA stability. The regulatory region 5 ' of mef(E) was highly conserved in other mef/mel(msr)-containing elements including Tn1207.1 and the 5612IQ complex in pneumococci and Tn1207.3 in Group A streptococci, indicating a regulatory mechanism common to a wide variety of Gram-positive bacteria containing mef/mel(msr) elements.	[Chancey, Scott T.; Bai, Xianhe; Stephens, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Chancey, Scott T.; Bai, Xianhe; Stephens, David S.] Dept Vet Affairs Med Ctr, Labs Microbial Pathogenesis, Atlanta, GA USA; [Kumar, Nikhil; Drabek, Elliott F.; Daugherty, Sean C.; Colon, Thomas; Ott, Sandra; Sengamalay, Naomi; Sadzewicz, Lisa; Tallon, Luke J.; Fraser, Claire M.; Tettelin, Herve] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Fraser, Claire M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Tettelin, Herve] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Emory University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Stephens, DS (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	dstep01@emory.edu		Fraser, Claire/0000-0003-1462-2428	National Institutes of Health [R01 AI070829]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HSN272200900009C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part with an R01 grant from the National Institutes of Health (#R01 AI070829 (to DSS) and with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900009C. The funders had no role in study design, data collection and analysis, or preparation of the manuscript, but signed off on the publication after the authors sent them a copy for review.	Ambrose KD, 2005, ANTIMICROB AGENTS CH, V49, P4203, DOI 10.1128/AAC.49.10.4203-4209.2005; BECHHOFER DH, 1987, P NATL ACAD SCI USA, V84, P498, DOI 10.1073/pnas.84.2.498; BECHHOFER DH, 1989, J BACTERIOL, V171, P5803, DOI 10.1128/jb.171.11.5803-5811.1989; Chancey ST, 2012, FUTURE MICROBIOL, V7, P959, DOI [10.2217/fmb.12.63, 10.2217/FMB.12.63]; Chancey ST, 2011, ANTIMICROB AGENTS CH, V55, P3413, DOI 10.1128/AAC.00060-11; Chancey ST, 2008, MACROLIDE EFFLUX SYS; Choi SS, 1997, J BACTERIOL, V179, P2065, DOI 10.1128/jb.179.6.2065-2067.1997; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; de Vries Lisbeth E, 2012, Mob Genet Elements, V2, P72; Drider D, 2002, MOL MICROBIOL, V43, P1319, DOI 10.1046/j.1365-2958.2002.02830.x; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farley Monica M, 2002, J Med Assoc Ga, V91, P20; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Gay K, 2001, J INFECT DIS, V184, P56, DOI 10.1086/321001; GRYCZAN T, 1984, MOL GEN GENET, V194, P349, DOI 10.1007/BF00425543; Gupta P, 2013, MOL CELL, V52, P629, DOI 10.1016/j.molcel.2013.10.013; Halfmann A, 2007, FEMS MICROBIOL LETT, V268, P217, DOI 10.1111/j.1574-6968.2006.00584.x; Hu P, 2011, J BACTERIOL, V193, P2375, DOI 10.1128/JB.00083-11; Hummel A, 2007, SYST APPL MICROBIOL, V30, P1, DOI 10.1016/j.syapm.2006.02.004; KIM HS, 1993, J GEN MICROBIOL, V139, P601, DOI 10.1099/00221287-139-3-601; KWAK JH, 1991, J BACTERIOL, V173, P4725, DOI 10.1128/jb.173.15.4725-4735.1991; Kwon AR, 2006, ARCH PHARM RES, V29, P1154, DOI 10.1007/BF02969307; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Malhotra-Kumar S, 2009, J ANTIMICROB CHEMOTH, V63, P42, DOI 10.1093/jac/dkn432; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Miller JH, 1972, EXPT MOL GENETICS LA; Min YH, 2008, ARCH PHARM RES, V31, P377, DOI [10.1007/s12272-001-1167-8, 10.1007/s00000-001-1167-8]; Mingoia M, 2007, ANTIMICROB AGENTS CH, V51, P3983, DOI 10.1128/AAC.00790-07; Rosato A, 1999, J ANTIMICROB CHEMOTH, V43, P559, DOI 10.1093/jac/43.4.559; ROSS JI, 1990, MOL MICROBIOL, V4, P1207, DOI 10.1111/j.1365-2958.1990.tb00696.x; SABELNIKOV AG, 1995, J MOL BIOL, V250, P144, DOI 10.1006/jmbi.1995.0366; SANDLER P, 1989, J BACTERIOL, V171, P6680, DOI 10.1128/jb.171.12.6680-6688.1989; Santagati M, 2003, MICROB DRUG RESIST, V9, P243, DOI 10.1089/107662903322286445; Santagati M, 2000, ANTIMICROB AGENTS CH, V44, P2585, DOI 10.1128/AAC.44.9.2585-2587.2000; Sharma D, 2013, PEDIATR INFECT DIS J, V32, pE45, DOI 10.1097/INF.0b013e3182788fdd; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Zahner D, 2010, ANTIMICROB AGENTS CH, V54, P3516, DOI 10.1128/AAC.01756-09; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	43	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116254	10.1371/journal.pone.0116254	http://dx.doi.org/10.1371/journal.pone.0116254			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695510	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300012
J	Bordi, L; Lalle, E; Caglioti, C; Travaglini, D; Lapa, D; Marsella, P; Quartu, S; Kis, Z; Arien, KK; Huemer, HP; Meschi, S; Ippolito, G; Di Caro, A; Capobianchi, MR; Castilletti, C				Bordi, Licia; Lalle, Eleonora; Caglioti, Claudia; Travaglini, Damiano; Lapa, Daniele; Marsella, Patrizia; Quartu, Serena; Kis, Zoltan; Arien, Kevin K.; Huemer, Hartwig P.; Meschi, Silvia; Ippolito, Giuseppe; Di Caro, Antonino; Capobianchi, Maria R.; Castilletti, Concetta			Antagonistic Antiviral Activity between IFN-Lambda and IFN-Alpha against Lethal Crimean-Congo Hemorrhagic Fever Virus In Vitro	PLOS ONE			English	Article							HUMAN MXA PROTEIN; INTERFERON-LAMBDA; REPLICATION; DISTINCT; ACTIVATION; OUTBREAK; CELLS	Background and Aims Crimean Congo Hemorrhagic fever virus (CCHFV) is the causative agent of Crimean-Congo hemorrhagic fever, a severe disease with a mortality rate of around 30% in humans. Previous studies demonstrate that pre-treatment with type I IFNs have an antiviral effect against CCHFV, while established CCHFV infection is almost insensitive to subsequent IFN-alpha treatment. No data concerning type III IFNs antiviral activity against CCHFV are available so far. The aim of the present study was to explore the capability of IFN-lambda 1 to inhibit the replication of CCHFV and the possible synergism/antagonism between IFN-alpha and IFN-lambda 1 both in the inhibition of CCHFV replication and in the activation of intracellular pathways of IFN response. Methods Human A549 and HuH7 cells were treated with increasing amounts of IFN-lambda 1, or IFN-alpha or a combination of them, infected with CCHF; the extent of virus yield inhibition and the induction of MxA and 2'-5' OAS mRNA was measured. Results and Conclusions Our study pointed out that type III IFN possess an antiviral activity against CCHFV, even if lower than type I IFN. Moreover, a clear antagonism between IFN-lambda and IFN-alpha was observed in both cell lines (A549 and HuH7 cells), in terms of antiviral effect and activation of pivotal ISGs, i.e. MxA and 2'-5' OAS. Elucidating the interplay between type I and III IFNs will help to better understand innate defence mechanisms against viral infections and may provide novel scientific evidence for a more rational planning of available and future treatments, particularly against human diseases caused by high concern viruses.	[Bordi, Licia; Lalle, Eleonora; Caglioti, Claudia; Travaglini, Damiano; Lapa, Daniele; Marsella, Patrizia; Quartu, Serena; Meschi, Silvia; Capobianchi, Maria R.; Castilletti, Concetta] Natl Inst Infect Dis L Spallanzani, Virol Lab, Rome, Italy; [Kis, Zoltan] Natl Ctr Epidemiol, Div Virol, Budapest, Hungary; [Arien, Kevin K.] Inst Trop Med, Virol Unit, B-2000 Antwerp, Belgium; [Huemer, Hartwig P.] Med Univ Innsbruck, Dept Hyg Microbiol & Social Med, A-6020 Innsbruck, Austria; [Ippolito, Giuseppe] Natl Inst Infect Dis L Spallanzani, Sci Direct, Rome, Italy; [Di Caro, Antonino] Natl Inst Infect Dis L Spallanzani, Lab Microbiol & Biorepository, Rome, Italy	IRCCS Lazzaro Spallanzani; Institute of Tropical Medicine (ITM); Medical University of Innsbruck; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Capobianchi, MR (corresponding author), Natl Inst Infect Dis L Spallanzani, Virol Lab, Rome, Italy.	maria.capobianchi@inmi.it	Bordi, Licia/B-6827-2017; Ippolito, Giuseppe/J-7207-2017; Di Caro, Antonino/K-6854-2016; Castilletti, Concetta/AAA-8408-2019; Castilletti, Concetta/B-6545-2016	Bordi, Licia/0000-0003-3962-3646; Di Caro, Antonino/0000-0001-6027-3009; Castilletti, Concetta/0000-0001-9819-236X; Castilletti, Concetta/0000-0001-9819-236X; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Ippolito, Giuseppe/0000-0002-1076-2979; lalle, eleonora/0000-0002-7063-9905; meschi, silvia/0000-0003-0924-993X	Italian Ministry of Health; Ricerca Corrente; Ricerca Finalizzata	Italian Ministry of Health(Ministry of Health, Italy); Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This study has been partly supported by grants from Italian Ministry of Health, Ricerca Corrente and Ricerca Finalizzata	Andersson I, 2006, J MED VIROL, V78, P216, DOI 10.1002/jmv.20530; Andersson I, 2004, J VIROL, V78, P4323, DOI 10.1128/JVI.78.8.4323-4329.2004; Andersson I, 2008, J MED VIROL, V80, P1397, DOI 10.1002/jmv.21222; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Bordi L, 2013, J BIOL REG HOMEOS AG, V27, P1001; BURNEY MI, 1980, AM J TROP MED HYG, V29, P941, DOI 10.4269/ajtmh.1980.29.941; Capobianchi MR, 2006, CELL MOL BIOL, V52, P3, DOI 10.1170/T692; Chinikar S, 2004, J MED VIROL, V73, P404, DOI 10.1002/jmv.20106; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Egli A, 2014, J INFECT DI IN PRESS; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Keshtkar-Jahromi M, 2011, ANTIVIR RES, V90, P85, DOI 10.1016/j.antiviral.2011.02.010; Kohli A, 2012, J VIRAL HEPATITIS, V19, P843, DOI 10.1111/j.1365-2893.2012.01610.x; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; NICHOL ST, 2001, FIELDS VIROLOGY, P1603; Pagliaccetti NE, 2008, J BIOL CHEM, V283, P30079, DOI 10.1074/jbc.M804296200; PAVLOVIC J, 1995, J VIROL, V69, P4506, DOI 10.1128/JVI.69.7.4506-4510.1995; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shindo H, 2013, J VIRAL HEPATITIS, V20, P281, DOI 10.1111/j.1365-2893.2012.01649.x; SULEIMAN MNEH, 1980, LANCET, V2, P939; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116816	10.1371/journal.pone.0116816	http://dx.doi.org/10.1371/journal.pone.0116816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693189	Green Published, gold			2022-12-27	WOS:000350061500023
J	Gassman, NR; Coskun, E; Stefanick, DF; Horton, JK; Jaruga, P; Dizdaroglu, M; Wilson, SH				Gassman, Natalie R.; Coskun, Erdem; Stefanick, Donna F.; Horton, Julie K.; Jaruga, Pawel; Dizdaroglu, Miral; Wilson, Samuel H.			Bisphenol A Promotes Cell Survival Following Oxidative DNA Damage in Mouse Fibroblasts	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; BREAST-CANCER; GLYCOSYLASE; EXPOSURE; ENZYME; NEIL1; IDENTIFICATION; GENOTOXICITY; EXPRESSION; RESPONSES	Bisphenol A (BPA) is a biologically active industrial chemical used in production of consumer products. BPA has become a target of intense public scrutiny following concerns about its association with human diseases such as obesity, diabetes, reproductive disorders, and cancer. Recent studies link BPA with the generation of reactive oxygen species, and base excision repair (BER) is responsible for removing oxidatively induced DNA lesions. Yet, the relationship between BPA and BER has yet to be examined. Further, the ubiquitous nature of BPA allows continuous exposure of the human genome concurrent with the normal endogenous and exogenous insults to the genome, and this co-exposure may impact the DNA damage response and repair. To determine the effect of BPA exposure on base excision repair of oxidatively induced DNA damage, cells compromised in double-strand break repair were treated with BPA alone or co-exposed with either potassium bromate (KBrO3) or laser irradiation as oxidative damaging agents. In experiments with KBrO3, co-treatment with BPA partially reversed the KBrO3-induced cytotoxicity observed in these cells, and this was coincident with an increase in guanine base lesions in genomic DNA. The improvement in cell survival and the increase in oxidatively induced DNA base lesions were reminiscent of previous results with alkyl adenine DNA glycosylase-deficient cells, suggesting that BPA may prevent initiation of repair of oxidized base lesions. With laser irradiation-induced DNA damage, treatment with BPA suppressed DNA repair as revealed by several indicators. These results are consistent with the hypothesis that BPA can induce a suppression of oxidized base lesion DNA repair by the base excision repair pathway.	[Gassman, Natalie R.; Stefanick, Donna F.; Horton, Julie K.; Wilson, Samuel H.] NIEHS, Genom Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Coskun, Erdem; Jaruga, Pawel; Dizdaroglu, Miral] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Coskun, Erdem] Gazi Univ, Fac Pharm, Ankara, Turkey	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institute of Standards & Technology (NIST) - USA; Gazi University	Wilson, SH (corresponding author), NIEHS, Genom Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Jaruga, Pawel/M-4378-2015; Wilson, Samuel H/E-6644-2019; Coskun, Erdem/AAR-8312-2020	Wilson, Samuel H/0000-0002-1702-5293; Coskun, Erdem/0000-0002-9927-4188; Jaruga, Pawel/0000-0001-9192-6084; Gassman, Natalie/0000-0002-8488-2332	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01-ES050158, Z01-ES050159];  [1K99ES023813-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050159, ZIAES050159, ZIAES050158, Z01ES050158] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by Research Project Numbers Z01-ES050158 and Z01-ES050159 in the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences. NRG is funded by 1K99ES023813-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Certain commercial equipment or materials are identified in this paper in order to specify adequately the experimental procedure. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose.	Allard P, 2011, CELL CYCLE, V10, P183, DOI 10.4161/cc.10.2.14478; ATKINSON A, 1995, ENVIRON MOL MUTAGEN, V26, P60, DOI 10.1002/em.2850260109; ATKINSON A, 1995, BIOCHEM BIOPH RES CO, V210, P424, DOI 10.1006/bbrc.1995.1678; Audebert M, 2011, ARCH TOXICOL, V85, P1463, DOI 10.1007/s00204-011-0721-2; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Chan MK, 2009, DNA REPAIR, V8, P786, DOI 10.1016/j.dnarep.2009.03.001; Choi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086358; Dizdaroglu M, 2003, MUTAT RES-FUND MOL M, V531, P109, DOI 10.1016/j.mrfmmm.2003.07.003; Dizdaroglu M, 2011, J MOL BIOMARK DIAG S, VS2; Dobrzynska MM, 2013, DRUG CHEM TOXICOL, V36, P19, DOI 10.3109/01480545.2011.644561; Edmonds JS, 2004, BIOCHEM BIOPH RES CO, V319, P556, DOI 10.1016/j.bbrc.2004.05.024; Fernandez SV, 2010, TOXICOL PATHOL, V38, P110, DOI 10.1177/0192623309354108; Fernandez SV, 2012, INT J ONCOL, V41, P369, DOI 10.3892/ijo.2012.1444; Gama V, 2009, CELL DEATH DIFFER, V16, P758, DOI 10.1038/cdd.2009.6; Gassman NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049301; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Horton JK, 2013, DNA REPAIR, V12, P774, DOI 10.1016/j.dnarep.2013.06.004; Iso T, 2006, BIOL PHARM BULL, V29, P206, DOI 10.1248/bpb.29.206; Izzotti A, 2009, MUTAT RES-GEN TOX EN, V679, P28, DOI 10.1016/j.mrgentox.2009.07.011; Jaruga P, 2010, BIOCHEMISTRY-US, V49, P1053, DOI 10.1021/bi902161f; Jaruga P, 2008, FREE RADICAL BIO MED, V45, P1601, DOI 10.1016/j.freeradbiomed.2008.09.019; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; LaPensee EW, 2009, ENVIRON HEALTH PERSP, V117, P175, DOI 10.1289/ehp.11788; Li H, 2013, MUTAT RES-FUND MOL M, V745, P16, DOI 10.1016/j.mrfmmm.2013.03.010; Masaoka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066801; Masaoka A, 2012, J BIOL CHEM, V287, P27648, DOI 10.1074/jbc.M112.370759; Nishimura Y, 2014, CELL BIOL INT, V38, P868, DOI 10.1002/cbin.10269; Reddy PT, 2013, J PROTEOME RES, V12, P1049, DOI 10.1021/pr301037t; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Roth RB, 2002, CANCER RES, V62, P656; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; Tiwari D, 2012, MUTAT RES-GEN TOX EN, V743, P83, DOI 10.1016/j.mrgentox.2011.12.023; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wu HJ, 2013, MUTAT RES-GEN TOX EN, V752, P57, DOI 10.1016/j.mrgentox.2013.01.005; Xin F, 2014, MUTAT RES-GEN TOX EN, V769, P29, DOI 10.1016/j.mrgentox.2014.04.019; Yang YJ, 2009, ENVIRON RES, V109, P797, DOI 10.1016/j.envres.2009.04.014; Yin R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098635	41	34	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118819	10.1371/journal.pone.0118819	http://dx.doi.org/10.1371/journal.pone.0118819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693136	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500131
J	Gu, J; Lau, JTF; Wang, Z; Wu, AMS; Tan, X				Gu, Jing; Lau, Joseph T. F.; Wang, Zixin; Wu, Anise M. S.; Tan, Xuhui			Perceived Empathy of Service Providers Mediates the Association between Perceived Discrimination and Behavioral Intention to Take Up HIV Antibody Testing Again among Men Who Have Sex with Men	PLOS ONE			English	Article							INJECTING DRUG-USERS; HONG-KONG; SELF-STIGMA; RISK BEHAVIORS; UNITED-STATES; CARE MEASURE; TRANSGENDER WOMEN; PLANNED BEHAVIOR; PUBLIC-HEALTH; CONDOM USE	HIV antibody testing is a key measure of HIV prevention for men who have sex with men (MSM). The World Health Organization recommends sexually active and at-risk MSM to take up HIV antibody testing regularly. This study aimed to investigate the prevalence of behavioral intention to take up HIV antibody testing in the next six months among Hong Kong MSM who were ever-testers. An anonymous cross-sectional survey recruited 326 MSM who had taken up HIV antibody testing from gay-friendly venues and internet in Hong Kong. Of the participants, 40.8% had had unprotected anal intercourse with regular or non-regular male sex partners in the last six months; they were at risk of HIV transmission despite experience in HIV antibody testing. Only 37.2% showed a strong intention to take up HIV antibody testing again in the next six months. Adjusted analysis showed that both perceived discrimination toward Hong Kong MSM (AOR = .60, 95% CI:.36-.98) and the CARE Measure assessing perceived empathy of service providers (AOR = 1.05, 95% CI: 1.02-1.08) were significantly associated with intention for retesting. Perceived discrimination, however, became statistically non-significant (AOR = .68, 95% CI:.41-1.14), when both CARE Measure and perceived discrimination entered into the adjusted model. It is warranted to increase HIV retesting rate by removing perceived discrimination and reducing the negative effect of perceived discrimination through enhancement of empathy of service providers.	[Gu, Jing] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Lau, Joseph T. F.; Wang, Zixin] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Lau, Joseph T. F.; Wang, Zixin] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Wu, Anise M. S.] Univ Macau, Fac Social Sci, Dept Psychol, Macau, Peoples R China; [Tan, Xuhui] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; University of Macau; Southern Medical University - China	Lau, JTF (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Wu, Anise M.S./AAJ-4293-2020	Wu, Anise M.S./0000-0001-8174-6581	Hong Kong Council for the AIDS Trust Fund [SPF028]; JTFL	Hong Kong Council for the AIDS Trust Fund; JTFL	The study was funded by Hong Kong Council for the AIDS Trust Fund (ref#SPF028): http://www.atf.gov.hk/eindex.html. The funding was received by JTFL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; Altiner A, 2007, J ANTIMICROB CHEMOTH, V60, P638, DOI 10.1093/jac/dkm254; [Anonymous], 2007, PRISM HIV PREV RISK; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baxter EA, 1995, JEFFERSON J PSYCHIAT, V12, P6; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Bonell C, 2006, HEALTH EDUC RES, V21, P452, DOI 10.1093/her/cyh071; Brick N, 2013, PUBLIC HEALTH NURS, V30, P382, DOI 10.1111/phn.12037; Brohan E, 2010, SCHIZOPHR RES, V122, P232, DOI 10.1016/j.schres.2010.02.1065; Cahill S, 2013, J PUBLIC HEALTH POL, V34, P69, DOI 10.1057/jphp.2012.59; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corrigan PW, 2010, J COMMUNITY PSYCHOL, V38, P259, DOI 10.1002/jcop.20363; Corrigan PW, 2002, CLIN PSYCHOL-SCI PR, V9, P35, DOI 10.1093/clipsy/9.1.35; Department of Health The Government of Hong Kong Special Adminstrative Region, 2012, FAC PRISM HIV PREV R; Edwards N, 2006, PATIENT EDUC COUNS, V63, P3, DOI 10.1016/j.pec.2006.07.008; Emdadi SH, 2007, J RES HEALTH SCI, V7, P25; Foster MD, 2000, J SOC PSYCHOL, V140, P93, DOI 10.1080/00224540009600448; Fung CSC, 2009, FAM PRACT, V26, P398, DOI 10.1093/fampra/cmp044; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P621, DOI 10.1089/apc.2013.0245; Gu J, 2011, PUBLIC HEALTH, V125, P275, DOI 10.1016/j.puhe.2011.01.010; Gu J, 2008, DRUG ALCOHOL DEPEN, V97, P257, DOI 10.1016/j.drugalcdep.2008.03.029; Gu J, 2009, AIDS CARE, V21, P967, DOI 10.1080/09540120802657548; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; Juan S, 2011, CHINA DAILY; Kilmarx PH, 2013, CURR OPIN HIV AIDS, V8, P59, DOI 10.1097/COH.0b013e32835b806e; Lau JTF, 2008, AIDS CARE, V20, P820, DOI 10.1080/09540120701694048; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2013, PREV MED, V57, P813, DOI 10.1016/j.ypmed.2013.09.005; Lau JTF, 2012, AIDS CARE, V24, P59, DOI 10.1080/09540121.2011.592813; Lau JT, 2013, ARCH SEX BEHAV; Lau JTF, 2005, SEX TRANSM INFECT, V81, P113, DOI 10.1136/sti.2004.011767; Li L, 2013, AIDS EDUC PREV, V25, P327, DOI 10.1521/aeap.2013.25.4.327; Liu Hongjie, 2011, Stigma Res Action, V1, P27; Liu JX, 2006, AIDS BEHAV, V10, pS25, DOI 10.1007/s10461-006-9123-5; Liu J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-356; Liu SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-250; Mak WWS, 2010, AM J ORTHOPSYCHIAT, V80, P267, DOI 10.1111/j.1939-0025.2010.01030.x; McDaid LM, 2011, SEX TRANSM INFECT, V87, P221, DOI 10.1136/sti.2010.044560; Mercer SW, 2005, FAM PRACT, V22, P328, DOI 10.1093/fampra/cmh730; Mercer SW, 2004, FAM PRACT, V21, P699, DOI 10.1093/fampra/cmh621; Mercer SW, 2002, BRIT J GEN PRACT, V52, pS9; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nelson JM, 2014, J CLIN NURS, V23, P461, DOI 10.1111/jocn.12183; Norfolk T, 2007, MED EDUC, V41, P690, DOI 10.1111/j.1365-2923.2007.02789.x; Nuwaha F, 2002, East Afr Med J, V79, P626; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P47, DOI 10.1037/0278-6133.13.1.47; Reynolds W J, 1999, J Psychiatr Ment Health Nurs, V6, P363, DOI 10.1046/j.1365-2850.1999.00228.x; Rogers SJ, 2014, AIDS CARE, V26, P538, DOI 10.1080/09540121.2013.844762; Rotheram-Borus MJ, 2000, J ACQ IMMUN DEF SYND, V25, pS105, DOI 10.1097/00126334-200012152-00004; Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64; Rusch N, 2009, BRIT J PSYCHIAT, V195, P551, DOI 10.1192/bjp.bp.109.067157; Sengupta S, 2011, AIDS BEHAV, V15, P1075, DOI 10.1007/s10461-010-9847-0; Shiono Satoshi, 2013, Nihon Koshu Eisei Zasshi, V60, P639; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Steward WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071778; Takacs J, 2013, SEX RES SOC POLICY, V10, P24, DOI 10.1007/s13178-012-0102-5; van Boekel LC, 2013, DRUG ALCOHOL DEPEN, V131, P23, DOI 10.1016/j.drugalcdep.2013.02.018; van Ryn M, 2003, AM J PUBLIC HEALTH, V93, P248, DOI 10.2105/AJPH.93.2.248; Wang Yi, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P636; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Wong LP, 2013, AIDS CARE, V25, P1356, DOI 10.1080/09540121.2013.766302; World Health Organization, 2011, GLOB HLTH SECT STRAT; World Health Organization, 2007, GUID PROV IN HIV TES; Wu Z, 2009, WHO M MSM; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yap MBH, 2012, PSYCHIAT RES, V196, P315, DOI 10.1016/j.psychres.2011.10.004; Zhang HB, 2010, JAIDS-J ACQ IMM DEF, V53, pS88, DOI 10.1097/QAI.0b013e3181c7de63; Zhang L, 2013, SEX TRANSM DIS, V40, P235, DOI 10.1097/OLQ.0b013e31827ca6b9; Zhang YQ, 2012, SEX TRANSM INFECT, V88, P444, DOI 10.1136/sextrans-2011-050295; Zou HC, 2010, JAIDS-J ACQ IMM DEF, V53, pS81, DOI 10.1097/QAI.0b013e3181c7dd2b	74	14	14	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117376	10.1371/journal.pone.0117376	http://dx.doi.org/10.1371/journal.pone.0117376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25693179	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500052
J	Razgado-Hernandez, LF; Espadas-Alvarez, AJ; Reyna-Velazquez, P; Sierra-Sanchez, A; Anaya-Martinez, V; Jimenez-Estrada, I; Bannon, MJ; Martinez-Fong, D; Aceves-Ruiz, J				Razgado-Hernandez, Luis F.; Espadas-Alvarez, Armando J.; Reyna-Velazquez, Patricia; Sierra-Sanchez, Arturo; Anaya-Martinez, Veronica; Jimenez-Estrada, Ismael; Bannon, Michael J.; Martinez-Fong, Daniel; Aceves-Ruiz, Jorge			The Transfection of BDNF to Dopamine Neurons Potentiates the Effect of Dopamine D3 Receptor Agonist Recovering the Striatal Innervation, Dendritic Spines and Motor Behavior in an Aged Rat Model of Parkinson's Disease	PLOS ONE			English	Article							BASAL GANGLIA DYSFUNCTION; SUBSTANTIA-NIGRA; D-3 RECEPTOR; NEUROTROPHIC FACTOR; MESSENGER-RNA; SUBVENTRICULAR ZONE; OPEN-FIELD; IN-VIVO; SOMATOTOPIC ORGANIZATION; HEMIPARKINSONIAN RATS	The progressive degeneration of the dopamine neurons of the pars compacta of substantia nigra and the consequent loss of the dopamine innervation of the striatum leads to the impairment of motor behavior in Parkinson's disease. Accordingly, an efficient therapy of the disease should protect and regenerate the dopamine neurons of the substantia nigra and the dopamine innervation of the striatum. Nigral neurons express Brain Derived Neurotropic Factor (BDNF) and dopamine D3 receptors, both of which protect the dopamine neurons. The chronic activation of dopamine D3 receptors by their agonists, in addition, restores, in part, the dopamine innervation of the striatum. Here we explored whether the over-expression of BDNF by dopamine neurons potentiates the effect of the activation of D3 receptors restoring nigrostriatal innervation. Twelve-month old Wistar rats were unilaterally injected with 6-hydroxydopamine into the striatum. Five months later, rats were treated with the D3 agonist 7-hydroxy-N, N-di-n-propyl-2-aminotetralin (7-OH-DPAT) administered i.p. during 41/2 months via osmotic pumps and the BDNF gene transfection into nigral cells using the neurotensin-polyplex nanovector (a non-viral transfection) that selectively transfect the dopamine neurons via the high-affinity neurotensin receptor expressed by these neurons. Two months after the withdrawal of 7-OH-DPAT when rats were aged (24 months old), immunohistochemistry assays were made. The over-expression of BDNF in rats receiving the D3 agonist normalized gait and motor coordination; in addition, it eliminated the muscle rigidity produced by the loss of dopamine. The recovery of motor behavior was associated with the recovery of the nigral neurons, the dopamine innervation of the striatum and of the number of dendritic spines of the striatal neurons. Thus, the over-expression of BDNF in dopamine neurons associated with the chronic activation of the D3 receptors appears to be a promising strategy for restoring dopamine neurons in Parkinson's disease.	[Razgado-Hernandez, Luis F.; Espadas-Alvarez, Armando J.; Reyna-Velazquez, Patricia; Sierra-Sanchez, Arturo; Jimenez-Estrada, Ismael; Martinez-Fong, Daniel; Aceves-Ruiz, Jorge] CINVESTAV, Dept Fisiol Biofis & Neurociencias, Mexico City 14000, DF, Mexico; [Anaya-Martinez, Veronica] Univ Nacl Autonoma Mexico, Neuromorphol Lab, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico; [Bannon, Michael J.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Martinez-Fong, Daniel] CINVESTAV, Programa Nanociencias & Nanotecnol, Mexico City 14000, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Nacional Autonoma de Mexico; Wayne State University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Aceves-Ruiz, J (corresponding author), CINVESTAV, Dept Fisiol Biofis & Neurociencias, Mexico City 14000, DF, Mexico.	jaceves@fisio.cinvestav.mx		Espadas, Armando J/0000-0002-5776-9713	El Consejo Nacional de Ciencia y Tecnologia (CONACYT) [166638]; El Fondo Sectorial de Innovacion (FINNOVA) [224222]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006470] Funding Source: NIH RePORTER	El Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); El Fondo Sectorial de Innovacion (FINNOVA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by El Consejo Nacional de Ciencia y Tecnologia (CONACYT) grant #166638 (JA) and El Fondo Sectorial de Innovacion (FINNOVA) grant #224222 (DMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LFRH, AEA and PRV were fellows from El Consejo Nacional de Ciencia y Tecnologia (CONACYT).	Alvarez-Maya I, 2001, MOL MED, V7, P186, DOI 10.1007/BF03401952; Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; Avila-Costa MR, 2004, NEUROCHEM RES, V29, P1365, DOI 10.1023/B:NERE.0000026398.86113.7d; Avila-Costa MR, 1999, NEUROSCI LETT, V270, P107, DOI 10.1016/S0304-3940(99)00458-9; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Blochl A, 1996, J BIOL CHEM, V271, P21100; BROWN LL, 1992, P NATL ACAD SCI USA, V89, P7403, DOI 10.1073/pnas.89.16.7403; BROWN LL, 1995, BRAIN RES, V686, P207, DOI 10.1016/0006-8993(95)00457-2; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Casarrubea M, 2006, PHYSIOL BEHAV, V89, P552, DOI 10.1016/j.physbeh.2006.07.014; CENCI MA, 1992, EUR J NEUROSCI, V4, P376, DOI 10.1111/j.1460-9568.1992.tb00885.x; CHIO CL, 1994, MOL PHARMACOL, V45, P51; Collo G, 2008, EUR J NEUROSCI, V28, P1231, DOI 10.1111/j.1460-9568.2008.06423.x; Connor B, 1999, GENE THER, V6, P1936, DOI 10.1038/sj.gt.3301033; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Coronas V, 2004, J NEUROCHEM, V91, P1292, DOI 10.1111/j.1471-4159.2004.02823.x; Diaz J, 1997, J NEUROSCI, V17, P4282; Dickerson JW, 2009, NEUROSCIENCE, V163, P482, DOI 10.1016/j.neuroscience.2009.06.008; DOUBLE KL, 1995, P NATL ACAD SCI USA, V92, P1669, DOI 10.1073/pnas.92.5.1669; Du F, 2005, EUR J NEUROSCI, V22, P2422, DOI 10.1111/j.1460-9568.2005.04438.x; Durieux PF, 2012, EMBO J, V31, P640, DOI 10.1038/emboj.2011.400; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Filipe VM, 2006, J NEUROSCI METH, V153, P55, DOI 10.1016/j.jneumeth.2005.10.006; Fleming Sheila M, 2005, NeuroRx, V2, P495, DOI 10.1602/neurorx.2.3.495; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Glajch KE, 2012, BEHAV BRAIN RES, V230, P309, DOI 10.1016/j.bbr.2011.12.007; Goggi J, 2002, BRAIN RES, V941, P34, DOI 10.1016/S0006-8993(02)02505-2; Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Griffon N, 1997, J NEUROCHEM, V68, P1; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Hernandez-Baltazar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051341; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Im SH, 2010, NEUROSCIENCE, V169, P259, DOI 10.1016/j.neuroscience.2010.04.038; Ingham CA, 1998, J NEUROSCI, V18, P4732; Jaunarajs KLE, 2010, BEHAV PHARMACOL, V21, P627, DOI 10.1097/FBP.0b013e32833e7e80; Kim Y, 2010, J NEUROCHEM, V114, P750, DOI 10.1111/j.1471-4159.2010.06799.x; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Lee HY, 2012, MED BIOL ENG COMPUT, V50, P937, DOI 10.1007/s11517-012-0933-5; LEVESQUE D, 1995, P NATL ACAD SCI USA, V92, P1719, DOI 10.1073/pnas.92.5.1719; Lindner MD, 1999, BEHAV BRAIN RES, V102, P1, DOI 10.1016/S0166-4328(98)00160-0; LINDSAY RM, 1995, NATURE, V373, P289, DOI 10.1038/373289a0; Ma YL, 2011, BRIT MED BULL, V100, P173, DOI 10.1093/bmb/ldr040; Martinez-Fong D, 2012, NANOMED-NANOTECHNOL, V8, P1052, DOI 10.1016/j.nano.2012.02.009; Metz GA, 2005, EUR J NEUROSCI, V22, P735, DOI 10.1111/j.1460-9568.2005.04238.x; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Navarro-Quiroga I, 2002, MOL BRAIN RES, V105, P86, DOI 10.1016/S0169-328X(02)00396-0; PILON C, 1994, EUR J PHARM-MOLEC PH, V268, P129, DOI 10.1016/0922-4106(94)90182-1; Polinski NK, 2014, NEUROBIOL AGING, DOI [10.1016/j.neurobiolaging.2014.11.019, DOI 10.1016/J.NEUROBIOLAGING.2014.11.019]; Politis M, 2011, MOVEMENT DISORD, V26, P1997, DOI 10.1002/mds.23743; Porritt M, 2005, MOVEMENT DISORD, V20, P810, DOI 10.1002/mds.20399; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Razgado LF, 2013, SOC NEUROSCI; Rozas G, 1997, BRAIN RES, V749, P188, DOI 10.1016/S0006-8993(96)01162-6; Rozas G, 1998, J NEUROSCI METH, V83, P165, DOI 10.1016/S0165-0270(98)00078-8; Ryoo HL, 1998, MOVEMENT DISORD, V13, P788, DOI 10.1002/mds.870130506; Sacchetti P, 1999, MOL BRAIN RES, V74, P167, DOI 10.1016/S0169-328X(99)00275-2; SHEN RY, 1994, P NATL ACAD SCI USA, V91, P8920, DOI 10.1073/pnas.91.19.8920; Shin E, 2014, NEUROBIOL DIS, V62, P233, DOI 10.1016/j.nbd.2013.09.021; Singh Shalini, 2006, Indian Journal of Experimental Biology, V44, P699; Soderstrom KE, 2010, EUR J NEUROSCI, V31, P478, DOI 10.1111/j.1460-9568.2010.07077.x; Sokoloff P, 2002, NEUROTOX RES, V4, DOI 10.1080/1029842021000045499; Solis O, 2007, SYNAPSE, V61, P450, DOI 10.1002/syn.20381; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; Takakusaki K, 2003, NEUROSCIENCE, V119, P293, DOI 10.1016/S0306-4522(03)00095-2; Takakusaki K, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-4004-7; Unsicker Klaus, 1994, Progress in Growth Factor Research, V5, P73, DOI 10.1016/0955-2235(94)90018-3; Van Kampen JM, 2006, J NEUROSCI, V26, P7272, DOI 10.1523/JNEUROSCI.0837-06.2006; Van Kampen JM, 2005, NEUROSCIENCE, V136, P381, DOI 10.1016/j.neuroscience.2005.07.054; Van Kampen JM, 2004, EUR J NEUROSCI, V19, P2377, DOI 10.1111/j.0953-816X.2004.03342.x; VENERO JL, 1994, NEUROREPORT, V5, P429, DOI 10.1097/00001756-199401120-00014; Vinuela A, 2008, BRAIN, V131, P3361, DOI 10.1093/brain/awn192; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang XH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-142; WICTORIN K, 1989, NEUROSCIENCE, V30, P313, DOI 10.1016/0306-4522(89)90256-X; Yurek DM, 1996, EXP NEUROL, V137, P105, DOI 10.1006/exnr.1996.0011; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200; ZHOU JW, 1994, BRAIN RES, V656, P147, DOI 10.1016/0006-8993(94)91376-5; Zhou JW, 1997, DEV BRAIN RES, V100, P43, DOI 10.1016/S0165-3806(97)00019-9	82	55	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117391	10.1371/journal.pone.0117391	http://dx.doi.org/10.1371/journal.pone.0117391			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693197	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500053
J	Svalo, J; Sheykhzade, M; Nordling, J; Matras, C; Bouchelouche, P				Svalo, Julie; Sheykhzade, Majid; Nordling, Jorgen; Matras, Christina; Bouchelouche, Pierre			Functional and Molecular Evidence for K(v)7 Channel Subtypes in Human Detrusor from Patients with and without Bladder Outflow Obstruction	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; URINARY-BLADDER; SMOOTH-MUSCLE; BETA-ADRENOCEPTORS; PROTEIN-KINASE; KV7 CHANNELS; K+ CHANNELS; RELAXATION; RETIGABINE; EXPRESSION	The aim of the study was to investigate whether K(v)7 channels and their ancillary beta-subunits, KCNE, are functionally expressed in the human urinary bladder. K(v)7 channels were examined at the molecular level and by functional studies using RT-qPCR and myography, respectively. We found mRNA expression of KCNQ1, KCNQ3-KCNQ5 and KCNE1-5 in the human urinary bladder from patients with normal bladder function (n = 7) and in patients with bladder outflow obstruction (n = 3). Interestingly, a 3.4-fold up-regulation of KCNQ1 was observed in the latter. The K(v)7 channel subtype selective modulators, ML277 (activator of K(v)7.1 channels, 10 mu M) and ML213 (activator of K(v)7.2, K(v)7.4, K(v)7.4/7.5 and K(v)7.5 channels, 10 mu M), reduced the tone of 1 mu M carbachol pre-constricted bladder strips. XE991 (blocker of K(v)7.1-7.5 channels, 10 mu M) had opposing effects as it increased contractions achieved with 20 mM KPSS. Furthermore, we investigated if there is interplay between K(v)7 channels and beta-adrenoceptors. Using cumulative additions of isoprenaline (beta-adrenoceptor agonist) and forskolin (adenylyl cyclase activator) in combination with the K(v)7 channel activator and blocker, retigabine and XE991, we did not find interplay between K(v)7 channels and beta-adrenoceptors in the human urinary bladder. The performed gene expression analysis combined with the organ bath studies imply that compounds that activate K(v)7 channels could be useful for treatment of overactive bladder syndrome.	[Svalo, Julie; Bouchelouche, Pierre] Copenhagen Univ Hosp, Dept Clin Biochem, Smooth Muscle Res Ctr, Koege, Denmark; [Svalo, Julie; Sheykhzade, Majid] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Nordling, Jorgen] Copenhagen Univ Hosp, Dept Urol, Herlev, Denmark; [Matras, Christina] Copenhagen Univ Hosp, Dept Urol, Naestved, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Svalo, J (corresponding author), Copenhagen Univ Hosp, Dept Clin Biochem, Smooth Muscle Res Ctr, Koege, Denmark.	juliesvaloe@hotmail.com		Bouchelouche, Pierre/0000-0002-0441-8194; Sheykhzade, Majid/0000-0002-4561-0326	Region Zealand Health Foundation	Region Zealand Health Foundation	This work was supported by Region Zealand Health Foundation, http://www.regionsjaelland.dk/Sundhed/forskning/forskningsfinansiering/Sider/oekonomi.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Afeli SAY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075875; Anderson UA, 2013, BRIT J PHARMACOL, V169, P1290, DOI 10.1111/bph.12210; Anderson UA, 2009, J UROLOGY, V182, P330, DOI 10.1016/j.juro.2009.02.108; Andersson KE, 2013, J UROLOGY, V190, P1173, DOI 10.1016/j.juro.2013.02.104; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Biers SM, 2006, BJU INT, V98, P1310, DOI 10.1111/j.1464-410X.2006.06564.x; Brickel N, 2012, EPILEPSIA, V53, P606, DOI 10.1111/j.1528-1167.2012.03441.x; Brueggemann LI, 2014, MOL PHARM; Brueggemann LI, 2014, J BIOL CHEM, V289, P2099, DOI 10.1074/jbc.M113.527820; Brueggemann LI, 2012, AM J PHYSIOL-LUNG C, V302, pL120, DOI 10.1152/ajplung.00194.2011; Chadha PS, 2012, HYPERTENSION, V59, P877, DOI 10.1161/HYPERTENSIONAHA.111.187427; Chambard JM, 2005, PFLUG ARCH EUR J PHY, V450, P34, DOI 10.1007/s00424-004-1366-2; Ferro A, 2006, N-S ARCH PHARMACOL, V373, P183, DOI 10.1007/s00210-006-0065-2; Frazier EP, 2005, J PHARMACOL EXP THER, V313, P260, DOI 10.1124/jpet.104.077768; French JA, 2011, NEUROLOGY, V76, P1555, DOI 10.1212/WNL.0b013e3182194bd3; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Igawa Y, 2001, J UROLOGY, V165, P240, DOI 10.1097/00005392-200101000-00071; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Joshi S, 2009, J PHARMACOL EXP THER, V329, P368, DOI 10.1124/jpet.108.147785; King CH, 2014, J COMP NEUROL, V522, P3262, DOI 10.1002/cne.23595; Kurokawa J, 2004, P NATL ACAD SCI USA, V101, P16374, DOI 10.1073/pnas.0405583101; Linley JE, 2012, J PHYSIOL-LONDON, V590, P793, DOI 10.1113/jphysiol.2011.223404; Mani BK, 2013, J CARDIOVASC PHARM, V61, P51, DOI 10.1097/FJC.0b013e3182771708; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mattmann ME, 2012, BIOORG MED CHEM LETT, V22, P5936, DOI 10.1016/j.bmcl.2012.07.060; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Michel MC, 2006, BRIT J PHARMACOL, V147, pS88, DOI 10.1038/sj.bjp.0706619; Mucha M, 2010, J NEUROSCI, V30, P13235, DOI 10.1523/JNEUROSCI.1981-10.2010; Ng FL, 2011, BRIT J PHARMACOL, V162, P42, DOI 10.1111/j.1476-5381.2010.01027.x; Nomiya M, 2003, J UROLOGY, V170, P649, DOI 10.1097/01.ju.0000067621.62736.7c; Potet F, 2001, AM J PHYSIOL-HEART C, V280, pH2038, DOI 10.1152/ajpheart.2001.280.5.H2038; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Rode F, 2010, EUR J PHARMACOL, V638, P121, DOI 10.1016/j.ejphar.2010.03.050; Rose K, 2011, PAIN, V152, P742, DOI 10.1016/j.pain.2010.12.028; Rosenbaum ST, 2012, J CELL MOL MED, V16, P3001, DOI 10.1111/j.1582-4934.2012.01627.x; Sacco E, 2012, THER ADV UROL, V4, P315, DOI 10.1177/1756287212457114; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SCHAAP P, 1993, J BIOL CHEM, V268, P6323; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Stott JB, 2014, DRUG DISCOV TODAY, V19, P413, DOI 10.1016/j.drudis.2013.12.003; Streng T, 2004, J UROLOGY, V172, P2054, DOI 10.1097/01.ju.0000138155.33749.f4; Svalo J, 2011, BASIC CLIN PHARM TOX; Svalo J, 2013, EUR J PHARMACOL, V715, P312, DOI 10.1016/j.ejphar.2013.05.005; Uchida H, 2005, EUR J PHARMACOL, V518, P195, DOI 10.1016/j.ejphar.2005.06.029; Yamaguchi O, 2009, WORLD J UROL, V27, P722, DOI 10.1007/s00345-009-0470-5; Yu HB, 2011, ACS CHEM NEUROSCI, V2, P572, DOI 10.1021/cn200065b; Zaika O, 2007, J NEUROSCI, V27, P8914, DOI 10.1523/JNEUROSCI.1739-07.2007; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019	54	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117350	10.1371/journal.pone.0117350	http://dx.doi.org/10.1371/journal.pone.0117350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692982	Green Submitted, gold, Green Published			2022-12-27	WOS:000350061500050
J	Caetano-Anolles, K; Mishra, S; Rodriguez-Zas, SL				Caetano-Anolles, Kelsey; Mishra, Sanjibita; Rodriguez-Zas, Sandra L.			Synergistic and Antagonistic Interplay between Myostatin Gene Expression and Physical Activity Levels on Gene Expression Patterns in Triceps Brachii Muscles of C57/BL6 Mice	PLOS ONE			English	Article							MYOSIN LIGHT-CHAIN; ALPHA-ACTININ-BINDING; SKELETAL-MUSCLE; LIM PROTEIN; DISCOVERY; EXERCISE; DEFICIENT; REGULATOR; MLP; CARDIOMYOPATHY	Levels of myostatin expression and physical activity have both been associated with transcriptome dysregulation and skeletal muscle hypertrophy. The transcriptome of triceps brachii muscles from male C57/BL6 mice corresponding to two genotypes (wild-type and myostatin-reduced) under two conditions (high and low physical activity) was characterized using RNA-Seq. Synergistic and antagonistic interaction and ortholog modes of action of myostatin genotype and activity level on genes and gene pathways in this skeletal muscle were uncovered; 1,836, 238, and 399 genes exhibited significant (FDR-adjusted P-value < 0.005) activity-by-genotype interaction, genotype and activity effects, respectively. The most common differentially expressed profiles were (i) inactive myostatin-reduced relative to active and inactive wild-type, (ii) inactive myostatin-reduced and active wild-type, and (iii) inactive myostatin-reduced and inactive wild-type. Several remarkable genes and gene pathways were identified. The expression profile of nascent polypeptide-associated complex alpha subunit (Naca) supports a synergistic interaction between activity level and myostatin genotype, while Gremlin 2 (Grem2) displayed an antagonistic interaction. Comparison between activity levels revealed expression changes in genes encoding for structural proteins important for muscle function (including troponin, tropomyosin and myoglobin) and for fatty acid metabolism (some linked to diabetes and obesity, DNA-repair, stem cell renewal, and various forms of cancer). Conversely, comparison between genotype groups revealed changes in genes associated with G1-to-S-phase transition of the cell cycle of myoblasts and the expression of Grem2 proteins that modulate the cleavage of the myostatin propeptide. A number of myostatin-feedback regulated gene products that are primarily regulatory were uncovered, including microRNA impacting central functions and Piezo proteins that make cationic current-controlling mechanosensitive ion channels. These important findings extend hypotheses of myostatin and physical activity master regulation of genes and gene pathways, impacting medical practices and therapies associated with muscle atrophy in humans and companion animal species and genome-enabled selection practices applied to food-production animal species.	[Caetano-Anolles, Kelsey; Mishra, Sanjibita; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Mishra, Sanjibita] Indo US Sci & Technol Forum, Khorana Scholars Program, New Delhi, India; [Mishra, Sanjibita] Natl Inst Technol, Rourkel, India; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Urbana, IL USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; National Institute of Technology (NIT System); National Institute of Technology Rourkela; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.	rodrgzzs@illinois.edu		Caetano-Anolles, Kelsey/0000-0001-6310-6679; Rodriguez-Zas, Sandra/0000-0003-1122-4758	USDA NIFA ILLU [538-632, 538-909]; NIH [R21 DA027548, R21 MH096030]; Khorana Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH096030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027548] Funding Source: NIH RePORTER	USDA NIFA ILLU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Khorana Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The support of USDA NIFA ILLU projects no. 538-632 and 538-909, NIH grant numbers: R21 DA027548 and R21 MH096030 and the Khorana Program is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAIR TH, 1990, AM J PHYSIOL, V259, pR393, DOI 10.1152/ajpregu.1990.259.3.R393; Andruchov O, 2006, J PHYSIOL-LONDON, V571, P231, DOI 10.1113/jphysiol.2005.099770; Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Barash IA, 2005, AM J PHYSIOL-CELL PH, V289, pC1312, DOI 10.1152/ajpcell.00117.2005; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011307; Blankenberg D, 2011, CURR PROTOC MOL BIOL; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Cassar-Malek I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-63; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Cummins B, 1999, BASIC APPL MYOL, V9, P19; DAVIS MJ, 1992, AM J PHYSIOL, V262, pC1083, DOI 10.1152/ajpcell.1992.262.4.C1083; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ecarnot-Laubriet A, 2000, J MOL CELL CARDIOL, V32, P2385, DOI 10.1006/jmcc.2000.1269; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehler E, 2001, J CELL BIOL, V153, P763, DOI 10.1083/jcb.153.4.763; Elmabsout AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036839; Fajardo VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084304; Flick MJ, 2000, J CELL SCI, V113, P1553; Giannesini B, 2013, AM J PHYSIOL-ENDOC M, V305, pE33, DOI 10.1152/ajpendo.00651.2012; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gineste C, 2013, NEUROMUSCULAR DISORD, V23, P357, DOI 10.1016/j.nmd.2012.12.011; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hamrick MW, 2002, CALCIFIED TISSUE INT, V71, P63, DOI 10.1007/s00223-001-1109-8; Harper BD, 2000, BIOCHEM J, V350, P269, DOI 10.1042/0264-6021:3500269; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hinoki A, 2010, HYPERTENSION, V55, P161, DOI 10.1161/HYPERTENSIONAHA.109.143057; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hughes PE, 1999, NEUROSCIENCE, V92, P197, DOI 10.1016/S0306-4522(98)00724-6; Kadi F, 2000, Acta Physiol Scand Suppl, V646, P1; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kingwell BA, 2000, CLIN EXP PHARMACOL P, V27, P239, DOI 10.1046/j.1440-1681.2000.03232.x; KIRBER MT, 1988, PFLUG ARCH EUR J PHY, V412, P339, DOI 10.1007/BF01907549; Knoll Ralph, 2002, Exp Clin Cardiol, V7, P104; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Kozakowska M, 2012, ANTIOXID REDOX SIGN, V16, P113, DOI 10.1089/ars.2011.3964; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Lee Se-Jin, 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P183; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; MacKenzie MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068743; MARKS AR, 1992, J BIOL CHEM, V267, P15459; Matsakas A, 2012, EXP PHYSIOL, V97, P125, DOI 10.1113/expphysiol.2011.063008; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; MORRIS CM, 1991, ONCOGENE, V6, P1093; Mosler S, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.262; NADALGINARD B, 1989, J CLIN INVEST, V84, P1693, DOI 10.1172/JCI114351; Noma T, 2001, BIOCHEM J, V358, P225, DOI 10.1042/0264-6021:3580225; Ocaya PA, 2011, J VASC RES, V48, P23, DOI 10.1159/000317397; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Personius KE, 2010, J APPL PHYSIOL, V109, P886, DOI 10.1152/japplphysiol.00300.2010; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Ravenscroft G, 2008, NEUROMUSCULAR DISORD, V18, P953, DOI 10.1016/j.nmd.2008.09.010; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Rushforth AM, 1998, GENETICS, V150, P1067; SALMONS S, 1969, J PHYSIOL-LONDON, V201, P535, DOI 10.1113/jphysiol.1969.sp008771; SAMSON F, 1992, GENOMICS, V13, P1374, DOI 10.1016/0888-7543(92)90077-6; Savage KJ, 2010, MUSCLE NERVE, V42, P355, DOI 10.1002/mus.21688; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schneeberger D, 2003, DEVELOPMENT, V130, P427, DOI 10.1242/dev.00248; Schneider AG, 1999, AM J PHYSIOL-CELL PH, V276, pC900, DOI 10.1152/ajpcell.1999.276.4.C900; Sriram S, 2014, J BIOL CHEM, V289, P5784, DOI 10.1074/jbc.M113.483115; Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x; Starck CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009170; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Timson DJ, 2003, BIOCHIMIE, V85, P639, DOI 10.1016/S0300-9084(03)00131-7; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Udan RS, 2013, WIRES DEV BIOL, V2, P327, DOI 10.1002/wdev.91; Wang SCM, 2010, MOL CELL ENDOCRINOL, V315, P146, DOI 10.1016/j.mce.2009.07.012; WITTENBERG JB, 1970, PHYSIOL REV, V50, P559, DOI 10.1152/physrev.1970.50.4.559; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Wone B, 2011, COMP BIOCHEM PHYS D, V6, P399, DOI 10.1016/j.cbd.2011.09.003; YU QT, 1993, CIRCULATION, V87, P406, DOI 10.1161/01.CIR.87.2.406; Zhang SZ, 2009, BIOL RES, V42, P121, DOI [10.4067/S0716-97602009000100013, /S0716-97602009000100013]; Zhao BP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-305	91	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116828	10.1371/journal.pone.0116828	http://dx.doi.org/10.1371/journal.pone.0116828			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710176	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900018
J	Nilsson, EK; Ernst, B; Voisin, S; Almen, MS; Benedict, C; Mwinyi, J; Fredriksson, R; Schultes, B; Schioth, HB				Nilsson, Emil K.; Ernst, Barbara; Voisin, Sarah; Almen, Markus Sallman; Benedict, Christian; Mwinyi, Jessica; Fredriksson, Robert; Schultes, Bernd; Schioth, Helgi B.			Roux-En Y Gastric Bypass Surgery Induces Genome-Wide Promoter-Specific Changes in DNA Methylation in Whole Blood of Obese Patients	PLOS ONE			English	Article							ADENOSINE	Context DNA methylation has been proposed to play a critical role in many cellular and biological processes. Objective To examine the influence of Roux-en-Y gastric bypass (RYGB) surgery on genome-wide promoter-specific DNA methylation in obese patients. Promoters are involved in the initiation and regulation of gene transcription. Methods Promoter-specific DNA methylation in whole blood was measured in 11 obese patients (presurgery BMI >35 kg/m(2), 4 females), both before and 6 months after RYGB surgery, as well as once only in a control group of 16 normal-weight men. In addition, body weight and fasting plasma glucose were measured after an overnight fast. Results The mean genome-wide distance between promoter-specific DNA methylation of obese patients at six months after RYGB surgery and controls was shorter, as compared to that at baseline (p < 0.001). Moreover, postsurgically, the DNA methylation of 51 promoters was significantly different from corresponding values that had been measured at baseline (28 upregulated and 23 downregulated, P < 0.05 for all promoters, Bonferroni corrected). Among these promoters, an enrichment for genes involved in metabolic processes was found (n = 36, P < 0.05). In addition, the mean DNA methylation of these 51 promoters was more similar after surgery to that of controls, than it had been at baseline (P < 0.0001). When controlling for the RYGB surgery-induced drop in weight (-24% of respective baseline value) and fasting plasma glucose concentration (-16% of respective baseline value), the DNA methylation of only one out of 51 promoters (similar to 2%) remained significantly different between the pre-and postsurgery time points. Conclusions Epigenetic modifications are proposed to play an important role in the development of and predisposition to metabolic diseases, including type II diabetes and obesity. Thus, our findings may form the basis for further investigations to unravel the molecular effects of gastric bypass surgery.	[Nilsson, Emil K.; Voisin, Sarah; Almen, Markus Sallman; Benedict, Christian; Mwinyi, Jessica; Schioth, Helgi B.] BMC, Dept Neurosci, S-75124 Uppsala, Sweden; [Ernst, Barbara; Schultes, Bernd] eSwiss Med & Surg Ctr, Interdisciplinary Obes Ctr, St Gallen, Switzerland		Nilsson, EK (corresponding author), BMC, Dept Neurosci, Box 593, S-75124 Uppsala, Sweden.	emil.nilsson@neuro.uu.se	Benedict, Christian/K-2190-2017; Fredriksson, Robert/AAH-3921-2019; Schioth, Helgi/AAQ-7239-2020	Benedict, Christian/0000-0002-8911-4068; Fredriksson, Robert/0000-0002-2810-3226; Sallman Almen, Markus/0000-0001-9591-9228; Voisin, Sarah/0000-0002-4074-7083	Swedish Research Council; Swedish Brain Research Foundation; Novo Nordisk Foundation; Olle Enqkvist Byggmastare Foundation; Novo Nordisk Fonden [NNF12OC1016287, NNF15OC0016184, NNF13OC0005723] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Olle Enqkvist Byggmastare Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	Work from CB and HBS is supported by the Swedish Research Council, Swedish Brain Research Foundation, Novo Nordisk Foundation, and Olle Enqkvist Byggmastare Foundation. The funding sources had no input in the design and conduct of this study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Adams TD, 2009, OBESITY, V17, P796, DOI 10.1038/oby.2008.610; Almen MS, 2012, GENOMICS, V99, P132, DOI 10.1016/j.ygeno.2011.12.007; Arias AMP, 2001, METABOLISM, V50, P1030, DOI 10.1053/meta.2001.25800; Baumer N, 2011, J BIOL CHEM, V286, P28210, DOI 10.1074/jbc.M110.203471; Barres R, 2013, CELL REP, V3, P1020, DOI 10.1016/j.celrep.2013.03.018; Bojsen-Moller KN, 2013, J CLIN ENDOCR METAB, V98, pE1066, DOI 10.1210/jc.2013-1286; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; CHAPAL J, 1985, BRIT J PHARMACOL, V86, P565, DOI 10.1111/j.1476-5381.1985.tb08932.x; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Fried M, 2007, INT J OBESITY, V31, P569, DOI 10.1038/sj.ijo.0803560; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Kirchner H, 2014, SURG OBES RELAT DIS; Kirchner H, 2013, TRENDS CELL BIOL, V23, P203, DOI 10.1016/j.tcb.2012.11.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Rusing D, 2006, J PHARM PHARMACOL, V58, P1639, DOI 10.1211/jpp.58.12.0011; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Team RC, 2012, R LANG ENV STAT COMP; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Xu XJ, 2013, EPIGENETICS-US, V8, P522, DOI 10.4161/epi.24506; Yang BT, 2011, DIABETOLOGIA, V54, P360, DOI 10.1007/s00125-010-1967-6	21	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0115186	10.1371/journal.pone.0115186	http://dx.doi.org/10.1371/journal.pone.0115186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710379	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000350683900003
J	Egger, C; Lupinek, C; Ristl, R; Lemell, P; Horak, F; Zieglmayer, P; Spitzauer, S; Valenta, R; Niederberger, V				Egger, Cornelia; Lupinek, Christian; Ristl, Robin; Lemell, Patrick; Horak, Friedrich; Zieglmayer, Petra; Spitzauer, Susanne; Valenta, Rudolf; Niederberger, Verena			Effects of Nasal Corticosteroids on Boosts of Systemic Allergen-Specific IgE Production Induced by Nasal Allergen Exposure	PLOS ONE			English	Article							GRASS-POLLEN IMMUNOTHERAPY; BLOCKING ANTIBODIES; SEASONAL INCREASES; BLOOD LYMPHOCYTES; PHLEUM-PRATENSE; MAJOR ALLERGEN; HAY-FEVER; ASTHMA; CHALLENGE; RESPONSES	Background Allergen exposure via the respiratory tract and in particular via the nasal mucosa boosts systemic allergen-specific IgE production. Intranasal corticosteroids (INCS) represent a first line treatment of allergic rhinitis but their effects on this boost of allergen-specific IgE production are unclear. Aim Here we aimed to determine in a double-blind, placebo-controlled study whether therapeutic doses of an INCS preparation, i.e., nasal fluticasone propionate, have effects on boosts of allergen-specific IgE following nasal allergen exposure. Methods Subjects (n = 48) suffering from grass and birch pollen allergy were treated with daily fluticasone propionate or placebo nasal spray for four weeks. After two weeks of treatment, subjects underwent nasal provocation with either birch pollen allergen Bet v 1 or grass pollen allergen Phl p 5. Bet v 1 and Phl p 5-specific IgE, IgG1-4, IgM and IgA levels were measured in serum samples obtained at the time of provocation and one, two, four, six and eight weeks thereafter. Results Nasal allergen provocation induced a median increase to 141.1% of serum IgE levels to allergens used for provocation but not to control allergens 4 weeks after provocation. There were no significant differences regarding the boosts of allergen-specific IgE between INCS-and placebo-treated subjects. Conclusion In conclusion, the application of fluticasone propionate had no significant effects on the boosts of systemic allergen- specific IgE production following nasal allergen exposure.	[Egger, Cornelia; Lupinek, Christian; Valenta, Rudolf] Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Ristl, Robin] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat, Vienna, Austria; [Lemell, Patrick; Horak, Friedrich; Zieglmayer, Petra] Allergy Ctr Vienna West, Dept Vienna Challenge Chamber, Vienna, Austria; [Spitzauer, Susanne] Med Univ Vienna, Dept Med & Chem Lab Diagnost, Vienna, Austria; [Niederberger, Verena] Med Univ Vienna, Vienna Gen Hosp, Dept Otolaryngol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Niederberger, V (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Dept Otolaryngol, Vienna, Austria.	verena.niederberger@meduniwien.ac.at	Lupinek, Christian/I-3311-2019; Zieglmayer, Petra/AAG-1006-2020	Lupinek, Christian/0000-0002-8612-8245; Ristl, Robin/0000-0002-4163-9236; Lemell, Patrick/0000-0003-0262-4047; Valenta, Rudolf/0000-0001-5944-3365	Austrian Science Fund (FWF) [SFB F4605, F4613]; Christian Doppler Research Association, Vienna, Austria	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Christian Doppler Research Association, Vienna, Austria	This study was supported by grants SFB F4605 and F4613 of the Austrian Science Fund (FWF), by the Christian Doppler Research Association, Vienna, Austria, and by the following research grants from commercial funders: Biomay, Vienna, Austria, and Thermofisher/Phadia, Uppsala, Sweden. Trial Medication was provided by GlaxoSmithKline, Brentford, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERTOFT L, 1994, RESP MED, V88, P373, DOI 10.1016/0954-6111(94)90044-2; Andersson K, 2003, INT ARCH ALLERGY IMM, V130, P87, DOI 10.1159/000069013; Bieber T, 1997, IMMUNOL TODAY, V18, P311, DOI 10.1016/S0167-5699(97)01046-3; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; BOHLE B, 1995, CLIN EXP IMMUNOL, V101, P474; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; Cho YJ, 2000, CLIN EXP ALLERGY, V30, P1576, DOI 10.1046/j.1365-2222.2000.00991.x; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Dente FL, 2000, RESP MED, V94, P1073, DOI 10.1053/rmed.2000.0907; Derendorf H, 2008, ALLERGY, V63, P1292, DOI 10.1111/j.1398-9995.2008.01750.x; Durham SR, 1997, INT ARCH ALLERGY IMM, V113, P128, DOI 10.1159/000237525; Durham SR, 1997, EUR J IMMUNOL, V27, P2899, DOI 10.1002/eji.1830271123; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Egger C, 2010, J ALLERGY CLIN IMMUN, V126, P1312, DOI 10.1016/j.jaci.2010.06.008; FENNERTY AG, 1987, CLIN ALLERGY, V17, P365, DOI 10.1111/j.1365-2222.1987.tb02026.x; Ferreira FD, 1996, J ALLERGY CLIN IMMUN, V97, P95, DOI 10.1016/S0091-6749(96)70287-7; FISCHER A, 1990, IMMUNOLOGY, V71, P473; Fokkens W, 2005, ALLERGY, V60, P583, DOI 10.1111/j.1398-9995.2005.00830.x; Gadermaier E, 2011, ALLERGY, V66, P1174, DOI 10.1111/j.1398-9995.2011.02592.x; Gieras A, 2007, J ALLERGY CLIN IMMUN, V119, P384, DOI 10.1016/j.jaci.2006.09.034; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; Hanf G, 2004, EUR RESPIR J, V23, P414, DOI 10.1183/09031936.04.00024504; Hansen KS, 2001, J CHROMATOGR B, V756, P19, DOI 10.1016/S0378-4347(01)00068-8; HEMADY Z, 1985, J ALLERGY CLIN IMMUN, V75, P304, DOI 10.1016/0091-6749(85)90062-4; HENDERSON LL, 1975, J ALLERGY CLIN IMMUN, V55, P10, DOI 10.1016/S0091-6749(75)80003-0; HENDERSON LL, 1973, J ALLERGY CLIN IMMUN, V52, P352, DOI 10.1016/0091-6749(73)90094-8; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; LAFFER S, 1994, J ALLERGY CLIN IMMUN, V94, P689, DOI 10.1016/0091-6749(94)90176-7; Mosges R, 2009, ASIAN PAC J ALLERGY, V27, P181; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Mothes N, 2003, CLIN EXP ALLERGY, V33, P1198, DOI 10.1046/j.1365-2222.2003.01699.x; Naclerio RM, 1997, J ALLERGY CLIN IMMUN, V100, P505, DOI 10.1016/S0091-6749(97)70143-X; NACLERIO RM, 1993, J ALLERGY CLIN IMMUN, V92, P717, DOI 10.1016/0091-6749(93)90015-8; Niederberger V, 2004, P NATL ACAD SCI USA, V101, P14677, DOI 10.1073/pnas.0404735101; Niederberger V, 2007, INT ARCH ALLERGY IMM, V142, P133, DOI 10.1159/000096439; Passalacqua G, 2000, ALLERGY, V55, P16, DOI 10.1034/j.1398-9995.2000.00370.x; PERONI DG, 1994, AM J RESP CRIT CARE, V149, P1442, DOI 10.1164/ajrccm.149.6.8004296; Pullerits T, 1997, J ALLERGY CLIN IMMUN, V100, P601, DOI 10.1016/S0091-6749(97)70162-3; RAK S, 1994, CLIN EXP ALLERGY, V24, P930, DOI 10.1111/j.1365-2222.1994.tb02724.x; Saini SS, 2002, CURR OPIN IMMUNOL, V14, P694, DOI 10.1016/S0952-7915(02)00404-1; Schappi GF, 1999, CLIN EXP ALLERGY, V29, P633, DOI 10.1046/j.1365-2222.1999.00567.x; SELROOS O, 1995, CHEST, V108, P1228, DOI 10.1378/chest.108.5.1228; Southam DS, 2007, J ALLERGY CLIN IMMUN, V119, P848, DOI 10.1016/j.jaci.2006.12.623; STAHLSKOV P, 1977, CLIN EXP IMMUNOL, V27, P432; van Neerven RJ, 2006, INT ARCH ALLERGY IMM, V141, P119, DOI 10.1159/000094714; Vrtala S, 1998, J IMMUNOL, V160, P6137; VRTALA S, 1993, J IMMUNOL, V151, P4773; ZIEG G, 1994, J ALLERGY CLIN IMMUN, V94, P222, DOI 10.1016/0091-6749(94)90044-2	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0114991	10.1371/journal.pone.0114991	http://dx.doi.org/10.1371/journal.pone.0114991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705889	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100005
J	Hegarty, SE; Hyslop, T; Dicker, AP; Showalter, TN				Hegarty, Sarah E.; Hyslop, Terry; Dicker, Adam P.; Showalter, Timothy N.			Radiation Therapy after Radical Prostatectomy for Prostate Cancer: Evaluation of Complications and Influence of Radiation Timing on Outcomes in a Large, Population-Based Cohort	PLOS ONE			English	Article							ADJUVANT RADIOTHERAPY; SALVAGE RADIOTHERAPY; UNITED-STATES; DISEASE; RISK; CARE	Purpose To evaluate the influence of timing of salvage and adjuvant radiation therapy on outcomes after prostatectomy for prostate cancer. Methods Using the Surveillance, Epidemiology, and End Results-Medicare linked database, we identified prostate cancer patients diagnosed during 1995-2007 who had one or more adverse pathological features after prostatectomy. The final cohort of 6,137 eligible patients included men who received prostatectomy alone (n = 4,509) or with adjuvant (n = 894) or salvage (n = 734) radiation therapy. Primary outcomes were genitourinary, gastrointestinal, and erectile dysfunction events and survival after treatment(s). Results Radiation therapy after prostatectomy was associated with higher rates of gastrointestinal and genitourinary events, but not erectile dysfunction. In adjusted models, earlier treatment with adjuvant radiation therapy was not associated with increased rates of genitourinary or erectile dysfunction events compared to delayed salvage radiation therapy. Early adjuvant radiation therapy was associated with lower rates of gastrointestinal events that salvage radiation therapy, with hazard ratios of 0.80 (95% CI, 0.67-0.95) for procedure-defined and 0.70 (95% CI, 0.59, 0.83) for diagnosis-defined events. There was no significant difference between ART and non-ART groups (SRT or RP alone) for overall survival (HR = 1.13 95% CI = (0.96, 1.34) p = 0.148). Conclusions Radiation therapy after prostatectomy is associated with increased rates of gastrointestinal and genitourinary events. However, earlier radiation therapy is not associated with higher rates of gastrointestinal, genitourinary or sexual events. These findings oppose the conventional belief that delaying radiation therapy reduces the risk of radiation-related complications.	[Hegarty, Sarah E.] Thomas Jefferson Univ, Div Biostat, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Hegarty, Sarah E.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Hyslop, Terry] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA; [Dicker, Adam P.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Dicker, Adam P.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Showalter, Timothy N.] Univ Virginia, Sch Med, Dept Radiat Oncol, Charlottesville, VA 22908 USA	Jefferson University; Jefferson University; Duke University; Jefferson University; Jefferson University; University of Virginia	Showalter, TN (corresponding author), Univ Virginia, Sch Med, Dept Radiat Oncol, Charlottesville, VA 22908 USA.	tns3b@virginia.edu		Showalter, Timothy/0000-0003-1373-8496; Dicker, Adam/0000-0003-0733-3337	Prostate Cancer Foundation Ben Franklin Young Investigator Award; American Cancer Society Institutional Research Grant [08-060-04]	Prostate Cancer Foundation Ben Franklin Young Investigator Award; American Cancer Society Institutional Research Grant(American Cancer Society)	This research was supported by a 2011 Prostate Cancer Foundation Ben Franklin Young Investigator Award (T. N. S.) and an American Cancer Society Institutional Research Grant #08-060-04 (T. N. S. and Kimmel Cancer Center, Thomas Jefferson University). The funders had no role in the following: the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Atkinson EJ, 2008, TECHNICAL REPORT SER; Bekelman JE, 2011, INT J RADIAT ONCOL, V81, pE325, DOI 10.1016/j.ijrobp.2011.02.006; Bernard JR, 2010, INT J RADIAT ONCOL, V76, P735, DOI 10.1016/j.ijrobp.2009.02.049; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Crandley EF, 2014, CANCER MED-US, V3, P397, DOI 10.1002/cam4.205; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Ghia AJ, 2010, UROLOGY, V76, P1169, DOI 10.1016/j.urology.2010.04.047; Giordano SH, 2006, CANCER, V107, P423, DOI 10.1002/cncr.21999; Goldin GH, 2013, JAMA INTERN MED, V173, P1136, DOI 10.1001/jamainternmed.2013.1020; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Hoffman KE, 2011, J UROLOGY, V185, P116, DOI 10.1016/j.juro.2010.08.086; Hu JC, 2009, JAMA-J AM MED ASSOC, V302, P1557, DOI 10.1001/jama.2009.1451; King CR, 2008, INT J RADIAT ONCOL, V71, P346, DOI 10.1016/j.ijrobp.2007.10.008; King CR, 2008, INT J RADIAT ONCOL, V71, P23, DOI 10.1016/j.ijrobp.2007.09.047; Leslie S, 2007, PAPER 184; Mishra MV, 2011, FUTURE ONCOL, V7, P1429, DOI [10.2217/FON.11.120, 10.2217/fon.11.120]; Nielsen ME, 2010, J NATL COMPR CANC NE, V8, P228, DOI 10.6004/jnccn.2010.0015; Ohri N, 2012, EUR J CANCER, V48, P837, DOI 10.1016/j.ejca.2011.08.013; Penson DF, 2007, J UROLOGY, V177, P2020, DOI 10.1016/j.juro.2007.01.121; Potosky AL, 2002, MED CARE, V40, P62; Powell TM, 2012, SAS GLOBAL FORUM, V2012, P10; Schreiber D, 2010, CANCER-AM CANCER SOC, V116, P5757, DOI 10.1002/cncr.25561; Sheets NC, 2012, JAMA-J AM MED ASSOC, V307, P1611, DOI 10.1001/jama.2012.460; Showalter Timothy N, 2012, Int J Radiat Oncol Biol Phys, V82, pe233, DOI 10.1016/j.ijrobp.2011.04.003; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Swanson GP, 2007, UROL ONCOL-SEMIN ORI, V25, P110, DOI 10.1016/j.urolonc.2006.06.003; Thompson IM, 2009, J CLIN ONCOL, V27, P2898, DOI 10.1200/JCO.2008.20.9460; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; Valicenti RK, 2013, INT J RADIAT ONCOL, V86, P822, DOI 10.1016/j.ijrobp.2013.05.029; Virnig BA, 2002, MED CARE, V40, P49; Warren JL, 2002, MED CARE, V40, P3; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Yu JB, 2009, ONCOLOGY-NY, V23, P288	35	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118430	10.1371/journal.pone.0118430	http://dx.doi.org/10.1371/journal.pone.0118430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706657	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100180
J	Izquierdo-Garcia, JL; Viswanath, P; Eriksson, P; Chaumeil, MM; Pieper, RO; Phillips, JJ; Ronen, SM				Izquierdo-Garcia, Jose L.; Viswanath, Pavithra; Eriksson, Pia; Chaumeil, Myriam M.; Pieper, Russell O.; Phillips, Joanna J.; Ronen, Sabrina M.			Metabolic Reprogramming in Mutant IDH1 Glioma Cells	PLOS ONE			English	Article							MUTATIONS; 2-HYDROXYGLUTARATE; DEHYDROGENASE; SPECTROSCOPY; PROFILES	Background Mutations in isocitrate dehydrogenase (IDH) 1 have been reported in over 70% of low-grade gliomas and secondary glioblastomas. IDH1 is the enzyme that catalyzes the oxidative decarboxylation of isocitrate to alpha-ketoglutarate while mutant IDH1 catalyzes the conversion of alpha-ketoglutarate into 2-hydroxyglutarate. These mutations are associated with the accumulation of 2-hydroxyglutarate within the tumor and are believed to be one of the earliest events in the development of low-grade gliomas. The goal of this work was to determine whether the IDH1 mutation leads to additional magnetic resonance spectroscopy (MRS)-detectable changes in the cellular metabolome. Methods Two genetically engineered cell models were investigated, a U87-based model and an E6/E7/hTERT immortalized normal human astrocyte (NHA)-based model. For both models, wild-type IDH1 cells were generated by transduction with a lentiviral vector coding for the wild-type IDH1 gene while mutant IDH1 cells were generated by transduction with a lentiviral vector coding for the R132H IDH1 mutant gene. Metabolites were extracted from the cells using the dual-phase extraction method and analyzed by H-1-MRS. Principal Component Analysis was used to analyze the MRS data. Results Principal Component Analysis clearly discriminated between wild-type and mutant IDH1 cells. Analysis of the loading plots revealed significant metabolic changes associated with the IDH1 mutation. Specifically, a significant drop in the concentration of glutamate, lactate and phosphocholine as well as the expected elevation in 2-hydroxyglutarate were observed in mutant IDH1 cells when compared to their wild-type counterparts. Conclusion The IDH1 mutation leads to several, potentially translatable MRS-detectable metabolic changes beyond the production of 2-hydroxyglutarate.	[Izquierdo-Garcia, Jose L.; Viswanath, Pavithra; Eriksson, Pia; Chaumeil, Myriam M.; Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Pieper, Russell O.; Phillips, Joanna J.] Univ Calif San Francisco, Helen Diller Res Ctr, Dept Neurol Surg, San Francisco, CA 94143 USA; [Pieper, Russell O.; Phillips, Joanna J.; Ronen, Sabrina M.] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Izquierdo-Garcia, JL (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	jose.izquierdo@uscf.edu	Izquierdo-Garcia, Jose/L-3293-2013; Izquierdo Garcia, Jose/L-2654-2015; Viswanath, Pavithra/I-4318-2015	Izquierdo-Garcia, Jose/0000-0002-7907-3776; Viswanath, Pavithra/0000-0003-2980-3109; Chaumeil, Myriam/0000-0002-2110-4613	National Institute of Health [NIH R01CA172845, NIH RO1CA154915, NIH R21CA161545]; NATIONAL CANCER INSTITUTE [R21CA161545, R01CA154915, R01CA172845] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institute of Health NIH R01CA172845 to SMR, National Institute of Health NIH RO1CA154915 to SMR and National Institute of Health NIH R21CA161545 to SMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Andronesi OC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002693; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; Chaumeil MM, 2014, CANCER RES, V74, P4247, DOI 10.1158/0008-5472.CAN-14-0680; Chaumeil MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3429; Chesnelong C, 2014, NEURO-ONCOLOGY, V16, P686, DOI 10.1093/neuonc/not243; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; CuperlovicCulf M, 2013, WOODH PUB SER BIOMED, P1, DOI 10.1533/9781908818263; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Elkhaled A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002796; Eriksson L., 1999, INTRO MULTI MEGAVARI; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Izquierdo-Garcia JL, 2011, PROG NUCL MAG RES SP, V59, P263, DOI 10.1016/j.pnmrs.2011.02.001; Izquierdo-Garcia JL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-363; KENNEDY EP, 1956, CAN J BIOCHEM PHYS, V34, P334, DOI 10.1139/o56-036; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; Lindon JC, 2008, ANNU REV ANAL CHEM, V1, P45, DOI 10.1146/annurev.anchem.1.031207.113026; Lodi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026155; Lodi A, 2011, ACS CHEM BIOL, V6, P169, DOI 10.1021/cb900300j; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Morrison D. F., 1967, MULTIVARIATE STAT ME; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Peet AC, 2007, NMR BIOMED, V20, P692, DOI 10.1002/nbm.1181; Pope WB, 2012, J NEURO-ONCOL, V107, P197, DOI 10.1007/s11060-011-0737-8; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Righi V, 2009, NMR BIOMED, V22, P629, DOI 10.1002/nbm.1377; Ronen SM, 2001, BRIT J CANCER, V84, P691, DOI 10.1054/bjoc.2000.1663; Sonoda Y, 2001, CANCER RES, V61, P4956; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xi YX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-324; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang H, 2012, CLIN CANCER RES, V18, P5562, DOI 10.1158/1078-0432.CCR-12-1773	40	54	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118781	10.1371/journal.pone.0118781	http://dx.doi.org/10.1371/journal.pone.0118781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706986	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100204
J	Karah, N; Samuelsen, O; Zarrilli, R; Sahl, JW; Wai, SN; Uhlin, BE				Karah, Nabil; Samuelsen, Orjan; Zarrilli, Raffaele; Sahl, Jason W.; Wai, Sun Nyunt; Uhlin, Bernt Eric			CRISPR-cas Subtype I-Fb in Acinetobacter baumannii: Evolution and Utilization for Strain Subtyping	PLOS ONE			English	Article							CLONAL LINEAGES; DIVERSITY; SEQUENCE; RESISTANCE; EPIDEMIC; SYSTEM; HOSPITALS; INSIGHTS	Clustered regularly interspaced short palindromic repeats (CRISPR) are polymorphic elements found in the genome of some or all strains of particular bacterial species, providing them with a system of acquired immunity against invading bacteriophages and plasmids. Two CRISPR-Cas systems have been identified in Acinetobacter baumannii, an opportunistic pathogen with a remarkable capacity for clonal dissemination. In this study, we investigated the mode of evolution and diversity of spacers of the CRISPR-cas subtype I-Fb locus in a global collection of 76 isolates of A. baumannii obtained from 14 countries and 4 continents. The locus has basically evolved from a common ancestor following two main lineages and several pathways of vertical descent. However, this vertical passage has been interrupted by occasional events of horizontal transfer of the whole locus between distinct isolates. The isolates were assigned into 40 CRISPR-based sequence types (CST). CST1 and CST23-24 comprised 18 and 9 isolates, representing two main sub-clones of international clones CC1 and CC25, respectively. Epidemiological data showed that some of the CST1 isolates were acquired or imported from Iraq, where it has probably been endemic for more than one decade and occasionally been able to spread to USA, Canada, and Europe. CST23-24 has shown a remarkable ability to cause national outbreaks of infections in Sweden, Argentina, UAE, and USA. The three isolates of CST19 were independently imported from Thailand to Sweden and Norway, raising a concern about the prevalence of CST19 in Thailand. Our study highlights the dynamic nature of the CRISPR-cas subtype I-Fb locus in A. baumannii, and demonstrates the possibility of using a CRISPR-based approach for subtyping a significant part of the global population of A. baumannii.	[Karah, Nabil; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Karah, Nabil; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Samuelsen, Orjan] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway; [Zarrilli, Raffaele] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Zarrilli, Raffaele] CEINGE Biotecnol Avanzate, Naples, Italy; [Sahl, Jason W.] Translat Genom Res Inst, Dept Pathogen Genom, Flagstaff, AZ USA	Umea University; Umea University; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Naples Federico II; CEINGE Biotecnologie Avanzate; Translational Genomics Research Institute	Karah, N (corresponding author), Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.	nabil.karah@molbiol.umu.se	Samuelsen, Ørjan/K-9068-2019; Zarrilli, Raffaele/F-5067-2012; Uhlin, Bernt Eric/AAO-6292-2021	Samuelsen, Ørjan/0000-0002-5525-2614; Zarrilli, Raffaele/0000-0003-4191-9032; Uhlin, Bernt Eric/0000-0002-2991-8072; Wai, Sun Nyunt/0000-0003-4793-4671; , Jason/0000-0002-2497-0138	Swedish Research Council [VR-MH 2010-3031, VR-NT 2012-4638, VR-MH 2013-3878, 349-2007-8673]; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University	This work was supported by project grants from the Swedish Research Council (VR-MH 2010-3031, VR-NT 2012-4638, and VR-MH 2013-3878). The work was performed as part of the Umea Centre for Microbial Research (UCMR) Linnaeus Program supported by Umea University and the Swedish Research Council (349-2007-8673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Almendros C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050797; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bonnin RA, 2012, CLIN MICROBIOL INFEC, V18, pE362, DOI 10.1111/j.1469-0691.2012.03928.x; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Di Popolo A, 2011, CLIN MICROBIOL INFEC, V17, P197, DOI 10.1111/j.1469-0691.2010.03254.x; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; DiMarzio M, 2013, ANTIMICROB AGENTS CH, V57, P4282, DOI 10.1128/AAC.00913-13; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Giannouli M, 2013, BMC INFECT DIS, V13, DOI [10.1186/1471-2334-13-470, 10.1186/1471-2334-13-282]; Gogou V, 2011, J ANTIMICROB CHEMOTH, V66, P2767, DOI 10.1093/jac/dkr390; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hauck Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044597; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Karah N, 2011, MICROB DRUG RESIST, V17, P545, DOI 10.1089/mdr.2011.0089; Karah N, 2011, J MED MICROBIOL, V60, P515, DOI 10.1099/jmm.0.028340-0; Ketter P, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00026-14; Krizova L, 2011, ANTIMICROB AGENTS CH, V55, P3201, DOI 10.1128/AAC.00221-11; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Li H, 2014, J CLIN MICROBIOL, V52, P2955, DOI 10.1128/JCM.00696-14; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nemec A, 1999, J MED MICROBIOL, V48, P287, DOI 10.1099/00222615-48-3-287; ORSKOV F, 1983, J INFECT DIS, V148, P346, DOI 10.1093/infdis/148.2.346; Pettengill JB, 2014, PEERJ, V2, DOI 10.7717/peerj.340; Revathi G, 2013, INT J INFECT DIS, V17, pE1255, DOI 10.1016/j.ijid.2013.07.016; Richter C, 2013, BIOCHEM SOC T, V41, P1468, DOI 10.1042/BST20130151; Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Stietz MS, 2013, INFECT GENET EVOL, V14, P294, DOI 10.1016/j.meegid.2012.12.020; Snitkin ES, 2013, GENOME RES, V23, P1155, DOI 10.1101/gr.154328.112; Sonnevend A, 2013, J MED MICROBIOL, V62, P582, DOI 10.1099/jmm.0.055681-0; Touchon M, 2014, GENOME BIOL EVOL, V6, P2866, DOI 10.1093/gbe/evu225; Turton JF, 2006, J CLIN MICROBIOL, V44, P2630, DOI 10.1128/JCM.00547-06; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008; Zurawski DV, 2012, J BACTERIOL, V194, P1619, DOI 10.1128/JB.06749-11	45	28	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118205	10.1371/journal.pone.0118205	http://dx.doi.org/10.1371/journal.pone.0118205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706932	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100152
J	Lau, C; Nygard, S; Fure, H; Olstad, OK; Holden, M; Lappegard, KT; Brekke, OL; Espevik, T; Hovig, E; Mollnes, TE				Lau, Corinna; Nygard, Stale; Fure, Hilde; Olstad, Ole Kristoffer; Holden, Marit; Lappegard, Knut Tore; Brekke, Ole-Lars; Espevik, Terje; Hovig, Eivind; Mollnes, Tom Eirik			CD14 and Complement Crosstalk and Largely Mediate the Transcriptional Response to Escherichia coli in Human Whole Blood as Revealed by DNA Microarray	PLOS ONE			English	Article							GENE-EXPRESSION; RECEPTOR; TOLL; SEPSIS; LIPOPOLYSACCHARIDE; INFLAMMATION; BIOMARKERS; MICRORNAS; PATTERN; GAMMA	Systemic inflammation like in sepsis is still lacking specific diagnostic markers and effective therapeutics. The first line of defense against intruding pathogens and endogenous damage signals is pattern recognition by e.g., complement and Toll-like receptors (TLR). Combined inhibition of a key complement component (C3 and C5) and TLR-co-receptor CD14 has been shown to attenuate certain systemic inflammatory responses. Using DNA microarray and gene annotation analyses, we aimed to decipher the effect of combined inhibition of C3 and CD14 on the transcriptional response to bacterial challenge in human whole blood. Importantly, combined inhibition reversed the transcriptional changes of 70% of the 2335 genes which significantly responded to heat-inactivated Escherichia coli by on average 80%. Single inhibition was less efficient (p < 0.001) but revealed a suppressive effect of C3 on 21% of the responding genes which was partially counteracted by CD14. Furthermore, CD14 dependency of the Escherichia coli-induced response was increased in C5-deficient compared to C5-sufficient blood. The observed crucial distinct and synergistic roles for complement and CD14 on the transcriptional level correspond to their broad impact on the inflammatory response in human blood, and their combined inhibition may become inevitable in the early treatment of acute systemic inflammation.	[Lau, Corinna; Fure, Hilde; Brekke, Ole-Lars; Mollnes, Tom Eirik] Nordland Hosp, Res Lab, Bodo, Norway; [Lau, Corinna; Fure, Hilde; Brekke, Ole-Lars; Mollnes, Tom Eirik] Nordland Hosp, Dept Lab Med, Bodo, Norway; [Nygard, Stale; Hovig, Eivind] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Nygard, Stale; Hovig, Eivind] Oslo Univ Hosp, Bioinformat Core Facil, Oslo, Norway; [Nygard, Stale; Hovig, Eivind] Oslo Univ Hosp, Inst Med Informat, Oslo, Norway; [Olstad, Ole Kristoffer] OUS, Dept Med Biochem, Oslo, Norway; [Holden, Marit] Norwegian Comp Ctr, Oslo, Norway; [Lappegard, Knut Tore; Brekke, Ole-Lars; Mollnes, Tom Eirik] Univ Tromso, Fac Hlth Sci, Tromso, Norway; [Lappegard, Knut Tore] Nordland Hosp, Div Med, Bodo, Norway; [Espevik, Terje; Mollnes, Tom Eirik] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway; [Hovig, Eivind] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Dept Canc Genet & Informat, Oslo, Norway; [Mollnes, Tom Eirik] Oslo Univ Hosp, Rikshosp, Inst Immunol, Oslo, Norway; [Mollnes, Tom Eirik] Univ Oslo, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Lau, C (corresponding author), Nordland Hosp, Res Lab, Bodo, Norway.	corinna.lau@nordlandssykehuset.no	Hovig, Eivind/H-2474-2011; Mollnes, Tom/ABI-5183-2020; Nygård, Ståle/AGU-4330-2022	Hovig, Eivind/0000-0002-9103-1077; Lau, Corinna/0000-0003-1750-8065; Nygard, Stale/0000-0002-5263-4748	Northern Norway Regional Health Authority [SFP914-10]	Northern Norway Regional Health Authority	This work was supported by the Northern Norway Regional Health Authority (Grant SFP914-10 to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt-Due A, 2012, IMMUNOBIOLOGY, V217, P1047, DOI 10.1016/j.imbio.2012.07.019; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Chuang SY, 2013, P NATL ACAD SCI USA, V110, P16079, DOI 10.1073/pnas.1306556110; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fan HK, 2011, BBA-MOL CELL RES, V1813, P466, DOI 10.1016/j.bbamcr.2011.01.012; Finch AM, 1999, J MED CHEM, V42, P1965, DOI 10.1021/jm9806594; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; Hobson MJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10527; Hou YZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2270; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Katragadda M, 2006, J MED CHEM, V49, P4616, DOI 10.1021/jm0603419; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CY, 2012, J IMMUNOL, V188, P6328, DOI 10.4049/jimmunol.1102266; Mollnes TE, 2002, BLOOD, V100, P1869; Mollnes TE, 2008, ADV EXP MED BIOL, V632, P253, DOI 10.1007/978-0-387-78952-1_18; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Oku R, 2013, CYTOKINE, V61, P112, DOI 10.1016/j.cyto.2012.09.003; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Rivers EP, 2013, SHOCK, V39, P127, DOI 10.1097/SHK.0b013e31827dafa7; Seow V, 2013, J IMMUNOL, V191, P4308, DOI 10.4049/jimmunol.1301355; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Wang HJ, 2012, J TRAUMA ACUTE CARE, V73, P850, DOI 10.1097/TA.0b013e31825a7560; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Warnes GR, 2012, VENABLES B GPLOTS VA; Weber C, 2012, IMMUNOLOGY, V136, P64, DOI 10.1111/j.1365-2567.2012.03559.x; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Yan CG, 2012, J BIOL CHEM, V287, P3217, DOI 10.1074/jbc.M111.280834	42	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117261	10.1371/journal.pone.0117261	http://dx.doi.org/10.1371/journal.pone.0117261			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706641	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100070
J	Ning, BT; Feldkamp, MD; Cortez, D; Chazin, WJ; Friedman, KL; Fanning, E				Ning, Boting; Feldkamp, Michael D.; Cortez, David; Chazin, Walter J.; Friedman, Katherine L.; Fanning, Ellen			Simian Virus Large T Antigen Interacts with the N-Terminal Domain of the 70 kD Subunit of Replication Protein A in the Same Mode as Multiple DNA Damage Response Factors	PLOS ONE			English	Article							SV40 LARGE-T; BINDING; CHECKPOINT; COMPLEX; RPA; TRANSFORMATION; INITIATION; PATHWAYS; HELICASE; MUTANTS	Simian virus 40 (SV40) serves as an important model organism for studying eukaryotic DNA replication. Its helicase, Large T-antigen (Tag), is a multi-functional protein that interacts with multiple host proteins, including the ubiquitous ssDNA binding protein Replication Protein A (RPA). Tag recruits RPA, actively loads it onto the unwound DNA, and together they promote priming of the template. Although interactions of Tag with RPA have been mapped, no interaction between Tag and the N-terminal protein interaction domain of the RPA 70kDa subunit (RPA70N) has been reported. Here we provide evidence of direct physical interaction of Tag with RPA70N and map the binding sites using a series of pull-down and mutational experiments. In addition, a monoclonal anti-Tag antibody, the epitope of which overlaps with the binding site, blocks the binding of Tag to RPA70N. We use NMR chemical shift perturbation analysis to show that Tag uses the same basic cleft in RPA70N as multiple of DNA damage response proteins. Mutations in the binding sites of both RPA70N and Tag demonstrate that specific charge reversal substitutions in either binding partner strongly diminish the interaction. These results expand the known repertoire of contacts between Tag and RPA, which mediate the many critical roles of Tag in viral replication.	[Ning, Boting; Friedman, Katherine L.; Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Feldkamp, Michael D.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Feldkamp, Michael D.; Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Feldkamp, Michael D.; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	Walter.chazin@vanderbit.edu; Katherine.friedman@vanderbilt.edu			National Institutes of Health (NIH) [RO1 GM52948, RO1 GM65484]; NIH grants [F32 ES021690, P30 ES00267, P30 CA6868485, S10 RR025677]; Vanderbilt University matching funds; NATIONAL CANCER INSTITUTE [R13CA068684] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, F32ES021690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065484, R01GM052948] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University matching funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by operating grants from the National Institutes of Health (NIH; www.nih.gov) RO1 GM52948 to EF/KLF and RO1 GM65484 to WJC, as well as NIH grants F32 ES021690 to MDF, P30 ES00267 to the Vanderbilt Center in Molecular Toxicology, and P30 CA6868485 to the Vanderbilt-Ingram Cancer Center. The NMR instrumentation was supported by NIH S10 RR025677 and Vanderbilt University matching funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; An P, 2012, ANNU REV MICROBIOL, V66, P213, DOI 10.1146/annurev-micro-092611-150154; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; CLARK R, 1983, MOL CELL BIOL, V3, P220, DOI 10.1128/MCB.3.2.220; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Frank AO, 2014, J MED CHEM, V57, P2455, DOI 10.1021/jm401730y; Guler GD, 2012, J BIOL CHEM, V287, P6469, DOI 10.1074/jbc.M111.324582; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; KALDERON D, 1984, VIROLOGY, V139, P109, DOI 10.1016/0042-6822(84)90334-9; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; MANOS MM, 1985, J VIROL, V53, P120, DOI 10.1128/JVI.53.1.120-127.1985; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Pipas JM, 1983, MOL CELL BIOL, V3, P204; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; Stenlund A, 2003, NAT REV MOL CELL BIO, V4, P777, DOI 10.1038/nrm1226; STILLMAN B, 1985, EMBO J, V4, P2933, DOI 10.1002/j.1460-2075.1985.tb04026.x; TEGTMEYER P, 1972, J VIROL, V10, P591, DOI 10.1128/JVI.10.4.591-598.1972; WAGA S, 1994, J BIOL CHEM, V269, P10923; Wang M, 2000, NUCLEIC ACIDS RES, V28, P4742, DOI 10.1093/nar/28.23.4742; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Williams CK, 2012, ARCH BIOCHEM BIOPHYS, V518, P111, DOI 10.1016/j.abb.2011.12.014; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08	31	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116093	10.1371/journal.pone.0116093	http://dx.doi.org/10.1371/journal.pone.0116093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706313	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100027
J	van Zelst, C; van Nierop, M; van Dam, DS; Bartels-Velthuis, AA; Delespaul, P				van Zelst, Catherine; van Nierop, Martine; van Dam, Daniella S.; Bartels-Velthuis, Agna A.; Delespaul, Philippe		GRP-Investigators	Associations between Stereotype Awareness, Childhood Trauma and Psychopathology: A Study in People with Psychosis, Their Siblings and Controls	PLOS ONE			English	Article							NEGATIVE-SYNDROME-SCALE; SEVERE MENTAL-ILLNESS; SELF-STIGMA; INTERNALIZED STIGMA; SCHIZOPHRENIA; EXPERIENCES; ESTEEM; MODEL; SENSITIVITY; ENVIRONMENT	Introduction Stereotype awareness-or an individual's perception of the degree to which negative beliefs or stereotypes are held by the public-is an important factor mediating public stigma, self-stigma and their negative consequences. Research is required to assess how individuals become more sensitive to perceive stereotypes, pointing the way to therapeutic options to reduce its negative effects and increase stigma resilience. Because perception and interpretation can be guided by belief systems, and childhood trauma (CT) is reported to impact such beliefs, CT is explored in relation to stereotype awareness (SA) in persons with psychosis, their siblings and controls. Method Data from the GROUP project (Genetic Risk and Outcome of Psychosis) were analyzed. SA was measured by devaluation scales which assess a respondent's perception of the degree to which stereotypes about people with mental illness and about their families are held by the public. CT was measured using the Childhood Trauma Questionnaire (short form). Results In patients, symptoms of disorganization and emotional distress were associated with SA about people with mental illness. In siblings, schizotypal features were associated with both types of SA (more schizotypy = more SA). In both patients and siblings, CT was associated with both types of SA (more CT = more SA), independent of symptoms (patients) or schizotypy (siblings). Conclusion CT in people with psychosis and their siblings may sensitize to SA. Thus, CT may not only impact on risk for illness onset, it may also increase SA associated with mental illness, potentially interfering with the recovery process. CT-induced SA may indicate a heightened sensitivity to threat, which may also impact psychopathology.				ph.delespaul@maastrichtuniversity.nl	Delespaul, Philippe/L-1396-2019; van Os, Jim/C-2113-2014; Myin-Germeys, Inez/L-5106-2014; Delespaul, Philippe/E-8982-2011	Delespaul, Philippe/0000-0001-7420-0898; Delespaul, Philippe/0000-0001-7420-0898; van Nierop, Martine/0000-0003-2734-0550; Bruggeman, Richard/0000-0002-3238-8471; Myin-Germeys, Inez/0000-0002-3731-4930	Geestkracht program of the Dutch Health Research Council (ZON-MW) [10-000-1002]; mental health care organizations (Site Amsterdam: Academic Psychiatric Centre AMC); mental health care organizations (Site Amsterdam: Ingeest); mental health care organizations (Site Amsterdam: Arkin); mental health care organizations (Site Amsterdam: Dijk en Duin); mental health care organizations (Site Amsterdam: Rivierduinen); mental health care organizations (Site Amsterdam: Erasmus MC); mental health care organizations (Site Amsterdam: GGZ Noord Holland Noord); mental health care organizations (Site Utrecht: University Medical Centre Utrecht); mental health care organizations (Site Utrecht: Altrecht); mental health care organizations (Site Utrecht: Symfora); mental health care organizations (Site Utrecht: Meerkanten); mental health care organizations (Site Utrecht: Riagg Amersfoort); mental health care organizations (Site Utrecht: Delta); mental health care organizations (Site Groningen: University Medical Centre Groningen); mental health care organizations (Site Groningen: Lentis); mental health care organizations (Site Groningen: GGZ Friesland); mental health care organizations (Site Groningen: GGZ Drenthe); mental health care organizations (Site Groningen: Dimence); mental health care organizations (Site Groningen: Mediant); mental health care organizations (Site Groningen: GGZ De Grote Rivieren); mental health care organizations (Site Groningen: Parnassia psychomedical centre); mental health care organizations (Site Maastricht: Maastricht University Medical Centre); mental health care organizations (Site Maastricht: GGZ Eindhoven); mental health care organizations (Site Maastricht: GGZ Midden-Brabant); mental health care organizations (Site Maastricht: GGZ Oost-Brabant); mental health care organizations (Site Maastricht: GGZ Noord-Midden Limburg); mental health care organizations (Site Maastricht: Mondriaan Zorggroep); mental health care organizations (Site Maastricht: Prins Clauscentrum Sittard); mental health care organizations (Site Maastricht: RIAGG Roermond); mental health care organizations (Site Maastricht: Universitair Centrum Sint-Jozef Kortenberg); mental health care organizations (Site Maastricht: CAPRI University of Antwerp); mental health care organizations (Site Maastricht: PC Ziekeren Sint-Truiden); mental health care organizations (Site Maastricht: PZ Sancta Maria Sint-Truiden); mental health care organizations (Site Maastricht: GGZ Overpelt); mental health care organizations (Site Maastricht: OPZ Rekem); Jansen-Cilag; Eli Lilly; Astra-Zeneca; Lundbeck; European Community [HEALTH-F2-2009-241909]	Geestkracht program of the Dutch Health Research Council (ZON-MW); mental health care organizations (Site Amsterdam: Academic Psychiatric Centre AMC); mental health care organizations (Site Amsterdam: Ingeest); mental health care organizations (Site Amsterdam: Arkin); mental health care organizations (Site Amsterdam: Dijk en Duin); mental health care organizations (Site Amsterdam: Rivierduinen); mental health care organizations (Site Amsterdam: Erasmus MC); mental health care organizations (Site Amsterdam: GGZ Noord Holland Noord); mental health care organizations (Site Utrecht: University Medical Centre Utrecht); mental health care organizations (Site Utrecht: Altrecht); mental health care organizations (Site Utrecht: Symfora); mental health care organizations (Site Utrecht: Meerkanten); mental health care organizations (Site Utrecht: Riagg Amersfoort); mental health care organizations (Site Utrecht: Delta); mental health care organizations (Site Groningen: University Medical Centre Groningen); mental health care organizations (Site Groningen: Lentis); mental health care organizations (Site Groningen: GGZ Friesland); mental health care organizations (Site Groningen: GGZ Drenthe); mental health care organizations (Site Groningen: Dimence); mental health care organizations (Site Groningen: Mediant); mental health care organizations (Site Groningen: GGZ De Grote Rivieren); mental health care organizations (Site Groningen: Parnassia psychomedical centre); mental health care organizations (Site Maastricht: Maastricht University Medical Centre); mental health care organizations (Site Maastricht: GGZ Eindhoven); mental health care organizations (Site Maastricht: GGZ Midden-Brabant); mental health care organizations (Site Maastricht: GGZ Oost-Brabant); mental health care organizations (Site Maastricht: GGZ Noord-Midden Limburg); mental health care organizations (Site Maastricht: Mondriaan Zorggroep); mental health care organizations (Site Maastricht: Prins Clauscentrum Sittard); mental health care organizations (Site Maastricht: RIAGG Roermond); mental health care organizations (Site Maastricht: Universitair Centrum Sint-Jozef Kortenberg); mental health care organizations (Site Maastricht: CAPRI University of Antwerp); mental health care organizations (Site Maastricht: PC Ziekeren Sint-Truiden); mental health care organizations (Site Maastricht: PZ Sancta Maria Sint-Truiden); mental health care organizations (Site Maastricht: GGZ Overpelt); mental health care organizations (Site Maastricht: OPZ Rekem); Jansen-Cilag; Eli Lilly(Eli Lilly); Astra-Zeneca(AstraZeneca); Lundbeck(Lundbeck Corporation); European Community(European Commission)	This work was supported by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number 10-000-1002) and matching funds from participating universities and mental health care organizations (Site Amsterdam: Academic Psychiatric Centre AMC, Ingeest, Arkin, Dijk en Duin, Rivierduinen, Erasmus MC, GGZ Noord Holland Noord; Site Utrecht: University Medical Centre Utrecht, Altrecht, Symfora, Meerkanten, Riagg Amersfoort, Delta; Site Groningen: University Medical Centre Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGZ De Grote Rivieren, and Parnassia psychomedical centre; Site Maastricht: Maastricht University Medical Centre, GGZ Eindhoven, GGZ Midden-Brabant, GGZ Oost-Brabant, GGZ Noord-Midden Limburg, Mondriaan Zorggroep, Prins Clauscentrum Sittard, RIAGG Roermond, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem). The analyses were supported by unrestricted grants from Jansen-Cilag, Eli Lilly and Company, Astra-Zeneca and Lundbeck. The research leading to these results has received funding from the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams Madeleine Seifter, 2009, Am J Psychother, V63, P305; Ahmed AO, 2012, ACTA PSYCHIAT SCAND, V125, P54, DOI 10.1111/j.1600-0447.2011.01800.x; APA, 2000, DIAGN STAT MAN MENT; Beck A, 1979, COGNITIVE THERAPY DE; Bendall S, 2013, EARLY INTERV PSYCHIA, V7, P1, DOI 10.1111/eip.12008; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Collip D, 2008, SCHIZOPHRENIA BULL, V34, P220, DOI 10.1093/schbul/sbm163; Corrigan PW, 2006, J SOC CLIN PSYCHOL, V25, P875, DOI 10.1521/jscp.2006.25.8.875; Corrigan PW, 2005, ON THE STIGMA OF MENTAL ILLNESS: PRACTICAL STRATEGIES FOR RESEARCH AND SOCIAL CHANGE, P11, DOI 10.1037/10887-001; Crocker J., 1998, HDB SOCIAL PSYCHOL, V4th ed, P504, DOI DOI 10.1002/9780470561119; Downey G, 1996, J PERS SOC PSYCHOL, V70, P1327, DOI 10.1037/0022-3514.70.6.1327; Ewertzon Mats, 2012, Issues Ment Health Nurs, V33, P157, DOI 10.3109/01612840.2011.633735; Fallot RD, 2002, COMMUNITY MENT HLT J, V38, P475, DOI 10.1023/A:1020880101769; Garety PA, 2001, PSYCHOL MED, V31, P189, DOI 10.1017/S0033291701003312; Garety PA, 2007, PSYCHOL MED, V37, P1377, DOI 10.1017/S003329170700013X; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Harvey MR, 1996, J TRAUMA STRESS, V9, P3, DOI 10.1007/BF02116830; Hasson-Ohayon I, 2014, COMPR PSYCHIAT, V55, P675, DOI 10.1016/j.comppsych.2013.11.009; Hasson-Ohayon I, 2012, PSYCHIAT RES, V200, P802, DOI 10.1016/j.psychres.2012.07.038; Hasson-Ohayon I, 2011, COMPR PSYCHIAT, V52, P75, DOI 10.1016/j.comppsych.2010.04.008; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Iwaniec D., 2006, CHILD FAMILY SOCIAL, V11, P73, DOI [10.1111/j.1365-2206.2006.00398.x, DOI 10.1111/J.1365-2206.2006.00398.X]; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Kranke DA, 2011, PSYCHIAT SERV, V62, P893, DOI 10.1176/ps.62.8.pss6208_0893; Lardinois M, 2011, ACTA PSYCHIAT SCAND, V123, P28, DOI 10.1111/j.1600-0447.2010.01594.x; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; LINK BG, 1989, AM SOCIOL REV, V54, P400, DOI 10.2307/2095613; Lysaker PH, 2007, PSYCHIAT RES, V149, P89, DOI 10.1016/j.psychres.2006.03.007; Mak WWS, 2008, J APPL RES INTELLECT, V21, P532, DOI 10.1111/j.1468-3148.2008.00426.x; Mashiach-Eizenberg M, 2013, PSYCHIAT RES, V208, P15, DOI 10.1016/j.psychres.2013.03.013; Nabors LM, 2014, COMPR PSYCHIAT, V55, P792, DOI 10.1016/j.comppsych.2014.01.011; Outcalt SD, 2012, PSYCHOSIS, V4, P32, DOI 10.1080/17522439.2011.591422; Perlick DA, 2007, BRIT J PSYCHIAT, V190, P535, DOI 10.1192/bjp.bp.105.020826; Pineles SL, 2007, BEHAV RES THER, V45, P1903, DOI 10.1016/j.brat.2006.08.021; Pineles SL, 2009, BEHAV RES THER, V47, P1050, DOI 10.1016/j.brat.2009.08.001; Platt M, 2012, PSYCHOL TRAUMA-US, V4, P370, DOI 10.1037/a0024253; Read J, 2008, ATTACH NEW DIR PSYCH, V2, P1; Roe D, 2010, J NERV MENT DIS, V198, P807, DOI 10.1097/NMD.0b013e3181f97c50; Rosenbach C, 2011, VERHALTENSTHERAPIE, V21, P87, DOI 10.1159/000328839; Rusch N, 2009, ACTA PSYCHIAT SCAND, V120, P320, DOI 10.1111/j.1600-0447.2009.01403.x; Schneider DavidJ., 2004, PSYCHOL STEREOTYPING; Schulze B, 2003, SOC SCI MED, V56, P299, DOI 10.1016/S0277-9536(02)00028-X; Sin J, 2008, J PSYCHOSOC NURS, V46, P33, DOI 10.3928/02793695-20080601-11; Stalberg G, 2004, SCHIZOPHRENIA BULL, V30, P445, DOI 10.1093/oxfordjournals.schbul.a007091; Statacorp, 2009, STAT STAT SOFTW REL; Struening FL, 2001, PSYCHIATR SERV, V52, P1633; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; van Zelst C, 2008, SCHIZOPHRENIA BULL, V34, P1106, DOI 10.1093/schbul/sbn113; van Zelst C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088586; vandeBongardt Daphne, 2014, PSYCHOL MED, V19, P1, DOI [10.1186/1687-9856-2014-15, DOI 10.1186/1687-9856-2014-15]; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482; Yanos PT, 2012, PSYCHOL SERV, V9, P248, DOI 10.1037/a0028048	54	5	5	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117386	10.1371/journal.pone.0117386	http://dx.doi.org/10.1371/journal.pone.0117386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25705878	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100085
J	Wang, H; Xu, QS; Zhou, LF				Wang, Hong; Xu, Qingsong; Zhou, Lifeng			Large Unbalanced Credit Scoring Using Lasso-Logistic Regression Ensemble	PLOS ONE			English	Article							CLASSIFICATION ALGORITHMS; NEURAL-NETWORKS; MODELS; SELECTION; CRITERIA; MACHINE; RISK	Recently, various ensemble learning methods with different base classifiers have been proposed for credit scoring problems. However, for various reasons, there has been little research using logistic regression as the base classifier. In this paper, given large unbalanced data, we consider the plausibility of ensemble learning using regularized logistic regression as the base classifier to deal with credit scoring problems. In this research, the data is first balanced and diversified by clustering and bagging algorithms. Then we apply a Lasso-logistic regression learning ensemble to evaluate the credit risks. We show that the proposed algorithm outperforms popular credit scoring models such as decision tree, Lasso-logistic regression and random forests in terms of AUC and F-measure. We also provide two importance measures for the proposed model to identify important variables in the data.	[Wang, Hong; Xu, Qingsong; Zhou, Lifeng] Cent South Univ, Sch Math & Stat, Changsha, Hunan, Peoples R China	Central South University	Zhou, LF (corresponding author), Cent South Univ, Sch Math & Stat, Changsha, Hunan, Peoples R China.	lfzhou@csu.edu.cn	Xu, Qingsong/G-6562-2012; Wang, Hong/Q-4557-2016	Wang, Hong/0000-0002-6938-9507; Zhou, Lifeng/0000-0001-7038-0967				Abdou HA, 2011, INTELL SYST ACCOUNT, V18, P59, DOI 10.1002/isaf.325; Adler J, 2010, R NUTSHELL DESKTOP Q; Alejo R., 2013, ADV INTELLIGENT SYST, V220, P1, DOI [DOI 10.1007/978-3-319-00569-0_1, 10.1007/978-3-319-00569-0_1]; ALTMAN EI, 1968, J FINANC, V23, P589, DOI 10.2307/2978933; ALTMAN EI, 1994, J BANK FINANC, V18, P505, DOI 10.1016/0378-4266(94)90007-8; ANG JS, 1979, J MONEY CREDIT BANK, V11, P222, DOI 10.2307/1991836; Arminger G, 1997, COMPUTATIONAL STAT, V12; Baesens B, 2003, J OPER RES SOC, V54, P627, DOI 10.1057/palgrave.jors.2601545; Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Bellotti T, 2009, EXPERT SYST APPL, V36, P3302, DOI 10.1016/j.eswa.2008.01.005; Bhattacharyya S, 2011, DECIS SUPPORT SYST, V50, P602, DOI 10.1016/j.dss.2010.08.008; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown I, 2012, EXPERT SYST APPL, V39, P3446, DOI 10.1016/j.eswa.2011.09.033; Demsar J, 2006, J MACH LEARN RES, V7, P1; Desai VS, 1996, EUR J OPER RES, V95, P24, DOI 10.1016/0377-2217(95)00246-4; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Durand D, 1941, RISK ELEMENTS COUNSU; Freund Y, 1995, COMPUTATIONAL LEARNI, P23, DOI [10.1007/3-540-59119-2_166, DOI 10.1007/3-540-59119-2_166]; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Fumera G, 2005, IEEE T PATTERN ANAL, V27, P942, DOI 10.1109/TPAMI.2005.109; Galar M, 2012, IEEE T SYST MAN CY C, V42, P463, DOI 10.1109/TSMCC.2011.2161285; Garcia S, 2013, IEEE T KNOWL DATA EN, V25, P734, DOI 10.1109/TKDE.2012.35; Garcia V, 2012, KNOWL-BASED SYST, V25, P13, DOI 10.1016/j.knosys.2011.06.013; Garcia V, 2012, LECT NOTES COMPUT SC, V7664, P68, DOI 10.1007/978-3-642-34481-7_9; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Han L, 2013, ENG APPL ARTIF INTEL, V26, P848, DOI 10.1016/j.engappai.2012.10.005; Hastie T., 2009, UNSUPERVISED LEARNIN; Hsieh NC, 2010, EXPERT SYST APPL, V37, P534, DOI 10.1016/j.eswa.2009.05.059; Hsieh NC, 2005, EXPERT SYST APPL, V28, P655, DOI 10.1016/j.eswa.2004.12.022; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Hyndman RobJ., 2018, FORECASTING PRINCIPL; Janitza S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-119; KEENE ON, 1995, STAT MED, V14, P811, DOI 10.1002/sim.4780140810; Koh H. C., 2004, SINGAPORE MANAGEMENT, V26, P25; Kuncheva L., 2014, COMBINING PATTERN CL; Lahsasna A, 2010, INT ARAB J INF TECHN, V7, P115; Li J, 2013, MATH PROBLEMS ENG; Liu Y, 1999, NEURAL NETWORKS, V12, P1399, DOI 10.1016/S0893-6080(99)00073-8; Marques AI, 2013, J OPER RES SOC, V64, P1060, DOI 10.1057/jors.2012.120; Paass G, 1998, LECT NOTES ARTIF INT, V1394, P234; Paleologo G, 2010, EUR J OPER RES, V201, P490, DOI 10.1016/j.ejor.2009.03.008; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Polikar R, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-9326-7_1; Sharma D, 2013, ELEMENTS OPTIMAL PRE; Thomas LC, 2005, J OPER RES SOC, V56, P1006, DOI 10.1057/palgrave.jors.2602018; Thomas LC, 2000, INT J FORECASTING, V16, P149, DOI 10.1016/S0169-2070(00)00034-0; Thomas LC, 2002, CREDIT SCORING ITS A; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tsai CF, 2008, EXPERT SYST APPL, V34, P2639, DOI 10.1016/j.eswa.2007.05.019; Wang CM, 2009, EXPERT SYST APPL, V36, P5900, DOI 10.1016/j.eswa.2008.07.026; Wang G, 2011, EXPERT SYST APPL, V38, P223, DOI 10.1016/j.eswa.2010.06.048; West D, 2000, COMPUT OPER RES, V27, P1131, DOI 10.1016/S0305-0548(99)00149-5; WIGINTON JC, 1980, J FINANC QUANT ANAL, V15, P757, DOI 10.2307/2330408; Yap BW, 2011, EXPERT SYST APPL, V38, P13274, DOI 10.1016/j.eswa.2011.04.147; Zhou LG, 2010, EXPERT SYST APPL, V37, P127, DOI 10.1016/j.eswa.2009.05.024	58	44	47	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117844	10.1371/journal.pone.0117844	http://dx.doi.org/10.1371/journal.pone.0117844			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706988	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100124
J	Liu, J; Yuan, YZ; Wu, Z; Li, N; Chen, YL; Qin, TT; Geng, H; Xiong, L; Liu, DL				Liu, Jing; Yuan, Yongze; Wu, Zhi; Li, Na; Chen, Yuanlei; Qin, Tingting; Geng, Hui; Xiong, Li; Liu, Deli			A Novel Sterol Regulatory Element-Binding Protein Gene (sreA) Identified in Penicillium digitatum Is Required for Prochloraz Resistance, Full Virulence and erg11 (cyp51) Regulation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR UPC2P; CITRUS GREEN MOLD; CANDIDA-ALBICANS; DRUG-RESISTANCE; UP-REGULATION; 14-ALPHA-DEMETHYLASE GENE; FUNGICIDE RESISTANCE; IMAZALIL RESISTANCE; EXPRESSION; MRR1	Penicillium digitatum is the most destructive postharvest pathogen of citrus fruits, causing fruit decay and economic loss. Additionally, control of the disease is further complicated by the emergence of drug-resistant strains due to the extensive use of triazole antifungal drugs. In this work, an orthologus gene encoding a putative sterol regulatory element-binding protein (SREBP) was identified in the genome of P. digitatum and named sreA. The putative SreA protein contains a conserved domain of unknown function (DUF2014) at its carboxyl terminus and a helix-loop-helix (HLH) leucine zipper DNA binding domain at its amino terminus, domains that are functionally associated with SREBP transcription factors. The deletion of sreA (Delta sreA) in a prochloraz-resistant strain (PdHS-F6) by Agrobacterium tumefaciens-mediated transformation led to increased susceptibility to prochloraz and a significantly lower EC50 value compared with the HS-F6 wild-type or complementation strain (COsreA). A virulence assay showed that the Delta sreA strain was defective in virulence towards citrus fruits, while the complementation of sreA could restore the virulence to a large extent. Further analysis by quantitative real-time PCR demonstrated that prochloraz-induced expression of cyp51A and cyp51B in PdHS-F6 was completely abolished in the Delta sreA strain. These results demonstrate that sreA is a critical transcription factor gene required for prochloraz resistance and full virulence in P. digitatum and is involved in the regulation of cyp51 expression.	[Liu, Jing; Yuan, Yongze; Wu, Zhi; Li, Na; Chen, Yuanlei; Qin, Tingting; Geng, Hui; Xiong, Li; Liu, Deli] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China	Central China Normal University	Liu, DL (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China.	ldl@mail.ccnu.edu.cn			National Natural Science Foundations of China [31371893, 31071653, 31101595]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundations of China (NO. 31371893, 31071653, 31101595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Blosser SJ, 2012, ANTIMICROB AGENTS CH, V56, P248, DOI 10.1128/AAC.05027-11; Bowyer P., 2001, MOL CELLULAR BIOL FI, P33; De Backer MD, 2001, ANTIMICROB AGENTS CH, V45, P1660, DOI 10.1128/AAC.45.6.1660-1670.2001; Dharia NV, 2010, P NATL ACAD SCI USA, V107, P20045, DOI 10.1073/pnas.1003776107; Dunkel N, 2008, MOL MICROBIOL, V69, P827, DOI 10.1111/j.1365-2958.2008.06309.x; Dunkel N, 2008, EUKARYOT CELL, V7, P1180, DOI 10.1128/EC.00103-08; ECKERT JW, 1994, PLANT DIS, V78, P971, DOI 10.1094/PD-78-0971; Fan JR, 2013, NEW PHYTOL, V198, P821, DOI 10.1111/nph.12193; Flaherty JE, 1997, APPL ENVIRON MICROB, V63, P3995, DOI 10.1128/AEM.63.10.3995-4000.1997; Flowers SA, 2012, EUKARYOT CELL, V11, P1289, DOI 10.1128/EC.00215-12; Gallo-Ebert C, 2014, ANTIMICROB AGENTS CH, V58, P258, DOI 10.1128/AAC.01677-13; Ghosoph JM, 2007, POSTHARVEST BIOL TEC, V44, P9, DOI 10.1016/j.postharvbio.2006.11.008; Hamamoto H, 2001, PESTIC BIOCHEM PHYS, V70, P19, DOI 10.1006/pest.2001.2530; Hamamoto H, 2000, APPL ENVIRON MICROB, V66, P3421, DOI 10.1128/AEM.66.8.3421-3426.2000; Han R, 2010, J AGR FOOD CHEM, V58, P12810, DOI 10.1021/jf103243m; Holmes GJ, 1999, PHYTOPATHOLOGY, V89, P716, DOI 10.1094/PHYTO.1999.89.9.716; Hoot SJ, 2011, ANTIMICROB AGENTS CH, V55, P940, DOI 10.1128/AAC.00995-10; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; JosephHorne T, 1997, FEMS MICROBIOL LETT, V149, P141, DOI 10.1111/j.1574-6968.1997.tb10321.x; Li WJ, 2013, J AGR FOOD CHEM, V61, P1419, DOI 10.1021/jf305355u; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohberger A, 2014, EUKARYOT CELL, V13, P127, DOI 10.1128/EC.00245-13; Luo CX, 2008, APPL ENVIRON MICROB, V74, P359, DOI 10.1128/AEM.02159-07; MacPherson S, 2005, ANTIMICROB AGENTS CH, V49, P1745, DOI 10.1128/AAC.49.5.1745-1752.2005; Maguire SL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004076; Malonek S, 2001, CURR GENET, V40, P152, DOI 10.1007/s002940100236; Marcet-Houben M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-646; Marie C, 2008, FUNGAL GENET BIOL, V45, P1430, DOI 10.1016/j.fgb.2008.07.004; Mogavero S, 2011, ANTIMICROB AGENTS CH, V55, P2061, DOI 10.1128/AAC.01467-10; Oerke E. C., 1994, CROP PROTECTION CROP; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Sanchez-Torres P, 2011, POSTHARVEST BIOL TEC, V59, P159, DOI 10.1016/j.postharvbio.2010.08.017; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Schubert S, 2011, ANTIMICROB AGENTS CH, V55, P2212, DOI 10.1128/AAC.01343-10; Silver PM, 2004, EUKARYOT CELL, V3, P1391, DOI 10.1128/EC.3.6.1391-1397.2004; Smilanick JL, 2006, POSTHARVEST BIOL TEC, V42, P75, DOI 10.1016/j.postharvbio.2006.05.008; Sun XP, 2013, FEMS MICROBIOL LETT, V348, P11, DOI 10.1111/1574-6968.12235; Sun XP, 2011, APPL MICROBIOL BIOT, V91, P1107, DOI 10.1007/s00253-011-3355-7; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Vasicek EM, 2014, EUKARYOT CELL, V13, P933, DOI 10.1128/EC.00221-13; Vinggaard AM, 2006, INT J ANDROL, V29, P186, DOI 10.1111/j.1365-2605.2005.00604.x; Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P823, DOI 10.1631/jzus.B0860006; Wang JY, 2012, AFR J MICROBIOL RES, V6, P95, DOI 10.5897/AJMR11.1045; Wang JL, 2014, J MICROBIOL, V52, P762, DOI 10.1007/s12275-014-4112-2; White TC, 2005, BIOCHEM SOC T, V33, P1215, DOI 10.1042/BST20051215; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Wolfger H, 2001, RES MICROBIOL, V152, P375, DOI 10.1016/S0923-2508(01)01209-8; Zhang JH, 2010, PEST MANAG SCI, V66, P1344, DOI 10.1002/ps.2021; Zhao L, 2007, FEMS MICROBIOL LETT, V277, P37, DOI 10.1111/j.1574-6968.2007.00929.x; Znaidi S, 2007, MOL MICROBIOL, V66, P440, DOI 10.1111/j.1365-2958.2007.05931.x	54	92	95	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117115	10.1371/journal.pone.0117115	http://dx.doi.org/10.1371/journal.pone.0117115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699519	Green Published, gold, Green Submitted			2022-12-27	WOS:000349789800018
J	Masum, AKM; Azad, MAK; Beh, LS				Masum, Abdul Kadar Muhammad; Azad, Md. Abul Kalam; Beh, Loo-See			Determinants of Academics' Job Satisfaction: Empirical Evidence from Private Universities in Bangladesh	PLOS ONE			English	Article							VOLUNTARY TURNOVER; RETENTION; SUPPORT	The job satisfaction of academics is related to a number of variables of complex function such as demographic characters, the work itself, pay, work responsibilities, variety of tasks, promotional opportunities, relationship with co-workers and others. Academics may be simultaneously satisfied with some facets of the job and dissatisfied with others. This paper aims at determining the influential factors that contribute to the enhancement or reduction of academics' job satisfaction among private universities in Bangladesh with special reference to Dhaka, the capital city of Bangladesh. A total of 346 respondents are considered from ten private universities using non-probability sampling. A pre-tested and closed-ended questionnaire using a seven-point Likert scale is used for data collection. In this study, descriptive statistics, Pearson product moment correlation, multiple regression, and factor analysis are exercised as statistical tools. A conceptual model of job satisfaction is developed and applied for academics' job satisfaction. The results reveal that compensation package, supervisory support, job security, training and development opportunities, team cohesion, career growth, working conditions, and organizational culture and policies are positively associated with the academics' job satisfaction. Amongst them, three factors stood out as significant contributors for job satisfaction of academics i.e. compensation package, job security, and working conditions. Therefore, the management of private universities should focus their effort on these areas of human resource management for maintaining academics' job satisfaction and employee retention. The study will be useful for university management in improving overall job satisfaction as it suggests some strategies for employee satisfaction practices.	[Masum, Abdul Kadar Muhammad; Beh, Loo-See] Univ Malaya, Fac Econ & Adm, Dept Adm Studies & Polit, Kuala Lumpur, Malaysia; [Masum, Abdul Kadar Muhammad; Azad, Md. Abul Kalam] Int Islamic Univ Chittagong, Dept Business Adm, Chittagong, Bangladesh; [Azad, Md. Abul Kalam] Univ Malaya, Dept Appl Stat, Fac Econ & Adm, Kuala Lumpur, Malaysia	Universiti Malaya; International Islamic University Chittagong (IIUC); Universiti Malaya	Masum, AKM (corresponding author), Univ Malaya, Fac Econ & Adm, Dept Adm Studies & Polit, Kuala Lumpur, Malaysia.	akmmasum@yahoo.com	Beh, Loo-See/B-4549-2009; Azad, Abul Kalam/E-2814-2016	Beh, Loo-See/0000-0001-7061-9317; Azad, Abul Kalam/0000-0003-3463-2738	Bright Spark Scheme of the University of Malaya, Malaysia	Bright Spark Scheme of the University of Malaya, Malaysia	This research was funded by grants awarded by Bright Spark Scheme of the University of Malaya, Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysekera R., 2007, CONT MANAG RES, V3, P233, DOI [10.7903/cmr.94, DOI 10.7903/CMR.94]; Akhtar I, 2008, J BUS STUD, V4, P25; Ali T., 2009, INT BUSINESS RES, V2, P167, DOI [10.5539/ibr.v2n4p167, DOI 10.5539/IBR.V2N4P167]; Alpern R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079053; Anik L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075509; Arah OA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025983; ASHFORD SJ, 1989, ACAD MANAGE J, V32, P803, DOI 10.2307/256569; Ashraf M, 2009, FACULTY SHIFTING PRI; Ashraf MA, 2010, INT J MANAG STUD, V17, P165; Bartlett MS, 1950, B J PSYCHOL-STAT SEC, V3, P77, DOI 10.1111/j.2044-8317.1950.tb00285.x; Bierstedt R., 1964, EXCHANGE POWER SOCIA; Billah MM, 2009, AMDIB MANAGE REV, V1, P23; Boerebach BC, 2014, EVAL HLTH PROF; Boerebach BCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069449; Boerebach BCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032089; Chang EM, 2005, HUM RELAT, V58, P523, DOI 10.1177/0018726705055037; Chang SC, 2007, LEARN ORGAN, V14, P155, DOI 10.1108/09696470710727014; Chew J, 2008, INT J MANPOWER, V29, P503, DOI 10.1108/01437720810904194; Clarke K F, 2001, Empl Benefits J, V26, P21; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dash, 2012, MARKETING RES APPL O; Denison DR, 2004, ORGAN DYN, V33, P98, DOI 10.1016/j.orgdyn.2003.11.008; Ehrenberg RG, 1991, ECON EDUC REV, V10, P99, DOI DOI 10.1016/0272-7757(91)90002-7; Eisenberger R, 2002, J APPL PSYCHOL, V87, P565, DOI 10.1037//0021-9010.87.3.565; Gibson K.R., 1994, TOOLS LANGUAGE COGNI, DOI DOI 10.1016/j.jas.2008.06.011; GOULDNER AW, 1960, AM SOCIOL REV, V25, P161, DOI 10.2307/2092623; Grace D, 2003, INDEPENDENT SCH, V62, P20; Greenberg J, 2011, BEHAV ORG, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011]; Haines VY, 2010, IND LABOR RELAT REV, V63, P228, DOI 10.1177/001979391006300203; Hair JF, 2003, MULTIVARIATE DATA AN; Herzberg F., 1987, ONE MORE TIME DO YOU; Huang Y, 2004, J MANAGE SYST, V11, P485; Jack H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057940; Jalil M, 2009, IMPROVING HUMAN RESO; Joarder MH, 2011, INT J SOC SCI EC ART, V1, P118; Johnson G., 2004, TRAINING, V41, P4; Khatri N., 2001, HUM RESOUR MANAG J, V11, P54, DOI [10.1111/j.1748-8583.2001.tb00032.x, DOI 10.1111/J.1748-8583.2001.TB00032.X]; Klassen RM, 2010, J EXP EDUC, V78, P464, DOI 10.1080/00220970903292975; Kreitner R., 2001, ORG BEHAV; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Maertz CP, 2004, J MANAGE, V30, P667, DOI 10.1016/j.jm.2004.04.001; Mansor M., 2010, INT J BUSINESS SOCIA, V1, P81; Marsland D., 1999, FAM PRACT MANAG, V6, P26; Mueller CW, 2008, ADV GROUP PROCESS, V25, P117, DOI 10.1016/S0882-6145(08)25006-X; Mumtaz A, 2012, IND ENG LETT, V1, P10; Navaie-Waliser M, 2004, J NURS ADMIN, V34, P88, DOI 10.1097/00005110-200402000-00007; Nguyen N, 2013, J RES INT BUS MANAGE, V3, P169; Noordin F., 2009, ASIAN SOCIAL SCI, V5, P122, DOI DOI 10.5539/ASS.V5N5P122; Ovadje F., 2010, INT J BUS RES, V10, P64; Rahman MasudI., 2006, J ICMAB, V34, P73, DOI [10.2139/ssrn.1155303, DOI 10.2139/SSRN.1155303]; Saleem Q., 2011, INT J COMPUT BUS RES, V2, P2229; Samuel MO, 2009, AFR J BUS MANAGE, V3, P410; Schmalenberg C, 2008, NURS RES, V57, P2, DOI 10.1097/01.NNR.0000280657.04008.2a; Shahzad K., 2008, INT REV BUS RES PAP, V4, P302; Ssesanga K, 2005, HIGH EDUC, V50, P33, DOI 10.1007/s10734-004-6346-0; Tsai WC, 2003, PERS REV, V32, P151, DOI 10.1108/00483480310460199; Veerasamy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077698; Viswesvaran C, 1998, J BUS ETHICS, V17, P365, DOI 10.1023/A:1017956516324; Wang, 2006, TQM MAG, V18, P484, DOI [10.1108/09544780610685467, DOI 10.1108/09544780610685467, https://doi.org/10.1108/09544780610685467]; WARR P, 1979, J OCCUP PSYCHOL, V52, P129, DOI 10.1111/j.2044-8325.1979.tb00448.x; Way SA, 2002, J MANAGE, V28, P765, DOI 10.1177/014920630202800604; WEILER WC, 1985, RES HIGH EDUC, V23, P270, DOI 10.1007/BF00973790; Zafar, 2006, APPL HUMAN RESOURCE, V11, P39, DOI DOI 10.4236/JSS.2019.75024	63	16	16	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117834	10.1371/journal.pone.0117834	http://dx.doi.org/10.1371/journal.pone.0117834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB7EQ	25699518	Green Submitted, gold, Green Published			2022-12-27	WOS:000349789800030
J	Prince, K; Lorrilliere, R; Barbet-Massin, M; Leger, F; Jlguet, F				Prince, Karine; Lorrilliere, Romain; Barbet-Massin, Morgane; Leger, Francois; Jlguet, Frederic			Forecasting the Effects of Land Use Scenarios on Farmland Birds Reveal a Potential Mitigation of Climate Change Impacts	PLOS ONE			English	Article							AGRICULTURAL INTENSIFICATION; POPULATION TRENDS; BIODIVERSITY; LANDSCAPE; ABUNDANCE; MODELS; CONSERVATION; RANGE; DISTRIBUTIONS; MANAGEMENT	Climate and land use changes are key drivers of current biodiversity trends, but interactions between these drivers are poorly modeled, even though they could amplify or mitigate negative impacts of climate change. Here, we attempt to predict the impacts of different agricultural change scenarios on common breeding birds within farmland included in the potential future climatic suitable areas for these species. We used the Special Report on Emissions Scenarios (SRES) to integrate likely changes in species climatic suitability, based on species distribution models, and changes in area of farmland, based on the IMAGE model, inside future climatic suitable areas. We also developed six farmland cover scenarios, based on expert opinion, which cover a wide spectrum of potential changes in livestock farming and cropping patterns by 2050. We ran generalized linear mixed models to calibrate the effects of farmland cover and climate change on bird specific abundance within 386 small agricultural regions. We used model outputs to predict potential changes in bird populations on the basis of predicted changes in regional farmland cover, in area of farmland and in species climatic suitability. We then examined the species sensitivity according to their habitat requirements. A scenario based on extensification of agricultural systems (i.e., low-intensity agriculture) showed the greatest potential to reduce reverse current declines in breeding birds. To meet ecological requirements of a larger number of species, agricultural policies accounting for regional disparities and landscape structure appear more efficient than global policies uniformly implemented at national scale. Interestingly, we also found evidence that farmland cover changes can mitigate the negative effect of climate change. Here, we confirm that there is a potential for countering negative effects of climate change by adaptive management of landscape. We argue that such studies will help inform sustainable agricultural policies for the future.	[Prince, Karine; Lorrilliere, Romain; Barbet-Massin, Morgane; Jlguet, Frederic] UPMC, CNRS, Ctr Rech Biol Populat Oiseaux, Museum Natl Hist Nat,UMR MNHN 7204, Paris, France; [Prince, Karine] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Barbet-Massin, Morgane] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Leger, Francois] AgroParisTech, UMR SAD APT INRA, Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Wisconsin System; University of Wisconsin Madison; Yale University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Prince, K (corresponding author), UPMC, CNRS, Ctr Rech Biol Populat Oiseaux, Museum Natl Hist Nat,UMR MNHN 7204, CP 51, Paris, France.	karine.prince@gmail.com	Lorrilliere, Romain/F-4888-2013; Princé, Karine/T-4491-2017	Lorrilliere, Romain/0000-0003-1870-0278; Princé, Karine/0000-0001-7739-7438	ANR (Agence Nationale de la Recherche); French National Research Agency under the Systerra program-Ecosystems and Sustainable Development [ANR-08-STRA-007]; FRB (Fondation pour la Recherche en Biodiversite); MOBILIS program-Modeling for Scenarios and Sustainable Management of Biodiversity, Farming and Forestry Facing Climate Change	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); French National Research Agency under the Systerra program-Ecosystems and Sustainable Development(French National Research Agency (ANR)); FRB (Fondation pour la Recherche en Biodiversite); MOBILIS program-Modeling for Scenarios and Sustainable Management of Biodiversity, Farming and Forestry Facing Climate Change	This work was carried out with the financial support of both the ANR (Agence Nationale de la Recherche) and The French National Research Agency under the Systerra program-Ecosystems and Sustainable Development (project ANR-08-STRA-007, FARMBIRD-Coviability models of FARMing and BIRD biodiversity) and the FRB (Fondation pour la Recherche en Biodiversite) with the MOBILIS program-Modeling for Scenarios and Sustainable Management of Biodiversity, Farming and Forestry Facing Climate Change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agreste, 2011, UT TERR 2010, P4; [AND International CNASEA], 2008, EV EXP PLAN DEV RUR; ANDERSON G. Q., 2004, BIOMASS AGR SUSTAINA, V572, P199; Anderson GQA, 2006, IBIS, V148, P180, DOI 10.1111/j.1474-919X.2006.00535.x; Araujo MB, 2008, ENVIRON SCI POLICY, V11, P38, DOI 10.1016/j.envsci.2007.07.002; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2009, P NATL ACAD SCI USA, V106, pE45, DOI 10.1073/pnas.0813294106; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; BirdLife International, 2011, EUR BIRD POP EST TRE; BirdLife International, 2004, BIRDS EUR POP EST TR; Bouwman AF, 2006, INTEGRATED MODELLING, P228; Britschgi A, 2006, BIOL CONSERV, V130, P193, DOI 10.1016/j.biocon.2005.12.013; Busch G, 2006, AGR ECOSYST ENVIRON, V114, P121, DOI 10.1016/j.agee.2005.11.007; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; BWPi, 2006, BIRDS W PAL INT; Chamberlain D, 2012, IBIS, V154, P205, DOI 10.1111/j.1474-919X.2011.01196.x; Chamberlain DE, 1999, J APPL ECOL, V36, P856, DOI 10.1046/j.1365-2664.1999.00453.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Concepcion ED, 2012, J APPL ECOL, V49, P695, DOI 10.1111/j.1365-2664.2012.02131.x; Concepcion ED, 2011, AGR ECOSYST ENVIRON, V142, P303, DOI 10.1016/j.agee.2011.05.028; de Chazal J, 2009, GLOBAL ENVIRON CHANG, V19, P306, DOI 10.1016/j.gloenvcha.2008.09.007; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Donald PF, 2006, J APPL ECOL, V43, P209, DOI 10.1111/j.1365-2664.2006.01146.x; Dormann CF, 2008, ECOL LETT, V11, P235, DOI 10.1111/j.1461-0248.2007.01142.x; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Doxa A, 2010, J APPL ECOL, V47, P1348, DOI 10.1111/j.1365-2664.2010.01869.x; Eglington SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030407; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; European Commission, 2011, EC AN EV CAP 2020; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Filippi-Codaccioni O, 2010, BIOL CONSERV, V143, P1493, DOI 10.1016/j.biocon.2010.03.031; Firbank LG, 2008, PHILOS T R SOC B, V363, P777, DOI 10.1098/rstb.2007.2183; Fischer J, 2011, SCIENCE, V334, P593, DOI 10.1126/science.334.6056.593-a; Fuller RJ, 1997, ECOGRAPHY, V20, P295, DOI 10.1111/j.1600-0587.1997.tb00374.x; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; GATZ DF, 1995, ATMOS ENVIRON, V29, P1185, DOI 10.1016/1352-2310(94)00210-C; Gordon LJ, 2008, TRENDS ECOL EVOL, V23, P211, DOI 10.1016/j.tree.2007.11.011; Gottschalk TK, 2010, ECOL INDIC, V10, P15, DOI 10.1016/j.ecolind.2009.05.008; Gregory RD, 2010, ORNITHOL SCI, V9, P3, DOI 10.2326/osj.9.3; Guerrero I, 2012, BIOL CONSERV, V152, P74, DOI 10.1016/j.biocon.2012.04.001; Guinde L., 2008, REV ETUDES AGR ENV, V89, P55; Guyomard H, 2008, PROSPECTIVE AGR 2013, P24; Harding JW, 2007, GEN LINEAR MODELS EX, P192; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiguet F, 2012, ACTA OECOL, V44, P58, DOI 10.1016/j.actao.2011.05.003; Jiguet F, 2010, P ROY SOC B-BIOL SCI, V277, P3601, DOI 10.1098/rspb.2010.0796; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Lemoine N, 2007, CONSERV BIOL, V21, P495, DOI 10.1111/j.1523-1739.2006.00633.x; Luoto M, 2006, J BIOGEOGR, V33, P1764, DOI 10.1111/j.1365-2699.2005.01395.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mcneely J. A, 2003, ECOAGRICULTURE STRAT; Mouysset L, 2014, CONSERV BIOL, V28, P187, DOI 10.1111/cobi.12184; Mouysset L, 2013, ECOL APPL, V23, P96, DOI 10.1890/11-1887.1; Mouysset L, 2012, ECOL INDIC, V14, P209, DOI 10.1016/j.ecolind.2011.08.012; Mouysset L, 2011, ECOL ECON, V70, P617, DOI 10.1016/j.ecolecon.2010.12.006; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pigot AL, 2010, ECOL LETT, V13, P705, DOI 10.1111/j.1461-0248.2010.01462.x; Pinheiro J., 2011, PACKAGE R SOFTWARE S, P21; R Core Team, 2016, R FDN STAT COMP; Rademaekers K, 2010, POLICY OPTIONS FUTUR, P160, DOI DOI 10.1017/S1744133109990338; Reino L, 2013, DIVERS DISTRIB, V19, P423, DOI 10.1111/ddi.12019; Rigby RA, 2008, COMPUT STAT DATA AN, V53, P381, DOI 10.1016/j.csda.2008.07.043; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Sanderson FJ, 2013, AGR ECOSYST ENVIRON, V168, P16, DOI 10.1016/j.agee.2013.01.015; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Trivino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029373; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Vert J, 2010, PROSPECTIVE AGR ENER, P245; Wilson JD, 2010, IBIS, V152, P176, DOI 10.1111/j.1474-919X.2009.00992.x; World Health Organization, 2005, EC HUM WELL BEING SY; Wretenberg J, 2010, BIOL CONSERV, V143, P375, DOI 10.1016/j.biocon.2009.11.001	95	17	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117850	10.1371/journal.pone.0117850	http://dx.doi.org/10.1371/journal.pone.0117850			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699673	Green Submitted, Green Published, gold			2022-12-27	WOS:000349789800031
J	Yan, Y; Luo, J; Guo, D; Wen, SZ				Yan, Ying; Luo, Jing; Guo, Dan; Wen, Shizhu			Dynamic Dielectrophoresis Model of Multi-Phase Ionic Fluids	PLOS ONE			English	Article							AC-ELECTROKINETICS; DROPLET; MICROFLUIDICS; FLOW	Ionic-based dielectrophoretic microchips have attracted significant attention due to their wide-ranging applications in electro kinetic and biological experiments. In this work, a numerical method is used to simulate the dynamic behaviors of ionic droplets in a microchannel under the effect of dielectrophoresis. When a discrete liquid dielectric is encompassed within a continuous fluid dielectric placed in an electric field, an electric force is produced due to the dielectrophoresis effect. If either or both of the fluids are ionic liquids, the magnitude and even the direction of the force will be changed because the net ionic charge induced by an electric field can affect the polarization degree of the dielectrics. However, using a dielectrophoresis model, assuming ideal dielectrics, results in significant errors. To avoid the inaccuracy caused by the model, this work incorporates the electrode kinetic equation and defines a relationship between the polarization charge and the net ionic charge. According to the simulation conditions presented herein, the electric force obtained in this work has an error exceeding 70% of the actual value if the false effect of net ionic charge is not accounted for, which would result in significant issues in the design and optimization of experimental parameters. Therefore, there is a clear motivation for developing a model adapted to ionic liquids to provide precise control for the dielectrophoresis of multi-phase ionic liquids.	[Yan, Ying; Luo, Jing; Guo, Dan; Wen, Shizhu] Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China	Tsinghua University	Guo, D (corresponding author), Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China.	guodan26@mail.tsinghua.edu.cn	Guo, Dan/S-8823-2019		National Natural Science Foundation of China [51375255, 51321092]; International Science&Technology Cooperation Project [2011DFA70980]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science&Technology Cooperation Project	This research is supported by National Natural Science Foundation of China (No. 51375255 and No. 51321092) (http://www.nsfc.gov.cn/publish/portal1/) and the International Science&Technology Cooperation Project (No. 2011DFA70980) (http://www.most.gov.cn/eng/cooperation/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle MJ, 1988, CRC HDB CHEM PHYS, V69, pD; Braff WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076751; Chang HC, 2010, ELECTROKINETICALLY D; deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062; Fryd MM, 2014, SOFT MATTER, V10, P4662, DOI 10.1039/c4sm00453a; Gallo-Villanueva RC, 2014, ELECTROPHORESIS, V35, P352, DOI 10.1002/elps.201300171; Jones J, 2003, PHYS FLUIDS, V16, P393, DOI [10.1063/1.1694354, DOI 10.1063/1.1694354]; Jones T. B., 2005, ELECTROMECHANICS PAR; Jung YM, 2008, J COLLOID INTERF SCI, V322, P617, DOI 10.1016/j.jcis.2008.04.019; Kang KH, 2002, LANGMUIR, V18, P10318, DOI 10.1021/la0263615; Kirby B., 2010, MICRO NANOSCALE FLUI; Kiss MM, 2008, ANAL CHEM, V80, P8975, DOI 10.1021/ac801276c; Koo HJ, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4804249; Lee DW, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4723633; Li D. Q., 2004, ELECTROKINETICS MICR, V2; Luo J, 2011, ELECTROPHORESIS, V32, P414, DOI 10.1002/elps.201000345; Moncada-Hernandez H, 2011, ELECTROPHORESIS, V32, P2502, DOI 10.1002/elps.201100168; Ng WY, 2011, LAB CHIP, V11, P4241, DOI 10.1039/c1lc20495e; Nilsson E, 2000, THESIS ROYAL I TECHN; Plecis A, 2011, LAB CHIP, V11, P795, DOI 10.1039/c0lc00079e; Ramos A, 1998, J PHYS D APPL PHYS, V31, P2338, DOI 10.1088/0022-3727/31/18/021; Singh P, 2007, ELECTROPHORESIS, V28, P644, DOI 10.1002/elps.200600549; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Studer V, 2004, ANALYST, V129, P944, DOI 10.1039/b408382m; Vaillier C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095231; Wu CY, 2011, LAB CHIP, V11, P1740, DOI [10.1039/c0lc00620c, 10.1039/c01c00620c]; Yi CQ, 2006, ANAL CHIM ACTA, V560, P1, DOI 10.1016/j.aca.2005.12.037; Young PM, 2008, J FLUID ENG-T ASME, V130, DOI 10.1115/1.2956606; Zeng J, 2004, LAB CHIP, V4, P265, DOI 10.1039/b403082f	29	1	1	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117456	10.1371/journal.pone.0117456	http://dx.doi.org/10.1371/journal.pone.0117456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699513	gold, Green Published, Green Submitted			2022-12-27	WOS:000349789800024
J	Jobanputra, K; Parker, LA; Azih, C; Okello, V; Maphalala, G; Kershberger, B; Khogali, M; Lujan, J; Antierens, A; Teck, R; Ellman, T; Kosgei, R; Reid, T				Jobanputra, Kiran; Parker, Lucy Anne; Azih, Charles; Okello, Velephi; Maphalala, Gugu; Kershberger, Bernard; Khogali, Mohammed; Lujan, Johnny; Antierens, Annick; Teck, Roger; Ellman, Tom; Kosgei, Rose; Reid, Tony			Factors Associated with Virological Failure and Suppression after Enhanced Adherence Counselling, in Children, Adolescents and Adults on Antiretroviral Therapy for HIV in Swaziland	PLOS ONE			English	Article								ntroduction This study explores factors associated with virological detectability, and viral re-suppression after enhanced adherence counselling, in adults and children on antiretroviral therapy (ART) in Swaziland. Methods This descriptive study used laboratory data from 7/5/2012 to 30/9/2013, which were linked with the national ART database to provide information on time on ART and CD4 count; information on enhanced adherence counselling was obtained from file review in health facilities. Multivariable logistic regression was used to explore the relationship between viral load, gender, age, time on ART, CD4 count and receiving (or not receiving) enhanced adherence counselling. Results From 12,063 patients undergoing routine viral load monitoring, 1941 (16%) had detectable viral loads. Children were more likely to have detectable viral loads (AOR 2.6, 95%CI 1.5-4.5), as were adolescents (AOR 3.2, 95%CI 2.2-4.8), patients with last CD4<350 cells/mu l (AOR 2.2, 95%CI 1.7-2.9) or WHO Stage 3/4 disease (AOR 1.3, 95%CI 1.1-1.6), and patients on ART for longer (AOR 1.1, 95%CI 1.1-1.2). At retesting, 450 (54% of those tested) showed viral re-suppression. Children were less likely to re-suppress (AOR 0.2, 95%CI 0.1-0.7), as were adolescents (AOR 0.3, 95%CI 0.2-0.8), those with initial viral load> 1000 copies/ml (AOR 0.3, 95%CI 0.1-0.7), and those with last CD4<350 cells/mu l (AOR 0.4, 95%CI 0.2-0.7). Receiving (or not receiving) enhanced adherence counselling was not associated with likelihood of re-suppression. Conclusions Children, adolescents and those with advanced disease were most likely to have high viral loads and least likely to achieve viral suppression at retesting; receiving adherence counselling was not associated with higher likelihood of viral suppression. Although the level of viral resistance was not quantified, this study suggests the need for ART treatment support that addresses the adherence problems of younger people; and to define the elements of optimal enhanced adherence support for patients of all ages with detectable viral loads.	[Jobanputra, Kiran; Parker, Lucy Anne; Kershberger, Bernard] Med Sans Frontieres Operat Ctr Geneva, Mbabane, Eswatini; [Azih, Charles; Okello, Velephi] Minist Hlth, Swaziland Natl ART Program, Mbabane, Eswatini; [Maphalala, Gugu] Swaziland Natl Reference Lab, Mbabane, Eswatini; [Khogali, Mohammed; Kosgei, Rose; Reid, Tony] Med Sans Frontieres Operat Res Unit, Luxembourg, Luxembourg; [Lujan, Johnny; Antierens, Annick; Teck, Roger] Med Sans Frontieres Operat Ctr Geneva, Geneva, Switzerland; [Ellman, Tom] Med Sans Frontieres Southern Africa Med Unit, Cape Town, South Africa	Doctors Without Borders	Jobanputra, K (corresponding author), Med Sans Frontieres Operat Ctr Geneva, Mbabane, Eswatini.	kiranjimmy@gmail.com	; Parker, Lucy Anne/R-3622-2017	Jobanputra, Kiran/0000-0002-7378-0189; Parker, Lucy Anne/0000-0002-2362-4057				Cheti E, 2013, IS SYSTEMAT IN PRESS; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Greig JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071407; Jobanputra Kiran, 2014, J Acquir Immune Defic Syndr, V67, P45, DOI 10.1097/QAI.0000000000000224; Laprise C, 2013, CLIN INFECT DIS, V57, P1489, DOI 10.1093/cid/cit529; Lee PK, 2006, J ANTIMICROB CHEMOTH, V57, P803, DOI 10.1093/jac/dkl092; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; Mutwa PR, 2014, PEDIATR INFECT DIS J, V33, P63, DOI 10.1097/INF.0b013e31829e6b9f; Nkambule R, 2012, SHIMS SWAZILAND HIV; Penazzato M, 2013, 5 INT WORKSH HIV PAE; Strategic Information Department-Ministry of Health-Kingdom of Swaziland, 2012, ART PROGRAM ANN REPO, V2012, P0; van Griensven J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-39; von Elm E, 2008, REV ESP SALUD PUBLIC, V82, P251; WHO, 2013, HIV AD GUID HIV TEST; World Health Organization, 2013, CONSOLIDATED GUIDELI	15	109	110	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116144	10.1371/journal.pone.0116144	http://dx.doi.org/10.1371/journal.pone.0116144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695494	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300011
J	Zhang, JH; Li, L; Hale, TW; Chee, W; Xing, CG; Jiang, C; Lu, JX				Zhang, Jinhui; Li, Li; Hale, Thomas W.; Chee, Wayne; Xing, Chengguo; Jiang, Cheng; Lu, Junxuan			Single Oral Dose Pharmacokinetics of Decursin and Decursinol Angelate in Healthy Adult Men and Women	PLOS ONE			English	Article							KOREAN ANGELICA-GIGAS; ANTICANCER; METABOLISM; ANTIANDROGEN; COMPOUND; EXTRACT	The ethanol extract of Angelica gigas Nakai (AGN) root has promising anti-cancer and other bioactivities in rodent models. It is currently believed that the pyranocoumarin isomers decursin (D) and decursinol angelate (DA) contribute to these activities. We and others have documented that D and DA were rapidly converted to decursinol (DOH) in rodents. However, our in vitro metabolism studies suggested that D and DA might be metabolized differently in humans. To test this hypothesis and address a key question for human translatability of animal model studies of D and DA or AGN extract, we conducted a single oral dose human pharmacokinetic study of D and DA delivered through an AGN-based dietary supplement Cogni.Q (purchased from Quality of Life Labs, Purchase, NY) in twenty healthy subjects, i.e., 10 men and 10 women, each consuming 119 mg D and 77 mg DA from 4 vegicaps. Analyses of plasma samples using UHPLC-MS/MS showed mean time to peak concentration (T-max) of 2.1, 2.4 and 3.3 h and mean peak concentration (C-max) of 5.3, 48.1 and 2,480 nmol/L for D, DA and DOH, respectively. The terminal elimination half-life (t(1/2)) for D and DA was similar (17.4 and 19.3 h) and each was much longer than that of DOH (7.4 h). The mean area under the curve (AUC(0-48h)) for D, DA and DOH was estimated as 37, 335 and 27,579 h nmol/L, respectively. Gender-wise, men absorbed the parent compounds faster and took shorter time to reach DOH peak concentration. The human data supported an extensive conversion of D and DA to DOH, even though they metabolized DA slightly slower than rodents. Therefore, the data generated in rodent models concerning anti-cancer efficacy, safety, tissue distribution and pharmacodynamic biomarkers will likely be relevant for human translation.	[Zhang, Jinhui; Li, Li; Chee, Wayne; Jiang, Cheng; Lu, Junxuan] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX 79107 USA; [Hale, Thomas W.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Clin Res Unit, Amarillo, TX USA; [Xing, Chengguo] Univ Minnesota, Coll Pharm, Dept Med Chem, Minneapolis, MN 55455 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Minnesota System; University of Minnesota Twin Cities	Zhang, JH (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX 79107 USA.	jinhui.zhang@ttuhsc.edu; junxuan.lu@ttuhsc.edu	zhang, jin/GXV-9154-2022; zhang, jinhui/GXF-6528-2022	Lu, Junxuan/0000-0002-2354-7186	Texas Tech University Health Sciences Center School of Pharmacy; National Center for Complementary and Alternative Medicine (NCCAM) [AT007395]; Laura W. Bush Institute for Women's Health seed grant; National Center for Complementary & Integrative Health [R01AT007395] Funding Source: NIH RePORTER	Texas Tech University Health Sciences Center School of Pharmacy; National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Laura W. Bush Institute for Women's Health seed grant; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Texas Tech University Health Sciences Center School of Pharmacy start-up fund (JL), National Center for Complementary and Alternative Medicine (NCCAM) grant AT007395 (JL), and Laura W. Bush Institute for Women's Health seed grant (JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang A, 2012, PHYTOTHER RES, V26, P510, DOI 10.1002/ptr.3597; Choi SS, 2003, LIFE SCI, V73, P471, DOI 10.1016/S0024-3205(03)00311-4; ClinicalTrials.gov, 2011, EFF SAF STUD INM 176; Cohen J.E., 1988, STAT POWER ANAL BEHA; FDA, 2003, GUID IND BIOAV BIOEQ; Guo JM, 2007, MOL CANCER THER, V6, P907, DOI 10.1158/1535-7163.MCT-06-0231; HOMMA M, 1992, ANAL BIOCHEM, V202, P179, DOI 10.1016/0003-2697(92)90225-V; Jiang C, 2006, CANCER RES, V66, P453, DOI 10.1158/0008-5472.CAN-05-1865; Jiang C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1790; Kang SY, 2007, J PHARM PHARMACOL, V59, P863, DOI 10.1211/jpp.59.6.0013; Kim Jihae, 2003, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V42, P254; Kim YK, 2007, PHYTOTHER RES, V21, P288, DOI 10.1002/ptr.2043; Lee HJ, 2009, AM J CHINESE MED, V37, P127, DOI 10.1142/S0192415X09006722; Li L, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1155/2013/467245; Li L, 2013, PLANTA MED, V79, P1536, DOI 10.1055/s-0033-1350796; Li L, 2013, PLANTA MED, V79, P275, DOI 10.1055/s-0032-1328202; Li L, 2012, PLANTA MED, V78, P252, DOI 10.1055/s-0031-1280384; LoRusso PM, 2009, J CLIN ONCOL, V27, P2586, DOI 10.1200/JCO.2008.21.5798; Park HS, 2012, PLANTA MED, V78, P909, DOI 10.1055/s-0031-1298517; Park SJ, 2012, J ETHNOPHARMACOL, V143, P611, DOI 10.1016/j.jep.2012.07.019; R Core Team, 2021, R LANGUAGE ENV STAT; Regitz-Zagrosek V, 2012, PHARMACOKINETICS PHA, DOI [10.1007/s12070-012-0514-9, DOI 10.1007/S12070-012-0514-9]; Sarker SD, 2004, CURR MED CHEM, V11, P1479, DOI 10.2174/0929867043365189; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Son SH, 2011, PHYTOTHER RES, V25, P959, DOI 10.1002/ptr.3372; Son SH, 2009, CANCER LETT, V280, P86, DOI 10.1016/j.canlet.2009.02.012; TAM YK, 1993, CLIN PHARMACOKINET, V25, P300, DOI 10.2165/00003088-199325040-00005; Tang S, 2013, P AACR; Wang L, 2011, P AACR; Xin GZ, 2011, CURR DRUG METAB, V12, P809, DOI 10.2174/138920011797470164; Yim D, 2005, CANCER RES, V65, P1035; Zhang J, 2014, MOL CARCINOG; Zhang J, 2012, P AACR; Zhang J, 2013, ANN M EXP AAPS AM AS; Zhang JH, 2012, ANTI-CANCER AGENT ME, V12, P1239, DOI 10.2174/187152012803833071	35	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0114992	10.1371/journal.pone.0114992	http://dx.doi.org/10.1371/journal.pone.0114992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695490	gold, Green Published, Green Submitted			2022-12-27	WOS:000350062300003
J	Guzman-Venegas, RA; Picand, JLB; de la Rosa, FJB				Guzman-Venegas, Rodrigo A.; Biotti Picand, Jorge L.; Berral de la Rosa, Francisco J.			Functional Compartmentalization of the Human Superficial Masseter Muscle	PLOS ONE			English	Article							FIBER-TYPE COMPOSITION; HUMAN JAW MUSCLES; BITE FORCE; ELECTROMYOGRAPHIC HETEROGENEITY; MOTOR UNITS; SPATIAL-DISTRIBUTION; HUMAN TEMPORALIS; MYOSIN; EMG; MOTONEURONS	Some muscles have demonstrated a differential recruitment of their motor units in relation to their location and the nature of the motor task performed; this involves functional compartmentalization. There is little evidence that demonstrates the presence of a compartmentalization of the superficial masseter muscle during biting. The aim of this study was to describe the topographic distribution of the activity of the superficial masseter (SM) muscle's motor units using high-density surface electromyography (EMGs) at different bite force levels. Twenty healthy natural dentate participants (men: 4; women: 16; age 20 +/- 2 years; mass: 60 +/- 12 kg, height: 163 +/- 7 cm) were selected from 316 volunteers and included in this study. Using a gnathodynamometer, bites from 20 to 100% maximum voluntary bite force (MVBF) were randomly requested. Using a two-dimensional grid (four columns, six electrodes) located on the dominant SM, EMGs in the anterior, middle-anterior, middle-posterior and posterior portions were simultaneously recorded. In bite ranges from 20 to 60% MVBF, the EMG activity was higher in the anterior than in the posterior portion (p-value = 0.001). The center of mass of the EMG activity was displaced towards the posterior part when bite force increased (p-value = 0.001). The topographic distribution of EMGs was more homogeneous at high levels of MVBF (p-value = 0.001). The results of this study show that the superficial masseter is organized into three functional compartments: an anterior, a middle and a posterior compartment. However, this compartmentalization is only seen at low levels of bite force (20-60% MVBF).	[Guzman-Venegas, Rodrigo A.] Univ Los Andes, Fac Med, Escuela Kinesiol, Lab Integrat Biomecan & Fisiol Esfuerzo, Santiago, Chile; [Biotti Picand, Jorge L.] Univ Los Andes, Fac Odontol, Santiago, Chile; [Berral de la Rosa, Francisco J.] Univ Pablo Olavide, Lab Biomecan Kinesiol & Cineantropometria, Seville, Spain	Universidad de los Andes - Chile; Universidad de los Andes - Chile; Universidad Pablo de Olavide	Guzman-Venegas, RA (corresponding author), Univ Los Andes, Fac Med, Escuela Kinesiol, Lab Integrat Biomecan & Fisiol Esfuerzo, Santiago, Chile.	rguzman@uandes.cl	Berral de la Rosa, Francisco José/C-6553-2013; De La Rosa, Francisco/GWU-4894-2022	Guzman-Venegas, Rodrigo/0000-0003-0567-4867	"Fondo de Ayuda a la Investigacion" of los Andes University [IN0GTO201157KIN-001-11]	"Fondo de Ayuda a la Investigacion" of los Andes University	This study was supported by "Fondo de Ayuda a la Investigacion" of los Andes University (IN0GTO201157KIN-001-11). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAYA R, 1992, SOC PSYCH PSYCH EPID, V27, P168, DOI 10.1007/BF00789001; Arima T, 2013, J ORAL REHABIL, V40, P900, DOI 10.1111/joor.12097; BLANKSMA NG, 1995, J DENT RES, V74, P1318, DOI 10.1177/00220345950740061201; BLANKSMA NG, 1992, J DENT RES, V71, P47, DOI 10.1177/00220345920710010801; Blanksma NG, 1997, J DENT RES, V76, P542, DOI 10.1177/00220345970760010401; Castroflorio T, 2005, J ORAL REHABIL, V32, P708, DOI 10.1111/j.1365-2842.2005.01490.x; Castroflorio T, 2012, J ORAL REHABIL, V39, P81, DOI 10.1111/j.1365-2842.2011.02246.x; De Leeuw R., 2008, OROFACIAL PAIN GUIDE, V4th; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Farina D, 2008, J ELECTROMYOGR KINES, V18, P16, DOI 10.1016/j.jelekin.2006.08.005; Fitton LC, 2012, J ANAT, V221, P55, DOI 10.1111/j.1469-7580.2012.01516.x; GASPARD M, 1973, J BIOL BUCCALE, V1, P7; Groning F, 2012, ANAT REC, V295, P853, DOI 10.1002/ar.22455; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P599, DOI 10.1152/jn.1965.28.3.599; Hoh JFY, 2002, J EXP BIOL, V205, P2203; Korfage JAM, 2005, J DENT RES, V84, P784, DOI 10.1177/154405910508400902; Korfage JAM, 2005, J DENT RES, V84, P774, DOI 10.1177/154405910508400901; MASUDA T, 1991, J ELECTROMYOGR KINES, V1, P107, DOI 10.1016/1050-6411(91)90004-O; MCMILLAN AS, 1992, ARCH ORAL BIOL, V37, P849, DOI 10.1016/0003-9969(92)90119-S; Merletti R, 2004, ELECTROMYOGRAPHY PHY; Merletti R, 2008, J ELECTROMYOGR KINES, V18, P879, DOI 10.1016/j.jelekin.2008.09.002; Ogawa T, 2006, J ORAL REHABIL, V33, P729, DOI 10.1111/j.1365-2842.2006.01617.x; Osterlund C, 2011, ANAT REC, V294, P1158, DOI 10.1002/ar.21272; Sano R, 2007, J ANAT, V211, P464, DOI 10.1111/j.1469-7580.2007.00783.x; SCIOTE JJ, 1994, J NEUROL SCI, V126, P15, DOI 10.1016/0022-510X(94)90089-2; Scutter SD, 2000, ARCH ORAL BIOL, V45, P617, DOI 10.1016/S0003-9969(99)00146-6; Serra CM, 2013, J ORAL REHABIL, V40, P563, DOI 10.1111/joor.12068; SERRATRICE G, 1976, J NEUROL SCI, V30, P189, DOI 10.1016/0022-510X(76)90266-5; Shi JF, 2012, J THEOR BIOL, V310, P21, DOI 10.1016/j.jtbi.2012.06.006; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; van Kampen FMC, 2002, J DENT RES, V81, P170, DOI 10.1177/154405910208100305; Yang J, 2001, ARCH ORAL BIOL, V46, P989, DOI 10.1016/S0003-9969(01)00075-9; Yoshikawa T., 1969, Anatomischer Anzeiger, V125, P363	33	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116923	10.1371/journal.pone.0116923	http://dx.doi.org/10.1371/journal.pone.0116923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692977	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500030
J	Liu, C; Chen, J; Li, ET; Fan, Q; Wang, DY; Zhang, CS; Li, P; Li, XP; Chen, XY; Qiu, SL; Gao, ZZ; Li, HQ; Hu, YL				Liu, Cui; Chen, Jin; Li, Entao; Fan, Qiang; Wang, Deyun; Zhang, Cunshuai; Li, Peng; Li, Xiuping; Chen, Xingying; Qiu, Shulei; Gao, Zhenzhen; Li, Hongquan; Hu, Yuanliang			Solomonseal Polysaccharide and Sulfated Codonopsis pilosula Polysaccharide Synergistically Resist Newcastle Disease Virus	PLOS ONE			English	Article							INDIRECT IMMUNOFLUORESCENCE ASSAY; CELLULAR INFECTIVITY; ANTIVIRAL ACTIVITY; IN-VITRO; EPIMEDIUM POLYSACCHARIDE; ND VACCINE; MODIFIERS; CHICKENS; ENHANCE; TISSUE	Five combinations of three ratios (PS9-sPS(1), PS7-sPS(3) and PS6-sPS(4)) were prepared with polysaccharide (PS) and sulfated polysaccharide (sPS). The antiviral activities of these compounds were subsequently compared in vitro using the MTT assay, observation of the virus structure and immunofluorescence. The results demonstrated that SP9-sCP(1), CP7-sCA(3), EP7-sAP(3), CA(9)-sEP(1) and EP7-sCA(3) presented higher activities, and SP9-sCP(1) displayed the highest virus inhibition rate and clearly killed the virus and inhibited viral antigen expression. In an in vivo test, 28-day-old chickens were challenged with Newcastle disease virus (NDV) and were administered the five drug combinations. On day 14 after the challenge, the morbidity, mortality and cure rate in each group were calculated. The results indicated that SP9-sCP(1) presented the lowest morbidity and mortality and the highest cure rate. These results indicate that Solomonseal polysaccharide and sulfated Codonopsis pilosula polysaccharide synergistically resist NDV. Moreover, SP9-sCP(1) had the highest efficacy and may be used as a new antiviral drug.	[Liu, Cui; Li, Entao; Wang, Deyun; Li, Peng; Li, Xiuping; Chen, Xingying; Qiu, Shulei; Gao, Zhenzhen; Hu, Yuanliang] Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Chen, Jin] Jiangsu Acad Agr Sci, Natl Res Ctr Vet Biol Engn & Technol, Nanjing 210014, Jiangsu, Peoples R China; [Fan, Qiang; Zhang, Cunshuai] China Inst Vet Drug Control, Beijing 100081, Peoples R China; [Li, Hongquan] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Shanxi, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; China Institute of Veterinary Drug Control; Shanxi Agricultural University	Hu, YL (corresponding author), Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing 210095, Jiangsu, Peoples R China.	ylhu@njau.edu.cn			National Special Fund for Agro-Scientific Research in the Public Interest of China [201403051]; National Natural Science Foundation of China [30871887, 31272596]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Key Scientific and Technological Grant from Shanxi Province [2010311047]	National Special Fund for Agro-Scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Key Scientific and Technological Grant from Shanxi Province	The project was supported by the National Special Fund for Agro-Scientific Research in the Public Interest of China (201403051), the National Natural Science Foundation of China (30871887, 31272596), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and a Key Scientific and Technological Grant from Shanxi Province (2010311047). The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	Alban S, 2002, CARBOHYD POLYM, V47, P267, DOI 10.1016/S0144-8617(01)00178-3; Amornrut C, 1999, CARBOHYD RES, V321, P121, DOI 10.1016/S0008-6215(99)00188-3; Antarasena C, 2007, RES VET SCI, V83, P279, DOI 10.1016/j.rvsc.2006.12.007; Bedekovic T, 2011, J VIROL METHODS, V178, P59, DOI 10.1016/j.jviromet.2011.08.012; Bogoyavlenskiy A, 2009, VIRUS GENES, V39, P94, DOI 10.1007/s11262-009-0370-1; Fan YP, 2010, INT J BIOL MACROMOL, V47, P87, DOI 10.1016/j.ijbiomac.2010.05.017; Ghosh P, 2004, PHYTOCHEMISTRY, V65, P3151, DOI 10.1016/j.phytochem.2004.07.025; [辜红梅 Gu Hongmei], 2003, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V9, P21; Guo ZH, 2009, VACCINE, V27, P660, DOI 10.1016/j.vaccine.2008.11.038; Han SQ, 2010, CARBOHYD POLYM, V80, P1111, DOI 10.1016/j.carbpol.2010.01.031; Hong W, 2014, ANTIVIR RES, V102, P1, DOI 10.1016/j.antiviral.2013.11.013; Huang XY, 2008, INT J BIOL MACROMOL, V42, P166, DOI 10.1016/j.ijbiomac.2007.10.019; Kim M, 2013, ANTIVIR RES, V100, P460, DOI 10.1016/j.antiviral.2013.08.002; Li T, 2013, ANTIVIR RES, V97, P1, DOI 10.1016/j.antiviral.2012.10.006; Liu L, 2007, CARBOHYD POLYM, V70, P304, DOI 10.1016/j.carbpol.2007.04.012; Lu Y, 2008, CARBOHYD POLYM, V71, P180, DOI 10.1016/j.carbpol.2007.05.024; Rahman MM, 2012, VACCINE, V30, P7165, DOI 10.1016/j.vaccine.2012.10.011; Saxena P, 2011, J SURG RES, V171, P311, DOI 10.1016/j.jss.2009.11.011; Sun YX, 2008, INT J BIOL MACROMOL, V43, P279, DOI 10.1016/j.ijbiomac.2008.06.009; TAKEUCHI H, 1991, J VIROL METHODS, V33, P61, DOI 10.1016/0166-0934(91)90008-N; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; Talorete TPN, 2006, CYTOTECHNOLOGY, V52, P189, DOI 10.1007/s10616-007-9057-4; Nguyen TL, 2012, CARBOHYD POLYM, V90, P1254, DOI 10.1016/j.carbpol.2012.06.060; Wang C, 2000, ADV BIO PRO, V2, P3; Wang JM, 2010, INT J BIOL MACROMOL, V46, P212, DOI 10.1016/j.ijbiomac.2009.11.011; Yang S J, 2009, THESIS NANJING AGR U; Yin Z, 1997, VIROLOGY ANIMAL, P204, DOI [10.1007/BF02899922, DOI 10.1007/BF02899922]; Zhang XH, 2005, CHIN J CHROMATOGR, V23, P394; [张玉清 Zhang Yuqing], 2012, [南京农业大学学报, Journal of Nanjing Agricultural University], V35, P105; Zhao XN, 2011, INT J BIOL MACROMOL, V49, P44, DOI 10.1016/j.ijbiomac.2011.03.010; 任丽靖, 2008, [中草药, Chinese Traditional and Herbal Drugs], V39, P986	31	6	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							0117916	10.1371/journal.pone.0117916	http://dx.doi.org/10.1371/journal.pone.0117916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692886	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500079
J	Bacallao, K; Monje, PV				Bacallao, Ketty; Monje, Paula V.			Requirement of cAMP Signaling for Schwann Cell Differentiation Restricts the Onset of Myelination	PLOS ONE			English	Article							SOLUBLE ADENYLYL-CYCLASE; BASAL LAMINA; INHIBITION; GPR126; PROLIFERATION; ACTIVATION; PROTEINS; DEFINES; INVITRO; EVENTS	Isolated Schwann cells (SCs) respond to cAMP elevation by adopting a differentiated postmitotic state that exhibits high levels of Krox-20, a transcriptional enhancer of myelination, and mature SC markers such as the myelin lipid galactocerebroside (O1). To address how cAMP controls myelination, we performed a series of cell culture experiments which compared the differentiating responses of isolated and axon-related SCs to cAMP analogs and ascorbate, a known inducer of axon ensheathment, basal lamina formation and myelination. In axon-related SCs, cAMP induced the expression of Krox-20 and O1 without a concomitant increase in the expression of myelin basic protein (MBP) and without promoting axon ensheathment, collagen synthesis or basal lamina assembly. When cAMP was provided together with ascorbate, a dramatic enhancement of MBP expression occurred, indicating that cAMP primes SCs to form myelin only under conditions supportive of basal lamina formation. Experiments using a combination of cell permeable cAMP analogs and type-selective adenylyl cyclase (AC) agonists and antagonists revealed that selective transmembrane AC (tmAC) activation with forskolin was not sufficient for full SC differentiation and that the attainment of an O1 positive state also relied on the activity of the soluble AC (sAC), a bicarbonate sensor that is insensitive to forskolin and GPCR activation. Pharmacological and immunological evidence indicated that SCs expressed sAC and that sAC activity was required for morphological differentiation and the expression of myelin markers such as O1 and protein zero. To conclude, our data indicates that cAMP did not directly drive myelination but rather the transition into an O1 positive state, which is perhaps the most critical cAMP-dependent rate limiting step for the onset of myelination. The temporally restricted role of cAMP in inducing differentiation independently of basal lamina formation provides a clear example of the uncoupling of signals controlling differentiation and myelination in SCs.	[Bacallao, Ketty; Monje, Paula V.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Monje, Paula V.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA	University of Miami; University of Miami	Monje, PV (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	pmonje@med.miami.edu	Monje, Paula/AAB-9099-2020		NIH-NINDS [NS009923]; Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009923] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH-NINDS Grant NS009923, The Miami Project to Cure Paralysis, and The Buoniconti Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacallao K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082354; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Bitterman JL, 2013, J PHARMACOL EXP THER, V347, P589, DOI 10.1124/jpet.113.208496; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BUNGE MB, 1990, ANN NY ACAD SCI, V580, P281, DOI 10.1111/j.1749-6632.1990.tb17937.x; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Corredor RG, 2012, J NEUROSCI, V32, P7734, DOI 10.1523/JNEUROSCI.5288-11.2012; Court FA, 2006, CURR OPIN NEUROBIOL, V16, P501, DOI 10.1016/j.conb.2006.08.005; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; ELDRIDGE CF, 1988, EXP CELL RES, V174, P491, DOI 10.1016/0014-4827(88)90318-7; Fabbri E, 1991, J Enzyme Inhib, V5, P87, DOI 10.3109/14756369109069062; FERNANDEZVALLE C, 1993, DEVELOPMENT, V119, P867; Geng WD, 2009, J CELL PHYSIOL, V220, P332, DOI 10.1002/jcp.21767; Glenn TD, 2013, DEVELOPMENT, V140, P3167, DOI 10.1242/dev.093401; Guo L, 2012, J NEUROSCI, V32, P17251, DOI 10.1523/JNEUROSCI.2461-12.2012; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Howe DG, 2000, J NEUROSCI, V20, P3513, DOI 10.1523/JNEUROSCI.20-10-03513.2000; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monje PV, 2010, J BIOL CHEM, V285, P31024, DOI 10.1074/jbc.M110.116970; Monje PV, 2009, GLIA, V57, P947, DOI 10.1002/glia.20819; Monje PV, 2008, J BIOL CHEM, V283, P34087, DOI 10.1074/jbc.M802318200; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Quintes S, 2010, J PERIPHER NERV SYST, V15, P10, DOI 10.1111/j.1529-8027.2010.00247.x; Rosenberg SS, 2007, CELL MOL LIFE SCI, V64, P3059, DOI 10.1007/s00018-007-7265-x; SOBUE G, 1986, BRAIN RES, V362, P23, DOI 10.1016/0006-8993(86)91394-6; Sparrow N, 2012, J NEUROSCI, V32, P5284, DOI 10.1523/JNEUROSCI.6207-11.2012; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; WOOD PM, 1976, BRAIN RES, V115, P361, DOI 10.1016/0006-8993(76)90355-3; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	45	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116948	10.1371/journal.pone.0116948	http://dx.doi.org/10.1371/journal.pone.0116948			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705874	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100055
J	Carneiro, B; Braga, ACS; Batista, MN; Harris, M; Rahal, P				Carneiro, Bruno; Silva Braga, Ana Claudia; Batista, Mariana Nogueira; Harris, Mark; Rahal, Paula			Evaluation of Canonical siRNA and Dicer Substrate RNA for Inhibition of Hepatitis C Virus Genome Replication - A Comparative Study	PLOS ONE			English	Article							PROTEIN EXPRESSION; GENE-EXPRESSION; INTERFERING RNAS; CELL-CULTURE; IN-VITRO; REPLICON; TRANSLATION; SELECTION; POTENCY; ESCAPE	Hepatitis C virus (HCV) frequently establishes persistent infections in the liver, leading to the development of chronic hepatitis and, potentially, to liver cirrhosis and hepatocellular carcinoma at later stages. The objective of this study was to test the ability of five Dicer substrate siRNAs (DsiRNA) to inhibit HCV replication and to compare these molecules to canonical 21 nt siRNA. DsiRNA molecules were designed to target five distinct regions of the HCV genome -the 5' UTR and the coding regions for NS3, NS4B, NS5A or NS5B. These molecules were transfected into Huh7.5 cells that stably harboured an HCV subgenomic replicon expressing a firefly luciferase/neoR reporter (SGR-Feo-JFH-1) and were also tested on HCVcc-infected cells. All of the DsiRNAs inhibited HCV replication in both the subgenomic system and HCVcc-infected cells. When DsiRNAs were transfected prior to infection with HCVcc, the inhibition levels reached 99.5%. When directly compared, canonical siRNA and DsiRNA exhibited similar potency of virus inhibition. Furthermore, both types of molecules exhibited similar dynamics of inhibition and frequencies of resistant mutants after 21 days of treatment. Thus, DsiRNA molecules are as potent as 21 nt siRNAs for the inhibition of HCV replication and may provide future approaches for HCV therapy if the emergence of resistant mutants can be addressed.	[Carneiro, Bruno; Silva Braga, Ana Claudia; Batista, Mariana Nogueira; Rahal, Paula] Sao Paulo State Univ, IBILCE, Genom Study Lab, Sao Jose Do Rio Preto, SP, Brazil; [Carneiro, Bruno; Harris, Mark] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	Universidade Estadual Paulista; University of Leeds	Carneiro, B (corresponding author), Sao Paulo State Univ, IBILCE, Genom Study Lab, Sao Jose Do Rio Preto, SP, Brazil.	brunocopo@yahoo.com.br; prahal@ibilce.unesp.br	Carneiro, Bruno/P-2415-2019; Rahal, Paula/D-3871-2012; Carneiro, Bruno/J-5870-2013	Rahal, Paula/0000-0001-5693-6148; Harris, Mark/0000-0002-9821-1003; Carneiro, Bruno/0000-0002-2355-7907	Sao Paulo Research Foundation [2009/08534-9-BC]; Coordination for the Improvement of Higher Level Personnel [5290/11-2-BC]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Level Personnel	This study was supported by Sao Paulo Research Foundation (www.fapesp.br), grant 2009/08534-9-BC; Coordination for the Improvement of Higher Level Personnel (www.capes.gov.br), grant 5290/11-2-BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-161; Bartenschlager R, 2000, BEST PRACT RES CL GA, V14, P241, DOI 10.1053/bega.1999.0073; Berkhout B, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.22; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Chevalier C, 2007, MOL THER, V15, P1452, DOI 10.1038/sj.mt.6300186; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foster DJ, 2012, RNA, V18, P557, DOI 10.1261/rna.031120.111; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Gvozdeva OV, 2014, FEBS LETT, V588, P1037, DOI 10.1016/j.febslet.2014.02.015; Haasnoot J, 2007, RNA INTERFERENCE VIR, V25; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harborth J, 2001, J CELL SCI, V114, P4557; HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; Khaliq S, 2010, BIOTECHNOL ADV, V28, P27, DOI 10.1016/j.biotechadv.2009.08.004; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kim M, 2006, VIRUS RES, V122, P1, DOI 10.1016/j.virusres.2006.05.003; Konishi M, 2006, J VIRAL HEPATITIS, V13, P756, DOI 10.1111/j.1365-2893.2006.00752.x; Korf M, 2005, J HEPATOL, V43, P225, DOI 10.1016/j.jhep.2005.02.046; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Liu M, 2006, BIOSCI BIOTECH BIOCH, V70, P2049, DOI 10.1271/bbb.60001; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Pichu S, 2012, PHARMACOL RES, V65, P48, DOI 10.1016/j.phrs.2011.09.001; Prabhu R, 2005, J MED VIROL, V76, P511, DOI 10.1002/jmv.20391; Prabhu R, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-100; Randall G, 2003, P NATL ACAD SCI USA, V100, P235, DOI 10.1073/pnas.0235524100; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Roche B, 2012, LIVER INT, V32, P120, DOI 10.1111/j.1478-3231.2011.02714.x; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Ross-Thriepland D, 2013, J GEN VIROL, V94, P1009, DOI 10.1099/vir.0.050633-0; Salomon W, 2010, NUCLEIC ACIDS RES, V38, P3771, DOI 10.1093/nar/gkq055; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Sen A, 2003, VIRUS RES, V96, P27, DOI 10.1016/S0168-1702(03)00170-9; Snead NM, 2013, NUCLEIC ACIDS RES, V41, P6209, DOI 10.1093/nar/gkt200; Takigawa Y, 2004, MICROBIOL IMMUNOL, V48, P591, DOI 10.1111/j.1348-0421.2004.tb03556.x; Trejo-Avila L, 2007, ANN HEPATOL, V6, P174; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; WHO, 2014, GUID SCREEN CAR TREA; Wilson JA, 2005, J VIROL, V79, P7050, DOI 10.1128/JVI.79.11.7050-7058.2005; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Younossi Z, 2014, DIGEST LIVER DIS, V46, pS186, DOI 10.1016/j.dld.2014.09.025	53	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117742	10.1371/journal.pone.0117742	http://dx.doi.org/10.1371/journal.pone.0117742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705875	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100115
J	Iijima, S; Matsuura, K; Watanabe, T; Onomoto, K; Fujita, T; Ito, K; Iio, E; Miyaki, T; Fujiwara, K; Shinkai, N; Kusakabe, A; Endo, M; Nojiri, S; Joh, T; Tanaka, Y				Iijima, Sayuki; Matsuura, Kentaro; Watanabe, Tsunamasa; Onomoto, Koji; Fujita, Takashi; Ito, Kyoko; Iio, Etsuko; Miyaki, Tomokatsu; Fujiwara, Kei; Shinkai, Noboru; Kusakabe, Atsunori; Endo, Mio; Nojiri, Shunsuke; Joh, Takashi; Tanaka, Yasuhito			Influence of Genes Suppressing Interferon Effects in Peripheral Blood Mononuclear Cells during Triple Antiviral Therapy for Chronic Hepatitis C	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PEGYLATED INTERFERON; VIRUS-INFECTION; STIMULATED GENES; ADAPTER PROTEIN; DENDRITIC CELLS; INTERLEUKIN 28B; INNATE IMMUNITY; IL28B GENOTYPE; HCV INFECTION	The levels of expression of interferon-stimulated genes (ISGs) in liver are associated with response to treatment with pegylated interferon (PEG-IFN) plus ribavirin (RBV). However, associations between the responses of ISGs to IFN-based therapy and treatment efficacy or interleukin-28B (IL28B) genotype have not yet been determined. Therefore, we investigated the early responses of ISGs and interferon-lambdas (IFN-lambda s) in peripheral blood mononuclear cells (PBMCs) during PEG-IFN/RBV plus NS3/4 protease inhibitor (PI) therapy. We prospectively enrolled 50 chronic hepatitis C patients with HCV genotype 1, and collected PBMCs at baseline, 8 and 24 h after the initial administration of PEG-IFN/RBV/PI. Levels of mRNAs for selected ISGs and IFN-lambda s were evaluated by real-time PCR. All 31 patients with a favorable IL28B genotype and 13 of 19 with an unfavorable genotype achieved sustained virological responses (SVR). Levels of mRNA for A20, SOCS1, and SOCS3, known to suppress antiviral activity by interfering with the IFN signaling pathway, as well as IRF1 were significantly higher at 8 h in patients with an unfavorable IL28B genotype than in those with a favorable one (P = 0.007, 0.026, 0.0004, 0.0006, respectively), especially in the non-SVR group. Particularly, the fold-change of IRF1 at 8 h relative to baseline was significantly higher in non-SVR than in SVR cases with an unfavorable IL28B genotype (P = 0.035). In conclusion, levels of several mRNAs of genes suppressing antiviral activity in PBMCs during PEG-IFN/RBV/PI differed according to IL28B genotypes, paralleling treatment efficacy.	[Iijima, Sayuki; Matsuura, Kentaro; Watanabe, Tsunamasa; Ito, Kyoko; Iio, Etsuko; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Iijima, Sayuki; Matsuura, Kentaro; Watanabe, Tsunamasa; Ito, Kyoko; Iio, Etsuko; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Matsuura, Kentaro; Iio, Etsuko; Fujiwara, Kei; Shinkai, Noboru; Endo, Mio; Nojiri, Shunsuke; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Matsuura, Kentaro] NIH, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Onomoto, Koji; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan; [Miyaki, Tomokatsu] Toyokawa City Hosp, Div Internal Med, Toyokawa, Japan; [Kusakabe, Atsunori] Nagoya Daini Red Cross Hosp, Div Gastroenterol, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University; Nagoya City University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Kyoto University; Japanese Red Cross Nagoya Daini Hospital	Tanaka, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan.	ytanaka@med.nagoya-cu.ac.jp		Tanaka, Yasuhito/0000-0002-2473-6966	Ministry of Health, Labour and Welfare of Japan [H25-kanen-ippan-005]; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [25461004, 24115004, 24590988] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a grant-in-aid from the Ministry of Health, Labour and Welfare of Japan (H25-kanen-ippan-005) and The Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J MED VIROL, V83, P1597, DOI 10.1002/jmv.22158; Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Asahina Y, 2008, GASTROENTEROLOGY, V134, P1396, DOI 10.1053/j.gastro.2008.02.019; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Bota S, 2013, CLIN DRUG INVEST, V33, P325, DOI 10.1007/s40261-013-0074-0; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Honda M, 2014, HEPATOLOGY, V59, P828, DOI 10.1002/hep.26788; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kalkeri G, 2013, ANTIMICROB AGENTS CH, V57, P4417, DOI 10.1128/AAC.00399-13; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Nakagawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059611; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sulkowski MS, 2013, HEPATOLOGY, V57, P2143, DOI 10.1002/hep.26276; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Watanabe T, 2013, GUT, V62, P1340, DOI 10.1136/gutjnl-2012-302553; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshida H, 2004, GUT, V53, P425, DOI 10.1136/gut.2003.030353; Yoshio S, 2013, HEPATOLOGY, V57, P1705, DOI 10.1002/hep.26182; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhang SY, 2013, GASTROENTEROLOGY, V144, P414, DOI 10.1053/j.gastro.2012.10.034	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118000	10.1371/journal.pone.0118000	http://dx.doi.org/10.1371/journal.pone.0118000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706116	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100136
J	Itakura, G; Kobayashi, Y; Nishimura, S; Iwai, H; Takano, M; Iwanami, A; Toyama, Y; Okano, H; Nakamura, M				Itakura, Go; Kobayashi, Yoshiomi; Nishimura, Soraya; Iwai, Hiroki; Takano, Morito; Iwanami, Akio; Toyama, Yoshiaki; Okano, Hideyuki; Nakamura, Masaya			Controlling Immune Rejection Is a Fail-Safe System against Potential Tumorigenicity after Human iPSC-Derived Neural Stem Cell Transplantation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; INDUCED PLURIPOTENT; STEM/PROGENITOR CELLS; IN-VITRO; FUNCTIONAL RECOVERY; IMMUNOGENICITY; MOUSE; BRAIN; CNS	Our previous work reported functional recovery after transplantation of mouse and human induced pluripotent stem cell-derived neural stem/progenitor cells (hiPSC-NS/PCs) into rodent models of spinal cord injury (SCI). Although hiPSC-NS/PCs proved useful for the treatment of SCI, the tumorigenicity of the transplanted cells must be resolved before they can be used in clinical applications. The current study sought to determine the feasibility of ablation of the tumors formed after hiPSC-NS/PC transplantation through immunoregulation. Tumorigenic hiPSC-NS/PCs were transplanted into the intact spinal cords of immunocompetent BALB/cA mice with or without immunosuppressant treatment. In vivo bioluminescence imaging was used to evaluate the chronological survival and growth of the transplanted cells. The graft survival rate was 0% in the group without immunosuppressants versus 100% in the group with immunosuppressants. Most of the mice that received immunosuppressants exhibited hind-limb paralysis owing to tumor growth at 3 months after iPSC-NS/PC transplantation. Histological analysis showed that the tumors shared certain characteristics with low-grade gliomas rather than with teratomas. After confirming the progression of the tumors in immunosuppressed mice, the immunosuppressant agents were discontinued, resulting in the complete rejection of iPSC-NS/PC-derived masses within 42 days after drug cessation. In accordance with the tumor rejection, hind-limb motor function was recovered in all of the mice. Moreover, infiltration of microglia and lymphocytes was observed during the course of tumor rejection, along with apoptosis of iPSC-NS/PC-generated cells. Thus, immune rejection can be used as a fail-safe system against potential tumorigenicity after transplantation of iPSC-NS/PCs to treat SCI.	[Itakura, Go; Kobayashi, Yoshiomi; Nishimura, Soraya; Iwai, Hiroki; Takano, Morito; Iwanami, Akio; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Itakura, Go; Nishimura, Soraya; Iwai, Hiroki; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University; Keio University	Okano, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hidokano@a2.keio.jp; masa@a8.keio.jp	Okano, Hideyuki/X-9131-2019; Kobayashi, Yoshiomi/W-5573-2019; Nakamura, Masaya/K-4111-2013; Okano, Hideyuki/I-7584-2019	Okano, Hideyuki/0000-0001-7482-5935; Iwai, Hiroki/0000-0002-5722-8706	Japan Science and Technology (JST)-California Institute for Regenerative Medicine (CIRM) collaborative program; Zenkyoren (National Mutual Insurance Federation of Agricultural Cooperatives) Research Foundation; General Insurance Association of Japan; Centers for Clinical Application Research on Specific Disease/Organ from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JST; Japan Society for the Promotion of Science (JSPS); Keio Gijuku Academic Development Funds; MEXT	Japan Science and Technology (JST)-California Institute for Regenerative Medicine (CIRM) collaborative program; Zenkyoren (National Mutual Insurance Federation of Agricultural Cooperatives) Research Foundation; General Insurance Association of Japan; Centers for Clinical Application Research on Specific Disease/Organ from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JST(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio Gijuku Academic Development Funds; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Japan Science and Technology (JST)-California Institute for Regenerative Medicine (CIRM) collaborative program; a Grant-in-Aid from the Zenkyoren (National Mutual Insurance Federation of Agricultural Cooperatives) Research Foundation; a Grant-in-Aid from the General Insurance Association of Japan to MN; Grants-in-Aid for the Research Center Network for Realization of Regenerative Medicine and the Centers for Clinical Application Research on Specific Disease/Organ from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the JST; Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS); Keio Gijuku Academic Development Funds; a Grant-in-Aid for the Global Center of Excellence (COE) program from the MEXT to Keio University; and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the MEXT to HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson E, 2009, STEM CELL RES, V2, P56, DOI 10.1016/j.scr.2008.06.002; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Auchincloss H, 1998, ANNU REV IMMUNOL, V16, P433, DOI 10.1146/annurev.immunol.16.1.433; Boyd AS, 2012, STEM CELLS, V30, P797, DOI 10.1002/stem.1066; BRUNDIN P, 1989, EXP BRAIN RES, V75, P195; Capetian P, 2011, SEMIN IMMUNOPATHOL, V33, P619, DOI 10.1007/s00281-011-0272-x; Chen F, 2013, BIOMATERIALS, V34, P1701, DOI 10.1016/j.biomaterials.2012.11.018; Cheng FY, 2012, BIOMATERIALS, V33, P3195, DOI 10.1016/j.biomaterials.2012.01.023; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; Dace DS, 2008, IMMUNOLOGY, V123, P367, DOI 10.1111/j.1365-2567.2007.02700.x; de Almeida PE, 2013, CIRC RES, V112, P549, DOI 10.1161/CIRCRESAHA.111.249243; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Dressel R, 2011, SEMIN IMMUNOPATHOL, V33, P573, DOI 10.1007/s00281-011-0266-8; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Engelhardt B, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-4; Fainstein N, 2008, MOL CELL NEUROSCI, V39, P335, DOI 10.1016/j.mcn.2008.07.007; Fainstein N, 2013, GLIA, V61, P140, DOI 10.1002/glia.22420; Frenzel LP, 2009, STEM CELLS, V27, P307, DOI 10.1634/stemcells.2008-0528; Grinnemo KH, 2008, CELL TISSUE RES, V331, P67, DOI 10.1007/s00441-007-0486-3; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hara-Miyauchi C, 2012, BIOCHEM BIOPH RES CO, V419, P188, DOI 10.1016/j.bbrc.2012.01.141; Hickey WF, 1999, SEMIN IMMUNOL, V11, P125, DOI 10.1006/smim.1999.0168; Hori Junko, 2007, Chem Immunol Allergy, V92, P290, DOI 10.1159/000099279; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Kadereit S, 2011, SEMIN IMMUNOPATHOL, V33, P551, DOI 10.1007/s00281-011-0265-9; Kaneko S, 2013, CELL STEM CELL, V12, P385, DOI 10.1016/j.stem.2013.03.008; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; Kaplan Henry J, 2007, Chem Immunol Allergy, V92, P11, DOI 10.1159/000099237; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787; Lee MK, 2003, TRANSPLANTATION, V75, P1415, DOI 10.1097/01.TP.0000064296.65628.6C; Liu J, 2013, STEM CELL RES, V10, P325, DOI 10.1016/j.scr.2013.01.001; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Mohamad O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064160; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakamura M, 2001, EXP NEUROL, V169, P407, DOI 10.1006/exnr.2001.7670; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Odeberg J, 2005, J NEUROIMMUNOL, V161, P1, DOI 10.1016/j.jneuroim.2004.11.016; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Okano H, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-22; Okano H, 2013, CIRC RES, V112, P523, DOI 10.1161/CIRCRESAHA.111.256149; Okita K, 2011, CIRC RES, V109, P720, DOI 10.1161/RES.0b013e318232e187; Pearl JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005090; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Porrett PM, 2008, ARCH IMMUNOL THER EX, V56, P193, DOI 10.1007/s00005-008-0019-0; Sontag CJ, 2013, STEM CELL TRANSL MED, V2, P731, DOI 10.5966/sctm.2012-0175; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Takahashi T, 1997, IMMUNOL RES, V16, P273, DOI 10.1007/BF02786395; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Werbowetski-Ogilvie TE, 2012, STEM CELLS, V30, P392, DOI 10.1002/stem.1017; Xu L, 2010, STEM CELL REV REP, V6, P121, DOI 10.1007/s12015-009-9104-y; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	61	30	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116413	10.1371/journal.pone.0116413	http://dx.doi.org/10.1371/journal.pone.0116413			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706286	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100037
J	Pham, PH; Shipman, WJ; Erikson, GA; Schork, NJ; Torkamani, A				Pham, Phillip H.; Shipman, William J.; Erikson, Galina A.; Schork, Nicholas J.; Torkamani, Ali			Scripps Genome ADVISER: Annotation and Distributed Variant Interpretation SERver	PLOS ONE			English	Article							DE-NOVO MUTATIONS; SNP; ASSOCIATION; DATABASE; INHERITANCE; SOFTWARE; DISEASES; TOOL	Interpretation of human genomes is a major challenge. We present the Scripps Genome ADVISER (SG-ADVISER) suite, which aims to fill the gap between data generation and genome interpretation by performing holistic, in-depth, annotations and functional predictions on all variant types and effects. The SG-ADVISER suite includes a de-identification tool, a variant annotation web-server, and a user interface for inheritance and annotation-based filtration. SG-ADVISER allows users with no bioinformatics expertise to manipulate large volumes of variant data with ease - without the need to download large reference databases, install software, or use a command line interface. SG-ADVISER is freely available at genomics.scripps.edu/ADVISER.	[Shipman, William J.; Erikson, Galina A.; Schork, Nicholas J.; Torkamani, Ali] Scripps Hlth, La Jolla, CA 92037 USA; [Shipman, William J.; Erikson, Galina A.; Schork, Nicholas J.; Torkamani, Ali] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Torkamani, Ali] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Schork, Nicholas J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Pham, Phillip H.; Schork, Nicholas J.; Torkamani, Ali] Cypher Genom Inc, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Torkamani, A (corresponding author), Scripps Hlth, La Jolla, CA 92037 USA.	atorkama@scripps.edu		Shipman, William/0000-0002-5108-1109; Schork, Nicholas/0000-0003-0920-5013	NHGRI Genome Sequencing Informatics Tools (GS-IT) Program via grant National Institute of Health [U01 HG006476]; National Institute of Health - National Center for Advancing Translational Sciences Clinical and Translational Science Award (CTSA) [5 UL1 RR025774]; Scripps Genomic Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006476] Funding Source: NIH RePORTER	NHGRI Genome Sequencing Informatics Tools (GS-IT) Program via grant National Institute of Health; National Institute of Health - National Center for Advancing Translational Sciences Clinical and Translational Science Award (CTSA); Scripps Genomic Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the NHGRI Genome Sequencing Informatics Tools (GS-IT) Program via grant National Institute of Health U01 HG006476 to Ali Torkamani. Further information available at: (http://iseqtools.org). Further support is provided by Scripps Genomic Medicine, a National Institute of Health - National Center for Advancing Translational Sciences Clinical and Translational Science Award (CTSA; 5 UL1 RR025774) to STSI. The funders had no role in study design, datacollection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asmann YW, 2012, BIOINFORMATICS, V28, P277, DOI 10.1093/bioinformatics/btr612; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P31, DOI 10.1093/nar/25.1.31; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Chen YZ, 2014, ANN NEUROL; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Ge DL, 2011, BIOINFORMATICS, V27, P1998, DOI 10.1093/bioinformatics/btr317; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r9; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li ST, 2007, NUCLEIC ACIDS RES, V35, pD707, DOI 10.1093/nar/gkl969; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Makarov V, 2012, BIOINFORMATICS, V28, P724, DOI 10.1093/bioinformatics/bts032; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Medina I, 2012, NUCLEIC ACIDS RES, V40, pW54, DOI 10.1093/nar/gks572; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shetty AC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-471; Sifrim A, 2012, GENOME MED, V4, DOI 10.1186/gm374; Sincan M, 2012, HUM MUTAT, V33, P593, DOI 10.1002/humu.22034; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116815	10.1371/journal.pone.0116815	http://dx.doi.org/10.1371/journal.pone.0116815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706643	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100050
J	Rebula, JR; Kuo, AD				Rebula, John R.; Kuo, Arthur D.			The Cost of Leg Forces in Bipedal Locomotion: A Simple Optimization Study	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TO-STEP TRANSITIONS; HUMAN WALKING; SKELETAL-MUSCLE; ENERGY-COST; INVERTED PENDULUM; MODEL; WORK; ENERGETICS; MECHANICS	Simple optimization models show that bipedal locomotion may largely be governed by the mechanical work performed by the legs, minimization of which can automatically discover walking and running gaits. Work minimization can reproduce broad aspects of human ground reaction forces, such as a double-peaked profile for walking and a single peak for running, but the predicted peaks are unrealistically high and impulsive compared to the much smoother forces produced by humans. The smoothness might be explained better by a cost for the force rather than work produced by the legs, but it is unclear what features of force might be most relevant. We therefore tested a generalized force cost that can penalize force amplitude or its n-th time derivative, raised to the p-th power (or p-norm), across a variety of combinations for n and p. A simple model shows that this generalized force cost only produces smoother, human-like forces if it penalizes the rate rather than amplitude of force production, and only in combination with a work cost. Such a combined objective reproduces the characteristic profiles of human walking (R-2 = 0.96) and running (R-2 = 0.92), more so than minimization of either work or force amplitude alone (R-2 = -0.79 and R-2 = 0.22, respectively, for walking). Humans might find it preferable to avoid rapid force production, which may be mechanically and physiologically costly.				jrebula@umich.edu			Department of Defense [W81XWH-09-2-0142]; National Institutes of Health [AG0308]; Defense Advanced Research Project Agency (Atlas Program); Defense Advanced Research Project Agency (Boston Dynamics, Inc.); NATIONAL INSTITUTE ON AGING [Z01AG000308] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Project Agency (Atlas Program); Defense Advanced Research Project Agency (Boston Dynamics, Inc.); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Department of Defense (W81XWH-09-2-0142), the National Institutes of Health (AG0308), and the Defense Advanced Research Projects Agency (Atlas Program; Boston Dynamics, Inc.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2010, J BIOMECH, V43, P1055, DOI 10.1016/j.jbiomech.2009.12.012; Adamczyk PG, 2009, J EXP BIOL, V212, P2668, DOI 10.1242/jeb.027581; ALEXANDER RM, 1990, INT J ROBOT RES, V9, P53, DOI 10.1177/027836499000900205; BERGSTROM M, 1988, J APPL PHYSIOL, V65, P1500, DOI 10.1152/jappl.1988.65.4.1500; Collins SH, 2009, P ROY SOC B-BIOL SCI, V276, P3679, DOI 10.1098/rspb.2009.0664; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; Dean JC, 2011, J APPL PHYSIOL, V110, P873, DOI 10.1152/japplphysiol.00505.2010; Doke J, 2005, J EXP BIOL, V208, P439, DOI 10.1242/jeb.01408; Doke J, 2007, J EXP BIOL, V210, P2390, DOI 10.1242/jeb.02782; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Donelan JM, 2002, J EXP BIOL, V205, P3717; Engelbrecht SE, 2001, J MATH PSYCHOL, V45, P497, DOI 10.1006/jmps.2000.1295; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229, DOI 10.1098/rspb.2000.1361; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Gordon KE, 2009, ARCH PHYS MED REHAB, V90, P136, DOI 10.1016/j.apmr.2008.07.014; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hepple RT, 2010, AM J PHYSIOL-REG I, V298, pR983, DOI 10.1152/ajpregu.00715.2009; Hogan MC, 1998, AM J PHYSIOL-ENDOC M, V274, pE397, DOI 10.1152/ajpendo.1998.274.3.E397; HOGAN N, 1984, J NEUROSCI, V4, P2745; HOROWITZ JF, 1994, INT J SPORTS MED, V15, P152, DOI 10.1055/s-2007-1021038; Kerdok AE, 2002, J APPL PHYSIOL, V92, P469, DOI 10.1152/japplphysiol.01164.2000; Kistemaker DA, 2010, J NEUROPHYSIOL, V104, P2985, DOI 10.1152/jn.00483.2010; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; KUO AD, 1994, HUM MOVEMENT SCI, V13, P635, DOI 10.1016/0167-9457(94)90010-8; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Kuo AD, 2007, HUM MOVEMENT SCI, V26, P617, DOI 10.1016/j.humov.2007.04.003; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; MA SP, 1991, J BIOMECH, V24, P21, DOI 10.1016/0021-9290(91)90323-F; Margaria R, 1968, Int Z Angew Physiol, V25, P339; MATLAB, 2011, VERS 7 12 0 635 R201; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; Miller RH, 2014, J BIOMECH, V47, P1373, DOI 10.1016/j.jbiomech.2014.01.049; Miller RH, 2012, P ROY SOC B-BIOL SCI, V279, P1498, DOI 10.1098/rspb.2011.2015; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; PANDY MG, 1990, J BIOMECH, V23, P1185, DOI 10.1016/0021-9290(90)90376-E; Prilutsky BI, 1997, J BIOMECH, V30, P1025, DOI 10.1016/S0021-9290(97)00068-7; Roberts TJ, 2002, COMP BIOCHEM PHYS A, V133, P1087, DOI 10.1016/S1095-6433(02)00244-1; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Srinivasan M, 2011, J R SOC INTERFACE, V8, P74, DOI 10.1098/rsif.2009.0544; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Umberger BR, 2006, J BIOMECH, V39, P1472, DOI 10.1016/j.jbiomech.2005.03.025; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Whittle MW, 1999, GAIT POSTURE, V10, P264, DOI 10.1016/S0966-6362(99)00041-7; Zelik KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031143; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297	51	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117384	10.1371/journal.pone.0117384	http://dx.doi.org/10.1371/journal.pone.0117384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25707000	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100084
J	Rottenkolber, M; Voogd, E; van Dijk, L; Primatesta, P; Becker, C; Schlienger, R; de Groot, MCH; Alvarez, Y; Durand, J; Slattery, J; Afonso, A; Requena, G; Gil, M; Alvarez, A; Hesse, U; Gerlach, R; Hasford, J; Fischer, R; Klungel, OH; Schmiedl, S				Rottenkolber, Marietta; Voogd, Eef; van Dijk, Liset; Primatesta, Paola; Becker, Claudia; Schlienger, Raymond; de Groot, Mark C. H.; Alvarez, Yolanda; Durand, Julie; Slattery, Jim; Afonso, Ana; Requena, Gema; Gil, Miguel; Alvarez, Arturo; Hesse, Ulrik; Gerlach, Roman; Hasford, Joerg; Fischer, Rainald; Klungel, Olaf H.; Schmiedl, Sven			Time Trends of Period Prevalence Rates of Patients with Inhaled Long-Acting Beta-2-Agonists-Containing Prescriptions: A European Comparative Database Study	PLOS ONE			English	Article							OVERLAP SYNDROME; GENERAL-PRACTICE; ASTHMA; SALMETEROL; PERSISTENCE; MEDICATION; DISEASE	Background Inhaled, long-acting beta-2-adrenoceptor agonists (LABA) have well-established roles in asthma and/or COPD treatment. Drug utilisation patterns for LABA have been described, but few studies have directly compared LABA use in different countries. We aimed to compare the prevalence of LABA-containing prescriptions in five European countries using a standardised methodology. Methods A common study protocol was applied to seven European healthcare record databases (Denmark, Germany, Spain, the Netherlands (2), and the UK (2)) to calculate crude and age-and sex-standardised annual period prevalence rates (PPRs) of LABA-containing prescriptions from 2002-2009. Annual PPRs were stratified by sex, age, and indication (asthma, COPD, asthma and COPD). Results From 2002-2009, age-and sex-standardised PPRs of patients with LABA-containing medications increased in all databases (58.2%-185.1%). Highest PPRs were found in men >= 80 years old and women 70-79 years old. Regarding the three indications, the highest age-and sex-standardised PPRs in all databases were found in patients with "asthma and COPD" but with large inter-country variation. In those with asthma or COPD, lower PPRs and smaller inter-country variations were found. For all three indications, PPRs for LABA-containing prescriptions increased with age. Conclusions Using a standardised protocol that allowed direct inter-country comparisons, we found highest rates of LABA-containing prescriptions in elderly patients and distinct differences in the increased utilisation of LABA-containing prescriptions within the study period throughout the five European countries.	[Rottenkolber, Marietta; Hasford, Joerg] Univ Munich, Inst Med Informat Sci Biometry & Epidemiol, Munich, Germany; [Voogd, Eef; van Dijk, Liset; de Groot, Mark C. H.; Afonso, Ana; Klungel, Olaf H.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Voogd, Eef; van Dijk, Liset] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Primatesta, Paola] Novartis Pharma AG, Basel, Switzerland; [Becker, Claudia] Univ Basel, Div Clin Pharm & Epidemiol, Basel, Switzerland; [Alvarez, Yolanda; Durand, Julie; Slattery, Jim] European Med Agcy, London, England; [Requena, Gema] Univ Alcala, Sch Med & Hlth Sci, Dept Biomed Sci 2, Pharmacol Unit, Madrid, Spain; [Gil, Miguel; Alvarez, Arturo] Spanish Agcy Med & Med Devices, Div Pharmacoepidemiol & Pharmacovigilance, BIFAP Unit, Madrid, Spain; [Hesse, Ulrik] Danish Med Agcy Laegemiddelstyrelsen, Med Control Div, Copenhagen, Denmark; [Gerlach, Roman] Natl Assoc Statutory Hlth Insurance Phys Bavaria, Munich, Germany; [Fischer, Rainald] Univ Munich, Univ Hosp, Med Klin & Poliklin 5, Munich, Germany; [Schmiedl, Sven] Univ Witten Herdecke, Fac Hlth, Sch Med, Dept Clin Pharmacol, Witten, Germany; [Schmiedl, Sven] HELIOS Clin Wuppertal, Clin Pharmacol, Philipp Klee Inst, Wuppertal, Germany	University of Munich; Utrecht University; Netherlands Institute for Health Services Research; Novartis; University of Basel; Universidad de Alcala; University of Munich; Witten Herdecke University	Rottenkolber, M (corresponding author), Univ Munich, Inst Med Informat Sci Biometry & Epidemiol, Munich, Germany.	rottenk@ibe.med.uni-muenchen.de	de Groot, Mark CH/A-9891-2012; Alvarez, Yolanda/I-4672-2019	de Groot, Mark CH/0000-0002-5764-5788; 	Innovative Medicine Initiative Joint Undertaking [115004]; European Union's Seventh Framework Programme (FP7); Pfizer; AstraZeneca	Innovative Medicine Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); Pfizer(Pfizer); AstraZeneca(AstraZeneca)	The PROTECT project has received support from the Innovative Medicine Initiative Joint Undertaking (www.imi.europa.eu) under Grant Agreement no 115004, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies' in-kind contribution. In addition, as a special form of the IMI JU grant, Utrecht University and University of Alcala received a direct financial contribution from Pfizer and AstraZeneca, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Paola Primatesta and Raymond Schlienger are employed by Novartis Pharma AG. Novartis Pharma AG provided support in the form of salaries for authors PP and RS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbing-Karahagopian V, 2014, CURR CLIN PHARMACOL, V9, P130, DOI 10.2174/1574884708666131111211802; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Baiardi P, 2010, ACTA PAEDIATR, V99, P544, DOI 10.1111/j.1651-2227.2009.01668.x; Bianchi M, 2010, EUR J CLIN PHARMACOL, V66, P929, DOI 10.1007/s00228-010-0845-y; Buffels Johan, 2009, Prim Care Respir J, V18, P34, DOI 10.3132/pcrj.2008.00047; Cai B, 2012, PHARMACOEPIDEM DR S, V21, P770, DOI 10.1002/pds.3277; Cates CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006924.pub3; Cates CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006922.pub3; Chong J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009157.pub2; DiSantostefano RL, 2011, DRUG SAFETY, V34, P511, DOI 10.2165/11587370-000000000-00000; Furu K, 2007, EUR J CLIN PHARMACOL, V63, P693, DOI 10.1007/s00228-007-0301-9; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Global Initiative for Asthma (GINA), 2014, GLOB STRAT ASTHM MAN; GOLD, 2011, GLOB STRAT DIAGN MAN; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036328; Hasford J, 2010, ALLERGY, V65, P347, DOI 10.1111/j.1398-9995.2009.02161.x; Haupt D, 2008, PHARM WORLD SCI, V30, P509, DOI 10.1007/s11096-008-9197-4; Higashi A, 2011, J GEN INTERN MED, V26, P1465, DOI 10.1007/s11606-011-1796-4; Klein RJ, 2001, HLTH PEOPLE 2010 STA, V20, P1; Lurie P, 2005, LANCET, V366, P1261, DOI 10.1016/S0140-6736(05)67518-6; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Papaiwannou A, 2014, J THORAC DIS, V6, pS146, DOI 10.3978/j.issn.2072-1439.2014.03.04; ROBERTS SJ, 1994, THORAX, V49, P1090, DOI 10.1136/thx.49.11.1090; Schmiedl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105110; Sen EF, 2011, EUR J PEDIATR, V170, P81, DOI 10.1007/s00431-010-1275-7; Spiegelman M, 1968, INTRO DEMOGRAPHY; Stirbu-Wagner I, 2010, LANDELIJK INFOMATIEN; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117628	10.1371/journal.pone.0117628	http://dx.doi.org/10.1371/journal.pone.0117628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706152	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100106
J	Ziakas, PD; Zacharioudakis, IM; Zervou, FN; Grigoras, C; Pliakos, EE; Mylonakis, E				Ziakas, Panayiotis D.; Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Grigoras, Christos; Pliakos, Elina Eleftheria; Mylonakis, Eleftherios			Asymptomatic Carriers of Toxigenic C. difficile in Long-Term Care Facilities: A Meta-Analysis of Prevalence and Risk Factors	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; MOLECULAR EPIDEMIOLOGY; INFECTION; COLONIZATION; TRANSMISSION; DIARRHEA; CONTAMINATION; SURVEILLANCE; ACQUISITION; ADMISSIONS	Background The impact of Clostridium difficile colonization in C. difficile infection (CDI) is inadequately explored. As a result, asymptomatic carriage is not considered in the development of infection control policies and the burden of carrier state in long-term care facilities (LTCFs) is unknown. Purpose To explore the epidemiology of C. difficile colonization in LTCFs, identify predisposing factors and describe its impact on healthcare management. Data Sources PubMed, Embase and Web of Science (up to June 2014) without language restriction, complemented by reference lists of eligible studies. Study Selection All studies providing extractable data on the prevalence of toxigenic C. difficile colonization among asymptomatic residents in LTCFs. Data Extraction Two authors extracted data independently. Statistical Methods The pooled colonization estimates were calculated using the double arcsine methodology and reported along with their 95% random-effects confidence intervals (CIs), using DerSimonian-Laird weights. We assessed the impact of patient-level covariates on the risk of colonization and effects were reported as odds ratios (OR, 95% CI). We used the colonization estimates to simulate the effective reproduction number R through a Monte Carlo technique. Results Based on data from 9 eligible studies that met the specified criteria and included 1,371 subjects, we found that 14.8% (95% CI 7.6%-24.0%) of LTCF residents are asymptomatic carriers of toxigenic C. difficile. Colonization estimates were significantly higher in facilities with prior CDI outbreak (30.1% vs. 6.5%, p = 0.01). Patient history of CDI (OR 6.07; 95% CI 2.06-17.88; effect derived from 3 studies), prior hospitalization (OR 2.11; 95% CI 1.084.13; derived from 3 studies) and antimicrobial use within previous 3 months (OR 3.68; 95% CI 2.04-6.62; derived from 4 studies) were associated with colonization. The predicted colonization rate at admission was 8.9%. Conclusion Asymptomatic carriage of toxigenic C. difficile represents a significant burden in LTCFs and is associated with prior CDI outbreaks in the facility, a history of CDI, prior hospitalization and antimicrobial use. These findings can impact infection control measures at LTCFs.	[Ziakas, Panayiotis D.; Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Grigoras, Christos; Pliakos, Elina Eleftheria; Mylonakis, Eleftherios] Brown Univ, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Ziakas, PD (corresponding author), Brown Univ, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02912 USA.	emylonakis@lifespan.org	Pliakos, Elina/L-2322-2019	Pliakos, Elina/0000-0003-3345-2655; Ziakas, Panayiotis/0000-0002-5943-8635	SURDNA Fellowship Program from the Center for Gerontology and Healthcare Research, Brown University	SURDNA Fellowship Program from the Center for Gerontology and Healthcare Research, Brown University	The study was supported by the SURDNA 2015 Fellowship Program from the Center for Gerontology and Healthcare Research, Brown University (available at: http://brown.edu/research/projects/gerontology-healthcare-research/fellowshipprograms/surdna-fellowship-program). PDZ received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030183; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; BENDER BS, 1986, LANCET, V2, P11, DOI 10.1016/S0140-6736(86)92559-6; BENNETT RG, 1992, J DIARRHOEAL DIS RES, V10, P87; Berry N, 2014, J HOSP INFECT, V87, P109, DOI 10.1016/j.jhin.2014.03.005; BROOKS SE, 1992, INFECT CONT HOSP EP, V13, P98; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Centers for Disease Control and Prevention. Vital and Health Statistics, 2009, NAT NURS HOM SURV 20; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; Department of Health and Human Services. Office of Inspector General, MED NURS HOM RES HOS; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eyre DW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003059; Fawley WN, 2001, EPIDEMIOL INFECT, V126, P343, DOI 10.1017/S095026880100557X; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Galdys AL, 2014, EXPERT REV ANTI-INFE, V12, P967, DOI 10.1586/14787210.2014.920252; Garg S, 2013, DIGEST DIS SCI, V58, P3407, DOI 10.1007/s10620-013-2848-x; Hensgens MPM, 2014, CLIN MICROBIOL INFEC, V20, pO1067, DOI 10.1111/1469-0691.12758; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Hung YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042415; Janarthanan S, 2012, AM J GASTROENTEROL, V107, P1001, DOI 10.1038/ajg.2012.179; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; Jump RLP, 2012, INFECT CONT HOSP EP, V33, P1185, DOI 10.1086/668429; KERR RB, 1990, AM J INFECT CONTROL, V18, P332, DOI 10.1016/0196-6553(90)90233-I; Kim JH, 2011, INFECT CONT HOSP EP, V32, P656, DOI 10.1086/660767; Koo HL, 2014, INFECT CONT HOSP EP, V35, P667, DOI 10.1086/676433; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lanzas C, 2011, INFECT CONT HOSP EP, V32, P553, DOI 10.1086/660013; Lanzas C, 2014, INFECT CONT HOSP EP, V35, P1043, DOI 10.1086/677162; LARSON E, 1992, AM J INFECT CONTROL, V20, P11, DOI 10.1016/S0196-6553(05)80118-X; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Marwick CA, 2013, J ANTIMICROB CHEMOTH, V68, P2927, DOI 10.1093/jac/dkt257; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Moher D, 2009, ANN INTERN MED, V151, P264; Mylonakis E, 2001, ARCH INTERN MED, V161, P525, DOI 10.1001/archinte.161.4.525; Mylotte JM, 2013, J AM GERIATR SOC, V61, P122, DOI 10.1111/jgs.12041; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pakyz A, 2011, PHARMACOTHERAPY, V31, P546, DOI 10.1592/phco.31.6.546; Pawar D, 2012, INFECT CONT HOSP EP, V33, P1107, DOI 10.1086/668031; Rea MC, 2012, J CLIN MICROBIOL, V50, P867, DOI 10.1128/JCM.05176-11; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rivera Emmanuel V, 2003, J Gend Specif Med, V6, P27; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Ryan J, 2010, IRISH J MED SCI, V179, P245, DOI 10.1007/s11845-009-0361-1; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Schoevaerdts D, 2011, J AM GERIATR SOC, V59, P2179, DOI 10.1111/j.1532-5415.2011.03685.x; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Simor AE, 2002, INFECT CONT HOSP EP, V23, P696, DOI 10.1086/501997; SIMOR AE, 1993, CLIN INFECT DIS, V17, P672, DOI 10.1093/clinids/17.4.672; Simor AE, 2010, J AM GERIATR SOC, V58, P1556, DOI 10.1111/j.1532-5415.2010.02958.x; Stone ND, 2012, INFECT CONT HOSP EP, V33, P965, DOI 10.1086/667743; THOMAS DR, 1990, J AM GERIATR SOC, V38, P415, DOI 10.1111/j.1532-5415.1990.tb03539.x; Vesteinsdottir I, 2012, EUR J CLIN MICROBIOL, V31, P2601, DOI 10.1007/s10096-012-1603-0; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; WALKER KJ, 1993, J AM GERIATR SOC, V41, P940, DOI 10.1111/j.1532-5415.1993.tb06759.x; Wei HL, 2013, J MICROBIOL IMMUNOL; Wells G.A., NEWCASTLE OTTAWA SCA; Wilcox MH, 2003, J HOSP INFECT, V54, P109, DOI 10.1016/S0195-6701(02)00400-0; World Health Organization, HLTH TOP DIS OUTBR; Zacharioudakis IM, 2014, AM J KIDNEY DIS; Zacharioudakis Ioannis M, 2014, Biol Blood Marrow Transplant, V20, P1650, DOI 10.1016/j.bbmt.2014.06.001; Ziakas PD, 2014, AM J TRANSPLANT, V14, P1887, DOI 10.1111/ajt.12784; Ziakas PD, 2014, CRIT CARE MED, V42, P433, DOI 10.1097/CCM.0b013e3182a66bb8; Ziakas PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075658	70	47	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117195	10.1371/journal.pone.0117195	http://dx.doi.org/10.1371/journal.pone.0117195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25707002	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100064
J	Stone, JW; Bleckley, S; Lavelle, S; Schroeder, SJ				Stone, Jonathan W.; Bleckley, Samuel; Lavelle, Sean; Schroeder, Susan J.			A Parallel Implementation of the Wuchty Algorithm with Additional Experimental Filters to More Thoroughly Explore RNA Conformational Space	PLOS ONE			English	Article							MOSAIC-VIRUS RNA; SECONDARY STRUCTURES; PREDICTION; CONSTRAINTS; ENSEMBLE	We present new modifications to the Wuchty algorithm in order to better define and explore possible conformations for an RNA sequence. The new features, including parallelization, energy-independent lonely pair constraints, context-dependent chemical probing constraints, helix filters, and optional multibranch loops, provide useful tools for exploring the landscape of RNA folding. Chemical probing alone may not necessarily define a single unique structure. The helix filters and optional multibranch loops are global constraints on RNA structure that are an especially useful tool for generating models of encapsidated viral RNA for which cryoelectron microscopy or crystallography data may be available. The computations generate a combinatorially complete set of structures near a free energy minimum and thus provide data on the density and diversity of structures near the bottom of a folding funnel for an RNA sequence. The conformational landscapes for some RNA sequences may resemble a low, wide basin rather than a steep funnel that converges to a single structure.	[Stone, Jonathan W.; Bleckley, Samuel; Lavelle, Sean; Schroeder, Susan J.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Stone, Jonathan W.; Bleckley, Samuel; Lavelle, Sean; Schroeder, Susan J.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Schroeder, SJ (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	sjschroeder114@gmail.com		Schroeder, Susan/0000-0003-4755-2294	National Science Foundation CAREER [0844913]; Oklahoma Center for the Advancement of Science and Technology [HR13-206]; Pharmaceutical Research and Manufacturers of America Foundation; Div Of Molecular and Cellular Bioscience [0844913] Funding Source: National Science Foundation	National Science Foundation CAREER(National Science Foundation (NSF)); Oklahoma Center for the Advancement of Science and Technology; Pharmaceutical Research and Manufacturers of America Foundation; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation CAREER grant no. 0844913, the Oklahoma Center for the Advancement of Science and Technology HR13-206, and the Pharmaceutical Research and Manufacturers of America Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman F, 2013, LECT NOTES COMPUT SC, V8213, P1, DOI 10.1007/978-3-319-02624-4_1; Bleckley S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051204, DOI 10.1371/JOURNAL.PONE.0051204]; Bleckley S, 2012, RNA, V18, P1309, DOI 10.1261/rna.032326.112; Bompfunewerer AF, 2008, J MATH BIOL, V56, P129, DOI 10.1007/s00285-007-0107-5; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Ding Y, 2001, NUCLEIC ACIDS RES, V29, P1034, DOI 10.1093/nar/29.5.1034; Ding Y, 2006, J MOL BIOL, V359, P554, DOI 10.1016/j.jmb.2006.01.056; Forum MP, 1994, MPI MESSAGE PASSING; Giegerich R, 2004, NUCLEIC ACIDS RES, V32, P4843, DOI 10.1093/nar/gkh779; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Hofacker IL, 2014, METHODS MOL BIOL, V1097, P71, DOI 10.1007/978-1-62703-709-9_4; Janssen S, 2014, METHODS MOL BIOL, V1097, P215, DOI 10.1007/978-1-62703-709-9_11; Larson SB, 1998, J MOL BIOL, V277, P37, DOI 10.1006/jmbi.1997.1570; Larson SB, 2001, CURR OPIN STRUC BIOL, V11, P59, DOI 10.1016/S0959-440X(00)00166-4; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathews DH, 2006, J MOL BIOL, V359, P526, DOI 10.1016/j.jmb.2006.01.067; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; PIPAS JM, 1975, P NATL ACAD SCI USA, V72, P2017, DOI 10.1073/pnas.72.6.2017; Proctor JR, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt174; Rudinger-Thirion J, 2011, P NATL ACAD SCI USA, V108, pE794, DOI 10.1073/pnas.1103698108; Schroeder SJ, 2014, BIOCHEMISTR IN PRESS; Schroeder SJ, 2011, BIOPHYS J, V101, P167, DOI 10.1016/j.bpj.2011.05.053; Schroeder SJ, 2009, J VIROL, V83, P6326, DOI 10.1128/JVI.00251-09; Shepherd CM, 2006, NUCLEIC ACIDS RES, V34, pD386, DOI 10.1093/nar/gkj032; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Washietl S, 2012, NUCLEIC ACIDS RES, V40, P4261, DOI 10.1093/nar/gks009; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	33	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117217	10.1371/journal.pone.0117217	http://dx.doi.org/10.1371/journal.pone.0117217			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695434	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300018
J	Aspden, JW; Armstrong, CL; Gutierrez-Ibanez, CI; Hawkes, R; Iwaniuk, AN; Kohl, T; Graham, DJ; Wylie, DR				Aspden, Joel W.; Armstrong, Carol L.; Gutierrez-Ibanez, Cristian I.; Hawkes, Richard; Iwaniuk, Andrew N.; Kohl, Tobias; Graham, David J.; Wylie, Douglas R.			Zebrin II/Aldolase C Expression in the Cerebellum of the Western Diamondback Rattlesnake (Crotalus atrox)	PLOS ONE			English	Article							PURKINJE-CELL COMPARTMENTATION; CLIMBING FIBER PROJECTIONS; PIGEONS COLUMBA-LIVIA; ALDOLASE-C; ANTIGENIC COMPARTMENTATION; FUNCTIONAL-ORGANIZATION; COMPARATIVE MORPHOLOGY; ZONAL ORGANIZATION; VENTRAL UVULA; II EXPRESSION	Aldolase C, also known as Zebrin II (ZII), is a glycolytic enzyme that is expressed in cerebellar Purkinje cells of the vertebrate cerebellum. In both mammals and birds, ZII is expressed heterogeneously, such that there are sagittal stripes of Purkinje cells with high ZII expression (ZII+), alternating with stripes of Purkinje cells with little or no expression (ZII-). The patterns of ZII+ and ZII- stripes in the cerebellum of birds and mammals are strikingly similar, suggesting that it may have first evolved in the stem reptiles. In this study, we examined the expression of ZII in the cerebellum of the western diamondback rattlesnake (Crotalus atrox). In contrast to birds and mammals, the cerebellum of the rattlesnake is much smaller and simpler, consisting of a small, unfoliated dome of cells. A pattern of alternating ZII+ and ZII- sagittal stripes cells was not observed: rather all Purkinje cells were ZII+. This suggests that ZII stripes have either been lost in snakes or that they evolved convergently in birds and mammals.	[Aspden, Joel W.; Gutierrez-Ibanez, Cristian I.; Graham, David J.; Wylie, Douglas R.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB T6G 2E9, Canada; [Armstrong, Carol L.] Mt Royal Univ, Dept Biol, Calgary, AB T3E 6K6, Canada; [Gutierrez-Ibanez, Cristian I.; Kohl, Tobias] Tech Univ Munich, Lehrstuhl Zool, D-85354 Freising Weihenstephan, Germany; [Hawkes, Richard] Univ Calgary, Dept Cell Biol & Anat, Genes & Dev Res Grp, Calgary, AB T2N 4N1, Canada; [Hawkes, Richard] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB T2N 4N1, Canada; [Iwaniuk, Andrew N.] Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada	University of Alberta; Mount Royal University; Technical University of Munich; University of Calgary; University of Calgary; University of Lethbridge	Wylie, DR (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB T6G 2E9, Canada.	dwylie@ualberta.ca	Iwaniuk, Andrew/H-7255-2019; Hawkes, Richard/F-7971-2011	Iwaniuk, Andrew/0000-0001-9273-3655; Gutierrez-Ibanez, Cristian/0000-0002-0468-8223	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Supported by funding from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/Index_eng.asp) to DRW and ANI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN AH, 1994, DEVELOPMENT, V120, P2081; AKINTUNDE A, 1994, J CHEM NEUROANAT, V7, P75, DOI 10.1016/0891-0618(94)90009-4; ANDERSSON G, 1978, EXP BRAIN RES, V32, P565; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Armstrong CL, 2000, J COMP NEUROL, V416, P383, DOI 10.1002/(SICI)1096-9861(20000117)416:3<383::AID-CNE9>3.0.CO;2-M; BANGMA GC, 1984, J COMP NEUROL, V228, P447, DOI 10.1002/cne.902280311; BANGMA GC, 1983, J COMP NEUROL, V215, P258, DOI 10.1002/cne.902150303; Bastianelli E, 2003, CEREBELLUM, V2, P242, DOI 10.1080/14734220310022289; Black D. G., 1983, THESIS MONASH U CLAY; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; CHOCKKAN V, 1994, J COMP NEUROL, V345, P33, DOI 10.1002/cne.903450103; DAVIS CA, 1993, METHOD ENZYMOL, V225, P502; DENT JA, 1989, DEVELOPMENT, V105, P61; DEZEEUW CI, 1994, J COMP NEUROL, V349, P428, DOI 10.1002/cne.903490308; Ebner TJ, 2012, CEREBELLUM, V11, P418, DOI 10.1007/s12311-011-0347-1; EISENMAN LM, 1993, J COMP NEUROL, V335, P586, DOI 10.1002/cne.903350410; EKEROT CF, 1973, BRAIN RES, V64, P446, DOI 10.1016/0006-8993(73)90203-5; Fong JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048990; Fujita H, 2010, J COMP NEUROL, V518, P1764, DOI 10.1002/cne.22301; Gao WC, 2006, J NEUROSCI, V26, P8377, DOI 10.1523/JNEUROSCI.2434-06.2006; Graham DJ, 2012, J NEUROSCI, V32, P12769, DOI 10.1523/JNEUROSCI.0197-12.2012; GRAVEL C, 1990, J COMP NEUROL, V291, P79, DOI 10.1002/cne.902910107; HAWKES R, 1992, BIOCHEM SOC T, V20, P391, DOI 10.1042/bst0200391; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; Hedges SB, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-64; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Horn KM, 2010, J NEUROSCI, V30, P9411, DOI 10.1523/JNEUROSCI.0440-10.2010; Iwaniuk AN, 2006, BRAIN BEHAV EVOLUT, V67, P53, DOI 10.1159/00089120; Iwaniuk AN, 2007, BRAIN BEHAV EVOLUT, V69, P196, DOI 10.1159/000096987; Iwaniuk AN, 2009, J CHEM NEUROANAT, V37, P55, DOI 10.1016/j.jchemneu.2008.10.001; JI Z, 1994, NEUROSCIENCE, V61, P935, DOI 10.1016/0306-4522(94)90414-6; Karam SD, 2001, J COMP NEUROL, V440, P127, DOI 10.1002/cne.1374; Kim JY, 2009, J COMP NEUROL, V517, P193, DOI 10.1002/cne.22147; Larsell O, 1967, CEREBELLUM MYXINOIDS; LECLERC N, 1988, J COMP NEUROL, V273, P399, DOI 10.1002/cne.902730310; Lee MSY, 2013, CURR BIOL, V23, pR513, DOI 10.1016/j.cub.2013.05.011; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; Llinas R., 1969, NEUROBIOLOGY CEREBEL, P43; Lyson TR, 2012, BIOL LETTERS, V8, P1028, DOI 10.1098/rsbl.2012.0462; Marzban H, 2004, J NEUROCYTOL, V33, P117, DOI 10.1023/B:NEUR.0000029652.96456.0d; Marzban H, 2003, BRAIN RES, V974, P176, DOI 10.1016/S0006-8993(03)02576-9; Marzban H, 2012, BRAIN BEHAV EVOLUT, V80, P196, DOI 10.1159/000340069; Marzban H, 2011, CEREBELLUM, V10, P422, DOI 10.1007/s12311-010-0208-3; Marzban H, 2011, CEREBELLUM, V10, P435, DOI 10.1007/s12311-011-0251-8; Marzban H, 2010, J COMP NEUROL, V518, P2221, DOI 10.1002/cne.22328; MATSUSHITA M, 1991, EXP BRAIN RES, V84, P133; Mostofi A, 2010, J NEUROSCI, V30, P8920, DOI 10.1523/JNEUROSCI.6117-09.2010; Pakan JMP, 2008, NEUROSCIENCE, V157, P57, DOI 10.1016/j.neuroscience.2008.08.062; Pakan JMP, 2007, J COMP NEUROL, V501, P619, DOI 10.1002/cne.21266; Pakan JMP, 2014, J COMP NEUROL, V522, P3629, DOI 10.1002/cne.23626; Pakan JMP, 2011, VISUAL NEUROSCI, V28, P163, DOI 10.1017/S0952523810000532; Pakan JMP, 2010, J COMP NEUROL, V518, P175, DOI 10.1002/cne.22192; Paukert M, 2010, J NEUROSCI, V30, P7290, DOI 10.1523/JNEUROSCI.5118-09.2010; Redies C, 2002, BRAIN RES BULL, V57, P341, DOI 10.1016/S0361-9230(01)00724-9; Rieppel Olivier, 2008, P345; Rivkin A, 2003, MOL CELL NEUROSCI, V24, P887, DOI 10.1016/S1044-7431(03)00240-9; Ruigrok TJH, 2003, J COMP NEUROL, V466, P278, DOI 10.1002/cne.10889; Sanchez M, 2002, J COMP NEUROL, V444, P159, DOI 10.1002/cne.10144; Sillitoe RV, 2005, PROG BRAIN RES, V148, P283, DOI 10.1016/S0079-6123(04)48022-4; Sillitoe RV, 2002, J HISTOCHEM CYTOCHEM, V50, P235, DOI 10.1177/002215540205000211; Sites JW, 2011, ANNU REV ECOL EVOL S, V42, P227, DOI 10.1146/annurev-ecolsys-102710-145051; Steida L, 1875, Z WISS ZOOL, V20, P1; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Sugihara I, 2007, J NEUROSCI, V27, P9696, DOI 10.1523/JNEUROSCI.1579-07.2007; Sugihara I, 2007, J COMP NEUROL, V500, P1076, DOI 10.1002/cne.21219; Sugihara I, 2007, J COMP NEUROL, V501, P13, DOI 10.1002/cne.21223; Sugihara I, 2011, CEREBELLUM, V10, P449, DOI 10.1007/s12311-010-0226-1; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; TANO D, 1992, J COMP NEUROL, V323, P128, DOI 10.1002/cne.903230111; ten Donkelaar H.J., 1998, P1315; TENDONKELAAR HJ, 1992, BIOL REPTIL, V17, P496; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; Voogd J, 2003, J NEUROSCI, V23, P4645; Voogd J, 1967, Prog Brain Res, V25, P94; Voogd J, 1998, TRENDS COGN SCI, V2, P307, DOI 10.1016/S1364-6613(98)01210-8; Voogd J., 1980, INFERIOR OLIVARY NUC, P207; Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539; Winship IR, 2003, J COMP NEUROL, V456, P127, DOI 10.1002/cne.10507; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O; Wylie DR, 2013, J CHEM NEUROANAT, V52, P95, DOI 10.1016/j.jchemneu.2013.07.005; Wylie DR, 2012, J COMP NEUROL, V520, P1532, DOI 10.1002/cne.22810; Wylie DRW, 2003, J COMP NEUROL, V465, P179, DOI 10.1002/cne.10857; Xiao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105633; Zhou HB, 2014, ELIFE, V3, DOI 10.7554/eLife.02536	86	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117539	10.1371/journal.pone.0117539	http://dx.doi.org/10.1371/journal.pone.0117539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692946	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500060
J	Bertrand, S; de Bex, GDL; Wildemauwe, C; Lunguya, O; Phoba, MF; Ley, B; Jacobs, J; Vanhoof, R; Mattheus, W				Bertrand, Sophie; de Bex, Guillaume De lamine; Wildemauwe, Christa; Lunguya, Octavie; Phoba, Marie France; Ley, Benedikt; Jacobs, Jan; Vanhoof, Raymond; Mattheus, Wesley			Multi Locus Variable-Number Tandem Repeat (MLVA) Typing Tools Improved the Surveillance of Salmonella Enteritidis: A 6 Years Retrospective Study	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; SUSCEPTIBILITY; TYPHI	Surveillance of Salmonella enterica subsp. enterica serovar Enteritidis is generally considered to benefit from molecular techniques like multiple-locus variable-number of tandem repeats analysis (MLVA), which allow early detection and confinement of outbreaks. Here, a surveillance study, including phage typing, antimicrobial susceptibility testing and MLVA on 1,535 Salmonella Enteritidis isolates collected between 2007 and 2012, was used to evaluate the added value of MLVA for public health surveillance in Belgium. Phage types PT4, PT8, PT21, PT1, PT6, PT14b, PT28 and PT13 dominate the Belgian Salmonella Enteritidis population. The isolates of Salmonella Enteritidis were most frequently susceptible to all antibiotics tested. 172 different MLVA profiles were detected, of which 9 frequent profiles included 67.2% of the Salmonella Enteritidis population. During a serial passage experiment on selected isolates to investigate the in vitro stability of the 5 MLVA loci, no variations over time were observed indicating that the MLVA profiles were stable. The MLVA profile of isolates originating from different outbreaks in the Democratic Republic of the Congo (DRC) between 2010 and 2011 were distinct from any of the MLVA profiles found in Belgian isolates throughout the six year observational period and demonstrates that MLVA improves public health surveillance of Salmonella Enteritidis. However, MLVA should be complemented with other subtyping methods when investigating outbreaks is caused by the most common MLVA profile.	[Bertrand, Sophie; de Bex, Guillaume De lamine; Wildemauwe, Christa; Vanhoof, Raymond; Mattheus, Wesley] Natl Reference Ctr Salmonellas, Sci Inst Publ Hlth, Div Bacterial Dis, Brussels, Belgium; [Lunguya, Octavie; Phoba, Marie France] Natl Inst Biomed Res, Dept Clin Microbiol, Kinshasa, DEM REP CONGO; [Ley, Benedikt; Jacobs, Jan] Inst Trop Med Antwerp, Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Fac Med, Dept Microbiol & Immunol, Louvain, Belgium	Institute Nacional de Recherche Biomedical; Institute of Tropical Medicine (ITM); KU Leuven	Bertrand, S (corresponding author), Natl Reference Ctr Salmonellas, Sci Inst Publ Hlth, Div Bacterial Dis, Brussels, Belgium.	sophie.bertrand@wiv-isp.be	Jacobs, Jan/GRX-7316-2022	Ley, Benedikt/0000-0002-5734-0845	Belgian Ministry of Social Affairs within Health Insurance System	Belgian Ministry of Social Affairs within Health Insurance System	The authors received no specific funding for this work, but the Belgian reference center for Salmonella is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON ES, 1961, ZBL BAKT PARASIT, V181, P368; Asai T, 2008, NEW MICROBIOL, V31, P555; Bertrand S, 2013, D2012250530; Boxrud D, 2007, J CLIN MICROBIOL, V45, P536, DOI 10.1128/JCM.01595-06; Collard JM, 2008, EPIDEMIOL INFECT, V136, P771, DOI 10.1017/S095026880700920X; Danoff-Burg J, MEASURING BIOL DIVER; Dewaele I, 2013, ZOONOSES PUBLIC HLTH, DOI [10.1111/zph.12096, DOI 10.1111/ZPH.12096]; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; HICKMANBRENNER FW, 1983, J CLIN MICROBIOL, V17, P172, DOI 10.1128/JCM.17.1.172-174.1983; Holtby I, 2006, PUBLIC HEALTH, V120, P817, DOI 10.1016/j.puhe.2006.05.010; Hopkins KL, 2011, EURO SURVEILL, V16, ppii; Hrivniakova L, 2011, EURO SURVEILL, V16; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Hur J, 2011, CAN J VET RES, V75, P49; Lunguya O, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002103; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Malorny B, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-84; Mezal EH, 2014, FOOD MICROBIOL, V38, P67, DOI 10.1016/j.fm.2013.08.003; Mossong J, 2012, Bull Soc Sci Med Grand Duche Luxemb, P49; Nadon CA, 2013, EURO SURVEILL, V18; National Committee for Clinical Laboratory Standards, 2001, MS100S12 NCCLS; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; The European Committee on Antimicrobial Susceptibility Testing, 2013, 31 EUCAST; THRELFALL EJ, 1990, J APPL BACTERIOL, V68, P5, DOI 10.1111/j.1365-2672.1990.tb02542.x; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Wuyts V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084055	27	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117950	10.1371/journal.pone.0117950	http://dx.doi.org/10.1371/journal.pone.0117950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693200	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500083
J	Kumar, J; Dhar, P; Tayade, AB; Gupta, D; Chaurasia, OP; Upreti, DK; Toppo, K; Arora, R; Suseela, MR; Srivastava, RB				Kumar, Jatinder; Dhar, Priyanka; Tayade, Amol B.; Gupta, Damodar; Chaurasia, Om P.; Upreti, Dalip K.; Toppo, Kiran; Arora, Rajesh; Suseela, M. R.; Srivastava, Ravi B.			Chemical Composition and Biological Activities of Trans-Himalayan Alga Spirogyra porticalis (Muell.) Cleve	PLOS ONE			English	Article							COLD DESERT LADAKH; TRADITIONAL MEDICINAL-PLANTS; FUNCTIONAL FOOD INGREDIENTS; TOTAL PHENOLIC CONTENT; ANTIOXIDANT ACTIVITY; ETHYL LINOLEATE; OXIDATIVE STRESS; HYPOBARIC HYPOXIA; CAPSICUM-ANNUUM; DRUG DISCOVERY	The freshwater alga Spirogyra porticalis (Muell.) Cleve, a filamentous charophyte, collected from the Indian trans-Himalayan cold desert, was identified on the basis of morpho-anatomical characters. Extracts of this alga were made using solvents of varying polarity viz. n-hexane, acetonitrile, methanol and water. The antioxidant capacities and phenolic profile of the extracts were estimated. The methanol extract showing highest antioxidant capacity and rich phenolic attributes was further investigated and phytochemical profiling was conducted by gas chromatography-mass spectrometry (GC/MS) hyphenated technique. The cytotoxic activity of methanol extract was evaluated on human hepatocellular carcinoma HepG2 and colon carcinoma RKO cell lines. The anti-hypoxic effect of methanol extract of the alga was tested on in vivo animal system to confirm its potential to ameliorate oxidative stress. The antioxidant assays viz. ferric reducing antioxidant power (FRAP), 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), 1,1-diphenyl-2-picrylhydrazyl (DPPH) and nitric oxide (NO) radical scavenging capacities, beta-carotene-linoleic acid bleaching property and lipid peroxidation exhibited analogous results, wherein the algal extracts showed significantly high antioxidant potential. The extracts were also found to possess high content of total proanthocyanidin, flavonoid and polyphenol. GC/MS analysis revealed the presence of thirteen chemotypes in the methanol extract representing different phytochemical groups like fatty acid esters, sterols, unsaturated alcohols, alkynes etc. with substantial phyto-pharmaceutical importance. The methanol extract was observed to possess anticancer activity as revealed from studies on HepG2 and RKO cell lines. In the present study, Spirogyra porticalis methanol extract also provided protection from hypoxia-induced oxidative stress and accelerated the onset of adaptative changes in rats during exposure to hypobaric hypoxia. The bioactive phytochemicals present in this trans-Himalayan alga are of enormous interest and can be utilized sustainably for discovery of novel drugs against oxidative stress.	[Kumar, Jatinder; Dhar, Priyanka; Tayade, Amol B.; Chaurasia, Om P.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India; [Gupta, Damodar; Arora, Rajesh] Def Res & Dev Org, Inst Nucl Med & Allied Sci, Med & Aromat Plants Lab, Radiat Biotechnol Grp, Delhi, India; [Arora, Rajesh] Off Director General Life Sci, New Delhi, India; [Upreti, Dalip K.; Toppo, Kiran; Suseela, M. R.] Natl Bot Res Inst, Lucknow 226001, Uttar Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR); Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Chaurasia, OP (corresponding author), Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India.	dropchaurasiadihardrdo@gmail.com	CHAURASIA, OM/AAW-6347-2021; Arora, Rajesh/AAE-4596-2021; CHAURASIA, OM PRAKASH/AAP-3358-2021	Arora, Rajesh/0000-0001-7307-9221; CHAURASIA, OM PRAKASH/0000-0003-2921-2755	Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India	Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India	The study was entirely supported by Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z., 2007, ETHNOBOTANY PLANTS T, P1, DOI DOI 10.1007/S12033-007-0062-9; Ando H, 1998, ARCH DERMATOL RES, V290, P375, DOI 10.1007/s004030050320; Ando H, 2006, BIOCHEM J, V394, P43, DOI 10.1042/BJ20051419; Australasian College for Emergency Medicine, 2013, G24 AUSTR COLL EM ME, P1, DOI [10.1097/ACC.0b013e31829c6877, DOI 10.1097/ACC.0B013E31829C6877]; Bajpai PK, 2014, LWT-FOOD SCI TECHNOL, V59, P981, DOI 10.1016/j.lwt.2014.07.055; Balboa EM, 2013, FOOD CHEM, V138, P1764, DOI 10.1016/j.foodchem.2012.11.026; Ballabh B, 2008, J ETHNOPHARMACOL, V118, P331, DOI 10.1016/j.jep.2008.04.022; Ballabh B, 2007, J ETHNOPHARMACOL, V112, P341, DOI 10.1016/j.jep.2007.03.020; Ballabh B, 2009, INDIAN J TRADIT KNOW, V8, P185; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; Boyd MR, 1992, ANTITUMOR DRUG DISCO, P11; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Burritt DJ, 2002, PLANTA, V215, P829, DOI 10.1007/s00425-002-0805-6; Cardozo KHM, 2007, COMP BIOCHEM PHYS C, V146, P60, DOI 10.1016/j.cbpc.2006.05.007; Chacon-Lee TL, 2010, COMPR REV FOOD SCI F, V9, P655, DOI 10.1111/j.1541-4337.2010.00132.x; Chandrasekar MJN, 2006, PHARM BIOL, V44, P100, DOI 10.1080/13880200600592046; Charakida A, 2007, BRIT J DERMATOL, V157, P569, DOI 10.1111/j.1365-2133.2007.08083.x; COMPERE P, 1983, B SOC ROY BOT BELG, V116, P141; Cragg GM, 2014, J NAT PROD, V77, P703, DOI 10.1021/np5000796; Dai F, 2009, BIOL PLANTARUM, V53, P257, DOI 10.1007/s10535-009-0048-5; Dapkevicius A, 1998, J SCI FOOD AGR, V77, P140, DOI 10.1002/(SICI)1097-0010(199805)77:1&lt;140::AID-JSFA18&gt;3.0.CO;2-K; De Rosa S, 2003, Z NATURFORSCH C, V58, P325; Dhar P, 2013, THESIS BHARATHIAR U; Dhar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083008; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; DOWNING DT, 1986, J AM ACAD DERMATOL, V14, P221, DOI 10.1016/S0190-9622(86)70025-X; Duval B, 1999, J APPL PHYCOL, V11, P559, DOI 10.1023/A:1008178208949; Frankel EN, 2000, J SCI FOOD AGR, V80, P1925, DOI 10.1002/1097-0010(200010)80:13&lt;1925::AID-JSFA714&gt;3.0.CO;2-4; Freile-Pelegriin Y, 2014, BIOACTIVE COMPOUNDS, P113; Frikha F, 2011, CIENC MAR, V37, P113, DOI 10.7773/cm.v37i2.1712; Gad HA, 2013, PHYTOCHEM ANALYSIS, V24, P1, DOI 10.1002/pca.2378; Gao XQ, 2000, J AGR FOOD CHEM, V48, P1485, DOI 10.1021/jf991072g; Goiris K, 2012, J APPL PHYCOL, V24, P1477, DOI 10.1007/s10811-012-9804-6; Guiry MD, 2014, SPIROGYRA PORTICALIS; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Hajimahmoodi M, 2010, J APPL PHYCOL, V22, P43, DOI 10.1007/s10811-009-9424-y; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; HOLMER G, 1962, Z ERNAHRUNGSWISS, V2, P223, DOI 10.1007/BF02020814; Hota KB, 2011, INNOVATIONS AGROANIM, P277; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; HUTSELL TC, 1967, LIPIDS, V2, P342, DOI 10.1007/BF02532123; Ikram EHK, 2009, J FOOD COMPOS ANAL, V22, P388, DOI 10.1016/j.jfca.2009.04.001; ILAVAZHAGAN G, 1996, DIPAS2696; Ismail Amin Jr, 2002, Malays J Nutr, V8, P167; JELENKO C, 1975, ANN SURG, V182, P562, DOI 10.1097/00000658-197511000-00005; Jeong WY, 2011, J SEP SCI, V34, P2967, DOI 10.1002/jssc.201100524; Junthip R., 2013, ADV MATER RES-KR, V699, P693; Kashiwagi T, 2005, Z NATURFORSCH C, V60, P739; Khalid MN, 2012, PAK J BOT, V44, P1815; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kimura J, 2002, J NAT PROD, V65, P57, DOI 10.1021/np0103057; Korekar G, 2014, LWT-FOOD SCI TECHNOL, V55, P157, DOI 10.1016/j.lwt.2013.09.006; Kovacik J, 2010, PHOTOCHEM PHOTOBIOL, V86, P612, DOI 10.1111/j.1751-1097.2010.00708.x; Kumar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098696; Kumar KS, 2008, FOOD CHEM, V107, P289, DOI 10.1016/j.foodchem.2007.08.016; Lagunin AA, 2014, NAT PROD REP, V31, P1585, DOI 10.1039/c4np00068d; LEBEL CP, 1990, TOXICOL APPL PHARM, V104, P17, DOI 10.1016/0041-008X(90)90278-3; Lee Seung-Hong, 2010, Algae, V25, P45, DOI 10.4490/algae.2010.25.1.045; Li HB, 2007, FOOD CHEM, V102, P771, DOI 10.1016/j.foodchem.2006.06.022; Lifongo LL, 2014, NAT PRODUCT BIOPROSP, V4, P1, DOI 10.1007/s13659-014-0005-7; Lordan S, 2011, MAR DRUGS, V9, P1056, DOI 10.3390/md9061056; Maiti P, 2006, NEUROCHEM INT, V49, P709, DOI 10.1016/j.neuint.2006.06.002; MIZUGUCHI K, 1993, EUR J PHARMACOL, V235, P221, DOI 10.1016/0014-2999(93)90140-D; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Mungmai L, 2014, CHIANG MAI J SCI, V41, P14; Nabavi SF, 2013, J AQUAT FOOD PROD T, V22, P58, DOI 10.1080/10498850.2011.624292; Naik A.A., 2012, INT MULTIDISCIPLINAR, V2, P13; Nakanishi I, 1995, J PHYSIOL-LONDON, V489, P869, DOI 10.1113/jphysiol.1995.sp021099; Natrah FMI, 2007, J APPL PHYCOL, V19, P711, DOI 10.1007/s10811-007-9192-5; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OKADA N, 1994, PHYTOCHEMISTRY, V37, P281, DOI 10.1016/0031-9422(94)85042-9; OKUNADE AL, 1985, J NAT PROD, V48, P472, DOI 10.1021/np50039a020; Ontawong A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/820786; Ordonez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024; Percot A, 2009, NAT PROD RES, V23, P460, DOI 10.1080/14786410802076069; Plaza M, 2008, TRENDS FOOD SCI TECH, V19, P31, DOI 10.1016/j.tifs.2007.07.012; Ponnamma S. U, 2012, ANDERS INT J PHARM B, V3, P570; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Prescott GW, 1951, ALGAE W GREAT LAKES, P318; Priyadarshani I., 2012, J ALGAL BIOMASS UTIL, V3, P89; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RILEY V, 1960, P SOC EXP BIOL MED, V104, P751; Rodriguez-Garcia I, 2008, FOOD CHEM, V108, P1023, DOI 10.1016/j.foodchem.2007.11.059; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Ruberto G, 2000, PLANTA MED, V66, P687, DOI 10.1055/s-2000-9773; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Rubio L, 2013, CRIT REV FOOD SCI, V53, P943, DOI 10.1080/10408398.2011.574802; SaiRam M, 1998, INT J BIOMETEOROL, V42, P55, DOI 10.1007/s004840050084; Sarker Satyajit D, 2012, Methods Mol Biol, V864, P301, DOI 10.1007/978-1-61779-624-1_12; Satoh N, 2007, DIABETES CARE, V30, P144, DOI 10.2337/dc06-1179; Shalaby EA, 2011, PLANT SIGNAL BEHAV, V6, P1338, DOI 10.4161/psb.6.9.16779; Shellie RA, 2009, J SEP SCI, V32, P3720, DOI 10.1002/jssc.200900422; Singh B., 2000, Acta Horticulturae, P65; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Solecka D, 1997, ACTA PHYSIOL PLANT, V19, P257, DOI 10.1007/s11738-997-0001-1; Sun JS, 1998, BURNS, V24, P225, DOI 10.1016/S0305-4179(97)00115-0; Tayade AB, 2013, J FOOD SCI, V78, pC402, DOI 10.1111/1750-3841.12054; Tayade AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052797; Thumvijit Tarika, 2013, Interdiscip Toxicol, V6, P152, DOI 10.2478/intox-2013-0024; Wang ZH, 2009, FOOD CHEM, V112, P914, DOI 10.1016/j.foodchem.2008.06.078; Yano T, 1997, LIFE SCI, V61, P2007, DOI 10.1016/S0024-3205(97)00859-X; YANO T, 1995, YAKUGAKU ZASSHI, V115, P843, DOI 10.1248/yakushi1947.115.10_843; Yoshimura Y, 1997, ARCTIC ALPINE RES, V29, P126, DOI 10.2307/1551843; Zhang DL, 2004, FOOD CHEM, V88, P503, DOI 10.1016/j.foodchem.2004.01.065; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n; Ziboh VA, 2000, AM J CLIN NUTR, V71, p361S, DOI 10.1093/ajcn/71.1.361s	108	15	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118255	10.1371/journal.pone.0118255	http://dx.doi.org/10.1371/journal.pone.0118255			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693168	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500112
J	Kung, LHW; Rajpar, MH; Preziosi, R; Briggs, MD; Boot-Handford, RP				Kung, Louise H. W.; Rajpar, M. Helen; Preziosi, Richard; Briggs, Michael D.; Boot-Handford, Raymond P.			Increased Classical Endoplasmic Reticulum Stress Is Sufficient to Reduce Chondrocyte Proliferation Rate in the Growth Plate and Decrease Bone Growth	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOCHONDRAL OSSIFICATION; EPIPHYSEAL DYSPLASIA; CONGENITAL GOITER; TRANSGENIC MICE; MURINE MODEL; ER STRESS; CARTILAGE; MUTATION; PSEUDOACHONDROPLASIA	Mutations in genes encoding cartilage oligomeric matrix protein and matrilin-3 cause a spectrum of chondrodysplasias called multiple epiphyseal dysplasia (MED) and pseudoachondroplasia (PSACH). The majority of these diseases feature classical endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR) as a result of misfolding of the mutant protein. However, the importance and the pathological contribution of ER stress in the disease pathogenesis are unknown. The aim of this study was to investigate the generic role of ER stress and the UPR in the pathogenesis of these diseases. A transgenic mouse line (ColllTg(cog)) was generated using the collagen II promoter to drive expression of an ER stress-inducing protein (Tg(cog)) in chondrocytes. The skeletal and histological phenotypes of these ColllTg(cog) mice were characterised. The expression and intracellular retention of Tg(cog) induced ER stress and activated the UPR as characterised by increased BiP expression, phosphorylation of eIF2 alpha and spliced Xbp1. ColllTg(cog) mice exhibited decreased long bone growth and decreased chondrocyte proliferation rate. However, there was no disruption of chondrocyte morphology or growth plate architecture and perturbations in apoptosis were not apparent. Our data demonstrate that the targeted induction of ER stress in chondrocytes was sufficient to reduce the rate of bone growth, a key clinical feature associated with MED and PSACH, in the absence of any growth plate dysplasia. This study establishes that classical ER stress is a pathogenic factor that contributes to the disease mechanism of MED and PSACH. However, not all the pathological features of MED and PSACH were recapitulated, suggesting that a combination of intra- and extra-cellular factors are likely to be responsible for the disease pathology as a whole	[Kung, Louise H. W.; Rajpar, M. Helen; Boot-Handford, Raymond P.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Preziosi, Richard] Univ Manchester, Fac Life Sci, Environm Ecol & Evolut Res Grp, Manchester, Lancs, England; [Briggs, Michael D.] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Manchester; University of Manchester; Newcastle University - UK	Boot-Handford, RP (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	Ray.Boot-Handford@manchester.ac.uk	Preziosi, Richard F/A-8626-2010	Preziosi, Richard F/0000-0003-0468-6655; Boot-Handford, Raymond/0000-0002-6167-8419; Kung, Louise/0000-0002-1959-7009	Arthritis Research UK [19501]; Wellcome Trust Institutional Strategic Support Fund [097820/Z/11/A, 084353/Z/07/Z]; Versus Arthritis [19501] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Versus Arthritis(Versus Arthritis)	This work was supported by Arthritis Research UK (19501) to RPBH and MDB, the Wellcome Trust Institutional Strategic Support Fund [097820/Z/11/A] to RPBH and MDB, the BBSRC through a PhD studentship (to LHWK) and the Wellcome Trust Senior Research Fellowship in Basic Biomedical Science (Grant 084353/Z/07/Z) to MDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell PA, 2013, BIOL OPEN, V2, P802, DOI 10.1242/bio.20135280; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boot-Handford RP, 2010, CELL TISSUE RES, V339, P197, DOI 10.1007/s00441-009-0877-8; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Cameron TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024600; Furuichi T, 2011, MAMM GENOME, V22, P318, DOI 10.1007/s00335-011-9329-3; Goeckeler JL, 2010, DIABETES OBES METAB, V12, P32, DOI 10.1111/j.1463-1326.2010.01273.x; Gualeni B, 2013, DIS MODEL MECH, V6, P1414, DOI 10.1242/dmm.013342; Hall CM, 2002, AM J MED GENET, V113, P65, DOI 10.1002/ajmg.10828; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Kung LHW, 2012, J HISTOCHEM CYTOCHEM, V60, P734, DOI 10.1369/0022155412458436; Leighton MP, 2007, HUM MOL GENET, V16, P1728, DOI 10.1093/hmg/ddm121; Liang GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086894; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Newman B, 2003, CLIN GENET, V63, P241, DOI 10.1034/j.1399-0004.2003.00046.x; Nundlall S, 2010, CELL STRESS CHAPERON, V15, P835, DOI 10.1007/s12192-010-0193-y; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Patterson SE, 2014, DEV DYNAM, V243, P875, DOI [10.1002/DVDY.24131, 10.1002/dvdy.24131]; Pirog KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085145; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Posey KL, 2008, CELL MOL LIFE SCI, V65, P687, DOI 10.1007/s00018-007-7485-0; Posey KL, 2009, AM J PATHOL, V175, P1555, DOI 10.2353/ajpath.2009.090184; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sakai K, 2001, MATRIX BIOL, V19, P761, DOI 10.1016/S0945-053X(00)00122-0; Schmitz M, 2008, MATRIX BIOL, V27, P67, DOI 10.1016/j.matbio.2007.08.001; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Suleman F, 2012, HUM MUTAT, V33, P218, DOI 10.1002/humu.21631; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Yamaguchi Y, 2008, J BIOL CHEM, V283, P17020, DOI 10.1074/jbc.M802466200; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	42	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117016	10.1371/journal.pone.0117016	http://dx.doi.org/10.1371/journal.pone.0117016			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693198	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000350061500033
J	Saloma, C; Perez, GJ; Gavile, CA; Ick-Joson, JJ; Palmes-Saloma, C				Saloma, Caesar; Perez, Gay Jane; Gavile, Catherine Ann; Ick-Joson, Jacqueline Judith; Palmes-Saloma, Cynthia			Prior Individual Training and Self-Organized Queuing during Group Emergency Escape of Mice from Water Pool	PLOS ONE			English	Article							BEHAVIOR; DYNAMICS; DESIGN	We study the impact of prior individual training during group emergency evacuation using mice that escape from an enclosed water pool to a dry platform via any of two possible exits. Experimenting with mice avoids serious ethical and legal issues that arise when dealing with unwitting human participants while minimizing concerns regarding the reliability of results obtained from simulated experiments using 'actors'. First, mice were trained separately and their individual escape times measured over several trials. Mice learned quickly to swim towards an exit-they achieved their fastest escape times within the first four trials. The trained mice were then placed together in the pool and allowed to escape. No two mice were permitted in the pool beforehand and only one could pass through an exit opening at any given time. At first trial, groups of trained mice escaped seven and five times faster than their corresponding control groups of untrained mice at pool occupancy rate. of 11.9% and 4%, respectively. Faster evacuation happened because trained mice: (a) had better recognition of the available pool space and took shorter escape routes to an exit, (b) were less likely to form arches that blocked an exit opening, and (c) utilized the two exits efficiently without preference. Trained groups achieved continuous egress without an apparent leader-coordinator (self-organized queuing)-a collective behavior not experienced during individual training. Queuing was unobserved in untrained groups where mice were prone to wall seeking, aimless swimming and/or blind copying that produced circuitous escape routes, biased exit use and clogging. The experiments also reveal that faster and less costly group training at rho= 4%, yielded an average individual escape time that is comparable with individualized training. However, group training in a more crowded pool (rho = 11.9%) produced a longer average individual escape time.	[Saloma, Caesar; Perez, Gay Jane] Univ Philippines, Coll Sci, Natl Inst Phys, Quezon City 1101, Philippines; [Gavile, Catherine Ann; Ick-Joson, Jacqueline Judith; Palmes-Saloma, Cynthia] Univ Philippines, Coll Sci, Natl Inst Mol Biol & Biotechnol, Quezon City 1101, Philippines	University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Diliman	Saloma, C (corresponding author), Univ Philippines, Coll Sci, Natl Inst Phys, Quezon City 1101, Philippines.	csaloma@nip.upd.edu.ph	Saloma, Caesar/HHZ-5074-2022		University of the Philippines System; University of the Philippines Diliman	University of the Philippines System; University of the Philippines Diliman	This work was supported by the University of the Philippines System (www.up.edu.ph) and University of the Philippines Diliman (www.upd.edu.ph). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051128; Ball Philip, 2003, ComPlexUs, V1, P190, DOI 10.1159/000082449; Bode NWF, 2013, ANIM BEHAV, V86, P347, DOI 10.1016/j.anbehav.2013.05.025; BRYAN J. L., 2002, FIRE PROTECTION ENG, V16, P4; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Juanico DE, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041905; Levitt SD, 2008, SCIENCE, V319, P909, DOI 10.1126/science.1153640; Morris R, 1984, NEUROSCI METH, V11, P47; Nolfi Stefano, 2004, ComPlexUs, V2, P195, DOI 10.1159/000093690; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Perez GJ, 2009, PHYSICA A, V388, P2469, DOI 10.1016/j.physa.2009.02.037; Perez GJ, 2002, PHYSICA A, V312, P609, DOI 10.1016/S0378-4371(02)00987-1; Saloma C, 2003, P NATL ACAD SCI USA, V100, P11947, DOI 10.1073/pnas.2031912100; Schadschneider A., 2009, ENCY COMPLEXITY SYST, V3, P3142; Sobel Robert., 1988, PANIC WALL STREET CL; Still G. K., CROWD DISASTERS; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Waldau N., 2007, PEDESTRIAN EVACUATIO; Wenk G, 1998, CURRENT PROTOCOLS NE; Zhao DL, 2006, J FIRE PROT ENG, V16, P269, DOI 10.1177/1042391506061523	25	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118508	10.1371/journal.pone.0118508	http://dx.doi.org/10.1371/journal.pone.0118508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693170	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500122
J	Arnold, LE; Hodgkins, P; Caci, H; Kahle, J; Young, S				Arnold, L. Eugene; Hodgkins, Paul; Caci, Herve; Kahle, Jennifer; Young, Susan			Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; FOLLOW-UP; ACADEMIC-ACHIEVEMENT; MULTIMODAL TREATMENT; ADULT ADHD; CHILDREN; PREVALENCE; MTA; MEDICATION; METHYLPHENIDATE	Background Evaluation of treatments for attention-deficit/hyperactivity disorder (ADHD) previously focused on symptom control, but attention has shifted to functional outcomes. The effect of different ADHD treatment periods and modalities (pharmacological, non-pharmacological, and combination) on long-term outcomes needs to be more comprehensively understood. Methods A systematic search of 12 literature databases using Cochrane's guidelines yielded 403 English-language peer-reviewed, primary studies reporting long-term outcomes (>= 2 years). We evaluated relative effects of treatment modalities and durations and effect sizes of outcomes reported as statistically significantly improved with treatment. Results The highest proportion of improved outcomes was reported with combination treatment (83% of outcomes). Among significantly improved outcomes, the largest effect sizes were found for combination treatment. The greatest improvements were associated with academic, self-esteem, or social function outcomes. A majority of outcomes improved regardless of age of treatment initiation (60%-75%) or treatment duration (62%-72%). Studies with short treatment duration had shorter follow-up times (mean 3.2 years total study length) than those with longer treatment durations (mean 7.1 years total study length). Studies with follow-up times < 3 years reported benefit with treatment for 93% of outcomes, whereas those with follow-up times >= 3 years reported treatment benefit for 57% of outcomes. Post-hoc analysis indicated that this result was related to the measurement of outcomes at longer periods (3.2 versus 0.4 years) after treatment cessation in studies with longer total study length. Conclusions While the majority of long-term outcomes of ADHD improve with all treatment modalities, the combination of pharmacological and non-pharmacological treatment was most consistently associated with improved long-term outcomes and large effect sizes. Older treatment initiation age or longer durations did not markedly affect proportion of improved outcomes reported, but measurement of outcomes long periods after treatment cessation may attenuate results.	[Arnold, L. Eugene] Ohio State Univ, Res Unit Pediat Psychopharmacol, Columbus, OH 43210 USA; [Hodgkins, Paul] Global Hlth Econ & Outcomes Res, Wayne, PA USA; [Caci, Herve] CHU Lenval, Hop Pediat Nice, F-06200 Nice, France; [Kahle, Jennifer] BPS Int, San Diego, CA 92130 USA; [Young, Susan] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London SW7 2AZ, England	University System of Ohio; Ohio State University; CHU Nice; Imperial College London	Kahle, J (corresponding author), BPS Int, San Diego, CA 92130 USA.	jkahle@bpsintl.com	CACI, Herve/J-9493-2016	CACI, Herve/0000-0003-3859-3086; Kahle, Jennifer/0000-0002-3176-6610	Shire Development LLC	Shire Development LLC	This work was sponsored by Shire Development LLC (www.shire.com). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abikoff H, 2004, J AM ACAD CHILD PSY, V43, P820, DOI 10.1097/01.chi.0000128797.91601.1a; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Arnold LE, 2013, 4 WORLD C ADHD MIL I; Brod M, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-47; Buitelaar JK, 2007, BIOL PSYCHIAT, V61, P694, DOI 10.1016/j.biopsych.2006.03.066; Caci HM, 2014, J NERV MENT DIS, V202, P324, DOI 10.1097/NMD.0000000000000126; CHARLES L, 1981, J ABNORM CHILD PSYCH, V9, P495, DOI 10.1007/BF00917798; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conners CK, 2001, J AM ACAD CHILD PSY, V40, P159, DOI 10.1097/00004583-200102000-00010; Emilsson B, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-116; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Gilchrist RH, 2008, PEDIATR ANN, V37, P46, DOI 10.3928/00904481-20080101-05; Hazell P, 2011, CURR OPIN PSYCHIATR, V24, P286, DOI 10.1097/YCO.0b013e32834742db; Hechtman L, 2004, J AM ACAD CHILD PSY, V43, P812, DOI 10.1097/01.chi.0000128796.84202.eb; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jensen PS, 2001, J AM ACAD CHILD PSY, V40, P147, DOI 10.1097/00004583-200102000-00009; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Langberg JM, 2012, CLIN CHILD FAM PSYCH, V15, P215, DOI 10.1007/s10567-012-0117-8; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; McMenamy J, 2011, J PEDIATR HEALTH CAR, V25, P77, DOI 10.1016/j.pedhc.2009.08.008; Mill J, 2006, ARCH GEN PSYCHIAT, V63, P462, DOI 10.1001/archpsyc.63.4.462; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Parker J, 2013, PSYCHOL RES BEHAV MA, V6, P87, DOI 10.2147/PRBM.S49114; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Powers RL, 2008, J CHILD ADOL PSYCHOP, V18, P449, DOI 10.1089/cap.2008.021; Rasmussen P, 2000, J AM ACAD CHILD PSY, V39, P1424, DOI 10.1097/00004583-200011000-00017; SATTERFIELD JH, 1981, J PEDIATR-US, V98, P650, DOI 10.1016/S0022-3476(81)80788-3; Savolainen J, 2010, EUR J CRIMINOL, V7, P442, DOI 10.1177/1477370810376568; Schultz BK, 2009, SCHOOL PSYCHOL REV, V38, P14; Shaw M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-99; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Skovgaard AM, 2010, DAN MED BULL, V57; Sourander A, 2006, J AM ACAD CHILD PSY, V45, P578, DOI 10.1097/01.chi0000205699.58626.b5; Swanson J, 2008, J ATTEN DISORD, V12, P4, DOI 10.1177/1087054708319345; Swanson JM, 2001, J AM ACAD CHILD PSY, V40, P168, DOI 10.1097/00004583-200102000-00011; van de Loo-Neus GHH, 2011, EUR NEUROPSYCHOPHARM, V21, P584, DOI 10.1016/j.euroneuro.2011.03.008; WEITHORN CJ, 1985, PSYCHOL SCHOOLS, V22, P449, DOI 10.1002/1520-6807(198510)22:4<449::AID-PITS2310220415>3.0.CO;2-K; Whalen CK, 2003, PSYCHOL ADDICT BEHAV, V17, P332, DOI 10.1037/0893-164X.17.4.332; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Young S, 2013, J ATTEN DISORD, V17, P598, DOI 10.1177/1087054711430333; Young SJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-32; Zoega H, 2012, PEDIATRICS, V130, pE53, DOI 10.1542/peds.2011-3493	45	52	53	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116407	10.1371/journal.pone.0116407	http://dx.doi.org/10.1371/journal.pone.0116407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714373	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700018
J	Xu, JS; Calhoun, VD; Worhunsky, PD; Xiang, H; Li, J; Wall, JT; Pearlson, GD; Potenza, MN				Xu, Jiansong; Calhoun, Vince D.; Worhunsky, Patrick D.; Xiang, Hui; Li, Jian; Wall, John T.; Pearlson, Godfrey D.; Potenza, Marc N.			Functional Network Overlap as Revealed by fMRI Using sICA and Its Potential Relationships with Functional Heterogeneity, Balanced Excitation and Inhibition, and Sparseness of Neuron Activity	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; MODEL ORDER SELECTION; WORKING-MEMORY; DEFAULT-MODE; BLIND SEPARATION; CORTICAL-NEURONS; TASK-DIFFICULTY; CEREBRAL-CORTEX; HUMAN BRAIN; CONNECTIVITY	Functional magnetic resonance imaging (fMRI) studies traditionally use general linear model based analysis (GLM-BA) and regularly report task-related activation, deactivation, or no change in activation in separate brain regions. However, several recent fMRI studies using spatial independent component analysis (sICA) find extensive overlap of functional networks (FNs), each exhibiting different task-related modulation (e.g., activation vs. deactivation), different from the dominant findings of GLM-BA. This study used sICA to assess overlap of FNs extracted from four datasets, each related to a different cognitive task. FNs extracted from each dataset overlapped with each other extensively across most or all brain regions and showed task-related concurrent increases, decreases, or no changes in activity. These findings indicate that neural substrates showing task-related concurrent but different modulations in activity intermix with each other and distribute across most of the brain. Furthermore, spatial correlation analyses found that most FNs were highly consistent in spatial patterns across different datasets. This finding indicates that these FNs probably reflect large-scale patterns of task-related brain activity. We hypothesize that FN overlaps as revealed by sICA might relate to functional heterogeneity, balanced excitation and inhibition, and population sparseness of neuron activity, three fundamental properties of the brain. These possibilities deserve further investigation.	[Xu, Jiansong; Calhoun, Vince D.; Worhunsky, Patrick D.; Xiang, Hui; Li, Jian; Pearlson, Godfrey D.; Potenza, Marc N.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Pearlson, Godfrey D.; Potenza, Marc N.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Pearlson, Godfrey D.] Olin Neuropsychiat Res Ctr, Inst Living, Hartford, CT USA; [Calhoun, Vince D.] Univ New Mexico, Dept ECE, Albuquerque, NM 87131 USA; [Xiang, Hui] Guizhou Prov Peoples Hosp, Dept Psychiat, Guiyang, Guizhou Provinc, Peoples R China; [Wall, John T.] Univ Toledo, Dept Neurosci, Toledo, OH 43606 USA; [Li, Jian] China Med Univ, Hosp 1, Dept Radiol, Shenyang 110001, Liaoning, Peoples R China	Yale University; Yale University; Yale University; Lovelace Respiratory Research Institute; University of New Mexico; University System of Ohio; University of Toledo; China Medical University	Xu, JS (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	Jiansong.xu@yale.edu	Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747; Worhunsky, Patrick/0000-0001-9629-1428	National Institutes of Health [R03 DA022364, K01DA027750, R01 DA020908, R01 DA035058, P20 DA027844, P20GM103472, P50 DA09241]; Connecticut State Department of Mental Health and Addiction Services; Connecticut Mental Health Center; Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming; National Science Foundation [OCI-1331441]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035058, K01DA027750, P50DA009241, P20DA027844, R03DA022364, R01DA020908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut State Department of Mental Health and Addiction Services; Connecticut Mental Health Center; Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health grants R03 DA022364, K01 DA027750, R01 DA020908, R01 DA035058, P20 DA027844, P20GM103472, and P50 DA09241; the Connecticut State Department of Mental Health and Addiction Services; the Connecticut Mental Health Center; and a Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming. The open fmri was funded by a grant from the National Science Foundation (OCI-1331441). The funding agencies did not have input into the content of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Balodis IM, 2012, BIOL PSYCHIAT, V71, P749, DOI 10.1016/j.biopsych.2012.01.006; Balsters JH, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00207; Bandyopadhyay S, 2007, J NEUROPHYSIOL, V97, P4120, DOI 10.1152/jn.00898.2006; Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; Barth AL, 2012, TRENDS NEUROSCI, V35, P345, DOI 10.1016/j.tins.2012.03.008; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beldzik E, 2013, NEUROIMAGE, V76, P304, DOI 10.1016/j.neuroimage.2013.03.014; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bell AH, 2011, J NEUROSCI, V31, P12229, DOI 10.1523/JNEUROSCI.5865-10.2011; Borra E, 2010, CEREB CORTEX, V20, P257, DOI 10.1093/cercor/bhp096; Boudreau CE, 2006, J NEUROPHYSIOL, V96, P2377, DOI 10.1152/jn.01072.2005; Braga RM, 2013, J NEUROSCI, V33, P14031, DOI 10.1523/JNEUROSCI.0570-13.2013; Calhoun VD, 2002, MAGNET RESON MED, V48, P180, DOI 10.1002/mrm.10202; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Calhoun Vince D, 2012, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Ciccarelli O, 2009, HUM BRAIN MAPP, V30, P615, DOI 10.1002/hbm.20527; Costumero V, 2014, BRAIN STRUCT FUNCT; Domagalik A, 2012, NEUROIMAGE, V62, P1325, DOI 10.1016/j.neuroimage.2012.06.006; Donovan DM, 2013, J SUBST ABUSE TREAT, V44, P426, DOI 10.1016/j.jsat.2012.08.019; Druga R, 2009, FOLIA BIOL-PRAGUE, V55, P201; Economides JR, 2011, NAT NEUROSCI, V14, P1574, DOI 10.1038/nn.2958; Esposito F, 2011, CURR OPIN NEUROL, V24, P378, DOI 10.1097/WCO.0b013e32834897a5; Fino E, 2013, NEUROSCIENTIST, V19, P228, DOI 10.1177/1073858412456743; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Fuster JM, 2009, J COGNITIVE NEUROSCI, V21, P2047, DOI 10.1162/jocn.2009.21280; Geranmayeh F, 2014, J NEUROSCI, V34, P8728, DOI 10.1523/JNEUROSCI.0428-14.2014; Goense J, 2012, NEURON, V76, P629, DOI 10.1016/j.neuron.2012.09.019; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Kim DI, 2009, SCHIZOPHRENIA BULL, V35, P67, DOI 10.1093/schbul/sbn133; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Lim S, 2013, NAT NEUROSCI, V16, P1306, DOI 10.1038/nn.3492; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P368, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<368::AID-HBM7>3.3.CO;2-5; Meda SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007911; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Menz MM, 2009, HUM BRAIN MAPP, V30, P3339, DOI 10.1002/hbm.20756; Merchant H, 2012, PROG NEUROBIOL, V99, P163, DOI 10.1016/j.pneurobio.2012.08.005; Moran JM, 2012, J NEUROSCI, V32, P5553, DOI 10.1523/JNEUROSCI.5511-11.2012; Mullinger KJ, 2014, NEUROIMAGE, V94, P263, DOI 10.1016/j.neuroimage.2014.02.029; Mullinger KJ, 2013, P NATL ACAD SCI USA, V110, P13636, DOI 10.1073/pnas.1221287110; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Poldrack RA, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00012; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Popivanov ID, 2014, J NEUROSCI, V34, P95, DOI 10.1523/JNEUROSCI.2748-13.2014; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Ray KL, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00237; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Roth G, 2012, PROG BRAIN RES, V195, P413, DOI 10.1016/B978-0-444-53860-4.00020-9; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Serences JT, 2012, NEUROPSYCHOLOGIA, V50, P435, DOI 10.1016/j.neuropsychologia.2011.07.013; Shapley R, 2011, VISION RES, V51, P701, DOI 10.1016/j.visres.2011.02.012; Shapley RM, 2013, NEURAL NETWORKS, V37, P170, DOI 10.1016/j.neunet.2012.09.005; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; St Jacques PL, 2011, NEUROIMAGE, V57, P608, DOI 10.1016/j.neuroimage.2011.04.039; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Swindale NV, 1998, CURR BIOL, V8, pR270, DOI 10.1016/S0960-9822(98)70170-8; Takeda K, 2007, CORTEX, V43, P38, DOI 10.1016/S0010-9452(08)70444-1; Taub AH, 2013, J NEUROSCI, V33, P14359, DOI 10.1523/JNEUROSCI.1748-13.2013; Tolhurst DJ, 2009, J NEUROSCI, V29, P2355, DOI 10.1523/JNEUROSCI.3869-08.2009; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van Wageningen H, 2009, HUM BRAIN MAPP, V30, P3616, DOI 10.1002/hbm.20789; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Verduzco-Flores S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006399; Wolfe J, 2010, CURR OPIN NEUROBIOL, V20, P306, DOI 10.1016/j.conb.2010.03.006; Wu X, 2009, NEUROIMAGE, V45, P1347, DOI 10.1016/j.neuroimage.2008.12.050; Xu J., 2013, FRONT NEUROSCI, V7, P154, DOI DOI 10.3389/FNINS.2013.00154; Xu JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087078; Xu JS, 2013, NEUROIMAGE, V79, P62, DOI 10.1016/j.neuroimage.2013.04.038; Yeo BTT, 2014, NEUROIMAGE, V88, P212, DOI 10.1016/j.neuroimage.2013.10.046; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Ystad M, 2010, NEUROIMAGE, V52, P379, DOI 10.1016/j.neuroimage.2010.03.062; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197	98	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117029	10.1371/journal.pone.0117029	http://dx.doi.org/10.1371/journal.pone.0117029			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714362	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700027
J	Cuesta-Vargas, AI; Gonzalez-Sanchez, M				Ignacio Cuesta-Vargas, Antonio; Gonzalez-Sanchez, Manuel			Changes in Disability, Physical/Mental Health States and Quality of Life during an 8-Week Multimodal Physiotherapy Programme in Patients with Chronic Non-Specific Neck Pain: A Prospective Cohort Study	PLOS ONE			English	Article							LOW-BACK-PAIN; SPANISH VERSION; EXERCISE; POPULATION; THERAPY; CLASSIFICATION; MANIPULATION; EDUCATION; TRIAL; INDEX	Aim The aim of this study was to analyse the effect of an 8-week multimodal physiotherapy programme (MPP), integrating physical land-based therapeutic exercise (TE), adapted swimming and health education, as a treatment for patients with chronic non-specific neck pain (CNSNP), on disability, general health/mental states and quality of life. Methods 175 CNSNP patients from a community-based centre were recruited to participate in this prospective study. Intervention: 60-minute session (30 minutes of land-based exercise dedicated to improving mobility, motor control, resistance and strengthening of the neck muscles, and 30 minutes of adapted swimming with aerobic exercise keeping a neutral neck position using a snorkel). Health education was provided using a decalogue on CNSNP and constant repetition of brief advice by the physiotherapist during the supervision of the exercises in each session. Study outcomes: primary: disability (Neck Disability Index); secondary: physical and mental health states and quality of life of patients (SF-12 and EuroQoL-5D respectively). Differences between baseline data and that at the 8-week follow-up were calculated for all outcome variables. Results Disability showed a significant improvement of 24.6% from a mean (SD) of 28.2 (13.08) at baseline to 16.88 (11.62) at the end of the 8-week intervention. All secondary outcome variables were observed to show significant, clinically relevant improvements with increase ranges between 13.0% and 16.3% from a mean of 0.70 (0.2) at baseline to 0.83 (0.2), for EuroQoL-5D, and from a mean of 40.6 (12.7) at baseline to 56.9 (9.5), for mental health state, at the end of the 8-week intervention. Conclusion After 8 weeks of a MPP that integrated land-based physical TE, health education and adapted swimming, clinically-relevant and statistically-significant improvements were observed for disability, physical and mental health states and quality of life in patients who suffer CNSNP. The clinical efficacy requires verification using a randomised controlled study design.	[Ignacio Cuesta-Vargas, Antonio] Queensland Univ Technol, Fac Hlth, Sch Clin Sci, Brisbane, Qld 4001, Australia; [Ignacio Cuesta-Vargas, Antonio; Gonzalez-Sanchez, Manuel] Univ Malaga, Catedra Fisioterapia & Discapacidad, Inst Biomed Malaga IBIMA,Dept Psiquiatria & Fisio, Andalucia Tech,Fac Ciencias Salud,Grp Clinimetria, E-29071 Malaga, Spain	Queensland University of Technology (QUT); Universidad de Malaga	Cuesta-Vargas, AI (corresponding author), Queensland Univ Technol, Fac Hlth, Sch Clin Sci, Brisbane, Qld 4001, Australia.	acuesta.var@gmail.com		Cuesta-Vargas, Antonio I/0000-0002-8880-4315				Ortega JAA, 2010, SPINE, V35, pE114, DOI 10.1097/BRS.0b013e3181afea5d; Badia X, 1999, MED CLIN-BARCELONA, V112, P79; Barbosa T, 2010, EUR J APPL PHYSIOL, V109, P1155, DOI 10.1007/s00421-010-1459-x; Becker BE, 2009, PM&R, V1, P859, DOI 10.1016/j.pmrj.2009.05.017; Bertozzi L, 2013, PHYS THER, V93, P1026, DOI 10.2522/ptj.20120412; Borghouts JAJ, 1998, PAIN, V77, P1, DOI 10.1016/S0304-3959(98)00058-X; Bronfort G, 2001, SPINE, V26, P788, DOI 10.1097/00007632-200104010-00020; Childs JD, 2008, J ORTHOP SPORT PHYS, V38, pA1, DOI 10.2519/jospt.2008.0303; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cote P, 2004, PAIN, V112, P267, DOI 10.1016/j.pain.2004.09.004; Cuesta-Vargas AI, 2012, CLIN RHEUMATOL, V31, P1073, DOI 10.1007/s10067-012-1977-5; Cuesta-Vargas AI, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-13; Cuesta-Vargas AI, 2011, CLIN RHEUMATOL, V30, P1455, DOI 10.1007/s10067-011-1825-z; Damgaard Pia, 2013, ISRN Pain, V2013, P567175, DOI 10.1155/2013/567175; Dankaerts W, 2011, MANUAL THER, V16, P9, DOI 10.1016/j.math.2010.10.006; EVANS RJW, 2012, NEW YORK REV BOOKS, V59, P37, DOI DOI 10.1097/BRS.0B013E31823B3BDF; Fersum KV, 2013, EUR J PAIN, V17, P916, DOI 10.1002/j.1532-2149.2012.00252.x; Freburger JK, 2009, ARTHRIT RHEUM-ARTHR, V61, P192, DOI 10.1002/art.24234; Gabel CP, 2014, SPINE J, V14, P1410, DOI 10.1016/j.spinee.2013.08.026; Gross AR, 2009, J ORTHOP SPORT PHYS, V39, P351, DOI 10.2519/jospt.2009.2831; Hanney WJ, 2010, AM J LIFESTYLE MED, V4, P166, DOI 10.1177/1559827609351134; Heywood S, 2008, CHURCHILL FELLOW, V1162, DOI [10.1007/s00421-010-1459-x, DOI 10.1007/S00421-010-1459-X]; Hoving JL, 2001, SPINE, V26, P196, DOI 10.1097/00007632-200101150-00015; Cuesta-Vargas AI, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-19; Cuesta-Vargas AI, 2011, AM J PHYS MED REHAB, V90, P1030, DOI 10.1097/PHM.0b013e318238a29c; Cuesta-Vargas AI, 2011, AM J PHYS MED REHAB, V90, P526, DOI 10.1097/PHM.0b013e31821a71d0; Lee LJ, 2011, GAIT POSTURE, V33, P588, DOI 10.1016/j.gaitpost.2011.01.014; Lee LJ, 2009, J ELECTROMYOGR KINES, V19, P46, DOI 10.1016/j.jelekin.2007.06.015; Lee LJ, 2005, SPINE, V30, P870, DOI 10.1097/01.brs.0000158956.77897.ec; Mallin G, 2013, J BODYW MOV THER, V17, P376, DOI 10.1016/j.jbmt.2013.03.003; Masumoto K, 2008, EXERC SPORT SCI REV, V36, P160, DOI 10.1097/JES.0b013e31817bfe73; McLean SM, 2013, MANUAL THER, V18, P199, DOI 10.1016/j.math.2012.09.005; Michalsen A, 2012, J PAIN, V13, P1122, DOI 10.1016/j.jpain.2012.08.004; Monticone Marco, 2013, G Ital Med Lav Ergon, V35, P36; Pool JJM, 2007, SPINE, V32, P3047, DOI 10.1097/BRS.0b013e31815cf75b; Saavedra-Hernandez M, 2013, CLIN REHABIL, V27, P504, DOI 10.1177/0269215512464501; Schuller W, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-53; Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955	39	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118395	10.1371/journal.pone.0118395	http://dx.doi.org/10.1371/journal.pone.0118395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IY	25710539	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900055
J	van den Berg, S; Koedijk, DGAM; Back, JW; Neef, J; Dreisbach, A; van Dijl, JM; Bakker-Woudenberg, IAJM; Buist, G				van den Berg, Sanne; Koedijk, Dennis G. A. M.; Back, Jaap Willem; Neef, Jolanda; Dreisbach, Annette; van Dijl, Jan Maarten; Bakker-Woudenberg, Irma A. J. M.; Buist, Girbe			Active Immunization with an Octa-Valent Staphylococcus aureus Antigen Mixture in Models of S. aureus Bacteremia and Skin Infection in Mice	PLOS ONE			English	Article							PHENOL-SOLUBLE MODULINS; METHICILLIN-RESISTANT; LACTOCOCCUS-LACTIS; CONJUGATE VACCINE; PATIENT OUTCOMES; DOUBLE-BLIND; PHASE-II; MORTALITY; MULTICENTER; EXPRESSION	Proteomic studies with different Staphylococcus aureus isolates have shown that the cell surface-exposed and secreted proteins IsaA, LytM, Nuc, the propeptide of Atl (pro-Atl) and four phenol-soluble modulins alpha (PSM alpha) are invariantly produced by this pathogen. Therefore the present study was aimed at investigating whether these proteins can be used for active immunization against S. aureus infection in mouse models of bacteremia and skin infection. To this end, recombinant His-tagged fusions of IsaA, LytM, Nuc and pro-Atl were isolated from Lactococcus lactis or Escherichia coli, while the PSM alpha 1-4 peptides were chemically synthesized. Importantly, patients colonized by S. aureus showed significant immunoglobulin G (IgG) responses against all eight antigens. BALB/cBYJ mice were immunized subcutaneously with a mixture of the antigens at day one (5 mu g each), and boosted twice (25 mu g of each antigen) with 28 days interval. This resulted in high IgG responses against all antigens although the response against pro-Atl was around one log lower compared to the other antigens. Compared to placebo-immunized mice, immunization with the octa-valent antigen mixture did not reduce the S. aureus isolate P load in blood, lungs, spleen, liver, and kidneys in a bacteremia model in which the animals were challenged for 14 days with a primary load of 3 x 10(5) CFU. Discomfort scores and animal survival rates over 14 days did not differ between immunized mice and placebo-immunized mice upon bacteremia with S. aureus USA300 (6 x 10(5) CFU). In addition, this immunization did not reduce the S. aureus isolate P load in mice with skin infection. These results show that the target antigens are immunogenic in both humans and mice, but in the used animal models do not result in protection against S. aureus infection.	[van den Berg, Sanne; Bakker-Woudenberg, Irma A. J. M.] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Koedijk, Dennis G. A. M.; Neef, Jolanda; Dreisbach, Annette; van Dijl, Jan Maarten; Buist, Girbe] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Back, Jaap Willem] Pepscan Therapeut BV, Lelystad, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen; Pepscan Therapeutics B.V.	van den Berg, S (corresponding author), Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	s.vandenberg@erasmusmc.nl	Back, JW/B-3641-2009; B, Jw/N-7879-2019	Back, JW/0000-0002-1310-4373; B, Jw/0000-0002-1310-4373; Neef, Jolanda/0000-0002-4898-4948; van den Berg, Sanne/0000-0001-9209-0178	Top Institute Pharma [T4-502]	Top Institute Pharma	This study was financially supported by Top Institute Pharma project T4-502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2012, J INFECT DIS, V206, P915, DOI 10.1093/infdis/jis462; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Beenken KE, 2012, INFECT IMMUN, V80, P1634, DOI 10.1128/IAI.06134-11; Benjamin DK, 2006, J PERINATOL, V26, P290, DOI 10.1038/sj.jp.7211496; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Bosma T, 2006, APPL ENVIRON MICROB, V72, P880, DOI 10.1128/AEM.72.1.880-889.2006; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; den Reijer PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053391; Dreisbach A, 2011, PROTEOMICS, V11, P3154, DOI 10.1002/pmic.201000823; Dreisbach A, 2010, PROTEOMICS, V10, P3082, DOI 10.1002/pmic.201000062; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; Fattom AI, 2004, VACCINE, V22, P880, DOI 10.1016/j.vaccine.2003.11.034; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fowler VG, 2013, JAMA-J AM MED ASSOC, V309, P1368, DOI 10.1001/jama.2013.3010; Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Joshi A, 2012, HUM VACC IMMUNOTHER, V8, DOI [10.4161/hv.8.3.18946, 10.4161/hv.18946]; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kolata J, 2011, PROTEOMICS, V11, P3914, DOI 10.1002/pmic.201000760; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lambert ML, 2011, LANCET INFECT DIS, V11, P30, DOI 10.1016/S1473-3099(10)70258-9; Lesens O, 2003, INFECT CONT HOSP EP, V24, P890, DOI 10.1086/502156; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Lorenz U, 2011, ANTIMICROB AGENTS CH, V55, P165, DOI 10.1128/AAC.01144-10; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MYLOTTE JM, 1987, REV INFECT DIS, V9, P891; Neef J, STRAIGHTFORWARD ONE; Neef J, 2014, APPL MICROBIOL BIOTE; Oesterreich B, 2014, HUM VACC IMMUNOTHER, V10, P926, DOI 10.4161/hv.27692; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Rupp ME, 2007, ANTIMICROB AGENTS CH, V51, P4249, DOI 10.1128/AAC.00570-07; Shinefield H, 2002, NEW ENGL J MED, V346, P491, DOI 10.1056/NEJMoa011297; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Swierstra J, 2014, INFECT IMMUN; Timmerman P, 2004, MOL DIVERS, V8, P61, DOI 10.1023/B:MODI.0000025650.94399.bb; Tsompanidou E, 2013, TRENDS MICROBIOL, V21, P313, DOI 10.1016/j.tim.2013.04.007; Tsompanidou E, 2013, APPL ENVIRON MICROB, V79, P886, DOI 10.1128/AEM.03157-12; Tsompanidou E, 2011, J BACTERIOL, V193, P1267, DOI 10.1128/JB.01276-10; van den Berg S, 2015, INT J MED M IN PRESS; van den Berg S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059107; van den Berg S, 2011, J IMMUNOL METHODS, V365, P142, DOI 10.1016/j.jim.2010.12.013; van der Kooi-Pol MM, 2013, J INVEST DERMATOL, V133, P847, DOI 10.1038/jid.2012.347; Verkaik NJ, 2011, IMMUNOTHERAPY-UK, V3, P1063, DOI [10.2217/imt.11.84, 10.2217/IMT.11.84]; Verkaik NJ, 2010, CLIN INFECT DIS, V50, P61, DOI 10.1086/648673; Weems JJ, 2006, ANTIMICROB AGENTS CH, V50, P2751, DOI 10.1128/AAC.00096-06; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313	65	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116847	10.1371/journal.pone.0116847	http://dx.doi.org/10.1371/journal.pone.0116847			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710376	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900019
J	Whiley, RA; Fleming, EV; Makhija, R; Waite, RD				Whiley, Robert A.; Fleming, Emily V.; Makhija, Ridhima; Waite, Richard D.			Environment and Colonisation Sequence Are Key Parameters Driving Cooperation and Competition between Pseudomonas aeruginosa Cystic Fibrosis Strains and Oral Commensal Streptococci	PLOS ONE			English	Article							TRANSMISSIBLE STRAINS; LUNG; INFECTIONS; DIVERSITY; INTERFERENCE; COMMUNITIES; POPULATIONS; ECOLOGY	Cystic fibrosis (CF) patient airways harbour diverse microbial consortia that, in addition to the recognized principal pathogen Pseudomonas aeruginosa, include other bacteria commonly regarded as commensals. The latter include the oral (viridans) streptococci, which recent evidence indicates play an active role during infection of this environmentally diverse niche. As the interactions between inhabitants of the CF airway can potentially alter disease progression, it is important to identify key cooperators/competitors and environmental influences if therapeutic intervention is to be improved and pulmonary decline arrested. Importantly, we recently showed that virulence of the Pseudomonas aeruginosa Liverpool Epidemic Strain (LES) could be potentiated by the Anginosus-group of streptococci (AGS). In the present study we explored the relationships between other viridans streptococci (Streptococcus oralis, Streptococcus mitis, Streptococcus gordonii and Streptococcus sanguinis) and the LES and observed that co-culture outcome was dependent upon inoculation sequence and environment. All four streptococcal species were shown to potentiate LES virulence factor production in co-culture biofilms. However, in the case of Streptococcus oralis interactions were environmentally determined; in air cooperation within a high cell density co-culture biofilm occurred together with stimulation of LES virulence factor production, while in an atmosphere containing added CO2 this species became a competitor antagonising LES growth through hydrogen peroxide (H2O2) production, significantly altering biofilm population dynamics and appearance. Streptococcus mitis, Streptococcus gordonii and Streptococcus sanguinis were also capable of H2O2 mediated inhibition of Pseudomonas aeruginosa growth, but this was only visible when inoculated as a primary coloniser prior to introduction of the LES. Therefore, these observations, which are made in conditions relevant to the biology of CF disease pathogenesis, show that the pathogenic and colonisation potential of Pseudomonas aeruginosa isolates can be modulated positively and negatively by the presence of oral commensal streptococci.	[Whiley, Robert A.; Makhija, Ridhima] Queen Mary Univ London, Barts & London Sch Med & Dent, Dept Clin & Diagnost Oral Sci, London E1 2AT, England; [Fleming, Emily V.; Waite, Richard D.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Immunol & Infect Dis, Blizard Inst, London E1 2AT, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Whiley, RA (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Dept Clin & Diagnost Oral Sci, 4 Newark St, London E1 2AT, England.	Richard.D.Waite@gmail.com		Das, Ridhima/0000-0002-4515-4711				Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Conrad D, 2013, AM J RESP CELL MOL, V48, P150, DOI 10.1165/rcmb.2012-0059PS; CORKILL JE, 1994, PEDIATR RES, V35, P299, DOI 10.1203/00006450-199403000-00003; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fauroux B, 2011, MINERVA ANESTESIOL, V77, P1108; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Fothergill JL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-45; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; Fothergill JL, 2010, J MED MICROBIOL, V59, P472, DOI 10.1099/jmm.0.015875-0; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Kenna DT, 2007, MICROBIOL-SGM, V153, P1852, DOI 10.1099/mic.0.2006/005082-0; Kononen E, 2002, J MED MICROBIOL, V51, P723, DOI 10.1099/0022-1317-51-9-723; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Maeda Y, 2011, J CYST FIBROS, V10, P133, DOI 10.1016/j.jcf.2010.11.003; Nguyen PTM, 2002, CURR MICROBIOL, V44, P262, DOI 10.1007/s00284-001-0001-0; Okahashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062563; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; Purcell P, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-130; Quinn RA, 2014, MBIO, V5, DOI 10.1128/mBio.00956-13; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Segal Leopoldo N, 2014, Ann Am Thorac Soc, V11, P108, DOI 10.1513/AnnalsATS.201310-339FR; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Waite RD, 2012, J BACTERIOL, V194, P4521, DOI 10.1128/JB.06678-11; Waite RD, 2012, J CLIN MICROBIOL, V50, P1430, DOI 10.1128/JCM.06184-11; Whiley RA, 2014, J INFECT DIS, V209, P769, DOI 10.1093/infdis/jit568; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062339; Zhu L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/717843	35	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0115513	10.1371/journal.pone.0115513	http://dx.doi.org/10.1371/journal.pone.0115513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710466	gold, Green Submitted, Green Published			2022-12-27	WOS:000350683900004
J	Harris, R; Cormack, D; Stanley, J; Rameka, R				Harris, Ricci; Cormack, Donna; Stanley, James; Rameka, Ruruhira			Investigating the Relationship between Ethnic Consciousness, Racial Discrimination and Self-Rated Health in New Zealand	PLOS ONE			English	Article							MAORI HEALTH; CARE; DEPRIVATION; EXPERIENCES; DISPARITIES; MORTALITY	In this study, we examine race/ethnic consciousness and its associations with experiences of racial discrimination and health in New Zealand. Racism is an important determinant of health and cause of ethnic inequities. However, conceptualising the mechanisms by which racism impacts on health requires racism to be contextualised within the broader social environment. Race/ethnic consciousness (how often people think about their race or ethnicity) is understood as part of a broader assessment of the 'racial climate'. Higher race/ethnic consciousness has been demonstrated among non-dominant racial/ethnic groups and linked to adverse health outcomes in a limited number of studies. We analysed data from the 2006/07 New Zealand Health Survey, a national population-based survey of New Zealand adults, to examine the distribution of ethnic consciousness by ethnicity, and its association with individual experiences of racial discrimination and self-rated health. Findings showed that European respondents were least likely to report thinking about their ethnicity, with people from non-European ethnic groupings all reporting relatively higher ethnic consciousness. Higher ethnic consciousness was associated with an increased likelihood of reporting experience of racial discrimination for all ethnic groupings and was also associated with fair/poor self-rated health after adjusting for age, sex and ethnicity. However, this difference in health was no longer evident after further adjustment for socioeconomic position and individual experience of racial discrimination. Our study suggests different experiences of racialised social environments by ethnicity in New Zealand and that, at an individual level, ethnic consciousness is related to experiences of racial discrimination. However, the relationship with health is less clear and needs further investigation with research to better understand the racialised social relations that create and maintain ethnic inequities in health in attempts to better address the impacts of racism on health.				ricci.harris@otago.ac.nz			Health Research Council of New Zealand;  [10/416]	Health Research Council of New Zealand(Health Research Council of New Zealand); 	The Crown is the owner of the copyright of the data and the Ministry of Health is the funder of the data collection. This current study was funded by the Health Research Council of New Zealand as a 3-year project grant. The project number is 10/416. The funder's website is: (www.hrc.govt.nz). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The results presented in this paper are the work of the authors.	[Anonymous], 2004, ETHN DAT PROT HLTH D; Atkinson J, NZ CENSUS MORTALITY; Ayyagari P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053278; Becares L, 2013, SOC SCI MED, V88, P76, DOI 10.1016/j.socscimed.2013.04.007; Brewer LC, 2013, AM J HYPERTENS, V26, P1346, DOI 10.1093/ajh/hpt116; Brondolo E, 2009, J BEHAV MED, V32, P1, DOI 10.1007/s10865-008-9190-3; Cameron JE, 2004, SELF IDENTITY, V3, P239, DOI 10.1080/13576500444000047; Carter K, 2011, AUSTRALAS EPIDEMIOL, V18, P26; Centers for Disease Control and Prevention (CDC), 2004, RISK FACT SURV SYST; Cormack DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084039; Crawford ND, 2010, ETHNIC DIS, V20, P359; Crengle S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-45; Daniels J, 2006, GENDER RACE CLASS HL, P89, DOI [10.1016/S1567-5688(14)70002-9, DOI 10.1016/S1567-5688(14)70002-9]; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Harris R, 2006, SOC SCI MED, V63, P1428, DOI 10.1016/j.socscimed.2006.04.009; Harris R, 2006, LANCET, V367, P2005, DOI 10.1016/S0140-6736(06)68890-9; Harris R, 2012, AM J PUBLIC HEALTH, V102, P1012, DOI 10.2105/AJPH.2011.300626; Harris R, 2012, SOC SCI MED, V74, P408, DOI 10.1016/j.socscimed.2011.11.004; Harris RB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-844; Hausmann L, 2009, AM J PUBLIC HEALTH, V99, pS718, DOI DOI 10.2105/AJPH.2008.150730; Hausmann LRM, 2008, MED CARE, V46, P905, DOI 10.1097/MLR.0b013e3181792562; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jensen J., 2005, ELSI SHORT FORM USER; Jones, 1999, MAORI PAKEHA HLTH DI; JONES C. P., 2002, PHYLON ANN ARBOR, V50, P7, DOI [10.2307/4149999, DOI 10.2307/4149999]; Karlsen S., 2006, HLTH SOCIAL RES MULT, P20; Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544; LaVeist T, 2002, RACE ETHNICITY HLTH, P115; Lee DL, 2013, J COUNS PSYCHOL, V60, P1, DOI 10.1037/a0031275; Ministry of Health, 2013, NZ HLTH SURV ANN UPD, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Ministry of Health, 2012, TUP OL MOUI PAC HLTH, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; Ministry of Health, 2006, AS HLTH CHART BOOK 2; Ministry of Health, 2015, TAT KAH MAOR HLTH CH; Ministry of Health, 2006, 2006 07 NZ HLTH SURV; Ministry of Health, 2012, HLTH NZ AD 2011 12 K, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; Ministry of Health, 2008, METH REP 2006 07 NZ; Ministry of Social Development, 2010, SOC REP 2010; Paradies Y, 2006, CRIT PUBLIC HEALTH, V16, P143, DOI [10.1080/09581590600828881, DOI 10.1080/09581590600828881]; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Paradies Y, 2009, ETHNIC RACIAL STUD, V32, P548, DOI 10.1080/01419870802065234; Robson B, 2007, HAUORA MAORI STANDAR, DOI [10.1016/j.adolescence.2015.01.002, DOI 10.1016/J.ADOLESCENCE.2015.01.002]; Salmond C, 2005, NZIDEP NZ INDEX SOCI; Salmond C, 2007, NZDEP2006 INDEX DEPR, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Scott KM, 2000, SOC SCI MED, V51, P1655, DOI 10.1016/S0277-9536(00)00083-6; Statistics New Zealand, 2012, NZ GEN SOC SURV 2012; Statistics New Zealand, 2013, TE KUP 2013 SURV MAO, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Vines AI, 2006, ETHNIC DIS, V16, P101; Williams DR, 2013, AM BEHAV SCI, V57, P1200, DOI 10.1177/0002764213487341; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Wolinsky FD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-827	50	21	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117343	10.1371/journal.pone.0117343	http://dx.doi.org/10.1371/journal.pone.0117343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706560	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100079
J	Militz, TA; Hutson, KS				Militz, Thane A.; Hutson, Kate S.			Beyond Symbiosis: Cleaner Shrimp Clean Up in Culture	PLOS ONE			English	Article							WRASSE LABRUS-BERGYLTA; BENEDENIA-SERIOLAE; FISH; MONOGENEA; PARASITES; DISEASE; GILLS; SKIN; HYPOSALINITY; AQUACULTURE	Cleaner organisms exhibit a remarkable natural behaviour where they consume ectoparasites attached to "client" organisms. While this behaviour can be utilized as a natural method of parasitic disease control (or biocontrol), it is not known whether cleaner organisms can also limit reinfection from parasite eggs and larvae within the environment. Here we show that cleaner shrimp, Lysmata amboinensis, consume eggs and larvae of a harmful monogenean parasite, Neobenedenia sp., in aquaculture. Shrimp consumed parasite eggs under diurnal (63%) and nocturnal (14%) conditions as well as infectious larvae (oncomiracidia) diurnally (26%). Furthermore, we trialled the inclusion of cleaner shrimp for preventative parasite management of ornamental fish, Pseudanthias squamipinnis, and found shrimp reduced oncomiracidia infection success of host fish by half compared to controls (held without shrimp). Fish held without cleaner shrimp exhibited pigmentation changes as a result of infection, possibly indicative of a stress response. These results provide the first empirical evidence that cleaner organisms reduce parasite loads in the environment through non-symbiotic cleaning activities. Our research findings have relevance to aquaculture and the marine ornamental trade, where cleaner shrimp could be applied for prophylaxis and control of ectoparasite infections.	[Militz, Thane A.; Hutson, Kate S.] James Cook Univ, Coll Marine & Environm Sci, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia	James Cook University	Hutson, KS (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.	kate.hutson@jcu.edu.au	Militz, Thane A./AAQ-1854-2021	Militz, Thane A./0000-0002-6476-8559; Hutson, Kate/0000-0003-2408-3990	Centre for Sustainable Tropical Fisheries and Aquaculture, James Cook University	Centre for Sustainable Tropical Fisheries and Aquaculture, James Cook University	KSH and TAM received funding for this research from the Centre for Sustainable Tropical Fisheries and Aquaculture, James Cook University (http://research.jcu.edu.au/stfa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JH, 2004, CORAL REEFS, V23, P515, DOI 10.1007/s00338-004-0429-3; Bjordal A., 1991, Progress in Underwater Science, V16, P17; Bunkley-Williams L, 1998, CRUSTACEANA, V71, P862, DOI 10.1163/156854098X00888; Calado R, 2008, AQUACULTURE, V285, P264, DOI 10.1016/j.aquaculture.2008.08.019; Colihueque N, 2010, REV FISH BIOL FISHER, V20, P71, DOI 10.1007/s11160-009-9121-6; COWELL LE, 1993, AQUACULTURE, V113, P189, DOI 10.1016/0044-8486(93)90473-C; DEBELIUS HD, 2001, CRUSTACEA GUIDE WORL; Deveney MR, 2001, DIS AQUAT ORGAN, V46, P79, DOI 10.3354/dao046079; DIGGLES BK, 1993, INT J PARASITOL, V23, P877, DOI 10.1016/0020-7519(93)90053-2; ELLIS EP, 1993, AQUACULTURE, V117, P15, DOI 10.1016/0044-8486(93)90119-J; Frazer LN, 2012, P ROY SOC B-BIOL SCI, V279, P1950, DOI 10.1098/rspb.2011.2210; Grutter AS, 2002, PARASITOLOGY, V124, pS65, DOI 10.1017/S0031182002001488; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2002, J FISH BIOL, V61, P1098, DOI 10.1006/jfbi.2002.2121; Grutter AS, 1999, NATURE, V398, P672, DOI 10.1038/19443; IGER Y, 1995, GEN COMP ENDOCR, V97, P188, DOI 10.1006/gcen.1995.1018; JOHNSON WS, 1988, ENVIRON BIOL FISH, V23, P225, DOI 10.1007/BF00004913; Karlsbakk E, 2013, AQUACULTURE, V412, P41, DOI 10.1016/j.aquaculture.2013.07.007; Kearn G. C., 1986, Advances in Parasitology, V25, P175, DOI 10.1016/S0065-308X(08)60344-9; KEARN GC, 1992, ZOOL SCI, V9, P451; KEARN GC, 1994, INT J PARASITOL, V24, P1227, DOI 10.1016/0020-7519(94)90193-7; Kvenseth PG, 1996, WRASSE: BIOLOGY AND USE IN AQUACULTURE, P196; Lafferty KD, 1999, LIMNOL OCEANOGR, V44, P925, DOI 10.4319/lo.1999.44.3_part_2.0925; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Liao IC, 2004, AQUACULTURE, V237, P155, DOI 10.1016/j.aquaculture.2004.03.007; MACDONALD S, 1978, J HELMINTHOL, V52, P23, DOI 10.1017/S0022149X00005071; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Marcogliese DJ, 2005, INT J PARASITOL, V35, P705, DOI 10.1016/j.ijpara.2005.01.015; Militz TA, 2014, J FISH DIS, V37, P451, DOI 10.1111/jfd.12129; Mueller Karl W., 1992, Journal of the World Aquaculture Society, V23, P199, DOI 10.1111/j.1749-7345.1992.tb00769.x; Ohno Y, 2009, AQUACULTURE, V292, P248, DOI 10.1016/j.aquaculture.2009.04.012; Owens L, 2012, AQUACULTURE: FARMING AQUATIC ANIMALS AND PLANTS, 2ND EDITION, P214; PRINCE PW, 1980, EVOLUTIONARY BIOL PA; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Rhyne AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035808; Seng LT, 1997, INT J PARASITOL, V27, P1177, DOI 10.1016/S0020-7519(97)00115-X; Sharp NJ, 2004, AQUACULTURE, V236, P67, DOI 10.1016/j.aquaculture.2004.02.005; Sitja-Bobadilla A, 2006, AQUACULTURE, V261, P856, DOI 10.1016/j.aquaculture.2006.09.012; Skiftesvik AB, 2013, AQUACULTURE, V402, P113, DOI 10.1016/j.aquaculture.2013.03.032; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Hoai TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108801; Tziouveli V, 2011, J MORPHOL, V272, P1080, DOI 10.1002/jmor.10962; Whittington I. D., 2008, Fish diseases, Volume 2, P683; Whittington ID, 2012, FISH PARASITES: PATHOBIOLOGY AND PROTECTION, P225, DOI 10.1079/9781845938062.0225; Whittington ID, 1996, J HELMINTHOL, V70, P177, DOI 10.1017/S0022149X00015388	45	16	16	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117723	10.1371/journal.pone.0117723	http://dx.doi.org/10.1371/journal.pone.0117723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706952	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000350662100113
J	Soetens, LC; van Benthem, BHB; Urbanus, A; Cremer, J; Benschop, KSM; Rietveld, A; van Dijk, EI; Hahne, SJM				Soetens, Loes C.; van Benthem, Birgit H. B.; Urbanus, Anouk; Cremer, Jeroen; Benschop, Kimberly S. M.; Rietveld, Ariene; van Dijk, Erik I.; Hahne, Susan J. M.			Ongoing Transmission of Hepatitis B Virus in Rural Parts of the Netherlands, 2009-2013	PLOS ONE			English	Article							VACCINATION PROGRAM; MEN; SEX	Background Reported acute hepatitis B incidence in the Netherlands reached its nadir in 2013. However, regional signals about increased number of hepatitis B cases raised the question how hepatitis B incidence was distributed over the country. In this study, regional differences in hepatitis B epidemiology were investigated using epidemiological and molecular data. Methods Acute hepatitis B virus (HBV) infections, reported between 2009-2013, were included. If serum was available, a fragment of S and C gene of the HBV was amplified and sequenced. Regional differences in incidence were studied by geographical mapping of cases and cluster analysis. Regional differences in transmission were studied by constructing regional maximum parsimony trees based on the C gene to assess genetic clustering of cases. Results Between 2009 and 2013, 881 cases were notified, of which respectively 431 and 400 cases had serum available for S and C gene sequencing. Geographical mapping of notified cases revealed that incidences in rural border areas of the Netherlands were highest. Cluster analysis identified two significant clusters (p<0.000) in the South-western and North-eastern regions. Genetic cluster analysis showed that rural border areas had relatively large clusters of cases with indistinguishable sequences, while other regions showed more single introductions. Conclusion This study showed that regional differences in HBV epidemiology were present in the Netherlands. Rural border regions showed higher incidences and more ongoing transmission, mainly among MSM, than the more urban inland areas. Therefore, preventive measures should be enhanced in these regions.	[Soetens, Loes C.; van Benthem, Birgit H. B.; Hahne, Susan J. M.] Natl Inst Publ Hlth & Environm, Epidemiol & Surveillance Unit, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Urbanus, Anouk] Natl Inst Publ Hlth & Environm, Natl Coordinat Ctr Communicable Dis Control, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Cremer, Jeroen; Benschop, Kimberly S. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Rietveld, Ariene] Municipal Hlth Serv Hart voor Brabant, Dept Infect Dis Control, sHertogenbosch, Netherlands; [van Dijk, Erik I.] Municipal Hlth Serv Drenthe, Dept Infect Dis Control, Assen, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Soetens, LC (corresponding author), Natl Inst Publ Hlth & Environm, Epidemiol & Surveillance Unit, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	loes.soetens@rivm.nl		Benschop, Kimberley/0000-0002-8328-0882	Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Health, Welfare and Sport	This study was funded by the Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars JE, 2011, EUR J PUBLIC HEALTH, V21, P333, DOI 10.1093/eurpub/ckq117; Bartholomeusz A, 2004, REV MED VIROL, V14, P3, DOI 10.1002/rmv.400; Boot HJ, 2008, J MED VIROL, V80, P233, DOI 10.1002/jmv.21080; de Wit JBF, 2005, PREV MED, V40, P795, DOI 10.1016/j.ypmed.2004.09.026; ECDC, 2013, ANN EP REP 2013 REP; Hahne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067866; Kakietek J, 2011, AIDS EDUC PREV, V23, P118, DOI 10.1521/aeap.2011.23.2.118; Kretzschmar M, 2009, VACCINE, V27, P1254, DOI 10.1016/j.vaccine.2008.12.009; Kulldorff M, SATSCAN SOFTWARE SPA; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; van Aar F, 2014, SEXUALLY TRANSMITTED, DOI [10.5271/sjweh.3476, DOI 10.5271/SJWEH.3476]; van Houdt R, 2007, J MED VIROL, V79, P895, DOI 10.1002/jmv.20820; van Rijckevorsel G, 2013, J HEPATOL, V59, P1177, DOI 10.1016/j.jhep.2013.08.002; Xiridou M, 2013, SEX TRANSM INFECT, V89, P666, DOI 10.1136/sextrans-2012-050900; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	15	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117703	10.1371/journal.pone.0117703	http://dx.doi.org/10.1371/journal.pone.0117703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706759	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100111
J	Wang, Z; Brandt, S; Medeiros, A; Wang, SJ; Wu, H; Dent, A; Serezani, CH				Wang, Zhuo; Brandt, Stephanie; Medeiros, Alexandra; Wang, Soujuan; Wu, Hao; Dent, Alexander; Serezani, C. Henrique			MicroRNA 21 Is a Homeostatic Regulator of Macrophage Polarization and Prevents Prostaglandin E-2-Mediated M2 Generation	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; INFLAMMATORY RESPONSE; IMMUNE-RESPONSE; INNATE IMMUNITY; NADPH OXIDASE; ACTIVATION; CELLS; E-2; PHAGOCYTOSIS; EXPRESSION	Macrophages dictate both initiation and resolution of inflammation. During acute inflammation classically activated macrophages (M1) predominate, and during the resolution phase alternative macrophages (M2) are dominant. The molecular mechanisms involved in macrophage polarization are understudied. MicroRNAs are differentially expressed in M1 and M2 macrophages that influence macrophage polarization. We identified a role of miR-21 in macrophage polarization, and found that cross-talk between miR-21 and the lipid mediator prostaglandin E-2 (PGE(2)) is a determining factor in macrophage polarization. miR-21 inhibition impairs expression of M2 signature genes but not M1 genes. PGE(2) and its downstream effectors PKA and Epac inhibit miR-21 expression and enhance expression of M2 genes, and this effect is more pronounced in miR-21-/-cells. Among potential targets involved in macrophage polarization, we found that STAT3 and SOCS1 were enhanced in miR-21-/-cells and further enhanced by PGE2. We found that STAT3 was a direct target of miR-21 in macrophages. Silencing the STAT3 gene abolished PGE(2)-mediated expression of M2 genes in miR-21-/-macrophages. These data shed light on the molecular brakes involved in homeostatic macrophage polarization and suggest new therapeutic strategies to prevent inflammatory responses.	[Wang, Zhuo; Brandt, Stephanie; Wang, Soujuan; Wu, Hao; Dent, Alexander; Serezani, C. Henrique] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Medeiros, Alexandra] Univ Estadual Paulista, Fac Ciencias Farmaceut, Dept Ciencias Biol, BR-14801902 Araraquara, SP, Brazil	Indiana University System; Indiana University Bloomington; Universidade Estadual Paulista	Serezani, CH (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hserezan@iu.edu	Medeiros, Alexandra I. AIM/J-6103-2012; Wu, Hao/L-9050-2017; serezani, C. Henrique/H-1675-2013	Medeiros, Alexandra I. AIM/0000-0001-6048-3647; serezani, C. Henrique/0000-0002-5363-415X	National Institutes of Health [1R21AI079349-01, HL-103777-01, HL-124159-01, T32AI060519]; Ralph W. and Grace M. Showalter Research Trust Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124159, R00HL103777, K99HL103777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079349, T32AI060519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants 1R21AI079349-01 (to A. D.), HL-103777-01 and HL-124159-01 (C.H.S.) and T32AI060519 (to S.B.), Ralph W. and Grace M. Showalter Research Trust Fund and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2011, EUR J IMMUNOL, V41, P2482, DOI 10.1002/eji.201141740; Aronoff DM, 2008, J IMMUNOL, V180, P8222, DOI 10.4049/jimmunol.180.12.8222; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Banerjee S, 2013, J BIOL CHEM, V288, P35428, DOI 10.1074/jbc.M112.426866; Banerjee S, 2013, J IMMUNOL, V190, P6542, DOI 10.4049/jimmunol.1202496; Barclay JL, 2007, MOL ENDOCRINOL, V21, P2516, DOI 10.1210/me.2007-0030; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Brock TG, 2008, EXP CELL RES, V314, P255, DOI 10.1016/j.yexcr.2007.10.011; Cheon H, 2006, J IMMUNOL, V177, P1092, DOI 10.4049/jimmunol.177.2.1092; Domingo-Gonzalez R, 2013, J IMMUNOL, V190, P5809, DOI 10.4049/jimmunol.1203274; Dominguez-Soto A, 2011, J IMMUNOL, V186, P2192, DOI 10.4049/jimmunol.1000475; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; El Gazzar M, 2011, J LEUKOCYTE BIOL, V90, P509, DOI 10.1189/jlb.0211074; Flamand N, 2007, CELL MOL LIFE SCI, V64, P2657, DOI 10.1007/s00018-007-7228-2; Frias MA, 2008, CARDIOVASC RES, V80, P69, DOI 10.1093/cvr/cvn171; Frias MA, 2007, CARDIOVASC RES, V73, P57, DOI 10.1016/j.cardiores.2006.09.016; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jiang MH, 2012, AGING CELL, V11, P29, DOI 10.1111/j.1474-9726.2011.00757.x; Kim SH, 2011, J BIOL CHEM, V286, P8875, DOI 10.1074/jbc.M110.187815; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee MMK, 2012, J IMMUNOL, V189, P5266, DOI 10.4049/jimmunol.1103359; Lee SP, 2009, J IMMUNOL, V182, P530, DOI 10.4049/jimmunol.182.1.530; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Luo F, 2013, TOXICOL APPL PHARM, V273, P27, DOI 10.1016/j.taap.2013.08.025; Mardente S, 2012, ONCOL REP, V28, P2285, DOI 10.3892/or.2012.2058; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Medeiros A, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/327568; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Morato-Marques M, 2011, J BIOL CHEM, V286, P28902, DOI 10.1074/jbc.M111.235309; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Rogers LM, 2014, AM J REPROD IMMUNOL, V71, P34, DOI 10.1111/aji.12153; Rummel C, 2006, AM J PHYSIOL-REG I, V291, pR1316, DOI 10.1152/ajpregu.00301.2006; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shi CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066814; Singh P, 2012, BLOOD, V119, P1671, DOI 10.1182/blood-2011-03-342428; Spence S, 2013, IMMUNITY, V38, P66, DOI 10.1016/j.immuni.2012.09.013; Tacke RS, 2011, J BIOL CHEM, V286, P10847, DOI 10.1074/jbc.M110.217653; Wang Z, 2014, J IMMUNOL, V192, P2349, DOI 10.4049/jimmunol.1302982; Wei J, 2013, MOL IMMUNOL, V55, P303, DOI 10.1016/j.molimm.2013.03.004; Weinlich R, 2008, CELL DEATH DIFFER, V15, P1901, DOI 10.1038/cdd.2008.128; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Xu GX, 2014, J CELL BIOCHEM, V115, P919, DOI 10.1002/jcb.24734; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Zaslona Z, 2012, BLOOD, V119, P2358, DOI 10.1182/blood-2011-08-374207	57	102	105	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115855	10.1371/journal.pone.0115855	http://dx.doi.org/10.1371/journal.pone.0115855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706647	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100020
J	Zhang, Y; An, J; Yang, GY; Bai, AX; Zheng, BS; Lou, ZY; Wu, G; Ye, W; Chen, HF; Feng, Y; Manco, G				Zhang, Yu; An, Jiao; Yang, Guang-Yu; Bai, Aixi; Zheng, Baisong; Lou, Zhiyong; Wu, Geng; Ye, Wei; Chen, Hai-Feng; Feng, Yan; Manco, Giuseppe			Active Site Loop Conformation Regulates Promiscuous Activity in a Lactonase from Geobacillus kaustophilus HTA426	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PARTICLE MESH EWALD; AMIDOHYDROLASE SUPERFAMILY; THERMOSTABLE PHOSPHOTRIESTERASE; DEINOCOCCUS-RADIODURANS; SULFOLOBUS-SOLFATARICUS; 3-DIMENSIONAL STRUCTURE; STRUCTURAL BASIS; ENZYME; HYDROLYSIS	Enzyme promiscuity is a prerequisite for fast divergent evolution of biocatalysts. A phosphotriesterase-like lactonase (PLL) from Geobacillus kaustophilus HTA426 (GkaP) exhibits main lactonase and promiscuous phosphotriesterase activities. To understand its catalytic and evolutionary mechanisms, we investigated a "hot spot" in the active site by saturation mutagenesis as well as X-ray crystallographic analyses. We found that position 99 in the active site was involved in substrate discrimination. One mutant, Y99L, exhibited 11-fold improvement over wild-type in reactivity (k(cat)/K-m) toward the phosphotriesterase substrate ethyl-paraoxon, but showed 15-fold decrease toward the lactonase substrate delta-decanolactone, resulting in a 157-fold inversion of the substrate specificity. Structural analysis of Y99L revealed that the mutation causes a similar to 6.6 angstrom outward shift of adjacent loop 7, which may cause increased flexibility of the active site and facilitate accommodation and/or catalysis of organophosphate substrate. This study provides for the PLL family an example of how the evolutionary route from promiscuity to specificity can derive from very few mutations, which promotes alteration in the conformational adjustment of the active site loops, in turn draws the capacity of substrate binding and activity.	[Zhang, Yu; An, Jiao; Yang, Guang-Yu; Wu, Geng; Ye, Wei; Chen, Hai-Feng; Feng, Yan] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Zhang, Yu; An, Jiao; Bai, Aixi; Zheng, Baisong; Feng, Yan] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China; [Zhang, Yu] Environm Sci Res & Design Inst Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Lou, Zhiyong] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Manco, Giuseppe] CNR, Inst Prot Biochem, Naples, Italy	Shanghai Jiao Tong University; Jilin University; Tsinghua University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Feng, Y (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	yfeng2009@sjtu.edu.cn; g.manco@ibp.cnr.it	Manco, Giuseppe/AAL-3777-2020; Chen, Haifeng/AAT-7444-2020	Manco, Giuseppe/0000-0001-6191-3952; 	National Basic Research Program of China (973 program) [2012CB721000, 2011CBA00800]; EU/MIUR [PON01_01585]; Natural Science Foundation of China [31070056]	National Basic Research Program of China (973 program)(National Basic Research Program of China); EU/MIUR; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Basic Research Program of China (973 program, 2012CB721000 and 2011CBA00800), the EU/MIUR project PON01_01585 and the Natural Science Foundation of China (31070056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Babtie A, 2010, CURR OPIN CHEM BIOL, V14, P200, DOI 10.1016/j.cbpa.2009.11.028; Case DA, 2012, AMBER; Cerutti DS, 2013, J PHYS CHEM B, V117, P2328, DOI 10.1021/jp311851r; Chapman E, 2002, BIOORGAN MED CHEM, V10, P551, DOI 10.1016/S0968-0896(01)00306-6; Cheng TC, 1997, J IND MICROBIOL BIOT, V18, P49, DOI 10.1038/sj.jim.2900358; Chow JY, 2010, J BIOL CHEM, V285, P40911, DOI 10.1074/jbc.M110.177139; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Elias M, 2008, J MOL BIOL, V379, P1017, DOI 10.1016/j.jmb.2008.04.022; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hawwa R, 2009, ARCH BIOCHEM BIOPHYS, V488, P109, DOI 10.1016/j.abb.2009.06.005; Hawwa R, 2009, J MOL BIOL, V393, P36, DOI 10.1016/j.jmb.2009.06.083; Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f; Hiblot J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075272; Hiblot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047028; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Horne I, 2002, APPL ENVIRON MICROB, V68, P3371, DOI 10.1128/AEM.68.7.3371-3376.2002; Jackson CJ, 2009, P NATL ACAD SCI USA, V106, P21631, DOI 10.1073/pnas.0907548106; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Kolakowski JE, 1997, BIOCATAL BIOTRANSFOR, V15, P297, DOI 10.3109/10242429709003196; Kuo JM, 1997, BIOCHEMISTRY-US, V36, P1982, DOI 10.1021/bi962099l; Meier MM, 2013, J AM CHEM SOC, V135, P11670, DOI 10.1021/ja405911h; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Merone L, 2010, BIORESOURCE TECHNOL, V101, P9204, DOI 10.1016/j.biortech.2010.06.102; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Porzio E, 2007, BIOCHIMIE, V89, P625, DOI 10.1016/j.biochi.2007.01.007; Raushel FM, 2000, ADV ENZYMOL RAMB, V74, P51; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; SAMBROOK J, 2001, MOL CLONING LAB MANU; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; SETHUNATHAN N, 1973, CAN J MICROBIOL, V19, P873, DOI 10.1139/m73-138; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Vanhooke JL, 1996, BIOCHEMISTRY-US, V35, P6020, DOI 10.1021/bi960325l; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watkins LM, 1997, J BIOL CHEM, V272, P25596, DOI 10.1074/jbc.272.41.25596; Xiang DF, 2009, BIOCHEMISTRY-US, V48, P2237, DOI 10.1021/bi802274f; Zhang Y, 2012, APPL ENVIRON MICROB, V78, P6647, DOI 10.1128/AEM.01122-12; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	44	15	17	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115130	10.1371/journal.pone.0115130	http://dx.doi.org/10.1371/journal.pone.0115130			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706379	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100008
J	Zhou, LH; Xia, JD; Qiu, XF; Wang, PJ; Jia, RP; Chen, Y; Yang, B; Dai, YT				Zhou, Liuhua; Xia, Jiadong; Qiu, Xuefeng; Wang, Pengji; Jia, Ruipeng; Chen, Yun; Yang, Bin; Dai, Yutian			In Vitro Evaluation of Endothelial Progenitor Cells from Adipose Tissue as Potential Angiogenic Cell Sources for Bladder Angiogenesis	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR; ACELLULAR MATRIX; BIOACTIVE FACTORS; REGENERATION; VASCULARIZATION; MODEL; LINEAGE; BLOOD	Autologous endothelial progenitor cells (EPCs) might be alternative angiogenic cell sources for vascularization of tissue-engineered bladder, while isolation and culture of EPCs from peripheral blood in adult are usually time-consuming and highly inefficient. Recent evidence has shown that EPCs also exist in the adipose tissue. As adipose tissue is plentiful in the human body and can be easily harvested through a minimally invasive method, the aim of this study was to culture and characterize EPCs fromadipose tissue (ADEPCs) and investigate their potential for the neovascularization of tissue-engineered bladder. Adipose stromal vascular fraction (SVF) was isolated and used for the culture of ADEPCs and adipose derived stemcells (ADSCs). After SVF was cultured for one week, ADEPCs with typical cobblestone morphology emerged and could be isolated from ADSCs according to their different responses to trypsinization. Rat bladder smoothmuscle cells (RBSMCs) were isolated and cultured from rat bladder. RBSMCs exhibited typical spindle-shaped morphology. ADEPCs had higher proliferative potential than ADSCs and RBSMCs. ADEPCs stained positive for CD34, Stro-1, VEGFR-2, eNOS and CD31 but negative for alpha-SMA, CD14 and CD45. ADSCs stained positive for CD34, Stro-1 and a-SMA but negative for VEGFR-2, eNOS, CD31, CD14 and CD45. RBSMCs stained only positive for a-SMA. ADEPCs could be expanded from a single cell at an early passage to a cell cluster containing more than 10,000 cells. ADEPCs were able to uptake DiI-Ac-LDL, bind UEA-1 and form capillary-like structures in three-dimensional scaffolds (Matrigel and bladder acellular matrix). ADEPCs were also able to enhance the human umbilical vein endothelial cells' capability of capillary-like tube formation on Matrigel. Additionally, significantly higher levels of mRNA and protein of vascular endothelial growth factor were found in ADEPCs than in RBSMCs. These results suggest the potential use of ADEPCs as angiogenic cell sources for engineering bladder tissue.	[Zhou, Liuhua; Qiu, Xuefeng; Wang, Pengji; Chen, Yun; Yang, Bin; Dai, Yutian] Nanjing Univ, Sch Med, Dept Urol & Androl, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Liuhua; Jia, Ruipeng] Nanjing Med Univ, Nanjing Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Xia, Jiadong] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Yang, Bin] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Urol, Shanghai 200092, Peoples R China	Nanjing University; Nanjing Medical University; Nanjing Medical University; Tongji University	Yang, B (corresponding author), Nanjing Univ, Sch Med, Dept Urol & Androl, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.	yangbnju@gmail.com; ytdainjmu@sina.com	Zhou, Liuhua/I-1639-2014	Zhou, Liuhua/0000-0003-0736-4117	National Natural Science Foundation of China [31100702, 81170563]; Nanjing Medical University, China [2013NJMU081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University, China	This work was supported by the National Natural Science Foundation of China (31100702; 81170563) and Nanjing Medical University, China (2013NJMU081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0; Camussi G, 2010, CURR OPIN NEPHROL HY, V19, P7, DOI 10.1097/MNH.0b013e328332fb6f; Chen BS, 2011, INT J ARTIF ORGANS, V34, P1137, DOI 10.5301/ijao.5000069; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Eom YW, 2014, BIOCHEM BIOPH RES CO, V445, P16, DOI 10.1016/j.bbrc.2014.01.084; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Horst M, 2013, J TISSUE ENG REGEN M, V7, P515, DOI 10.1002/term.547; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a; Kawamoto A, 2001, CIRCULATION, V103, P634; Lang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053980; Lin Ching-Shwun, 2010, World J Stem Cells, V2, P1, DOI 10.4252/wjsc.v2.i1.1; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Lopatina T, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-26; Metharom P, 2008, ATHEROSCLEROSIS, V198, P29, DOI 10.1016/j.atherosclerosis.2007.09.020; Ning HX, 2011, BIOCHEM BIOPH RES CO, V413, P353, DOI 10.1016/j.bbrc.2011.08.104; Ning HX, 2009, J SEX MED, V6, P967, DOI 10.1111/j.1743-6109.2008.01172.x; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Post MJ, 2013, REGEN MED, V8, P759, DOI 10.2217/rme.13.74; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Ryu JK, 2012, J SEX MED, V9, P3051, DOI 10.1111/j.1743-6109.2012.02962.x; Scherschel JA, 2008, MOL THER, V16, P1129, DOI 10.1038/mt.2008.64; Sharma AK, 2009, J UROLOGY, V182, P1898, DOI 10.1016/j.juro.2009.03.014; Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057; Yang B, 2014, J SURG RES, V186, P63, DOI 10.1016/j.jss.2013.07.044; Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]; Yang B, 2011, LANCET, V378, P568, DOI 10.1016/S0140-6736(11)61290-7; Yang B, 2010, J BIOMED MATER RES A, V93A, P1100, DOI 10.1002/jbm.a.32534; Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692; Youssif M, 2005, UROLOGY, V66, P201, DOI 10.1016/j.urology.2005.01.054; Zhang HY, 2012, STEM CELLS DEV, V21, P1391, DOI 10.1089/scd.2011.0244; Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x; Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]	38	34	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117644	10.1371/journal.pone.0117644	http://dx.doi.org/10.1371/journal.pone.0117644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706311	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100107
J	Kelwick, R; Kopniczky, M; Bower, I; Chi, WQ; Chin, MHW; Fan, S; Pilcher, J; Strutt, J; Webb, AJ; Jensen, K; Stan, GB; Kitney, R; Freemont, P				Kelwick, Richard; Kopniczky, Margarita; Bower, Iain; Chi, Wenqiang; Chin, Matthew Ho Wai; Fan, Sisi; Pilcher, Jemma; Strutt, James; Webb, Alexander J.; Jensen, Kirsten; Stan, Guy-Bart; Kitney, Richard; Freemont, Paul			A Forward-Design Approach to Increase the Production of Poly-3-Hydroxybutyrate in Genetically Engineered Escherichia coli	PLOS ONE			English	Article							RALSTONIA-EUTROPHA; POLY(3-HYDROXYBUTYRATE); POLYHYDROXYALKANOATES	Biopolymers, such as poly-3-hydroxybutyrate (P(3HB)) are produced as a carbon store in an array of organisms and exhibit characteristics which are similar to oil-derived plastics, yet have the added advantages of biodegradability and biocompatibility. Despite these advantages, P(3HB) production is currently more expensive than the production of oil-derived plastics, and therefore, more efficient P(3HB) production processes would be desirable. In this study, we describe the model-guided design and experimental validation of several engineered P(3HB) producing operons. In particular, we describe the characterization of a hybrid phaCAB operon that consists of a dual promoter (native and J23104) and RBS (native and B0034) design. P(3HB) production at 24 h was around six-fold higher in hybrid phaCAB engineered Escherichia coli in comparison to E. coli engineered with the native phaCAB operon from Ralstonia eutropha H16. Additionally, we describe the utilization of non-recyclable waste as a low-cost carbon source for the production of P(3HB).	[Kelwick, Richard; Kopniczky, Margarita; Bower, Iain; Chi, Wenqiang; Chin, Matthew Ho Wai; Fan, Sisi; Pilcher, Jemma; Strutt, James; Webb, Alexander J.; Jensen, Kirsten; Stan, Guy-Bart; Kitney, Richard; Freemont, Paul] Ctr Synthet Biol & Innovat, London, England; [Kelwick, Richard; Kopniczky, Margarita; Webb, Alexander J.; Jensen, Kirsten; Freemont, Paul] Dept Med, London, England; [Bower, Iain; Fan, Sisi; Pilcher, Jemma; Strutt, James] Dept Life Sci, London, England; [Chi, Wenqiang; Chin, Matthew Ho Wai; Stan, Guy-Bart; Kitney, Richard] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Imperial College London	Kelwick, R (corresponding author), Ctr Synthet Biol & Innovat, South Kensington Campus, London, England.	r.kelwick@imperial.ac.uk; r.kitney@imperial.ac.uk; p.freemont@imperial.ac.uk		Kelwick, Richard/0000-0002-0054-6893; Kitney, Richard/0000-0002-6499-5209; Webb, Alexander/0000-0002-7782-269X; Stan, Guy-Bart/0000-0002-5560-902X; Chin, Matthew/0000-0003-1633-7786	EPSRC [EP/K034359/1, EP/J02175X/1]; Bill and Melinda Gates Foundation [OPP1046311]; Wellcome Trust [084369/Z/07/Z]; ERASysBio; GeneArt; Eppendorf; Bioline; Powerday; EPSRC [EP/M002187/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M002187/1, EP/J02175X/1, EP/K034359/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); ERASysBio; GeneArt; Eppendorf; Bioline; Powerday; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	EPSRC [EP/K034359/1; EP/J02175X/1], Bill and Melinda Gates Foundation [OPP1046311], The Wellcome Trust [084369/Z/07/Z]. The authors would also like to thank the companies Eppendorf (http://www.eppendorf.com/UK-en/), Bioline (www.bioline.com/), GeneArt (http://www.lifetechnologies.com/uk/en/home/life-science/cloning/gene-synthesis/geneart-gene-synthesis.html), Powerday (http://www.powerday.co.uk/), and additionally ERASysBio (www.erasysbio.net/) for sponsoring the 2013 Imperial College London iGEM project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Harding KG, 2007, J BIOTECHNOL, V130, P57, DOI 10.1016/j.jbiotec.2007.02.012; Heinrich D, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-59; Hiroe A, 2012, APPL ENVIRON MICROB, V78, P3177, DOI 10.1128/AEM.07715-11; Jensen JW, 2013, METHODS PROCESSING M; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Kelwick R, 2014, FRONTIERS BIOENGINEE, V2, DOI [10.3389/fbioe.2014.00083, DOI 10.3389/FBIOE.2014.00083]; Le Meur S, 2013, MICROB CELL FACT, V12, DOI [10.1186/1475-2859-12-129, DOI 10.1186/1475-2859-12-129]; Lee JH, 2013, APPL BIOCHEM BIOTECH, V170, P1767, DOI 10.1007/s12010-013-0311-2; Li MJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-19; Li ZJ, 2009, APPL MICROBIOL BIOT, V83, P939, DOI 10.1007/s00253-009-1943-6; Muller S, 1999, J BIOTECHNOL, V75, P81, DOI 10.1016/S0168-1656(99)00130-3; Philp JC, 2013, NEW BIOTECHNOL, V30, P635, DOI 10.1016/j.nbt.2012.11.021; Quinn JP, 2013, 93 BBF RFC; Raberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095907; Salehizadeh H, 2004, BIOTECHNOL ADV, V22, P261, DOI 10.1016/j.biotechadv.2003.09.003; Shakeri S, 2011, JUNDISHAPUR J MICROB, V4, P229; SLATER SC, 1988, J BACTERIOL, V170, P4431, DOI 10.1128/jb.170.10.4431-4436.1988; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Verlinden RAJ, 2007, J APPL MICROBIOL, V102, P1437, DOI 10.1111/j.1365-2672.2007.03335.x; Weaver DS, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-79; Yang JE, 2014, APPL MICROBIOL BIOT, V98, P95, DOI 10.1007/s00253-013-5285-z	21	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117202	10.1371/journal.pone.0117202	http://dx.doi.org/10.1371/journal.pone.0117202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699671	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800019
J	Varga, M; Visu-Petra, G; Miclea, M; Visu-Petra, L				Varga, Mihai; Visu-Petra, George; Miclea, Mircea; Visu-Petra, Laura			The "Good Cop, Bad Cop" Effect in the RT-Based Concealed Information Test: Exploring the Effect of Emotional Expressions Displayed by a Virtual Investigator	PLOS ONE			English	Article							BEHAVIOR RATING INVENTORY; MOTIVATED POSITIVE AFFECT; GUILTY KNOWLEDGE TEST; INDIVIDUAL-DIFFERENCES; EXECUTIVE FUNCTIONS; PSYCHOPHYSIOLOGICAL DETECTION; COGNITIVE MECHANISMS; SELECTIVE ATTENTION; DETECTING DECEPTION; SOCIAL FACILITATION	Concealing the possession of relevant information represents a complex cognitive process, shaped by contextual demands and individual differences in cognitive and socio-emotional functioning. The Reaction Time-based Concealed Information Test (RT-CIT) is used to detect concealed knowledge based on the difference in RTs between denying recognition of critical (probes) and newly encountered (irrelevant) information. Several research questions were addressed in this scenario implemented after a mock crime. First, we were interested whether the introduction of a social stimulus (facial identity) simulating a virtual investigator would facilitate the process of deception detection. Next, we explored whether his emotional displays (friendly, hostile or neutral) would have a differential impact on speed of responses to probe versus irrelevant items. We also compared the impact of introducing similar stimuli in a working memory (WM) updating context without requirements to conceal information. Finally, we explored the association between deceptive behavior and individual differences in WM updating proficiency or in internalizing problems (state / trait anxiety and depression). Results indicated that the mere presence of a neutral virtual investigator slowed down participants' responses, but not the appended lie-specific time (difference between probes and irrelevants). Emotional expression was shown to differentially affect speed of responses to critical items, with positive displays from the virtual examiner enhancing lie-specific time, compared to negative facial expressions, which had an opposite impact. This valence-specific effect was not visible in the WM updating context. Higher levels of trait / state anxiety were related to faster responses to probes in the negative condition (hostile facial expression) of the RT-CIT. These preliminary findings further emphasize the need to take into account motivational and emotional factors when considering the transfer of deception detection techniques from the laboratory to real-life settings.	[Varga, Mihai; Visu-Petra, George; Miclea, Mircea] Univ Babes Bolyai, Appl Cognit Psychol Ctr, Dept Psychol, R-3400 Cluj Napoca, Romania; [Visu-Petra, Laura] Univ Babes Bolyai, Dev Psychol Lab, R-3400 Cluj Napoca, Romania; [Miclea, Mircea] COGNITROM Ltd, Cluj Napoca, Romania	Babes Bolyai University from Cluj; Babes Bolyai University from Cluj	Visu-Petra, L (corresponding author), Univ Babes Bolyai, Appl Cognit Psychol Ctr, Dept Psychol, R-3400 Cluj Napoca, Romania.	laurapetra@psychology.ro			Romanian National Authority for Scientific Research, CNCS - UEFISCDI [POSDRU/107/1.5/S/76841, PN-II-RU-TE-2012-3-0323]	Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by a POSDRU/107/1.5/S/76841 grant awarded to the first author and by a PN-II-RU-TE-2012-3-0323 grant awarded to the corresponding author by the Romanian National Authority for Scientific Research, CNCS - UEFISCDI. The publishing fee for the article will be covered by COGNITROM Ltd. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abe N, 2006, CEREB CORTEX, V16, P192, DOI 10.1093/cercor/bhi097; Abe N, 2009, CURR OPIN NEUROL, V22, P594, DOI 10.1097/WCO.0b013e328332c3cf; Ambach W, 2008, INT J PSYCHOPHYSIOL, V68, P6, DOI 10.1016/j.ijpsycho.2007.11.004; Ambach W, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00510; Ambach W, 2011, INT J PSYCHOPHYSIOL, V80, P217, DOI 10.1016/j.ijpsycho.2011.03.010; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2002, CHILD NEUROPSYCHOL; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; Ben-Shakhar G, 2003, J APPL PSYCHOL, V88, P131, DOI 10.1037/0021-9010.88.1.131; Ben-Shakhar G, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00342; Bertocci MA, 2012, PSYCHOL MED, V42, P1417, DOI 10.1017/S003329171100242X; Bond GD, 2012, J APPL RES MEM COGN, V1, P128, DOI 10.1016/j.jarmac.2012.04.003; Bradley MM, 1996, PSYCHOPHYSIOLOGY, V33, P662, DOI 10.1111/j.1469-8986.1996.tb02362.x; CACIOPPO JT, 1993, PSYCHOL SCI, V4, P108, DOI 10.1111/j.1467-9280.1993.tb00470.x; Carmel D, 2003, J EXP PSYCHOL-APPL, V9, P261, DOI 10.1037/1076-898X.9.4.261; Casey B. J., 2000, FUNCTIONAL NEUROIMAG, P155; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen N, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00033; Cottrell N. B., 1972, EXPT SOCIAL PSYCHOL, V185, P236; Debey E, 2014, PSYCH RES; Debey E, 2012, ACTA PSYCHOL, V140, P133, DOI 10.1016/j.actpsy.2012.03.004; Dennis Tracy A, 2008, Depress Anxiety, V25, pE1, DOI 10.1002/da.20308; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Dolcos F, 2011, J COGN PSYCHOL, V23, P669, DOI 10.1080/20445911.2011.594433; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Elaad E, 2009, INT J PSYCHOPHYSIOL, V71, P225, DOI 10.1016/j.ijpsycho.2008.10.001; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Farrow TFD, 2010, AM J PSYCHOL, V123, P447; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Frost P, 2010, AM J PSYCHOL, V123, P221; FUREDY JJ, 1991, PSYCHOPHYSIOLOGY, V28, P163, DOI 10.1111/j.1469-8986.1991.tb00407.x; Gable PA, 2008, PSYCHOL SCI, V19, P476, DOI 10.1111/j.1467-9280.2008.02112.x; Gamer M., 2011, MEMORY DETECTION THE, P90, DOI [DOI 10.1017/CB09780511975196.006, 10.1007/ s10484- 014- 9244- y]; Gamer M, 2007, HUM BRAIN MAPP, V28, P1287, DOI 10.1002/hbm.20343; Gamer M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00256; GEEN RG, 1977, PSYCHOL BULL, V84, P1267, DOI 10.1037/0033-2909.84.6.1267; GIESEN M, 1980, J RES PERS, V14, P1, DOI 10.1016/0092-6566(80)90035-5; Gioia GA, 2000, BEHAV RATING INVENTO; Gloster AT, 2008, J AFFECT DISORDERS, V110, P248, DOI 10.1016/j.jad.2008.01.023; Gombos VA, 2006, GENET SOC GEN PSYCH, V132, P197, DOI 10.3200/MONO.132.3.197-214; Harmon-Jones E, 2009, PSYCHOL SCI, V20, P406, DOI 10.1111/j.1467-9280.2009.02302.x; HARRISON AA, 1978, US SOC PSYCHOL, V41, P156, DOI 10.2307/3033575; Hu XQ, 2013, ACTA PSYCHOL, V142, P278, DOI 10.1016/j.actpsy.2012.12.006; Hu XQ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00488; Inbau F. E., 2013, CRIMINAL INTERROGATI, V5th; Isen AM., 2009, OXFORD HDB POSITIVE, P503, DOI DOI 10.1093/OXFORDHB/9780195187243.013.0048; Johnson KJ, 2010, COGNITION EMOTION, V24, P299, DOI 10.1080/02699930903384667; Johnson R, 2004, NEUROPSYCHOLOGIA, V42, P878, DOI 10.1016/j.neuropsychologia.2003.12.005; Jones E. E., 1967, FDNS SOCIAL PSYCHOL; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Kanske P, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00042; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; Kellough JL, 2008, BEHAV RES THER, V46, P1238, DOI 10.1016/j.brat.2008.07.004; Kensinger EA, 2009, EMOT REV, V1, P99, DOI 10.1177/1754073908100432; Koster EHW, 2005, EMOTION, V5, P446, DOI 10.1037/1528-3542.5.4.446; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Krebs RM, 2010, COGNITION, V117, P341, DOI 10.1016/j.cognition.2010.08.018; Kristjansson A, 2013, J EXP PSYCHOL HUMAN, V39, P298, DOI 10.1037/a0028683; Ladouceur CD, 2005, J ABNORM CHILD PSYCH, V33, P165, DOI 10.1007/s10802-005-1825-z; Lambert AJ, 2003, J PERS SOC PSYCHOL, V84, P277, DOI 10.1037/0022-3514.84.2.277; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; LYKKEN DT, 1974, AM PSYCHOL, V29, P725, DOI 10.1037/h0037441; LYKKEN DT, 1959, J APPL PSYCHOL, V43, P385, DOI 10.1037/h0046060; Martin EA, 2011, COGNITION EMOTION, V25, P265, DOI 10.1080/02699931.2010.491652; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Meijer EH, 2009, OPEN ACCESS J FORENS, P1; Meijer EH, 2007, PSYCHOPHYSIOLOGY, V44, P814, DOI 10.1111/j.1469-8986.2007.00543.x; Meissner CA, 2002, LAW HUMAN BEHAV, V26, P469, DOI 10.1023/A:1020278620751; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Morgan CJ, 2009, SOC NEUROSCI, V4, P554, DOI 10.1080/17470910802299987; Mueller SC, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00327; Mullin BC, 2012, PSYCHIAT RES-NEUROIM, V201, P196, DOI 10.1016/j.pscychresns.2011.09.002; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Peth J, 2012, PSYCHOPHYSIOLOGY, V49, P381, DOI 10.1111/j.1469-8986.2011.01313.x; RIGGIO RE, 1983, J PERS SOC PSYCHOL, V45, P899, DOI 10.1037/0022-3514.45.4.899; Roth RM., 2005, BRIEF A BEHAV RATING; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Seymour TL, 2000, J APPL PSYCHOL, V85, P30, DOI 10.1037/0021-9010.85.1.30; Seymour TL, 2008, APPL COGNITIVE PSYCH, V22, P475, DOI 10.1002/acp.1375; Seymour TL, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00614; Sip KE, 2008, TRENDS COGN SCI, V12, P48, DOI 10.1016/j.tics.2007.11.008; Spence SA, 2004, J ROY SOC MED, V97, P6, DOI 10.1258/jrsm.97.1.6; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Sproull L, 1996, HUM-COMPUT INTERACT, V11, P97, DOI 10.1207/s15327051hci1102_1; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Toplak ME, 2009, CHILD NEUROPSYCHOL, V15, P53, DOI 10.1080/09297040802070929; Van Bockstaele B, 2012, FRONT PSYCHOL, V5, P256; Vanlessen N, 2013, COGN AFFECT BEHAV NE, V13, P60, DOI 10.3758/s13415-012-0130-x; Verschuere B, 2004, PSYCHOPHYSIOLOGY, V41, P461, DOI 10.1111/j.1469-8986.00167.x; Verschuere B, 2011, MEMORY DETECTION THE, P128, DOI [10.1017/CBO9780511975196.008, DOI 10.1017/CBO9780511975196.008, 10.1017/CBO9780511975196.004]; Verschuere B, 2011, CONSCIOUS COGN, V20, P908, DOI 10.1016/j.concog.2010.10.023; Verschuere B, 2010, APPL COGNITIVE PSYCH, V24, P991, DOI 10.1002/acp.1601; Visu-Petra G, 2014, PSYCHOL CRIME LAW, V20, P20, DOI 10.1080/1068316X.2012.736509; Visu-Petra G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00146; Visu-Petra G, 2012, APPL COGNITIVE PSYCH, V26, P342, DOI 10.1002/acp.1827; Vrij A, 2006, TRENDS COGN SCI, V10, P141, DOI 10.1016/j.tics.2006.02.003; Vrij A., 2000, DETECTING LIES DECEI; Walczyk JJ, 2003, APPL COGNITIVE PSYCH, V17, P755, DOI 10.1002/acp.914; WASSERMAN S, 1989, PSYCHOPHYSIOLOGY, V26, P208, DOI 10.1111/j.1469-8986.1989.tb03159.x; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6; ZAHNWAXLER C, 1990, NEBR SYM MOTIV, V36, P183; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269; Zuckerman M., 1981, ADV EXP SOC PSYCHOL, V14, P1, DOI DOI 10.1016/S0065-2601(08)60369-X	112	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116087	10.1371/journal.pone.0116087	http://dx.doi.org/10.1371/journal.pone.0116087			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB7EQ	25699516	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800006
J	Bales, EK; Hyman, OJ; Loudon, AH; Harris, RN; Lipps, G; Chapman, E; Roblee, K; Kleopfer, JD; Terrell, KA				Bales, Emma K.; Hyman, Oliver J.; Loudon, Andrew H.; Harris, Reid N.; Lipps, Gregory; Chapman, Eric; Roblee, Kenneth; Kleopfer, John D.; Terrell, Kimberly A.			Pathogenic Chytrid Fungus Batrachochytrium dendrobatidis, but Not B. salamandrivorans, Detected on Eastern Hellbenders	PLOS ONE			English	Article							CRYPTOBRANCHUS-ALLEGANIENSIS-ALLEGANIENSIS; EMERGING DISEASE; CHYTRIDIOMYCOSIS; AMPHIBIANS; POPULATIONS; INFECTION; USA	Recent worldwide declines and extinctions of amphibian populations have been attributed to chytridiomycosis, a disease caused by the pathogenic fungus Batrachochytrium dendrobatidis (Bd). Until recently, Bd was thought to be the only Batrachochytrium species that infects amphibians; however a newly described species, Batrachochytrium salamandrivorans (Bs), is linked to die-offs in European fire salamanders (Salamandra salamandra). Little is known about the distribution, host range, or origin of Bs. In this study, we surveyed populations of an aquatic salamander that is declining in the United States, the eastern hellbender (Cryptobranchus alleganiensis alleganiensis), for the presence of Bs and Bd. Skin swabs were collected from a total of 91 individuals in New York, Pennsylvania, Ohio, and Virginia, and tested for both pathogens using duplex qPCR. Bs was not detected in any samples, suggesting it was not present in these hellbender populations (0% prevalence, 95% confidence intervals of 0.0-0.04). Bd was found on 22 hellbenders (24% prevalence, 95% confidence intervals of 0.16 <= 0.24 <= 0.34), representing all four states. All positive samples had low loads of Bd zoospores (12.7 +/- 4.9 S.E.M. genome equivalents) compared to other Bd susceptible species. More research is needed to determine the impact of Batrachochytrium infection on hellbender fitness and population viability. In particular, understanding how hellbenders limit Bd infection intensity in an aquatic environment may yield important insights for amphibian conservation. This study is among the first to evaluate the distribution of Bs in the United States, and is consistent with another, which failed to detect Bs in the U.S. Knowledge about the distribution, host-range, and origin of Bs may help control the spread of this pathogen, especially to regions of high salamander diversity, such as the eastern United States.	[Bales, Emma K.; Hyman, Oliver J.; Loudon, Andrew H.; Harris, Reid N.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Lipps, Gregory] Gregory Lipps LLC, Toledo, OH USA; [Chapman, Eric] Western Penn Conservancy, Pittsburgh, PA USA; [Roblee, Kenneth] New York Dept Environm Conservat, Albany, NY USA; [Kleopfer, John D.] Virginia Dept Game & Inland Fisheries, Richmond, VA USA; [Terrell, Kimberly A.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA	James Madison University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Terrell, KA (corresponding author), Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA.	terrellk@si.edu	Lipps, Gregory J/A-5995-2018	Lipps, Gregory J/0000-0002-8518-873X	Columbus Zoo; Aquarium Conservation fund; National Science Foundation [1136602]	Columbus Zoo; Aquarium Conservation fund; National Science Foundation(National Science Foundation (NSF))	Funding was provided by the Columbus Zoo and Aquarium Conservation fund (Grant awarded to RNH and AHL) https://globalimpact. columbuszoo.org/about/columbus-zoo-fund-forconservation and National Science Foundation grant 1136602 (awarded to RNH) http://www.nsf.gov/funding/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author GL is the owner and sole employee of Gregory Lipps, LLC. Gregory Lipps, LLC provided support in the form of salary for author GL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions' section.	[Anonymous], 2010, SALAMANDERS US CANAD; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Blooi M, 2013, J CLIN MICROBIOL, V51, P4173, DOI 10.1128/JCM.02313-13; Bodinof CM, 2011, DIS AQUAT ORGAN, V96, P1, DOI 10.3354/dao02380; Briggler Jeffrey T., 2008, Herpetological Review, V39, P443; Briggler Jeffrey T., 2007, Herpetological Review, V38, P174; Burgmeier NG, 2011, J WILDLIFE DIS, V47, P836, DOI 10.7589/0090-3558-47.4.836; Furniss L.L., 2003, CONSERVATION ASSESSM; Garmyn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035038; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Goyner JL, 2011, HERPETOLOGICAL REV, V42, P58; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Hyman OJ, 2012, DIS AQUAT ORGAN, V97, P185, DOI 10.3354/dao02423; Junge RE, 2012, FOWLERS ZOO WILD ANI, V7, P260; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kolby JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089660; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Mayasich J., 2003, E HELLBENDER STATUS; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Muletz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103728; Nickerson CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028906; Nickerson M, 1973, HELLBENDERS N AM GIA; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; PETERSON CL, 1983, COPEIA, P225, DOI 10.2307/1444718; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Regester Kurt J., 2012, Herpetological Review, V43, P90; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Souza MJ, 2012, J WILDLIFE DIS, V48, P560, DOI 10.7589/0090-3558-48.3.560; Terrell KA, 2013, J EXP BIOL, V216, P4204, DOI 10.1242/jeb.089896; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wheeler BA, 2003, BIOL CONSERV, V109, P151, DOI 10.1016/S0006-3207(02)00136-2; Wyngaard G.A., 1982, P485; Zhu W, 2014, CURR ZOOL, V60, P729, DOI 10.1093/czoolo/60.6.729; Zhu W, 2014, ECOHEALTH, V11, P241, DOI 10.1007/s10393-013-0894-7	35	30	32	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0116405	10.1371/journal.pone.0116405	http://dx.doi.org/10.1371/journal.pone.0116405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695636	Green Submitted, Green Published, gold			2022-12-27	WOS:000350062300013
J	Xu, QL; Liu, JX; Wang, ZL; Guo, XH; Zhou, GB; Liu, YA; Huang, QB; Su, L				Xu, Qiulin; Liu, Jingxian; Wang, Zhenglian; Guo, Xiaohua; Zhou, Gengbiao; Liu, Yanan; Huang, Qiaobing; Su, Lei			Heat Stress-Induced Disruption of Endothelial Barrier Function Is via PAR1 Signaling and Suppressed by Xuebijing Injection	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; EZRIN/RADIXIN/MOESIN PROTEINS; MOESIN PHOSPHORYLATION; CELLS; PERMEABILITY; MICE; STROKE; INCREASES; INJURY	Increased vascular permeability leading to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is central to the pathogenesis of heatstroke. Protease-activated receptor 1 (PAR1), the receptor for thrombin, plays a key role in disruption of endothelial barrier function in response to extracellular stimuli. However, the role of PAR1 in heat stress-induced endothelial hyper-permeability is unknown. In this study, we measured PAR1 protein expression in heat-stressed human umbilical venous endothelial cells (HUVECs), investigated the influences of PAR1 on endothelial permeability, F-actin rearrangement, and moesin phosphorylation by inhibiting PAR1 with its siRNA, neutralizing antibody (anti-PAR1), specific inhibitor(RWJ56110), and Xuebijing injection (XBJ), a traditional Chinese medicine used for sepsis treatment, and evaluated the role of PAR1 in heatstroke- related ALI/ARDS in mice by suppressing PAR1 with RWJ56110, anti-PAR1and XBJ. We found that heat stress induced PAR1 protein expression 2h after heat stress in endothelial cells, caused the release of endothelial matrix metalloprotease 1, an activator of PAR1, after 60 or 120 min of heat stimulation, as well as promoted endothelial hyper-permeability and F-actin rearrangement, which were inhibited by suppressing PAR1 with RWJ56110, anti-PAR1 and siRNA. PAR1 mediated moesin phosphorylation, which caused F-actin rearrangement and disruption of endothelial barrier function. To corroborate findings from in vitro experiments, we found that RWJ56110 and the anti-PAR1 significantly decreased lung edema, pulmonary microvascular permeability, protein exudation, and leukocytes infiltrations in heatstroke mice. Additionally, XBJ was found to suppress PAR1-moesin signal pathway and confer protective effects on maintaining endothelial barrier function both in vitro and in vivo heat-stressed model, similar to those observed above with the inhibition of PAR1. These results suggest that PAR1 is a potential therapeutic target in heatstroke.	[Xu, Qiulin; Su, Lei] Guangzhou Mil Command, Gen Hosp, Dept ICU, Key Lab Trop Zone Trauma Care & Tissue Repair PLA, Guangzhou, Guangdong, Peoples R China; [Xu, Qiulin] Huabo Biopharmaceut Res Inst, Postdoctoral Workstn, Guangzhou, Guangdong, Peoples R China; [Liu, Jingxian; Liu, Yanan] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Wang, Zhenglian; Zhou, Gengbiao] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, Peoples R China; [Guo, Xiaohua; Huang, Qiaobing] Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Southern Medical University - China; Guangzhou University of Chinese Medicine; Southern Medical University - China	Huang, QB (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	bing@smu.edu.cn; slei_icu@163.com			Natural Science Foundation of Guangdong Province, China [S2013040015661]; China Postdoctoral Science Foundation [2014M552180]; National Natural Science Foundation of China [31300950]; Project of Medical Research of People's Liberation Army [BWS12J108]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Medical Research of People's Liberation Army	This work was supported by the PhD Start-up Fund of Natural Science Foundation of Guangdong Province, China (S2013040015661, http://pro.gdstc.gov.cn/egrantweb/), China Postdoctoral Science Foundation(2014M552180, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx), National Natural Science Foundation of China (31300950, http://www.nsfc.gov.cn/), and Project of Medical Research of People's Liberation Army (BWS12J108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adyshev DM, 2013, AM J PHYSIOL-LUNG C, V305, P1240, DOI 10.1152/ajplung.00355.2012; Asehnoune K, 2013, CRIT CARE, V17, DOI 10.1186/cc12502; Austin KM, 2013, BLOOD, V121, P431, DOI 10.1182/blood-2012-09-355958; Broquet A, 2014, CRIT CARE MED, V42, pE441, DOI 10.1097/CCM.0000000000000311; Chen Y, 2013, J TRADIT CHIN MED, V33, P243, DOI 10.1016/S0254-6272(13)60133-8; Chui A., 2014, PLACENTA; Dematte JE, 1998, ANN INTERN MED, V129, P173, DOI 10.7326/0003-4819-129-3-199808010-00001; Guo XH, 2009, AM J PHYSIOL-HEART C, V297, pH238, DOI 10.1152/ajpheart.00196.2009; Helwig BG, 2011, PHYSIOL GENOMICS, V43, P1096, DOI 10.1152/physiolgenomics.00076.2011; Hirano Katsuya, 2003, J Atheroscler Thromb, V10, P211; Jeon S, 2010, NEUROCHEM INT, V56, P810, DOI 10.1016/j.neuint.2010.03.005; Ji J, 2014, EXP THER MED, V7, P1745, DOI 10.3892/etm.2014.1639; Juncker-Jensen A, 2013, CANCER RES, V73, P4196, DOI 10.1158/0008-5472.CAN-12-4495; Kim HS, 2010, J NEUROCHEM, V113, P1565, DOI 10.1111/j.1471-4159.2010.06713.x; Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218; Li QQ, 2011, BRAIN RES, V1373, P1, DOI 10.1016/j.brainres.2010.12.032; Ng KY, 2004, J PHARM SCI-US, V93, P896, DOI 10.1002/jps.20015; Pirot N, 2014, AM J PHYSIOL-LUNG C, V306, pL775, DOI 10.1152/ajplung.00200.2013; SHARMA HS, 1990, ACT NEUR S, V51, P383; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Varghese GM, 2005, EMERG MED J, V22, P185, DOI 10.1136/emj.2003.009365; Wang JP, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-7; Wang LJ, 2012, ACTA DIABETOL, V49, P47, DOI 10.1007/s00592-011-0267-z; Wang LQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090472; WIJSMAN JA, 1993, ACTA NEUROPATHOL, V86, P49, DOI 10.1007/BF00454898; Zhang YL, 2013, J MOL MED, V91, P117, DOI 10.1007/s00109-012-0940-x	26	9	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118057	10.1371/journal.pone.0118057	http://dx.doi.org/10.1371/journal.pone.0118057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693178	gold, Green Submitted, Green Published			2022-12-27	WOS:000350061500092
J	Chao, CS; McKnight, KD; Cox, KL; Chang, AL; Kim, SK; Feldman, BJ				Chao, Christina S.; McKnight, Kristen D.; Cox, Kenneth L.; Chang, Anne L.; Kim, Seung K.; Feldman, Brian J.			Novel GATA6 Mutations in Patients with Pancreatic Agenesis and Congenital Heart Malformations	PLOS ONE			English	Article							NEONATAL DIABETES-MELLITUS; CHILD; DIFFERENTIATION; ASSOCIATION; PROMOTER; DELETION; DEFECTS; HERNIA; ROLES; PDX-1	Patients with pancreatic agenesis are born without a pancreas, causing permanent neonatal diabetes and pancreatic enzyme insufficiency. These patients require insulin and enzyme replacement therapy to survive, grow, and maintain normal blood glucose levels. Pancreatic agenesis is an uncommon condition but high-throughput sequencing methods provide a rare opportunity to identify critical genes that are necessary for human pancreas development. Here we present the clinical history, evaluation, and the genetic and molecular analysis from two patients with pancreatic agenesis. Both patients were born with intrauterine growth restriction, minor heart defects and neonatal diabetes. In both cases, pancreatic agenesis was confirmed by imaging studies. The patients are clinically stable with pancreatic enzymes and insulin therapy. In order identify the etiology for their disease, we performed whole exome sequencing on both patients. For each proband we identified a de novo heterozygous mutation in the GATA6 gene. GATA6 is a homeobox containing transcription factor involved in both early development of the pancreas and heart. In vitro functional analysis of one of the variants revealed that the mutation creates a premature stop codon in the coding sequence resulting in the production of a truncated protein with loss of activity. These results show how genetic mutations in GATA6 may lead to functional inactivity and pancreatic agenesis in humans.	[Chao, Christina S.; Cox, Kenneth L.; Feldman, Brian J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [McKnight, Kristen D.; Kim, Seung K.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Chang, Anne L.] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Kim, Seung K.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Feldman, Brian J.] Stanford Univ, Cardiovasc Inst, Sch Med, Stanford, CA 94305 USA; [Feldman, Brian J.] Stanford Univ, Program Regenerat Med, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	seungkim@stanford.edu; feldman@stanford.edu		Kim, Seung/0000-0001-6135-7810	National Institutes of Health, NIDDK, T32 fellowship [T32-DK007217]; Tashia and John Morgridge Endowed Postdoctoral Fellowship; Stanford CTSA [UL1 TR000093]; Child Health Research Institute at Stanford; Snyder; Child Health Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007217] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK, T32 fellowship; Tashia and John Morgridge Endowed Postdoctoral Fellowship; Stanford CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Child Health Research Institute at Stanford; Snyder; Child Health Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	C.S.C. was supported by a National Institutes of Health, NIDDK, T32 fellowship (T32-DK007217), the Tashia and John Morgridge Endowed Postdoctoral Fellowship, Child Health Research Institute, and the Stanford CTSA (UL1 TR000093). The research was supported by a grant from the Child Health Research Institute at Stanford to B.J.F., and by an award from the Snyder	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Allen HL, 2012, NAT GENET, V44, P20, DOI 10.1038/ng.1035; Ashraf A, 2005, PEDIATR DIABETES, V6, P239, DOI 10.1111/j.1399-543X.2005.00114.x; Balasubramanian M, 2010, AM J MED GENET A, V152A, P340, DOI 10.1002/ajmg.a.33194; Barbarini DS, 2009, PEDIATR DIABETES, V10, P487, DOI 10.1111/j.1399-5448.2009.00523.x; Baumeister FAM, 2005, KLIN PADIATR, V217, P76, DOI 10.1055/s-2004-822657; BINGHAM PM, 1988, TRENDS GENET, V4, P134, DOI 10.1016/0168-9525(88)90136-9; Bonnefond A, 2012, DIABETOLOGIA, V55, P2845, DOI 10.1007/s00125-012-2645-7; BRUCE MB, 1982, AUST NZ J SURG, V52, P313, DOI 10.1111/j.1445-2197.1982.tb05408.x; Carrasco M, 2012, J CLIN INVEST, V122, P3504, DOI 10.1172/JCI63240; Chen R, 2008, PEDIATRICS, V121, pE1541, DOI 10.1542/peds.2007-3543; D'Amato E, 2010, DIABETIC MED, V27, P1195, DOI 10.1111/j.1464-5491.2010.03046.x; De Franco E, 2013, DIABETES, V62, P993, DOI 10.2337/db12-0885; Decker K, 2006, DEV BIOL, V298, P415, DOI 10.1016/j.ydbio.2006.06.046; Eifes S, 2013, CLIN CASE REP, V1, P86, DOI 10.1002/ccr3.33; Giannattasio A, 2009, PEDIATRIC REP, V1, P20, DOI 10.4081/pr.2009.e6; Gurson C T, 1970, Helv Paediatr Acta, V25, P522; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nakao A, 2013, AJP REP, V3, P119, DOI 10.1055/s-0033-1353388; Offield MF, 1996, DEVELOPMENT, V122, P983; Samaee H, 2008, ARCH IRAN MED, V11, P335, DOI 08113/AIM.0018; Schwitzgebel VM, 2003, J CLIN ENDOCR METAB, V88, P4398, DOI 10.1210/jc.2003-030046; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Sferruzzi-Perri AN, 2013, CURR OPIN CLIN NUTR, V16, P298, DOI 10.1097/MCO.0b013e32835e3643; Shaw-Smith C, 2014, DIABETES; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Stanescu DE, 2014, PEDIATR DIABETES; Stingl H, 2002, J CLIN ENDOCR METAB, V87, P4678, DOI 10.1210/jc.2002-020036; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Suzuki S, 2014, AM J MED GENET A, V164, P476, DOI 10.1002/ajmg.a.36275; Taha D, 2008, PEDIATR DIABETES, V9, P240, DOI 10.1111/j.1399-5448.2007.00365.x; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Thomas IH, 2009, PEDIATR DIABETES, V10, P492, DOI 10.1111/j.1399-5448.2009.00526.x; Verwest AM, 2000, VIRCHOWS ARCH, V437, P680, DOI 10.1007/s004280000305; VOLDSGAARD P, 1994, ACTA PAEDIATR, V83, P791, DOI 10.1111/j.1651-2227.1994.tb13144.x; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352; Yamagata K, 2014, VITAM HORM, V95, P407, DOI 10.1016/B978-0-12-800174-5.00016-8; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	43	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118449	10.1371/journal.pone.0118449	http://dx.doi.org/10.1371/journal.pone.0118449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706805	Green Published, gold			2022-12-27	WOS:000350662100181
J	Jun, E; Kim, S; Kim, JH; Cha, K; So, IS; Son, HN; Lee, BH; Kim, K; Kwon, IC; Kim, SY; Kim, IS				Jun, Eunsung; Kim, Soyoun; Kim, Jong-Ho; Cha, Kiweon; So, In-Seop; Son, Hye-Nam; Lee, Byung-Heon; Kim, Kwangmeyung; Kwon, Ick Chan; Kim, Sang Yoon; Kim, In-San			Design of a Multicomponent Peptide-Woven Nanocomplex for Delivery of siRNA	PLOS ONE			English	Article							DE-NOVO PEPTIDE; STRUCTURE PREDICTION; INTRACELLULAR DELIVERY; MOLECULAR-DYNAMICS; ENDOSOMAL ESCAPE; INTERFERING RNA; CELLULAR UPTAKE; CANCER-THERAPY; PEP-FOLD; GENE	We developed and tested a multicomponent peptide-woven siRNA nanocomplex (PwSN) comprising different peptides designed for efficient cellular targeting, endosomal escape, and release of siRNA. To enhance tumor-specific cellular uptake, we connected an interleukin-4 receptor-targeting peptide (I4R) to a nine-arginine peptide (9r), yielding I4R-9r. To facilitate endosomal escape, we blended endosomolytic peptides into the I4R-9r to form a multicomponent nanocomplex. Lastly, we modified 9r peptides by varying the number and positions of positive charges to obtain efficient release of siRNA from the nanocomplex in the cytosol. Using this step-wise approach for overcoming the biological challenges of siRNA delivery, we obtained an optimized PwSN with significant biological activity in vitro and in vivo. Interestingly, surface plasmon resonance analyses and three-dimensional peptide models demonstrated that our designed peptide adopted a unique structure that was correlated with faster complex disassembly and a better gene-silencing effect. These studies further elucidate the siRNA nanocomplex delivery pathway and demonstrate the applicability of our stepwise strategy to the design of siRNA carriers capable of overcoming multiple challenges and achieving efficient delivery.	[Jun, Eunsung; Kim, Soyoun; So, In-Seop; Son, Hye-Nam; Lee, Byung-Heon] Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, Dept Biochem & Cell Biol, Daegu, South Korea; [Kim, Jong-Ho] Kyung Hee Univ, Coll Pharm, Dept Pharmaceut Sci, Seoul, South Korea; [Cha, Kiweon] Korea Ctr Dis Control & Prevent KCDC, Korea Natl Inst Hlth, Div High Risk Pathogen Res, Osong, Chungbuk, South Korea; [Jun, Eunsung; Kim, Kwangmeyung; Kwon, Ick Chan; Kim, Sang Yoon; Kim, In-San] Korea Inst Sci & Technol, Ctr Theragnosis, Biomed Res Inst, Seoul, South Korea; [Kim, Sang Yoon] Univ Ulsan, Coll Med, Dept Otolaryngol, Seoul, South Korea	Kyungpook National University; Kyung Hee University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Korea Institute of Science & Technology (KIST); University of Ulsan	Kim, IS (corresponding author), Korea Inst Sci & Technol, Ctr Theragnosis, Biomed Res Inst, Seoul, South Korea.	iskim14@kist.re.kr	김, 인산/I-8988-2014; Kim, In-San/D-3956-2017; Kim, Soyoun/Y-1276-2018; Kim, Kwangmeyung/ABB-2882-2021; KWON, ICK CHAN/AAS-4776-2020	KWON, ICK CHAN/0000-0003-1272-7074	National Research Foundation of Korea(NRF) - Korea government(MEST) [2010-0029206]; National Research Foundation of Korea( NRF) - Korea government [2014R1A5A2009242]; KIST Institutional Program [2E25000]	National Research Foundation of Korea(NRF) - Korea government(MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); National Research Foundation of Korea( NRF) - Korea government; KIST Institutional Program(Korea Institute of Science & Technology (KIST))	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MEST) (2010-0029206); by the National Research Foundation of Korea( NRF) grant funded by the Korea government (2014R1A5A2009242); by the KIST Institutional Program (Project No. 2E25000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi HM, 2012, BIOMATERIALS, V33, P2546, DOI 10.1016/j.biomaterials.2011.11.079; Beloor J, 2012, BIOMATERIALS, V33, P1640, DOI 10.1016/j.biomaterials.2011.11.008; Bruno K, 2011, ADV DRUG DELIVER REV, V63, P1210, DOI 10.1016/j.addr.2011.09.003; Choi KM, 2011, ACS NANO, V5, P8690, DOI 10.1021/nn202597c; Ding Y, 2012, BIOMATERIALS, V33, P8893, DOI 10.1016/j.biomaterials.2012.08.057; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Han L, 2012, ACS NANO, V6, P7340, DOI 10.1021/nn3024688; Nguyen J, 2012, ACCOUNTS CHEM RES, V45, P1153, DOI 10.1021/ar3000162; Jung HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040010; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kim JH, 2012, J CONTROL RELEASE, V157, P493, DOI 10.1016/j.jconrel.2011.09.070; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kwok A, 2011, NANOMED-NANOTECHNOL, V7, P210, DOI 10.1016/j.nano.2010.07.005; Kwon EJ, 2008, BIOCONJUGATE CHEM, V19, P920, DOI 10.1021/bc700448h; Kwon EJ, 2010, MOL PHARMACEUT, V7, P1260, DOI 10.1021/mp1000668; Kwon YJ, 2012, ACCOUNTS CHEM RES, V45, P1077, DOI 10.1021/ar200241v; Lee MY, 2011, ACS NANO, V5, P6138, DOI 10.1021/nn2017793; Lee SY, 2010, J CONTROL RELEASE, V141, P339, DOI 10.1016/j.jconrel.2009.10.007; Li X, 2013, BIOMATERIALS, V34, P1391, DOI 10.1016/j.biomaterials.2012.10.072; Lobovkina T, 2011, ACS NANO, V5, P9977, DOI 10.1021/nn203745n; Lundberg P, 2007, FASEB J, V21, P2664, DOI 10.1096/fj.06-6502com; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Nam JO, 2012, MOL CANCER RES, V10, P1010, DOI 10.1158/1541-7786.MCR-11-0600; Ouyang DF, 2010, J PHYS CHEM B, V114, P9220, DOI 10.1021/jp911906e; Ouyang DF, 2010, J PHYS CHEM B, V114, P9231, DOI 10.1021/jp911913c; Paredes-Gamero EJ, 2012, MOL PHARMACEUT, V9, P2686, DOI 10.1021/mp300251j; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Pulford B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011085; Ren Y, 2012, ACS NANO, V6, P8620, DOI 10.1021/nn301975s; SAHLIN S, 1983, J IMMUNOL METHODS, V60, P115, DOI 10.1016/0022-1759(83)90340-X; Sakurai Y, 2011, BIOMATERIALS, V32, P5733, DOI 10.1016/j.biomaterials.2011.04.047; Sethi D, 2012, BIOCONJUGATE CHEM, V23, P158, DOI 10.1021/bc2004507; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Strumberg D, 2012, INT J CLIN PHARM TH, V50, P76, DOI 10.5414/CPP50076; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; van Asbeck AH, 2013, ACS NANO, V7, P3797, DOI 10.1021/nn305754c; Vasumathi V, 2013, SOFT MATTER, V9, P1372, DOI 10.1039/c2sm26804c; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P758, DOI 10.1016/j.bbrc.2006.05.205; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu XL, 2010, BIOCONJUGATE CHEM, V21, P208, DOI 10.1021/bc9005283; Ye SF, 2012, NANOMED-NANOTECHNOL, V8, P833, DOI 10.1016/j.nano.2011.10.003	45	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118310	10.1371/journal.pone.0118310	http://dx.doi.org/10.1371/journal.pone.0118310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705892	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100165
J	Koroleva, A; Deiwick, A; Nguyen, A; Schlie-Wolter, S; Narayan, R; Timashev, P; Popov, V; Bagratashvili, V; Chichkov, B				Koroleva, Anastasia; Deiwick, Andrea; Nguyen, Alexander; Schlie-Wolter, Sabrina; Narayan, Roger; Timashev, Peter; Popov, Vladimir; Bagratashvili, Viktor; Chichkov, Boris			Osteogenic Differentiation of Human Mesenchymal Stem Cells in 3-D Zr-Si Organic-Inorganic Scaffolds Produced by Two-Photon Polymerization Technique	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; MEDICAL APPLICATIONS; STROMAL CELLS; BONE; EXPRESSION; POROSITY; CONTACT	Two-photon polymerization (2PP) is applied for the fabrication of 3-D Zr-Si scaffolds for bone tissue engineering. Zr-Si scaffolds with 150, 200, and 250 mu m pore sizes are seeded with human bone marrow stem cells (hBMSCs) and human adipose tissue derived stem cells (hASCs) and cultured in osteoinductive and control media for three weeks. Osteogenic differentiation of hASCs and hBMSCs and formation of bone matrix is comparatively analyzed via alkaline phosphatase activity (ALP), calcium quantification, osteocalcin staining and scanning electron microscopy (SEM). It is observed that the 150 mu m pore size Zr-Si scaffolds support the strongest matrix mineralization, as confirmed by calcium deposition. Analysis of ALP activity, osteocalcin staining and SEM observations of matrix mineralization reveal that mesenchymal stem cells cultured on 3-D scaffolds without osteogenic stimulation spontaneously differentiate towards osteogenic lineage. Nanoindentation measurements show that aging of the 2PP-produced Zr-Si scaffolds in aqueous or alcohol media results in an increase in the scaffold Young's modulus and hardness. Moreover, accelerated formation of bone matrix by hASCs is noted, when cultured on the scaffolds with lower Young's moduli and hardness values (non aged scaffolds) compared to the cells cultured on scaffolds with higher Young's modulus and hardness values (aged scaffolds). Presented results support the potential application of Zr-Si scaffolds for autologous bone tissue engineering.	[Koroleva, Anastasia; Deiwick, Andrea; Schlie-Wolter, Sabrina; Chichkov, Boris] Laser Zentrum Hannover, Nanotechnol Dept, Hannover, Germany; [Nguyen, Alexander; Narayan, Roger] N Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; [Timashev, Peter; Popov, Vladimir; Bagratashvili, Viktor] Inst Laser & Informat Technol, Moscow, Russia	University of North Carolina; North Carolina State University; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Koroleva, A (corresponding author), Laser Zentrum Hannover, Nanotechnol Dept, Hannover, Germany.	a.koroleva@lzh.de	Koroleva, Anastasia/J-6078-2015; Chichkov, Boris/M-4112-2015; Popov, Vladimir/AAA-7818-2019; Chichkov, Boris/ABG-9694-2020; Timashev, Peter/B-2375-2014	Koroleva, Anastasia/0000-0003-1937-1031; Chichkov, Boris/0000-0002-8129-7373; Chichkov, Boris/0000-0002-8129-7373; Timashev, Peter/0000-0001-7773-2435; Popov, Vladimir/0000-0002-9305-6964	Cluster of Excellence REBIRTH; Low Saxony Progect Biofabrication; Grant of the Government of the Russian Federation [14.B25.31.0019]; Div Of Chem, Bioeng, Env, & Transp Sys [1445727] Funding Source: National Science Foundation; Russian Science Foundation [14-25-00055] Funding Source: Russian Science Foundation	Cluster of Excellence REBIRTH; Low Saxony Progect Biofabrication; Grant of the Government of the Russian Federation; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Russian Science Foundation(Russian Science Foundation (RSF))	Funding from The Cluster of Excellence REBIRTH (http://www.rebirth-hannover.de), Low Saxony Progect Biofabrication for NIFE (http://biofabrication.info), and Grant of the Government of the Russian Federation for the Support of Scientific Investigations under the Supervision of Leading Scientists, Contract No. 14.B25.31.0019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt A, 2009, J TISSUE ENG REGEN M, V3, P54, DOI 10.1002/term.134; Bernhardt A, 2013, CLIN ORAL IMPLAN RES, V24, P441, DOI 10.1111/j.1600-0501.2011.02350.x; Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025; Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019; DORSHKIND K, 1993, BLOOD, V82, P38, DOI 10.1182/blood.V82.1.38.bloodjournal82138; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; GOLUB EE, 1992, BONE MINER, V17, P273, DOI 10.1016/0169-6009(92)90750-8; Gruene M, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/015005; Haslam G, 2000, CYTOTECHNOLOGY, V32, P63, DOI 10.1023/A:1008121125755; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104; Kufelt O, 2014, BIOMACROMOLECULES, V15, P650, DOI 10.1021/bm401712q; Lewandrowski KU, 2000, J BIOMAT SCI-POLYM E, V11, P879, DOI 10.1163/156856200744075; Li T, 2013, COMPARATIVE STUDIES, P1; Miller PR, 2011, AM CERAM SOC BULL, V90, P24; Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824; Moravec R, 2002, CYTOTOX ONE HOMOGENE, P15; Nguyen AK, 2013, REGEN MED, V8, P725, DOI 10.2217/rme.13.60; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; Oubaha M, 2011, J MATER SCI, V46, P400, DOI 10.1007/s10853-010-4853-1; Ovsianikov A, 2007, APPL SURF SCI, V253, P6599, DOI 10.1016/j.apsusc.2007.01.058; Ovsianikov A, 2011, ACTA BIOMATER, V7, P967, DOI 10.1016/j.actbio.2010.10.023; Ovsianikov A., 2008, Laser Chemistry, DOI 10.1155/2008/493059; Ovsianikov A, 2012, EXPERT REV MED DEVIC, V9, P613, DOI [10.1586/ERD.12.48, 10.1586/erd.12.48]; Ovsianikov A, 2008, ACS NANO, V2, P2257, DOI 10.1021/nn800451w; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Psycharakis S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045008; Raimondi MT, 2013, ACTA BIOMATER, V9, P4579, DOI 10.1016/j.actbio.2012.08.022; Raimondi MT, 2012, J APPL BIOMATER FUNC, V10, P56, DOI 10.5301/JABFM.2012.9278; Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Skarmoutsou A, 2013, J MECH BEHAV BIOMED, V25, P48, DOI 10.1016/j.jmbbm.2013.05.003; Skoog SA, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4873688; Suga H, 2007, CYTOTHERAPY, V9, P738, DOI 10.1080/14653240701679873; Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006; Terzaki K, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045002; Terzaki K, 2013, J BIOMED MATER RES A, V101, P2283, DOI 10.1002/jbm.a.34516; ZOLLIKOFER CPE, 1995, IEEE COMPUT GRAPH, V15, P48, DOI 10.1109/38.469515; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	44	62	64	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118164	10.1371/journal.pone.0118164	http://dx.doi.org/10.1371/journal.pone.0118164			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706270	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100147
J	Lamatsch, DK; Adolfsson, S; Senior, AM; Christiansen, G; Pichler, M; Ozaki, Y; Smeds, L; Schartl, M; Nakagawa, S				Lamatsch, Dunja K.; Adolfsson, Sofia; Senior, Alistair M.; Christiansen, Guntram; Pichler, Maria; Ozaki, Yuichi; Smeds, Linnea; Schartl, Manfred; Nakagawa, Shinichi			A Transcriptome Derived Female-Specific Marker from the Invasive Western Mosquitofish (Gambusia affinis)	PLOS ONE			English	Article							SEX-CHROMOSOME EVOLUTION; LINKAGE MAP; CYNOGLOSSUS-SEMILAEVIS; DETERMINATION LOCUS; DETERMINING GENES; POECILIID FISHES; Y-CHROMOSOME; SEQUENCE; ALIGNMENT; HETEROGAMETY	Sex-specific markers are a prerequisite for understanding reproductive biology, genetic factors involved in sex differences, mechanisms of sex determination, and ultimately the evolution of sex chromosomes. The Western mosquitofish, Gambusia affinis, may be considered a model species for sex-chromosome evolution, as it displays female heterogamety (ZW/ZZ), and is also ecologically interesting as a worldwide invasive species. Here, de novo RNA-sequencing on the gonads of sexually mature G. affinis was used to identify contigs that were highly transcribed in females but not in males (i.e., transcripts with ovary-specific expression). Subsequently, 129 primer pairs spanning 79 contigs were tested by PCR to identify sex-specific transcripts. Of those primer pairs, one female-specific DNA marker was identified, Sanger sequenced and subsequently validated in 115 fish. Sequence analyses revealed a high similarity between the identified sex-specific marker and the 3' UTR of the aminomethyl transferase (amt) gene of the closely related platyfish (Xiphophorus maculatus). This is the first time that RNA-seq has been used to successfully characterize a sex-specific marker in a fish species in the absence of a genome map. Additionally, the identified sex-specific marker represents one of only a handful of such markers in fishes.	[Lamatsch, Dunja K.; Christiansen, Guntram; Pichler, Maria] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria; [Adolfsson, Sofia; Smeds, Linnea] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Senior, Alistair M.; Ozaki, Yuichi; Nakagawa, Shinichi] Univ Otago, Dept Zool, Dunedin, New Zealand; [Senior, Alistair M.] Univ Sydney, Charles Perkins Ctr, Sch Biol Sci, Sydney, NSW 2006, Australia; [Schartl, Manfred] Univ Wurzburg, Physiol Chem, Bioctr, D-97070 Wurzburg, Germany	University of Innsbruck; Uppsala University; University of Otago; University of Sydney; University of Wurzburg	Lamatsch, DK (corresponding author), Univ Innsbruck, Res Inst Limnol, Mondsee, Austria.	dunja.lamatsch@uibk.ac.at	Nakagawa, Shinichi/B-5571-2011; Senior, Alistair/AAH-8409-2021	Nakagawa, Shinichi/0000-0002-7765-5182; Schartl, Manfred/0000-0001-9882-5948; Smeds, Linnea/0000-0002-8415-9259	Marsden Fund (New Zealand) [UOO0812]; European Union Seventh Framework Programme [253511]; Hans Ellegren through a European Research Council; Leopold-Franzens-University of Innsbruck	Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); European Union Seventh Framework Programme(European Commission); Hans Ellegren through a European Research Council; Leopold-Franzens-University of Innsbruck	AS and SN were funded by the Marsden Fund (New Zealand, UOO0812). SA acknowledges funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 253511, and financial support from Hans Ellegren through a European Research Council Advanced Investigator Grant. Printing costs were partly covered by financial support of the Vice Rector for Research of the Leopold-Franzens-University of Innsbruck to DKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arthington A.H., 1989, P333; Bachtrog D., 2013, PRINCETON GUIDE EVOL, P387; Bachtrog D, 2011, TRENDS GENET, V27, P350, DOI 10.1016/j.tig.2011.05.005; BLACK DA, 1979, COPEIA, P509, DOI 10.2307/1443231; Brunelli JP, 2004, T AM FISH SOC, V133, P1247, DOI 10.1577/T03-049.1; Bull J.J., 1983, EVOLUTION SEX DETERM; Burridge CP, 2008, EVOLUTION, V62, P1484, DOI 10.1111/j.1558-5646.2008.00377.x; CAMPOS HH, 1971, COPEIA, P566; Charlesworth D, 2010, GENETICS, V186, P9, DOI 10.1534/genetics.110.117697; Chen N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-183; Chen SL, 2008, AQUACULTURE, V283, P7, DOI 10.1016/j.aquaculture.2008.07.015; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; CHEN TR, 1968, COPEIA, P70; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cui JZ, 2006, AQUACULTURE, V257, P30, DOI 10.1016/j.aquaculture.2006.03.003; da Silva EM, 2012, FISH PHYSIOL BIOCHEM, V38, P1487, DOI 10.1007/s10695-012-9638-9; Valentim FCD, 2013, GENETICA, V141, P381, DOI 10.1007/s10709-013-9737-2; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; Ezaz T, 2006, CURR BIOL, V16, pR736, DOI 10.1016/j.cub.2006.08.021; Graves JAM, 2014, NAT GENET, V46, P215, DOI 10.1038/ng.2903; Graves JM, 2014, CHROMOSOME RES, P1, DOI [10.1007/s10577-014-9413-0, DOI 10.1007/S10577-014-9413-0]; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; HAYNES JL, 1995, J FISH BIOL, V46, P1026, DOI 10.1111/j.1095-8649.1995.tb01407.x; Kazianis Steven, 2005, P381; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kenta T, 2008, MOL ECOL RESOUR, V8, P1230, DOI 10.1111/j.1755-0998.2008.02190.x; Keyvanshokooh S, 2010, AQUAC RES, V41, pe1, DOI 10.1111/j.1365-2109.2009.02463.x; Kikuchi K, 2013, DEV DYNAM, V242, P339, DOI 10.1002/dvdy.23927; Knapp R, 2011, BIOL LETTERS, V7, P150, DOI 10.1098/rsbl.2010.0514; Komak S, 2000, WILDLIFE RES, V27, P185, DOI 10.1071/WR99028; KOSSWIG C, 1964, EXPERIENTIA, V20, P190, DOI 10.1007/BF02135395; Lampert KP, 2010, CURR BIOL, V20, P1729, DOI 10.1016/j.cub.2010.08.029; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Ling N, 2004, NEW ZEAL J MAR FRESH, V38, P473, DOI 10.1080/00288330.2004.9517254; Liu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-58; LYDEARD C, 1995, SYST BIOL, V44, P221, DOI 10.1093/sysbio/44.2.221; LYDEARD C, 1995, CAN J ZOOL, V73, P213, DOI 10.1139/z95-025; Mank JE, 2009, SEX DEV, V3, P60, DOI 10.1159/000223071; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mcnair A, 2012, BIOL REV, V87, P900, DOI 10.1111/j.1469-185X.2012.00230.x; NAKAYAMA I, 1994, CHROMOSOMA, V103, P31, DOI 10.1007/BF00364723; NANAO K, 1994, GENOMICS, V19, P27, DOI 10.1006/geno.1994.1007; Ohno S., 1967, SEX CHROMOSOMES SEX; Olmstead AW, 2011, ENVIRON SCI TECHNOL, V45, P3090, DOI 10.1021/es103327r; Palaiokostas C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-566; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; RAB P, 1984, FOLIA ZOOL, V33, P229; Rondeau EB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-452; Rossler Johannes, 2009, PLOS GENET, P5; Sato T, 2001, GENETICA, V111, P71, DOI 10.1023/A:1013755701696; Schartl M, 2011, ECOLOGY EVOLUTION PO; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Senior AM, 2013, FISH FISH, V14, P60, DOI 10.1111/j.1467-2979.2011.00446.x; Shen XY, 2014, MOL ECOL RESOUR, V14, P622, DOI 10.1111/1755-0998.12212; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Sun FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068452; Takehana Y, 2007, CHROMOSOMA, V116, P463, DOI 10.1007/s00412-007-0110-z; Tao WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063604; Tripathi N, 2009, GENETICS, V182, P365, DOI 10.1534/genetics.108.098541; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vale L, 2014, MOL BIOL REP, V41, P1501, DOI 10.1007/s11033-013-2995-3; van Doorn GS, 2010, GENETICS, V186, P629, DOI 10.1534/genetics.110.118596; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Volff JN, 2001, GENETICA, V111, P101, DOI 10.1023/A:1013795415808; Williamson KS, 2005, T AM FISH SOC, V134, P1253, DOI 10.1577/T04-208.1; Woram RA, 2003, GENOME RES, V13, P272, DOI 10.1101/gr.578503; Xia XH, 2011, FISH PHYSIOL BIOCHEM, V37, P53, DOI 10.1007/s10695-010-9415-6; Zhuang ZM, 2006, J APPL ICHTHYOL, V22, P437, DOI 10.1111/j.1439-0426.2006.00765.x	73	23	23	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118214	10.1371/journal.pone.0118214	http://dx.doi.org/10.1371/journal.pone.0118214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25707007	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100154
J	Lee, PH; Liu, CM; Ho, TS; Tsai, YC; Lin, CC; Wang, YF; Chen, YL; Yu, CK; Wang, SM; Liu, CC; Shiau, AL; Lei, HY; Chang, CP				Lee, Pei-Huan; Liu, Chia-Ming; Ho, Tzong-Shiann; Tsai, Yi-Che; Lin, Chi-Cheng; Wang, Ya-Fang; Chen, Yuh-Ling; Yu, Chun-Keung; Wang, Shih-Min; Liu, Ching-Chuan; Shiau, Ai-Li; Lei, Huan-Yao; Chang, Chih-Peng			Enterovirus 71 Virion-Associated Galectin-1 Facilitates Viral Replication and Stability	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RIBOSOMAL ENTRY SITE; INFECTION; BINDS; VIRUS; TEMPERATURE; INTERACTS; RECEPTOR; PROTEIN; TAIWAN	Enterovirus 71 (EV71) infection causes a myriad of diseases from mild hand-foot-and-mouth disease or herpangina to fatal brain stem encephalitis complicated with pulmonary edema. Several severe EV71 endemics have occurred in Asia-Pacific region, including Taiwan, and have become a serious threat to children's health. EV71 infection is initiated by the attachment of the virion to the target cell surface. Although this process relies primarily upon interaction between viruses and cell surface receptors, soluble factors may also influence the binding of EV71 to host cells. Galectin-1 has been reported to participate in several virus infections, but is not addressed in EV71. In this study, we found that the serum levels of galectin-1 in EV71-infected children were higher than those in non-infected people. In EV71 infected cells, galectin-1 was found to be associated with the EV71 VP1 and VP3 via carbohydrate residues and subsequently released and bound to another cell surface along with the virus. EV71 propagated from galectin-1 knockdown SK-N-SH cells exhibited lower infectivity in cultured cells and less pathogenicity in mice than the virus propagated from parental cells. In addition, this galectin-1-free EV71 virus was sensitive to high temperature and lost its viability after long-term storage, which could be restored following supplement of recombinant galectin-1. Taken together, our findings uncover a new role of galectin-1 in facilitating EV71 virus infection.	[Lee, Pei-Huan; Liu, Chia-Ming; Tsai, Yi-Che; Yu, Chun-Keung; Shiau, Ai-Li; Lei, Huan-Yao; Chang, Chih-Peng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan; [Ho, Tzong-Shiann] Natl Cheng Kung Univ, Dept Emergency Med, Tainan 701, Taiwan; [Chen, Yuh-Ling] Natl Cheng Kung Univ, Coll Med, Dept Oral Med, Tainan 701, Taiwan; [Wang, Shih-Min; Liu, Ching-Chuan] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 701, Taiwan; [Ho, Tzong-Shiann; Lin, Chi-Cheng; Yu, Chun-Keung; Wang, Shih-Min; Liu, Ching-Chuan; Lei, Huan-Yao; Chang, Chih-Peng] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan; [Wang, Ya-Fang] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan 350, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Health Research Institutes - Taiwan	Chang, CP (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan.	cpchang@mail.ncku.edu.tw	Ho, Tzong-Shiann/M-9852-2019; Wang, Shih-Min/V-7886-2019; Chen, Yuh-Ling/AAS-7957-2021	Ho, Tzong-Shiann/0000-0003-2951-6679; Chang, Chih-Peng/0000-0002-0061-3478	National Science Council, Taiwan [NSC 100 -2320-B-006-017, NSC 102-2320-B-006 -024 -MY3]; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan	This work was supported by grant NSC 100 -2320-B-006-017 and NSC 102-2320-B-006 -024 -MY3 from the National Science Council, Taiwan, and Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; Bertrand I, 2012, J APPL MICROBIOL, V112, P1059, DOI 10.1111/j.1365-2672.2012.05267.x; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Chen LC, 2006, J MED VIROL, V78, P780, DOI 10.1002/jmv.20623; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Du N, 2014, J VIROL; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Elola MT, 2005, J BIOMED SCI, V12, P13, DOI 10.1007/s11373-004-8169-5; Garner OB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000993; HASHIMOTO I, 1983, ACTA NEUROPATHOL, V60, P266, DOI 10.1007/BF00691875; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Kung YH, 2010, VIROLOGY, V396, P1, DOI 10.1016/j.virol.2009.10.017; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Lin JY, 2009, NUCLEIC ACIDS RES, V37, P47, DOI 10.1093/nar/gkn901; Lin YW, 2009, EXP BIOL MED, V234, P1166, DOI 10.3181/0903-RM-116; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Liu SD, 2009, J IMMUNOL, V182, P5283, DOI 10.4049/jimmunol.0803811; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Overath T, 2012, MOL CELL PROTEOMICS, V11, P467, DOI 10.1074/mcp.M111.015966; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Phueaouan T, 2013, ONCOL REP, V30, P2929, DOI 10.3892/or.2013.2794; Rabinovich GA, 1999, CELL DEATH DIFFER, V6, P711, DOI 10.1038/sj.cdd.4400535; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11; St-Pierre C, 2010, METHOD ENZYMOL, V480, P267, DOI 10.1016/S0076-6879(10)80013-8; Su PY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-162; Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12; Tang WF, 2007, J BIOL CHEM, V282, P5888, DOI 10.1074/jbc.M611145200; Tsou YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077133; Vyakarnam A, 1997, MOL CELL BIOL, V17, P4730, DOI 10.1128/MCB.17.8.4730; Wang RYL, 2013, VIROLOGY, V443, P236, DOI 10.1016/j.virol.2013.05.001; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang ML, 2011, J VIROL, V85, P10010, DOI 10.1128/JVI.00301-11; Yang SL, 2011, J VIROL, V85, P11809, DOI 10.1128/JVI.00297-11	46	19	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116278	10.1371/journal.pone.0116278	http://dx.doi.org/10.1371/journal.pone.0116278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706563	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100029
J	Park, JI; Kim, M; Kim, H; An, JN; Lee, J; Yang, SH; Cho, JH; Kim, YL; Park, KS; Oh, YK; Lim, CS; Kim, DK; Kim, YS; Lee, JP				Park, Ji In; Kim, Myounghee; Kim, Ho; An, Jung Nam; Lee, Jeonghwan; Yang, Seung Hee; Cho, Jang-Hee; Kim, Yong-Lim; Park, Ki-Soo; Oh, Yun Kyu; Lim, Chun Soo; Kim, Dong Ki; Kim, Yon Su; Lee, Jung Pyo			Not Early Referral but Planned Dialysis Improves Quality of Life and Depression in Newly Diagnosed End Stage Renal Disease Patients: A Prospective Cohort Study in Korea	PLOS ONE			English	Article							SUBOPTIMAL INITIATION; PRACTICE PATTERNS; MENTAL-HEALTH; ASSOCIATION; MORTALITY; OUTCOMES; NEPHROLOGIST; IMPACT	Background Health-related quality of life (HRQOL) has recently become an important issue. It reportedly affects morbidity and mortality in patients with end-stage renal disease (ESRD). In this study, we investigated whether early referral and planned dialysis improve the HRQOL and depression of patients with ESRD. Methods We prospectively enrolled newly diagnosed patients with ESRD, from 31 hospitals in Korea, who completed questionnaires at 3 months after dialysis. We also got follow-up survey at 1 year after dialysis. To measure HRQOL and depression, Kidney Disease Quality of Life Short Form 36 (KDQOL-36) and Beck's Depression Inventory (BDI) were utilized. Results A total of 643 patients were analyzed. Referral type did not affect either KDQOL-36 or BDI scores. However, the planned dialysis group showed significantly better scores in 4 of 5 KDQOL-36 domains than did the unplanned group at 3 months after dialysis and partly, the effect was sustained for 1 year after dialysis. The benefit of planned dialysis was significant after adjusting for age, sex, type of dialysis, marital status, educational attainment, occupation, modified Charlson comorbidity index, albumin, and hemoglobin levels. BDI scores were also lower which indicate less depressive mood in planned dialysis group than those in unplanned group both at 3 months and 1 year after dialysis. Conclusions Not early referral but planned dialysis improved both the short-and long-term HRQOL and depression of patients with ESRD. Nephrologists should try to help patients to initiate dialysis in a planned manner.				nephrolee@gmail.com	Oh, Yun Kyu/J-5542-2012; Cho, Jang-hee/ABD-3534-2020; Kim, Ho/AAS-2402-2021; Lee, Jeonghwan/C-5214-2011; Kim, Dong Ki/J-5389-2012	Cho, Jang-hee/0000-0002-7031-5214; Kim, Ho/0000-0001-7472-3752; Lee, Jeonghwan/0000-0003-3199-635X; Kim, Dong Ki/0000-0002-5195-7852; Park, Ji In/0000-0003-4662-3759	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea. (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Buck J, 2007, NEPHROL DIAL TRANSPL, V22, P3240, DOI 10.1093/ndt/gfm387; Caskey FJ, 2003, NEPHROL DIAL TRANSPL, V18, P1330, DOI 10.1093/ndt/gfg156; Chilcot J, 2011, NEPHROL DIAL TRANSPL, V26, P1628, DOI 10.1093/ndt/gfq611; Choi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084257; Cukor D, 2006, NAT CLIN PRACT NEPHR, V2, P678, DOI 10.1038/ncpneph0359; Farrokhi F, 2014, AM J KIDNEY DIS, V63, P623, DOI 10.1053/j.ajkd.2013.08.024; Finkelstein FO, 2000, NEPHROL DIAL TRANSPL, V15, P1911, DOI 10.1093/ndt/15.12.1911; Hughes SA, 2013, NEPHROL DIAL TRANSPL, V28, P392, DOI 10.1093/ndt/gfs431; Kim DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055323; Kim JY, 2013, QUAL LIFE RES, V22, P753, DOI 10.1007/s11136-012-0203-x; Kimmel PL, 2000, KIDNEY INT, V57, P2093, DOI 10.1046/j.1523-1755.2000.00059.x; Knight EL, 2003, KIDNEY INT, V63, P1843, DOI 10.1046/j.1523-1755.2003.00931.x; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099460; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Loos C, 2003, J AM GERIATR SOC, V51, P229, DOI 10.1046/j.1532-5415.2003.51062.x; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; Marron B, 2006, NEPHROL DIAL TRANSPL, V21, pii51; Mendelssohn DC, 2011, NEPHROL DIAL TRANSPL, V26, P2959, DOI 10.1093/ndt/gfq843; Mendelssohn DC, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-22; Rayner HC, 2014, AM J KIDNEY DIS; Sesso R, 1997, NEPHROL DIAL TRANSPL, V12, P2111, DOI 10.1093/ndt/12.10.2111; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Yokoyama Y, 2009, NEPHRON CLIN PRACT, V113, pC191, DOI 10.1159/000232601	25	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117582	10.1371/journal.pone.0117582	http://dx.doi.org/10.1371/journal.pone.0117582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706954	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100103
J	Singh, S; Barr, H; Liu, YC; Robins, A; Heeb, S; Williams, P; Fogarty, A; Camara, M; Martinez-Pomares, L				Singh, Sonali; Barr, Helen; Liu, Yi-Chia; Robins, Adrian; Heeb, Stephan; Williams, Paul; Fogarty, Andrew; Camara, Miguel; Martinez-Pomares, Luisa			Granulocyte-Macrophage Colony Stimulatory Factor Enhances the Pro-Inflammatory Response of Interferon-gamma-Treated Macrophages to Pseudomonas aeruginosa Infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; GM-CSF; SUPPRESSOR-CELLS; LUNG INFECTION; T-CELLS; ALTERNATIVE ACTIVATION; CYTOKINE PROFILE; IMMUNE-RESPONSE; HOST RESPONSE; PHAGOCYTOSIS	Pseudomonas aeruginosa is an opportunistic pathogen that can cause severe infections at compromised epithelial surfaces, such those found in burns, wounds, and in lungs damaged by mechanical ventilation or recurrent infections, particularly in cystic fibrosis (CF) patients. CF patients have been proposed to have a Th2 and Th17-biased immune response suggesting that the lack of Th1 and/ or over exuberant Th17 responses could contribute to the establishment of chronic P. aeruginosa infection and deterioration of lung function. Accordingly, we have observed that interferon (IFN)-gamma production by peripheral blood mononuclear cells from CF patients positively correlated with lung function, particularly in patients chronically infected with P. aeruginosa. In contrast, IL-17A levels tended to correlate negatively with lung function with this trend becoming significant in patients chronically infected with P. aeruginosa. These results are in agreement with IFN-gamma and IL-17A playing protective and detrimental roles, respectively, in CF. In order to explore the protective effect of IFN-gamma in CF, the effect of IFN-gamma alone or in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), on the ability of human macrophages to control P. aeruginosa growth, resist the cytotoxicity induced by this bacterium or promote inflammation was investigated. Treatment of macrophages with IFN-gamma, in the presence and absence of GM-CSF, failed to alter bacterial growth or macrophage survival upon P. aeruginosa infection, but changed the inflammatory potential of macrophages. IFN-gamma caused up-regulation of monocyte chemoattractant protein-1 (MCP-1) and TNF-alpha and down-regulation of IL-10 expression by infected macrophages. GM-CSF in combination with IFN-gamma promoted IL-6 production and further reduction of IL-10 synthesis. Comparison of TNF-alpha vs. IL-10 and IL-6 vs. IL-10 ratios revealed the following hierarchy in regard to the pro-inflammatory potential of human macrophages infected with P. aeruginosa: untreated < treated with GM-CSF < treated with IFN-gamma < treated with GM-CSF and IFN-gamma.				luisa.martinez-pomares@nottingham.ac.uk; miguel.camara@nottingham.ac.uk	Williams, Paul/P-5224-2019; Heeb, Stephan/AGD-5189-2022	Williams, Paul/0000-0002-1920-5036; Heeb, Stephan/0000-0002-5079-3622; Camara, Miguel/0000-0003-4585-7385; Singh, Sonali/0000-0003-0600-9084; Martinez-Pomares, Luisa/0000-0002-2331-127X	MRC Biomarkers project [G0801558]; NABATIVI FP7-HEALTH REF; University of Nottingham FRSG Research Enhancement Fund; University of Nottingham Overseas Research Scholarship;  [223670]; MRC [G0801558] Funding Source: UKRI; Medical Research Council [G0801558] Funding Source: researchfish; National Institute for Health Research [CL-2011-12-501] Funding Source: researchfish	MRC Biomarkers project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NABATIVI FP7-HEALTH REF; University of Nottingham FRSG Research Enhancement Fund; University of Nottingham Overseas Research Scholarship; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the MRC Biomarkers project Ref. G0801558 to AF, MC and PW, for providing CF patient samples; NABATIVI FP7-HEALTH REF; 223670 project; University of Nottingham FRSG Research Enhancement Fund. SS received a University of Nottingham Overseas Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauermeister K, 1998, NEPHROL DIAL TRANSPL, V13, P1412, DOI 10.1093/ndt/13.6.1412; Bayes HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090263; Brazova J, 2005, CLIN IMMUNOL, V115, P210, DOI 10.1016/j.clim.2005.01.013; Britigan BE, 2000, INFECT IMMUN, V68, P1271, DOI 10.1128/IAI.68.3.1271-1275.2000; CEUPPENS JL, 1988, J IMMUNOL, V141, P3868; Chan YR, 2013, J ALLERGY CLIN IMMUN, V131, P1117, DOI 10.1016/j.jaci.2012.05.036; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cohen TS, 2013, J CLIN INVEST, V123, P1630, DOI 10.1172/JCI66142; Decraene A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-177; del Fresno C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002667; Dubin PJ, 2007, INFLAMM RES, V56, P221, DOI 10.1007/s00011-007-6187-2; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Han YL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035506, 10.1371/journal.pone.0048966]; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hayworth JL, 2012, IMMUNOL CELL BIOL, V90, P699, DOI 10.1038/icb.2011.90; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Heslet L, 2012, J INFLAMM RES, V5, P19, DOI 10.2147/JIR.S22986; Hirahara K, 2013, J ALLERGY CLIN IMMUN, V131, P1276, DOI 10.1016/j.jaci.2013.03.015; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johansen HK, 1996, CLIN EXP IMMUNOL, V103, P212, DOI 10.1046/j.1365-2249.1996.d01-618.x; Kamei A, 2013, J INFECT DIS, V207, P39, DOI 10.1093/infdis/jis657; Kannan S, 2008, J IMMUNOL, V180, P2396, DOI 10.4049/jimmunol.180.4.2396; Kushwah R, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-138; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Lehtonen A, 2002, J LEUKOCYTE BIOL, V71, P511; Limoli DH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004083; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moser C, 1997, APMIS, V105, P838, DOI 10.1111/j.1699-0463.1997.tb05092.x; Moser C, 2005, APMIS, V113, P400, DOI 10.1111/j.1600-0463.2005.apm_142.x; Moser C, 2000, APMIS, V108, P329, DOI 10.1034/j.1600-0463.2000.d01-64.x; Murphy BS, 2008, J ANTIMICROB CHEMOTH, V61, P554, DOI 10.1093/jac/dkn007; Murphy BS, 2010, J CYST FIBROS, V9, P314, DOI 10.1016/j.jcf.2010.04.006; Piper C, 2014, ARTHRITIS RHEUMATOL, V66, P1955, DOI 10.1002/art.38647; Power MR, 2007, J IMMUNOL, V178, P3170, DOI 10.4049/jimmunol.178.5.3170; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Recalcati S, 2012, SEMIN IMMUNOL, V24, P393, DOI 10.1016/j.smim.2013.01.001; Rieber N, 2013, J IMMUNOL, V190, P1276, DOI 10.4049/jimmunol.1202144; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schultz MJ, 2003, INFECT IMMUN, V71, P1630, DOI 10.1128/IAI.71.4.1630-1634.2003; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; SPEERT DP, 1991, INFECT IMMUN, V59, P1893, DOI 10.1128/IAI.59.6.1893-1898.1991; SPEERT DP, 1992, J CLIN INVEST, V90, P1085, DOI 10.1172/JCI115924; SPEERT DP, 1988, J CLIN INVEST, V82, P872, DOI 10.1172/JCI113692; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; Verschoor CP, 2013, J LEUKOCYTE BIOL, V93, P633, DOI 10.1189/jlb.0912461; Vogt G, 2011, J CLIN INVEST, V121, P3889, DOI 10.1172/JCI57235	63	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117447	10.1371/journal.pone.0117447	http://dx.doi.org/10.1371/journal.pone.0117447			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706389	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100088
J	Boivin, V; Beyersdorf, N; Palm, D; Nikolaev, VO; Schlipp, A; Muller, J; Schmidt, D; Kocoski, V; Kerkau, T; Hunig, T; Ertl, G; Lohse, MJ; Jahns, R				Boivin, Valerie; Beyersdorf, Niklas; Palm, Dieter; Nikolaev, Viacheslav O.; Schlipp, Angela; Mueller, Justus; Schmidt, Doris; Kocoski, Vladimir; Kerkau, Thomas; Huenig, Thomas; Ertl, Georg; Lohse, Martin J.; Jahns, Roland			Novel Receptor-Derived Cyclopeptides to Treat Heart Failure Caused by Anti-beta(1)-Adrenoceptor Antibodies in a Human-Analogous Rat Model	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; PROTEIN-COUPLED-RECEPTOR; 2ND EXTRACELLULAR LOOP; FAILING HUMAN HEART; BETA(1)-ADRENERGIC RECEPTORS; AUTOIMMUNE-DISEASE; CARDIAC AUTOANTIBODIES; CLINICAL CARDIOLOGY; PLASMA-CELLS; IN-VIVO	Despite recent therapeutic advances the prognosis of heart failure remains poor. Recent research suggests that heart failure is a heterogeneous syndrome and that many patients have stimulating auto-antibodies directed against the second extracellular loop of the beta(1) adrenergic receptor (beta(1)EC2). In a human-analogous rat model such antibodies cause myocyte damage and heart failure. Here we used this model to test a novel antibody-directed strategy aiming to prevent and/or treat antibody-induced cardiomyopathy. To generate heart failure, we immunised n = 76/114 rats with a fusion protein containing the human beta(1)EC2 (amino-acids 195-225) every 4 weeks; n = 38/114 rats were control-injected with 0.9% NaCl. Intravenous application of a novel cyclic peptide mimicking beta(1)EC2 (beta(1)EC2-CP, 1.0 mg/kg every 4 weeks) or administration of the beta(1)-blocker bisoprolol (15 mg/kg/day orally) was initiated either 6 weeks (cardiac function still normal, prevention-study, n = 24 (16 treated vs. 8 untreated)) or 8.5 months after the 1st immunisation (onset of cardiomyopathy, therapy-study, n = 52 (40 treated vs. 12 untreated)); n = 8/52 rats from the therapy-study received beta(1)EC2-CP/bisoprolol co-treatment. We found that beta(1)EC2-CP prevented and (alone or as add-on drug) treated antibody-induced cardiac damage in the rat, and that its efficacy was superior to mono-treatment with bisoprolol, a standard drug in heart failure. While bisoprolol mono-therapy was able to stop disease-progression, beta(1)EC2-CP mono-therapy -or as an add-on to bisoprolol-almost fully reversed antibody-induced cardiac damage. The cyclo-peptide acted both by scavenging free anti-beta(1)EC2-antibodies and by targeting beta(1)EC2-specific memory B-cells involved in antibody-production. Our model provides the basis for the clinical translation of a novel double-acting therapeutic strategy that scavenges harmful anti-beta(1)EC2-antibodies and also selectively depletes memory B-cells involved in the production of such antibodies. Treatment with immuno-modulating cyclopeptides alone or as an add-on to beta(1)-blockade represents a promising new therapeutic option in immune-mediated heart failure.	[Boivin, Valerie; Nikolaev, Viacheslav O.; Schlipp, Angela; Lohse, Martin J.; Jahns, Roland] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Boivin, Valerie; Palm, Dieter; Schlipp, Angela; Lohse, Martin J.; Jahns, Roland] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Beyersdorf, Niklas; Schmidt, Doris; Kocoski, Vladimir; Kerkau, Thomas; Huenig, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-97070 Wurzburg, Germany; [Mueller, Justus] Univ Wurzburg, Inst Pathol, D-97070 Wurzburg, Germany; [Boivin, Valerie; Ertl, Georg; Lohse, Martin J.; Jahns, Roland] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr CHFC, Wurzburg, Germany; [Schlipp, Angela] Univ Munchen LMU, Lehrstuhl Anat 1, Munich, Germany	University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Munich	Boivin, V (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany.	valerie.jahns@toxi.uni-wuerzburg.de	Nikolaev, Vyacheslav/AAT-7746-2020; Kerkau, Thomas/ABE-8007-2020; Lohse, Martin J/A-7160-2012; Beyersdorf, Niklas/S-3845-2016	Lohse, Martin J/0000-0002-0599-3510; Beyersdorf, Niklas/0000-0002-9236-5415	German Research Foundation ("Deutsche Forschungs-gemeinschaft") [Ja 706/2-4]; Interdisciplinary Center for Clinical Research (IZKF) Wurzburg [A-52]; German Ministry of Research and Education ("Bundesministerium fur Bildung und Forschung" (BMBF)) [GoBio-1, FKZ 0315031, FKZ 0315363, MolDiag FKZ 01ES0901]	German Research Foundation ("Deutsche Forschungs-gemeinschaft")(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) Wurzburg; German Ministry of Research and Education ("Bundesministerium fur Bildung und Forschung" (BMBF))(Federal Ministry of Education & Research (BMBF))	The present work was publicly funded by grants of the German Research Foundation ("Deutsche Forschungs-gemeinschaft" [Grant Ja 706/2-4]), by the Interdisciplinary Center for Clinical Research (IZKF) Wurzburg, [Project A-52], and by the German Ministry of Research and Education ("Bundesministerium fur Bildung und Forschung" (BMBF) [Grants GoBio-1, FKZ 0315031, FKZ 0315363, and MolDiag FKZ 01ES0901]). All authors have read and approved submission of the final manuscript.	Bornholz B, 2013, CARDIOVASC RES, V97, P472, DOI 10.1093/cvr/cvs350; Bristow MR, 2011, CIRC RES, V109, P1176, DOI 10.1161/CIRCRESAHA.111.245092; BRISTOW MR, 1993, J AM COLL CARDIOL, V22, pA61, DOI 10.1016/0735-1097(93)90465-D; Caforio ALP, 2007, CIRCULATION, V115, P76, DOI 10.1161/CIRCULATIONAHA.106.641472; Caforio ALP, 2002, EUR J HEART FAIL, V4, P411, DOI 10.1016/S1388-9842(02)00010-7; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; ENDO K, 1978, J CLIN ENDOCR METAB, V46, P734, DOI 10.1210/jcem-46-5-734; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Freedman NJ, 2004, J CLIN INVEST, V113, P1379, DOI 10.1172/JCI200421748; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; FU LX, 1993, J CLIN INVEST, V91, P1964, DOI 10.1172/JCI116416; Goser S, 2006, CIRCULATION, V114, P1693, DOI 10.1161/CIRCULATIONAHA.106.635664; Haberland A, 2011, CIRC RES, V109, P986, DOI 10.1161/CIRCRESAHA.111.253849; Hebert TE, 2007, CARDIOVASC RES, V76, P5, DOI 10.1016/j.cardiores.2007.07.011; Hershko AY, 2005, ANN NY ACAD SCI, V1051, P635, DOI 10.1196/annals.1361.108; Hoebeke J, 1996, INT J CARDIOL, V54, P103, DOI 10.1016/0167-5273(96)02586-7; Hoyer PF, 2004, TRANSPL P, V36, p197S, DOI 10.1016/j.transproceed.2004.01.051; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; Iwata M, 2001, CIRC RES, V88, P578, DOI 10.1161/01.RES.88.6.578; Iwata M, 2001, J AM COLL CARDIOL, V37, P418, DOI 10.1016/S0735-1097(00)01109-8; Jahns R, 1996, EUR J PHARMACOL, V316, P111, DOI 10.1016/S0014-2999(96)00654-1; Jahns R, 2000, J AM COLL CARDIOL, V36, P1280, DOI 10.1016/S0735-1097(00)00881-0; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Jahns R, 1999, CIRCULATION, V99, P649, DOI 10.1161/01.CIR.99.5.649; Jane-Wit D, 2007, CIRCULATION, V116, P399, DOI 10.1161/CIRCULATIONAHA.106.683193; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kaliyaperumal A, 1999, J IMMUNOL, V162, P5775; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156; Limas CJ, 2004, AM J CARDIOL, V93, P1189, DOI 10.1016/j.amjcard.2004.01.060; LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luppi P, 1998, CIRCULATION, V98, P777, DOI 10.1161/01.CIR.98.8.777; MacLellan WR, 2003, NAT MED, V9, P1455, DOI 10.1038/nm1203-1455; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; MAGNUSSON Y, 1989, CLIN EXP IMMUNOL, V78, P42; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; NAPARSTEK Y, 1993, ANNU REV IMMUNOL, V11, P79, DOI 10.1146/annurev.iy.11.040193.000455; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Nikolaev VO, 2007, J AM COLL CARDIOL, V50, P423, DOI 10.1016/j.jacc.2007.03.051; Noutsias M, 2011, EUR J HEART FAIL, V13, P611, DOI 10.1093/eurjhf/hfr014; Orciuolo E, 2007, BRIT J HAEMATOL, V138, P396, DOI 10.1111/j.1365-2141.2007.06659.x; Penela P, 2006, CARDIOVASC RES, V69, P46, DOI 10.1016/j.cardiores.2005.09.011; Rose NR, 2001, J CLIN INVEST, V107, P943, DOI 10.1172/JCI12673; Savelyeva N, 2005, P NATL ACAD SCI USA, V102, P10987, DOI 10.1073/pnas.0505108102; Schmidt J, 2003, J NEUROIMMUNOL, V140, P143, DOI 10.1016/S0165-5728(03)00182-6; SCHULZE K, 1990, CIRCULATION, V81, P959, DOI 10.1161/01.CIR.81.3.959; Staudt A, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.027; Stork S, 2006, AM HEART J, V152, P697, DOI 10.1016/j.ahj.2006.05.004; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; TZARTOS SJ, 1982, P NATL ACAD SCI-BIOL, V79, P188, DOI 10.1073/pnas.79.1.188; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; UNGERER M, 1994, CIRC RES, V74, P206, DOI 10.1161/01.RES.74.2.206; Wallukat G, 2002, NEW ENGL J MED, V347, P1806, DOI 10.1056/NEJM200211283472220; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	60	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117589	10.1371/journal.pone.0117589	http://dx.doi.org/10.1371/journal.pone.0117589			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700031	gold, Green Submitted, Green Published			2022-12-27	WOS:000349789800027
J	Fraser, SDS; Aitken, G; Taal, MW; Mindell, JS; Moon, G; Day, J; O'Donoghue, D; Roderick, PJ				Fraser, Simon D. S.; Aitken, Grant; Taal, Maarten W.; Mindell, Jennifer S.; Moon, Graham; Day, Julie; O'Donoghue, Donal; Roderick, Paul J.			Exploration of Chronic Kidney Disease Prevalence Estimates Using New Measures of Kidney Function in the Health Survey for England	PLOS ONE			English	Article							SERUM CYSTATIN-C; GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; UNITED-STATES; ALL-CAUSE; CREATININE; EQUATION; RISK; ASSOCIATION; DIET	Background Chronic kidney disease (CKD) diagnosis relies on glomerular filtration rate (eGFR) estimation, traditionally using the creatinine-based Modification of Diet in Renal Disease (MDRD) equation. The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation performs better in estimating eGFR and predicting mortality and CKD progression risk. Cystatin C is an alternative glomerular filtration marker less influenced by muscle mass. CKD risk stratification is improved by combining creatinine eGFR with cystatin C and urinary albumin to creatinine ratio (uACR). We aimed to identify the impact of introducing CKDEPI and cystatin C on the estimated prevalence and risk stratification of CKD in England and to describe prevalence and associations of cystatin C. Methods and Findings Cross sectional study of 5799 people in the nationally representative 2009 and 2010 Health Surveys for England. Primary outcome measures: prevalence of MDRD, CKDEPI and cystatin C-defined eGFR<60ml/min/1.73m(2); prevalence of CKD biomarker combinations (creatinine, cystatin C, uACR). Using CKDEPI instead of MDRD reduced the prevalence of eGFR<60ml/min/1.73m(2) from 6.0% (95% CI 5.4-6.6%) to 5.2% (4.7-5.8%) equivalent to around 340,000 fewer individuals in England. Those reclassified as not having CKD evidenced a lower risk profile. Prevalence of cystatin C eGFR<60ml/min/1.73m(2) was 7.7% and independently associated with age, lack of qualifications, being an ex-smoker, BMI, hypertension, and albuminuria. Measuring cystatin C in the 3.9% people with CKDEPI-defined eGFR<60ml/min/1.73m(2) without albuminuria (CKD Category G3a A1) reclassified about a third into a lower risk group with one of three biomarkers and two thirds into a group with two of three. Measuring cystatin C in the 6.7% people with CKDEPI eGFR >60ml/min/1.73m(2) with albuminuria (CKD Category G1-2) reclassified almost a tenth into a higher risk group. Limitations Cross sectional study, single eGFR measure, no measured ('true') GFR. Conclusions Introducing the CKDEPI equation and targeted cystatin C measurement reduces estimated CKD prevalence and improves risk stratification.	[Fraser, Simon D. S.; Roderick, Paul J.] Univ Southampton, Fac Med, Acad Unit Primary Care & Populat Sci, Southampton SO16 6YD, Hants, England; [Aitken, Grant; Moon, Graham] Univ Southampton, Fac Social & Human Sci, Southampton SO17 1BJ, Hants, England; [Taal, Maarten W.] Univ Nottingham, Div Med Sci & Grad Entry Med, Derby DE22 3DT, England; [Mindell, Jennifer S.] UCL, Res Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Day, Julie] Royal Victoria Infirm, Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Clin Biochem, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [O'Donoghue, Donal] Salford Royal NHS Fdn Trust, Renal Unit, Salford M6 8HD, Lancs, England	University of Southampton; University of Southampton; University of Nottingham; University of London; University College London; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Salford Royal NHS Foundation Trust	Fraser, SDS (corresponding author), Univ Southampton, Fac Med, Acad Unit Primary Care & Populat Sci, Southampton SO16 6YD, Hants, England.	s.fraser@soton.ac.uk	Mindell, Jennifer S/G-2241-2011; Fraser, Simon DS/HCH-3208-2022	Mindell, Jennifer S/0000-0002-7604-6131; Taal, Maarten/0000-0002-9065-212X; Fraser, Simon D/0000-0002-4172-4406	NHS Kidney Care; University of Southampton PhD scholarship; National Institute for Health Research [CL-2014-26-002] Funding Source: researchfish	NHS Kidney Care; University of Southampton PhD scholarship; National Institute for Health Research(National Institute for Health Research (NIHR))	Kidney function testing in the Health Surveys for England was funded by NHS Kidney Care. GA is funded by a University of Southampton PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, NATL I HLTH CLIN EXC; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Craig R, 2010, HLTH SURVEY ENGLAND; de Lusignan S, 2011, NEPHRON CLIN PRACT, V117, pC213, DOI 10.1159/000320341; Grams ME, 2013, AM J KIDNEY DIS, V62, P253, DOI 10.1053/j.ajkd.2013.03.013; Grubb A, 2005, CLIN CHEM, V51, P1420, DOI 10.1373/clinchem.2005.051557; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jordan H, 2004, J EPIDEMIOL COMMUN H, V58, P250, DOI 10.1136/jech.2003.013011; KDIGO. (Kidney Disease: Improving Global Outcomes) CKD Work Group, 2012, KIDNEY INT S, V2013, P150; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, P1; Kottgen A, 2008, AM J KIDNEY DIS, V51, P385, DOI 10.1053/j.ajkd.2007.11.019; KYHSEANDERSEN J, 1994, CLIN CHEM, V40, P1921; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mindell J., 2011, HLTH SURVEY ENGLAND; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; Muntner P, 2008, AM J MED, V121, P341, DOI 10.1016/j.amjmed.2008.01.003; National Institute for Health and Care Excellence, 2014, COST STAT CHRON KIDN; National Institute for Health and Care Excellence, 2014, CHRON KIDN DIS EARL; National Institute for Health and Clinical Excellence, 2006, NICE CLIN GUID 43 OB; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS17; NHS Employers, 2011, QUAL OUTC FRAM GUID; NHS Employers and British Medical Association, 2011, QUALITY AND OUTCOMES; NHS Health Check Programme, 2013, NHS HLTH CHECK PROGR; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; O'Callaghan CA, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000308; Office for National Statistics, 2012, 2011 CENS POP HOUS E; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Peralta CA, 2011, J AM SOC NEPHROL, V22, P147, DOI 10.1681/ASN.2010050483; Rule AD, 2013, CLIN J AM SOC NEPHRO, V8, P1414, DOI 10.2215/CJN.01240213; Servais A, 2008, AM J MED, V121, P426, DOI 10.1016/j.amjmed.2008.01.040; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Shlipak MG, 2011, CLIN CHEM, V57, P737, DOI 10.1373/clinchem.2010.158915; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Tangri N, 2013, ANN INTERN MED, V158, P596, DOI 10.7326/0003-4819-158-8-201304160-00004; Tangri N, 2011, KIDNEY INT, V79, P471, DOI 10.1038/ki.2010.431; The National Service Framework for Renal Services, 2005, CHRON KIDN DIS AC 2; Voskoboev NV, 2012, CLIN CHEM LAB MED, V50, P1591, DOI 10.1515/cclm-2012-0063; Voskoboev NV, 2011, CLIN CHEM, V57, P1209, DOI 10.1373/clinchem.2011.164798; Waheed S, 2013, CLIN J AM SOC NEPHRO, V8, P434, DOI 10.2215/CJN.04960512; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011	46	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118676	10.1371/journal.pone.0118676	http://dx.doi.org/10.1371/journal.pone.0118676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700182	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000349789800040
J	Ghisolfi, RD; da Silva, MP; dos Santos, FT; Servino, RN; Cirano, M; Thompson, FL				Ghisolfi, Renato David; da Silva, Meyre Pereira; dos Santos, Felipe Thomaz; Servino, Ricardo Nogueira; Cirano, Mauro; Thompson, Fabiano Lopes			Physical Forcing Mechanisms Controlling the Variability of Chlorophyll-a over the Royal-Charlotte and Abrolhos Banks-Eastern Brazilian Shelf	PLOS ONE			English	Article							CORAL-REEFS; SEASONAL-VARIATIONS; CONTINENTAL-SHELF; GLOBAL OCEAN; CIRCULATION; SEAWIFS; BLOOM; SEA; ALGORITHMS; PATTERNS	The Abrolhos Bank is part of the so-called Eastern Brazilian Shelf and is an area of high ecological and economic importance. The bank supports the largest and richest coral reefs in the South Atlantic and the largest rhodolith bed in the world. The spatial and seasonal variation of phytoplankton concentration, however, and the dynamic processes controlling that variability have remained poorly known. The present study investigates the seasonal and spatial distributions of chlorophyll-a (Chl-a) and water conditions by analyzing nine years (2003-2011) of level-3 Moderate-resolution Imaging Spectroradiometer (MODIS) derived Chl-a, National Centers for Environmental Prediction (NCEP)/ETA model-derived winds, NCEP model-derived heat fluxes, thermohaline and velocity results from the Hybrid Circulation Ocean Model (HYCOM) 1/12 degrees assimilated simulation. The results show that low/high concentrations occurred in austral spring-summer (wet season)/autumn-winter (dry season), with the highest values observed in the northern portion of the Abrolhos Bank. The typical meteorological and oceanographic conditions during austral summer favor the development of strong stratification. These conditions are 1) N-NE winds that favor an upwelling-type Ekman circulation; 2) coupling between the open ocean and the continental shelf through the western boundary current, which promotes cooler subsurface water to rise onto the shelf break; and 3) positive net heat flux. In contrast, the S-SE winds during autumn are in the opposite direction of the predominant current system over the Abrolhos Bank, thus reducing their speed and inducing an inverse shear. The warmer ocean and a somewhat cool and dry atmosphere promote the evaporative cooling of the surface layer. The above processes drive mixed layer cooling and deepening that reaches its maximum in winter. The blooming of phytoplankton in the Abrolhos Bank waters appears to be regulated by changes in the mixed layer depth, with Chl-a levels that start to increase during autumn and reach their peak in June-July.	[Ghisolfi, Renato David; da Silva, Meyre Pereira; dos Santos, Felipe Thomaz; Servino, Ricardo Nogueira] Univ Fed Espirito Santo, Oceanog & Ecol Dept, Vitoria, ES, Brazil; [Cirano, Mauro] Univ Fed Bahia, Inst Fis, Dept Fis Terra & Meio Ambiente, Rede Modelagem & Observ Oceanog REMO, Salvador, Bahia, Brazil; [Thompson, Fabiano Lopes] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil; [Thompson, Fabiano Lopes] Univ Fed Rio de Janeiro, COPPE, SAGE, Rio De Janeiro, RJ, Brazil	Universidade Federal do Espirito Santo; Universidade Federal da Bahia; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Ghisolfi, RD (corresponding author), Univ Fed Espirito Santo, Oceanog & Ecol Dept, Vitoria, ES, Brazil.	renato.ghisolfi@ufes.br	Cirano, Mauro/AAT-7082-2020; CIRANO, M/G-6392-2012	Cirano, Mauro/0000-0002-0789-1120; CIRANO, M/0000-0002-0789-1120; Thompson, Fabiano/0000-0002-7562-1683	Conservation International-Brazil; Conselho Nacional de Pesquisa e Inovacao [307240/2012-6]; Fundacao de Apoio a Pesquisa do Espirito SantoConselho Nacional de Pesquisa e Inovacao [55108385]	Conservation International-Brazil; Conselho Nacional de Pesquisa e Inovacao; Fundacao de Apoio a Pesquisa do Espirito SantoConselho Nacional de Pesquisa e Inovacao	This study was funded by Conservation International-Brazil. Mauro Cirano was supported by a grant (number 307240/2012-6) from Conselho Nacional de Pesquisa e Inovacao (www.cnpq.br) and Meyre P. da Silva has a research support from Fundacao de Apoio a Pesquisa do Espirito Santo (www.fapes.es.gov.br)/Conselho Nacional de Pesquisa e Inovacao (www.cnpq.br) (Grant number 55108385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AL, 2014, CONT SHELF RES, V85, P42, DOI 10.1016/j.csr.2014.04.013; Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; BLACK TL, 1994, WEATHER FORECAST, V9, P265, DOI 10.1175/1520-0434(1994)009<0265:TNNMEM>2.0.CO;2; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Brodie J, 2007, MAR FRESHWATER RES, V58, P342, DOI 10.1071/MF06236; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Castro BM, 2013, CONT SHELF RES, V70, P3, DOI 10.1016/j.csr.2013.09.025; Ciotti A.M., 2007, CARACTERISTICAS HIDR, P61, DOI DOI 10.3978/J.ISSN.2072-1439.2013.06.23; Ciotti A.M., 2010, J AQUAT SCI, V5, P236; Ciotti AM, 2000, 15 OC OPT S, P1; Costa OS, 2006, J MARINE SYST, V60, P63, DOI 10.1016/j.jmarsys.2005.11.006; Costa OS, 2000, HYDROBIOLOGIA, V440, P307, DOI 10.1023/A:1004104118208; Costa OS, 2008, J S AM EARTH SCI, V25, P257, DOI 10.1016/j.jsames.2007.10.002; Cupelo ACG, 2000, THESIS U SAO PAULO S; DANDONNEAU Y, 1984, DEEP-SEA RES, V31, P1377, DOI 10.1016/0198-0149(84)90078-5; Darecki M, 2004, REMOTE SENS ENVIRON, V89, P326, DOI 10.1016/j.rse.2003.10.012; Dierssen HM, 2010, P NATL ACAD SCI USA, V107, P17073, DOI 10.1073/pnas.0913800107; Dogliotti AI, 2009, INT J REMOTE SENS, V30, P251, DOI 10.1080/01431160802311133; Dutra LXC, 2006, J COASTAL RES, P633; Emery W.J., 2001, DATA ANAL METHODS PH; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Gaeta SA, 1999, ARCH FISH MAR RES, V47, P253; Kahru M, 2011, GLOBAL CHANGE BIOL, V17, P1733, DOI 10.1111/j.1365-2486.2010.02312.x; Kampel M, 2013, CARACTERIZACAO BLOOM; Knoppers B, 1999, ARCH FISH MAR RES, V47, P285; Knoppers B, 1999, GEO-MAR LETT, V19, P171, DOI 10.1007/s003670050106; KNOPPERS B, 2002, BIOL MARINHA, P353; Ku┬ppen, 1900, GEOGR Z, V6, P657, DOI DOI 10.2307/27803939; Leao ZMAN, 2005, MAR POLLUT BULL, V51, P599, DOI 10.1016/j.marpolbul.2005.04.024; Levitus S., 1982, CLIMATOLOGICAL ATLAS; Lopes RM, 2013, CONT SHELF RES, V70, P1, DOI 10.1016/j.csr.2013.11.008; Mahiny AS, 2013, INDIAN J GEO-MAR SCI, V42, P924; Mesinger F, 2012, METEOROL ATMOS PHYS, V116, P63, DOI 10.1007/s00703-012-0182-z; Morel A, 2007, BIOGEOSCIENCES, V4, P913, DOI 10.5194/bg-4-913-2007; Moura RL, 2013, CONT SHELF RES, V70, P109, DOI 10.1016/j.csr.2013.04.036; Navarro G, 2012, ADV SPACE RES, V50, P1164, DOI 10.1016/j.asr.2011.11.034; Nemeth RS, 1999, USVI B MAR SCI, V69, P759; Noernberg MA, 2007, ESTUDO VARABILIDADE; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; Pereira CS, 1988, REV BRAS METEOROL, V3, P233; PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Platt T, 2008, REMOTE SENS ENVIRON, V112, P3426, DOI 10.1016/j.rse.2007.10.016; Platt T, 2007, ICES J MAR SCI, V64, P863, DOI 10.1093/icesjms/fsm072; Platt T, 2009, ECOL MODEL, V220, P3057, DOI 10.1016/j.ecolmodel.2008.11.022; Racault MF, 2012, ECOL INDIC, V14, P152, DOI 10.1016/j.ecolind.2011.07.010; Ryan JP, 2001, DEEP-SEA RES PT II, V48, P159, DOI 10.1016/S0967-0645(00)00117-X; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; Soutelino RG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046276; Souza RB, 2007, CLIMATOLOGIA VARIABI; Susini-Ribeiro SMM, 1999, ARCH FISH MAR RES, V47, P271; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Teixeira CEP, 2013, CONT SHELF RES, V70, P13, DOI 10.1016/j.csr.2013.09.003; Tenenbaum D. R., 2007, SERIE DOCUMENTOS REV, P83, DOI [DOI 10.3978/J.ISSN.2072-1439.2013.06.23, 10.3978/j.issn.2072-1439.2013.06.23]; Tomczak M., 1994, REGIONAL OCEANOGRAPH; Wilkin JL, 2013, J GEOPHYS RES-OCEANS, V118, P2919, DOI 10.1002/jgrc.20223; Xu Y, 2011, CONT SHELF RES, V31, P1640, DOI 10.1016/j.csr.2011.05.019; Yamada K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024792; Yoder JA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001942; YODER JA, 1993, GLOBAL BIOGEOCHEM CY, V7, P181, DOI 10.1029/93GB02358; Yu LS, 2006, J CLIMATE, V19, P6153, DOI 10.1175/JCLI3970.1; Zar J, 2010, BIOESTATISTICAL ANAL	62	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117082	10.1371/journal.pone.0117082	http://dx.doi.org/10.1371/journal.pone.0117082			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700269	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800017
J	Paynter, L; Koehler, E; Howard, AG; Herring, AH; Gordon-Larsen, P				Paynter, Lauren; Koehler, Elizabeth; Howard, Annie Green; Herring, Amy H.; Gordon-Larsen, Penny			Characterizing Long-Term Patterns of Weight Change in China Using Latent Class Trajectory Modeling	PLOS ONE			English	Article							BODY-MASS INDEX; EARLY ADULTHOOD; SAS PROCEDURE; HEALTH; NUTRITION; OBESITY; URBANIZATION; TRANSITION; OVERWEIGHT; URBAN	Background Over the past three decades, obesity-related diseases have increased tremendously in China, and are now the leading causes of morbidity and mortality. Patterns of weight change can be used to predict risk of obesity-related diseases, increase understanding of etiology of disease risk, identify groups at particularly high risk, and shape prevention strategies. Methods Latent class trajectory modeling was used to compute weight change trajectories for adults aged 18 to 66 using the China Health and Nutrition Survey (CHNS) data (n = 12,611). Weight change trajectories were computed separately for males and females by age group at baseline due to differential age-related patterns of weight gain in China with urbanization. Generalized linear mixed effects models examined the association between weight change trajectories and baseline characteristics including urbanicity, BMI category, age, and year of study entry. Results Trajectory classes were identified for each of six age-sex subgroups corresponding to various degrees of weight loss, maintenance and weight gain. Baseline BMI status was a significant predictor of trajectory membership for all age-sex subgroups. Baseline overweight/ obesity increased odds of following 'initial loss with maintenance' trajectories. We found no significant association between baseline urbanization and trajectory membership after controlling for other covariates. Conclusion Trajectory analysis identified patterns of weight change for age by gender groups. Lack of association between baseline urbanization status and trajectory membership suggests that living in a rural environment at baseline was not protective. Analyses identified age-specific nuances in weight change patterns, pointing to the importance of subgroup analyses in future research.	[Paynter, Lauren; Gordon-Larsen, Penny] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA; [Koehler, Elizabeth; Howard, Annie Green; Herring, Amy H.] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Howard, Annie Green; Herring, Amy H.; Gordon-Larsen, Penny] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gordon-Larsen, P (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.	pglarsen@unc.edu		Herring, Amy/0000-0003-1552-8871	NIH: NIDDK [R21DK089306]; NHLBI [R01-HL108427]; NIH: NICHD [R01-HD30880]; Carolina Population Center [R24 HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, R01HD030880] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK089306] Funding Source: NIH RePORTER	NIH: NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH: NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Carolina Population Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH: NIDDK (R21DK089306) and NHLBI (R01-HL108427). NIH had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. This research uses data from the China Health and Nutrition Survey, funded by NIH: NICHD (R01-HD30880), although no direct support was received from the grant for this analysis. The authors also are grateful to the Carolina Population Center (R24 HD050924) for general support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Clarke P, 2009, INT J EPIDEMIOL, V38, P499, DOI 10.1093/ije/dyn214; Clarke PJ, 2010, AM J EPIDEMIOL, V172, P540, DOI 10.1093/aje/kwq156; Croudace TJ, 2003, AM J EPIDEMIOL, V157, P834, DOI 10.1093/aje/kwg049; Hamil-Luker J, 2004, SOC SCI RES, V33, P300, DOI 10.1016/S0049-089X(03)00060-7; Hu Y., 2003, CHINA REV, V3, P49, DOI DOI 10.2307/23461904; Hunter AM, 2010, J PSYCHIATR RES, V44, P90, DOI 10.1016/j.jpsychires.2009.06.006; *INT DIAB I, 2000, AS PAC PERSP RED OB; Jaacks LM, 2013, INT J EPIDEMIOL, V42, P828, DOI 10.1093/ije/dyt052; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Jun HJ, 2012, AM J PREV MED, V42, P348, DOI 10.1016/j.amepre.2011.11.011; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Li C, 2007, OBESITY SILVER SPRIN, V15, P76; Muthen B, 2002, BIOSTATISTICS, V3, P459, DOI 10.1093/biostatistics/3.4.459; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Ostbye T, 2011, INT J EPIDEMIOL, V40, P240, DOI 10.1093/ije/dyq142; Padmadas SS, 2006, PUBLIC HEALTH NUTR, V9, P204, DOI 10.1079/PHN2005842; Popkin BM, 2001, ASIA PAC J CLIN NUTR, V10, pS13, DOI 10.1046/j.1440-6047.2001.00211.x; POPKIN BM, 1995, AM J PUBLIC HEALTH, V85, P690, DOI 10.2105/AJPH.85.5.690; Popkin BM, 2010, INT J EPIDEMIOL, V19, P853; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Sotres-Alvarez D, 2013, AM J EPIDEMIOL, V177, P852, DOI 10.1093/aje/kws303; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x; Zhang KH, 2003, CHINA ECON REV, V14, P386, DOI 10.1016/j.chieco.2003.09.018	31	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0116190	10.1371/journal.pone.0116190	http://dx.doi.org/10.1371/journal.pone.0116190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CB7EQ	25699674	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800007
J	Revilla, TA; Encinas-Viso, F				Revilla, Tomas A.; Encinas-Viso, Francisco			Dynamical Transitions in a Pollination-Herbivory Interaction: A Conflict between Mutualism and Antagonism	PLOS ONE			English	Article							MANDUCA-SEXTA; POPULATION INTERACTIONS; DATURA-WRIGHTII; COMPETITION; STABILITY; TOBACCO; BENEFITS; DENSITY; NECTAR; GROWTH	Plant-pollinator associations are often seen as purely mutualistic, while in reality they can be more complex. Indeed they may also display a diverse array of antagonistic interactions, such as competition and victim-exploiter interactions. In some cases mutualistic and antagonistic interactions are carried-out by the same species but at different life-stages. As a consequence, population structure affects the balance of inter-specific associations, a topic that is receiving increased attention. In this paper, we developed a model that captures the basic features of the interaction between a flowering plant and an insect with a larval stage that feeds on the plant's vegetative tissues (e. g. leaves) and an adult pollinator stage. Our model is able to display a rich set of dynamics, the most remarkable of which involves victim-exploiter oscillations that allow plants to attain abundances above their carrying capacities and the periodic alternation between states dominated by mutualism or antagonism. Our study indicates that changes in the insect's life cycle can modify the balance between mutualism and antagonism, causing important qualitative changes in the interaction dynamics. These changes in the life cycle could be caused by a variety of external drivers, such as temperature, plant nutrients, pesticides and changes in the diet of adult pollinators.	[Revilla, Tomas A.] CNRS, Ctr Biodivers Theory & Modelling, Stn Ecol Expt, Moulis, France; [Encinas-Viso, Francisco] Univ Groningen, Ctr Ecol & Evolutionary Studies, Community & Conservat Ecol Grp, Groningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); University of Groningen	Revilla, TA (corresponding author), Acad Sci Czech Republic, Ctr Biol, Ceske Budejovice, Czech Republic.	tomrevilla@gmail.com	Revilla, Tomás Augusto/K-6470-2015; Encinas-Viso, Francisco/M-8408-2013	Revilla, Tomás Augusto/0000-0001-6772-3412; 	TULIP Laboratory of Excellence [ANR-10-LABX-41]; OCE postdoctoral fellowship at CSIRO	TULIP Laboratory of Excellence; OCE postdoctoral fellowship at CSIRO	TAR was supported by the TULIP Laboratory of Excellence (ANR-10-LABX-41). FEV was supported by the OCE postdoctoral fellowship at CSIRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1987, OECOLOGIA, V73, P272, DOI 10.1007/BF00377518; Adler LS, 2004, ECOLOGY, V85, P1519, DOI 10.1890/03-0409; Alarcon R, 2008, ECOL ENTOMOL, V33, P503, DOI 10.1111/j.1365-2311.2008.00996.x; Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Altermatt F, 2011, AM NAT, V178, P372, DOI 10.1086/661248; BALDWIN IT, 1988, OECOLOGIA, V77, P378, DOI 10.1007/BF00378046; Barron-Gafford GA, 2012, PHOTOSYNTH RES, V113, P249, DOI 10.1007/s11120-012-9741-x; Bonhomme R, 2000, EUR J AGRON, V13, P1, DOI 10.1016/S1161-0301(00)00058-7; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Bronstein JL, 2009, ANN BOT-LONDON, V103, P1435, DOI 10.1093/aob/mcp053; CAMPBELL CD, 1991, J ECON ENTOMOL, V84, P1662, DOI 10.1093/jee/84.6.1662; Case T. J, 2000, ILLUSTRATED GUIDE TH; DEV S, 1986, Proceedings of the Indian National Science Academy Part B Biological Sciences, V52, P17; Eaton J. W., 2008, GNU OCTAVE MANUAL VE; Encinas-Viso F, 2014, J THEOR BIOL, V352, P24, DOI 10.1016/j.jtbi.2014.02.030; Ermentrout B, 2003, XPPAUT 5 41 DIFFEREN; Fagan WF, 2014, THEOR ECOL-NETH, V7, P289, DOI 10.1007/s12080-014-0218-8; FREEDMAN HI, 1976, MATH BIOSCI, V31, P207, DOI 10.1016/0025-5564(76)90080-8; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hernandez MJ, 2009, J THEOR BIOL, V261, P107, DOI 10.1016/j.jtbi.2009.07.001; Hernandez MJ, 1998, P ROY SOC B-BIOL SCI, V265, P1433, DOI 10.1098/rspb.1998.0454; Holland JN, 2013, THEOR ECOL-NETH, V6, P475, DOI 10.1007/s12080-013-0181-9; Holland JN, 2010, ECOLOGY, V91, P1286, DOI 10.1890/09-1163.1; Holland JN, 2002, AM NAT, V159, P231, DOI 10.1086/338510; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HUNT WF, 1976, PLANT PHYSIOL, V57, P802, DOI 10.1104/pp.57.5.802; Irwin RE, 2010, CURR BIOL, V20, pR100, DOI 10.1016/j.cub.2009.12.005; Johnson CA, 2013, J THEOR BIOL, V328, P54, DOI 10.1016/j.jtbi.2013.03.016; Jones EI, 2012, ANN NY ACAD SCI, V1256, P66, DOI 10.1111/j.1749-6632.2012.06552.x; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Kessler D, 2010, CURR BIOL, V20, P237, DOI 10.1016/j.cub.2009.11.071; MATLAB, 2010, MATLAB VERS 7 14 0 R; MCFADDEN MW, 1968, J ECON ENTOMOL, V61, P352, DOI 10.1093/jee/61.2.352; Miller TEX, 2011, TRENDS ECOL EVOL, V26, P457, DOI 10.1016/j.tree.2011.05.005; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PRIMACK RB, 1985, ANNU REV ECOL SYST, V16, P15, DOI 10.1146/annurev.es.16.110185.000311; REINECKE JP, 1980, BIOL BULL-US, V158, P129, DOI 10.2307/1540764; Rinaldi S, 2000, ECOSYSTEMS, V3, P507, DOI 10.1007/s100210000045; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Rudolf VHW, 2011, ECOL LETT, V14, P75, DOI 10.1111/j.1461-0248.2010.01558.x; SCHOENER TW, 1978, THEOR POPUL BIOL, V13, P365, DOI 10.1016/0040-5809(78)90052-7; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Vasseur DA, 2005, AM NAT, V166, P184, DOI 10.1086/431285; Wackers FL, 2007, ANNU REV ENTOMOL, V52, P301, DOI 10.1146/annurev.ento.52.110405.091352; Wang YS, 2012, MATH BIOSCI ENG, V9, P431, DOI 10.3934/mbe.2012.9.431; Wolfram Research Inc., 2010, MATH VERS 8 0; Woods HA, 1999, PHYSIOL BIOCHEM ZOOL, V72, P445, DOI 10.1086/316678; ZIEGLER R, 1991, J COMP PHYSIOL B, V161, P125, DOI 10.1007/BF00262874	52	12	12	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117964	10.1371/journal.pone.0117964	http://dx.doi.org/10.1371/journal.pone.0117964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700003	Green Submitted, Green Published, gold			2022-12-27	WOS:000349789800032
J	Jiang, HJ; Chen, KH; Jaw, FS				Jiang, Han-Jia; Chen, Kuang-Hsuan; Jaw, Fu-Shan			Deep-Brain Electrical Microstimulation Is an Effective Tool to Explore Functional Characteristics of Somatosensory Neurons in the Rat Brain	PLOS ONE			English	Article							STIMULATION	In neurophysiology researches, peripheral stimulation is used along with recordings of neural activities to study the processing of somatosensory signals in the brain. However, limited precision of peripheral stimulation makes it difficult to activate the neuron with millisecond resolution and study its functional properties in this scale. Also, tissue/receptor damage that could occur in some experiments often limits the amount of responses that can be recorded and hence reduces data reproducibility. To overcome these limitations, electrical microstimulation (ES) of the brain could be used to directly and more precisely evoke neural responses. For this purpose, a deep-brain ES protocol for rat somatosensory relay neurons was developed in this study. Three male Wistar rats were used in the experiment. The ES was applied to the thalamic region responsive to hindpaw tactile stimulation (TS) via a theta glass microelectrode. The resulting ES-evoked cortical responses showed action potentials and thalamocortical relay latencies very similar to those evoked by TS. This result shows that the developed deep-brain ES protocol is an effective tool to bypass peripheral tissue for in vivo functional analysis of specific types of somatosensory neurons. This protocol could be readily applied in researches of nociception and other somatosensory systems to allow more extensive exploration of the neural functional networks.	[Jiang, Han-Jia; Chen, Kuang-Hsuan; Jaw, Fu-Shan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan	National Taiwan University	Jaw, FS (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	jaw@ntu.edu.tw		Jiang, Han-Jia/0000-0002-9633-2573	Ministry of Science and Technology [MOST 103-2221-E-002-014-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by Ministry of Science and Technology (http://www.most.gov.tw) under grant number MOST 103-2221-E-002-014-MY2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDTNIELSEN L, 1988, J NEUROL NEUROSUR PS, V51, P35, DOI 10.1136/jnnp.51.1.35; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Clark KL, 2011, P ROY SOC B-BIOL SCI, V278, P1121, DOI 10.1098/rspb.2010.2211; Histed MH, 2013, PROG NEUROBIOL, V103, P115, DOI 10.1016/j.pneurobio.2012.01.006; Krack P, 1999, CURR OPIN NEUROL, V12, P417, DOI 10.1097/00019052-199908000-00008; Le Bars D, 2001, PHARMACOL REV, V53, P597; McCreery DB, 2008, HEARING RES, V242, P64, DOI 10.1016/j.heares.2007.11.014; Neagu B, 2005, J NEUROSCI METH, V144, P153, DOI 10.1016/j.jneumeth.2004.10.021; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pikov V, 2008, P IEEE, V96, P1120, DOI 10.1109/JPROC.2008.922583; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Tsai MF, 2000, THESIS NATL TAIWAN U	12	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117289	10.1371/journal.pone.0117289	http://dx.doi.org/10.1371/journal.pone.0117289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695538	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300020
J	Kiss, B; Laszlo, JF; Szalai, A; Porszasz, R				Kiss, Balazs; Laszlo, Janos F.; Szalai, Andrea; Porszasz, Robert			Analysis of the Effect of Locally Applied Inhomogeneous Static Magnetic Field-Exposure on Mouse Ear Edema - A Double Blind Study	PLOS ONE			English	Article							PAIN; RESPONSES; CHANNELS	The effect static magnetic field (SMF)-exposure may exert on edema development has been investigated. A 6 h long whole-body (WBSMF) or local (LSMF), continuous, inhomogeneous SMF-exposure was applied on anesthetized mice in an in vivo model of mustard oil (MO)-induced ear edema. LSMF was applied below the treated ear, below the lumbar spine, or below the mandible. Ear thickness (v) was checked 8 times during the exposure period (at 0, 0.25, 1, 2, 3, 4, 5, and 6 h). The effect size of the applied treatment (eta) on ear thickness was calculated by the formula eta = 100% x (1-v(j)/v(i)), where group i is the control group and j is the treated group. Results showed that MO treatment in itself induced a significant ear edema with an effect of 9% (p< 0.001). WBSMF or LSMF on the spine in combination with MO treatment increased ear thickness even further resulting in an effect eta> 11% in both cases compared to SMF-exposure alone (p< 0.001). In these cases SMF-exposure alone without MO treatment reduced ear thickness significantly (p< 0.05), but within estimated experimental error. In cases of LSMF-exposure on the head, a significant SMF-exposure induced ear thickness reduction was found (eta = 5%, p< 0.05). LSMF-exposure on the spine affected ear thickness with and without MO treatment almost identically, which provides evidence that the place of local SMF action may be in the lower spinal region.	[Kiss, Balazs] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Kiss, Balazs] Semmelweis Univ, MTA SE Mol Biophys Res Grp, H-1085 Budapest, Hungary; [Laszlo, Janos F.] Univ Debrecen, Dept Comp Sci, Debrecen, Hungary; [Laszlo, Janos F.] E Comers LLC, Budapest, Hungary; [Szalai, Andrea; Porszasz, Robert] Univ Debrecen, Med & Hlth Sci Ctr, Dept Pharmacol & Pharmacotherapy, Debrecen, Hungary	Semmelweis University; Semmelweis University; University of Debrecen; University of Debrecen	Kiss, B (corresponding author), Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary.	balazs.kiss@eok.sote.hu	Kiss, Balazs/J-8371-2017; Porszasz, Robert/HGD-4008-2022	Kiss, Balazs/0000-0002-2347-5928; Porszasz, Robert/0000-0001-7910-9145				AlChaer ED, 1997, NEUROREPORT, V8, P3267, DOI 10.1097/00001756-199710200-00016; Alves LA, 2013, MOLECULES, V18, P10953, DOI 10.3390/molecules180910953; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Gabor Miklos, 2003, Methods Mol Biol, V225, P129; Gyires K, 2008, BIOELECTROMAGNETICS, V29, P456, DOI 10.1002/bem.20413; He YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054376; Holcomb RR, 1994, USA Patents, Patent No. [US 5312321 A, 5312321]; Jokela K, 2011, HEALTH PHYS, V100, P641, DOI 10.1097/HP.0b013e318202ec7e; Kiss B, 2013, BIOELECTROMAGNETICS, V34, P385, DOI 10.1002/bem.21781; Laszlo J, 2011, HORIZONS NEUROSCIENC, P106; Laszlo J, 2007, BIOELECTROMAGNETICS, V28, P615, DOI 10.1002/bem.20341; Laszlo J, 2009, LIFE SCI, V84, P12, DOI 10.1016/j.lfs.2008.10.009; Laszlo JF, 2012, INT J RADIAT BIOL, V88, P430, DOI 10.3109/09553002.2012.661916; LASZLO JF, 2010, PROGR ELECTROMAGNETI, V6, P307, DOI DOI 10.2529/PIERS091005062944; Li ZY, 2007, IN VIVO, V21, P61; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Morris C, 2005, BIOELECTROMAGNETICS, V26, P1, DOI 10.1002/bem.20047; Morris CE, 2008, AM J PHYSIOL-HEART C, V294, pH50, DOI 10.1152/ajpheart.00529.2007; Morris CE, 2007, J APPL PHYSIOL, V103, P629, DOI 10.1152/japplphysiol.01133.2006; Ohkubo C, 1997, IN VIVO, V11, P221; Okano H, 1999, BIOELECTROMAGNETICS, V20, P161, DOI 10.1002/(SICI)1521-186X(1999)20:3<161::AID-BEM2>3.0.CO;2-O; Okano H, 2005, BIOELECTROMAGNETICS, V26, P611, DOI 10.1002/bem.20144; Okano H, 2001, BIOELECTROMAGNETICS, V22, P408, DOI 10.1002/bem.68; Pereda J, 2006, BRIT J PHARMACOL, V149, P450, DOI 10.1038/sj.bjp.0706871; Rosen AD, 2003, BIOELECTROMAGNETICS, V24, P517, DOI 10.1002/bem.10124; Sandor K, 2007, LIFE SCI, V81, P97, DOI 10.1016/j.lfs.2007.04.029; Sprenger C, 2012, CURR BIOL, V22, P1019, DOI 10.1016/j.cub.2012.04.006; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vergallo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072374; Waltham MA, 2012, COMP ANATOMY HISTOLO	30	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118089	10.1371/journal.pone.0118089	http://dx.doi.org/10.1371/journal.pone.0118089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695832	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300040
J	Taylor, DL; Ante, VM; Bina, XR; Howard, MF; Bina, JE				Taylor, Dawn L.; Ante, Vanessa M.; Bina, X. Renee; Howard, Mondraya F.; Bina, James E.			Substrate-Dependent Activation of the Vibrio cholerae vexAB RND Efflux System Requires vexR	PLOS ONE			English	Article							FAMILY TRANSCRIPTIONAL REGULATOR; VIRULENCE FACTOR PRODUCTION; ESCHERICHIA-COLI; TETR-FAMILY; MULTIDRUG EFFLUX; CRYSTAL-STRUCTURE; BILE RESISTANCE; EPIPHYTIC FITNESS; EXPRESSION; PROTEIN	Vibrio cholerae encodes six resistance-nodulation-division (RND) efflux systems which function in antimicrobial resistance, virulence factor production, and intestinal colonization. Among the six RND efflux systems, VexAB exhibited broad substrate specificity and played a predominant role in intrinsic antimicrobial resistance. The VexAB system was encoded in an apparent three gene operon that included vexR; which encodes an uncharacterized TetR family regulator. In this work we examined the role of vexR in vexRAB expression. We found that VexR bound to the vexRAB promoter and vexR deletion resulted in decreased vexRAB expression and increased susceptibility to VexAB antimicrobial substrates. Substrate-dependent induction of vexRAB was dependent on vexR and episomal vexR expression provided a growth advantage in the presence of the VexAB substrate deoxycholate. The expression of vexRAB increased, in a vexR-dependent manner, in response to the loss of RND efflux activity. This suggested that VexAB may function to export intracellular metabolites. Support for this hypothesis was provided by data showing that vexRAB was upregulated in several metabolic mutants including tryptophan biosynthetic mutants that were predicted to accumulate indole. In addition, vexRAB was found to be upregulated in response to exogenous indole and to contribute to indole resistance. The collective results indicate that vexR is required for vexRAB expression in response to VexAB substrates and that the VexAB RND efflux system modulates the intracellular levels of metabolites that could otherwise accumulate to toxic levels.	[Taylor, Dawn L.; Ante, Vanessa M.; Bina, X. Renee; Howard, Mondraya F.; Bina, James E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bina, JE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	JBina@pitt.edu		Ante, Vanessa/0000-0002-7762-3930	National Institutes of Health (NIH) award [R01AI091845]; NIH training grant [T32AI049820]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049820, R01AI091845] Funding Source: NIH RePORTER	National Institutes of Health (NIH) award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) award R01AI091845. DLT and MFH were supported by NIH training grant T32AI049820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050562; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Alvarez-Ortega C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00007; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; Bina JE, 2006, ARCH MICROBIOL, V186, P171, DOI 10.1007/s00203-006-0133-5; Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001; Bina XR, 2008, INFECT IMMUN, V76, P3595, DOI 10.1128/IAI.01620-07; Bina XWR, 2009, J ANTIMICROB CHEMOTH, V63, P103, DOI 10.1093/jac/dkn466; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Cerda-Maira FA, 2008, J BACTERIOL, V190, P7441, DOI 10.1128/JB.00584-08; Chatterjee A, 2007, APPL ENVIRON MICROB, V73, P3684, DOI 10.1128/AEM.02445-06; Chattoraj P, 2011, J BACTERIOL, V193, P6605, DOI 10.1128/JB.06122-11; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Delmar JA, 2014, ANNU REV BIOPHYS, V43, P93, DOI 10.1146/annurev-biophys-051013-022855; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; Goulart CL, 2010, MICROBIOL-SGM, V156, P3011, DOI 10.1099/mic.0.043117-0; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hankins JV, 2012, P NATL ACAD SCI USA, V109, P8722, DOI 10.1073/pnas.1201313109; Hatzios SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043175; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Helling RB, 2002, J BACTERIOL, V184, P3699, DOI 10.1128/JB.184.13.3699-3703.2002; Hirano S, 2008, MICROBIOL-SGM, V154, P905, DOI 10.1099/mic.0.2007/014381-0; Hu B, 2012, J BACTERIOL, V194, P2802, DOI 10.1128/JB.00061-12; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; de Eugenio LI, 2010, ENVIRON MICROBIOL, V12, P207, DOI [10.1111/j.1462-2920.2009.02061.x, 10.1111/j.1462-2920.2010.02199.x]; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kawamura-Sato K, 1999, FEMS MICROBIOL LETT, V179, P345, DOI 10.1016/S0378-1097(99)00433-4; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; Mathur J, 2004, INFECT IMMUN, V72, P3577, DOI 10.1128/IAI.72.6.3577-3583.2004; Merrell DS, 2001, J BACTERIOL, V183, P2746, DOI 10.1128/JB.183.9.2746-2754.2001; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Morin CE, 2009, FEMS IMMUNOL MED MIC, V57, P69, DOI 10.1111/j.1574-695X.2009.00580.x; Mueller RS, 2007, J BACTERIOL, V189, P5348, DOI 10.1128/JB.01867-06; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Park H, 2011, J BACTERIOL, V193, P6288, DOI 10.1128/JB.05649-11; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Provenzano D, 2000, INFECT IMMUN, V68, P1491, DOI 10.1128/IAI.68.3.1491-1497.2000; Quinones B, 2004, MOL PLANT MICROBE IN, V17, P521, DOI 10.1094/MPMI.2004.17.5.521; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rosner JL, 2013, J BACTERIOL, V195, P1042, DOI 10.1128/JB.01996-12; Rosner JL, 2009, J BACTERIOL, V191, P5283, DOI 10.1128/JB.00507-09; Ruiz C, 2014, J ANTIMICROB CHEMOTH, V69, P390, DOI 10.1093/jac/dkt352; Sahota G, 2010, BIOINFORMATICS, V26, P2672, DOI 10.1093/bioinformatics/btq501; Schild S, 2007, CELL HOST MICROBE, V2, P264, DOI 10.1016/j.chom.2007.09.004; Slamti L, 2009, J BACTERIOL, V191, P5044, DOI 10.1128/JB.00406-09; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Taylor DL, 2014, INFECT IMMUN, V82, P2980, DOI 10.1128/IAI.00025-14; Taylor DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038208; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; Van Bambeke F, 2003, J ANTIMICROB CHEMOTH, V51, P1055, DOI 10.1093/jac/dkg224	64	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117890	10.1371/journal.pone.0117890	http://dx.doi.org/10.1371/journal.pone.0117890			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695834	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350062300032
J	Ueda, S; Nagano, Y; Kataoka, Y; Komatsu, T; Itioka, T; Shimizu-kaya, U; Inui, Y; Itino, T				Ueda, Shouhei; Nagano, Yusuke; Kataoka, Yowsuke; Komatsu, Takashi; Itioka, Takao; Shimizu-kaya, Usun; Inui, Yoko; Itino, Takao			Congruence of Microsatellite and Mitochondrial DNA Variation in Acrobat Ants (Crematogaster Subgenus Decacrema, Formicidae: Myrmicinae) Inhabiting Macaranga (Euphorbiaceae) Myrmecophytes	PLOS ONE			English	Article							ANTIHERBIVORE DEFENSE; SPECIES-SPECIFICITY; PLANT ASSOCIATION; INFERENCE; SELECTION; PARTNER; QUEENS; ADAPTATIONS; COEVOLUTION; HYMENOPTERA	A previously reported mitochondrial DNA (mtDNA) phylogeny of Crematogaster (subgenus Decacrema) ants inhabiting Macaranga myrmecophytes indicated that the partners diversified synchronously and their specific association has been maintained for 20 million years. However, the mtDNA clades did not exactly match morphological species, probably owing to introgressive hybridization among younger species. In this study, we determined the congruence between nuclear simple sequence repeat (SSR, also called microsatellite) genotyping and mtDNA phylogeny to confirm the suitability of the mtDNA phylogeny for inferring the evolutionary history of Decacrema ants. Analyses of ant samples from Lambir Hills National park, northeastern Borneo, showed overall congruence between the SSR and mtDNA groupings, indicating that mtDNA markers are useful for delimiting species, at least at the local level. We also found overall high host-plant specificity of the SSR genotypes of Decacrema ants, consistent with the specificity based on the mtDNA phylogeny. Further, we detected cryptic genetic assemblages exhibiting high specificity toward particular plant species within a single mtDNA clade. This finding, which may be evidence for rapid ecological and genetic differentiation following a host shift, is a new insight into the previously suggested long-term codiversification of Decacrema ants and Macaranga plants.	[Ueda, Shouhei; Nagano, Yusuke; Kataoka, Yowsuke; Komatsu, Takashi; Itino, Takao] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 3908621, Japan; [Itioka, Takao; Shimizu-kaya, Usun] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Itioka, Takao] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Inui, Yoko] Osaka Kyoiku Univ, Fac Educ, Dept Arts & Sci, Div Nat Sci, Kashiwara, Osaka 5828582, Japan; [Itino, Takao] Shinshu Univ, Inst Mt Sci, Matsumoto, Nagano 3908621, Japan	Shinshu University; Kyoto University; Kyoto University; Osaka University of Education; Shinshu University	Ueda, S (corresponding author), Shinshu Univ, Fac Sci, Dept Biol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	ueda32@shinshu-u.ac.jp	Ueda, Shouhei/AAI-6275-2020	Ueda, Shouhei/0000-0002-9051-5504	Japan Society for the Promotion of Science [22255001, 23770018]; Grants-in-Aid for Scientific Research [22255001] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (A), Grant Numbers 22255001 for T. Itino (URL: http://kaken.nii.ac.jp/d/p/22255001/2010/3/ja.en.html); the Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B), Grant Numbers 23770018 for SU (URL: http://kaken.nii.ac.jp/d/p/23770018/2011/1/ja.	Althoff DM, 2012, MOL PHYLOGENET EVOL, V62, P898, DOI 10.1016/j.ympev.2011.11.024; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Cook JM, 2010, ECOL ENTOMOL, V35, P54, DOI 10.1111/j.1365-2311.2009.01148.x; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; Davies SJ, 2001, EVOLUTION, V55, P1542, DOI 10.1111/j.0014-3820.2001.tb00674.x; Davies Stuart J., 2001, Harvard Papers in Botany, V6, P371; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Eck G, 2001, J CHEM ECOL, V27, P1979, DOI 10.1023/A:1012234702403; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Federle W, 2005, BIOL J LINN SOC, V84, P177, DOI 10.1111/j.1095-8312.2005.000423.x; Federle W, 1997, OECOLOGIA, V112, P217, DOI 10.1007/s004420050303; Federle W, 2002, OECOLOGIA, V132, P264, DOI 10.1007/s00442-002-0947-z; Feldhaar H, 2004, MOL ECOL NOTES, V4, P409, DOI 10.1111/j.1471-8286.2004.00668.x; Feldhaar H, 2003, INSECT SOC, V50, P9, DOI 10.1007/s000400300002; Feldhaar H, 2008, PHILOS T R SOC B, V363, P2891, DOI 10.1098/rstb.2008.0022; Feldhaar H, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P193, DOI 10.1007/978-3-642-12425-9_10; Fiala B, 1999, BIOL J LINN SOC, V66, P305, DOI 10.1006/bijl.1998.0279; FIALA B, 1989, OECOLOGIA, V79, P463, DOI 10.1007/BF00378662; FIALA B, 1990, INSECT SOC, V37, P212, DOI 10.1007/BF02224049; Frederickson ME, 2006, OECOLOGIA, V149, P418, DOI 10.1007/s00442-006-0460-x; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Grangier J, 2009, BIOL J LINN SOC, V97, P90, DOI 10.1111/j.1095-8312.2008.01188.x; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heckroth HP, 1998, J TROP ECOL, V14, P427, DOI 10.1017/S0266467498000327; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyodo F, 2011, INSECT SOC, V58, P417, DOI 10.1007/s00040-011-0159-9; Inui Y, 2001, J CHEM ECOL, V27, P2029, DOI 10.1023/A:1012290820150; Inui Y, 2007, J CHEM ECOL, V33, P2054, DOI 10.1007/s10886-007-9369-z; Itino T, 2001, ECOL RES, V16, P787, DOI 10.1046/j.1440-1703.2001.00442.x; Itino T, 2001, ECOL RES, V16, P765, DOI 10.1046/j.1440-1703.2001.00432.x; Itino T, 2001, ECOL RES, V16, P775, DOI 10.1046/j.1440-1703.2001.00433.x; Itino T, 2005, ECOL STU AN, V174, P172; Itioka T, 2000, BIOTROPICA, V32, P318, DOI 10.1111/j.1744-7429.2000.tb00475.x; Itioka T, 2005, ECOL STU AN, V174, P158; Jobb G, 2008, TREEFINDER VERSION O; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Jurgens A, 2006, BIOCHEM SYST ECOL, V34, P97, DOI 10.1016/j.bse.2005.08.005; Linnen CR, 2007, EVOLUTION, V61, P1417, DOI 10.1111/j.1558-5646.2007.00114.x; Morrison H., 1921, Philippine Journal of Science, V18, P637; Murase K, 2002, J ETHOL, V20, P19, DOI 10.1007/s10164-002-0049-8; Murase K, 2010, SOCIOBIOLOGY, V55, P883; Nomura M, 2000, ECOL RES, V15, P1, DOI 10.1046/j.1440-1703.2000.00318.x; Nomura M, 2011, PLANT ECOL, V212, P143, DOI 10.1007/s11258-010-9810-1; Pritchard JK, 2000, GENETICS, V155, P945; Quek SP, 2007, MOL ECOL, V16, P2045, DOI 10.1111/j.1365-294X.2007.03294.x; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Seppa P, 2011, MYRMECOL NEWS, V15, P31; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; Sota T, 2001, SYST BIOL, V50, P39, DOI 10.1080/713849547; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Ueda S, 2008, P ROY SOC B-BIOL SCI, V275, P2319, DOI 10.1098/rspb.2008.0573; Ueda S, 2010, POPUL ECOL, V52, P137, DOI 10.1007/s10144-009-0162-4; Whitmore T. C., 1969, Biological Journal of the Linnean Society, V1, P223, DOI 10.1111/j.1095-8312.1969.tb01821.x; Whitmore TC, 1975, KEW B ADDITIONAL SER, P140; Whitmore TC, 2008, GENUS MACARANGA PROD; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; YANG ZB, 1994, J MOL EVOL, V39, P105	65	6	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116602	10.1371/journal.pone.0116602	http://dx.doi.org/10.1371/journal.pone.0116602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692953	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500020
J	Zhang, J; Zhu, ZL; Liu, Y; Jin, XY; Xu, ZW; Yu, QY; Li, K				Zhang, Jun; Zhu, Zhenli; Liu, Yan; Jin, Xueyuan; Xu, Zhiwei; Yu, Qiuyan; Li, Ke			Diagnostic Value of Multiple Tumor Markers for Patients with Esophageal Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SERUM P53 ANTIBODIES; CARCINOEMBRYONIC ANTIGEN; ANTI-P53 ANTIBODIES; GASTROINTESTINAL CANCER; CLINICAL-EVALUATION; SYSTEMATIC REVIEWS; LYMPH-NODE; EPIDEMIOLOGY; METAANALYSIS	Background Various studies assessing the diagnostic value of serum tumormarkers in patients with esophageal cancer remain controversial. This study aims to comprehensively and quantitatively summarize the potential diagnostic value of 5 serum tumour markers in esophageal cancer. Methods We systematically searched PubMed, Embase, Chinese National Knowledge Infrastructure (CNKI) and Chinese Biomedical Database (CBM), through February 28, 2013, without language restriction. Studies were assessed for quality using QUADAS (quality assessment of studies of diagnostic accuracy). The positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were pooled separately and compared with overall accuracy measures using diagnostic odds ratios (DORs) and symmetric summary receiver operating characteristic (SROC) curves. Results Of 4391 studies initially identified, 44 eligible studies including five tumor markers met the inclusion criteria for the meta-analysis, while meta-analysis could not be conducted for 12 other tumor markers. Approximately 79.55% (35/44) of the included studies were of relatively high quality (QUADAS score >= 7). The summary estimates of the positive likelihood ratio (PLR), negative likelihood ratio (NLR) and diagnostic odds ratio (DOR) for diagnosing EC were as follows: CEA, 5.94/0.76/9.26; Cyfra21-1, 12.110.59/22.27; p53 antibody, 6.71/0.75/ 9.60; SCC-Ag, 7.66/0.68/12.41; and VEGF-C, 0.74/0.37/8.12. The estimated summary receiver operating characteristic curves showed that the performance of all five tumor markers was reasonable. Conclusions The current evidence suggests that CEA, Cyfra21-1, p53, SCC-Ag and VEGF-C have a potential diagnostic value for esophageal carcinoma.	[Zhang, Jun; Zhu, Zhenli; Liu, Yan; Yu, Qiuyan; Li, Ke] Shantou Univ, Coll Med, Dept Prevent Med, Shantou 515041, Guangdong, Peoples R China; [Jin, Xueyuan] 302 PLA Hosp, Dept Int Ctr Liver Dis Treatment, Beijing 100017, Peoples R China; [Xu, Zhiwei] 302 PLA Hosp, Dept Med Qual Control, Beijing 100017, Peoples R China	Shantou University; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Li, K (corresponding author), Shantou Univ, Coll Med, Dept Prevent Med, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China.	kli@stu.edu.cn	xiaoxiao, zhang/HHN-4916-2022					BAUMANN M, 1988, ONCOLOGY, V45, P153, DOI 10.1159/000226553; Bosetti C, 2008, INT J CANCER, V122, P1118, DOI 10.1002/ijc.23232; Brockmann JG, 2000, ANTICANCER RES, V20, P4899; Cai HY, 2008, WORLD J GASTROENTERO, V14, P4082, DOI 10.3748/wjg.14.4082; Cao M, 2011, TISSUE ANTIGENS, V78, P120, DOI 10.1111/j.1399-0039.2011.01716.x; Cao M, 2009, CLIN EXP METASTAS, V26, P751, DOI 10.1007/s10585-009-9274-7; Cawley HM, 1998, GASTROENTEROLOGY, V115, P19, DOI 10.1016/S0016-5085(98)70360-9; Chen Z, 2008, J XINJIANG MED U, V31; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Crew KD, 2004, SEMIN ONCOL, V31, P450, DOI 10.1053/j.seminoncol.2004.04.021; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Dong Y, 2011, RADIOIMMUNOLOGY, V24, P387; Du X, 2010, J XINJIANG MED U, P46; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng X, 2006, HENAN MED RES, V15, P322; Gamian A, 2011, INCREASE SERUM PLATE; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Graves RS, 2002, J MED LIBR ASSOC, V90, P482; Gu P, 2007, J CLIN LAB ANAL, V21, P398, DOI 10.1002/jcla.20208; Hagiwara Nobutoshi, 2000, Journal of Nippon Medical School, V67, P110, DOI 10.1272/jnms.67.110; He J, 2011, J SHANXI MED, V40, P280; He YT, 2008, EUR J CANCER PREV, V17, P71, DOI 10.1097/CEJ.0b013e3282b6fd97; Huang Z, 2011, CONT MED, V17, P115; Ikeda A, 2012, BIOMED CHROMATOGR, V26, P548, DOI 10.1002/bmc.1671; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kato H, 2005, ANTICANCER RES, V25, P3231; Kollarova Helena, 2007, Biomedical Papers (Olomouc), V151, P17; Kozlowski M, 2001, FOLIA HISTOCHEM CYTO, V39, P173; Kozlowski M, 2010, EUR J CARDIO-THORAC, V38, P260, DOI 10.1016/j.ejcts.2010.01.061; Krzystek-Korpacka M, 2008, CYTOKINE, V41, P232, DOI 10.1016/j.cyto.2007.11.011; Krzystek-Korpacka M, 2007, CANCER LETT, V249, P171, DOI 10.1016/j.canlet.2006.08.011; Liu W, 2010, SHANDONG MED, V50, P68; Looi K, 2006, ONCOL REP, V16, P1105; Lu CL, 2010, CANCER CAUSE CONTROL, V21, P269, DOI 10.1007/s10552-009-9458-0; Lukaszewicz-Zajac M, 2012, DIS ESOPHAGUS, V25, P242, DOI 10.1111/j.1442-2050.2011.01242.x; Ma JB, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/302620; Megliorino R, 2005, CANCER DETECT PREV, V29, P241, DOI 10.1016/j.cdp.2005.03.002; MOSKAL TL, 1995, CANCER EPIDEM BIOMAR, V4, P127; Mroczko B, 2008, CLIN CHIM ACTA, V389, P61, DOI 10.1016/j.cca.2007.11.023; Muller M, 2006, INT J ONCOL, V29, P973; MUNCKWIKLAND E, 1988, CANCER, V62, P2281, DOI 10.1002/1097-0142(19881201)62:11<2281::AID-CNCR2820621102>3.0.CO;2-1; Parashar K, 1998, MUTAT RES-FUND MOL M, V422, P271, DOI 10.1016/S0027-5107(98)00207-3; Ralhan R, 2000, INT J CANCER, V85, P791, DOI 10.1002/(SICI)1097-0215(20000315)85:6&lt;791::AID-IJC9&gt;3.0.CO;2-K; Ren J, 2000, CANCER, V88, P280; Sakai Hiroshi, 2002, Rinsho Byori, V50, P90; Samantaray S, 2004, J CANCER RES CLIN, V130, P37, DOI 10.1007/s00432-003-0500-4; Shimada H, 2000, CANCER-AM CANCER SOC, V89, P1677, DOI 10.1002/1097-0142(20001015)89:8<1677::AID-CNCR5>3.0.CO;2-9; Shimada H, 2003, CANCER-AM CANCER SOC, V97, P682, DOI 10.1002/cncr.11092; Shimada H, 2002, SURGERY, V132, P41, DOI 10.1067/msy.2002.125307; Simard EP, 2012, CA CANC J CLIN; Smidt N, 2011, COCHRANE HDB SYSTEMA; UEMURA M, 1990, CLIN CHEM, V36, P598; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang J, 2000, J CAPITAL U MED SCI, V21, P292; Wang Ming-Hui, 2004, Ai Zheng, V23, P467; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wu M, 2010, MOL BIOL REP, V37, P339, DOI 10.1007/s11033-009-9744-7; Wu X, 2009, CHINESE PRACTICAL ME, V4, P77; Yamamoto K, 1997, CANCER-AM CANCER SOC, V79, P1647; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhao W, 2009, CLIN SIGNIFICANCE PL; Zhou SL, 2010, WORLD J GASTROENTERO, V16, P2348, DOI 10.3748/wjg.v16.i19.2348; 毛小红, 2009, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V27, P384	67	33	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0116951	10.1371/journal.pone.0116951	http://dx.doi.org/10.1371/journal.pone.0116951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693076	gold, Green Published, Green Submitted			2022-12-27	WOS:000350061500031
J	Chen, CS; Anaya, JM; Chen, EYT; Farr, E; Chin, WC				Chen, Chi-Shuo; Anaya, Jesse M.; Chen, Eric Y-T; Farr, Erik; Chin, Wei-Chun			Ocean Warming-Acidification Synergism Undermines Dissolved Organic Matter Assembly	PLOS ONE			English	Article							MARINE MICROGELS; CARBON FLUX; TEMPERATURE; SNOW	Understanding the influence of synergisms on natural processes is a critical step toward determining the full-extent of anthropogenic stressors. As carbon emissions continue unabated, two major stressors-warming and acidification-threaten marine systems on several scales. Here, we report that a moderate temperature increase (from 30 degrees C to 32 degrees C) is sufficient to slow-even hinder-the ability of dissolved organic matter, a major carbon pool, to self-assemble to form marine microgels, which contribute to the particulate organic matter pool. Moreover, acidification lowers the temperature threshold at which we observe our results. These findings carry implications for the marine carbon cycle, as self-assembled marine microgels generate an estimated global seawater budget of similar to 10(16) g C. We used laser scattering spectroscopy to test the influence of temperature and pH on spontaneous marine gel assembly. The results of independent experiments revealed that at a particular point, both pH and temperature block microgel formation (32 degrees C, pH 8.2), and disperse existing gels (35 degrees C). We then tested the hypothesis that temperature and pH have a synergistic influence on marine gel dispersion. We found that the dispersion temperature decreases concurrently with pH: from 32 degrees C at pH 8.2, to 28 degrees C at pH 7.5. If our laboratory observations can be extrapolated to complex marine environments, our results suggest that a warming-acidification synergism can decrease carbon and nutrient fluxes, disturbing marine trophic and trace element cycles, at rates faster than projected.	[Chen, Chi-Shuo; Chen, Eric Y-T; Chin, Wei-Chun] Univ Calif Merced, Sch Engn, Merced, CA 95343 USA; [Anaya, Jesse M.; Farr, Erik] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Merced; University of California System; University of California Merced	Chin, WC (corresponding author), Univ Calif Merced, Sch Engn, Merced, CA 95343 USA.	wchin2@ucmerced.edu	Chin, Wei-Chun/A-6068-2008; Anaya, Juan-Manuel/J-1960-2016; /AAL-3738-2021	Chin, Wei-Chun/0000-0003-4881-9085; Anaya, Juan-Manuel/0000-0002-6444-1249; Farr, Erik/0000-0003-0029-2755	US National Science Foundation [CBET-0932404]; California Sea Grant [NA10OAR4170060]; UC Merced Center of Excellence on Health Disparities from the National Center on Minority Health and Health Disparities [1P20MD005049-01]; UC LEADS program; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD005049] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); California Sea Grant; UC Merced Center of Excellence on Health Disparities from the National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); UC LEADS program; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by the US National Science Foundation (CBET-0932404) and California Sea Grant (NA10OAR4170060) to WCC. CSC was supported by UC Merced Center of Excellence on Health Disparities (1P20MD005049-01 from the National Center on Minority Health and Health Disparities). JMA was supported by UC LEADS program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; COSOVIC B, 1993, MAR CHEM, V42, P1, DOI 10.1016/0304-4203(93)90245-J; De Gennes PG., 1979, SCALING CONCEPTS POL; Ding YX, 2008, MAR CHEM, V112, P11, DOI 10.1016/j.marchem.2008.05.003; Dittmar T, 2003, MAR CHEM, V82, P115, DOI 10.1016/S0304-4203(03)00068-9; Engel A, 2011, J PLANKTON RES, V33, P357, DOI 10.1093/plankt/fbq122; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hung CC, 2012, GEOCHIM COSMOCHIM AC, V91, P60, DOI 10.1016/j.gca.2012.05.017; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Johnson NC, 2010, NAT GEOSCI, V3, P842, DOI [10.1038/ngeo1008, 10.1038/NGEO1008]; Karl DM, 2002, TRENDS MICROBIOL, V10, P410, DOI 10.1016/S0966-842X(02)02430-7; Kiorboe T, 2002, APPL ENVIRON MICROB, V68, P3996, DOI 10.1128/AEM.68.8.3996-4006.2002; Kiorboe T, 2001, SCI MAR, V65, P57, DOI 10.3989/scimar.2001.65s257; Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309; Oliver AE, 2000, BIOPHYS J, V78, P2116, DOI 10.1016/S0006-3495(00)76758-0; Orellana MV, 2007, MAR CHEM, V105, P229, DOI 10.1016/j.marchem.2007.02.002; Orellana MV, 2011, P NATL ACAD SCI USA, V108, P13612, DOI 10.1073/pnas.1102457108; Passow U, 2012, MAR CHEM, V128, P72, DOI 10.1016/j.marchem.2011.10.004; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Solomon S., 2007, PHYS SCI BASIS WORKI; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Sunda WG, 2010, SCIENCE, V327, P654, DOI 10.1126/science.1186151; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; Verdugo P, 2012, ANNU REV MAR SCI, V4, P375, DOI 10.1146/annurev-marine-120709-142759; Verdugo P, 2010, DEEP-SEA RES PT II, V57, P1486, DOI 10.1016/j.dsr2.2010.03.002; Vergugo P., 2012, ANNU REV MAR SCI, V4, P1; WELLS ML, 1993, MAR CHEM, V41, P353, DOI 10.1016/0304-4203(93)90267-R; Zhang SJ, 2014, ENVIRON SCI TECHNOL, V48, P11218, DOI 10.1021/es502003q	36	20	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118300	10.1371/journal.pone.0118300	http://dx.doi.org/10.1371/journal.pone.0118300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714090	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700061
J	Farfan, IDB; De La Fuente, GN; Murray, SC; Isakeit, T; Huang, PC; Warburton, M; Williams, P; Windham, GL; Kolomiets, M				Farfan, Ivan D. Barrero; De La Fuente, Gerald N.; Murray, Seth C.; Isakeit, Thomas; Huang, Pei-Cheng; Warburton, Marilyn; Williams, Paul; Windham, Gary L.; Kolomiets, Mike			Genome Wide Association Study for Drought, Aflatoxin Resistance, and Important Agronomic Traits of Maize Hybrids in the Sub-Tropics	PLOS ONE			English	Article							MULTIPLE-TESTING CORRECTION; GRAIN-YIELD; TROPICAL MAIZE; ASPERGILLUS-FLAVUS; GERMPLASM LINES; PLANT HEIGHT; CONTRIBUTING RESISTANCE; NONSTRESS ENVIRONMENTS; GENETIC ARCHITECTURE; POPULATION-STRUCTURE	The primary maize (Zea mays L.) production areas are in temperate regions throughout the world and this is where most maize breeding is focused. Important but lower yielding maize growing regions such as the sub-tropics experience unique challenges, the greatest of which are drought stress and aflatoxin contamination. Here we used a diversity panel consisting of 346 maize inbred lines originating in temperate, sub-tropical and tropical areas testcrossed to stiff-stalk line Tx714 to investigate these traits. Testcross hybrids were evaluated under irrigated and non-irrigated trials for yield, plant height, ear height, days to anthesis, days to silking and other agronomic traits. Irrigated trials were also inoculated with Aspergillus flavus and evaluated for aflatoxin content. Diverse maize testcrosses out-yielded commercial checks in most trials, which indicated the potential for genetic diversity to improve sub-tropical breeding programs. To identify genomic regions associated with yield, aflatoxin resistance and other important agronomic traits, a genome wide association analysis was performed. Using 60,000 SNPs, this study found 10 quantitative trait variants for grain yield, plant and ear height, and flowering time after stringent multiple test corrections, and after fitting different models. Three of these variants explained 5-10% of the variation in grain yield under both water conditions. Multiple identified SNPs co-localized with previously reported QTL, which narrows the possible location of causal polymorphisms. Novel significant SNPs were also identified. This study demonstrated the potential to use genome wide association studies to identify major variants of quantitative and complex traits such as yield under drought that are still segregating between elite inbred lines.	[Farfan, Ivan D. Barrero; De La Fuente, Gerald N.; Murray, Seth C.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Isakeit, Thomas; Huang, Pei-Cheng; Kolomiets, Mike] Texas A&M Univ, Dept Plant Pathol, College Stn, TX USA; [Warburton, Marilyn; Williams, Paul; Windham, Gary L.] ARS, USDA, Corn Host Plant Resistance Res Unit, Mississippi State, MS USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Mississippi State University; United States Department of Agriculture (USDA)	Murray, SC (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	sethmurray@tamu.edu	Huang, Pei-Cheng/AAN-9738-2021; Warburton, Marilyn/J-2250-2017	Huang, Pei-Cheng/0000-0002-7016-6917; Warburton, Marilyn/0000-0002-9542-9912; Murray, Seth/0000-0002-2960-8226	USDA-NIFA-AFRI [2010-85117-20539]	USDA-NIFA-AFRI(United States Department of Agriculture (USDA))	This work was supported by USDA-NIFA-AFRI. #2010-85117-20539: Improving Drought Tolerance and Aflatoxin Resistance in Maize; Education, Extension, and Translational Breeding via Altered Lipid Metabolism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas HK, 2002, J AGR FOOD CHEM, V50, P5246, DOI 10.1021/jf020266k; AJMONEMARSAN P, 1994, MAYDICA, V39, P133; AJMONEMARSAN P, 1995, THEOR APPL GENET, V90, P415, DOI 10.1007/BF00221984; Alwala Sreedhar, 2008, Journal of New Seeds, V9, P1, DOI 10.1080/15228860701879067; Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Austin DF, 1996, THEOR APPL GENET, V92, P817, DOI 10.1007/BF00221893; Badu-Apraku B, 2004, J AGR SCI, V142, P445, DOI 10.1017/S0021859604004538; Banziger M, 1999, CROP SCI, V39, P1035, DOI 10.2135/cropsci1999.0011183X003900040012x; Banziger M., 1997, Crop Science, V37, P1103, DOI 10.2135/cropsci1997.0011183X003700040013x; Banziger M, 2000, DROUGHT AND NITROGEN; BEAVIS WD, 1994, CROP SCI, V34, P882, DOI 10.2135/cropsci1994.0011183X003400040010x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betran FJ, 2004, CROP SCI, V44, P1028, DOI 10.2135/cropsci2004.1028; Betran FJ, 2003, CROP SCI, V43, P797, DOI 10.2135/cropsci2003.0797; Betran J, 2005, FOOD SCI, V151, P353; Boer MP, 2007, GENETICS, V177, P1801, DOI 10.1534/genetics.107.071068; Bohn M, 1997, CROP SCI, V37, P1892, DOI 10.2135/cropsci1997.0011183X003700060038x; BOLANOS J, 1993, FIELD CROP RES, V31, P233, DOI 10.1016/0378-4290(93)90064-T; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brooks TD, 2005, CROP SCI, V45, P171; Brown RL, 1999, PHYTOPATHOLOGY, V89, P113, DOI 10.1094/PHYTO.1999.89.2.113; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cairns JE, 2013, CROP SCI, V53, P1335, DOI 10.2135/cropsci2012.09.0545; Campbell BC, 2003, J TOXICOL-TOXIN REV, V22, P225, DOI 10.1081/TXR-120024093; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; Carson ML, 2006, CROP SCI, V46, P1825, DOI 10.2135/cropsci2005.08-0283; Chapman SC, 1999, CROP SCI, V39, P1315, DOI 10.2135/cropsci1999.3951315x; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Cullis B, 1998, BIOMETRICS, V54, P1, DOI 10.2307/2533991; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; CULLIS BR, 1991, BIOMETRICS, V47, P1449, DOI 10.2307/2532398; De La Fuente GN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053973; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans Harry C., 2002, Mycologist, V16, P148, DOI 10.1017/S0269915X02004093; Farfan IDB, 2013, FIELD CROP RES, V149, P167, DOI 10.1016/j.fcr.2013.04.017; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Frey KJ, 1996, SPECIAL REPORT 98; Fuglie KO, 2000, TRENDS IN AGRICULTUR, P9; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gao XY, 2011, GENET EPIDEMIOL, V35, P154, DOI 10.1002/gepi.20563; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Gilmour A.R., 2009, ASREML USER GUIDE RE; GOLDMAN IL, 1993, THEOR APPL GENET, V87, P217, DOI 10.1007/BF00223767; GOLDMAN IL, 1994, CROP SCI, V34, P908, DOI 10.2135/cropsci1994.0011183X003400040013x; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guo BZ, 2011, J PLANT REGIST, V5, P211, DOI 10.3198/jpr2010.08.0386crg; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Horne CW, 1991, MYCOTOXINS IN FEED A; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kelley RY, 2009, TOXIN REV, V28, P129, DOI 10.1080/15569540903089239; Krill AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009958; Larsson SJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003246; Lee BH, 2009, PLANT PHYSIOL, V150, P205, DOI 10.1104/pp.109.137034; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Llorente CF, 2004, CROP SCI, V44, P1036, DOI 10.2135/cropsci2004.1036a; Malosetti M, 2013, FRONT PHYSIOL, P4, DOI [10.3389/fphys.2013.00414, DOI 10.3389/FPHYS.2013.00414]; Marsan PA, 2001, THEOR APPL GENET, V102, P230, DOI 10.1007/s001220051640; Mathews KL, 2008, THEOR APPL GENET, V117, P1077, DOI 10.1007/s00122-008-0846-8; Mayfield KL, 2011, CROP SCI, V51, P2489, DOI 10.2135/cropsci2011.02.0112; Mayfield K, 2012, J PLANT REGIST, V6, P88, DOI 10.3198/jpr2010.12.0675crg; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Mideros SX, 2014, CROP SCI, V54, P127, DOI 10.2135/cropsci2013.04.0249; Mikel MA, 2006, CROP SCI, V46, P1193, DOI 10.2135/cropsci2005.10-0371; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Murray SC, 2009, PLANT GENOME-US, V2, P48, DOI 10.3835/plantgenome2008.10.0011; Murray SC, 2008, CROP SCI, V48, P2180, DOI 10.2135/cropsci2008.01.0068; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nelson PT, 2006, MAYDICA, V51, P255; Nelson PT, 2008, CROP SCI, V48, P1673, DOI 10.2135/cropsci2008.02.0092; Nelson PT, 2008, CROP SCI, V48, P85, DOI 10.2135/cropsci2007.05.0287; Oakey H, 2006, THEOR APPL GENET, V113, P809, DOI 10.1007/s00122-006-0333-z; Ortiz R, 2010, CROP SCI, V50, P13, DOI 10.2135/cropsci2009.06.0297; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Paul C, 2003, THEOR APPL GENET, V107, P263, DOI 10.1007/s00122-003-1241-0; Payne G, 1998, MYCOTOXINS IN AGRICU, P277; Piepho HP, 2004, EUPHYTICA, V137, P147, DOI 10.1023/B:EUPH.0000040512.84025.16; Pongpanich M, 2010, BIOINFORMATICS, V26, P1731, DOI 10.1093/bioinformatics/btq272; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Quesada T, 2010, GENETICS, V186, P677, DOI 10.1534/genetics.110.117549; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rengel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045249; Robens J, 2003, J TOXICOL-TOXIN REV, V22, P139, DOI 10.1081/TXR-120024089; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Rosenzweig C, 2002, GLOBAL ENVIRON CHANG, V12, P197, DOI 10.1016/S0959-3780(02)00008-0; Sabadin PK, 2012, THEOR APPL GENET, V124, P1389, DOI 10.1007/s00122-012-1795-9; Schaeffer M, 2006, MAYDICA, V51, P357; Scheidegger KA, 2003, J TOXICOL-TOXIN REV, V22, P423, DOI 10.1081/TXR-120024100; Schimmelpfennig DE, 2004, AGR ECON, V30, P157, DOI [10.1016/j.agecon.2002.11.001, 10.1111/j.1574-0862.2004.tb00184.x]; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; SCOTT GE, 1990, CROP SCI, V30, P1378, DOI 10.2135/cropsci1990.0011183X003000060080x; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Smith R, 2011, SOUTHWEST FARMERS AN, V38, P4; van Eeuwijk FA, 2010, CURR OPIN PLANT BIOL, V13, P193, DOI 10.1016/j.pbi.2010.01.001; VELDBOOM LR, 1994, THEOR APPL GENET, V89, P451, DOI 10.1007/BF00225380; Veldboom LR, 1996, CROP SCI, V36, P1320, DOI 10.2135/cropsci1996.0011183X003600050041x; Veldboom LR, 1996, CROP SCI, V36, P1310, DOI 10.2135/cropsci1996.0011183X003600050040x; Walker RD, 2001, PLANT DIS, V85, P322, DOI 10.1094/PDIS.2001.85.3.322; Warburton ML, 2011, MOL BREEDING, V27, P491, DOI 10.1007/s11032-010-9446-9; Warburton ML, 2013, CHARACTERIZATION OF; Weber AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008227; Whitehead FC, 2006, MAYDICA, V51, P43; Wicklow Donald T., 1998, Mycoscience, V39, P167, DOI 10.1007/BF02464055; Widstrom NW, 2003, J TOXICOL-TOXIN REV, V22, P195, DOI 10.1081/TXR-120024092; Williams M, 2013, DEMOCRAT MARX, P1; Williams WP, 2012, J PLANT REGIST, V6, P200, DOI 10.3198/jpr2011.09.0489crg; Williams WP, 2003, J TOXICOL-TOXIN REV, V22, P175, DOI 10.1081/TXR-120024091; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Windham GL, 2005, FOOD SCI, V151, P407; Windham GL, 2003, J TOXICOL-TOXIN REV, V22, P313, DOI 10.1081/TXR-120024096; Windham GL, 2002, PLANT DIS, V86, P232, DOI 10.1094/PDIS.2002.86.3.232; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wisser RJ, 2006, PHYTOPATHOLOGY, V96, P120, DOI 10.1094/PHYTO-96-0120; Wuebbles D. J., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P335, DOI 10.1023/B:MITI.0000038843.73424.de; Xiang K, 2010, MAYDICA, V55, P281; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	128	62	69	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117737	10.1371/journal.pone.0117737	http://dx.doi.org/10.1371/journal.pone.0117737			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714370	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700036
J	Yin, F; Hayworth, JS; Clement, TP				Yin, Fang; Hayworth, Joel S.; Clement, T. Prabhakar			A Tale of Two Recent Spills-Comparison of 2014 Galveston Bay and 2010 Deepwater Horizon Oil Spill Residues	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; CRUDE-OIL; PETROLEUM BIOMARKERS; TOXICITY; IMPACT; IDENTIFICATION; QUANTITATION; COMMUNITY; PRODUCTS; FATE	Managing oil spill residues washing onto sandy beaches is a common worldwide environmental problem. In this study, we have analyzed the first-arrival oil spill residues collected from two Gulf of Mexico (GOM) beach systems following two recent oil spills: the 2014 Galveston Bay (GB) oil spill, and the 2010 Deepwater Horizon (DWH) oil spill. This is the first study to provide field observations and chemical characterization data for the 2014 GB oil spill. Here we compare the physical and chemical characteristics of GB oil spill samples with DWH oil spill samples and present their similarities and differences. Our field observations indicate that both oil spills had similar shoreline deposition patterns; however, their physical and chemical characteristics differed considerably. We highlight these differences, discuss their implications, and interpret GB data in light of lessons learned from previously published DWH oil spill studies. These analyses are further used to assess the long-term fate of GB oil spill residues and their potential environmental impacts.	[Yin, Fang; Hayworth, Joel S.; Clement, T. Prabhakar] Auburn Univ, Dept Civil Engn, Environm Engn Program, Auburn, AL 36849 USA	Auburn University System; Auburn University	Clement, TP (corresponding author), Auburn Univ, Dept Civil Engn, Environm Engn Program, Auburn, AL 36849 USA.	clement@auburn.edu		Yin, Fang/0000-0003-2585-278X	Alabama Emergency Management Agency (AEMA); National Science Foundation (NSF-MRI) [G00006697]	Alabama Emergency Management Agency (AEMA); National Science Foundation (NSF-MRI)(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported, in part, by funding received from the Alabama Emergency Management Agency (AEMA). The GC/MS/MS facility and the characterization methods were developed using grant funds received from the National Science Foundation (NSF-MRI grant #G00006697). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeppli C, 2014, ENVIRON SCI TECHNOL, V48, P6726, DOI 10.1021/es500825q; Aeppli C, 2012, ENVIRON SCI TECHNOL, V46, P8799, DOI 10.1021/es3015138; [Anonymous], 2014, OSAT3; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; ATSDR (Agency for Toxic Substances and Disease Registry), 1995, TOX PROF POL AR HYDR; Barata C, 2005, ENVIRON TOXICOL CHEM, V24, P2992, DOI 10.1897/05-189R.1; Bellas J, 2008, MAR POLLUT BULL, V57, P493, DOI 10.1016/j.marpolbul.2008.02.039; Di Toro DM, 2007, ENVIRON TOXICOL CHEM, V26, P24, DOI 10.1897/06174R.1; Douglas GS, 1996, ENVIRON SCI TECHNOL, V30, P2332, DOI 10.1021/es950751e; Dubansky B, 2013, ENVIRON SCI TECHNOL, V47, P5074, DOI 10.1021/es400458p; Fallahtafti S, 2012, AQUAT TOXICOL, V106, P56, DOI 10.1016/j.aquatox.2011.10.007; Fingas MF, 1997, J HAZARD MATER, V56, P227, DOI 10.1016/S0304-3894(97)00050-2; Fisher CR, 2014, P NATL ACAD SCI USA, V111, P11744, DOI 10.1073/pnas.1403492111; Hayworth JS, 2011, HYDROL EARTH SYST SC, V15, P3639, DOI 10.5194/hess-15-3639-2011; Hayworth JS, 2015, MAR POLLUT BULL, V90, P95, DOI 10.1016/j.marpolbul.2014.11.016; Incardona JP, 2014, P NATL ACAD SCI USA, V111, pE1510, DOI 10.1073/pnas.1320950111; Incardona JP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051204, DOI 10.1371/JOURNAL.PONE.0051204]; John GF, 2014, RAPID COMMUN MASS SP, V28, P948, DOI 10.1002/rcm.6868; Lin H, 2015, AQUATIC TOX IN PRESS; Liu ZF, 2012, ENVIRON RES LETT, V7; Martinez ML, 2012, FRONT ECOL ENVIRON, V10, P44, DOI 10.1890/100151; Mason OU, 2014, ISME J, V8, P1464, DOI 10.1038/ismej.2013.254; McCrea-Strub A, 2011, FISHERIES, V36, P332, DOI 10.1080/03632415.2011.589334; Meador JP, 2008, ENVIRON TOXICOL CHEM, V27, P845, DOI 10.1897/07-434.1; Mulabagal V, 2013, MAR POLLUT BULL, V70, P147, DOI 10.1016/j.marpolbul.2013.02.026; NOAA, 2014, KIRB BARG OIL SPILL; NOAA, 2014, PROGR TEX CIT OIL SP; Peters KE, 2004, BIOMARKER GUIDE, V1; Plant N.G., 2013, 20121234 US GEOL SUR; Radovic JR, 2014, MAR POLLUT BULL, V79, P268, DOI 10.1016/j.marpolbul.2013.11.029; ROSENBAUER R. J., 2010, RECONNAISSANCE MACON; Ruddy BM, 2014, ENERG FUEL, V28, P4043, DOI 10.1021/ef500427n; Sammarco PW, 2013, MAR POLLUT BULL, V73, P129, DOI 10.1016/j.marpolbul.2013.05.029; Smith LL, 2007, J AGR FOOD CHEM, V55, P7301, DOI 10.1021/jf071313h; Somasundaran P, 2014, OIL SPILL REMEDIATION: COLLOID CHEMISTRY-BASED PRINCIPLES AND SOLUTIONS, P1, DOI 10.1002/9781118825662; TGLO, 2010, GALV BAY STAT TRENDS; Turcotte D, 2011, ENVIRON TOXICOL CHEM, V30, P487, DOI 10.1002/etc.404; Vermeire M. B., 2012, EVERYTHING YOU NEED; WANG ZD, 1994, ENVIRON SCI TECHNOL, V28, P1733, DOI 10.1021/es00058a027; WANG ZD, 1994, J CHROMATOGR SCI, V32, P361, DOI 10.1093/chromsci/32.9.361; Wang ZD, 2003, MAR POLLUT BULL, V47, P423, DOI 10.1016/S0025-326X(03)00215-7; Wang ZD, 1999, J CHROMATOGR A, V843, P369, DOI 10.1016/S0021-9673(99)00120-X; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Xia K, 2012, ENVIRON SCI TECHNOL, V46, P5310, DOI 10.1021/es2042433; Yim UH, 2011, J HAZARD MATER, V197, P60, DOI 10.1016/j.jhazmat.2011.09.055; Yin F, 2015, SCI TOTAL ENVIRON, V508, P46, DOI 10.1016/j.scitotenv.2014.10.105; Zuijdgeest A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051204, DOI 10.1371/JOURNAL.PONE.0051204]	47	22	22	7	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118098	10.1371/journal.pone.0118098	http://dx.doi.org/10.1371/journal.pone.0118098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714100	Green Published, gold			2022-12-27	WOS:000350168700052
J	Duong, YT; Kassanjee, R; Welte, A; Morgan, M; De, A; Dobbs, T; Rottinghaus, E; Nkengasong, J; Curlin, ME; Kittinunvorakoon, C; Raengsakulrach, B; Martin, M; Choopanya, K; Vanichseni, S; Jiang, Y; Qiu, MF; Yu, HY; Hao, Y; Shah, N; Le, LV; Kim, AA; Nguyen, TA; Ampofo, W; Parekh, BS				Duong, Yen T.; Kassanjee, Reshma; Welte, Alex; Morgan, Meade; De, Anindya; Dobbs, Trudy; Rottinghaus, Erin; Nkengasong, John; Curlin, Marcel E.; Kittinunvorakoon, Chonticha; Raengsakulrach, Boonyos; Martin, Michael; Choopanya, Kachit; Vanichseni, Suphak; Jiang, Yan; Qiu, Maofeng; Yu, Haiying; Hao, Yan; Shah, Neha; Linh-Vi Le; Kim, Andrea A.; Tuan Anh Nguyen; Ampofo, William; Parekh, Bharat S.			Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CAPTURE ENZYME-IMMUNOASSAY; UNITED-STATES; ASSAY; SEROCONVERSION; PREVENTION; ANTIBODIES; INDEX; PREVALENCE; VALIDATION	Background Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as proportion false recent (PFR), are critical parameters for laboratory-based assays for estimating HIV-1 incidence. Recent review of the data by us and others indicated that MDRI of LAg-Avidity EIA estimated previously required recalibration. We present here results of recalibration efforts using >250 seroconversion panels and multiple statistical methods to ensure accuracy and consensus. Methods A total of 2737 longitudinal specimens collected from 259 seroconverting individuals infected with diverse HIV-1 subtypes were tested with the LAg-Avidity EIA as previously described. Data were analyzed for determination of MDRI at ODn cutoffs of 1.0 to 2.0 using 7 statistical approaches and sub-analyzed by HIV-1 subtypes. In addition, 3740 specimens from individuals with infection >1 year, including 488 from patients with AIDS, were tested for PFR at varying cutoffs. Results Using different statistical methods, MDRI values ranged from 88-94 days at cutoff ODn = 1.0 to 177-183 days at ODn = 2.0. The MDRI values were similar by different methods suggesting coherence of different approaches. Testing for misclassification among long-term infections indicated that overall PFRs were 0.6% to 2.5% at increasing cutoffs of 1.0 to 2.0, respectively. Balancing the need for a longer MDRI and smaller PFR (<2.0%) suggests that a cutoff ODn = 1.5, corresponding to an MDRI of 130 days should be used for cross-sectional application. The MDRI varied among subtypes from 109 days (subtype A&D) to 152 days (subtype C). Conclusions Based on the new data and revised analysis, we recommend an ODn cutoff = 1.5 to classify recent and long-term infections, corresponding to an MDRI of 130 days (118-142). Determination of revised parameters for estimation of HIV-1 incidence should facilitate application of the LAg-Avidity EIA for worldwide use.	[Duong, Yen T.; Dobbs, Trudy; Rottinghaus, Erin; Nkengasong, John; Parekh, Bharat S.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Int Lab Branch, Atlanta, GA 30333 USA; [Morgan, Meade; De, Anindya] Ctr Dis Control & Prevent, Div Global HIV AIDS, Epidemiol & Strateg Informat Branch, Atlanta, GA USA; [Kassanjee, Reshma; Welte, Alex] Univ Stellenbosch, South African DST NRF Ctr Excellence Epidemiol Mo, ZA-7600 Stellenbosch, South Africa; [Kassanjee, Reshma] Univ Witwatersrand, Sch Computat & Appl Math, Johannesburg, South Africa; [Curlin, Marcel E.; Kittinunvorakoon, Chonticha; Raengsakulrach, Boonyos; Martin, Michael; Choopanya, Kachit; Vanichseni, Suphak] Thailand Minist Publ Health US CDC Collaborat, Bangkok, Thailand; [Jiang, Yan; Qiu, Maofeng; Yu, Haiying; Hao, Yan] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Natl AIDS Reference Lab, Beijing, Peoples R China; [Shah, Neha] Calif Dept Publ Hlth, Richmond, CA USA; [Linh-Vi Le] Ctr Dis Control & Prevent, Div Global HIV AIDS, Hanoi, Vietnam; [Kim, Andrea A.] CDC Kenya, Nairobi, Kenya; [Tuan Anh Nguyen] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Ampofo, William] Noguchi Mem Inst Med Res, Accra, Ghana	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Stellenbosch University; University of Witwatersrand; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; California Department of Public Health; National Institute of Hygiene & Epidemiology (NIHE); University of Ghana	Parekh, BS (corresponding author), Ctr Dis Control & Prevent, Div Global HIV AIDS, Int Lab Branch, Atlanta, GA 30333 USA.	bparekh@cdc.gov		PAREKH, BHARAT/0000-0002-1088-4263; Kassanjee, Reshma/0000-0002-1200-8726	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC); Bill and Melinda Gates Foundation through Consortium for the Evaluation and Performance of HIV Incidence Assays; HIV Modeling Consortium	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill and Melinda Gates Foundation through Consortium for the Evaluation and Performance of HIV Incidence Assays; HIV Modeling Consortium	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC/Agency for Toxic Substances and Disease Registry. AW and RK are grateful for support from the Bill and Melinda Gates Foundation through (and to their colleagues at) the Consortium for the Evaluation and Performance of HIV Incidence Assays, and the HIV Modeling Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2013, INFECT GENET EVOL, V18, P125, DOI 10.1016/j.meegid.2013.03.050; Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Chemaitelly H, 2013, SEX TRANSM INFECT, V89, P138, DOI 10.1136/sextrans-2012-050651; Constantine NT, 2003, JAIDS-J ACQ IMM DEF, V32, P94, DOI 10.1097/00126334-200301010-00014; Curtis KA, 2012, AIDS RES HUM RETROV, V28, P188, DOI [10.1089/aid.2011.0037, 10.1089/AID.2011.0037]; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Efron B., 1993, INTRO BOOTSTRAP; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Granade TC, 2013, AIDS RES HUM RETROV, V29, P61, DOI 10.1089/aid.2012.0121; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2011, CURR OPIN HIV AIDS, V6, P102, DOI 10.1097/COH.0b013e328343bfdb; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Heimer R, 2008, INT J DRUG POLICY, V19, pS65, DOI 10.1016/j.drugpo.2007.12.004; Hladik W, 2008, AIDS, V22, P503, DOI 10.1097/QAD.0b013e3282f470be; Hoare A, 2008, SEX HEALTH, V5, P169, DOI 10.1071/SH07099; Hudgens MG, 2002, AM J EPIDEMIOL, V155, P159, DOI 10.1093/aje/155.2.159; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Kim Andrea A, 2011, PLoS One, V6, pe17535, DOI 10.1371/journal.pone.0017535; Kim AA, 2010, AIDS RES HUM RETROV, V26, P1051, DOI 10.1089/aid.2009.0218; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Lavreys L, 2004, J INFECT DIS, V189, P303, DOI 10.1086/380974; Li HZ, 2007, PROC WRLD ACAD SCI E, V1, P1; Mastro TD, 2013, J INFECT DIS, V207, P204, DOI 10.1093/infdis/jis661; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2005, INDIAN J MED RES, V121, P510; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parekh BS, 2001, AIDS RES HUM RETROV, V17, P137, DOI 10.1089/08892220150217229; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Sharma UK, 2012, AIDS RES HUM RETROVI; Sill AM, 2007, J CLIN LAB ANAL, V21, P40, DOI 10.1002/jcla.20144; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; Smolen-Dzirba J, 2011, MED SCI MONITOR, V17, pRA124, DOI 10.12659/MSM.881757; Soroka SD, 2005, CLIN DIAGN LAB IMMUN, V12, P918, DOI 10.1128/CDLI.12.8.918-921.2005; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; Suligoi B, 2011, J CLIN MICROBIOL, V49, P2610, DOI 10.1128/JCM.02115-10; Sweeting M, 2010, STATISTICS IN MEDICI, DOI [10.1002/sim.0000, DOI 10.1002/SIM.0000]; UNAIDS, 2010, UNAIDS REPORT ON THE; VANGRIENSVEN GJP, 1987, AM J EPIDEMIOL, V125, P1048, DOI 10.1093/oxfordjournals.aje.a114620; Walker PT, 2008, SEX TRANSM INFECT, V84, pII42, DOI 10.1136/sti.2008.029975; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; WHO/UNAIDS, 2012, UNAIDS WHO WORKING G; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Wilson KM, 2004, AIDS, V18, P2253, DOI 10.1097/00002030-200411190-00005; Ying S, 2010, ANALYZING INTERVAL C; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522	59	65	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0114947	10.1371/journal.pone.0114947	http://dx.doi.org/10.1371/journal.pone.0114947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710171	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900002
J	Heysell, SK; Ahmed, S; Ferdous, SS; Khan, MSR; Rahman, SMM; Gratz, J; Rahman, MT; Mahmud, AM; Houpt, ER; Banu, S				Heysell, Scott K.; Ahmed, Shahriar; Ferdous, Sara Sabrina; Khan, Md. Siddiqur Rahman; Rahman, S. M. Mazidur; Gratz, Jean; Rahman, Md. Toufiq; Mahmud, Asif Mujtaba; Houpt, Eric R.; Banu, Sayera			Quantitative Drug-Susceptibility in Patients Treated for Multidrug-Resistant Tuberculosis in Bangladesh: Implications for Regimen Choice	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RPOB MUTATIONS; POPULATION PHARMACOKINETICS; PROPORTION METHOD; RIFABUTIN; 2ND-LINE; RIFAMPICIN; PLATE	Background Multidrug-resistant tuberculosis (MDR-TB) treatment in Bangladesh is empiric or based on qualitative drug-susceptibility testing (DST) by comparative growth in culture media with and without a single drug concentration. Methods Adult patients were enrolled throughout Bangladesh during the period of 2011-2013 at MDR-TB treatment initiation. Quantitative DST by minimum inhibitory concentration (MIC) testing for 12 first and second-line anti-TB drugs was compared to pretreatment clinical characteristics and treatment outcomes. MIC values at or one dilution lower than the resistance breakpoint used for qualitative DST were categorized as borderline susceptible, and MIC values one or two dilutions greater as borderline resistant. Results Seventy-four patients were enrolled with a mean age of 35 +/- 15 years, and 51 (69%) were men. Of the rifampin isolates with MIC > 1.0 mu g/ml, 12 (19%) were fully susceptible or borderline susceptible to rifabutin (MIC <= 0.5 mu g/ml). Amikacin was fully susceptible in 73 isolates (99%), but kanamycin in only 54 (75%) (p<0.001). Ofloxacin was borderline susceptible in 64%, and fully susceptible in only 14 (19%) compared to 60 (81%) of isolates fully susceptible for moxifloxacin (p<0.001). Kanamycin non-susceptibility and receipt of the WHO Category IV regimen trended with interim treatment failure: adjusted odd ratios respectively of 5.4 [95% CI 0.82-36.2] (p = 0.08) and 7.2 [0.64-80.7] (p = 0.11). Conclusions Quantitative MIC testing could impact MDR-TB regimen choice in Bangladesh. Comparative trials of higher dose or later generation fluoroquinolone, within class change from kanamycin to amikacin, and inclusion of rifabutin appear warranted.	[Heysell, Scott K.; Gratz, Jean; Houpt, Eric R.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22904 USA; [Ahmed, Shahriar; Ferdous, Sara Sabrina; Khan, Md. Siddiqur Rahman; Rahman, S. M. Mazidur; Rahman, Md. Toufiq; Banu, Sayera] Bangladesh Icddr B, Int Ctr Diarrhoeal Dis Res, Mycobacteriol Lab, Dhaka, Bangladesh; [Mahmud, Asif Mujtaba] Natl Inst Dis Chest & Hosp, Dhaka, Bangladesh	University of Virginia; International Centre for Diarrhoeal Disease Research (ICDDR)	Heysell, SK (corresponding author), Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22904 USA.	skh8r@virginia.edu	AHMED, SHAHRIAR/N-8532-2019; Ahmed, Shahriar/A-3109-2019; Rahman Khan, Mohammad Siddiqur/J-3025-2018	AHMED, SHAHRIAR/0000-0002-8833-4130; Ahmed, Shahriar/0000-0002-8833-4130; Banu, Sayera/0000-0002-5121-1962; Rahman, Syed Mohammad Mazidur/0000-0003-2887-6250; Rahman Khan, Mohammad Siddiqur/0000-0003-2479-6405	National Institutes of Health [R01AI093358, K23AI099019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI099019, K24AI102972, R01AI093358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01AI093358 (ERH) and the National Institutes of Health grant K23AI099019 (SKH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuali MM, 2012, EUR J CLIN MICROBIOL, V31, P835, DOI 10.1007/s10096-011-1382-z; Akkerman OW, 2013, EUR RESPIR J, V42, P1750, DOI 10.1183/09031936.00047413; Banu S, 2014, J CLIN MICROBIOL, V52, P156, DOI 10.1128/JCM.02378-13; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boeree M, 2013, 20TH CONFERENCE ON R; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Chigutsa E, 2012, ANTIMICROB AGENTS CH, V56, P3857, DOI 10.1128/AAC.00048-12; Clinical Laboratory Standards Institute, 2003, CLSI DOCUMENT M24 A; Diel R, 2014, EUR RESPIR J, V43, P554, DOI 10.1183/09031936.00079413; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Hall L, 2012, J CLIN MICROBIOL, V50, P3732, DOI 10.1128/JCM.02048-12; HEIFETS L, 1988, AM REV RESPIR DIS, V137, P1217, DOI 10.1164/ajrccm/137.5.1217; Heysell SK, 2013, TUBERC RES TREAT, DOI [10.1155/2013/129723, DOI 10.1155/2013/129723.]; Iseman M., 2000, CLIN GUIDE TUBERCULO, P323, DOI [10.4103/0974-1208.147490, DOI 10.4103/0974-1208.147490]; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P2157, DOI 10.1128/JCM.00691-14; Jo KW, 2013, RESP MED, V107, P292, DOI 10.1016/j.rmed.2012.10.021; Lee J, 2014, ANTIMICROB AGENTS CH, V58, P11, DOI 10.1128/AAC.01209-13; Mpagama SG, 2014, ANTIMICROB AGENTS CH, V58, P782, DOI 10.1128/AAC.01549-13; Mpagama SG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-432; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Peloquin CA, 2008, ANTIMICROB AGENTS CH, V52, P852, DOI 10.1128/AAC.01036-07; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P3179, DOI 10.1128/JCM.37.10.3179-3186.1999; Rowlinson MC, 2013, SAN DIEGO EIGHTH NAT; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020; Somoskovi A, 2013, J CLIN MICROBIOL, V51, P3127, DOI 10.1128/JCM.01377-13; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; van Ingen J, 2011, CLIN INFECT DIS, V52, pE194, DOI 10.1093/cid/cir184; Velasquez GE, 2014, CLIN INFECT DIS; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Williamson DA, 2012, INT J TUBERC LUNG D, V16, P216, DOI 10.5588/ijtld.11.0178; World Health Organization, 2007, USE OF LIQUID TB CUL; World Health Organization, 2011, GUIDELINE FOR THE PR; World Health Organization, 2013, GLOBAL TUBERCULOSIS, DOI [10.1002/cpp.1875, DOI 10.1002/CPP.1875]; Yang B, 1998, J ANTIMICROB CHEMOTH, V42, P621, DOI 10.1093/jac/42.5.621; Zaunbrecher MA, 2009, PROC NAT ACAD SCIENC, V106	39	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116795	10.1371/journal.pone.0116795	http://dx.doi.org/10.1371/journal.pone.0116795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710516	gold, Green Published, Green Submitted			2022-12-27	WOS:000350683900015
J	Ibanez, B; Gomez-Aparicio, L; Stoll, P; Avila, JM; Perez-Ramos, IM; Maranon, T				Ibanez, Beatriz; Gomez-Aparicio, Lorena; Stoll, Peter; Avila, Jose M.; Perez-Ramos, Ignacio M.; Maranon, Teodoro			A Neighborhood Analysis of the Consequences of Quercus suber Decline for Regeneration Dynamics in Mediterranean Forests	PLOS ONE			English	Article							TREE MORTALITY; RECRUITMENT LIMITATION; SEEDLING ESTABLISHMENT; DENSITY-DEPENDENCE; PLANT INTERACTIONS; SPATIAL-PATTERNS; SEVERE DROUGHT; OLEA-EUROPAEA; OAK DECLINE; CANOPY	In forests, the vulnerable seedling stage is largely influenced by the canopy, which modifies the surrounding environment. Consequently, any alteration in the characteristics of the canopy, such as those promoted by forest dieback, might impact regeneration dynamics. Our work analyzes the interaction between canopy neighbors and seedlings in Mediterranean forests affected by the decline of their dominant species (Quercus suber). Our objective was to understand how the impacts of neighbor trees and shrubs on recruitment could affect future dynamics of these declining forests. Seeds of the three dominant tree species (Quercus suber, Olea europaea and Quercus canariensis) were sown in six sites during two consecutive years. Using a spatially-explicit, neighborhood approach we developed models that explained the observed spatial variation in seedling emergence, survival, growth and photochemical efficiency as a function of the size, identity, health, abundance and distribution of adult trees and shrubs in the neighborhood. We found strong neighborhood effects for all the performance estimators, particularly seedling emergence and survival. Tree neighbors positively affected emergence, independently of species identity or health. Alternatively, seedling survival was much lower in neighborhoods dominated by defoliated and dead Q. suber trees than in neighborhoods dominated by healthy trees. For the two oak species, these negative effects were consistent over the three years of the experimental seedlings. These results indicate that ongoing changes in species' relative abundance and canopy trees' health might alter the successional trajectories of Mediterranean oak-forests through neighbor-specific impacts on seedlings. The recruitment failure of dominant late-successional oaks in the gaps opened after Q. suber death would indirectly favor the establishment of other coexisting woody species, such as drought-tolerant shrubs. This could lead current forests to shift into open systems with lower tree cover. Adult canopy decline would therefore represent an additional factor threatening the recruitment of Quercus forests worldwide.	[Ibanez, Beatriz; Gomez-Aparicio, Lorena; Avila, Jose M.; Perez-Ramos, Ignacio M.; Maranon, Teodoro] CSIC, Inst Recursos Nat & Agrobiol IRNAS, E-41080 Seville, Spain; [Stoll, Peter] Univ Basel, Sect Conservat Biol, Inst Environm Sci, CH-4056 Basel, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); University of Basel	Ibanez, B (corresponding author), CSIC, Inst Recursos Nat & Agrobiol IRNAS, POB 1052, E-41080 Seville, Spain.	bibanez@irnase.csic.es	Stoll, Peter/A-8881-2010; Gómez-Aparicio, Lorena/K-6905-2014; Avila, Jose Manuel/P-5981-2014; Perez-Ramos, Ignacio M/H-6048-2015; Maranon, Teodoro/K-6648-2014	Stoll, Peter/0000-0003-1509-1702; Avila, Jose Manuel/0000-0002-7075-7450; Perez-Ramos, Ignacio M/0000-0003-2332-7818; Maranon, Teodoro/0000-0002-7751-9316	FPI (Formacion de Personal Investigador) fellowship (MICINN-Ministerio de Ciencia e Innovacion); FPU (Formacion de Personal Universitario) fellowship (MECD-Ministerio de Educacion, Cultura y Deporte); JAE doc-CSIC (Consejo Superior de Investigaciones Cientificas) contract; INTERBOS-Interacciones ecologicas y Cambio Global en el bosque mediterraneo project [CGL2008-04503-C03-03]; DIVERBOS-Diversidad funcional y resiliencia del bosque mediterraneo project [CGL2011-30285-C02-01]; RETROBOS-El papel de los procesos de Retroalimentacion planta-suelo en la dinamica de Bosques de Quercus con decaimiento project [CGL2011-26877]; ANASINQUE-Analisis comparativo y sintesis de los patrones de regeneracion, decaimiento y distribucion de las especies de Quercus project [PGC2010-RNM-5782]	FPI (Formacion de Personal Investigador) fellowship (MICINN-Ministerio de Ciencia e Innovacion); FPU (Formacion de Personal Universitario) fellowship (MECD-Ministerio de Educacion, Cultura y Deporte); JAE doc-CSIC (Consejo Superior de Investigaciones Cientificas) contract; INTERBOS-Interacciones ecologicas y Cambio Global en el bosque mediterraneo project; DIVERBOS-Diversidad funcional y resiliencia del bosque mediterraneo project; RETROBOS-El papel de los procesos de Retroalimentacion planta-suelo en la dinamica de Bosques de Quercus con decaimiento project; ANASINQUE-Analisis comparativo y sintesis de los patrones de regeneracion, decaimiento y distribucion de las especies de Quercus project	BI was supported by a FPI (Formacion de Personal Investigador) fellowship (MICINN-Ministerio de Ciencia e Innovacion), JMA was supported by a FPU (Formacion de Personal Universitario) fellowship (MECD-Ministerio de Educacion, Cultura y Deporte), IMPR was supported by a JAE doc-CSIC (Consejo Superior de Investigaciones Cientificas) contract. This research was supported by INTERBOS-Interacciones ecologicas y Cambio Global en el bosque mediterraneo-CGL2008-04503-C03-03 (http://www.irnase.csic.es/users/interbos/inicio.php), DIVERBOS-Diversidad funcional y resiliencia del bosque mediterraneo-CGL2011-30285-C02-01 (http://www.diverbos.com/es/), RETROBOS-El papel de los procesos de Retroalimentacion planta-suelo en la dinamica de Bosques de Quercus con decaimiento-CGL2011-26877 and ANASINQUE-Analisis comparativo y sintesis de los patrones de regeneracion, decaimiento y distribucion de las especies de Quercus-PGC2010-RNM-5782 (http://www.anasinque.com/) projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acacio V, 2007, ECOSYSTEMS, V10, P1220, DOI 10.1007/s10021-007-9089-9; Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Ameztegui A, 2013, FOREST ECOL MANAG, V303, P25, DOI 10.1016/j.foreco.2013.04.011; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; [Anonymous], 2005, PORN PRUG PDS PARQUE; Aponte C, 2010, SOIL BIOL BIOCHEM, V42, P788, DOI 10.1016/j.soilbio.2010.01.014; Ayres E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005964; Battles JJ, 2000, ECOL APPL, V10, P760, DOI 10.1890/1051-0761(2000)010[0760:GDFFDA]2.0.CO;2; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; BRASIER CM, 1992, NATURE, V360, P539, DOI 10.1038/360539a0; Brasier CM, 1996, ANN SCI FOREST, V53, P347, DOI 10.1051/forest:19960217; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caldeira MC, 2014, J APPL ECOL, V51, P349, DOI 10.1111/1365-2664.12189; Canham C. D., 1985, The ecology of natural disturbance and patch dynamics, P197; Carnicer J, 2014, GLOBAL ECOL BIOGEOGR, V23, P371, DOI 10.1111/geb.12111; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; Garcia LV, 2011, BIOL CONSERV, V144, P764, DOI 10.1016/j.biocon.2010.11.007; Gomez-Aparicio L, 2008, OIKOS, V117, P1683, DOI 10.1111/j.1600-0706.2008.16814.x; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gomez-Aparicio L, 2008, J ECOL, V96, P1128, DOI 10.1111/j.1365-2745.2008.01431.x; Gomez-Aparicio L, 2008, J ECOL, V96, P78, DOI 10.1111/j.1365-2745.2007.01317.x; Gomez-Aparicio L, 2012, NEW PHYTOL, V194, P1014, DOI 10.1111/j.1469-8137.2012.04108.x; Gourlet-Fleury S, 2000, FOREST ECOL MANAG, V131, P269, DOI 10.1016/S0378-1127(99)00212-1; Gray AN, 1996, J ECOL, V84, P635, DOI 10.2307/2261327; Gray AN, 2002, CAN J FOREST RES, V32, P332, DOI [10.1139/x01-200, 10.1139/X01-200]; Harper J. L., 1977, Population biology of plants.; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; HUBBELL SP, 1990, PHILOS T R SOC B, V330, P269, DOI 10.1098/rstb.1990.0198; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kabrick JM, 2008, FOREST ECOL MANAG, V255, P1409, DOI 10.1016/j.foreco.2007.10.054; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Kneeshaw DD, 1998, ECOLOGY, V79, P783, DOI 10.1890/0012-9658(1998)079[0783:CGCATR]2.0.CO;2; Koepke DF, 2010, OECOLOGIA, V163, P1079, DOI 10.1007/s00442-010-1671-8; Lloret F, 2004, J VEG SCI, V15, P237, DOI 10.1111/j.1654-1103.2004.tb02258.x; McCarthy John, 2001, Environmental Reviews, V9, P1, DOI 10.1139/a00-012; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Mendoza I, 2009, J VEG SCI, V20, P367, DOI 10.1111/j.1654-1103.2009.05705.x; Mittlbock M, 1996, STAT MED, V15, P1987, DOI 10.1002/(SICI)1097-0258(19961015)15:19<1987::AID-SIM318>3.3.CO;2-0; Ojeda F, 2000, BIODIVERS CONSERV, V9, P1323, DOI 10.1023/A:1008923213321; Pausas J., 2009, CORK OAK WOODLANDS E, P115; Perez-Ramos IM, 2012, J VEG SCI, V23, P526, DOI 10.1111/j.1654-1103.2011.01365.x; Perez-Ramos IM, 2012, J ECOL, V100, P467, DOI 10.1111/j.1365-2745.2011.01912.x; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Phillips PD, 2003, ECOL MODEL, V159, P1, DOI 10.1016/S0304-3800(02)00126-6; Pickett S.T.A., 1985, ECOLOGY NATURAL DIST, P371, DOI [DOI 10.1016/B978-0-12-554520-4.50026-5, 10.1016/B978-0-12-554520-4.50026-5]; Pulido FJ, 2002, REV CHIL HIST NAT, V75, P5, DOI 10.4067/S0716-078X2002000100002; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; Quero JL, 2006, NEW PHYTOL, V170, P819, DOI 10.1111/j.1469-8137.2006.01713.x; R Core Team, 2020, R LANG ENV STAT COMP; Redmond MD, 2013, NEW PHYTOL, V200, P402, DOI 10.1111/nph.12366; Rey PJ, 2004, ECOSCIENCE, V11, P310, DOI 10.1080/11956860.2004.11682838; Rizzo DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.1890/1540-9295(2003)001[0197:SODECA]2.0.CO;2; Rodriguez-Garcia E, 2011, FOREST ECOL MANAG, V262, P244, DOI 10.1016/j.foreco.2011.03.029; Romero MA, 2007, J PHYTOPATHOL, V155, P289, DOI 10.1111/j.1439-0434.2007.01230.x; Royer PD, 2011, J ECOL, V99, P714, DOI 10.1111/j.1365-2745.2011.01804.x; Ruiz-Benito P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056843; Sanchez M. E., 2006, PROGR RES PHYTOPHTHO, P149; Sheffer E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090178; Sheffer E, 2013, ECOLOGY, V94, P1718, DOI 10.1890/12-2121.1; Shugart H. H., 1984, A theory of forest dynamics. The ecological implications of forest succession models.; Silvertown J., 2001, INTRO PLANT POPULATI; Stoll P, 2005, ECOLOGY, V86, P3048, DOI 10.1890/04-1540; Suarez ML, 2008, CAN J FOREST RES, V38, P3002, DOI 10.1139/X08-149; Tilman David, 1993, P13; Urbieta IR, 2008, CAN J FOREST RES, V38, P2382, DOI 10.1139/X08-089; Urbieta IR, 2008, J BIOGEOGR, V35, P1688, DOI 10.1111/j.1365-2699.2008.01914.x; Vila-Cabrera A, 2011, ECOL APPL, V21, P1162, DOI 10.1890/10-0647.1; VOYIATZIS DG, 1987, J HORTIC SCI BIOTECH, V62, P405, DOI 10.1080/14620316.1987.11515799; WEINER J, 1984, J ECOL, V72, P183, DOI 10.2307/2260012	77	32	34	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117827	10.1371/journal.pone.0117827	http://dx.doi.org/10.1371/journal.pone.0117827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706723	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100121
J	Mikami, Y; Fukushima, A; Kuwada-Kusunose, T; Sakurai, T; Kitano, T; Komiyama, Y; Iwase, T; Komiyama, K				Mikami, Yoshikazu; Fukushima, Atsushi; Kuwada-Kusunose, Takao; Sakurai, Tetsuya; Kitano, Taiichi; Komiyama, Yusuke; Iwase, Takashi; Komiyama, Kazuo			Whole Transcriptome Analysis Using Next-Generation Sequencing of Sterile-Cultured Eisenia andrei for Immune System Research	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; RNA-SEQ DATA; REFERENCE GENOME; CELOMIC FLUID; EARTHWORM; RESPONSES; EXPOSURE; FOETIDA; MODEL; TOOL	Recently, earthworms have become a useful model for research into the immune system, and it is expected that results obtained using this model will shed light on the sophisticated vertebrate immune system and the evolution of the immune response, and additionally help identify new biomolecules with therapeutic applications. However, for earthworms to be used as a genetic model of the invertebrate immune system, basic molecular and genetic resources, such as an expressed sequence tag (EST) database, must be developed for this organism. Next-generation sequencing technologies have generated EST libraries by RNA-seq in many model species. In this study, we used Illumina RNA-sequence technology to perform a comprehensive transcriptome analysis using an RNA sample pooled from sterile-cultured Eisenia andrei. All clean reads were assembled de novo into 41,423 unigenes using the Trinity program. Using this transcriptome data, we performed BLAST analysis against the GenBank non-redundant (NR) database and obtained a total of 12,285 significant BLAST hits. Furthermore, gene ontology (GO) analysis assigned 78 unigenes to 24 immune class GO terms. In addition, we detected a unigene with high similarity to beta-1,3-glucuronyltransferase 1 (GlcAT-P), which mediates a glucuronyl transfer reaction during the biosynthesis of the carbohydrate epitope HNK-1 (human natural killer-1, also known as CD57), a marker of NK cells. The identified transcripts will be used to facilitate future research into the immune system using E. andrei.	[Mikami, Yoshikazu; Kitano, Taiichi; Iwase, Takashi; Komiyama, Kazuo] Nihon Univ, Sch Dent, Dept Pathol, Chiyoda Ku, Tokyo 1018310, Japan; [Fukushima, Atsushi; Sakurai, Tetsuya] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Kuwada-Kusunose, Takao] Nihon Univ, Sch Dent Matsudo, Dept Liberal Arts Chem, Matsudo, Chiba 2718587, Japan; [Komiyama, Yusuke] Tokyo Univ Hosp, Intens Care Unit, Bunkyo Ku, Tokyo 1130033, Japan	Nihon University; RIKEN; Nihon University; University of Tokyo	Komiyama, K (corresponding author), Nihon Univ, Sch Dent, Dept Pathol, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	komiyama.kazuo@nihon-u.ac.jp	Fukushima, Atsushi/C-9279-2017; Sakurai, Tetsuya/B-2690-2010	Fukushima, Atsushi/0000-0001-9015-1694; Sakurai, Tetsuya/0000-0003-2046-8973				Adams EJ, 2001, IMMUNOL REV, V183, P41, DOI 10.1034/j.1600-065x.2001.1830104.x; Aitlhadj L, 2014, DRUG DISCOV TODAY, V19, P730, DOI 10.1016/j.drudis.2014.01.014; [Anonymous], 2014, PYMOL MOL GRAPH SYST; Ashburner M, 2001, GENOME RES, V11, P1425; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooper EL, 2006, IMMUNOL LETT, V104, P18, DOI 10.1016/j.imlet.2005.11.012; COOPER EL, 1980, ENDEAVOUR, V4, P160, DOI 10.1016/0160-9327(80)90006-X; COSSARIZZA A, 1995, BIOCHEM BIOPH RES CO, V214, P503, DOI 10.1006/bbrc.1995.2315; Elingarami S, 2013, J NANOSCI NANOTECHNO, V13, P4539, DOI 10.1166/jnn.2013.7522; Engelmann P, 2002, ZOOLOGY, V105, P257, DOI 10.1078/0944-2006-00068; FRANCESCHI C, 1991, EUR J IMMUNOL, V21, P489, DOI 10.1002/eji.1830210235; Gao YH, 2013, ECOTOX ENVIRON SAFE, V89, P239, DOI 10.1016/j.ecoenv.2012.12.004; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gui D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072417; Kakuda S, 2004, J BIOL CHEM, V279, P22693, DOI 10.1074/jbc.M400622200; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karaka A, 2011, BIOL EARTHWORMS SOIL, P24; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khalturin K, 2003, P NATL ACAD SCI USA, V100, P622, DOI 10.1073/pnas.0234104100; Kobayashi H, 2004, INT REV CYTOL, V236, P45, DOI 10.1016/S0074-7696(04)36002-X; Kosuge T, 2014, NUCLEIC ACIDS RES, V42, pD44, DOI 10.1093/nar/gkt1066; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; MATANGKASOMBUT P, 1970, Journal of the Medical Association of Thailand, V53, P831; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Pauwels M, 2013, ENVIRON POLLUT, V179, P343, DOI 10.1016/j.envpol.2013.05.005; Pelosi C, 2013, CHEMOSPHERE, V90, P895, DOI 10.1016/j.chemosphere.2012.09.034; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Salzet M, 2002, PROSTAG LEUKOTR ESS, V66, P353, DOI 10.1054/plef.2001.0347; Salzet M, 2006, CURR PHARM DESIGN, V12, P3043, DOI 10.2174/138161206777947551; Seavey MM, 2012, BIOCHEM PHARMACOL, V83, P1136, DOI 10.1016/j.bcp.2011.12.024; Spurgeon DJ, 2005, ENVIRON POLLUT, V136, P443, DOI 10.1016/j.envpol.2005.01.013; SUZUKI MM, 1995, ZOOL SCI, V12, P443, DOI 10.2108/zsj.12.443; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Turner DJ, 2009, MAMM GENOME, V20, P327, DOI 10.1007/s00335-009-9187-4; Wang YB, 2012, BRIEF FUNCT GENOMICS, V11, P96, DOI 10.1093/bfgp/els002; WILKIE BN, 1982, J AM VET MED ASSOC, V181, P1074; Xu JJ, 2013, PLANT MOL BIOL, V83, P77, DOI 10.1007/s11103-013-0025-4; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuk J, 2012, ECOTOXICOLOGY, V21, P1301, DOI 10.1007/s10646-012-0884-5	43	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118587	10.1371/journal.pone.0118587	http://dx.doi.org/10.1371/journal.pone.0118587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706644	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100190
J	Osinga, HM; Marshall, JAR				Osinga, Hinke M.; Marshall, James A. R.			Adaptive Topographies and Equilibrium Selection in an Evolutionary Game	PLOS ONE			English	Article								It has long been known in the field of population genetics that adaptive topographies, in which population equilibria maximise mean population fitness for a trait regardless of its genetic bases, do not exist. Whether one chooses to model selection acting on a single locus or multiple loci does matter. In evolutionary game theory, analysis of a simple and general game involving distinct roles for the two players has shown that whether strategies are modelled using a single 'locus' or one 'locus' for each role, the stable population equilibria are unchanged and correspond to the fitness-maximising evolutionary stable strategies of the game. This is curious given the aforementioned population genetical results on the importance of the genetic bases of traits. Here we present a dynamical systems analysis of the game with roles detailing how, while the stable equilibria in this game are unchanged by the number of 'loci' modelled, equilibrium selection may differ under the two modelling approaches.	[Osinga, Hinke M.] Univ Auckland, Dept Math, Auckland 1142, New Zealand; [Marshall, James A. R.] Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England	University of Auckland; University of Sheffield	Marshall, JAR (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England.	James.Marshall@sheffield.ac.uk		Marshall, James/0000-0002-1506-167X; Osinga, Hinke/0000-0003-2169-0883				BOMZE IM, 1983, BIOL CYBERN, V48, P201, DOI 10.1007/BF00318088; Diekmann O., 2004, MATH MODELLING POPUL, V63, P47, DOI [DOI 10.4064/BC63-0-2, 10.4064/bc63-0-2]; Doedel E. J ., 2007, AUTO 07P CONTINUATIO; Doedel EJ., 1981, CONG NUMER, V30, P265; Feldman MW, 2009, THEOR POPUL BIOL, V75, P233, DOI 10.1016/j.tpb.2009.01.002; Gardner A, 2007, AM NAT, V169, P207, DOI 10.1086/510602; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; Grafen A., 1984, BEHAV ECOLOGY EVOLUT, V2, P62; GUCKENHEIMER J, 1988, MATH PROC CAMBRIDGE, V103, P189, DOI 10.1017/S0305004100064732; Guckenheimer J., 1983, J APPL MECH, DOI DOI 10.1115/1.3167759; Hofbauer J, 1998, EVOLUTIONARY GAMES P; KIMURA M, 1965, GENETICS, V52, P875; Kirkpatrick M, 2002, GENETICS, V161, P1727; Krauskopf B, 2005, INT J BIFURCAT CHAOS, V15, P763, DOI 10.1142/S0218127405012533; Krauskopf B., 2007, NUMERICAL CONTINUATI, P117, DOI DOI 10.1007/978-1-4020-6356-5_4; Kuznetsov Yu.A., 1995, APPL MATH SCI, V112; Marshall JAR, 2009, J THEOR BIOL, V260, P386, DOI 10.1016/j.jtbi.2009.07.008; Maynard Smith J., 1982, pi; MORAN PAP, 1964, ANN HUM GENET, V27, P383; Queller DC, 1996, ANIM BEHAV, V51, P229, DOI 10.1006/anbe.1996.0020; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; TRIVERS RL, 1974, AM ZOOL, V14, P249	24	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116307	10.1371/journal.pone.0116307	http://dx.doi.org/10.1371/journal.pone.0116307			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706762	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100031
J	Wang, YY; Zhang, YJ; Pan, C; Ma, FX; Zhang, SZ				Wang, Yanyan; Zhang, Yujie; Pan, Chi; Ma, Feixia; Zhang, Suzhan			Prediction of Poor Prognosis in Breast Cancer Patients Based on MicroRNA-21 Expression: A Meta-Analysis	PLOS ONE			English	Article							CELL LUNG-CANCER; MIR-21; OVEREXPRESSION; IDENTIFICATION; METASTASIS; STATISTICS; CARCINOMAS; SURVIVAL; TARGETS; MARKERS	Background MicroRNA-21 (miRNA-21 or miR-21) may act as a prognostic biomarker of cancer. However, the available evidence is controversial. Therefore, the present meta-analysis summarizes this evidence and evaluates the prognostic role of this gene in breast cancer. Methods The meta-analysis was conducted by searching the databases of PubMed, EMBASE, Web of Science and Chinese database-China National Knowledge Infrastructure (CNKI). Data were extracted from studies that investigated the association between miR-21 expression and survival outcomes in breast cancer patients. With respect to survival outcomes, the pooled hazard ratios (HRs) of miR-21 were calculated given a 95% confidence interval (CI). Results Our meta-analysis identified a total of 10 studies involving 1,439 cases. Further investigation demonstrated that a high miR-21 expression can predict poor overall survival (OS) (HR = 2.57, 95% CI: 1.37-4.81, P = 0.003) and shortened disease-free/recurrence-free survival (DFS/RFS) (HR = 1.45, 95% CI: 1.16-1.82, P = 0.001) in breast cancer patients. Moreover, high miR-21 expression was significantly correlated with lowered OS in the Asian group (HR = 5.07, 95% CI: 2.89-8.92, P < 0.001), but not in the Caucasian cohort (HR = 1.44, 95% CI: 0.99-2.10, P = 0.058). Furthermore, odds ratios (ORs) showed that up-regulated miR-21 levels were associated with multiple clinical characteristics. Conclusion Our results indicated that miR-21 can predict unfavorable prognoses in breast cancer patients, especially in Asians.	[Wang, Yanyan; Ma, Feixia; Zhang, Suzhan] Zhejiang Univ, Sch Med, Dept Surg Oncol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Yujie] Zhejiang Univ, Sch Med, Dept Orthopaed Surg, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Chi] Zhejiang Univ, Sch Med, Inst Canc, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhang, SZ (corresponding author), Zhejiang Univ, Sch Med, Dept Surg Oncol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	zrsj@zju.edu.cn	Wang, Yanbo/HFZ-8018-2022; wang, yan/GSE-6489-2022; Pan, Chi/GRR-6330-2022		SZZ's National Natural Science Foundation of China [91229104]	SZZ's National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from SZZ's National Natural Science Foundation of China (No. 91229104), www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anfossi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083113; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chakraborty P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058291, 10.1371/journal.pone.0068543]; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Dong GZ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0057-x; Duffy MJ, 2005, CLIN CHEM, V51, P494, DOI 10.1373/clinchem.2004.046227; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fu XN, 2011, EUR J CLIN INVEST, V41, P1245, DOI 10.1111/j.1365-2362.2011.02535.x; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hayes DF, 2001, J MAMMARY GLAND BIOL, V6, P375, DOI 10.1023/A:1014778713034; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lee JA, 2011, J BREAST CANCER, V14, P269, DOI 10.4048/jbc.2011.14.4.269; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Ma XL, 2012, ASIAN PAC J CANCER P, V13, P2329, DOI 10.7314/APJCP.2012.13.5.2329; MANTEL N, 1959, BIOMETRICS, V15, P639; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Markou A, 2014, CLIN CHEM, V60, P197, DOI 10.1373/clinchem.2013.210542; Menendez P, 2013, J SURG ONCOL, V108, P369, DOI 10.1002/jso.23415; Michael MZ, 2003, MOL CANCER RES, V1, P882; Muller V, 2014, BREAST CANCER RES TR, V147, P61, DOI 10.1007/s10549-014-3079-3; Ota D, 2011, INT J ONCOL, V38, P955, DOI 10.3892/ijo.2011.926; Ozgun A, 2013, ONKOLOGIE, V36, P115, DOI 10.1159/000348678; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Sun B, 2009, THESIS ACAD MILITARY; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walter BA, 2011, J CANCER, V2, P67, DOI 10.7150/jca.2.67; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089223; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Xia XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080426; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; [颜黎栩 YAN Li-xu], 2009, [中国病理生理杂志, Chinese Journal of Pathophysiology], V25, P676; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhong H, 2012, EXP THER MED, V3, P763, DOI 10.3892/etm.2012.502; Zhou X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102413; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; Zhu WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103373	58	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118647	10.1371/journal.pone.0118647	http://dx.doi.org/10.1371/journal.pone.0118647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706383	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100198
J	De Re, V; Caggiari, L; De Zorzi, M; Repetto, O; Zignego, AL; Izzo, F; Tornesello, ML; Buonaguro, FM; Mangia, A; Sansonno, D; Racanelli, V; De Vita, S; Pioltelli, P; Vaccher, E; Beretta, M; Mazzaro, C; Libra, M; Gini, A; Zucchetto, A; Cannizzaro, R; De Paoll, P				De Re, Valli; Caggiari, Laura; De Zorzi, Mariangela; Repetto, Ombretta; Zignego, Anna Linda; Izzo, Francesco; Tornesello, Maria Lina; Buonaguro, Franco Maria; Mangia, Alessandra; Sansonno, Domenico; Racanelli, Vito; De Vita, Salvatore; Pioltelli, Pietro; Vaccher, Emanuela; Beretta, Massimiliano; Mazzaro, Cesare; Libra, Massimo; Gini, Andrea; Zucchetto, Antonella; Cannizzaro, Renato; De Paoll, Paolo			Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEPATOCELLULAR-CARCINOMA; HEPATOMA-CELLS; RECEPTOR GENES; INCREASED RISK; HCV INFECTION; HLA; LYMPHOMA; GENOTYPE; INNATE	Background The variability in the association of host innate immune response to Hepatitis C virus (HCV) infection requires ruling out the possible role of host KIR and HLA genotypes in HCV-related disorders: therefore, we therefore explored the relationships between KIR/HLA genotypes and chronic HCV infection (CHC) as they relate to the risk of HCV-related hepatocarcinoma (HCC) or lymphoproliferative disease progression. Methods and Findings We analyzed data from 396 HCV-positive patients with CHC (n = 125), HCC (118), and lymphoproliferative diseases (153), and 501 HCV-negative patients. All were HIV and HBV negative. KIR-SSO was used to determine the KIR typing. KIR2DL5 and KIR2DS4 variants were performed using PCR and GeneScan analysis. HLA/class-I genotyping was performed using PCR-sequence-based typing. The interaction between the KIR gene and ligand HLA molecules was investigated. Differences in frequencies were estimated using Fisher's exact test, and Cochran-Armitage trend test. The non-random association of KIR alleles was estimated using the linkage disequilibrium test. We found an association of KIR2DS2/KIR2DL2 genes, with the HCV-related lymphoproliferative disorders. Furthermore, individuals with a HLA-Bw6 KIR3DL1+ combination of genes showed higher risk of developing lymphoma than cryoglobulinemia. KIR2DS3 gene was found to be the principal gene associated with chronic HCV infection, while a reduction of HLA-Bw4 + KIR3DS1+ was associated with an increased risk of developing HCC. Conclusions Our data highlight a role of the innate-systemin developing HCV-related disorders and specifically KIR2DS3 and KIR2D genes demonstrated an ability to direct HCV disease progression, and mainly towards lymphoproliferative disorders. Moreover the determination of KIR3D/HLA combination of genes direct the HCV progression towards a lymphoma rather than an hepatic disease. In this contest IFN-alpha therapy, a standard therapy for HCV-infection and lymphoproliferative diseases, known to be able to transiently enhance the cytotoxicity of NK-cells support the role of NK cells to counterstain HCV-related and lymphoproliferative diseases.	[De Re, Valli; Caggiari, Laura; De Zorzi, Mariangela; Repetto, Ombretta; De Paoll, Paolo] CRO Natl Canc Inst, Facil Bioproteom Dir Sc, Aviano, Pordenone, Italy; [Zignego, Anna Linda] Univ Florence, Florence, Italy; [Izzo, Francesco] Natl Canc Inst Fdn Pascale, Hepatobiliary Unit, Naples, Italy; [Tornesello, Maria Lina; Buonaguro, Franco Maria] Natl Canc Inst Fdn Pascale, Naples, Italy; [Mangia, Alessandra] IRCCS, Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, Italy; [Sansonno, Domenico; Racanelli, Vito] Univ Bari, Sch Med, Bari, Italy; [De Vita, Salvatore] Univ Hosp Santa Maria Misericordia, Udine, Italy; [Pioltelli, Pietro] Univ Milano Bicocca, San Gerardo Hosp, Hematol & Transplant Unit, Monza, Italy; [Vaccher, Emanuela; Beretta, Massimiliano; Mazzaro, Cesare] Ctr Riferimento Oncol, Aviano, Pordenone, Italy; [Libra, Massimo] Univ Catania, Catania, Italy; [Gini, Andrea; Zucchetto, Antonella; Cannizzaro, Renato] CRO Natl Canc Inst, Aviano, Pordenone, Italy	IRCCS Aviano (CRO); University of Florence; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; Hospital Santa Maria della Misericordia; San Gerardo Hospital; University of Milano-Bicocca; IRCCS Aviano (CRO); University of Catania; IRCCS Aviano (CRO)	De Re, V (corresponding author), CRO Natl Canc Inst, Facil Bioproteom Dir Sc, Aviano, Pordenone, Italy.	vdere@cro.it	Mazzaro, Cesare/P-7794-2019; CAGGIARI, LAURA/Q-6125-2019; Maria, Buonaguro Franco/AAF-4888-2019; De Zorzi, Mariangela/AAA-8832-2019; Zucchetto, Antonella/ABC-8649-2020; Repetto, Ombretta/V-6342-2019; Buonaguro, Franco M./T-6028-2019; Cannizzaro, Renato/V-3804-2018; Gini, Andrea/GLN-7977-2022; DE RE, VALLI/AAA-1374-2019; Libra, Massimo/ABF-6654-2020; Mangia, A/AAL-5357-2020; Zignego, Anna Linda/AAL-8205-2021; Tornesello, Maria Lina/A-1964-2008; De Re, Valli/K-4121-2016; Racanelli, Vito/J-8511-2018; Libra, Massimo/L-8241-2018; Vaccher, Emanuela/AAC-9372-2020; De Paoli, Paolo/AAG-2586-2021; Pizzichetta, Maria Antonietta/F-5407-2019; Berretta, Massimiliano/None; Izzo, Francesco/K-5261-2016	Mazzaro, Cesare/0000-0002-0305-6574; CAGGIARI, LAURA/0000-0003-1651-6653; De Zorzi, Mariangela/0000-0002-3794-270X; Zucchetto, Antonella/0000-0003-2812-6345; Repetto, Ombretta/0000-0002-0785-5066; Buonaguro, Franco M./0000-0002-7491-7220; Cannizzaro, Renato/0000-0002-2020-222X; Gini, Andrea/0000-0002-7696-0580; DE RE, VALLI/0000-0001-6100-9373; Libra, Massimo/0000-0002-7232-7737; Mangia, A/0000-0002-2600-3555; Tornesello, Maria Lina/0000-0002-3523-3264; De Re, Valli/0000-0001-6100-9373; Racanelli, Vito/0000-0002-8639-1940; Libra, Massimo/0000-0002-7232-7737; Vaccher, Emanuela/0000-0003-3386-5142; Pizzichetta, Maria Antonietta/0000-0002-4201-8490; Berretta, Massimiliano/0000-0002-9837-9148; Izzo, Francesco/0000-0003-3093-5408; De Paoli, Paolo/0000-0002-9502-1781; SANSONNO, Domenico Ettore/0000-0001-6520-1653; , Salvatore/0000-0002-2757-3373	Italian Association for Cancer Research (AIRC) [10266]; Dir Sc. CRO	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Dir Sc. CRO	Italian Association for Cancer Research (AIRC n. 10266) grant funding to part of the research reagents. Laura caggiari, Mariangela De Zorzi and Ombretta Repetto fellowships are funded by 5% Dir Sc. CRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Bray SM, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/249281; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Caggiari L, 2011, INT J BIOL MARKER, V26, P221, DOI 10.5301/JBM.2011.8903; Cai L, 2008, CLIN IMMUNOL, V129, P428, DOI 10.1016/j.clim.2008.08.012; Cariani E, 2013, CLIN CANCER RES, V19, P5465, DOI 10.1158/1078-0432.CCR-13-0986; Chang KC, 2013, BRIT J CANCER, V109, P2481, DOI 10.1038/bjc.2013.564; Cheent K, 2011, GUT, V60, P268, DOI 10.1136/gut.2010.212555; Crotta S, 2010, J HEPATOL, V52, P183, DOI 10.1016/j.jhep.2009.11.003; de Arias AE, 2009, LIVER TRANSPLANT, V15, P390, DOI 10.1002/lt.21673; De Re V, 2010, TISSUE ANTIGENS, V75, P127, DOI 10.1111/j.1399-0039.2009.01414.x; De Re V, 2008, BLOOD, V111, P5760, DOI 10.1182/blood-2008-04-149567; De Re V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084940; DERE V, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/710642EPUB;%2014FEB26.:710642; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Fadda L, 2011, J VIROL, V85, P5970, DOI 10.1128/JVI.00412-11; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gourraud PA, 2010, IMMUNOGENETICS, V62, P729, DOI 10.1007/s00251-010-0478-4; Hu XL, 2014, J INTERF CYTOK RES, V34, P366, DOI 10.1089/jir.2013.0049; Kawamura Y, 2007, AM J MED, V120, P1034, DOI 10.1016/j.amjmed.2007.06.022; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Larkin J, 2006, J INTERF CYTOK RES, V26, P854, DOI 10.1089/jir.2006.26.854; Lee MH, 2010, J CLIN ONCOL, V28, P4587, DOI 10.1200/JCO.2010.29.1500; Legaz I, 2013, TRANSPLANTATION, V95, P1037, DOI 10.1097/TP.0b013e318286486c; Li Y, 2004, J LEUKOCYTE BIOL, V76, P1171, DOI 10.1189/jlb.0604372; Littera R, 2013, HUM IMMUNOL, V74, P1288, DOI 10.1016/j.humimm.2013.05.007; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Martin AM, 2004, GENE, V335, P121, DOI 10.1016/j.gene.2004.03.018; Miyagi T, 2004, HEPATOLOGY, V40, P1190, DOI 10.1002/hep.20447; Miyagi T, 2003, INT J CANCER, V106, P81, DOI 10.1002/ijc.11163; Moesta AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00336; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Park SH, 2012, GASTROENTEROLOGY, V143, P1048, DOI 10.1053/j.gastro.2012.06.005; Parsons MS, 2012, J VIROL, V86, P4488, DOI 10.1128/JVI.06112-11; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Quartuccio L, 2014, RHEUMATOLOGY, V53, P2209, DOI 10.1093/rheumatology/keu271; Schonberg K, 2011, BLOOD, V117, P98, DOI 10.1182/blood-2010-03-273656; Sharma D, 2009, J IMMUNOL, V183, P4569, DOI 10.4049/jimmunol.0901734; Shindoh J, 2013, J CLIN ONCOL, V31, P766, DOI 10.1200/JCO.2012.44.3234; Stegmann KA, 2012, J INFECT DIS, V205, P1351, DOI 10.1093/infdis/jis210; Stegmann KA, 2010, GASTROENTEROLOGY, V138, P1885, DOI 10.1053/j.gastro.2010.01.051; Tatsumi T, 2007, HEPATOLOGY, V45, P22, DOI 10.1002/hep.21447; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Winter CC, 1998, J IMMUNOL, V161, P571; X-Jaffe ES, 2001, PATHOLOGY GENETICS T; Yamagiwa S, 2008, HEPATOL RES, V38, P664, DOI 10.1111/j.1872-034X.2008.00317.x; Zhao F, 2012, DIGEST DIS, V30, P477, DOI 10.1159/000341695; Zuniga J, 2009, MOL IMMUNOL, V46, P2723, DOI 10.1016/j.molimm.2009.05.014	52	40	40	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117420	10.1371/journal.pone.0117420	http://dx.doi.org/10.1371/journal.pone.0117420			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700262	Green Published, Green Submitted, gold			2022-12-27	WOS:000349789800023
J	Guo, SY; Lucas, RM; Joshy, G; Banks, E				Guo, Shuyu; Lucas, Robyn M.; Joshy, Grace; Banks, Emily			Cardiovascular Disease Risk Factor Profiles of 263,356 Older Australians According to Region of Birth and Acculturation, with a Focus on Migrants Born in Asia	PLOS ONE			English	Article							BODY-MASS INDEX; UNITED-STATES; PHYSICAL-ACTIVITY; PREVALENCE; AMERICANS; SMOKING; IMMIGRANTS; MORTALITY; HEALTH; ASSOCIATION	Risk factors for cardiovascular disease (CVD), such as obesity, diabetes, hypertension and physical inactivity, are common in Australia, but the prevalence varies according to cultural background. We examined the relationship between region of birth, measures of acculturation, and CVD risk profiles in immigrant, compared to Australian-born, older Australians. Cross-sectional data from 263,356 participants aged 45 and over joining the population-based 45 and Up Study cohort from 2006-2008 were used. Prevalence ratios for CVD risk factors in Australian-versus overseas-born participants were calculated using modified Poisson regression, adjusting for age, sex and socioeconomic factors and focusing on Asian migrants. The association between time resident in Australia and age at migration and CVD risk factors in Asian migrants was also examined. Migrants from Northeast (n = 3,213) and South-east Asia (n = 3,942) had lower levels of overweight/obesity, physical activity and female smoking than Australian-born participants (n = 199,356), although differences in prevalence of overweight/obesity were sensitive to body-mass-index cut-offs used. Compared to Australian-born participants, migrants from Northeast Asia were 20-30% less likely, and from-Southeast Asia 10-20% more likely, to report being treated for hypertension and/or hypercholesterolaemia; Southeast Asian migrants were 40-60% more likely to report diabetes. Northeast Asian-born individuals were less likely than Australian-born to have 3 or more CVD risk factors. Diabetes, treated hypertension and hypercholesterolaemia occurred at relatively low average body-mass-index in Southeast Asian migrants. The CVD risk factor profiles of migrants tended to approximate those of Australian-born with increasing acculturation, in both favourable (e.g., increased physical activity) and unfavourable directions (e.g., increased female smoking). Minimizing CVD risk in migrant populations may be achieved through efforts to retain the healthy facets of the traditional lifestyle, such as a normal body mass index and low prevalence of smoking in women, in addition to adopting healthy aspects of the host country lifestyle, such as increased physical activity.	[Guo, Shuyu; Lucas, Robyn M.; Joshy, Grace; Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia; [Banks, Emily] Sax Inst, Sydney, NSW, Australia; [Lucas, Robyn M.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	Australian National University; University of Sydney; Telethon Kids Institute; University of Western Australia	Guo, SY (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia.	Shuyu.guo@anu.edu.au		Banks, Emily/0000-0002-4617-1302; Lucas, Robyn/0000-0003-2736-3541; Joshy, Grace/0000-0002-0718-6368	National Heart Foundation, NSW Cardiovascular Research Network through 45 and Up Study Cardiovascular Research Collaboration	National Heart Foundation, NSW Cardiovascular Research Network through 45 and Up Study Cardiovascular Research Collaboration	This specific project was supported by a development grant from the National Heart Foundation, NSW Cardiovascular Research Network, made available through the 45 and Up Study Cardiovascular Research Collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-252; An N, 2008, NICOTINE TOB RES, V10, P579, DOI 10.1080/14622200801979126; [Anonymous], 2011, WHO TECH REP SER; [Anonymous], 2005, NAT PHYS ACT GUID AD; Aoki Yutaka, 2014, NCHS Data Brief, P1; Australian Bureau of Statistics, 2010, MIGR AUSTR 2008 09; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; BENNETT SA, 1993, AUST J PUBLIC HEALTH, V17, P251; Chiu M, 2012, CAN J CARDIOL, V28, P20, DOI 10.1016/j.cjca.2011.06.002; Cho Juhee, 2006, Prev Chronic Dis, V3, pA79; Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481; de Looper M., 2002, AIHW B, V2; Tran DT, 2014, J COMMUN HEALTH, V39, P99, DOI 10.1007/s10900-013-9745-2; Frank ATH, 2014, CIRCULATION, V129, P570, DOI 10.1161/CIRCULATIONAHA.113.005757; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Hauck K, 2011, HEALTH PLACE, V17, P78, DOI 10.1016/j.healthplace.2010.08.016; HSUHAGE BHH, 1993, AUST J PUBLIC HEALTH, V17, P306; Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182; Kandula NR, 2005, ANN EPIDEMIOL, V15, P257, DOI 10.1016/j.annepidem.2004.06.006; Koya DL, 2007, J GEN INTERN MED, V22, P841, DOI 10.1007/s11606-007-0163-y; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Ma GX, 2004, HEALTH EDUC RES, V19, P615, DOI 10.1093/her/cyg070; McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; Ngo-Metzger Q, 2004, MED CARE, V42, P893, DOI 10.1097/01.mlr.0000135819.15178.bc; NHDC & AIHW, 1992, IMM AUSTR HLTH PROF; Poulter N, 1999, AM J HYPERTENS, V12, p92S; SAS, 2011, SAS VERS 9 3; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; Singh GK, 2002, HUM BIOL, V74, P83, DOI 10.1353/hub.2002.0011; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Tang H, 2005, CANCER-AM CANCER SOC, V104, P2982, DOI 10.1002/cncr.21523; Tremblay MS, 2006, CAN J PUBLIC HEALTH, V97, P277, DOI 10.1007/BF03405603; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; United Nations, 2013, INT MIGR REP 2013; Weber MF, 2011, DRUG ALCOHOL REV, V30, P597, DOI 10.1111/j.1465-3362.2010.00247.x; Weber MF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-144; WHO, 2010, GLOB STAT REP NONC D; Wong RJ, 2014, J COMMUN HEALTH, V39, P437, DOI 10.1007/s10900-013-9792-8; World Health Organization, 2011, GLOB ATL CARD DIS PR, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Zhang J, 2008, NICOTINE TOB RES, V10, P791, DOI 10.1080/14622200802027230	44	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115627	10.1371/journal.pone.0115627	http://dx.doi.org/10.1371/journal.pone.0115627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695771	Green Published, gold, Green Submitted			2022-12-27	WOS:000350062300007
J	Silva, RR; Mariante, RM; Silva, AA; dos Santos, ALB; Roffe, E; Santiago, H; Gazzinelli, RT; Lannes-Vieira, J				Silva, Rafael Rodrigues; Mariante, Rafael M.; Silva, Andrea Alice; Barbosa dos Santos, Ana Luiza; Roffe, Ester; Santiago, Helton; Gazzinelli, Ricardo Tostes; Lannes-Vieira, Joseli			Interferon-Gamma Promotes Infection of Astrocytes by Trypanosoma cruzi	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; IFN-GAMMA; CHAGAS-DISEASE; T-CELLS; TOXOPLASMA-GONDII; OXIDATIVE STRESS; BETA; EXPRESSION	The inflammatory cytokine interferon-gamma (IFN gamma) is crucial for immunity against intracellular pathogens such as the protozoan parasite Trypanosoma cruzi, the causative agent of Chagas disease (CD). IFN gamma is a pleiotropic cytokine which regulates activation of immune and non-immune cells; however, the effect of IFN. in the central nervous system (CNS) and astrocytes during CD is unknown. Here we show that parasite persists in the CNS of C3H/He mice chronically infected with the Colombian T. cruzi strain despite the increased expression of IFN gamma mRNA. Furthermore, most of the T. cruzi-bearing cells were astrocytes located near IFN gamma(+) cells. Surprisingly, in vitro experiments revealed that pretreatment with IFN gamma promoted the infection of astrocytes by T. cruzi increasing uptake and proliferation of intracellular forms, despite inducing increased production of nitric oxide (NO). Importantly, the effect of IFN gamma on T. cruzi uptake and growth is completely blocked by the anti-tumor necrosis factor (TNF) antibody Infliximab and partially blocked by the inhibitor of nitric oxide synthesis L-NAME. These data support that IFN gamma fuels astrocyte infection by T. cruzi and critically implicate IFN gamma-stimulated T. cruzi-infected astrocytes as sources of TNF and NO, which may contribute to parasite persistence and CNS pathology in CD.	[Silva, Rafael Rodrigues; Mariante, Rafael M.; Barbosa dos Santos, Ana Luiza; Roffe, Ester; Lannes-Vieira, Joseli] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Interacoes, BR-21045900 Rio De Janeiro, Brazil; [Silva, Andrea Alice] Univ Fed Fluminense, Dept Clin Med, Lab Multidisciplinar Apoio Pesquisa, Rio De Janeiro, Brazil; [Silva, Andrea Alice] Univ Fed Fluminense, Fac Med, Dept Patol, Rio De Janeiro, Brazil; [Roffe, Ester] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Santiago, Helton; Gazzinelli, Ricardo Tostes] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Immunol, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade Federal Fluminense; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Lannes-Vieira, J (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Interacoes, BR-21045900 Rio De Janeiro, Brazil.	lannes@ioc.fiocruz.br	Santiago, Helton/F-8704-2012; Santiago, Helton/AAA-8558-2021; Roffê, Ester/H-4688-2012; Silva, Andrea Alice/J-6729-2012; Mariante, Rafael/AAM-6010-2021	Santiago, Helton/0000-0002-5695-8256; Silva, Andrea Alice/0000-0001-5856-6128; Mariante, Rafael/0000-0001-8024-9612; Gazzinelli, Ricardo/0000-0003-2427-7699	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ [APQ1-E-26/111.756/2008, CNE/E-26/101.549/2010, E-26/110.153/2013, E-26/111.709/2013]; Brazilian Research Council?CNPq [474234/2012-6-Universal, 302534/2008-3, 403979/2012-9-DECIT]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Research Council?CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro/FAPERJ (Grants # APQ1-E-26/111.756/2008 and CNE/E-26/101.549/2010, E-26/110.153/2013, E-26/111.709/2013) and the Brazilian Research Council?CNPq (Grants #474234/2012-6-Universal and #302534/2008-3; National Institute for Science and Technology for Vaccines - INCTV?CNPq; #403979/2012-9-DECIT). J. Lannes-Vieira and R.T. Gazzinelli are research fellows of the CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Aebischer J, 2011, CELL DEATH DIFFER, V18, P754, DOI 10.1038/cdd.2010.143; Aliberti JCS, 1999, INFECT IMMUN, V67, P4819, DOI 10.1128/IAI.67.9.4819-4826.1999; Aliberti JCS, 2001, AM J PATHOL, V158, P1433, DOI 10.1016/S0002-9440(10)64094-1; Antunes ACM, 2002, ARQ NEURO-PSIQUIAT, V60, P730, DOI 10.1590/S0004-282X2002000500009; Arankowsky-Sandoval G, 2001, NEUROSCI LETT, V306, P65, DOI 10.1016/S0304-3940(01)01866-3; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Bombeiro AL, 2010, NEUROIMMUNOMODULAT, V17, P67, DOI 10.1159/000258689; Vargas-Zambrano JC, 2013, MEM I OSWALDO CRUZ, V108, P212, DOI 10.1590/0074-0276108022013014; Carroll-Anzinger D, 2006, J VIROL, V80, P541, DOI 10.1128/JVI.80.1.541-544.2006; Ceravolo IP, 1999, INFECT IMMUN, V67, P2233; Cole C, 2012, IMMUNITY, V36, P807, DOI 10.1016/j.immuni.2012.03.011; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; Da Mata JR, 2000, BRAIN RES BULL, V53, P153, DOI 10.1016/S0361-9230(00)00326-9; Diniz LP, 2014, GLIA, V62, P1917, DOI 10.1002/glia.22713; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; dos Santos PVA, 2001, MICROBES INFECT, V3, P971, DOI 10.1016/S1286-4579(01)01461-7; Drechsel DA, 2012, NEUROTOX RES, V22, P251, DOI 10.1007/s12640-012-9322-y; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Falsig J, 2006, J NEUROCHEM, V96, P893, DOI 10.1111/j.1471-4159.2005.03622.x; Fichera LE, 2004, INFECT IMMUN, V72, P359, DOI 10.1128/IAI.72.1.359-363.2004; FIERZ W, 1985, J IMMUNOL, V134, P3785; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Fu YY, 2014, CELL MOL NEUROBIOL, V34, P651, DOI 10.1007/s10571-014-0039-8; GAZZINELLI RT, 1992, EUR J IMMUNOL, V22, P2501, DOI 10.1002/eji.1830221006; Gimsa U, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/320519; GREEN LC, 1981, SCIENCE, V212, P56, DOI 10.1126/science.6451927; He F, 2007, INT J BIOCHEM CELL B, V39, P661, DOI 10.1016/j.biocel.2006.10.022; HIRSCH MR, 1983, NEUROSCI LETT, V41, P199, DOI 10.1016/0304-3940(83)90247-1; Hua LWL, 2002, J NEUROCHEM, V83, P1120, DOI 10.1046/j.1471-4159.2002.01226.x; Jensen CJ, 2013, J NEUROIMMUNE PHARM, V8, P824, DOI 10.1007/s11481-013-9480-6; Jorg ME, 1981, MEM I O CRUZ, V67, P353; Kawanokuchi J, 2006, MULT SCLER J, V12, P558, DOI 10.1177/1352458506070763; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim JH, 2010, J NEUROCHEM, V115, P1161, DOI 10.1111/j.1471-4159.2010.07004.x; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Koppula S, 2012, INT J MOL SCI, V13, P10608, DOI 10.3390/ijms130810608; Lannes-Vieira J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000645; Laureys G, 2014, J NEUROINFLAMM, V11, P1, DOI [10.1186/1687-9856-2014-11, DOI 10.1186/1687-9856-2014-11]; LEE SC, 1993, J NEUROIMMUNOL, V46, P19, DOI 10.1016/0165-5728(93)90229-R; Li W, 2011, J IMMUNOL, V186, P6771, DOI 10.4049/jimmunol.1100099; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Machado FS, 2000, CIRCULATION, V102, P3003, DOI 10.1161/01.CIR.102.24.3003; Meeuwsen S, 2003, GLIA, V43, P243, DOI 10.1002/glia.10259; Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; Moncada GB, 1987, ARCH VENEZ PUERIC PE, V50, P106, DOI 10.1016/j.jad.2014.08.011; Otsmane B, 2014, NEUROREPORT, V25, P49, DOI 10.1097/WNR.0000000000000043; Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525; Paiva CN, 2009, J LEUKOCYTE BIOL, V86, P1239, DOI 10.1189/jlb.0309187; Pereira IR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/798078; Perez AR, 2011, J NEUROIMMUNOL, V235, P84, DOI 10.1016/j.jneuroim.2011.03.010; Pinto AMT, 2011, CELL MICROBIOL, V13, P1518, DOI 10.1111/j.1462-5822.2011.01636.x; PLATA F, 1984, EUR J IMMUNOL, V14, P930, DOI 10.1002/eji.1830141013; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; ROCHA A, 1994, AM J TROP MED HYG, V50, P261, DOI 10.4269/ajtmh.1994.50.261; Roffe E, 2003, J NEUROIMMUNOL, V142, P17, DOI 10.1016/S0165-5728(03)00254-6; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Rozenfeld C, 2003, INFECT IMMUN, V71, P2047, DOI 10.1128/IAI.71.4.2047-2057.2003; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Silva AA, 1999, CLIN IMMUNOL, V92, P56, DOI 10.1006/clim.1999.4716; Silva AA, 2010, J NEUROPARASITOL, V1, P1, DOI DOI 10.4303/JNP/N100901; Silverio JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002645; Tarassishin L, 2014, GLIA, V62, P999, DOI 10.1002/glia.22657; Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3; VESPA GNR, 1994, INFECT IMMUN, V62, P5177, DOI 10.1128/IAI.62.11.5177-5182.1994; Vilar-Pereira G, 2012, BRAIN BEHAV IMMUN, V26, P1136, DOI 10.1016/j.bbi.2012.07.009; Villela E., 1926, MEM I O CRUZ, V19, P199; Wang XS, 2007, J INTERF CYTOK RES, V27, P599, DOI 10.1089/jir.2006.0157; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	72	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118600	10.1371/journal.pone.0118600	http://dx.doi.org/10.1371/journal.pone.0118600			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695249	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300057
J	Rostro-Garcia, S; Kamler, JF; Hunter, LTB				Rostro-Garcia, Susana; Kamler, Jan F.; Hunter, Luke T. B.			To Kill, Stay or Flee: The Effects of Lions and Landscape Factors on Habitat and Kill Site Selection of Cheetahs in South Africa	PLOS ONE			English	Article							BLACK-BACKED JACKALS; KRUGER-NATIONAL-PARK; ACINONYX-JUBATUS; RESOURCE SELECTION; PREDATOR AVOIDANCE; FEEDING ECOLOGY; HOME-RANGE; COMPETITION; CARNIVORES; SAVANNA	Understanding how animals utilize available space is important for their conservation, as it provides insight into the ecological needs of the species, including those related to habitat, prey and inter and intraspecific interactions. We used 28 months of radio telemetry data and information from 200 kill locations to assess habitat selection at the 3rd order (selection of habitats within home ranges) and 4th order (selection of kill sites within the habitats used) of a reintroduced population of cheetahs Acinonyx jubatus in Phinda Private Game Reserve, South Africa. Along with landscape characteristics, we investigated if lion Panthera leo presence affected habitat selection of cheetahs. Our results indicated that cheetah habitat selection was driven by a trade-off between resource acquisition and lion avoidance, and the balance of this trade-off varied with scale: more open habitats with high prey densities were positively selected within home ranges, whereas more closed habitats with low prey densities were positively selected for kill sites. We also showed that habitat selection, feeding ecology, and avoidance of lions differed depending on the sex and reproductive status of cheetahs. The results highlight the importance of scale when investigating a species' habitat selection. We conclude that the adaptability of cheetahs, together with the habitat heterogeneity found within Phinda, explained their success in this small fenced reserve. The results provide information for the conservation and management of this threatened species, especially with regards to reintroduction efforts in South Africa.	[Rostro-Garcia, Susana; Kamler, Jan F.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Abingdon, Oxon, England; [Hunter, Luke T. B.] Panthera, New York, NY 10018 USA	University of Oxford	Hunter, LTB (corresponding author), Panthera, 8 West 40th St,18th Floor, New York, NY 10018 USA.	lhunter@panthera.org	Kamler, Jan F/F-8520-2011; Hunter, Luke T.B./H-3324-2019	Hunter, Luke T.B./0000-0001-9653-6544	IUCN Cat Specialist Group; Pittsburgh Zoo Conservation Fund University of Pretoria; Foundation for Research Development; W.H. Craib Memorial Trust	IUCN Cat Specialist Group; Pittsburgh Zoo Conservation Fund University of Pretoria; Foundation for Research Development; W.H. Craib Memorial Trust	Funding was provided by the IUCN Cat Specialist Group, Pittsburgh Zoo Conservation Fund University of Pretoria, Foundation for Research Development and W.H. Craib Memorial Trust. Conservation Corporation Africa (CCA) provided in-kind support in the form of room, board and fuel for the research vehicle. Funding per se was not received from CCA for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awaida J, 2013, GRASS GIS MANUAL R C; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Barton K, 2020, MUMIN MULTIMODEL INF; Bates DM, 2006, LINEAR MIXED EFFECTS; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Bissett C, 2007, J ZOOL, V271, P310, DOI 10.1111/j.1469-7998.2006.00217.x; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Broekhuis F, 2012, THESIS U OXFORD; Broekhuis F, 2013, J ANIM ECOL, V82, P1097, DOI 10.1111/1365-2656.12077; Broomhall LS, 2003, J ZOOL, V261, P119, DOI 10.1017/S0952836903004059; Caro T., 1994, CHEETAHS SERENGETI P; Caro TM, 2003, BIOL CONSERV, V110, P67, DOI 10.1016/S0006-3207(02)00177-5; Ciarniello LM, 2007, ECOL APPL, V17, P1424, DOI 10.1890/06-1100.1; Cozzi G, 2013, J ANIM ECOL, V82, P707, DOI 10.1111/1365-2656.12039; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; Di Minin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071788; Durant S.M., 1998, CAT NEWS, V28, P14; Durant SM, 2000, ANIM BEHAV, V60, P121, DOI 10.1006/anbe.2000.1433; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; FULLER TK, 1990, AFR J ECOL, V28, P330, DOI 10.1111/j.1365-2028.1990.tb01168.x; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gros PM, 1999, BIODIVERS CONSERV, V8, P1561, DOI 10.1023/A:1008950114827; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Houser AM, 2009, J ZOOL, V278, P108, DOI 10.1111/j.1469-7998.2009.00554.x; Hunter JS, 2007, AFR J ECOL, V45, P275, DOI 10.1111/j.1365-2028.2006.00702.x; Hunter JS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1033, DOI 10.1007/s00265-006-0336-4; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; Hunter LTB, 1998, THESIS PRETORIA U PR; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kamler JF, 2013, J MAMMAL, V94, P295, DOI 10.1644/12-MAMM-A-122.1; Klare U, 2010, J WILDLIFE MANAGE, V74, P1030, DOI 10.2193/2009-211; Koper Nicola, 2012, Rangifer, V32, P195; Landguth EL, 2012, ECOGRAPHY, V35, P9, DOI 10.1111/j.1600-0587.2011.07149.x; LAURENSON MK, 1994, J ZOOL, V234, P387, DOI 10.1111/j.1469-7998.1994.tb04855.x; Lindsey P, 2011, ORYX, V45, P587, DOI 10.1017/S003060531000150X; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; Low A.R., 1996, VEGETATION S AFRICA; Manly B.F.J., 2002, RESOURCE SELECTION A; Marker L, 2002, THESIS U OXFORD; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; Muntifering JR, 2006, ANIM CONSERV, V9, P103, DOI 10.1111/j.1469-1795.2005.00008.x; Oliveira T, 2013, J MAMMAL EVOL; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Palomares F, 2001, WILDLIFE MONOGR, P1; Pettorelli N, 2009, J ZOOL, V277, P141, DOI 10.1111/j.1469-7998.2008.00522.x; Purchase GK, 2000, S AFR J WILDL RES, V30, P139; QGIS Development Team, 2018, QGIS GEOGR INF SYST; R Core Team, 2021, R LANGUAGE ENV STAT; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; SCHALLER G B, 1972, P480; Schulze BR., 1965, CLIMATE S AFRICA 8; Switzer TS, 2004, J SEA RES, V51, P229, DOI 10.1016/j.seares.2003.10.001; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; Thompson CM, 2002, LANDSCAPE ECOL, V17, P569, DOI 10.1023/A:1021501231182; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; van der Meer E, 2013, MAMM BIOL, V78, P336, DOI 10.1016/j.mambio.2013.04.006; van Dyk G, 2003, AFR ZOOL, V38, P79; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1; Wasserman T., 2012, USDA FOREST SERVICE; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x; Yurewicz KL, 2004, COPEIA, P28, DOI 10.1643/0045-8511(2004)004[0028:RAACOR]2.0.CO;2	68	46	46	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117743	10.1371/journal.pone.0117743	http://dx.doi.org/10.1371/journal.pone.0117743			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693067	gold, Green Submitted, Green Published			2022-12-27	WOS:000350061500071
J	Howe, SE; Konjufca, VH				Howe, Savannah E.; Konjufca, Vjollca H.			Per-Oral Immunization with Antigen-Conjugated Nanoparticles followed by Sub-Cutaneous Boosting Immunization Induces Long-Lasting Mucosal and Systemic Antibody Responses in Mice	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; EPITHELIAL-CELLS; CHOLERA-TOXIN; BIODEGRADABLE MICROPARTICLES; MONOCLONAL-ANTIBODIES; PROTECTIVE EFFICACY; SECRETORY IGA; IMMUNE-SYSTEM; T-CELLS; VACCINE	Food or water-borne enteric pathogens invade their hosts via intestinal mucosal surfaces, thus developing effective oral vaccines would greatly reduce the burden of infectious diseases. The nature of the antigen, as well as the mode of its internalization in the intestinal mucosa affects the ensuing immune response. We show that model protein antigen ovalbumin (Ova) given per-orally (p.o.) induces oral tolerance (OT), characterized by systemic IgG1-dominated antibody response, which cannot be boosted by sub-cutaneous (s.c.) immunization with Ova in complete Freund's adjuvant (CFA). Intestinal IgA generated in response to Ova feeding diminished over time and was abrogated by s.c. immunization with Ova+CFA. Humoral response to Ova was altered by administering Ova conjugated to 20 nm nanoparticles (NP-Ova). P.o. administration of NP-Ova induced systemic IgG1/IgG2c, and primed the intestinal mucosa for secretion of IgA. These responses were boosted by secondary s.c. immunization with Ova+CFA or p.o. immunization with NP-Ova. However, only in s.c.-boosted mice serum and mucosal antibody titers remained elevated for 6 months after priming. In contrast, s.c. priming with NP-Ova induced IgG1-dominated serum antibodies, but did not prime the intestinal mucosa for secretion of IgA, even after secondary p.o. immunization with NP-Ova. These results indicate that Ova conjugated to NPs reaches the internal milieu in an immunogenic form and that mucosal immunization with NP-Ova is necessary for induction of a polarized Th1/Th2 immune response, as well as intestinal IgA response. In addition, mucosal priming with NP-Ova, followed by s.c. boosting induces superior systemic and mucosal memory responses. These findings are important for the development of efficacious mucosal vaccines.	[Howe, Savannah E.; Konjufca, Vjollca H.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Konjufca, VH (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	vjollca@micro.siu.edu		Konjufca, Vjollca/0000-0002-7736-5097	Southern Illinois University	Southern Illinois University	This work was supported by start-up funds provided to VK by Southern Illinois University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhiani AA, 2002, J IMMUNOL, V169, P6977, DOI 10.4049/jimmunol.169.12.6977; APTER FM, 1993, INFECT IMMUN, V61, P5279, DOI 10.1128/IAI.61.12.5279-5285.1993; APTER FM, 1993, INFECT IMMUN, V61, P5271, DOI 10.1128/IAI.61.12.5271-5278.1993; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Belyakov IM, 2001, NAT MED, V7, P1320, DOI 10.1038/nm1201-1320; BLANCHARD TG, 1995, INFECT IMMUN, V63, P1394, DOI 10.1128/IAI.63.4.1394-1399.1995; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Challacombe SJ, 1997, VACCINE, V15, P169, DOI 10.1016/S0264-410X(96)00159-4; CHALLACOMBE SJ, 1992, IMMUNOLOGY, V76, P164; Chang SY, 2008, J IMMUNOL, V180, P1609, DOI 10.4049/jimmunol.180.3.1609; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; Chorny A, 2010, ADV IMMUNOL, V107, P31, DOI [10.1016/S0065-2776(10)07006-9, 10.1016/B978-0-12-381300-8.00002-2]; de Haan L, 2001, VACCINE, V19, P2898, DOI 10.1016/S0264-410X(00)00556-9; de Jong R, 1998, SCIENCE, V280, P1435; Desai MP, 1996, PHARMACEUT RES, V13, P1838, DOI 10.1023/A:1016085108889; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Forbes SJ, 2008, INFECT IMMUN, V76, P4137, DOI 10.1128/IAI.00416-08; Forbes SJ, 2011, MBIO, V2, DOI 10.1128/mBio.00042-11; Gallichan WS, 1996, J EXP MED, V184, P1879, DOI 10.1084/jem.184.5.1879; Grassly NC, 2012, J INFECT DIS, V205, P1554, DOI 10.1093/infdis/jis241; Gregory AE, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00013; HANSON DG, 1979, J IMMUNOL, V122, P2261; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Herremans TMPT, 1999, J IMMUNOL, V162, P5011; Horton RE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00200; Howe SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114601; Howe SE, 2014, PLOS ONE, V9, DOI [10.1371/ journal. pone. 0086656, DOI 10.1371/J0URNAL.P0NE.0086656]; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Iankov ID, 2004, MICROBES INFECT, V6, P901, DOI 10.1016/j.micinf.2004.05.007; JANI P, 1990, J PHARM PHARMACOL, V42, P821, DOI 10.1111/j.2042-7158.1990.tb07033.x; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; LYCKE N, 1987, SCAND J IMMUNOL, V25, P407, DOI 10.1111/j.1365-3083.1987.tb02207.x; LYCKE N, 1987, SCAND J IMMUNOL, V25, P413, DOI 10.1111/j.1365-3083.1987.tb02208.x; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Mantis NJ, 2010, IMMUNOL INVEST, V39, P383, DOI 10.3109/08820131003622635; MAURER PH, 1954, J IMMUNOL, V72, P119; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; PHALIPON A, 1995, J EXP MED, V182, P769, DOI 10.1084/jem.182.3.769; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Robinson JK, 2001, J IMMUNOL, V166, P3688, DOI 10.4049/jimmunol.166.6.3688; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; THOMAS HC, 1974, IMMUNOLOGY, V27, P631; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Zhu Q, 2012, NAT MED, V18, P1291, DOI 10.1038/nm.2866	59	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118067	10.1371/journal.pone.0118067	http://dx.doi.org/10.1371/journal.pone.0118067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710518	Green Published, gold			2022-12-27	WOS:000350683900047
J	Moumene, A; Marcelino, I; Ventosa, M; Gros, O; Lefrancois, T; Vachiery, N; Meyer, DF; Coelho, AV				Moumene, Amal; Marcelino, Isabel; Ventosa, Miguel; Gros, Olivier; Lefrancois, Thierry; Vachiery, Nathalie; Meyer, Damien F.; Coelho, Ana V.			Proteomic Profiling of the Outer Membrane Fraction of the Obligate Intracellular Bacterial Pathogen Ehrlichia ruminantium	PLOS ONE			English	Article							IV SECRETION SYSTEM; PROTEIN SUBCELLULAR-LOCALIZATION; SURFACE-EXPOSED PROTEINS; ESCHERICHIA-COLI; MULTIGENE FAMILY; HELICOBACTER-PYLORI; STRUCTURAL BIOLOGY; BINDING PROTEIN; YAET COMPLEX; CHAFFEENSIS	The outer membrane proteins (OMPs) of Gram-negative bacteria play a crucial role in virulence and pathogenesis. Identification of these proteins represents an important goal for bacterial proteomics, because it aids in vaccine development. Here, we have developed such an approach for Ehrlichia ruminantium, the obligate intracellular bacterium that causes heartwater. A preliminary whole proteome analysis of elementary bodies, the extracellular infectious form of the bacterium, had been performed previously, but information is limited about OMPs in this organism and about their role in the protective immune response. Identification of OMPs is also essential for understanding Ehrlichia's OM architecture, and how the bacterium interacts with the host cell environment. First, we developed an OMP extraction method using the ionic detergent sarkosyl, which enriched the OM fraction. Second, proteins were separated via one-dimensional electrophoresis, and digested peptides were analyzed via nano-liquid chromatographic separation coupled with mass spectrometry (LC-MALDI-TOF/TOF). Of 46 unique proteins identified in the OM fraction, 18 (39%) were OMPs, including 8 proteins involved in cell structure and biogenesis, 4 in transport/virulence, 1 porin, and 5 proteins of unknown function. These experimental data were compared to the predicted subcellular localization of the entire E. ruminantium proteome, using three different algorithms. This work represents the most complete proteome characterization of the OM fraction in Ehrlichia spp. The study indicates that suitable subcellular fractionation experiments combined with straightforward computational analysis approaches are powerful for determining the predominant subcellular localization of the experimentally observed proteins. We identified proteins potentially involved in E. ruminantium pathogenesis, which are good novel targets for candidate vaccines. Thus, combining bioinformatics and investigating new vaccines against this organism. In summary, we provide both pioneering data and novel insights into the pathogenesis of this obligate intracellular bacterium.	[Moumene, Amal; Vachiery, Nathalie; Meyer, Damien F.] CIRAD, UMR CMAEE, Site Duclos, F-97170 Petit Bourg, Guadeloupe, France; [Moumene, Amal; Lefrancois, Thierry; Vachiery, Nathalie; Meyer, Damien F.] INRA, UMR CMAEE 1309, F-34398 Montpellier, France; [Moumene, Amal] Univ Antilles Guyane, Pointe a Pitre 97159, Guadeloupe, France; [Marcelino, Isabel; Ventosa, Miguel] Inst Biol Expt & Tecnol, P-2780901 Oeiras, Portugal; [Marcelino, Isabel; Ventosa, Miguel; Coelho, Ana V.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780157 Oeiras, Portugal; [Gros, Olivier] Univ Antilles Guyane, Inst Biol Paris Seine, UMR UPMC CNRS 7138, Dept Biol,UFR Sci Exactes & Nat,Equipe Biol Mangr, Pointe a Pitre 97159, Guadeloupe, France	CIRAD; INRAE; Universite des Antilles; Universidade Nova de Lisboa; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Universite des Antilles	Meyer, DF (corresponding author), CIRAD, UMR CMAEE, Site Duclos, F-97170 Petit Bourg, Guadeloupe, France.	damien.meyer@cirad.fr	Coelho, Ana V/H-8885-2012; lefrancois, thierry/C-5070-2011; Coelho, Ana V Varela/O-3977-2014; Marcelino, Isabel/D-6503-2017; Meyer, Damien/G-2607-2013	Coelho, Ana V/0000-0002-6143-4203; lefrancois, thierry/0000-0001-8793-5228; Coelho, Ana V Varela/0000-0002-6143-4203; Marcelino, Isabel/0000-0001-5454-8811; Meyer, Damien/0000-0003-2735-176X	FEDER grant, "Risque en sante animale et vegetale" [FED 1/1.4-30305]; PAUILF; Identification des proteines de la membrane externe de la Rickettsiales Ehrlichia ruminantium par une approche de proteomique; Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/CVT/114118/2009, PEst-OE/EQB/LA0004/2011, SFRH/BPD/45978/2008]	FEDER grant, "Risque en sante animale et vegetale"; PAUILF; Identification des proteines de la membrane externe de la Rickettsiales Ehrlichia ruminantium par une approche de proteomique; Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors acknowledge financial support from FEDER grant FED 1/1.4-30305, 2007-2013, "Risque en sante animale et vegetale" (PhD grant to AM), a PAUILF grant (Programme des Actions Universitaires Inteegrees Luso-Francaises), 2011-2012, "Identification des proteines de la membrane externe de la Rickettsiales Ehrlichia ruminantium par une approche de proteomique," and the Fundacao para a Ciencia e Tecnologia (FCT, Lisbon, Portugal; research project PTDC/CVT/114118/2009, research grant PEst-OE/EQB/LA0004/2011, and Post-doc grant SFRH/BPD/45978/2008 to IM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Allsopp BA, 2010, VET PARASITOL, V167, P123, DOI 10.1016/j.vetpar.2009.09.014; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ayalew S, 2010, PROTEOMICS, V10, P2151, DOI 10.1002/pmic.200900557; Bekker CPJ, 2005, J BACTERIOL, V187, P4782, DOI 10.1128/JB.187.14.4782-4791.2005; Boonjakuakul JK, 2007, INFECT IMMUN, V75, P2548, DOI 10.1128/IAI.01974-06; Brown RN, 2010, J PROTEOME RES, V9, P4454, DOI 10.1021/pr100215h; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Christie PJ, 2009, NATURE, V462, P992, DOI 10.1038/462992b; Coquet L, 2005, J PROTEOME RES, V4, P1988, DOI 10.1021/pr050165c; Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x; Doerrler WT, 2005, J BIOL CHEM, V280, P27679, DOI 10.1074/jbc.M504796200; E-Komon T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-63; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; Faburay B, 2007, VACCINE, V25, P7939, DOI 10.1016/j.vaccine.2007.09.002; Felek S, 2003, J CLIN MICROBIOL, V41, P886, DOI 10.1128/JCM.41.2.886-888.2003; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; Franco CF, 2011, PROTEOMICS, V11, P3587, DOI 10.1002/pmic.201000745; Frisk A, 1998, INFECT IMMUN, V66, P1252, DOI 10.1128/IAI.66.3.1252-1257.1998; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Frutos R, 2006, J BACTERIOL, V188, P2533, DOI 10.1128/JB.188.7.2533-2542.2006; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Galdiero S, 2012, CURR PROTEIN PEPT SC, V13, P843, DOI 10.2174/138920312804871120; Garduno RA, 1998, INFECT IMMUN, V66, P4602; Ge Y, 2007, J BACTERIOL, V189, P7819, DOI 10.1128/JB.00866-07; Ge Y, 2007, INFECT IMMUN, V75, P3833, DOI 10.1128/IAI.00188-07; Gros O, 2012, ENVIRON MICROBIOL, V14, P1584, DOI 10.1111/j.1462-2920.2012.02748.x; Hennequin C, 2001, MICROB PATHOGENESIS, V31, P255, DOI 10.1006/mpat.2001.0468; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Hicks SW, 2013, NAT REV MICROBIOL, V11, P316, DOI 10.1038/nrmicro3009; Hoang HH, 2011, MBIO, V2, DOI 10.1128/mBio.00246-11; Hobb RI, 2009, MICROBIOL-SGM, V155, P979, DOI 10.1099/mic.0.024539-0; Hoge R., 2010, CURR RES TECHNOL ED, P383; Huesca M, 1996, INFECT IMMUN, V64, P2643, DOI 10.1128/IAI.64.7.2643-2648.1996; Jagannadham MV, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004549; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; JONGEJAN F, 1991, ONDERSTEPOORT J VET, V58, P227; Jongejan F, 1993, Rev Elev Med Vet Pays Trop, V46, P223; Khemiri A, 2008, ANAL BIOANAL CHEM, V390, P1861, DOI 10.1007/s00216-008-1923-1; Kossmehl S, 2013, PROTEOMICS, V13, P2743, DOI 10.1002/pmic.201300112; Kulkarni HM, 2014, J PROTEOME RES, V13, P1345, DOI 10.1021/pr4009223; KUSUKAWA N, 1989, EMBO J, V8, P3517, DOI 10.1002/j.1460-2075.1989.tb08517.x; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Lopez JE, 2007, INFECT IMMUN, V75, P2333, DOI 10.1128/IAI.00061-07; Magnus M, 2012, BBA-PROTEINS PROTEOM, V1824, P1425, DOI 10.1016/j.bbapap.2012.05.018; Mahan SM, 2001, VET PARASITOL, V97, P295, DOI 10.1016/S0304-4017(01)00437-X; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Marcelino I, 2005, VET MICROBIOL, V110, P87, DOI 10.1016/j.vetmic.2005.07.012; Marcelino I, 2007, VACCINE, V25, P4903, DOI 10.1016/j.vaccine.2007.04.055; Marcelino I, 2012, VET MICROBIOL, V156, P305, DOI 10.1016/j.vetmic.2011.11.022; Meyer DF, 2013, NUCLEIC ACIDS RES, V41, P9218, DOI 10.1093/nar/gkt718; Morse K, 2012, INFECT IMMUN, V80, P215, DOI 10.1128/IAI.05798-11; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NOWALK AJ, 1994, BIOCHEMISTRY-US, V33, P12769, DOI 10.1021/bi00209a007; Ohashi N, 1998, J CLIN MICROBIOL, V36, P2671, DOI 10.1128/JCM.36.9.2671-2680.1998; Ohashi N, 1998, INFECT IMMUN, V66, P132, DOI 10.1128/IAI.66.1.132-139.1998; Oleastro Monica, 2013, Biology (Basel), V2, P1110, DOI 10.3390/biology2031110; Papanastasiou M, 2013, MOL CELL PROTEOMICS, V12, P599, DOI 10.1074/mcp.M112.024711; Peter TF, 2002, TRENDS PARASITOL, V18, P214, DOI 10.1016/S1471-4922(02)02251-1; Postigo M, 2008, VET MICROBIOL, V128, P136, DOI 10.1016/j.vetmic.2007.09.023; Pretorius A, 2007, VACCINE, V25, P2316, DOI 10.1016/j.vaccine.2006.11.061; Raliniaina M, 2010, VET PARASITOL, V167, P187, DOI 10.1016/j.vetpar.2009.09.020; Rhomberg TA, 2004, PROTEOMICS, V4, P3021, DOI 10.1002/pmic.200400933; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Roszczenko P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046563; SCORPIO A, 1994, J BACTERIOL, V176, P6449, DOI 10.1128/JB.176.21.6449-6456.1994; Seo GM, 2008, INFECT IMMUN, V76, P4823, DOI 10.1128/IAI.00484-08; Seyer D., 2005, BIOFILMS, V2, P27, DOI [10.1017/S1479050505001638, DOI 10.1017/S1479050505001638]; Shevchuk O, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00074; Shouldice SR, 2003, J BIOL CHEM, V278, P11513, DOI 10.1074/jbc.M211780200; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Stekhoven DJ, 2014, J PROTEOMICS, V99, P123, DOI 10.1016/j.jprot.2014.01.015; Tellez R, 2012, J BACTERIOL, V194, P317, DOI 10.1128/JB.06192-11; Traidej M, 2003, INVEST OPHTH VIS SCI, V44, P190, DOI 10.1167/iovs.02-0458; Unver A, 2002, INFECT IMMUN, V70, P4701, DOI 10.1128/IAI.70.8.4701-4704.2002; Vachiery N, 2013, DEV BIOLOGICALS, V135, P191, DOI 10.1159/000190050; van den Berg B, 2013, NAT STRUCT MOL BIOL, V20, P1237, DOI 10.1038/nsmb.2709; van Heerden H, 2004, GENE, V330, P159, DOI 10.1016/j.gene.2004.01.020; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; Weiner JH, 2008, BBA-BIOMEMBRANES, V1778, P1698, DOI 10.1016/j.bbamem.2007.07.020; Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x; Wolff S, 2008, MOL CELL PROTEOMICS, V7, P1460, DOI 10.1074/mcp.M700554-MCP200; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	90	13	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0116758	10.1371/journal.pone.0116758	http://dx.doi.org/10.1371/journal.pone.0116758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710494	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900014
J	von der Heyde, S; Wagner, S; Czerny, A; Nietert, M; Ludewig, F; Salinas-Riester, G; Arlt, D; Beissbarth, T				von der Heyde, Silvia; Wagner, Steve; Czerny, Alexander; Nietert, Manuel; Ludewig, Fabian; Salinas-Riester, Gabriela; Arlt, Dorit; Beissbarth, Tim			mRNA Profiling Reveals Determinants of Trastuzumab Efficiency in HER2-Positive Breast Cancer	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; IGFBP-3 POLYMORPHISMS; CIRCULATING LEVELS; GENETIC-VARIATION; QUANTITATIVE PCR; PATHWAY GENES; EXPRESSION; CELLS; RESISTANCE; CYCLOOXYGENASE-2	Intrinsic and acquired resistance to the monoclonal antibody drug trastuzumab is a major problem in the treatment of HER2-positive breast cancer. A deeper understanding of the underlying mechanisms could help to develop new agents. Our intention was to detect genes and single nucleotide polymorphisms (SNPs) affecting trastuzumab efficiency in cell culture. Three HER2-positive breast cancer cell lines with different resistance phenotypes were analyzed. We chose BT474 as model of trastuzumab sensitivity, HCC1954 as model of intrinsic resistance, and BTR50, derived from BT474, as model of acquired resistance. Based on RNA-Seq data, we performed differential expression analyses on these cell lines with and without trastuzumab treatment. Differentially expressed genes between the resistant cell lines and BT474 are expected to contribute to resistance. Differentially expressed genes between untreated and trastuzumab treated BT474 are expected to contribute to drug efficacy. To exclude false positives from the candidate gene set, we removed genes that were also differentially expressed between untreated and trastuzumab treated BTR50. We further searched for SNPs in the untreated cell lines which could contribute to trastuzumab resistance. The analysis resulted in 54 differentially expressed candidate genes that might be connected to trastuzumab efficiency. 90% of 40 selected candidates were validated by RT-qPCR. ALPP, CALCOCO1, CAV1, CYP1A2 and IGFBP3 were significantly higher expressed in the trastuzumab treated than in the untreated BT474 cell line. GDF15, IL8, LCN2, PTGS2 and 20 other genes were significantly higher expressed in HCC1954 than in BT474, while NCAM2, COLEC12, AFF3, TFF3, NRCAM, GREB1 and TFF1 were significantly lower expressed. Additionally, we inferred SNPs in HCC1954 for CAV1, PTGS2, IL8 and IGFBP3. The latter also had a variation in BTR50. 20% of the validated subset have already been mentioned in literature. For half of them we called and analyzed SNPs. These results contribute to a better understanding of trastuzumab action and resistance mechanisms.	[von der Heyde, Silvia; Czerny, Alexander; Nietert, Manuel; Beissbarth, Tim] Univ Med Ctr Gottingen, Dept Med Stat, Stat Bioinformat, Gottingen, Germany; [von der Heyde, Silvia] IndivuTest GmbH, Hamburg, Germany; [Wagner, Steve; Arlt, Dorit] German Canc Res Ctr, Div Stem Cells & Canc, Heidelberg, Germany; [Wagner, Steve; Arlt, Dorit] German Canc Res Ctr, Div Mol Genome Anal, Heidelberg, Germany; [Ludewig, Fabian; Salinas-Riester, Gabriela] Univ Gottingen, Dept Dev Biochem, DNA Microarray & Deep Sequencing Facil Gottingen, D-37073 Gottingen, Germany	University of Gottingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Gottingen	Beissbarth, T (corresponding author), Univ Med Ctr Gottingen, Dept Med Stat, Stat Bioinformat, Gottingen, Germany.	tim.beissbarth@ams.med.uni-goettingen.de		Wolff, Alexander/0000-0003-2262-9056; Nietert, Manuel/0000-0001-5443-7943	German Federal Ministry of Education and Research in the platform MedSys via the project BreastSys [0315396A]; German Federal Ministry of Education and Research in the platform e:Bio via the project MetastaSys [0316173A]; German Federal Ministry of Education and Research in the platform e:Med via the project Her2Low [031A429C]; BreastSys; MetastaSys; Open Access Publication Funds of the Gottingen University	German Federal Ministry of Education and Research in the platform MedSys via the project BreastSys; German Federal Ministry of Education and Research in the platform e:Bio via the project MetastaSys; German Federal Ministry of Education and Research in the platform e:Med via the project Her2Low; BreastSys; MetastaSys; Open Access Publication Funds of the Gottingen University	This work was supported by the German Federal Ministry of Education and Research in the platform MedSys via the project BreastSys (grant 0315396A, URL http://www.ams.med.uni-goettingen.de/breastsys/), in the platform e:Bio via the project MetastaSys (grant 0316173A, URL http://www.ams.med.unigoettingen.de/metastasys/) and in the platform e:Med via the project Her2Low (grant 031A429C, URL http://www.ams.med.uni-goettingen.de/her2low/). TB received the mentioned funding. Above that SvdH, MN, SW and DA were funded by BreastSys. AC was funded by MetastaSys. The authors also acknowledge support by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JE, 2009, CLIN CANCER RES, V15, P2181, DOI 10.1158/1078-0432.CCR-08-0716; Agnihotri N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3371; Ahmed ARH, 2012, AM J PATHOL, V180, P904, DOI 10.1016/j.ajpath.2011.11.022; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Axlund SD, 2013, HORM CANCER-US, V4, P36, DOI 10.1007/s12672-012-0127-5; Ayari I, 2013, MOL MED REP, V7, P280, DOI 10.3892/mmr.2012.1164; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Basu GD, 2004, MOL CANCER RES, V2, P632; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit V, 2004, ONCOGENE, V23, P1631, DOI 10.1038/sj.onc.1207295; Benusiglio PR, 2005, BREAST CANCER RES, V7, pR204, DOI 10.1186/bcr982; Breyer JP, 2009, CANCER EPIDEM BIOMAR, V18, P1252, DOI 10.1158/1055-9965.EPI-08-1202; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; Cheng I, 2007, J CLIN ENDOCR METAB, V92, P3660, DOI 10.1210/jc.2007-0790; Cho HY, 2009, CANCER LETT, V282, P87, DOI 10.1016/j.canlet.2009.03.007; Collins DC, 2015, ONCOGENE, V34, P525, DOI 10.1038/onc.2013.586; Cox DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1635; D'Aloisio AA, 2009, CANCER EPIDEM BIOMAR, V18, P954, DOI 10.1158/1055-9965.EPI-08-0856; Dang CT, 2004, CLIN CANCER RES, V10, P4062, DOI 10.1158/1078-0432.CCR-03-0463; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Cello F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068630; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Dokmanovic M, 2011, MOL CANCER THER, V10, P917, DOI 10.1158/1535-7163.MCT-10-0980; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Einarsdottir K, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1623; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Evans AH, 2010, BRIT J CANCER, V102, P1235, DOI 10.1038/sj.bjc.6605641; Festa-Vasconcellos JS, 2012, BREAST CANCER RES TR, V132, P251, DOI 10.1007/s10549-011-1828-0; Figueroa-Magalhaes MC, 2014, BREAST, V23, P128, DOI 10.1016/j.breast.2013.11.011; FISHMAN WH, 1987, CLIN BIOCHEM, V20, P387, DOI 10.1016/0009-9120(87)90003-8; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Flowers M, 2009, J ARCHIT EDUC, V62, P4, DOI 10.1111/j.1531-314X.2009.00996.x; Gerger A, 2010, BREAST CANCER RES TR, V119, P701, DOI 10.1007/s10549-009-0417-y; Gianni L, 2002, ONCOLOGY-BASEL, V63, P47, DOI 10.1159/000066197; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Goncalves A, 2008, MOL CELL PROTEOMICS, V7, P1420, DOI 10.1074/mcp.M700487-MCP200; Gray IC, 2000, HUM MOL GENET, V9, P2403, DOI 10.1093/hmg/9.16.2403; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Heil J, 2012, BREAST, V21, P303, DOI 10.1016/j.breast.2012.01.009; Henjes F, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.16; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; Janssen JWG, 2002, INT J CANCER, V102, P608, DOI 10.1002/ijc.10765; Jelovac D, 2012, CURR TREAT OPTION ON, V13, P230, DOI 10.1007/s11864-012-0186-4; Jerome L, 2006, CANCER RES, V66, P7245, DOI 10.1158/0008-5472.CAN-05-3555; Ji Q, 2004, CANCER RES, V64, P7610, DOI 10.1158/0008-5472.CAN-04-1608; Joshi JP, 2011, BIOCHEM PHARMACOL, V82, P1090, DOI 10.1016/j.bcp.2011.07.082; Jung JH, 2010, J CANCER RES CLIN, V136, P685, DOI 10.1007/s00432-009-0707-0; Kataoka Y, 2010, ANN ONCOL, V21, P255, DOI 10.1093/annonc/mdp304; Knutson TP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3211; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Kumandan S, 2013, CANCER LETT, V329, P236, DOI 10.1016/j.canlet.2012.11.014; Kwok Pui-Yan, 2003, Current Issues in Molecular Biology, V5, P43; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Lee YK, 2012, CANCER SCI, V103, P1280, DOI 10.1111/j.1349-7006.2012.02302.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XY, 2014, ONCOTARGET, V5, P788, DOI 10.18632/oncotarget.1772; Lin HH, 2011, INT J BIOL SCI, V7, P74, DOI 10.7150/ijbs.7.74; Liu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046410; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SL, 2013, MODERN PATHOL, V26, P485, DOI 10.1038/modpathol.2012.187; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Luo LY, 2002, BRIT J CANCER, V86, P1790, DOI 10.1038/sj.bjc.6600323; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Mann M, 2001, GASTROENTEROLOGY, V120, P1713, DOI 10.1053/gast.2001.24844; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moore AE, 2012, ONCOGENE, V31, P1592, DOI 10.1038/onc.2011.349; Morrison LE, 2007, GENE CHROMOSOME CANC, V46, P397, DOI 10.1002/gcc.20419; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Patel AV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002578; Prat A, 2014, CLIN CANCER RES, V20, P511, DOI 10.1158/1078-0432.CCR-13-0239; Qian BY, 2011, BREAST CANCER RES TR, V130, P217, DOI 10.1007/s10549-011-1552-9; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; R Core Team, 2021, R LANGUAGE ENV STAT; Ristimaki A, 2002, CANCER RES, V62, P632; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sekhar SC, 2013, J CANCER, V4, P391, DOI 10.7150/jca.6470; Sherry ST, 1999, GENOME RES, V9, P677; Srinivasan S, 2013, NAT CHEM BIOL, V9, P326, DOI [10.1038/NCHEMBIO.1214, 10.1038/nchembio.1214]; Su XF, 2010, INT J CANCER, V126, P180, DOI 10.1002/ijc.24674; Tamimi RM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1655; Tong L, 2012, ASIAN PAC J CANCER P, V13, P5599, DOI 10.7314/APJCP.2012.13.11.5599; Vadlamudi R, 1999, ONCOGENE, V18, P305, DOI 10.1038/sj.onc.1202307; Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Verma P, 2010, MOL BIOL CELL, V21, P2226, DOI 10.1091/mbc.E09-05-0417; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Yousef GM, 2004, BRIT J CANCER, V90, P167, DOI 10.1038/sj.bjc.6601451; Yousef GM, 2002, CLIN CHEM, V48, P1241; Yu JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2821; Yu KD, 2010, BREAST CANCER RES TR, V122, P251, DOI 10.1007/s10549-009-0688-3; Zhao CY, 2009, ENDOCRINE, V36, P224, DOI 10.1007/s12020-009-9233-8; Zhu W, 2010, MOL BIOL REP, V37, P277, DOI 10.1007/s11033-009-9685-1	99	27	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117818	10.1371/journal.pone.0117818	http://dx.doi.org/10.1371/journal.pone.0117818			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710561	Green Submitted, Green Published, gold			2022-12-27	WOS:000350683900039
J	Aduda, DSO; Ouma, C; Onyango, R; Onyango, M; Bertrand, J				Aduda, Dickens S. Omondi; Ouma, Collins; Onyango, Rosebella; Onyango, Mathews; Bertrand, Jane			Voluntary Medical Male Circumcision Scale-Up in Nyanza, Kenya: Evaluating Technical Efficiency and Productivity of Service Delivery	PLOS ONE			English	Article							HIV PREVENTION; HEALTH-CARE; QUALITY; PERFORMANCE; DEA	Background Voluntary medical male circumcision (VMMC) service delivery is complex and resource-intensive. In Kenya's context there is still paucity of information on resource use vis-a-vis outputs as programs scale up. Knowledge of technical efficiency, productivity and potential sources of constraints is desirable to improve decision-making. Objective To evaluate technical efficiency and productivity of VMMC service delivery in Nyanza in 2011/2012 using data envelopment analysis. Design Comparative process evaluation of facilities providing VMMC in Nyanza in 2011/2012 using output orientated data envelopment analysis. Results Twenty one facilities were evaluated. Only 1 of 7 variables considered (total elapsed operation time) significantly improved from 32.8 minutes (SD 8.8) in 2011 to 30 minutes (SD 6.6) in 2012 (95% CI = 0.0350-5.2488; p = 0.047). Mean scale technical efficiency significantly improved from 91% (SD 19.8) in 2011 to 99% (SD 4.0) in 2012 particularly among outreach compared to fixed service delivery facilities (CI -31.47959-4.698508; p = 0.005). Increase in mean VRS technical efficiency from 84% (SD 25.3) in 2011 and 89% (SD 25.1) in 2012 was not statistically significant. Benchmark facilities were #119 and #125 in 2011 and #103 in 2012. Malmquist Productivity Index (MPI) at fixed facilities declined by 2.5% but gained by 4.9% at outreach ones by 2012. Total factor productivity improved by 83% (p = 0.032) in 2012, largely due to progress in technological efficiency by 79% (p = 0.008). Conclusions Significant improvement in scale technical efficiency among outreach facilities in 2012 was attributable to accelerated activities. However, ongoing pure technical inefficiency requires concerted attention. Technological progress was the key driver of service productivity growth in Nyanza. Incorporating service-quality dimensions and using stepwise-multiple criteria in performance evaluation enhances comprehensiveness and validity. These findings highlight site-level resource use and sources of variations in VMMC service productivity, which are important for program planning.	[Aduda, Dickens S. Omondi; Onyango, Rosebella] Maseno Univ, Dept Publ Hlth & Community Dev, Maseno, Kenya; [Ouma, Collins] Maseno Univ, Dept Biomed Sci & Technol, Maseno, Kenya; [Onyango, Mathews] Kisumu Off, Male Circumcis Consortium, Kisumu, Kenya; [Bertrand, Jane] Tulane Univ, Dept Global Hlth Syst & Dev, New Orleans, LA 70112 USA	Maseno University; Maseno University; Tulane University	Aduda, DSO (corresponding author), Maseno Univ, Dept Publ Hlth & Community Dev, Maseno, Kenya.	omondisda@yahoo.com		Ouma, Collins/0000-0001-8205-8887	USAID|Project SEARCH - US Agency for International Development [GHH-I-00-07-00032-00]; President's Emergency Plan for AIDS Relief	USAID|Project SEARCH - US Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by USAID|Project SEARCH, Task Order No. 2, funded by the US Agency for International Development under Contract No. GHH-I-00-07-00032-00, beginning 30 September 2008, and supported by the President's Emergency Plan for AIDS Relief. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduda DSO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101235; Afonso A, 2008, 072008DEUECE WP LISB; [Anonymous], 2003, QUANTITATIVE MODELS; Arah OA, 2003, INT J QUAL HEALTH C, V15, P377, DOI 10.1093/intqhc/mzg049; Avkiran NK, 2001, SOCIOECON PLANN SCI, V35, P57, DOI DOI 10.1016/S0038-0121(00)00010-0; Balk BM, 2001, J PROD ANAL, V15, P159, DOI 10.1023/A:1011117324278; BANKER RD, 1986, MANAGE SCI, V32, P1613, DOI 10.1287/mnsc.32.12.1613; Bertrand JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082518; Bessent A, 1979, 361 CCS; Bollinger L, 2009, 1 FUT GROUP HLTH POL, DOI [10.1111/jsm.12703, DOI 10.1111/JSM.12703]; Chowdhury H., 2010, EFFICIENCY TECHNOLOG; Cooper W., 2006, DATA ENVELOPMENT ANA; Cooper WW., 2007, DATA ENVELOPMENT ANA, V2nd; Derose SF, 2002, ANNU REV PUBL HEALTH, V23, P1, DOI 10.1146/annurev.publhealth.23.092601.095644; Donthu N, 1998, J RETAILING, V74, P89, DOI 10.1016/S0022-4359(99)80089-X; Fried HO, 2002, J PROD ANAL, V17, P157, DOI 10.1023/A:1013548723393; Galagedera DUA, 2004, DOES MODEL MISSPECIF; Giuffrida A, MEASURING PERFORMANC; Hathorn E, 2011, SEX TRANSM INFECT, V87, P508, DOI 10.1136/sextrans-2011-050107; Herman-Roloff A, 2010, MONITORING EVALUATIO; Hirschberg JG, 2001, ECONOMICS; Hollingsworth B, 2008, HEALTH ECON, V17, P1107, DOI 10.1002/hec.1391; Hollingsworth Bruce, 2003, Health Care Manag Sci, V6, P203, DOI 10.1023/A:1026255523228; Hulten C.R., 2001, NEW DEV PRODUCTIVITY, P1, DOI 10.7208/chicago/9780226360645.001.0001; Jacobs R, 2006, MEASURING EFFICIENCY; Jennings L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079524; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kinoti SN, 2010, OVERCOMING HUMAN RES; Kirigia J M, 1998, Afr J Health Sci, V5, P79; Kirigia JM, 2004, J MED SYST, V28, P155, DOI 10.1023/B:JOMS.0000023298.31972.c9; Kirigia MJ, 2002, J MED SYSTEMS, V26; Kundurjiev T, 2011, TECHNICAL EFFIENCY H; Lee ST, 2000, IMPACT NOISY CATCH D; Lukas CV, 2010, CHALLENGES MEASURING; Marketta V, 2008, TECHNICAL EFFICIENCY; McGlynn EA., 2008, IDENTIFYING CATEGORI, V08-0030; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Nalwadda G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027908; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Ozgen H, 2002, HEALTH SERV RES, V37, P711, DOI 10.1111/1475-6773.00045; Park J, 2012, INT J INNOV COMPUT I, V8, P5821; PEPFAR, 2013, PEPFARS BEST PRACT V; Perry L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084215; Rech D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080577; Rech D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084271; Sherman HD, 2006, ANN OPER RES, V145, P301, DOI 10.1007/s10479-006-0037-4; Shimshak DG, 2009, OMEGA-INT J MANAGE S, V37, P672, DOI 10.1016/j.omega.2008.05.004; Simar L, 2006, ECONOMET REV, V25, P497, DOI 10.1080/07474930600972582; Spinks J, 2005, HLTH PRODUCTION SOCI; Wang YM, 2009, J COMPUT APPL MATH, V223, P469, DOI 10.1016/j.cam.2008.01.022; Wegbreit J, 2006, AIDS, V20, P1217, DOI 10.1097/01.aids.0000232229.96134.56; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization (WHO), 2010, CONS IMPL MOD OPT VO; Worthington AC, 2004, MED CARE RES REV, V61, P135, DOI 10.1177/1077558704263796; Zere Eyob, 2006, Cost Eff Resour Alloc, V4, P5	56	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118152	10.1371/journal.pone.0118152	http://dx.doi.org/10.1371/journal.pone.0118152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706119	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100146
J	Bodilsen, AC; Juul-Larsen, HG; Petersen, J; Beyer, N; Andersen, O; Bandholm, T				Bodilsen, Ann Christine; Juul-Larsen, Helle Gybel; Petersen, Janne; Beyer, Nina; Andersen, Ove; Bandholm, Thomas			Feasibility and Inter-Rater Reliability of Physical Performance Measures in Acutely Admitted Older Medical Patients	PLOS ONE			English	Article							LOWER-EXTREMITY FUNCTION; CUMULATED AMBULATION SCORE; EARLY WARNING SCORE; MEASUREMENT ERROR; MEANINGFUL CHANGE; GAIT SPEED; HIP; HOSPITALIZATION; STRENGTH; DISABILITY	Objective Physical performance measures can be used to predict functional decline and increased dependency in older persons. However, few studies have assessed the feasibility or reliability of such measures in hospitalized older patients. Here we assessed the feasibility and inter-rater reliability of four simple measures of physical performance in acutely admitted older medical patients. Design During the first 24 hours of hospitalization, the following were assessed twice by different raters in 52 (>= 65 years) patients admitted for acute medical illness: isometric hand grip strength, 4-meter gait speed, 30-s chair stand and Cumulated Ambulation Score. Relative reliability was expressed as weighted kappa for the Cumulated Ambulation Score or as intra-class correlation coefficient (ICC1,1) and lower limit of the 95%-confidence interval (LL95%) for grip strength, gait speed, and 30-s chair stand. Absolute reliability was expressed as the standard error of measurement and the smallest real difference as a percentage of their respective means (SEM% and SRD%). Results The primary reasons for admission of the 52 included patients were infectious disease and cardiovascular illness. The mean +/- SD age was 78 +/- 8.3 years, and 73.1% were women. All patients performed grip strength and Cumulated Ambulation Score testing, 81% performed the gait speed test, and 54% completed the 30-s chair stand test (46% were unable to rise without using the armrests). No systematic bias was found between first and second tests or between raters. The weighted kappa for the Cumulated Ambulation Score was 0.76 (0.60-0.92). The ICC1,1 values were as follows: grip strength, 0.95 (LL95% 0.92); gait speed, 0.92 (LL95% 0.73), and 30-s chair stand, 0.82 (LL95% 0.67). The SEM% values for grip strength, gait speed, and 30-s chair stand were 8%, 7%, and 18%, and the SRD95% values were 22%, 17%, and 49%. Conclusion In acutely admitted older medical patients, grip strength, gait speed, and the Cumulated Ambulation Score measurements were feasible and showed high inter-rater reliability when administered by different raters. The feasibility and inter-rater reliability of the 30-s chair stand were moderate, complicating the use of the 30-s chair stand in acutely admitted older medical patients. However, the predefined modified version of the chair stand test was both feasible and with high inter-rater reliability in this population.	[Bodilsen, Ann Christine; Juul-Larsen, Helle Gybel; Petersen, Janne; Andersen, Ove; Bandholm, Thomas] Copenhagen Univ Hosp, Clin Res Ctr, Optimized Senior Patient Program, Hvidovre, Denmark; [Bodilsen, Ann Christine; Bandholm, Thomas] Copenhagen Univ Hosp, Phys Med & Rehabil Res Copenhagen, Hvidovre, Denmark; [Bodilsen, Ann Christine; Bandholm, Thomas] Copenhagen Univ Hosp, Dept Physiotherapy, Hvidovre, Denmark; [Beyer, Nina] Univ Copenhagen, Bispebjerg Hosp, Dept Phys Therapy, Musculoskeletal Rehabil Res Unit, DK-1168 Copenhagen, Denmark; [Beyer, Nina] Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med, DK-1168 Copenhagen, Denmark; [Beyer, Nina] Univ Copenhagen, Frederiksberg Hosp, DK-1168 Copenhagen, Denmark; [Andersen, Ove] Copenhagen Univ Hosp, Emergency Dept, Hvidovre, Denmark; [Bandholm, Thomas] Copenhagen Univ Hosp, Dept Orthopaed Surg, Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen	Bodilsen, AC (corresponding author), Copenhagen Univ Hosp, Clin Res Ctr, Optimized Senior Patient Program, Hvidovre, Denmark.	Ann.Christine.Bodilsen@regionh.dk	Bandholm, Thomas/AAZ-8632-2020; Andersen, Ove/D-3091-2019; Zixuan, Huang/ABI-3557-2020	Bandholm, Thomas/0000-0001-6884-1971; Andersen, Ove/0000-0002-2274-548X; Petersen, Janne/0000-0001-7323-2548	Danish Association of Physical Therapists; Lundbeck Foundation [FP 11/2013, FP 40/2012]	Danish Association of Physical Therapists; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Association of Physical Therapists with a grant for ACB [http://fysio.dk/fafo/fonde/Fonden-for-forskning-uddannelse-og-praksisudvikling/Uddannelse/ Tildelinger/Tildelinger-efterar-2011/] and the Lundbeck Foundation with two grants for ACB: J. nr. FP 40/2012 and J. nr. FP 11/2013 [http://www.ucsf.dk/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2011, J AM GERIATR SOC, V59, P1650, DOI 10.1111/j.1532-5415.2011.03560.x; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Baldwin CE, 2012, J CRIT CARE; Benton MJ, 2009, AM J PHYS MED REHAB, V88, P579, DOI 10.1097/PHM.0b013e3181aa2ff8; Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; Brown CJ, 2009, ANN INTERN MED, V150, P372, DOI 10.7326/0003-4819-150-6-200903170-00005; Catananti C, 2010, SURG ONCOL, V19, P140, DOI 10.1016/j.suronc.2009.11.010; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; Charter RA, 2001, J CLIN EXP NEUROPSYC, V23, P530, DOI 10.1076/jcen.23.4.530.1227; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; Foss NB, 2006, CLIN REHABIL, V20, P701, DOI 10.1191/0269215506cre987oa; Garcia-Pena C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069849; Gill S, 2008, PHYSIOTHER RES INT, V13, P141, DOI 10.1002/pri.411; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Giraudeau B, 2001, STAT MED, V20, P3205, DOI 10.1002/sim.935; Goldberg A, 2011, AGING CLIN EXP RES, V23, P406, DOI 10.1007/BF03325236; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Huang WNW, 2010, J AM GERIATR SOC, V58, P844, DOI 10.1111/j.1532-5415.2010.02820.x; Hughes MA, 1996, J BIOMECH, V29, P1509, DOI 10.1016/0021-9290(96)00083-8; Humphreys J, 2002, NUTRITION, V18, P616, DOI 10.1016/S0899-9007(02)00756-6; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Kottner J, 2011, INT J NURS STUD, V48, P661, DOI 10.1016/j.ijnurstu.2011.01.016; Kristensen MT, 2008, J REHABIL MED, V40, P589, DOI 10.2340/16501977-0217; Kristensen Morten Tange, 2005, Ugeskr Laeger, V167, P3297; Kristensen MT, 2012, DAN MED J, V59; Kristensen MT, 2009, CLIN REHABIL, V23, P1116, DOI 10.1177/0269215509342330; Kwon S, 2009, J NUTR HEALTH AGING, V13, P538, DOI 10.1007/s12603-009-0104-z; Mahoney JE, 1998, J GERONTOL A-BIOL, V53, pM307, DOI 10.1093/gerona/53A.4.M307; Overend T, 2010, PHYSIOTHER CAN, V62, P122, DOI 10.3138/physio.62.2.122; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Sager MA, 1996, ARCH INTERN MED, V156, P645, DOI 10.1001/archinte.156.6.645; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Volpato S, 2011, J GERONTOL A-BIOL, V66, P89, DOI 10.1093/gerona/glq167; Volpato S, 2008, J GERONTOL A-BIOL, V63, P1393, DOI 10.1093/gerona/63.12.1393; Wang CY, 2002, ARCH PHYS MED REHAB, V83, P811, DOI 10.1053/apmr.2002.32743; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	44	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118248	10.1371/journal.pone.0118248	http://dx.doi.org/10.1371/journal.pone.0118248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706553	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100159
J	Cai, S; Qin, L; Tanoue, L; Hu, AM; Jia, XJ; Luo, H; Chen, Y; Chen, P; Peng, H				Cai, Shan; Qin, Li; Tanoue, Lynn; Hu, Anmei; Jia, Xiujie; Luo, Hong; Chen, Yan; Chen, Ping; Peng, Hong			Effects of One-Hour Training Course and Spirometry on the Ability of Physicians to Diagnose and Treat Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							PRIMARY-CARE; CHINA; COPD; PREVENTION; PREVALENCE; MANAGEMENT; PROVINCE	Backgrounds In China, the prevalence of chronic obstructive pulmonary disease (COPD) in persons 40 years of age or older is estimated at 8.2%, but this is likely a substantial underestimate. Methods Eight secondary hospitals which didn't have spirometries were chosen randomly in Hunan province of central south China. Physician subjects at these hospitals underwent a one-hour training course on the Chinese COPD guidelines. Physicians answered questionnaires assessing their knowledge of the guidelines before and after the training session. The mean correct scores of questionnaires were compared before and after training. Four out of the eight hospitals were given access to spirometry. Eligible patient subjects underwent spirometry testing prior to the physician visit. After seeing the patient, physicians were asked to answer a questionnaire relating to the diagnosis and severity of COPD. Physicians were then given the results of the spirometry, and asked to answer the same questionnaire. Physicians' responses before and after receiving the spirometry results were compared. Results 225 physicians participated in the training session. 207 questionnaires were completed. Mean scores (out of 100) before and after the training were 53.1 +/- 21.7 and 93.3 +/- 9.8, respectively. 18 physicians and 307 patient subjects participated in the spirometry intervention. Based on spirometric results, the prevalence of COPD was 38.8%. Physicians correctly identified the presence of COPD without spirometric data in 85 cases (76.6%); this increased to 117 cases (97.4%) once spirometric data were available. Without spirometric data, physicians incorrectly diagnosed COPD in 38 patients; this decreased to 6 patients once spirometric data were available. Spirometric data also improved the ability of physicians to correctly grade COPD severity. Conclusions Simple educational training can substantially improve physicians' knowledge relating to COPD. Spirometry combined with education improves the ability of physicians to diagnose COPD and to assess its severity.				dianaph6@hotmail.com		Peng, Hong/0000-0003-3235-3348	Chia Fellowship of Yale-China Program; Chronic Respiratory Disease Funds of the Chinese Medical Association [07010310039]; National Key Clinical Specialty Construction Projects	Chia Fellowship of Yale-China Program; Chronic Respiratory Disease Funds of the Chinese Medical Association; National Key Clinical Specialty Construction Projects	This study was supported by the Chia Fellowship of Yale-China Program, Chronic Respiratory Disease Funds of the Chinese Medical Association (07010310039), and National Key Clinical Specialty Construction Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bei CL, 2013, IRAN J PUBLIC HEALTH, V42, P543; Caramori G, 2005, Monaldi Arch Chest Dis, V63, P6; China MoHotPsRo, 2011, YB CHINESE HLTH STAT; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Griffiths C, 1999, RESP MED, V93, P903, DOI 10.1016/S0954-6111(99)90057-4; Group CMACOPDS, 2007, ZHONGHUA JIE HE HE H, P8; Hou Gang, 2010, Journal of China Medical University, V39, P464; Naberan K, 2006, ARCH BRONCONEUMOL, V42, P638, DOI 10.1016/S1579-2129(07)60006-8; Quan Y, 2009, ZHONG HUA QUAN KE ZA, V8, P320; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Voelkel NF, 2000, CHEST, V117, p372S, DOI 10.1378/chest.117.5_suppl_2.372S; Walker PP, 2006, EUR RESPIR J, V28, P945, DOI 10.1183/09031936.06.00019306; Wright AA, 2007, NEW ENGL J MED, V356, P1493, DOI 10.1056/NEJMp078018; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Yoon HI, 2011, CHEST, V139, P735, DOI 10.1378/chest.10-3022; Zhao Tian, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P100; Zheng JP, 2007, TXB PULMONARY FUCTIO, P50; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou E, 2010, CLIN MISDIAGNOSIS MI, V23, P9	19	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117348	10.1371/journal.pone.0117348	http://dx.doi.org/10.1371/journal.pone.0117348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706774	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100081
J	Jia, XC; Tian, HS; Tang, L; Zheng, L; Zheng, LL; Yang, T; Yu, BJ; Wang, ZT; Lin, P; Li, XK; Wang, XJ				Jia, Xuechao; Tian, Haishan; Tang, Lu; Zheng, Long; Zheng, Lulu; Yang, Ting; Yu, Bingjie; Wang, Zhitao; Lin, Peng; Li, Xiaokun; Wang, Xiaojie			High-Efficiency Expression of TAT-bFGF Fusion Protein in Escherichia coli and the Effect on Hypertrophic Scar Tissue	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CELL-PENETRATING PEPTIDES; HIGH-LEVEL EXPRESSION; LOCALIZATION; PURIFICATION; SEQUENCE; SKIN	Background Basic fibroblast growth factor (bFGF) is a member of the fibroblast growth factor family that has effects on wounding healing and neuro-protection. However, it is difficult to use bFGF to treat diseases that are separated by physiological barriers, such as the dermal barrier and blood brain barrier. Methodology/Principal Findings To improve bFGF's penetration ability, we fused the recombinant human fibroblast growth factor (rhbFGF) gene with TAT. We constructed a pET3c vector that contained the recombinant bFGF gene and successfully expressed this gene in the E. coli strain BL21 (DE3) pLsS. The fusion protein was purified using CM Sepharose FF and heparin affinity chromatography. The purity of the TAT-rhbFGF was greater than 95%, as detected by SDS-PAGE. An in vitro MTT trial revealed that the modified bFGF significantly promoted the proliferation of NIH3T3 cells. The cell penetration trial and the mouse skin penetration trial demonstrated that the fusion protein had certain penetration abilities. The animal experiments confirmed that TAT-rhbFGF was effective in the treatment of the hypertrophic scars. Conclusions/Significance We have successfully expressed and purified a TAT-rhbFGF fusion protein in this study. Our results have shown that the fusion protein had a greater ability to penetrate the dermal skin layer. TAT-rhbFGF improved the physical appearance of hypertrophic scars. TATrhbFGF may be a potential fusion protein in the treatment of dermal disorders, including hypertrophic scar.				xiaokunli@163.net; wangxiaojie1972@126.com	zheng, long/AFT-4046-2022; zheng, lu/GXH-7035-2022	ZHENG, LONG/0000-0003-3899-105X	National Natural Science Foundation of China [8107071 4]; Zhejiang Science and Technology Agency [2013C37004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Science and Technology Agency	This research was funded by a grant from the National Natural Science Foundation of China (No. 8107071 4), Zhejiang Science and Technology Agency (No. 2013C37004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2001, PHARMACOL RES, V43, P307, DOI 10.1006/phrs.2000.0794; ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; Andres C, 2013, PAIN, V154, P2216, DOI 10.1016/j.pain.2013.07.005; Bloemen MCT, 2009, BURNS, V35, P463, DOI 10.1016/j.burns.2008.07.016; Burd A, 2005, PLAST RECONSTR SURG, V116, p150E, DOI 10.1097/01.prs.0000191977.51206.43; Chen XJ, 2002, ACTA PHARMACOL SIN, V23, P782; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; Gasparian ME, 2009, BIOCHEMISTRY-MOSCOW+, V74, P221, DOI 10.1134/S000629790902014X; GOSPODAROWICZ D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0; Jin R, 2013, PLAST RECONSTR SURG, V132, P1747, DOI 10.1097/PRS.0b013e3182a97e43; Kim DW, 2003, MOL CELLS, V16, P402; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Kwong KWY, 2013, APPL MICROBIOL BIOT, V97, P9071, DOI 10.1007/s00253-013-5090-8; Lim Jun Man, 2003, J Cosmet Sci, V54, P483; Manosroi J, 2011, J PHARM SCI-US, V100, P1525, DOI 10.1002/jps.22355; Miller MC, 2005, BIODRUGS, V19, P363, DOI 10.2165/00063030-200519060-00004; Mohamed Mohamed Ragaa, 2004, Methods Mol Biol, V269, P41; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Mu XP, 2008, PROTEIN EXPRES PURIF, V59, P282, DOI 10.1016/j.pep.2008.02.009; Nasrollahi SA, 2012, CHEM BIOL DRUG DES, V80, P639, DOI 10.1111/cbdd.12008; Nuc Przemyslaw, 2006, Postepy Biochem, V52, P448; Ono I, 2007, WOUND REPAIR REGEN, V15, P617, DOI 10.1111/j.1524-475X.2007.00293.x; Rabiskova M, 2004, Ceska Slov Farm, V53, P300; Sakiyama H, 1998, CELL BIOCHEM FUNCT, V16, P159; Sgadari C, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/452729; Shi HX, 2013, PLOS ONE, V8, P2; Song LT, 2014, APPL MICROBIOL BIOT, V98, P695, DOI 10.1007/s00253-013-4929-3; TESSLER S, 1990, J CELL PHYSIOL, V145, P310, DOI 10.1002/jcp.1041450216; van der Veer WM, 2010, ANN PLAS SURG, V65, P321, DOI 10.1097/SAP.0b013e3181c60f88; Vaysse L, 2006, J GENE MED, V8, P754, DOI 10.1002/jgm.883; Verhaegen PD, 2012, WOUND REPAIR REGEN, V20, P658, DOI 10.1111/j.1524-475X.2012.00827.x; Verhaegen PDHM, 2012, J MICROSC-OXFORD, V245, P82, DOI 10.1111/j.1365-2818.2011.03547.x; Wang Y, 2013, INT J PHARMACEUT, V441, P748, DOI 10.1016/j.ijpharm.2012.10.019; WARD R S, 1991, Journal of Burn Care and Rehabilitation, V12, P257, DOI 10.1097/00004630-199105000-00011; Wu XF, 2001, PROTEIN EXPRES PURIF, V21, P192, DOI 10.1006/prep.2000.1358; Xie JL, 2008, J CUTAN MED SURG, V12, P155, DOI 10.2310/7750.2008.07041	36	5	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117448	10.1371/journal.pone.0117448	http://dx.doi.org/10.1371/journal.pone.0117448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706539	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100089
J	Jiang, W; Qiu, QH; Hao, J; Zhang, XJ; Shui, W; Hu, ZM				Jiang, Wei; Qiu, QuanHe; Hao, Jie; Zhang, XiaoJun; Shui, Wei; Hu, ZhenMing			Percutaneous Fibrin Gel Injection under C-Arm Fluoroscopy Guidance: A New Minimally Invasive Choice for Symptomatic Sacral Perineural Cysts	PLOS ONE			English	Article							TECHNICAL CASE-REPORT; TARLOV CYSTS; MENINGEAL CYSTS; MICROSURGICAL TREATMENT; CEREBROSPINAL-FLUID; GLUE THERAPY; DRAINAGE; SPINE	Background Symptomatic sacral perineural cysts are a common cause of chronic pain. Surgery is one choice for symptom relief but has a high risk of cyst recurrence and complications. As a simple and safe method to manage symptomatic sacral perineural cysts, C-arm fluoroscopy-guided fibrin gel injection may represent a new minimally invasive alternative. To evaluate the efficacy of this new method, we conducted a retrospective study of 42 patients. Methods and Findings From June 2009 to August 2012, a total of 42 patients with symptomatic sacral perineural cysts underwent C-arm fluoroscopy-guided percutaneous fibrin gel injection therapy. Patient outcomes in terms of improvements in pain and neurologic function were evaluated during a follow-up period of 13-39 months. The preoperative and postoperative pain severity were assessed according to a 10-cm visual analog pain scale, and imaging changes were evaluated by magnetic resonance imaging. We also assessed postoperative complications. Most patients experienced benefit from the procedure: twenty-five patients (59.5%) reported excellent recovery, eleven (26.2%) reported good recovery, three (7.1%) reported fair recovery, and three (7.1%) reported poor recovery. The overall effectiveness rate (excellent and good recoveries) was 85.7%. No serious postoperative complications were observed. Conclusion Percutaneous fibrin gel injection under C-arm fluoroscopy guidance could be a simple, safe and effective treatment option for symptomatic sacral perineural cysts.	[Jiang, Wei; Qiu, QuanHe; Hao, Jie; Zhang, XiaoJun; Shui, Wei; Hu, ZhenMing] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Chongqing, Peoples R China	Chongqing Medical University	Hu, ZM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Chongqing, Peoples R China.	spinecenter@163.com	zhang, jin/GXV-9154-2022					Acosta FL, 2003, NEU ROSURGICAL FOCUS, P15, DOI 10.3171/foc.2003.15.2.15; Bartels RHMA, 1997, NEUROSURGERY, V40, P861, DOI 10.1097/00006123-199704000-00044; Caspar W, 2003, SURG NEUROL, V59, P101, DOI 10.1016/S0090-3019(02)00981-3; Guo DS, 2007, NEUROSURGERY, V60, P1059, DOI 10.1227/01.NEU.0000255457.12978.78; Hoshino Y, 2005, INTERNAL MED, V44, P271, DOI 10.2169/internalmedicine.44.271; KATO T, 1988, Neurological Surgery, V16, P893; Langdown AJ, 2005, J SPINAL DISORD TECH, V18, P29, DOI 10.1097/01.bsd.0000133495.78245.71; Lucantoni C, 2011, NEUROSURG FOCUS, V31, P14; Mitra R, 2008, SPINE, V33, pE565, DOI 10.1097/BRS.0b013e31817e2cc9; Morio Y, 2001, SPINE, V26, P451, DOI 10.1097/00007632-200102150-00025; Mummaneni PV, 2000, NEUROSURGERY, V47, P74, DOI 10.1097/00006123-200007000-00016; Murphy KJ, 2011, SEMIN MUSCULOSKEL R, V15, P163, DOI 10.1055/s-0031-1275599; NABORS MW, 1988, J NEUROSURG, V68, P366, DOI 10.3171/jns.1988.68.3.0366; Park HJ, 2008, J KOREAN NEUROSURG S, V44, P174, DOI 10.3340/jkns.2008.44.3.174; Patel MR, 1997, AM J ROENTGENOL, V168, P367, DOI 10.2214/ajr.168.2.9016209; PAULSEN RD, 1994, AM J NEURORADIOL, V15, P293; REXED BA, 1959, J NEUROSURG, V16, P73, DOI 10.3171/jns.1959.16.1.0073; SCHREIBER F, 1951, J NEUROSURG, V8, P504, DOI 10.3171/jns.1951.8.5.0504; Shao Z, 2011, AM J NEURORADIOL, V32, P1469, DOI [10.3174/ajnr.A2048, 10.3174/ajnr.A2595]; SIEDENTOP KH, 1986, LARYNGOSCOPE, V96, P1062; TARLOV IM, 1952, J NEUROPATH EXP NEUR, V11, P88; Voyadzis JM, 2001, J NEUROSURG, V95, P25, DOI 10.3171/spi.2001.95.1.0025; Xu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039958; Zhang T, 2007, J NEUROSURG-SPINE, V7, P145, DOI 10.3171/SPI-07/08/145	24	10	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118254	10.1371/journal.pone.0118254	http://dx.doi.org/10.1371/journal.pone.0118254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706639	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100160
J	Kaatabi, H; Bamosa, AO; Badar, A; Al-Elq, A; Abou-Hozaifa, B; Lebda, F; Al-Khadra, A; Al-Almaie, S				Kaatabi, Huda; Bamosa, Abdullah Omar; Badar, Ahmed; Al-Elq, Abdulmohsen; Abou-Hozaifa, Bodour; Lebda, Fatma; Al-Khadra, Akram; Al-Almaie, Sameeh			Nigella sativa Improves Glycemic Control and Ameliorates Oxidative Stress in Patients with Type 2 Diabetes Mellitus: Placebo Controlled Participant Blinded Clinical Trial	PLOS ONE			English	Article							ANTIOXIDANT DEFENSE SYSTEM; PANCREATIC BETA-CELLS; LIPID-PEROXIDATION; INSULIN-RESISTANCE; THYMOQUINONE; DAMAGE; OIL; HYPERGLYCEMIA; EXPRESSION; EXTRACT	Background and Objective Oxidative stress plays an important role in pathogenesis of diabetes mellitus and its complications. Our previous study has shown glucose lowering effect produced by 3 months supplementation of Nigella sativa (NS) in combination with oral hypoglycemic drugs among type 2 diabetics. This study explored the long term glucose lowering effect (over one year) of NS in patients with type 2 diabetes mellitus on oral hypoglycemic drugs and to study its effect on redox status of such patients. Methods 114 type 2 diabetic patients on standard oral hypoglycemic drugs were assigned into 2 groups by convenience. The control group (n = 57) received activated charcoal as placebo and NS group (n = 57) received 2g NS, daily, for one year in addition to their standard medications. Fasting blood glucose (FBG), glycosylated hemoglobin (HbA(1c)), C-peptide, total antioxidant capacity (TAC), superoxide dismutase (SOD), catalase (CAT), glutathione and thiobarbituric acid reactive substances (TBARS) at the baseline, and every 3 months thereafter were determined. Insulin resistance and beta-cell activity were calculated using HOMA 2 calculator. Results Comparison between the two groups showed a significant drop in FBG (from 180 +/- 5.75 to 180 +/- 5.59 in control Vs from 195 +/- 6.57 to 172 +/- 5.83 in NS group), HbA1c (from 8.2 +/- 0.12 to 8.5 +/- 0.14 in control VS from 8.6 +/- 0.13 to 8.2 +/- 0.14 in NS group), and TBARS (from 48.3 +/- 6.89 to 52.9 +/- 5.82 in control VS from 54.1 +/- 4.64 to 41.9 +/- 3.16 in NS group), in addition to a significant elevation in TAC, SOD and glutathione in NS patients compared to controls. In NS group, insulin resistance was significantly lower, while beta-cell activity was significantly higher than the baseline values during the whole treatment period. Conclusion Long term supplementation with Nigella sativa improves glucose homeostasis and enhances antioxidant defense system in type 2 diabetic patients treated with oral hypoglycemic drugs.	[Kaatabi, Huda; Bamosa, Abdullah Omar; Badar, Ahmed; Abou-Hozaifa, Bodour; Lebda, Fatma] Univ Dammam, Coll Med, Dept Physiol, Dammam, Saudi Arabia; [Al-Elq, Abdulmohsen; Al-Khadra, Akram] Univ Dammam, Coll Med, Dept Med, Dammam, Saudi Arabia; [Al-Almaie, Sameeh] Univ Dammam, Coll Med, Dept Family Med, Dammam, Saudi Arabia	Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University	Bamosa, AO (corresponding author), Univ Dammam, Coll Med, Dept Physiol, Dammam, Saudi Arabia.	aosbamosa@gmail.com	Bamosa, Abdullah/AAD-5564-2019; Badar, Ahmed/A-2650-2009; Elq, Abdulmohsen Al/AAP-2276-2021; alkhadra, Akram/D-4199-2017	Badar, Ahmed/0000-0001-5183-7570; Elq, Abdulmohsen Al/0000-0002-3906-0188; bamosa, Abdullah/0000-0001-5941-4353; alkhadra, Akram/0000-0001-6302-9378	University of Dammam	University of Dammam	This study was supported by University of Dammam, from its own budget. There is no external source of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Wafai RJ, 2013, PANCREAS, V42, P841, DOI 10.1097/MPA.0b013e318279ac1c; Al-Logmani A, 2011, J DIAB MELL, V1; Alimohammadi S, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-137; Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; ASAYAMA K, 1993, FREE RADICAL BIO MED, V15, P597, DOI 10.1016/0891-5849(93)90162-N; Badary OA, 2003, DRUG CHEM TOXICOL, V26, P87, DOI 10.1081/DCT-120020404; Bamosa Abdullah O, 2010, Indian J Physiol Pharmacol, V54, P344; Benhaddou-Andaloussi A, 2008, PHARM BIOL, V46, P96, DOI 10.1080/13880200701734810; Benhaddou-Andaloussi A, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/538671; El-Gharieb Mahmood A., 2010, Toxicological and Environmental Chemistry, V92, P395, DOI 10.1080/02772240902955719; Fararh KM, 2004, RES VET SCI, V77, P123, DOI 10.1016/j.rvsc.2004.03.002; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Hamdy NM, 2009, PHARMACOLOGY, V84, P127, DOI 10.1159/000234466; Ismail M, 2010, FREE RADICAL BIO MED, V48, P664, DOI 10.1016/j.freeradbiomed.2009.12.002; Kanter M, 2004, ANAT REC PART A, V279A, P685, DOI 10.1002/ar.a.20056; Khanam M, 2008, BANGL J PHARMACOL, V4, P17; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Meral I, 2001, J VET MED A, V48, P593, DOI 10.1046/j.1439-0442.2001.00393.x; Najmi A, 2008, INT J DIABETES DEV C, V28, P11, DOI 10.4103/0973-3930.41980; Pari L, 2009, LIFE SCI, V85, P830, DOI 10.1016/j.lfs.2009.10.021; Pitocco D, 2013, INT J MOL SCI, V14, P21525, DOI 10.3390/ijms141121525; Pourghassem-Gargari B, 2009, J MED PLANTS RES, V3, P815; Shi Y, 2009, J DIABETES, V1, P151, DOI 10.1111/j.1753-0407.2009.00030.x; Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323; Soskic SS, 2011, OPEN CARDIOVASC MED, V5, P153, DOI 10.2174/1874192401105010153; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tahraoui A, 2007, J ETHNOPHARMACOL, V110, P105, DOI 10.1016/j.jep.2006.09.011; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	31	64	65	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0113486	10.1371/journal.pone.0113486	http://dx.doi.org/10.1371/journal.pone.0113486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706772	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100001
J	Tsukagoshi, H; Suzuki, T; Nishikawa, K; Agarie, S; Ishiguro, S; Higashiyama, T				Tsukagoshi, Hironaka; Suzuki, Takamasa; Nishikawa, Kouki; Agarie, Sakae; Ishiguro, Sumie; Higashiyama, Tetsuya			RNA-Seq Analysis of the Response of the Halophyte, Mesembryanthemum crystallinum (Ice Plant) to High Salinity	PLOS ONE			English	Article							BINDING TRANSCRIPTION FACTOR; IMPROVES DROUGHT TOLERANCE; INDUCED OVER-EXPRESSION; SALT-TOLERANCE; ARABIDOPSIS; GENE; GROWTH; COMPONENT; GENOME; ACID	Understanding the molecular mechanisms that convey salt tolerance in plants is a crucial issue for increasing crop yield. The ice plant (Mesembryanthemum crystallinum) is a halophyte that is capable of growing under high salt conditions. For example, the roots of ice plant seedlings continue to grow in 140 mM NaCl, a salt concentration that completely inhibits Arabidopsis thaliana root growth. Identifying the molecular mechanisms responsible for this high level of salt tolerance in a halophyte has the potential of revealing tolerance mechanisms that have been evolutionarily successful. In the present study, deep sequencing (RNAseq) was used to examine gene expression in ice plant roots treated with various concentrations of NaCl. Sequencing resulted in the identification of 53,516 contigs, 10,818 of which were orthologs of Arabidopsis genes. In addition to the expression analysis, a web-based ice plant database was constructed that allows broad public access to the data. The results obtained from an analysis of the RNAseq data were confirmed by RT-qPCR. Novel patterns of gene expression in response to high salinity within 24 hours were identified in the ice plant when the RNAseq data from the ice plant was compared to gene expression data obtained from Arabidopsis plants exposed to high salt. Although ABA responsive genes and a sodium transporter protein (HKT1), are up-regulated and down-regulated respectively in both Arabidopsis and the ice plant; peroxidase genes exhibit opposite responses. The results of this study provide an important first step towards analyzing environmental tolerance mechanisms in a non-model organism and provide a useful dataset for predicting novel gene functions.	[Tsukagoshi, Hironaka] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi 46401, Japan; [Tsukagoshi, Hironaka] Nagoya Univ, Program Leading Grad Sch, Chikusa Ku, Nagoya, Aichi 46401, Japan; [Tsukagoshi, Hironaka] JST, PRESTO, Kawaguchi, Saitama, Japan; [Suzuki, Takamasa; Higashiyama, Tetsuya] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 46401, Japan; [Suzuki, Takamasa; Higashiyama, Tetsuya] Nagoya Univ, JST, ERATO, Higashiyama Live Holon Project,Chikusa Ku, Nagoya, Aichi 46401, Japan; [Nishikawa, Kouki; Ishiguro, Sumie] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 46401, Japan; [Agarie, Sakae] Kagawa Univ, Fac Agr, Takamatsu, Kagawa 760, Japan; [Higashiyama, Tetsuya] Nagoya Univ, WPI ITbM, Chikusa Ku, Nagoya, Aichi 46401, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University; Japan Science & Technology Agency (JST); Nagoya University; Nagoya University; Kagawa University; Nagoya University	Tsukagoshi, H (corresponding author), Nagoya Univ, Ctr Gene Res, Chikusa Ku, Furo Cho, Nagoya, Aichi 46401, Japan.	hiroupb@gene.nagoya-u.ac.jp	Ishiguro, Sumie/AAH-2592-2019; Higashiyama, Tetsuya/C-2882-2012; Tsukagoshi, Hironaka/D-5832-2018; ISHIGURO, Sumie/I-6903-2014	Ishiguro, Sumie/0000-0002-6160-7434; Higashiyama, Tetsuya/0000-0002-7346-360X; Tsukagoshi, Hironaka/0000-0003-0058-4926; Agarie, Sakae/0000-0003-0594-2104	JST ERATO; Ministry of Education, Culture, Sports, Science, and Technology of Japan [26870262]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [26870262] Funding Source: KAKEN	JST ERATO(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST ERATO (T.S. and T.H.), and Grants-in-Aid for Scientific Research (26870262 to H.T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P, 1998, NEW PHYTOL, V138, P171, DOI 10.1046/j.1469-8137.1998.00111.x; Agarie S, 2007, J EXP BOT, V58, P1957, DOI 10.1093/jxb/erm057; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Chen JH, 2011, GENE, V483, P36, DOI 10.1016/j.gene.2011.05.010; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; Cui M, 2011, PLANT PHYSIOL BIOCH, V49, P1384, DOI 10.1016/j.plaphy.2011.09.012; Cushman JC, 2008, J EXP BOT, V59, P1875, DOI 10.1093/jxb/ern008; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; DEROCHER EJ, 1990, SCIENCE, V250, P99, DOI 10.1126/science.250.4977.99; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Geng Y, 2013, PLANT CELL, V25, P2132, DOI 10.1105/tpc.113.112896; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Henson J, 2012, PHARMACOGENOMICS, V13, P901, DOI [10.2217/PGS.12.72, 10.2217/pgs.12.72]; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Llorente F, 2002, PLANT J, V32, P13, DOI 10.1046/j.1365-313X.2002.01398.x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MEYER G, 1990, MOL GEN GENET, V224, P347, DOI 10.1007/BF00262428; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Orlando DA, 2009, METHODS MOL BIOL, V553, P57, DOI 10.1007/978-1-60327-563-7_4; Reis RR, 2014, PLANT SCI, V221, P59, DOI 10.1016/j.plantsci.2014.02.003; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; SAVOURE A, 1995, FEBS LETT, V372, P13, DOI 10.1016/0014-5793(95)00935-3; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; THOMAS JC, 1992, PLANT PHYSIOL, V100, P416, DOI 10.1104/pp.100.1.416; THOMAS JC, 1993, PLANT PHYSIOL, V103, P1299, DOI 10.1104/pp.103.4.1299; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xie YJ, 2011, PLANT J, V66, P280, DOI 10.1111/j.1365-313X.2011.04488.x; Zhang P, 2014, GENE, V536, P123, DOI 10.1016/j.gene.2013.11.060; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	38	44	47	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118339	10.1371/journal.pone.0118339	http://dx.doi.org/10.1371/journal.pone.0118339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706745	Green Submitted, Green Published			2022-12-27	WOS:000350662100171
J	Franz, NM; Chen, MM; Yu, SZ; Kianmajd, P; Bowers, S; Ludascher, B				Franz, Nico M.; Chen, Mingmin; Yu, Shizhuo; Kianmajd, Parisa; Bowers, Shawn; Ludaescher, Bertram			Reasoning over Taxonomic Change: Exploring Alignments for the Perelleschus Use Case	PLOS ONE			English	Article							COLEOPTERA; TAXA; ONTOLOGIES; SYSTEM; MODEL; NAMES; REPRESENTATION; CURCULIONIDAE; PHYLOGENY; ORGANISM	Classifications and phylogenetic inferences of organismal groups change in light of new insights. Over time these changes can result in an imperfect tracking of taxonomic perspectives through the re-/use of Code-compliant or informal names. To mitigate these limitations, we introduce a novel approach for aligning taxonomies through the interaction of human experts and logic reasoners. We explore the performance of this approach with the Perelleschus use case of Franz & Cardona-Duque (2013). The use case includes six taxonomies published from 1936 to 2013, 54 taxonomic concepts (i.e., circumscriptions of names individuated according to their respective source publications), and 75 expert-asserted Region Connection Calculus articulations (e. g., congruence, proper inclusion, overlap, or exclusion). An Open Source reasoning toolkit is used to analyze 13 paired Perelleschus taxonomy alignments under heterogeneous constraints and interpretations. The reasoning workflow optimizes the logical consistency and expressiveness of the input and infers the set of maximally informative relations among the entailed taxonomic concepts. The latter are then used to produce merge visualizations that represent all congruent and non-congruent taxonomic elements among the aligned input trees. In this small use case with 653 input concepts per alignment, the information gained through the reasoning process is on average one order of magnitude greater than in the input. The approach offers scalable solutions for tracking provenance among succeeding taxonomic perspectives that may have differential biases in naming conventions, phylogenetic resolution, ingroup and outgroup sampling, or ostensive (member-referencing) versus intensional (property-referencing) concepts and articulations.	[Franz, Nico M.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Chen, Mingmin; Yu, Shizhuo; Kianmajd, Parisa; Ludaescher, Bertram] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Bowers, Shawn] Gonzaga Univ, Dept Comp Sci, Spokane, WA 99258 USA	Arizona State University; Arizona State University-Tempe; University of California System; University of California Davis; Gonzaga University	Franz, NM (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	nico.franz@asu.edu			National Science Foundation [DEB-1155984, DBI-1342595, IIS-118088, DBI-1147273]; Direct For Biological Sciences [1155984] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1147273] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support was provided by the National Science Foundation (http://www.nsf.gov/) by grants DEB-1155984 and DBI-1342595 to NMF and IIS-118088 and DBI-1147273 to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral C, 2004, LECT NOTES ARTIF INT, V2923, P21; Baskauf SJ, 2014, SEMANTIC WE IN PRESS; BEACH JH, 1993, ADVANCES IN COMPUTER METHODS FOR SYSTEMATIC BIOLOGY, P241; Berendsohn W.G., 2003, SCHRIFTENREIHE VEGET, V39, P1; Berendsohn WG, 1997, TAXON, V46, P283, DOI 10.2307/1224098; BERENDSOHN WG, 1995, TAXON, V44, P207, DOI 10.2307/1222443; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Bouchard P, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.88.807; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; Brewka G, 2011, COMMUN ACM, V54, P92, DOI 10.1145/2043174.2043195; Brigandt I, 2009, ACTA BIOTHEOR, V57, P77, DOI 10.1007/s10441-008-9056-7; Bryant D., 2003, Bioconsensus. DIMACS Working Group Meetings on Bioconsensus, P163; Bryant HN, 2002, BIOL REV, V77, P39, DOI 10.1017/S1464793101005802; Cha SH, 2009, J PATTERN RECOGNIT R, V4, P1, DOI 10.13176/11.44; Chawuthai R, 2013, S4BIODIV 2013 SEMANT, V797, P1; Chen M, 2015, EULER PROJECT SOURCE; Chen M., 2014, ARXIV14021992CSLO; Chen M, 2014, LECT NOTES COMPUT SC, V8620, P127, DOI DOI 10.1007/978-3-319-09870-8_; Chen M, 2014, LECT NOTES IN PRESS; Chen M, 2014, THESIS U CALIFORNIA; Cheney J, 2007, FOUND TRENDS DATABAS, V1, P379, DOI 10.1561/1900000006; Cui H, 2012, J AM SOC INF SCI TEC, V63, P738, DOI 10.1002/asi.22618; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; de Paula R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S6; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; Devitt M., 1999, LANGUAGE REALITY INT; Erdem Esra, 2011, Logic Programming, Knowledge Representation, and Nonmonotonic Reasoning. Essays Dedicated to Michael Gelfond on the Occasion of his 65th Birthday, P415, DOI 10.1007/978-3-642-20832-4_26; Euzenat J., 2013, ONTOLOGY MATCHING, V2; FABRICIUS JC, 1792, SECUNDUM CLASSES ORD, V1; Ferreiros J, 2001, B SYMB LOG, V7, P441, DOI 10.2307/2687794; Franz NM, 2009, SYST BIODIVERS, V7, P5, DOI 10.1017/S147720000800282X; Franz N.M., 2009, LETT LINNAEUS, P63; Franz NM, 2008, SYST ASSOC SPEC VOL, V76, P63; Franz NM, 2013, SYST BIODIVERS, V11, P209, DOI 10.1080/14772000.2013.806371; Franz Nico M., 2010, Biodiversity Informatics, V7, P45; Franz NM, 2006, SYST ENTOMOL, V31, P220, DOI 10.1111/j.1365-3113.2005.00308.x; Franz NM, 2005, CLADISTICS, V21, P495, DOI 10.1111/j.1096-0031.2005.00080.x; Franz NM, 2003, INSECT SYST EVOL, V34, P153, DOI 10.1163/187631203788964818; Franz NM, 2001, T AM ENTOMOL SOC, V127, P255; Franz NM, 2015, SEMANTIC WE IN PRESS; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Gebser M, 2011, AI COMMUN, V24, P107, DOI 10.3233/AIC-2011-0491; Gelfond M, 2008, FOUND ARTIF INTELL, P285, DOI 10.1016/S1574-6526(07)03007-6; GEOFFROY M., 2003, SCHRIFT VEGETATIONSK, V39, P71; Geoffroy M, 2003, SCHRIFT VEGETATIONSK, V39, P83; Gradstein SR, 2001, TAXON, V50, P1075, DOI 10.2307/1224722; Graham M, 2010, INFORM VISUAL, V9, P235, DOI 10.1057/ivs.2009.29; GUNTHER K, 1936, ENTOMOLOGISCHE RUNDS, V53, P190; Hendler J, 2008, FOUND ARTIF INTELL, P821, DOI 10.1016/S1574-6526(07)03021-0; Howse J, 2002, LECT NOTES ARTIF INT, V2317, P76; ICZN (International Commission on Zoological Nomenclature), 1999, INT CODE ZOOLOGICAL, V4th; Kennedy J, 2006, OMICS, V10, P220, DOI 10.1089/omi.2006.10.220; Kennedy JB, 2005, LECT NOTES COMPUT SC, V3615, P80; KOPERSKI M, 1999, STUTTGARTER BEITR C, V590, P1; KOPERSKI M., 2000, SCHRIFTENREIHE VEGET, V34, P1; Lacordaire T., 1863, HIST NATURELLE INSEC, V6; Lifschitz V, 2008, LECT NOTES COMPUT SC, V5366, P37, DOI 10.1007/978-3-540-89982-2_8; Lukasiewicz T, 2010, IEEE T KNOWL DATA EN, V22, P1577, DOI 10.1109/TKDE.2010.111; Marakeby H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089142; McCarthy J., 1989, PHILOS LOGIC ARTIFIC, P161; McCune W, 2010, PROVER9 AND MACE4; McNEILL J., 2012, INT CODE NOMENCLATUR; Meiri S, 2007, PLOS BIOL, V5, P1385, DOI 10.1371/journal.pbio.0050194; Midford PE, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-34; Moreau Luc, 2010, Foundations and Trends in Web Science, V2, P99, DOI 10.1561/1800000010; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Padial JM, 2006, SYST BIOL, V55, P859, DOI 10.1080/1063515060081588; Page R., 2011, DARK TAXA GENBANK PO; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Page Roderic D.M., 2006, Biodiversity Informatics, V3, P1; Page RDM, 2013, PEERJ, V1, DOI 10.7717/peerj.190; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson DJ, 2010, TRENDS ECOL EVOL, V25, P686, DOI 10.1016/j.tree.2010.09.004; Prendini L, 2001, SYST BIOL, V50, P290, DOI 10.1080/10635150118650; Randell D. A., 1992, Principles of Knowledge Representation and Reasoning: Proceedings of the Third International Conference (KR '92), P165; Reimer M., 2010, STANFORD ENCY PHILOS; Sangster G, 2014, BIOL REV, V89, P199, DOI 10.1111/brv.12051; Schuh RT, 2003, BOT REV, V69, P59, DOI 10.1663/0006-8101(2003)069[0059:TLSAIY]2.0.CO;2; SCHUH RT, 2009, BIOL SYSTEMATICS PRI; Schulz S, 2008, BIOINFORMATICS, V24, pI313, DOI 10.1093/bioinformatics/btn158; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith SA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003223; Thau D, 2008, P 2 INT WORKSH ONT I, P47, DOI DOI 10.1145/1458484.1458492; Thau D, 2008, PH D RSQUO 08, P11; Thau D, 2009, P AAAI SPRING S BENC, P49; Thau D, 2007, ECOL INFORM, V2, P195, DOI 10.1016/j.ecoinf.2007.07.005; Thau D, 2009, LECT NOTES COMPUT SC, V5871, P1103, DOI 10.1007/978-3-642-05151-7_26; Thau D, 2010, I C DATA ENGIN WORKS, P151, DOI 10.1109/ICDEW.2010.5452756; Thau DM, 2010, THESIS U CALIFORNIA; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Tschope O, 2013, TAXON, V62, P1248, DOI 10.12705/626.4; Tuominen J, 2011, LECT NOTES COMPUT SC, V6644, P255, DOI 10.1007/978-3-642-21064-8_18; Vane-Wright R.I., 2003, Systematics and Biodiversity, V1, P3, DOI 10.1017/S1477200003001063; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Voss E., 1954, Beitraege zur Fauna-Perus Jena Bd, V4, P193; Weakley A. S., 2012, FLORA SO MIDATLANTIC; Wibmer G. J., 1986, MEM AM ENTOMOL I, V39, P1; Witteveen J, 2014, BIOL PHIL IN PRESS	101	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118247	10.1371/journal.pone.0118247	http://dx.doi.org/10.1371/journal.pone.0118247			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700173	Green Submitted, Green Published, gold			2022-12-27	WOS:000349789800034
J	Ngongo, CJ; Frick, KD; Hightower, AW; Mathingau, FA; Burke, H; Breiman, RF				Ngongo, Carrie J.; Frick, Kevin D.; Hightower, Allen W.; Mathingau, Florence Alice; Burke, Heather; Breiman, Robert F.			The Perils of Straying from Protocol: Sampling Bias and Interviewer Effects	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; CONTINGENT VALUATION; INSECTICIDE	Fidelity to research protocol is critical. In a contingent valuation study in an informal urban settlement in Nairobi, Kenya, participants responded differently to the three trained interviewers. Interviewer effects were present during the survey pilot, then magnified at the start of the main survey after a seemingly slight adaptation of the survey sampling protocol allowed interviewers to speak with the "closest neighbor" in the event that no one was home at a selected household. This slight degree of interviewer choice led to inferred sampling bias. Multinomial logistic regression and post-estimation tests revealed that the three interviewers' samples differed significantly from one another according to six demographic characteristics. The two female interviewers were 2.8 and 7.7 times less likely to talk with respondents of low socio-economic status than the male interviewer. Systematic error renders it impossible to determine which of the survey responses might be "correct." This experience demonstrates why researchers must take care to strictly follow sampling protocols, consistently train interviewers, and monitor responses by interview to ensure similarity between interviewers' groups and produce unbiased estimates of the parameters of interest.	[Ngongo, Carrie J.; Burke, Heather; Breiman, Robert F.] Ctr Dis Control & Prevent Kenya, Nairobi, Kenya; [Frick, Kevin D.] Johns Hopkins Carey Business Sch, Baltimore, MD USA; [Hightower, Allen W.] Ctr Dis Control & Prevent, Nairobi, Kenya; [Mathingau, Florence Alice] Kenyatta Univ, Sch Publ Hlth, Nairobi, Kenya	Johns Hopkins University; Kenyatta University	Ngongo, CJ (corresponding author), Grameen Fdn, Nairobi, Kenya.	cngongo@gmail.com	Ngongo, Carrie/GPK-6029-2022	Ngongo, Carrie/0000-0002-6501-5532; Frick, Kevin/0000-0002-0178-5319	Centers for Disease Control and Prevention in Kenya	Centers for Disease Control and Prevention in Kenya	This work was primarily done on a voluntary basis by two graduate students (studying at Kenyatta University and the Johns Hopkins Bloomberg School of Public Health). The students were sponsored as graduate student interns in 2006-07 by the Centers for Disease Control and Prevention in Kenya, meaning that they were provided with workspace and guidance. CDC/Kenya paid for the staff and transport costs to implement the survey. The funder therefore had a role in the study design and data collection phases. Subsequently, data analysis and discussion of the findings happened without formal CDC/Kenya involvement. The students continued to correspond with their mentors who had formerly worked with Johns Hopkins and CDC/Kenya, though the students no longer had a formal relationship with either institution. The students consulted these mentors on the preparation of the manuscript and the decision to publish.	BECKER S, 1995, STUD FAMILY PLANN, V26, P233, DOI 10.2307/2137848; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Davis RE, 2010, HEALTH EDUC RES, V25, P14, DOI 10.1093/her/cyp046; DIAMOND PA, 1994, J ECON PERSPECT, V8, P45, DOI 10.1257/jep.8.4.45; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Frew EJ, 2004, HEALTH POLICY, V68, P289, DOI 10.1016/j.healthpol.2003.10.003; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P846, DOI 10.1046/j.1365-3156.2002.00929.x; Klose T, 1999, HEALTH POLICY, V47, P97, DOI 10.1016/S0168-8510(99)00010-X; Kreuter F, 2008, ENCY RES METHODS, P370, DOI DOI 10.4135/9781412963947.N242; Mitullah W, 2003, UN HABITAT GLOBAL RE, P195; Ngongo CJ, 2008, INT Q COMMUNITY HEAL, V28, P33, DOI 10.2190/IQ.28.1.d; Njuguna HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058437; Onwujekwe O, 2000, TROP MED INT HEALTH, V5, P370, DOI 10.1046/j.1365-3156.2000.00558.x; Retsinas NP, 2006, KIBERA KENYA SLUM UP, P20; RUSSELL S, 1995, HEALTH POLICY PLANN, V10, P94, DOI 10.1093/heapol/10.1.94; Smith R, 1999, CTR HLTH PROGRAM EVA, V84, P42; Warah R, 2007, STATE WORLD 2007 OUR; WILLIAMS JA, 1968, PUBLIC OPIN QUART, V32, P287, DOI 10.1086/267606	18	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118025	10.1371/journal.pone.0118025	http://dx.doi.org/10.1371/journal.pone.0118025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25693077	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500091
J	Ouennane, S; Leprohon, P; Moineau, S				Ouennane, Siham; Leprohon, Philippe; Moineau, Sylvain			Diverse Virulent Pneumophages Infect Streptococcus mitis	PLOS ONE			English	Article							FATAL PNEUMOCOCCAL PNEUMONIA; BACTERIOPHAGE LYTIC ENZYME; LACTOCOCCUS-LACTIS; TEMPERATE BACTERIOPHAGE; GENOMIC ANALYSIS; DNA-REPLICATION; ENDOLYSIN CPL-1; RESCUES MICE; PHAGE; EVOLUTION	Streptococcus mitis has emerged as one of the leading causes of bacterial endocarditis and is related to Streptococcus pneumoniae. Antibiotic resistance has also increased among strains of S. mitis and S. pneumoniae. Phages are being reinvestigated as alternatives to antibiotics for managing infections. In this study, the two virulent phages Cp-1 (Podoviridae) and Dp-1 (Siphoviridae), previously isolated from S. pneumoniae, were found to also infect S. mitis. Microbiological assays showed that both pneumophages could not only replicate in S. mitis but also produced more visible plaques on this host. However, the burst size and phage adsorption data were lower in S. mitis as compared to S. pneumoniae. A comparison of the genomes of each phage grown on both hosts produced identical nucleotide sequences, confirming that the same phages infect both bacterial species. We also discovered that the genomic sequence of podophage Cp-1 of the Felix d'Herelle collection is different than the previously reported sequence and thus renamed SOCP.	[Ouennane, Siham; Moineau, Sylvain] Univ Laval, Fac Med Dent, Felix Herelle Reference Ctr Bacterial Viruses, Grp Rech Ecol Buccale,Fac Sci & Genie,Dept Bioch, Quebec City, PQ, Canada; [Leprohon, Philippe] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Moineau, S (corresponding author), Univ Laval, Fac Med Dent, Felix Herelle Reference Ctr Bacterial Viruses, Grp Rech Ecol Buccale,Fac Sci & Genie,Dept Bioch, Quebec City, PQ, Canada.	Sylvain.Moineau@bcm.ulaval.ca	Moineau, Sylvain/N-3578-2013; Leprohon, Philippe/U-5474-2019; Moineau, Sylvain/I-7231-2019	Moineau, Sylvain/0000-0002-2832-5101	Canadian Institutes of Health Research (CIHR); Programme Canadien de Bourse de la Francophonie (PCBF); CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Programme Canadien de Bourse de la Francophonie (PCBF); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by an Emerging Team Grant from the Canadian Institutes of Health Research (CIHR). S.O. is the recipient of a scholarship from the Programme Canadien de Bourse de la Francophonie (PCBF) and (CIHR). S.M. holds a Tier 1 Canada Research Chair in Bacteriophages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai J, 2011, J CLIN MICROBIOL, V49, P1646, DOI 10.1128/JCM.01990-10; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Benmayor R, 2009, CURR BIOL, V19, P764, DOI 10.1016/j.cub.2009.03.023; CARRASCOSA M, 1994, CLIN INFECT DIS, V19, P781, DOI 10.1093/clinids/19.4.781; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; Djurkovic S, 2005, ANTIMICROB AGENTS CH, V49, P1225, DOI 10.1128/AAC.49.3.1225-1228.2005; Doehn JM, 2013, J ANTIMICROB CHEMOTH, V68, P2111, DOI 10.1093/jac/dkt131; Doern CD, 2010, J CLIN MICROBIOL, V48, P3829, DOI 10.1128/JCM.01563-10; Donkor ES, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00007; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Gindreau E, 2000, J VIROL, V74, P7803, DOI 10.1128/JVI.74.17.7803-7813.2000; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Hauser R, 2011, J BACTERIOL, V193, P3135, DOI 10.1128/JB.01481-10; Hall JPJ, 2013, CURR OPIN VIROL, V3, P572, DOI 10.1016/j.coviro.2013.07.001; Henderson-Begg SK, 2006, J ANTIMICROB CHEMOTH, V57, P849, DOI 10.1093/jac/dkl064; Ikryannikova LN, 2013, CLIN MICROBIOL INFEC, V19, P1066, DOI 10.1111/1469-0691.12113; Joyce EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-404; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Kotsonis SE, 2008, APPL ENVIRON MICROB, V74, P3453, DOI 10.1128/AEM.02379-07; Kraemer L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-41; KRAUSE RM, 1957, J EXP MED, V106, P365, DOI 10.1084/jem.106.3.365; Loeffler JM, 2003, ANTIMICROB AGENTS CH, V47, P375, DOI 10.1128/AAC.47.1.375-377.2003; Loeffler JM, 2003, INFECT IMMUN, V71, P6199, DOI 10.1128/IAI.71.11.6199-6204.2003; Longas E, 2008, P NATL ACAD SCI USA, V105, P18290, DOI 10.1073/pnas.0809882105; LOPEZ R, 1982, J BACTERIOL, V151, P1581, DOI 10.1128/JB.151.3.1581-1590.1982; LOPEZ R, 1977, J VIROL, V24, P201, DOI 10.1128/JVI.24.1.201-210.1977; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Madhour A, 2011, IRAN J MICROBIOL, V3, P58; MARK DF, 1976, P NATL ACAD SCI USA, V73, P780, DOI 10.1073/pnas.73.3.780; Martin AC, 1996, J MOL BIOL, V260, P369, DOI 10.1006/jmbi.1996.0407; Martin AC, 1998, J VIROL, V72, P3491; McCullers JA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030028; MCDONNELL M, 1975, VIROLOGY, V63, P577, DOI 10.1016/0042-6822(75)90329-3; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; MOINEAU S, 1993, APPL ENVIRON MICROB, V59, P208, DOI 10.1128/AEM.59.1.208-212.1993; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Ramirez M, 1999, J BACTERIOL, V181, P3618, DOI 10.1128/JB.181.12.3618-3625.1999; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Rigvava S, 2013, CAN J MICROBIOL, V59, P18, DOI 10.1139/cjm-2012-0385; Romero P, 2009, J BACTERIOL, V191, P4854, DOI 10.1128/JB.01272-08; RONDA C, 1981, J VIROL, V40, P551, DOI 10.1128/JVI.40.2.551-559.1981; RONDA C, 1989, FEMS MICROBIOL LETT, V65, P187, DOI 10.1016/0378-1097(89)90389-3; RONDALAIN C, 1977, J VIROL, V21, P366, DOI 10.1128/JVI.21.1.366-374.1977; Rousseau GM, 2009, APPL ENVIRON MICROB, V75, P5336, DOI 10.1128/AEM.00761-09; Rukke HV, 2012, MOL ORAL MICROBIOL, V27, P95, DOI 10.1111/j.2041-1014.2011.00635.x; Sabri M, 2011, J BACTERIOL, V193, P551, DOI 10.1128/JB.01117-10; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samson JE, 2010, APPL ENVIRON MICROB, V76, P6843, DOI 10.1128/AEM.00796-10; Serwer P, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-21; Sheppard CL, 2004, J MED MICROBIOL, V53, P189, DOI 10.1099/jmm.0.05460-0; Siboo IR, 2003, J BACTERIOL, V185, P6968, DOI 10.1128/JB.185.23.6968-6975.2003; Staden R, 2000, Methods Mol Biol, V132, P115; Sunderkotter C, 2014, HAUTARZT, V65, P113, DOI 10.1007/s00105-013-2743-6; TIRABY JG, 1975, VIROLOGY, V68, P566, DOI 10.1016/0042-6822(75)90300-1; Witzenrath M, 2009, CRIT CARE MED, V37, P642, DOI 10.1097/CCM.0b013e31819586a6; Zahner D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025124	57	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118807	10.1371/journal.pone.0118807	http://dx.doi.org/10.1371/journal.pone.0118807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692983	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500130
J	Schaafsma, A; Limay-Rios, V; Baute, T; Smith, J; Xue, YG				Schaafsma, Arthur; Limay-Rios, Victor; Baute, Tracey; Smith, Jocelyn; Xue, Yingen			Neonicotinoid Insecticide Residues in Surface Water and Soil Associated with Commercial Maize (Corn) Fields in Southwestern Ontario	PLOS ONE			English	Article							HONEY-BEES; PESTICIDE-RESIDUES; COLONY LOSSES; EXPOSURE; DECLINES; WINTER; RISKS; SEEDS; USA	Neonicotinoid insecticides have come under scrutiny for their potential unintended effects on non-target organisms, particularly pollinators in agro-ecosystems. As part of a larger study of neonicotinoid residues associated with maize (corn) production, 76 water samples within or around the perimeter of 18 commercial maize fields and neighbouring apiaries were collected in 5 maize-producing counties of southwestern Ontario. Residues of clothianidin (mean = 2.28, max. = 43.60 ng/mL) and thiamethoxam (mean = 1.12, max. = 16.50 ng/mL) were detected in 100 and 98.7% of the water samples tested, respectively. The concentration of total neonicotinoid residues in water within maize fields increased sixfold during the first five weeks after planting, and returned to pre-plant levels seven weeks after planting. However, concentrations in water sampled from outside the fields were similar throughout the sampling period. Soil samples from the top 5 cm of the soil profile were also collected in these fields before and immediately following planting. The mean total neonicotinoid residue was 4.02 (range 0.07 to 20.30) ng/g, for samples taken before planting, and 9.94 (range 0.53 to 38.98) ng/g, for those taken immediately after planting. Two soil samples collected from within an conservation area contained detectable (0.03 and 0.11 ng/g) concentrations of clothianidin. Of three drifted snow samples taken, the drift stratum containing the most wind-scoured soil had 0.16 and 0.20 ng/mL mainly clothianidin in the melted snow. The concentration was at the limit of detection (0.02 ng/mL) taken across the entire vertical profile. With the exception of one sample, water samples tested had concentrations below those reported to have acute, chronic or sublethal effects to honey bees. Our results suggest that neonicotinoids may move off-target by wind erosion of contaminated soil. These results are informative to risk assessment models for other non-target species in maize agro-ecosytems.	[Schaafsma, Arthur; Limay-Rios, Victor; Smith, Jocelyn; Xue, Yingen] Univ Guelph, Dept Plant Agr, Ridgetown, ON, Canada; [Baute, Tracey] Ontario Minist Agr Food & Rural Affairs, Ridgetown, ON, Canada	University of Guelph	Schaafsma, A (corresponding author), Univ Guelph, Dept Plant Agr, Ridgetown Campus, Ridgetown, ON, Canada.	aschaafs@uoguelph.ca	Smith, Jocelyn/AAG-8545-2019; Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; Smith, Jocelyn/0000-0001-6747-9798; Limay-Rios, Victor/0000-0002-0866-3568; Schaafsma, Arthur W/0000-0002-5527-5664	Ontario Ministry of Agriculture Food and Rural Affairs; Agriculture and Agri-Food Canada through the Canadian Agricultural Adaptation Program (CAAP)	Ontario Ministry of Agriculture Food and Rural Affairs; Agriculture and Agri-Food Canada through the Canadian Agricultural Adaptation Program (CAAP)	Funding for this study was provided by the Ontario Ministry of Agriculture Food and Rural Affairs, and by Agriculture and Agri-Food Canada through the Canadian Agricultural Adaptation Program (CAAP) (http://www.agr.gc.ca/eng/?id=1286477571817), administered by the Agricultural Adaptation Council (http://www.adaptcouncil.org/), with the Grain Farmers of Ontario (http://www.gfo.ca/), as the applicant and grant holder and the University of Guelph as the investigators. The authors were asked to independently look for neonicotinoid residues in the maize production ecosystem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anastassiades M, 2003, J AOAC INT, V86, P412; Bacandritsos N, 2010, J INVERTEBR PATHOL, V105, P335, DOI 10.1016/j.jip.2010.08.004; Beketov MA, 2008, ENVIRON TOXICOL CHEM, V27, P461, DOI 10.1897/07-322R.1; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Bonmatin JM, 2014, ENV SCI POLLUTION RE; CAAP, 2007, CAPA STAT COL COLL D; Chagnon M, 2015, ENVIRON SCI POLLUT R, V22, P119, DOI 10.1007/s11356-014-3277-x; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Currie LA, 1999, ANAL CHIM ACTA, V391, P105, DOI 10.1016/S0003-2670(99)00104-X; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; DeSutter TM, 1998, J ENVIRON SCI HEAL B, V33, P683, DOI 10.1080/03601239809373172; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Environment Canada, 2014, CAN CLIM NORM 1981 2; EPA/PMRA, 2012, WHIT PAP SUPP PROP R; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3295; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3068; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3066; FREE JB, 1958, J EXP BIOL, V35, P930; Gibbons D, 2014, ENV SCI POLLUTION RE; Girolami V, 2012, J APPL ENTOMOL, V136, P17, DOI 10.1111/j.1439-0418.2011.01648.x; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Greatti Moreno, 2006, Bulletin of Insectology, V59, P99; Greatti Moreno, 2003, Bulletin of Insectology, V56, P69; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Health Canada, 2013, PONCHO 600 FS SEED T; Health Canada, 2013, EV CAN MORT REL NEON; Health Canada, 2013, DROP; Health Canada, 2013, CRUIS 350FS SEED TER; Health Canada, 2012, EV CAN BEE MORT COIN; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; Hoffmann EJ, 2012, J ECON ENTOMOL, V105, P67, DOI 10.1603/EC11251; Hopwood J., 2012, ARE NEONICOTINOIDS K; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; JOHANSEN CA, 1983, ENVIRON ENTOMOL, V12, P1513, DOI 10.1093/ee/12.5.1513; Jones A, 2014, PEST MANAG SCI, V70, P1780, DOI 10.1002/ps.3836; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kuhar TP, 2002, CROP PROT, V21, P25, DOI 10.1016/S0261-2194(01)00056-4; Kuhnholz S, 1997, BEHAV ECOL SOCIOBIOL, V41, P407, DOI 10.1007/s002650050402; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nicolson SW, 2009, J EXP BIOL, V212, P429, DOI 10.1242/jeb.022343; *NRC, 2007, STAT POLL N AM; Nuyttens D, 2013, PEST MANAG SCI, V69, P564, DOI 10.1002/ps.3485; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Phillips PJ, 2004, PEST MANAG SCI, V60, P531, DOI 10.1002/ps.879; Pistorius J., 2009, P118; Pochi D, 2012, B ENVIRON CONTAM TOX, V89, P354, DOI 10.1007/s00128-012-0664-1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ramasubramanian T, 2012, WATER AIR SOIL POLL, V223, P6045, DOI 10.1007/s11270-012-1338-7; Schmaranzer S, 2000, J INSECT PHYSIOL, V46, P1187, DOI 10.1016/S0022-1910(00)00039-1; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Scholer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091573; Sharpe R.J., 2009, BIOSCI HYPOTHESES, V2, P439, DOI [10.1016/j.bihy.2009.01.004, DOI 10.1016/J.BIHY.2009.01.004]; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Steward G, 2013, NEONICOTINOIDS FIELD; Stokvis E, 2005, RAPID COMMUN MASS SP, V19, P401, DOI 10.1002/rcm.1790; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Tanner G, 2011, J AGR FOOD CHEM, V59, P12271, DOI 10.1021/jf202775m; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; USDA, 2012, REP NAT STAK C HON B; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Visscher PK, 1996, J INSECT PHYSIOL, V42, P1089, DOI 10.1016/S0022-1910(96)00058-3; Xing ZS, 2013, ARCH ENVIRON CON TOX, V64, P208, DOI 10.1007/s00244-012-9833-9	76	152	155	15	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118139	10.1371/journal.pone.0118139	http://dx.doi.org/10.1371/journal.pone.0118139			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710560	Green Published, gold			2022-12-27	WOS:000350683900048
J	Simmons, MM; Moore, SJ; Lockey, R; Chaplin, MJ; Konold, T; Vickery, C; Spiropoulos, J				Simmons, Marion M.; Moore, S. Jo; Lockey, Richard; Chaplin, Melanie J.; Konold, Timm; Vickery, Christopher; Spiropoulos, John			Phenotype Shift from Atypical Scrapie to CH1641 following Experimental Transmission in Sheep	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CLASSICAL SCRAPIE; PRION PROTEIN; GREAT-BRITAIN; UNITED-KINGDOM; PRP GENOTYPES; MICE; NOR98; IMMUNOHISTOCHEMISTRY; PATTERNS	The interactions of host and infecting strain in ovine transmissible spongiform encephalopathies are known to be complex, and have a profound effect on the resulting phenotype of disease. In contrast to classical scrapie, the pathology in naturally-occurring cases of atypical scrapie appears more consistent, regardless of genotype, and is preserved on transmission within sheep homologous for the prion protein (PRNP) gene. However, the stability of transmissible spongiform encephalopathy phenotypes on passage across and within species is not absolute, and there are reports in the literature where experimental transmissions of particular isolates have resulted in a phenotype consistent with a different strain. In this study, intracerebral inoculation of atypical scrapie between two genotypes both associated with susceptibility to atypical forms of disease resulted in one sheep displaying an altered phenotype with clinical, pathological, biochemical and murine bioassay characteristics all consistent with the classical scrapie strain CH1641, and distinct from the atypical scrapie donor, while the second sheep did not succumb to challenge. One of two sheep orally challenged with the same inoculum developed atypical scrapie indistinguishable from the donor. This study adds to the range of transmissible spongiform encephalopathy phenotype changes that have been reported following various different experimental donor-recipient combinations. While these circumstances may not arise through natural exposure to disease in the field, there is the potential for iatrogenic exposure should current disease surveillance and feed controls be relaxed. Future sheep to sheep transmission of atypical scrapie might lead to instances of disease with an alternative phenotype and onward transmission potential which may have adverse implications for both public health and animal disease control policies.	[Simmons, Marion M.; Moore, S. Jo; Lockey, Richard; Chaplin, Melanie J.; Konold, Timm; Vickery, Christopher; Spiropoulos, John] Anim & Plant Hlth Agcy Weybridge, Addlestone KT15 3NB, Surrey, England	Animal & Plant Health Agency UK	Simmons, MM (corresponding author), Anim & Plant Hlth Agcy Weybridge, Woodham Lane, Addlestone KT15 3NB, Surrey, England.	marion.simmons@apha.gsi.gov.uk	Simmons, Marion/C-2586-2011; Konold, Timm/C-6498-2011	Moore, S Jo/0000-0001-5276-1723	Department for the Environment Food and Rural Affairs (Defra) UK [SE1847]	Department for the Environment Food and Rural Affairs (Defra) UK(Department for Environment, Food & Rural Affairs (DEFRA))	This work was entirely funded by the Department for the Environment Food and Rural Affairs (Defra) UK (https://www.gov.uk/government/organisations/department-for-environment-food-ruralaffairs), through research grant SE1847. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015839; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Beck KE, 2010, J NEUROPATH EXP NEUR, V69, P483, DOI 10.1097/NEN.0b013e3181db2497; Beck KE, 2010, BRAIN PATHOL, V20, P313, DOI 10.1111/j.1750-3639.2009.00273.x; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Bruce ME, 2007, VET REC, V160, P665, DOI 10.1136/vr.160.19.665; Capobianco R, 2007, PLOS PATHOG, V3, DOI [10.1371/journal.ppat.0030198, DOI 10.1371/JOURNAL.PPAT.0030198]; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; Fediaevsky A, 2010, VET J, V185, P338, DOI 10.1016/j.tvjl.2009.06.019; Fediaevsky A, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-19; Fediaevsky A, 2009, EMERG INFECT DIS, V15, P710, DOI 10.3201/eid1505.081119; FOSTER JD, 1988, VET REC, V123, P5, DOI 10.1136/vr.123.1.5; Gavier-Widen D, 2004, J VET DIAGN INVEST, V16, P562, DOI 10.1177/104063870401600611; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gonzalez L, 2010, J GEN VIROL, V91, P2630, DOI 10.1099/vir.0.022574-0; Griffiths PC, 2010, J GEN VIROL, V91, P2132, DOI 10.1099/vir.0.018986-0; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Kittelberger R, 2010, J VET DIAGN INVEST, V22, P863, DOI 10.1177/104063871002200604; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Ligios C, 2002, J COMP PATHOL, V127, P45, DOI 10.1053/jcpa.2002.0589; Mazza M, 2010, RES VET SCI, V88, P478, DOI 10.1016/j.rvsc.2009.11.015; Moore SJ, 2008, ACTA NEUROPATHOL, V116, P547, DOI 10.1007/s00401-008-0433-8; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; Onnasch H, 2004, VET REC, V155, P636, DOI 10.1136/vr.155.20.636; Orge L, 2010, J GEN VIROL, V91, P1646, DOI 10.1099/vir.0.018879-0; Saunders GC, 2006, J GEN VIROL, V87, P3141, DOI 10.1099/vir.0.81779-0; Simmons HA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-8; Simmons Marion M, 2007, BMC Vet Res, V3, P20, DOI 10.1186/1746-6148-3-20; Simmons MM, 2011, EMERG INFECT DIS, V17, P848, DOI 10.3201/eid1705.101654; Simmons MM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-14; Spiropoulos J, 2007, NEUROPATH APPL NEURO, V33, P398, DOI 10.1111/j.1365-2990.2007.00800.x; Torres JM, 2011, EMERG INFECT DIS, V17, P1636, DOI 10.3201/eid1709.101403; Vickery CM, 2013, INT J EXP PATHOL, V94, P320, DOI 10.1111/iep.12036; Webb PR, 2009, J VET DIAGN INVEST, V21, P826, DOI 10.1177/104063870902100609; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192; Wells GA, 2004, TECHNIQUES PRION RES; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Yokoyama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015450	41	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117063	10.1371/journal.pone.0117063	http://dx.doi.org/10.1371/journal.pone.0117063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710519	Green Published, Green Submitted, gold			2022-12-27	WOS:000350683900022
J	Cheng, J; Cho, M; Cen, JM; Cai, MY; Xu, S; Ma, ZW; Liu, XG; Yang, XL; Chen, C; Suh, Y; Xiong, XD				Cheng, Jie; Cho, Miook; Cen, Jin-ming; Cai, Meng-yun; Xu, Shun; Ma, Ze-wei; Liu, Xinguang; Yang, Xi-li; Chen, Can; Suh, Yousin; Xiong, Xing-dong			A TagSNP in SIRT1 Gene Confers Susceptibility to Myocardial Infarction in a Chinese Han Population	PLOS ONE			English	Article							POLYMORPHISMS; ASSOCIATION; SENESCENCE; RESVERATROL; ENDOTHELIUM; DISEASE; TARGET; ROLES; HEART	SIRT1 exerts protective effects against endothelial cells dysfunction, inflammation and atherosclerosis, indicating an important role on myocardial infarction (MI) pathogenesis. Nonetheless, the effects of SIRT1 variants on MI risk remain poorly understood. Here we aimed to investigate the influence of SIRT1 polymorphisms on individual susceptibility to MI. Geno-typing of three tagSNPs (rs7069102, rs3818292 and rs4746720) in SIRT1 gene was performed in a Chinese Han population, consisting of 287 MI cases and 654 control subjects. In a logistic regression analysis, we found that G allele of rs7069102 had increased MI risk with odds ratio (OR) of 1.57 [95% confidence interval (CI) = 1.15-2.16, Bonferroni corrected P (P-c) = 0.015] after adjustment for conventional risk factors compared to C allele. Similarly, the combined CG/GG genotypes was associated with the increased MI risk (OR = 1.64, 95% CI = 1.14-2.35, P-c = 0.021) compared to the CC genotype. Further stratified analysis revealed a more significant association with MI risk among younger subjects (<= 55 years old). Consistent with these results, the haplotype rs7069102G-rs3818292A-rs4746720T containing the rs7069102 G allele was also associated with the increased MI risk (OR = 1.41, 95% CI = 1.09-1.84, P-c = 0.040). However, we did not detect any association of rs3818292 and rs4746720 with MI risk. Our study provides the first evidence that the tagSNP rs7069102 and haplotype rs7069102G-rs3818292A-rs4746720T in SIRT1 gene confer susceptibility to MI in the Chinese Han population.	[Cheng, Jie; Cai, Meng-yun; Xu, Shun; Ma, Ze-wei; Liu, Xinguang; Suh, Yousin; Xiong, Xing-dong] Guangdong Med Coll, Inst Aging Res, Dongguan, Peoples R China; [Cheng, Jie; Cai, Meng-yun; Xu, Shun; Ma, Ze-wei; Liu, Xinguang; Xiong, Xing-dong] Guangdong Prov Key Lab Med Mol Diagnost, Dongguan, Peoples R China; [Cheng, Jie; Liu, Xinguang; Xiong, Xing-dong] Guangdong Med Coll, Inst Biochem & Mol Biol, Zhanjiang, Peoples R China; [Cho, Miook; Suh, Yousin] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Cen, Jin-ming; Yang, Xi-li] First Peoples Hosp Foshan, Dept Cardiovasc Dis, Foshan, Peoples R China; [Chen, Can] Affiliated Hosp Guangdong Med Coll, Dept Cardiovasc Dis, Zhanjiang, Peoples R China; [Suh, Yousin] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Guangdong Medical University; Guangdong Medical University; Yeshiva University; Albert Einstein College of Medicine; Guangdong Medical University; Yeshiva University; Albert Einstein College of Medicine	Suh, Y (corresponding author), Guangdong Med Coll, Inst Aging Res, Dongguan, Peoples R China.	yousin.suh@einstein.yu.edu; xiongxingdong@126.com		Liu, Xin Guang/0000-0001-9033-9099	National Natural Science Foundation of China [81000143, 81370456]; Natural Science Foundation of Guangdong Province [S2012010008219, S2011010002922]; Medical Scientific Research Foundation of Guangdong Province [B2009191, A2011431]; Science and Technology Planning Project for University Research Institutions and Medical and Health Organizations of Dongguan City [2011105102007]; Guangdong University Students Innovative Pilot Program [KY1232, 1057113012, 201310571006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province; Science and Technology Planning Project for University Research Institutions and Medical and Health Organizations of Dongguan City; Guangdong University Students Innovative Pilot Program	This work was supported by grants from the National Natural Science Foundation of China (81000143, 81370456), the Natural Science Foundation of Guangdong Province (S2012010008219, S2011010002922), the Medical Scientific Research Foundation of Guangdong Province (B2009191, A2011431), the Science and Technology Planning Project for University Research Institutions and Medical and Health Organizations of Dongguan City (2011105102007) and the Guangdong University Students Innovative Pilot Program KY1232, 1057113012 and 201310571006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brandes RP, 2008, CARDIOVASC RES, V80, P163, DOI 10.1093/cvr/cvn245; Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Cui YH, 2012, BIOCHEM BIOPH RES CO, V426, P232, DOI 10.1016/j.bbrc.2012.08.071; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Figarska SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058636; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fujimaki T, 2010, ATHEROSCLEROSIS, V210, P468, DOI 10.1016/j.atherosclerosis.2009.11.050; Ghaderian SMH, 2010, CORONARY ARTERY DIS, V21, P330, DOI 10.1097/MCA.0b013e32833ce065; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Helisalmi S, 2008, J NEUROL, V255, P668, DOI 10.1007/s00415-008-0774-1; Homma K, 2010, ATHEROSCLEROSIS, V212, P42, DOI 10.1016/j.atherosclerosis.2010.04.021; Huang Jin, 2013, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V30, P55, DOI 10.3760/cma.j.issn.1003-9406.2013.01.013; Inamori T, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-4; Kallel A, 2010, CLIN BIOCHEM, V43, P1461, DOI 10.1016/j.clinbiochem.2010.08.029; Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kilic U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090428; Kishi T, 2011, HUM PSYCHOPHARM CLIN, V26, P445, DOI 10.1002/hup.1223; Kuningas M, 2007, J GERONTOL A-BIOL, V62, P960, DOI 10.1093/gerona/62.9.960; Li J, 2014, LANCET; Li L, 2011, CIRC RES, V108, P1180, DOI 10.1161/CIRCRESAHA.110.237875; Maeda S, 2011, CLIN EXP NEPHROL, V15, P381, DOI 10.1007/s10157-011-0418-0; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Ota H, 2010, J ATHEROSCLER THROMB, V17, P431, DOI 10.5551/jat.3525; Peeters AV, 2008, HUM GENET, V124, P431, DOI 10.1007/s00439-008-0567-8; Potente M, 2008, CELL CYCLE, V7, P2117, DOI 10.4161/cc.7.14.6267; Schmitt CA, 2010, BIOFACTORS, V36, P342, DOI 10.1002/biof.109; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shimoyama Y, 2012, J RENAL NUTR, V22, P114, DOI 10.1053/j.jrn.2011.10.025; Shimoyama Y, 2011, TRANSL RES, V157, P339, DOI 10.1016/j.trsl.2011.02.004; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Tong C, 2013, FASEB J, V27, P4332, DOI 10.1096/fj.12-216473; Wang F, 2013, CURR MOL MED, V13, P155, DOI 10.2174/156652413804486223; Wang Y, 2011, FEBS LETT, V585, P986, DOI 10.1016/j.febslet.2010.11.047; Yamada Y, 2011, ATHEROSCLEROSIS, V215, P145, DOI 10.1016/j.atherosclerosis.2010.12.005; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhang WG, 2010, CLIN CHIM ACTA, V411, P1679, DOI 10.1016/j.cca.2010.06.030; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zillikens MC, 2010, AM J CLIN NUTR, V91, P1387, DOI 10.3945/ajcn.2009.28627; Zillikens MC, 2009, DIABETES, V58, P2828, DOI 10.2337/db09-0536; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	50	175	180	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115339	10.1371/journal.pone.0115339	http://dx.doi.org/10.1371/journal.pone.0115339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706717	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100011
J	Kopp, TI; Andersen, V; Tjonneland, A; Vogel, U				Kopp, Tine Iskov; Andersen, Vibeke; Tjonneland, Anne; Vogel, Ulla			Polymorphisms in NFKB1 and TLR4 and Interaction with Dietary and Life Style Factors in Relation to Colorectal Cancer in a Danish Prospective Case-Cohort Study	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; RESISTANCE 1 MDR1; CROHNS-DISEASE; ULCERATIVE-COLITIS; EPIDEMIOLOGIC EVIDENCE; PROMOTER POLYMORPHISM; BACTERIAL METABOLITES; GENE INTERACTIONS	Maintenance of a balance between commensal bacteria and the mucosal immune system is crucial and intestinal dysbiosis may be a key event in the pathogenesis of colorectal cancer (CRC). The toll-like receptor 4 (TLR4) is an important pattern-recognition receptor that regulates inflammation and barrier function in the gut by a mechanism that involves activation of the nuclear factor-kappa B (NF-kappa B) transcription factor. Dietary and life style factors may impact these functions. We therefore used a Danish prospective case-cohort study of 1010 CRC cases and 1829 randomly selected participants from the Danish Diet, Cancer and Health cohort to investigate three polymorphisms in NFKB1 and TLR4 and their possible interactions with diet and life style factors in relation to risk of CRC. Homozygous carriage of the variant allele of the TLR4/rs5030728 polymorphism was associated with increased risk of CRC (incidence rate ratio (IRR) = 1.30; 95% confidence interval (CI): 1.05-1.60; P = 0.02 (gene-dose model); IRR = 1.24; 95% CI: 1.01-1.51; P = 0.04 (recessive model)). Del-carriers of the NFKB1/rs28362491 polymorphism had a 17% (95% CI: 1.03-1.34; P = 0.02) increased risk of CRC compared to homozygous carriers of the ins-allele. However, none of these risk estimates withstood adjustment for multiple comparisons. We found no strong gene-environment interactions between the examined polymorphism and diet and life style factors in relation to CRC risk.	[Kopp, Tine Iskov] Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark; [Andersen, Vibeke] Hosp Southern Jutland, Organ Ctr, DK-6200 Aabenraa, Denmark; [Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, DK-5000 Odense, Denmark; [Andersen, Vibeke] Reg Hosp Viborg, Dept Med, DK-8800 Viborg, Denmark; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, DK-2100 Copenhagen, Denmark	Technical University of Denmark; University of Southern Denmark; Danish Cancer Society; National Research Centre for the Working Environment	Kopp, TI (corresponding author), Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark.	tinis@food.dtu.dk	Vogel, Ulla B/I-5048-2012; Vogel, Ulla/ABC-2212-2020; Andersen, Vibeke/I-7932-2012	Vogel, Ulla B/0000-0001-6807-1524; Vogel, Ulla/0000-0001-6807-1524; Andersen, Vibeke/0000-0002-0127-2863; Tjonneland, Anne/0000-0003-4385-2097; Kopp, Tine/0000-0003-3729-4420	Danish Research Councils in the programme 'An integrated approach to risk-benefit assessment of human health effects of food and food contaminants'; Danish Council for Independent Research [09-06 7572]; Danish Council for Independent Research Medical Sciences [09-073597]	Danish Research Councils in the programme 'An integrated approach to risk-benefit assessment of human health effects of food and food contaminants'; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF))	The project was supported by a PhD stipend from the Danish Research Councils in the programme 'An integrated approach to risk-benefit assessment of human health effects of food and food contaminants' (Forskeruddannelse 2009-10), and by a Mobility PhD grant (09-06 7572) from the Danish Council for Independent Research (www.ufm.dk) and as part of the project: "Beef versus pork consumption in the etiology of cancers in the colon and rectum: investigations performed within the Diet, Cancer and Health cohort" also from the Danish Council for Independent Research; Medical Sciences (grant no. 09-073597) (www.ufm.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Andersen V, 2013, ALIMENT PHARM THER, V37, P383, DOI 10.1111/apt.12180; Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078366; Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072119; Andersen V, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-183; Andersen V, 2012, SCAND J GASTROENTERO, V47, P572, DOI 10.3109/00365521.2012.668933; Andersen V, 2011, WORLD J GASTROENTERO, V17, P197, DOI 10.3748/wjg.v17.i2.197; Andersen V, 2011, EUR J GASTROEN HEPAT, V23, P282, DOI 10.1097/MEG.0b013e3283417f76; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Andersen V, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-18; Bank S, 2014, PHARMACOGENOMICS J; Bank S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098815; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BINGHAM SA, 1990, P NUTR SOC, V49, P153, DOI 10.1079/PNS19900021; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; Borm MEA, 2005, INT J IMMUNOGENET, V32, P401, DOI 10.1111/j.1744-313X.2005.00546.x; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Browning BL, 2007, AM J GASTROENTEROL, V102, P2504, DOI 10.1111/j.1572-0241.2007.01463.x; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Cogliano VJ, 2011, JNCI-J NATL CANCER I, V103, P1827, DOI 10.1093/jnci/djr483; Cuda C, 2011, METABOLISM, V60, P1131, DOI 10.1016/j.metabol.2010.12.006; CUMMINGS JH, 1979, AM J CLIN NUTR, V32, P2094, DOI 10.1093/ajcn/32.10.2094; Davoodi H, 2011, IRAN J ALLERGY ASTHM, V10, P91, DOI 010.02/ijaai.9199; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; De Preter V, 2013, INFLAMM BOWEL DIS, V19, pE43, DOI 10.1002/ibd.22970; Durko L, 2014, CURR COLORECT CANC R, V10, P45, DOI 10.1007/s11888-013-0203-4; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Ferlay J, 2014, IARC CANCERBASE; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Friis S, 2009, CANCER CAUSE CONTROL, V20, P731, DOI 10.1007/s10552-008-9286-7; Fukata M, 2007, BIOCHEM SOC T, V35, P1473, DOI 10.1042/BST0351473; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Fukata M, 2009, INFLAMM BOWEL DIS, V15, P997, DOI 10.1002/ibd.20880; Garlanda C, 2007, CANCER RES, V67, P6017, DOI 10.1158/0008-5472.CAN-07-0560; Gast A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024370; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hansen RD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-54; Hansen RD, 2007, MUTAT RES-FUND MOL M, V619, P68, DOI 10.1016/j.mrfmmm.2007.02.002; Hansen RD, 2009, MUTAT RES-FUND MOL M, V664, P13, DOI 10.1016/j.mrfmmm.2009.01.009; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Jelavic TB, 2006, CLIN GENET, V70, P156, DOI 10.1111/j.1399-0004.2006.00651.x; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Kopp TI, 2013, CANCER GENET-NY, V206, P266, DOI 10.1016/j.cancergen.2013.06.001; Kutikhin AG, 2014, TUMOUR BIOL; Landi S, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-15; Le Leu RK, 2007, CANCER BIOL THER, V6, P259, DOI 10.4161/cbt.6.2.4078; Le Leu R, 2013, DIGEST DIS SCI, V58, P3475, DOI 10.1007/s10620-013-2844-1; Lewander A, 2007, SCAND J GASTROENTERO, V42, P1332, DOI 10.1080/00365520701396026; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murphy N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039361; Omrane I, 2014, TUMOR BIOL, V35, P545, DOI 10.1007/s13277-013-1075-6; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pimentel-Nunes P, 2013, DIGEST LIVER DIS, V45, P63, DOI 10.1016/j.dld.2012.08.006; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Slattery ML, 2012, INT J CANCER, V130, P2974, DOI 10.1002/ijc.26314; Suzairi MSM, 2013, CANCER EPIDEMIOL, V37, P634, DOI 10.1016/j.canep.2013.05.007; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vogel U, 2007, MUTAT RES-FUND MOL M, V624, P88, DOI 10.1016/j.mrfmmm.2007.04.006; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; WHITEHEAD RH, 1986, GUT, V27, P1457, DOI 10.1136/gut.27.12.1457; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Young GP, 2005, MOL NUTR FOOD RES, V49, P571, DOI 10.1002/mnfr.200500026	73	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116394	10.1371/journal.pone.0116394	http://dx.doi.org/10.1371/journal.pone.0116394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705893	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100035
J	Laclaustra, M; Van den Berg, ELM; Hurtado-Roca, Y; Castellote, JM				Laclaustra, Martin; Van den Berg, Elizabeth Louise Maayken; Hurtado-Roca, Yamilee; Manuel Castellote, Juan			Serum Lipid Profile in Subjects with Traumatic Spinal Cord Injury	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; SYMPATHETIC-NERVOUS-SYSTEM; RESTING METABOLIC-RATE; HEART-DISEASE; EXERCISE; CATECHOLAMINES; PARTICIPATION; INDIVIDUALS; PARAPLEGIA; OBESITY	Background and Aims Few large studies have examined the relationship between spinal cord injury (SCI) and lipid profile. We studied serum lipid concentrations in subjects with traumatic SCI in relation to the degree of neurological involvement and time since injury, and compared them with values from a reference sample for the Spanish population (DRECE study). Materials and Methods A retrospective cohort was built from 177 consecutive cases with traumatic SCI admitted to the SCI unit of the Miguel Servet Hospital in Aragon (Spain). Outcome measures (cholesterol, triglycerides, HDL-c and LDL-c levels) were analyzed according to the ASIA Impairment Scale (AIS), neurological level of injury (involvement of all limbs vs. only lower limbs), and time since injury. All analyses were adjusted for age and sex. Results Cases without preserved motor function (AIS A or B) had lower total and HDL cholesterol than the others (-11.4 [-21.5, -1.4] mg/dL total cholesterol and -5.1 [-8.8, -1.4] mg/dL HDL-c), and cases with all-limb involvement had lower total, HDL, and LDL cholesterol than those with only lower-limb involvement (-14.0 [-24.6, -3.4] mg/dL total cholesterol, -4.1 [-8.0, -0.2] mg/dL HDL-c, and -10.0 [-19.7, -0.3] mg/dL LDL-c) (all p < 0.05). No association was found between lipid concentrations and time since injury. Concentrations of lipid subfractions and triglycerides in SCI subjects were lower than in sex- and age-stratified values from the reference sample. Conclusion A high degree of neurological involvement in SCI (anatomically higher lesions and AIS A or B) is associated with lower total cholesterol and HDL-c.	[Laclaustra, Martin; Hurtado-Roca, Yamilee] Ctr Nacl Invest Cardiovasc, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain; [Laclaustra, Martin] Univ Autonoma Madrid, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Laclaustra, Martin] St Louis Univ, Dept Epidemiol, St Louis, MO 63103 USA; [Van den Berg, Elizabeth Louise Maayken] Flinders Univ S Australia, Sch Hlth Sci, Dept Rehabil Aged & Extended Care, Adelaide, SA 5001, Australia; [Manuel Castellote, Juan] Carlos III Inst Hlth, Natl Sch Occupat Med, Madrid, Spain; [Manuel Castellote, Juan] Univ Complutense Madrid, Dept Phys Med & Rehabil, Sch Med, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Saint Louis University; Flinders University South Australia; Instituto de Salud Carlos III; Escuela Nacional de Medicina del Trabajo (ENMT); Complutense University of Madrid	Castellote, JM (corresponding author), Carlos III Inst Hlth, Natl Sch Occupat Med, Madrid, Spain.	jmcastel@isciii.es	Castellote, Juan M./ABG-4178-2020; Laclaustra, Martín/C-6709-2015	Laclaustra, Martín/0000-0003-3963-0846; HURTADO-ROCA, YAMILEE/0000-0003-1993-6223	Spanish Instituto de Salud Carlos III [FIS CP08/00112, PI10/00021]; Instituto de Salud Carlos III [TPY 1115/07, PI13/00526, TPY 1444/08, ESVI 1338/12-1]; Peruvian government [088-FINCyT-BDE-2014]	Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Peruvian government	Dr. Laclaustra was supported in part by grants FIS CP08/00112 and PI10/00021 from the Spanish Instituto de Salud Carlos III. Dr. Castellote was supported in part by grants TPY 1115/07, PI13/00526, TPY 1444/08 and ESVI 1338/12-1 from the Instituto de Salud Carlos III. Dr. Hurtado was supported by Fellowship N degrees 088-FINCyT-BDE-2014 from the Peruvian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apstein MD, 1998, METABOLISM, V47, P367, DOI 10.1016/S0026-0495(98)90044-0; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; BAUMAN WA, 1992, MT SINAI J MED, V59, P163; Bauman WA, 1998, SPINAL CORD, V36, P13, DOI 10.1038/sj.sc.3100513; BAUMAN WA, 1992, PARAPLEGIA, V30, P697, DOI 10.1038/sc.1992.136; Bauman WA, 1999, SPINAL CORD, V37, P485, DOI 10.1038/sj.sc.3100862; Buchholz AC, 2005, SPINAL CORD, V43, P513, DOI 10.1038/sj.sc.3101744; Buchholz AC, 2003, AM J CLIN NUTR, V77, P371, DOI 10.1093/ajcn/77.2.371; Davis GM, 2008, ARTIF ORGANS, V32, P625, DOI 10.1111/j.1525-1594.2008.00622.x; Fernhall Bo, 2008, J Health Hum Serv Adm, V30, P468; Gomez-Gerique JA, 1999, MED CLIN-BARCELONA, V113, P730; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jeon JY, 2003, J CLIN ENDOCR METAB, V88, P402, DOI 10.1210/jc.2002-020939; Kehn M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-168; KRUM H, 1992, PARAPLEGIA, V30, P381, DOI 10.1038/sc.1992.87; Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI [10.1016/j.numecd.2006.10.005, 10.1038/ki.2008.517]; Lavis Timothy D, 2007, Phys Med Rehabil Clin N Am, V18, P317, DOI 10.1016/j.pmr.2007.03.003; Libin Alexander, 2013, Top Spinal Cord Inj Rehabil, V19, P183, DOI 10.1310/sci1903-183; Magnuson B, 2011, NUTR CLIN PRACT, V26, P253, DOI 10.1177/0884533611405673; Matos-Souza JR, 2010, SPINAL CORD, V48, P740, DOI 10.1038/sc.2010.12; McKinley WO, 2004, NEUROREHABILITATION, V19, P79; Munakata M, 1997, J HYPERTENS, V15, P1745, DOI 10.1097/00004872-199715120-00083; Nash MS, 2007, ARCH PHYS MED REHAB, V88, P751, DOI 10.1016/j.apmr.2007.02.031; Sabour H, 2011, J RES MED SCI, V16, P335; Sassolas A, 1999, ANN BIOL CLIN-PARIS, V57, P555; Schmid A, 1998, J APPL PHYSIOL, V85, P635, DOI 10.1152/jappl.1998.85.2.635; Schmid A, 1998, J AUTONOM NERV SYST, V68, P96, DOI 10.1016/S0165-1838(97)00127-6; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285; Stiens SA, 2002, ARCH PHYS MED REHAB, V83, pS72, DOI 10.1053/apmr.2002.32178; Van Den Berg M, 2011, J NEUROTRAUM, V28, P469, DOI 10.1089/neu.2010.1608; van den Berg MEE, 2012, ARCH PHYS MED REHAB, V93, P325, DOI 10.1016/j.apmr.2011.08.027; van den Berg MEL, 2010, J NEUROTRAUM, V27, P1517, DOI 10.1089/neu.2009.1138; Wahman K, 2011, J REHABIL MED, V43, P237, DOI 10.2340/16501977-0658; Wahman K, 2010, J REHABIL MED, V42, P489, DOI 10.2340/16501977-0541; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, P1793, DOI 10.1016/j.apmr.2004.04.024; Wilt Timothy J, 2008, Evid Rep Technol Assess (Full Rep), P1; Wong S, 2012, BRIT J NUTR, V108, P918, DOI 10.1017/S0007114511006234; YEKUTIEL M, 1989, PARAPLEGIA, V27, P58, DOI 10.1038/sc.1989.9	38	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115522	10.1371/journal.pone.0115522	http://dx.doi.org/10.1371/journal.pone.0115522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706982	gold, Green Published			2022-12-27	WOS:000350662100014
J	Manhica, H; Toivanen, S; Hjern, A; Rostila, M				Manhica, Helio; Toivanen, Susanna; Hjern, Anders; Rostila, Mikael			Mortality in Adult Offspring of Immigrants: A Swedish National Cohort Study	PLOS ONE			English	Article							2ND-GENERATION IMMIGRANTS; SOCIOECONOMIC-STATUS; FOLLOW-UP; HEALTH INEQUALITIES; SOCIAL-CLASS; DRUG-ABUSE; SWEDEN; GENDER; 1ST-GENERATION; MIGRATION	Background Higher risks of psychiatric disorders and lower-than-average subjective health in adulthood have been demonstrated in offspring of immigrants in Sweden compared with offspring of native Swedes, and linked to relative socioeconomic disadvantage. The present study investigated mortality rates in relation to this inequity from a gender perspective. Methods We used data from national registers covering the entire Swedish population aged 18-65 years. Offspring of foreign-born parents who were either Swedish born or had received residency in Sweden before school age (<7 years) were defined as "offspring of immigrants." We used Cox regression models to examine the association between parental country of birth and mortality between 1990 and 2008, with adjustment for education, income, age and family type. Results Male offspring of immigrants from the Middle East (HR:2.00, CI:1.66-2.26), other non-European countries (HR: 1.80, CI:1.36-2.36) and Finland (HR: 1.56, CI:1.48-1.65) showed an age-adjusted excess mortality risk from all causes of death when compared to offspring with Swedish-born parents. Income, but not education, greatly attenuated these increased mortality risks. No excess mortality rates were found among female offspring of immigrants, with the exception of external cause of death among offspring of Finnish immigrants. Conclusion The study demonstrates high mortality rates in male offspring of immigrants from Finland and non-European countries that are associated with economic, but not educational, disadvantage. No increased mortality rates were found among female offspring of immigrants. Future studies are needed to explain this gender differential and why income, but not education, predicts mortality in male offspring of immigrants.	[Manhica, Helio; Toivanen, Susanna; Hjern, Anders] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden; [Hjern, Anders] Karolinska Inst, Dept Clin Epidemiol, Stockholm, Sweden; [Rostila, Mikael] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Rostila, Mikael] Stockholm Univ, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Stockholm University; Stockholm University	Manhica, H (corresponding author), Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden.	helio.manhica@chess.su.se	MANHICA, Helio/ABG-2029-2021; Toivanen, Susanna/AAH-6758-2021	Toivanen, Susanna/0000-0002-3965-1666	Swedish Council for Health, Working Life and Welfare; Swedish National Board of Health and Welfare [2012-1190]	Swedish Council for Health, Working Life and Welfare; Swedish National Board of Health and Welfare	This study was supported by the Swedish Council for Health, Working Life and Welfare. The study received funding from the Swedish National Board of Health and Welfare, grant #2012-1190. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan Sharareh, 2007, Work, V28, P135; Aneshensel CS, 1986, SERIES CLIN COMMUNIT, P99; Bambra C, 2009, J EPIDEMIOL COMMUN H, V63, P38, DOI 10.1136/jech.2007.070292; Basu S, 2010, AGE OF ENTRY EFFECTS; Behrenz L, 2007, INT REV APPL ECON, V21, P157, DOI 10.1080/02692170601035074; Bergmark A, 2003, INT J SOC WELF, V12, P108, DOI 10.1111/1468-2397.00249; Carlsson S, 2003, DIABETES CARE, V26, P2785, DOI 10.2337/diacare.26.10.2785; CEDERLOF R, 1982, INT J EPIDEMIOL, V11, P387, DOI 10.1093/ije/11.4.387; Constant A, 2005, POPUL RES POLICY REV, V24, P489, DOI 10.1007/s11113-005-4675-z; Dribe M, 2008, ACTA SOCIOL, V51, P329, DOI 10.1177/0001699308097377; Faresjo T, 1997, SCAND J SOC MED, V25, P28, DOI 10.1177/140349489702500107; Gadd M, 2003, J INTERN MED, V254, P236, DOI 10.1046/j.1365-2796.2003.01178.x; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gushulak BD, 2011, CAN MED ASSOC J, V183, pE952, DOI 10.1503/cmaj.090287; Harkonen J, 2011, NORD J WORKING LIFE, V1, P23; Hjern A, 2004, PSYCHOL MED, V34, P1025, DOI 10.1017/S003329170300148X; Hjern A, 2004, ADDICTION, V99, P229, DOI 10.1046/j.1360-0443.2003.00562.x; Hjern A, 2004, SCAND J PUBLIC HEALT, V32, P40, DOI 10.1080/14034940310001677; Hjern A, 2002, SOC PSYCH PSYCH EPID, V37, P423, DOI 10.1007/s00127-002-0564-5; Hjern A, 2012, SCAND J PUBLIC HEALT, V40, P255, DOI 10.1177/1403494812459610; HOUSE JS, 1975, AM J SOCIOL, V81, P395, DOI 10.1086/226079; Howard G, 2000, ANN EPIDEMIOL, V10, P214, DOI 10.1016/S1047-2797(00)00038-7; Iyer A, 2008, Glob Public Health, V3 Suppl 1, P13, DOI 10.1080/17441690801892174; Jablonska B, 2009, PSYCHOL MED, V39, P87, DOI 10.1017/S0033291708003176; Jorgensen L, 2005, SCAND J PUBLIC HEALT, V33, P285, DOI 10.1080/14034940510005734; Karlsen S, 2002, AM J PUBLIC HEALTH, V92, P624, DOI 10.2105/AJPH.92.4.624; Leao TS, 2006, SUBST USE MISUSE, V41, P283, DOI 10.1080/10826080500409100; Leao TS, 2006, J NERV MENT DIS, V194, P27, DOI 10.1097/01.nmd.0000195312.81334.81; Llacer A, 2007, J EPIDEMIOL COMMUN H, V61, P4, DOI 10.1136/jech.2007.061770; Lundberg J, 2009, SOCIOL HEALTH ILL, V31, P478, DOI 10.1111/j.1467-9566.2008.01148.x; Malmusi D, 2010, SOC SCI MED, V71, P1610, DOI 10.1016/j.socscimed.2010.07.043; McCartney G, 2011, TOB CONTROL, V20, P166, DOI 10.1136/tc.2010.037929; PEARLIN LI, 1977, AM SOCIOL REV, V42, P704, DOI 10.2307/2094860; Reitz J.G., 2004, J INT MIGR INT REV I, V5, P385, DOI DOI 10.1007/S12134-004-1021-Y; Rooth DO, 2003, J POPUL ECON, V16, P787, DOI 10.1007/s00148-003-0163-0; Rostila M, 2014, AM J PUBLIC HEALTH, V104, P686, DOI 10.2105/AJPH.2013.301613; Rostila M, 2010, SOCIOL HEALTH ILL, V32, P382, DOI 10.1111/j.1467-9566.2009.01196.x; Statistics Sweden, 2014, WOM MEN SWED FACTS F; Sundquist J, 2002, RAPPORT HALSAN OLIKA, DOI [10.1016/j.ijsu.2015.01.018, DOI 10.1016/J.IJSU.2015.01.018]; Van de Velde S, 2013, SOCIOL HEALTH ILL, V35, P682, DOI 10.1111/j.1467-9566.2012.01521.x; Van de Velde S, 2010, SOC SCI MED, V71, P305, DOI 10.1016/j.socscimed.2010.03.035; WALDRON I, 1976, SOC SCI MED, V10, P349, DOI 10.1016/0037-7856(76)90090-1; Wallby T, 2008, ACTA PAEDIATR, V97, P1542, DOI 10.1111/j.1651-2227.2008.00964.x; Wamala S, 2007, BRIT J PSYCHIAT, V190, P75, DOI 10.1192/bjp.bp.105.021188; Wei M, 1996, ANN EPIDEMIOL, V6, P307, DOI 10.1016/S1047-2797(96)00026-9; Weitoft GR, 1999, INT J EPIDEMIOL, V28, P756, DOI 10.1093/ije/28.4.756	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e011699	10.1371/journal.pone.0116999	http://dx.doi.org/10.1371/journal.pone.0116999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706297	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100057
J	Mathur, C; Kathuria, PC; Dahiya, P; Singh, AB				Mathur, Chandni; Kathuria, Pooran C.; Dahiya, Pushpa; Singh, Anand B.			Lack of Detectable Allergenicity in Genetically Modified Maize Containing "Cry" Proteins as Compared to Native Maize Based on In Silico & In Vitro Analysis	PLOS ONE			English	Article							FOOD	Background Genetically modified, (GM) crops with potential allergens must be evaluated for safety and endogenous IgE binding pattern compared to native variety, prior to market release. Objective To compare endogenous IgE binding proteins of three GM maize seeds containing Cry 1Ab, 1Ac, 1C transgenic proteins with non GM maize. Methods An integrated approach of in silico & in vitro methods was employed. Cry proteins were tested for presence of allergen sequence by FASTA in allergen databases. Biochemical assays for maize extracts were performed. Specific IgE (sIgE) and Immunoblot using food sensitized patients sera (n = 39) to non GM and GM maize antigens was performed. Results In silico approaches, confirmed for non sequence similarity of stated transgenic proteins in allergen databases. An insignificant (p> 0.05) variation in protein content between GM and non GM maize was observed. Simulated Gastric Fluid (SGF) revealed reduced number of stable protein fractions in GM then non GM maize which might be due to shift of constituent protein expression. Specific IgE values from patients showed insignificant difference in non GM and GM maize extracts. Five maize sensitized cases, recognized same 7 protein fractions of 88-28 kD as IgE bindng in both GM and non-GM maize, signifying absence of variation. Four of the reported IgE binding proteins were also found to be stable by SGF. Conclusion Cry proteins did not indicate any significant similarity of >35% in allergen databases. Immunoassays also did not identify appreciable differences in endogenous IgE binding in GM and non GM maize.				singha49@hotmail.com	KATHURIA, P.C/AAG-6750-2019; matthur, chandni/AAP-1646-2021	matthur, chandni/0000-0002-3223-3111	Council of Scientific & Industrial Research (CSIR), India	Council of Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The study is funded by Council of Scientific & Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Batista R, 2005, J ALLERGY CLIN IMMUN, V116, P403, DOI 10.1016/j.jaci.2005.04.014; Burks AW, 1995, J ALLERGY CLIN IMMUN, V96, P1008, DOI 10.1016/S0091-6749(95)70243-1; Buzoianu SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047851; Codex Alimentarious Commission, 2003, 25 SESS ROM IT 30 JU; Dhillon BS, 2001, MAIZE BREEDING FIELD, P147; Fasoli E, 2009, J PROTEOMICS, V72, P501, DOI 10.1016/j.jprot.2009.01.013; Food and Agriculture Organization/World Health Organization FAO/WHO, 2001, EV ALL GEN MOD FOODS; Goodman RE, 2011, CURR ALLERGY ASTHM R, V11, P317, DOI 10.1007/s11882-011-0195-6; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hileman RE, 2002, INT ARCH ALLERGY IMM, V128, P280, DOI 10.1159/000063861; [ICMR Indian Council of Medical Research], 2008, IND COUNC MED RES GU; IGMORIS, IND GMO RES INF SYST; Ivanciuc O, 2003, NUCLEIC ACIDS RES, V31, P359, DOI 10.1093/nar/gkg010; Kasera R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027193; KAUFFMAN HF, 1983, J ALLERGY CLIN IMMUN, V72, P255, DOI 10.1016/0091-6749(83)90029-5; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; Ladics GS, 2011, REGUL TOXICOL PHARM, V60, P46, DOI 10.1016/j.yrtph.2011.02.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCann MC, 2005, J AGR FOOD CHEM, V53, P5331, DOI 10.1021/jf0504317; Metcalfe DD, 1996, CRIT REV FOOD SCI, V36, pS165, DOI 10.1080/10408399609527763; Noteborn HPJM, 1995, ACS SYM SER, V605, P134; OECD, 1998, ORG EC COOP DEV WORK; Ofori-Anti AO, 2008, REGUL TOXICOL PHARM, V52, P94, DOI 10.1016/j.yrtph.2008.06.006; Pastorello EA, 2000, J ALLERGY CLIN IMMUN, V106, P744, DOI 10.1067/mai.2000.108712; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Randhawa GJ, 2011, FOOD CHEM TOXICOL, V49, P356, DOI 10.1016/j.fct.2010.11.008; Satoh R, 2011, REGUL TOXICOL PHARM, V59, P437, DOI 10.1016/j.yrtph.2011.01.008; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Taylor SL, 1997, ENVIRON TOXICOL PHAR, V4, P121, DOI 10.1016/S1382-6689(97)10052-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; United States Pharmacopeia Convention Committee of Revision, 1989, NATL FORMULARY, VXXII, P1788; Verma AK, 2011, IMMUNOPHARM IMMUNOT, V33, P410, DOI 10.3109/08923973.2010.523704; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177	38	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117340	10.1371/journal.pone.0117340	http://dx.doi.org/10.1371/journal.pone.0117340			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706412	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100078
J	Noordam, AC; Carvajal-Velez, L; Sharkey, AB; Young, M; Cals, JWL				Noordam, Aaltje Camielle; Carvajal-Velez, Liliana; Sharkey, Alyssa B.; Young, Mark; Cals, Jochen W. L.			Care Seeking Behaviour for Children with Suspected Pneumonia in Countries in Sub-Saharan Africa with High Pneumonia Mortality	PLOS ONE			English	Article							ACUTE RESPIRATORY-INFECTIONS; HEALTH-CARE; CHILDHOOD ILLNESS; CASE-MANAGEMENT; HOUSEHOLD; COMMUNITY; DIARRHEA; DETERMINANTS; MALARIA; POOR	Pneumonia is the leading cause of childhood mortality in sub-Saharan Africa (SSA). Because effective antibiotic treatment exists, timely recognition of pneumonia and subsequent care seeking for treatment can prevent deaths. For six high pneumonia mortality countries in SSA we examined if children with suspected pneumonia were taken for care, and if so, from which type of care providers, using national survey data of 76530 children. We also assessed factors independently associated with care seeking from health providers, also known as 'appropriate' providers. We report important differences in care seeking patterns across these countries. In Tanzania 85% of children with suspected pneumonia were taken for care, whereas this was only 30% in Ethiopia. Most of the children living in these six countries were taken to a primary health care facility; 86, 68 and 59% in Ethiopia, Tanzania and Burkina Faso respectively. In Uganda, hospital care was sought for 60% of children. 16-18% of children were taken to a private pharmacy in Democratic Republic of Congo (DRC), Tanzania and Nigeria. In Tanzania, children from the richest households were 9.5 times (CI 2.3-39.3) more likely to be brought for care than children from the poorest households, after controlling for the child's age, sex, caregiver's education and urban-rural residence. The influence of the age of a child, when controlling for sex, urban-rural residence, education and wealth, shows that the youngest children (<2 years) were more likely to be brought to a care provider in Nigeria, Ethiopia and DRC. Urban-rural residence was not significantly associated with care seeking, after controlling for the age and sex of the child, caregivers education and wealth. The study suggests that it is crucial to understand country-specific care seeking patterns for children with suspected pneumonia and related determinants using available data prior to planning programmatic responses.	[Noordam, Aaltje Camielle; Cals, Jochen W. L.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, NL-6200 MD Maastricht, Netherlands; [Carvajal-Velez, Liliana] United Nations Children Fund UNICEF, Div Policy & Strategy, Data & Analyt Sect, New York, NY USA; [Sharkey, Alyssa B.; Young, Mark] United Nations Children Fund UNICEF, Hlth Sect, New York, NY USA	Maastricht University; UNICEF; UNICEF	Noordam, AC (corresponding author), Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, NL-6200 MD Maastricht, Netherlands.	camielle.noordam@maastrichtuniversity.nl	Cals, Jochen WL/A-1262-2007	Cals, Jochen WL/0000-0001-9550-5674	Netherlands Organization for Health Research and Development (ZonMw) [91614078]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	ACN is an external PhD candidate at the University of Maastricht; she received no funding for this work. LCV, ABS and MY are employed by the United Nations Children's Fund (UNICEF), they received no specific funding for this work. JWLC is employed by the University of Maastricht and is supported by a Veni-grant (91614078) of the Netherlands Organization for Health Research and Development (ZonMw) [http://www.zonmw.nl/en/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aremu O, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-13; Awoke W., 2013, OPEN J PREVENTIVE ME, V3, P155, DOI [10.4236/ojpm.2013.32020, DOI 10.4236/OJPM.2013.32020]; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Campbell H, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001422, 10.1371/journal.pmed.1001421]; Chenge MF, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-173; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; Ellis AA, 2013, J BIOSOC SCI, V45, P743, DOI 10.1017/S0021932013000163; Ferdous F, 2013, SCI J PUBLIC HLTH, V1, P69, DOI DOI 10.11648/J.SJPH.20130102.14; Hancioglu A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001391; Hazir T, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001448, DOI 10.1371/JOURNAL.PMED.1001448]; Hildenwall H, 2008, BMC INT HEALTH HUM R, V8, P12, DOI DOI 10.1186/1472-698X-8-12; Hodgins S, 2013, GLOB HEALTH-SCI PRAC, V1, P328, DOI 10.9745/GHSP-D-13-00023; Holtz TH, 2003, T ROY SOC TROP MED H, V97, P491, DOI 10.1016/S0035-9203(03)80003-2; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Kahabuka C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-315; Kahabuka C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058789; Kallander K, 2005, ANN TROP PAEDIATR, V25, P283, DOI 10.1179/146532805X72430; Ketsela T, OPPORTUNITIES AFRICA; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Maketa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084314; Mebratie AD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004020; Miller NP, 2014, AM J TROP MED HYG, V91, P424, DOI 10.4269/ajtmh.13-0751; Mosites Emily M, 2014, BMC Public Health, V14, P446, DOI 10.1186/1471-2458-14-446; Noordam AC, 2015, HEALTH POLICY PLANN, V30, P696, DOI 10.1093/heapol/czu047; Okeke TA, 2010, HEALTH POLICY, V95, P62, DOI 10.1016/j.healthpol.2009.11.005; Onwujekwe O, 2011, TROP MED INT HEALTH, V16, P1087, DOI 10.1111/j.1365-3156.2011.02821.x; Pandey A, 2002, J HEALTH POPUL NUTR, V20, P306; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Pio A, 2003, B WORLD HEALTH ORGAN, V81, P298; Quinley J, 2007, TREATMENT CHILDHOOD; Ridde V, 2011, HEALTH POLICY PLANN, V26, P1, DOI 10.1093/heapol/czq021; Rutstein S. O., 2004, DHS COMP REPORTS; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Scott K, 2014, HEALTH POLICY PLANN, V29, P292, DOI 10.1093/heapol/czt016; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Simoes EAF, 2006, DIS CONTROL PRIORITI; Sreeramareddy CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051904; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; Tinuade O, 2010, J PAEDIATR CHILD H, V46, P238, DOI 10.1111/j.1440-1754.2009.01677.x; Tsion A, 2008, ETHIOP J HEALTH SCI, V18, P87; Ukwaja KN, 2010, AFR J RESPIR MED, V6, P18; Ukwaja KN, 2012, INT HEALTH, V4, P289, DOI 10.1016/j.inhe.2012.09.001; UNICEF, 2013, END PREV CHILD DEATH; UNICEF, 2020, LEV TRENDS CHILD MOR; UNICEF, 2014, COMM CHILD SURV PROM; UNICEF, 2015, COMMITTING CHILD SUR; UNICEF W. H. O, 2006, PNEUM FORG KILL CHIL; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World health organization and UNICEF, 2012, PNEUM DIARRH TACKL D	54	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117919	10.1371/journal.pone.0117919	http://dx.doi.org/10.1371/journal.pone.0117919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706531	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100129
J	van der Worp, MP; ten Haaf, DSM; van Cingel, R; de Wijer, A; Nijhuis-van der Sanden, MWG; Staal, JB				van der Worp, Maarten P.; ten Haaf, Dominique S. M.; van Cingel, Robert; de Wijer, Anton; Nijhuis-van der Sanden, Maria W. G.; Staal, J. Bart			Injuries in Runners; A Systematic Review on Risk Factors and Sex Differences	PLOS ONE			English	Review							LOWER-EXTREMITY INJURIES; OVERUSE INJURIES; RUNNING INJURIES; PATELLOFEMORAL PAIN; ALIGNMENT; COHORT; NECK	Background The popularity of running continues to increase, which means that the incidence of running-related injuries will probably also continue to increase. Little is known about risk factors for running injuries and whether they are sex-specific. Objectives The aim of this study was to review information about risk factors and sex-specific differences for running-induced injuries in adults. Search Strategy The databases PubMed, EMBASE, CINAHL and Psych-INFO were searched for relevant articles. Selection Criteria Longitudinal cohort studies with a minimal follow-up of 1 month that investigated the association between risk factors (personal factors, running/training factors and/ or health and lifestyle factors) and the occurrence of lower limb injuries in runners were included. Data Collection and Analysis Two reviewers' independently selected relevant articles from those identified by the systematic search and assessed the risk of bias of the included studies. The strength of the evidence was determined using a best-evidence rating system. Sex differences in risk were determined by calculating the sex ratio for risk factors (the risk factor for women divided by the risk factor for men). Main Results Of 400 articles retrieved, 15 longitudinal studies were included, of which 11 were considered high-quality studies and 4 moderate-quality studies. Overall, women were at lower risk than men for sustaining running-related injuries. Strong and moderate evidence was found that a history of previous injury and of having used orthotics/inserts was associated with an increased risk of running injuries. Age, previous sports activity, running on a concrete surface, participating in a marathon, weekly running distance (30-39 miles) and wearing running shoes for 4 to 6 months were associated with a greater risk of injury in women than in men. A history of previous injuries, having a running experience of 0-2 years, restarting running, weekly running distance (20-29 miles) and having a running distance of more than 40 miles per week were associated with a greater risk of running-related injury in men than in women. Conclusions Previous injury and use of orthotic/inserts are risk factors for running injuries. There appeared to be differences in the risk profile of men and women, but as few studies presented results for men and women separately, the results should be interpreted with caution. Further research should attempt to minimize methodological bias by paying attention to recall bias for running injuries, follow-up time, and the participation rate of the identified target group.	[van der Worp, Maarten P.; de Wijer, Anton] Univ Appl Sci Utrecht, Dept Phys Therapy, Acad Inst, Utrecht, Netherlands; [van der Worp, Maarten P.; ten Haaf, Dominique S. M.; van Cingel, Robert; Staal, J. Bart] Univ Appl Sci Nijmegen, Inst Hlth Studies, HAN, Nijmegen, Netherlands; [van der Worp, Maarten P.; Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands; [van Cingel, Robert] Sport Med Ctr Papendal, Arnhem, Netherlands; [de Wijer, Anton] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Oral Funct & Prosthet Dent, NL-6525 ED Nijmegen, Netherlands; [Nijhuis-van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van der Worp, MP (corresponding author), Univ Appl Sci Utrecht, Dept Phys Therapy, Acad Inst, Utrecht, Netherlands.	MvdWorp@Gmail.com	Haaf, Dominique S.M. ten/G-6124-2016; Staal, J. Bart/A-9632-2014; Staal, Bart/ABA-4313-2020; der Sanden, Maria WG Nijhuis-van/B-3463-2012; Wijer, A./L-4757-2015; van der Worp, Maarten/I-7856-2013	Haaf, Dominique S.M. ten/0000-0001-5095-8688; Staal, J. Bart/0000-0002-0083-6380; Staal, Bart/0000-0002-0083-6380; der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; van der Worp, Maarten/0000-0003-3703-7600	Netherlands Organization for Health Research and Development (ZonMw) [50-50310-98-156]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was financially supported by the Netherlands Organization for Health Research and Development (ZonMw), grant no. 50-50310-98-156.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Ariens GA, 2000, SCAND J WORK ENV HEA, V26, P7, DOI 10.5271/sjweh.504; Boles CA, 2010, RADIOL CLIN N AM, V48, P1249, DOI 10.1016/j.rcl.2010.07.015; Bongers PM, 2006, J OCCUP REHABIL, V16, P279, DOI 10.1007/s10926-006-9044-1; Bongers PM, 2002, AM J IND MED, V41, P315, DOI 10.1002/ajim.10050; Booth A, 2006, J MED LIBR ASSOC, V94, P421; Borchers AT, 2012, AUTOIMMUN REV, V11, pA413, DOI 10.1016/j.autrev.2011.11.016; Bottenburg van M, 2006, TWEEDE LOOPGOLF GROE; Broniecki M, 2010, J BACK MUSCULOSKELET, V23, P165, DOI 10.3233/BMR-2010-0265; Buist I, 2010, BRIT J SPORT MED, V44, P598, DOI 10.1136/bjsm.2007.044677; Buist I, 2011, BRIT J SPORT MED, V45, P338, DOI DOI 10.1136/BJSM.2011.084038.79; Buist I, 2010, AM J SPORT MED, V38, P273, DOI 10.1177/0363546509347985; Cameron KL, 2010, J ATHL TRAINING, V45, P58, DOI 10.4085/1062-6050-45.1.58; da Costa BR, 2010, AM J IND MED, V53, P285, DOI 10.1002/ajim.20750; Dutch cochrane centre, EV BAS GUID DEV; Fields KB, 2010, CURR SPORT MED REP, V9, P176, DOI 10.1249/JSR.0b013e3181de7ec5; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Finestone A, 2004, FOOT ANKLE INT, V25, P462, DOI 10.1177/107110070402500704; Hesar NGZ, 2009, BRIT J SPORT MED, V43, P1057, DOI 10.1136/bjsm.2008.055723; Hespanhol LC, 2013, J PHYSIOTHER, V59, P263, DOI 10.1016/S1836-9553(13)70203-0; Hirschmuller A, 2012, MED SCI SPORT EXER, V44, P199, DOI 10.1249/MSS.0b013e31822b7318; HOEBERIGS JH, 1992, SPORTS MED, V13, P408, DOI 10.2165/00007256-199213060-00004; Hooftman WE, 2004, SCAND J WORK ENV HEA, V30, P261, DOI 10.5271/sjweh.794; Hootman JM, 2002, CLIN J SPORT MED, V12, P99, DOI 10.1097/00042752-200203000-00006; Hreljac A, 2000, MED SCI SPORT EXER, V32, P1635; Hreljac A, 2004, MED SCI SPORT EXER, V36, P845, DOI 10.1249/01.MSS.0000126803.66636.DD; IJmker S, 2007, OCCUP ENVIRON MED, V64, P211, DOI 10.1136/oem.2006.026468; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lun V, 2004, BRIT J SPORT MED, V38, P576, DOI 10.1136/bjsm.2003.005488; Lynch SL, 2010, CLIN SPORT MED, V29, P477, DOI 10.1016/j.csm.2010.03.003; MACERA CA, 1992, SPORTS MED, V13, P50, DOI 10.2165/00007256-199213010-00005; MACERA CA, 1989, ARCH INTERN MED, V149, P2565, DOI 10.1001/archinte.149.11.2565; Mattila VM, 2011, SCAND J MED SCI SPOR, V21, P804, DOI 10.1111/j.1600-0838.2010.01116.x; McKean KA, 2006, CLIN J SPORT MED, V16, P149, DOI 10.1097/00042752-200603000-00011; Meeuwisse W., 1994, CLIN J SPORT MED, V1994, P166, DOI DOI 10.1097/00042752-199407000-00004; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P215; Nielsen RO, 2011, BRIT J SPORT MED, V45, P365; Ostrowska Antonina, 2012, Przegl Lek, V69, P61; Reinking MF, 2013, INT J SPORTS PHYS TH, V8, P269; Rolf C., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P181; Saragiotto BT, 2014, SPORTS MED; Satterthwaite P, 1999, BRIT J SPORT MED, V33, P22, DOI 10.1136/bjsm.33.1.22; Senn SJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-10; STANISH WD, 1984, MED SCI SPORT EXER, V16, P1; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taunton JE, 2003, BRIT J SPORT MED, V37, P239, DOI 10.1136/bjsm.37.3.239; Thijs Y, 2008, BRIT J SPORT MED, V42, P466, DOI 10.1136/bjsm.2008.046649; Thijs Y, 2011, AM J SPORT MED, V39, P1877, DOI 10.1177/0363546511407617; van der Worp MP, 2012, SPORTS MED, V42, P969, DOI 10.2165/11635400-000000000-00000; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; Van Ginckel A, 2009, GAIT POSTURE, V29, P387, DOI 10.1016/j.gaitpost.2008.10.058; Van Middelkoop M, 2008, SCAND J MED SCI SPOR, V18, P691, DOI 10.1111/j.1600-0838.2007.00768.x; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; van Tulder MW, 2009, SPINE, V34, P1685, DOI 10.1097/BRS.0b013e3181ab6a78; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Veiligheid NL, 2012, HARDL BLESS; WALTER SD, 1989, ARCH INTERN MED, V149, P2561, DOI 10.1001/archinte.149.11.2561; Walther M, 2005, ORTHOPADE, V34, P399, DOI 10.1007/s00132-005-0790-0; Wen DY, 1997, MED SCI SPORT EXER, V29, P1291, DOI 10.1097/00005768-199710000-00003; Wen DY, 1998, CLIN J SPORT MED, V8, P187, DOI 10.1097/00042752-199807000-00005; West S, 2002, Evid Rep Technol Assess (Summ), P1; Zeegers M P, 2000, Ned Tijdschr Geneeskd, V144, P1393	64	143	146	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0114937	10.1371/journal.pone.0114937	http://dx.doi.org/10.1371/journal.pone.0114937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706955	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100003
J	Wu, XY; Li, XJ; Zhang, QS; Wulin, SZ; Bai, XF; Zhang, TT; Wang, Y; Liu, M; Zhang, Y				Wu, Xiaoying; Li, Xiaojun; Zhang, Qingshan; Wulin, Shaozhou; Bai, Xiaofei; Zhang, Tingting; Wang, Yue; Liu, Ming; Zhang, Yun			Identification of a Conserved B-Cell Epitope on Duck Hepatitis A Type 1 Virus VP1 Protein	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; COXSACKIEVIRUS A9; MONOCLONAL-ANTIBODIES; MOLECULAR ANALYSIS; SEROTYPE; PARECHOVIRUS; SEQUENCE; VACCINE; GENUS	Background The VP1 protein of duck hepatitis A virus (DHAV) is a major structural protein that induces neutralizing antibodies in ducks; however, B-cell epitopes on the VP1 protein of duck hepatitis A genotype 1 virus (DHAV-1) have not been characterized. Methods and Results To characterize B-cell epitopes on VP1, we used the monoclonal antibody (mAb) 2D10 against Escherichia coli-expressed VP1 of DHAV-1. In vitro, mAb 2D10 neutralized DHAV-1 virus. By using an array of overlapping 12-mer peptides, we found that mAb 2D10 recognized phages displaying peptides with the consensus motif LPAPTS. Sequence alignment showed that the epitope (173)LPAPTS(178) is highly conserved among the DHAV-1 genotypes. Moreover, the six amino acid peptide LPAPTS was proven to be the minimal unit of the epitope with maximal binding activity to mAb 2D10. DHAV-1-positive duck serum reacted with the epitope in dot blotting assay, revealing the importance of the six amino acids of the epitope for antibody-epitope binding. Competitive inhibition assays of mAb 2D10 binding to synthetic LPAPTS peptides and truncated VP1 protein fragments, detected by Western blotting, also verify that LPAPTS was the VP1 epitope. Conclusions and Significance We identified LPAPTS as a VP1-specific linear B-cell epitope recognized by the neutralizing mAb 2D10. Our findings have potential applications in the development of diagnostic techniques and epitope-based marker vaccines against DHAV-1.	[Wu, Xiaoying; Li, Xiaojun; Zhang, Qingshan; Wulin, Shaozhou; Bai, Xiaofei; Zhang, Tingting; Wang, Yue; Liu, Ming; Zhang, Yun] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Liu, M (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China.	liuming04@126.com; yunzhang03@yahoo.com			China Agriculture Research System [CARS-43-10]; Chinese Special Fund for Agro-scientific Research in the Public Interest [201003012]; Natural Science Foundation of China [31072132]	China Agriculture Research System; Chinese Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from China Agriculture Research System (CARS-43-10), Chinese Special Fund for Agro-scientific Research in the Public Interest (201003012), and Natural Science Foundation of China (31072132). Yun Zhang is funder in the study design as described in manuscript. Xiaoying Wu and Xiaojun Li could identify who received the fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonyakiat Y, 2001, J VIROL, V75, P10000, DOI 10.1128/JVI.75.20.10000-10004.2001; Cho JG, 2012, HYBRIDOMA, V31, P358, DOI 10.1089/hyb.2012.0034; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Duque H, 2003, J VIROL, V77, P2500, DOI 10.1128/JVI.77.4.2500-2511.2003; DWORETZKY SI, 1988, J CELL BIOL, V107, P1279, DOI 10.1083/jcb.107.4.1279; Fu YZ, 2012, VET MICROBIOL, V160, P314, DOI 10.1016/j.vetmic.2012.06.022; Guo DC, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-37; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Kim MC, 2007, ARCH VIROL, V152, P2059, DOI 10.1007/s00705-007-1023-0; Kim MC, 2008, AVIAN PATHOL, V37, P171, DOI 10.1080/03079450801918670; Kim MC, 2006, J GEN VIROL, V87, P3307, DOI 10.1099/vir.0.81804-0; Kouzmitcheva GA, 2001, CLIN DIAGN LAB IMMUN, V8, P150, DOI 10.1128/CDLI.8.1.150-160.2001; Leippert M, 2001, J GEN VIROL, V82, P1703, DOI 10.1099/0022-1317-82-7-1703; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; LEVINE PP, 1950, CORNELL VET, V40, P71; Li YF, 2012, VIRUS RES, V163, P546, DOI 10.1016/j.virusres.2011.12.006; Liu M, 2011, VET MICROBIOL, V152, P280, DOI 10.1016/j.vetmic.2011.05.015; Liu M, 2010, J VIROL METHODS, V169, P66, DOI 10.1016/j.jviromet.2010.06.018; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Pulli T, 1997, J BIOL CHEM, V272, P21176, DOI 10.1074/jbc.272.34.21176; Pulli T, 1998, VIROLOGY, V240, P202, DOI 10.1006/viro.1997.8908; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; Tseng CH, 2007, VIRUS RES, V126, P19, DOI 10.1016/j.virusres.2007.01.012; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; Williams CH, 2004, J VIROL, V78, P6967, DOI 10.1128/JVI.78.13.6967-6973.2004; Woolcock PR., 2003, DIS POULTRY CHAPTER, V11, P343, DOI DOI 10.1111/1750-3841.12436; Zhang TT, 2014, J VIROL METHODS, V208, P166, DOI 10.1016/j.jviromet.2014.07.035	28	103	111	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118041	10.1371/journal.pone.0118041	http://dx.doi.org/10.1371/journal.pone.0118041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706372	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100138
J	An, GZ; Xu, H; Zhou, Y; Du, L; Miao, X; Jiang, DP; Li, KC; Guo, GZ; Zhang, C; Ding, GR				An, Guang-Zhou; Xu, Hui; Zhou, Yan; Du, Le; Miao, Xia; Jiang, Da-Peng; Li, Kang-Chu; Guo, Guo-Zhen; Zhang, Chen; Ding, Gui-Rong			Effects of Long-Term 50Hz Power-Line Frequency Electromagnetic Field on Cell Behavior in Balb/c 3T3 Cells	PLOS ONE			English	Article							MAGNETIC-FIELD; LEUKEMIA RISK; EXPOSURE; APOPTOSIS; DIFFERENTIATION; TRANSFORMATION; GROWTH	Power-line frequency electromagnetic field (PF-EMF) was reported as a human carcinogen by some epidemiological research, but the conclusion is lack of robust experiment evidence. To identify the effects of long-term PF-EMF exposure on cell behavior, Balb/c 3T3 cells in exponential growth phase were exposed or sham-exposed to 50 Hertz (Hz) PF-EMF at 2.3 mT for 2 hours (h) one day, 5 days every week. After 11 weeks exposure, cells were collected instantly. Cell morphology was observed under invert microscope and Giemsa staining, cell viability was detected by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, cell cycle and apoptosis was examined by flow cytometry, the protein level of Proliferating Cell Nuclear Antigen (PCNA) and CyclinD1 was detected by western blot, cell transformation was examined by soft agar clone assay and plate clone forming test, and cell migration ability was observed by scratch adhesion test. It was found that after PF-EMF exposure, cell morphology, apoptosis, cell migration ability and cell transformation didn't change. However, compared with sham group, cell viability obviously decreased and cell cycle distribution also changed after 11 weeks PF-EMF exposure. Meanwhile, the protein level of PCNA and CyclinD1 significantly decreased after PF-EMF exposure. These data suggested that although long-term 50Hz PF-EMF exposure under this experimental condition had no effects on apoptosis, cell migration ability and cell transformation, it could affect cell proliferation and cell cycle by down-regulation the expression of PCNA and CyclinD1 protein.	[An, Guang-Zhou; Zhou, Yan; Du, Le; Miao, Xia; Jiang, Da-Peng; Li, Kang-Chu; Guo, Guo-Zhen; Ding, Gui-Rong] Fourth Mil Med Univ, Fac Prevent Med, Dept Radiat Med, Xian 710032, Shaanxi Provinc, Peoples R China; [Xu, Hui] Taishan Med Coll, Radiol Coll, Taishan, Shandong, Peoples R China; [Zhang, Chen] China Acad Telecommun Res, Minist Ind & Informat Technol, Beijing, Peoples R China	Air Force Military Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhang, C (corresponding author), China Acad Telecommun Res, Minist Ind & Informat Technol, Beijing, Peoples R China.	zhangchen@emcite.com; dingzhao@fmmu.edu.cn			National Natural Science Foundation of China [31170798]; National Basic Research Program of China [2011CB503705, 2011CB503704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (31170798) and National Basic Research Program of China (2011CB503705, 2011CB503704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi I, 2011, INT J CANCER, V129, P1477, DOI 10.1002/ijc.25765; Chen QS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069272; Cho H, 2012, BIOTECHNOL PROGR, V28, P1329, DOI 10.1002/btpr.1607; Cho S, 2014, DRUG CHEM TOXICOL, V37, P440, DOI 10.3109/01480545.2013.879662; Fedrowitz M, 2004, CANCER RES, V1, P234; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ismael SJ, 1998, BIOELECTROMAGNETICS, V19, P131, DOI 10.1002/(SICI)1521-186X(1998)19:2<131::AID-BEM13>3.0.CO;2-T; Kheifets LI, 1997, AM J EPIDEMIOL, V146, P87, DOI 10.1093/oxfordjournals.aje.a009194; Lim K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/296019; LONDON SJ, 1994, AM J IND MED, V26, P47, DOI 10.1002/ajim.4700260105; LOSCHER W, 1994, LIFE SCI, V54, P1531, DOI 10.1016/0024-3205(94)90024-8; Morabito C, 2010, CELL PHYSIOL BIOCHEM, V26, P947, DOI 10.1159/000324003; ONO M, 1988, MOL CELL BIOL, V8, P4190, DOI 10.1128/MCB.8.10.4190; RANNUG A, 1993, BIOELECTROMAGNETICS, V14, P17, DOI 10.1002/bem.2250140105; Reid A, 2011, BRIT J CANCER, V105, P1409, DOI 10.1038/bjc.2011.365; Reipert BM, 1997, LIFE SCI, V61, P1571, DOI 10.1016/S0024-3205(97)00736-4; Sermage-Faure C, 2013, BRIT J CANCER, V108, P1899, DOI 10.1038/bjc.2013.128; Simko M, 1998, BIOELECTROMAGNETICS, V19, P85, DOI 10.1002/(SICI)1521-186X(1998)19:2<85::AID-BEM5>3.0.CO;2-#; Sulpizio M, 2011, J CELL BIOCHEM, V112, P3797, DOI 10.1002/jcb.23310; UMEDA M, 1989, CARCINOGENESIS, V10, P1665, DOI 10.1093/carcin/10.9.1665; Vianale G, 2008, BRIT J DERMATOL, V158, P1189, DOI 10.1111/j.1365-2133.2008.08540.x; Wang Xing, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P821; Yan JH, 2010, ELECTROMAGN BIOL MED, V29, P165, DOI 10.3109/01676830.2010.505490; Zhou J, 2014, BIOELECTROMAGNETICS, V35, P30, DOI 10.1002/bem.21794; Zhou J, 2011, BONE, V49, P753, DOI 10.1016/j.bone.2011.06.026	25	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117672	10.1371/journal.pone.0117672	http://dx.doi.org/10.1371/journal.pone.0117672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695503	gold, Green Published, Green Submitted			2022-12-27	WOS:000350062300027
J	Bubl, E; Dorr, M; Riedel, A; Ebert, D; Philipsen, A; Bach, M; van Elst, LT				Bubl, Emanuel; Doerr, Michael; Riedel, Andreas; Ebert, Dieter; Philipsen, Alexandra; Bach, Michael; van Elst, Ludger Tebartz			Elevated Background Noise in Adult Attention Deficit Hyperactivity Disorder Is Associated with Inattention	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; MEDICATION-TREATED ADULTS; DEFICIT/HYPERACTIVITY DISORDER; PREFRONTAL CORTEX; METHYLPHENIDATE RITALIN; SUPERIOR COLLICULUS; NUCLEUS-ACCUMBENS; RECEPTOR ACTIONS; WORKING-MEMORY; RATING-SCALE	Background Inattention and distractibility are core symptoms of attention deficit hyperactivity disorder (ADHD). Still the neuronal organization is largely unknown. Previously we studied the electrophysiological activity of a distinct neuronal network-the retina-and found no change in stimulus-driven neural activity in patients with ADHD. However there is growing evidence for an elevated non stimulus-driven neural activity, or neuronal background noise, as underlying pathophysiological correlate. To further examine the biological bases that might underlie ADHD and problems with inattention, we performed a new analysis to test the hypothesis of an elevated background noise as underlying neuronal correlate for ADHD and problems with inattention in humans. A direct measure of background noise in patients with ADHD has not been described yet. Methods The retinal background noise was assessed based on pattern electroretinogram (PERG) data in 20 unmedicated ADHD patients and 20 healthy controls. The PERG is an electrophysiological measure for retinal ganglion cell function. ADHD severity was assessed by interview and questionnaire. Results Noise amplitude was significantly higher (138%) in patients with ADHD compared to the control group (p = 0.0047). Noise amplitude correlated significantly with psychometric measures for ADHD (CAARS) especially inattention (r = 0.44, p = 0.004). Conclusions The data provide evidence that an elevated background noise is associated with symptoms of inattention in ADHD and support the use of therapeutic interventions that reduce noise and distraction in patients with ADHD.	[Bubl, Emanuel; Doerr, Michael; Riedel, Andreas; Ebert, Dieter; Philipsen, Alexandra; van Elst, Ludger Tebartz] Univ Freiburg, Dept Psychiat & Psychotherapy, D-79106 Freiburg, Germany; [Bach, Michael] Univ Freiburg, Univ Eye Hosp, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Bubl, E (corresponding author), Univ Freiburg, Dept Psychiat & Psychotherapy, Hauptstr 5, D-79106 Freiburg, Germany.	emanuel.bubl@uniklinik-freiburg.de	Bach, Michael/A-6637-2010; Philipsen, Alexandra/E-4505-2017	Bach, Michael/0000-0003-2028-535X; Philipsen, Alexandra/0000-0001-6876-518X; Bubl, Emanuel/0000-0003-4951-8970				Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Arnsten AFT, 2009, CNS DRUGS, V23, P33, DOI 10.2165/00023210-200923000-00005; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Bach M, 1997, SPATIAL VISION, V10, P403, DOI 10.1163/156856897X00311; Bach M, 1999, DOC OPHTHALMOL, V99, P69, DOI 10.1023/A:1002648202420; Bach M., 2006, PRINCIPLES PRACTICE, P185; Bach M., 2000, FREIBURG EVOKED POTE; Bach M., 2007, PREPARATION MONTAGE; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Bodis-Wollner I, 2009, J NEURAL TRANSM, V116, P1493, DOI 10.1007/s00702-009-0292-z; Brennan AR, 2008, ANN NY ACAD SCI, V1129, P236, DOI 10.1196/annals.1417.007; Bubl E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061728; Bubl E, 2012, BRIT J PSYCHIAT, V201, P151, DOI 10.1192/bjp.bp.111.100560; Bubl E, 2010, BIOL PSYCHIAT, V68, P205, DOI 10.1016/j.biopsych.2010.02.009; Bundesarztekammer B, 2007, BUNDESARZTEKAMMER 7; Comoli E, 2003, NAT NEUROSCI, V6, P974, DOI 10.1038/nn1113; Conners C K, 2002, J Atten Disord, V6 Suppl 1, pS17; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Dommett EJ, 2009, NEUROSCIENCE, V164, P1369, DOI 10.1016/j.neuroscience.2009.09.007; DOWLING JE, 1986, TRENDS NEUROSCI, V9, P236, DOI 10.1016/0166-2236(86)90065-2; First M. B., 1997, STRUCTURED CLIN INTE; Forssberg Hans, 2006, Behav Brain Funct, V2, P40, DOI 10.1186/1744-9081-2-40; GHILARDI MF, 1989, ANN NEUROL, V25, P357, DOI 10.1002/ana.410250407; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; Kim Y, 2009, P NATL ACAD SCI USA, V106, P2915, DOI 10.1073/pnas.0813179106; Kiyatkin EA, 1996, J NEUROPHYSIOL, V75, P142, DOI 10.1152/jn.1996.75.1.142; Kroener S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006507; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mazer JA, 2011, BIOL PSYCHIAT, V69, P1147, DOI 10.1016/j.biopsych.2011.03.014; Meigen T, 1999, DOC OPHTHALMOL, V98, P207, DOI 10.1023/A:1002097208337; National Institute for Health and Care Excellence, CLIN GUID; NORCIA AM, 1989, VISION RES, V29, P627, DOI 10.1016/0042-6989(89)90048-5; Retz W, 2012, WORLD J BIOL PSYCHIA, V13, P48, DOI 10.3109/15622975.2010.540257; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; ROLLS ET, 1984, NEUROSCIENCE, V12, P1201, DOI 10.1016/0306-4522(84)90014-9; Rosler M, 2004, NERVENARZT, V75, P888, DOI 10.1007/s00115-003-1622-2; Safren SA, 2005, BEHAV RES THER, V43, P831, DOI 10.1016/j.brat.2004.07.001; Safren SA, 2010, JAMA-J AM MED ASSOC, V304, P875, DOI 10.1001/jama.2010.1192; Schulz KP, 2012, ARCH GEN PSYCHIAT, V69, P952, DOI 10.1001/archgenpsychiatry.2011.2053; STRASBURGER H, 1987, CLIN VISION SCI, V1, P245; SWANSON JM, 1995, NEW ENGL J MED, V333, P944, DOI 10.1056/NEJM199510053331419; SYKES DH, 1971, J CHILD PSYCHOL PSYC, V12, P129, DOI 10.1111/j.1469-7610.1971.tb01056.x; SYKES DH, 1972, PSYCHOPHARMACOLOGIA, V25, P262, DOI 10.1007/BF00422506; van Elst LT, 1997, BRAIN, V120, P2219, DOI 10.1093/brain/120.12.2219; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Volkow N D, 2001, J Neurosci, V21, pRC121; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Volkow ND, 2004, AM J PSYCHIAT, V161, P1173, DOI 10.1176/appi.ajp.161.7.1173; Volkow ND, 2007, ARCH GEN PSYCHIAT, V64, P932, DOI 10.1001/archpsyc.64.8.932; Volkow ND, 2012, J NEUROSCI, V32, P841, DOI 10.1523/JNEUROSCI.4461-11.2012; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Volkow ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002017; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Wilmshurst L, 2011, J ATTEN DISORD, V15, P11, DOI 10.1177/1087054709347261; WURTZ RH, 1972, INVEST OPHTH VISUAL, V11, P441	62	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118271	10.1371/journal.pone.0118271	http://dx.doi.org/10.1371/journal.pone.0118271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25693192	gold, Green Submitted, Green Published			2022-12-27	WOS:000350061500113
J	Kaur, P; Ghosh, A; Krishnamurthy, RV; Bhattacharjee, DG; Achar, V; Datta, S; Narayanan, S; Anbarasu, A; Ramaiah, S				Kaur, Parvinder; Ghosh, Anirban; Krishnamurthy, Ramya Vadageri; Bhattacharjee, Deepa Gagwani; Achar, Vijayashree; Datta, Santanu; Narayanan, Shridhar; Anbarasu, Anand; Ramaiah, Sudha			A High-Throughput Cidality Screen for Mycobacterium Tuberculosis	PLOS ONE			English	Article							INFECTION; DISCOVERY; ASSAY	Exposure to Mycobacterium tuberculosis (Mtb) aerosols is a major threat to tuberculosis (TB) researchers, even in bio-safety level-3 (BSL-3) facilities. Automation and highthroughput screens (HTS) in BSL3 facilities are essential for minimizing manual aerosolgenerating interventions and facilitating TB research. In the present study, we report the development and validation of a high-throughput, 24-well 'spot-assay' for selecting bactericidal compounds against Mtb. The bactericidal screen concept was first validated in the fastgrowing surrogate Mycobacterium smegmatis (Msm) and subsequently confirmed in Mtb using the following reference anti-tubercular drugs: rifampicin, isoniazid, ofloxacin and ethambutol (RIOE, acting on different targets). The potential use of the spot-assay to select bactericidal compounds from a large library was confirmed by screening on Mtb, with parallel plating by the conventional gold standard method (correlation, r(2) = 0.808). An automated spot-assay further enabled an MBC90 determination on resistant and sensitive Mtb clinical isolates. The implementation of the spot-assay in kinetic screens to enumerate residual Mtb after either genetic silencing (anti-sense RNA, AS-RNA) or chemical inhibition corroborated its ability to detect cidality. This relatively simple, economical and quantitative HTS considerably minimized the bio-hazard risk and enabled the selection of novel vulnerable Mtb targets and mycobactericidal compounds. Thus, spot-assays have great potential to impact the TB drug discovery process.	[Kaur, Parvinder; Bhattacharjee, Deepa Gagwani; Achar, Vijayashree; Narayanan, Shridhar] AstraZeneca India Private Ltd, Bangalore, Karnataka, India; [Ghosh, Anirban] Katholieke Univ Leuven, Dept Microbial & Mol Syst, B-3001 Leuven, Belgium; [Krishnamurthy, Ramya Vadageri] Gangagen Biotech Private Ltd, Bangalore, Karnataka, India; [Datta, Santanu] Cellworks India, Bangalore, Karnataka, India; [Anbarasu, Anand; Ramaiah, Sudha] VIT Univ, Sch Biosci & Technol, Med & Biol Comp Lab, Vellore, Tamil Nadu, India	AstraZeneca; KU Leuven; Vellore Institute of Technology	Kaur, P (corresponding author), AstraZeneca India Private Ltd, Bangalore, Karnataka, India.	parvinder149@gmail.com	Anbarasu, Anand/U-6323-2019; Ramaiah, Sudha/T-3682-2019; Anbarasu, Anand/K-4076-2017	Anbarasu, Anand/0000-0003-2216-7488				Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Beydon MH, 2000, J BIOMOL SCREEN, V5, P13, DOI 10.1177/108705710000500105; CLSI-Clinical and Laboratory Standards Institute (CLSI), SUSC TEST MYC NOC OT; Collins LA, 1998, ANTIMICROB AGENTS CH, V42, P344; COOKSEY RC, 1995, ANTIMICROB AGENTS CH, V39, P754, DOI 10.1128/AAC.39.3.754; Davey HM, 2011, APPL ENVIRON MICROB, V77, P5571, DOI 10.1128/AEM.00744-11; GILCHRIS.JE, 1973, APPL MICROBIOL, V25, P244, DOI 10.1108/03068299810193425; Jagannathan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014336; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; McNerney R, 2004, J CLIN MICROBIOL, V42, P2115, DOI 10.1128/JCM.42.5.2115-2120.2004; Primm T. D., 2007, CURRENT BIOACTIVE CO, V3, P1; RILEY RL, 1957, AM REV TUBERC PULM, V75, P420; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Wedum AG, 1969, ASSESSMENT RISK HUMA; Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097; World Health Organization, 2021, 10 THREATS GLOB HLTH; Zhang L, 2011, INT DRUG DISCOV, P60	19	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117577	10.1371/journal.pone.0117577	http://dx.doi.org/10.1371/journal.pone.0117577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693161	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500062
J	Knudsen, S; Hother, C; Gronbaek, K; Jensen, T; Hansen, A; Mazin, W; Dahlgaard, J; Moller, MB; Ralfkiaer, E; Brown, PD				Knudsen, Steen; Hother, Christoffer; Gronbaek, Kirsten; Jensen, Thomas; Hansen, Anker; Mazin, Wiktor; Dahlgaard, Jesper; Moller, Michael Boe; Ralfkiaer, Elizabeth; Brown, Peter de Nully			Development and Blind Clinical Validation of a MicroRNA Based Predictor of Response to Treatment with R-CHO(E)P in DLBCL	PLOS ONE			English	Article							CELL; EXPRESSION; CANCER; SURVIVAL; MODEL	MicroRNAs (miRNA) are a group of short noncoding RNAs that regulate gene expression at the posttranscriptional level. It has been shown that microRNAs are independent predictors of outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with the drug combination R-CHOP. Based on the measured growth inhibition of 60 human cancer cell lines (NCI60) in the presence of doxorubicine, cyclophosphamide, vincristine and etoposide as well as the baseline microRNA expression of the 60 cell lines, a microRNA based response predictor to CHOP was developed. The response predictor consisting of 20 microRNAs was blindly validated in a cohort of 116 de novo DLBCL patients treated with R-CHOP or R-CHOEP as first line treatment. The predicted sensitivity based on diagnostic FFPE samples matched the clinical response, with decreasing sensitivity in poor responders (P = 0.03). When the International Prognostic Index (IPI) was included in the prediction analysis, the separation between responders and non-responders improved (P = 0.001). Thirteen patients developed relapse, and five patients predicted sensitive to their second and third line treatment survived a median 1194 days, while eight patients predicted not sensitive to their second and third line treatment survived a median 187 days (90% CI: 485 days versus 227 days). Among the latter group it was predicted that four would have been sensitive to another second line treatment than the one they received. The predictions were almost the same when diagnostic biopsies were used as when relapse biopsies were used. These preliminary findings warrant testing in a larger cohort of relapse patients to confirm whether the miRNA based predictor can select the optimal second line treatment and increase survival.	[Knudsen, Steen; Jensen, Thomas; Hansen, Anker; Mazin, Wiktor; Dahlgaard, Jesper] Med Prognosis Inst, Horsholm, Denmark; [Hother, Christoffer; Gronbaek, Kirsten; Brown, Peter de Nully] Rigshosp, Dept Hematol, DK-2100 Copenhagen, Denmark; [Ralfkiaer, Elizabeth] Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Moller, Michael Boe] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Knudsen, S (corresponding author), Med Prognosis Inst, Horsholm, Denmark.	steen@medical-prognosis.com	Møller, Michael B/G-8340-2016; Møller, Michael Boe/AAD-2113-2019	Møller, Michael B/0000-0003-2041-3630; Møller, Michael Boe/0000-0003-2041-3630; Dahlgaard, Jesper/0000-0002-1798-6799; Gronbaek, Kirsten/0000-0002-1535-9601	Danish Council for Strategic Research; MPI; Novo Nordisk Fonden [NNF13OC0003435] Funding Source: researchfish	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); MPI; Novo Nordisk Fonden(Novo Nordisk Foundation)	MPI acknowledges support from the Danish Council for Strategic Research (http://ufm.dk/forskning-og-innovation/rad-og-udvalg/detstrategiske-forskningsrad). ER acknowledges support from MPI. MPI had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alencar AJ, 2011, CLIN CANCER RES, V17, P4125, DOI 10.1158/1078-0432.CCR-11-0224; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Chen JJ, 2012, MOL CANCER THER, V11, P34, DOI 10.1158/1535-7163.MCT-11-0620; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Glinsmann-Gibson BJ, 2010, BLOOD, V116, P1282; Han S, 2003, BREAST CANCER RES TR, V82, P11, DOI 10.1023/B:BREA.0000003843.53726.63; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Knudsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087415; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Li C, 2009, BLOOD, V113, P6681, DOI 10.1182/blood-2009-01-202028; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Montes-Moreno S, 2011, BLOOD, V118, P1034, DOI 10.1182/blood-2010-11-321554; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049918; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang WT, 2013, JNCI-J NATL CANCER I, V105, P1284, DOI 10.1093/jnci/djt202; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	20	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115538	10.1371/journal.pone.0115538	http://dx.doi.org/10.1371/journal.pone.0115538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692889	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500009
J	Marzinelli, EM; Williams, SB; Babcock, RC; Barrett, NS; Johnson, CR; Jordan, A; Kendrick, GA; Pizarro, OR; Smale, DA; Steinberg, PD				Marzinelli, Ezequiel M.; Williams, Stefan B.; Babcock, Russell C.; Barrett, Neville S.; Johnson, Craig R.; Jordan, Alan; Kendrick, Gary A.; Pizarro, Oscar R.; Smale, Dan A.; Steinberg, Peter D.			Large-Scale Geographic Variation in Distribution and Abundance of Australian Deep-Water Kelp Forests	PLOS ONE			English	Article							NEW-SOUTH-WALES; ECKLONIA-RADIATA; CLIMATE-CHANGE; SUBTIDAL HABITAT; SEA-URCHINS; CORAL-REEFS; BIODIVERSITY; COMMUNITIES; TEMPERATURE; RESILIENCE	Despite the significance of marine habitat-forming organisms, little is known about their largescale distribution and abundance in deeper waters, where they are difficult to access. Such information is necessary to develop sound conservation and management strategies. Kelps are main habitat-formers in temperate reefs worldwide; however, these habitats are highly sensitive to environmental change. The kelp Ecklonia radiate is the major habitat-forming organism on subtidal reefs in temperate Australia. Here, we provide large-scale ecological data encompassing the latitudinal distribution along the continent of these kelp forests, which is a necessary first step towards quantitative inferences about the effects of climatic change and other stressors on these valuable habitats. We used the Autonomous Underwater Vehicle (AUV) facility of Australia's IntegratedMarine Observing System (IMOS) to survey 157,000 m(2) of seabed, of which ca 13,000 m(2) were used to quantify kelp covers at multiple spatial scales (10100 m to 100-1,000 km) and depths (15-60 m) across several regions ca 2-6 degrees latitude apart along the East and West coast of Australia. We investigated the large-scale geographic variation in distribution and abundance of deep-water kelp (>15 m depth) and their relationships with physical variables. Kelp cover generally increased with latitude despite great variability at smaller spatial scales. Maximum depth of kelp occurrence was 40-50 m. Kelp latitudinal distribution along the continent was most strongly related to water temperature and substratum availability. This extensive survey data, coupled with ongoing AUV missions, will allow for the detection of long-term shifts in the distribution and abundance of habitat-forming kelp and the organisms they support on a continental scale, and provide information necessary for successful implementation and management of conservation reserves.	[Marzinelli, Ezequiel M.; Steinberg, Peter D.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Marzinelli, Ezequiel M.; Steinberg, Peter D.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Marzinelli, Ezequiel M.; Steinberg, Peter D.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Williams, Stefan B.; Pizarro, Oscar R.] Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia; [Babcock, Russell C.] CSIRO Marine & Atmospher Res, Brisbane, Qld, Australia; [Barrett, Neville S.; Johnson, Craig R.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Jordan, Alan] New South Wales Govt, Port Stephens Fisheries Inst, Dept Primary Ind, Nelson Bay, NSW, Australia; [Kendrick, Gary A.; Smale, Dan A.] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Kendrick, Gary A.; Smale, Dan A.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Smale, Dan A.] The Lab, Marine Biol Assoc United Kingdom, Plymouth, Devon, England	Sydney Institute of Marine Science; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; NSW Department of Primary Industries; University of Western Australia; University of Western Australia; Marine Biological Association United Kingdom	Marzinelli, EM (corresponding author), Sydney Inst Marine Sci, Mosman, NSW, Australia.	e.marzinelli@unsw.edu.au	Kendrick, Gary Andrew/B-3460-2011; Babcock, Russell C/A-3794-2012; Johnson, Craig R/E-1788-2013; Smale, Daniel/Y-2909-2019; Marzinelli, Ezequiel/AAH-2906-2019; Barrett, Neville S/J-7593-2014; Williams, Stefan/AAE-4376-2020	Kendrick, Gary Andrew/0000-0002-0276-6064; Babcock, Russell C/0000-0002-7756-1290; Johnson, Craig R/0000-0002-9511-905X; Smale, Daniel/0000-0003-4157-541X; Marzinelli, Ezequiel/0000-0002-3762-3389; Barrett, Neville S/0000-0002-6167-1356; Williams, Stefan/0000-0001-9416-5639; Pizarro, Oscar/0000-0001-6612-2738; Steinberg, Peter/0000-0002-1781-0726	IMOS through the Department of Innovation, Industry, Science and Research National Collaborative Research Infrastructure Scheme and Education Investment Fund; Office of Science and Research; University of Western Australia; University of Sydney, Sydney Institute of Marine Science; NSW Office of Environment and Heritage; Institute of Marine and Antarctic Studies; Natural Environment Research Council [NE/K008439/1] Funding Source: researchfish; NERC [NE/K008439/1] Funding Source: UKRI	IMOS through the Department of Innovation, Industry, Science and Research National Collaborative Research Infrastructure Scheme and Education Investment Fund; Office of Science and Research; University of Western Australia; University of Sydney, Sydney Institute of Marine Science; NSW Office of Environment and Heritage; Institute of Marine and Antarctic Studies; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by IMOS through the Department of Innovation, Industry, Science and Research National Collaborative Research Infrastructure Scheme and Education Investment Fund. Additional funding in NSW was provided by the Office of Science and Research. Logistic support was provided by the University of Western Australia, University of Sydney, Sydney Institute of Marine Science, NSW Office of Environment and Heritage, Institute of Marine and Antarctic Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2007, PLYMOUTH PRIMER E, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; ANDREW NL, 1993, MAR ECOL PROG SER, V99, P89, DOI 10.3354/meps099089; [Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Bearham D, 2013, MAR ECOL PROG SER, V476, P59, DOI 10.3354/meps10148; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Connell Sean D., 2007, P378; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; CRESSWELL GR, 1983, AUST J MAR FRESH RES, V34, P105; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; DAYTON PK, 1984, ECOL MONOGR, V54, P253, DOI 10.2307/1942498; DAYTON PK, 1985, ECOL MONOGR, V55, P447, DOI 10.2307/2937131; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Fairhead VA, 2004, MAR BIOL, V145, P41, DOI 10.1007/s00227-004-1308-8; FLETCHER WJ, 1987, ECOL MONOGR, V57, P89, DOI 10.2307/1942640; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fowler-Walker MJ, 2002, MAR ECOL PROG SER, V240, P49, DOI 10.3354/meps240049; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson C.R., 2005, 2001044 U TASM SCH Z; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Jordan A, 2010, SEABED HABITAT MAPPI, P207; KIRKMAN H, 1984, J EXP MAR BIOL ECOL, V76, P119, DOI 10.1016/0022-0981(84)90060-1; LARKUM AWD, 1986, J EXP MAR BIOL ECOL, V96, P177, DOI 10.1016/0022-0981(86)90241-8; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Mabin CJT, 2013, MAR ECOL PROG SER, V483, P117, DOI 10.3354/meps10261; Mann KH, 1973, SCIENCE, P182; Menge BA, 2011, J EXP MAR BIOL ECOL, V400, P236, DOI 10.1016/j.jembe.2011.02.003; Nichol S., 2009, SE TASMANIA TEMPERAT; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parnell PE, 2010, LIMNOL OCEANOGR, V55, P2686, DOI 10.4319/lo.2010.55.6.2686; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Rossi V, 2014, J GEOPHYS RES-OCEANS, V119, P445, DOI 10.1002/2013JC009284; Roughan M., 2004, J GEOPHYS RES-OCEANS, V1978-2012, P109; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Schaeffer A, 2013, J PHYS OCEANOGR, V43, P1042, DOI 10.1175/JPO-D-12-0177.1; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; SCHIEL DR, 1986, OCEANOGR MAR BIOL, V24, P265; Sherman AD, 2009, DEEP-SEA RES PT II, V56, P1754, DOI 10.1016/j.dsr2.2009.05.020; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Smale DA, 2013, ECOL EVOL, V3, P4016, DOI 10.1002/ece3.774; Smale DA, 2012, ICES J MAR SCI, V69, P1108, DOI 10.1093/icesjms/fss082; Steneck RS, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P315; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Thompson PA, 2011, DEEP-SEA RES PT II, V58, P645, DOI 10.1016/j.dsr2.2010.10.003; Toohey BD, 2007, OIKOS, V116, P1618, DOI 10.1111/j.2007.0030-1299.15689.x; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; UNDERWOOD AJ, 1991, AUST J ECOL, V16, P231, DOI 10.1111/j.1442-9993.1991.tb01050.x; Underwood AJ, 1993, SPECIES DIVERSITY EC, P38; Vanderklift MA, 2005, MAR ECOL PROG SER, V299, P101, DOI 10.3354/meps299101; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Wernberg T, 2003, MAR BIOL, V143, P47, DOI 10.1007/s00227-003-1069-9; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Williams SB, 2012, IEEE ROBOT AUTOM MAG, V19, P73, DOI 10.1109/MRA.2011.2181772; Winer B.J., 1991, STAT PRINCIPLES EXPT; WITMAN JD, 1988, TRENDS ECOL EVOL, V3, P285, DOI 10.1016/0169-5347(88)90099-7; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	64	56	56	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118390	10.1371/journal.pone.0118390	http://dx.doi.org/10.1371/journal.pone.0118390			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693066	gold, Green Accepted, Green Published			2022-12-27	WOS:000350061500121
J	van Bussel, FCG; van Bussel, BCT; Hoeks, APG; Op't Roodt, J; Henry, RMA; Ferreira, I; Vanmolkot, FHM; Schalkwijk, CG; Stehouwer, CDA; Reesink, KD				van Bussel, Frank C. G.; van Bussel, Bas C. T.; Hoeks, Arnold P. G.; Op't Roodt, Jos; Henry, Ronald M. A.; Ferreira, Isabel; Vanmolkot, Floris H. M.; Schalkwijk, Casper G.; Stehouwer, Coen D. A.; Reesink, Koen D.			A Control Systems Approach to Quantify Wall Shear Stress Normalization by Flow-Mediated Dilation in the Brachial Artery	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT VASODILATION; ULTRASOUND ASSESSMENT; HYPERGLYCEMIA; REPRODUCIBILITY; DYSFUNCTION; AGREEMENT; RESPONSES; IMPAIRS; IMPACT; ADULTS	Flow-mediated dilation is aimed at normalization of local wall shear stress under varying blood flow conditions. Blood flow velocity and vessel diameter are continuous and opposing influences that modulate wall shear stress. We derived an index FMDv to quantify wall shear stress normalization performance by flow-mediated dilation in the brachial artery. In 22 fasting presumed healthy men, we first assessed intra-and inter-session reproducibilities of two indices pFMD(v) and mFMD(v), which consider the relative peak and relative mean hyperemic change in flow velocity, respectively. Second, utilizing oral glucose loading, we evaluated the tracking performance of both FMDv indices, in comparison with existing indices [i.e., the relative peak diameter increase (%FMD), the peak to baseline diameter ratio (D-peak/D-base), and the relative peak diameter increase normalized to the full area under the curve of blood flow velocity with hyperemia (FMD/shear(AUC)) or with area integrated to peak hyperemia (FMD/shear(AUC_peak))]. Inter-session and intra-session reproducibilities for pFMD(v), mFMD(v) and %FMD were comparable (intra-class correlation coefficients within 0.521-0.677 range). Both pFMD(v) and mFMD(v) showed more clearly a reduction after glucose loading (reduction of similar to 45%, p <= 0.001) than the other indices (% given are relative reductions): %FMD (similar to 11%, p >= 0.074); D-peak/D-base (similar to 11%, p >= 0.074); FMD/shear(AUC_peak) (similar to 20%, p >= 0.016) and FMD/shear(AUC) (similar to 38%, p <= 0.038). Further analysis indicated that wall shear stress normalization under normal (fasting) conditions is already far from ideal (FMDv << 1), which (therefore) does not materially change with glucose loading. Our approach might be useful in intervention studies to detect intrinsic changes in shear stress normalization performance in conduit arteries.	[van Bussel, Frank C. G.; Hoeks, Arnold P. G.; Reesink, Koen D.] Maastricht Univ, Med Ctr, Dept Biomed Engn, NL-6200 MD Maastricht, Netherlands; [van Bussel, Frank C. G.] Maastricht Univ, Med Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands; [van Bussel, Bas C. T.; Op't Roodt, Jos; Henry, Ronald M. A.; Ferreira, Isabel; Vanmolkot, Floris H. M.; Schalkwijk, Casper G.; Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [Ferreira, Isabel] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, NL-6200 MD Maastricht, Netherlands; [van Bussel, Bas C. T.; Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab NUTRIM, NL-6200 MD Maastricht, Netherlands; [Hoeks, Arnold P. G.; Op't Roodt, Jos; Henry, Ronald M. A.; Ferreira, Isabel; Vanmolkot, Floris H. M.; Schalkwijk, Casper G.; Stehouwer, Coen D. A.; Reesink, Koen D.] Maastricht Univ, Med Ctr, Sch Cardiovasc Dis CARIM, NL-6200 MD Maastricht, Netherlands; [van Bussel, Frank C. G.] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci MHeNS, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University	Reesink, KD (corresponding author), Maastricht Univ, Med Ctr, Dept Biomed Engn, NL-6200 MD Maastricht, Netherlands.	k.reesink@maastrichtuniversity.nl	Ferreira, Isabel/B-6033-2008; Stehouwer, Coen/AAB-3435-2021	Ferreira, Isabel/0000-0003-1434-0607; Reesink, Koen/0000-0003-2354-883X; Stehouwer, Coen/0000-0001-8752-3223; Schalkwijk, Casper G/0000-0003-0190-2690; op 't Roodt, Jos/0000-0003-3535-6894	Dutch Organization for Scientific Research (NWO) [Veni-STW10261]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by grant Veni-STW10261 for Dr Reesink from the Dutch Organization for Scientific Research (NWO; Ministry of Education, Culture, and Science, the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari CM, 1998, J VASC SURG, V28, P687, DOI 10.1016/S0741-5214(98)70095-3; Atkinson G, 2013, J HYPERTENS, V31, P287, DOI 10.1097/HJH.0b013e32835b8164; Black MA, 2008, HYPERTENSION, V51, P203, DOI 10.1161/HYPERTENSIONAHA.107.101014; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bland JM, 2005, DO I ANAL OBSERVER S; Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Davies PF, 2005, ANN BIOMED ENG, V33, P1714, DOI 10.1007/s10439-005-8774-0; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Donald AE, 2008, J AM COLL CARDIOL, V51, P1959, DOI 10.1016/j.jacc.2008.02.044; Ghiadoni L, 2012, J HYPERTENS, V30, P1399, DOI 10.1097/HJH.0b013e328353f222; Green DJ, 2011, HYPERTENSION, V57, P363, DOI 10.1161/HYPERTENSIONAHA.110.167015; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; Henry RMA, 2004, ATHEROSCLEROSIS, V174, P49, DOI 10.1016/j.atherosclerosis.2004.01.002; Hilgers RHP, 2003, ARTERIOSCL THROM VAS, V23, P1826, DOI 10.1161/01.ATV.0000090672.07568.60; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Kawano H, 1999, J AM COLL CARDIOL, V34, P146, DOI 10.1016/S0735-1097(99)00168-0; Mah E, 2011, J NUTR, V141, P1961, DOI 10.3945/jn.111.144592; Major-Pedersen A, 2008, EXP DIABETES RES, DOI 10.1155/2008/672021; Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68; Nicholls SJ, 2006, J AM COLL CARDIOL, V48, P715, DOI 10.1016/j.jacc.2006.04.080; Nishiyama SK, 2007, J APPL PHYSIOL, V103, P843, DOI 10.1152/japplphysiol.00273.2007; Padilla J, 2008, CARDIOVASC ULTRASOUN, V6, DOI 10.1186/1476-7120-6-44; Parker BA, 2009, J APPL PHYSIOL, V107, P1357, DOI 10.1152/japplphysiol.91302.2009; Pyke KE, 2004, J APPL PHYSIOL, V97, P499, DOI 10.1152/japplphysiol.01245.2003; Pyke KE, 2007, J APPL PHYSIOL, V102, P1510, DOI 10.1152/japplphysiol.01024.2006; Renaudin C, 1998, DIABETOLOGIA, V41, P26, DOI 10.1007/s001250050862; Reneman RS, 2006, J VASC RES, V43, P251, DOI 10.1159/000091648; Siafarikas A, 2004, CLIN SCI, V107, P191, DOI 10.1042/CS20040004; Silber HA, 2001, J AM COLL CARDIOL, V38, P1859, DOI 10.1016/S0735-1097(01)01649-7; SORENSEN KE, 1995, BRIT HEART J, V74, P247; Stoner L, 2012, J ATHEROSCLER THROMB, DOI [10.3390/jpm2020050, DOI 10.3390/JPM2020050]; Thijssen DHJ, 2008, AM J PHYSIOL-HEART C, V295, pH1594, DOI 10.1152/ajpheart.00669.2008; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Title LM, 2000, J AM COLL CARDIOL, V36, P2185, DOI 10.1016/S0735-1097(00)00980-3; Twisk JWR, 2003, APPL LONGITUDINAL DA; Watanabe K, 2011, EUR J CLIN INVEST, V41, P465, DOI 10.1111/j.1365-2362.2010.02424.x; Welsch MA, 2002, MED SCI SPORT EXER, V34, P960, DOI 10.1097/00005768-200206000-00009; Weseler AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028460; Woodman RJ, 2001, J APPL PHYSIOL, V91, P929, DOI 10.1152/jappl.2001.91.2.929; Xiang GD, 2008, CLIN ENDOCRINOL, V68, P716, DOI 10.1111/j.1365-2265.2007.03099.x	42	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0115977	10.1371/journal.pone.0115977	http://dx.doi.org/10.1371/journal.pone.0115977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693114	Green Submitted, Green Published, gold			2022-12-27	WOS:000350061500011
J	Hasegawa, T; Sakamoto, A; Wada, A; Fukai, T; Iida, H; Ikeda, S				Hasegawa, Toshio; Sakamoto, Atsushi; Wada, Akino; Fukai, Tatsuo; Iida, Hideo; Ikeda, Shigaku			Keratinocyte Progenitor Cells Reside in Human Subcutaneous Adipose Tissue	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HAIR FOLLICLE; DIFFERENTIATION; EPIDERMIS; LINEAGE; P63; PROLIFERATION	The differentiation of adipose-derived stem cells (ASCs) towards epithelial lineages has yet to be demonstrated using a standardized method. This study investigated whether keratinocyte progenitor cells are present in the ASC population. ASCs isolated from subcutaneous adipose tissue were cultured and examined for the expression of the keratinocyte progenitor markers p63 and desmoglein 3 (DSG3) by immunofluorescence microscopy and flow cytometry. In addition, p63 and DSG3 expression levels were assessed before and after differentiation of ASCs into adipocytes by real-time PCR and western blot analysis, as well as in subcutaneous adipose tissue by real-time reverse transcriptase polymerase chain reaction. Both markers were expressed in ASCs, but were downregulated after the differentiation of ASCs into adipocytes; p63-positive cells were also detected in subcutaneous adipose tissue. ASCs co-cultured with human fibroblasts and incubated with all-trans retinoic acid and bone morphologic protein 4 showed an upregulation in DSG3 level, which was also increased in the presence of type IV collagen. They also showed an upregulation in cytokeratin-5 level only in the presence of type IV collagen. These results provide the demonstration that keratinocyte progenitor cells reside in subcutaneous adipose tissue.	[Hasegawa, Toshio; Sakamoto, Atsushi; Wada, Akino; Fukai, Tatsuo; Iida, Hideo; Ikeda, Shigaku] Juntendo Univ, Grad Sch Med, Dept Dermatol & Allergol, Bunkyo Ku, Tokyo 1138421, Japan; [Ikeda, Shigaku] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan	Juntendo University; Juntendo University	Ikeda, S (corresponding author), Juntendo Univ, Grad Sch Med, Dept Dermatol & Allergol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ikeda@juntendo.ac.jp		Fukai, Tatsuo/0000-0002-7884-5201	MEXT (Ministry of Education, Culture, Sports, Science and Technology) Supported Program for the Strategic Research Foundation at Private University [S1201013]	MEXT (Ministry of Education, Culture, Sports, Science and Technology) Supported Program for the Strategic Research Foundation at Private University	This study was supported in part by a Grant-in-Aide (S1201013) from MEXT (Ministry of Education, Culture, Sports, Science and Technology) Supported Program for the Strategic Research Foundation at Private University, 2012 - 2016. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Chavez-Munoz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080587; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Paunescu V, 2007, J CELL MOL MED, V11, P502, DOI 10.1111/j.1582-4934.2007.00041.x; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; POTTEN CS, 1988, J CELL SCI, P45; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yu G, 2011, METHODS MOL BIOL, V702, P193, DOI 10.1007/978-1-61737-960-4_14; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	17	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118402	10.1371/journal.pone.0118402	http://dx.doi.org/10.1371/journal.pone.0118402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714344	Green Published, Green Submitted, gold			2022-12-27	WOS:000350168700071
J	Muir, P; Wallace, C; Bridge, TCL; Bongaerts, P				Muir, Paul; Wallace, Carden; Bridge, Tom C. L.; Bongaerts, Pim			Diverse Staghorn Coral Fauna on the Mesophotic Reefs of North-East Australia	PLOS ONE			English	Article							BUILDING CORALS; ACROPORA; ECOLOGY; DEPTH; SCLERACTINIA; REVISION; ZONATION; ISOPORA; DAMAGE; ROLES	Concern for the future of reef-building corals in conditions of rising sea temperatures combined with recent technological advances has led to a renewed interest in documenting the biodiversity of mesophotic coral ecosystems (MCEs) and their potential to provide lineage continuation for coral taxa. Here, we examine species diversity of staghorn corals (genera Acropora and Isopora) in the mesophotic zone (below 30 m depth) of the Great Barrier Reef and western Coral Sea. Using specimen-based records we found 38 staghorn species in the mesophotic zone, including three species newly recorded for Australia and five species that only occurred below 30 m. Staghorn corals became scarce at depths below 50 m but were found growing in-situ to 73 m depth. Of the 76 staghorn coral species recorded for shallow waters (depth <= 30 m) in north-east Australia, 21% extended to mesophotic depths with a further 22% recorded only rarely to 40 m depth. Extending into the mesophotic zone provided shallow water species no significant advantage in terms of their estimated global range-size relative to species restricted to shallow waters (means 86.2 X 10(6) km(2) and 85.7 X 10(6) km(2) respectively, p = 0.98). We found four staghorn coral species at mesophotic depths on the Great Barrier Reef that were previously considered rare and endangered on the basis of their limited distribution in central Indonesia and the far western Pacific. Colonies below 40 m depth showed laterally flattened branches, light and fragile skeletal structure and increased spacing between branches and corallites. The morphological changes are discussed in relation to decreased light, water movement and down-welling coarse sediments. Staghorn corals have long been regarded as typical shallow-water genera, but here we demonstrate the significant contribution of this group to the region's mesophotic fauna and the importance of considering MCEs in reef biodiversity estimates and management.	[Muir, Paul] Queensland Museum, Townsville, Qld, Australia; [Wallace, Carden] Queensland Museum, South Brisbane, Australia; [Bridge, Tom C. L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bridge, Tom C. L.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Bongaerts, Pim] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Bongaerts, Pim] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia	Queensland Museum; Queensland Museum; James Cook University; Australian Institute of Marine Science; University of Queensland; University of Queensland	Muir, P (corresponding author), Queensland Museum, Townsville, Qld, Australia.	paul.muir@qm.qld.gov.au	Bridge, Tom/J-2693-2014	Bridge, Tom/0000-0003-3951-284X; Bongaerts, Pim/0000-0001-6747-6044	Catlin Seaview Survey; Queensland Museum; James Cook University	Catlin Seaview Survey; Queensland Museum; James Cook University	This work was supported by the Catlin Seaview Survey, Queensland Museum, James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2005, FUNCT ECOL, V19, P17, DOI 10.1111/j.0269-8463.2005.00925.x; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; ATKINSON MJ, 1992, LIMNOL OCEANOGR, V37, P273, DOI 10.4319/lo.1992.37.2.0273; Bare AY, 2010, CORAL REEFS, V29, P369, DOI 10.1007/s00338-010-0600-y; Barnes D.J., 1990, P109; Blyth-Skyrme VJ, 2013, H1302 NAT MAR FISH S; Bongaerts P, 2013, CORAL REEFS, V32, P935, DOI 10.1007/s00338-013-1052-y; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-303; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Bridge TCL, 2012, CORAL REEFS, V31, P179, DOI 10.1007/s00338-011-0828-1; Bridge TCL, 2014, F1000RESEARCH, DOI 10.12688/f1000research.2-187.v3; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Brodie J, 2007, MAR FRESHWATER RES, V58, P342, DOI 10.1071/MF06236; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Budd AF, 2008, PALAEONTOLOGY, V51, P1387, DOI 10.1111/j.1475-4983.2008.00820.x; Cabioch G, 2011, CORAL REEFS, V30, P1101, DOI 10.1007/s00338-011-0810-y; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; COLIN PL, 1986, B MAR SCI, V38, P111; Done T.J., 1983, Australian Institute of Marine Science Contribution, P107; Done Terry, 2011, P281; Edinger EN, 2000, POLL B, V40, P606; Einbinder S, 2009, MAR ECOL PROG SER, V381, P167, DOI 10.3354/meps07908; Englebert N, 2015, MAR BIODIVERS, V45, P1, DOI 10.1007/s12526-014-0221-8; Frade PR, 2008, LIMNOL OCEANOGR, V53, P2711, DOI 10.4319/lo.2008.53.6.2711; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Goldstein R, 2007, MARINE REEF AQUARIUM, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; GOREAU TF, 1973, B MAR SCI, V23, P399; Grigg RW, 2006, CORAL REEFS, V25, P77, DOI 10.1007/s00338-005-0073-6; Harris PT, 2013, ICES J MAR SCI, V70, P284, DOI 10.1093/icesjms/fss165; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; IUCN, 2007, IUCN RED LIST THREAT; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kleypas JA, 1999, AM ZOOL, V39, P146; KUHLMANN DHH, 1983, HELGOLANDER MEERESUN, V36, P183; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Pratchett MS, 2010, CORAL REEFS, V29, P717, DOI 10.1007/s00338-010-0602-9; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Richards ZT, 2013, DIVERS DISTRIB, V2013, P1; Risk Michael J., 2011, P575, DOI 10.1007/978-90-481-2639-2_25; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; SEBENS KP, 1997, P 8 INT COR REEF S, P1053; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; Sheppard C, 2005, J NAT HIST, V39, P103, DOI 10.1080/00222930310001657900; Sinniger F, 2013, CORAL REEFS, V32, P153, DOI 10.1007/s00338-012-0973-1; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J.E.N., 1984, SCLERACTINIA E AUSTR; Veron J.E.N., 1986, CORALS AUSTR INDOPAC; Wagner Daniel, 2014, Marine Biodiversity Records, V7, pe68, DOI 10.1017/S1755267214000785; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wallace Carden C., 1994, Invertebrate Taxonomy, V8, P961, DOI 10.1071/IT9940961; Wallace Carden C., 2012, Memoirs of the Queensland Museum, V57, P1; Wallace CC, 1998, ZOOL J LINN SOC-LOND, V123, P199, DOI 10.1111/j.1096-3642.1998.tb01302.x; WELLS JW, 1985, PAC SCI, V39, P338	58	36	36	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0117933	10.1371/journal.pone.0117933	http://dx.doi.org/10.1371/journal.pone.0117933			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714341	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350168700044
J	van der Linden, SL; Leiserowitz, AA; Feinberg, GD; Maibach, EW				van der Linden, Sander L.; Leiserowitz, Anthony A.; Feinberg, Geoffrey D.; Maibach, Edward W.			The Scientific Consensus on Climate Change as a Gateway Belief: Experimental Evidence	PLOS ONE			English	Article							SUPPORT; PERCEPTIONS	There is currently widespread public misunderstanding about the degree of scientific consensus on human-caused climate change, both in the US as well as internationally. Moreover, previous research has identified important associations between public perceptions of the scientific consensus, belief in climate change and support for climate policy. This paper extends this line of research by advancing and providing experimental evidence for a "gateway belief model" (GBM). Using national data (N = 1104) from a consensus-message experiment, we find that increasing public perceptions of the scientific consensus is significantly and causally associated with an increase in the belief that climate change is happening, human-caused and a worrisome threat. In turn, changes in these key beliefs are predictive of increased support for public action. In short, we find that perceived scientific agreement is an important gateway belief, ultimately influencing public responses to climate change.	[van der Linden, Sander L.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [van der Linden, Sander L.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Leiserowitz, Anthony A.; Feinberg, Geoffrey D.] Yale Univ, Sch Forestry & Environm Studies, Yale Project Climate Change Commun, New Haven, CT 06511 USA; [Maibach, Edward W.] George Mason Univ, Dept Commun, Ctr Climate Change Commun, Fairfax, VA 22030 USA	Princeton University; Princeton University; Yale University; George Mason University	van der Linden, SL (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	sander.vanderlinden@princeton.edu	Leiserowitz, Anthony/ABE-6529-2020; Leiserowitz, Anthony/HGB-4208-2022; van der Linden, Sander/ABE-6441-2020; Maibach, Edward/A-7102-2009	Leiserowitz, Anthony/0000-0001-5349-409X; van der Linden, Sander/0000-0002-0269-1744; Maibach, Edward/0000-0003-3409-9187	American Association for the Advancement of Science (AAAS); Rockefeller Family Fund (RFF)	American Association for the Advancement of Science (AAAS); Rockefeller Family Fund (RFF)	This research has been funded, in part, by the American Association for the Advancement of Science (AAAS) and the Rockefeller Family Fund (RFF) as well as by Lawrence Linden, Robert Litterman and Henry Paulson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklin M, 2014, ENVIRON SCI POLICY, V38, P173, DOI 10.1016/j.envsci.2013.10.006; Bast J, 2014, WALL STREET J; Cook J, 2014, REPORTS NATL CTR SCI, V34, P1; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Dunlap R.E., 2011, OXFORD HDB CLIMATE C, P144; Edenhofer O., 2014, CONTRIBUTION WORKING; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kahan DM, ADV POL PSY IN PRESS; Leiserowitz A, 2014, CLIMATE CHANGE AM MI; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Maibach E, 2014, EARTHS FUTURE, V2, P295, DOI 10.1002/2013EF000226; McCright AM, 2013, CLIMATIC CHANGE, V119, P511, DOI 10.1007/s10584-013-0704-9; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; van der Linden SL, 2014, CLIMATIC CHANGE, V126, P255, DOI 10.1007/s10584-014-1190-4; World Public Opinion Poll, 2009, PUBL ATT CLIM CHANG; Wynne B, 2010, NATURE, V466, P441, DOI 10.1038/466441a; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	25	312	313	4	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118489	10.1371/journal.pone.0118489	http://dx.doi.org/10.1371/journal.pone.0118489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714347	Green Published, gold, Green Submitted			2022-12-27	WOS:000350168700080
J	Derocles, SAP; Evans, DM; Nichols, PC; Evans, SA; Lunt, DH				Derocles, Stephane A. P.; Evans, Darren M.; Nichols, Paul C.; Evans, S. Aifionn; Lunt, David H.			Determining Plant - Leaf Miner - Parasitoid Interactions: A DNA Barcoding Approach	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; ECOLOGICAL NETWORKS; MOLECULAR ANALYSIS; PREDATORS; IDENTIFICATION; AGROMYZIDAE; ROBUSTNESS; SERVICES; DIPTERA	A major challenge in network ecology is to describe the full-range of species interactions in a community to create highly-resolved food-webs. We developed a molecular approach based on DNA full barcoding and mini-barcoding to describe difficult to observe plant - leaf miner - parasitoid interactions, consisting of animals commonly regarded as agricultural pests and their natural enemies. We tested the ability of universal primers to amplify the remaining DNA inside leaf miner mines after the emergence of the insect. We compared the results of a) morphological identification of adult specimens; b) identification based on the shape of the mines; c) the COI Mini-barcode (130 bp) and d) the COI full barcode (658 bp) fragments to accurately identify the leaf-miner species. We used the molecular approach to build and analyse a tri-partite ecological network of plant - leaf miner - parasitoid interactions. We were able to detect the DNA of leaf-mining insects within their feeding mines on a range of host plants using mini-barcoding primers: 6% for the leaves collected empty and 33% success after we observed the emergence of the leaf miner. We suggest that the low amplification success of leaf mines collected empty was mainly due to the time since the adult emerged and discuss methodological improvements. Nevertheless our approach provided new species-interaction data for the ecological network. We found that the 130 bp fragment is variable enough to identify all the species included in this study. Both COI fragments reveal that some leaf miner species could be composed of cryptic species. The network built using the molecular approach was more accurate in describing tri-partite interactions compared with traditional approaches based on morphological criteria.	[Derocles, Stephane A. P.; Evans, Darren M.; Nichols, Paul C.; Evans, S. Aifionn; Lunt, David H.] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Hull	Derocles, SAP (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	s.derocles@hull.ac.uk	Evans, Darren Mark/J-9782-2012	Lunt, David H/0000-0002-9000-7470; Evans, Darren/0000-0003-4061-6726	University of Hull	University of Hull	The project was funded by the University of Hull. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1973, AGROMYZIDAE DIPTERA; Bauer F, 2012, ZOOL SCR, V41, P248, DOI 10.1111/j.1463-6409.2012.00532.x; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bohan DA, 2013, ADV ECOL RES, V49, P1, DOI 10.1016/B978-0-12-420002-9.00001-9; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P1160, DOI 10.1111/1755-0998.12265; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Derocles SAP, 2014, MOL ECOL, V23, P3900, DOI 10.1111/mec.12701; Derocles SAP, 2012, MOL ECOL RESOUR, V12, P197, DOI 10.1111/j.1755-0998.2011.03083.x; Dormann C.F., 2008, R NEWS, V8, P8; Evans DM, 2013, ECOL LETT, V16, P844, DOI 10.1111/ele.12117; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Hering EM, 1951, BIOL LEAF MINERS; Kaartinen R, 2010, ECOL ENTOMOL, V35, P623, DOI 10.1111/j.1365-2311.2010.01224.x; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; Lewis OT, 2002, J ANIM ECOL, V71, P855, DOI 10.1046/j.1365-2656.2002.00651.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Macfadyen S, 2009, ECOL LETT, V12, P229, DOI 10.1111/j.1461-0248.2008.01279.x; May RM, 2009, PHILOS T R SOC B, V364, P1643, DOI 10.1098/rstb.2008.0280; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; Nakamura S, 2013, MOL ECOL RESOUR, V13, P96, DOI 10.1111/1755-0998.12025; Pinol J, 2014, MOL ECOL RESOUR, V14, P18, DOI 10.1111/1755-0998.12156; Pitkins B, 2014, LEAF STEM MINES BRIT; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Pons J, 2006, MOL ECOL NOTES, V6, P623, DOI 10.1111/j.1471-8286.2006.01353.x; R Core Team, 2016, R FDN STAT COMP; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reitz SR, 1999, AGR ECOSYST ENVIRON, V73, P185, DOI 10.1016/S0167-8809(99)00016-X; Roy HE, 2012, FUNCT ECOL, V26, P1238, DOI 10.1111/j.1365-2435.2012.02032.x; Sandhu HS, 2008, ECOL ECON, V64, P835, DOI 10.1016/j.ecolecon.2007.05.007; Scheffer SJ, 2007, MOL PHYLOGENET EVOL, V42, P756, DOI 10.1016/j.ympev.2006.12.018; Sha ZL, 2007, J ZOOL SYST EVOL RES, V45, P128, DOI 10.1111/j.1439-0469.2006.00375.x; Smith MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014424; Spencer K.A., 1990, SERIES ENTOMOLOGICA, V45, P444, DOI [DOI 10.1007/978-94-009-1874-0, 10.1007/978-94-009-1874-0]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traugott M, 2008, MOL ECOL, V17, P3928, DOI 10.1111/j.1365-294X.2008.03878.x; Traugott M, 2013, ADV ECOL RES, V49, P177, DOI 10.1016/B978-0-12-420002-9.00003-2; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; Wirta HK, 2014, P NATL ACAD SCI USA, V111, P1885, DOI 10.1073/pnas.1316990111; Woodward G, 2013, ADV ECOLOGICAL RES, V49; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	54	24	26	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117872	10.1371/journal.pone.0117872	http://dx.doi.org/10.1371/journal.pone.0117872			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710377	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900043
J	Henseler, JF; Raz, Y; Nagels, J; van Zwet, EW; Raz, V; Nelissen, RGHH				Henseler, Jan F.; Raz, Yotam; Nagels, Jochem; van Zwet, Erik W.; Raz, Vered; Nelissen, Rob G. H. H.			Multivariate Analyses of Rotator Cuff Pathologies in Shoulder Disability	PLOS ONE			English	Article							FATTY DEGENERATION; MUSCLE ACTIVATION; GENERAL-PRACTICE; UPPER-EXTREMITY; TENDON TRANSFER; TEARS; CLASSIFICATION; COMPLAINTS; MIGRATION; REPAIR	Background Disability of the shoulder joint is often caused by a tear in the rotator cuff (RC) muscles. Four RC muscles coordinate shoulder movement and stability, among them the supraspinatus and infraspinatus muscle which are predominantly torn. The contribution of each RC muscle to tear pathology is not fully understood. We hypothesized that muscle atrophy and fatty infiltration, features of RC muscle degeneration, are predictive of superior humeral head translation and shoulder functional disability. Methods Shoulder features, including RC muscle surface area and fatty infiltration, superior humeral translation and RC tear size were obtained from a consecutive series of Magnetic Resonance Imaging with arthrography (MRA). We investigated patients with superior (supraspinatus, n = 39) and posterosuperior (supraspinatus and infraspinatus, n = 30) RC tears, and patients with an intact RC (n = 52) as controls. The individual or combinatorial contribution of RC measures to superior humeral translation, as a sign of RC dysfunction, was investigated with univariate or multivariate models, respectively. Results Using the univariate model the infraspinatus surface area and fatty infiltration in both the supraspinatus and infraspinatus had a significant contribution to RC dysfunction. With the multivariate model, however, the infraspinatus surface area only affected superior humeral translation (p<0.001) and discriminated between superior and posterosuperior tears. In contrast neither tear size nor fatty infiltration of the supraspinatus or infraspinatus contributed to superior humeral translation. Conclusion Our study reveals that infraspinatus atrophy has the strongest contribution to RC tear pathologies. This suggests a pivotal role for the infraspinatus in preventing shoulder disability.	[Henseler, Jan F.; Raz, Yotam; Nagels, Jochem; Nelissen, Rob G. H. H.] Leiden Univ, Med Ctr, Dept Orthopaed, NL-2300 RC Leiden, Netherlands; [van Zwet, Erik W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, NL-2300 RC Leiden, Netherlands; [Raz, Yotam; Raz, Vered] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Henseler, JF (corresponding author), Leiden Univ, Med Ctr, Dept Orthopaed, Postzone J-11-R,POB 9600, NL-2300 RC Leiden, Netherlands.	j.f.henseler@lumc.nl	Nelissen, Rob/AAD-8134-2020	Nelissen, Rob/0000-0003-1228-4162; Raz, Yotam/0000-0001-9628-632X; raz, vered/0000-0003-3152-1952	Dutch Arthritis Association (DAA), Dutch Arthritis Association [2013-1-060]; ReumaFonds [13-1-303] Funding Source: researchfish	Dutch Arthritis Association (DAA), Dutch Arthritis Association; ReumaFonds	This study is funded by the Dutch Arthritis Association (DAA), Dutch Arthritis Association and grant number 2013-1-060. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth R, 2007, BRIT J SPORT MED, V41, P200, DOI 10.1136/bjsm.2006.032524; Ashry R, 2007, SKELETAL RADIOL, V36, P841, DOI 10.1007/s00256-007-0307-5; Barry JJ, 2013, J SHOULDER ELB SURG, V22, P18, DOI 10.1016/j.jse.2011.12.014; Bot SDM, 2005, ANN RHEUM DIS, V64, P118, DOI 10.1136/ard.2003.019349; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Davidson JFJ, 2005, ARTHROSCOPY, V21, P1428, DOI 10.1016/j.arthro.2005.09.015; de Jesus JO, 2009, AM J ROENTGENOL, V192, P1701, DOI 10.2214/AJR.08.1241; Dorrestijn O, 2011, RHEUMATOLOGY, V50, P389, DOI 10.1093/rheumatology/keq333; Dunn WR, 2005, J BONE JOINT SURG AM, V87A, P1978, DOI 10.2106/JBJS.D.02944; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; Gerber C, 2006, J BONE JOINT SURG AM, V88A, P113, DOI 10.2106/JBJS.E.00282; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Greving K, 2012, SCAND J RHEUMATOL, V41, P150, DOI 10.3109/03009742.2011.605390; Hansen ML, 2008, J BONE JOINT SURG AM, V90A, P316, DOI 10.2106/JBJS.F.00880; Henseler JF, 2014, MED BIOL ENG COMPUT, V52, P233, DOI 10.1007/s11517-013-1057-2; Henseler JF, 2013, BONE JOINT J, V95B, P523, DOI 10.1302/0301-620X.95B4.30390; Henseler JF, 2014, J SHOULDER ELB SURG, V23, P553, DOI 10.1016/j.jse.2013.07.055; Hirooka A, 1996, ACTA ORTHOP SCAND, V67, P258, DOI 10.3109/17453679608994684; Keener JD, 2009, J BONE JOINT SURG AM, V91A, P1405, DOI 10.2106/JBJS.H.00854; Kim JR, 2012, AM J SPORT MED, V40, P786, DOI 10.1177/0363546511434546; Klatte-Schulz F, 2012, EUR CELLS MATER, V24, P74, DOI 10.22203/eCM.v024a06; Lehtinen JT, 2001, ANN RHEUM DIS, V60, P322, DOI 10.1136/ard.60.4.322; Lippe J, 2012, ARTHROSCOPY, V28, P154, DOI 10.1016/j.arthro.2011.07.016; Lugo R, 2008, EUR J RADIOL, V68, P16, DOI 10.1016/j.ejrad.2008.02.051; Mall NA, 2010, J BONE JOINT SURG AM, V92A, P2623, DOI 10.2106/JBJS.I.00506; Matsen Frederick A 3rd, 2008, N Engl J Med, V358, P2138, DOI 10.1056/NEJMcp0800814; McCully SP, 2006, CLIN BIOMECH, V21, P545, DOI 10.1016/j.clinbiomech.2006.02.001; Melis B, 2009, ORTHOP TRAUMATOL-SUR, V95, P319, DOI 10.1016/j.otsr.2009.05.001; Melis B, 2010, J SHOULDER ELB SURG, V19, P757, DOI 10.1016/j.jse.2009.12.002; Meyer DC, 2012, AM J SPORT MED, V40, P2242, DOI 10.1177/0363546512457587; Moosmayer S, 2014, J BONE JOINT SURG AM, V96A, P1504, DOI 10.2106/JBJS.M.01393; Moosmayer S, 2010, ACTA ORTHOP, V81, P361, DOI 10.3109/17453674.2010.483993; Nagels J, 2008, J SHOULDER ELB SURG, V17, P241, DOI 10.1016/j.jse.2007.07.011; Nakajima D, 2012, J ORTHOP SCI, V17, P136, DOI 10.1007/s00776-011-0186-4; Oh LS, 2007, CLIN ORTHOP RELAT R, P52, DOI 10.1097/BLO.0b013e31802fc175; Roquelaure Y, 2006, ARTHRIT RHEUM-ARTHR, V55, P765, DOI 10.1002/art.22222; Rozing PM, 1999, J SHOULDER ELB SURG, V8, P438, DOI 10.1016/S1058-2746(99)90073-3; SHER JS, 1995, J BONE JOINT SURG AM, V77A, P10, DOI 10.2106/00004623-199501000-00002; Slabaugh MA, 2012, AM J SPORT MED, V40, P1728, DOI 10.1177/0363546512452714; Steenbrink F, 2006, MANUAL THER, V11, P231, DOI 10.1016/j.math.2006.07.004; Steenbrink F, 2009, J BIOMECH, V42, P1740, DOI 10.1016/j.jbiomech.2009.04.011; Steenbrink F, 2010, J BIOMECH, V43, P2049, DOI 10.1016/j.jbiomech.2010.04.012; Steinbach LS, 2002, RADIOGRAPHICS, V22, P1223, DOI 10.1148/radiographics.22.5.g02se301223; van de Sande MAJ, 2006, CLIN ORTHOP RELAT R, P260, DOI 10.1097/01.blo.0000196043.34789.73; van de Sande MAJ, 2005, INVEST RADIOL, V40, P313, DOI 10.1097/01.rli.0000160014.16577.86; van der Zwaal P, 2012, ARTHROSCOPY, V28, P1329, DOI 10.1016/j.arthro.2012.04.054; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; VECCHIO P, 1995, BRIT J RHEUMATOL, V34, P440	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118158	10.1371/journal.pone.0118158	http://dx.doi.org/10.1371/journal.pone.0118158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710703	Green Submitted, gold, Green Published			2022-12-27	WOS:000350683900049
J	Chen, B; Miller, AL; Rebelatto, M; Brewah, Y; Rowe, DC; Clarke, L; Czapiga, M; Rosenthal, K; Imamichi, T; Chen, Y; Chang, CS; Chowdhury, PS; Naiman, B; Wang, Y; Yang, D; Humbles, AA; Herbst, R; Sims, GP				Chen, Bo; Miller, Allison L.; Rebelatto, Marlon; Brewah, Yambasu; Rowe, Daniel C.; Clarke, Lori; Czapiga, Meggan; Rosenthal, Kim; Imamichi, Tomozumi; Chen, Yan; Chang, Chew-Shun; Chowdhury, Partha S.; Naiman, Brian; Wang, Yue; Yang, De; Humbles, Alison A.; Herbst, Ronald; Sims, Gary P.			S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro and In Vivo	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; BRONCHOALVEOLAR LAVAGE FLUID; INTERSTITIAL LUNG-DISEASES; ACTIVATED PROTEIN-KINASE; CALCIUM-BINDING PROTEIN; GROUP BOX-1 PROTEIN; ENDOTHELIAL-CELLS; CHEMOTACTIC ACTIVITY; RAGE; EXPRESSION	Release of endogenous damage associated molecular patterns (DAMPs), including members of the S100 family, are associated with infection, cellular stress, tissue damage and cancer. The extracellular functions of this family of calcium binding proteins, particularly S100A8, S100A9 and S100A12, are being delineated. They appear to mediate their functions via receptor for advanced glycation endproducts (RAGE) or TLR4, but there remains considerable uncertainty over the relative physiological roles of these DAMPs and their pattern recognition receptors. In this study, we surveyed the capacity of S100 proteins to induce proinflammatory cytokines and cell migration, and the contribution RAGE and TLR4 to mediate these responses in vitro. Using adenoviral delivery of murine S100A9, we also examined the potential for S100A9 homodimers to trigger lung inflammation in vivo. S100A8, S100A9 and S100A12, but not the S100A8/ A9 heterodimer, induced modest levels of TLR4-mediated cytokine production from human PBMC. In contrast, for most S100s including S100A9, RAGE blockade inhibited S100-mediated cell migration of THP1 cells and major leukocyte populations, whereas TLR4-blockade had no effect. Intranasal administration of murine S100A9 adenovirus induced a specific, time-dependent predominately macrophage infiltration that coincided with elevated S100A9 levels and proinflammatory cytokines in the BAL fluid. Inflammatory cytokines were markedly ablated in the TLR4-defective mice, but unexpectedly the loss of TLR4 signaling or RAGE-deficiency did not appreciably impact the S100A9-mediated lung pathology or the inflammatory cell infiltrate in the alveolar space. These data demonstrate that physiological levels of S100A9 homodimers can trigger an inflammatory response in vivo, and despite the capacity of RAGE and TLR4 blockade to inhibit responses in vitro, the response is predominately independent of both these receptors.	[Chen, Bo; Miller, Allison L.; Rebelatto, Marlon; Brewah, Yambasu; Rowe, Daniel C.; Clarke, Lori; Czapiga, Meggan; Rosenthal, Kim; Imamichi, Tomozumi; Chen, Yan; Chang, Chew-Shun; Chowdhury, Partha S.; Naiman, Brian; Wang, Yue; Humbles, Alison A.; Herbst, Ronald; Sims, Gary P.] MedImmune LLC, Gaithersburg, MD 20878 USA; [Imamichi, Tomozumi] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Appl & Dev Directorate, Lab Human Retrovirol, Frederick, MD 21702 USA; [Yang, De] NCI, Mol Immunoregulat Lab, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	AstraZeneca; Medimmune; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sims, GP (corresponding author), MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878 USA.	simsg@medimmune.com	, gary/Q-6552-2019	Imamichi, Tomozumi/0000-0002-1474-1796	MedImmune LLC	MedImmune LLC(AstraZenecaMedimmune)	This work was sponsored by MedImmune LLC. The funder provided support in the form of salaries for authors BC, ALM, MR, YB, DCR, LC MC, KR, YC, CSC, PSC, BN, YW, AAH, RH and GPS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bargagli E, 2008, INFLAMMATION, V31, P351, DOI 10.1007/s10753-008-9085-z; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Foell D, 2013, AM J RESP CRIT CARE, V187, P1324, DOI 10.1164/rccm.201209-1602OC; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Heizmann C. W., 2007, V45, P93; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; Korthagen NM, 2010, CLIN EXP IMMUNOL, V161, P342, DOI 10.1111/j.1365-2249.2010.04181.x; Kuipers MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068694; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lee TH, 2013, ANN ALLERG ASTHMA IM, V111, P268, DOI 10.1016/j.anai.2013.06.028; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Lorenz E, 2008, RESP MED, V102, P567, DOI 10.1016/j.rmed.2007.11.011; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Magi B, 2002, ELECTROPHORESIS, V23, P3434, DOI 10.1002/1522-2683(200210)23:19<3434::AID-ELPS3434>3.0.CO;2-R; Miller AL, 2012, J INFECT DIS, V205, P1311, DOI 10.1093/infdis/jir826; Miranda LP, 2001, FEBS LETT, V488, P85, DOI 10.1016/S0014-5793(00)02392-9; Nisapakultorn K, 2001, INFECT IMMUN, V69, P4242, DOI 10.1128/IAI.69.7.4242-4247.2001; Passey RJ, 1999, J IMMUNOL, V163, P2209; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Riva M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061832; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; SOHNLE PG, 1991, J INFECT DIS, V163, P187, DOI 10.1093/infdis/163.1.187; Spiekerkoetter E, 2009, CIRC RES, V105, P639, DOI 10.1161/CIRCRESAHA.109.205120; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; Sun Y, 2013, MOL IMMUNOL, V53, P443, DOI 10.1016/j.molimm.2012.10.002; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; van Lent PL, 2010, ARTHRITIS RHEUM-US, V62, P3353, DOI 10.1002/art.27654; van Zoelen MAD, 2009, AM J RESP CRIT CARE, V180, P1098, DOI 10.1164/rccm.200810-1552OC; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; WILKINSON MM, 1988, J CELL SCI, V91, P221; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Xu X, 2013, CLIN EXP IMMUNOL, V173, P523, DOI 10.1111/cei.12139	60	63	66	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0115828	10.1371/journal.pone.0115828	http://dx.doi.org/10.1371/journal.pone.0115828			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706559	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100019
J	Fonseca, FCD; Firmino, AAP; de Macedo, LLP; Coelho, RR; de Sousa, JDA; Silva, OB; Togawa, RC; Pappas, GJ; de Gois, LAB; da Silva, MCM; Grossi-de-Sa, MF				de Assis Fonseca, Fernando Campos; Pereira Firmino, Alexandre Augusto; Pepino de Macedo, Leonardo Lima; Coelho, Roberta Ramos; Antonino de Sousa Junior, Jose Dijair; Silva-Junior, Orzenil Bonfim; Togawa, Roberto Coiti; Pappas, Georgios Joannis, Jr.; Brandao de Gois, Luiz Avelar; Mattar da Silva, Maria Cristina; Grossi-de-Sa, Maria Fatima			Sugarcane Giant Borer Transcriptome Analysis and Identification of Genes Related to Digestion	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; AMINOPEPTIDASE-N; MANDUCA-SEXTA; HELICOVERPA-ARMIGERA; SUBSTRATE-SPECIFICITY; ALKALINE-PHOSPHATASE; PROTEOLYTIC ACTIVITY; PLUTELLA-XYLOSTELLA; MOLECULAR-CLONING; RNA INTERFERENCE	Sugarcane is a widely cultivated plant that serves primarily as a source of sugar and ethanol. Its annual yield can be significantly reduced by the action of several insect pests including the sugarcane giant borer (Telchin licus licus), a lepidopteran that presents a long life cycle and which efforts to control it using pesticides have been inefficient. Although its economical relevance, only a few DNA sequences are available for this species in the GenBank. Pyrosequencing technology was used to investigate the transcriptome of several developmental stages of the insect. To maximize transcript diversity, a pool of total RNA was extracted from whole body insects and used to construct a normalized cDNA database. Sequencing produced over 650,000 reads, which were de novo assembled to generate a reference library of 23,824 contigs. After quality score and annotation, 43% of the contigs had at least one BLAST hit against the NCBI non-redundant database, and 40% showed similarities with the lepidopteran Bombyx mori. In a further analysis, we conducted a comparison with Manduca sexta midgut sequences to identify transcripts of genes involved in digestion. Of these transcripts, many presented an expansion or depletion in gene number, compared to B. mori genome. From the sugarcane giant borer (SGB) transcriptome, a number of aminopeptidase N (APN) cDNAs were characterized based on homology to those reported as Cry toxin receptors. This is the first report that provides a large-scale EST database for the species. Transcriptome analysis will certainly be useful to identify novel developmental genes, to better understand the insect's biology and to guide the development of new strategies for insect-pest control.	[de Assis Fonseca, Fernando Campos; Pereira Firmino, Alexandre Augusto; Pepino de Macedo, Leonardo Lima; Coelho, Roberta Ramos; Antonino de Sousa Junior, Jose Dijair; Silva-Junior, Orzenil Bonfim; Togawa, Roberto Coiti; Mattar da Silva, Maria Cristina; Grossi-de-Sa, Maria Fatima] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [de Assis Fonseca, Fernando Campos; Coelho, Roberta Ramos; Antonino de Sousa Junior, Jose Dijair; Pappas, Georgios Joannis, Jr.] Univ Brasilia, Brasilia, DF, Brazil; [Pereira Firmino, Alexandre Augusto] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Pepino de Macedo, Leonardo Lima; Silva-Junior, Orzenil Bonfim; Grossi-de-Sa, Maria Fatima] Univ Catolica Brasilia, Brasilia, DF, Brazil; [Brandao de Gois, Luiz Avelar] Usina Triunfo, Maceio, Alagoas, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade Federal do Rio Grande do Sul; Universidade Catolica de Brasilia	Fonseca, FCD (corresponding author), Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	fcafonseca@gmail.com; fatima.grossi@embrapa.br	Grossi-de-Sa, Maria Fatima/N-7856-2017; Silva-Junior, Orzenil/B-3488-2013; Pappas, Georgios J/D-5933-2016; de Souza, Jose Dijair Antonino/I-1028-2014; Pappas, Georgios J./N-8071-2019; Fonseca, Fernando/AAX-6839-2021	Silva-Junior, Orzenil/0000-0002-2104-2010; Pappas, Georgios J/0000-0002-1100-976X; de Souza, Jose Dijair Antonino/0000-0002-4992-0698; Pappas, Georgios J./0000-0002-1100-976X; Fonseca, Fernando/0000-0001-6434-5954; Togawa, Roberto/0000-0001-7179-3210; GROSSI-DE-SA, MARIA FATIMA/0000-0001-8184-9599	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Empresa Brasileira de Pesquisa Agropecuaria; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Apoio a Pesquisa do Distrito Federal	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Empresa Brasileira de Pesquisa Agropecuaria(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Distrito Federal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/), Empresa Brasileira de Pesquisa Agropecuaria (http://www.embrapa.br/), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/), and Fundacao de Apoio a Pesquisa do Distrito Federal (http://www.fap.df.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agunbiade TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079929; Ahn SC, 2000, BIOTECHNIQUES, V29, P466; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angelucci C, 2008, INSECT BIOCHEM MOLEC, V38, P685, DOI 10.1016/j.ibmb.2008.03.010; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Bass C, 2012, INSECT SCI, V19, P1, DOI 10.1111/j.1744-7917.2011.01440.x; Bown DP, 1997, INSECT BIOCHEM MOLEC, V27, P625, DOI 10.1016/S0965-1748(97)00043-X; Brioschi D, 2007, INSECT BIOCHEM MOLEC, V37, P1283, DOI 10.1016/j.ibmb.2007.07.016; Broehan G, 2010, INSECT BIOCHEM MOLEC, V40, P274, DOI 10.1016/j.ibmb.2009.10.009; Budatha M, 2007, BIOCHEM J, V405, P287, DOI 10.1042/BJ20070054; Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chikate YR, 2013, INSECT MOL BIOL, V22, P258, DOI 10.1111/imb.12018; Chrisman JD, 2009, INT J HYG ENVIR HEAL, V212, P310, DOI 10.1016/j.ijheh.2008.07.006; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; Christy LA, 2009, PLANT CELL REP, V28, P175, DOI 10.1007/s00299-008-0628-4; Coates BS, 2013, INSECT BIOCHEM MOLEC, V43, P1152, DOI 10.1016/j.ibmb.2013.09.003; Coates BS, 2006, INSECT MOL BIOL, V15, P13, DOI 10.1111/j.1365-2583.2006.00598.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Crava CM, 2010, INSECT BIOCHEM MOLEC, V40, P506, DOI 10.1016/j.ibmb.2010.04.010; Craveiro KIC, 2010, J BIOTECHNOL, V145, P215, DOI 10.1016/j.jbiotec.2009.11.011; Diaz-Mendoza M, 2007, J INSECT PHYSIOL, V53, P428, DOI 10.1016/j.jinsphys.2006.12.015; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Franco OL, 2003, PHYTOCHEMISTRY, V63, P343, DOI 10.1016/S0031-9422(03)00108-0; Gatehouse AMR, 1999, J INSECT PHYSIOL, V45, P545, DOI 10.1016/S0022-1910(98)00161-9; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Khan AR, 1998, PROTEIN SCI, V7, P815; Klein B, 1996, INT J BIOCHEM CELL B, V28, P551, DOI 10.1016/1357-2725(95)00169-7; Knight PJK, 2004, INSECT BIOCHEM MOLEC, V34, P101, DOI 10.1016/j.ibmb.2003.09.007; KNIGHT PJK, 1995, J BIOL CHEM, V270, P17765, DOI 10.1074/jbc.270.30.17765; KOZIEL MG, 1993, BIO-TECHNOL, V11, P194, DOI 10.1038/nbt0293-194; Lahens NF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r86; Laustsen PG, 2001, EUR J BIOCHEM, V268, P98, DOI 10.1046/j.1432-1327.2001.01848.x; Law JH, 2006, ADV ENZYMOLOGY RELAT, P389; Lu YJ, 1996, INSECT BIOCHEM MOLEC, V26, P33, DOI 10.1016/0965-1748(95)00058-5; Ma WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038151; Magalhaes LC, 2013, ENTOMOL EXP APPL, V146, P364, DOI 10.1111/eea.12035; MASSON L, 1995, J BIOL CHEM, V270, P20309, DOI 10.1074/jbc.270.35.20309; Mendonca AF, 1996, PRAGAS CANA DE ACUCA, P133; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Moraes SS, 2009, REV BRAS ENTOMOL, V53, P245, DOI 10.1590/S0085-56262009000200007; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Nakanishi K, 2002, FEBS LETT, V519, P215, DOI 10.1016/S0014-5793(02)02708-4; Nayak P, 1997, P NATL ACAD SCI USA, V94, P2111, DOI 10.1073/pnas.94.6.2111; Negre V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-322; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; Ningshen TJ, 2013, COMP BIOCHEM PHYS B, V166, P194, DOI 10.1016/j.cbpb.2013.09.005; Nirmala X, 2013, GENE, V517, P212, DOI 10.1016/j.gene.2012.12.012; Oliveira CM, 2014, CROP PROT, V56, P50, DOI 10.1016/j.cropro.2013.10.022; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Park Y, 2013, J INVERTEBR PATHOL, V114, P285, DOI 10.1016/j.jip.2013.09.006; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Firmino AAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085079; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Pimentel David, 2009, P89, DOI 10.1007/978-1-4020-8992-3_4; Pinto AS, 2006, ATUALIZACAO PRODUCAO, p415p; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Quilis J, 2014, PLANT BIOTECHNOL J, V12, P367, DOI 10.1111/pbi.12143; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajagopal R, 2003, BIOCHEM J, V370, P971, DOI 10.1042/BJ20021741; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-484; Reboucas LMC, 1999, QUIM NOVA, V22, P645, DOI 10.1590/S0100-40421999000500003; Rodriguez-Cabrera L, 2010, ENVIRON MICROBIOL, V12, P2894, DOI 10.1111/j.1462-2920.2010.02259.x; Rohde C, 2006, NEOTROP ENTOMOL, V35, P231, DOI 10.1590/S1519-566X2006000200012; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Rufino FPS, 2013, PLANT PHYSIOL BIOCH, V63, P70, DOI 10.1016/j.plaphy.2012.11.013; Sangadala S, 2001, INSECT BIOCHEM MOLEC, V32, P97, DOI 10.1016/S0965-1748(01)00086-8; Schwarz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-633; Silva-Brandao KL, 2013, B ENTOMOL RES, V103, P89, DOI 10.1017/S0007485312000430; Sivakumar S, 2007, J BIOL CHEM, V282, P7312, DOI 10.1074/jbc.M607442200; Srikanth J., 2011, Tropical Plant Biology, V4, P52, DOI 10.1007/s12042-011-9077-2; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; Srinivasan T, 2009, PLANT CELL PHYSIOL, V50, P541, DOI 10.1093/pcp/pcp014; Stephens E, 2004, EUR J BIOCHEM, V271, P4241, DOI 10.1111/j.1432-1033.2004.04364.x; Sun JZ, 2010, INSECT SCI, V17, P163, DOI 10.1111/j.1744-7917.2010.01348.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Warr E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-37; Weng LX, 2011, TRANSGENIC RES, V20, P759, DOI 10.1007/s11248-010-9456-8; White WH, 2008, CROP PROT, V27, P1256, DOI 10.1016/j.cropro.2008.03.011; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043769; Yang YL, 2010, INSECT BIOCHEM MOLEC, V40, P592, DOI 10.1016/j.ibmb.2010.05.006; Yang ZX, 2012, J APPL ENTOMOL, V136, P539, DOI 10.1111/j.1439-0418.2011.01683.x; Yao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044090; Zhang Fujie, 2010, BMC Genomics, V11, P1; Zhang S, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/876064; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003; Zhao P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-405; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, P1; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x	129	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118231	10.1371/journal.pone.0118231	http://dx.doi.org/10.1371/journal.pone.0118231			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706301	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100157
J	Jasso-Chavez, R; Santiago-Martinez, MG; Lira-Silva, E; Pineda, E; Zepeda-Rodriguez, A; Belmont-Diaz, J; Encalada, R; Saavedra, E; Moreno-Sanchez, R				Jasso-Chavez, Ricardo; Geovanni Santiago-Martinez, M.; Lira-Silva, Elizabeth; Pineda, Erika; Zepeda-Rodriguez, Armando; Belmont-Diaz, Javier; Encalada, Rusely; Saavedra, Emma; Moreno-Sanchez, Rafael			Air-Adapted Methanosarcina acetivorans Shows High Methane Production and Develops Resistance against Oxygen Stress	PLOS ONE			English	Article							POLYPHOSPHATE KINASE; SUPEROXIDE-DISMUTASE; METHANOBREVIBACTER-ARBORIPHILUS; OXIDATIVE STRESS; SP-NOV; BIOFILM; ARCHAEON; ASSAY; PURIFICATION; CUTICULARIS	Methanosarcina acetivorans, considered a strict anaerobic archaeon, was cultured in the presence of 0.4-1% O-2 (atmospheric) for at least 6 months to generate air-adapted cells; further, the biochemical mechanisms developed to deal with O-2 were characterized. Methane production and protein content, as indicators of cell growth, did not change in air-adapted cells respect to cells cultured under anoxia (control cells). In contrast, growth and methane production significantly decreased in control cells exposed for the first time to O-2. Production of reactive oxygen species was 50 times lower in air-adapted cells versus control cells, suggesting enhanced anti-oxidant mechanisms that attenuated the O-2 toxicity. In this regard, (i) the transcripts and activities of superoxide dismutase, catalase and peroxidase significantly increased; and (ii) the thiol-molecules (cysteine + coenzyme M-SH + sulfide) and polyphosphate contents were respectively 2 and 5 times higher in air-adapted cells versus anaerobic-control cells. Long-term cultures (18 days) of air-adapted cells exposed to 2% O-2 exhibited the ability to form biofilms. These data indicate that M. acetivorans develops multiple mechanisms to contend with O-2 and the associated oxidative stress, as also suggested by genome analyses for some methanogens.				rjass_cardiol@yahoo.com.mx	Saavedra, Emma/ABB-8989-2020; lira-silva, elizabeth/GQH-9313-2022	Pineda, Erika/0000-0003-2386-1586; Saavedra, Emma/0000-0001-8661-9813; Lira-Silva, Elizabeth/0000-0001-8261-0010; Santiago Martinez, Michel Geovanni/0000-0002-9872-7894	CONACyT, Mexico [156969, 178638, 80534, 123636]; ICyTDF, Mexico [PICS08-5]	CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ICyTDF, Mexico	This work was partially supported by grants Nos. 156969 (RJC), 178638 (ES) and 80534 and 123636 (RMS) from CONACyT, Mexico and No. PICS08-5 (RMS, RJC) from ICyTDF, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 2012, APPL ENVIRON MICROB, V78, P1473, DOI 10.1128/AEM.06964-11; Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Brioukhanov AL, 2006, BIOCHEMISTRY-MOSCOW+, V71, P441, DOI 10.1134/S0006297906040134; Brioukhanov AL, 2006, MICROBIOL-SGM, V152, P1671, DOI 10.1099/mic.0.28542-0; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Cruz F, 2006, BBA-GEN SUBJECTS, V1760, P858, DOI 10.1016/j.bbagen.2006.02.016; Erkel C, 2006, SCIENCE, V313, P370, DOI 10.1126/science.1127062; Ferry JG, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P288; Ferry JG, 2010, ANNU REV MICROBIOL, V64, P453, DOI 10.1146/annurev.micro.112408.134051; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Horne AJ, 2013, FEMS MICROBIOL LETT, V343, P13, DOI 10.1111/1574-6968.12115; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Kawagucci S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00270; Kim HJ, 2007, CURR MICROBIOL, V54, P219, DOI 10.1007/s00284-006-0361-6; Kletzin A, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P14; Kratzer C, 2011, FEBS J, V278, P442, DOI 10.1111/j.1742-4658.2010.07964.x; La Rotta CE, 2002, APPL BIOCHEM BIOTECH, V98, P191, DOI 10.1385/ABAB:98-100:1-9:191; LaPaglia C, 1997, APPL ENVIRON MICROB, V63, P3158, DOI 10.1128/AEM.63.8.3158-3163.1997; Leadbetter JR, 1996, APPL ENVIRON MICROB, V62, P3620, DOI 10.1128/AEM.62.10.3620-3631.1996; LEBEL D, 1978, ANAL BIOCHEM, V85, P86, DOI 10.1016/0003-2697(78)90277-4; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; Lira-Silva E, 2013, ENV MICROBIOL REP, V5, P799, DOI 10.1111/1758-2229.12080; Lira-Silva E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048779; Liu CT, 2008, CURR MICROBIOL, V56, P214, DOI 10.1007/s00284-007-9059-7; McCarver AC, 2014, FEBS J, V281, P4598, DOI 10.1111/febs.12964; Moran James J., 2005, Archaea, V1, P303, DOI 10.1155/2005/650670; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Olin-Sandoval V, 2012, FEBS J, V279, P1811, DOI 10.1111/j.1742-4658.2012.08557.x; Orell A, 2012, EXTREMOPHILES, V16, P573, DOI 10.1007/s00792-012-0457-9; Pedone E, 2004, FRONT BIOSCI-LANDMRK, V9, P2909, DOI 10.2741/1447; Qian YL, 2011, INT J FOOD MICROBIOL, V145, P320, DOI 10.1016/j.ijfoodmicro.2010.11.026; Rao N N, 1999, Prog Mol Subcell Biol, V23, P183; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Rodriguez-Zavala JS, 2010, J APPL MICROBIOL, V109, P2160, DOI 10.1111/j.1365-2672.2010.04848.x; Rohlin L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-62; Scholten JCM, 2007, BIOCHEM BIOPH RES CO, V358, P571, DOI 10.1016/j.bbrc.2007.04.160; Seedorf H, 2004, ARCH MICROBIOL, V182, P126, DOI 10.1007/s00203-004-0675-3; Shima S, 1999, ARCH MICROBIOL, V171, P317, DOI 10.1007/s002030050716; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; SOWERS KR, 1995, APPL ENVIRON MICROB, V61, P4382, DOI 10.1128/AEM.61.12.4382-4388.1995; SOWERS KR, 1984, APPL ENVIRON MICROB, V47, P971, DOI 10.1128/AEM.47.5.971-978.1984; SOWERS KR, 1993, APPL ENVIRON MICROB, V59, P3832, DOI 10.1128/AEM.59.11.3832-3839.1993; Sprenger WW, 2007, FEMS MICROBIOL ECOL, V60, P266, DOI 10.1111/j.1574-6941.2007.00287.x; Tholen A, 2007, FEMS MICROBIOL ECOL, V62, P303, DOI 10.1111/j.1574-6941.2007.00390.x; Thorgersen MP, 2012, P NATL ACAD SCI USA, V109, P18547, DOI 10.1073/pnas.1208605109; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; WONG H, 1994, ANAL BIOCHEM, V223, P251, DOI 10.1006/abio.1994.1581; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	54	22	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117331	10.1371/journal.pone.0117331	http://dx.doi.org/10.1371/journal.pone.0117331			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706146	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100076
J	Lee, YS; Chen, YT; Jeng, MJ; Tsao, PC; Yen, HJ; Lee, PC; Li, SY; Liu, CJ; Chen, TJ; Chou, P; Soong, WJ				Lee, Yu-Sheng; Chen, Yung-Tai; Jeng, Mei-Jy; Tsao, Pei-Chen; Yen, Hsiu-Ju; Lee, Pi-Chang; Li, Szu-Yuan; Liu, Chia-Jen; Chen, Tzeng-Ji; Chou, Pesus; Soong, Wen-Jue			The Risk of Cancer in Patients with Congenital Heart Disease: A Nationwide Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							CHILDHOOD-CANCER; BIRTH-DEFECTS; CARDIAC-CATHETERIZATION; RECORD-LINKAGE; CHILDREN; PREVALENCE; MALFORMATIONS; VALIDATION; ANOMALIES; INFANTS	Background The relationship between congenital heart disease (CHD) and malignancies has not been determined. This study aimed to explore the association of CHD with malignancies and examine the risk factors for the development of cancer after a diagnosis of CHD. Patients and Methods This nationwide, population-based cohort study on cancer risk evaluated 31,961 patients with newly diagnosed CHD using the Taiwan National Health Insurance Research Database (NHIRD) between 1998 and 2006. The standardized incidence ratios (SIRs) for all and specific cancer types were analyzed, while the Cox proportional hazard model was used to evaluate risk factors of cancer occurrence. Results Among patients with newly diagnosed CHD regardless of ages, 187 (0.6%) subsequently developed cancers after a diagnosis of CHD. Patients with CHD had increased risk of cancer (SIR, 1.45; 95% CI, 1.25-1.67), as well as significantly elevated risks of hematologic (SIR, 4.04; 95% CI, 2.76-5.70), central nervous system (CNS) (SIR, 3.51; 95% CI, 1.92-5.89), and head and neck (SIR, 1.81; 95% CI, 1.03-2.94) malignancies. Age (HR, 1.06; 95% CI, 1.05-1.06) and co-morbid chronic liver disease (HR, 1.91; 95% CI, 1.27-2.87) were independent risk factors for cancer occurrence among CHD patients. Conclusion Patients with CHD have significantly increased cancer risk, particularly hematologic, CNS, and head and neck malignancies. Physicians who care for patients with CHD should be aware of their predisposition to malignancy after the diagnosis of CHD. Further studies are warranted to clarify the association between CHD and malignancies.	[Lee, Yu-Sheng; Jeng, Mei-Jy; Tsao, Pei-Chen; Soong, Wen-Jue] Taipei Vet Gen Hosp, Dept Pediat, Div Gen Pediat, Taipei, Taiwan; [Lee, Yu-Sheng; Jeng, Mei-Jy; Tsao, Pei-Chen; Yen, Hsiu-Ju; Lee, Pi-Chang; Soong, Wen-Jue] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan; [Lee, Yu-Sheng; Liu, Chia-Jen; Chou, Pesus] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Yu-Sheng; Liu, Chia-Jen; Chou, Pesus] Natl Yang Ming Univ, Sch Med, Community Med Res Ctr, Taipei 112, Taiwan; [Chen, Yung-Tai; Li, Szu-Yuan] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Chen, Yung-Tai] Taipei City Hosp, Heping Fuyou Branch, Dept Med, Taipei, Taiwan; [Jeng, Mei-Jy] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Yen, Hsiu-Ju] Taipei Vet Gen Hosp, Div Pediat Hematol & Oncol, Dept Pediat, Taipei, Taiwan; [Lee, Pi-Chang] Taipei Vet Gen Hosp, Div Pediat Cardiol, Dept Pediat, Taipei, Taiwan; [Li, Szu-Yuan] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Liu, Chia-Jen] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Chou, P (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan.	pschou@ym.edu.tw; wjsoong@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021		Taipei Veterans General Hospital [V102B-047]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by a grant from Taipei Veterans General Hospital (V102B-047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha MM, 2005, CANCER-AM CANCER SOC, V103, P1939, DOI 10.1002/cncr.20985; Altmann AE, 1998, BRIT J CANCER, V78, P1244, DOI 10.1038/bjc.1998.662; Andreassi MG, 2006, EUR HEART J, V27, P2703, DOI 10.1093/eurheartj/ehl014; Bernier Pierre-Luc, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P26, DOI 10.1053/j.pcsu.2010.02.005; Bernstein D, 2011, NELSON TXB PEDIAT, V19th; Bille C, 2005, AM J EPIDEMIOL, V161, P1047, DOI 10.1093/aje/kwi132; Billett J, 2008, HEART, V94, P1194, DOI 10.1136/hrt.2007.122671; Bjorge T, 2008, CANCER EPIDEM BIOMAR, V17, P500, DOI 10.1158/1055-9965.EPI-07-2630; Breslow N E, 1987, IARC Sci Publ, P1; Carozza SE, 2012, AM J EPIDEMIOL, V175, P1217, DOI 10.1093/aje/kwr470; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YJ, 2012, ARCH DERMATOL, V148, P103, DOI 10.1001/archdermatol.2011.682; Chen YJ, 2011, ARTHRITIS RHEUM-US, V63, P352, DOI 10.1002/art.30134; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Dastgiri S, 2002, ARCH DIS CHILD, V86, P257, DOI 10.1136/adc.86.4.257; Deanfield J, 2003, EUR HEART J, V24, P1035, DOI 10.1016/S0195-668X(03)00131-3; Diller GP, 2011, DTSCH ARZTEBL INT, V108, P452, DOI 10.3238/arztebl.2011.0452; Feudtner C, 2000, PEDIATRICS, V106, P205; Fisher PG, 2012, J PEDIATR-US, V160, P978, DOI 10.1016/j.jpeds.2011.12.006; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hwang CY, 2012, INT J CANCER, V130, P1160, DOI 10.1002/ijc.26105; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Li WH, 2012, NEPHROL DIAL TRANSPL, V27, P833, DOI 10.1093/ndt/gfr277; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin SY, 2014, EUR J INTERN MED, V25, P276, DOI 10.1016/j.ejim.2014.01.001; Liu CJ, 2012, EUR J NEUROL, V19, P746, DOI 10.1111/j.1468-1331.2011.03621.x; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Massin MM, 2007, ACTA PAEDIATR, V96, P753, DOI 10.1111/j.1651-2227.2007.00275.x; MCLAUGHLIN JR, 1993, INT J EPIDEMIOL, V22, P584, DOI 10.1093/ije/22.4.584; MILI F, 1993, AM J EPIDEMIOL, V137, P629, DOI 10.1093/oxfordjournals.aje.a116720; MILI F, 1993, AM J EPIDEMIOL, V137, P639, DOI 10.1093/oxfordjournals.aje.a116721; MILLER RW, 1966, NEW ENGL J MED, V275, P87, DOI 10.1056/NEJM196607142750208; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; Modan B, 2000, INT J EPIDEMIOL, V29, P424, DOI 10.1093/ije/29.3.424; Moodie D, 2011, TEX HEART I J, V38, P705; Narod SA, 1997, AM J HUM GENET, V60, P474; Rankin J, 2008, PEDIATR BLOOD CANCER, V51, P608, DOI 10.1002/pbc.21682; SPENGLER RF, 1983, PEDIATRICS, V71, P235; Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Weng MY, 2012, ANN RHEUM DIS, V71, P524, DOI 10.1136/annrheumdis-2011-200402; WINDHAM GC, 1985, AM J EPIDEMIOL, V121, P49, DOI 10.1093/oxfordjournals.aje.a113982; Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414; Wu CY, 2011, CANCER-AM CANCER SOC, V117, P618, DOI 10.1002/cncr.25616; Wu CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089655; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Wu WC, 2013, LIVER INT, V33, P616, DOI 10.1111/liv.12103	48	29	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116844	10.1371/journal.pone.0116844	http://dx.doi.org/10.1371/journal.pone.0116844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706872	gold, Green Submitted, Green Published			2022-12-27	WOS:000350662100052
J	Montero-Serra, I; Linares, C; Garcia, M; Pancaldi, F; Frleta-Valic, M; Ledoux, JB; Zuberer, F; Merad, D; Drap, P; Garrabou, J				Montero-Serra, Ignasi; Linares, Cristina; Garcia, Marina; Pancaldi, Francesca; Frleta-Valic, Masa; Ledoux, Jean-Baptiste; Zuberer, Frederic; Merad, Djamel; Drap, Pierre; Garrabou, Joaquim			Harvesting Effects, Recovery Mechanisms, and Management Strategies for a Long-Lived and Structural Precious Coral	PLOS ONE			English	Article							RED CORAL; MASS MORTALITY; LIFE-HISTORY; RUBRUM L.; POPULATIONS; REPRODUCTION; CONSERVATION; INSIGHTS; DECLINE; GROWTH	Overexploitation is a major threat for the integrity of marine ecosystems. Understanding the ecological consequences of different extractive practices and the mechanisms underlying the recovery of populations is essential to ensure sustainable management plans. Precious corals are long-lived structural invertebrates, historically overfished, and their conservation is currently a worldwide concern. However, the processes underlying their recovery are poorly known. Here, we examined harvesting effects and recovery mechanisms of red coral Corallium rubrum by analyzing long-term photographic series taken on two populations that were harvested. We compared the relative importance of reproduction and re-growth as drivers of resilience. Harvesting heavily impacted coral populations causing large decreases in biomass and strong size-class distribution shifts towards populations dominated by small colonies. At the end of the study (after 4 and 7 years) only partial recovery was observed. The observed general pattern of low recruitment and high mortality of new recruits demonstrated limited effects of reproduction on population recovery. Adversely, low mortality of partially harvested adults and a large proportion of colonies showing new branches highlighted the importance of re-growth in the recovery process. The demographic projections obtained through stochastic models confirmed that the recovery rates of C. rubrum can be strongly modulated depending on harvesting procedures. Thus, leaving the basal section of the colonies when harvesting to avoid total mortality largely enhances the resilience of C. rubrum populations and quickens their recovery. On the other hand, the high survival of harvested colonies and the significant biomass reduction indicated that abundance may not be an adequate metric to assess the conservation status of clonal organisms because it can underestimate harvesting effects. This study highlights the unsustainability of current harvesting practices of C. rubrum and provides urgently needed data to improve management practices that are still largely based on untested assumptions.	[Montero-Serra, Ignasi; Linares, Cristina] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Garcia, Marina; Pancaldi, Francesca; Frleta-Valic, Masa; Ledoux, Jean-Baptiste; Garrabou, Joaquim] Inst Ciencies Mar ICM CSIC, Barcelona, Spain; [Zuberer, Frederic] Inst Pytheas, Stn Marine Endoume, UMS 3470, Marseille, France; [Merad, Djamel; Drap, Pierre] CNRS, LSIS, UMR 7296, Marseille, France; [Ledoux, Jean-Baptiste] Univ Porto, CIMAR CIIMAR Ctr Interdisciplinar Invest Marinha, P-4100 Oporto, Portugal; [Garrabou, Joaquim] Univ Sud Toulon Var, Aix Marseille Univ, Mediterranean Inst Oceanog MIO, CNRS,INSU,IRD,UM110, Marseille, France	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universidade do Porto; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Montero-Serra, I (corresponding author), Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain.	monteroserra@gmail.com	Linares, Cristina/A-5244-2018	Linares, Cristina/0000-0003-3855-2743; Montero-Serra, Ignasi/0000-0003-0284-0591; Drap, Pierre/0000-0003-0528-9280; Ledoux, Jean-Baptiste/0000-0001-8796-6163; Frleta - Valic, Masa/0000-0002-5393-1867	FPI grant [BES-2013-066150]; Ramon y Cajal research [RyC-2011-08134]; Spanish Ministry of Economy and Innovation [CTM2009-08045, CGL2012-32194]; Generalitat de Catalunya [SGR 1174]	FPI grant; Ramon y Cajal research(Spanish Government); Spanish Ministry of Economy and Innovation(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Support for this work was provided by a FPI grant (BES-2013-066150) to I. Montero-Serra and by a Ramon y Cajal research contract (RyC-2011-08134) to C. Linares. This study was partially funded by the Spanish Ministry of Economy and Innovation Biorock project (CTM2009-08045) and Smart project (CGL2012-32194). The authors are part of the Marine Conservation research group (2009 SGR 1174) from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBIATI M, 1992, NETH J SEA RES, V30, P219, DOI 10.1016/0077-7579(92)90060-R; Bavestrello G, 2015, MAR ECOL-EVOL PERSP, V36, P1354, DOI 10.1111/maec.12235; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bramanti L, 2005, J EXP MAR BIOL ECOL, V314, P69, DOI 10.1016/j.jembe.2004.08.029; Bramanti L, 2013, GLOBAL CHANGE BIOL, V19, P1897, DOI 10.1111/gcb.12171; Bruckner AW, 2014, CURR OPIN ENV SUST, V7, P1, DOI 10.1016/j.cosust.2013.11.024; Bruckner AW, 2010, MAR ECOL PROG SER, V418, P299, DOI 10.3354/meps08898; Bruckner AW, 2009, MAR ECOL PROG SER, V397, P319, DOI 10.3354/meps08110; Cau A, 2013, ADAPTIVE MANAGEMENT, DOI [10.1016/j.jfo.2013.06.003PMID:25632406, DOI 10.1016/J.JFO.2013.06.003]; Cerrano C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01457; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; Drap P, 2013, INT ARCH PHOTOGRAMM, V40-5-W2, P231; Gallmetzer I, 2010, ESTUAR COAST SHELF S, V90, P1, DOI 10.1016/j.ecss.2010.04.018; GARCIA-RODRIGUEZ M, 1986, Boletin Instituto Espanol de Oceanografia, V3, P61; Garrabou J, 2002, J ANIM ECOL, V71, P966, DOI 10.1046/j.1365-2656.2002.00661.x; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Grigg RW, 2008, MARINE ECOLOGY, V5, P57; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hereu B, 1999, SEGUIMENT TEMPORAL I; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Husebo A, 2002, HYDROBIOLOGIA, V471, P91, DOI 10.1023/A:1016549203368; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Lasker HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074587; Ledoux JB, 2010, MOL ECOL, V19, P675, DOI 10.1111/j.1365-294X.2009.04516.x; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Linares C, 2012, CONSERV BIOL, V26, P88, DOI 10.1111/j.1523-1739.2011.01795.x; Linares C, 2010, MAR ECOL PROG SER, V402, P69, DOI 10.3354/meps08436; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Santangelo G, 2003, MAR ECOL PROG SER, V248, P99, DOI 10.3354/meps248099; Santangelo G, 2010, MAR ECOL PROG SER, V418, P295, DOI 10.3354/meps08897; Santangelo G, 1993, SCI MAR, V57, P139; Torrents O, 2008, J EXP MAR BIOL ECOL, V357, P7, DOI 10.1016/j.jembe.2007.12.006; Torrents O, 2005, BIOL CONSERV, V121, P391, DOI 10.1016/j.biocon.2004.05.010; Torrents O, 2007, THESIS U MEDITERRANE; Tsounis G, 2007, ECOSYSTEMS, V10, P975, DOI 10.1007/s10021-007-9072-5; Tsounis G, 2013, MAR POLICY, V39, P361, DOI 10.1016/j.marpol.2012.12.010; Tsounis G, 2010, OCEANOGR MAR BIOL, V48, P161, DOI 10.1201/EBK1439821169-c3; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1	45	20	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117250	10.1371/journal.pone.0117250	http://dx.doi.org/10.1371/journal.pone.0117250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706556	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100069
J	Smerieri, A; Testa, C; Lazzeroni, P; Nuti, F; Grossi, E; Cesari, S; Montanini, L; Latini, G; Bernasconi, S; Papini, AM; Street, ME				Smerieri, Arianna; Testa, Chiara; Lazzeroni, Pietro; Nuti, Francesca; Grossi, Enzo; Cesari, Silvia; Montanini, Luisa; Latini, Giuseppe; Bernasconi, Sergio; Papini, Anna Maria; Street, Maria E.			Di-(2-Ethylhexyl) Phthalate Metabolites in Urine Show Age-Related Changes and Associations with Adiposity and Parameters of Insulin Sensitivity in Childhood	PLOS ONE			English	Article							BODY-MASS INDEX; DI(2-ETHYLHEXYL) PHTHALATE; TEMPORAL VARIABILITY; WAIST CIRCUMFERENCE; THYROID-FUNCTION; IN-VITRO; EXPOSURE; GLUCOSE; SYSTEM; DEHP	Objectives Phthalates might be implicated with obesity and insulin sensitivity. We evaluated the levels of primary and secondary metabolites of Di-(2-ethylhexyl) phthalate (DEHP) in urine in obese and normal-weight subjects both before and during puberty, and investigated their relationships with auxological parameters and indexes of insulin sensitivity. Design and Methods DEHP metabolites (MEHP, 6-OH-MEHP, 5-oxo-MEHP, 5-OH-MEHP, and 5-CX-MEHP), were measured in urine by RP-HPLC-ESI-MS. Traditional statistical analysis and a data mining analysis using the Auto-CM analysis were able to offer an insight into the complex biological connections between the studied variables. Results The data showed changes in DEHP metabolites in urine related with obesity, puberty, and presence of insulin resistance. Changes in urine metabolites were related with age, height and weight, waist circumference and waist to height ratio, thus to fat distribution. In addition, clear relationships in both obese and normal-weight subjects were detected among MEHP, its products of oxidation and measurements of insulin sensitivity. Conclusion It remains to be elucidated whether exposure to phthalates per se is actually the risk factor or if the ability of the body to metabolize phthalates is actually the key point. Further studies that span from conception to elderly subjects besides further understanding of DEHP metabolism are warranted to clarify these aspects.	[Smerieri, Arianna; Lazzeroni, Pietro; Cesari, Silvia; Montanini, Luisa; Bernasconi, Sergio; Street, Maria E.] Univ Hosp Parma, Dept Pediat, Parma, Italy; [Testa, Chiara; Nuti, Francesca; Papini, Anna Maria] Www Peptlab Eu, Interdepartimental Lab Peptide & Prot Chem Biol, Florence, Italy; [Testa, Chiara; Nuti, Francesca; Papini, Anna Maria] Univ Florence, Dept Chem Ugo Schiff, Sesto Fiorentino, Italy; [Testa, Chiara; Nuti, Francesca; Papini, Anna Maria] Univ Cergy Pontoise, LCB EA 4505, PeptLab UCP, Cergy Pontoise, France; [Grossi, Enzo] Villa Santa Maria Inst, Tavernerio, Italy; [Latini, Giuseppe] Natl Res Council Italy, Lecce Sect, Clin Physiol Inst IFC CNR, Lecce, Italy; [Latini, Giuseppe] Perrino Hosp, Div Neonatol, Brindisi, Italy; [Street, Maria E.] S Maria Nuova Hosp & Res Inst, Depts Paediat, Reggio Emilia, Italy; [Street, Maria E.] S Maria Nuova Hosp & Res Inst, Dept Res & Stat, Reggio Emilia, Italy	University of Parma; University Hospital of Parma; University of Florence; CY Cergy Paris Universite; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Street, ME (corresponding author), Univ Hosp Parma, Dept Pediat, Parma, Italy.	mariaelisabeth.street@asmn.re.it	Street, Maria E/B-7099-2011; Bernasconi, Sergio/AAA-9419-2021; Testa, Chiara/B-3027-2016; Papini, Anna Maria/AAZ-5204-2020; Grossi, Enzo/AAF-7765-2020; Nuti, Francesca/L-6282-2015	Street, Maria E/0000-0001-8427-8971; Testa, Chiara/0000-0002-2945-1257; Nuti, Francesca/0000-0001-9908-5996; Papini, Anna Maria/0000-0002-2947-7107	Dept. of Paediatrics, University of Parma, Italy; Bracco Foundation, Milan, Italy; Fondazione Ente Cassa di Risparmio di Firenze (Italy); Regione Toscana (Italy): POR CReO FESR ASSE 1- Linea di intervento 1.1.C Bando Regionale; ANR(France) for the Chaire d'Excellence [ANR-09-CEXC-013-01]; Ecole Doctorale Sciences et Ingenierie de l'Universite de Cergy-Pontoise	Dept. of Paediatrics, University of Parma, Italy; Bracco Foundation, Milan, Italy; Fondazione Ente Cassa di Risparmio di Firenze (Italy)(Fondazione Cassa Risparmio Firenze); Regione Toscana (Italy): POR CReO FESR ASSE 1- Linea di intervento 1.1.C Bando Regionale; ANR(France) for the Chaire d'Excellence(French National Research Agency (ANR)); Ecole Doctorale Sciences et Ingenierie de l'Universite de Cergy-Pontoise	This study was supported by funds of the Dept. of Paediatrics, University of Parma, Italy, by Bracco Foundation, Milan, Italy, by Fondazione Ente Cassa di Risparmio di Firenze (Italy), the Regione Toscana (Italy): POR CReO FESR 2007-2013 ASSE 1- Linea di intervento 1.1.C Bando Regionale 2009, the ANR(France) for the Chaire d'Excellence to AMP Project PepKit ANR-09-CEXC-013-01 and the Ecole Doctorale Sciences et Ingenierie de l'Universite de Cergy-Pontoise for the PhD fellowship at CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379; ATSDR(AgencyforToxicSubstancesandDiseaseRegistry), 2002, TOX PROF DI 2 ETH PH; Belfiore F, 1998, MOL GENET METAB, V63, P134, DOI 10.1006/mgme.1997.2658; Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Buscema M, 2008, CURR ALZHEIMER RES, V5, P481, DOI 10.2174/156720508785908928; Cacciari E, 2002, EUR J CLIN NUTR, V56, P171, DOI 10.1038/sj.ejcn.1601314; Casals-Casas C, 2008, INT J OBESITY, V32, pS53, DOI 10.1038/ijo.2008.207; Centers for Disease Control and Prevention, 2021, 4 NAT REP HUM EXP EN; Choi K, 2012, TOXICOL IN VITRO, V26, P315, DOI 10.1016/j.tiv.2011.12.002; Clark K, 2003, HANDB ENVIRON CHEM, V3, P227; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 2002, EUR J CLIN NUTR, V56, P1194, DOI 10.1038/sj.ejcn.1601473; Crinnion WJ, 2010, ALTERN MED REV, V15, P190; d'Annunzio Giuseppe, 2009, Acta Biomed, V80, P21; Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017; Driven HAAM, 1993, BIOCHEM PHARMACOL, V45, P2425; Eller-Vainicher C, 2011, DIABETES CARE, V34, P2186, DOI 10.2337/dc11-0764; Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217; Gironi M, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-1; Hatch EE, 2010, INT J ANDROL, V33, P324, DOI 10.1111/j.1365-2605.2009.01035.x; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001; Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515, DOI 10.1289/ehp.02110515; Ito Y, 2005, ARCH TOXICOL, V79, P147, DOI 10.1007/s00204-004-0615-7; Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Latini G, 2009, ENVIRON INT, V35, P987, DOI 10.1016/j.envint.2009.03.008; Licastro F, 2010, NEUROBIOL AGING, V31, P257, DOI 10.1016/j.neurobiolaging.2008.03.019; Lind PM, 2012, DIABETES CARE, V35, P1519, DOI 10.2337/dc11-2396; Low S, 2009, ANN ACAD MED SINGAP, V38, P57; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Norris JM, 2012, ARTERIOSCL THROM VAS, V32, P2091, DOI 10.1161/ATVBAHA.112.255463; Nuti F, 2005, BIOORGAN MED CHEM, V13, P3461, DOI 10.1016/j.bmc.2005.03.005; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378; Penco S, 2005, ANN HUM GENET, V69, P693, DOI 10.1111/j.1529-8817.2005.00206.x; Philippat C, 2012, ENVIRON HEALTH PERSP, V120, P464, DOI 10.1289/ehp.1103634; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882; Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Testa C, 2012, ASN NEURO, V4, P223, DOI 10.1042/AN20120015; Trasande L, 2013, ENVIRON HEALTH PERSP, V121, P501, DOI 10.1289/ehp.1205526; Uwaifo GI, 2002, DIABETES CARE, V25, P2081, DOI 10.2337/diacare.25.11.2081; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056800; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	59	40	40	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117831	10.1371/journal.pone.0117831	http://dx.doi.org/10.1371/journal.pone.0117831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706863	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100122
J	Satoh, S; Mori, K; Ueda, Y; Sejima, H; Dansako, H; Ikeda, M; Kato, N				Satoh, Shinya; Mori, Kyoko; Ueda, Youki; Sejima, Hiroe; Dansako, Hiromichi; Ikeda, Masanori; Kato, Nobuyuki			Establishment of Hepatitis C Virus RNA-Replicating Cell Lines Possessing Ribavirin-Resistant Phenotype	PLOS ONE			English	Article							NON-B-HEPATITIS; NON-A; HUMAN HEPATOCYTES; INFECTION; INTERFERON; TELAPREVIR; THERAPY; CULTURE; GENOME; BOCEPREVIR	Background Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy using direct acting antivirals for patients with chronic hepatitis C. However, the precise mechanisms underlying RBV action against hepatitis C virus (HCV) replication are not yet understood. To clarify this point, we attempted to develop RBV-resistant cells from RBV-sensitive HCV RNA-replicating cells. Methodology/Principal Findings By repetitive RBV (100 mu M) treatment (10 weeks) of 3.5-year-cultured OL8 cells, in which genome-length HCV RNA (O strain of genotype 1b) efficiently replicates, dozens of colonies that survived RBV treatment were obtained. These colonies were mixed together and further treated with high doses of RBV (up to 200 mu M). By such RBV treatment, we successfully established 12 RBV-survived genome-length HCV RNA-replicating cell lines. Among them, three representative cell lines were characterized. HCV RNA replication in these cells resisted RBV significantly more than that in the parental OL8 cells. Genetic analysis of HCV found several common and conserved amino acid substitutions in HCV proteins among the three RBV-resistant cell species. Furthermore, using cDNA microarray and quantitative RT-PCR analyses, we identified 5 host genes whose expression levels were commonly altered by more than four-fold among these RBV-resistant cells compared with the parental cells. Moreover, to determine whether viral or host factor contributes to RBV resistance, we developed newly HCV RNA-replicating cells by introducing total RNAs isolated from RBV-sensitive parental cells or RBV-resistant cells into the HCV RNA-cured-parental or -RBV-resistant cells using an electroporation method, and evaluated the degrees of RBV resistance of these developed cells. Consequently, we found that RBV-resistant phenotype was conferred mainly by host factor and partially by viral factor. Conclusions/Significance These newly established HCV RNA-replicating cell lines should become useful tools for further understanding the anti-HCV mechanisms of RBV.	[Satoh, Shinya; Mori, Kyoko; Ueda, Youki; Sejima, Hiroe; Dansako, Hiromichi; Ikeda, Masanori; Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Okayama 7008558, Japan	Okayama University	Kato, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	nkato@md.okayama-u.ac.jp	Dansako, Hiromichi/M-1421-2019; Dansako, Hiromichi/N-3109-2019; Ueda, Youki/J-3529-2015; DANSAKO, Hiromichi/B-2025-2011	Dansako, Hiromichi/0000-0002-2353-3024; Ueda, Youki/0000-0002-2627-8524; DANSAKO, Hiromichi/0000-0002-2353-3024	Ministry of Health, Labor, and Welfare of Japan; Japan Society for the Promotion of Science (JSPS) [25293110]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for research on hepatitis from the Ministry of Health, Labor, and Welfare of Japan; and by a grant-in-aid for Scientific Research (B) (Grant no. 25293110) from the Japan Society for the Promotion of Science (JSPS). Y.U. was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Chevaliez S, 2007, ADV DRUG DELIVER REV, V59, P1222, DOI 10.1016/j.addr.2007.07.002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Esteban R, 2012, BEST PRACT RES CL GA, V26, P445, DOI 10.1016/j.bpg.2012.09.001; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Fukuchi Y, 2010, J HEPATOL, V52, P486, DOI 10.1016/j.jhep.2010.01.011; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hayes CN, 2015, J FORMOS MED ASSOC, V114, P204, DOI 10.1016/j.jfma.2014.09.001; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Ibarra KD, 2009, J VIROL, V83, P4538, DOI 10.1128/JVI.02280-08; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kato N, 2005, J GEN VIROL, V86, P645, DOI 10.1099/vir.0.80479-0; Kato N, 2003, BIOCHEM BIOPH RES CO, V306, P756, DOI 10.1016/S0006-291X(03)01047-7; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kato N, 2009, ARCH VIROL, V154, P77, DOI 10.1007/s00705-008-0282-8; Kato N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091156; Kato N, 2009, VIRUS RES, V146, P41, DOI 10.1016/j.virusres.2009.08.006; Koh C, 2014, ANTIVIR RES, V104, P34, DOI 10.1016/j.antiviral.2014.01.005; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Mori K, 2013, HEPATOLOGY, V58, P1236, DOI 10.1002/hep.26421; Mori K, 2011, VIRUS RES, V157, P61, DOI 10.1016/j.virusres.2011.02.005; Mori K, 2010, HEPATOL RES, V40, P1248, DOI 10.1111/j.1872-034X.2010.00730.x; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sejima H, 2012, VIRUS RES, V167, P74, DOI 10.1016/j.virusres.2012.04.008; Thomas DL, 2000, CURR TOP MICROBIOL, V242, P25; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	36	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0118313	10.1371/journal.pone.0118313	http://dx.doi.org/10.1371/journal.pone.0118313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25699517	Green Published, gold, Green Submitted			2022-12-27	WOS:000349789800036
J	Hamada-Tsutsumi, S; Iio, E; Watanabe, T; Murakami, S; Isogawa, M; Iijima, S; Inoue, T; Matsunami, K; Tajiri, K; Ozawa, T; Kishi, H; Muraguchi, A; Joh, T; Tanaka, Y				Hamada-Tsutsumi, Susumu; Iio, Etsuko; Watanabe, Tsunamasa; Murakami, Shuko; Isogawa, Masanori; Iijima, Sayuki; Inoue, Takako; Matsunami, Kayoko; Tajiri, Kazuto; Ozawa, Tatsuhiko; Kishi, Hiroyuki; Muraguchi, Atsushi; Joh, Takashi; Tanaka, Yasuhito			Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo Infection	PLOS ONE			English	Article							SURFACE-ANTIGEN; CELL-LINE; VACCINE; DNA; DIVERSITY; MUTATION; EPITOPE; BLOOD	Vaccines based on hepatitis B virus (HBV) genotype A have been used worldwide for immunoprophylaxis and are thought to prevent infections by non-A HBV strains effectively, whereas, vaccines generated from genotype C have been used in several Asian countries, including Japan and Korea, where HBV genotype C is prevalent. However, acute hepatitis B caused by HBV genotype A infection has been increasing in Japan and little is known about the efficacy of immunization with genotype C-based vaccines against non-C infection. We have isolated human monoclonal antibodies (mAbs) from individuals who were immunized with the genotype C-based vaccine. In this study, the efficacies of these two mAbs, HB0116 and HB0478, were analyzed using in vivo and in vitro models of HBV infection. Intravenous inoculation of HBV genotype C into chimeric mice with human hepatocytes resulted in the establishment of HBV infection after five weeks, whereas preincubation of the inocula with HB0116 or HB0478 protected chimeric mice from genotype C infection completely. Interestingly, both HB0116 and HB0478 were found to block completely genotype A infection. Moreover, infection by a genotype C strain with an immune escape substitution of amino acid 145 in the hepatitis B surface protein was also completely inhibited by incubation with HB0478. Finally, in vitro analysis of dose dependency revealed that the amounts of HB0478 required for complete protection against genotype C and genotype A infection were 5.5 mIU and 55 mIU, respectively. These results suggested that genotype C-based vaccines have ability to induce cross-genotype immunity against HBV infection.	[Hamada-Tsutsumi, Susumu; Iio, Etsuko; Watanabe, Tsunamasa; Murakami, Shuko; Isogawa, Masanori; Iijima, Sayuki; Inoue, Takako; Matsunami, Kayoko; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Hamada-Tsutsumi, Susumu; Iio, Etsuko; Watanabe, Tsunamasa; Murakami, Shuko; Isogawa, Masanori; Iijima, Sayuki; Inoue, Takako; Matsunami, Kayoko; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Iio, Etsuko; Matsunami, Kayoko; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Tajiri, Kazuto] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Internal Med 3, Toyama 930, Japan; [Tajiri, Kazuto; Ozawa, Tatsuhiko; Kishi, Hiroyuki; Muraguchi, Atsushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama 930, Japan	Nagoya City University; Nagoya City University; Nagoya City University; University of Toyama; University of Toyama	Tanaka, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan.	ytanaka@med.nagoya-cu.ac.jp	Isogawa, Masanori/AAN-8969-2021	Isogawa, Masanori/0000-0001-8730-4303; Tanaka, Yasuhito/0000-0002-2473-6966; Ozawa, Tatsuhiko/0000-0002-3112-452X	Ministry of Health, Labour, and Welfare of Japan [009, 011, 013]; Ministry of Education, Culture, Sports, Science and Technology, Japan [25293176]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants from the Ministry of Health, Labour, and Welfare of Japan (009, 011, and 013), and a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (25293176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1999, J CLIN MICROBIOL, V37, P2899, DOI 10.1128/JCM.37.9.2899-2903.1999; Allweiss L, 2014, J HEPATOL, V60, P500, DOI 10.1016/j.jhep.2013.10.021; Avazova D, 2008, J MED VIROL, V80, P217, DOI 10.1002/jmv.21035; Cassidy A, 2011, EXPERT REV VACCINES, V10, P1709, DOI [10.1586/ERV.11.151, 10.1586/erv.11.151]; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; Cooreman MP, 2001, J BIOMED SCI, V8, P237, DOI 10.1007/BF02256597; Fujiwara K, 2005, J VIROL, V79, P14404, DOI 10.1128/JVI.79.22.14404-14410.2005; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; ITOH Y, 1986, P NATL ACAD SCI USA, V83, P9174, DOI 10.1073/pnas.83.23.9174; IWARSON S, 1985, J MED VIROL, V16, P89, DOI 10.1002/jmv.1890160112; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; Komatsu Haruki, 2012, BMC Res Notes, V5, P22, DOI 10.1186/1756-0500-5-22; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Laras A, 2006, HEPATOLOGY, V44, P694, DOI 10.1002/hep.21299; Lee PI, 1997, J INFECT DIS, V176, P427, DOI 10.1086/514060; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Miyakawa Y, 2003, INTERVIROLOGY, V46, P329, DOI 10.1159/000074988; Ogata Norio, 2009, Rinsho Byori, V57, P954; Qiu XX, 1996, J IMMUNOL, V156, P3350; Shokrgozar MA, 2002, VACCINE, V20, P2215, DOI 10.1016/S0264-410X(02)00116-0; Stramer SL, 2011, NEW ENGL J MED, V364, P236, DOI 10.1056/NEJMoa1007644; Sugiyama M, 2009, GASTROENTEROLOGY, V136, P652, DOI 10.1053/j.gastro.2008.10.048; Tajiri K, 2007, CYTOM PART A, V71A, P961, DOI 10.1002/cyto.a.20471; Tajiri K, 2010, ANTIVIR RES, V87, P40, DOI 10.1016/j.antiviral.2010.04.006; Tokilmitsu Y, 2007, CYTOM PART A, V71A, P1003, DOI 10.1002/cyto.a.20478; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	30	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0118062	10.1371/journal.pone.0118062	http://dx.doi.org/10.1371/journal.pone.0118062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693196	Green Published, gold, Green Submitted			2022-12-27	WOS:000350061500093
J	Kim, Y; Myung, W; Won, HH; Shim, S; Jeon, HJ; Choi, J; Carroll, BJ; Kim, DK				Kim, Youngdon; Myung, Woojae; Won, Hong-Hee; Shim, Sanghong; Jeon, Hong Jin; Choi, Junbae; Carroll, Bernard J.; Kim, Doh Kwan			Association between Air Pollution and Suicide in South Korea: A Nationwide Study	PLOS ONE			English	Article							PARTICULATE MATTER; RISK-FACTOR; OZONE; INFLAMMATION; METAANALYSIS; DEPRESSION; SICKNESS; ILLNESS; 5-HIAA; TIME	Suggestive associations of suicide with air pollutant concentrations have been reported. Recognizing regional and temporal variability of pollutant concentrations and of suicide, we undertook a detailed meta-analysis of completed suicides in relation to 5 major pollutants over 6 years in the 16 administrative regions of the Republic of Korea, while also controlling for other established influences on suicide rates. Of the 5 major pollutants examined, ozone concentrations had a powerful association with suicide rate, extending back to 4 weeks. Over the range of 2 standard deviations (SD) around the annual mean ozone concentration, the adjusted suicide rate increased by an estimated 7.8% of the annual mean rate. Particulate matter pollution also had a significant effect, strongest with a 4-week lag, equivalent to 3.6% of the annual mean rate over the same 2 SD range that approximated the half of annual observed range. These results strongly suggest deleterious effects of ozone and particulate matter pollution on the major public health problem of suicide.	[Kim, Youngdon; Myung, Woojae; Jeon, Hong Jin; Choi, Junbae; Kim, Doh Kwan] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, Seoul, South Korea; [Won, Hong-Hee; Shim, Sanghong] Samsung Biomed Res Inst, Seoul, South Korea; [Carroll, Bernard J.] Pacific Behav Res Fdn, Carmel, CA USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, Seoul, South Korea.	paulkim@skku.edu	Kim, Doh Kwan/F-4616-2014; Myung, Woojae/AAD-3016-2021; Won, Hong-Hee/D-2672-2011	Kim, Doh Kwan/0000-0002-2302-6153; Myung, Woojae/0000-0001-9985-2032; Won, Hong-Hee/0000-0001-5719-0552	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI13C1590]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI13C1590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD REPORT VIOLENC; Bach H, 2014, SYNAPSE, V68, P127, DOI 10.1002/syn.21695; Bertolote JM, 2005, AM J MED GENET C, V133C, P8, DOI 10.1002/ajmg.c.30041; Biermann T, 2009, MED HYPOTHESES, V72, P338, DOI 10.1016/j.mehy.2008.09.042; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Ceccherini-Nelli A, 2011, SOC PSYCH PSYCH EPID, V46, P975, DOI 10.1007/s00127-010-0275-2; Chatzittofis A, 2013, EUR NEUROPSYCHOPHARM, V23, P1280, DOI 10.1016/j.euroneuro.2013.02.002; Cheong Kyu-Seok, 2012, J Prev Med Public Health, V45, P70, DOI 10.3961/jpmph.2012.45.2.70; Cho J, 2014, J AFFECT DISORDERS, V157, P45, DOI 10.1016/j.jad.2014.01.002; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Deisenhammer EA, 2003, ACTA PSYCHIAT SCAND, V108, P402, DOI 10.1046/j.0001-690X.2003.00209.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Dunn AJ, 1998, ANN NY ACAD SCI, V840, P577, DOI 10.1111/j.1749-6632.1998.tb09596.x; EASTWOOD MR, 1976, BRIT J PSYCHIAT, V129, P472, DOI 10.1192/bjp.129.5.472; FRIEDRICH MJ, 2014, JAMA J AM MED ASSOC, V311, P2372; GonzalezPina R, 1997, NEUROCHEM RES, V22, P63, DOI 10.1023/A:1027329405112; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Inoue K, 2012, J FORENSIC SCI, V57, P783, DOI 10.1111/j.1556-4029.2011.02051.x; Kim C, 2010, AM J PSYCHIAT, V167, P1100, DOI 10.1176/appi.ajp.2010.09050706; KOREN HS, 1989, AM REV RESPIR DIS, V139, P407, DOI 10.1164/ajrccm/139.2.407; Madrigano J, 2012, AM J EPIDEMIOL, V176, P224, DOI 10.1093/aje/kwr523; MALDONADO G, 1991, SUICIDE LIFE-THREAT, V21, P174; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; Odermatt A, 2008, BIOCHEM PHARMACOL, V76, P1184, DOI 10.1016/j.bcp.2008.07.019; OECD, 2013, SUIC 2013 2; PHILLIPS DP, 1974, AM SOCIOL REV, V39, P340, DOI 10.2307/2094294; Quan H, 2002, SOC PSYCH PSYCH EPID, V37, P190, DOI 10.1007/s001270200014; Szyszkowicz M, 2010, ENVIRON HEALTH INSIG, V4, P79, DOI 10.4137/EHI.S5662; Thomson EM, 2013, TOXICOL SCI, V135, P169, DOI 10.1093/toxsci/kft137; Tsai JF, 2012, J AFFECT DISORDERS, V136, P412, DOI 10.1016/j.jad.2011.11.010; Waern M, 2002, BMJ-BRIT MED J, V324, P1355, DOI 10.1136/bmj.324.7350.1355; WASSERMAN IM, 1984, AM SOCIOL REV, V49, P427, DOI 10.2307/2095285; WHO, 2006, AIR QUAL GUID GLOB U; Won HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061809; Yang AC, 2011, J AFFECT DISORDERS, V129, P275, DOI 10.1016/j.jad.2010.08.010	40	45	46	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117929	10.1371/journal.pone.0117929	http://dx.doi.org/10.1371/journal.pone.0117929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0WZ	25693115	Green Published, gold			2022-12-27	WOS:000350061500081
J	Lacerda, MB; Schultz, CL; Bertoni-Machado, C				Lacerda, Marcel B.; Schultz, Cesar L.; Bertoni-Machado, Cristina			First 'Rauisuchian' archosaur (Pseudosuchia, Loricata) for theMiddle Triassic Santacruzodon Assemblage Zone (SantaMaria Supersequence), Rio Grande do Sul State, Brazil	PLOS ONE			English	Article							SOUTHERN BRAZIL; DIAPSIDA; TRAVERSODONTIDS; EUCYNODONTIA; MADAGASCAR; CYNODONT; BASIN	The ` Rauisuchia' are a group of Triassic pseudosuchian archosaurs that displayed a near worldwide distribution. In Brazil, their fossils are found only in the Santa Maria Formation (Parana Basin) of the Rio Grande do Sul State, specifically in the Middle Triassic Dinodontosaurus assemblage zone (AZ) and the Late Triassic Hyperodapedon AZ (Rauisuchus tiradentes). Between these two cenozones is the Santacruzodon AZ (Middle Triassic), whose record was, until now, restricted to non-mammalian cynodonts and the proterochampsian Chanaresuchus bonapartei. Here we present the first occurrence of a rauisuchian archosaur for this cenozone, from the Schoenstatt outcrop, located near the city of Santa Cruz do Sul and propose a new species, based on biostratigraphical evidence and a comparative osteological analysis.	[Lacerda, Marcel B.; Schultz, Cesar L.] Univ Fed Rio Grande do Sul, Inst Geociencias, Lab Paleovertebrados, Porto Alegre, RS, Brazil; [Bertoni-Machado, Cristina] Fac Engn, Ctr Super Tecnol TECBrasil, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Lacerda, MB (corresponding author), Univ Fed Rio Grande do Sul, Inst Geociencias, Lab Paleovertebrados, Porto Alegre, RS, Brazil.	marcel.lacerda@yahoo.com.br	Bertoni-Machado, Cristina/C-4835-2013; Schultz, Cesar/I-4127-2013	Schultz, Cesar/0000-0001-7121-0409; Baeta Lacerda Santos, Marcel/0000-0002-1292-2059	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Brazilian government	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Brazilian government	The funding was made possible by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Brazilian government in the form of scholarships for two of the authors (MBL and CLS, specifically). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2003, ZOOL J LINN SOC-LOND, V139, P529, DOI 10.1111/j.1096-3642.2003.00096.x; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; BENTON MJ, 1986, PALAEONTOLOGY, V29, P293; Bertoni-Machado C. B., 2003, PALEONTOLOGIA DESTAQ, V18, P47, DOI DOI 10.1097/PHM.0000000000000020; Bertoni-Machado Cristina, 2006, REVISTA BRASILEIRA DE PALEONTOLOGIA, V9, P273; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Butler RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025693; Flynn JJ, 2000, J VERTEBR PALEONTOL, V20, P422, DOI 10.1671/0272-4634(2000)020[0422:NTSEFT]2.0.CO;2; Flynn JJ, 2010, PALAEONTOLOGY, V53, P669, DOI 10.1111/j.1475-4983.2010.00954.x; Franca MAG, 2011, NATURWISSENSCHAFTEN, V98, P389, DOI 10.1007/s00114-011-0782-3; Gauthier JA, 2011, B PEABODY MUS NAT HI, V52, P107, DOI 10.3374/014.052.0102; Gebauer EVI, 2004, NEUES JAHRB GEOL P-A, V231, P1; Gower DJ, 2009, J VERTEBR PALEONTOL, V29, P103, DOI 10.1080/02724634.2009.10010365; Gower David J., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V280, P1; Gower DJ, 2000, NEUES JAHRB GEOL P-A, V218, P447, DOI 10.1127/njgpa/218/2000/447; Horn BLD, 2014, J S AM EARTH SCI, V55, P123, DOI 10.1016/j.jsames.2014.07.007; Huene F. V, 1938, NEUES JB MINERALOGIE, V1938, P142; HUENE FV, 1942, FOSSILEN REPTILIEN S; Jalil NE, 2007, PALAEONTOLOGY, V50, P417, DOI 10.1111/j.1475-4983.2007.00640.x; KREBS B, 1976, HDB PALAOHERPETOL 13, P40; LAUTENSCHLAGER S, 2008, REVISION RAUISUCHUS; Lautenschlager S, 2011, PALAEONTOL Z, V85, P357, DOI 10.1007/s12542-011-0105-1; Mastrantonio B.M., 2010, DESCRICAO OSTEOLOGIC; Melo T. P., 2009, PALEO RS 2009 RESUMO, P16; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; Nesbitt SJ, 2003, P ROY SOC B-BIOL SCI, V270, pS234, DOI 10.1098/rsbl.2003.0066; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2013, GEOL SOC SPEC PUBL, V379, P241, DOI 10.1144/SP379.1; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Raugust T, 2013, GEOL SOC SPEC PUBL, V379, P303, DOI 10.1144/SP379.22; Sereno P. C., 1991, J VERTEBRATE PALE S3, V10, P1; SILL W D, 1974, Bulletin of the Museum of Comparative Zoology, V146, P317; Soares MB, 2011, AN ACAD BRAS CIENC, V83, P329, DOI 10.1590/S0001-37652011000100021; Sulej T, 2005, J VERTEBR PALEONTOL, V25, P78, DOI 10.1671/0272-4634(2005)025[0078:ANRRDA]2.0.CO;2; Trotteyn M. J., 2011, AMEGHINIANA, V48, P605, DOI DOI 10.5710/AMGH.V48I1(265); Weinbaum JC, 2010, PALEOBIOS, V30, P18; Weinbaum JC, 2013, GEOL SOC SPEC PUBL, V379, P525, DOI 10.1144/SP379.7; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4	38	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0118563	10.1371/journal.pone.0118563	http://dx.doi.org/10.1371/journal.pone.0118563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2IM	25714091	gold, Green Submitted, Green Published			2022-12-27	WOS:000350168700088
J	Dafna, E; Tarasiuk, A; Zigel, Y				Dafna, Eliran; Tarasiuk, Ariel; Zigel, Yaniv			Sleep-Wake Evaluation from Whole-Night Non-Contact Audio Recordings of Breathing Sounds	PLOS ONE			English	Article							WRIST ACTIGRAPHY; APNEA; VALIDATION; MOVEMENT; RESPIRATION; ADOLESCENTS; DIAGNOSIS; PATTERNS; DEVICE; ONSET	Study Objectives To develop and validate a novel non-contact system for whole-night sleep evaluation using breathing sounds analysis (BSA). Design Whole-night breathing sounds (using ambient microphone) and polysomnography (PSG) were simultaneously collected at a sleep laboratory (mean recording time 7.1 hours). A set of acoustic features quantifying breathing pattern were developed to distinguish between sleep and wake epochs (30 sec segments). Epochs (n = 59,108 design study and n = 68,560 validation study) were classified using AdaBoost classifier and validated epoch-by-epoch for sensitivity, specificity, positive and negative predictive values, accuracy, and Cohen's kappa. Sleep quality parameters were calculated based on the sleep/wake classifications and compared with PSG for validity. Setting University affiliated sleep-wake disorder center and biomedical signal processing laboratory. Patients One hundred and fifty patients (age 54.0 +/- 14.8 years, BMI 31.6 +/- 5.5 kg/m(2), m/f97/53) referred for PSG were prospectively and consecutively recruited. The system was trained (design study) on 80 subjects; validation study was blindly performed on the additional 70 subjects. Measurements and Results Epoch-by-epoch accuracy rate for the validation study was 83.3% with sensitivity of 92.2% (sleep as sleep), specificity of 56.6% (awake as awake), and Cohen's kappa of 0.508. Comparing sleep quality parameters of BSA and PSG demonstrate average error of sleep latency, total sleep time, wake after sleep onset, and sleep efficiency of 16.6 min, 35.8 min, and 29.6 min, and 8%, respectively. Conclusions This study provides evidence that sleep-wake activity and sleep quality parameters can be reliably estimated solely using breathing sound analysis. This study highlights the potential of this innovative approach to measure sleep in research and clinical circumstances.	[Dafna, Eliran; Zigel, Yaniv] Ben Gurion Univ Negev, Fac Engn, Dept Biomed Engn, IL-84105 Beer Sheva, Israel; [Tarasiuk, Ariel] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Sleep Wake Disorders Unit, IL-84105 Beer Sheva, Israel; [Tarasiuk, Ariel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Zigel, Y (corresponding author), Ben Gurion Univ Negev, Fac Engn, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.	yaniv@bgu.ac.il		Zigel, Yaniv/0000-0002-1994-4242	Israel Ministry of Economics - the Kamin Program [46168]	Israel Ministry of Economics - the Kamin Program	This work was supported by the Israel Ministry of Economics - the Kamin Program, award no. 46168 to YZ and AT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Akhter S, 2013, IEEE ENG MED BIO, P1318, DOI 10.1109/EMBC.2013.6609751; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Appelboom G, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-28; Ben-Israel N, 2012, SLEEP, V35, P1299, DOI 10.5665/sleep.2092; Berthomier C, 2007, SLEEP, V30, P1587, DOI 10.1093/sleep/30.11.1587; Blackwell T, 2008, SLEEP, V31, P283, DOI 10.1093/sleep/31.2.283; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chesson Jr A. L., 2007, THE AASM MANUAL FOR; Choi JH, 2010, ACTA OTO-LARYNGOL, V130, P838, DOI 10.3109/00016480903431139; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Colrain IM, 1989, VENTILATION DURING S; COOTE JH, 1982, J EXP BIOL, V100, P223; COOTE JH, 1993, EUR J APPL PHYSIOL O, V66, P249, DOI 10.1007/BF00235102; Dafna E, 2012, 34TH ANNUAL INTERNAT; Dafna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084139; de Chazal P, 2011, J SLEEP RES, V20, P356, DOI 10.1111/j.1365-2869.2010.00876.x; DOUGLAS NJ, 1982, THORAX, V37, P840, DOI 10.1136/thx.37.11.840; Edwards BA, 2011, HEAD NECK-J SCI SPEC, V33, pS37, DOI 10.1002/hed.21841; Elliott R.J., 1995, HIDDEN MARKOV MODELS; Fogel RB, 2005, J PHYSIOL-LONDON, V564, P549, DOI 10.1113/jphysiol.2005.083659; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Goldshtein E, 2011, IEEE T BIO-MED ENG, V58, P1373, DOI 10.1109/TBME.2010.2100096; Hasan MK, 2004, IEEE SIGNAL PROC LET, V11, P450, DOI 10.1109/LSP.2004.824017; Hedner J, 2004, SLEEP, V27, P1560, DOI 10.1093/sleep/27.8.1560; HOFFSTEIN V, 1994, SLEEP, V17, P522, DOI 10.1093/sleep/17.6.522; Hwang S, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-26; Johnson NL, 2007, SLEEP, V30, P899, DOI 10.1093/sleep/30.7.899; Kantelhardt JW, 2003, PHYSICA A, V319, P447, DOI 10.1016/S0378-4371(02)01502-9; Kim JW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178104; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liao WH, 2008, INT C PATT RECOG, P1774; Lichstein KL, 2006, SLEEP, V29, P232; Lotjonen J, 2003, SLEEP, V26, P86; Malik V, 2012, SLEEP MED CLIN, V7, P497, DOI 10.1016/j.jsmc.2012.06.011; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; Montgomery-Downs HE, 2012, SLEEP BREATH, V16, P913, DOI 10.1007/s11325-011-0585-y; PHILLIPSON EA, 1978, ANNU REV PHYSIOL, V40, P133, DOI 10.1146/annurev.ph.40.030178.001025; Reuveni H, 2004, SLEEP, V27, P1518, DOI 10.1093/sleep/27.8.1518; Robinson PA, 2011, PHILOS T R SOC A, V369, P3840, DOI 10.1098/rsta.2011.0120; Rostig S, 2005, SLEEP, V28, P411, DOI 10.1093/sleep/28.4.411; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; Scalart P, 1996, INT CONF ACOUST SPEE, P629, DOI 10.1109/ICASSP.1996.543199; Scatena M, 2012, CLIN NEUROPHYSIOL, V123, P318, DOI 10.1016/j.clinph.2011.07.026; Smith L, 2012, J APPL PHYSIOL, V113, P691, DOI [10.1152/japplphysiol.00091.2012, DOI 10.1152/JAPPLPHYSIOL.00091.2012]; Sommermeyer D, 2010, IFMBE PROC, V25, P1271; Tilmanne J, 2009, J SLEEP RES, V18, P85, DOI 10.1111/j.1365-2869.2008.00706.x; TRINDER J, 1992, J APPL PHYSIOL, V73, P2462, DOI 10.1152/jappl.1992.73.6.2462; Trinder J, 1997, J APPL PHYSIOL, V83, P1986, DOI 10.1152/jappl.1997.83.6.1986; Vashist SK, 2014, DIAGNOSTICS, V4, P104, DOI 10.3390/diagnostics4030104; Wilkinson V, 2008, SLEEP, V31, P525, DOI 10.1093/sleep/31.4.525; Worsnop C, 2000, J APPL PHYSIOL, V88, P1831, DOI 10.1152/jappl.2000.88.5.1831	52	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117382	10.1371/journal.pone.0117382	http://dx.doi.org/10.1371/journal.pone.0117382			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710495	Green Published, gold			2022-12-27	WOS:000350683900030
J	Morris, EJA; Penegar, S; Whiffin, N; Broderick, P; Bishop, DT; Northwood, E; Quirke, P; Finan, P; Houlston, RS				Morris, Eva J. A.; Penegar, Steve; Whiffin, Nicola; Broderick, Peter; Bishop, D. Timothy; Northwood, Emma; Quirke, Philip; Finan, Paul; Houlston, Richard S.			A Retrospective Observational Study of the Relationship between Single Nucleotide Polymorphisms Associated with the Risk of Developing Colorectal Cancer and Survival	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; FAMILY-HISTORY; COLON-CANCER; DIAGNOSIS; PROGNOSIS; SMAD7; METAANALYSIS; OUTCOMES	Background There is variability in clinical outcome for patients with apparently the same stage colorectal cancer (CRC). Single nucleotide polymorphisms (SNPs) mapping to chromosomes 1q41, 3q26.2, 6p21, 8q23.3, 8q24.21, 10p14, 11q13, 11q23.1, 12q13.13, 14q22, 14q22.2, 15q13.3, 16q22.1, 18q21.1, 19q13.11, 20p12, 20p12.3, 20q13.33 and Xp22 have robustly been shown to be associated with the risk of developing CRC. Since germline variation can also influence patient outcome the relationship between these SNPs and patient survivorship from CRC was examined. Methods All enrolled into the National Study of Colorectal Cancer Genetics (NSCCG) were genotyped for 1q41, 3q26.2, 6p21, 8q23.3, 8q24.21, 10p14, 11q13, 11q23.1, 12q13.13, 14q22, 14q22.2, 15q13.3, 16q22.1, 18q21.1, 19q13.11, 20p12, 20p12.3, 20q13.33 and xp22 SNPs. Linking this information to the National Cancer Data Repository allowed patient genotype to be related to survival. Results The linked dataset consisted of 4,327 individuals. 14q22.22 genotype defined by the SNP rs4444235 showed a significant association with overall survival. Specifically, the C allele was associated with poorer observed survival (per allele hazard ratio 1.13, 95% confidence interval 1.05-1.22, P = 0.0015). Conclusion The CRC susceptibility SNP rs4444235 also appears to exert an influence in modulating patient survival and warrants further evaluation as a potential prognostic marker.	[Morris, Eva J. A.; Bishop, D. Timothy; Northwood, Emma] Univ Leeds, Leeds Inst Canc & Pathol, Sect Epidemiol & Biostat, Leeds LS9 7TF, W Yorkshire, England; [Penegar, Steve; Whiffin, Nicola; Broderick, Peter; Houlston, Richard S.] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Quirke, Philip] St James Univ Hosp, Leeds Inst Canc & Pathol, Pathol & Tumour Biol, Leeds LS9 7TF, W Yorkshire, England; [Finan, Paul] St James Univ Hosp, Leeds Teaching Hosp, John Goligher Colorectal Unit, Leeds LS9 7TF, W Yorkshire, England; [Finan, Paul] Natl Canc Intelligence Network, London SW1E 5RS, England	University of Leeds; University of London; Institute of Cancer Research - UK; Saint James's University Hospital; Saint James's University Hospital; University of Leeds	Morris, EJA (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Sect Epidemiol & Biostat, Leeds LS9 7TF, W Yorkshire, England.	e.morris@leeds.ac.uk	Quirke, Philip/AAI-1362-2019; W, Nicola/AAG-3227-2020	W, Nicola/0000-0003-1554-6594; Quirke, Philip/0000-0002-3597-5444; Bishop, Tim/0000-0002-8752-8785; Penegar, Steven/0000-0002-3768-0236; Houlston, Richard/0000-0002-5268-0242	Cancer Research UK Bobby Moore Fund [C23434/A9805, C1298/A8362]; Leeds MRC Medical Bioinformatics Centre [MR/L01629X/1]; Yorkshire Cancer Research [L354PA]; Cancer Research UK [C588/A10589]; CORE; European Union Framework 6; Cancer Research UK [9805, 10589, 19167, 15116] Funding Source: researchfish; Medical Research Council [MR/L01629X/1] Funding Source: researchfish; MRC [MR/L01629X/1] Funding Source: UKRI	Cancer Research UK Bobby Moore Fund; Leeds MRC Medical Bioinformatics Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Yorkshire Cancer Research; Cancer Research UK(Cancer Research UK); CORE(Luxembourg National Research Fund); European Union Framework 6(European Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	EJAM was funded by the Cancer Research UK Bobby Moore Fund (C23434/A9805) and the Leeds MRC Medical Bioinformatics Centre (MR/L01629X/1). PQ was funded by Yorkshire Cancer Research (L354PA). ELN and DTB were funded by Cancer Research UK (C588/A10589). The NSCCG has been supported by grants from Cancer Research UK Bobby Moore Fund (C1298/A8362), CORE, and the European Union Framework 6 awarded to RSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuli A, 2013, CARCINOGENESIS, V34, P2286, DOI 10.1093/carcin/bgt179; Bass AJ, 2008, CANCER, V112, P1222, DOI 10.1002/cncr.23294; Birgisson H, 2009, FAM CANCER, V8, P555, DOI 10.1007/s10689-009-9286-0; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Chan JA, 2008, JAMA-J AM MED ASSOC, V299, P2515, DOI 10.1001/jama.299.21.2515; Cicek MS, 2009, CANCER EPIDEM BIOMAR, V18, P2492, DOI 10.1158/1055-9965.EPI-09-0362; Dai JY, 2012, CARCINOGENESIS, V33, P1327, DOI 10.1093/carcin/bgs147; Dotor E, 2006, J CLIN ONCOL, V24, P1603, DOI 10.1200/JCO.2005.03.5253; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Garcia-Albeniz X, 2013, CARCINOGENESIS, V34, P292, DOI 10.1093/carcin/bgs335; Hoskins JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041954; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Kallioniemi A, 2012, CANCER GENET-NY, V205, P267, DOI 10.1016/j.cancergen.2012.05.009; Kim JG, 2008, CLIN CANCER RES, V14, P62, DOI 10.1158/1078-0432.CCR-07-1537; Lindstrom LS, 2007, LANCET ONCOL, V8, P1001, DOI 10.1016/S1470-2045(07)70282-6; Lubbe SJ, 2012, ONCOGENE, V31, P3777, DOI 10.1038/onc.2011.564; Marcuello E, 2004, INT J CANCER, V112, P733, DOI 10.1002/ijc.20487; Morris EJA, 2013, BRIT J CANCER, V108, P1502, DOI 10.1038/bjc.2013.91; Morris EJA, 2010, BRIT J SURG, V97, P1110, DOI 10.1002/bjs.7032; National Cancer Intelligence Network, 2014, COL CANC SURV STAG; National Cancer Intelligence Network, 2011, NAT CANC DAT REP; Passarelli MN, 2011, GENE CHROMOSOME CANC, V50, P875, DOI 10.1002/gcc.20913; Penegar S, 2007, BRIT J CANCER, V97, P1305, DOI 10.1038/sj.bjc.6603997; Phipps AI, 2012, GASTROENTEROLOGY, V143, P51, DOI 10.1053/j.gastro.2012.04.052; Slattery ML, 2012, INT J CANCER, V130, P653, DOI 10.1002/ijc.26047; Tenesa A, 2010, CLIN CANCER RES, V16, P3754, DOI 10.1158/1078-0432.CCR-10-0439; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Xing JL, 2011, EUR J CANCER, V47, P1699, DOI 10.1016/j.ejca.2011.02.004; Zell JA, 2008, CANCER EPIDEM BIOMAR, V17, P3134, DOI 10.1158/1055-9965.EPI-08-0587	31	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117816	10.1371/journal.pone.0117816	http://dx.doi.org/10.1371/journal.pone.0117816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710502	Green Accepted, gold, Green Published			2022-12-27	WOS:000350683900038
J	Weissmiller, AM; Natera-Naranjo, O; Reyna, SM; Pearn, ML; Zhao, XB; Nguyen, P; Cheng, S; Goldstein, LSB; Tanzi, RE; Wagner, SL; Mobley, WC; Wu, CB				Weissmiller, April M.; Natera-Naranjo, Orlangie; Reyna, Sol M.; Pearn, Matthew L.; Zhao, Xiaobei; Phuong Nguyen; Cheng, Soan; Goldstein, Lawrence S. B.; Tanzi, Rudolph E.; Wagner, Steven L.; Mobley, William C.; Wu, Chengbiao			A gamma-Secretase Inhibitor, but Not a gamma-Secretase Modulator, Induced Defects in BDNF Axonal Trafficking and Signaling: Evidence for a Role for APP	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CARBOXYL-TERMINAL FRAGMENT; ALZHEIMER-DISEASE; A-BETA; MOUSE MODEL; IN-VIVO; NEUROTROPHIC FACTORS; MEMORY DEFICITS; DOWN-SYNDROME; TRANSPORT	Clues to Alzheimer disease (AD) pathogenesis come from a variety of different sources including studies of clinical and neuropathological features, biomarkers, genomics and animal and cellular models. An important role for amyloid precursor protein (APP) and its processing has emerged and considerable interest has been directed at the hypothesis that A beta peptides induce changes central to pathogenesis. Accordingly, molecules that reduce the levels of A beta peptides have been discovered such as.-secretase inhibitors (GSIs) and modulators (GSMs). GSIs and GSMs reduce A beta levels through very different mechanisms. However, GSIs, but not GSMs, markedly increase the levels of APP CTFs that are increasingly viewed as disrupting neuronal function. Here, we evaluated the effects of GSIs and GSMs on a number of neuronal phenotypes possibly relevant to their use in treatment of AD. We report that GSI disrupted retrograde axonal trafficking of brain-derived neurotrophic factor (BDNF), suppressed BDNF-induced downstream signaling pathways and induced changes in the distribution within neuronal processes of mitochondria and synaptic vesicles. In contrast, treatment with a novel class of GSMs had no significant effect on these measures. Since knockdown of APP by specific siRNA prevented GSI-induced changes in BDNF axonal trafficking and signaling, we concluded that GSI effects on APP processing were responsible, at least in part, for BDNF trafficking and signaling deficits. Our findings argue that with respect to anti-amyloid treatments, even an APP-specific GSI may have deleterious effects and GSMs may serve as a better alternative.	[Weissmiller, April M.; Natera-Naranjo, Orlangie; Zhao, Xiaobei; Phuong Nguyen; Cheng, Soan; Wagner, Steven L.; Mobley, William C.; Wu, Chengbiao] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Reyna, Sol M.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA; [Pearn, Matthew L.] Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92103 USA; [Pearn, Matthew L.] VA San Diego Healthcare Syst, San Diego, CA USA; [Tanzi, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Harvard University; Massachusetts General Hospital	Mobley, WC (corresponding author), Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA.	wmobley@ucsd.edu; chw049@ucsd.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Weissmiller, April/0000-0003-4505-0530	NIH [PN2 EY016525]; Down Syndrome Research and Treatment Foundation; Larry L. Hillblom Foundation; Thrasher Research Fund; Cure Alzheimer's Fund; ADRC Pilot Grant; NIH Neuroplasticity of Aging Predoctoral training grant; SfN Neuroscience Scholars Program; Genetics Training grant; Cellular and Molecular Medicine Electron Microscopy Facility of UCSD; UCSD Neuroscience Microscopy Shared Facility [P30 NS047101];  [NIH-AG032180]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009, R37MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045860, P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011337, P50AG005131, RF1AG048080, P01AG004953, R01AG032180, R13AG026970, P50AG005134, RF1AG048083, P01AG015379, R01AG014713] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Down Syndrome Research and Treatment Foundation; Larry L. Hillblom Foundation; Thrasher Research Fund; Cure Alzheimer's Fund; ADRC Pilot Grant; NIH Neuroplasticity of Aging Predoctoral training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SfN Neuroscience Scholars Program; Genetics Training grant; Cellular and Molecular Medicine Electron Microscopy Facility of UCSD; UCSD Neuroscience Microscopy Shared Facility; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH (PN2 EY016525) and the Down Syndrome Research and Treatment Foundation (AMW, CW, WCM), the Larry L. Hillblom Foundation (CW, WCM), the Thrasher Research Fund (WCM), the Cure Alzheimer's Fund (SLW, WCM), the ADRC Pilot Grant (CW) and NIH-AG032180 grant to LSBG. The authors thank the NIH Neuroplasticity of Aging Predoctoral training grant (AMW, ONN), SfN Neuroscience Scholars Program (AMW), and Genetics Training grant (SMR). The authors thank Dr M. Farquhar, Y. Jones and T. Meerloo and the Cellular and Molecular Medicine Electron Microscopy Facility of UCSD for performing embedding and sectioning of coverslips and the UCSD Neuroscience Microscopy Shared Facility (Grant P30 NS047101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JJ, 2005, BIOCHEM PHARMACOL, V69, P689, DOI 10.1016/j.bcp.2004.11.015; Bittner T, 2009, J NEUROSCI, V29, P10405, DOI 10.1523/JNEUROSCI.2288-09.2009; Borgegard T, 2012, J BIOL CHEM; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Chao MV, 2010, DEV NEUROBIOL, V70, P269, DOI 10.1002/dneu.20779; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Choi S.H., 2014, NATURE; Choi SH, 2001, FASEB J, V15, P1816, DOI 10.1096/fj.00-0859fje; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; Coric V., 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI [10.1001/archneurol.2012.2194, DOI 10.1001/ARCHNEUROL.2012.2194]; Crump CJ, 2013, BIOCHEMISTRY-US, V52, P3197, DOI 10.1021/bi400377p; Crump CJ, 2012, BIOCHEMISTRY-US, V51, P7209, DOI 10.1021/bi301137h; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; FUKUCHI K, 1992, BIOCHEM BIOPH RES CO, V182, P165, DOI 10.1016/S0006-291X(05)80126-3; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Grosveld GC, 2009, NAT MED, V15, P20, DOI 10.1038/nm0109-20; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Holtzman D.M., 2012, COLD SPRING HARB PER, V2; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; KAMMESHEIDT A, 1992, P NATL ACAD SCI USA, V89, P10857, DOI 10.1073/pnas.89.22.10857; Kokubo H, 2009, INT J ALZHEIMERS DIS; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Liu Q, 2014, JAMA NEUROL; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Martone RL, 2009, J PHARMACOL EXP THER, V331, P598, DOI 10.1124/jpet.109.152975; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Nagahara AH, 2013, J NEUROSCI, V33, P15596, DOI 10.1523/JNEUROSCI.5195-12.2013; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; NEVE RL, 1992, P NATL ACAD SCI USA, V89, P3448, DOI 10.1073/pnas.89.8.3448; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pensalfini A, 2014, NEUROBIOL DIS, V71, P53, DOI 10.1016/j.nbd.2014.07.011; Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Rodrigues EM, 2012, HUM MOL GENET, V21, P4587, DOI 10.1093/hmg/dds297; Rogers K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-61; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Sarsoza F, 2009, ACTA NEUROPATHOL, V118, P505, DOI 10.1007/s00401-009-0530-3; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011460; Selkoe DJ, 2000, JAMA-J AM MED ASSOC, V283, P1615, DOI 10.1001/jama.283.12.1615; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Selkoe DJ, 2005, ARCH NEUROL-CHICAGO, V62, P192, DOI 10.1001/archneur.62.2.192; SELKOE DJ, 1980, ANN NEUROL, V8, P468, DOI 10.1002/ana.410080504; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Soreghan B, 2002, NEUROMOL MED, V1, P81; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Suh YH, 1997, J NEUROCHEM, V68, P1781; Sung KJ, 2011, J NEUROSCI METH, V200, P121, DOI 10.1016/j.jneumeth.2011.06.020; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Wagner SL, 2014, BIOCHEMISTRY-US, V53, P702, DOI 10.1021/bi401537v; Wagner SL, 2012, ARCH NEUROL-CHICAGO, V69, P1255, DOI 10.1001/archneurol.2012.540; Walter J, 1997, P NATL ACAD SCI USA, V94, P5349, DOI 10.1073/pnas.94.10.5349; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weissmiller AM, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-14; Wolfe MS, 2012, J NEUROCHEM, V120, P89, DOI 10.1111/j.1471-4159.2011.07501.x; Xia WM, 2012, J ALZHEIMERS DIS, V31, P685, DOI 10.3233/JAD-2012-120751; Xie WJ, 2012, INTEGR BIOL-UK, V4, P953, DOI 10.1039/c2ib20062g; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YOSHIKAWA K, 1992, NATURE, V359, P64, DOI 10.1038/359064a0; Zhang K, 2013, J NEUROSCI, V33, P7451, DOI 10.1523/JNEUROSCI.4322-12.2013; Zhang YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080571; Zhao XB, 2014, JOVE-J VIS EXP, DOI 10.3791/51899; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	102	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118379	10.1371/journal.pone.0118379	http://dx.doi.org/10.1371/journal.pone.0118379			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710492	gold, Green Published, Green Submitted			2022-12-27	WOS:000350683900054
J	Fujimura, K; Niidome, T; Shinozuka, Y; Izumi, Y; Kihara, T; Sugimoto, H; Akaike, A; Kume, T				Fujimura, Kazuhiko; Niidome, Tetsuhiro; Shinozuka, Yoriko; Izumi, Yasuhiko; Kihara, Takeshi; Sugimoto, Hachiro; Akaike, Akinori; Kume, Toshiaki			Integrin-Associated Protein Promotes Neuronal Differentiation of Neural Stem/Progenitor Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; CORTICAL NEUROGENESIS; GENERATION; ACTIVATION; EXPRESSION; CD47	Neural stem/progenitor cells (NSPCs) proliferate and differentiate depending on their intrinsic properties and local environment. During the development of the mammalian nervous system, NSPCs generate neurons and glia sequentially. However, little is known about the mechanism that determines the timing of switch from neurogenesis to gliogenesis. In this study, we established a culture system in which the neurogenic potential of NSPCs is decreased in a time-dependent manner, so that short-term-cultured NSPCs differentiate into more neurons compared with long-term-cultured NSPCs. We found that short-term-cultured NSPCs express high levels of integrin-associated protein form 2 (IAP2; so-called CD47) mRNA using differential display analysis. Moreover, IAP2 overexpression in NSPCs induced neuronal differentiation of NSPCs. These findings reveal a novel mechanism by which IAP2 induces neuronal differentiation of NSPCs.	[Fujimura, Kazuhiko; Izumi, Yasuhiko; Akaike, Akinori; Kume, Toshiaki] Kyoto Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Niidome, Tetsuhiro; Shinozuka, Yoriko; Kihara, Takeshi] Kyoto Univ, Dept Neurosci Drug Discovery, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Sugimoto, Hachiro] Kyoto Univ, Grad Sch Pharmaceut Sci, World Leading Drug Discovery Res Ctr, Kyoto, Japan; [Akaike, Akinori] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan	Kyoto University; Kyoto University; Kyoto University; Nagoya University	Kume, T (corresponding author), Kyoto Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Kyoto, Japan.	tkume@pharm.kyoto-u.ac.jp			Grants-in-Aid for Scientific Research [24390139, 25670036] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Huang AM, 1998, J NEUROSCI, V18, P4305; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; REINHOLD MI, 1995, J CELL SCI, V108, P3419; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Takada T, 1998, J BIOL CHEM, V273, P9234, DOI 10.1074/jbc.273.15.9234; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174	21	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116741	10.1371/journal.pone.0116741	http://dx.doi.org/10.1371/journal.pone.0116741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706387	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100048
J	Jin, QL; Vogt, S; Lai, B; Chen, S; Finney, L; Gleber, SC; Ward, J; Deng, JJ; Mak, R; Moonier, N; Jacobsen, C				Jin, Qiaoling; Vogt, Stefan; Lai, Barry; Chen, Si; Finney, Lydia; Gleber, Sophie-Charlotte; Ward, Jesse; Deng, Junjing; Mak, Rachel; Moonier, Nena; Jacobsen, Chris			Ultraviolet Germicidal Irradiation and Its Effects on Elemental Distributions in Mouse Embryonic Fibroblast Cells in X-Ray Fluorescence Microanalysis	PLOS ONE			English	Article							CRYOELECTRON TOMOGRAPHY; ETHANOLAMINE PHOSPHATIDES; TISSUE-PREPARATION; LIQUID-NITROGEN; STERILIZATION; MICROSCOPY; INACTIVATION; PRESERVATION; RESOLUTION; CHOLINE	Rapidly-frozen hydrated (cryopreserved) specimens combined with cryo-scanning x-ray fluorescence microscopy provide an ideal approach for investigating elemental distributions in biological cells and tissues. However, because cryopreservation does not deactivate potentially infectious agents associated with Risk Group 2 biological materials, one must be concerned with contamination of expensive and complicated cryogenic x-ray microscopes when working with such materials. We employed ultraviolet germicidal irradiation to decontaminate previously cryopreserved cells under liquid nitrogen, and then investigated its effects on elemental distributions under both frozen hydrated and freeze dried states with xray fluorescence microscopy. We show that the contents and distributions of most biologically important elements remain nearly unchanged when compared with non-ultravioletirradiated counterparts, even after multiple cycles of ultraviolet germicidal irradiation and cryogenic x-ray imaging. This provides a potential pathway for rendering Risk Group 2 biological materials safe for handling in multiuser cryogenic x-ray microscopes without affecting the fidelity of the results.				cjacobsen@anl.gov	Deng, Junjing/GPC-6400-2022; Jacobsen, Chris Johnson/E-2827-2015; Vogt, Stefan/B-9547-2009; Vogt, Stefan/J-7937-2013; Deng, Junjing/H-3160-2017	Jacobsen, Chris Johnson/0000-0001-8562-0353; Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513; Deng, Junjing/0000-0003-4472-3385; August, Sophie-Charlotte/0000-0002-6941-9331	National Institute for General Medical Sciences, National Institutes for Health [R01 GM104530]; Office of Science, US Department of Energy [DE-AC0206CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104530] Funding Source: NIH RePORTER	National Institute for General Medical Sciences, National Institutes for Health; Office of Science, US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the National Institute for General Medical Sciences, National Institutes for Health (http://nigms.nih.gov), for support under grant R01 GM104530 (QJ, RM, JD, CJ). The authors thank the Office of Science, US Department of Energy(http://science.energy.gov), for support of the Advanced Photon Source under contract DE-AC0206CH11357 (SV, BL, SC, LF, SG, JW, JD, RM, NM, RF, CJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beetz T, 2003, J SYNCHROTRON RADIAT, V10, P280, DOI 10.1107/S0909049503003261; Blatchley III E.R., 2001, DISINFECTION STERILI, P823; Bohic S, 2012, J STRUCT BIOL, V177, P248, DOI 10.1016/j.jsb.2011.12.006; Botzenhart K, 1976, Prakt Anaesth, V11, P320; Carzaniga R, 2014, PROTOPLASMA, V251, P449, DOI 10.1007/s00709-013-0583-y; Chen S, 2014, J SYNCHROTRON RADIAT, V21, P66, DOI 10.1107/S1600577513029676; COETZEE J, 1989, J ELECTRON MICR TECH, V11, P155, DOI 10.1002/jemt.1060110210; COPE G. H., 1968, J ROY MICROSCOP SOC, V88, P259; Cope GH, 1969, J MICROSC-OXFORD, V90, P47, DOI 10.1111/j.1365-2818.1969.tb00693.x; Cope GH, 1969, J MICROSC-OXFORD, V90, P31, DOI 10.1111/j.1365-2818.1969.tb00692.x; de Jonge MD, 2010, CURR OPIN STRUC BIOL, V20, P606, DOI 10.1016/j.sbi.2010.09.002; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Echlin P., 1992, LOW TEMPERATURE MICR; Fahrni CJ, 2007, CURR OPIN CHEM BIOL, V11, P121, DOI 10.1016/j.cbpa.2007.02.039; Fittschen UEA, 2011, SPECTROCHIM ACTA B, V66, P567, DOI 10.1016/j.sab.2011.06.006; FREUDENRICH CC, 1994, J STRUCT BIOL, V112, P173; HOROWITZ P, 1972, SCIENCE, V178, P608, DOI 10.1126/science.178.4061.608; Jin QL, 2010, STEM CELLS DEV, V19, P1241, DOI 10.1089/scd.2009.0324; JONES KW, 1988, ULTRAMICROSCOPY, V24, P313, DOI 10.1016/0304-3991(88)90318-X; KELLENBERGER E, 1992, J MICROSC-OXFORD, V168, P181, DOI 10.1111/j.1365-2818.1992.tb03260.x; Ko G, 2002, ENVIRON HEALTH PERSP, V110, P95, DOI 10.1289/ehp.0211095; Koch-Paiz CA, 2004, MUTAT RES-FUND MOL M, V549, P65, DOI 10.1016/j.mrfmmm.2004.01.010; Lucic V, 2013, J CELL BIOL, V202, P407, DOI 10.1083/jcb.201304193; Mader A, 2010, METHOD ENZYMOL, V483, P245, DOI 10.1016/S0076-6879(10)83012-5; Majumdar S, 2012, ANAL CHIM ACTA, V755, P1, DOI 10.1016/j.aca.2012.09.050; MARTIN LS, 1985, J INFECT DIS, V152, P400, DOI 10.1093/infdis/152.2.400; MARTIN LS, 1987, APPL ENVIRON MICROB, V53, P708, DOI 10.1128/AEM.53.4.708-709.1987; Maser J, 2000, J MICROSC-OXFORD, V197, P68, DOI 10.1046/j.1365-2818.2000.00630.x; Matsuyama S, 2010, X-RAY SPECTROM, V39, P260, DOI 10.1002/xrs.1256; Meyer-Ilse W, 2001, J MICROSC-OXFORD, V201, P395, DOI 10.1046/j.1365-2818.2001.00845.x; Myatt TA, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-5; Nicas M, 1999, Appl Occup Environ Hyg, V14, P317; OTOOLE E, 1993, J STRUCT BIOL, V110, P55, DOI 10.1006/jsbi.1993.1004; Parmegiani L, 2010, FERTIL STERIL, V94, P1525, DOI 10.1016/j.fertnstert.2009.05.089; Parmegiani L, 2009, HUM REPROD, V24, P2969, DOI 10.1093/humrep/dep329; Paunesku T, 2006, J CELL BIOCHEM, V99, P1489, DOI 10.1002/jcb.21047; QUALLS RG, 1983, APPL ENVIRON MICROB, V45, P872, DOI 10.1128/AEM.45.3.872-877.1983; RILEY RL, 1976, AM REV RESPIR DIS, V113, P413; Rudnick SN, 2001, AIHAJ, V62, P434, DOI 10.1080/15298660108984645; Russell AD, 1982, THE DESTRUCTION OF B; Sambol AR, 2006, APPL BIOSAF, V11, P81; SAUBERMANN AJ, 1975, J MICROSC-OXFORD, V105, P155, DOI 10.1111/j.1365-2818.1975.tb04048.x; SAUBERMANN AJ, 1987, J MICROSC-OXFORD, V146, P169, DOI 10.1111/j.1365-2818.1987.tb01338.x; Schneider G, 1998, ULTRAMICROSCOPY, V75, P85, DOI 10.1016/S0304-3991(98)00054-0; Schwebach JR, 2001, J CLIN MICROBIOL, V39, P769, DOI 10.1128/JCM.39.2.769-771.2001; Sparks C. J.  Jr., 1980, Synchrotron radiation research, P459; Steinbrecht R, 1987, CRYOTECHNIQUES IN BI; Szczerbowska-Boruchowska M, 2008, X-RAY SPECTROM, V37, P21, DOI 10.1002/xrs.1007; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; Turnbull PC, 2008, APPLIED BIOSAFETY, V13, P164; Twining BS, 2003, ANAL CHEM, V75, P3806, DOI 10.1021/ac034227z; Vanhecke D, 2011, J MICROSC-OXFORD, V242, P221, DOI 10.1111/j.1365-2818.2010.03478.x; Varnam AH, 1996, FOODBORNE PATHOGENS; Vesley D, 2000, BIOLOGICAL SAFETY PR; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; ZIEROLD K, 1982, J MICROSC-OXFORD, V125, P149, DOI 10.1111/j.1365-2818.1982.tb00332.x	56	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117437	10.1371/journal.pone.0117437	http://dx.doi.org/10.1371/journal.pone.0117437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706293	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100087
J	Joshi, M; Rice, SJ; Liu, X; Miller, B; Belani, CP				Joshi, Monika; Rice, Shawn J.; Liu, Xin; Miller, Bruce; Belani, Chandra P.			Trametinib with or without Vemurafenib in BRAF Mutated Non-Small Cell Lung Cancer	PLOS ONE			English	Article							MEK INHIBITION; RESISTANCE; MUTATIONS; MELANOMA; PATHWAY; MCL-1; ACTIVATION; PACLITAXEL; DEPENDENCE; GEFITINIB	V-Raf Murine Sarcoma Viral Oncogene Homolog B (BRAF) mutated lung cancer is relatively aggressive and is resistant to currently available therapies. In a recent phase II study for patients with BRAF-V600E non-small cell lung cancer (NSCLC), BRAF V600E inhibitor demonstrated evidence of activity, but 30% of this selected group progressed while on treatment, suggesting a need for developing alternative strategies. We tested two different options to enhance the efficacy of vemurafenib (BRAF V600E inhibitor) in BRAF mutated NSCLC. The first option was the addition of erlotinib to vemurafenib to see whether the combination provided synergy. The second was to induce MEK inhibition (downstream of RAF) with trametinib (MEK inhibitor). We found that the combination of vemurafenib and erlotinib was not synergistic to the inhibition of p-ERK signaling in BRAF-V600E cells. Vemurafenib caused significant apoptosis, G1 arrest and upregulation of BIM in BRAF-V600 cells. Trametinib was effective as a single agent in BRAF mutated cells, either V600E or non-V600E. Finally, the combination of vemurafenib and trametinib caused a small but significant increase in apoptosis as well as a significant upregulation of BIM when compared to either single agent. Thus, hinting at the possibility of utilizing a combinational approach for the management of this group of patients. Importantly, trametinib alone caused upregulation of p-AKT in BRAF non-V600 mutated cells, while this effect was nullified with the combination. This finding suggests that, the combination of a MEK inhibitor with a BRAF inhibitor will be more efficacious in the clinical setting for patients with BRAF mutated NSCLC.	[Joshi, Monika; Rice, Shawn J.; Liu, Xin; Miller, Bruce; Belani, Chandra P.] Penn State Hershey Canc Inst, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Belani, CP (corresponding author), Penn State Hershey Canc Inst, Hershey, PA 17033 USA.	cbelani@psu.edu	Joshi, Monika/N-8286-2019	Joshi, Monika/0000-0003-4286-8492				Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Foster JS, 2003, J BIOL CHEM, V278, P41355, DOI 10.1074/jbc.M302830200; Haferkamp S, 2013, J INVEST DERMATOL, V133, P1601, DOI 10.1038/jid.2013.6; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Li R, 2005, CELL DEATH DIFFER, V12, P292, DOI 10.1038/sj.cdd.4401554; Lin LP, 2014, P NATL ACAD SCI USA, V111, pE748, DOI 10.1073/pnas.1320956111; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Memmott RM, 2010, CLIN CANCER RES, V16, P4, DOI 10.1158/1078-0432.CCR-09-0234; Meng JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013026; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moulding DA, 2000, BLOOD, V96, P1756, DOI 10.1182/blood.V96.5.1756.h8001756_1756_1763; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Naoki K, 2002, CANCER RES, V62, P7001; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Planchard D, 2013, ASCO M, V31, P8009; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sarris EG, 2012, PHARMACEUTICALS-BASE, V5, P1236, DOI 10.3390/ph5111236; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Troiani T, 2012, BRIT J CANCER, V106, P1648, DOI 10.1038/bjc.2012.129; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	35	46	48	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118210	10.1371/journal.pone.0118210	http://dx.doi.org/10.1371/journal.pone.0118210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706985	gold, Green Submitted, Green Published			2022-12-27	WOS:000350662100153
J	Kanda, T; Kiritoshi, T; Osawa, M; Toyoda, K; Oba, H; Kotoku, J; Kitajima, K; Furui, S				Kanda, Tomonori; Kiritoshi, Tomoki; Osawa, Marie; Toyoda, Keiko; Oba, Hiroshi; Kotoku, Jun'ichi; Kitajima, Kazuhiro; Furui, Shigeru			The Incidence of Double Hypoglossal Canal in Japanese: Evaluation with Multislice Computed Tomography	PLOS ONE			English	Article							POPULATIONS; NERVE; FORM; CT	Background and Purpose Double hypoglossal canal, namely a hypoglossal canal bridging, is a normal variation of the hypoglossal canal. Racial differences in the prevalence of double hypoglossal canal have been reported. We evaluated the prevalence of double hypoglossal canal in a Japanese population with multidetector computed tomography (MDCT). Materials and Methods We reviewed five hundred and ninety consecutive patients (mean age, 61 years: range, 15-94 years: 254 men, 336 women) who underwent computed tomographic angiography (CTA) of the brain for a variety of CNS abnormalities. Two radiologists achieved consensus on the canal being single or double, and measured the sizes of single canals on CT images. Kappa statistics was used to test the reliability between the 2 investigators. A logistic regression was used to evaluate the prevalence of double hypoglossal canal and the following factors: sex, age, and laterality. Student's t-test was used to evaluate the asymmetry of single hypoglossal canal diameters. Statistical significance was accepted at P < 0.05. Results Double hypoglossal canal was identified in 16.9% of the patients, and was bilateral in 2.2%. Double hypoglossal canal was significantly more frequent on the left side than right (P = 0.004, odds ratio = 1.79) and in males than females (P = 0.011, odds ratio = 1.67). A larger left or right-sided canal was found in 31.6% and 12.2% of the patients, respectively, following the same side preference as that of double hypoglossal canal. Almost perfect agreement was achieved between the two readers (k = 0.975). Conclusions In this Japanese population, the prevalence of a double hypoglossal canal was 16.9%, of which 2.2% were bilateral. Double hypoglossal canal was more frequent in males than females, and on the left side than right.	[Kanda, Tomonori; Kiritoshi, Tomoki; Osawa, Marie; Toyoda, Keiko; Oba, Hiroshi; Furui, Shigeru] Teikyo Univ, Sch Med, Dept Radiol, Tokyo 173, Japan; [Kotoku, Jun'ichi] Teikyo Univ, Fac Med Technol, Sch Med, Dept Radiol Technol, Tokyo 173, Japan; [Kitajima, Kazuhiro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan	Teikyo University; Teikyo University; Kobe University	Kanda, T (corresponding author), Teikyo Univ, Sch Med, Dept Radiol, Tokyo 173, Japan.	k_a@hotmail.co.jp			Grants-in-Aid for Scientific Research [25861128] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alves P, 2010, EUR J RADIOL, V74, P368, DOI 10.1016/j.ejrad.2009.08.028; BERLIS A, 1992, BRIT J RADIOL, V65, P653, DOI 10.1259/0007-1285-65-776-653; Borges A, 2007, EUR RADIOL, V17, P2112, DOI 10.1007/s00330-006-0575-9; DODO Y, 1980, J ANTHROPOL SOC NIP, V88, P229; Eroglu S, 2010, HOMO, V61, P33, DOI 10.1016/j.jchb.2010.01.002; Hanihara T, 2001, J ANAT, V199, P251, DOI 10.1046/j.1469-7580.2001.19930251.x; HAUSER G, 1985, AM J PHYS ANTHROPOL, V67, P7, DOI 10.1002/ajpa.1330670103; Kondo Y., 2007, J NEUROENDOVASCULAR, V1, P31, DOI [10.5797/jnet.1.31, DOI 10.5797/JNET.1.31]; Linn J, 2009, AM J NEURORADIOL, V30, P34, DOI 10.3174/ajnr.A1281; OKUDERA T, 1994, AM J NEURORADIOL, V15, P1871; Paraskevas GK, 2009, MED SCI MONITOR, V15, pBR75; Sakushima K, 2011, J NEUROIMAGING, V21, pe177, DOI 10.1111/j.1552-6569.2010.00498.x; Santarius T, 2012, J NEUROSURG-PEDIATR, V10, P130, DOI 10.3171/2012.3.PEDS11555; Tanoue S, 2010, BRIT J RADIOL, V83, P831, DOI 10.1259/bjr/85248833; Tubbs R, 2009, SURG RADIOL ANAT, V31, P173, DOI 10.1007/s00276-008-0422-6; Uchino A, 2013, NEURORADIOLOGY, V55, P17, DOI 10.1007/s00234-012-1074-0; VOYVODIC F, 1995, AM J NEURORADIOL, V16, P1707; Wysocki Jaroslaw, 2004, Folia Morphologica, V63, P11; Yousry I, 2002, J NEUROSURG, V96, P1113, DOI 10.3171/jns.2002.96.6.1113; Zaidi SHH, 2011, J ANAT SOC INDIA, V60, P224	20	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118317	10.1371/journal.pone.0118317	http://dx.doi.org/10.1371/journal.pone.0118317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706378	Green Submitted, gold, Green Published			2022-12-27	WOS:000350662100168
J	Matsuda, S; Matsumoto, H; Furubayashi, T; Hanajima, R; Tsuji, S; Ugawa, Y; Terao, Y				Matsuda, Shunichi; Matsumoto, Hideyuki; Furubayashi, Toshiaki; Hanajima, Ritsuko; Tsuji, Shoji; Ugawa, Yoshikazu; Terao, Yasuo			The 3-Second Rule in Hereditary Pure Cerebellar Ataxia: A Synchronized Tapping Study	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; SENSORIMOTOR SYNCHRONIZATION; TEMPORAL INFORMATION; BRAIN ACTIVATION; MOTOR CONTROL; DEGENERATION; POTENTIALS; MOVEMENTS; DISSOCIATION; PERCEPTION	The 3-second rule' has been proposed based on miscellaneous observations that a time period of around 3 seconds constitutes the fundamental unit of time related to the neuro-cognitive machinery in normal humans. The aim of paper was to investigate the temporal processing in patients with spinocerebellar ataxia type 6 (SCA6) and SCA31, pure cerebellar types of spinocerebellar degeneration, using a synchronized tapping task. Seventeen SCA patients (11 SCA6, 6 SCA31) and 17 normal age-matched volunteers participated. The task required subjects to tap a keyboard in synchrony with sequences of auditory stimuli presented at fixed interstimulus intervals (ISIs) between 200 and 4800 ms. In this task, the subjects required non-motor components to estimate the time of forthcoming tone in addition to motor components to tap. Normal subjects synchronized their taps to the presented tones at shorter ISIs, whereas as the ISI became longer, the normal subjects displayed greater latency between the tone and the tapping (transition zone). After the transition zone, normal subjects pressed the button delayed relative to the tone. On the other hand, SCA patients could not synchronize their tapping with the tone even at shorter ISIs, although they pressed the button delayed relative to the tone earlier than normal subjects did. The earliest time of delayed tapping appearance after the transition zone was 4800 ms in normal subjects but 1800 ms in SCA patients. The span of temporal integration in SCA patients is shortened compared to that in normal subjects. This could represent non-motor cerebellar dysfunction in SCA patients.	[Matsuda, Shunichi; Matsumoto, Hideyuki; Hanajima, Ritsuko; Tsuji, Shoji; Terao, Yasuo] Univ Tokyo, Dept Neurol, Tokyo, Japan; [Furubayashi, Toshiaki; Ugawa, Yoshikazu] Fukushima Med Univ, Dept Neurol, Sch Med, Fukushima, Japan	University of Tokyo; Fukushima Medical University	Matsumoto, H (corresponding author), Univ Tokyo, Dept Neurol, Tokyo, Japan.	hideyukimatsumoto.jp@gmail.com	Ugawa, Yoshikazu/AAM-2052-2020	Ugawa, Yoshikazu/0000-0002-8016-152X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Research, and Dainippon Sumitomo Pharma. Co., Ltd; Ministry of Health and Welfare of Japan; Ministry of Public Management, Home Affairs, Post and Telecommunications; Uehara Memorial Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; GlaxoSmithKline; Boehringer Ingelheim; Dainippon Sumitomo Pharma Co., Ltd; Kyowa Hakko Kilin Co., Ltd; Grants-in-Aid for Scientific Research [25461309] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research, and Dainippon Sumitomo Pharma. Co., Ltd; Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Public Management, Home Affairs, Post and Telecommunications; Uehara Memorial Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Dainippon Sumitomo Pharma Co., Ltd(Dainippon Sumitomo Pharma Co., Ltd.); Kyowa Hakko Kilin Co., Ltd; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Dr. Hanajima was supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Research, and Dainippon Sumitomo Pharma. Co., Ltd; and has received a speaker's honorarium from Kyowa Hakko Kilin Co., Ltd. Dr. Ugawa was supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by grants for the Research Committee on degenerative ataxia from the Ministry of Health and Welfare of Japan; by the Research Committee on insomnia in Parkinson's disease from the Ministry of Health and Welfare of Japan; by a grant from the Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications; and by a grant from the Uehara Memorial Foundation. Dr. Terao was supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and GlaxoSmithKline and Boehringer Ingelheim, and has received a speaker's honorarium from Boehringer Ingelheim. Dr. Matsuda, Dr. Matsumoto, Mr. Furubayashi, and Dr. Tsuji have no disclosures. There are no conflicts of interest. The funding from a commercial source, Dainippon Sumitomo Pharma Co., Ltd, Kyowa Hakko Kilin Co., Ltd, GlaxoSmithKline and Boehringer Ingelheim does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso K, 2010, J COGNITIVE NEUROSCI, V22, P2913, DOI 10.1162/jocn.2010.21429; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Dykiert D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045759; ELBERT T, 1991, PSYCHOPHYSIOLOGY, V28, P648, DOI 10.1111/j.1469-8986.1991.tb01009.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Hayashi MJ, 2014, J COGNITIVE NEUROSCI, V23, P1, DOI DOI 10.1162/J0CN_; IKEDA A, 1992, BRAIN, V115, P1017, DOI 10.1093/brain/115.4.1017; Ikeda A, 1997, ELECTROEN CLIN NEURO, V102, P142, DOI 10.1016/S0921-884X(96)95067-5; IKEDA A, 1994, ELECTROEN CLIN NEURO, V90, P359, DOI 10.1016/0013-4694(94)90051-5; IOANNIDES AA, 1994, ELECTROEN CLIN NEURO, V91, P399, DOI 10.1016/0013-4694(94)90125-2; Ishikawa K, 1999, J NEUROL NEUROSUR PS, V67, P86, DOI 10.1136/jnnp.67.1.86; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Martin B, 2013, NEUROPSYCHOLOGIA, V51, P358, DOI 10.1016/j.neuropsychologia.2012.07.002; MATES J, 1994, J COGNITIVE NEUROSCI, V6, P332, DOI 10.1162/jocn.1994.6.4.332; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Mento G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062896; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Morillon B, 2009, J NEUROSCI, V29, P14803, DOI 10.1523/JNEUROSCI.3222-09.2009; Muller K, 2000, J COGNITIVE NEUROSCI, V12, P546, DOI 10.1162/089892900562282; Nichelli P, 1996, NEUROPSYCHOLOGIA, V34, P863, DOI 10.1016/0028-3932(96)00001-2; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Pollok B, 2008, J COGNITIVE NEUROSCI, V20, P828, DOI 10.1162/jocn.2008.20506; Poppel E, 1978, HDB SENSORY PHYSL, P713, DOI 10.1007/978-3-642-46354-9_23; Poppel E., 1988, MINDWORKS TIME CONSC; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rektor I, 2004, EXP BRAIN RES, V158, P289, DOI 10.1007/s00221-004-1901-6; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Riecker A, 2003, NEUROIMAGE, V18, P731, DOI 10.1016/S1053-8119(03)00003-X; Sang L, 2012, NEUROIMAGE, V61, P1213, DOI 10.1016/j.neuroimage.2012.04.011; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schlerf JE, 2007, CEREBELLUM, V6, P221, DOI 10.1080/14734220701370643; Smith A, 2003, NEUROIMAGE, V20, P344, DOI 10.1016/S1053-8119(03)00337-9; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6	41	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118592	10.1371/journal.pone.0118592	http://dx.doi.org/10.1371/journal.pone.0118592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706752	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100191
J	Nishino, Y; Gilmour, S; Shibuya, K				Nishino, Yoshitaka; Gilmour, Stuart; Shibuya, Kenji			Inequality in Diabetes-Related Hospital Admissions in England by Socioeconomic Deprivation and Ethnicity: Facility-Based Cross-Sectional Analysis	PLOS ONE			English	Article							PRIMARY-CARE; INTERMEDIATE OUTCOMES; SOUTH ASIANS; PREVALENCE; QUALITY; 21ST-CENTURY; PREVENTION; FRAMEWORK; DATABASE; OBESITY	Objective To investigate the effect of social deprivation and ethnicity on inpatient admissions due to diabetes in England. Design Facility-based cross-sectional analysis. Setting National Health Service (NHS) trusts in England reporting inpatient admissions with better than 80% data reporting quality from 2010-2011 (355 facilities). Participants Non-obstetric patients over 16 years old in all NHS facilities in England. The sample size after exclusions was 5,147,859 all-cause admissions. Main Outcome Measures The relative risk of inpatient admissions and readmissions due to diabetes adjusted for confounders. Results There were 445,504 diabetes-related hospital admissions in England in 2010, giving a directly (age-sex) standardized rate of 1049.0 per 100,000 population (95% confidence interval (CI): 1046.0-1052.1). The relative risk of inpatient admission in the most deprived quintile was 2.08 times higher than that of the least deprived quintile (95% CI: 2.02-2.14), and the effect of deprivation varied across ethnicities. About 30.1% of patients admitted due to diabetes were readmitted at least once due to diabetes. South Asians showed 2.62 times (95% CI: 2.51 - 2.74) higher admission risk. Readmission risk increased with IMD among white British but not other ethnicities. South Asians showed slightly lower risk of readmission than white British (0.86, 95% CI: 0.80 - 0.94). Conclusions More deprived areas had higher rates of inpatient admissions and readmissions due to diabetes. South Asian British showed higher admission risk and lower readmission risk than white British. However, there was almost no difference by ethnicity in readmission due to diabetes. Higher rates of admission among deprived people may not necessarily reflect higher prevalence, but higher admission rates in south Asian British may be explained by their higher prevalence because their lower readmission risk suggests no inequality in primary care to prevent readmission. Better interventions in poorer areas, are needed to reduce these inequalities.	[Nishino, Yoshitaka; Gilmour, Stuart; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Nishino, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ny28tom@cameo.plala.or.jp		Shibuya, Kenji/0000-0003-2528-7530	Ministry of Health, Labour and Welfare, Japan [H24-25-007]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was in part supported by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare, Japan (Grant No. H24-25-007) (http://www.mhlw.go.jp/english/policy/other/research-projects/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agyemang C, 2011, EPIDEMIOLOGY, V22, P563, DOI 10.1097/EDE.0b013e31821d1096; Appleby J, 2011, BMJ, V342; Ashworth M, 2007, BRIT J GEN PRACT, V57, P441; Blackledge HM, 2003, HEART, V89, P615, DOI 10.1136/heart.89.6.615; BRADDON FFM, 1986, BMJ-BRIT MED J, V293, P299, DOI 10.1136/bmj.293.6542.299; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Correa-De-Araujo R, 2006, WOMEN HEALTH ISS, V16, P56, DOI 10.1016/j.whi.2005.08.003; Dalton ARH, 2011, DIABETIC MED, V28, P525, DOI 10.1111/j.1464-5491.2011.03251.x; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010 T; Dixon A, 2012, EUR J PUBLIC HEALTH, V22, P9, DOI 10.1093/eurpub/ckq177; Engelgau MM, 2003, J AM SOC NEPHROL, V14, pS88, DOI 10.1097/01.ASN.0000070143.71933.B0; Farmer A, 2012, DIABETIC MED; Fischbacher CM, 2009, J PUBLIC HEALTH-UK, V31, P239, DOI 10.1093/pubmed/fdp003; Forouhi NG, 2006, DIABETIC MED, V23, P189, DOI 10.1111/j.1464-5491.2005.01787.x; Gray A, 2002, BRIT MED J, V325, P860, DOI 10.1136/bmj.325.7369.860; Gulliford MC, 2007, DIABETIC MED, V24, P505, DOI 10.1111/j.1464-5491.2007.02090.x; Guthrie B, 2009, DIABETIC MED, V26, P1269, DOI 10.1111/j.1464-5491.2009.02837.x; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; Imkampe AK, 2011, EUR J PUBLIC HEALTH, V21, P484, DOI 10.1093/eurpub/ckq106; James GD, 2012, J ROY SOC MED, V105, P300, DOI 10.1258/jrsm.2012.110289; Majeed A, 2000, BRIT MED J, V321, P1057, DOI 10.1136/bmj.321.7268.1057; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; National Institute for Health and Care Excellence, 2013, ASS BOD MASS IND WAI; NHS England, 2013, NHS ENGL BOARD AGR I; Office for National Statistics, 2012, 2011 CENS ENGL WAL P; Office for National Statistics Neighbourhood Statistics, LOW SUP OUTP AR POP; Office of National Statistics, 2012, EX SUMM 2010 BAS NPP; Reid FDA, 1999, BRIT MED J, V319, P98, DOI 10.1136/bmj.319.7202.98; Ricci-Cabello I, 2010, HEALTH SOC CARE COMM, V18, P572, DOI 10.1111/j.1365-2524.2010.00960.x; Riste L, 2001, DIABETES CARE, V24, P1377, DOI 10.2337/diacare.24.8.1377; Sheikh A, 2011, BMJ-BRIT MED J, V343, P343, DOI DOI 10.1136/BMJ.D6054; Smith JA, 2012, BMJ, V344; The Health and Social Care Information Centre, 2010, HES DAT DICT; Thompson R, 2012, DIABETIC MED; Waller J, 2009, BRIT J CANCER, V101, pS24, DOI 10.1038/sj.bjc.6605387	36	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116689	10.1371/journal.pone.0116689	http://dx.doi.org/10.1371/journal.pone.0116689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25705895	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100045
J	Stohr, AC; Lopez-Bueno, A; Blahak, S; Caeiro, MF; Rosa, GM; de Matos, APA; Martel, A; Alejo, A; Marschang, RE				Stoehr, Anke C.; Lopez-Bueno, Alberto; Blahak, Silvia; Caeiro, Maria F.; Rosa, Goncalo M.; Alves de Matos, Antonio Pedro; Martel, An; Alejo, Ali; Marschang, Rachel E.			Phylogeny and Differentiation of Reptilian and Amphibian Ranaviruses Detected in Europe	PLOS ONE			English	Article							MAJOR CAPSID PROTEIN; FROG VIRUS 3; COMPLETE SEQUENCE DETERMINATION; COMPLETE GENOME SEQUENCE; SOFT-SHELLED TURTLE; FAMILY-IRIDOVIRIDAE; INFECTIOUS-DISEASES; GROUPER IRIDOVIRUS; MASS-MORTALITY; HOST-RANGE	Ranaviruses in amphibians and fish are considered emerging pathogens and several isolates have been extensively characterized in different studies. Ranaviruses have also been detected in reptiles with increasing frequency, but the role of reptilian hosts is still unclear and only limited sequence data has been provided. In this study, we characterized a number of ranaviruses detected in wild and captive animals in Europe based on sequence data from six genomic regions (major capsid protein (MCP), DNA polymerase (DNApol), ribonucleoside diphosphate reductase alpha and beta subunit-like proteins (RNR-alpha and -beta), viral homolog of the alpha subunit of eukaryotic initiation factor 2, eIF-2 alpha (vIF-2 alpha) genes and microsatellite region). A total of ten different isolates from reptiles (tortoises, lizards, and a snake) and four ranaviruses from amphibians (anurans, urodeles) were included in the study. Furthermore, the complete genome sequences of three reptilian isolates were determined and a new PCR for rapid classification of the different variants of the genomic arrangement was developed. All ranaviruses showed slight variations on the partial nucleotide sequences from the different genomic regions (92.6-100%). Some very similar isolates could be distinguished by the size of the band from the microsatellite region. Three of the lizard isolates had a truncated vIF-2a gene; the other ranaviruses had full-length genes. In the phylogenetic analyses of concatenated sequences from different genes (3223 nt/10287 aa), the reptilian ranaviruses were often more closely related to amphibian ranaviruses than to each other, and most clustered together with previously detected ranaviruses from the same geographic region of origin. Comparative analyses show that among the closely related amphibian-like ranaviruses (ALRVs) described to date, three recently split and independently evolving distinct genetic groups can be distinguished. These findings underline the wide host range of ranaviruses and the emergence of pathogen pollution via animal trade of ectothermic vertebrates.	[Stoehr, Anke C.; Marschang, Rachel E.] Univ Hohenheim, Fachgebiet Umwelt & Tierhyg, Stuttgart, Germany; [Lopez-Bueno, Alberto] Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Blahak, Silvia] Chem & Vet Untersuchungsamt Ostwestfalen Lippe CV, Detmold, Germany; [Caeiro, Maria F.; Alves de Matos, Antonio Pedro] Ctr Estudos Ambiente & Mar CESAM Lisboa, Lisbon, Portugal; [Caeiro, Maria F.] Univ Lisbon, Dept Biol Vegetal, Fac Ciencias, P-1699 Lisbon, Portugal; [Rosa, Goncalo M.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Rosa, Goncalo M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Rosa, Goncalo M.] Univ Lisbon, Fac Sci, Ctr Ecol Evolut & Environm Changes CE3C, P-1699 Lisbon, Portugal; [Alves de Matos, Antonio Pedro] Ctr Invest Interdisciplinar Egas Moniz CiiEM, Monte De Caparica, Portugal; [Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, B-9000 Ghent, Belgium; [Alejo, Ali] Inst Nacl Invest Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim, Valdeolmos, Spain; [Marschang, Rachel E.] Laboklin GmbH & Co KG, Lab Clin Diagnost, Bad Kissingen, Germany	University Hohenheim; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidade de Lisboa; University of Kent; Zoological Society of London; Universidade de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; Ghent University; LABOKLIN GmbH & Co. KG	Marschang, RE (corresponding author), Univ Hohenheim, Fachgebiet Umwelt & Tierhyg, Stuttgart, Germany.	rachel.marschang@googlemail.com	Alejo, Ali/AAF-1477-2020; Caeiro, Maria/C-1200-2014; Matos, Antonio P. A./A-4539-2013; Rosa, Gonçalo M./C-6028-2012	Alejo, Ali/0000-0002-1613-6063; Caeiro, Maria/0000-0003-0559-6344; Matos, Antonio P. A./0000-0001-9386-0349; Rosa, Gonçalo M./0000-0002-8658-8436; Lopez-Bueno, Alberto/0000-0002-6324-8623; Marschang, Rachel/0000-0002-0578-8963	American Association of Zoo Veterinarians; "Ramon y Cajal" contract from The Spanish Ministry of Economy and Competitiveness; Laboklin GmbH Co	American Association of Zoo Veterinarians; "Ramon y Cajal" contract from The Spanish Ministry of Economy and Competitiveness; Laboklin GmbH Co	This work was supported by a grant to REM from the American Association of Zoo Veterinarians (www.aazv.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ALB was a recipient of a "Ramon y Cajal" contract from The Spanish Ministry of Economy and Competitiveness. Laboklin GmbH & Co provided support in the form of salaries for authors [REM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Abbas MD, 2011, VET MICROBIOL, V150, P70, DOI 10.1016/j.vetmic.2011.01.010; Abrams AJ, 2013, J GEN VIROL, V94, P2082, DOI 10.1099/vir.0.052837-0; AHNE W, 1989, J VET MED B, V36, P333, DOI 10.1111/j.1439-0450.1989.tb00611.x; Allender MC, 2012, THESIS U ILLINOIS UR; de Matos APA, 2011, MICROSC MICROANAL, V17, P101, DOI 10.1017/S143192761009433X; Ariel E, 2011, P 1 INT S RAN JOINT, P90; Ariel E, 2010, ARCH VIROL, V155, P1261, DOI 10.1007/s00705-010-0715-z; Balseiro A, 2010, VET J, V186, P256, DOI 10.1016/j.tvjl.2009.07.038; Balseiro A, 2009, DIS AQUAT ORGAN, V84, P95, DOI 10.3354/dao02032; Bandin I, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-67; Bao Y, 2008, ENCY VIROLOGY, V5, P342; Behncke H, 2013, VET REC, V173, P248, DOI 10.1136/vr.101545; BLAHAK S, 2010, P 1 INT C REPT AMPH, P17; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bovo G., 1993, B SOC IT PATOL ITTIC, V11, P3; Bovo G, 1999, P 9 INT C EUR ASS FI, P153; Brenes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092476; Chen GC, 2011, J VIROL, V85, P11131, DOI 10.1128/JVI.05589-11; Chen ZY, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-101; Chen ZX, 1999, VIRUS RES, V63, P147, DOI 10.1016/S0168-1702(99)00069-6; Chinchar VG, 2009, CURR TOP MICROBIOL, V328, P123; Chinchar VG, 2011, VIRUSES-BASEL, V3, P1959, DOI 10.3390/v3101959; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Duffus ALJ, 2013, J WILDLIFE DIS, V49, P464, DOI 10.7589/2012-05-147; Echaubard P, 2014, EVOL APPL, V7, P723, DOI 10.1111/eva.12169; Essbauer S, 2001, VIRUS GENES, V23, P347, DOI 10.1023/A:1012533625571; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Geng Y, 2011, J COMP PATHOL, V145, P95, DOI 10.1016/j.jcpa.2010.11.012; GRANOFF A, 1965, ANN NY ACAD SCI, V126, P237, DOI 10.1111/j.1749-6632.1965.tb14278.x; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; He JG, 2002, VIROLOGY, V292, P185, DOI 10.1006/viro.2001.1245; Holopainen R, 2009, DIS AQUAT ORGAN, V85, P81, DOI 10.3354/dao02074; Huang YH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-224; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyatt AD, 2000, ARCH VIROL, V145, P301, DOI 10.1007/s007050050025; Jancovich JK, 2011, J VIROL, V85, P5061, DOI 10.1128/JVI.01488-10; Jancovich JK, 2010, J VIROL, V84, P2636, DOI 10.1128/JVI.01991-09; Jancovich JK, 1997, DIS AQUAT ORGAN, V31, P161, DOI 10.3354/dao031161; Jancovich JK, 2005, MOL ECOL, V14, P213, DOI 10.1111/j.1365-294X.2004.02387.x; Jancovich JK, 2003, VIROLOGY, V316, P90, DOI 10.1016/j.virol.2003.08.001; JENSEN NJ, 1979, NORD VET MED, V31, P436; Kik M, 2011, VET J, V190, P284, DOI 10.1016/j.tvjl.2011.08.031; Kolby JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090750; LANGDON JS, 1988, J FISH DIS, V11, P93, DOI 10.1111/j.1365-2761.1988.tb00527.x; LANGDON JS, 1986, J FISH DIS, V9, P263, DOI 10.1111/j.1365-2761.1986.tb01011.x; Lei XY, 2012, ARCH VIROL, V157, P1559, DOI 10.1007/s00705-012-1316-9; Majji S, 2006, DIS AQUAT ORGAN, V73, P1, DOI 10.3354/dao073001; Mao JH, 1997, VIROLOGY, V229, P212, DOI 10.1006/viro.1996.8435; Marschang RE, 2005, J ZOO WILDLIFE MED, V36, P295, DOI 10.1638/04-008.1; Marschang RE, 1999, ARCH VIROL, V144, P1909, DOI 10.1007/s007050050714; Marsh IB, 2002, MOL CELL PROBE, V16, P137, DOI 10.1006/mcpr.2001.0400; Mavian C, 2012, J VIROL, V86, P6365, DOI 10.1128/JVI.00618-12; Mavian C, 2012, J VIROL, V86, P3617, DOI 10.1128/JVI.07108-11; Miller D, 2011, VIRUSES-BASEL, V3, P2351, DOI 10.3390/v3112351; OIE, 2013, AQ AN HLTH COD; POZET F, 1992, DIS AQUAT ORGAN, V14, P35, DOI 10.3354/dao014035; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; Robert J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112904; Rothenburg S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-56; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schock DM, 2008, COPEIA, P133, DOI 10.1643/CP-06-134; Song WJ, 2004, J VIROL, V78, P12576, DOI 10.1128/JVI.78.22.12576-12590.2004; SPEARE R, 1992, DIS AQUAT ORGAN, V14, P51, DOI 10.3354/dao014051; Stohr AC, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-84; Stohr AC, 2013, VET J, V197, P238, DOI 10.1016/j.tvjl.2013.02.014; Stohr AC, 2013, DIS AQUAT ORGAN, V103, P185, DOI 10.3354/dao02556; Storfer A, 2007, ECOL LETT, V10, P1075, DOI 10.1111/j.1461-0248.2007.01102.x; Tan WGH, 2004, VIROLOGY, V323, P70, DOI 10.1016/j.virol.2004.02.019; Tapiovaara H, 1998, DIS AQUAT ORGAN, V32, P185, DOI 10.3354/dao032185; Tsai CT, 2005, J VIROL, V79, P2010, DOI 10.1128/JVI.79.4.2010-2023.2005; Waltzek TB, 2014, DIS AQUAT ORGAN, V111, P219, DOI 10.3354/dao02761; Wang N, 2014, GENOME ANNOUNC; Weng SP, 2002, J FISH DIS, V25, P423, DOI 10.1046/j.1365-2761.2002.00386.x; Whittington RJ, 2010, J FISH DIS, V33, P95, DOI 10.1111/j.1365-2761.2009.01110.x; Zhang QiYa, 1996, Acta Hydrobiologica Sinica, V20, P390	76	48	50	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118633	10.1371/journal.pone.0118633	http://dx.doi.org/10.1371/journal.pone.0118633			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706285	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100197
J	Marsili, S; Genini, S; Sudharsan, R; Gingrich, J; Aguirre, GD; Beltran, WA				Marsili, Stefania; Genini, Sem; Sudharsan, Raghavi; Gingrich, Jeremy; Aguirre, Gustavo D.; Beltran, William A.			Exclusion of the Unfolded Protein Response in Light-Induced Retinal Degeneration in the Canine T4R RHO Model of Autosomal Dominant Retinitis Pigmentosa	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PHOTORECEPTOR DEGENERATION; RHODOPSIN MUTATIONS; MUTANT RHODOPSIN; QUALITY-CONTROL; ER STRESS; IN-VIVO; TRANSGENIC MICE; CELL-DEATH; CROSS-TALK	Purpose To examine the occurrence of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) following acute light damage in the naturally-occurring canine model of RHO-adRP (T4R RHO dog). Methods The left eyes of T4R RHO dogs were briefly light-exposed and retinas collected 3, 6 and 24 hours later. The contra-lateral eyes were shielded and used as controls. To evaluate the time course of cell death, histology and TUNEL assays were performed. Electron microscopy was used to examine ultrastructural alterations in photoreceptors at 15 min, 1 hour, and 6 hours after light exposure. Gene expression of markers of ER stress and UPR were assessed by RT-PCR, qRT-PCR and western blot at the 6 hour time-point. Calpain and caspase-3 activation were assessed at 1, 3 and 6 hours after exposure. Results A brief exposure to clinically-relevant levels of white light causes within minutes acute disruption of the rod outer segment disc membranes, followed by prominent ultrastructural alterations in the inner segments and the initiation of cell death by 6 hours. Activation of the PERK and IRE1 pathways, and downstream targets (BIP, CHOP) of the UPR was not observed. However increased transcription of caspase-12 and hsp70 occurred, as well as calpain activation, but not that of caspase-3. Conclusion The UPR is not activated in the early phase of light-induced photoreceptor cell death in the T4R RHO model. Instead, disruption in rods of disc and plasma membranes within minutes after light exposure followed by increase in calpain activity and caspase-12 expression suggests a different mechanism of degeneration.	[Marsili, Stefania; Genini, Sem; Sudharsan, Raghavi; Gingrich, Jeremy; Aguirre, Gustavo D.; Beltran, William A.] Univ Penn, Sch Vet Med, Dept Clin Studies, Sect Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania	Beltran, WA (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Sect Ophthalmol, Philadelphia, PA 19104 USA.	wbeltran@vet.upenn.edu	marsili, stefania/AAY-9743-2020	marsili, stefania/0000-0003-0117-8874; Aguirre, Gustavo/0000-0002-5228-256X	National Institutes of Health (NIH) [R24EY022012, EY-006855, PN2EY018241, P30EY001583]; Foundation Fighting Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018241, U01EY006855, R24EY022012, P30EY001583, R01EY006855] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by: National Institutes of Health (NIH) R24EY022012 (WAB), EY-006855 (GDA), PN2EY018241 (WAB), P30EY001583, and Foundation Fighting Blindness (GDA).	Adekeye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083871; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Budzynski E, 2010, J BIOL CHEM, V285, P14521, DOI 10.1074/jbc.M110.112409; Chen YY, 2014, J BIOL CHEM, V289, P9288, DOI 10.1074/jbc.M114.551713; Chen YF, 2011, J CELL BIOCHEM, V112, P520, DOI 10.1002/jcb.22942; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Gorbatyuk M, 2013, MOL VIS, V19, P1985; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Griciuc A, 2011, TRENDS MOL MED, V17, P442, DOI 10.1016/j.molmed.2011.04.002; Gu D, 2007, INVEST OPHTH VIS SCI, V48, P4907, DOI 10.1167/iovs.07-0428; Gu D, 2009, INVEST OPHTH VIS SCI, V50, P3482, DOI 10.1167/iovs.08-3111; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; Heier CR, 2013, EMBO MOL MED, V5, P1569, DOI 10.1002/emmm.201302621; Hiramatsu N, 2007, FEBS LETT, V581, P2055, DOI 10.1016/j.febslet.2007.04.040; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Iannaccone A, 2006, VISION RES, V46, P4556, DOI 10.1016/j.visres.2006.08.018; INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/hmg/1.1.41; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Krizaj D, 2012, ADV EXP MED BIOL, V740, P873, DOI 10.1007/978-94-007-2888-2_39; Kroeger H, 2012, INVEST OPHTH VIS SCI, V53, P7590, DOI 10.1167/iovs.12-10221; Kunte MM, 2012, INVEST OPHTH VIS SCI, V53, P3792, DOI 10.1167/iovs.11-9235; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu XR, 1997, J CELL SCI, V110, P2589; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mizukoshi S, 2010, EXP EYE RES, V91, P353, DOI 10.1016/j.exer.2010.06.004; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nakanishi T, 2013, J NEUROCHEM, V125, P111, DOI 10.1111/jnc.12116; Nashine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063205; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Olivari S, 2007, FEBS LETT, V581, P3658, DOI 10.1016/j.febslet.2007.04.070; Organisciak DT, 2003, INVEST OPHTH VIS SCI, V44, P486, DOI 10.1167/iovs.02-0708; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Parfitt DA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.214; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Sakami S, 2014, HUM MOL GENET, V23, P1723, DOI 10.1093/hmg/ddt561; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Saliba RS, 2002, J CELL SCI, V115, P2907; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tam BM, 2014, J NEUROSCI, V34, P13336, DOI 10.1523/JNEUROSCI.1655-14.2014; Tam BM, 2010, INVEST OPHTH VIS SCI, V51, P1327, DOI 10.1167/iovs.09-4123; Tam BM, 2009, J NEUROSCI, V29, P15145, DOI 10.1523/JNEUROSCI.4259-09.2009; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang M, 1997, VISUAL NEUROSCI, V14, P55, DOI 10.1017/S0952523800008750; White DA, 2007, INVEST OPHTH VIS SCI, V48, P1942, DOI 10.1167/iovs.06-1131; Yamashita K, 1999, BBA-GEN SUBJECTS, V1473, P147, DOI 10.1016/S0304-4165(99)00175-0; Yang LP, 2008, J NEUROSCI RES, V86, P910, DOI 10.1002/jnr.21535; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yang Y, 2005, MOL CELLS, V20, P173; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015; Zhu L, 2004, J BIOL CHEM, V279, P53828, DOI 10.1074/jbc.M408472200	75	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0115723	10.1371/journal.pone.0115723	http://dx.doi.org/10.1371/journal.pone.0115723			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695253	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300009
J	White, PA; Belant, JL				White, Paula A.; Belant, Jerrold L.			Provisioning of Game Meat to Rural Communities as a Benefit of Sport Hunting in Zambia	PLOS ONE			English	Article							WILDLIFE CONSERVATION; BUSHMEAT TRADE; LAND; CONFLICTS; DRIVERS; IMPACTS; AFRICA	Sport hunting has reportedly multiple benefits to economies and local communities; however, few of these benefits have been quantified. As part of their lease agreements with the Zambia Wildlife Authority, sport hunting operators in Zambia are required to provide annually to local communities free of charge i.e., provision a percentage of the meat obtained through sport hunting. We characterized provisioning of game meat to rural communities by the sport hunting industry in Zambia for three game management areas (GMAs) during 2004-2011. Rural communities located within GMAs where sport hunting occurred received on average > 6,000 kgs per GMA of fresh game meat annually from hunting operators. To assess hunting industry compliance, we also compared the amount of meat expected as per the lease agreements versus observed amounts of meat provisioned from three GMAs during 2007-2009. In seven of eight annual comparisons of these GMAs, provisioning of meat exceeded what was required in the lease agreements. Provisioning occurred throughout the hunting season and peaked during the end of the dry season (September-October) coincident with when rural Zambians are most likely to encounter food shortages. We extrapolated our results across all GMAs and estimated 129,771 kgs of fresh game meat provisioned annually by the sport hunting industry to rural communities in Zambia at an approximate value for the meat alone of > US$600,000 exclusive of distribution costs. During the hunting moratorium (2013-2014), this supply of meat has halted, likely adversely affecting rural communities previously reliant on this food source. Proposed alternatives to sport hunting should consider protein provisioning in addition to other benefits (e.g., employment, community pledges, anti-poaching funds) that rural Zambian communities receive from the sport hunting industry.	[White, Paula A.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA 90089 USA; [Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Starkville, MS USA	University of California System; University of California Los Angeles; Mississippi State University	White, PA (corresponding author), Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA 90089 USA.	paw@carnivoreconservation.com	Belant, Jerrold/HDM-7749-2022					AfricaHunting, 2014, HUNT INF COUNTR; Ahmed AU, 2007, WORLDS MOST DEPRIVED, P107; Ahmed J, 2001, LESSONS LEARNED CASE; Astle WL, 1999, HIST WILDLIFE CONSER; Baldus RD, 2004, TOURIST HUNTING ITS; Baldus RD, 2009, PRACTICAL SUMMARY EX; Barnett R., 1997, FOOD THOUGHT UTILIZA; Barnett R, 2005, SPORT HUNTING SO AFR; Becker M, 2013, BIOL CONSERV, V158, P26, DOI 10.1016/j.biocon.2012.08.017; Bennett EL, 2002, CONSERV BIOL, V16, P590, DOI 10.1046/j.1523-1739.2002.01637.x; Bennett EL, 2007, CONSERV BIOL, V21, P884, DOI 10.1111/j.1523-1739.2006.00595.x; Bond Ivan, 1994, Traffic Bulletin, V14, P117; Booth VR, 2009, COMP PRICES HUNTING; Bothma JP., 2010, GAME RANCH MANAGEMEN; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brown T, 2007, CONSERV SCI PRACT, V2, P92; Bulletin and Record, 2013, KILL FIELDS ZAMB, V2; Campbell R, 2013, 200 MILLION QUESTION, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; CBD, 2011, CBD TECHN SER, V56, DOI [10.1016/j.recot.2011.11.003, DOI 10.1016/J.RECOT.2011.11.003]; Child BA, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-18; Damm G.R, 2008, BEST PRACTICES SUSTA, P5; Davies G, 2007, BUSHMEAT LIVELIHOODS, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; FAO, 2014, FOOD NUTR NUMB, DOI [10.1016/j.fsigen.2014.12.009, DOI 10.1016/J.FSIGEN.2014.12.009]; FAO, 2010, FOOD BAL SHEETS; FAO, 2014, STAT YB 2014 AFR FOO; FEWS, 2014, FOOD SEC OUTL UPD; FTF, 2011, ZAMB FY 2011 2015 MU; GAFSP, 2013, ANN REPORT; Haller T, 2008, HUM ECOL, V36, P699, DOI 10.1007/s10745-008-9191-4; Harvie B.A, 2013, J ECOLOGY NATURAL EN, V5, P88, DOI [10.5897/jene2013.0364, DOI 10.5897/JENE2013.0364]; Henley EC, 2010, ADV FOOD NUTR RES, V60, P21, DOI 10.1016/S1043-4526(10)60002-2; IRIN, 2014, ZAMB MOSQ NET FISH T; Jackson JJ, 1996, TOURIST HUNTING TANZ, P7; King A, 2011, CITES CBNRM P INT S, P78; Leader-Williams N, 2005, CONSERV BIOL SER, V9, P140; Lewis D, 2005, CONSERV BIOL SER, V9, P239; Lewis D, 2005, Conservation and Development Interventions at the Wildlife/Livestock Interface, P153; Lewis DM, 2007, CONSERV SCI PRACT, V2, P177; Lewis DM, 1997, CONSERV BIOL, V11, P59, DOI 10.1046/j.1523-1739.1997.94389.x; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Lindsey PA, 2011, ORYX, V45, P84, DOI 10.1017/S0030605310001274; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Loveridge Andrew J., 2006, P222; Marks Stuart A., 2005, LARGE MAMMALS BRAVE; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; NASCO, 2013, NASCO 2012 ANN REP; Nasi R, 2008, CONSERVATION USE WIL; Norton-Griffiths M., 1998, CONSERVATION BIOL RE, P279; Nyirenda VR, 2008, ATLAS NATL PARKS ZAM; Oates J. F., 1999, MYTH REALITY RAIN FO; OECD, 2012, AFR EC OUTL, DOI [10.1016/j.asjsur.2012.06.010, DOI 10.1016/J.ASJSUR.2012.06.010]; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Sanjay Gubbi, 2010, Economic and Political Weekly, V45, P22; Shurter S, 2013, GNUSLETTER, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Simasiku P, 2008, IMPACT WILDLIFE MANA; Skinner J. D., 1990, MAMMALS SO AFRICAN S; SLCS, 2013, OCT NOV DEC NEWSL; Stier JC, 1973, SAFARI HUNTING LUANG; Von Braun J., 2009, POOREST HUNGRY ASSES; WB, 1986, POV HUNG ISS OPT FOO; Weaver Chris, 2011, Occasional Papers of the IUCN Species Survival Commission, V46, P59; Weaver LC, 2008, BEST PRACTICES SUSTA, V1, P48; Wikipedia, 2014, AIR TRAV DISR 2010 E; ZCSO, 2014, MONTHL NOV 2014, DOI [10.1016/j.fsigen.2014.12.009, DOI 10.1016/J.FSIGEN.2014.12.009]; ZCSO, 2014, MONTHL FEBR 2014, DOI [10.1016/j.fsigen.2014.12.009, DOI 10.1016/J.FSIGEN.2014.12.009]; ZCSO, 2014, ZAMB FIG 1964 2014 R; ZVAC, 2004, ZAMB LIV MAP REZ BAS	68	7	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117237	10.1371/journal.pone.0117237	http://dx.doi.org/10.1371/journal.pone.0117237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25693191	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500043
J	Fernandez-Vargas, M; Johnston, RE				Fernandez-Vargas, Marcela; Johnston, Robert E.			Ultrasonic Vocalizations in Golden Hamsters (Mesocricetus auratus) Reveal Modest Sex Differences and Nonlinear Signals of Sexual Motivation	PLOS ONE			English	Article							FREQUENCY ACOUSTIC-SIGNALS; RAT RATTUS-NORVEGICUS; MICE MUS-MUSCULUS; TO-NOISE RATIO; FEMALE MICE; COURTSHIP VOCALIZATIONS; MATING VOCALIZATIONS; HORMONAL-CONTROL; VOCAL CUES; COMMUNICATION	Vocal signaling is one of many behaviors that animals perform during social interactions. Vocalizations produced by both sexes before mating can communicate sex, identity and condition of the caller. Adult golden hamsters produce ultrasonic vocalizations (USV) after intersexual contact. To determine whether these vocalizations are sexually dimorphic, we analyzed the vocal repertoire for sex differences in: 1) calling rates, 2) composition (structural complexity, call types and nonlinear phenomena) and 3) acoustic structure. In addition, we examined it for individual variation in the calls. The vocal repertoire was mainly composed of 1-note simple calls and at least half of them presented some degree of deterministic chaos. The prevalence of this nonlinear phenomenon was confirmed by low values of harmonic-to-noise ratio for most calls. We found modest sexual differences between repertoires. Males were more likely than females to produce tonal and less chaotic calls, as well as call types with frequency jumps. Multivariate analysis of the acoustic features of 1-note simple calls revealed significant sex differences in the second axis represented mostly by entropy and bandwidth parameters. Male calls showed lower entropy and inter-quartile bandwidth than female calls. Because the variation of acoustic structure within individuals was higher than among individuals, USV could not be reliably assigned to the correct individual. Interestingly, however, this high variability, augmented by the prevalence of chaos and frequency jumps, could be the result of increased vocal effort. Hamsters motivated to produce high calling rates also produced longer calls of broader bandwidth. Thus, the sex differences found could be the result of different sex preferences but also of a sex difference in calling motivation or condition. We suggest that variable and complex USV may have been selected to increase responsiveness of a potential mate by communicating sexual arousal and preventing habituation to the caller.	[Fernandez-Vargas, Marcela; Johnston, Robert E.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	Cornell University	Fernandez-Vargas, M (corresponding author), Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA.	mf463@cornell.edu			The National Institute of Mental Health [NIMH 5 R01 MHO58001-10]; The National Science Foundation [1210649]; Department of Psychology; Cornell Open Access Publication Fund	The National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); The National Science Foundation(National Science Foundation (NSF)); Department of Psychology; Cornell Open Access Publication Fund	This work was supported by The National Institute of Mental Health grant NIMH 5 R01 MHO58001-10 to REJ (http://grants.nih.gov/grants/oer.htm), The National Science Foundation under Grant Number (1210649) to REJ and MF (http://www.nsf.gov/funding/), the Department of Psychology and the Cornell Open Access Publication Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2005, MONOGRAPHS BEHAV ECO; Arriaga G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046610; BARFIELD RJ, 1979, AM ZOOL, V19, P469; Bee MA, 2010, ETHOLOGY, V116, P564, DOI 10.1111/j.1439-0310.2010.01773.x; Blumstein DT, 2009, ETHOLOGY, V115, P1074, DOI 10.1111/j.1439-0310.2009.01691.x; Boersma P., 2013, PRAAT DOING PHONETIC; Bouchet H, 2010, AM J PRIMATOL, V72, P360, DOI 10.1002/ajp.20791; Bradbury Jack W., 1998, pi; Briggs JR, 2011, ANIM BEHAV, V82, P1263, DOI 10.1016/j.anbehav.2011.09.003; Brudzynski S.M., 2010, HDB MAMMALIAN VOCALI, DOI 10.1016/s1569-7339(10)70001-1; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Brudzynski SM, 2010, HBK BEHAV NEUROSCI, V19, P69, DOI 10.1016/B978-0-12-374593-4.00008-5; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; Burgdorf J, HDB MAMMALIAN VOCALI, P209; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; Charif RA, 2010, RAVEN PRO 1 4 USERS; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; CHERRY JA, 1986, HORM BEHAV, V20, P34, DOI 10.1016/0018-506X(86)90027-9; CHERRY JA, 1989, ANIM BEHAV, V38, P138, DOI 10.1016/S0003-3472(89)80073-9; Choi H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-104; Digby A, 2014, BIOACOUSTICS, V23, P113, DOI 10.1080/09524622.2013.829755; Erb WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083131; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; FLOODY OR, 1977, J COMP PHYSIOL PSYCH, V91, P807, DOI 10.1037/h0077361; FLOODY OR, 1979, HORM BEHAV, V12, P172, DOI 10.1016/0018-506X(79)90019-9; FLOODY OR, 1979, HORM BEHAV, V12, P164, DOI 10.1016/0018-506X(79)90018-7; FLOODY OR, 1987, HORM BEHAV, V21, P522, DOI 10.1016/0018-506X(87)90010-9; FLOODY OR, 1977, J COMP PHYSIOL PSYCH, V91, P794, DOI 10.1037/h0077359; FLOODY OR, 1977, J COMP PHYSIOL PSYCH, V91, P820, DOI 10.1037/h0077360; FLOODY OR, 1987, HORM BEHAV, V21, P17, DOI 10.1016/0018-506X(87)90027-4; Gahr M, 2007, ADV GENET, V59, P67, DOI 10.1016/S0065-2660(07)59003-6; Garcia M, 2012, ETHOLOGY, V118, P292, DOI 10.1111/j.1439-0310.2011.02011.x; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hammerschmidt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041133; Hanson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040782; Hashimoto H, 2004, EXP ANIM TOKYO, V53, P409, DOI 10.1538/expanim.53.409; Hoffmann F, 2012, J ETHOL, V30, P173, DOI 10.1007/s10164-011-0312-y; Hoffmann F, 2012, PHYSIOL BEHAV, V105, P766, DOI 10.1016/j.physbeh.2011.10.011; HOLMAN SD, 1980, BEHAV NEURAL BIOL, V28, P183, DOI 10.1016/S0163-1047(80)91535-6; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; HUCK UW, 1986, ANIM BEHAV, V34, P971, DOI 10.1016/S0003-3472(86)80156-7; HUCK UW, 1985, BEHAV ECOL SOCIOBIOL, V17, P239, DOI 10.1007/BF00300142; Johnson AM, 2010, J ACOUST SOC AM, V128, pEL75, DOI 10.1121/1.3462234; Johnston RE, 2003, J MAMMAL, V84, P1141, DOI 10.1644/BLe-010; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Kapusta J, 2009, BEHAVIOUR, V146, P939, DOI 10.1163/156853908X396818; Karp D, 2014, ETHOLOGY, V120, P189, DOI 10.1111/eth.12195; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lai WS, 2005, J NEUROSCI, V25, P11239, DOI 10.1523/JNEUROSCI.2124-05.2005; Lisk R. D., 1985, The hamster - reproduction and behavior., P23; LISK RD, 1983, ANIM BEHAV, V31, P659, DOI 10.1016/S0003-3472(83)80221-8; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Mathevon Nicolas, 2010, BMC Ecology, V10, P9, DOI 10.1186/1472-6785-10-9; MATOCHIK JA, 1991, HORM BEHAV, V25, P445, DOI 10.1016/0018-506X(91)90013-8; MITANI JC, 1989, BEHAVIOUR, V109, P20, DOI 10.1163/156853989X00141; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; Neilans EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085405; NUNEZ AA, 1978, HORM BEHAV, V11, P264, DOI 10.1016/0018-506X(78)90030-2; NUNEZ AA, 1985, PHYSIOL BEHAV, V34, P901, DOI 10.1016/0031-9384(85)90011-3; NYBY J, 1983, BEHAV NEURAL BIOL, V39, P128, DOI 10.1016/S0163-1047(83)90722-7; NYBY J, 1977, J COMP PHYSIOL PSYCH, V91, P1424, DOI 10.1037/h0077411; NYBY J, 1977, ANIM BEHAV, V25, P333, DOI 10.1016/0003-3472(77)90009-4; Panksepp J, 2010, HBK BEHAV NEUROSCI, V19, P201, DOI 10.1016/B978-0-12-374593-4.00020-6; Patel ER, 2007, J ACOUST SOC AM, V121, P575, DOI 10.1121/1.2390662; PAYNE AP, 1972, ANIM BEHAV, V20, P782, DOI 10.1016/S0003-3472(72)80152-0; PIERCE JD, 1989, BEHAV NEURAL BIOL, V51, P211, DOI 10.1016/S0163-1047(89)90842-X; Pitcher BJ, 2014, BEHAV ECOL, V25, P392, DOI 10.1093/beheco/art131; POMERANTZ SM, 1983, BEHAV NEUROSCI, V97, P462, DOI 10.1037/0735-7044.97.3.462; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2012, ANIM COGN, V15, P265, DOI 10.1007/s10071-011-0451-0; Rendall D, 2004, J ACOUST SOC AM, V115, P411, DOI 10.1121/1.1635838; Rendall D, 2010, HBK BEHAV NEUROSCI, V19, P177, DOI 10.1016/B978-0-12-374593-4.00018-8; Rice AN, 2011, P ROY SOC B-BIOL SCI, V278, P3762, DOI 10.1098/rspb.2011.0656; Riede T, 2004, AM J PRIMATOL, V64, P277, DOI 10.1002/ajp.20078; Riede T, 2001, J ACOUST SOC AM, V110, P2191, DOI 10.1121/1.1398052; Riede T, 2013, J EXP ZOOL PART A, V319A, P213, DOI 10.1002/jez.1785; Riede T, 2011, J NEUROPHYSIOL, V106, P2580, DOI 10.1152/jn.00478.2011; ROBERTS LH, 1975, ULTRASONICS, V13, P83, DOI 10.1016/0041-624X(75)90052-9; SALES G D, 1972, Journal of Zoology (London), V168, P149; Sales GD, 2010, HBK BEHAV NEUROSCI, V19, P77, DOI 10.1016/B978-0-12-374593-4.00009-7; Scattoni ML, 2010, HBK BEHAV NEUROSCI, V19, P89, DOI 10.1016/B978-0-12-374593-4.00010-3; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schehka S, 2009, BEHAV BRAIN RES, V203, P223, DOI 10.1016/j.bbr.2009.05.007; Scheumann M, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-36; Schneider N, 2011, MAMM BIOL, V76, P549, DOI 10.1016/j.mambio.2011.03.002; Shepard KN, 2011, GENES BRAIN BEHAV, V10, P28, DOI 10.1111/j.1601-183X.2010.00580.x; Snoeren EMS, 2014, J COMP PSYCHOL, V128, P40, DOI 10.1037/a0033204; Snoeren EMS, 2013, BEHAV NEUROSCI, V127, P439, DOI 10.1037/a0032027; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Suthers RA, 2006, J EXP BIOL, V209, P4984, DOI 10.1242/jeb.02594; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; THOMAS DA, 1985, ANIM BEHAV, V33, P720, DOI 10.1016/S0003-3472(85)80002-6; Tokuda I, 2002, J ACOUST SOC AM, V111, P2908, DOI 10.1121/1.1474440; Townsend SW, 2011, BIOL LETTERS, V7, P47, DOI 10.1098/rsbl.2010.0537; Tyson RB, 2007, J ACOUST SOC AM, V122, P1365, DOI 10.1121/1.2756263; Volodin IA, 2011, ETHOLOGY, V117, P294, DOI 10.1111/j.1439-0310.2011.01874.x; von Merten S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097244; WHITE NR, 1990, J COMP PSYCHOL, V104, P255, DOI 10.1037/0735-7036.104.3.255; WHITE NR, 1987, J COMP PSYCHOL, V101, P73, DOI 10.1037/0735-7036.101.1.73; WHITE NR, 1990, J COMP PSYCHOL, V104, P140, DOI 10.1037/0735-7036.104.2.140; WHITNEY G, 1973, J COMP PHYSIOL PSYCH, V84, P445, DOI 10.1037/h0034899; Wohr M, 2008, PHYSIOL BEHAV, V93, P766, DOI 10.1016/j.physbeh.2007.11.031; Wohr M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001365; Wohr M, 2010, HBK BEHAV NEUROSCI, V19, P113, DOI 10.1016/B978-0-12-374593-4.00012-7; Wright JM, 2010, PSYCHOPHARMACOLOGY, V211, P1, DOI 10.1007/s00213-010-1859-y; Wyman MT, 2012, ANIM BEHAV, V84, P1381, DOI 10.1016/j.anbehav.2012.08.037; YUMOTO E, 1982, J ACOUST SOC AM, V71, P1544, DOI 10.1121/1.387808	120	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2015	10	2							e0116789	10.1371/journal.pone.0116789	http://dx.doi.org/10.1371/journal.pone.0116789			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC2IM	25714096	Green Submitted, Green Published, gold			2022-12-27	WOS:000350168700025
J	Oh, J; Sanders, IF; Chen, EZ; Li, HZ; Tobias, JW; Isett, RB; Penubarthi, S; Sun, H; Baldwin, DA; Fraser, NW				Oh, Jaewook; Sanders, Iryna F.; Chen, Eric Z.; Li, Hongzhe; Tobias, John W.; Isett, R. Benjamin; Penubarthi, Sindura; Sun, Hao; Baldwin, Don A.; Fraser, Nigel W.			Genome Wide Nucleosome Mapping for HSV-1 Shows Nucleosomes Are Deposited at Preferred Positions during Lytic Infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; LATENCY-ASSOCIATED TRANSCRIPTS; TYPE-1 DNA; VIRAL-DNA; CHROMATIN; SEQUENCE; RNA; ORGANIZATION; EXPRESSION; HISTONES	HSV is a large double stranded DNA virus, capable of causing a variety of diseases from the common cold sore to devastating encephalitis. Although DNA within the HSV virion does not contain any histone protein, within 1 h of infecting a cell and entering its nucleus the viral genome acquires some histone protein (nucleosomes). During lytic infection, partial micrococcal nuclease (MNase) digestion does not give the classic ladder band pattern, seen on digestion of cell DNA or latent viral DNA. However, complete digestion does give a mono-nucleosome band, strongly suggesting that there are some nucleosomes present on the viral genome during the lytic infection, but that they are not evenly positioned, with a 200bp repeat pattern, like cell DNA. Where then are the nucleosomes positioned? Here we perform HSV-1 genome wide nucleosome mapping, at a time when viral replication is in full swing (6hr PI), using a microarray consisting of 50mer oligonucleotides, covering the whole viral genome (152kb). Arrays were probed with MNase-protected fragments of DNA from infected cells. Cells were not treated with crosslinking agents, thus we are only mapping tightly bound nucleosomes. The data show that nucleosome deposition is not random. The distribution of signal on the arrays suggest that nucleosomes are located at preferred positions on the genome, and that there are some positions that are not occupied (nucleosome free regions -NFR or Nucleosome depleted regions -NDR), or occupied at frequency below our limit of detection in the population of genomes. Occupancy of only a fraction of the possible sites may explain the lack of a typical MNase partial digestion band ladder pattern for HSV DNA during lytic infection. On average, DNA encoding Immediate Early (IE), Early (E) and Late (L) genes appear to have a similar density of nucleosomes.	[Oh, Jaewook; Sanders, Iryna F.; Penubarthi, Sindura; Fraser, Nigel W.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chen, Eric Z.; Sun, Hao] Chinese Univ Hong Kong, Dept Chem Pathol, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Tobias, John W.; Isett, R. Benjamin] Univ Penn, Penn Mol Profiling Facil, Perelman Sch Med, Philadelphia, PA 19104 USA; [Baldwin, Don A.] Pathonomics LLC, Philadelphia, PA 19104 USA; [Chen, Eric Z.; Li, Hongzhe] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Chinese University of Hong Kong; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Fraser, NW (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	nfraser@mail.med.upenn.edu	Sun, Hao/J-9964-2013; Sun, Hao/T-5576-2019; c, c/I-5855-2016; sun, hao/GRS-7732-2022	Sun, Hao/0000-0002-5547-9501; Sun, Hao/0000-0002-5547-9501; Isett, Benjamin/0000-0001-8995-8335	NIH [NS33768, NS082240]; NIH training grant [T32-CA115299]; NATIONAL CANCER INSTITUTE [T32CA115299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082240, P01NS033768, P50NS033768] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant NS33768 and NS082240. I.S. was supported by NIH training grant T32-CA115299. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; Bock CT, 2001, J MOL BIOL, V307, P183, DOI 10.1006/jmbi.2000.4481; Burgess RJ, 2010, PROTEIN CELL, V1, P607, DOI 10.1007/s13238-010-0086-y; Chung HR, 2009, J MOL BIOL, V386, P1411, DOI 10.1016/j.jmb.2008.11.049; Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08; Cui F, 2010, J BIOMOL STRUCT DYN, V27, P821, DOI 10.1080/073911010010524947; Cui P, 2010, BIOCHEM BIOPH RES CO, V391, P884, DOI 10.1016/j.bbrc.2009.11.157; CUNNINGHAM C, 1993, VIROLOGY, V197, P116, DOI 10.1006/viro.1993.1572; Davey C, 2003, J MOL BIOL, V325, P873, DOI 10.1016/S0022-2836(02)01340-2; DESHMANE SL, 1989, J VIROL, V63, P943, DOI 10.1128/JVI.63.2.943-947.1989; DRESSLER GR, 1987, J GEN VIROL, V68, P1761, DOI 10.1099/0022-1317-68-6-1761; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; FRASER NW, 1992, VIROLOGY, V191, P1, DOI 10.1016/0042-6822(92)90160-Q; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; GIBSON W, 1971, P NATL ACAD SCI USA, V68, P2818, DOI 10.1073/pnas.68.11.2818; GRIFFITH JP, 1992, NATURE, V355, P652, DOI 10.1038/355652a0; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Hancock MH, 2010, J VIROL, V84, P1366, DOI 10.1128/JVI.01727-09; Herrera FJ, 2004, J VIROL, V78, P9689, DOI 10.1128/JVI.78.18.9689-9696.2004; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Huang KJ, 2002, J BIOL CHEM, V277, P21071, DOI 10.1074/jbc.M201785200; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2010, NAT STRUCT MOL BIOL, V17, P918, DOI 10.1038/nsmb0810-918; Kent JR, 2004, J VIROL, V78, P10178, DOI 10.1128/JVI.78.18.10178-10186.2004; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Kubat NJ, 2004, J VIROL, V78, P1139, DOI 10.1128/JVI.78.3.1139-1149.2004; KUNKEL GR, 1981, NUCLEIC ACIDS RES, V9, P6869, DOI 10.1093/nar/9.24.6869; Kutluay SB, 2009, BBA-GEN SUBJECTS, V1790, P456, DOI 10.1016/j.bbagen.2009.03.019; Lacasse JJ, 2012, J VIROL, V86, P11287, DOI 10.1128/JVI.01468-12; Lacasse JJ, 2010, J VIROL, V84, P1920, DOI 10.1128/JVI.01934-09; LEINBACH SS, 1980, J GEN VIROL, V51, P45, DOI 10.1099/0022-1317-51-1-45; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; LUCCHINI R, 1987, J MOL BIOL, V196, P829, DOI 10.1016/0022-2836(87)90408-6; MERTZ JE, 1982, MOL CELL BIOL, V2, P1608, DOI 10.1128/MCB.2.12.1608; MUGGERIDGE MI, 1986, J VIROL, V59, P764, DOI 10.1128/JVI.59.3.764-767.1986; Murugesapillai D, 2014, NUCLEIC ACIDS RES, V42, P8996, DOI 10.1093/nar/gku635; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; NICOSIA M, 1993, J VIROL, V67, P7276, DOI 10.1128/JVI.67.12.7276-7283.1993; Nitzsche A, 2008, J VIROL, V82, P11167, DOI 10.1128/JVI.01218-08; Oh J, 2008, J VIROL, V82, P3530, DOI 10.1128/JVI.00586-07; Oh J, 2012, J VIROL, V86, P12313, DOI 10.1128/JVI.01570-12; Peng H, 2010, P NATL ACAD SCI USA, V107, P2461, DOI 10.1073/pnas.0911128107; Placek BJ, 2010, BBA-GENE REGUL MECH, V1799, P223, DOI 10.1016/j.bbagrm.2010.01.012; Placek BJ, 2009, J VIROL, V83, P1416, DOI 10.1128/JVI.01276-08; Radwan A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-186; Rapoport AE, 2011, J BIOMOL STRUCT DYN, V28, P567, DOI 10.1080/07391102.2011.10531243; ROCK DL, 1985, J VIROL, V55, P849, DOI 10.1128/JVI.55.3.849-852.1985; Roitman-Shemer V, 2007, BIOCHEM BIOPH RES CO, V353, P424, DOI 10.1016/j.bbrc.2006.12.038; Roizman B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Silva L, 2012, MBIO, V3, DOI 10.1128/mBio.00300-11; SPIVACK JG, 1987, J VIROL, V61, P3841, DOI 10.1128/JVI.61.12.3841-3847.1987; SPIVACK JG, 1988, J VIROL, V62, P3281, DOI 10.1128/JVI.62.9.3281-3287.1988; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Stingley SW, 2000, J VIROL, V74, P9916, DOI 10.1128/JVI.74.21.9916-9927.2000; Strang BL, 2005, J VIROL, V79, P12487, DOI 10.1128/JVI.79.19.12487-12494.2005; Su YH, 2002, J GEN VIROL, V83, P2943, DOI 10.1099/0022-1317-83-12-2943; TATE VE, 1979, NUCLEIC ACIDS RES, V6, P2769, DOI 10.1093/nar/6.8.2769; Tempera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002180; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; Travers AA, 2012, BIOCHEM SOC T, V40, P335, DOI 10.1042/BST20110757; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Yen KY, 2013, CELL, V154, P1246, DOI 10.1016/j.cell.2013.08.043; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zalckvar E, 2013, P NATL ACAD SCI USA, V110, P13126, DOI 10.1073/pnas.1305548110; Zhang Y, 2010, NAT STRUCT MOL BIOL, V17, P920, DOI 10.1038/nsmb0810-920; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhou J, 2005, EMBO J, V24, P1406, DOI 10.1038/sj.emboj.7600609	77	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117471	10.1371/journal.pone.0117471	http://dx.doi.org/10.1371/journal.pone.0117471			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710170	gold, Green Published, Green Submitted			2022-12-27	WOS:000350683900034
J	Zhang, R; Ding, J; Liu, CX; Cai, CP; Zhou, BL; Zhang, TZ; Guo, WZ				Zhang, Rui; Ding, Jian; Liu, Chunxiao; Cai, Caiping; Zhou, Baoliang; Zhang, Tianzhen; Guo, Wangzhen			Molecular Evolution and Phylogenetic Analysis of Eight COL Superfamily Genes in Group I Related to Photoperiodic Regulation of Flowering Time in Wild and Domesticated Cotton (Gossypium) Species	PLOS ONE			English	Article							CONSTANS-LIKE GENE; ARTIFICIAL SELECTION; ARABIDOPSIS; EXPRESSION; FAMILY; ADAPTATION; DIVERSITY; HIRSUTUM; ORIGIN; RICE	Flowering time is an important ecological trait that determines the transition from vegetative to reproductive growth. Flowering time in cotton is controlled by short-day photoperiods, with strict photoperiod sensitivity. As the CO-FT (CONSTANS-FLOWER LOCUS T) module regulates photoperiodic flowering in several plants, we selected eight CONSTANS genes (COL) in group I to detect their expression patterns in long-day and short-day conditions. Further, we individually cloned and sequenced their homologs from 25 different cotton accessions and one outgroup. Finally, we studied their structures, phylogenetic relationship, and molecular evolution in both coding region and three characteristic domains. All the eight COLs in group I show diurnal expression. In the orthologous and homeologous loci, each gene structure in different cotton species is highly conserved, while length variation has occurred due to insertions/deletions in intron and/or exon regions. Six genes, COL2 to COL5, COL7 and COL8, exhibit higher nucleotide diversity in the D-subgenome than in the A-subgenome. The Ks values of 98.37% in all allotetraploid cotton species examined were higher in the A-D and At-Dt comparison than in the A-At and D-Dt comparisons, and the Pearson's correlation coefficient (r) of Ks between A vs. D and At vs. Dt also showed positive, high correlations, with a correlation coefficient of at least 0.797. The nucleotide polymorphism in wild species is significantly higher compared to G. hirsutum and G. barbadense, indicating a genetic bottleneck associated with the domesticated cotton species. Three characteristic domains in eight COLs exhibit different evolutionary rates, with the CCT domain highly conserved, while the B-box and Var domain much more variable in allotetraploid species. Taken together, COL1, COL2 and COL8 endured greater selective pressures during the domestication process. The study improves our understanding of the domestication-related genes/traits during cotton evolutionary process.	[Zhang, Rui; Ding, Jian; Liu, Chunxiao; Cai, Caiping; Zhou, Baoliang; Zhang, Tianzhen; Guo, Wangzhen] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Hybrid Cotton R&D Engn Res Ctr, MOE, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Guo, WZ (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Hybrid Cotton R&D Engn Res Ctr, MOE, Nanjing, Jiangsu, Peoples R China.	moelab@njau.edu.cn			State Key Basic Research and Development Plan of China [2011CB109300]; Priority Academic Program Development of Jiangsu Higher Education Institutions; JCIC-MCP	State Key Basic Research and Development Plan of China(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions; JCIC-MCP	This program was financially supported in part by The State Key Basic Research and Development Plan of China (2011CB109300), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and JCIC-MCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Y, 2011, P NATL ACAD SCI USA, V108, P21152, DOI 10.1073/pnas.1115926109; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Brubaker CL, 2001, GENETIC IMPROVEMENT OF COTTON, P81; BRUBAKER CL, 1994, AM J BOT, V81, P1309, DOI 10.2307/2445407; Buriev ZT, 2011, THEOR APPL GENET, V123, P1359, DOI 10.1007/s00122-011-1672-y; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Chia TYP, 2008, J EXP BOT, V59, P2735, DOI 10.1093/jxb/ern129; Cockram J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045307; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; Cronn RC, 1999, P NATL ACAD SCI USA, V96, P14406, DOI 10.1073/pnas.96.25.14406; Cronn RC, 2002, AM J BOT, V89, P707, DOI 10.3732/ajb.89.4.707; DEJOODE DR, 1992, AM J BOT, V79, P1311, DOI 10.2307/2445059; Fan CM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-9; FU YX, 1993, GENETICS, V133, P693; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; [顾超 Gu Chao], 2013, [新疆农业科学, Xinjiang Agricultural Sciences], V50, P214; Guo WZ, 2005, J INTEGR PLANT BIOL, V47, P1418, DOI 10.1111/j.1744-7909.2005.00157.x; Harlan JR, 1992, CROPS MAN, V2nd; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Huang CL, 2012, PLANT J, V70, P769, DOI 10.1111/j.1365-313X.2012.04915.x; Huang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048242; HUDSON RR, 1988, GENETICS, V120, P831; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; HUTCHINSON JB, 1951, HEREDITY, V5, P161, DOI 10.1038/hdy.1951.19; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kikuchi R, 2012, J EXP BOT, V63, P773, DOI 10.1093/jxb/err299; Kim SK, 2008, PLANTA, V228, P355, DOI 10.1007/s00425-008-0742-0; Kumagai T, 2008, BIOSCI BIOTECH BIOCH, V72, P1539, DOI 10.1271/bbb.80041; Lagercrantz U, 2000, MOL BIOL EVOL, V17, P1499, DOI 10.1093/oxfordjournals.molbev.a026249; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JY, 2001, PLANT PHYSIOL, V125, P1821, DOI 10.1104/pp.125.4.1821; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubbers Edward L., 2009, V3, P23, DOI 10.1007/978-0-387-70810-2_2; Martin J, 2004, PLANT MOL BIOL, V56, P159, DOI 10.1007/s11103-004-2647-z; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Murakami M, 2005, BIOSCI BIOTECH BIOCH, V69, P410, DOI 10.1271/bbb.69.410; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Olsen KM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00290; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Percy Richard G., 2009, V3, P53, DOI 10.1007/978-0-387-70810-2_3; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Romero JM, 2009, PLANT SIGNAL BEHAV, V4, P642, DOI 10.4161/psb.4.7.8975; Roux F, 2006, TRENDS PLANT SCI, V11, P375, DOI 10.1016/j.tplants.2006.06.006; Serrano G, 2009, CURR BIOL, V19, P359, DOI 10.1016/j.cub.2009.01.044; Shimizu M, 2004, BIOCHEM BIOPH RES CO, V324, P1296, DOI 10.1016/j.bbrc.2004.09.194; Shin BS, 2004, MOL CELLS, V17, P10; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi Y, 2011, GENES GENET SYST, V86, P175, DOI 10.1266/ggs.86.175; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; WENDEL JF, 1994, PLANT SYST EVOL, V192, P49, DOI 10.1007/BF00985907; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1990, BIOCHEM SYST ECOL, V18, P517, DOI 10.1016/0305-1978(90)90123-W; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035; Wu WX, 2013, P NATL ACAD SCI USA, V110, P2775, DOI 10.1073/pnas.1213962110; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhu HY, 2012, MOL PHYLOGENET EVOL, V63, P589, DOI 10.1016/j.ympev.2012.01.025; Zobell O, 2005, PLANT BIOLOGY, V7, P266, DOI 10.1055/s-2005-865621	78	10	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118669	10.1371/journal.pone.0118669	http://dx.doi.org/10.1371/journal.pone.0118669			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25710777	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900064
J	Achia, TNO				Achia, Thomas N. O.			Tobacco Use and Mass Media Utilization in Sub-Saharan Africa	PLOS ONE			English	Article							ENVIRONMENTAL-INFLUENCES; SEMEN QUALITY; SUBSTANCE USE; DETERMINANTS; ALCOHOL; SMOKING; EXPOSURE; ADOLESCENTS; PHARYNGEAL; WOMEN	Background Media utilization has been identified as an important determinant of tobacco use. We examined the association between self-reported tobacco use and frequency of mass media utilization by women and men in nine low-to middle-income sub-Saharan African countries. Methodology/Principal Findings Data for the study came from Demographic and Health Surveys conducted in Burkina Faso, Ethiopia, Liberia, Lesotho, Malawi, Swaziland, Uganda, Zambia and Zimbabwe over the period 2006-2011. Each survey population was a cross-sectional sample of women aged 15-49 years and men aged 15-59 years, with information on tobacco use and media access being obtained by face-to-face interviews. An index of media utilization was constructed based on responses to questions on the frequency of reading newspapers, frequency of watching television and frequency of listening to the radio. Demographic and socioeconomic variables were considered as potentially confounding covariates. Logistic regression models with country and cluster specific random effects were estimated for the pooled data. Results The risk of cigarette smoking increased with greater utilization to mass media. The use of smokeless tobacco and tobacco use in general declined with greater utilization to mass media. The risk of tobacco use was 5% lower in women with high media utilization compared to those with low media utilization [Adjusted Odds Ratio (AOR) = 0.95, 95% confidence interval (CI): 0.82-1.00]. Men with a high media utilization were 21% less likely to use tobacco compared to those with low media utilization [AOR = 0.79, 95% CI = 0.73-0.85]. In the male sample, tobacco use also declined with the increased frequency of reading newspapers (or magazines), listening to radio and watching television. Conclusions Mass media campaigns, conducted in the context of comprehensive tobacco control programmes, can reduce the prevalence of tobacco smoking in sub-Saharan Africa. The reach, intensity, duration and type of messages are important aspects of the campaigns but need to also address all forms of tobacco use.	[Achia, Thomas N. O.] Univ Witwatersrand, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa; [Achia, Thomas N. O.] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa	University of Witwatersrand; University of the Western Cape	Achia, TNO (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa.	thomas.achia@wits.ac.za	Achia, Thomas N. O./I-3674-2013	Achia, Thomas N. O./0000-0002-0700-9468	Vlaamse Interuniversitaire Raad (VLIR), Belgium; School of Public Health, University of the Western Cape	Vlaamse Interuniversitaire Raad (VLIR), Belgium; School of Public Health, University of the Western Cape	The study was partly supported through a post-doctoral fellowship at the School of Public Health, University of the Western Cape, (website: www.uwc.ac.za/Faculties/CHS/soph) and funded by Vlaamse Interuniversitaire Raad (VLIR), Belgium (website: www.vliruos.be/). This study was undertaken whilst serving as an employee of the School of Public Health, University of Witwatersrand (website: http://www.wits.ac.za/academic/health/10374/publichealth.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair T, 2011, AUST NZ J PUBL HEAL, V35, P212, DOI 10.1111/j.1753-6405.2011.00700.x; Alam AY, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-50; Amos A, 2000, TOB CONTROL, V9, P3, DOI 10.1136/tc.9.1.3; Arora M, 2012, TOB CONTROL, V21, P482, DOI 10.1136/tc.2011.043539; BETTES BA, 1990, CHILD DEV, V61, P557, DOI 10.2307/1131115; Bloch M, 2008, AM J PUBLIC HEALTH, V98, P1833, DOI 10.2105/AJPH.2007.117887; Boisvert D, 2013, J CRIM JUST, V41, P262, DOI 10.1016/j.jcrimjus.2013.05.007; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Office ICF-International I, 2010, SWAZ DEM HLTH SURV 2; Central Statistical Office (Zambia) Ministry of Health (Zambia) Tropical Diseases Research Centre University of Zambia Macro International., 2007, ZAMB DEM HLTH SURV 2; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dani JA, 2011, TRENDS NEUROSCI, V34, P383, DOI 10.1016/j.tins.2011.05.001; Flay B. R., 1993, NICOTINE ADDICTION P; Glynn T, 2010, CA-CANCER J CLIN, V60, P50, DOI 10.3322/caac.20052; Govender VG, 2008, HLTH CARE WORKERS KN; Han C, 1999, ADDICTION, V94, P981, DOI 10.1046/j.1360-0443.1999.9479814.x; HENNINGFIELD JE, 1988, PHARMACOL BIOCHEM BE, V30, P221, DOI 10.1016/0091-3057(88)90449-2; Hoang VM, 2010, INDIAN J MED RES, V131, P600; ICF Macro, 2010, LESOTHO DEMOGRAPHIC; Institut National de la Statistique et de la Demographie (INSD) Ministere de l'Economie et des Finances ICF-International, 2010, BURK FAS DEM HLTH SU; Jha P., 2000, TOBACCO CONTROL DEV; Kaleta D, 2011, CENT EUR J PUBL HEAL, V19, P73, DOI 10.21101/cejph.a3639; Kelishadi R, 2007, INT J PUBLIC HEALTH, V52, P173, DOI 10.1007/s00038-007-6017-x; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P674, DOI 10.1001/archpsyc.65.6.674; KOZLOWSKI LT, 1984, J APPL SOC PSYCHOL, V14, P244, DOI 10.1111/j.1559-1816.1984.tb02234.x; Kunzle R, 2003, FERTIL STERIL, V79, P287, DOI 10.1016/S0015-0282(02)04664-2; Liberia Institute of Statistics and Geo-Information Services Ministry of Health and Social Welfare National AIDS Control Program ICF-International, 2013, LIB DHS 2013 PREL RE; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; McGue M, 2000, AM J MED GENET, V96, P671, DOI 10.1002/1096-8628(20001009)96:5<671::AID-AJMG14>3.0.CO;2-W; Myers M, 2008, RADIO DEV AFRICA; National Statistical Office ICF Macro, 2010, MAL DEM HLTH SURV 20; Nemeth JM, 2012, J COMMUN HEALTH, V37, P1208, DOI 10.1007/s10900-012-9556-x; Nunez-Smith M, 2010, SUBST ABUS, V31, P174, DOI 10.1080/08897077.2010.495648; Pampel F, 2008, SOC SCI MED, V66, P1772, DOI 10.1016/j.socscimed.2007.12.003; Panday S, 2007, HEALTH PROMOT INT, V22, P207, DOI 10.1093/heapro/dam018; POMERLEAU OF, 1993, J CONSULT CLIN PSYCH, V61, P723, DOI 10.1037/0022-006X.61.5.723; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Said TM, 2005, FERTIL STERIL, V84, P649, DOI 10.1016/j.fertnstert.2005.03.052; Sargent James D, 2005, Adolesc Med Clin, V16, P345, DOI 10.1016/j.admecli.2005.02.003; Sargent JD, 2009, ADDICTION, V104, P815, DOI 10.1111/j.1360-0443.2009.02542.x; Simons-Morton B, 1999, PREV MED, V28, P138, DOI 10.1006/pmed.1998.0404; Storer B, 2014, FERTIL STERIL, V101, pE11, DOI 10.1016/j.fertnstert.2013.11.066; STREBEL P, 1989, J EPIDEMIOL COMMUN H, V43, P209, DOI 10.1136/jech.43.3.209; Swan GE, 2003, CANCER EPIDEM BIOMAR, V12, P994; Tafawa AO, 2012, CANCER CAUSE CONTROL, V23, P45, DOI 10.1007/s10552-012-9898-9; Tumwine J, 2011, INT J ENV RES PUB HE, V8, P4312, DOI 10.3390/ijerph8114312; Uganda Bureau of Statistics, 2011, UG DEM HLTH SURV 201; WHO, 2003, PROT EL ILL TRAD TOB; WHO, 2007, SIFT EV GEND GLOB TO, DOI [10.1093/jxb/erm028PMID:25506957, DOI 10.1093/JXB/ERM028]; Zimbabwe National Statistics Agency ICF-International, 2012, ZIMBABWE DEMOGRAPHIC; Znaor A, 2003, INT J CANCER, V105, P681, DOI 10.1002/ijc.11114	51	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117219	10.1371/journal.pone.0117219	http://dx.doi.org/10.1371/journal.pone.0117219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9BI	25706131	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100066
J	Martins, MVA; Silva, F; Laut, LLM; Frontalini, F; Clemente, IMMM; Miranda, P; Figueira, R; Sousa, SHM; Dias, JMA				Alves Martins, Maria Virgnia; Silva, Frederico; Laut, Lazaro L. M.; Frontalini, Fabrizio; Clemente, Iara M. M. M.; Miranda, Paulo; Figueira, Rubens; Sousa, Silvia H. M.; Alveirinho Dias, Joao M.			Response of Benthic Foraminifera to Organic Matter Quantity and Quality and Bioavailable Concentrations of Metals in Aveiro Lagoon (Portugal)	PLOS ONE			English	Article							HEAVY-METALS; COASTAL SEDIMENTS; WATER-QUALITY; TROPHIC STATE; ESTUARY RIA; POLLUTION; MERCURY; MARINE; ASSEMBLAGES; OXYGEN	This work analyses the distribution of living benthic foraminiferal assemblages of surface sediments in different intertidal areas of Ria de Aveiro (Portugal), a polihaline and anthropized coastal lagoon. The relationships among foraminiferal assemblages in association with environmental parameters (temperature, salinity, Eh and pH), grain size, the quantity and quality of organic matter (enrichment in carbohydrates, proteins and lipids), pollution caused by metals, and mineralogical data are studied in an attempt to identify indicators of adaptability to environmental stress. In particular, concentrations of selected metals in the surficial sediment are investigated to assess environmental pollution levels that are further synthetically parameterised by the Pollution Load Index (PLI). The PLI variations allowed the identification of five main polluted areas. Concentrations of metals were also analysed in three extracted phases to evaluate their possible mobility, bioavailability and toxicity in the surficial sediment. Polluted sediment in the form of both organic matter and metals can be found in the most confined zones. Whereas enrichment in organic matter and related biopolymers causes an increase in foraminifera density, pollution by metals leads to a decline in foraminiferal abundance and diversity in those zones. The first situation may be justified by the existence of opportunistic species (with high reproduction rate) that can live in low oxic conditions. The second is explained by the sensitivity of some species to pressure caused by metals. The quality of the organic matter found in these places and the option of a different food source should also explain the tolerance of several species to pollution caused by metals, despite their low reproductive rate in the most polluted areas. In this study, species that are sensitive and tolerant to organic matter and metal enrichment are identified, as is the differential sensitivity/tolerance of some species to metals enrichment.	[Alves Martins, Maria Virgnia; Clemente, Iara M. M. M.] Univ Estado Rio de Janeiro, Fac Geol, Dept Estratig & Paleontol, BR-20550013 Rio De Janeiro, RJ, Brazil; [Alves Martins, Maria Virgnia; Miranda, Paulo] Univ Aveiro, Dept Geociencias, P-3810193 Aveiro, Portugal; [Silva, Frederico] Univ Fed Rio de Janeiro, Lab Palinofacies & Facies Organ LAFO, BR-21949900 Rio De Janeiro, RJ, Brazil; [Laut, Lazaro L. M.] Univ Fed Estado Rio de Janeiro UNIRIO, Lab Micropaleontol LabMicro, BR-22290240 Rio De Janeiro, RJ, Brazil; [Frontalini, Fabrizio] Univ Urbino Carlo Bo, Dipartimento Sci Terra Vita & Ambiente DiSTeVA, Urbino, Italy; [Figueira, Rubens; Sousa, Silvia H. M.] Univ Sao Paulo, Inst Oceanog, BR-30916502 Sao Paulo, Brazil; [Alveirinho Dias, Joao M.] Univ Algarve, Ctr Invest Marinha & Ambiental, Faro, Portugal	Universidade do Estado do Rio de Janeiro; Universidade de Aveiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; University of Urbino; Universidade de Sao Paulo; Universidade do Algarve	Martins, MVA (corresponding author), Univ Estado Amazonas, Av Djalma Batista 3578, BR-69050010 Manaus, Amazonas, Brazil.	virginia.martins@ua.pt	Alves Martins, Maria Virginia/AAD-3531-2021; Figueira, Rubens RCL/C-5958-2013; Frontalini, Fabrizio/C-4819-2008; Figueira, Rubens/AAC-1045-2022; Laut, Lazaro L.M./K-4782-2012; Laut, Lazaro/O-4193-2019; Martins, Maria Virginia Alves/O-2893-2013; da Silva, Frederico/AAB-3872-2020; de Mello e Sousa, Silvia Helena/ABH-5834-2020	Alves Martins, Maria Virginia/0000-0001-8348-8862; Frontalini, Fabrizio/0000-0002-0425-9306; Figueira, Rubens/0000-0001-8945-4540; Laut, Lazaro L.M./0000-0002-5637-1930; Laut, Lazaro/0000-0002-5637-1930; Martins, Maria Virginia Alves/0000-0001-8348-8862; Mello e Sousa, Silvia Helena/0000-0002-8860-9042; Dias, Joao/0000-0002-1653-1821; da Silva, Frederico/0000-0002-8412-8460	CNPq [401803/2010-4];  [PEst-OE/CTE/UI4035/2014]; Fundação para a Ciência e a Tecnologia [PEst-OE/CTE/UI4035/2014] Funding Source: FCT	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ; Fundação para a Ciência e a Tecnologia	Funding: This work was supported by Project PEst-OE/CTE/UI4035/2014 and CNPq 401803/2010-4. The funds of PEst-OE/CTE/UI4035/2014 and CNPq (401803/2010-4) were applied to data collection and analysis.	Aloulou F, 2012, ENVIRON MONIT ASSESS, V184, P777, DOI 10.1007/s10661-011-2001-2; ALVE E, 1995, J FORAMIN RES, V25, P190, DOI 10.2113/gsjfr.25.3.190; ALVE E, 1991, J FORAMIN RES, V21, P1, DOI 10.2113/gsjfr.21.1.1; American Society for Testing and Materials (ASTM), 2008, 4239 ASTM; Ariza Maria E., 1994, In Vivo (Attiki), V8, P559; Avilavalappil A, 2014, SCI MAR, V78, P389, DOI 10.3989/scimar.03945.16B; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouchet VMP, 2007, MAR ENVIRON RES, V64, P358, DOI 10.1016/j.marenvres.2007.02.007; Buchman M. F., 1999, 991 NOAA HAZMAT; Calderon J, 2003, ECOTOX ENVIRON SAFE, V56, P93, DOI 10.1016/S0147-6513(03)00053-8; Cardoso PG, 2013, MAR POLLUT BULL, V72, P188, DOI 10.1016/j.marpolbul.2013.04.004; Caruso A, 2011, CHEM ECOL, V27, P9, DOI 10.1080/02757540.2010.529076; Coccioni R, 2009, MAR POLLUT BULL, V59, P257, DOI 10.1016/j.marpolbul.2009.08.009; Coelho JP, 2007, MAR POLLUT BULL, V54, P475, DOI 10.1016/j.marpolbul.2006.11.020; Coelho JP, 2006, ESTUAR COAST SHELF S, V69, P629, DOI 10.1016/j.ecss.2006.05.027; Correia MJ, 2000, SYMBIOSIS, V29, P343; Cotano U, 2006, MAR POLLUT BULL, V52, P404, DOI 10.1016/j.marpolbul.2005.09.027; Cunha MA, 1999, ACTA OECOL, V20, P227, DOI 10.1016/S1146-609X(99)00143-5; Cunha MA, 2003, ACTA OECOL, V24, pS97, DOI 10.1016/S1146-609X(03)00014-6; DAME R, 1986, MAR ECOL PROG SER, V33, P217, DOI 10.3354/meps033217; Danovaro R, 1993, THESIS U PISA; Debenay JP, 2000, T GEOBIOL, V15, P39; Debenay JP, 2001, MAR MICROPALEONTOL, V43, P75, DOI 10.1016/S0377-8398(01)00023-8; Dell'Anno A, 2002, MAR POLLUT BULL, V44, P611, DOI 10.1016/S0025-326X(01)00302-2; Denoyelle M, 2012, ECOL INDIC, V12, P17, DOI 10.1016/j.ecolind.2011.05.011; Dey M, 2012, WETLANDS, V32, P813, DOI 10.1007/s13157-012-0312-x; Dias JM, 1999, OCEANOL ACTA, V22, P473, DOI 10.1016/S0399-1784(00)87681-1; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dupuy C, 2010, J FORAMIN RES, V40, P305, DOI 10.2113/gsjfr.40.4.305; Ellis B, 1941, AM NUS NAT HIST SPEC; Ferraro L, 2006, ENVIRON POLLUT, V142, P274, DOI 10.1016/j.envpol.2005.10.026; Folk R. L., 1957, J SEDIMENT PETROL, V27, P3, DOI [10.1306/74d70646-2b21-11d7-8648000102c1865, 10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D]; Fontana LF, 2006, ANU I GEOC UFRJ, V29, P415; Frontalini Fabrizio, 2011, Revue de Micropaleontologie, V54, P115, DOI 10.1016/j.revmic.2011.03.001; Frontalini F, 2010, ENVIRON MONIT ASSESS, V170, P245, DOI 10.1007/s10661-009-1229-6; Frontalini F, 2009, MAR POLLUT BULL, V58, P858, DOI 10.1016/j.marpolbul.2009.01.015; Genio L, 2008, J SEA RES, V59, P133, DOI 10.1016/j.seares.2007.09.001; GERCHAKO.SM, 1972, LIMNOL OCEANOGR, V17, P938, DOI 10.4319/lo.1972.17.6.0938; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Harwood J.L., 1984, LIPIDS PLANTS MICROB; Horton BP, 1999, MAR MICROPALEONTOL, V36, P205, DOI 10.1016/S0377-8398(99)00003-1; KNIGHT R, 1985, MAR ECOL PROG SER, V23, P241, DOI 10.3354/meps023241; Lee JJ, 2006, SYMBIOSIS, V42, P63; Levinton JS, 1979, ECOLOGY MARINE DEPOS, P1; Lipps J.H., 1983, Topics in Geobiology, V3, P331; Loeblich AR., 1987, FORAMINIFERAL GENERA; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Lopes JF, 2006, J HYDROL, V319, P176, DOI 10.1016/j.jhydrol.2005.07.019; Lopes JF, 2005, MAR ENVIRON RES, V60, P594, DOI 10.1016/j.marenvres.2005.05.001; Lopes JF, 2008, ENVIRON MODELL SOFTW, V23, P479, DOI 10.1016/j.envsoft.2007.07.001; Lopes JF, 2006, ECOL MODEL, V197, P67, DOI 10.1016/j.ecolmodel.2006.03.012; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; MARSH JB, 1966, J LIPID RES, V7, P574; Martins V, 2010, ESTUAR COAST SHELF S, V87, P293, DOI 10.1016/j.ecss.2010.01.011; Martins V, 2007, MAR GEOL, V239, P1, DOI 10.1016/j.margeo.2006.11.001; Martins VA, 2013, MAR POLLUT BULL, V70, P18, DOI 10.1016/j.marpolbul.2013.02.003; Muri G, 2004, ORG GEOCHEM, V35, P1083, DOI 10.1016/j.orggeochem.2004.06.004; Murray J. W., 1991, ECOLOGY PALAEOECOLOG; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Murray JW, 2000, J FORAMIN RES, V30, P66, DOI 10.2113/0300066; Murrell MC, 1999, LIMNOL OCEANOGR, V44, P295, DOI 10.4319/lo.1999.44.2.0295; Nilin J, 2012, SCI TOTAL ENVIRON, V435, P44, DOI 10.1016/j.scitotenv.2012.06.107; Pascal PY, 2008, J EXP MAR BIOL ECOL, V359, P55, DOI 10.1016/j.jembe.2008.02.018; Pereira ME, 2009, ENVIRON MONIT ASSESS, V155, P39, DOI 10.1007/s10661-008-0416-1; Platon E, 2001, COAST EST S, V58, P147; Pusceddu A, 2000, POLAR BIOL, V23, P288, DOI 10.1007/s003000050446; Pusceddu A., 2007, CHEM ECOL, V23, P1; Pastorinho MR, 2012, ENVIRON EARTH SCI, V67, P2043, DOI 10.1007/s12665-012-1643-x; RICE DL, 1982, MAR ECOL PROG SER, V9, P153, DOI 10.3354/meps009153; Sabbatini A, 2012, J MARINE SYST, V105, P163, DOI 10.1016/j.jmarsys.2012.07.009; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; Schumacher BA., 2002, ECOLOGICAL RISK ASSE; SenGupta BK, 1996, GEOLOGY, V24, P227, DOI 10.1130/0091-7613(1996)024<0227:SODICS>2.3.CO;2; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Tchounwou PB, 2003, ENVIRON TOXICOL, V18, P149, DOI 10.1002/tox.10116; TOMLINSON DL, 1980, HELGOLANDER MEERESUN, V33, P566, DOI 10.1007/BF02414780; Vaz N, 2005, OCEAN DYNAM, V55, P416, DOI 10.1007/s10236-005-0015-4; Vaz N, 2008, J MARINE SYST, V70, P168, DOI 10.1016/j.jmarsys.2007.05.002; Ward JN, 2003, MAR ENVIRON RES, V56, P515, DOI 10.1016/S0141-1136(03)00040-0; Welker C, 2002, ESTUAR COAST SHELF S, V55, P259, DOI 10.1006/ecss.2001.0901	80	71	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118077	10.1371/journal.pone.0118077	http://dx.doi.org/10.1371/journal.pone.0118077			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706860	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100141
J	Bremond, P; Roca, Y; Breniere, SF; Walter, A; Barja-Simon, Z; Fernandez, RT; Vargas, J				Bremond, Philippe; Roca, Yelin; Breniere, Simone Frederique; Walter, Annie; Barja-Simon, Zaira; Torres Fernandez, Roberto; Vargas, Jorge			Evolution of Dengue Disease and Entomological Monitoring in Santa Cruz, Bolivia 2002-2008	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; MAYARO-VIRUS; TRANSMISSION; FEVER; COMMUNICATION; PRODUCTIVITY; CONTAINERS; INFECTION; EPIDEMIC; IDENTIFY	Background In the context of a rapid increase of dengue cases in the Americas, a monitoring system based on systematic serological control (IgM) of patients consulting for suspected dengue was developed in Bolivia at the end of the 1990s. In the most affected city of Santa Cruz, this system was complemented by an entomological surveillance program based on periodical search for immature stages of Aedes aegypti in dwelling water-holding containers. Here, we analyze these data and describe dengue patterns over 6 years (2002-2008), highlighting the spatial distribution of patients and vectors. Methodology/Principal Findings Data mining concerned six annual epidemic cycles (2002-2008), with continuous serological and clinical results and entomological data from 16 surveys, examined at the scales of 36 urban areas and four concentric areas covering the entire city. Annual incidence varied from 0.28% to 0.95%; overall incidence was higher in women and adults, and dengue dynamics followed successive periods of high (January-June) and low (July-December) transmission. Lower numbers of cases from the city center to the periphery were observed, poorly related to the more homogeneous and permanent distribution of A. aegypti. "Plant pots" were a major vector source in the city center, and "Tires" and "Odds and ends" beyond the second ring of the city. Conclusions/Significance Over the years, the increasing trend of dengue cases has been highlighted as well as its widespread distribution over the entire city, but an underestimation of the number of cases is strongly suspected. Contrary to popular belief, the city center appears more affected than the periphery, and dengue is not particularly related to waste. Interestingly, the clinical diagnosis of dengue by physicians improved over the years, whatever the gender, age and residential area of suspected cases.	[Bremond, Philippe; Breniere, Simone Frederique; Walter, Annie] IRD, INTERTRYP, CIRAD, Interact Hote Vecteur Parasite Malad Dues Trypano, Montpellier, France; [Torres Fernandez, Roberto] Serv Dept Salud, Santa Cruz, Bolivia	CIRAD; Institut de Recherche pour le Developpement (IRD)	Breniere, SF (corresponding author), IRD, INTERTRYP, CIRAD, Interact Hote Vecteur Parasite Malad Dues Trypano, Montpellier, France.	Frederique.breniere@ird.fr	Breniere, Simone Frederique/J-9214-2016	Breniere, Simone Frederique/0000-0003-4385-3989				Abad-Franch F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001846; [Anonymous], 2011, POINT EPIDEMIO, V2, P1; Barrera R, 1995, Bull Pan Am Health Organ, V29, P193; Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2; Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002; Chiaravalloti Neto F, 1997, Rev Soc Bras Med Trop, V30, P279; Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Garcia-Rejon JE, 2011, AM J TROP MED HYG, V84, P489, DOI 10.4269/ajtmh.2011.10-0654; Gianella A, 1998, SALUD PUBLICA MEXICO, V40, P469, DOI 10.1590/S0036-36341998000600002; Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277; Lenhart AE, 2006, ANN TROP MED PARASIT, V100, pS53, DOI 10.1179/136485906X105516; Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Macoris M L, 1997, Rev Panam Salud Publica, V1, P280, DOI 10.1590/S1020-49891997000400004; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; Mazine CAB, 1996, J AM MOSQUITO CONTR, V12, P732; Morrison AC, 2006, ANN TROP MED PARASIT, V100, pS73, DOI 10.1179/136485906X105534; Nathan MB, 2006, ANN TROP MED PARASIT, V100, pS1, DOI 10.1179/136485906X105462; de Melo DPO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042125; Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012; Peredo Carlos, 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P207, DOI 10.1590/S0036-46651999000300015; PINHEIRO Valéria Cristina Soares, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P245, DOI 10.1590/S0036-46652002000500002; REITER P, 1987, J AM MOSQUITO CONTR, V3, P494; Roca Y, 2009, REV ENFERMEDADES INF, V1, P6; Roca Y, 2009, VECTOR-BORNE ZOONOT, V9, P337, DOI 10.1089/vbz.2008.0187; Romero-Vivas CME, 2006, ANN TROP MED PARASIT, V100, pS87, DOI 10.1179/136485906X105543; Souza-Santos Reinaldo, 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P373, DOI 10.1590/S0037-86821999000400007; Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P14, DOI 10.1179/2046904712Z.00000000046; Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002; Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070; Tumioto GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104394; TunLin W, 1995, AM J TROP MED HYG, V53, P591, DOI 10.4269/ajtmh.1995.53.591; Van der Stuyft P, 1998, TROP MED INT HEALTH, V3, P857; Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003	36	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118337	10.1371/journal.pone.0118337	http://dx.doi.org/10.1371/journal.pone.0118337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706631	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100170
J	Huang, J; Marchal, E; Hult, EF; Tobe, SS				Huang, Juan; Marchal, Elisabeth; Hult, Ekaterina F.; Tobe, Stephen S.			Characterization of the Juvenile Hormone Pathway in the Viviparous Cockroach, Diploptera punctata	PLOS ONE			English	Article							HMG-COA REDUCTASE; ACID-O-METHYLTRANSFERASE; COENZYME-A REDUCTASE; CORPORA-ALLATA; REPRODUCTIVE-CYCLE; MEVALONATE PATHWAY; MOLECULAR-CLONING; CORPUS ALLATUM; BIOSYNTHESIS; EXPRESSION	Juvenile hormones (JHs) are key regulators of insect development and reproduction. The JH biosynthetic pathway is known to involve 13 discrete enzymatic steps. In the present study, we have characterized the JH biosynthetic pathway in the cockroach Diploptera punctata. The effect of exogenous JH precursors on JH biosynthesis was also determined. Based on sequence similarity, orthologs for the genes directly involved in the pathway were cloned, and their spatial and temporal transcript profiles were determined. The effect of shutting down the JH pathway in adult female cockroaches was studied by knocking down genes encoding HMG-CoA reductase (HMGR) and Juvenile hormone acid methyltransferase (JHAMT). As a result, oocyte development slowed as a consequence of reduction in JH biosynthesis. Oocyte length, fat body transcription of Vg and ovarian vitellin content significantly decreased. In addition, silencing HMGR and JHAMT resulted in a decrease in the transcript levels of other genes in the pathway.	[Huang, Juan; Marchal, Elisabeth; Hult, Ekaterina F.; Tobe, Stephen S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Marchal, Elisabeth] Katholieke Univ Leuven, Inst Zool, Dept Biol, Leuven, Belgium	University of Toronto; KU Leuven	Tobe, SS (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	stephen.tobe@utoronto.ca	Tobe, Stephen S./A-1445-2008	Marchal, Elisabeth/0000-0003-1310-4792	Natural Sciences and Engineering Research Council of Canada; China Scholarship Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); China Scholarship Council(China Scholarship Council)	The authors wish to thank the Natural Sciences and Engineering Research Council of Canada and the China Scholarship Council doctoral award for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bomtorin AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086923; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao L, 2009, BIOCHEM BIOPH RES CO, V380, P188, DOI 10.1016/j.bbrc.2009.01.079; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Cheng DJ, 2014, GENET MOL BIOL, V37, P444, DOI [10.1590/S1415-47572014005000006, 10.1590/S1415-47572014000300018]; CLARKE CF, 1987, MOL CELL BIOL, V7, P3138, DOI 10.1128/MCB.7.9.3138; COUILLAUD F, 1991, INSECT BIOCHEM, V21, P131, DOI 10.1016/0020-1790(91)90042-D; DEBERNARD S, 1994, GEN COMP ENDOCR, V95, P92, DOI 10.1006/gcen.1994.1105; Defelipe LA, 2011, INSECT BIOCHEM MOLEC, V41, P228, DOI 10.1016/j.ibmb.2010.12.008; FEYEREISEN R, 1987, MOL CELL ENDOCRINOL, V53, P227, DOI 10.1016/0303-7207(87)90178-X; FEYEREISEN R, 1981, ANAL BIOCHEM, V111, P372, DOI 10.1016/0003-2697(81)90575-3; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goodman W.G., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2.10008-1; Granger NA, 1996, ARCH INSECT BIOCHEM, V32, P449, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;449::AID-ARCH17&gt;3.0.CO;2-C; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Hiruma K, 2013, CURR TOP DEV BIOL, V103, P73, DOI 10.1016/B978-0-12-385979-2.00003-4; Huang J, 2014, INSECT BIOCHEM MOLEC, V54, P61, DOI 10.1016/j.ibmb.2014.09.001; Kaneko Y, 2014, DEV BIOL, V393, P312, DOI 10.1016/j.ydbio.2014.07.014; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Li WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081616; Marchal E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106737; Marchal Elisabeth, 2013, BMC Res Notes, V6, P237, DOI 10.1186/1756-0500-6-237; Marchal E, 2013, GEN COMP ENDOCR, V188, P85, DOI 10.1016/j.ygcen.2013.04.018; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; MARTINEZGONZALEZ J, 1993, EUR J BIOCHEM, V213, P233, DOI 10.1111/j.1432-1033.1993.tb17753.x; Mayoral JG, 2009, P NATL ACAD SCI USA, V106, P21091, DOI 10.1073/pnas.0909938106; Mayoral JG, 2009, INSECT BIOCHEM MOLEC, V39, P31, DOI 10.1016/j.ibmb.2008.09.010; Meigs TE, 1997, ARCH BIOCHEM BIOPHYS, V345, P1, DOI 10.1006/abbi.1997.0200; Meigs TE, 1996, J BIOL CHEM, V271, P7916, DOI 10.1074/jbc.271.14.7916; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; MONGER DJ, 1982, BIOCHEM BIOPH RES CO, V105, P1374, DOI 10.1016/0006-291X(82)90939-1; MUNDALL EC, 1981, J INSECT PHYSIOL, V27, P821, DOI 10.1016/0022-1910(81)90083-4; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013; Nouzova M, 2011, INSECT BIOCHEM MOLEC, V41, P660, DOI 10.1016/j.ibmb.2011.04.008; Nyati P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071967; PRATT GE, 1972, J EXP BIOL, V56, P201; Pszczolkowski MA, 1999, MOL CELL ENDOCRINOL, V158, P163, DOI 10.1016/S0303-7207(99)00167-7; RANKIN SM, 1984, GEN COMP ENDOCR, V54, P382, DOI 10.1016/0016-6480(84)90151-5; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Rivera-Perez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043784; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; STAY B, 1978, GEN COMP ENDOCR, V34, P276, DOI 10.1016/0016-6480(78)90249-6; Stoltzman CA, 1997, EUR J ENTOMOL, V94, P335; THOMPSON CS, 1990, J COMP PHYSIOL B, V160, P241, DOI 10.1007/BF00302589; TOBE SS, 1979, NATURE, V281, P481, DOI 10.1038/281481a0; TOBE SS, 1985, INSECT BIOCHEM, V15, P175, DOI 10.1016/0020-1790(85)90005-8; TOBE SS, 1985, EXPERIENTIA, V41, P1028, DOI 10.1007/BF01952127; Ueda H, 2009, J INSECT PHYSIOL, V55, P798, DOI 10.1016/j.jinsphys.2009.04.013; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067732; Weaver RJ, 2009, ANN NY ACAD SCI, V1163, P316, DOI 10.1111/j.1749-6632.2009.04459.x	54	31	35	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117291	10.1371/journal.pone.0117291	http://dx.doi.org/10.1371/journal.pone.0117291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706877	gold, Green Submitted, Green Published			2022-12-27	WOS:000350662100072
J	Kania, I				Kania, Iwona			Subfamily Limoniinae Speiser, 1909 (Diptera, Limoniidae) from Baltic Amber (Eocene): The Genus Elephantomyia Osten Sacken, 1860	PLOS ONE			English	Article								A revision of the genus Elephantomyia Osten Sacken (Diptera: Limoniidae) from Baltic amber (Eocene) is presented. Four species-E. baltica Alexander, E. brevipalpa Loew, E. longirostris Loew, and E. pulchella Loew-are redescribed and documented with photographs and drawings. In addition, two new species of the genus are described: Elephantomyia bozenae sp. nov., and Elephantomyia irinae sp. nov. All these fossil species are placed within the subgenus Elephantomyia. A key to the extinct species of Elephantomyia is provided, and the genus' ecological pattern and evolutionary aspects are discussed.				ikania@univ.rzeszow.pl		Kania, Iwona/0000-0002-2325-4308				Alexander C. P., 1938, Annals & Magazine of Natural History London 1938 (11), V1, P336; Alexander C. P., 1921, Proceedings of the Academy of Natural Sciences of Philadelphia, V73, P39; Alexander C. P., 1923, Annals of the Entomological Society of America, V16, P57; ALEXANDER CHARLES P., 1931, BERNSTEIN FORSCHUNGEN [AMBER STUDIES], V2, P1; Alexander CP., 1965, J KANSAS ENTOMOL SOC, V38, P401; BENGTSON P, 1988, PALAEONTOLOGY, V31, P223; Friis EM, 2011, EARLY FLOWERS ANGIOS, DOI [10.1093/aob/mcr088, DOI 10.1093/AOB/MCR088]; Kania I, 2013, INSECT SYST EVOL, V44, P231, DOI 10.1163/1876312X-44032093; KRZEMINSKI W, 1992, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V65, P39; Krzeminski W, 2014, CRETACEOUS RES, V48, P96, DOI 10.1016/j.cretres.2013.12.001; Krzeminski Wieslaw, 2002, Acta Zoologica Cracoviensia, V45, P317; Labandeira Conrad C., 2005, P217; Latreille P.A., 1828, ENCY METHODIQUE HIST, V10, P345, DOI DOI 10.5962/BHL.TITLE.82248; Linnaeus C, 1758, SYSTEMA NATURE PER R, VI; Loew H., 1850, PROGRAMM KONIGLICHEN, V1850, P1, DOI [10.5962/bhl.title.98386, DOI 10.5962/BHL.TITLE.98386]; Loew H., 1851, LINNAEA ENTOMOLOGICA, V5, P385; MATTHEWS S C, 1973, Palaeontology (Oxford), V16, P713; Meunier F., 1906, Annales des Sciences Naturelles Zoologie Paris ser 9, V4; Oosterbroek P., 2014, CATALOGUE CRANE FLIE; Osten Sacken C. R., 1860, P ACAD NAT SCI PHILA, V1859, P197; Osten Sacken CR, 1869, SMITHSONIAN MISCELLA, V8, P1; Petersen MJ, 2010, SYST ENTOMOL, V35, P526, DOI 10.1111/j.1365-3113.2010.00524.x; Podenas S, 2012, P ENTOMOL SOC WASH, V114, P347, DOI 10.4289/0013-8797.114.3.347; Ribeiro Guilherme Cunha, 2006, Zootaxa, V1110, P47; Ribeiro Guilherme Cunha, 2003, Studia Dipterologica, V9, P403; Scudder SH., 1894, P AM PHILOS SOC, V32, P163; Speiser P, 1909, WISSENSCHAFTLICHE ER, V10, P31; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; Thien LB, 2009, AM J BOT, V96, P166, DOI 10.3732/ajb.0800016; Westwood JO., 1836, ANN SOC ENTOMOL FR, V4, P681	30	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117434	10.1371/journal.pone.0117434	http://dx.doi.org/10.1371/journal.pone.0117434			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706127	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100086
J	Mathur, R; Ince, PG; Minett, T; Garwood, CJ; Shaw, PJ; Matthews, FE; Brayne, C; Simpson, JE; Wharton, SB				Mathur, Ryan; Ince, Paul G.; Minett, Thais; Garwood, Claire J.; Shaw, Pamela J.; Matthews, Fiona E.; Brayne, Carol; Simpson, Julie E.; Wharton, Stephen B.		MRC Cognitive Function Ageing	A Reduced Astrocyte Response to beta-Amyloid Plaques in the Ageing Brain Associates with Cognitive Impairment	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; ALZHEIMERS-DISEASE; CINGULATE CORTEX; CEREBRAL-CORTEX; APOE GENOTYPE; DEPOSITS; MICROGLIA; DEMENTIA; NEUROPATHOLOGY; MECHANISMS	Aims beta-amyloid (A beta) plaques are a key feature of Alzheimer's disease pathology but correlate poorly with dementia. They are associated with astrocytes which may modulate the effect of A beta-deposition on the neuropil. This study characterised the astrocyte response to A beta plaque subtypes, and investigated their association with cognitive impairment. Methods A beta plaque subtypes were identified in the cingulate gyrus using dual labelling immunohistochemistry to A beta and GFAP(+) astrocytes, and quantitated in two cortical areas: the area of densest plaque burden and the deep cortex near the white matter border (layer VI). Three subtypes were defined for both diffuse and compact plaques (also known as classical or core-plaques): A beta plaque with (1) no associated astrocytes, (2) focal astrogliosis or (3) circumferential astrogliosis. Results In the area of densest burden, diffuse plaques with no astrogliosis (beta = -0.05, p = 0.001) and with focal astrogliosis (beta = -0.27, p = 0.009) significantly associated with lower MMSE scores when controlling for sex and age at death. In the deep cortex (layer VI), both diffuse and compact plaques without astrogliosis associated with lower MMSE scores (beta = -0.15, p = 0.017 and beta = -0.81, p = 0.03, respectively). Diffuse plaques with no astrogliosis in layer VI related to dementia status (OR = 1.05, p = 0.025). In the area of densest burden, diffuse plaques with no astrogliosis or with focal astrogliosis associated with increasing Braak stage (beta = 0.01, p< 0.001 and beta = 0.07, p< 0.001, respectively), and ApoE epsilon 4 genotype OR = 1.02, p = 0.001 and OR = 1.10, p = 0.016, respectively). In layer VI all plaque subtypes associated with Braak stage, and compact amyloid plaques with little and no associated astrogliosis associated with ApoE epsilon 4 genotype ( OR = 1.50, p = 0.014 and OR = 0.10, p = 0.003, respectively). Conclusions Reactive astrocytes in close proximity to either diffuse or compact plaques may have a neuroprotective role in the ageing brain, and possession of at least one copy of the ApoEe4 allele impacts the astroglial response to A beta plaques.	[Mathur, Ryan; Ince, Paul G.; Garwood, Claire J.; Shaw, Pamela J.; Simpson, Julie E.; Wharton, Stephen B.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Minett, Thais; Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Matthews, Fiona E.] MRC Biostat Unit, Cambridge, England	University of Sheffield; University of Cambridge; MRC Biostatistics Unit	Simpson, JE (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.	julie.simpson@sheffield.ac.uk	Simpson, Julie/C-7914-2009; Matthews, Fiona/O-6932-2015; Brayne, Carol/AAA-4285-2020; minett, thais/B-8733-2008	Simpson, Julie/0000-0002-3753-4271; Matthews, Fiona/0000-0002-1728-2388; Brayne, Carol/0000-0001-5307-663X; minett, thais/0000-0002-3232-9455; Wharton, Stephen B/0000-0003-2785-333X; Shaw, Pamela/0000-0002-8925-2567; Garwood, Claire/0000-0001-8611-177X	Medical Research Council [MRC/G0900582/1]; Sheffield charity Neurocare; MRC [MRJ004308/1]; ARUK [ART:PG2010-5]; Department of Health and the Medical Research Council [MRC/G9901400, MRC U.1052.00.0013]; UKNIHR Biomedical Research Centre for Ageing and Age-related Disease Award; MRC [G0400074, G9901400, G0300126, MR/L022656/1, G0900582, MR/L016451/1, G0502157, MC_U105292687, G0900652, G1100540, MR/J004308/1] Funding Source: UKRI; Alzheimers Research UK [ART-PG2010-5] Funding Source: researchfish; Medical Research Council [G0900652, MC_U105292687, G0300126, G0900582, G0502157, G0400074, MR/J004308/1, G9901400, MR/L016451/1, G1100540, MR/L022656/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sheffield charity Neurocare; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ARUK(Alzheimer's Research UK (ARUK)); Department of Health and the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKNIHR Biomedical Research Centre for Ageing and Age-related Disease Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Medical Research Council (MRC/G0900582/1) and the imaging equipment used in this study funded by Sheffield charity Neurocare. JES is supported by the MRC (MRJ004308/1). CG is supported by ARUK (ART:PG2010-5). CFAS is supported by the Department of Health and the Medical Research Council (grants MRC/G9901400 and MRC U.1052.00.0013); the UKNIHR Biomedical Research Centre for Ageing and Age-related Disease Award to the Newcastle upon Tyne Hospitals Foundation Trust; the Cambridge Brain Bank is supported by the NIHR Cambridge Biomedical Research Centre; The Cambridgeshire and Peterborough NIHR CLAHRC; Nottingham University Hospitals NHS Trust; University of Sheffield and the Sheffield Teaching Hospitals NHS Foundation Trust; The Thomas Willis Oxford Brain Collection, supported by the Oxford Biomedical Research Centre; The Walton Centre NHS Foundation Trust, Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 1999, GLIA, V25, P324, DOI 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brayne C, 1998, PSYCHOL MED, V28, P319; Broe M, 2004, BRAIN, V127, P2214, DOI 10.1093/brain/awh250; Christensen DZ, 2010, ACTA NEUROPATHOL, V119, P555, DOI 10.1007/s00401-010-0666-1; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; DeWitt DA, 1998, EXP NEUROL, V149, P329, DOI 10.1006/exnr.1997.6738; Dickson TC, 2001, NEUROSCIENCE, V105, P99, DOI 10.1016/S0306-4522(01)00169-5; Esiri MM, 2001, LANCET, V357, P169; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Gozes I, 1999, ANN NY ACAD SCI, V897, P125, DOI 10.1111/j.1749-6632.1999.tb07884.x; Greenfield JG, 2008, GREENFIELDS NEUROPAT; Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Huang CR, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-9; IKEDA K, 1992, ACTA NEUROPATHOL, V85, P101, DOI 10.1007/BF00304639; INCE PG, 1995, DEMENTIA, V6, P162, DOI 10.1159/000106940; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Kamphuis W, 2014, NEUROBIOL AGING, V35, P492, DOI 10.1016/j.neurobiolaging.2013.09.035; Kersaitis C, 2004, ACTA NEUROPATHOL, V108, P515, DOI 10.1007/s00401-004-0917-0; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marlatt MW, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/693851; Masliah E, 2000, ANN NY ACAD SCI, V924, P68; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; McNamara MJ, 1998, ARCH NEUROL-CHICAGO, V55, P1001, DOI 10.1001/archneur.55.7.1001; Medeiros R, 2013, EXP NEUROL, V239, P133, DOI 10.1016/j.expneurol.2012.10.007; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4; Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nicoll JAR, 2011, NEUROPATH APPL NEURO, V37, P285, DOI 10.1111/j.1365-2990.2010.01130.x; Oh D, 1999, ARCH PATHOL LAB MED, V123, P917; Olichney JM, 1996, NEUROLOGY, V47, P190, DOI 10.1212/WNL.47.1.190; Overmyer M, 1999, DEMENT GERIATR COGN, V10, P252, DOI 10.1159/000017128; Paradisi S, 2004, GLIA, V46, P252, DOI 10.1002/glia.20005; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Romito-DiGiacomo RR, 2007, J NEUROSCI, V27, P8496, DOI 10.1523/JNEUROSCI.1008-07.2007; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Serrano-Pozo A, 2013, J NEUROPATH EXP NEUR, V72, P462, DOI 10.1097/NEN.0b013e3182933788; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Serrano-Pozo A, 2011, AM J PATHOL, V179, P1373, DOI 10.1016/j.ajpath.2011.05.047; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Simpson JE, 2011, NEUROBIOL AGING, V32, P1795, DOI 10.1016/j.neurobiolaging.2011.04.013; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sparks DL, 1996, J NEUROL SCI, V138, P97, DOI 10.1016/0022-510X(96)00008-1; SUTHERLAND RJ, 1988, J NEUROSCI, V8, P1863; TAGLIAVINI F, 1988, NEUROSCI LETT, V93, P191, DOI 10.1016/0304-3940(88)90080-8; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Thal DR, 2000, J NEUROPATH EXP NEUR, V59, P733, DOI 10.1093/jnen/59.8.733; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wharton SB, 2011, J ALZHEIMERS DIS, V25, P359, DOI 10.3233/JAD-2011-091402; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yang CN, 2011, NEUROBIOL DIS, V42, P221, DOI 10.1016/j.nbd.2011.01.005; Yip AG, 2002, J MED GENET, V39, P639, DOI 10.1136/jmg.39.9.639	75	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118463	10.1371/journal.pone.0118463	http://dx.doi.org/10.1371/journal.pone.0118463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25707004	gold, Green Published, Green Accepted			2022-12-27	WOS:000350662100184
J	Steenhoff, AP; Schall, JI; Samuel, J; Seme, B; Marape, M; Ratshaa, B; Goercke, I; Tolle, M; Nnyepi, MS; Mazhani, L; Zemel, BS; Rutstein, RM; Stallings, VA				Steenhoff, Andrew P.; Schall, Joan I.; Samuel, Julia; Seme, Boitshepo; Marape, Marape; Ratshaa, Bakgaki; Goercke, Irene; Tolle, Michael; Nnyepi, Maria S.; Mazhani, Loeto; Zemel, Babette S.; Rutstein, Richard M.; Stallings, Virginia A.			Vitamin D-3 Supplementation in Batswana Children and Adults with HIV: A Pilot Double Blind Randomized Controlled Trial	PLOS ONE			English	Article							D-BINDING PROTEIN; D DEFICIENCY; INFECTED PATIENTS; DISEASE PROGRESSION; CHOLECALCIFEROL; INSUFFICIENCY; TUBERCULOSIS; ADOLESCENTS; EFAVIRENZ; CALCIUM	Objectives Since vitamin D insufficiency is common worldwide in people with HIV, we explored safety and efficacy of high dose cholecalciferol (D-3) in Botswana, and evaluated potential modifiers of serum 25 hydroxy vitamin D change (Delta 25D). Design Prospective randomized double-blind 12-week pilot trial of subjects ages 5.0-50.9 years. Methods Sixty subjects randomized within five age groups to either 4000 or 7000IU per day of D3 and evaluated for vitamin D, parathyroid hormone, HIV, safety and growth status. Efficacy was defined as serum 25 hydroxy vitamin D (25D) >= 32ng/mL, and safety as no simultaneous elevation of serum calcium and 25D. Also assessed were HIV plasma viral RNA viral load (VL), CD4%, anti-retroviral therapy (ART) regime, and height-adjusted (HAZ), weight-adjusted (WAZ) and Body Mass Index (BMIZ) Z scores. Results Subjects were 50% male, age (mean +/- SD) 19.5 +/- 11.8 years, CD4% 31.8 +/- 10.4, with baseline VL log10 range of <1.4 to 3.8 and VL detectable (>1.4) in 22%. From baseline to 12 weeks, 25D increased from 36 +/- 9ng/ml to 56 +/- 18ng/ml (p<0.0001) and 68% and 90% had 25D >= 32ng/ml, respectively (p = 0.02). Delta 25D was similar by dose. No subjects had simultaneously increased serum calcium and 25D. WAZ and BMIZ improved by 12 weeks ( p<0.04). HAZ and CD4% increased and VL decreased in the 7000IU/d group (p<0.04). Younger (5-13y) and older (30-50y) subjects had greater Delta 25D than those 14-29y (26 +/- 17 and 28 +/- 12 vs. 11 +/- 11ng/ml, respectively, p <= 0.001). Delta 25D was higher with efavirenz or nevirapine compared to protease inhibitor based treatment (22 +/- 12, 27 +/- 17, vs. 13 +/- 10, respectively, p <= 0.03). Conclusions In a pilot study in Botswana, 12-week high dose D-3 supplementation was safe and improved vitamin D, growth and HIV status; age and ART regimen were significant effect modifiers.	[Steenhoff, Andrew P.; Seme, Boitshepo; Ratshaa, Bakgaki; Goercke, Irene] Botswana UPenn Partnership, Gaborone, Botswana; [Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Schall, Joan I.; Samuel, Julia; Zemel, Babette S.; Stallings, Virginia A.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Rutstein, Richard M.] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.; Zemel, Babette S.; Rutstein, Richard M.; Stallings, Virginia A.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Marape, Marape; Tolle, Michael] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana; [Nnyepi, Maria S.] Univ Botswana, Dept Nutr, Gaborone, Botswana; [Steenhoff, Andrew P.; Mazhani, Loeto] Univ Botswana, Sch Med, Dept Pediat & Adolescent Hlth, Gaborone, Botswana	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Baylor College of Medicine; University of Botswana; University of Botswana	Steenhoff, AP (corresponding author), Botswana UPenn Partnership, Gaborone, Botswana.	steenhoff@email.chop.edu	Zemel, Babette S./D-1117-2009; Nnyepi, Maria/L-9630-2019	Zemel, Babette S./0000-0002-6164-7348; Nnyepi, Maria/0000-0002-4446-9439	National Center for Research Resources [UL1RR024134]; National Center for Advancing Translational Sciences [UL1TR000003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Jean A. Cortner Endowed Chair, Nutrition Center and the Research Institute at Children's Hospital of Philadelphia (CHOP). The project described was supported by the National Center for Research Resources, Grant UL1RR024134, and is now at the National Center for Advancing Translational Sciences, Grant UL1TR000003. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena C, 2012, J ANTIMICROB CHEMOTH, V67, P2222, DOI 10.1093/jac/dks176; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Arpadi SM, 2012, AM J CLIN NUTR, V95, P678, DOI 10.3945/ajcn.111.024786; Baum MK, 2013, JAMA-J AM MED ASSOC, V310, P2154, DOI 10.1001/jama.2013.280923; BOGIN B, 1979, AM J PHYS ANTHROPOL, V51, P287, DOI 10.1002/ajpa.1330510215; Conesa-Botella A, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-40; Dao CN, 2011, CLIN INFECT DIS, V52, P396, DOI 10.1093/cid/ciq158; Dougherty KA, 2014, JOURNAL PEDIATRIC IN; Ganmaa D, 2012, AM J CLIN NUTR, V96, P391, DOI 10.3945/ajcn.112.034967; Giacomet V, 2013, HIV CLIN TRIALS, V14, P51, DOI 10.1310/hct1402-51; HAUG C, 1994, J INFECT DIS, V169, P889, DOI 10.1093/infdis/169.4.889; Havens PL, 2012, J CLIN ENDOCR METAB, V97, P4004, DOI 10.1210/jc.2012-2600; Kakalia S, 2011, J PEDIATR-US, V159, P951, DOI 10.1016/j.jpeds.2011.06.010; Kuczmarski R J, 2000, Adv Data, P1; LINDSKOG U, 1987, HUM NUTR-CLIN NUTR, V41C, P409; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; Meyzer C, 2013, PEDIATR INFECT DIS J, V32, P1240, DOI 10.1097/INF.0b013e3182a735ed; Mirwald RL, 1997, AM J HUM BIOL, V9, P709, DOI 10.1002/(SICI)1520-6300(1997)9:6<709::AID-AJHB4>3.0.CO;2-M; Pasquet A, 2011, AIDS, V25, P873, DOI 10.1097/QAD.0b013e32834542fa; Pettifor JM, 2008, INDIAN J MED RES, V128, P673; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Rich-Edwards JW, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-28; Rutstein R, 2011, CLIN NUTR, V30, P624, DOI 10.1016/j.clnu.2011.02.005; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Steenhoff AP, 2012, JAIDS-J ACQ IMM DEF, V61, pE21, DOI 10.1097/QAI.0b013e3182683cd2; Teichmann J, 2003, J INFECTION, V46, P221, DOI 10.1053/jinf.2002.1109; Teichmann J, 2000, METABOLISM, V49, P1134, DOI 10.1053/meta.2000.8609; Vieth R, 2012, SCAND J CLIN LAB INV, V72, P144, DOI 10.3109/00365513.2012.682893; Welz T, 2010, AIDS, V24, P1923, DOI 10.1097/QAD.0b013e32833c3281	32	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0117123	10.1371/journal.pone.0117123	http://dx.doi.org/10.1371/journal.pone.0117123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706751	gold, Green Published, Green Submitted			2022-12-27	WOS:000350662100061
J	Takasu, M; Kaichi, Y; Tani, C; Date, S; Akiyama, Y; Kuroda, Y; Sakai, A; Awai, K				Takasu, Miyuki; Kaichi, Yoko; Tani, Chihiro; Date, Shuji; Akiyama, Yuji; Kuroda, Yoshiaki; Sakai, Akira; Awai, Kazuo			Iterative Decomposition of Water and Fat with Echo Asymmetry and Least-Squares Estimation (IDEAL) Magnetic Resonance Imaging as a Biomarker for Symptomatic Multiple Myeloma	PLOS ONE			English	Article							INDEPENDENT RISK-FACTOR; BONE-MARROW ASPIRATION; LIGHT-CHAIN RATIO; MONOCLONAL GAMMOPATHY; TREPHINE BIOPSY; DIXON TECHNIQUE; STAGING SYSTEM; PROGRESSION; QUANTIFICATION; SEPARATION	Introduction To evaluate the effectiveness of iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) magnetic resonance imaging (MRI)to discriminate between symptomatic and asymptomatic myeloma in lumbar bone marrow without visible focal lesions. Materials and Methods The lumbar spine was examined with 3-T MRI in 11 patients with asymptomatic myeloma and 24 patients with symptomatic myeloma. The fat-signal fraction was calculated from the ratio of the signal intensity in the fat image divided by the signal intensity of the corresponding ROI in the in-phase IDEAL image. The t test was used to compare the asymptomatic and symptomatic groups. ROC curves were constructed to determine the ability of variables to discriminate between symptomatic and asymptomatic myeloma. Results Univariate analysis showed that beta 2-microglobulin and bone marrow plasma cell percent (BMPC%) were significantly higher and fat-signal fraction was significantly lower with symptomatic myeloma than with asymptomatic myeloma. Areas under the curve were 0.847 for beta 2;-microglobulin, 0.834 for fat-signal fraction, and 0.759 for BMPC%. Conclusion The fat-signal fraction as a biomarker for multiple myeloma enables discrimination of symptomatic myeloma from asymptomatic myeloma. The fat-signal fraction offers superior sensitivity and specificity to BMPC% of biopsy specimens.	[Takasu, Miyuki; Kaichi, Yoko; Tani, Chihiro; Date, Shuji; Akiyama, Yuji; Awai, Kazuo] Hiroshima Univ, Dept Diagnost Radiol, Grad Sch Biomed Sci, Hiroshima, Japan; [Kuroda, Yoshiaki] Hiroshima Univ, Dept Hematol & Oncol, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Sakai, Akira] Fukushima Med Univ, Sch Med, Dept Radiat Life Sci, Fukushima, Japan	Hiroshima University; Hiroshima University; Fukushima Medical University	Takasu, M (corresponding author), Hiroshima Univ, Dept Diagnost Radiol, Grad Sch Biomed Sci, Hiroshima, Japan.	my-takasu@syd.odn.ne.jp	Takasu, Miyuki/AAG-7737-2019	Takasu, Miyuki/0000-0001-7375-6501	Japan and International Myeloma Foundation Japan's Research Grants	Japan and International Myeloma Foundation Japan's Research Grants	MT supported by Japan and International Myeloma Foundation Japan's Research Grants 2012, which provided funding for the Japan Myeloma Study Group, 35 Gengo Moriokamachi Obu-shi Aichi, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain BJ, 2006, HAEMATOLOGICA, V91, P1293; Bain BJ, 2003, BRIT J HAEMATOL, V121, P949, DOI 10.1046/j.1365-2141.2003.04329.x; Barlogie B, 2008, BLOOD, V112, P3122, DOI 10.1182/blood-2008-06-164228; BATAILLE R, 1984, BLOOD, V63, P468; Berber I, 2014, MED PRIN PRACT, V23, P380, DOI 10.1159/000358173; Berglund J, 2011, MAGN RESON MED, V65, P994, DOI 10.1002/mrm.22679; Breyer RJ, 2006, SKELETAL RADIOL, V35, P632, DOI 10.1007/s00256-006-0127-z; Bydder M, 2008, MAGN RESON IMAGING, V26, P347, DOI 10.1016/j.mri.2007.08.012; Dimopoulos MA, 2012, ANN ONCOL, V23, P722, DOI 10.1093/annonc/mdr276; Dispenzieri A, 2008, BLOOD, V111, P785, DOI 10.1182/blood-2007-08-108357; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Durie BGM, 2002, J NUCL MED, V43, P1457; Durie BGM, 2004, J CLIN ONCOL, V22, P1857, DOI 10.1200/JCO.2004.05.111; Duvauferrier R, 2013, Diagn Interv Imaging, V94, P169, DOI 10.1016/j.diii.2012.12.001; Eggers H, 2011, MAGN RESON MED, V65, P96, DOI 10.1002/mrm.22578; Facon T, 2001, BLOOD, V97, P1566, DOI 10.1182/blood.V97.6.1566; GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Gorospe L, 2005, NUCL MED COMMUN, V26, P671, DOI 10.1097/01.mnm.0000171779.65284.eb; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Guiu B, 2009, RADIOLOGY, V250, P95, DOI 10.1148/radiol.2493080217; Hanrahan CJ, 2010, RADIOGRAPHICS, V30, P127, DOI 10.1148/rg.301095066; HARDY PA, 1995, JMRI-J MAGN RESON IM, V5, P181, DOI 10.1002/jmri.1880050213; Hines CDG, 2010, RADIOLOGY, V254, P119, DOI [10.1148/radiol.09090131, 10.1148/radiol.2531090131]; Korde N, 2011, BLOOD, V117, P5573, DOI 10.1182/blood-2011-01-270140; KRICUN ME, 1985, SKELETAL RADIOL, V14, P10, DOI 10.1007/BF00361188; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2007, NEW ENGL J MED, V356, P2582, DOI 10.1056/NEJMoa070389; Landgren O, 2011, CLIN CANCER RES, V17, P1243, DOI 10.1158/1078-0432.CCR-10-1822; Liu CY, 2007, MAGN RESON MED, V58, P354, DOI 10.1002/mrm.21301; Musto P, 2008, CANCER-AM CANCER SOC, V113, P1588, DOI 10.1002/cncr.23783; O'Regan DP, 2008, RADIOLOGY, V247, P550, DOI 10.1148/radiol.2472070880; Rajkumar SV, 2011, NEW ENGL J MED, V365, P474, DOI 10.1056/NEJMc1106428; Rajkumar SV, 2003, LEUKEMIA, V17, P775, DOI 10.1038/sj.leu.2402866; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Reeder SB, 2004, MAGNET RESON MED, V51, P35, DOI 10.1002/mrm.10675; RICCI C, 1990, RADIOLOGY, V177, P83, DOI 10.1148/radiology.177.1.2399343; Rossi D, 2010, CANCER-AM CANCER SOC, V116, P2188, DOI 10.1002/cncr.24959; Stabler A, 1996, AM J ROENTGENOL, V167, P1029; Takasu M, 2012, EUR RADIOL, V22, P1114, DOI 10.1007/s00330-011-2351-8; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; WISMER GL, 1985, AM J ROENTGENOL, V145, P1031, DOI 10.2214/ajr.145.5.1031; Xiang QS, 2006, MAGN RESON MED, V56, P572, DOI 10.1002/mrm.20984; YEUNG HN, 1986, RADIOLOGY, V159, P783, DOI 10.1148/radiology.159.3.3704157; Yu HZ, 2008, MAGN RESON MED, V60, P1122, DOI 10.1002/mrm.21737; Yu HZ, 2007, J MAGN RESON IMAGING, V26, P1153, DOI 10.1002/jmri.21090	49	23	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116842	10.1371/journal.pone.0116842	http://dx.doi.org/10.1371/journal.pone.0116842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706753	Green Published, Green Submitted, gold			2022-12-27	WOS:000350662100051
J	Wang, JF; Zhang, X; Wang, LL; Yang, YM; Dong, ZG; Wang, HY; Du, LT; Wang, CX				Wang, Jinfeng; Zhang, Xin; Wang, Lili; Yang, Yongmei; Dong, Zhaogang; Wang, Haiyan; Du, Lutao; Wang, Chuanxin			MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer	PLOS ONE			English	Article							INVASIVE UROTHELIAL CARCINOMA; OVARIAN-CANCER; GROWTH-FACTOR; CELLS; CONTRIBUTES; PROGRESSION; MIGRATION; MOTILITY; RNAS	MicroRNA-214 (miR-214) has been reported to be dysregulated in human bladder cancer tissues. We aimed to investigate the clinical correlation, biological significance and molecular network of miR-214 in bladder cancer. Our results showed miR-214 was down-regulated in bladder cancer tissues and significantly associated with tumor stage, lymph node status, grade, multifocality, history of non-muscle-invasive bladder cancer (NMIBC). Moreover, miR-214 could serve as an independent factor of recurrence-free survival (RFS) and overall survival (OS) for patients with muscle-invasive bladder cancer (MIBC). Restoration of miR-214 expression in bladder cancer cell lines inhibited cell proliferation, migration, invasion and markedly promoted apoptosis. Dual-luciferase reporter assay recognized PDRG1 as direct downstream target gene of miR-214. PDRG1 was significantly increased in tumors low of miR-214 and knockdown of PDRG1 mimicked the effects of miR-214 overexpression. Our findings manifest that miR-214 could exert tumor-suppressive effects in bladder cancer by directly down-regulating oncogene PDRG1 and suggest an appealing novel indicator for prognostic and therapeutic intervention of bladder cancer.	[Wang, Jinfeng; Zhang, Xin; Wang, Lili; Yang, Yongmei; Dong, Zhaogang; Wang, Haiyan; Du, Lutao; Wang, Chuanxin] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China; [Wang, Jinfeng] Linyi Peoples Hosp, Dept Clin Lab, Linyi, Shandong, Peoples R China	Shandong University	Wang, CX (corresponding author), Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China.	cxwang@sdu.edu.cn	wang, lili/HDL-7210-2022	Wang, Jinfeng/0000-0002-4454-8997	National Natural Science Foundation of China [81271916]; Natural Science Foundation of Shandong Province [ZR2013HQ063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study received financial support from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to CW (No. 81271916) and the Natural Science Foundation of Shandong Province (http://www.sdnsf.gov.cn/portal/) to XZ (ZR2013HQ063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Deng M, 2013, TUMOR BIOL, V34, P1793, DOI 10.1007/s13277-013-0718-y; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eble J, 2004, WHO CLASSIFICATION T; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirata H, 2012, CARCINOGENESIS, V33, P41, DOI 10.1093/carcin/bgr239; Huang SD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-51; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang LY, 2011, CANCER BIOL THER, V11, P567, DOI 10.4161/cbt.11.6.14412; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kim SM, 2013, KOREAN J UROL, V54, P791, DOI 10.4111/kju.2013.54.11.791; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Penna E, 2013, CANCER RES, V73, P4098, DOI 10.1158/0008-5472.CAN-12-3686; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Pignot G, 2013, INT J CANCER, V132, P2479, DOI 10.1002/ijc.27949; Pollard C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001407; Ratert N, 2013, J MOL DIAGN, V15, P695, DOI 10.1016/j.jmoldx.2013.05.008; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sobin LH, 2009, TNM CLASSIFICATION O; Song T, 2010, ASIAN PAC J CANCER P, V11, P905; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Ueno K, 2012, MOL CANCER THER, V11, P244, DOI 10.1158/1535-7163.MCT-11-0592; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Villadsen SB, 2012, BRIT J CANCER, V106, P366, DOI 10.1038/bjc.2011.520; Xu CX, 2012, J BIOL CHEM, V287, P34970, DOI 10.1074/jbc.M112.374611; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23	39	61	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118086	10.1371/journal.pone.0118086	http://dx.doi.org/10.1371/journal.pone.0118086			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706919	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100142
J	Wu, YK; Fujishima, K; Kengaku, M				Wu, You Kure; Fujishima, Kazuto; Kengaku, Mineko			Differentiation of Apical and Basal Dendrites in Pyramidal Cells and Granule Cells in Dissociated Hippocampal Cultures	PLOS ONE			English	Article							DENTATE GYRUS; SEMAPHORIN 3A; PROTEIN; EXPRESSION; NEURONS; NEUROGENESIS; MIGRATION; DYNAMICS; REELIN; BRAIN	Hippocampal pyramidal cells and dentate granule cells develop morphologically distinct dendritic arbors, yet also share some common features. Both cell types form a long apical dendrite which extends from the apex of the cell soma, while short basal dendrites are developed only in pyramidal cells. Using quantitative morphometric analyses of mouse hippocampal cultures, we evaluated the differences in dendritic arborization patterns between pyramidal and granule cells. Furthermore, we observed and described the final apical dendrite determination during dendritic polarization by time-lapse imaging. Pyramidal and granule cells in culture exhibited similar dendritic patterns with a single principal dendrite and several minor dendrites so that the cell types were not readily distinguished by appearance. While basal dendrites in granule cells are normally degraded by adulthood in vivo, cultured granule cells retained their minor dendrites. Asymmetric growth of a single principal dendrite harboring the Golgi was observed in both cell types soon after the onset of dendritic growth. Time-lapse imaging revealed that up until the second week in culture, final principal dendrite designation was not stabilized, but was frequently replaced by other minor dendrites. Before dendritic polarity was stabilized, the Golgi moved dynamically within the soma and was repeatedly repositioned at newly emerging principal dendrites. Our results suggest that polarized growth of the apical dendrite is regulated by cell intrinsic programs, while regression of basal dendrites requires cue(s) from the extracellular environment in the dentate gyrus. The apical dendrite designation is determined from among multiple growing dendrites of young developing neurons.	[Wu, You Kure; Kengaku, Mineko] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Fujishima, Kazuto; Kengaku, Mineko] Kyoto Univ, Inst Integrated Cell Mat Sci WPI ICeMS, Kyoto, Japan	Kyoto University; Kyoto University	Kengaku, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.	kengaku@icems.kyoto-u.ac.jp			NEXT program of the Japan Society for the Promotion of Science (JSPS); Ministry of Education, Science, Sports and Culture of Japan	NEXT program of the Japan Society for the Promotion of Science (JSPS); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the NEXT program of the Japan Society for the Promotion of Science (JSPS) and Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1990, J COMP NEUROL, V301, P343, DOI 10.1002/cne.903010303; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; Arikkath J, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00061; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Baba A, 2002, J NEUROCYTOL, V31, P41, DOI 10.1023/A:1022519632041; BANKER G, 1998, CULTURING NERVE CELL; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; BARTHOLOMA A, 1994, MECH DEVELOP, V48, P217, DOI 10.1016/0925-4773(94)90061-2; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Das SS, 2006, J NEUROSCI, V26, P8115, DOI 10.1523/JNEUROSCI.1015-06.2006; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Fujishima K, 2012, DEVELOPMENT, V139, P3442, DOI 10.1242/dev.081315; Galceran J, 2000, DEVELOPMENT, V127, P469; Galeeva A, 2007, NEUROSCIENCE, V146, P604, DOI 10.1016/j.neuroscience.2007.02.002; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2006, BRAIN CELL BIOL, V35, P29, DOI 10.1007/s11068-006-9003-y; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kitazawa A, 2014, J NEUROSCI, V34, P1115, DOI 10.1523/JNEUROSCI.2254-13.2014; Kurisu J, 2010, J NEUROCHEM, V113, P1598, DOI 10.1111/j.1471-4159.2010.06714.x; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Matsuki T, 2008, J CELL SCI, V121, P1869, DOI 10.1242/jcs.027334; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Meseke M, 2013, EUR J NEUROSCI, V37, P1404, DOI 10.1111/ejn.12153; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nakahara S, 2009, HIPPOCAMPUS, V19, P379, DOI 10.1002/hipo.20529; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Nakamura F, 2009, J COMP NEUROL, V516, P360, DOI 10.1002/cne.22125; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Niisato E, 2013, DEV NEUROBIOL, V73, P142, DOI 10.1002/dneu.22048; Patel LS, 2004, J NEUROSCI, V24, P9005, DOI 10.1523/JNEUROSCI.2943-04.2004; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Ribak CE, 2000, J COMP NEUROL, V428, P240, DOI 10.1002/1096-9861(20001211)428:2<240::AID-CNE4>3.0.CO;2-Q; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; SERESS L, 1987, BRAIN RES, V405, P169, DOI 10.1016/0006-8993(87)91003-1; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Spigelman I, 1998, NEUROSCIENCE, V86, P109, DOI 10.1016/S0306-4522(98)00028-1; Srivastava DP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001350; STANFIELD BB, 1979, J COMP NEUROL, V185, P423, DOI 10.1002/cne.901850303; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628	51	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118482	10.1371/journal.pone.0118482	http://dx.doi.org/10.1371/journal.pone.0118482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25705877	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100185
J	Yang, CY				Yang, Chao-Yie			Identification of Potential Small Molecule Allosteric Modulator Sites on IL-1R1 Ectodomain Using Accelerated Conformational Sampling Method	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; INTERLEUKIN-1 RECEPTOR; CRYSTAL-STRUCTURE; DRUG DISCOVERY; RESP MODEL; ANTAGONIST; PROTEIN; CYTOKINE; FAMILY; ST2	The interleukin-1 receptor (IL-1R) is the founding member of the interleukin 1 receptor family which activates innate immune response by its binding to cytokines. Reports showed dysregulation of cytokine production leads to aberrant immune cells activation which contributes to auto-inflammatory disorders and diseases. Current therapeutic strategies focus on utilizing antibodies or chimeric cytokine biologics. The large protein-protein interaction interface between cytokine receptor and cytokine poses a challenge in identifying binding sites for small molecule inhibitor development. Based on the significant conformational change of IL-1R type 1 (IL-1R1) ectodomain upon binding to different ligands observed in crystal structures, we hypothesized that transient small molecule binding sites may exist when IL-1R1 undergoes conformational transition and thus suitable for inhibitor development. Here, we employed accelerated molecular dynamics (MD) simulation to efficiently sample conformational space of IL-1R1 ectodomain. Representative IL-1R1 ectodomain conformations determined from the hierarchy cluster analysis were analyzed by the SiteMap program which leads to identify small molecule binding sites at the protein-protein interaction interface and allosteric modulator locations. The cosolvent mapping analysis using phenol as the probe molecule further confirms the allosteric modulator site as a binding hotspot. Eight highest ranked fragment molecules identified from in silico screening at the modulator site were evaluated by MD simulations. Four of them restricted the IL-1R1 dynamical motion to inactive conformational space. The strategy from this study, subject to in vitro experimental validation, can be useful to identify small molecule compounds targeting the allosteric modulator sites of IL-1R and prevent IL-1R from binding to cytokine by trapping IL-1R in inactive conformations.	Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Yang, CY (corresponding author), Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA.	chaoyie@umich.edu	Yang, Chao-Yie/A-3930-2015	Yang, Chao-Yie/0000-0002-5445-0109	National Institute of Health, National Cancer Institute, USA [R01 CA174667]; NATIONAL CANCER INSTITUTE [R01CA174667] Funding Source: NIH RePORTER	National Institute of Health, National Cancer Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The author acknowledges the generous computational resources support in part by the National Science Foundation through Extreme Science and Engineering Discovery Environment (XSEDE) Science Gateway. The author is also grateful for the financial support in part from the National Institute of Health, National Cancer Institute, USA, (R01 CA174667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson AL, 1996, J BIOL CHEM, V271, P30517, DOI 10.1074/jbc.271.48.30517; Atanasova M, 2012, CRIT REV BIOCHEM MOL, V47, P502, DOI 10.3109/10409238.2012.729561; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Case DA, 2012, AMBER 12; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P469, DOI 10.1016/j.smim.2013.10.008; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P389, DOI 10.1016/j.smim.2013.10.001; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Frisch G. W., 2013, GAUSSIAN 09; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hailey KL, 2013, J MOL BIOL, V425, P2382, DOI 10.1016/j.jmb.2013.03.016; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Hou JZ, 2013, P NATL ACAD SCI USA, V110, P3913, DOI 10.1073/pnas.1217996110; Hubbard SJ, 1993, NACCESS COMPUTER PRO; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Kravchenko VV, 2012, BIOORG MED CHEM LETT, V22, P2043, DOI 10.1016/j.bmcl.2012.01.024; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Nelson RP, 2014, BIOL BLOOD MARROW TR, V20, P1861, DOI 10.1016/j.bbmt.2014.06.039; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schreuder H, 1997, NATURE, V386, P194, DOI 10.1038/386194a0; SYMONS JA, 1995, P NATL ACAD SCI USA, V92, P1714, DOI 10.1073/pnas.92.5.1714; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tajima S, 2007, EXP LUNG RES, V33, P81, DOI 10.1080/01902140701198583; Team DC, 2010, R LANG ENV STAT COMP; Thomas C, 2012, NAT STRUCT MOL BIOL, V19, P455, DOI 10.1038/nsmb.2260; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Vigers GPA, 2000, J BIOL CHEM, V275, P36927, DOI 10.1074/jbc.M006071200; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Yang CY, 2012, ACS MED CHEM LETT, V3, P308, DOI 10.1021/ml200301w; Yang CY, 2011, ACS MED CHEM LETT, V2, P280, DOI 10.1021/ml100276b; Yang CY, 2010, ACS MED CHEM LETT, V1, P125, DOI 10.1021/ml100026a; Yanofsky SD, 1996, P NATL ACAD SCI USA, V93, P7381, DOI 10.1073/pnas.93.14.7381	50	23	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0118671	10.1371/journal.pone.0118671	http://dx.doi.org/10.1371/journal.pone.0118671			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25706624	Green Published, gold, Green Submitted			2022-12-27	WOS:000350662100200
J	Han, XF; Yang, YX; Yan, HL; Wang, XL; Qu, L; Chen, YL				Han, Xufeng; Yang, Yuxin; Yan, Hailong; Wang, Xiaolong; Qu, Lei; Chen, Yulin			Rumen Bacterial Diversity of 80 to 110-Day-Old Goats Using 16S rRNA Sequencing	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; OIL SUPPLEMENTATION; MICROBIOME; IMPACT; PREVOTELLA; NUMBER; DIET	The ability of rumen microorganisms to use fibrous plant matter plays an important role in ruminant animals; however, little information about rumen colonization by microbial populations after weaning has been reported. In this study, high-throughput sequencing was used to investigate the establishment of this microbial population in 80 to 110-day-old goats. Illumina sequencing of goat rumen samples yielded 101,356,610 nucleotides that were assembled into 256,868 reads with an average read length of 394 nucleotides. Taxonomic analysis of metagenomic reads indicated that the predominant phyla were distinct at different growth stages. The phyla Firmicutes and Synergistetes were predominant in samples taken from 80 to 100-day-old goats, but Bacteroidetes and Firmicutes became the most abundant phyla in samples from 110-day-old animals. There was a remarkable variation in the microbial populations with age; Firmicutes and Synergistetes decreased after weaning, but Bacteroidetes and Proteobacteria increased from 80 to 110 day of age. These findings suggested that colonization of the rumen by microorganisms is related to their function in the rumen digestive system. These results give a better understanding of the role of rumen microbes and the establishment of the microbial population, which help to maintain the host's health and improve animal performance.	[Han, Xufeng; Yang, Yuxin; Wang, Xiaolong; Chen, Yulin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Yan, Hailong; Qu, Lei] Yulin Univ, Coll Life Sci, Yulin, Shaanxi, Peoples R China	Northwest A&F University - China; Yulin University	Chen, YL (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	chenyulindk@163.com	yang, yx/GZM-0464-2022		National Special Research Fund for Nonprofit Sector (Agriculture) [20130305905]; China Agriculture Research System [CARS-40-13]	National Special Research Fund for Nonprofit Sector (Agriculture); China Agriculture Research System	This research was supported by The National Special Research Fund for Nonprofit Sector (Agriculture) (20130305905) and China Agriculture Research System (CARS-40-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, FRESHWATER FISHERY; [Anonymous], [No title captured]; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Bhatt VD, 2013, MOL BIOL REP, V40, P3363, DOI 10.1007/s11033-012-2411-4; Brown K R, 1977, Trop Doct, V7, P111; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cho YI, 2010, J VET DIAGN INVEST, V22, P509, DOI 10.1177/104063871002200403; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; He Li, 2009, Chinese Journal of Applied and Environmental Biology, V15, P414, DOI 10.3724/SP.J.1145.2009.00414; Hespell Robert B., 1997, P59; Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Kehoe SI, 2007, J DAIRY SCI, V90, P4108, DOI 10.3168/jds.2007-0040; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Mackie RI, 2002, INTEGR COMP BIOL, V42, P319, DOI 10.1093/icb/42.2.319; MORRILL JL, 1995, J DAIRY SCI, V78, P902, DOI 10.3168/jds.S0022-0302(95)76704-2; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quast C., 2012, NUCLEIC ACIDS RES, V41, pD590, DOI DOI 10.1093/NAR/GKS1219; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Signorini ML, 2012, RES VET SCI, V93, P250, DOI 10.1016/j.rvsc.2011.05.001; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Singh KM, 2012, MOL BIOL REP, V39, P4841, DOI 10.1007/s11033-011-1278-0; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tomsic B, 2007, CARBOHYD POLYM, V69, P478, DOI 10.1016/j.carbpol.2007.01.003; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yang SL, 2009, ANIMAL, V3, P1562, DOI 10.1017/S1751731109990462; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163	48	65	70	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2015	10	2							e0117811	10.1371/journal.pone.0117811	http://dx.doi.org/10.1371/journal.pone.0117811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7EQ	25700157	gold, Green Submitted, Green Published			2022-12-27	WOS:000349789800028
J	Flores-Trevino, S; Morfin-Otero, R; Rodriguez-Noriega, E; Gonzalez-Diaz, E; Perez-Gomez, HR; Bocanegra-Garcia, V; Vera-Cabrera, L; Garza-Gonzalez, E				Flores-Trevino, Samantha; Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo; Gonzalez-Diaz, Esteban; Perez-Gomez, Hector R.; Bocanegra-Garcia, Virgilio; Vera-Cabrera, Lucio; Garza-Gonzalez, Elvira			Genetic Diversity of Mycobacterium tuberculosis from Guadalajara, Mexico and Identification of a Rare Multidrug Resistant Beijing Genotype	PLOS ONE			English	Article							LENGTH-POLYMORPHISM PATTERNS; MOLECULAR EPIDEMIOLOGY; STRAINS; STABILITY; DIFFERENTIATION; SPOLIGOTYPES; MONTERREY; COMPLEX; LINEAGE	Determining the genetic diversity of M. tuberculosis strains allows identification of the distinct Mycobacterium tuberculosis genotypes responsible for tuberculosis in different regions. Several studies have reported the genetic diversity of M. tuberculosis strains in Mexico, but little information is available from the state of Jalisco. Therefore, the aim of this study was to determine the genetic diversity of Mycobacterium tuberculosis clinical isolates from Western Mexico. Sixty-eight M. tuberculosis isolates were tested for susceptibility to first-line drugs using manual Mycobacteria Growth Indicator Tube method and genotyped using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) pattern analyses. Forty-seven (69.1%) isolates were grouped into 10 clusters and 21 isolates displayed single patterns by spoligotyping. Three of the 21 single patterns corresponded to orphan patterns in the SITVITWEB database, and 1 new type that contained 2 isolates was created. The most prevalent lineages were T (38.2%), Haarlem (17.7%), LAM (17.7%), X (7.4%), S (5.9%), EAI (1.5%) and Beijing (1.5%). Six (12.8%) of the clustered isolates were MDR, and type 406 of the Beijing family was among the MDR isolates. Seventeen (26.2%) isolates were grouped into 8 clusters and 48 isolates displayed single patterns by IS6110-RFLP. Combination of IS6110-RFLP and spoligotyping reduced the clustering rate to 20.0%. The results show that T, Haarlem, and LAM are predominant lineages among clinical isolates of M. tuberculosis in Guadalajara, Mexico. Clustering rates indicated low transmission of MDR strains. We detected a rare Beijing genotype, SIT406, which was a highly resistant strain. This is the first report of this Beijing genotype in Latin America.	[Flores-Trevino, Samantha; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo; Gonzalez-Diaz, Esteban; Perez-Gomez, Hector R.] Univ Guadalajara, Hosp Civil Guadalajara, Guadalajara 44430, Jalisco, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo; Gonzalez-Diaz, Esteban; Perez-Gomez, Hector R.] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Patol Infecc & Expt, Guadalajara 44430, Jalisco, Mexico; [Bocanegra-Garcia, Virgilio] Inst Politecn Nacl, Ctr Biotecnolog Genom, Lab Med Conservac, Reynosa, Tamaulipas, Mexico; [Vera-Cabrera, Lucio] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Dermatol, Monterrey, Nuevo Leon, Mexico; [Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Dept Clin Pathol, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad de Guadalajara; Universidad de Guadalajara; Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Garza-Gonzalez, E (corresponding author), Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico.	elvira_garza_gzz@yahoo.com	Vera-Cabrera, Lucio/AAM-3641-2020; Gonzalez-Diaz, Esteban/GVU-0915-2022; Flores-Treviño, Samantha M/E-8601-2019; Flores-Treviño, Samantha/AAB-4537-2020; Morfín-Otero, Rayo/AAR-8027-2021	Vera-Cabrera, Lucio/0000-0002-0890-9660; Gonzalez-Diaz, Esteban/0000-0002-9743-3739; Flores-Treviño, Samantha M/0000-0003-1259-7425; Flores-Treviño, Samantha/0000-0003-1259-7425; Morfín-Otero, Rayo/0000-0001-9576-1950; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815	Instituto Politecnico Nacional	Instituto Politecnico Nacional	VBG is a COFAA and EDI scholarship recipient of the Instituto Politecnico Nacional. We thank Sergio Lozano-Rodriguez, M.D., from the Hospital Universitario for his review of the manuscript.	Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Aleksic E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055423; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Belisle John T., 2008, V465, P1, DOI 10.1007/978-1-59745-207-6_1; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Buu TN, 2010, CLIN INFECT DIS, V51, P879, DOI 10.1086/656410; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Flores-Trevino S, 2014, ENFERM INFEC MICR CL, DOI [10.1016/j.eimc.2014.10.020, DOI 10.1016/J.EIMC.2014.10.020]; Flores-Trevino S, 2014, SALUD PUBLICA MEXICO, V56, P63; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Lok KH, 2002, EMERG INFECT DIS, V8, P1310, DOI 10.3201/eid0811.020291; Lopez-Alvarez R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-82; Lopez-Rocha Estela, 2013, BMC Res Notes, V6, P172, DOI 10.1186/1756-0500-6-172; Macias Parra Mercedes, 2011, Tuberc Res Treat, V2011, P239042, DOI 10.1155/2011/239042; Martinez-Gamboa A, 2008, ARCH MED RES, V39, P809, DOI 10.1016/j.arcmed.2008.08.006; Martinez-Guarneros A, 2013, INFECT GENET EVOL, V14, P434, DOI 10.1016/j.meegid.2012.12.024; Molina-Torres CA, 2010, J CLIN MICROBIOL, V48, P448, DOI 10.1128/JCM.01894-09; Murcia MI, 2010, INFECT GENET EVOL, V10, P678, DOI 10.1016/j.meegid.2010.03.010; Nakajima C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-118; Nava-Aguilera E, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/408375; Niemann S, 2000, J CLIN MICROBIOL, V38, P2563, DOI 10.1128/JCM.38.7.2563-2567.2000; Niemann S, 1999, J CLIN MICROBIOL, V37, P3078, DOI 10.1128/JCM.37.2.409-412.1999; Palomino JC, 1999, INT J TUBERC LUNG D, V3, P344; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Quitugua TN, 2002, J CLIN MICROBIOL, V40, P2716, DOI 10.1128/JCM.40.8.2716-2724.2002; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093848; Secretaria de Salud (Mexico), 2012, PERF EP TUB MEX SIST; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, 2012, WHOHTMTB201116; Yang ZH, 2001, INT J TUBERC LUNG D, V5, P313; Zazueta-Beltran J, 2009, J INFECT DEV COUNTR, V3, P162	41	17	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118095	10.1371/journal.pone.0118095	http://dx.doi.org/10.1371/journal.pone.0118095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695431	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000350062300042
J	Jiang, DD; Dumur, CI; Massey, HD; Ramakrishnan, V; Subler, MA; Windle, JJ				Jiang, Dadi; Dumur, Catherine I.; Massey, H. Davis; Ramakrishnan, Viswanathan; Subler, Mark A.; Windle, Jolene J.			Comparison of Effects of p53 Null and Gainof-Function Mutations on Salivary Tumors in MMTV-Hras Transgenic Mice	PLOS ONE			English	Article							P53-INDEPENDENT APOPTOTIC PATHWAYS; OF-FUNCTION PHENOTYPE; LI-FRAUMENI-SYNDROME; MUTANT P53; IN-VIVO; GENE-EXPRESSION; BREAST-CANCER; MOUSE MODELS; GENOMIC INSTABILITY; FAMILIAL SYNDROME	p53 is an important tumor suppressor gene which is mutated in similar to 50% of all human cancers. Some of these mutants appear to have acquired novel functions beyond merely losing wildtype functions. To investigate these gain-of-function effects in vivo, we generated mice of three different genotypes: MMTV-Hras/p53(+/+), MMTV-Hras/p53(-/-), and MMTV-Hras/ p53(R172H/R172H.) Salivary tumors from these mice were characterized with regard to age of tumor onset, tumor growth rates, cell cycle distribution, apoptotic levels, tumor histopathology, as well as response to doxorubicin treatment. Microarray analysis was also performed to profile gene expression. The MMTV-Hras/p53(-/-) and MMTV-Hras/p53(R172H/R172H) mice displayed similar properties with regard to age of tumor onset, tumor growth rates, tumor histopathology, and response to doxorubicin, while both groups were clearly distinct from the MMTV-Hras/p53(+/+) mice by these measurements. In addition, the gene expression profiles of the MMTV-Hras/p53(-/-) and MMTV-Hras/p53(R172H/R172H) tumors were tightly clustered, and clearly distinct from the profiles of the MMTV-Hras/p53(+/+) tumors. Only a small group of genes showing differential expression between the MMTV-Hras/p53(-/-) and MMTVHras/ p53(R172H/R172H) tumors, that did not appear to be regulated by wild-type p53, were identified. Taken together, these results indicate that in this MMTV-Hras-driven salivary tumor model, the major effect of the p53 R172H mutant is due to the loss of wild-type p53 function, with little or no gain-of-function effect on tumorigenesis, which may be explained by the tissue- and tumor type-specific properties of this gain-of-function mutant of p53.	[Jiang, Dadi; Subler, Mark A.; Windle, Jolene J.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Dumur, Catherine I.; Massey, H. Davis] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Dumur, Catherine I.; Massey, H. Davis; Windle, Jolene J.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Ramakrishnan, Viswanathan] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Medical University of South Carolina	Windle, JJ (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	jjwindle@vcu.edu	Dumur, Catherine/AAH-9489-2020	Windle, Jolene/0000-0001-6690-385X	Department of Defense Breast Cancer Research Program [BC981128]; VCU Massey Cancer Center Pilot Project Grant; Start-up funds	Department of Defense Breast Cancer Research Program(United States Department of Defense); VCU Massey Cancer Center Pilot Project Grant; Start-up funds	Support was provided by the Department of Defense Breast Cancer Research Program - grant # BC981128 (to JJW) [http://cdmrp.army.mil/funding/bcrp.shtml]; VCU Massey Cancer Center Pilot Project Grant - no # (to JJW and MAS) [https://www.massey. vcu.edu/research/funding/mcc-pilot-project-program/]; and Start-up funds (to JJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin S, 2011, J PATHOL, V225, P479, DOI 10.1002/path.2971; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Bearss DJ, 2000, ONCOGENE, V19, P1114, DOI 10.1038/sj.onc.1203275; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Broz DK, 2010, CARCINOGENESIS, V31, P1311, DOI 10.1093/carcin/bgp331; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Chicas A, 2000, BIOCHEM BIOPH RES CO, V279, P383, DOI 10.1006/bbrc.2000.3965; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; El-Hizawi S, 2002, CANCER RES, V62, P3264; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gallagher WM, 1999, ONCOGENE, V18, P3608, DOI 10.1038/sj.onc.1202937; Gohler T, 2005, NUCLEIC ACIDS RES, V33, P1087, DOI 10.1093/nar/gki252; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; GUALBERTO A, 1995, J BIOL CHEM, V270, P19680, DOI 10.1074/jbc.270.34.19680; Habelhah H, 1999, ONCOGENE, V18, P1771, DOI 10.1038/sj.onc.1202465; HSIAO M, 1994, AM J PATHOL, V145, P702; Hundley JE, 1997, MOL CELL BIOL, V17, P723, DOI 10.1128/MCB.17.2.723; Iwamoto KS, 1996, CANCER RES, V56, P3862; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jiang JH, 2007, MOL CELL BIOL, V27, P8770, DOI 10.1128/MCB.02302-06; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lanyi A, 1998, ONCOGENE, V16, P3169, DOI 10.1038/sj.onc.1201857; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; LI FP, 1969, J NATL CANCER I, V43, P1365; Li RZ, 1998, ONCOGENE, V16, P3269, DOI 10.1038/sj.onc.1201867; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Murphy KL, 2000, FASEB J, V14, P2291, DOI 10.1096/fj.00-0128com; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; O'Farrell TJ, 2004, CANCER RES, V64, P8199, DOI 10.1158/0008-5472.CAN-03-3639; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Peled A, 1996, CANCER RES, V56, P2148; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Poser I, 2004, ONCOGENE, V23, P6115, DOI 10.1038/sj.onc.1207797; PURDIE CA, 1994, ONCOGENE, V9, P603; Ravi R, 2002, CANCER RES, V62, P4180; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Sarig R, 2010, J EXP MED, V207, P2127, DOI 10.1084/jem.20100797; Scian MJ, 2004, CANCER RES, V64, P7447, DOI 10.1158/0008-5472.CAN-04-1568; Scian MJ, 2004, ONCOGENE, V23, P4430, DOI 10.1038/sj.onc.1207553; SHAULSKY G, 1991, CANCER RES, V51, P5232; Sigal A, 2001, ONCOGENE, V20, P4891, DOI 10.1038/sj.onc.1204724; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Suh YA, 2011, CANCER RES, V71, P7168, DOI 10.1158/0008-5472.CAN-11-0459; Tepper CG, 2005, PROSTATE, V65, P375, DOI 10.1002/pros.20308; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang XJ, 1998, ONCOGENE, V17, P35, DOI 10.1038/sj.onc.1201890; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Wijnhoven SWP, 2005, CANCER RES, V65, P8166, DOI 10.1158/0008-5472.CAN-05-1650; Will K, 1998, P NATL ACAD SCI USA, V95, P13681, DOI 10.1073/pnas.95.23.13681; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941	73	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118029	10.1371/journal.pone.0118029	http://dx.doi.org/10.1371/journal.pone.0118029			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695772	Green Submitted, gold, Green Published			2022-12-27	WOS:000350062300038
J	Pedisic, Z; Greblo, Z; Phongsavan, P; Milton, K; Bauman, AE				Pedisic, Zeljko; Greblo, Zrinka; Phongsavan, Philayrath; Milton, Karen; Bauman, Adrian E.			Are Total, Intensity- and Domain-Specific Physical Activity Levels Associated with Life Satisfaction among University Students?	PLOS ONE			English	Article							QUALITY-OF-LIFE; 18-TO 64-YEAR-OLD SWEDES; SELF-RATED HEALTH; LEISURE-TIME; SPORT PARTICIPATION; DEPRESSIVE SYMPTOMS; DOSE-RESPONSE; MENTAL-HEALTH; FOLLOW-UP; EXERCISE	Background Thorough information about the relationship between physical activity (PA) and life satisfaction is still lacking. Therefore, this study examined the cross-sectional relationships between life satisfaction and meeting the World Health Organization (WHO) moderate to vigorous-intensity PA recommendations, total volume and duration of PA, intensity-specific PA (walking, moderate- and vigorous-intensity), domain-specific PA (work, transport-related, domestic, and leisure-time), and 11 domain and intensity-specific PA types among university students. Additionally, we examined the associations between life satisfaction and gender, age, disposable income, community size, smoking, alcohol intake, body mass index (BMI), and self-rated health. Methods The study included a random sample of 1750 university students in Zagreb, Croatia (response rate = 71.7%; 62.4% females; mean age 21.5 +/- 1.8 years), using the International Physical Activity Questionnaire-long form and the Satisfaction with Life Scale. Results Higher life satisfaction was associated with female gender (beta = 0.13; p = < 0.001), younger age (beta = -0.07; p = 0.024), higher disposable income (beta = 0.10; p = 0.001), and better self-rated health (beta = 0.30; p = <0.001). No significant association was found between life satisfaction and size of community (p = 0.567), smoking status (p = 0.056), alcohol consumption (p = 0.058), or BMI (p = 0.508). Among all PA variables, only leisure-time vigorous-intensity PA was significantly associated with life satisfaction after adjustments for socio-demographic characteristics, lifestyle and self-rated general health (beta = 0.06; p = 0.045). Conclusions This study indicated a weak positive relationship between leisure-time vigorous-intensity PA and life satisfaction, whilst no such association was found for other PA variables. These findings underscore the importance of analyzing domain and intensity-specific PA levels in future studies among university students, as drawing conclusions about the relationship between PA and life satisfaction based on total PA levels only may be misleading.	[Pedisic, Zeljko] Univ Zagreb, Fac Kinesiol, Zagreb 41000, Croatia; [Pedisic, Zeljko; Phongsavan, Philayrath; Milton, Karen; Bauman, Adrian E.] Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia; [Greblo, Zrinka] Univ Zagreb, Ctr Croatian Studies, Dept Psychol, Zagreb 41000, Croatia	University of Zagreb; University of Zagreb, Faculty of Kinesiology; University of Sydney; University of Zagreb	Pedisic, Z (corresponding author), Univ Zagreb, Fac Kinesiol, Zagreb 41000, Croatia.	zeljko.pedisic@kif.hr		Phongsavan, Philayrath/0000-0003-2460-5031; Pedisic, Zeljko/0000-0003-2886-3556; Milton, Karen/0000-0002-0506-2214	Faculty of Kinesiology, University of Zagreb	Faculty of Kinesiology, University of Zagreb	This study was funded by the Faculty of Kinesiology, University of Zagreb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BAF, 2008, J CARDIOVASC NURS, V23, P90, DOI 10.1097/01.JCN.0000305074.43775.d8; Asztalos M, 2010, PUBLIC HEALTH NUTR, V13, P1207, DOI 10.1017/S1368980009992825; Bento TC, 2014, EUR J SPORT SCI, V14, pS352, DOI 10.1080/17461391.2012.704081; Bjarnason T, 2012, CHILD SOC, V26, P51, DOI 10.1111/j.1099-0860.2010.00324.x; Bohnke P, 2008, SOC INDIC RES, V87, P189, DOI 10.1007/s11205-007-9169-4; Bustamante EE, 2013, MENT HEALTH PHYS ACT, V6, P69, DOI 10.1016/j.mhpa.2013.05.001; Campbell A, 2009, J HEALTH PSYCHOL, V14, P780, DOI 10.1177/1359105309338977; Castillo I, 2009, REV PANAM SALUD PUBL, V26, P334, DOI 10.1590/S1020-49892009001000008; Cerin E., 2009, MENTAL HLTH PHYS ACT, V2, P55, DOI [10.1016/j.mhpa.2009.09.004, DOI 10.1016/J.MHPA.2009.09.004]; Chow HPH, 2005, SOC INDIC RES, V70, P139, DOI 10.1007/s11205-004-7526-0; Clark SD, 1999, J SOC BEHAV PERS, V14, P221; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collins AL, 2009, PSYCHOL AGING, V24, P696, DOI 10.1037/a0016777; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cummins RA, 1998, SOC INDIC RES, V43, P307, DOI 10.1023/A:1006831107052; De Vos J, 2013, TRANSPORT REV, V33, P421, DOI 10.1080/01441647.2013.815665; Della Giusta M, 2011, FEM ECON, V17, P1, DOI 10.1080/13545701.2011.582028; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E., 2000, J HAPPINESS STUD, V1, P41, DOI [10.1023/A:1010076127199, DOI 10.1023/A:1010076127199]; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Eid M, 2004, SOC INDIC RES, V65, P245, DOI 10.1023/B:SOCI.0000003801.89195.bc; Eime R, 2014, J PHYS ACT HEALTH, V11, P330, DOI 10.1123/jpah.2012-0073; Eime RM, 2010, MED SCI SPORT EXER, V42, P1022, DOI 10.1249/MSS.0b013e3181c3adaa; Elavsky S, 2005, ANN BEHAV MED, V30, P138, DOI 10.1207/s15324796abm3002_6; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; GEORGE LK, 1985, RES AGING, V7, P209, DOI 10.1177/0164027585007002004; Gilman R, 2003, SCHOOL PSYCHOL QUART, V18, P192, DOI 10.1521/scpq.18.2.192.21858; Gilman R, 2008, J YOUTH ADOLESCENCE, V37, P142, DOI 10.1007/s10964-007-9172-8; Grant N, 2009, INT J BEHAV MED, V16, P259, DOI 10.1007/s12529-009-9032-x; Greenleaf C, 2009, SEX ROLES, V61, P714, DOI 10.1007/s11199-009-9671-z; Hamer Mark, 2012, Methods Mol Biol, V934, P89, DOI 10.1007/978-1-62703-071-7_5; HAVIGHURST RJ, 1961, GERONTOLOGIST, V1, P8, DOI 10.1093/geront/1.1.8; Hawker CL, 2012, NURS EDUC TODAY, V32, P325, DOI 10.1016/j.nedt.2011.07.013; HOLSTEIN B E, 1990, Ugeskrift for Laeger, V152, P2721; International Physical Activity Questionnaire, 2005, INT PHYS ACT QUEST; Joseph RP, 2014, QUAL LIFE RES, V23, P661, DOI 10.1007/s11136-013-0492-8; Jurakic D, 2010, QUAL LIFE RES, V19, P1303, DOI 10.1007/s11136-010-9705-6; Koivumaa-Honkanen H, 2004, SOC PSYCH PSYCH EPID, V39, P994, DOI 10.1007/s00127-004-0833-6; Koivumaa-Honkanen H, 2001, AM J PSYCHIAT, V158, P433, DOI 10.1176/appi.ajp.158.3.433; Koivumaa-Honkanen H, 2000, AM J EPIDEMIOL, V152, P983, DOI 10.1093/aje/152.10.983; Korkeila M, 1998, INT J OBESITY, V22, P949, DOI 10.1038/sj.ijo.0800694; Ku PW, 2014, SOC INDIC RES, V117, P705, DOI 10.1007/s11205-013-0394-8; Kull M, 2012, HEALTH CARE WOMEN IN, V33, P457, DOI 10.1080/07399332.2011.645968; Laaksonen M, 2006, INT ARCH OCC ENV HEA, V79, P205, DOI 10.1007/s00420-005-0054-7; Lacruz ME, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-579; Linna MS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-231; LONGINO CF, 1982, J GERONTOL, V37, P713, DOI 10.1093/geronj/37.6.713; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; MacDonald JM, 2005, J INTERPERS VIOLENCE, V20, P1495, DOI 10.1177/0886260505278718; Maher JP, 2014, J SPORT EXERCISE PSY, V36, P166, DOI 10.1123/jsep.2013-0185; Maher JP, 2013, HEALTH PSYCHOL, V32, P647, DOI 10.1037/a0030129; Malebo A, 2007, S AFR J PSYCHOL, V37, P188, DOI 10.1177/008124630703700113; Marks GN, 1999, SOC INDIC RES, V46, P301; McAuley E, 2008, ANN BEHAV MED, V36, P13, DOI 10.1007/s12160-008-9036-9; McKercher C, 2012, MENTAL HLTH PHYS ACT, V5, P50, DOI [10.1186/S12888-014-0238-3, DOI 10.1016/J.MHPA.2012.03.004]; Melin R, 2003, J REHABIL MED, V35, P84, DOI 10.1080/16501970306119; Morgan K, 1998, AGE AGEING, V27, P35, DOI 10.1093/ageing/27.suppl_3.35; Murphy JG, 2005, PSYCHOL ADDICT BEHAV, V19, P184, DOI 10.1037/0893-164X.19.2.184; Nakamura PM, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-98; O'Loughlin EK, 2013, MENT HEALTH PHYS ACT, V6, P155, DOI 10.1016/j.mhpa.2013.07.003; PARKERSON GR, 1990, ACAD MED, V65, P586, DOI 10.1097/00001888-199009000-00009; Pavot W., 2008, J POSIT PSYCHOL, V3, P137, DOI [10.1080/17439760701756946, DOI 10.1080/17439760701756946]; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pedisic Z, 2015, BRIT J SPORT MED, V49, P219, DOI 10.1136/bjsports-2013-093407; Pedisic Z, 2011, KINESIOLOGY, V43, P185; Peeters G, 2014, BRIT J SPORT MED, V48, P996, DOI 10.1136/bjsports-2012-091103; Peiro-Velert C, 2008, EUR J SPORT SCI, V8, P163, DOI 10.1080/17461390802020868; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Proctor C, 2011, J POSIT PSYCHOL, V6, P377, DOI 10.1080/17439760.2011.594079; Proctor CL, 2009, J HAPPINESS STUD, V10, P583, DOI 10.1007/s10902-008-9110-9; Rangul V, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-144; Rangul V, 2011, J ADOLESCENT HEALTH, V48, P616, DOI 10.1016/j.jadohealth.2010.09.013; Valadares ALR, 2011, REV ASSOC MED BRAS, V57, P450, DOI 10.1590/S0104-42302011000400021; Rodriguez A, 2008, SOC INDIC RES, V86, P163, DOI 10.1007/s11205-007-9101-y; Sabiston CM, 2008, J SPORT EXERCISE PSY, V30, P3, DOI 10.1123/jsep.30.1.3; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Schnohr P, 2005, SCAND J MED SCI SPOR, V15, P107, DOI 10.1111/j.1600-0838.2004.00394.x; Spence JC, 2005, J SPORT EXERCISE PSY, V27, P311, DOI 10.1123/jsep.27.3.311; Strine TW, 2008, J COMMUN HEALTH, V33, P40, DOI 10.1007/s10900-007-9066-4; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Stubbe JH, 2007, PREV MED, V44, P148, DOI 10.1016/j.ypmed.2006.09.002; Thogersen-Ntoumani C, 2005, PSYCHOL SPORT EXERC, V6, P609, DOI 10.1016/j.psychsport.2004.12.004; Thome Jennifer, 2004, Eat Behav, V5, P337, DOI 10.1016/j.eatbeh.2004.04.002; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; UNGER JB, 1995, AM J HEALTH PROMOT, V9, P340, DOI 10.4278/0890-1171-9.5.340; Vaez M, 2003, J AM COLL HEALTH, V51, P156, DOI 10.1080/07448480309596344; Vaez Marjan, 2006, Work, V26, P167; Valois RF, 2004, J SCHOOL HEALTH, V74, P59, DOI 10.1111/j.1746-1561.2004.tb04201.x; van den Berg AE, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-74; Vassar M, 2008, SOC INDIC RES, V86, P47, DOI 10.1007/s11205-007-9113-7; Veenhoven R., 1984, CONDITIONS HAPPINESS; VILHJALMSSON R, 1992, SOCIOL QUART, V33, P637, DOI 10.1111/j.1533-8525.1992.tb00148.x; Waliczek TM, 2005, HORTSCIENCE, V40, P1360, DOI 10.21273/HORTSCI.40.5.1360; Waller K, 2010, MED SCI SPORT EXER, V42, P658, DOI 10.1249/MSS.0b013e3181bdeea3; Wang F, 2012, AM J EPIDEMIOL, V176, P1095, DOI 10.1093/aje/kws199; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Withall J, 2014, INT J ENV RES PUB HE, V11, P643, DOI 10.3390/ijerph110100643; Zhang J, 2014, ASIAN J PSYCHIATR, V10, P17, DOI 10.1016/j.ajp.2013.06.014; Zullig KJ, 2011, APPL RES QUAL LIFE, V6, P277, DOI 10.1007/s11482-010-9129-z; Zullig KJ, 2009, J HAPPINESS STUD, V10, P229, DOI 10.1007/s10902-007-9077-y	101	25	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0118137	10.1371/journal.pone.0118137	http://dx.doi.org/10.1371/journal.pone.0118137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC0XE	25695492	gold, Green Submitted, Green Published			2022-12-27	WOS:000350062300043
J	Yang, XR; Koltes, JE; Park, CA; Chen, DW; Reecy, JM				Yang, Xuerong; Koltes, James E.; Park, Carissa A.; Chen, Daiwen; Reecy, James M.			Gene Co-Expression Network Analysis Provides Novel Insights into Myostatin Regulation at Three Different Mouse Developmental Timepoints	PLOS ONE			English	Article							MUSCLE-FIBER-TYPE; TRANSCRIPTIONAL REGULATION; THYMOSIN BETA-4; SKELETAL; GROWTH; EXPRESSION; MICE; MASS; DATABASE; TARGET	Myostatin (Mstn) knockout mice exhibit large increases in skeletal muscle mass. However, relatively few of the genes that mediate or modify MSTN effects are known. In this study, we performed co-expression network analysis using whole transcriptome microarray data from MSTN-null and wild-type mice to identify genes involved in important biological processes and pathways related to skeletal muscle and adipose development. Genes differentially expressed between wild-type and MSTN-null mice were further analyzed for shared DNA motifs using DREME. Differentially expressed genes were identified at 13.5 d.p.c. during primary myogenesis and at d35 during postnatal muscle development, but not at 17.5 d.p.c. during secondary myogenesis. In total, 283 and 2034 genes were differentially expressed at 13.5 d.p.c. and d35, respectively. Over-represented transcription factor binding sites in differentially expressed genes included SMAD3, SP1, ZFP187, and PLAGL1. The use of regulatory (RIF) and phenotypic (PIF) impact factor and differential hubbing co-expression analyses identified both known and potentially novel regulators of skeletal muscle growth, including Apobec2, Atp2a2, and Mmp13 at d35 and Sox2, Tmsb4x, and Vdac1 at 13.5 d.p.c. Among the genes with the highest PIF scores were many fiber type specifying genes. The use of RIF, PIF, and differential hubbing analyses identified both known and potentially novel regulators of muscle development. These results provide new details of how MSTN may mediate transcriptional regulation as well as insight into novel regulators of MSTN signal transduction that merit further study regarding their physiological roles in muscle and adipose development.	[Yang, Xuerong; Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China; [Yang, Xuerong; Koltes, James E.; Park, Carissa A.; Reecy, James M.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	Sichuan Agricultural University; Iowa State University	Reecy, JM (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	jreecy@iastate.edu		Reecy, James/0000-0003-4602-0990	China Scholarship Council	China Scholarship Council(China Scholarship Council)	XRY was supported by a scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2010, DEV BIOL, V337, P396, DOI 10.1016/j.ydbio.2009.11.015; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bjornstad JL, 2012, CARDIOVASC RES, V93, P100, DOI 10.1093/cvr/cvr294; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Cheng Y, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-103; Chien YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071900; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cotten SW, 2014, AM J TRANSL RES, V6, P43; Deng X, 2012, J BIOL CHEM, V287, P20132, DOI 10.1074/jbc.M112.347211; Druet T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-796; DUXSON MJ, 1989, DEVELOPMENT, V107, P743; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Gaarenstroom T., 2014, SEMIN CELL DEV BIOL; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Goodman CA, 2013, MOL ENDOCRINOL; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jay A, 2013, CARDIOLOGY, V124, P248, DOI 10.1159/000347138; Koesterke L., 2013, P C EXTR SCI ENG DIS; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lei HQ, 2013, AM J PHYSIOL-CELL PH, V305, pC529, DOI 10.1152/ajpcell.00051.2013; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Liu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.31; Matsakas A, 2010, REJUV RES, V13, P717, DOI 10.1089/rej.2010.1065; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; ONTELL M, 1984, AM J ANAT, V171, P149, DOI 10.1002/aja.1001710203; Parakati R, 2002, J BIOL CHEM, V277, P9278, DOI 10.1074/jbc.M108411200; Parakati R, 2013, J BIOL CHEM, V288, P13876, DOI 10.1074/jbc.M113.457648; Peille AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080741; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Shoshan-Barmatzt V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00164; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spurney CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008976; Steelman CA, 2006, FASEB J, V20, P580, DOI 10.1096/fj.05-5125fje; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005; Swift F, 2012, P NATL ACAD SCI USA, V109, P3997, DOI 10.1073/pnas.1120172109; Tokura Y, 2011, J BIOCHEM, V149, P43, DOI 10.1093/jb/mvq115; Turbendian HK, 2013, DEVELOPMENT, V140, P1639, DOI 10.1242/dev.093260; Vangheluwe P, 2006, J MOL CELL CARDIOL, V41, P308, DOI 10.1016/j.yjmcc.2006.05.014; Vonica A, 2011, DEV BIOL, V350, P13, DOI 10.1016/j.ydbio.2010.09.016; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2015	10	2							e0117607	10.1371/journal.pone.0117607	http://dx.doi.org/10.1371/journal.pone.0117607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0XE	25695797	Green Published, Green Submitted, gold			2022-12-27	WOS:000350062300024
J	Pan, HS; Liu, B; Lu, YH; Wyckhuys, KAG				Pan, Hongsheng; Liu, Bing; Lu, Yanhui; Wyckhuys, Kris A. G.			Seasonal Alterations in Host Range and Fidelity in the Polyphagous Mirid Bug, Apolygus lucorum (Heteroptera: Miridae)	PLOS ONE			English	Article							TARNISHED PLANT BUG; HEMIPTERA-MIRIDAE; PEST-MANAGEMENT; BT COTTON; OVIPOSITION BEHAVIOR; PHYTOPHAGOUS INSECTS; NORTHERN CHINA; CENTRAL TEXAS; DIET BREADTH; PERFORMANCE	In herbivorous insects, host plant switching is commonly observed and plays an important role in their annual life cycle. However, much remains to be learned about seasonal host switching of various pestiferous arthropods under natural conditions. From 2006 until 2012, we assessed Apolygus lucorum (Meyer-Dr) host plant use in successive spring, summer and winter seasons at one single location (Langfang, China). Data were used to quantify changes in host plant breadth and host fidelity between seasons. Host fidelity of A. lucorum differed between seasons, with 87.9% of spring hosts also used in the summer and 36.1% of summer hosts used in winter. In contrast, as little as 25.6% host plant species were shared between winter and spring. Annual herbaceous plants are most often used for over-wintering, while perennial woody plants are relatively important for initial population build-up in the spring. Our study contributes to an improved understanding of evolutionary interactions between A. lucorum and its host plants and lays the groundwork for the design of population management strategies for this important pest in myriad crops.	[Pan, Hongsheng; Liu, Bing; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wyckhuys, Kris A. G.] Int Ctr Trop Agr CIAT Asia, Hanoi, Vietnam	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yhlu@ippcaas.cn	Wyckhuys, Kris/AAJ-4352-2020	Wyckhuys, Kris/0000-0003-0922-488X; Lu, Yanhui/0000-0002-6552-0248	National Basic Research Program of China [2012CB114104]; National Natural Science Funds [31222046, 31321004]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (No. 2012CB114104) and the National Natural Science Funds (No. 31222046, 31321004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bucheli S, 2002, CLADISTICS, V18, P71, DOI 10.1006/clad.2001.0181; Cane JH, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P99; Cao C. Y., 1983, MANAGEMENT COTTON MI; Carriere Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039862; Chen Zhan-Ce, 2010, Acta Entomologica Sinica, V53, P47; CLARIDGE MF, 1978, OECOLOGIA, V37, P247, DOI 10.1007/BF00344995; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Craig TP, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P20; Cronin JT, 2001, OIKOS, V93, P312, DOI 10.1034/j.1600-0706.2001.930214.x; Di Giulio M, 2003, ECOL ENTOMOL, V28, P51, DOI 10.1046/j.1365-2311.2002.00488.x; Dong JW, 2013, ARTHROPOD-PLANT INTE, V7, P83, DOI 10.1007/s11829-012-9222-3; Esquivel JF, 2007, ENVIRON ENTOMOL, V36, P725, DOI 10.1603/0046-225X(2007)36[725:HPOTTP]2.0.CO;2; Esquivel JF, 2009, ENVIRON ENTOMOL, V38, P766, DOI 10.1603/022.038.0329; Foster SP, 1997, ANNU REV ENTOMOL, V42, P123, DOI 10.1146/annurev.ento.42.1.123; Franzke A, 2010, ECOL ENTOMOL, V35, P126, DOI 10.1111/j.1365-2311.2009.01168.x; Geng HH, 2012, APPL ENTOMOL ZOOL, V47, P191, DOI 10.1007/s13355-012-0107-9; Gripenberg S, 2007, J ANIM ECOL, V76, P854, DOI 10.1111/j.1365-2656.2007.01261.x; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; HOLOPAINEN JK, 1991, J APPL ENTOMOL, V111, P484, DOI 10.1111/j.1439-0418.1991.tb00351.x; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P159, DOI 10.1046/j.1461-9563.2002.00152.x; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Kohno K, 2005, ENTOMOL SCI, V8, P313, DOI 10.1111/j.1479-8298.2005.00130.x; Lee KP, 2006, J EXP BIOL, V209, P2076, DOI 10.1242/jeb.02253; Lopez-Vaamonde C, 2003, EVOLUTION, V57, P1804, DOI 10.1111/j.0014-3820.2003.tb00588.x; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YH, 2009, CROP PROT, V28, P77, DOI 10.1016/j.cropro.2008.08.018; Lu YH, 2012, J ECON ENTOMOL, V105, P1603, DOI 10.1603/EC12003; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2010, CROP PROT, V29, P1026, DOI 10.1016/j.cropro.2010.03.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; MORAN NA, 1983, ECOL ENTOMOL, V8, P371, DOI 10.1111/j.1365-2311.1983.tb00517.x; Pan HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068980; Pan HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059000; PANIZZI AR, 1993, ENTOMOL EXP APPL, V68, P109, DOI 10.1007/BF02380529; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Powell G, 2001, APPL ENTOMOL ZOOL, V36, P259, DOI 10.1303/aez.2001.259; RAUSHER MD, 1987, ECOLOGY, V68, P869, DOI 10.2307/1938358; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; SAS Institute, 2005, SAS STAT US GUID VER; Schoonhoven L. M., 2005, Insect-plant biology; Schwarz J, 2009, J CHEM ECOL, V35, P58, DOI 10.1007/s10886-008-9575-3; Scott D.R., 1977, Bulletin Ent Soc Amer, V23, P19; Scriber JM, 2010, INSECT SCI, V17, P471, DOI 10.1111/j.1744-7917.2010.01357.x; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Simpson S.J., 1990, P111; SINGER MC, 1983, EVOLUTION, V37, P389, DOI 10.1111/j.1558-5646.1983.tb05547.x; Sivakoff FS, 2013, ENTOMOL EXP APPL, V149, P11, DOI 10.1111/eea.12101; SNODGRASS GL, 1984, ENVIRON ENTOMOL, V13, P110, DOI 10.1093/ee/13.1.110; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; VELASCO LRI, 1993, ENVIRON ENTOMOL, V22, P326, DOI 10.1093/ee/22.2.326; WALDBAUER GP, 1991, ANNU REV ENTOMOL, V36, P43, DOI 10.1146/annurev.en.36.010191.000355; Wang ZR., 1990, FARMLAND WEEDS CHINA; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; WOMACK CL, 1987, ENVIRON ENTOMOL, V16, P1266, DOI 10.1093/ee/16.6.1266; YOUNG OP, 1986, ANN ENTOMOL SOC AM, V79, P747, DOI 10.1093/aesa/79.4.747	61	21	32	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2015	10	2							e0117153	10.1371/journal.pone.0117153	http://dx.doi.org/10.1371/journal.pone.0117153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC0WZ	25692969	Green Published, Green Submitted, gold			2022-12-27	WOS:000350061500040
J	Sun, LM; Liao, K; Wang, DY				Sun, Lingmei; Liao, Kai; Wang, Dayong			Effects of Magnolol and Honokiol on Adhesion, Yeast-Hyphal Transition, and Formation of Biofilm by Candida albicans	PLOS ONE			English	Article							RETIGERIC ACID B; NATURAL-PRODUCTS; DRUG DISCOVERY; RESISTANCE; VIRULENCE; THERAPY	Background The first step in infection by Candida albicans is adhesion to host cells or implanted medical devices and this followed by hyphal growth and biofilm formation. Yeast-to-hyphal transition has long been identified as a key factor in fungal virulence. Following biofilm formation, C. albicans is usually less sensitive or insensitive to antifungals. Therefore, development of new antifungals with inhibitory action on adhesion, yeast-hyphal transition and biofilm formation by C. albicans is very necessary. Methods The effects of magnolol and honokiol on hypha growth were investigated using different induction media. Their inhibitory effects were determined using the 2,3-bis(2-methoxy-4-nitro-5- sulfophenyl)-2H-tetrazolium-5-carboxanilide assay, and biofilm thickness and viability were observed by a confocal scanning laser microscope. Mammalian cells were used in adhesion assays. Genes related to hyphae development and cell adhesions were analyzed by real-time reverse transcription-polymerase chain reaction. The exogenous cyclic adenosine monophosphate was used to determine the mechanisms of action of magnolol and honokiol. Caenorhabditis elegans was used as an in vivo model to estimate the antifungal activities of magnolol and honokiol. Results and conclusions Magnolol and honokiol inhibited adhesion, the transition from yeast to hypha, and biofilm formation by C. albicans through the Ras1-cAMP-Efg1 pathway. Moreover, magnolol and honokiol prolonged the survival of nematodes infected by C. albicans. Magnolol and honokiol have potential inhibitory effects against biofilm formation by C. albicans. General Significance This study provides useful information towards the development of new strategies to reduce the incidence of C. albicans biofilm-associated infection.	[Sun, Lingmei] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Liao, Kai] Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Sun, LM (corresponding author), Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China.	sunlingmei@seu.edu.cn; dayongw@seu.edu.cn	孙, 琳/HGE-6966-2022; shen, chen/AAC-2458-2020		National Natural Science Foundation of China [81302814]; Jiangsu Province Natural Science Foundation [BK20130640, BK20140624]; Doctoral Fund of Ministry of Education of China [20120092120068]; China Postdoctoral Science Foundation [2012M511182]; Fundamental Research Funds of Southeast University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds of Southeast University	This work was supported by grants from the National Natural Science Foundation of China (No. 81302814), Jiangsu Province Natural Science Foundation (No. BK20130640 and BK20140624), Doctoral Fund of Ministry of Education of China (No. 20120092120068), China Postdoctoral Science Foundation (No. 2012M511182), and Fundamental Research Funds of Southeast University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes PMDS, 2014, DIAGN MICR INFEC DIS, V79, P222, DOI 10.1016/j.diagmicrobio.2013.09.016; Ahariz M, 2010, MED DEVICES-EVID RES, V3, P33; Alexander BD, 1997, DRUGS, V54, P657, DOI 10.2165/00003495-199754050-00002; Bang KH, 2000, ARCH PHARM RES, V23, P46, DOI 10.1007/BF02976465; Bauer A, 2014, NAT PROD REP, V31, P35, DOI 10.1039/c3np70058e; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Chang WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041624; Chen G, 2014, EUR J PHARM SCI, V65, P21, DOI 10.1016/j.ejps.2014.09.001; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; de Freitas MM, 2011, IMPLANT DENT, V20, pE14, DOI 10.1097/ID.0b013e31820fb99e; Jacobo-Salcedo MD, 2011, NAT PROD COMMUN, V6, P1121; Fazly A, 2013, P NATL ACAD SCI USA, V110, P13594, DOI 10.1073/pnas.1305982110; Feldman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093225; Ferreira AV, 2013, MYCOPATHOLOGIA, V175, P265, DOI 10.1007/s11046-013-9638-z; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; FONZI WA, 1993, GENETICS, V134, P717; Harvey A, 2010, IDRUGS, V13, P70; Hogan DA, 2009, FUTURE MICROBIOL, V4, P1263, DOI 10.2217/FMB.09.106; Inigo M, 2012, INT J ARTIF ORGANS, V35, P780, DOI 10.5301/ijao.5000170; Jin J, 2010, LETT APPL MICROBIOL, V51, P351, DOI 10.1111/j.1472-765X.2010.02900.x; Larsen B, 2006, YEAST, V23, P795, DOI 10.1002/yea.1394; Lopez-Ribot JL, 2005, CURR BIOL, V15, pR453, DOI 10.1016/j.cub.2005.06.020; Miller LG, 2001, CLIN INFECT DIS, V32, P1110, DOI 10.1086/319613; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Perumal P, 2007, ANTIMICROB AGENTS CH, V51, P2454, DOI 10.1128/AAC.01237-06; Ruhnke M, 2014, CLIN MICROBIOL INFEC, V20, P11, DOI 10.1111/1469-0691.12622; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sun LM, 2010, J APPL MICROBIOL, V108, P341, DOI 10.1111/j.1365-2672.2009.04429.x; Sun LM, 2009, ANTIMICROB AGENTS CH, V53, P1586, DOI 10.1128/AAC.00940-08; Tobudic S, 2013, MYCOSES, V56, P623, DOI 10.1111/myc.12079; Toenjes KA, 2005, ANTIMICROB AGENTS CH, V49, P963, DOI 10.1128/AAC.49.3.963-972.2005; Wu XZ, 2009, BBA-GEN SUBJECTS, V1790, P770, DOI 10.1016/j.bbagen.2009.05.002	38	107	117	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117695	10.1371/journal.pone.0117695	http://dx.doi.org/10.1371/journal.pone.0117695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	26640948	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900036
J	Shi, SW; Han, PF; Zhang, P; Ding, F; Ma, CL				Shi, Sheng-wei; Han, Peng-fei; Zhang, Ping; Ding, Fan; Ma, Cheng-lin			The Impact of Afforestation on Soil Organic Carbon Sequestration on the Qinghai Plateau, China	PLOS ONE			English	Article							LAND-USE CHANGE; VERTICAL-DISTRIBUTION; AGRICULTURAL SOILS; NITROGEN ADDITIONS; STOCKS; FOREST; ACCUMULATION; GRASSLAND; DYNAMICS; MATTER	Afforestation, the conversion of non-forested land into forest, is widespread in China. However, the dynamics of soil organic carbon (SOC) after afforestation are not well understood, especially in plateau climate zones. For a total of 48 shrub- and/or tree-dominated afforestation sites on the Qinghai Plateau, Northwestern China, post-afforestation changes in SOC, total nitrogen (TN), the carbon-to-nitrogen ratio (C/N) and soil bulk density (BD) were investigated to a soil depth of 60 cm using the paired-plots method. SOC and TN accumulated at rates of 138.2 g C m(-2) yr(-1) and 4.6 g N m(-2) yr(-1), respectively, in shrub-dominated afforestation sites and at rates of 113.3 g C m(-2) yr(-1) and 6.7 g N m(-2)yr(-1), respectively, in tree-dominated afforestation sites. Soil BD was slightly reduced in all layers in the shrub-dominated afforestation plots, and significantly reduced in soil layers from 0-40cm in the tree-dominated afforestation plots. The C/N ratio was higher in afforested sites relative to the reference sites. SOC accumulation was closely related to TN accumulation following afforestation, and the inclusion of N-fixing species in tree-dominated afforestation sites additionally increased the soil accumulation capacity for SOC (p < 0.05). Multiple regression models including the age of an afforestation plot and total number of plant species explained 75% of the variation in relative SOC content change at depth of 0-20 cm, in tree-dominated afforestation sites. We conclude that afforestation on the Qinghai Plateau is associated with great capability of SOC and TN sequestration. This study improves our understanding of the mechanisms underlying SOC and TN accumulation in a plateau climate, and provides evidence on the C sequestration potentials associated with forestry projects in China.	[Shi, Sheng-wei; Han, Peng-fei; Zhang, Ping] Chinese Acad Sci, State Key Lab Atmospher Boundary Layer Phys & Atm, Inst Atmospher Phys, Beijing 100083, Peoples R China; [Shi, Sheng-wei; Han, Peng-fei; Ding, Fan; Ma, Cheng-lin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shi, Sheng-wei] Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China; [Ding, Fan; Ma, Cheng-lin] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Botany, CAS	Shi, SW (corresponding author), Chinese Acad Sci, State Key Lab Atmospher Boundary Layer Phys & Atm, Inst Atmospher Phys, Beijing 100083, Peoples R China.	weiweishi848@gmail.com	LAPC, IAP/AAI-6991-2020; Ding, Fan/A-3049-2015; Han, Pengfei/F-9082-2018	LAPC, IAP/0000-0002-0025-3484; Ding, Fan/0000-0002-7938-1015; Zhang, Min/0000-0001-5812-9518	national key fundamental research program for the Chinese Science and Technology Department [2010CB950604]	national key fundamental research program for the Chinese Science and Technology Department	This research was sponsored by the national key fundamental research program for the Chinese Science and Technology Department (2010CB950604).	Barcena TG, 2014, GLOBAL CHANGE BIOL, V20, P2393, DOI 10.1111/gcb.12576; Berry SL, 2002, GLOBAL ECOL BIOGEOGR, V11, P23, DOI 10.1046/j.1466-822X.2002.00183.x; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Binkley D, 2005, NATO SCI S SS IV EAR, V55, P155; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Bowman RA, 2002, COMMUN SOIL SCI PLAN, V33, P1629, DOI 10.1081/CSS-120004304; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Del Galdo I, 2003, GLOBAL CHANGE BIOL, V9, P1204, DOI 10.1046/j.1365-2486.2003.00657.x; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; [董旭 Dong Xu], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P45; Eclesia RP, 2012, GLOBAL CHANGE BIOL, V18, P3237, DOI 10.1111/j.1365-2486.2012.02761.x; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Fan GH, 2008, QINGHAI SCI TECHNOLO, V1, P17; Fornara DA, 2008, J ECOL, V96, P314, DOI 10.1111/j.1365-2745.2007.01345.x; [高国雄 GAO Guoxiong], 2007, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V21, P104; Giardina CP, 2004, OECOLOGIA, V139, P545, DOI 10.1007/s00442-004-1552-0; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; HANSEN EA, 1993, BIOMASS BIOENERG, V5, P431, DOI 10.1016/0961-9534(93)90038-6; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hoogmoed M, 2012, AGR ECOSYST ENVIRON, V159, P176, DOI 10.1016/j.agee.2012.07.011; Hoover CM, 2003, POTENTIAL OF U.S. FOREST SOILS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P211; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; [黄玉霞 Huang Yuxia], 2006, [气象, Meteorological Monthly], V32, P18; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Janssens IA, 2003, SCIENCE, V300, P1538, DOI 10.1126/science.1083592; Jarecki MK, 2003, CRIT REV PLANT SCI, V22, P471, DOI 10.1080/713608318; [敬文茂 Jing Wenmao], 2011, [甘肃农业大学学报, Journal of Gansu Agricultural University], V46, P81; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kaye JP, 2000, ECOLOGY, V81, P3267, DOI 10.1890/0012-9658(2000)081[3267:NACDIA]2.0.CO;2; Knops JMH, 2009, SOIL SCI SOC AM J, V73, P2096, DOI 10.2136/sssaj2009.0058; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Lin ZY, 1981, ACTA GEOGRAPHICA SIN, V1, P22; Liu F, 2011, GLOBAL CHANGE BIOL, V17, P1119, DOI 10.1111/j.1365-2486.2010.02251.x; Liu F, 2010, GLOBAL CHANGE BIOL, V16, P2213, DOI 10.1111/j.1365-2486.2009.02099.x; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Lu F, 2007, THESIS BEIJING FORES; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; LUGO AE, 1993, PLANT SOIL, V149, P27, DOI 10.1007/BF00010760; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Luo YQ, 2006, ECOLOGY, V87, P3, DOI 10.1890/05-0923; Mao R, 2010, ENVIRON MANAGE, V46, P110, DOI 10.1007/s00267-010-9504-4; McKinley DC, 2011, ECOL APPL, V21, P1902, DOI 10.1890/10-0697.1; Morris SJ, 2007, GLOBAL CHANGE BIOL, V13, P1145, DOI 10.1111/j.1365-2486.2007.01359.x; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Pineiro G, 2006, GLOBAL CHANGE BIOL, V12, P804, DOI 10.1111/j.1365-2486.2006.01139.x; Poeplau C, 2011, GLOBAL CHANGE BIOL, V17, P2415, DOI 10.1111/j.1365-2486.2011.02408.x; Powers JS, 2011, P NATL ACAD SCI USA, V108, P6318, DOI 10.1073/pnas.1016774108; Resh SC, 2002, ECOSYSTEMS, V5, P217, DOI 10.1007/s10021-001-0067-3; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Saiz G, 2012, GLOBAL CHANGE BIOL, V18, P1670, DOI 10.1111/j.1365-2486.2012.02657.x; Shi SW, 2013, FOREST ECOL MANAG, V296, P53, DOI 10.1016/j.foreco.2013.01.026; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Smith P, 2012, GLOBAL CHANGE BIOL, V18, P2089, DOI 10.1111/j.1365-2486.2012.02689.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song XZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04460; State Forestry Administration PCC, 2010, CHIN FOR STAT YB, P498; Tang JW, 2009, GLOBAL CHANGE BIOL, V15, P145, DOI 10.1111/j.1365-2486.2008.01741.x; Throop HL, 2008, GLOBAL CHANGE BIOL, V14, P2420, DOI 10.1111/j.1365-2486.2008.01650.x; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Wang SL, 2010, PLANT SOIL, V334, P501, DOI 10.1007/s11104-010-0400-8; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P2657, DOI 10.1111/j.1365-2486.2011.02447.x; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Zhang K, 2010, LAND DEGRAD DEV, V21, P13, DOI 10.1002/ldr.954; Zhou XH, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.17223; Zillich AJ, 2006, HYPERTENSION, V48, P219, DOI 10.1161/01.HYP.0000231552.10054.aa	73	27	29	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2015	10	2							e0116591	10.1371/journal.pone.0116591	http://dx.doi.org/10.1371/journal.pone.0116591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9BI	25621996	Green Submitted, Green Published, gold			2022-12-27	WOS:000350662100041
J	Shi, S; Zhang, M; Guo, R; Miao, Y; Hu, JJ; Xi, Y; Li, B				Shi, Shuo; Zhang, Min; Guo, Rui; Miao, Ying; Hu, Jiajia; Xi, Yun; Li, Biao			In vivo Molecular Imaging and Radionuclide (I-131) Therapy of Human Nasopharyngeal Carcinoma Cells Transfected with a Lentivirus Expressing Sodium Iodide Symporter	PLOS ONE			English	Article							GENE DELIVERY; SODIUM/IODIDE SYMPORTER; VIRAL VECTORS; PROMOTER; EFFICACY; VITRO; LINE	Introduction Despite recent improvements in the survival rates for nasopharyngeal carcinoma (NPC), novel treatment strategies are required to improve distant metastasis-free survival. The sodium iodine symporter (NIS) gene has been applied for in vivo imaging and cancer therapy. In this study, we examined the potential of NIS gene therapy as a therapeutic approach in NPC by performing non-invasive imaging using I-125 and I-131 therapy in vivo. Methods We constructed a lentiviral vector expressing NIS and enhanced green fluorescent protein (EGFP) under the control of the human elongation factor-1 alpha (EF1 alpha) promoter, and stably transfected the vector into CNE-2Z NPC cells to create CNE-2Z-NIS cells. CNE-2Z and CNE-2Z-NIS tumor xenografts were established in nude mice; I-125 uptake, accumulation and efflux were measured using micro-SPECT/CT imaging; the therapeutic effects of treatment with I-131 were assessed over 25 days by measuring tumor volume and immunohistochemical staining of the excised tumors. Results qPCR, immunofluorescence and Western blotting confirmed that CNE-2Z-NIS cells expressed high levels of NIS mRNA and protein. CNE-2Z-NIS cells and xenografts took up and accumulated significantly more I-125 than CNE-2Z cells and xenografts. In vitro, I-131 significantly reduced the clonogenic survival of CNE-2Z-NIS cells. In vivo, I-131 effectively inhibited the growth of CNE-2Z-NIS xenografts. At the end of I-131 therapy, CNE-2Z-NIS xenograft tumor cells expressed higher levels of NIS and caspase-3 and lower levels of Ki-67. Conclusion Lentiviruses effectively delivered and mediated long-lasting expression of NIS in CNE-2Z cells which enabled uptake and accumulation of radioisotopes and provided a significant therapeutic effect in an in vivo model of NPC. NIS-mediated radioiodine treatment merits further investigation as a potentially effective, low toxicity therapeutic strategy for NPC.	[Shi, Shuo; Zhang, Min; Guo, Rui; Miao, Ying; Hu, Jiajia; Xi, Yun; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Li, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China.	lb10363@rjh.com.cn	LAPC, IAP/AAI-6991-2020; Ding, Fan/A-3049-2015; Han, Pengfei/F-9082-2018	LAPC, IAP/0000-0002-0025-3484; Ding, Fan/0000-0002-7938-1015; Zhang, Min/0000-0001-5812-9518	National Natural Science Foundation of China [81071181]; Shanghai Outstanding Academic Leaders Project [11XD1403700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Outstanding Academic Leaders Project	This work was supported by grants from the National Natural Science Foundation of China (No. 81071181) (http://isisn.nsfc.gov.cn/egrantweb/), Shanghai Outstanding Academic Leaders Project (11XD1403700) (http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeciga-Diaz CJ, 2009, MOL BIOL REP, V36, P1863, DOI 10.1007/s11033-008-9392-3; Bosch EH, 2000, J APPL MICROBIOL, V89, P215, DOI 10.1046/j.1365-2672.2000.01098.x; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; De Meyer SF, 2006, BLOOD, V107, P4728, DOI 10.1182/blood-2005-09-3605; Guo R, 2011, NUCL MED COMMUN, V32, P402, DOI 10.1097/MNM.0b013e328344a1ad; Hingorani M, 2010, CURR CANCER DRUG TAR, V10, P242, DOI 10.2174/156800910791054194; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509; KAMINSKY SM, 1993, SOC GEN PHY, V48, P251; Li JH, 2000, INT J CANCER, V87, P606; Li JH, 1997, CLIN CANCER RES, V3, P507; Li JH, 2003, MOL THER, V8, P964, DOI 10.1016/j.ymthe.2003.08.018; Li Jia-Xin, 2010, Chin J Cancer, V29, P82; Li XP, 2006, INT J ONCOL, V29, P595; Liu BH, 2004, GENE THER, V11, P52, DOI 10.1038/sj.gt.3302126; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Moiani A, 2012, J CLIN INVEST, V122, P1653, DOI 10.1172/JCI61852; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061305; Petrich T, 2006, CLIN CANCER RES, V12, P1342, DOI 10.1158/1078-0432.CCR-05-1576; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Riesco-Eizaguirre G, 2006, EUR J ENDOCRINOL, V155, P495, DOI 10.1530/eje.1.02257; Sides MD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-152; Skugor M., 2009, CLEVELAND CLIN GUIDE; Vannucci L, 2013, NEW MICROBIOL, V36, P1; Vigna E, 2000, J GENE MED, V2, P308; Wang GL, 1999, BRIT J CANCER, V81, P1122, DOI 10.1038/sj.bjc.6690818; Weeks AJ, 2011, NUCL MED COMMUN, V32, P98, DOI 10.1097/MNM.0b013e3283419540; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Weinrib L, 2001, CANCER GENE THER, V8, P352, DOI 10.1038/sj.cgt.7700319; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1090, DOI 10.1210/endo-114-4-1090; Xu T, 2013, CURR ONCOL, V20, pE406, DOI 10.3747/co.20.1456; Zhang XJ, 2006, ADV DRUG DELIVER REV, V58, P515, DOI 10.1016/j.addr.2006.03.006	34	27	29	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0116531	10.1371/journal.pone.0116531	http://dx.doi.org/10.1371/journal.pone.0116531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25621996	Green Published, Green Submitted, gold			2022-12-27	WOS:000348470400005
J	Sun, L; Tian, JL; Yin, QQ; Xiao, J; Li, JQ; Guo, YJ; Feng, GS; Peng, XX; Qi, H; Xu, F; Jiao, WW; Shen, C; Shen, AD				Sun, Lin; Tian, Jian-ling; Yin, Qing-qin; Xiao, Jing; Li, Jie-qiong; Guo, Ya-jie; Feng, Guo-shuang; Peng, Xiao-xia; Qi, Hui; Xu, Fang; Jiao, Wei-wei; Shen, Chen; Shen, A-dong			Performance of the Interferon Gamma Release Assays in Tuberculosis Disease in Children Five Years Old or Less	PLOS ONE			English	Article							PEDIATRIC TUBERCULOSIS; SKIN-TEST; INFECTION; DIAGNOSIS; AGE	Interferon Gamma Release Assays (IGRAs) were developed for the indirect or immunologic diagnosis of tuberculosis infection; however, they have also been used to assist in difficult to diagnose cases of tuberculosis disease in adults, and to a lesser extent, in children, especially in those under 5 years old. We evaluated the utility of using an IGRA in pediatric tuberculosis in younger children in a hospital setting. The diagnostic accuracy of T-SPOT. TB and TST was assessed in 117 children with active tuberculosis and 413 children with respiratory tract infection. Sensitivity and specificity were calculated for the tests used individually and together. Concordance was also calculated. Sensitivity of T-SPOT. TB (82.9%) was higher than TST (78.6% using a 5mm cut-off), especially in children confirmed to have TB. T-SPOT. TB was more specific than TST using a 5mm cut-off (96.1% vs. 70.9%). Combining T-SPOT. TB and TST results improved the sensitivity to 96.6%. In conclusion, the results of the current study indicate that T-SPOT. TB has good sensitivity and specificity, supporting its use among patients of this age. A combination of IGRA and TST would be useful additions to assist in the diagnosis of childhood TB.	[Sun, Lin; Tian, Jian-ling; Yin, Qing-qin; Xiao, Jing; Li, Jie-qiong; Guo, Ya-jie; Qi, Hui; Xu, Fang; Jiao, Wei-wei; Shen, Chen; Shen, A-dong] Capital Med Univ, Key Lab Major Dis Children & Natl Key Discipline, Beijing Key Lab Pediat Resp Infect Dis,Beijing Ch, Beijing Pediat Res Inst,Minist Educ,Natl Clin Res, Beijing, Peoples R China; [Feng, Guo-shuang; Peng, Xiao-xia] Capital Med Univ, Beijing Childrens Hosp, Ctr Clin Epidemiol & Evidence Based Med, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Shen, AD (corresponding author), Capital Med Univ, Key Lab Major Dis Children & Natl Key Discipline, Beijing Key Lab Pediat Resp Infect Dis,Beijing Ch, Beijing Pediat Res Inst,Minist Educ,Natl Clin Res, Beijing, Peoples R China.	shenad16@hotmail.com	孙, 琳/HGE-6966-2022; shen, chen/AAC-2458-2020		National Science and Technology Major Project of China [2013ZX10003003-004]; National Natural Science Foundation of China [81200064]; Collaborative Innovation Center of Infectious Diseases [PXM2014_014226_000011]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center of Infectious Diseases	This work was supported by National Science and Technology Major Project of China (2013ZX10003003-004), National Natural Science Foundation of China (no. 81200064) and Collaborative Innovation Center of Infectious Diseases (no. PXM2014_014226_000011).	Blandinieres A, 2013, J INFECTION, V67, P391, DOI 10.1016/j.jinf.2013.06.011; Carvalho ACC, 2013, INFECTION, V41, P827, DOI 10.1007/s15010-013-0450-y; Committee On Infectious Diseases AAOP, 2009, RED BOOK REP COMM IN; Critselis E, 2012, J PEDIATR-US, V161, P632, DOI 10.1016/j.jpeds.2012.04.007; Cruz AT, 2010, PEDIATR REV, V31, P13, DOI 10.1542/pir.31-1-13; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Haimi-Cohen Y, 2001, CLIN INFECT DIS, V33, P1786, DOI 10.1086/323984; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nicol MP, 2009, PEDIATRICS, V123, P38, DOI 10.1542/peds.2008-0611; PAVIC I, 2011, PEDIATR INFECT DIS J, V30, P866, DOI DOI 10.1097/INF.0B013E318220C52A; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Schopfer K, 2014, EUR J PEDIATR, V173, P331, DOI 10.1007/s00431-013-2161-x; Sollai S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S6; Sun L, 2010, CHINESE MED J-PEKING, V123, P2786, DOI 10.3760/cma.j.issn.0366-6999.2010.20.007; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; Tuberculosis NTSG, 2002, REP 4 NAT EP SAMPL S, V2, P3; World Health Organization, 2014, GLOB TUB REP; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742; Zar HJ, 2010, EXPERT REV ANTI-INFE, V8, P277, DOI [10.1586/eri.10.9, 10.1586/ERI.10.9]	21	107	117	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143820	10.1371/journal.pone.0143820	http://dx.doi.org/10.1371/journal.pone.0143820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640948	gold, Green Published, Green Submitted			2022-12-27	WOS:000366902700029
J	Sapkota, S; Brien, JA; Greenfield, J; Aslani, P				Sapkota, Sujata; Brien, Jo-anne; Greenfield, Jerry; Aslani, Parisa			A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes-Impact on Adherence	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; SELF-MANAGEMENT; IMPROVE ADHERENCE; EDUCATIONAL INTERVENTIONS; COMMUNITY PHARMACIST; PHARMACEUTICAL CARE; AFRICAN-AMERICANS; SOCIAL SUPPORT; OLDER-ADULTS; MELLITUS	Background The global prevalence of diabetes is increasing. Medications are a recommended strategy to control hyperglycaemia. However, patient adherence can be variable, impacting health outcomes. A range of interventions for patients with type 2 diabetes have focused on improving treatment adherence. This review evaluates the impact of these interventions on adherence to anti-diabetic medications and focuses on the methods and tools used to measure adherence. Method Medline, Embase, CINAHL, IPA, PUBmed, and PsychINFO were searched for relevant articles published in 2000-2013, using appropriate search terms. Results Fifty two studies addressing adherence to anti-diabetic medications in patients with type 2 diabetes met the inclusion criteria and were reviewed. Each study was assessed for research design, method(s) used for measuring medication adherence, and impact of intervention on medication adherence and glycaemic control. Fourteen studies were published in 2000-2009 and 38 in 2010-2013. Twenty two interventions led to improvements in adherence to anti-diabetic medications, while only nine improved both medication adherence and glycaemic control. A single strategy could not be identified which would be guaranteed to improve anti-diabetic medication adherence consistently. Nonetheless, most interventions were successful in influencing one or more of the outcomes assessed, indicating the usefulness of these interventions under certain circumstances. Self-report, particularly the Summary of Diabetes Self-Care Activities questionnaire was the most commonly used tool to assess medication adherence, although other self-report tools were used in more recent studies. Overall, there was a slight increase in the number of studies that employed multiple methods to assess medication adherence in studies conducted after 2008. Conclusion The diversity of interventions and adherence measurements prevented a meta-analysis of the impact of interventions on adherence to therapy, highlighting the need for more consistency in methods in the area of adherence research. Whilst effective interventions were identified, it is not possible to conclude on an effective intervention that can be generalised to all patients with type 2 diabetes.	[Sapkota, Sujata; Brien, Jo-anne; Aslani, Parisa] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Greenfield, Jerry] St Vincent Hosp, Dept Endocrinol, Sydney, NSW, Australia	University of Sydney; St Vincents Hospital Sydney	Aslani, P (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	parisa.aslani@sydney.edu.au	Sapkota, Sujata/ABG-1745-2021	Greenfield, Jerry/0000-0002-0866-0973; Sapkota, Sujata/0000-0001-9887-6868				Adepu R, 2010, ASIAN J PHARM CLIN R, V3, P174; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Babamoto KS, 2009, HEALTH EDUC BEHAV, V36, P113, DOI 10.1177/1090198108325911; Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x; Barron JJ, 2012, AM J PHARM BENEFIST, V4, P29; Blackburn DF, 2013, PATIENT PREFER ADHER, V7, P183, DOI 10.2147/PPA.S30613; Blenkinsopp A, 2005, INT J PHARM PRACT, V13, P231, DOI 10.1211/ijpp.13.4.0001; Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344; Bogner HR, 2010, DIABETES EDUCATOR, V36, P284, DOI 10.1177/0145721709356115; Brennan TA, 2012, HEALTH AFFAIR, V31, P120, DOI 10.1377/hlthaff.2011.0931; Brown MT, 2011, MEDICATION ADHERENCE; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Castillo A, 2010, DIABETES EDUCATOR, V36, P586, DOI 10.1177/0145721710371524; Cha E, 2012, DIABETES EDUCATOR, V38, P835, DOI 10.1177/0145721712460283; Choi SE, 2012, DIABETES EDUCATOR, V38, P377, DOI 10.1177/0145721712443292; Cinar FI, 2010, TURKISH J ENDOCRINOL, V14, P1, DOI [10.1093/fampra/cmq069, DOI 10.1093/FAMPRA/CMQ069]; Clarke A, 2009, EUR DIABETES NURS, V6, P88, DOI [10.1177/1742395309343978, DOI 10.1177/1742395309343978]; Collins-McNeil J, 2012, CAN J NURS RES, V44, P126; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Borges APD, 2010, PHARM WORLD SCI, V32, P730, DOI 10.1007/s11096-010-9428-3; Doggrell SA, 2010, DIABETIC MED, V27, P1341, DOI 10.1111/j.1464-5491.2010.03137.x; Faridi Z, 2008, J EVAL CLIN PRACT, V14, P465, DOI 10.1111/j.1365-2753.2007.00881.x; Farmer A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-30; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Garcia-Huidobro D, 2011, FAM PRACT, V28, P4, DOI 10.1093/fampra/cmq069; Glasgow RE, 2009, CHRONIC ILLN, V5, P243, DOI 10.1177/1742395309343978; Gonzalez JS, 2010, J COGN PSYCHOTHER, V24, P329, DOI 10.1891/0889-8391.24.4.329; Grant RW, 2003, ANN PHARMACOTHER, V37, P962, DOI 10.1345/aph.1C452; Graziano Judith A, 2009, ANS Adv Nurs Sci, V32, pE28, DOI 10.1097/ANS.0b013e3181b0d6d6; Gregoire JP, 2010, VALUE HEALTH, V13, P820, DOI 10.1111/j.1524-4733.2010.00761.x; Hearnshaw H, 2006, EUROPEAN DIABETES NU, V3, P73; Hendricks LE, 2000, DIABETES EDUCATOR, V26, P995, DOI 10.1177/014572170002600612; Horne R., 2005, CONCORDANCE ADHERENC, P40; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kamar ME, MANAGEMENT TYPE 2 DI; Keeratiyutawong P, 2006, THAI J NURSING RES, V10, P85; Khan Mohammad A, 2011, Diabetes Ther, V2, P178, DOI 10.1007/s13300-011-0007-y; Kim G, 2012, J AM GERIATR SOC, V60, P2319, DOI 10.1111/jgs.12003; Kim HS, 2006, J NURS CARE QUAL, V21, P266, DOI 10.1097/00001786-200607000-00012; Kim HS, 2003, J ADV NURS, V44, P256, DOI 10.1046/j.1365-2648.2003.02800.x; Kolawole BA, 2010, INT Q COMMUNITY HEAL, V29, P381, DOI 10.2190/IQ.29.4.g; Kroese FM, 2012, HEALTH EDUC RES, V27, P825, DOI 10.1093/her/cys062; Lehmann A, 2014, INT J CLIN PHARM-NET, V36, P55, DOI 10.1007/s11096-013-9865-x; Lerman I, 2005, ARCH MED RES, V36, P300, DOI 10.1016/j.arcmed.2004.12.001; Lindenmeyer A, 2006, J CLIN PHARM THER, V31, P409, DOI 10.1111/j.1365-2710.2006.00759.x; Maddigan SL, 2004, DIABETES CARE, V27, P1306, DOI 10.2337/diacare.27.6.1306; Mehuys E, 2011, J CLIN PHARM THER, V36, P602, DOI 10.1111/j.1365-2710.2010.01218.x; Mitchell B, 2011, PATIENT EDUC COUNS, V83, P288, DOI 10.1016/j.pec.2011.04.027; Montori Victor M, 2004, ACP J Club, V140, P51; Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293; Odegard PS, 2012, J AM PHARM ASSOC, V52, P753, DOI 10.1331/JAPhA.2012.11001; Odegard PS, 2005, ANN PHARMACOTHER, V39, P433, DOI 10.1345/aph.1E438; Omran D, 2012, CAN J DIABETES, V36, P292, DOI 10.1016/j.jcjd.2012.07.002; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9; Pladevall M, 2004, DIABETES CARE, V27, P2800, DOI 10.2337/diacare.27.12.2800; Quinn CC, 2008, DIABETES TECHNOL THE, V10, P160, DOI 10.1089/dia.2008.0283; Ramanath KV, 2012, ARCH PHARM PRACT, V3, P170, DOI 10.4103/2045-080X.112813; Ramanath KVYLS, 2011, ASIAN J PHARM CLIN R, V4, P15; Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927; Rodin HA, 2009, AM J MANAG CARE, V15, P881; Rosen MI, 2004, BEHAV RES THER, V42, P409, DOI 10.1016/S0005-7967(03)00149-9; Sabatae E, 2003, ADHERENCE LONG TERM; Sacco WP, 2009, J BEHAV MED, V32, P349, DOI 10.1007/s10865-009-9209-4; Schectman JM, 2004, AM J MED SCI, V327, P19, DOI 10.1097/00000441-200401000-00005; Shetty Ananth Samith, 2011, J Assoc Physicians India, V59, P711; Sigurdardottir AK, 2007, PATIENT EDUC COUNS, V67, P21, DOI 10.1016/j.pec.2007.03.007; Smith SM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d715; Tang TS, 2010, PATIENT EDUC COUNS, V79, P178, DOI 10.1016/j.pec.2009.09.029; Thoolen BJ, 2009, PSYCHOL HEALTH, V24, P237, DOI 10.1080/08870440701864504; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Utz SW, 2008, DIABETES EDUCATOR, V34, P854, DOI 10.1177/0145721708323642; van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001; Vermeire EI, 2005, COCHRANE DATABASE SY; Vervloet M, 2012, INT J MED INFORM, V81, P594, DOI 10.1016/j.ijmedinf.2012.05.005; Vincent D, 2007, BIOL RES NURS, V9, P130, DOI 10.1177/1099800407304980; Wakefield BJ, 2011, TELEMED E-HEALTH, V17, P254, DOI 10.1089/tmj.2010.0176; Walker EA, 2011, DIABETES CARE, V34, P2, DOI 10.2337/dc10-1005; Wens J, 2008, DIABETES RES CLIN PR, V79, P377, DOI 10.1016/j.diabres.2007.06.006; Wermeille J, 2004, PHARM WORLD SCI, V26, P18, DOI 10.1023/B:PHAR.0000013465.24857.a8; Wilke T, 2010, VALUE HEALTH, V13, pA295, DOI 10.1016/S1098-3015(11)72123-4; Wolever RQ, 2010, DIABETES EDUCATOR, V36, P629, DOI 10.1177/0145721710371523; World Health Organization, 2003, SCREEN TYP 2 DIAB RE; Zhang YT, 2010, MED CARE, V48, P409, DOI 10.1097/MLR.0b013e3181d68978; Zolfaghari M, 2012, J CLIN NURS, V21, P1922, DOI 10.1111/j.1365-2702.2011.03951.x; Zomahoun HTV, 2012, J POPULATION THERAPE, V19, pe135	87	96	98	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0118296	10.1371/journal.pone.0118296	http://dx.doi.org/10.1371/journal.pone.0118296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9IY	26053004	gold, Green Published, Green Submitted			2022-12-27	WOS:000350683900052
J	Yuan, QL; Guo, TM; Liu, L; Sun, F; Zhang, YG				Yuan, Qi-ling; Guo, Tuan-mao; Liu, Liang; Sun, Fu; Zhang, Yin-gang			Traditional Chinese Medicine for Neck Pain and Low Back Pain: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; CHRONIC SPINAL PAIN; TERM-FOLLOW-UP; ACUPUNCTURE TREATMENT; COMPARING ACUPUNCTURE; THERAPY; EXERCISE; ACUPRESSURE; EFFICACY; PLACEBO	Background Neck pain (NP) and low back pain (LBP) are common symptoms bothering people in daily life. Traditional Chinese medicine (TCM) has been used to treat various symptoms and diseases in China and has been demonstrated to be effective. The objective of the present study was to review and analyze the existing data about pain and disability in TCM treatments for NP and LBP. Methods Studies were identified by a comprehensive search of databases, such as MEDLINE, EMBASE, and Cochrane Library, up to September 1, 2013. A meta-analysis was performed to evaluate the efficacy and safety of TCM in managing NP and LBP. Results Seventy five randomized controlled trials (n = 11077) were included. Almost all of the studies investigated individuals experiencing chronic NP (CNP) or chronic LBP (CLBP). We found moderate evidence that acupuncture was more effective than sham-acupuncture in reducing pain immediately post-treatment for CNP (visual analogue scale (VAS) 10 cm, mean difference (MD) = -0.58 (-0.94, -0.22), 95% confidence interval, p = 0.01), CLBP (standardized mean difference = -0.47 (-0.77, -0.17), p = 0.003), and acute LBP (VAS 10 cm, MD = -0.99 (-1.24, -0.73), p < 0.001). Cupping could bemore effective than waitlist in VAS (100mm) (MD = -19.10 (-27.61, -10.58), p < 0.001) for CNP or medications (e.g. NSAID) for CLBP (MD = -5.4 (-8.9, -0.19), p = 0.003). No serious or life-threatening adverse effects were found. Conclusions Acupuncture, acupressure, and cupping could be efficacious in treating the pain and disability associated with CNP or CLBP in the immediate term. Gua sha, tai chi, qigong, and Chinese manipulation showed fair effects, but we were unable to draw any definite conclusions, and further research is still needed. The efficacy of tuina and moxibustion is unknown because no direct evidence was obtained. These TCM modalities are relatively safe.	[Yuan, Qi-ling; Liu, Liang; Sun, Fu; Zhang, Yin-gang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Orthopaed, Xian 710061, Peoples R China; [Guo, Tuan-mao] Xianyang Cent Hosp, Dept Orthopaed 2, Xianyang 712000, Shaanxi, Peoples R China; [Sun, Fu] Xian Med Coll, Affiliated Hosp, Dept Orthopaed, Xian 710077, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University	Zhang, YG (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Orthopaed, Xian 710061, Peoples R China.	zyingang@mail.xjtu.edu.cn	Yuan, Qiling/AGX-7768-2022	Yuan, Qiling/0000-0002-4822-2513; Guo, Meiting/0000-0002-1497-7053	Natural Scientific Fund of China [81371987, 81171761]	Natural Scientific Fund of China	The authors are grateful for the support of the Natural Scientific Fund of China (no. 81371987, 81171761). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 1997, ADULT SPINE PRINCIPL; Birch S, 1998, CLIN J PAIN, V14, P248, DOI 10.1097/00002508-199809000-00012; Braun M, 2011, PAIN MED, V12, P362, DOI 10.1111/j.1526-4637.2011.01053.x; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Chen J, 2009, CHIN J TRADIT MED TR, V17, P32; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Cherkin DC, 2001, ARCH INTERN MED, V161, P1081, DOI 10.1001/archinte.161.8.1081; Cho YJ, 2013, SPINE, V38, P549, DOI 10.1097/BRS.0b013e318275e601; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; COAN RM, 1981, AM J CHINESE MED, V9, P326, DOI 10.1142/S0192415X81000433; COAN RM, 1980, AM J CHINESE MED, V8, P181, DOI 10.1142/S0192415X80000141; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015; Cramer H, 2011, FORSCH KOMPLEMENTMED, V18, P327, DOI 10.1159/000335294; D'Sylva J, 2010, MANUAL THER, V15, P415, DOI 10.1016/j.math.2010.04.003; Farhadi K, 2009, COMPLEMENT THER MED, V17, P9, DOI 10.1016/j.ctim.2008.05.003; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fu LM, 2009, J ALTERN COMPLEM MED, V15, P133, DOI 10.1089/acm.2008.0135; Fu WB, 2009, CHIN J INTEGR MED, V15, P426, DOI 10.1007/s11655-009-0426-z; Furlan AD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/953139; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gao S, 1993, ZHONG YI YAO DONG TA, V4, P25, DOI 1016/j.math.2010.04.003; Geng M, 1989, ZHEN JIU XUE BAO, V3, P29; Giles LGF, 2003, SPINE, V28, P1490, DOI 10.1097/00007632-200307150-00003; Giles LGF, 1999, J MANIP PHYSIOL THER, V22, P376, DOI 10.1016/S0161-4754(99)70082-5; Grant DJ, 1999, PAIN, V82, P9, DOI 10.1016/S0304-3959(99)00027-5; Gross A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004249.pub3; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Hall AM, 2011, ARTHRIT CARE RES, V63, P1576, DOI 10.1002/acr.20594; Hasegawa TM, 2013, ACUPUNCT MED; Hayden J, 2011, COCHRANE DB SYST REV; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; [洪永锋 HONG Yongfeng], 2006, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V21, P340; Hsieh LLC, 2006, BMJ-BRIT MED J, V332, P696, DOI 10.1136/bmj.38744.672616.AE; Hsieh LLC, 2004, PREV MED, V39, P168, DOI 10.1016/j.ypmed.2004.01.036; Hunter RF, 2012, CLIN J PAIN, V28, P259, DOI 10.1097/AJP.0b013e3182274018; Inoue Motohiro, 2006, Acupunct Med, V24, P103; Irnich D, 2001, BMJ-BRIT MED J, V322, P1574, DOI 10.1136/bmj.322.7302.1574; Itoh K, 2007, COMPLEMENT THER MED, V15, P172, DOI 10.1016/j.ctim.2006.05.003; Itoh Kazunori, 2006, Acupunct Med, V24, P5; Itoh Kazunori, 2004, Acupunct Med, V22, P170; Itoh Kazunori, 2009, Complement Ther Clin Pract, V15, P22, DOI 10.1016/j.ctcp.2008.09.003; Jacobs WCH, 2013, EUR SPINE J, V22, P1936, DOI 10.1007/s00586-013-2823-4; Kennedy S, 2008, COMPLEMENT THER MED, V16, P139, DOI 10.1016/j.ctim.2007.03.001; Kim JI, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-146; Kim TH, 2012, J OCCUP HEALTH, V54, P416, DOI 10.1539/joh.12-0133-OA; Lam M, 2013, SPINE, V38, P2124, DOI 10.1097/01.brs.0000435025.65564.b7; Lansinger B, 2007, SPINE, V32, P2415, DOI 10.1097/BRS.0b013e3181573b4b; Lao L., 2012, INTEGRATIVE PEDIAT O, P125; Lauche R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065378; Lauche R, 2012, AM J CHINESE MED, V40, P905, DOI 10.1142/S0192415X1250067X; Lauche R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/429718; Lauche R, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-63; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Leibing E, 2002, PAIN, V96, P189, DOI 10.1016/S0304-3959(01)00444-4; Li D, 2006, FLORA CHINA, V22, P7; Li JY, 2009, NEI MONGOL J TRADIT, V14, P31; Li Q, 2007, CHIN J CLIN REHABIL, V11, P4531; Liang ZH, 2011, COMPLEMENT THER MED, V19, pS26, DOI 10.1016/j.ctim.2010.11.005; Lin JH, 2013, MANUAL THER, V18, P308, DOI 10.1016/j.math.2012.11.005; Liu BX, 2008, CHINESE J REHABILITA, V14, P572; Macedo LG, 2013, PHYS THER, V93, P1587, DOI 10.2522/ptj.20120464; MAKELA M, 1991, AM J EPIDEMIOL, V134, P1356; Meng CF, 2003, RHEUMATOLOGY, V42, P1508, DOI 10.1093/rheumatology/keg405; Miyazaki S, 2009, CLIN J PAIN, V25, P438, DOI 10.1097/AJP.0b013e318193a6e1; Molsberger AF, 2002, PAIN, V99, P579, DOI 10.1016/S0304-3959(02)00269-5; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Muller R, 2005, J MANIP PHYSIOL THER, V28, P3, DOI 10.1016/j.jmpt.2004.12.004; Nabeta T, 2002, COMPLEMENT THER MED, V10, P217, DOI 10.1016/S0965-2299(02)00082-1; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; PETRIE JP, 1986, BRIT J RHEUMATOL, V25, P271; Rendant D, 2011, SPINE, V36, P419, DOI 10.1097/BRS.0b013e3181d51fca; Roelofs PD, 2011, COCHRANE DB SYST REV; Sahin N, 2010, ACUPUNCTURE ELECTRO, V35, P17, DOI 10.3727/036012910803860959; Sator-Katzenschlager SM, 2004, ANESTH ANALG, V98, P1359, DOI 10.1213/01.ANE.0000107941.16173.F7; Shankar Nilima, 2011, Indian J Physiol Pharmacol, V55, P25; Sherwin D C, 1992, Rehabil Nurs, V17, P253; Su Jiang-tao, 2010, Zhongguo Zhen Jiu, V30, P617; Suen Lorna K P, 2007, Complement Ther Clin Pract, V13, P63, DOI 10.1016/j.ctcp.2006.10.005; THOMAS M, 1991, AM J CHINESE MED, V19, P95, DOI 10.1142/S0192415X91000156; Trinh K, 2007, SPINE, V32, P236, DOI 10.1097/01.brs.0000252100.61002.d4; Tsui MLK, 2004, J ALTERN COMPLEM MED, V10, P803; Vas J, 2006, PAIN, V126, P245, DOI 10.1016/j.pain.2006.07.002; Vas J, 2012, PAIN, V153, P1883, DOI 10.1016/j.pain.2012.05.033; Vas Jorge, 2006, BMC Complement Altern Med, V6, P14, DOI 10.1186/1472-6882-6-14; von Trott P, 2009, J PAIN, V10, P501, DOI 10.1016/j.jpain.2008.11.004; Wang B. X., 2004, CHINESE J CLIN REHAB, V8, P3413; Weiss J, 2013, J ALTERN COMPLEMENT; White P, 2004, ANN INTERN MED, V141, P911, DOI 10.7326/0003-4819-141-12-200412210-00007; Witt CM, 2006, AM J EPIDEMIOL, V164, P487, DOI 10.1093/aje/kwj224; Xu M, 2009, LIAONING J TRADITION, V36, P1007; Xu M, 2013, AM J CHINESE MED, V41, P1, DOI 10.1142/S0192415X13500018; Xu Y, 1977, CHI JIAO YI SHENG ZA, V1, P34; Yang BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035032; Yeh CH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/196978; Yeung CKN, 2003, J ALTERN COMPLEM MED, V9, P479, DOI 10.1089/107555303322284767; Yip Y B, 2006, Complement Ther Clin Pract, V12, P18, DOI 10.1016/j.ctcp.2005.09.005; Yip YB, 2004, COMPLEMENT THER MED, V12, P28, DOI 10.1016/j.ctim.2003.12.003; Yun MD, 2012, J ALTERN COMPLEM MED, V18, P130, DOI 10.1089/acm.2010.0779; Zaringhalam Jalal, 2010, Chin Med, V5, P15, DOI 10.1186/1749-8546-5-15; [张洪来 Zhang Honglai], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P637; Zhu LG, 2005, CHIN J ORTHOP TRAUMA, V18, P489; Zhu XM, 2002, AM J CHINESE MED, V30, P13, DOI 10.1142/S0192415X02000028	105	176	193	8	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117146	10.1371/journal.pone.0117146	http://dx.doi.org/10.1371/journal.pone.0117146			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	25738838	Green Published, gold, Green Submitted			2022-12-27	WOS:000350683900024
J	Sapkota, S; Brien, JAE; Greenfield, JR; Aslani, P				Sapkota, Sujata; Brien, Jo-anne E.; Greenfield, Jerry R.; Aslani, Parisa			A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes-Components of Interventions	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; SELF-MANAGEMENT; IMPROVE ADHERENCE; EDUCATIONAL INTERVENTIONS; COMMUNITY PHARMACIST; PHARMACEUTICAL CARE; SOCIAL SUPPORT; OLDER-ADULTS; FOLLOW-UP; MELLITUS	Background Poor adherence to anti-diabetic medications contributes to suboptimal glycaemic control in patients with type 2 diabetes (T2D). A range of interventions have been developed to promote anti-diabetic medication adherence. However, there has been very little focus on the characteristics of these interventions and how effectively they address factors that predict non-adherence. In this systematic review we assessed the characteristics of interventions that aimed to promote adherence to anti-diabetic medications. Method Using appropriate search terms in Medline, Embase, CINAHL, International Pharmaceutical Abstracts (IPA), PUBmed, and PsychINFO (years 2000-2013), we identified 52 studies which met the inclusion criteria. Results Forty-nine studies consisted of patient-level interventions, two provider-level interventions, and one consisted of both. Interventions were classified as educational (n = 7), behavioural (n = 3), affective, economic (n = 3) or multifaceted (a combination of the above; n = 40). One study consisted of two interventions. The review found that multifaceted interventions, addressing several non-adherence factors, were comparatively more effective in improving medication adherence and glycaemic target in patients with T2D than single strategies. However, interventions with similar components and those addressing similar non-adherence factors demonstrated mixed results, making it difficult to conclude on effective intervention strategies to promote adherence. Educational strategies have remained the most popular intervention strategy, followed by behavioural, with affective components becoming more common in recent years. Most of the interventions addressed patient-related (n = 35), condition-related (n = 31), and therapy-related (n = 20) factors as defined by the World Health Organization, while fewer addressed health care system (n = 5) and socio-economic-related factors (n = 13). Conclusion There is a noticeable shift in the literature from using single to multifaceted intervention strategies addressing a range of factors impacting adherence to medications. However, research limitations, such as limited use of standardized methods and tools to measure adherence, lack of individually tailored adherence promoting strategies and variability in the interventions developed, reduce the ability to generalize the findings of the studies reviewed. Furthermore, this review highlights the need to develop multifaceted interventions which can be tailored to the individual patient's needs over the duration of their diabetes management.	[Sapkota, Sujata; Brien, Jo-anne E.; Aslani, Parisa] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Greenfield, Jerry R.] St Vincent Hosp, Dept Endocrinol, Sydney, NSW, Australia	University of Sydney; St Vincents Hospital Sydney	Aslani, P (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	parisa.aslani@sydney.edu.au	Sapkota, Sujata/ABG-1745-2021	Greenfield, Jerry/0000-0002-0866-0973; Sapkota, Sujata/0000-0001-9887-6868				Adepu R, 2010, ASIAN J PHARM CLIN R, V3, P174; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Babamoto KS, 2009, HEALTH EDUC BEHAV, V36, P113, DOI 10.1177/1090198108325911; Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x; Barnard KD, 2012, DIABETIC MED, V29, P1358, DOI 10.1111/j.1464-5491.2012.03727.x; Barron JJ, 2012, AM J PHARM BENEFIST, V4, P29; Blenkinsopp A, 2005, INT J PHARM PRACT, V13, P231, DOI 10.1211/ijpp.13.4.0001; Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344; Bogner HR, 2010, DIABETES EDUCATOR, V36, P284, DOI 10.1177/0145721709356115; Brennan TA, 2012, HEALTH AFFAIR, V31, P120, DOI 10.1377/hlthaff.2011.0931; Briesacher BA, 2008, PHARMACOTHERAPY, V28, P437, DOI 10.1592/phco.28.4.437; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Castillo A, 2010, DIABETES EDUCATOR, V36, P586, DOI 10.1177/0145721710371524; Cha E, 2012, DIABETES EDUCATOR, V38, P835, DOI 10.1177/0145721712460283; Choi SE, 2012, DIABETES EDUCATOR, V38, P377, DOI 10.1177/0145721712443292; Cinar FI, 2010, TURK J ENDOCRINOL ME, V14, P1; Clarke A, 2009, EUR DIABETES NURS, V6, P88, DOI [10.1177/1742395309343978, DOI 10.1177/1742395309343978]; Collins-McNeil J, 2012, CAN J NURS RES, V44, P126; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Borges APD, 2010, PHARM WORLD SCI, V32, P730, DOI 10.1007/s11096-010-9428-3; Doggrell SA, 2010, DIABETIC MED, V27, P1341, DOI 10.1111/j.1464-5491.2010.03137.x; Faridi Z, 2008, J EVAL CLIN PRACT, V14, P465, DOI 10.1111/j.1365-2753.2007.00881.x; Farmer A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-30; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Gambert SR, 2006, DIABETES SPECTRUM, V19; Garcia-Huidobro D, 2011, FAM PRACT, V28, P4, DOI 10.1093/fampra/cmq069; Glasgow RE, 2001, PATIENT EDUC COUNS, V44, P119, DOI 10.1016/S0738-3991(00)00186-5; Glasgow RE, 2009, CHRONIC ILLN, V5, P243, DOI 10.1177/1742395309343978; Gonzalez JS, 2010, J COGN PSYCHOTHER, V24, P329, DOI 10.1891/0889-8391.24.4.329; Grant RW, 2003, ANN PHARMACOTHER, V37, P962, DOI 10.1345/aph.1C452; Graziano Judith A, 2009, ANS Adv Nurs Sci, V32, pE28, DOI 10.1097/ANS.0b013e3181b0d6d6; Greenapple R, 2011, AM HEALTH DRUG BENEF, V4, P377; Hearnshaw H, 2006, EUROPEAN DIABETES NU, V3, P73; Hendricks LE, 2000, DIABETES EDUCATOR, V26, P995, DOI 10.1177/014572170002600612; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Kamar ME, 2012, ZAGAZIG U MED J, V18, p[826, 36]; Keeratiyutawong P, 2006, THAI J NURSING RES, V10, P85; Khan Mohammad A, 2011, Diabetes Ther, V2, P178, DOI 10.1007/s13300-011-0007-y; Kim G, 2012, J AM GERIATR SOC, V60, P2319, DOI 10.1111/jgs.12003; Kim HS, 2006, J NURS CARE QUAL, V21, P266, DOI 10.1097/00001786-200607000-00012; Kim HS, 2003, J ADV NURS, V44, P256, DOI 10.1046/j.1365-2648.2003.02800.x; Kolawole BA, 2010, INT Q COMMUNITY HEAL, V29, P381, DOI 10.2190/IQ.29.4.g; Krass I, 2015, DIABETIC MED; Kroese FM, 2012, HEALTH EDUC RES, V27, P825, DOI 10.1093/her/cys062; Lerman I, 2005, ARCH MED RES, V36, P300, DOI 10.1016/j.arcmed.2004.12.001; Lindenmeyer A, 2006, J CLIN PHARM THER, V31, P409, DOI 10.1111/j.1365-2710.2006.00759.x; Maddigan SL, 2004, DIABETES CARE, V27, P1306, DOI 10.2337/diacare.27.6.1306; Mehuys E, 2011, J CLIN PHARM THER, V36, P602, DOI 10.1111/j.1365-2710.2010.01218.x; Mitchell B, 2011, PATIENT EDUC COUNS, V83, P288, DOI 10.1016/j.pec.2011.04.027; Montori Victor M, 2004, ACP J Club, V140, P51; Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; Odegard PS, 2012, J AM PHARM ASSOC, V52, P753, DOI 10.1331/JAPhA.2012.11001; Odegard PS, 2005, ANN PHARMACOTHER, V39, P433, DOI 10.1345/aph.1E438; Omran D, 2012, CAN J DIABETES, V36, P292, DOI 10.1016/j.jcjd.2012.07.002; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9; Quinn CC, 2008, DIABETES TECHNOL THE, V10, P160, DOI 10.1089/dia.2008.0283; Ramanath KV, 2012, ARCH PHARM PRACT, V3, P170, DOI 10.4103/2045-080X.112813; Ramanath KVYLS, 2011, ASIAN J PHARM CLIN R, V4, P15; Rhee MK, DIABETES ED, V31, P240; Richard L, 1997, HLTH PROMOTION INTER; Rodin HA, 2009, AM J MANAG CARE, V15, P881; Rosen MI, 2004, BEHAV RES THER, V42, P409, DOI 10.1016/S0005-7967(03)00149-9; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Sabatae E, 2003, ADHERENCE LONG TERM; Sacco WP, 2009, J BEHAV MED, V32, P349, DOI 10.1007/s10865-009-9209-4; Sapkota S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0128581, 10.1371/journal.pone.0118296]; Schectman JM, 2004, AM J MED SCI, V327, P19, DOI 10.1097/00000441-200401000-00005; Shetty Ananth Samith, 2011, J Assoc Physicians India, V59, P711; Sigurdardottir AK, 2007, PATIENT EDUC COUNS, V67, P21, DOI 10.1016/j.pec.2007.03.007; Smith SM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d715; Tang TS, 2010, PATIENT EDUC COUNS, V79, P178, DOI 10.1016/j.pec.2009.09.029; Thoolen BJ, 2009, PSYCHOL HEALTH, V24, P237, DOI 10.1080/08870440701864504; Utz SW, 2008, DIABETES EDUCATOR, V34, P854, DOI 10.1177/0145721708323642; van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001; Vermeire E, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.Cd003638.pub2; Vervloet M, 2012, INT J MED INFORM, V81, P594, DOI 10.1016/j.ijmedinf.2012.05.005; Vincent D, 2007, BIOL RES NURS, V9, P130, DOI 10.1177/1099800407304980; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538; Wakefield BJ, 2011, TELEMED E-HEALTH, V17, P254, DOI 10.1089/tmj.2010.0176; Walker EA, 2011, DIABETES CARE, V34, P2, DOI 10.2337/dc10-1005; Wens J, 2008, DIABETES RES CLIN PR, V79, P377, DOI 10.1016/j.diabres.2007.06.006; Wermeille J, 2004, PHARM WORLD SCI, V26, P18, DOI 10.1023/B:PHAR.0000013465.24857.a8; Wilke T, 2010, VALUE HEALTH, V13, pA295, DOI 10.1016/S1098-3015(11)72123-4; Williams Joni L Strom, 2014, Diabetes Manag (Lond), V4, P29; Wolever RQ, 2010, DIABETES EDUCATOR, V36, P629, DOI 10.1177/0145721710371523; Zhang YT, 2010, MED CARE, V48, P409, DOI 10.1097/MLR.0b013e3181d68978; Zolfaghari M, 2012, J CLIN NURS, V21, P1922, DOI 10.1111/j.1365-2702.2011.03951.x; Zomahoun HTV, 2012, J POPULATION THERAPE, V19, pe135	91	96	98	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128581	10.1371/journal.pone.0128581	http://dx.doi.org/10.1371/journal.pone.0128581			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1GM	26053004	gold, Green Published, Green Submitted			2022-12-27	WOS:000355955300045
